PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garcia-Perez, J; Rueda, P; Staropoli, I; Kellenberger, E; Alcami, J; Arenzana-Seisdedos, F; Lagane, B				Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Kellenberger, Esther; Alcami, Jose; Arenzana-Seisdedos, Fernando; Lagane, Bernard			New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; MACROPHAGE-TROPIC HIV-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; BINDING-PROPERTIES; RESISTANT HIV-1; POTENT ACTIVITY; GP120 BINDING; IN-VITRO	CC chemokine receptor 5 (CCR5) is a G-protein-coupled receptor for the chemokines CCL3, -4, and -5 and a coreceptor for entry of R5-tropic strains of human immunodeficiency virus type 1 (HIV-1) into CD4(+) T-cells. We investigated the mechanisms whereby nonpeptidic, low molecular weight CCR5 ligands block HIV-1 entry and infection. Displacement binding assays and dissociation kinetics demonstrated that two of these molecules, i.e. TAK779 and maraviroc (MVC), inhibit CCL3 and the HIV-1 envelope glycoprotein gp120 binding to CCR5 by a noncompetitive and allosteric mechanism, supporting the view that they bind to regions of CCR5 distinct from the gp120- and CCL3-binding sites. We observed that TAK779 and MVC are full and weak inverse agonists for CCR5, respectively, indicating that they stabilize distinct CCR5 conformations with impaired abilities to activate G-proteins. Dissociation of [I-125] CCL3 from CCR5 was accelerated by TAK779, to a lesser extent by MVC, and by GTP analogs, suggesting that inverse agonism contributes to allosteric inhibition of the chemokine binding to CCR5. TAK779 and MVC also promote dissociation of [S-35] gp120 from CCR5 with an efficiency that correlates with their ability to act as inverse agonists. Displacement experiments revealed that affinities of MVC and TAK779 for the [S-35]gp120-binding receptors are in the same range (IC50 similar to 6.4 versus 22 nM), although we found that MVC is 100-fold more potent than TAK779 for inhibiting HIV infection. This suggests that allosteric CCR5 inhibitors not only act by blocking gp120 binding but also alter distinct steps of CCR5 usage in the course of HIV infection.	[Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, Unite Pathogenie Virale, F-75724 Paris 15, France; [Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Arenzana-Seisdedos, Fernando; Lagane, Bernard] INSERM, U819, F-75724 Paris 15, France; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Majadahonda Madrid 28220, Spain; [Kellenberger, Esther] Univ Strasbourg, Lab Therapeut Innovat, F-67400 Illkirch Graffenstaden, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Instituto de Salud Carlos III; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lagane, B (corresponding author), Inst Pasteur, Unite Pathogenie Virale, 28 Rue Docteur Roux, F-75724 Paris 15, France.	bernard.lagane@pasteur.fr	Lagane, Bernard/K-8446-2016; Lagane, Bernard/AAA-2205-2019; García-Pérez, Javier/F-9248-2019; Kellenberger, Esther/AFN-2081-2022; Arenzana-Seisdedos, Fernando/E-5835-2016; Alcami, Pepe/T-2242-2018	Lagane, Bernard/0000-0002-3459-7867; García-Pérez, Javier/0000-0001-7551-7803; Kellenberger, Esther/0000-0002-9320-4840; Alcami, Pepe/0000-0003-0023-7377; Rueda, Patricia/0000-0003-1553-0840	Agence Nationale de Recherche sur le SIDA; INSERM; Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006, PI08075]; Fundacion para la Investigacion y la Prevencion del SIDA en Espana [36630/07]	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion para la Investigacion y la Prevencion del SIDA en Espana	This work was supported in part by the Agence Nationale de Recherche sur le SIDA, INSERM, the Instituto de Salud Carlos III Projects ISCIII-RETIC RD06/0006 and PI08075, and the Fundacion para la Investigacion y la Prevencion del SIDA en Espana Project 36630/07.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Brower ET, 2009, BIOCHEMISTRY-US, V48, P779, DOI 10.1021/bi8021476; Buontempo PJ, 2009, VIROLOGY, V395, P268, DOI 10.1016/j.virol.2009.09.029; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chen G, 2000, MOL PHARMACOL, V57, P125; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 1997, BIOCHEM PHARMACOL, V53, P795, DOI 10.1016/S0006-2952(96)00814-3; Cicala C, 1999, J IMMUNOL, V163, P420; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Gonzalez N, 2010, J VIROL, V84, P4341, DOI 10.1128/JVI.02449-09; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Haworth B, 2007, BIOCHEM PHARMACOL, V74, P891, DOI 10.1016/j.bcp.2007.06.032; Heredia A, 2008, P NATL ACAD SCI USA, V105, P20476, DOI 10.1073/pnas.0810843106; Hu QX, 2010, J GEN VIROL, V91, P2965, DOI 10.1099/vir.0.025270-0; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lee S, 2000, J VIROL, V74, P5016, DOI 10.1128/JVI.74.11.5016-5023.2000; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; McNicholas P, 2010, J INFECT DIS, V201, P1470, DOI 10.1086/652189; Meanger J, 1997, BIOTECHNIQUES, V23, P432, DOI 10.2144/97233bm18; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Napier C, 2005, BIOCHEM PHARMACOL, V71, P163, DOI 10.1016/j.bcp.2005.10.024; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Pugach P, 2009, VIROLOGY, V387, P296, DOI 10.1016/j.virol.2009.02.044; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Safarian D, 2006, VIROLOGY, V352, P477, DOI 10.1016/j.virol.2006.05.016; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Verrier FC, 1997, P NATL ACAD SCI USA, V94, P9326, DOI 10.1073/pnas.94.17.9326; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	68	63	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4978	4990		10.1074/jbc.M110.168955	http://dx.doi.org/10.1074/jbc.M110.168955			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118814	Green Published, hybrid			2022-12-27	WOS:000287230600006
J	Harris, SR; Zhang, GF; Sadhukhan, S; Murphy, AM; Tomcik, KA; Vazquez, EJ; Anderson, VE; Tochtrop, GP; Brunengraber, H				Harris, Stephanie R.; Zhang, Guo-Fang; Sadhukhan, Sushabhan; Murphy, Anne M.; Tomcik, Kristyen A.; Vazquez, Edwin J.; Anderson, Vernon E.; Tochtrop, Gregory P.; Brunengraber, Henri			Metabolism of Levulinate in Perfused Rat Livers and Live Rats CONVERSION TO THE DRUG OF ABUSE 4-HYDROXYPENTANOATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; NADP+-DEPENDENT OXIDOREDUCTASE; GAMMA-HYDROXYBUTYRATE; CALCIUM LEVULINATE; ISOTOPIC ENRICHMENT; ETHANOL-METABOLISM; DEHYDROGENASE; KINETICS; GHB; COA	Calcium levulinate (4-ketopentanoate) is used as an oral and parenteral source of calcium. We hypothesized that levulinate is converted in the liver to 4-hydroxypentanoate, a new drug of abuse, and that this conversion is accelerated by ethanol oxidation. We confirmed these hypotheses in live rats, perfused rat livers, and liver subcellular preparations. Levulinate is reduced to (R)-4-hydroxypentanoate by a cytosolic and a mitochondrial dehydrogenase, which are NADPH-and NADH-dependent, respectively. A mitochondrial dehydrogenase or racemase system also forms (S)-4-hydroxypentanoate. In livers perfused with [C-13(5)] levulinate, there was substantial CoA trapping in levulinyl-CoA, 4-hydroxypentanoyl-CoA, and 4-phosphopentanoyl-CoA. This CoA trapping was increased by ethanol, with a 6-fold increase in the concentration of 4-phosphopentanoyl-CoA. Levulinate is catabolized by 3 parallel pathways to propionyl-CoA, acetyl-CoA, and lactate. Most intermediates of the 3 pathways were identified by mass isotopomer analysis and metabolomics. The production of 4-hydroxypentanoate from levulinate and its stimulation by ethanol is a potential public health concern.	[Harris, Stephanie R.; Zhang, Guo-Fang; Murphy, Anne M.; Tomcik, Kristyen A.; Vazquez, Edwin J.; Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Sadhukhan, Sushabhan; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Brunengraber, H (corresponding author), 10900 Euclid Ave,WG-48, Cleveland, OH 44106 USA.	hxb8@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020	Sadhukhan, Sushabhan/0000-0002-3302-5875; Harris, Stephanie/0000-0003-2239-0575; Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R33DK070291, R01ES013925, RO1HL053315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R33DK070291 (Roadmap grant) and R01ES013925 (to H.B.) and Grant RO1HL053315 (to G. P.T.).	Anderson IB, 2006, ANN EMERG MED, V47, P177, DOI 10.1016/j.annemergmed.2005.10.012; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Carter LP, 2005, DRUG ALCOHOL DEPEN, V78, P91, DOI 10.1016/j.drugalcdep.2004.10.002; Croes K, 1997, FEBS LETT, V407, P197, DOI 10.1016/S0014-5793(97)00343-8; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x; Gibson KM, 2005, IUBMB LIFE, V57, P639, DOI 10.1080/15216540500264588; Gordon B, 1933, J LAB CLIN MED, V18, P507; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; JOUBERT C, 1995, J LABELLED COMPD RAD, V36, P745, DOI 10.1002/jlcr.2580360806; KASHIWAGI T, 1982, MOL PHARMACOL, V21, P438; Kasumov T, 2002, ANAL BIOCHEM, V305, P90, DOI 10.1006/abio.2002.5639; KAUFMAN EE, 1981, J BIOL CHEM, V256, P6890; KAUFMAN EE, 1987, J NEUROCHEM, V48, P1935, DOI 10.1111/j.1471-4159.1987.tb05758.x; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; KOEPPE RE, 1959, J BIOL CHEM, V234, P2219; KOLVRAA S, 1977, CLIN CHIM ACTA, V77, P197, DOI 10.1016/0009-8981(77)90027-4; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; Marinetti L. J., 2003, THESIS WAYNE STATE U; Marinetti LJ, 2005, J ANAL TOXICOL, V29, P41, DOI 10.1093/jat/29.1.41; Mercer J, 2006, J ANAL TOXICOL, V30, P539, DOI 10.1093/jat/30.8.539; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; POWERS L, 1994, ANAL BIOCHEM, V221, P323, DOI 10.1006/abio.1994.1420; PREUVENEERS MJ, 1973, BIOCHEM J, V133, P133, DOI 10.1042/bj1330133; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Takayasu T, 1995, FORENSIC SCI INT, V76, P129, DOI 10.1016/0379-0738(95)01807-7; Tischer R., 1942, J AM PHARM ASSOC, V31, P217; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Veech R L, 1981, Curr Top Cell Regul, V18, P151; Williams M, 2007, Ned Tijdschr Geneeskd, V151, P1191; Zhang G. F., 2011, J BIOL CHEM IN PRESS, P286; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665	38	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5895	5904		10.1074/jbc.M110.196808	http://dx.doi.org/10.1074/jbc.M110.196808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21126961	Green Published, hybrid			2022-12-27	WOS:000287230600098
J	Micheli, L; Leonardi, L; Conti, F; Maresca, G; Colazingari, S; Mattei, E; Lira, SA; Farioli-Vecchioli, S; Caruso, M; Tirone, F				Micheli, Laura; Leonardi, Luca; Conti, Filippo; Maresca, Giovanna; Colazingari, Sandra; Mattei, Elisabetta; Lira, Sergio A.; Farioli-Vecchioli, Stefano; Caruso, Maurizia; Tirone, Felice			PC4/Tis7/IFRD1 Stimulates Skeletal Muscle Regeneration and Is Involved in Myoblast Differentiation as a Regulator of MyoD and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE-EXPRESSION; CELL-CYCLE; MYOGENIC DIFFERENTIATION; NUCLEAR-FACTOR; TRANSCRIPTION FACTOR; MOLECULAR REGULATION; MAMMALIAN-CELLS; SATELLITE CELLS; ACTIVATION	In skeletal muscle cells, the PC4 (Tis7/Ifrd1) protein is known to function as a coactivator of MyoD by promoting the transcriptional activity of myocyte enhancer factor 2C (MEF2C). In this study, we show that up-regulation of PC4 in vivo in adult muscle significantly potentiates injury-induced regeneration by enhancing myogenesis. Conversely, we observe that PC4 silencing in myoblasts causes delayed exit from the cell cycle, accompanied by delayed differentiation, and we show that such an effect is MyoD-dependent. We provide evidence revealing a novel mechanism underlying the promyo-genic actions of PC4, by which PC4 functions as a negative regulator of NF-kappa B, known to inhibit MyoD expression post-transcriptionally. In fact, up-regulation of PC4 in primary myoblasts induces the deacetylation, and hence the inactivation and nuclear export of NF-kappa B p65, in concomitance with induction of MyoD expression. On the contrary, PC4 silencing in myoblasts induces the acetylation and nuclear import of p65, in parallel with a decrease of MyoD levels. We also observe that PC4 potentiates the inhibition of NF-kappa B transcriptional activity mediated by histone deacetylases and that PC4 is able to form trimolecular complexes with p65 and HDAC3. This suggests that PC4 stimulates deacetylation of p65 by favoring the recruitment of HDAC3 to p65. As a whole, these results indicate that PC4 plays a role in muscle differentiation by controlling the MyoD pathway through multiple mechanisms, and as such, it positively regulates regenerative myogenesis.	[Micheli, Laura; Leonardi, Luca; Conti, Filippo; Maresca, Giovanna; Colazingari, Sandra; Mattei, Elisabetta; Farioli-Vecchioli, Stefano; Caruso, Maurizia; Tirone, Felice] Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, I-00143 Rome, Italy; [Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Icahn School of Medicine at Mount Sinai	Tirone, F (corresponding author), Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, Via Fosso di Fiorano 64, I-00143 Rome, Italy.	tirone@inmm.cnr.it	Caruso, Maurizia/G-8895-2013; Micheli, Laura/AAY-1641-2020; vecchioli, stefano farioli/ABE-2288-2020; Tirone, Felice/P-6745-2014	Caruso, Maurizia/0000-0001-5445-6343; MICHELI, LAURA/0000-0001-8647-7261; farioli vecchioli, stefano/0000-0001-7059-7779; Tirone, Felice/0000-0002-0980-4377	Telethon [GGP00582]; Fondo Investimenti Ricerca di Base [RBIN04P4ET]; Progetti di Ricerca Interesse Nazionale [20074Z3H3N_003]; Finanziaria Laziale di Sviluppo Regione Lazio	Telethon(Fondazione Telethon); Fondo Investimenti Ricerca di Base; Progetti di Ricerca Interesse Nazionale; Finanziaria Laziale di Sviluppo Regione Lazio	This work was supported in part by Telethon Grant GGP00582, Fondo Investimenti Ricerca di Base Project RBIN04P4ET, and Progetti di Ricerca Interesse Nazionale Project 20074Z3H3N_003.; Supported by Finanziaria Laziale di Sviluppo Regione Lazio.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buanne P, 1998, GENOMICS, V51, P233, DOI 10.1006/geno.1998.5260; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Fimia GM, 1998, MOL BIOL CELL, V9, P1449, DOI 10.1091/mbc.9.6.1449; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; GUARDAVACCARO D, 1995, CELL GROWTH DIFFER, V6, P159; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HOGAN BL, 1995, MANIPULATING MOUSE E; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jacquemin V, 2007, J CELL SCI, V120, P670, DOI 10.1242/jcs.03371; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MARTELLI F, 1994, ONCOGENE, V9, P3579; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Micheli L, 2005, MOL CELL BIOL, V25, P2242, DOI 10.1128/MCB.25.6.2242-2259.2005; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; SARTORELLI V, 2004, SCI STKE, pRE11, DOI DOI 10.1126/STKE.2442004RE11; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Soddu S, 1996, J CELL BIOL, V134, P193, DOI 10.1083/jcb.134.1.193; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Welcker M, 2005, CURR BIOL, V15, pR810, DOI 10.1016/j.cub.2005.09.018; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983	74	51	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5691	5707		10.1074/jbc.M110.162842	http://dx.doi.org/10.1074/jbc.M110.162842			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127072	hybrid, Green Published			2022-12-27	WOS:000287230600078
J	Huang, YL; Zhang, WW; Gunst, SJ				Huang, Youliang; Zhang, Wenwu; Gunst, Susan J.			Activation of Vinculin Induced by Cholinergic Stimulation Regulates Contraction of Tracheal Smooth Muscle Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING MEMBRANE PROTRUSION; ACTIN POLYMERIZATION; TENSION DEVELOPMENT; ALPHA-ACTININ; INTRAMOLECULAR ASSOCIATION; BINDING PROTEINS; STRUCTURAL BASIS; FOCAL ADHESIONS; ARP2/3 COMPLEX; CELL-ADHESION	Vinculin localizes to membrane adhesion junctions where it links actin filaments to the extracellular matrix by binding to the integrin-binding protein talin at its head domain (Vh) and to actin filaments at its tail domain (Vt). Vinculin can assume an inactive (closed) conformation in which Vh and Vt bind to each other, masking the binding sites for actin and talin, and an active (open) conformation in which the binding sites for talin and actin are exposed. We hypothesized that the contractile activation of smooth muscle tissues might regulate the activation of vinculin and thereby contribute to the regulation of contractile tension. Stimulation of tracheal smooth muscle tissues with acetylcholine (ACh) induced the recruitment of vinculin to cell membrane and its interaction with talin and increased the phosphorylation of membrane-localized vinculin at the C-terminal Tyr-1065. Expression of recombinant vinculin head domain peptide (Vh) in smooth muscle tissues, but not the talin-binding deficient mutant head domain, VhA50I, inhibited the ACh-induced recruitment of endogenous vinculin to the membrane and the interaction of vinculin with talin and also inhibited vinculin phosphorylation. Expression of Vh peptide also inhibited ACh-induced smooth muscle contraction and inhibited ACh-induced actin polymerization; however, it did not affect myosin light chain phosphorylation, which is necessary for cross-bridge cycling. Inactivation of RhoA inhibited vinculin activation in response to ACh. We conclude that ACh stimulation regulates vinculin activation in tracheal smooth muscle via RhoA and that vinculin activation contributes to the regulation of active tension by facilitating connections between actin filaments and talin-integrin adhesion complexes and by mediating the initiation of actin polymerization.	[Huang, Youliang; Zhang, Wenwu; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	National Institutes of Health [HL29289, HL074099]; American Heart Association; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL029289, R01HL074099, R01HL029289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL29289 and HL074099. This work was also supported by an American Heart Association post-doctoral fellowship (to Y. H.) and an American Lung Association post-doctoral fellowship (to W. Z.).	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bubeck P, 1997, J CELL SCI, V110, P1361; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; GEIGER B, 1981, J CELL BIOL, V91, P614, DOI 10.1083/jcb.91.3.614; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HATHAWAY DR, 1985, AM J PHYSIOL, V249, pC345; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; MURPHY RA, 1989, ANNU REV PHYSIOL, V51, P275, DOI 10.1146/annurev.ph.51.030189.001423; MURPHY RA, 1994, FASEB J, V8, P311, DOI 10.1096/fasebj.8.3.8143937; NORTH AJ, 1993, J CELL BIOL, V120, P1159, DOI 10.1083/jcb.120.5.1159; OPAZO SA, 2004, AM J PHYSIOL-CELL PH, V286, pC433; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; SMALL JV, 1985, EMBO J, V4, P45, DOI 10.1002/j.1460-2075.1985.tb02315.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; WOOD CK, 1994, J CELL SCI, V107, P709; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	55	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3630	3644		10.1074/jbc.M110.139923	http://dx.doi.org/10.1074/jbc.M110.139923			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21071443	hybrid, Green Published			2022-12-27	WOS:000286653200047
J	Stark, M; Bram, EE; Akerman, M; Mandel-Gutfreund, Y; Assaraf, YG				Stark, Michal; Bram, Eran E.; Akerman, Martin; Mandel-Gutfreund, Yael; Assaraf, Yehuda G.			Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR/THYMIDINE PHOSPHORYLASE; HELIX-UNWINDING PROTEINS; SPLICE-SITE SELECTION; MESSENGER-RNA; HNRNP-F; U937 CELLS; MACROPHAGE DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; ANTITUMOR-ACTIVITY; BINDING-PROTEINS	Thymidine phosphorylase (TP) catalyzes the conversion of thymidine to thymine and 2-deoxyribose-1-phosphate. The latter plays an important role in induction of angiogenesis. As such, many human malignancies exhibit TP overexpression that correlates with increased microvessel density, formation of aggressive tumors, and dismal prognosis. Because TP is frequently overexpressed in cancer, pro-drugs were developed that utilize TP activity for their bioactivation to cytotoxic drugs. In this respect, TP is indispensable for the pharmacologic activity of the chemotherapeutic drug capecitabine, as it converts its intermediary metabolite 5'-deoxyfluorouridine to 5-fluorouracil. Thus, loss of TP function confers resistance to the prodrug capecitabine, currently used for the treatment of metastatic colorectal cancer and breast cancer. However, drug resistance phenomena may frequently emerge that compromise the pharmacologic activity of capecitabine. Deciphering the molecular mechanisms underlying resistance to TP-activated prodrugs is an important goal toward the overcoming of such drug resistance phenomena. Here, we discovered that lack of TP protein in drug-resistant tumor cells is due to unsplicing of its pre-mRNA. Advanced bioinformatics identified the family of heterogeneous nuclear ribonucleoproteins (hnRNP) H/F as candidate splicing factors potentially responsible for impaired TP splicing. Indeed, whereas parental cells lacked nuclear localization of hnRNPs H1/H2 and F, drug-resistant cells harbored marked levels of these splicing factors. Nuclear RNA immunoprecipitation experiments established a strong binding of hnRNP H1/H2 to TP pre-mRNA, hence implicating them in TP splicing. Moreover, introduction of hnRNP H2 into drug-sensitive parental cells recapitulated aberrant TP splicing and 5'-deoxyfluorouridine resistance. Thus, this is the first study identifying altered function of hnRNP H1/H2 in tumor cells as a novel determinant of aberrant TP splicing thereby resulting in acquired chemoresistance to TP-activated fluoropyrimidine anticancer drugs.	[Stark, Michal; Bram, Eran E.; Assaraf, Yehuda G.] Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Akerman, Martin; Mandel-Gutfreund, Yael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il	Mandel-Gutfreund, Yael/AAI-4365-2021; Akerman, Martin/E-6248-2012; Stark, Michal/AAH-1763-2022; Stark, Michal/AFL-9651-2022	Mandel-Gutfreund, Yael/0000-0002-8946-8237; Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696; Assaraf, Yehuda G./0000-0001-6692-8221; Bram, Eran/0000-0002-7213-5321				Ackland SP, 1999, DRUG RESIST UPDATE, V2, P205, DOI 10.1054/drup.1999.0089; Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bagga PS, 1998, NUCLEIC ACIDS RES, V26, P5343, DOI 10.1093/nar/26.23.5343; Besnault-Mascard L, 2005, ONCOGENE, V24, P3268, DOI 10.1038/sj.onc.1208448; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Cathelin S, 2006, J BIOL CHEM, V281, P17779, DOI 10.1074/jbc.M600537200; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chou MY, 1999, MOL CELL BIOL, V19, P69; Ciccolini Joseph, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P71, DOI 10.2174/1568011043482089; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; de Bruin M, 2004, MOL PHARMACOL, V66, P1054, DOI 10.1124/mol.104.000315; de Bruin M, 2003, BRIT J CANCER, V88, P957, DOI 10.1038/sj.bjc.6600808; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Endo M, 1999, INT J CANCER, V83, P127, DOI 10.1002/(SICI)1097-0215(19990924)83:1<127::AID-IJC22>3.0.CO;2-6; FRIEDKIN M, 1954, J BIOL CHEM, V207, P245; Gamberi C, 1997, MOL CELL BIOL, V17, P2587, DOI 10.1128/MCB.17.5.2587; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; HARAGUCHI M, 1994, NATURE, V368, P198, DOI 10.1038/368198a0; HASS R, 1990, EUR J CELL BIOL, V51, P265; HASS R, 1989, EUR J CELL BIOL, V48, P282; HERRICK G, 1976, J BIOL CHEM, V251, P2142; HERRICK G, 1976, J BIOL CHEM, V251, P2133; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Honore B, 1999, FEBS LETT, V456, P274, DOI 10.1016/S0014-5793(99)00911-4; HONORE B, 1995, J BIOL CHEM, V270, P28780; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lu HY, 2009, CLIN CANCER RES, V15, P5136, DOI 10.1158/1078-0432.CCR-08-3203; Mahe D, 1997, J BIOL CHEM, V272, P1827, DOI 10.1074/jbc.272.3.1827; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matsuura T, 1999, CANCER RES, V59, P5037; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Morita T., 2001, Current Pharmaceutical Biotechnology, V2, P257, DOI 10.2174/1389201013378662; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sawada N, 1998, CLIN CANCER RES, V4, P1013; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHWARTZ EL, 1994, CANCER RES, V54, P1472; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Stark M, 2009, BLOOD, V113, P4362, DOI 10.1182/blood-2008-08-173799; Takebayashi Y, 1996, EUR J CANCER, V32A, P1227, DOI 10.1016/0959-8049(96)00061-5; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Ueda M, 1998, CANCER RES, V58, P2343; Van Cutsem E, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_4-1; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yonenaga F, 1998, PATHOL INT, V48, P850, DOI 10.1111/j.1440-1827.1998.tb03851.x; Zhang DH, 2008, PROTEOM CLIN APPL, V2, P99, DOI 10.1002/prca.200780099; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	64	38	38	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3741	3754		10.1074/jbc.M110.163444	http://dx.doi.org/10.1074/jbc.M110.163444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21068389	Green Published, hybrid			2022-12-27	WOS:000286653200056
J	Thuringer, D; Hammann, A; Benikhlef, N; Fourmaux, E; Bouchot, A; Wettstein, G; Solary, E; Garrido, C				Thuringer, Dominique; Hammann, Arlette; Benikhlef, Naima; Fourmaux, Eric; Bouchot, Andre; Wettstein, Guillaume; Solary, Eric; Garrido, Carmen			Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; SIGNAL-TRANSDUCTION; CALCIUM OSCILLATIONS; MALIGNANT GLIOMAS; TYROSINE KINASES; EPITHELIAL-CELLS; BRAIN-TUMORS; ASTROCYTES; CANCER; PATHWAY	Extracellular heat shock protein HSP90 alpha was reported to participate in tumor cell growth, invasion, and metastasis formation through poorly understood signaling pathways. Herein, we show that extracellular HSP90 alpha favors cell migration of glioblastoma U87 cells. More specifically, externally applied HSP90 alpha rapidly induced endocytosis of EGFR. This response was accompanied by a transient increase in cytosolic Ca2+ appearing after 1-3 min of treatment. In the presence of EGF, U87 cells showed HSP90 alpha-induced Ca2+ oscillations, which were reduced by the ATP/ADPase, apyrase, and inhibited by the purinergic P-2 inhibitor, suramin, suggesting that ATP release is requested. Disruption of lipid rafts with methyl beta-cyclodextrin impaired the Ca2+ rise induced by extracellular HSP90 alpha combined with EGF. Specific inhibition of TLR4 expression by blocking antibodies suppressed extracellular HSP90 alpha-induced Ca2+ signaling and the associated cell migration. HSPs are known to bind lipopolysaccharides (LPSs). Preincubating cells with Polymyxin B, a potent LPS inhibitor, partially abrogated the effects of HSP90 alpha without affecting Ca2+ oscillations observed with EGF. Extracellular HSP90 alpha induced EGFR phosphorylation at Tyr-1068, and this event was prevented by both the protein kinase C delta inhibitor, rottlerin, and the c-Src inhibitor, PP2. Altogether, our results suggest that extracellular HSP90 alpha transactivates EGFR/ErbB1 through TLR4 and a PKC delta/c-Src pathway, which induces ATP release and cytosolic Ca2+ increase and finally favors cell migration. This mechanism could account for the deleterious effects of HSPs on high grade glioma when released into the tumor cell microenvironment.	[Thuringer, Dominique; Hammann, Arlette; Benikhlef, Naima; Fourmaux, Eric; Wettstein, Guillaume; Solary, Eric; Garrido, Carmen] INSERM, U866, F-21000 Dijon, France; [Bouchot, Andre] Fac Med, Cell Imaging Platform IFR100, F-21000 Dijon, France; [Solary, Eric] Inst Gustave Roussy, INSERM, U1009, F-95008 Villejuif, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Thuringer, D (corresponding author), INSERM, U866, 7 Blvd Jeanne dArc, F-21000 Dijon, France.	dominique.thuringer@u-bourgogne.fr	Garrido, carmen/G-1633-2018; Thuringer, Dominique/AAA-7448-2020; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; Solary, Eric/0000-0002-8629-1341	CNRS; INSERM; Conseil Regional de Bourgogne (CRB); Ligue Nationale Contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Bourgogne (CRB)(Region Bourgogne-Franche-Comte); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the CNRS, INSERM, and by Conseil Regional de Bourgogne (CRB, Faber Program) and by grants from are supported by the Ligue Nationale Contre le Cancer (to E.S. and C.G.).	Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Baltuch GH, 1996, BRAIN RES, V710, P143, DOI 10.1016/0006-8993(95)01395-4; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Basu S, 2008, J BIOL CHEM, V283, P32369, DOI 10.1074/jbc.M805053200; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Bredel M, 1997, ACTA NEUROCHIR, V139, P1000, DOI 10.1007/BF01411552; Bryant JA, 2004, CANCER BIOL THER, V3, P1243, DOI 10.4161/cbt.3.12.1233; Climent E, 2000, NEUROSCI LETT, V288, P53, DOI 10.1016/S0304-3940(00)01207-6; COULDWELL WT, 1992, NEUROSURGERY, V31, P717; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Hur EM, 2004, J BIOL CHEM, V279, P5852, DOI 10.1074/jbc.M311687200; Hussaini IM, 2000, J BIOL CHEM, V275, P22348, DOI 10.1074/jbc.M003203200; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Kleihues P, 2000, TOXICOL PATHOL, V28, P164, DOI 10.1177/019262330002800121; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Morita M, 2005, J NEUROCHEM, V95, P871, DOI 10.1111/j.1471-4159.2005.03430.x; Morita M, 2003, J NEUROSCI, V23, P10944; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; Schwartzbaum J, 2005, CANCER RES, V65, P6459, DOI 10.1158/0008-5472.CAN-04-3728; Scott JN, 1998, CAN J NEUROL SCI, V25, P197, DOI 10.1017/S0317167100034016; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; SWANN K, 1991, FEBS LETT, V278, P175, DOI 10.1016/0014-5793(91)80110-O; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tu MT, 2000, BRIT J PHARMACOL, V129, P1481, DOI 10.1038/sj.bjp.0703182; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	44	67	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3418	3428		10.1074/jbc.M110.154823	http://dx.doi.org/10.1074/jbc.M110.154823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127066	Green Published, hybrid			2022-12-27	WOS:000286653200028
J	Basu, I; Locker, J; Cassera, MB; Belbin, TJ; Merino, EF; Dong, XY; Hemeon, I; Evans, GB; Guha, C; Schramm, VL				Basu, Indranil; Locker, Joseph; Cassera, Maria B.; Belbin, Thomas J.; Merino, Emilio F.; Dong, Xinyuan; Hemeon, Ivan; Evans, Gary B.; Guha, Chandan; Schramm, Vern L.			Growth and Metastases of Human Lung Cancer Are Inhibited in Mouse Xenografts by a Transition State Analogue of 5 '-Methylthioadenosine Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE BIOSYNTHESIS; S-ADENOSYLMETHIONINE; TUMOR PROGRESSION; POTENT INHIBITOR; CELL-LINE; KINASE 1; GENE; 5-METHYLTHIOADENOSINE	The S-adenosylmethionine (AdoMet) salvage enzyme 5'-methylthioadenosine phosphorylase (MTAP) has been implicated as both a cancer target and a tumor suppressor. We tested these hypotheses in mouse xenografts of human lung cancers. AdoMet recycling from 5'-methylthioadenosine (MTA) was blocked by inhibition of MTAP with methylthio-DADMe-Immucillin-A (MTDIA), an orally available, nontoxic, picomolar transition state analogue. Blood, urine, and tumor levels of MTA increased in response to MTDIA treatment. MTDIA treatment inhibited A549 (human non-small cell lung carcinoma) and H358 (human bronchioloalveolar non-small cell lung carcinoma cells) xenograft tumor growth in immunodeficient Rag2(-/-) gamma C-/- and NCr-nu mice. Systemic MTA accumulation is implicated as the tumor-suppressive metabolite because MTDIA is effective for in vivo treatment of A549 MTAP(-/-) and H358 MTAP(+/+)umors. Tumors from treated mice showed increased MTA and decreased polyamines but little alteration in AdoMet, methionine, or adenine levels. Gene expression profiles of A549 tumors from treated and untreated mice revealed only modest alterations with 62 up-regulated and 63 down-regulated mRNAs (>= 3-fold). MTDIA antitumor activity in xenografts supports MTAP as a target for lung cancer therapy.	[Basu, Indranil; Cassera, Maria B.; Merino, Emilio F.; Hemeon, Ivan; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Locker, Joseph; Belbin, Thomas J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Dong, Xinyuan; Guha, Chandan] Yeshiva Univ, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10461 USA; [Evans, Gary B.] Ind Res Ltd, Carbohydrate Chem Team, Lower Hutt 5040, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Callaghan Innovation	Schramm, VL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave,Rm 308, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu	Evans, Gary/B-8343-2011; Cassera, Maria/L-1572-2013; Evans, Gary/I-4123-2019	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002	National Institutes of Health [CA135405, CA85953];  [P30 CA013330]; NATIONAL CANCER INSTITUTE [R01CA085953, P30CA013330, R01CA135405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135405 and CA85953 and Pilot Project Award P30 CA013330. Conflict of interest: C. G., G. B. E., and V. L. S. are advisors to Pico Pharmaceuticals, Inc.	ABELOFF MD, 1986, CANCER TREAT REP, V70, P843; ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Belbin TJ, 2005, ARCH OTOLARYNGOL, V131, P10, DOI 10.1001/archotol.131.1.10; Bistulfi G, 2009, FASEB J, V23, P2888, DOI 10.1096/fj.09-130708; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Christopher SA, 2002, CANCER RES, V62, P6639; Crino L, 2002, SEMIN ONCOL, V29, P9, DOI 10.1053/sonc.2002.34266; ENOUF J, 1979, CANCER RES, V39, P4497; Evans GB, 2005, J MED CHEM, V48, P4679, DOI 10.1021/jm050269z; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; Gerner EW, 2010, CANCER PREV RES, V3, P125, DOI 10.1158/1940-6207.CAPR-09-0252; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gu J, 2004, ONCOGENE, V23, P1300, DOI 10.1038/sj.onc.1207239; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kadariya Y, 2009, CANCER RES, V69, P5961, DOI 10.1158/0008-5472.CAN-09-0145; Keppner S, 2009, CHEMMEDCHEM, V4, P1806, DOI 10.1002/cmdc.200900338; Kindler H, 2009, INVEST NEW DRUG, V27, P75, DOI 10.1007/s10637-008-9160-1; Kirsch SH, 2009, J CHROMATOGR B, V877, P3865, DOI 10.1016/j.jchromb.2009.09.039; Klastersky J, 2001, LUNG CANCER-J IASLC, V34, pS95; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Lee SH, 1997, J BIOCHEM MOL BIOL, V30, P403; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MIYAJI K, 1995, J NEUROSURG, V83, P690, DOI 10.3171/jns.1995.83.4.0690; OLOPADE OI, 1995, P NATL ACAD SCI USA, V92, P6489, DOI 10.1073/pnas.92.14.6489; PAJULA RL, 1979, FEBS LETT, V99, P343, DOI 10.1016/0014-5793(79)80988-6; PEGG AE, 1983, METHOD ENZYMOL, V94, P294; SAHOTA A, 2001, ADENINE PHOSPHORIBOS, P2571; Sajiki H, 2005, SYNLETT, P1385, DOI 10.1055/s-2005-868489; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stevens AP, 2009, J CELL BIOCHEM, V106, P210, DOI 10.1002/jcb.21984; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Szyf M, 2004, CANCER LETT, V211, P133, DOI 10.1016/j.canlet.2004.04.009; TANOUE LT, 2009, EXPERT REV ANTICANCE; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; WOODCOCK DM, 1983, NUCLEIC ACIDS RES, V11, P489, DOI 10.1093/nar/11.2.489; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607	41	50	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4902	4911		10.1074/jbc.M110.198374	http://dx.doi.org/10.1074/jbc.M110.198374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135097	Green Published, hybrid			2022-12-27	WOS:000286975700086
J	de Wet, B; Zech, T; Salek, M; Acuto, O; Harder, T				de Wet, Ben; Zech, Tobias; Salek, Mogjiborahman; Acuto, Oreste; Harder, Thomas			Proteomic Characterization of Plasma Membrane-proximal T Cell Activation Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SYNAPSE; SIGNALING COMPLEXES; RECEPTOR; PROTEINS; DOMAINS; FAMILY; LAT; ANTIGEN; MICROCLUSTERS; ACCUMULATION	Early downstream responses of T lymphocytes following T cell antigen receptor (TCR) activation are mediated by protein complexes that assemble in domains of the plasma membrane. Using stable isotope labeling with amino acids in cell culture and mass spectrometry, we quantitatively related the proteome of alpha CD3 immunoisolated native TCR signaling plasma membrane domains to that of control plasma membrane fragments not engaged in TCR signaling. Proteins were sorted according to their relative enrichment in isolated TCR signaling plasma membrane domains, identifying a complex protein network that is anchored in the vicinity of activated TCR. These networks harbor widespread mediators of plasma membrane-proximal T cell activities, including propagation, balancing, and attenuation of TCR signaling, immune synapse formation, as well as cytoskeletal arrangements relative to TCR activation clusters. These results highlight the unique potential of systematic characterizations of plasma membrane-proximal T cell activation proteome in the context of its native lipid bilayer platform.	[de Wet, Ben; Salek, Mogjiborahman; Acuto, Oreste; Harder, Thomas] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Zech, Tobias] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Oxford; Beatson Institute	Harder, T (corresponding author), S Parks Rd, Oxford OX1 3RE, England.	thomas.harder@path.ox.ac.uk		Zech, Tobias/0000-0001-8394-088X; Salek, Mogjiborahman/0000-0002-6664-4752	Wellcome Trust [082782/2/07/2]; Edward Penley Abraham Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Edward Penley Abraham Trust	This work was supported by Wellcome Trust Project Grant 082782/2/07/2.; Recipient of support from the Edward Penley Abraham Trust.	Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HARDER T, 2001, SCI SIGNAL TRANSDUCT; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Hawadle MA, 2002, BIOL RES, V35, P247, DOI 10.4067/S0716-97602002000200017; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sangani D, 2009, MOL MEMBR BIOL, V26, P159, DOI 10.1080/09687680802637660; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	39	18	18	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4072	4080		10.1074/jbc.M110.165415	http://dx.doi.org/10.1074/jbc.M110.165415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127068	hybrid, Green Published			2022-12-27	WOS:000286975700005
J	Kumari, D; Biacsi, RE; Usdin, K				Kumari, Daman; Biacsi, Rea Erika; Usdin, Karen			Repeat Expansion Affects Both Transcription Initiation and Elongation in Friedreich Ataxia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; EPIGENETIC CHANGES; METHYLTRANSFERASE COMPLEX; CHROMATIN-STRUCTURE; HISTONE H3; GENE; DNA; METHYLATION; SEQUENCES; IDENTIFICATION	Expansion of a GAA.TTC repeat in the first intron of the frataxin (FXN) gene causes an mRNA deficit that results in Friedreich ataxia (FRDA). The region flanking the repeat on FRDA alleles is associated with more extensive DNA methylation than is seen on normal alleles and histone modifications typical of repressed genes. However, whether these changes are responsible for the mRNA deficit is controversial. Using chromatin immunoprecipitation and cell lines from affected and unaffected individuals, we show that certain marks of active chromatin are also reduced in the promoter region of the FXN gene in patient cells. Thus, the promoter chromatin may be less permissive for transcription initiation than it is on normal alleles. Furthermore, we show that the initiating form of RNA polymerase II and histone H3 trimethylated on lysine 4, a chromatin mark tightly linked to transcription initiation, are both present at lower levels on FRDA alleles. In addition, a mark of transcription elongation, trimethylated H3K36, shows a reduced rate of accumulation downstream of the repeat. Our data thus suggest that repeat expansion reduces both transcription initiation and elongation in FRDA cells. Our findings may have implications for understanding the mechanism responsible for FRDA as well as for therapeutic approaches to reverse the transcription deficit.	[Kumari, Daman; Biacsi, Rea Erika; Usdin, Karen] NIDDK, Sect Gene Struct & Dis, Lab Mol & Cellular Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Usdin, K (corresponding author), NIDDK, Sect Gene Struct & Dis, Lab Mol & Cellular Biol, NIH, Bldg 8,Rm 2A19,8 Ctr Dr, Bethesda, MD 20892 USA.	ku@helix.nih.gov	Kumari, Daman/AAN-6704-2020		NIDDK, National Institutes of Health [DK057810]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057810, Z01DK057810, R01DK057810] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK057810 from the Intramural Program of the NIDDK (to K. U.).	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biacsi R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000017; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; HIRAKATA M, 1993, J CLIN INVEST, V91, P2665, DOI 10.1172/JCI116505; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; MISHINA M, 1982, EMBO J, V1, P1533, DOI 10.1002/j.1460-2075.1982.tb01351.x; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SASSONECORSI P, 1981, NUCLEIC ACIDS RES, V9, P3941, DOI 10.1093/nar/9.16.3941; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010	39	69	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4209	4215		10.1074/jbc.M110.194035	http://dx.doi.org/10.1074/jbc.M110.194035			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127046	Green Published, hybrid			2022-12-27	WOS:000286975700019
J	Nishimura, K; Sano, M; Ohtaka, M; Furuta, B; Umemura, Y; Nakajima, Y; Ikehara, Y; Kobayashi, T; Segawa, H; Takayasu, S; Sato, H; Motomura, K; Uchida, E; Kanayasu-Toyoda, T; Asashima, M; Nakauchi, H; Yamaguchi, T; Nakanishia, M				Nishimura, Ken; Sano, Masayuki; Ohtaka, Manami; Furuta, Birei; Umemura, Yoko; Nakajima, Yoshiro; Ikehara, Yuzuru; Kobayashi, Toshihiro; Segawa, Hiroaki; Takayasu, Satoko; Sato, Hideyuki; Motomura, Kaori; Uchida, Eriko; Kanayasu-Toyoda, Toshie; Asashima, Makoto; Nakauchi, Hiromitsu; Yamaguchi, Teruhide; Nakanishia, Mahito			Development of Defective and Persistent Sendai Virus Vector A UNIQUE GENE DELIVERY/EXPRESSION SYSTEM IDEAL FOR CELL REPROGRAMMING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; RNA INTERFERENCE; PARTICLE FORMATION; M-PROTEIN; EXPRESSION; GENERATION; EFFICIENT; INDUCTION; DIFFERENTIATION; FIBROBLASTS	The ectopic expression of transcription factors can reprogram differentiated tissue cells into induced pluripotent stem cells. However, this is a slow and inefficient process, depending on the simultaneous delivery of multiple genes encoding essential reprogramming factors and on their sustained expression in target cells. Moreover, once cell reprogramming is accomplished, these exogenous reprogramming factors should be replaced with their endogenous counterparts for establishing autoregulated pluripotency. Complete and designed removal of the exogenous genes from the reprogrammed cells would be an ideal option for satisfying this latter requisite as well as for minimizing the risk of malignant cell transformation. However, no single gene delivery/expression system has ever been equipped with these contradictory characteristics. Here we report the development of a novel replication-defective and persistent Sendai virus (SeVdp) vector based on a non-cytopathic variant virus, which fulfills all of these requirements for cell reprogramming. The SeVdp vector could accommodate up to four exogenous genes, deliver them efficiently into various mammalian cells (including primary tissue cells and human hematopoietic stem cells) and express them stably in the cytoplasm at a prefixed balance. Furthermore, interfering with viral transcription/replication using siRNA could erase the genomic RNA of SeVdp vector from the target cells quickly and thoroughly. A SeVdp vector installed with Oct4/Sox2/Klf4/c-Myc could reprogram mouse primary fibroblasts quite efficiently; similar to 1% of the cells were reprogrammed to Nanog-positive induced pluripotent stem cells without chromosomal gene integration. Thus, this SeVdp vector has potential as a tool for advanced cell reprogramming and for stem cell research.	[Nishimura, Ken; Sano, Masayuki; Ohtaka, Manami; Umemura, Yoko; Nakajima, Yoshiro; Takayasu, Satoko; Motomura, Kaori; Asashima, Makoto; Nakanishia, Mahito] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Ikehara, Yuzuru] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058562, Japan; [Segawa, Hiroaki] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan; [Nishimura, Ken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ohtaka, Manami; Takayasu, Satoko; Motomura, Kaori] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan; [Furuta, Birei; Kanayasu-Toyoda, Toshie; Yamaguchi, Teruhide] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Uchida, Eriko] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Kobayashi, Toshihiro; Sato, Hideyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Sato, Hideyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Uchida, Eriko; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Nakanishia, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, 1-1-1 Higashi,Cent 4, Tsukuba, Ibaraki 3058562, Japan.	mahito-nakanishi@aist.go.jp	Ikehara, yuzuru/R-2239-2019; Ikehara, yuzuru/L-7696-2018; Asashima, Makoto/O-8389-2018; Nakanishi, Mahito/I-9888-2018; Nishimura, KEN/HGC-6147-2022; Sano, Masayuki/M-1685-2018	Ikehara, yuzuru/0000-0002-1915-9172; Ikehara, yuzuru/0000-0002-1915-9172; Asashima, Makoto/0000-0002-0012-026X; Nakanishi, Mahito/0000-0002-7068-7587; Sano, Masayuki/0000-0001-7117-0515; Nishimura, Ken/0000-0002-0716-4142; Kobayashi, Toshihiro/0000-0001-8019-0008	New Energy and Industrial Technology Development Organization of Japan; National Institute of Biomedical Innovation; JST PRESTO Program	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); JST PRESTO Program	This work was supported in part by a grant from the New Energy and Industrial Technology Development Organization of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by JST PRESTO Program.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Eguchi A, 2000, J BIOL CHEM, V275, P17549, DOI 10.1074/jbc.M910004199; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Griesenbach U, 2005, CURR OPIN MOL THER, V7, P346; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; HOMANN HE, 1990, VIROLOGY, V177, P131, DOI 10.1016/0042-6822(90)90467-6; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; Hua J, 1996, J LEUKOCYTE BIOL, V60, P125, DOI 10.1002/jlb.60.1.125; Inoue M, 2003, J VIROL, V77, P3238, DOI 10.1128/JVI.77.5.3238-3246.2003; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lamb R. A., 2001, Fundamental virology, P689; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Murakami Y, 2008, J GENE MED, V10, P165, DOI 10.1002/jgm.1142; Nakanishi M, 1998, J CONTROL RELEASE, V54, P61, DOI 10.1016/S0168-3659(97)00220-4; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; O'Malley J, 2009, CURR OPIN BIOTECH, V20, P516, DOI 10.1016/j.copbio.2009.09.005; Ogino T, 2005, J BIOL CHEM, V280, P4429, DOI 10.1074/jbc.M411167200; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; Okabe J, 2004, HUM MOL GENET, V13, P285, DOI 10.1093/hmg/ddh032; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Plattet P, 2007, VIROLOGY, V362, P411, DOI 10.1016/j.virol.2006.12.033; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shimazu Y, 2008, VIROLOGY, V372, P64, DOI 10.1016/j.virol.2007.10.026; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Sutou S., 2008, NUCLEIC ACIDS RES, V36, P5812; TAIRA H, 1995, ARCH VIROL, V140, P187, DOI 10.1007/BF01309734; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YOSHIDA T, 1979, VIROLOGY, V92, P139, DOI 10.1016/0042-6822(79)90220-4; Yoshizaki M, 2006, J GENE MED, V8, P1151, DOI 10.1002/jgm.938; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zidovec S, 1999, CYTOKINE, V11, P140, DOI 10.1006/cyto.1998.0411	50	248	266	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4760	4771		10.1074/jbc.M110.183780	http://dx.doi.org/10.1074/jbc.M110.183780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138846	Green Published, hybrid			2022-12-27	WOS:000286975700074
J	Toyoda, T; An, D; Witczak, CA; Koh, HJ; Hirshman, MF; Fujii, N; Goodyear, LJ				Toyoda, Taro; An, Ding; Witczak, Carol A.; Koh, Ho-Jin; Hirshman, Michael F.; Fujii, Nobuharu; Goodyear, Laurie J.			Myo1c Regulates Glucose Uptake in Mouse Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN I-BETA; GLUT4 TRANSLOCATION; INSULIN-RECEPTOR; CORTICAL ACTIN; GLYCOGEN-SYNTHASE; TRANSPORT; CONTRACTION; EXERCISE; DISRUPTION; MEMBRANE	Contraction and insulin promote glucose uptake in skeletal muscle through GLUT4 translocation to cell surface membranes. Although the signaling mechanisms leading to GLUT4 translocation have been extensively studied in muscle, the cellular transport machinery is poorly understood. Myo1c is an actin-based motor protein implicated in GLUT4 translocation in adipocytes; however, the expression profile and role of Myo1c in skeletal muscle have not been investigated. Myo1c protein abundance was higher in more oxidative skeletal muscles and heart. Voluntary wheel exercise (4 weeks, 8.2 +/- 0.8 km/day), which increased the oxidative profile of the triceps muscle, significantly increased Myo1c protein levels by similar to 2-fold versus sedentary controls. In contrast, high fat feeding (9 weeks, 60% fat) significantly reduced Myo1c by 17% in tibialis anterior muscle. To study Myo1c regulation of glucose uptake, we expressed wild-type Myo1c or Myo1c mutated at the ATPase catalytic site (K111A-Myo1c) in mouse tibialis anterior muscles in vivo and assessed glucose uptake in vivo in the basal state, in response to 15 min of in situ contraction, and 15 min following maximal insulin injection (16.6 units/kg of body weight). Expression of wild-type Myo1c or K111A-Myo1c had no effect on basal glucose uptake. However, expression of wild-type Myo1c significantly increased contraction- and insulin-stimulated glucose uptake, whereas expression of K111A-Myo1c decreased both contraction-stimulated and insulin-stimulated glucose uptake. Neither wild-type nor K111A-Myo1c expression altered GLUT4 expression, and neither affected contraction- or insulin-stimulated signaling proteins. Myo1c is a novel mediator of both insulin-stimulated and contraction- stimulated glucose uptake in skeletal muscle.	[Toyoda, Taro; An, Ding; Witczak, Carol A.; Koh, Ho-Jin; Hirshman, Michael F.; Fujii, Nobuharu; Goodyear, Laurie J.] Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Goodyear, Laurie J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), 1 Joslin Pl, Boston, MA 02215 USA.	goodyear@joslin.harvard.edu	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033	National Institutes of Health [R01 AR45670, R01 AR42238, F32AR051663, K99AR056298]; Diabetes and Endocrinology Research Center [P30 DK36836]; Joslin Diabetes Center; Japan Society for the Promotion of Science Kakenhi [21240063]; Nakatomi Foundation; Naito Foundation; Uehara Memorial Foundation; American Diabetes Association; Canadian Institute for Health Research [MFE-83802]; Canadian Diabetes Association [PF-3-07-2255-DA]; American Physiological Society (APS); Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045670, K99AR056298, F32AR051663, R01AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center; Joslin Diabetes Center; Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); American Diabetes Association(American Diabetes Association); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; American Physiological Society (APS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR45670 and R01 AR42238 (to L. J. G.), F32AR051663 and K99AR056298 (to C. A. W.), and the Diabetes and Endocrinology Research Center grant P30 DK36836 (to the Joslin Diabetes Center). This work was also supported by funding from the Graetz Challenge Grant Program of the Joslin Diabetes Center (to L. J. G.); the Japan Society for the Promotion of Science Kakenhi 21240063 (to N. F.); grants from the Nakatomi Foundation, the Naito Foundation, the Uehara Memorial Foundation, and the Japan Society for the Promotion of Science (to T. T.); an American Diabetes Association Mentor-based Award (to L. J. G.); a fellowship from the Canadian Institute for Health Research (MFE-83802) and a Canadian Diabetes Association Incentive Award PF-3-07-2255-DA (to D. A.); and the American Physiological Society (APS) Fellowship in Physiological Genomics (to H.-J. K.).	Ai H, 2003, AM J PHYSIOL-ENDOC M, V285, pE836, DOI 10.1152/ajpendo.00238.2002; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; BONDAR RJL, 1974, CLIN CHEM, V20, P586; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Brozinick JT, 2004, J BIOL CHEM, V279, P40699, DOI 10.1074/jbc.M402697200; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Cartee GD, 2009, EXERC SPORT SCI REV, V37, P188, DOI 10.1097/JES.0b013e3181b7b7c5; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2004, AM J PHYSIOL-CELL PH, V287, pC200, DOI 10.1152/ajpcell.00415.2003; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Hayasaki H, 2001, ACTA HISTOCHEM, V103, P355, DOI 10.1078/0065-1281-00605; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; Ho RC, 2004, AM J PHYSIOL-REG I, V286, pR342, DOI 10.1152/ajpregu.00563.2003; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Kawanaka K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1311, DOI 10.1152/ajpendo.2000.279.6.E1311; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YC, 2010, J APPL PHYSIOL, V108, P1106, DOI 10.1152/japplphysiol.00401.2009; Lauritzen HPMM, 2010, AM J PHYSIOL-ENDOC M, V299, pE169, DOI 10.1152/ajpendo.00066.2010; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Mason S, 2007, ADV EXP MED BIOL, V618, P229; McCarthy AM, 2006, AM J PHYSIOL-CELL PH, V291, pC860, DOI 10.1152/ajpcell.00107.2006; Patti ME, 2004, CURR OPIN CLIN NUTR, V7, P383, DOI 10.1097/01.mco.0000134359.23288.72; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; RODNICK KJ, 1992, AM J PHYSIOL, V262, pC9, DOI 10.1152/ajpcell.1992.262.1.C9; RODNICK KJ, 1990, DIABETES, V39, P1425, DOI 10.2337/diabetes.39.11.1425; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; SEXTON WL, 1995, J APPL PHYSIOL, V79, P287, DOI 10.1152/jappl.1995.79.1.287; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; TERJUNG RL, 1976, AM J PHYSIOL, V230, P946, DOI 10.1152/ajplegacy.1976.230.4.946; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; VICARIO P, 1987, LIFE SCI, V41, P1233, DOI 10.1016/0024-3205(87)90201-3; VIHKO V, 1979, J APPL PHYSIOL, V47, P43, DOI 10.1152/jappl.1979.47.1.43; WILSON CM, 1994, BIOCHEM J, V299, P755, DOI 10.1042/bj2990755; Witczak CA, 2010, AM J PHYSIOL-ENDOC M, V298, pE1150, DOI 10.1152/ajpendo.00659.2009; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	58	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4133	4140		10.1074/jbc.M110.174938	http://dx.doi.org/10.1074/jbc.M110.174938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127070	Green Published, hybrid			2022-12-27	WOS:000286975700012
J	Xu, QS; Akama, R; Isaji, T; Lu, YY; Hashimoto, H; Kariya, Y; Fukuda, T; Du, YG; Gu, JG				Xu, Qingsong; Akama, Ryota; Isaji, Tomoya; Lu, Yingying; Hashimoto, Hirokazu; Kariya, Yoshinobu; Fukuda, Tomohiko; Du, Yuguang; Gu, Jianguo			Wnt/beta-Catenin Signaling Down-regulates N-Acetylglucosaminyltransferase III Expression THE IMPLICATIONS OF TWO MUTUALLY EXCLUSIVE PATHWAYS FOR REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROPELLER DOMAIN; E-CADHERIN; ALPHA-CATENIN; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; CELL-ADHESION; COMPLEX; SUPPRESSION; METASTASIS; STABILITY	In previous studies, we reported that N-acetylglucosaminyl-transferase III (GnT-III) activity and the enzyme product, bisected N-glycans, both were induced in cells cultured under dense conditions in an E-cadherin-dependent manner (Iijima, J., Zhao, Y., Isaji, T., Kameyama, A., Nakaya, S., Wang, X., Ihara, H., Cheng, X., Nakagawa, T., Miyoshi, E., Kondo, A., Narimatsu, H., Taniguchi, N., and Gu, J. (2006) J. Biol. Chem. 281, 13038-13046). Furthermore, we found that alpha-catenin, a component of the E-cadherin-catenin complex, was also required for this induction (Akama, R., Sato, Y., Kariya, Y., Isaji, T., Fukuda, T., Lu, L., Taniguchi, N., Ozawa, M., and Gu, J. (2008) Proteomics 8, 3221-3228). To further explore the molecular mechanism of this regulation, the roles of beta-catenin, an essential molecule in both cadherin-mediated cell adhesion and canonical Wnt signaling, were investigated. Unexpectedly, shRNA knockdown of beta-catenin resulted in a dramatic increase in GnT-III expression and its product, the bisected N-glycans, which was confirmed by RT-PCR and GnT-III activity and by E4-PHA lectin blot analysis. The induction of GnT-III expression increased bisecting GlcNAc residues on beta 1 integrin, which led to down-regulation of integrin-mediated cell adhesion and cell migration. Immunostaining showed that nuclear localization of beta-catenin was greatly suppressed; intriguingly, the knockdown of beta-catenin in the nuclei was more effective than that in cell-cell contacts in the knockdown cells, which was also confirmed by Western blot analysis. Stimulation of the Wnt signaling pathway by the addition of exogenous Wnt3a or BIO, a GSK-3 beta inhibitor, consistently and significantly inhibited GnT-III expression and its products. Conversely, the inhibition of beta-catenin translocation into the nuclei increased GnT-III activation. Taken together, the results of the present study are the first to clearly demonstrate that GnT-III expression may be precisely regulated by the interplay of E-cadherin-catenin complex-mediated cell-cell adhesion and Wnt/beta-catenin signaling, which are both crucial in the process of epithelial-mesenchymal transitions in physiological and pathological conditions.	[Xu, Qingsong; Du, Yuguang] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China; [Xu, Qingsong; Akama, Ryota; Isaji, Tomoya; Lu, Yingying; Hashimoto, Hirokazu; Kariya, Yoshinobu; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Tohoku Medical & Pharmaceutical University	Du, YG (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, 457 Zhongshan Rd, Dalian 116023, Peoples R China.	duyg@dicp.ac.cn; jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21370059]	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; the Academic Frontier Project for Private Universities of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and Grant-in-Aid for Scientific Research 21370059 from the Japan Society for the Promotion of Science.	ABERLE H, 1994, J CELL SCI, V107, P3655; Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Asada M, 1997, CANCER RES, V57, P1073; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Granovsky M, 2000, NAT MED, V6, P306; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; IHARA Y, 1993, J BIOCHEM-TOKYO, V113, P692, DOI 10.1093/oxfordjournals.jbchem.a124105; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Matsubara S, 2001, J CELL BIOL, V154, P573, DOI 10.1083/jcb.200103097; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Schachter H, 1986, Adv Exp Med Biol, V205, P53; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; TANIGUCHI N, 2001, HDB GLYCOSYLTRANSFER; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uozumi N, 1996, J BIOCHEM, V120, P385; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhou F, 2008, GLYCOCONJUGATE J, V25, P727, DOI 10.1007/s10719-008-9133-9	44	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4310	4318		10.1074/jbc.M110.182576	http://dx.doi.org/10.1074/jbc.M110.182576			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115490	hybrid, Green Published			2022-12-27	WOS:000286975700030
J	Ashraf, M; Yadav, B; Perinthottathil, S; Kumar, KS; Vats, D; Muthuswami, R; Komath, SS				Ashraf, Mohammad; Yadav, Bhawna; Perinthottathil, Sreejith; Kumar, Kokila Sree; Vats, Divya; Muthuswami, Rohini; Komath, Sneha Sudha			N-Acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase from Entamoeba histolytica METAL ALTERS CATALYTIC RATES BUT NOT SUBSTRATE AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHETIC-PATHWAY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; PIG-L; ANCHOR; EXPRESSION; YEAST; GLYCOPROTEIN; PURIFICATION; SPECIFICITY	PIG-L/GPI12 proteins are endoplasmic reticulum-resident membrane proteins involved in the second step of glycosylphosphatidylinositol anchor biosynthesis in eukaryotes. We show that the Entamoeba histolytica PIG-L protein is optimally active in the acidic pH range. The enzyme has an intrinsic low level of de-N-acetylase activity in the absence of metal and is significantly stimulated by divalent cations. Metal binding induces a large conformational change in the protein that appears to improve catalytic rates while not altering the affinity of the enzyme for its substrate.	[Ashraf, Mohammad; Yadav, Bhawna; Perinthottathil, Sreejith; Kumar, Kokila Sree; Vats, Divya; Muthuswami, Rohini; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	KOMATH, SNEHA SUDHA/AAE-6359-2020; Muthuswami, Rohini/Q-9841-2019; Peri, Sreejith/AAY-9076-2021	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; Muthuswami, Rohini/0000-0002-0559-9484; Peri, Sreejith/0000-0001-5445-3265	Council of Scientific and Industrial Research (CSIR), India; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Council of Scientific and Industrial Research (CSIR), India (to S.S.K. and R.M.) and CSIR junior and senior research fellowships (to M.A. and B.Y.)	Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1990, J BIOL CHEM, V265, P611; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Handa N, 2003, PROTEIN SCI, V12, P1621, DOI 10.1110/gad.03104003; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MILNE KG, 1994, J BIOL CHEM, V269, P16403; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Pottekat A, 2004, J BIOL CHEM, V279, P15743, DOI 10.1074/jbc.M313537200; Ramakrishnan G, 2000, EXP PARASITOL, V96, P57, DOI 10.1006/expr.2000.4543; Smith TK, 2002, BIOCHEMISTRY-US, V41, P12395, DOI 10.1021/bi020351l; Smith TK, 2001, EMBO J, V20, P3322, DOI 10.1093/emboj/20.13.3322; STEVENS VL, 1993, J BIOL CHEM, V268, P9718; Sutterlin C, 1997, J CELL SCI, V110, P2703; Urbaniak MD, 2005, J BIOL CHEM, V280, P22831, DOI 10.1074/jbc.M502402200; Vats D, 2005, INFECT IMMUN, V73, P8381, DOI 10.1128/IAI.73.12.8381-8392.2005; Victoria GS, 2010, MICROBIOL-SGM, V156, P3041, DOI 10.1099/mic.0.039628-0; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185	21	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2543	2549		10.1074/jbc.C110.178343	http://dx.doi.org/10.1074/jbc.C110.178343			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21118807	hybrid, Green Published			2022-12-27	WOS:000286464300019
J	Dasgupta, J; Bienkowska-Haba, M; Ortega, ME; Patel, HD; Bodevin, S; Spillmann, D; Bishop, B; Sapp, M; Chen, XS				Dasgupta, Jhimli; Bienkowska-Haba, Malgorzata; Ortega, Marcos E.; Patel, Hetalkumar D.; Bodevin, Sabrina; Spillmann, Dorothe; Bishop, Brooke; Sapp, Martin; Chen, Xiaojiang S.			Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE HEPARAN-SULFATE; VIRUS-LIKE PARTICLES; L1 PROTEIN; TYPE-16 L1; INFECTION; CAPSIDS; BINDING; L2; SITE	High risk human papillomavirus types 16 (HPV16) and 18 (HPV18) can cause cervical cancer. Efficient infection by HPV16 and HPV18 pseudovirions requires interactions of particles with cell-surface receptor heparan sulfate oligosaccharide. To understand the virus-receptor interactions for HPV infection, we determined the crystal structures of HPV16 and HPV18 capsids bound to the oligosaccharide receptor fragment using oligomeric heparin. The HPV-heparin structures revealed multiple binding sites for the highly negatively charged oligosaccharide fragment on the capsid surface, which is different from previously reported virus-receptor interactions in which a single type of binding pocket is present for a particular receptor. We performed structure-guided mutagenesis to generate mutant viruses, and cell binding and infectivity assays demonstrated the functional role of viral residues involved in heparin binding. These results provide a basis for understanding virus-heparan sulfate receptor interactions critical for HPV infection and for the potential development of inhibitors against HPV infection.	[Bishop, Brooke; Chen, Xiaojiang S.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Bienkowska-Haba, Malgorzata; Patel, Hetalkumar D.; Sapp, Martin] Louisiana State Univ, Dept Microbiol & Immunol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Bienkowska-Haba, Malgorzata; Patel, Hetalkumar D.; Sapp, Martin] Louisiana State Univ, Feist Weiller Canc Ctr, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Bodevin, Sabrina; Spillmann, Dorothe] Uppsala Univ, Inst Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden	University of Southern California; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Uppsala University	Chen, XS (corresponding author), Univ So Calif, Dept Mol & Computat Biol, 1050 Childs Way,MCB201, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu		Dasgupta, Jhimli/0000-0002-8030-1262	National Institutes of Health [AI081809]; USC Norris cancer center; Swedish Research Council [15023]; Swedish Cancer Society; Polysackaridforskning AB (Uppsala, Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris cancer center; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB (Uppsala, Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI081809 (to M. S.), USC Norris cancer center postdoctoral fellowship (to M. E. O.), and Swedish Research Council Grant 15023, the Swedish Cancer Society, and Polysackaridforskning AB (Uppsala, Sweden) (to S. B. and D. S.).	BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Bishop B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-3; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck Christopher B., 2006, PLoS Pathogens, V2, DOI 10.1372/journal.ppat.0020069; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Rommel O, 2005, J MED VIROL, V75, P114, DOI 10.1002/jmv.20245; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	32	70	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2617	2624		10.1074/jbc.M110.160184	http://dx.doi.org/10.1074/jbc.M110.160184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115492	hybrid, Green Published			2022-12-27	WOS:000286464300027
J	Jeffery, E; Peters, LR; Raghavan, M				Jeffery, Elise; Peters, Larry Robert; Raghavan, Malini			The Polypeptide Binding Conformation of Calreticulin Facilitates Its Cell-surface Expression under Conditions of Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTOCOMPATIBILITY MOLECULES; QUALITY-CONTROL; CHAPERONE; CALCIUM; DEATH; IMMUNOGENICITY; CALNEXIN; ERP57; PROTEINS; IDENTIFICATION	We define two classes of calreticulin mutants that retain glycan binding activity; those that display enhanced or reduced polypeptide-specific chaperone activity, due to conformational effects. Under normal conditions, neither set of mutants significantly impacts the ability of calreticulin to mediate assembly and trafficking of major histocompatibility complex class I molecules, which are calreticulin substrates. However, in cells treated with thapsigargin, which depletes endoplasmic reticulum calcium, major histocompatibility complex class I trafficking rates are accelerated coincident with calreticulin secretion, and detection of cell-surface calreticulin is dependent on its polypeptide binding conformations. Together, these findings identify a site on calreticulin that is an important determinant of the induction of its polypeptide binding conformation and demonstrate the relevance of the polypeptide binding conformations of calreticulin to endoplasmic reticulum stress-induced interactions.	[Jeffery, Elise; Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Peters, Larry Robert] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI066131]; University of Michigan Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066131 (to M.R.). This work was also supported by the University of Michigan Rheumatic Diseases Core Center.	BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu HM, 2009, MOL IMMUNOL, V46, P3198, DOI 10.1016/j.molimm.2009.08.012; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; Mandal M, 2003, METHOD ENZYMOL, V372, P319; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Tarr JM, 2010, J MOL BIOL, V401, P799, DOI 10.1016/j.jmb.2010.06.064; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	35	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2402	2415		10.1074/jbc.M110.180877	http://dx.doi.org/10.1074/jbc.M110.180877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075854	Green Published, hybrid			2022-12-27	WOS:000286464300004
J	Lelie, HL; Liba, A; Bourassa, MW; Chattopadhyay, M; Chan, PK; Gralla, EB; Miller, LM; Borchelt, DR; Valentine, JS; Whitelegge, JP				Lelie, Herman L.; Liba, Amir; Bourassa, Megan W.; Chattopadhyay, Madhuri; Chan, Pik K.; Gralla, Edith B.; Miller, Lisa M.; Borchelt, David R.; Valentine, Joan Selverstone; Whitelegge, Julian P.			Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-ACTIVATION ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DISEASE; X-RAY-FLUORESCENCE; CU,ZN-SUPEROXIDE DISMUTASE; SPINAL-CORDS; FAMILIAL ALS; MOUSE MODEL; CEREBROSPINAL-FLUID	Mutations in the metalloenzyme copper-zinc superoxide dismutase (SOD1) cause one form of familial amyotrophic lateral sclerosis (ALS), and metals are suspected to play a pivotal role in ALS pathology. To learn more about metals in ALS, we determined the metallation states of human wild-type or mutant (G37R, G93A, and H46R/H48Q) SOD1 proteins from SOD1-ALS transgenic mice spinal cords. SOD1 was gently extracted from spinal cord and separated into insoluble (aggregated) and soluble (supernatant) fractions, and then metallation states were determined by HPLC inductively coupled plasma MS. Insoluble SOD1-rich fractions were not enriched in copper and zinc. However, the soluble mutant and WT SOD1s were highly metallated except for the metal-binding-region mutant H46R/H48Q, which did not bind any copper. Due to the stability conferred by high metallation of G37R and G93A, it is unlikely that these soluble SOD1s are prone to aggregation in vivo, supporting the hypothesis that immature nascent SOD1 is the substrate for aggregation. We also investigated the effect of SOD1 overexpression and disease on metal homeostasis in spinal cord cross-sections of SOD1-ALS mice using synchrotron-based x-ray fluorescence microscopy. In each mouse genotype, except for the H46R/H48Q mouse, we found a redistribution of copper between gray and white matters correlated to areas of high SOD1. Interestingly, a disease-specific increase of zinc was observed in the white matter for all mutant SOD1 mice. Together these data provide a picture of copper and zinc in the cell as well as highlight the importance of these metals in understanding SOD1-ALS pathology.	[Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Borchelt, David R.] Univ Florida, Dept Neurosci, Santa Fe Hlth Care Alzheimers Dis Res Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA; [Bourassa, Megan W.; Miller, Lisa M.] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Bourassa, Megan W.; Miller, Lisa M.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Florida; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Valentine, JS (corresponding author), Box 951569,607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	jsv@chem.ucla.edu; jpw@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X	National Institutes of Health, NINDS [P01 NS049134-01]; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 NS049134-01 (NINDS).; We thank Alvin Acerbo, Dr. Antonio Lanzirotti, Dr. Andreana Leskovjan, Randy Smith, and Dr. Ryan Tappero for help with beamline X27A and with data analysis on tissue cross-sections and Dr. Sadaf Sehati for editing and proofreading the manuscript. The National Synchrotron Light Source is supported by the United States Department of Energy under Contract DE-AC02-98CH10886.	ARMON C, 1991, NEUROLOGY, V41, P1077, DOI 10.1212/WNL.41.7.1077; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; BANKS TE, 1954, NATURE, V173, P348, DOI 10.1038/173348a0; Bertoni-Freddari C, 2008, EXP GERONTOL, V43, P389, DOI 10.1016/j.exger.2007.11.001; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Broniatowski M, 2009, J PHYS CHEM B, V113, P4275, DOI 10.1021/jp810339e; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gellein K, 2003, BIOL TRACE ELEM RES, V96, P39, DOI 10.1385/BTER:96:1-3:39; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GREENE BDD, 1990, MICROBIAL OXYGENIC P, P280; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jou MY, 2009, J NUTR, V139, P835, DOI 10.3945/jn.108.100974; Jusic A, 1992, Neurol Croat, V41, P213; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; KHANDEKAR RN, 1987, SCI TOTAL ENVIRON, V66, P185, DOI 10.1016/0048-9697(87)90086-6; Kiaei M, 2004, J NEUROSCI, V24, P7945, DOI 10.1523/JNEUROSCI.2000-04.2004; KIHIRA T, 1990, J NEUROL SCI, V98, P251, DOI 10.1016/0022-510X(90)90266-P; Kim J, 2009, NEUROBIOL DIS, V34, P221, DOI 10.1016/j.nbd.2009.01.004; LEPOCK JR, 1985, ARCH BIOCHEM BIOPHYS, V241, P243, DOI 10.1016/0003-9861(85)90380-7; Levenson CW, 2005, PHYSIOL BEHAV, V86, P399, DOI 10.1016/j.physbeh.2005.08.010; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lopez-Alonso M, 2007, FOOD ADDIT CONTAM A, V24, P943, DOI 10.1080/02652030701216719; Markesbery WR, 1995, NEURODEGENERATION, V4, P383, DOI 10.1006/neur.1995.0046; NAGATA H, 1985, J NEUROL SCI, V67, P173, DOI 10.1016/0022-510X(85)90113-3; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Ostachowicz B, 2006, SPECTROCHIM ACTA B, V61, P1210, DOI 10.1016/j.sab.2006.08.008; Pamphlett R, 2001, NEUROTOXICOLOGY, V22, P401, DOI 10.1016/S0161-813X(01)00029-8; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Popescu BFG, 2009, CEREBELLUM, V8, P74, DOI 10.1007/s12311-008-0091-3; Praline J, 2007, CLIN NEUROL NEUROSUR, V109, P880, DOI 10.1016/j.clineuro.2007.07.008; Qureshi Muddasir, 2008, Open Neurol J, V2, P51, DOI 10.2174/1874205X00802010051; Rajan MT, 1997, J NEUROL SCI, V146, P153, DOI 10.1016/S0022-510X(96)00300-0; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sahawneh MA, 2010, J BIOL CHEM, V285, P33885, DOI 10.1074/jbc.M110.118901; SHAFIQURREHMAN, 1984, B ENVIRON CONTAM TOX, V32, P157, DOI 10.1007/BF01607479; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Sillevis Smitt Peter A. E., 1994, Biological Signals, V3, P193; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; SPENCER PS, 1992, ANN NY ACAD SCI, V648, P154, DOI 10.1111/j.1749-6632.1992.tb24533.x; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Tomik B, 2006, NEUROCHEM RES, V31, P321, DOI 10.1007/s11064-005-9030-6; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Yao XM, 2009, NEUROTOXICOLOGY, V30, P121, DOI 10.1016/j.neuro.2008.11.002; YOSHIMASU F, 1980, FOLIA PSYCHIAT NEU J, V34, P75; YOSHIMASU F, 1982, FOLIA PSYCHIAT NEU J, V36, P173; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	77	102	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2795	2806		10.1074/jbc.M110.186999	http://dx.doi.org/10.1074/jbc.M110.186999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068388	Green Published, hybrid			2022-12-27	WOS:000286464300045
J	Tavoulari, S; Rizwan, AN; Forrest, LR; Rudnick, G				Tavoulari, Sotiria; Rizwan, Ahsan N.; Forrest, Lucy R.; Rudnick, Gary			Reconstructing a Chloride-binding Site in a Bacterial Neurotransmitter Transporter Homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SUBSTRATE PERMEATION PATHWAY; SEROTONIN TRANSPORTER; LEUCINE TRANSPORTER; MEMBRANE-TRANSPORT; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; ION-BINDING; MECHANISM	In ion-coupled transport proteins, occupation of selective ion-binding sites is required to trigger conformational changes that lead to substrate translocation. Neurotransmitter transporters, targets of abused and therapeutic drugs, require Na+ and Cl- for function. We recently proposed a chloride-binding site in these proteins not present in Cl- -independent prokaryotic homologues. Here we describe conversion of the Cl- -independent prokaryotic tryptophan transporter TnaT to a fully functional Cl- -dependent form by a single point mutation, D268S. Mutations in TnaT-D268S, in wild type TnaT and in serotonin transporter provide direct evidence for the involvement of each of the proposed residues in Cl- coordination. In both SERT and TnaT-D268S, Cl- and Na+ mutually increased each other's potency, consistent with electrostatic interaction through adjacent binding sites. These studies establish the site where Cl- binds to trigger conformational change during neurotransmitter transport.	[Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany; Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Rizwan, Ahsan N.] Quintiles Corp, Overland Pk, KS 66211 USA	Max Planck Society; Yale University; IQVIA	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max Von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de; gary.rudnick@yale.edu	Tavoulari, Sotiria/G-3285-2012; Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985	National Institutes of Health [GM075347, DA007259]; Autism Speaks postdoctoral fellowship; Deutsche Forschungsgemeinschaft Collaborative Research Center [807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks postdoctoral fellowship; Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM075347 and DA007259 (to G. R.). This work was also supported by an Autism Speaks postdoctoral fellowship (to S. T.) and by the Deutsche Forschungsgemeinschaft Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (to L. R. F.).	Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; BENYONA A, 2010, J BIOL CHEM     1123, DOI DOI 10.1074/JBC.M110149732; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Chen NH, 2003, EUR J PHARMACOL, V479, P213, DOI 10.1016/j.ejphar.2003.08.070; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; Rudnick Gary, 2002, P25; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	44	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2834	2842		10.1074/jbc.M110.186064	http://dx.doi.org/10.1074/jbc.M110.186064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115480	Green Published, hybrid			2022-12-27	WOS:000286464300049
J	Wakamatsu, T; Kim, K; Uemura, Y; Nakagawa, N; Kuramitsu, S; Masui, R				Wakamatsu, Taisuke; Kim, Kwang; Uemura, Yuri; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji			Role of RecJ-like Protein with 5 '-3 ' Exonuclease Activity in Oligo(deoxy)nucleotide Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIRECTED MISMATCH REPAIR; THERMUS-THERMOPHILUS HB8; EXORIBONUCLEASE RNASE-R; ESCHERICHIA-COLI; MYCOPLASMA-PNEUMONIAE; SUBSTRATE-SPECIFICITY; PHOSPHATASE-ACTIVITY; RESTRICTION ENZYMES; BACILLUS-SUBTILIS	RecJ-like proteins belonging to the DHH family have been proposed to function as oligoribonucleases and 3 '-phosphoadenosine 5 '-phosphate (pAp) phosphatases in bacteria and archaea, which do not have Orn (oligoribonuclease) and CysQ (pAp phosphatase) homologs. In this study, we analyzed the biochemical and physiological characterization of the RecJ-like protein TTHA0118 from Thermus thermophilus HB8. TTHA0118 had high enzymatic activity as an oligodeoxyribo-nucleotide- and oligoribonucleotide-specific exonuclease and as pAp phosphatase. The polarity of degradation was 5 ' to 3 ', in contrast to previous reports about Bacillus subtilis NrnA, a RecJ-like protein. TTHA0118 preferentially hydrolyzed short oligodeoxyribonucleotides and oligoribonucleotides, whereas the RecJ exonuclease from T. thermophilus HB8 showed no such length dependence on oligodeoxyribonucleotide substrates. An insertion mutation of the ttha0118 gene led to growth reduction in minimum essential medium. Added 5 ' mononucleotides, nucleosides, and cysteine increased growth of the ttha0118 mutant in minimum essential medium. The RecJ-like protein Mpn140 from Mycoplasma pneumoniae M129, which cannot synthesize nucleic acid precursors de novo, showed similar biochemical features to TTHA0118. Furthermore, B. subtilis NrnA also hydrolyzed oligo(deoxy) ribonucleotides in a 5 '-3 ' direction. These results suggested that these RecJ-like proteins act in recycling short oligonucleotides to mononucleotides and in controlling pAp concentrations in vivo.	[Kim, Kwang; Uemura, Yuri; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Osaka 5600043, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Harima Inst, RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Osaka University; Osaka University; RIKEN	Masui, R (corresponding author), Osaka Univ, Dept Biol Sci, Grad Sch Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	rmasui@bio.sci.osaka-u.ac.jp	Wakamatsu, Taisuke/AAD-8007-2022		Ministry of Education, Science, Sports and Culture of Japan [20570131, 19770083]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research 20570131 (to R. M.) and 19770083 (to N. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; COOPER DL, 1993, J BIOL CHEM, V268, P11823; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; DATTA AK, 1975, J BIOL CHEM, V250, P7313; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Fang M, 2009, NUCLEIC ACIDS RES, V37, P5114, DOI 10.1093/nar/gkp527; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Krause A, 1999, BIOINFORMATICS, V15, P262, DOI 10.1093/bioinformatics/15.3.262; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; MURGUIA JR, 1995, SCIENCE, V267, P232; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; Nishino T, 2002, ONCOGENE, V21, P9022, DOI 10.1038/sj.onc.1206135; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Sapranauskas R, 2000, J BIOL CHEM, V275, P30878, DOI 10.1074/jbc.M003350200; Schneider B, 1998, J BIOL CHEM, V273, P28773, DOI 10.1074/jbc.273.44.28773; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wakamatsu T, 2008, J BACTERIOL, V190, P1108, DOI 10.1128/JB.01522-07; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Waldo RH, 2006, J BACTERIOL, V188, P569, DOI 10.1128/JB.188.2.569-575.2006; Wang LY, 2001, MOL MICROBIOL, V42, P1065, DOI 10.1046/j.1365-2958.2001.02700.x; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; WURST H, 1994, J BIOL CHEM, V269, P10996; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yamagata A, 2001, NUCLEIC ACIDS RES, V29, P4617, DOI 10.1093/nar/29.22.4617; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zhang JQ, 2009, J BACTERIOL, V191, P4330, DOI 10.1128/JB.00184-09; Zhang XL, 1998, J BACTERIOL, V180, P2779, DOI 10.1128/JB.180.10.2779-2781.1998; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	54	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2807	2816		10.1074/jbc.M110.161596	http://dx.doi.org/10.1074/jbc.M110.161596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087930	Green Published, hybrid			2022-12-27	WOS:000286464300046
J	Wei, XC; Schneider, JG; Shenouda, SM; Lee, A; Towler, DA; Chakravarthy, MV; Vita, JA; Semenkovich, CF				Wei, Xiaochao; Schneider, Jochen G.; Shenouda, Sherene M.; Lee, Ada; Towler, Dwight A.; Chakravarthy, Manu V.; Vita, Joseph A.; Semenkovich, Clay F.			De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PPAR-ALPHA; GENE; INHIBITION; GLUCOSE; OVEREXPRESSION; ANGIOGENESIS; HYPERTENSION; DYSFUNCTION; ELEVATION	Endothelial dysfunction leads to lethal vascular complications in diabetes and related metabolic disorders. Here, we demonstrate that de novo lipogenesis, an insulin-dependent process driven by the multifunctional enzyme fatty-acid synthase (FAS), maintains endothelial function by targeting endothelial nitric-oxide synthase (eNOS) to the plasma membrane. In mice with endothelial inactivation of FAS (FASTie mice), eNOS membrane content and activity were decreased. eNOS and FAS were physically associated; eNOS palmitoylation was decreased in FAS-deficient cells, and incorporation of labeled carbon into eNOS-associated palmitate was FAS-dependent. FASTie mice manifested a proinflammatory state reflected as increases in vascular permeability, endothelial inflammatory markers, leukocyte migration, and susceptibility to LPS-induced death that was reversed with an NO donor. FAS-deficient endothelial cells showed deficient migratory capacity, and angiogenesis was decreased in FASTie mice subjected to hindlimb ischemia. Insulin induced FAS in endothelial cells freshly isolated from humans, and eNOS palmitoylation was decreased in mice with insulin-deficient or insulin-resistant diabetes. Thus, disrupting eNOS bioavailability through impaired lipogenesis identifies a novel mechanism coordinating nutritional status and tissue repair that may contribute to diabetic vascular disease.	[Wei, Xiaochao; Schneider, Jochen G.; Lee, Ada; Towler, Dwight A.; Chakravarthy, Manu V.; Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Towler, Dwight A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Shenouda, Sherene M.; Vita, Joseph A.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Shenouda, Sherene M.; Vita, Joseph A.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Boston University; Boston University	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021	Chakravarthy, Manu/0000-0002-3699-150X; Vita, Joseph/0000-0001-5607-1797; Semenkovich, Clay/0000-0003-1163-1871; Towler, Dwight/0000-0003-2107-7923	National Institutes of Health [DK076729, P50 HL083762, DK20579, DK56341]; American Heart Association; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R01DK076729, R01DK088083, P30DK056341, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076729, P50 HL083762, and DK20579 (to Diabetes Research and Training Center) and DK56341 (to Nutrition Obesity Research Center). This work was also supported by an American Heart Association postdoctoral fellowship award and by the American Diabetes Association (mentor-based postdoctoral fellowship award).	Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Emanueli C, 2004, DIABETES, V53, P1096, DOI 10.2337/diabetes.53.4.1096; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOODRIDGE AG, 1986, FASEB J, V45, P2399; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Martinez-Villaluenga C, 2010, FEBS J, V277, P1481, DOI 10.1111/j.1742-4658.2010.07577.x; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Razani B, 2009, NAT MED, V15, P372, DOI 10.1038/nm0409-372; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Toda N, 2007, REV PHYSIOL BIOCH P, V157, P31, DOI 10.1007/s112_0601; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueno K, 1997, J BIOL CHEM, V272, P13519, DOI 10.1074/jbc.272.21.13519; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	48	90	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2933	2945		10.1074/jbc.M110.193037	http://dx.doi.org/10.1074/jbc.M110.193037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098489	Green Published, hybrid			2022-12-27	WOS:000286464300057
J	Zhou, XE; Suino-Powell, KM; Xu, Y; Chan, CW; Tanabe, O; Kruse, SW; Reynolds, R; Engel, JD; Xu, HE				Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, Yong; Chan, Cee-Wah; Tanabe, Osamu; Kruse, Schoen W.; Reynolds, Ross; Engel, James Douglas; Xu, H. Eric			The Orphan Nuclear Receptor TR4 Is a Vitamin A-activated Nuclear Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; GLOBIN GENE; COUP-TF; ALPHA; RXR; EXPRESSION; HETERODIMERIZATION; IDENTIFICATION; PROMOTER	Testicular receptors 2 and 4 (TR2/4) constitute a subgroup of orphan nuclear receptors that play important roles in spermatogenesis, lipid and lipoprotein regulation, and the development of the central nervous system. Currently, little is known about the structural features and the ligand regulation of these receptors. Here we report the crystal structure of the ligand-free TR4 ligand binding domain, which reveals an autorepressed conformation. The ligand binding pocket of TR4 is filled by the C-terminal half of helix 10, and the cofactor binding site is occupied by the AF-2 helix, thus preventing ligand-independent activation of the receptor. However, TR4 exhibits constitutive transcriptional activity on multiple promoters, which can be further potentiated by nuclear receptor coactivators. Mutations designed to disrupt cofactor binding, dimerization, or ligand binding substantially reduce the transcriptional activity of this receptor. Importantly, both retinol and retinoic acid are able to promote TR4 to recruit coactivators and to activate a TR4-regulated reporter. These findings demonstrate that TR4 is a ligand-regulated nuclear receptor and suggest that retinoids might have a much wider regulatory role via activation of orphan receptors such as TR4.	[Reynolds, Ross; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci & Drug Discovery, Grand Rapids, MI 49503 USA; [Tanabe, Osamu; Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Reynolds, Ross] Grand Valley State Univ, Dept Phys, Allendale, MI 49401 USA	Van Andel Institute; University of Michigan System; University of Michigan; Grand Valley State University		edward.zhou@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; Jay and Betty Van Andel Foundation; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the United States Department of Energy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 and DK066202 and HL089301 (to H. E. X.). This work was also supported in part by the Jay and Betty Van Andel Foundation.; We thank D. Nadziejka for editing the manuscript, M. Tsai for cDNAs of the SRC coactivators, and Z. Wawrzak and J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (Life Sciences Collaborative Access Team), which is in part funded by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.	[Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Desvergne B, 2007, VITAM HORM, V75, P1, DOI 10.1016/S0083-6729(06)75001-4; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Escriva H, 2000, BIOESSAYS, V22, P717; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Glass CK, 2000, GENE DEV, V14, P121; Helvering LM, 2000, GENE, V256, P123, DOI 10.1016/S0378-1119(00)00364-4; Jakel H, 2006, DRUG NEWS PERSPECT, V19, P91, DOI 10.1358/dnp.2006.19.2.977445; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lee CH, 1998, J BIOL CHEM, V273, P25209, DOI 10.1074/jbc.273.39.25209; Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Wada T, 2008, EXP BIOL MED, V233, P1191, DOI 10.3181/0802-MR-50; Waltner-Law M, 2003, J BIOL CHEM, V278, P10427, DOI 10.1074/jbc.M211846200; Wang CP, 2006, BIOCHEM BIOPH RES CO, V351, P204, DOI 10.1016/j.bbrc.2006.10.021; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779	39	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2877	2885		10.1074/jbc.M110.168740	http://dx.doi.org/10.1074/jbc.M110.168740			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068381	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000286464300053
J	Hwang, SM; Koo, NY; Jin, MH; Davies, AJ; Chun, GS; Choi, SY; Kim, JS; Park, K				Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Chun, Gae-Sig; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo			Intracellular Acidification Is Associated with Changes in Free Cytosolic Calcium and Inhibition of Action Potentials in Rat Trigeminal Ganglion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BICARBONATE COTRANSPORTER; FUNCTIONAL EXPRESSION; SENSORY NEURONS; PH REGULATION; NA+-HCO3-COTRANSPORTER; CULTURED ASTROCYTES; MOLECULAR-CLONING; PH(I) REGULATION; SALIVARY-GLANDS; ACINAR-CELLS	The effect of intracellular acidification and subsequent pH recovery in sensory neurons has not been well characterized. We have studied the mechanisms underlying Ca2+-induced acidification and subsequent recovery of intracellular pH (pH(i)) in rat trigeminal ganglion neurons and report their effects on neuronal excitability. Glutamate (500 mu M) and capsaicin (1 mu M) increased intracellular Ca2+ concentration ([Ca2+](i)) with a following decrease in pH(i). The recovery of [Ca2+](i) to the prestimulus level was inhibited by LaCl3 (1 mM) and o-vanadate (10 mM), a plasma membrane Ca2+/ATPase (PMCA) inhibitor. Removal of extracellular Ca2+ also completely inhibited the acidification induced by capsaicin. TRPV1 was expressed only in small and medium sized trigeminal ganglion neurons. mRNAs for Na+/H+ exchanger type 1 (NHE1), pancreatic Na+-HCO3- cotransporter type 1 (pNBC1), NBC3, NBC4, and PMCA types 1-3 were detected by RT-PCR. pH(i) recovery was significantly inhibited by pretreatment with NHE1 or pNBC1 siRNA. We found that the frequency of action potentials (APs) was dependent on pH(i). Application of the NHE1 inhibitor 5'-(N-ethyl-N-isopropyl) amiloride (5 mu M) or the pNBC1 inhibitor 4',4'-di-isothiocyanostilbene-2',2'-sulfonic acid (500 mu M) delayed pH(i) recovery and decreased AP frequency. Simultaneous application of 5'-(N-ethyl-N-isopropyl) amiloride and 4',4'-di-isothiocyanostilbene-2',2'-sulfonic acid almost completely inhibited APs. In summary, our results demonstrate that the rise in [Ca2+](i) in sensory neurons by glutamate and capsaicin causes intracellular acidification by activation of PMCA type 3, that the pH(i) recovery from acidification is mediated by membrane transporters NHE1 and pNBC1 specifically, and that the activity of these transporters has direct consequences for neuronal excitability.	[Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; [Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo] Dent Res Inst, Seoul 110749, South Korea; [Chun, Gae-Sig] Dankook Univ, Sch Dent, Dept Oral Physiol, Cheonan 330714, South Korea	Seoul National University (SNU); Dankook University	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea.	kppark@snu.ac.kr		Davies, Alexander/0000-0003-0072-1708; Choi, Se-Young/0000-0001-7534-5167	Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2010-0029479]	Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea	This work was supported by National Research Foundation of Korea Grant 2010-0029479 funded by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Bonnet U, 1999, BRAIN RES, V840, P16, DOI 10.1016/S0006-8993(99)01687-X; BRUNE T, 1995, GLIA, V14, P153, DOI 10.1002/glia.440140210; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; DAUGIRDAS JT, 1995, J CLIN INVEST, V95, P1480, DOI 10.1172/JCI117819; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Douglas RM, 2003, J APPL PHYSIOL, V95, P292, DOI 10.1152/japplphysiol.01089.2002; Eckert SP, 1997, J NEUROSCI METH, V77, P183, DOI 10.1016/S0165-0270(97)00125-8; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Gonzalez A, 1997, BIOCHEM BIOPH RES CO, V230, P652, DOI 10.1006/bbrc.1996.6026; Gonzalez A, 1997, PFLUG ARCH EUR J PHY, V434, P609, DOI 10.1007/s004240050443; Gover TD, 2007, CELL CALCIUM, V41, P389, DOI 10.1016/j.ceca.2006.08.014; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Kiss L, 1999, J NEUROPHYSIOL, V81, P1839, DOI 10.1152/jn.1999.81.4.1839; Koo NY, 2006, BIOCHEM BIOPH RES CO, V342, P1114, DOI 10.1016/j.bbrc.2006.02.064; Kostyuk P, 2003, NEUROCHEM RES, V28, P1543, DOI 10.1023/A:1025626526410; Lam DK, 2009, BRAIN RES, V1251, P130, DOI 10.1016/j.brainres.2008.11.029; LAX D, 1994, AM J PHYSIOL, V267, pH734, DOI 10.1152/ajpheart.1994.267.2.H734; Li J, 2006, AM J PHYSIOL-GASTR L, V291, pG1031, DOI 10.1152/ajpgi.00483.2005; Liu CN, 2008, TOXICOL SCI, V103, P346, DOI 10.1093/toxsci/kfn045; Liu L, 2000, PHYSIOL BEHAV, V69, P363, DOI 10.1016/S0031-9384(00)00209-2; Matsumoto Y, 2004, STROKE, V35, P185, DOI 10.1161/01.STR.0000106910.42815.C2; Park CK, 2006, J BIOL CHEM, V281, P17304, DOI 10.1074/jbc.M511072200; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Partosoedarso ER, 2000, AUTON NEUROSCI-BASIC, V83, P37, DOI 10.1016/S0165-1838(00)00109-0; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pedersen SF, 1998, J NEUROSCI RES, V51, P431, DOI 10.1002/(SICI)1097-4547(19980215)51:4<431::AID-JNR3>3.3.CO;2-C; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Prentice HM, 2008, AM J PHYSIOL-REG I, V294, pR448, DOI 10.1152/ajpregu.00846.2007; Roussa E, 2004, BIOCHEM BIOPH RES CO, V314, P382, DOI 10.1016/j.bbrc.2003.12.099; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; Taylor-Clark TE, 2005, J ALLERGY CLIN IMMUN, V116, P1282, DOI 10.1016/j.jaci.2005.08.043; Vale-Gonzalez C, 2006, J NEUROSCI RES, V84, P326, DOI 10.1002/jnr.20878; Vincent AM, 1999, J NEUROBIOL, V40, P171, DOI 10.1002/(SICI)1097-4695(199908)40:2<171::AID-NEU4>3.0.CO;2-F; Wu ML, 1999, AM J PHYSIOL-CELL PH, V277, pC717, DOI 10.1152/ajpcell.1999.277.4.C717; Yamada H, 2003, BIOCHEM BIOPH RES CO, V310, P1213, DOI 10.1016/j.bbrc.2003.09.147	44	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1719	1729		10.1074/jbc.M109.090951	http://dx.doi.org/10.1074/jbc.M109.090951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068392	hybrid, Green Published			2022-12-27	WOS:000286191500011
J	Mao, XM; Sano, Y; Park, JM; Payne, AS				Mao, Xuming; Sano, Yasuyo; Park, Jin Mo; Payne, Aimee S.			p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCALDED-SKIN SYNDROME; BULLOUS IMPETIGO; SUBSTRATE-SPECIFICITY; PROTEIN-KINASES; DESMOGLEIN 1; AUTOANTIBODIES; IGG; P38MAPK; DISEASE; PHOSPHORYLATION	Pemphigus vulgaris (PV) is a potentially fatal blistering disease characterized by autoantibodies against the desmosomal adhesion protein desmoglein (Dsg) 3. Whether autoantibody steric hindrance or signaling through pathways such as p38 MAPK is primary in disease pathogenesis is controversial. PV mAbs that cause endocytosis of Dsg3 but do not dissociate keratinocytes because of compensatory adhesion by Dsg1 do not activate p38. The same mAbs plus exfoliative toxin to inactivate Dsg1 but not exfoliative toxin alone activate p38, suggesting that p38 activation is secondary to loss of adhesion. Mice with epidermal p38 alpha deficiency blister after passive transfer of PV mAbs; however, acantholytic cells retain cell surface Dsg3 compared with wild-type mice. In cultured keratinocytes, p38 knockdown prevents loss of desmosomal Dsg3 by PV mAbs, and exogenous p38 activation causes internalization of Dsg3, desmocollin 3, and desmoplakin. p38 alpha MAPK is therefore not required for the loss of intercellular adhesion in PV, but may function downstream to augment blistering via Dsg3 endocytosis. Treatments aimed at increasing keratinocyte adhesion could be used in conjunction with immunosuppressive agents, potentially leading to safer and more effective combination therapy regimens.	Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Sano, Yasuyo; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Sano, Yasuyo; Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University	Payne, AS (corresponding author), 217A Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	paynea@mail.med.upenn.edu			National Institutes of Health [AR053505]; NIAMS [AR057001]; NIAID [AI074957]; Penn Skin Disease Research [AR057217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR053505, R01AR057001, P30AR057217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Skin Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053505 and AR057001 from NIAMS (to A. S. P.) and Grant AI074957 from NIAID (to J. M. P.). This work was also supported by Penn Skin Disease Research Core Grant AR057217.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Grando SA, 2003, J AM ACAD DERMATOL, V48, P86, DOI 10.1067/mjd.2003.39; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; Miyagawa S, 1999, BRIT J DERMATOL, V141, P1084, DOI 10.1046/j.1365-2133.1999.03209.x; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Payne AS, 2004, CURR OPIN CELL BIOL, V16, P536, DOI 10.1016/j.ceb.2004.07.006; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Sharma P, 2007, J DERMATOL SCI, V48, P1, DOI 10.1016/j.jdermsci.2007.05.005; Shirakata Y, 1998, J INVEST DERMATOL, V110, P76, DOI 10.1046/j.1523-1747.1998.00085.x; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170	42	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1283	1291		10.1074/jbc.M110.172874	http://dx.doi.org/10.1074/jbc.M110.172874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078676	Green Published, hybrid			2022-12-27	WOS:000286005000040
J	Pillai, R; Huypens, P; Huang, M; Schaefer, S; Sheinin, T; Wettig, SD; Joseph, JW				Pillai, Renjitha; Huypens, Peter; Huang, Mei; Schaefer, Stephanie; Sheinin, Tanya; Wettig, Shawn D.; Joseph, Jamie W.			Aryl Hydrocarbon Receptor Nuclear Translocator/Hypoxia-inducible Factor-1 beta Plays a Critical Role in Maintaining Glucose-stimulated Anaplerosis and Insulin Release from Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; MOUSE ISLETS; MALONYL-COA; PYRUVATE-CARBOXYLASE; COUPLING FACTORS; REGULATORY ROLE; SECRETION; EXOCYTOSIS	The metabolic pathways that are involved in regulating insulin secretion from pancreatic beta-cells are still incompletely understood. One potential regulator of the metabolic phenotype of beta-cells is the transcription factor aryl hydrocarbon receptor nuclear translocator (ARNT)/hypoxia-inducible factor (HIF)-1 beta. ARNT/HIF-1 beta levels are profoundly reduced in islets obtained from type 2 diabetic patients. However, no study to date has investigated key pathways involved in regulating insulin release in beta-cells that lack ARNT/HIF-1 beta. In this study, we confirm that siRNA-mediated knockdown of ARNT/HIF-1 beta inhibits glucose-stimulated insulin secretion. We next investigated the metabolic consequence of the loss of ARNT/HIF-1 beta knockdown. We demonstrate that beta-cells with reduced ARNT/HIF-1 beta expression levels exhibit a 31% reduction in glycolytic flux without significant changes in glucose oxidation or the ATP:ADP ratio. Metabolic profiling of beta-cells treated with siRNAs against the ARNT/HIF-1 beta gene revealed that glycolysis, anaplerosis, and glucose-induced fatty acid production were down-regulated, and all are key events involved in glucose-stimulated insulin secretion. In addition, both first and second phase insulin secretion in islets were significantly reduced after ARNT/HIF-1 beta knockdown. Together, our data suggest an important role for ARNT/HIF-1 beta in anaplerosis, and it may play a critical role in maintaining normal secretion competence of beta-cells.	[Pillai, Renjitha; Huypens, Peter; Huang, Mei; Schaefer, Stephanie; Sheinin, Tanya; Wettig, Shawn D.; Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Joseph, JW (corresponding author), Univ Waterloo, Sch Pharm, Hlth Sci Campus,Rm 3008,10 Victoria St S, Kitchener, ON N2G 1C5, Canada.	j3joseph@uwaterloo.ca	Huypens, Peter/B-3617-2010; Wettig, Shawn/ABE-5382-2020	Huypens, Peter/0000-0001-7922-5787; Wettig, Shawn/0000-0002-6490-264X	Canadian Institutes of Health Research; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Canadian Institutes of Health Research and Canada Foundation for Innovation grants (to J. W. J.).	ANTONSSON C, 1995, J BIOL CHEM, V270, P13968, DOI 10.1074/jbc.270.23.13968; Arpiainen S, 2007, J MOL BIOL, V369, P640, DOI 10.1016/j.jmb.2007.03.075; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 2000, IUBMB LIFE, V50, P27, DOI 10.1080/15216540050176557; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MEREDITH M, 1995, J CLIN INVEST, V96, P811, DOI 10.1172/JCI118127; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Ravier MA, 2009, ENDOCRINOLOGY, V150, P33, DOI 10.1210/en.2008-0617; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SATO Y, 1992, DIABETES, V41, P438, DOI 10.2337/diabetes.41.4.438; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0	56	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1014	1024		10.1074/jbc.M110.149062	http://dx.doi.org/10.1074/jbc.M110.149062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059654	hybrid, Green Published			2022-12-27	WOS:000286005000012
J	Resnik, N; Sepcic, K; Plemenitas, A; Windoffer, R; Leube, R; Veranic, P				Resnik, Natasa; Sepcic, Kristina; Plemenitas, Ana; Windoffer, Reinhard; Leube, Rudolf; Veranic, Peter			Desmosome Assembly and Cell-Cell Adhesion Are Membrane Raft-dependent Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; CAVEOLAE MEMBRANE; TIGHT JUNCTIONS; CHOLESTEROL; DOMAINS; PROTEINS; LOCALIZATION; MICRODOMAINS; CYCLODEXTRINS	The aim of our study was to investigate the association of desmosomal proteins with cholesterol-enriched membrane domains, commonly called membrane rafts, and the influence of cholesterol on desmosome assembly in epithelial Madin-Darby canine kidney cells (clone MDc-2). Biochemical analysis proved an association of desmosomal cadherin desmocollin 2 (Dsc2) in cholesterol-enriched fractions that contain membrane raft markers caveolin-1 and flotillin-1 and the novel raft marker ostreolysin. Cold detergent extraction of biotinylated plasma membranes revealed that similar to 60% of Dsc2 associates with membrane rafts while the remainder is present in nonraft and cholesterol-poor membranes. The results of immunofluorescence microscopy confirmed colocalization of Dsc2 and ostreolysin. Partial depletion of cholesterol with methyl-beta-cyclodextrin disturbs desmosome assembly, as revealed by sequential recordings of live cells. Moreover, cholesterol depletion significantly reduces the strength of cell-cell junctions and partially releases Dsc2 from membrane rafts. Our data indicate that a pool of Dsc2 is associated with membrane rafts, particularly with the ostreolysin type of membrane raft, and that intact membrane rafts are necessary for desmosome assembly. Taken together, these data suggest cholesterol as a potential regulator that promotes desmosome assembly.	[Resnik, Natasa; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1000 Ljubljana, Slovenia; [Sepcic, Kristina] Univ Ljubljana, Dept Biol, Biotech Fac, SI-1000 Ljubljana, Slovenia; [Plemenitas, Ana] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia; [Windoffer, Reinhard; Leube, Rudolf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, D-52062 Aachen, Germany	University of Ljubljana; University of Ljubljana; University of Ljubljana; RWTH Aachen University	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1000 Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si	Veranic, Peter/I-6276-2015; Sepcic, Kristina/S-5533-2018	Veranic, Peter/0000-0003-1999-9988; Sepcic, Kristina/0000-0002-4023-5379; Leube, Rudolf/0000-0002-5519-7379; Windoffer, Reinhard/0000-0003-1403-5880				Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kahya N, 2005, BIOCHEMISTRY-US, V44, P7479, DOI 10.1021/bi047429d; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Locke D, 2005, BIOCHEMISTRY-US, V44, P13027, DOI 10.1021/bi050495a; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; MATTEY DL, 1990, J CELL SCI, V97, P689; MATTEY DL, 1986, J CELL SCI, V85, P113; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Nusrat A, 2000, J CELL SCI, V113, P1771; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Shah Mehul B., 2007, V398, P21, DOI 10.1007/978-1-59745-513-8_3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; SKERROW CJ, 1974, J CELL BIOL, V63, P524, DOI 10.1083/jcb.63.2.524; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Suzuki T, 2006, ACTA HISTOCHEM CYTOC, V39, P155, DOI 10.1267/ahc.06024; Windoffer R, 2002, J CELL SCI, V115, P1717; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	42	62	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1499	1507		10.1074/jbc.M110.189464	http://dx.doi.org/10.1074/jbc.M110.189464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071449	Green Published, hybrid			2022-12-27	WOS:000286005000062
J	Daigo, K; Kawamura, T; Ohta, Y; Ohashi, R; Katayose, S; Tanaka, T; Aburatani, H; Naito, M; Kodama, T; Ihara, S; Hamakubo, T				Daigo, Kenji; Kawamura, Takeshi; Ohta, Yoshihiro; Ohashi, Riuko; Katayose, Satoshi; Tanaka, Toshiya; Aburatani, Hiroyuki; Naito, Makoto; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao			Proteomic Analysis of Native Hepatocyte Nuclear Factor-4 alpha (HNF4 alpha) Isoforms, Phosphorylation Status, and Interactive Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; CELL-SPECIFIC EXPRESSION; GENE-EXPRESSION; PROTEIN-KINASE; FACTOR (HNF)-4-ALPHA/GAMMA; COOPERATIVE INTERACTION; CENTRAL REGULATOR; HORMONE RECEPTOR; BINDING-SITES; MESSENGER-RNA	Hepatocyte nuclear factor-4 alpha (HNF4 alpha, NR2A1) is a nuclear receptor that has a critical role in hepatocyte differentiation and the maintenance of homeostasis in the adult liver. However, a detailed understanding of native HNF4 alpha in the steady-state remains to be elucidated. Here we report the native HNF4 alpha isoform, phosphorylation status, and complexes in the steady-state, as shown by shotgun proteomics in HepG2 hepatocarcinoma cells. Shotgun proteomic analysis revealed the complexity of native HNF4 alpha, including multiple phosphorylation sites and inter-isoform heterodimerization. The associating complexes identified by label-free semiquantitative proteomic analysis include the following: the DNA-dependent protein kinase catalytic subunit, histone acetyltransferase complexes, mRNA splicing complex, other nuclear receptor coactivator complexes, the chromatin remodeling complex, and the nucleosome remodeling and histone deacetylation complex. Among the associating proteins, GRB10 interacting GYF protein 2 (GIGYF2, PERQ2) is a new candidate cofactor in metabolic regulation. Moreover, an unexpected heterodimerization of HNF4 alpha and hepatocyte nuclear factor-4 alpha was found. A biochemical and genomewide analysis of transcriptional regulation showed that this heterodimerization activates gene transcription. The genes thus transcribed include the cell death-inducing DEF45-like effector b (CIDEB) gene, which is an important regulator of lipid metabolism in the liver. This suggests that the analysis of the distinctive stoichiometric balance of native HNF4 alpha and its cofactor complexes described here are important for an accurate understanding of transcriptional regulation.	[Daigo, Kenji; Kawamura, Takeshi; Ohta, Yoshihiro; Tanaka, Toshiya; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Div Cellular & Mol Pathol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Katayose, Satoshi] JSR Corp, Tsukuba Res Labs, Ibaraki 3050841, Japan	University of Tokyo; Niigata University; Eisai Co Ltd; JSR Corporation	Hamakubo, T (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, 4-6-1 Komaba, Tokyo 1538904, Japan.	hamakubo@lsbm.org	Ohashi, Riuko/AAH-1415-2019; Daigo, Kenji/S-8915-2016	Ohashi, Riuko/0000-0001-5820-7870; Daigo, Kenji/0000-0001-6398-3356	National Institute of Biomedical Innovation (NIBIO), Japan; New Energy and Industrial Technology Development Organization (NEDO), Japan; Ministry of Education, Culture, Sports, Science and Technology [19319129, 19800009, 20221010]	National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO), Japan, and Japan Grants-in-Aid for Scientific Research 19319129, 19800009, and 20221010 from the Ministry of Education, Culture, Sports, Science and Technology.	America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Archer A, 2005, MOL ENDOCRINOL, V19, P2320, DOI 10.1210/me.2004-0462; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drewes T, 1996, MOL CELL BIOL, V16, P925; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; HATA S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P211, DOI 10.1016/0167-4781(92)90080-J; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim HJ, 1998, MOL ENDOCRINOL, V12, P1038, DOI 10.1210/me.12.7.1038; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kritis AA, 1996, GENE, V173, P275, DOI 10.1016/0378-1119(96)00183-7; KTISTAKI E, 1995, P NATL ACAD SCI USA, V92, P9876, DOI 10.1073/pnas.92.21.9876; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Navas MA, 1999, DIABETES, V48, P1459, DOI 10.2337/diabetes.48.7.1459; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Ozeki T, 2003, PHARMACOGENETICS, V13, P49, DOI 10.1097/00008571-200301000-00007; Ozeki T, 2002, ARCH BIOCHEM BIOPHYS, V405, P185, DOI 10.1016/S0003-9861(02)00384-3; Ozeki T, 2001, BIOCHEM J, V355, P537, DOI 10.1042/0264-6021:3550537; Pascussi JM, 2007, HEPATOLOGY, V45, P1146, DOI 10.1002/hep.21592; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Petrescu AD, 2005, J BIOL CHEM, V280, P16714, DOI 10.1074/jbc.M405906200; Plengvidhya N, 1999, DIABETES, V48, pA186; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sakamoto A, 2007, J HISTOCHEM CYTOCHEM, V55, P641, DOI 10.1369/jhc.6A7120.2007; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Takegoshi S, 2009, PATHOL INT, V59, P61, DOI 10.1111/j.1440-1827.2008.02330.x; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wolfertstetter F, 1996, COMPUT APPL BIOSCI, V12, P71; Xu ZM, 2007, J BIOL CHEM, V282, P24607, DOI 10.1074/jbc.M611481200; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	73	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					674	686		10.1074/jbc.M110.154732	http://dx.doi.org/10.1074/jbc.M110.154732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047794	Green Published, hybrid			2022-12-27	WOS:000285782800068
J	Kaustov, L; Hui, OY; Amaya, M; Lemak, A; Nady, N; Duan, SL; Wasney, GA; Li, ZH; Vedadi, M; Schapira, M; Min, JR; Arrowsmith, CH				Kaustov, Lilia; Hui Ouyang; Amaya, Maria; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Wasney, Gregory A.; Li, Zhihong; Vedadi, Masoud; Schapira, Matthieu; Min, Jinrong; Arrowsmith, Cheryl H.			Recognition and Specificity Determinants of the Human Cbx Chromodomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; 3-WAY DECOMPOSITION; STRUCTURAL BASIS; H3; BINDING; NMR; PROTEINS; LOCUS; RNA; REPRESSION	The eight mammalian Cbx proteins are chromodomain-containing proteins involved in regulation of heterochromatin, gene expression, and developmental programs. They are evolutionarily related to the Drosophila HP1 (dHP1) and Pc (dPc) proteins that are key components of chromatin-associated complexes capable of recognizing repressive marks such as trimethylated Lys-9 and Lys-27, respectively, on histone H3. However, the binding specificity and function of the human homologs, Cbx1-8, remain unclear. To this end we employed structural, biophysical, and mutagenic approaches to characterize the molecular determinants of sequence contextual methyllysine binding to human Cbx1-8 proteins. Although all three human HP1 homologs (Cbx1, -3, -5) replicate the structural and binding features of their dHP counterparts, the five Pc homologs (Cbx2, -4, -6, -7, -8) bind with lower affinity to H3K9me3 or H3K27me3 peptides and are unable to distinguish between these two marks. Additionally, peptide permutation arrays revealed a greater sequence tolerance within the Pc family and suggest alternative nonhistone sequences as potential binding targets for this class of chromodomains. Our structures explain the divergence of peptide binding selectivity in the Pc subfamily and highlight previously unrecognized features of the chromodomain that influence binding and specificity.	[Kaustov, Lilia; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Kaustov, Lilia; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Hui Ouyang; Amaya, Maria; Wasney, Gregory A.; Li, Zhihong; Vedadi, Masoud; Schapira, Matthieu; Min, Jinrong; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto	Arrowsmith, CH (corresponding author), Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, 101 Coll St, Toronto, ON M5G 1L7, Canada.	carrow@uhnres.utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250; Kaustov, Lilia/0000-0002-8474-559X	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; Genome Canada through GlaxoSmithKline; Genome Canada through Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Ontario Ministry of Health and Long Term Care; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); Genome Canada through GlaxoSmithKline; Genome Canada through Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Cancer Society(Canadian Cancer Society (CCS))	We are grateful to Antoine Peters for fruitful discussions. We thank Chen Chen, Brett Larsen, and Andrew James (Dr. Pawson laboratory, University of Toronto) for help with MS data acquisition and analysis. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; This work was supported in part by the Ontario Ministry of Health and Long Term Care. This work was also supported by the Canadian Cancer Society.; Supported by a Doctoral Research Award from the Canadian Institutes of Health Research.	Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Biason-Lauber A, 2009, AM J HUM GENET, V84, P658, DOI 10.1016/j.ajhg.2009.03.016; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Raush E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007394; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	39	197	211	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					521	529		10.1074/jbc.M110.191411	http://dx.doi.org/10.1074/jbc.M110.191411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047797	Green Published, hybrid			2022-12-27	WOS:000285782800055
J	Rosenbaum, S; Kreft, S; Etich, J; Frie, C; Stermann, J; Grskovic, I; Frey, B; Mielenz, D; Poschl, E; Gaipl, U; Paulsson, M; Brachvogel, B				Rosenbaum, Sabrina; Kreft, Sandra; Etich, Julia; Frie, Christian; Stermann, Jacek; Grskovic, Ivan; Frey, Benjamin; Mielenz, Dirk; Poeschl, Ernst; Gaipl, Udo; Paulsson, Mats; Brachvogel, Bent			Identification of Novel Binding Partners (Annexins) for the Cell Death Signal Phosphatidylserine and Definition of Their Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; DYING CELLS; A5; PHAGOCYTOSIS; PROTEIN; CALCIUM; MICE; PHOSPHOLIPIDS; MACROPHAGES; ENGULFMENT	Identification and clearance of apoptotic cells prevents the release of harmful cell contents thereby suppressing inflammation and autoimmune reactions. Highly conserved annexins may modulate the phagocytic cell removal by acting as bridging molecules to phosphatidylserine, a characteristic phagocytosis signal of dying cells. In this study five members of the structurally and functionally related annexin family were characterized for their capacity to interact with phosphatidylserine and dying cells. The results showed that AnxA3, AnxA4, AnxA13, and the already described interaction partner AnxA5 can bind to phosphatidylserine and apoptotic cells, whereas AnxA8 lacks this ability. Sequence alignment experiments located the essential amino residues for the recognition of surface exposed phosphatidylserine within the calcium binding motifs common to all annexins. These amino acid residues were missing in the evolutionary young AnxA8 and when they were reintroduced by site directed mutagenesis AnxA8 gains the capability to interact with phosphatidylserine containing liposomes and apoptotic cells. By defining the evolutionary conserved amino acid residues mediating phosphatidylserine binding of annexins we show that the recognition of dying cells represent a common feature of most annexins. Hence, the individual annexin repertoire bound to the cell surface of dying cells may fulfil opsonin-like function in cell death recognition.	[Rosenbaum, Sabrina; Kreft, Sandra; Etich, Julia; Frie, Christian; Stermann, Jacek; Grskovic, Ivan; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Frey, Benjamin; Gaipl, Udo] Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Mielenz, Dirk] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Div Mol Immunol, D-91054 Erlangen, Germany; [Poeschl, Ernst] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Paulsson, Mats] CMMC, Cologne, Germany; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of East Anglia; University of Cologne; University of Cologne	Brachvogel, B (corresponding author), Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	bent.brachvogel@uni-koeln.de	Frey, Benjamin/D-9565-2017; Gaipl, Udo/AAE-1060-2020	Frey, Benjamin/0000-0001-6743-3351; Brachvogel, Bent/0000-0002-3923-0554; Etich, Julia/0000-0003-3238-6692	German Research Foundation [BR2304/4-1, GA1507/1-1]; MRC [G0802553] Funding Source: UKRI; Medical Research Council [G0802553] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by Grants BR2304/4-1 and GA1507/1-1 from the German Research Foundation.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; Blankenberg F, 2003, Q J NUCL MED, V47, P337; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Frey B, 2009, J CELL MOL MED, V13, P1391, DOI 10.1111/j.1582-4934.2008.00395.x; Gaipl US, 2007, AUTOIMMUNITY, V40, P254, DOI 10.1080/08916930701357331; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HIRATA F, 1981, P NATL ACAD SCI-BIOL, V78, P3190, DOI 10.1073/pnas.78.5.3190; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jin M, 2004, J BIOL CHEM, V279, P40351, DOI 10.1074/jbc.M405846200; Kenis H, 2006, EXP CELL RES, V312, P719, DOI 10.1016/j.yexcr.2005.11.023; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; MEERS P, 1993, BIOCHEMISTRY-US, V32, P5411, DOI 10.1021/bi00071a016; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Munoz LE, 2007, J LEUKOCYTE BIOL, V81, P6, DOI 10.1189/jlb.0306166; NELSON MR, 1995, BIOCHEMISTRY-US, V34, P3121, DOI 10.1021/bi00009a044; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Platt N, 2000, J IMMUNOL, V164, P4861, DOI 10.4049/jimmunol.164.9.4861; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Stach CM, 2000, CELL DEATH DIFFER, V7, P911, DOI 10.1038/sj.cdd.4400715; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yona S, 2005, PROSTAG LEUKOTR ESS, V72, P95, DOI 10.1016/j.plefa.2004.10.008; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	39	39	42	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5708	5716		10.1074/jbc.M110.193086	http://dx.doi.org/10.1074/jbc.M110.193086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131363	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000287230600079
J	Runager, K; Basaiawmoit, RV; Deva, T; Andreasen, M; Valnickova, Z; Sorensen, CS; Karring, H; Thogersen, IB; Christiansen, G; Underhaug, J; Kristensen, T; Nielsen, NC; Klintworth, GK; Otzen, DE; Enghild, JJ				Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Karring, Henrik; Thogersen, Ida B.; Christiansen, Gunna; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Klintworth, Gordon K.; Otzen, Daniel E.; Enghild, Jan J.			Human Phenotypically Distinct TGFBI Corneal Dystrophies Are Linked to the Stability of the Fourth FAS1 Domain of TGFBIp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CIRCULAR-DICHROISM SPECTRA; MATRIX PROTEIN BETA-IG-H3; CELL-ADHESION; GEL-ELECTROPHORESIS; SECONDARY STRUCTURE; KERATO-EPITHELIN; IN-VITRO; GENE; IDENTIFICATION	Mutations in the human TGFBI gene encoding TGFBIp have been linked to protein deposits in the cornea leading to visual impairment. The protein consists of an N-terminal Cys-rich EMI domain and four consecutive fasciclin 1 (FAS1) domains. We have compared the stabilities of wild-type (WT) human TGFBIp and six mutants known to produce phenotypically distinct deposits in the cornea. Amino acid substitutions in the first FAS1 (FAS1-1) domain (R124H, R124L, and R124C) did not alter the stability. However, substitutions within the fourth FAS1 (FAS1-4) domain (A546T, R555Q, and R555W) affected the overall stability of intact TGFBIp revealing the following stability ranking R555W>WT>R555Q>A546T. Significantly, the stability ranking of the isolated FAS1-4 domains mirrored the behavior of the intact protein. In addition, it was linked to the aggregation propensity as the least stable mutant (A546T) forms amyloid fibrils while the more stable variants generate non-amyloid amorphous deposits in vivo. Significantly, the data suggested that both an increase and a decrease in the stability of FAS1-4 may unleash a disease mechanism. In contrast, amino acid substitutions in FAS1-1 did not affect the stability of the intact TGFBIp suggesting that molecular the mechanism of disease differs depending on the FAS1 domain carrying the mutation.	[Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Thogersen, Ida B.; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Otzen, Daniel E.; Enghild, Jan J.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Thogersen, Ida B.; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Otzen, Daniel E.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Deva, Taru] Univ Copenhagen, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Karring, Henrik] Univ So Denmark, Inst Chem Engn Biotechnol & Environm Technol, DK-5230 Odense M, Denmark; [Christiansen, Gunna] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; [Klintworth, Gordon K.] Duke Univ, Dept Pathol & Ophthalmol, Med Ctr, Durham, NC 27710 USA	Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Aarhus University; Duke University	Otzen, DE (corresponding author), Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	dao@mb.au.dk; jje@mb.au.dk	Basaiawmoit, Rajiv V/H-3961-2014	Basaiawmoit, Rajiv V/0000-0001-8114-1857; Underhaug, Jarl/0000-0003-0346-3986; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989; Enghild, Jan Johannes/0000-0001-9292-9172; Andreasen, Maria/0000-0002-6096-2995; Nielsen, Niels Chr./0000-0003-2978-4366; Karring, Henrik/0000-0002-4672-1503	National Eye Institute [R01 EY012712]; Danish National Research Foundation (inSPIN); NATIONAL EYE INSTITUTE [R01EY012712] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Danish National Research Foundation (inSPIN)(Danmarks Grundforskningsfond); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (R01 EY012712) and the Danish National Research Foundation (inSPIN).	Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Ferguson JW, 2003, CELL TISSUE RES, V313, P93, DOI 10.1007/s00441-003-0743-z; Goldenberg D.P, 1989, PROTEIN STRUCTURE PR, P225; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4; HOLLECKER M, 1982, BIOCHIM BIOPHYS ACTA, V701, P395, DOI 10.1016/0167-4838(82)90243-6; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; Klintworth GK, 1998, AM J PATHOL, V152, P743; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Konishi M, 2000, CURR EYE RES, V21, P891, DOI 10.1076/ceyr.21.5.891.5536; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; LEBARON RG, 1995, J INVEST DERMATOL, V104, P844, DOI 10.1111/1523-1747.ep12607024; Lee SH, 2003, KIDNEY INT, V64, P1012, DOI 10.1046/j.1523-1755.2003.00158.x; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MANAVALAN P, 1985, J BIOSCIENCE, V8, P141, DOI 10.1007/BF02703972; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; Ohno S, 2002, J DENT RES, V81, pA407; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raffen R, 1999, PROTEIN SCI, V8, P509; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; Reinboth B, 2006, J BIOL CHEM, V281, P7816, DOI 10.1074/jbc.M511316200; RUBENSTEIN DS, 1991, J BIOL CHEM, V266, P11252; Runager K, 2009, ACTA CRYSTALLOGR F, V65, P299, DOI 10.1107/S1744309109005016; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stix B, 2005, INVEST OPHTH VIS SCI, V46, P1133, DOI 10.1167/iovs.04-1319; Takacs L, 1998, EXP EYE RES, V66, P739, DOI 10.1006/exer.1998.0471; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	42	51	52	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4951	4958		10.1074/jbc.M110.181099	http://dx.doi.org/10.1074/jbc.M110.181099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135107	Green Published, hybrid			2022-12-27	WOS:000287230600003
J	Spandl, J; Lohmann, D; Kuerschner, L; Moessinger, C; Thiele, C				Spandl, Johanna; Lohmann, Daniel; Kuerschner, Lars; Moessinger, Christine; Thiele, Christoph			Ancient Ubiquitous Protein 1 (AUP1) Localizes to Lipid Droplets and Binds the E2 Ubiquitin Conjugase G2 (Ube2g2) via Its G2 Binding Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CUE DOMAIN; MEMBRANE; DEGRADATION; IDENTIFICATION; PATHWAY; CELLS; DISLOCATION; REDUCTASE; BODIES	Lipid droplets (LDs), the major intracellular storage sites for neutral lipids, consist of a neutral lipid core surrounded by a phospholipid monolayer membrane. In addition to their function in lipid storage, LDs participate in lipid biosynthesis and recently were implicated in proteasomal protein degradation and autophagy. To identify components of the protein degradation machinery on LDs, we studied several candidates identified in previous LD proteome analyses. Here, we demonstrate that the highly conserved and broadly expressed ancient ubiquitous protein 1 (AUP1) localizes to LDs, where it integrates into the LD surface in a monotopic fashion with both termini facing the cytosol. AUP1 contains a C-terminal domain with strong homology to a domain known as G2BR, which binds E2 ubiquitin conjugases. We show that AUP1, by means of its G2BR domain, binds to Ube2g2. This binding is abolished by deletion or mutation of the G2BR domain, although the LD localization of AUP1 is not affected. The presence of the AUP1-Ube2g2 complex at LDs provides a direct molecular link between LDs and the cellular ubiquitination machinery.	[Spandl, Johanna; Lohmann, Daniel; Kuerschner, Lars; Moessinger, Christine; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany	University of Bonn	Thiele, C (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	cthiele@uni-bonn.de			German National Academic Foundation; Deutsche Forschungsgemeinschaft [TR83, SFB645]; European Union	German National Academic Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the German National Academic Foundation (to J. S.), Deutsche Forschungsgemeinschaft Grants TR83 (to C. M.) and SFB645 (to D. L.), and European Union Grant FP7 LipdomicNet (to C. T.).	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jang WH, 1996, GENOMICS, V36, P366, DOI 10.1006/geno.1996.0477; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Karpisheva K V, 2002, Tsitologiia, V44, P846; Karpisheva K V, 2002, Tsitologiia, V44, P830; Karpisheva K V, 2002, Tsitologiia, V44, P839; Kato A, 2002, J BIOL CHEM, V277, P28934, DOI 10.1074/jbc.M204340200; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200	59	78	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5599	5606		10.1074/jbc.M110.190785	http://dx.doi.org/10.1074/jbc.M110.190785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127063	hybrid, Green Published			2022-12-27	WOS:000287230600069
J	Hobor, F; Pergoli, R; Kubicek, K; Hrossova, D; Bacikova, V; Zimmermann, M; Pasulka, J; Hofr, C; Vanacova, S; Stefl, R				Hobor, Fruzsina; Pergoli, Roberto; Kubicek, Karel; Hrossova, Dominika; Bacikova, Veronika; Zimmermann, Michal; Pasulka, Josef; Hofr, Ctirad; Vanacova, Stepanka; Stefl, Richard			Recognition of Transcription Termination Signal by the Nuclear Polyadenylated RNA-binding (NAB) 3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; TORSION ANGLE DYNAMICS; MESSENGER-RNA; 3'-END FORMATION; NRD1; SEQUENCE; COMPLEX; QUALITY; EXOSOME; PATHWAY	Non-coding RNA polymerase II transcripts are processed by the poly(A)-independent termination pathway that requires the Nrd1 complex. The Nrd1 complex includes two RNA-binding proteins, the nuclear polyadenylated RNA-binding (Nab) 3 and the nuclear pre-mRNA down-regulation (Nrd) 1 that bind their specific termination elements. Here we report the solution structure of the RNA-recognition motif (RRM) of Nab3 in complex with a UCUU oligonucleotide, representing the Nab3 termination element. The structure shows that the first three nucleotides of UCUU are accommodated on the beta-sheet surface of Nab3 RRM, but reveals a sequence-specific recognition only for the central cytidine and uridine. The specific contacts we identified are important for binding affinity in vitro as well as for yeast viability. Furthermore, we show that both RNA-binding motifs of Nab3 and Nrd1 alone bind their termination elements with a weak affinity. Interestingly, when Nab3 and Nrd1 form a heterodimer, the affinity to RNA is significantly increased due to the cooperative binding. These findings are in accordance with the model of their function in the poly(A) independent termination, in which binding to the combined and/or repetitive termination elements elicits efficient termination.	[Pasulka, Josef; Vanacova, Stepanka; Stefl, Richard] Masaryk Univ, Natl Ctr Biomol Res, Fac Sci, CZ-62500 Brno, Czech Republic; [Zimmermann, Michal; Hofr, Ctirad] Masaryk Univ, Dept Funct Genom & Prote, Fac Sci, Cent European Inst Technol, CZ-62500 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Stefl, R (corresponding author), Univ Campus Bohunice, Kamenice 5-A4, CZ-62500 Brno, Czech Republic.	stefl@chemi.muni.cz	Kubicek, Karel/D-8495-2012; Vanacova, Stepanka/D-6858-2012; Hrossova, Dominika/D-7256-2012; Vanacova, Stepanka/AGO-9953-2022; Stefl, Richard/D-7010-2012; Hofr, Ctirad/E-3322-2012; Pasulka, Josef/D-8830-2012	Vanacova, Stepanka/0000-0001-8807-0684; Vanacova, Stepanka/0000-0001-8807-0684; Kubicek, Karel/0000-0002-8990-4481; Stefl, Richard/0000-0003-0558-5952; Pasulka, Josef/0000-0001-6190-0465	Howard Hughes Medical Institute/European Molecular Biology Organization; Human Frontier Science Program Career Development; Ministry of Education of the Czech Republic [MSM0021622413, MSM0021622415, Ingo LA08008]; Czech Science Foundation [204/08/1212, 305/10/1490]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA401630903]; Wellcome Trust [084316/Z/07/Z]; EMBO [1642]; Brno City Municipality; European Community [205872]; GACR [204/08/H054]; European Union [RII3-026145]	Howard Hughes Medical Institute/European Molecular Biology Organization(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); Human Frontier Science Program Career Development(Human Frontier Science Program); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Brno City Municipality; European Community(European Commission); GACR(Grant Agency of the Czech Republic); European Union(European Commission)	This work was supported in part by a Howard Hughes Medical Institute/European Molecular Biology Organization start-up grant, a Human Frontier Science Program Career Development Award, Ministry of Education of the Czech Republic Grants MSM0021622413, MSM0021622415, and Ingo LA08008, Czech Science Foundation Grants 204/08/1212 and 305/10/1490, Grant Agency of the Academy of Sciences of the Czech Republic IAA401630903, Wellcome Trust Grant 084316/Z/07/Z, and EMBO Installation Grant 1642.; Supported by Brno City Municipality Scholarships for Talented Ph.D. Students.; Supported by the European Community FP-7 Grant 205872.; Supported by the GACR Grant 204/08/H054.; We thank to Dr. D. Libri for the GAL1::Nab3 strain and Dr. J. L. Corden for the generous gift of the Nab3 2F12 antibodies and the pST39 plasmid, containing Nab3-(191-565) and Nrd1-(1-548). We are grateful to Massimo Lucci for assistance with NMR measurements at CERM Florence, Italy. The NOESY spectra including the intermolecular filter experiments were obtained at the CERM NMR facility supported by European Union-NMR program Grant RII3-026145.	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; [Anonymous], 2008, AMBER 10; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Conrad NK, 2000, GENETICS, V154, P557; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W.L, PYMOL MOL GRAPHICS S; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Padrta P, 2002, J BIOMOL NMR, V24, P1, DOI 10.1023/A:1020632900961; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Pergoli R, 2010, BIOMOL NMR ASSIGN, V4, P119, DOI 10.1007/s12104-010-9221-1; Peterson RD, 2004, J BIOMOL NMR, V28, P59, DOI 10.1023/B:JNMR.0000012861.95939.05; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Trantirek L, 2002, J BIOMOL NMR, V23, P1, DOI 10.1023/A:1015389118506; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	57	35	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3645	3657		10.1074/jbc.M110.158774	http://dx.doi.org/10.1074/jbc.M110.158774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084293	hybrid, Green Published			2022-12-27	WOS:000286653200048
J	Lin, HL; Li, LT; Jia, XA; Ward, DM; Kaplan, J				Lin, Huilan; Li, Liangtao; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry			Genetic and Biochemical Analysis of High Iron Toxicity in Yeast IRON TOXICITY IS DUE TO THE ACCUMULATION OF CYTOSOLIC IRON AND OCCURS UNDER BOTH AEROBIC AND ANAEROBIC CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; MITOCHONDRIAL; TRANSPORTER; SPECIFICITY; IDENTIFICATION; METABOLISM; EXPRESSION	Iron storage in yeast requires the activity of the vacuolar iron transporter Ccc1. Yeast with an intact CCC1 are resistant to iron toxicity, but deletion of CCC1 renders yeast susceptible to iron toxicity. We used genetic and biochemical analysis to identify suppressors of high iron toxicity in Delta ccc1 cells to probe the mechanism of high iron toxicity. All genes identified as suppressors of high iron toxicity in aerobically grown Delta ccc1 cells encode organelle iron transporters including mitochondrial iron transporters MRS3, MRS4, and RIM2. Overexpression of MRS3 suppressed high iron toxicity by decreasing cytosolic iron through mitochondrial iron accumulation. Under anaerobic conditions, Delta ccc1 cells were still sensitive to high iron toxicity, but overexpression of MRS3 did not suppress iron toxicity and did not result in mitochondrial iron accumulation. We conclude that Mrs3/Mrs4 can sequester iron within mitochondria under aerobic conditions but not anaerobic conditions. We show that iron toxicity in Delta ccc1 cells occurred under both aerobic and anaerobic conditions. Microarray analysis showed no evidence of oxidative damage under anaerobic conditions, suggesting that iron toxicity may not be solely due to oxidative damage. Deletion of TSA1, which encodes a peroxiredoxin, exacerbated iron toxicity in Delta ccc1 cells under both aerobic and anaerobic conditions, suggesting a unique role for Tsa1 in iron toxicity.	[Li, Liangtao; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; [Lin, Huilan] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Lin, Huilan/B-7671-2013		National Institutes of Health [DK030534, DK052830]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030534, R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK030534 and DK052830.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jensen LT, 2004, J BIOL CHEM, V279, P29938, DOI 10.1074/jbc.M402795200; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kwast KE, 1998, J EXP BIOL, V201, P1177; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	35	58	59	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3851	3862		10.1074/jbc.M110.190959	http://dx.doi.org/10.1074/jbc.M110.190959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115478	Green Published, hybrid			2022-12-27	WOS:000286653200066
J	Maduzia, LL; Yu, E; Zhang, YH				Maduzia, Lisa L.; Yu, Evan; Zhang, Yinhua			Caenorhabditis elegans Galectins LEC-6 and LEC-10 Interact with Similar Glycoconjugates in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING-PROTEIN; MOLECULES IN-VIVO; FUSION PROTEINS; FUCOSYL-TRANSFERASE; GLYCOPROTEINS; CELLS; RECOGNITION; SPECIFICITY; DIVERSITY; MEMBRANE	Galectins are a family of metazoan proteins that show binding to various beta-galactoside-containing glycans. Because of a lack of proper tools, the interaction of galectins with their specific glycan ligands in the cells and tissues are largely unknown. We have investigated the localization of galectin ligands in Caenorhabditis elegans using a novel technology that relies on the high binding specificity between galectins and their endogenous ligands. Fluorescently labeled recombinant galectin fusions are found to bind to ligands located in diverse tissues including the intestine, pharynx, and the rectal valve. Consistent with their role as galactoside-binding proteins, the interaction with their ligands is inhibited by galactose or lactose. Two of the galectins, LEC-6 and LEC-10, recognize ligands that co-localize along the intestinal lumen. The ligands for LEC-6 and LEC-10 are absent in three glycosylation mutants bre-1, fut-8, and galt-1, which have been shown to be required to synthesize the Gal-beta 1,4-Fuc modifications of the core N-glycans unique to C. elegans and several other invertebrates. Both galectins pull down the same set of glycoproteins in a manner dependent on the presence of these carbohydrate modifications. Endogenous LEC-6 and LEC-10 are expressed in the intestinal cells, but they are localized to different subcellular compartments that do not appear to overlap with each other or with the location of their glycan targets. An altered subcellular distribution of these ligands is found in mutants lacking both galectins. These results suggest a model where LEC-6 and LEC-10 interact with glycoproteins through specific glycans to regulate their cellular fate.	[Maduzia, Lisa L.; Yu, Evan; Zhang, Yinhua] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Zhang, YH (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	zhangy@neb.com		Zhang, Yinhua/0000-0003-0592-9153	National Center for Research Resources of the National Institutes of Health	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Donald Comb and New England Bio-labs, Inc for encouragement and support. We thank Tilde Carlow, Ana Egana, Brendan Galvin, Bill Jack, Liz Li, and Paula Magnelli for critical reading of the manuscript. We thank Markus Kunzler for providing the galt-1(op497) strain and the CGL2 clone, and the Mitani Laboratory of the National Bioresource Project for providing deletion strains carrying lec-6(tm3706) and lec-10(tm1262). Some C. elegans strains were obtained from the Caenorhabditis Genetic Center, which is funded by the National Center for Research Resources of the National Institutes of Health.	Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; BORGONIE G, 1995, FUND APPL NEMATOL, V18, P227; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, Vsecond, P475; Cummings R. D., 2009, ESSENTIALS GLYCOBIOL, P633; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; Hirabayashi J, 1996, J BIOL CHEM, V271, P2497, DOI 10.1074/jbc.271.5.2497; Hsu KL, 2008, MOL BIOSYST, V4, P654, DOI 10.1039/b800725j; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023; MCGHEE JD, 2007, WORMBOOK C ELEGANS I, DOI DOI 10.1895/WORMB00K.1.133.1; Nemoto-Sasaki Y, 2008, BBA-GEN SUBJECTS, V1780, P1131, DOI 10.1016/j.bbagen.2008.07.003; Nemoto-Sasaki Y, 2009, BIOL PHARM BULL, V32, P1973, DOI 10.1248/bpb.32.1973; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Pilobello Kanoelani T., 2007, V385, P193, DOI 10.1007/978-1-59745-426-1_14; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Takeuchi T, 2009, GLYCOBIOLOGY, V19, P1503, DOI 10.1093/glycob/cwp125; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Walser PJ, 2005, FUNGAL GENET BIOL, V42, P293, DOI 10.1016/j.fgb.2004.12.004; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zheng Q, 2008, GLYCOBIOLOGY, V18, P290, DOI 10.1093/glycob/cwn007	46	29	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4371	4381		10.1074/jbc.M110.188581	http://dx.doi.org/10.1074/jbc.M110.188581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115491	Green Published, hybrid			2022-12-27	WOS:000286975700037
J	Rajaiah, R; Puttabyatappa, M; Polumuri, SK; Moudgil, KD				Rajaiah, Rajesh; Puttabyatappa, Muraly; Polumuri, Swamy K.; Moudgil, Kamal D.			Interleukin-27 and Interferon-gamma Are Involved in Regulation of Autoimmune Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; GENE-ENVIRONMENT INTERACTIONS; IL-17-PRODUCING T-CELLS; CENTRAL-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; IFN-GAMMA; MULTIPLE-SCLEROSIS; MYCOBACTERIAL ADJUVANT; TERMINAL DETERMINANTS	Inflammation underlying immune pathology and tissue damage involves an intricate interplay between multiple immunological and biochemical mediators. Cytokines represent the key immune mediators that trigger a cascade of reactions that drive processes such as angiogenesis and proteolytic damage to tissues. IL-17 has now been shown to be a pivotal cytokine in many autoimmune diseases, supplanting the traditional Th1-Th2 paradigm. Also, the dual role of proinflammatory IFN-gamma has unraveled new complexities in the cytokine biology of such disorders. A major hurdle in fully understanding the effector pathways in these disorders is the lack of information regarding the temporal kinetics of the cytokines during the course of the disease, as well as the interplay among the key cytokines. Using an experimental model of arthritic inflammation, we demonstrate that the temporal expression of cytokines during the incubation phase is a critical determinant of disease susceptibility. The susceptible rats raised a vigorous IL-17 response early, followed by IFN-gamma and IL-27 response in that sequence, whereas the resistant rats displayed an early and concurrent response to these three cytokines. Accordingly, treatment with exogenous IFN-gamma/IL-27 successfully controlled arthritic inflammation and inhibited the defined mediators of inflammation, angiogenesis, cell survival, apoptosis, and tissue damage. Furthermore, IFN-gamma enhanced IL-27 secretion, revealing a cooperative interplay between the two cytokines. Our results offer a novel immunobiochemical perspective on the pathogenesis of autoimmune arthritis and its therapeutic control.	[Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Puttabyatappa, Muraly] Univ Maryland, Sch Med, Program Mol Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Moudgil, KD (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, HSF-1,Suite 380,685 W Baltimore St, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Puttabyatappa, Muraly/D-1592-2012; Rajaiah, rajesh/ABA-5509-2021; Rajaiah, Rajesh/A-3403-2012	Puttabyatappa, Muraly/0000-0002-1374-7619; 	National Institutes of Health [RO1AT004321, RO3AI076942]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AT004321 and RO3AI076942.	Afanasyeva M, 2005, P NATL ACAD SCI USA, V102, P180, DOI 10.1073/pnas.0408241102; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boissier MC, 2008, JOINT BONE SPINE, V75, P373, DOI 10.1016/j.jbspin.2008.04.005; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; de Carvalho Jozelio Freire, 2009, Front Biosci (Elite Ed), V1, P501; Di Paola R, 2008, AUTOIMMUN REV, V8, P73, DOI 10.1016/j.autrev.2008.07.029; Durai M, 2004, J IMMUNOL, V172, P2795, DOI 10.4049/jimmunol.172.5.2795; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Furlan Roberto, 2009, V549, P157, DOI 10.1007/978-1-60327-931-4_11; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Handel AE, 2009, NAT REV ENDOCRINOL, V5, P655, DOI 10.1038/nrendo.2009.216; Hembry Rosalind M., 2007, V135, P227; Invernizzi P, 2009, J AUTOIMMUN, V33, P290, DOI 10.1016/j.jaut.2009.07.008; Jonsen A, 2007, AUTOIMMUNITY, V40, P613, DOI 10.1080/08916930701511051; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kap YS, 2010, J NEUROIMMUNE PHARM, V5, P220, DOI 10.1007/s11481-009-9178-y; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kim EY, 2008, CLIN IMMUNOL, V127, P98, DOI 10.1016/j.clim.2008.01.003; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Nikoopour E, 2010, J IMMUNOL, V184, P4779, DOI 10.4049/jimmunol.0902822; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; PEARSON CM, 1963, AM J PATHOL, V42, P73; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Wang R, 2008, CELL MOL LIFE SCI, V65, P3851, DOI 10.1007/s00018-008-8540-1; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wildbaum G, 2010, AM J PATHOL, V176, P2764, DOI 10.2353/ajpath.2010.090855; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu SG, 2002, J IMMUNOL, V169, P3999, DOI 10.4049/jimmunol.169.7.3999; Zhang LM, 2007, NAT MED, V13, P1114, DOI 10.1038/nm1608	55	61	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2817	2825		10.1074/jbc.M110.187013	http://dx.doi.org/10.1074/jbc.M110.187013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21123181	hybrid, Green Published			2022-12-27	WOS:000286464300047
J	Zanotti, S; Smerdel-Ramoya, A; Canalis, E				Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto			HES1 (Hairy and Enhancer of Split 1) Is a Determinant of Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST PRECURSORS; CAUSES OSTEOPENIA; NERVOUS-SYSTEM; IN-VITRO; CELLS; GENES; TRANSCRIPTION; RECEPTOR	HES1 (hairy and enhancer of split) is a transcription factor that regulates osteoblastogenesis in vitro. The skeletal effects of HES1 misexpression were studied. Transgenic mice where a 3.6-kilobase fragment of the collagen type 1 alpha 1 promoter directs HES1 overexpression were created. Transgenics were osteopenic due to decreased osteoblast function in female and increased bone resorption in male mice. HES1 impaired osteoblastogenesis in vitro, and transgenic osteoblasts enhanced the resorptive activity of co-cultured osteoclast precursors. Mice homozygous for a Hes1 loxP-targeted allele were bred to transgenics, where the paired-related homeobox gene enhancer or the osteocalcin promoter direct Cre recombinase expression to inactivate Hes1 in the limb bud or in osteoblasts. To avoid genetic compensation, Hes1 was inactivated in the context of the global deletion of Hes3 and Hes5. Hes3 and Hes5 null mice had no skeletal phenotype. Hes1 inactivation in the limb bud increased femoral length and trabecular number. Hes1 inactivation in osteoblasts increased trabecular bone volume, number, and connectivity due to increased mineral apposition rate and suppressed bone resorption. Hes1 inactivation in vitro increased alkaline phosphatase expression and suppressed the resorptive activity of co-cultured osteoclast precursors. In conclusion, by inhibiting osteoblast function and inducing bone resorption, HES1 is an intracellular determinant of bone mass and structure.	[Zanotti, Stefano] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			National Institutes of Health, NIDDK [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK.	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2005, NEW ENGL J MED, V352, P2014, DOI 10.1056/NEJMe058080; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Cau E, 2000, DEVELOPMENT, V127, P2323; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; IRWIN N, 1989, SAMBROOK; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Karlsson C, 2010, CELLS TISSUES ORGANS, V192, P17, DOI 10.1159/000280416; Katoh M, 2004, INT J ONCOL, V25, P529; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12.100; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wyzga N, 2004, BONE, V35, P614, DOI 10.1016/j.bone.2004.04.022; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang Y, 2009, J CELL BIOCHEM, V108, P651, DOI 10.1002/jcb.22299	62	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2648	2657		10.1074/jbc.M110.183038	http://dx.doi.org/10.1074/jbc.M110.183038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084301	hybrid, Green Published			2022-12-27	WOS:000286464300030
J	Marjenberg, ZR; Ellis, IR; Hagan, RM; Prabhakaran, S; Hook, M; Talay, SR; Potts, JR; Staunton, D; Schwarz-Linek, U				Marjenberg, Zoe R.; Ellis, Ian R.; Hagan, Robert M.; Prabhakaran, Sabitha; Hoeoek, Magnus; Talay, Susanne R.; Potts, Jennifer R.; Staunton, David; Schwarz-Linek, Ulrich			Cooperative Binding and Activation of Fibronectin by a Bacterial Surface Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-STIMULATING FACTOR; STAPHYLOCOCCUS-AUREUS FNBPA; GROUP-A STREPTOCOCCI; TANDEM BETA-ZIPPER; EPITHELIAL-CELLS; GELATIN-BINDING; HOST-CELLS; PYOGENES; DOMAIN; ENTRY	Integrin-dependent cell invasion of some pathogenic bacteria is mediated by surface proteins targeting the extracellular matrix protein fibronectin (FN). Although the structural basis for bacterial FN recognition is well understood, it has been unclear why proteins such as streptococcal SfbI contain several FN-binding sites. We used microcalorimetry to reveal cooperative binding of FN fragments to arrays of binding sites in SfbI. In combination with thermodynamic analyses, functional cell-based assays show that SfbI induces conformational changes in the N-terminal 100-kDa region of FN (FN100kDa), most likely by competition with intramolecular interactions defining an inactive state of FN100kDa. This study provides insights into how long range conformational changes resulting in FN activation may be triggered by bacterial pathogens.	[Schwarz-Linek, Ulrich] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Ellis, Ian R.] Univ Dundee, Sch Dent, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland; [Prabhakaran, Sabitha; Hoeoek, Magnus] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Talay, Susanne R.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; [Staunton, David] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of St Andrews; University of Dundee; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Helmholtz Association; Helmholtz-Center for Infection Research; University of York - UK; University of York - UK; University of Oxford	Schwarz-Linek, U (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	us6@st-andrews.ac.uk	Ellis, Ian/AAM-9833-2021	Ellis, Ian/0000-0001-8035-6012; Schwarz-Linek, Ulrich/0000-0003-0526-223X	E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom); BBSRC [BB/D010608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER	E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom).	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Beer C, 2007, J VIROL, V81, P8247, DOI 10.1128/JVI.00312-07; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; CLARK RAF, 1988, J BIOL CHEM, V263, P12115; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1980, J CELL SCI, V41, P159; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Towers RJ, 2003, J CLIN MICROBIOL, V41, P5398, DOI 10.1128/JCM.41.12.5398-5406.2003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Zhao QS, 2001, EXP CELL RES, V268, P211, DOI 10.1006/excr.2001.5291	45	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1884	1894		10.1074/jbc.M110.183053	http://dx.doi.org/10.1074/jbc.M110.183053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059652	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000286191500029
J	Griesser, M; Pistis, V; Suzuki, T; Tejera, N; Pratt, DA; Schneider, C				Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Pratt, Derek A.; Schneider, Claus			Autoxidative and Cyclooxygenase-2 Catalyzed Transformation of the Dietary Chemopreventive Agent Curcumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE METHIDE FORMATION; KAPPA-B ACTIVATION; ANTIOXIDANT MECHANISM; DEGRADATION-PRODUCTS; ANTICANCER ACTIVITY; DNA-ADDUCTS; CANCER; INHIBITION; LIPOXYGENASE; CELLS	The efficacy of the diphenol curcumin as a cancer chemopreventive agent is limited by its chemical and metabolic instability. Non-enzymatic degradation has been described to yield vanillin, ferulic acid, and feruloylmethane through cleavage of the heptadienone chain connecting the phenolic rings. Here we provide evidence for an alternative mechanism, resulting in autoxidative cyclization of the heptadienone moiety as a major pathway of degradation. Autoxidative transformation of curcumin was pH-dependent with the highest rate at pH 8 (2.2 mu M/min) and associated with stoichiometric uptake of O-2. Oxidation was also catalyzed by recombinant cyclooxygenase-2 (COX-2) (50 nM; 7.5 mu M/min), and the rate was increased approximate to 10-fold by the addition of 300 mu M H2O2. The COX-2 catalyzed transformation was inhibited by acetaminophen but not indomethacin, suggesting catalysis occurred by the peroxidase activity. We propose a mechanism of enzymatic or autoxidative hydrogen abstraction from a phenolic hydroxyl to give a quinone methide and a delocalized radical in the heptadienone chain that undergoes 5-exo cyclization and oxygenation. Hydration of the quinone methide (measured by the incorporation of O-18 from H-2 O-18) and rearrangement under loss of water gives the final dioxygenated bicyclopentadione product. When curcumin was added to RAW264.7 cells, the bicyclopentadione was increased 1.8-fold in cells activated by LPS; vanillin and other putative cleavage products were negligible. Oxidation to a reactive quinone methide is the mechanistic basis of many phenolic anti-cancer drugs. It is possible, therefore, that oxidative transformation of curcumin, a prominent but previously unrecognized reaction, contributes to its cancer chemopreventive activity.	[Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Pratt, Derek A.] Queens Univ, Dept Chem, Kingston, ON KL7 3N6, Canada	Vanderbilt University; Vanderbilt University; Queens University - Canada	Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Pratt, Derek A/A-1453-2011; Suzuki, Takashi/B-7656-2014; Tejera, Noemi/O-1558-2016	Suzuki, Takashi/0000-0002-2058-3333; Tejera, Noemi/0000-0001-8100-6022	National Institutes of Health, Center of Molecular Toxicology [P30 ES000267]; NIGMS [R01GM076592]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Institutes of Health, Center of Molecular Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pilot and Feasibility Grant P30 ES000267 from the Center of Molecular Toxicology and Grant R01GM076592 from the NIGMS.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Appiah-Opong R, 2007, TOXICOLOGY, V235, P83, DOI 10.1016/j.tox.2007.03.007; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bodell WJ, 1998, CARCINOGENESIS, V19, P437, DOI 10.1093/carcin/19.3.437; BOLTON JL, 1995, CHEM-BIOL INTERACT, V95, P279, DOI 10.1016/0009-2797(94)03566-Q; Dempe JS, 2008, MOL NUTR FOOD RES, V52, P1074, DOI 10.1002/mnfr.200800029; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; Dhillon N, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-2362; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; Garcea G, 2005, CANCER EPIDEM BIOMAR, V14, P120; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; HAIM N, 1987, CANCER RES, V47, P5835; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; HUANG MT, 1991, CANCER RES, V51, P813; Ireson C, 2001, CANCER RES, V61, P1058; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; KHURANA A, 1988, J LIQ CHROMATOGR, V11, P2295, DOI 10.1080/01483918808067200; KLASING SA, 1985, P SOC EXP BIOL MED, V179, P529; KLEGERIS A, 1995, FREE RADICAL BIO MED, V18, P215, DOI 10.1016/0891-5849(94)00141-6; Koeberle A, 2009, MOL CANCER THER, V8, P2348, DOI 10.1158/1535-7163.MCT-09-0290; Litwinienko G, 2004, J ORG CHEM, V69, P5888, DOI 10.1021/jo049254j; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; MOORE HW, 1986, DRUG EXP CLIN RES, V12, P475; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; PETERSON DM, 1986, BIOCHEMISTRY-US, V25, P4077, DOI 10.1021/bi00362a014; Pfeiffer E, 2003, J FOOD ENG, V56, P257, DOI 10.1016/S0260-8774(02)00264-9; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Prasad NS, 2004, PROSTAG LEUKOTR ESS, V70, P521, DOI 10.1016/j.plefa.2003.11.006; Ramsewak RS, 2000, PHYTOMEDICINE, V7, P303, DOI 10.1016/S0944-7113(00)80048-3; Rao CV, 2007, ADV EXP MED BIOL, V595, P213; Reddy Bandaru S., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P155; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 1998, J MOL CATAL B-ENZYM, V4, P219, DOI 10.1016/S1381-1177(98)00002-2; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Shen L, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-1749; Skrzypczak-Jankun E, 2003, INT J MOL MED, V12, P17; Szewczuk LM, 2005, J NAT PROD, V68, P36, DOI 10.1021/np049702i; THOMPSON D, 1989, CHEM RES TOXICOL, V2, P186, DOI 10.1021/tx00009a011; THOMPSON DC, 1995, CHEM RES TOXICOL, V8, P323, DOI 10.1021/tx00045a001; THOMPSON DC, 1993, CHEM-BIOL INTERACT, V86, P129, DOI 10.1016/0009-2797(93)90117-H; TONNESEN HH, 1986, Z LEBENSM UNTERS FOR, V183, P116, DOI 10.1007/BF01041928; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P132, DOI 10.1007/BF01042637; Toth G, 2000, MAGN RESON CHEM, V38, P51, DOI 10.1002/(SICI)1097-458X(200001)38:1<51::AID-MRC593>3.3.CO;2-U; van der Woude H, 2005, CHEM RES TOXICOL, V18, P1907, DOI 10.1021/tx050201m; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Werz O, 2007, PLANTA MED, V73, P1331, DOI 10.1055/s-2007-990242	56	110	111	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1114	1124		10.1074/jbc.M110.178806	http://dx.doi.org/10.1074/jbc.M110.178806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071447	Green Published, hybrid			2022-12-27	WOS:000286005000022
J	Hernandez, D; Miquel-Serra, L; Docampo, MJ; Marco-Ramell, A; Cabrera, J; Fabra, A; Bassols, A				Hernandez, Daniel; Miquel-Serra, Laia; Docampo, Maria-Jose; Marco-Ramell, Anna; Cabrera, Jennifer; Fabra, Angels; Bassols, Anna			V3 Versican Isoform Alters the Behavior of Human Melanoma Cells by Interfering with CD44/ErbB-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CHONDROITIN SULFATE PROTEOGLYCAN; BREAST-CANCER; CLINICOPATHOLOGICAL FACTORS; CD44 EXPRESSION; CARCINOMA-CELLS; FACTOR RECEPTOR; OVARIAN-CANCER; COLON-CANCER; IN-VIVO	Versican is a hyaluronan-binding, extracellular chondroitin sulfate proteoglycan produced by several tumor types, including malignant melanoma, which exists as four different splice variants. The short V3 isoform contains the G1 and G3 terminal domains of versican that may potentially interact directly or indirectly with the hyaluronan receptor CD44 and the EGFR, respectively. We have previously described that overexpression of V3 in MeWo human melanoma cells markedly reduces tumor cell growth in vitro and in vivo. In this study we have investigated the signaling mechanism of V3 by silencing the expression of CD44 in control and V3-expressing melanoma cells. Suppression of CD44 had the same effects on cell proliferation and cell migration than those provoked by V3 expression, suggesting that V3 acts through a CD44-mediated mechanism. Furthermore, CD44-dependent hyaluronan internalization was blocked by V3 expression and CD44 silencing, leading to an accumulation of this glycosaminoglycan in the pericellular matrix and to changes in cell migration on hyaluronan. Furthermore, ERK1/2 and p38 activation after EGF treatment were decreased in V3-expressing cells suggesting that V3 may also interact with the EGFR through its G3 domain. The existence of a EGFR/ErbB2 receptor complex able to interact with CD44 was identified in MeWo melanoma cells. V3 overexpression resulted in a reduced interaction between EGFR/ErbB2 and CD44 in response to EGF treatment. Our results indicate that the V3 isoform of versican interferes with CD44 and the CD44-EGFR/ErbB2 interaction, altering the signaling pathways, such as ERK1/2 and p38 MAPK, that regulate cell proliferation and migration.	[Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Fabra, Angels] IDIBELL, Inst Recerca Oncol, Lhospitalet De Llobregat 08907, Spain	Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Bassols, A (corresponding author), Edifici 5, Cerdanyola Del Valles 08193, Spain.	anna.bassols@uab.cat	Bassols, Anna/K-7961-2014; Docampo, María José/A-4957-2009; Marco-Ramell, Anna/C-7799-2011	Bassols, Anna/0000-0003-4213-2274; Docampo, Maria Jose/0000-0003-1242-222X; Miquel Serra, Laia/0000-0001-8382-3341	Ministerio de Ciencia y Tecnologia [AGL2006-02365]; Generalitat de Catalunya [2009 SGR-1091]; European Union; Spanish Ministerio de Educacion	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Union(European Commission); Spanish Ministerio de Educacion(Spanish Government)	This work was supported in part by Grant AGL2006-02365 from the Ministerio de Ciencia y Tecnologia, Grant 2009 SGR-1091 from the Generalitat de Catalunya (to A.B.), and the FEDER program from the European Union.; Supported by a fellowship from the Spanish Ministerio de Educacion	Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Gordon-Thomson C, 2005, MELANOMA RES, V15, P21, DOI 10.1097/00008390-200502000-00005; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; HUA Q, 1993, J CELL SCI, V106, P365; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Isogai Z, 1996, CANCER RES, V56, P3902; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Li CZ, 2008, FOLIA BIOL-PRAGUE, V54, P180; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; New LG, 2001, J CELL BIOCHEM, V83, P585, DOI 10.1002/jcb.1253; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Pukkila M, 2007, J CLIN PATHOL, V60, P267, DOI 10.1136/jcp.2005.034181; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shi Y, 2007, ONCOL REP, V18, P397; STERN M, 1992, MATRIX, V12, P397, DOI 10.1016/S0934-8832(11)80036-3; Stove C, 2003, J INVEST DERMATOL, V121, P802, DOI 10.1046/j.1523-1747.2003.12522.x; Subramaniam V, 2007, EXP MOL PATHOL, V83, P332, DOI 10.1016/j.yexmp.2007.08.013; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Touab M, 2003, AM J CLIN PATHOL, V119, P587, DOI 10.1309/ME25J1G5E57LM3; Touab M, 2002, AM J PATHOL, V160, P549, DOI 10.1016/S0002-9440(10)64874-2; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Voutilainen K, 2003, INT J CANCER, V107, P359, DOI 10.1002/ijc.11423; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	48	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1475	1485		10.1074/jbc.M110.127522	http://dx.doi.org/10.1074/jbc.M110.127522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078678	hybrid, Green Published			2022-12-27	WOS:000286005000060
J	Rong, JA; Chen, LL; Toth, JI; Tcherpakov, M; Petroski, MD; Reed, JC				Rong, Juan; Chen, Lili; Toth, Julia I.; Tcherpakov, Marianna; Petroski, Matthew D.; Reed, John C.			Bifunctional Apoptosis Regulator (BAR), an Endoplasmic Reticulum (ER)-associated E3 Ubiquitin Ligase, Modulates BI-1 Protein Stability and Function in ER Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; CELL-DEATH; NEGATIVE REGULATOR; PROAPOPTOTIC BAX; INHIBITOR-1; DEGRADATION; IRE1-ALPHA; CHAINS; IRE1; ACTIVATION	Accumulation of misfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activates inositol-requiring protein-1 (IRE1), among other ER-associated signaling proteins of the unfolded protein response (UPR) in mammalian cells. IRE1 signaling becomes attenuated under prolonged ER stress. The mechanisms by which this occurs are not well understood. An ER resident protein, Bax inhibitor-1 (BI-1), interacts with IRE1 and directly inhibits IRE1 activity. However, little is known about regulation of the BI-1 protein. We show here that bifunctional apoptosis regulator (BAR) functions as an ER-associated RING-type E3 ligase, interacts with BI-1, and promotes proteasomal degradation of BI-1. Overexpression of BAR reduced BI-1 protein levels in a RING-dependent manner. Conversely, knockdown of endogenous BAR increased BI-1 protein levels and enhanced inhibition of IRE1 signaling during ER stress. We also found that the levels of endogenous BAR were reduced under prolonged ER stress. Our findings suggest that post-translational regulation of the BI-1 protein by E3 ligase BAR contributes to the dynamic control of IRE1 signaling during ER stress.	[Rong, Juan; Chen, Lili; Toth, Julia I.; Tcherpakov, Marianna; Petroski, Matthew D.; Reed, John C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org			National Institutes of Health [AG-15393]; American Heart Association [0825021F]; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-15393 (to J.C.R.) and American Heart Association Western States Affiliate Postdoctoral Fellowship 0825021F (to J.R.).	Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Isbat M, 2009, J PLANT PHYSIOL, V166, P1685, DOI 10.1016/j.jplph.2009.04.017; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Mukasa T, 2007, ACTA CRYSTALLOGR F, V63, P297, DOI 10.1107/S1744309107008925; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Schmidt SM, 2009, LEUKEMIA, V23, P1818, DOI 10.1038/leu.2009.138; Tcherpakov M, 2008, MOL BIOL CELL, V19, P5019, DOI 10.1091/mbc.E08-08-0839; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang ZL, 2004, J BIOL CHEM, V279, P48168, DOI 10.1074/jbc.M405022200; Watanabe N, 2008, PLANT SIGNAL BEHAV, V3, P564, DOI 10.4161/psb.3.8.5709; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xia Z. P., 2005, SCI STKE, V2005, ppe7; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	45	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1453	1463		10.1074/jbc.M110.175232	http://dx.doi.org/10.1074/jbc.M110.175232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068390	Green Published, hybrid			2022-12-27	WOS:000286005000058
J	Cacciottolo, M; Belcastro, V; Laval, S; Bushby, K; di Bernardo, D; Nigro, V				Cacciottolo, Mafalda; Belcastro, Vincenzo; Laval, Steve; Bushby, Kate; di Bernardo, Diego; Nigro, Vincenzo			Reverse Engineering Gene Network Identifies New Dysferlin-interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; TRANSCRIPT RELEASE FACTOR; MEMBRANE REPAIR; SKELETAL-MUSCLE; GENERALIZED LIPODYSTROPHY; POLYMERASE-I; PTRF-CAVIN; EXPRESSION; CAVEOLAE; PHOSPHORYLATION	Dysferlin (DYSF) is a type II transmembrane protein implicated in surface membrane repair of muscle. Mutations in dysferlin lead to Limb Girdle Muscular Dystrophy 2B (LGMD2B), Miyoshi Myopathy (MM), and Distal Myopathy with Anterior Tibialis onset (DMAT). The DYSF protein complex is not well understood, and only a few protein-binding partners have been identified thus far. To increase the set of interacting protein partners for DYSF we recovered a list of predicted interacting protein through a systems biology approach. The predictions are part of a "reverse-engineered" genome-wide human gene regulatory network obtained from experimental data by computational analysis. The reverse-engineering algorithm behind the analysis relates genes to each other based on changes in their expression patterns. DYSF and AHNAK were used to query the system and extract lists of potential interacting proteins. Among the 32 predictions the two genes share, we validated the physical interaction between DYSF protein with moesin (MSN) and polymerase I and transcript release factor (PTRF) in mouse heart lysate, thus identifying two novel Dysferlin-interacting proteins. Our strategy could be useful to clarify Dysferlin function in intracellular vesicles and its implication in muscle membrane resealing.	[Nigro, Vincenzo] TIGEM Telethon Inst Genet & Med, I-80131 Naples, Italy; [Laval, Steve; Bushby, Kate] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Nigro, Vincenzo] Seconda Univ Napoli, Dipartimento Patol Gen, Med Genet Lab, I-80138 Naples, Italy; [Nigro, Vincenzo] Seconda Univ Napoli, CIRM, I-80138 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Newcastle University - UK; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Nigro, V (corresponding author), TIGEM Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	vincenzo.nigro@unina2.it	Nigro, Vincenzo/AAB-2274-2022; di Bernardo, Diego/I-9440-2012; di Bernardo, Diego/AAF-5881-2021	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Nigro, Vincenzo/0000-0002-3378-5006; Cacciottolo, Mafalda/0000-0003-3093-0535; Belcastro, Vincenzo/0000-0003-3749-0018	Telethon [(TIGEM-TNP42TELC), FP7/2007-2013, 223143]; Ministero della Salute [(Ricerca Finalizzata RF-MUL-2007-666195)]; Telethon-UILDM; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0601943] Funding Source: UKRI	Telethon(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); Telethon-UILDM(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from Telethon (TIGEM-TNP42TELC) and FP7/2007-2013 under Grant agreement no. 223143 ( Project acronym: TECHGENE), from Ministero della Salute (Ricerca Finalizzata RF-MUL-2007-666195) and from Telethon-UILDM.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Ampong Beryl N, 2005, Acta Myol, V24, P134; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Butte A J, 2000, Pac Symp Biocomput, P418; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Nigro V, 2003, Acta Myol, V22, P35; Paradas C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0b013e3181ea1564; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Santoro L, 2010, MUSCLE NERVE, V41, P392, DOI 10.1002/mus.21506; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494; Walter MC, 2003, J NEUROL, V250, P1431, DOI 10.1007/s00415-003-0234-x	46	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5404	5413		10.1074/jbc.M110.173559	http://dx.doi.org/10.1074/jbc.M110.173559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21119217	Green Published, hybrid			2022-12-27	WOS:000287230600049
J	Tajima, N; Itokazu, Y; Korpi, ER; Somerharju, P; Kakela, R				Tajima, Nobuyoshi; Itokazu, Yutaka; Korpi, Esa R.; Somerharju, Pentti; Kakela, Reijo			Activity of BKCa Channel Is Modulated by Membrane Cholesterol Content and Association with Na+/K+-ATPase in Human Melanoma IGR39 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; ENDOTHELIAL-CELLS; SIGNALING COMPLEX; LARGE-CONDUCTANCE; NA/K-ATPASE; MASS-SPECTROMETRY; GLIOMA-CELLS; ION CHANNELS; CANCER CELLS	Interaction of large conductance Ca2+- and voltage-activated K+ ( BKCa) channels with Na+/K+-ATPase, caveolin-1, and cholesterol was studied in human melanoma IGR39 cells. Functional BKCa channels were enriched in caveolin-rich and detergent-resistant membranes, i.e. rafts, and blocking of the channels by a specific BKCa blocker paxilline reduced proliferation of the cells. Disruption of rafts by selective depletion of cholesterol released BKCa channels from these domains with a consequent increase in their activity. Consistently, cholesterol enrichment of the cells increased the proportion of BKCa channels in rafts and decreased their activity. Immunocytochemical analysis showed that BKCa channels co-localize with Na+/K+-ATPase in a cholesterol-dependent manner, thus suggesting their co-presence in rafts. Supporting this, ouabain, a specific blocker of Na+/K+-ATPase, inhibited BKCa whole-cell current markedly in control cells but not in cholesterol-depleted ones. This inhibition required the presence of external Na+. Collectively, these data indicate that the presence of Na+/K+-ATPase in rafts is essential for efficient functioning of BKCa channels, presumably because the pump maintains a low intracellular Na+ proximal to the BKCa channel. In conclusion, cholesterol could play an important role in cellular ion homeostasis and thus modulate many cellular functions and cell proliferation.	[Tajima, Nobuyoshi; Itokazu, Yutaka; Somerharju, Pentti; Kakela, Reijo] Univ Helsinki, Inst Biomed, Dept Med Biochem & Dev Biol, FI-00014 Helsinki, Finland; [Korpi, Esa R.] Univ Helsinki, Dept Pharmacol, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Kakela, R (corresponding author), Univ Helsinki, Dept Biosci, POB 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	reijo.kakela@helsinki.fi		Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [111261, 129148]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grants 111261 and 129148 (to R. K.).	Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Allard B, 2000, J BIOL CHEM, V275, P25556, DOI 10.1074/jbc.M002327200; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jha S, 2009, FEBS LETT, V583, P3109, DOI 10.1016/j.febslet.2009.08.039; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Kuhlmann CRW, 2005, PLANTA MED, V71, P520, DOI 10.1055/s-2005-864152; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Liu SI, 1998, BBA-BIOMEMBRANES, V1368, P256, DOI 10.1016/S0005-2736(97)00183-1; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Luedders DW, 2006, J CARDIOVASC PHARM, V47, P365; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Ma DWL, 2004, FASEB J, V18, P1040, DOI 10.1096/fj.03-1430fje; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rudiger C, 2004, J AM SOC NEPHROL, V15, P868, DOI 10.1097/01.ASN.0000115782.77586.88; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCOTT RE, 1979, J CELL SCI, V35, P229; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Yamamoto S, 1996, AM J PHYSIOL-CELL PH, V270, pC457, DOI 10.1152/ajpcell.1996.270.2.C457; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	70	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5624	5638		10.1074/jbc.M110.149898	http://dx.doi.org/10.1074/jbc.M110.149898			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135099	Green Published, hybrid			2022-12-27	WOS:000287230600072
J	van der Heide, LP; van Dinther, M; Moustakas, A; ten Dijke, P				van der Heide, Lars P.; van Dinther, Maarten; Moustakas, Aristidis; ten Dijke, Peter			TGF beta Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; PHOSPHORYLATION SITES; INDUCED APOPTOSIS; EPITHELIAL-CELLS; SMAD PROTEINS; CANCER CELLS; CREB; EXPRESSION; RESPONSES; PROTEIN-KINASE-1	Transforming growth factor-beta (TGF beta) binding to its receptor leads to intracellular phosphorylation of Smad2 and Smad3, which oligomerize with Smad4. These complexes accumulate in the nucleus and induce gene transcription. Here we describe mitogen-and stress-activated kinase 1 (MSK1) as an antagonist of TGF beta-induced cell death. Induction of MSK1 activity by TGF beta depends on Smad4 and p38 MAPK activation. Knockdown of GADD45, a Smad4-induced upstream regulator of p38 MAPK prevents TGF beta-induced p38 and MSK1 activity. MSK1 functionally regulates pro-apoptotic BH3-only BCL2 proteins, as MSK1 knockdown reduces Bad phosphorylation and enhances Noxa and Bim expression, leading to enhanced TGF beta-induced caspase-3 activity and cell death. This finding suggests that MSK1 represents a pro-survival pathway bifurcating downstream of p38 and antagonizes the established pro-apoptotic p38 MAPK function. Furthermore, EGF could reverse all the effects observed after MSK1 knockdown. Monitoring the status of MSK1 activity in cancer promises new therapeutic targets as inactivating both MSK1 and EGF signaling may (re)-sensitize cells to TGF beta-induced cell death.	[van der Heide, Lars P.; Moustakas, Aristidis; ten Dijke, Peter] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, S-75124 Uppsala, Sweden; [van der Heide, Lars P.; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [van der Heide, Lars P.; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Ctr Biomed Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Moustakas, Aristidis] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University	van der Heide, LP (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595, S-75124 Uppsala, Sweden.	lars.vdh@LICR.uu.se	Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; van der Heide, Lars P./0000-0003-1779-425X	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery [09 0773]	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery	This work was supported by the Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program and Cancerfonden (Contract Number: 09 0773).	Abecassis L, 2004, J BIOL CHEM, V279, P30474, DOI 10.1074/jbc.M403294200; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Olson CM, 2007, INFECT IMMUN, V75, P270, DOI 10.1128/IAI.01412-06; Piek E, 1999, J CELL SCI, V112, P4557; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; REILAND J, 1993, J CELL SCI, V105, P1085; Rosfjord EC, 1999, J MAMMARY GLAND BIOL, V4, P229, DOI 10.1023/A:1018789527533; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	37	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5003	5011		10.1074/jbc.M110.167379	http://dx.doi.org/10.1074/jbc.M110.167379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21106525	hybrid, Green Published			2022-12-27	WOS:000287230600008
J	Aslam, N; Zaheer, I				Aslam, Naveed; Zaheer, Irum			The Biosynthesis Characteristics of TTP and TNF Can Be Regulated through a Posttranscriptional Molecular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; MESSENGER-RNA; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; FOS PROTEIN; GM-CSF; GENE	The abundant expression of tumor necrosis factor (TNF) is a hallmark of chronic inflammation of the gastrointestinal tract. Prolonged inflammation can lead to inflammatory bowel disease. TNF biosynthesis is regulated both at transcription and posttranscriptional levels. However, the stimulation-induced increase in translation rate is much larger. This might indicate the possibility of a posttranscriptional regulatory mechanism. How, during basal conditions, is the free concentration of TNF tightly regulated at low levels? The stability and translational efficiency of TNF transcript are regulated by an AU-rich element (ARE) in the 3'-UTR of messenger RNA. A transacting protein, TTP, binds to ARE and enhances the mRNA turnover. Here, we examine a proposal that TNF homeostasis is regulated by a TTP-TNF interaction loop at the posttranscriptional level. We propose a computational framework of this regulatory loop by modeling the role of AREs in mediating the messenger RNA stability and translation. This posttranscriptional regulatory loop between TTP and TNF is composed of two feedback loops (i.e. positive and negative). The mutual interaction of these feedback loops regulates the biosynthesis response of TNF during basal and inflammatory conditions. Here, we also propose an explanation for why the p38 inhibitors become insensitive for TTP knock-out mice.	[Aslam, Naveed] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Zaheer, Irum] Methodist Hosp, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Aslam, N (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, 6431 Fannin St, Houston, TX 77030 USA.	naslam621@yahoo.com	Aslam, Naveed/AAX-1323-2020		National Institutes of Health [2 P01-NS038310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 P01-NS038310.	Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Jacob CO, 1996, J IMMUNOL, V156, P3043; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MILLER AD, 1984, CELL, V36, P51; NAIR APK, 1994, NATURE, V369, P239, DOI 10.1038/369239a0; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Pullmann R, 2005, J BIOL CHEM, V280, P22819, DOI 10.1074/jbc.M501106200; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRIGGS DR, 1990, CANCER RES, V50, P7101; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200	35	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3767	3776		10.1074/jbc.M110.168757	http://dx.doi.org/10.1074/jbc.M110.168757			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21088298	Green Published, hybrid			2022-12-27	WOS:000286653200058
J	Bermek, O; Grindley, NDF; Joyce, CM				Bermek, Oya; Grindley, Nigel D. F.; Joyce, Catherine M.			Distinct Roles of the Active-site Mg2+ Ligands, Asp(882) and Asp(705), of DNA Polymerase I (Klenow Fragment) during the Prechemistry Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; DEOXYNUCLEOSIDE TRIPHOSPHATE; NUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; TERNARY COMPLEX; BETA; MECHANISM; CATALYSIS; REPLICATION	DNA polymerases catalyze the incorporation of deoxynucleoside triphosphates into a growing DNA chain using a pair of Mg2+ ions, coordinated at the active site by two invariant aspartates, whose removal by mutation typically reduces the polymerase activity to barely detectable levels. Using two stopped-flow fluorescence assays that we developed previously, we have investigated the role of the carboxylate ligands, Asp(705) and Asp(882), of DNA polymerase I (Klenow fragment) in the early prechemistry steps that prepare the active site for catalysis. We find that neither carboxylate is required for an early conformational transition, reported by a 2-aminopurine probe, that takes place in the open ternary complex after binding of the complementary dNTP. However, the subsequent fingers-closing step requires Asp(882); this step converts the open ternary complex into the closed conformation, creating the active-site geometry required for catalysis. Crystal structures indicate that the Asp(882) position changes very little during fingers-closing; this side chain may therefore serve as an anchor point to receive the dNTP-associated metal ion as the nucleotide is delivered into the active site. The Asp(705) carboxylate is not required until after the fingers-closing step, and we suggest that its role is to facilitate the entry of the second Mg2+ into the active site. The two early prechemistry steps that we have studied take place normally at very low Mg2+ concentrations, although higher concentrations are needed for covalent nucleotide addition, consistent with the second metal ion entering the ternary complex after fingers-closing.	[Joyce, Catherine M.] Yale Univ, Bass Ctr Mol & Struct Biol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Joyce, CM (corresponding author), Yale Univ, Bass Ctr Mol & Struct Biol, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	catherine.joyce@yale.edu			National Institutes of Health [GM-28550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28550.	Arndt JW, 2001, BIOCHEMISTRY-US, V40, P5368, DOI 10.1021/bi002176j; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Florian J, 2003, J AM CHEM SOC, V125, P8163, DOI 10.1021/ja028997o; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 1995, METHOD ENZYMOL, V262, P3; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhong XJ, 1998, J AM CHEM SOC, V120, P235, DOI 10.1021/ja973507r	36	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3755	3766		10.1074/jbc.M110.167593	http://dx.doi.org/10.1074/jbc.M110.167593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084297	Green Published, hybrid			2022-12-27	WOS:000286653200057
J	Palomo, M; Pijning, T; Booiman, T; Dobruchowska, JM; van der Vlist, J; Kralj, S; Planas, A; Loos, K; Kamerling, JP; Dijkstra, BW; van der Maarel, MJEC; Dijkhuizen, L; Leemhuis, H				Palomo, Marta; Pijning, Tjaard; Booiman, Thijs; Dobruchowska, Justyna M.; van der Vlist, Jeroen; Kralj, Slavko; Planas, Antoni; Loos, Katja; Kamerling, Johannis P.; Dijkstra, Bauke W.; van der Maarel, Marc J. E. C.; Dijkhuizen, Lubbert; Leemhuis, Hans			Thermus thermophilus Glycoside Hydrolase Family 57 Branching Enzyme CRYSTAL STRUCTURE, MECHANISM OF ACTION, AND PRODUCTS FORMED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOCOCCUS-LITORALIS; BACTERIAL GLYCOGEN; 4-ALPHA-GLUCANOTRANSFERASE; IDENTIFICATION; PHOSPHORYLASE; EVOLUTION; PROTEINS; MARKER	Branching enzyme (EC 2.4.1.18; glycogen branching enzyme; GBE) catalyzes the formation of alpha 1,6-branching points in glycogen. Until recently it was believed that all GBEs belong to glycoside hydrolase family 13 (GH13). Here we describe the cloning and expression of the Thermus thermophilus family GH57-type GBE and report its biochemical properties and crystal structure at 1.35-angstrom resolution. The enzyme has a central (beta/alpha)(7)-fold catalytic domain A with an inserted domain B between beta 2 and alpha 5 and an alpha-helix-rich C-terminal domain, which is shown to be essential for substrate binding and catalysis. A maltotriose was modeled in the active site of the enzyme which suggests that there is insufficient space for simultaneously binding of donor and acceptor substrates, and that the donor substrate must be cleaved before acceptor substrate can bind. The biochemical assessment showed that the GH57 GBE possesses about 4% hydrolytic activity with amylose and in vitro forms a glucan product with a novel fine structure, demonstrating that the GH57 GBE is clearly different from the GH13 GBEs characterized to date.	[Palomo, Marta; Booiman, Thijs; Dobruchowska, Justyna M.; Kralj, Slavko; Kamerling, Johannis P.; van der Maarel, Marc J. E. C.; Dijkhuizen, Lubbert; Leemhuis, Hans] Groningen Biomol Sci & Biotechnol Inst GBB, Dept Microbiol, NL-9751 NN Haren, Netherlands; [Pijning, Tjaard; Dijkstra, Bauke W.] Univ Groningen, Zernike Inst Adv Mat, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [van der Vlist, Jeroen; Loos, Katja] Univ Groningen, Zernike Inst Adv Mat, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands; [Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain	University of Groningen; University of Groningen; University of Groningen; Universitat Ramon Llull; Institut Quimic de Sarria	Dijkhuizen, L (corresponding author), Groningen Biomol Sci & Biotechnol Inst GBB, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	L.Dijkhuizen@rug.nl	Institute, Zernike/W-7033-2019; Pijning, Tjaard/HDO-3704-2022; Loos, Katja/ABH-1104-2021; Dijkhuizen, Lubbert/E-9454-2014; DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; PLANAS, ANTONI/I-4803-2015; Pijning, Tjaard/ABA-2929-2021; Dijkstra, Bauke W./H-4308-2019; Dijkhuizen, Lubbert/K-3539-2019; Loos, Katja/B-9792-2008	Loos, Katja/0000-0002-4613-1159; PLANAS, ANTONI/0000-0001-7073-3320; Pijning, Tjaard/0000-0003-4107-3663; Dijkstra, Bauke W./0000-0001-9731-6586; Dijkhuizen, Lubbert/0000-0003-2312-7162; Loos, Katja/0000-0002-4613-1159; Kralj, Slavko/0000-0001-7855-4888	The Netherlands Organization of Applied Scientific Research Quality of Life	The Netherlands Organization of Applied Scientific Research Quality of Life	This work was supported by The Netherlands Organization of Applied Scientific Research Quality of Life.	BAILEY AE, 1994, PHYS REV E, V50, P4853, DOI 10.1103/PhysRevE.50.4853; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Boeck B, 1998, RES MICROBIOL, V149, P171, DOI 10.1016/S0923-2508(98)80077-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delano WL., 2002, PYMOL MOL GRAPHICS S; Dickmanns A, 2006, ACTA CRYSTALLOGR D, V62, P262, DOI [10.1107/S0907444905041363, 10.1107/S0904777905041363]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fiske CH, 1925, J BIOL CHEM, V66, P375; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; IDAKA M, 2003, CRYSTAL STRUCTURE TT, DOI DOI 10.2210/PDB1UFA/PDB; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Imamura H, 2001, BIOCHEMISTRY-US, V40, P12400, DOI 10.1021/bi011017c; JANECEK S, 2010, GLYCOSIDE HYDROLASE, V57; Kajiura H, 2008, BIOCATAL BIOTRANSFOR, V26, P133, DOI 10.1080/10242420701789411; Kelly RM, 2009, APPL MICROBIOL BIOT, V84, P119, DOI 10.1007/s00253-009-1988-6; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Sambrook J., 2002, MOL CLONING LAB MANU; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; Tang SY, 2006, BBA-PROTEINS PROTEOM, V1764, P1633, DOI 10.1016/j.bbapap.2006.08.013; Ugalde JE, 2003, P NATL ACAD SCI USA, V100, P10659, DOI 10.1073/pnas.1534787100; Uitdehaag JCM, 2001, PROTEINS, V43, P327, DOI 10.1002/prot.1044; VAGIN AA, 1997, J APPL CRYSTALLOGR, P1022; van der Vlist J, 2008, MACROMOL RAPID COMM, V29, P1293, DOI 10.1002/marc.200800248; VANDERMAAREL MJE, 2010, Patent No. 2010030185; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zona R, 2004, EUR J BIOCHEM, V271, P2863, DOI 10.1111/j.1432-1033.2004.04144.x	37	70	75	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3520	3530		10.1074/jbc.M110.179515	http://dx.doi.org/10.1074/jbc.M110.179515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097495	hybrid, Green Published			2022-12-27	WOS:000286653200037
J	Rahman, AKMNU; Bonsor, DA; Herfst, CA; Pollard, F; Peirce, M; Wyatt, AW; Kasper, KJ; Madrenas, J; Sundberg, EJ; McCormick, JK				Rahman, A. K. M. Nur-Ur; Bonsor, Daniel A.; Herfst, Christine A.; Pollard, Fraser; Peirce, Michael; Wyatt, Aaron W.; Kasper, Katherine J.; Madrenas, Joaquin; Sundberg, Eric J.; McCormick, John K.			The T Cell Receptor beta-Chain Second Complementarity Determining Region Loop (CDR2 beta) Governs T Cell Activation and V beta Specificity by Bacterial Superantigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; PYROGENIC EXOTOXIN-C; STAPHYLOCOCCAL-ENTEROTOXIN-B; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MOLECULAR REQUIREMENTS; ALLELIC DISCRIMINATION; STRUCTURAL BASIS	Superantigens (SAgs) are microbial toxins defined by their ability to activate T lymphocytes in a T cell receptor (TCR) beta-chain variable domain (V beta)-specific manner. Although existing structural information indicates that diverse bacterial SAgs all uniformly engage the V beta second complementarity determining region (CDR2 beta) loop, the molecular rules that dictate SAg-mediated T cell activation and V beta specificity are not fully understood. Herein we report the crystal structure of human V beta 2.1 (hV beta 2.1) in complex with the toxic shock syndrome toxin-1 (TSST-1) SAg, and mutagenesis of hV beta 2.1 indicates that the non-canonical length of CDR2 beta is a critical determinant for recognition by TSST-1 as well as the distantly related SAg streptococcal pyrogenic exotoxin C. Frame work (FR) region 3 is uniquely critical for TSST-1 function explaining the fine V beta-specificity exhibited by this SAg. Furthermore, domain swapping experiments with SAgs, which use distinct domains to engage both CDR2 beta and FR3/4 beta revealed that the CDR2 beta contacts dictate T lymphocyte V beta-specificity. These findings demonstrate that the TCR CDR2 beta loop is the critical determinant for functional recognition and V beta-specificity by diverse bacterial SAgs.	[Rahman, A. K. M. Nur-Ur; Herfst, Christine A.; Pollard, Fraser; Peirce, Michael; Wyatt, Aaron W.; Kasper, Katherine J.; Madrenas, Joaquin; McCormick, John K.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Rahman, A. K. M. Nur-Ur; Madrenas, Joaquin; McCormick, John K.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada; [Bonsor, Daniel A.; Sundberg, Eric J.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Herfst, Christine A.; McCormick, John K.] Lawson Hlth Res Inst, London, ON N6A 4V2, Canada; [Madrenas, Joaquin] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Boston Biomedical Research Institute; Western University (University of Western Ontario); Western University (University of Western Ontario)	McCormick, JK (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	john.mccormick@schulich.uwo.ca	McCormick, John/E-4232-2015; Madrenas, Quim/P-5008-2019	Sundberg, Eric/0000-0003-0478-3033; McCormick, John/0000-0003-3742-7289	National Institutes of Health [AI065690]; Canadian Institutes of Health Research (CIHR); Schulich School of Medicine and Dentistry; Ontario Ministry of Research and Innovation; Canadian Foundation for Innovation; Ontario Innovation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Schulich School of Medicine and Dentistry; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065690 (to E.J.S.) and a Canadian Institutes of Health Research (CIHR) operating grant (to J.K.M.). Stipend support (to A.K.M.N.R.) was provided in part by scholarships from the Schulich School of Medicine and Dentistry and from an Early Research Award from The Ontario Ministry of Research and Innovation. Laboratory infrastructure was supported by a New Opportunities Fund award from the Canadian Foundation for Innovation and the Ontario Innovation Trust (to J.K.M.).	Andersen PS, 2002, BIOCHEMISTRY-US, V41, P5177, DOI 10.1021/bi0200209; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Churchill HRO, 2000, J EXP MED, V191, P835, DOI 10.1084/jem.191.5.835; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GAZDAR AF, 1980, BLOOD, V55, P409; Gluschankof P, 2002, VIROLOGY, V300, P160, DOI 10.1006/viro.2002.1531; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; Gunther S, 2007, J MOL BIOL, V371, P210, DOI 10.1016/j.jmb.2007.05.038; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HURLEY JM, 1995, J EXP MED, V181, P2229, DOI 10.1084/jem.181.6.2229; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kasper KJ, 2008, J IMMUNOL, V181, P3384, DOI 10.4049/jimmunol.181.5.3384; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Lavoie PM, 2001, J IMMUNOL, V166, P7229, DOI 10.4049/jimmunol.166.12.7229; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2003, J IMMUNOL, V171, P1385, DOI 10.4049/jimmunol.171.3.1385; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; NORTON SD, 1990, J IMMUNOL, V144, P2089; Orwin PM, 2001, INFECT IMMUN, V69, P360, DOI 10.1128/IAI.69.1.360-366.2001; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Rahman AKMNU, 2006, J IMMUNOL, V177, P8595, DOI 10.4049/jimmunol.177.12.8595; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Sambrook J, 2001, MOL CLONING LAB MANU; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Sundberg EJ, 2009, METHODS MOL BIOL, V524, P347, DOI 10.1007/978-1-59745-450-6_25; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripp TJ, 2003, INFECT IMMUN, V71, P1548, DOI 10.1128/IAI.71.3.1548-1550.2003; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	47	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4871	4881		10.1074/jbc.M110.189068	http://dx.doi.org/10.1074/jbc.M110.189068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127057	Green Published, hybrid			2022-12-27	WOS:000286975700083
J	Swiecki, M; Scheaffer, SM; Allaire, M; Fremont, DH; Colonna, M; Brett, TJ				Swiecki, Melissa; Scheaffer, Suzanne M.; Allaire, Marc; Fremont, Daved H.; Colonna, Marco; Brett, Tom J.			Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; COILED-COIL; MOLECULAR-GRAPHICS; HIV-1 RELEASE; CELL-SURFACE; PROTEIN; DOMAIN; VPU; RESTRICTION; GLYCOPROTEIN	BST-2/tetherin is a host antiviral molecule that functions to potently inhibit the release of enveloped viruses from infected cells. In return, viruses have evolved antagonists to this activity. BST-2 traps budding virions by using two separate membrane-anchoring regions that simultaneously incorporate into the host and viral membranes. Here, we detailed the structural and biophysical properties of the full-length BST-2 ectodomain, which spans the two membrane anchors. The 1.6-angstrom crystal structure of the complete mouse BST-2 ectodomain reveals an similar to 145-angstrom parallel dimer in an extended alpha-helix conformation that predominantly forms a coiled coil bridged by three intermolecular disulfides that are required for stability. Sequence analysis in the context of the structure revealed an evolutionarily conserved design that destabilizes the coiled coil, resulting in a labile superstructure, as evidenced by solution x-ray scattering displaying bent conformations spanning 150 and 180 angstrom for the mouse and human BST-2 ectodomains, respectively. Additionally, crystal packing analysis revealed possible curvature-sensing tetrameric structures that may aid in proper placement of BST-2 during the genesis of viral progeny. Overall, this extended coiled-coil structure with inherent plasticity is undoubtedly necessary to accommodate the dynamics of viral budding while ensuring separation of the anchors.	[Scheaffer, Suzanne M.; Brett, Tom J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Swiecki, Melissa; Fremont, Daved H.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fremont, Daved H.; Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Allaire, Marc] Brookhaven Natl Lab, Upton, NY 11973 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Brookhaven National Laboratory	Brett, TJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	tbrett@wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Fremont, Daved/0000-0002-8544-2689; Colonna, Marco/0000-0001-5222-4987				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Eisenhaber B, 2001, PROTEIN ENG, V14, P17, DOI 10.1093/protein/14.1.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; GOFFINET C, 2010, J VIROL IN PRESS; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Iwabu Yukie, 2010, Commun Integr Biol, V3, P366; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Lim ES, 2009, J VIROL, V83, P11673, DOI 10.1128/JVI.00569-09; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RADOSHITZKY SR, 2010, J VIROL IN PRESS; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203	58	59	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2987	2997		10.1074/jbc.M110.190538	http://dx.doi.org/10.1074/jbc.M110.190538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084286	hybrid, Green Published			2022-12-27	WOS:000286464300062
J	Chavaroche, AAE; van den Broek, LAM; Springer, J; Boeriu, C; Eggink, G				Chavaroche, Anais A. E.; van den Broek, Lambertus A. M.; Springer, Jan; Boeriu, Carmen; Eggink, Gerrit			Analysis of the Polymerization Initiation and Activity of Pasteurella multocida Heparosan Synthase PmHS2, an Enzyme with Glycosyltransferase and UDP-sugar Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; HYALURONAN SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; GLYCOSIDASES; TRANSFERASE; MECHANISM; DISTINCT; SULFATE; HEPARIN	Heparosan synthase catalyzes the polymerization of heparosan (-4GlcUA beta 1-4GlcNAc alpha 1-)(n) by transferring alternatively the monosaccharide units from UDP-GlcUA and UDP-GlcNAc to an acceptor molecule. Details on the heparosan chain initiation by Pasteurella multocida heparosan synthase PmHS2 and its influence on the polymerization process have not been reported yet. By site-directed mutagenesis of PmHS2, the single action transferases PmHS2-GlcUA(+) and PmHS2-GlcNAc(+) were obtained. When incubated together in the standard polymerization conditions, the PmHS2-GlcUA(+)/PmHS2-GlcNAc(+) showed comparable polymerization properties as determined for PmHS2. We investigated the first step occurring in heparosan chain initiation by the use of the single action transferases and by studying the PmHS2 polymerization process in the presence of heparosan templates and various UDP-sugar concentrations. We observed that PmHS2 favored the initiation of the heparosan chains when incubated in the presence of an excess of UDP-GlcNAc. It resulted in a higher number of heparosan chains with a lower average molecular weight or in the synthesis of two distinct groups of heparosan chain length, in the absence or in the presence of heparosan templates, respectively. These data suggest that PmHS2 transfers GlcUA from UDP-GlcUA moiety to a UDP-GlcNAc acceptor molecule to initiate the heparosan polymerization; as a consequence, not only the UDP-sugar concentration but also the amount of each UDP-sugar is influencing the PmHS2 polymerization process. In addition, it was shown that PmHS2 hydrolyzes the UDP-sugars, UDP-GlcUA being more degraded than UDP-GlcNAc. However, PmHS2 incubated in the presence of both UDP-sugars favors the synthesis of heparosan polymers over the hydrolysis of UDP-sugars.	[Chavaroche, Anais A. E.; Eggink, Gerrit] Univ Wageningen & Res Ctr, Bioproc Engn Grp, NL-6700 EV Wageningen, Netherlands; [Chavaroche, Anais A. E.; van den Broek, Lambertus A. M.; Springer, Jan; Boeriu, Carmen; Eggink, Gerrit] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Eggink, G (corresponding author), Univ Wageningen & Res Ctr, Bioproc Engn Grp, POB 8129, NL-6700 EV Wageningen, Netherlands.	gerrit.eggink@wur.nl	Boeriu, Carmen/L-1173-2016; van den Broek, Lambertus/O-1253-2019; van den Broek, Lambertus/K-4930-2012	Boeriu, Carmen/0000-0003-4903-6621; van den Broek, Lambertus/0000-0002-4374-5753; van den Broek, Lambertus/0000-0002-4374-5753	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private NWO-ACTS	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private NWO-ACTS	This work was carried out in close collaboration with Merck Sharp & Dohme (Oss, The Netherlands) and supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-ACTS (Advanced Chemical Technologies for Sustainability) program.	Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chavaroche AAE, 2010, APPL MICROBIOL BIOT, V85, P1881, DOI 10.1007/s00253-009-2214-2; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Krupa JC, 2007, ANAL BIOCHEM, V361, P218, DOI 10.1016/j.ab.2006.11.011; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Orellana A, 1999, ANAL BIOCHEM, V272, P224, DOI 10.1006/abio.1999.4159; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Shaikh FA, 2008, BIOCHEM CELL BIOL, V86, P169, DOI 10.1139/O07-149; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	29	17	20	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1777	1785		10.1074/jbc.M110.136754	http://dx.doi.org/10.1074/jbc.M110.136754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084307	hybrid, Green Published			2022-12-27	WOS:000286191500017
J	Leinenweber, A; Machtens, JP; Begemann, B; Fahlke, C				Leinenweber, Ariane; Machtens, Jan-Philipp; Begemann, Birgit; Fahlke, Christoph			Regulation of Glial Glutamate Transporters by C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; AMYOTROPHIC-LATERAL-SCLEROSIS; CHLORIDE CHANNEL; MOLECULAR-MECHANISM; MULTIPLE-SCLEROSIS; ANION CONDUCTANCE; ION FLUXES; EAAC1; SUBSTRATE; KINETICS	Excitatory amino acid transporter 2 (EAAT2) is a high affinity glutamate transporter predominantly expressed in astroglia. Human EAAT2 encompasses eight transmembrane domains and a 74-amino acid C-terminal domain that resides in the cytoplasm. We examined the role of this region by studying various C-terminal truncations and mutations using heterologous expression in mammalian cells, whole-cell patch clamp recording and confocal imaging. Removal of the complete C terminus (K498X EAAT2) results in loss of function because of intracellular retention of truncated proteins in the cytoplasm. However, a short stretch of amino acids (E500X EAAT2) within the C terminus results in correctly processed transporters. E500X reduced glutamate transport currents by 90%. Moreover, the voltage and substrate dependence of E500X EAAT2 anion currents was significantly altered. WT and mutant EAAT2 anion channels are modified by external Na+ in the presence as well as in the absence of L-glutamate. Whereas Na+ stimulates EAAT2 anion currents in the presence of L-glutamate, increased [Na+] reduces such currents without glutamate. In cells internally dialyzed with Na+, WT, and truncated EAAT2 display comparable Na+ dependence. With K+ as main internal cation, E500X drastically increased the apparent dissociation constant for external Na+. The effects of E500X can be represented by a kinetic model that allows translocation of the empty transporter from the outward-to the inward-facing conformation and stabilization of the inward-facing conformation by internal K+. Our results demonstrate that the C terminus modifies the glutamate uptake cycle, possibly affecting the movements of the translocation domain of EAAT2 glutamate transporter.	Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Leinenweber, Ariane; Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School		fahlke.christoph@mh-hannover.de	Machtens, Jan-Philipp/M-8659-2013; Fahlke, Christoph/G-3635-2013	Machtens, Jan-Philipp/0000-0003-1673-8571; Fahlke, Christoph/0000-0001-8602-9952	Deutsche Forschungsgemeinschaft [FA301/9]; state of Lower Saxony, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Lower Saxony, Germany	These studies were supported by the Deutsche Forschungsgemeinschaft (FA301/9, to C. F.) and a Georg-Christoph-Lichtenberg fellowship by the state of Lower Saxony, Germany (to A. L.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Cheng CL, 2002, J NEUROSCI, V22, P10643; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Scott HL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0004.2002; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	50	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1927	1937		10.1074/jbc.M110.153486	http://dx.doi.org/10.1074/jbc.M110.153486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097502	Green Published, hybrid			2022-12-27	WOS:000286191500034
J	Nakamura, Y; Fujita, Y; Ueno, M; Takai, T; Yamashita, T				Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Takai, Toshiyuki; Yamashita, Toshihide			Paired Immunoglobulin-like Receptor B Knockout Does Not Enhance Axonal Regeneration or Locomotor Recovery after Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECOVERY; GENETIC DELETION; ANTAGONIST; MICE; NOGO; INHIBITION; PLASTICITY; GROWTH; PIRB	Myelin components that inhibit axonal regeneration are believed to contribute significantly to the lack of axonal regeneration noted in the adult central nervous system. Three proteins found in myelin, Nogo, myelin-associated glycoprotein, and oligodendrocyte-myelin glycoprotein, inhibit neurite outgrowth in vitro. All of these proteins interact with the same receptors, namely, the Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PIR-B). As per previous reports, corticospinal tract (CST) regeneration is not enhanced in NgR-knock-out mice after spinal cord injury. Therefore, we assessed CST regeneration in PIR-B-knock-out mice. We found that hindlimb motor function, as assessed using the Basso mouse scale, footprint test, inclined plane test, and beam walking test, did not differ between the PIR-B-knock-out and wildtype mice after dorsal hemisection of the spinal cord. Further, tracing of the CST fibers after injury did not reveal enhanced axonal regeneration or sprouting in the CST of the PIR-B-knock-out mice. Systemic administration of NEP1-40, a NgR antagonist, to PIR-B knock-out mice did not enhance the regenerative response. These results indicate that PIR-B knockout is not sufficient to induce extensive axonal regeneration after spinal cord injury.	[Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Yamashita, Toshihide] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, CREST, JST, Sendai, Miyagi 9808575, Japan	Osaka University; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Yamashita, T (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for young scientists from the Japan Society for the Promotion of Science.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Li SX, 2003, J NEUROSCI, V23, P4219; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Silver J, 2010, NEURON, V66, P619, DOI 10.1016/j.neuron.2010.05.028; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	16	55	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1876	1883		10.1074/jbc.M110.163493	http://dx.doi.org/10.1074/jbc.M110.163493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21087927	Green Published, hybrid			2022-12-27	WOS:000286191500028
J	Acehan, D; Vaz, F; Houtkooper, RH; James, J; Moore, V; Tokunaga, C; Kulik, W; Wansapura, J; Toth, MJ; Strauss, A; Khuchua, Z				Acehan, Devrim; Vaz, Frederic; Houtkooper, Riekelt H.; James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Kulik, Willem; Wansapura, Janaka; Toth, Matthew J.; Strauss, Arnold; Khuchua, Zaza			Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); MASS-SPECTROMETRY; HEART-FAILURE; GENE KNOCKDOWN; CARDIOLIPIN; MITOCHONDRIA; MICE; LIPIDOMICS; BRAIN; CARDIOMYOPATHY	Barth syndrome is an X-linked genetic disorder caused by mutations in the tafazzin (taz) gene and characterized by dilated cardiomyopathy, exercise intolerance, chronic fatigue, delayed growth, and neutropenia. Tafazzin is a mitochondrial transacylase required for cardiolipin remodeling. Although tafazzin function has been studied in non-mammalian model organisms, mammalian genetic loss of function approaches have not been used. We examined the consequences of tafazzin knockdown on sarcomeric mitochondria and cardiac function in mice. Tafazzin knockdown resulted in a dramatic decrease of tetralinoleoyl cardiolipin in cardiac and skeletal muscles and accumulation of monolysocardiolipins and cardiolipin molecular species with aberrant acyl groups. Electron microscopy revealed pathological changes in mitochondria, myofibrils, and mitochondrion-associated membranes in skeletal and cardiac muscles. Echocardiography and magnetic resonance imaging revealed severe cardiac abnormalities, including left ventricular dilation, left ventricular mass reduction, and depression of fractional shortening and ejection fraction in tafazzin-deficient mice. Tafazzin knockdown mice provide the first mammalian model system for Barth syndrome in which the pathophysiological relationships between altered content of mitochondrial phospholipids, ultrastructural abnormalities, myocardial and mitochondrial dysfunction, and clinical outcome can be completely investigated.	[James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Wansapura, Janaka; Strauss, Arnold; Khuchua, Zaza] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Wansapura, Janaka; Strauss, Arnold; Khuchua, Zaza] Univ Cincinnati, Cincinnati, OH 45229 USA; [Vaz, Frederic; Kulik, Willem] Univ Amsterdam, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Houtkooper, Riekelt H.] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Acehan, Devrim] NYU, Langone Med Ctr, Skirball Inst, New York, NY 10016 USA; [Toth, Matthew J.] Barth Syndrome Fdn Inc, Iselin, NJ 08830 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; New York University; NYU Langone Medical Center	Khuchua, Z (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, MLC 7020, Cincinnati, OH 45229 USA.	zaza.khuchua@cchmc.org	Khuchua, Zaza/J-6536-2016; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019	Khuchua, Zaza/0000-0003-3582-5670; Houtkooper, Riekelt H/0000-0001-9961-0842; Vaz, Frederic/0000-0002-9048-1041	Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108867, K25HL102244] Funding Source: NIH RePORTER	Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Barth Syndrome Foundation (to Z. K.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EILERS M, 1989, J BIOL CHEM, V264, P2945; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; HAWKINS WE, 1980, CELL TISSUE RES, V209, P87; Heerdt PM, 2002, ANN THORAC SURG, V73, P1216, DOI 10.1016/S0003-4975(01)03621-9; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2008, LIPIDS, V43, P951, DOI 10.1007/s11745-008-3197-y; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Lesnefsky EJ, 2009, J MOL CELL CARDIOL, V46, P1008, DOI 10.1016/j.yjmcc.2009.03.007; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Sandra F, 2005, CANCER RES, V65, P8286, DOI 10.1158/0008-5472.CAN-04-1913; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1991, EUR J BIOCHEM, V199, P459, DOI 10.1111/j.1432-1033.1991.tb16144.x; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; SVOBODA DJ, 1964, AM J PATHOL, V44, P645; Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646	50	184	196	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					899	908		10.1074/jbc.M110.171439	http://dx.doi.org/10.1074/jbc.M110.171439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068380	hybrid, Green Published			2022-12-27	WOS:000286005000001
J	Homma, D; Sumi-Ichinose, C; Tokuoka, H; Ikemoto, K; Nomura, T; Kondo, K; Katoh, S; Ichinose, H				Homma, Daigo; Sumi-Ichinose, Chiho; Tokuoka, Hirofumi; Ikemoto, Kazuhisa; Nomura, Takahide; Kondo, Kazunao; Katoh, Setsuko; Ichinose, Hiroshi			Partial Biopterin Deficiency Disturbs Postnatal Development of the Dopaminergic System in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPA-RESPONSIVE DYSTONIA; GTP CYCLOHYDROLASE-I; SEPIAPTERIN-REDUCTASE DEFICIENCY; TYROSINE-HYDROXYLASE ACTIVITY; MOUSE MODEL; TETRAHYDROBIOPTERIN BIOSYNTHESIS; PHENYLALANINE-HYDROXYLASE; MICE; HYPERPHENYLALANINEMIA; MUTATIONS	Postnatal development of dopaminergic system is closely related to the development of psychomotor function. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the biosynthesis of dopamine and requires tetrahydrobiopterin (BH4) as a cofactor. To clarify the effect of partial BH4 deficiency on postnatal development of the dopaminergic system, we examined two lines of mutant mice lacking a BH4-biosynthesizing enzyme, including sepiapterin reductase knock-out (Spr(-/-)) mice and genetically rescued 6-pyruvoyltetrahydropterin synthase knock-out (DPS-Pts(-/-)) mice. We found that biopterin contents in the brains of these knock-out mice were moderately decreased from postnatal day 0 (P0) and remained constant up to P21. In contrast, the effects of BH4 deficiency on dopamine and TH protein levels were more manifested during the postnatal development. Both of dopamine and TH protein levels were greatly increased from P0 to P21 in wild-type mice but not in those mutant mice. Serotonin levels in those mutant mice were also severely suppressed after P7. Moreover, striatal TH immunoreactivity in Spr(-/-) mice showed a drop in the late developmental stage, when those mice exhibited hind-limb clasping behavior, a type of motor dysfunction. Our results demonstrate a critical role of biopterin in the augmentation of TH protein in the postnatal period. The developmental manifestation of psychomotor symptoms in BH4 deficiency might be attributable at least partially to high dependence of dopaminergic development on BH4 availability.	[Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Sumi-Ichinose, Chiho; Ikemoto, Kazuhisa; Nomura, Takahide; Kondo, Kazunao] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi 4701192, Japan; [Katoh, Setsuko] Meikai Univ, Sch Dent, Sakado, Saitama 3500283, Japan	Tokyo Institute of Technology; Fujita Health University; Meikai University	Ichinose, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, 4259-B7, Yokohama, Kanagawa 2268501, Japan.	hichinos@bio.titech.ac.jp	Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Sumi-Ichinose, Chiho/0000-0001-5261-0853	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Japan Science and Technology Agency, CREST [21500305, 22090250]; Grants-in-Aid for Scientific Research [21500305] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan, and by the Japan Science and Technology Agency, CREST (21500305 and 22090250).	Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; Elzaouk L, 2003, J BIOL CHEM, V278, P28303, DOI 10.1074/jbc.M303986200; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Furukawa Y, 1999, NEUROLOGY, V53, P1032, DOI 10.1212/WNL.53.5.1032; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; KAPATOS G, 1983, BRAIN RES, V258, P351, DOI 10.1016/0006-8993(83)91165-4; Knudsen GM, 1995, J INHERIT METAB DIS, V18, P653, DOI 10.1007/BF02436753; Nagatsu I, 1995, J NEURAL TRANSM-GEN, V102, P175, DOI 10.1007/BF01281153; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; Ogawa S, 2006, NEUROSCI LETT, V401, P261, DOI 10.1016/j.neulet.2006.03.031; OKUNO S, 1985, J BIOL CHEM, V260, P2633; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Perez B, 2005, MOL GENET METAB, V86, pS11, DOI 10.1016/j.ymgme.2005.06.009; RAJPUT AH, 1994, ANN NEUROL, V35, P396, DOI 10.1002/ana.410350405; Sato K, 2008, P NATL ACAD SCI USA, V105, P12551, DOI 10.1073/pnas.0806065105; Segawa M, 2003, ANN NEUROL, V54, pS32, DOI 10.1002/ana.10630; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Sumi-Ichinose C, 2005, J NEUROCHEM, V95, P703, DOI 10.1111/j.1471-4159.2005.03402.x; Sumi-Ichinose C, 2001, J BIOL CHEM, V276, P41150, DOI 10.1074/jbc.M102237200; Takazawa C, 2008, BIOCHEM BIOPH RES CO, V367, P787, DOI 10.1016/j.bbrc.2008.01.028; Thony B, 2008, J NEUROCHEM, V106, P672, DOI 10.1111/j.1471-4159.2008.05423.x; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056; Urano F, 2006, J BIOCHEM, V139, P625, DOI 10.1093/jb/mvj073; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; YEOH GCT, 1988, DIFFERENTIATION, V38, P42, DOI 10.1111/j.1432-0436.1988.tb00590.x	30	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1445	1452		10.1074/jbc.M110.159426	http://dx.doi.org/10.1074/jbc.M110.159426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062748	hybrid, Green Published			2022-12-27	WOS:000286005000057
J	Hua, SS; Wang, ZK; Jiang, K; Huang, YJ; Ward, T; Zhao, LL; Dou, Z; Yao, XBA				Hua, Shasha; Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Ward, Tarsha; Zhao, Lingli; Dou, Zhen; Yao, Xuebiao			CENP-U Cooperates with Hec1 to Orchestrate Kinetochore-Microtubule Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; NDC80 COMPLEX; MITOTIC CHECKPOINT; CHROMOSOME SEGREGATION; CENTROMERE COMPLEX; OUTER KINETOCHORE; PROTEIN E; COMPONENT; CELLS; ARCHITECTURE	Mitosis is an orchestration of dynamic interaction between chromosomes and spindle microtubules by which genomic materials are equally distributed into two daughter cells. Previous studies showed that CENP-U is a constitutive centromere component essential for proper chromosome segregation. However, the precise molecular mechanism has remained elusive. Here, we identified CENP-U as a novel interacting partner of Hec1, an evolutionarily conserved kinetochore core component essential for chromosome plasticity. Suppression of CENP-U by shRNA resulted in mitotic defects with an impaired kinetochore-microtubule attachment. Interestingly, CENP-U not only binds microtubules directly but also displays a cooperative microtubule binding activity with Hec1 in vitro. Furthermore, we showed that CENP-U is a substrate of Aurora-B. Importantly, phosphorylation of CENP-U leads to reduced kinetochore-microtubule interaction, which contributes to the error-correcting function of Aurora-B. Taken together, our results indicate that CENP-U is a novel microtubule binding protein and plays an important role in kinetochore-microtubule attachment through its interaction with Hec1.	[Hua, Shasha; Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Zhao, Lingli; Dou, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Ward, Tarsha; Dou, Zhen] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Dou, Z (corresponding author), Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013	DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [K-56292, CA132389]; National Center for Research Resources [UL1 RR025008]; Chinese Natural Science Foundation [31071184, 31000602, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; Chinese 973 Project [2006CB943603, 2007CB914503, 2010CB912103]; China National Key Projects for Infectious Disease [2008ZX10002-021]; Georgia Cancer Coalition; Atlanta Clinical and Translational Science Award [P20RR011104]; Anhui Province Key Project [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008, P20RR011104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); China National Key Projects for Infectious Disease; Georgia Cancer Coalition; Atlanta Clinical and Translational Science Award; Anhui Province Key Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292 and CA132389 and National Center for Research Resources Grant UL1 RR025008 from the Clinical and Translational Science Award program. This work was also supported by Chinese Natural Science Foundation Grants 31071184 (to Z.D.), 31000602 (to L.Z.), and 90508002 and 90913016 (to X.Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, Chinese 973 Project Grants 2006CB943603, 2007CB914503, and 2010CB912103, China National Key Projects for Infectious Disease Grant 2008ZX10002-021, a Georgia Cancer Coalition breast cancer research grant, Atlanta Clinical and Translational Science Award Chemical Biology Grant P20RR011104, and Anhui Province Key Project Grant 08040102005.	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	44	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1627	1638		10.1074/jbc.M110.174946	http://dx.doi.org/10.1074/jbc.M110.174946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056971	hybrid, Green Published			2022-12-27	WOS:000286005000075
J	Sudo, Y; Ihara, K; Kobayashi, S; Suzuki, D; Irieda, H; Kikukawa, T; Kandori, H; Homma, M				Sudo, Yuki; Ihara, Kunio; Kobayashi, Shiori; Suzuki, Daisuke; Irieda, Hiroki; Kikukawa, Takashi; Kandori, Hideki; Homma, Michio			A Microbial Rhodopsin with a Unique Retinal Composition Shows Both Sensory Rhodopsin II and Bacteriorhodopsin-like Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; STRUCTURAL-CHANGES; PROTON PUMP; HALOBACTERIAL TRANSDUCER; PRIMARY PHOTOPRODUCT; STERIC CONSTRAINT; SIGNAL TRANSFER; PROTEIN; MECHANISM; BINDING	Rhodopsins possess retinal chromophore surrounded by seven transmembrane alpha-helices, are widespread in prokaryotes and in eukaryotes, and can be utilized as optogenetic tools. Although rhodopsins work as distinctly different photo-receptors in various organisms, they can be roughly divided according to their two basic functions, light-energy conversion and light-signal transduction. In microbes, light-driven proton transporters functioning as light-energy converters have been modified by evolution to produce sensory receptors that relay signals to transducer proteins to control motility. In this study, we cloned and characterized two newly identified microbial rhodopsins from Haloquadratum walsbyi. One of them has photochemical properties and a proton pumping activity similar to the well known proton pump bacteriorhodopsin (BR). The other, named middle rhodopsin (MR), is evolutionarily transitional between BR and the phototactic sensory rhodopsin II (SRII), having an SRII-like absorption maximum, a BR-like photocycle, and a unique retinal composition. The wild-type MR does not have a light-induced proton pumping activity. On the other hand, a mutant MR with two key hydrogen-bonding residues located at the interaction surface with the transducer protein HtrII shows robust phototaxis responses similar to SRII, indicating that MR is potentially capable of the signaling. These results demonstrate that color tuning and insertion of the critical threonine residue occurred early in the evolution of sensory rhodopsins. MR may be a missing link in the evolution from type 1 rhodopsins (microorganisms) to type 2 rhodopsins (animals), because it is the first microbial rhodopsin known to have 11-cis-retinal similar to type 2 rhodopsins.	[Sudo, Yuki; Kobayashi, Shiori; Suzuki, Daisuke; Irieda, Hiroki; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kikukawa, Takashi] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Hokkaido University; Nagoya Institute of Technology	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Sudo, Yuki/AGY-0493-2022; Kikukawa, Takashi/F-5266-2011; Irieda, Hiroki/N-8455-2015	Sudo, Yuki/0000-0001-8155-9356; Kikukawa, Takashi/0000-0002-6185-7281; Irieda, Hiroki/0000-0002-4545-9187	Ministry of Education, Culture, Sports, Science and Technology of Japan [477]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [20108001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research (KAKENHI) on a priority area (area 477) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y. S., H. K., and M. H.).	Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Furutani Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P874, DOI 10.1111/j.1751-1097.2008.00317.x; Furutani Y, 2006, BIOCHEMISTRY-US, V45, P11836, DOI 10.1021/bi0610597; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFRICHTER J, 1989, BIOPHYS J, V56, P693, DOI 10.1016/S0006-3495(89)82716-X; Ito M, 2008, BIOCHEMISTRY-US, V47, P6208, DOI 10.1021/bi8003507; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kawanabe A, 2009, J AM CHEM SOC, V131, P16439, DOI 10.1021/ja904855g; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1978, J BIOCHEM, V83, P661, DOI 10.1093/oxfordjournals.jbchem.a131957; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mathias G, 2007, P NATL ACAD SCI USA, V104, P6980, DOI 10.1073/pnas.0609229104; Mizuide N, 2006, BIOCHEMISTRY-US, V45, P10674, DOI 10.1021/bi060958s; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Ruiz-Gonzalez MX, 2004, J MOL EVOL, V58, P348, DOI 10.1007/s00239-003-2557-8; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; SPUDICH JL, 1988, ANNU REV BIOPHYS BIO, V17, P193; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 1995, ISR J CHEM, V35, P495; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2005, J AM CHEM SOC, V127, P16036, DOI 10.1021/ja056203a; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2008, BIOCHEMISTRY-US, V47, P2866, DOI 10.1021/bi701885k; Sudo Y, 2007, J BIOL CHEM, V282, P15550, DOI 10.1074/jbc.M701271200; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2010, SENSORS-BASEL, V10, P4010, DOI 10.3390/s100404010; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yagasaki J, 2010, BIOCHEMISTRY-US, V49, P1183, DOI 10.1021/bi901824a; YAN B, 1991, BIOCHEMISTRY-US, V30, P10686, DOI 10.1021/bi00108a012; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	57	52	56	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5967	5976		10.1074/jbc.M110.190058	http://dx.doi.org/10.1074/jbc.M110.190058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135094	Green Published, hybrid			2022-12-27	WOS:000287476400004
J	Ammosova, T; Yedavalli, VRK; Niu, XM; Jerebtsova, M; Van Eynde, A; Beullens, M; Bollen, M; Jeang, KT; Nekhai, S				Ammosova, Tatiana; Yedavalli, Venkat R. K.; Niu, Xiaomei; Jerebtsova, Marina; Van Eynde, Aleyde; Beullens, Monique; Bollen, Mathieu; Jeang, Kuan-Teh; Nekhai, Sergei			Expression of a Protein Phosphatase 1 Inhibitor, cdNIPP1, Increases CDK9 Threonine 186 Phosphorylation and Inhibits HIV-1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; LONG-TERMINAL REPEAT; P-TEFB; TAT TRANSACTIVATION; CYCLIN T1; 7SK SNRNA; KINASE; VIRUS; ACETYLATION; ELONGATION	CDK9/cyclin T1, a key enzyme in HIV-1 transcription, is negatively regulated by 7SK RNA and the HEXIM1 protein. Dephosphorylation of CDK9 on Thr(186) by protein phosphatase 1 (PP1) in stress-induced cells or by protein phosphatase M1A in normally growing cells activates CDK9. Our previous studies showed that HIV-1 Tat protein binds to PP1 through the Tat Q(35)VCF(38) sequence, which is similar to the PP1-binding RVXF motif and that this interaction facilitates HIV-1 transcription. In the present study, we analyzed the effect of expression of the central domain of nuclear inhibitor of PP1 (cdNIPP1) in an engineered cell line and also when cdNIPP1 was expressed as part of HIV-1 pNL4-3 in place of nef. Stable expression of cdNIPP1 increased CDK9 phosphorylation on Thr(186) and the association of CDK9 with 7SK RNA. The stable expression of cdNIPP1 disrupted the interaction of Tat and PP1 and inhibited HIV-1 transcription. Expression of cdNIPP1 as a part of the HIV-1 genome inhibited HIV-1 replication. Our study provides a proof-of-concept for the future development of PP1-targeting compounds as inhibitors of HIV-1 replication.	[Ammosova, Tatiana; Niu, Xiaomei; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20001 USA; [Yedavalli, Venkat R. K.; Jeang, Kuan-Teh] NIAID, Natl Inst Hlth, Mol Virol Sect, Mol Microbiol Lab, Bethesda, MD 20817 USA; [Jerebtsova, Marina] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Van Eynde, Aleyde; Beullens, Monique; Bollen, Mathieu] Catholic Univ Louvain, Dept Mol Cell Biol, B-3000 Louvain, Belgium	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's National Health System; Universite Catholique Louvain	Nekhai, S (corresponding author), Howard Univ, Ctr Sickle Cell Dis, 1840 7th St NW,HURB1,Suite 202, Washington, DC 20001 USA.	snekhai@howard.edu	, nekhai/AFO-2652-2022; , nekhai/AAW-3105-2021; Jeang, Kuan-Teh/A-2424-2008; Ammosova, Tatiana/J-7564-2018; Ammosova, Tatiana/HIA-0704-2022	Ammosova, Tatiana/0000-0001-8777-1032; 	National Institutes of Health Research by NHLBI [2 R25 HL003679-12]; Office of Research on Minority by National Institute for General Medical Sciences [1SC1GM082325-03]; Howard University; Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health [RCMI-NIH 2G12RR003048-22]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325] Funding Source: NIH RePORTER	National Institutes of Health Research by NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research on Minority by National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard University; Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Research Grant 2 R25 HL003679-12 funded by the NHLBI. This work was also supported by the Office of Research on Minority, Grant 1SC1GM082325-03, funded by the National Institute for General Medical Sciences; by a Howard University Seed Grant (to S. N.); and by Grant RCMI-NIH 2G12RR003048-22 from the Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health.	Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bharucha DC, 2002, VIROLOGY, V296, P6, DOI 10.1006/viro.2002.1438; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nekhai S, 2007, ONCOGENE, V26, P3899, DOI 10.1038/sj.onc.1210158; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Vanham G, 2000, AIDS, V14, P2299, DOI 10.1097/00002030-200010200-00011; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhang Y, 2008, J BIOL CHEM, V283, P24039, DOI 10.1074/jbc.M801878200; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	41	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3798	3804		10.1074/jbc.M110.196493	http://dx.doi.org/10.1074/jbc.M110.196493			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098020	Green Published, hybrid			2022-12-27	WOS:000286653200061
J	Neess, D; Bloksgaard, M; Bek, S; Marcher, AB; Elle, IC; Helledie, T; Due, M; Pagmantidis, V; Finsen, B; Wilbertz, J; Kruhoffer, M; Faergeman, N; Mandrup, S				Neess, Ditte; Bloksgaard, Maria; Bek, Signe; Marcher, Ann-Britt; Elle, Ida C.; Helledie, Torben; Due, Marianne; Pagmantidis, Vasileios; Finsen, Bente; Wilbertz, Johannes; Kruhoffer, Mogens; Faergeman, Nils; Mandrup, Susanne			Disruption of the Acyl-CoA-binding Protein Gene Delays Hepatic Adaptation to Metabolic Changes at Weaning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; FATTY-ACID-METABOLISM; TRANSCRIPTIONAL ACTIVITY; DOWN-REGULATION; LIGAND-BINDING; CHOLESTEROL; ACBP; EXPRESSION; LIVER; COENZYME	The acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor is an intracellular protein that binds C-14-C-22 acyl-CoA esters and is thought to act as an acyl-CoA transporter. In vitro analyses have indicated that ACBP can transport acyl-CoA esters between different enzymatic systems; however, little is known about the in vivo function in mammalian cells. We have generated mice with targeted disruption of ACBP (ACBP(-/-)). These mice are viable and fertile and develop normally. However, around weaning, the ACBP(-/-) mice go through a crisis with overall weakness and a slightly decreased growth rate. Using microarray analysis, we show that the liver of ACBP(-/-) mice displays a significantly delayed adaptation to weaning with late induction of target genes of the sterol regulatory element-binding protein (SREBP) family. As a result, hepatic de novo cholesterogenesis is decreased at weaning. The delayed induction of SREBP target genes around weaning is caused by a compromised processing and decreased expression of SREBP precursors, leading to reduced binding of SREBP to target sites in chromatin. In conclusion, lack of ACBP interferes with the normal metabolic adaptation to weaning and leads to delayed induction of the lipogenic gene program in the liver.	[Pagmantidis, Vasileios; Faergeman, Nils; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Finsen, Bente] Univ So Denmark, Inst Mol Med, DK-5230 Odense M, Denmark; [Wilbertz, Johannes] Karolinska Inst, Karolinska Ctr Transgene Technol, S-17177 Stockholm, Sweden; [Kruhoffer, Mogens] AROS Appl Biotechnol AS, DK-8200 Aarhus N, Denmark	University of Southern Denmark; University of Southern Denmark; Karolinska Institutet	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dk	Mandrup, Susanne/B-6693-2008	Bloksgaard, Maria/0000-0002-4474-9553; Faergeman, Nils/0000-0002-9281-5287; Finsen, Bente/0000-0002-8323-9329; Mandrup, Susanne/0000-0002-0961-5787; Marcher, Ann-Britt/0000-0002-4799-8870	Danish Natural Science Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Novo Scholarship Program; Lundbeck Foundation [R7-2006-648] Funding Source: researchfish	Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Scholarship Program; Lundbeck Foundation(Lundbeckfonden)	This project was supported by the Danish Natural Science Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, and the Novo Scholarship Program.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; BHUIYAN J, 1995, METABOLISM, V44, P1185, DOI 10.1016/0026-0495(95)90013-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobard A, 2005, J BIOL CHEM, V280, P199, DOI 10.1074/jbc.M406522200; Botolin D, 2003, J BIOL CHEM, V278, P6959, DOI 10.1074/jbc.M212846200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200; Chao H, 2002, BIOCHEMISTRY-US, V41, P10540, DOI 10.1021/bi0259498; COLE TG, 1982, J LIPID RES, V23, P81; Densupsoontorn N, 2007, LIPIDS, V42, P885, DOI 10.1007/s11745-007-3093-x; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Elholm M, 2000, J LIPID RES, V41, P538; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; Faergeman NJ, 2004, BIOCHEM J, V380, P907, DOI 10.1042/BJ20031949; Faergeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; FYRST H, 1995, BIOCHEM J, V306, P793, DOI 10.1042/bj3060793; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Gossett RE, 1998, ARCH BIOCHEM BIOPHYS, V350, P201, DOI 10.1006/abbi.1997.0521; HANSEN HO, 1991, BIOCHEM J, V277, P341, DOI 10.1042/bj2770341; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Helledie T, 2000, J LIPID RES, V41, P1740; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Just M, 2006, BBA-MOL BASIS DIS, V1762, P666, DOI 10.1016/j.bbadis.2006.05.005; Kannan L, 2003, BBA-MOL CELL BIOL L, V1631, P12, DOI 10.1016/S1388-1981(02)00367-0; KNUDSEN J, 1994, BIOCHEM J, V302, P479, DOI 10.1042/bj3020479; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; Landrock D, 2010, LIPIDS, V45, P567, DOI 10.1007/s11745-010-3437-9; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Loomis WF, 2010, J BIOL CHEM, V285, P21359, DOI 10.1074/jbc.M110.105858; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; MANDRUP S, 1992, J MOL BIOL, V228, P1011, DOI 10.1016/0022-2836(92)90888-Q; MANDRUP S, 1993, BIOCHEM J, V290, P369, DOI 10.1042/bj2900369; MANDRUP S, 1993, MOL CELL BIOCHEM, V123, P55, DOI 10.1007/BF01076475; MENDOZAFIGUEROA T, 1988, TOXICOLOGY, V52, P273, DOI 10.1016/0300-483X(88)90132-1; MIKKELSEN J, 1987, BIOCHEM J, V248, P709, DOI 10.1042/bj2480709; MOGENSEN IB, 1987, BIOCHEM J, V241, P189, DOI 10.1042/bj2410189; Neess D, 2006, MOL CELL BIOCHEM, V284, P149, DOI 10.1007/s11010-005-9039-9; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Oikari S, 2008, PFLUG ARCH EUR J PHY, V456, P369, DOI 10.1007/s00424-007-0416-y; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sandberg MB, 2005, J BIOL CHEM, V280, P5258, DOI 10.1074/jbc.M407515200; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Snyder MJ, 1997, CELL TISSUE RES, V288, P177, DOI 10.1007/s004410050804; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Vock C, 2010, CELL PHYSIOL BIOCHEM, V25, P675, DOI 10.1159/000315087; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Yang YY, 2001, LIPIDS, V36, P595, DOI 10.1007/s11745-001-0762-0	74	47	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3460	3472		10.1074/jbc.M110.161109	http://dx.doi.org/10.1074/jbc.M110.161109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106527	Green Published, hybrid			2022-12-27	WOS:000286653200032
J	Billam, P; Bonaparte, KL; Liu, J; Ruckwardt, TJ; Chen, M; Ryder, AB; Wang, R; Dash, P; Thomas, PG; Graham, BS				Billam, Padma; Bonaparte, Kathryn L.; Liu, Jie; Ruckwardt, Tracy J.; Chen, Man; Ryder, Alex B.; Wang, Rui; Dash, Pradyot; Thomas, Paul G.; Graham, Barney S.			T Cell Receptor Clonotype Influences Epitope Hierarchy in the CD8+T Cell Response to Respiratory Syncytial Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPERTOIRE SELECTION; STRUCTURAL BASIS; V-BETA; IMMUNODOMINANCE; VACCINE; COMPLEX; MICE; IMMUNOGENETICS; DIVERSITY	CD8+ T cell responses are important for recognizing and resolving viral infections. To better understand the selection and hierarchy of virus-specific T cell responses, we compared the T cell receptor (TCR) clonotype in parent and hybrid strains of respiratory syncytial virus-infected mice. K(d)M2(82-90) (SYIGSINNI) in BALB/c and (DM187-195)-M-b (NAITNAKII) in C57B1/6 are both dominant epitopes in parent strains but assume a distinct hierarchy, with K(d)M2(82-90) dominant to (DM187-195)-M-b in hybrid CB6F1/J mice. The dominant K(d)M2(82-90) response is relatively public and is restricted primarily to the highly prevalent V beta 13.2 in BALB/c and hybrid mice, whereas (DM187-195)-M-b responses in C57BL/6 mice are relatively private and involve multiple V beta subtypes, some of which are lost in hybrids. A significant frequency of TCR CDR3 sequences in the (DM187-195)-M-b response have a distinct "(D/E) WG" motif formed by a limited number of recombination strategies. Modeling of the dominant epitope suggested a flat, featureless structure, but (DM187-195)-M-b showed a distinctive structure formed by Lys(7). The data suggest that common recombination events in prevalent V beta genes may provide a numerical advantage in the T cell response and that distinct epitope structures may impose more limited options for successful TCR selection. Defining how epitope structure is interpreted to inform T cell function will improve the design of future gene-based vaccines.	[Billam, Padma; Bonaparte, Kathryn L.; Liu, Jie; Ruckwardt, Tracy J.; Chen, Man; Ryder, Alex B.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wang, Rui] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dash, Pradyot; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Rm 2502,40 Convent Dr,MSC 3017, Bethesda, MD 20892 USA.	bgraham@nih.gov	Thomas, Paul G./H-1063-2018; Graham, Barney S./AAC-5898-2019	Thomas, Paul G./0000-0001-7955-0256; Graham, Barney S./0000-0001-8112-0853; Dash, Pradyot/0000-0001-5467-0657	National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077714, ZIAAI005027] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Program.	Andreansky SS, 2005, J VIROL, V79, P4329, DOI 10.1128/JVI.79.7.4329-4339.2005; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brandenburg AH, 2001, VACCINE, V19, P2769, DOI 10.1016/S0264-410X(00)00536-3; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Collins PL, 2002, VIROLOGY, V296, P204, DOI 10.1006/viro.2002.1437; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Driver L C, 1999, Pediatr Nurs, V25, P527; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; GOVERMAN J, 1985, CELL, V40, P859, DOI 10.1016/0092-8674(85)90345-9; GOVERMAN J, 1986, CELL, V45, P475, DOI 10.1016/0092-8674(86)90279-5; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hussell T, 1998, J IMMUNOL, V161, P6215; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Kedzierska K, 2008, MOL IMMUNOL, V45, P607, DOI 10.1016/j.molimm.2006.05.017; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Koelle DM, 2003, P NATL ACAD SCI USA, V100, P12899, DOI 10.1073/pnas.2131705100; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Lefranc Marie-Paule, 2003, Novartis Found Symp, V254, P126; Lefranc Marie-Paule, 2007, V409, P19, DOI 10.1007/978-1-60327-118-9_2; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Liu J, 2010, J VIROL, V84, P10501, DOI 10.1128/JVI.00963-10; LOMBARDI V, 1992, AIDS RES HUM RETROV, V8, P1081, DOI 10.1089/aid.1992.8.1081; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Peebles RS, 2003, VIRAL IMMUNOL, V16, P25, DOI 10.1089/088282403763635429; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Stark JM, 2002, J MED VIROL, V67, P92, DOI 10.1002/jmv.2196; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Venturi V, 2006, P NATL ACAD SCI USA, V103, P18691, DOI 10.1073/pnas.0608907103; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6	73	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4829	4841		10.1074/jbc.M110.191437	http://dx.doi.org/10.1074/jbc.M110.191437			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118816	Green Published, hybrid			2022-12-27	WOS:000286975700080
J	Carley, AN; Kleinfeld, AM				Carley, Andrew N.; Kleinfeld, Alan M.			Fatty Acid (FFA) Transport in Cardiomyocytes Revealed by Imaging Unbound FFA Is Mediated by an FFA Pump Modulated by the CD36 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CARDIAC MYOCYTES; MEMBRANE-TRANSPORT; SKELETAL-MUSCLE; PALMITATE UPTAKE; PLASMA-MEMBRANE; BINDING-PROTEIN; HEART MYOCYTES; OLEATE UPTAKE; METABOLISM; ADIPOCYTES	Free fatty acid (FFA) transport across the cardiomyocyte plasma membrane is essential to proper cardiac function, but the role of membrane proteins and FFA metabolism in FFA transport remains unclear. Metabolism is thought to maintain intracellular FFA at low levels, providing the driving force for FFA transport, but intracellular FFA levels have not been measured directly. We report the first measurements of the intracellular unbound FFA concentrations (FFA(i)) in cardiomyocytes. The fluorescent indicator of FFA, ADIFAB (acrylodan-labeled rat intestinal fatty acid-binding protein), was microinjected into isolated cardiomyocytes from wild type (WT) and FAT/CD36 null C57B1/6 mice. Quantitative imaging of ADIFAB fluorescence revealed the time courses of FFA influx and efflux. For WT mice, rate constants for efflux (similar to 0.02 s(-1)) were twice influx, and steady state FFA(i) were more than 3-fold larger than extracellular unbound FFA (FFA(o)). The concentration gradient and the initial rate of FFA influx saturated with increasing FFA(o). Similar characteristics were observed for oleate, palmitate, and arachidonate. FAT/CD36 null cells revealed similar characteristics, except that efflux was 2-3-fold slower than WT cells. Rate constants determined with intracellular ADIFAB were confirmed by measurements of intracellular pH. FFA uptake by suspensions of cardiomyocytes determined by monitoring FFA(o) using extracellular ADIFAB confirmed the influx rate constants determined from FFA(i) measurements and demonstrated that rates of FFA transport and etomoxir-sensitive metabolism are regulated independently. We conclude that FFA influx in cardiac myocytes is mediated by a membrane pump whose transport rate constants may be modulated by FAT/CD36.	[Carley, Andrew N.; Kleinfeld, Alan M.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Torrey Pines Institute for Molecular Studies, California	Kleinfeld, AM (corresponding author), Torrey Pines Inst Mol Studies, 3550 Gen Atom Court, San Diego, CA 92121 USA.	akleinfeld@tpims.org	Carley, Andrew/U-6218-2019	Carley, Andrew/0000-0002-4348-2770	National Institutes of Health (NIDDK) [DK058762]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058762] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK058762 (NIDDK).; Supported by a postdoctoral fellowship from the American Heart Association.	ANEL A, 1993, BIOCHEMISTRY-US, V32, P530, DOI 10.1021/bi00053a018; Apple F.S., 2004, CLIN PROTEOMICS, V1, P41, DOI [10.1385/CP:1:1:041, DOI 10.1385/CP:1:1:041]; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Cantor WJ, 2008, J INVASIVE CARDIOL, V20, P186; Carley AN, 2004, AM J PHYSIOL-ENDOC M, V286, pE449, DOI 10.1152/ajpendo.00329.2003; Carley AN, 2009, BIOCHEMISTRY-US, V48, P10437, DOI 10.1021/bi901318a; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cupp D, 2004, BIOCHEMISTRY-US, V43, P4473, DOI 10.1021/bi036335l; DEGRELLA RF, 1980, J BIOL CHEM, V255, P9731; Demant EJF, 2002, BIOCHEM J, V363, P809, DOI 10.1042/0264-6021:3630809; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FORSDAHL K, 1995, J MOL CELL CARDIOL, V27, P893, DOI 10.1016/0022-2828(95)90039-X; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hamilton JA, 2007, PROSTAG LEUKOTR ESS, V77, P355, DOI 10.1016/j.plefa.2007.10.020; Huber AH, 2006, BIOCHEMISTRY-US, V45, P14263, DOI 10.1021/bi060703e; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Kampf JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1207, DOI 10.1152/ajpendo.00259.2007; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kampf JP, 2006, J BIOL CHEM, V281, P21566, DOI 10.1074/jbc.M602067200; Kampf JP, 2004, J BIOL CHEM, V279, P35775, DOI 10.1074/jbc.M403630200; Kleinfeld AM, 2004, J AM SOC MASS SPECTR, V15, P1572, DOI 10.1016/j.jasms.2004.07.010; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; LORUSSO SM, 1992, CELL MOTIL CYTOSKEL, V21, P111, DOI 10.1002/cm.970210204; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2001, AM J PHYSIOL-ENDOC M, V281, pE704, DOI 10.1152/ajpendo.2001.281.4.E704; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; Richieri GV, 1999, MOL CELL BIOCHEM, V192, P87, DOI 10.1023/A:1006878421990; Sandoval A, 2008, ARCH BIOCHEM BIOPHYS, V477, P363, DOI 10.1016/j.abb.2008.06.010; Satoh H, 1996, BIOPHYS J, V70, pTUP57; SERAYDAR.MW, 1969, BIOCHIM BIOPHYS ACTA, V180, P264, DOI 10.1016/0005-2728(69)90113-3; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; SORRENTINO D, 1989, J CLIN INVEST, V84, P1325, DOI 10.1172/JCI114301; STREMMEL W, 1988, J CLIN INVEST, V81, P844, DOI 10.1172/JCI113393; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Tatsumi T, 2003, CARDIOVASC RES, V59, P428, DOI 10.1016/S0008-6363(03)00391-2; Turcotte LP, 2000, MOL CELL BIOCHEM, V210, P53, DOI 10.1023/A:1007046929776; VANDERVUSSE GJ, 1995, J APPL PHYSIOL, V78, P1839, DOI 10.1152/jappl.1995.78.5.1839; VANDERVUSSE GJ, 1983, BIOCHIM BIOPHYS ACTA, V752, P361, DOI 10.1016/0005-2760(83)90266-7; Wu ML, 2000, CIRC RES, V86, pE55	45	32	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4589	4597		10.1074/jbc.M110.182162	http://dx.doi.org/10.1074/jbc.M110.182162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147770	Green Published, hybrid			2022-12-27	WOS:000286975700059
J	Ciampa, EJ; Welch, RC; Vanoye, CG; George, AL				Ciampa, Erin J.; Welch, Richard C.; Vanoye, Carlos G.; George, Alfred L., Jr.			KCNE4 Juxtamembrane Region Is Required for Interaction with Calmodulin and for Functional Suppression of KCNQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; KS POTASSIUM CHANNEL; PATCH-CLAMP TECHNIQUES; LONG-QT-SYNDROME; I-KS; ATRIAL-FIBRILLATION; K+ CHANNELS; MEMBRANE PATCHES; CELLS; MODULATION	Voltage-gated potassium (K-v) channels, such as KCNQ1 (K(v)7.1), are modulated by accessory subunits and regulated by intracellular second messengers. Accessory subunits belonging to the KCNE family exert diverse functional effects on KCNQ1, have been implicated in the pathogenesis of various genetic disorders of heart rhythm, and contribute to transducing intracellular signaling events into changes in K-v channel activity. We investigated the interactions between calmodulin (CaM), the ubiquitous Ca2+-transducing protein that binds and confers Ca2+ sensitivity to the biophysical properties of KCNQ1, and KCNE4. These studies were motivated by the observed similarities between the suppression of KCNQ1 function by pharmacological disruption of KCNQ1-CaM interactions and the effects of KCNE4 co-expression on the channel. We determined that KCNE4, but not KCNE1, can biochemically interact with CaM and that this interaction is Ca2+-dependent and requires a tetraleucine motif in the juxtamembrane region of the KCNE4 C terminus. Furthermore, disruption of the KCNE4-CaM interaction either by mutagenesis of the tetraleucine motif or by acute Ca2+ chelation impairs the ability of KCNE4 to inhibit KCNQ1. Our findings have potential relevance to KCNQ1 regulation both by KCNE accessory subunits and by an important intracellular signaling molecule.	[Welch, Richard C.; Vanoye, Carlos G.; George, Alfred L., Jr.] Vanderbilt Univ, Div Med Genet, Dept Med, Nashville, TN 37232 USA; [Ciampa, Erin J.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Med Genet, Dept Med, 529 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	al.george@vanderbilt.edu		Ciampa, Erin/0000-0002-6153-1994	National Institutes of Health [HL077188]; NIGMS [T32 GM07347]; American Heart Association [09PRE2220323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077188 (to A. L. G.) and USPHS Award T32 GM07347 from the NIGMS (to Vanderbilt Medical-Scientist Training Program). This work was also supported by American Heart Association Predoctoral Research Fellowship 09PRE2220323 (to E. J. C.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Boucherot A, 2001, J MEMBRANE BIOL, V182, P39, DOI 10.1007/s00232-001-0030-4; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001935; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Kerst G, 2001, PFLUG ARCH EUR J PHY, V443, P146, DOI 10.1007/s004240100632; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Kurokawa J, 2009, CHANNELS, V3, P16, DOI 10.4161/chan.3.1.7387; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2002, BIOCHEM J, V362, P499, DOI 10.1042/bj3620499; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Lundby A, 2008, CELL PHYSIOL BIOCHEM, V21, P47, DOI 10.1159/000113746; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Manderfield LJ, 2009, J PHYSIOL-LONDON, V587, P303, DOI 10.1113/jphysiol.2008.161281; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sah R, 2001, J PHYSIOL-LONDON, V533, P201, DOI 10.1111/j.1469-7793.2001.0201b.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shen ZJ, 1998, HEARING RES, V123, P157, DOI 10.1016/S0378-5955(98)00110-5; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Vanoye CG, 2009, J GEN PHYSIOL, V134, P207, DOI 10.1085/jgp.200910234; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Zhu MM, 2003, BIOCHEMISTRY-US, V42, P15388, DOI 10.1021/bi035188o	38	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4141	4149		10.1074/jbc.M110.158865	http://dx.doi.org/10.1074/jbc.M110.158865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118809	Green Published, hybrid			2022-12-27	WOS:000286975700013
J	Thoh, M; Babajan, B; Raghavendra, PB; Sureshkumar, C; Manna, SK				Thoh, Maikho; Babajan, Banaganapalli; Raghavendra, Pongali B.; Sureshkumar, Chitta; Manna, Sunil K.			Azadirachtin Interacts with Retinoic Acid Receptors and Inhibits Retinoic Acid-mediated Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; NUCLEAR RECEPTOR; RELA PHOSPHORYLATION; CELL-DEATH; IN-VITRO; ACTIVATION; APOPTOSIS; BINDING; TRANSACTIVATION; INTERLEUKIN-8	Considering the role of retinoids in regulation of more than 500 genes involved in cell cycle and growth arrest, a detailed understanding of the mechanism and its regulation is useful for therapy. The extract of the medicinal plant Neem (Azadirachta indica) is used against several ailments especially for anti-inflammatory, anti-itching, spermicidal, anticancer, and insecticidal activities. In this report we prove the detailed mechanism on the regulation of retinoic acid-mediated cell signaling by azadirachtin, active components of neem extract. Azadirachtin repressed all trans-retinoic acid (ATRA)-mediated nuclear transcription factor kappa B (NF-kappa B) activation, not the DNA binding but the NF-kappa B-dependent gene expression. It did not inhibit I kappa B alpha degradation, I kappa B alpha kinase activity, or p65 phosphorylation and its nuclear translocation but inhibited NF-kappa B-dependent reporter gene expression. Azadirachtin inhibited TRAF6-mediated, but not TRAF2-mediated NF-kappa B activation. It inhibited ATRA-induced Sp1 and CREB (cAMP-response element-binding protein) DNA binding. Azadirachtin inhibited ATRA binding with retinoid receptors, which is supported by biochemical and in silico evidences. Azadirachtin showed strong interaction with retinoid receptors. It suppressed ATRA-mediated removal of retinoid receptors, bound with DNA by inhibiting ATRA binding to its receptors. Overall, our data suggest that azadirachtin interacts with retinoic acid receptors and suppresses ATRA binding, inhibits falling off the receptors, and activates transcription factors like CREB, Sp1, NF-kappa B, etc. Thus, azadirachtin exerts anti-inflammatory and anti-metastatic responses by a novel pathway that would be beneficial for further anti-inflammatory and anti-cancer therapies.	[Thoh, Maikho; Sureshkumar, Chitta; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Babajan, Banaganapalli; Raghavendra, Pongali B.] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Sri Krishnadevaraya University	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in			Department of Science and Technology, Government of India; Centre for DNA Fingerprinting and Diagnostics; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Department of Science and Technology, Government of India grant and a Centre for DNA Fingerprinting and Diagnostics core grant.; Recipients of Council for Scientific and Industrial Research, Government of India fellowships.	Akudugu J, 2001, LIFE SCI, V68, P1153, DOI 10.1016/S0024-3205(00)01017-1; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Frenz DA, 1996, TERATOLOGY, V53, P292; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hofmann Clementine, 1994, P387; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; MANGELSDORF DJ, 1994, NUTR REV, V52, P32; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 2010, J BIOL CHEM, V285, P22318, DOI 10.1074/jbc.M110.131797; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Ryckebusch L, 2010, CIRC RES, V106, P686, DOI 10.1161/CIRCRESAHA.109.205732; Shimada J, 2001, MOL ENDOCRINOL, V15, P1677, DOI 10.1210/me.15.10.1677; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Sreenivasan Y, 2003, BIOCHEM PHARMACOL, V66, P2223, DOI 10.1016/j.bcp.2003.07.010; STAFFORD DL, 1995, PLAST RECONSTR SURG, V96, P1169, DOI 10.1097/00006534-199510000-00026; Subapriya R., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P149, DOI 10.2174/1568011053174828; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Vandersea MW, 1998, BIOL BULL-US, V194, P281, DOI 10.2307/1543098; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	33	15	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4690	4702		10.1074/jbc.M110.169334	http://dx.doi.org/10.1074/jbc.M110.169334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127062	Green Published, hybrid			2022-12-27	WOS:000286975700068
J	Tian, HB; Lu, Y; Shah, SP; Hong, S				Tian, Haibin; Lu, Yan; Shah, Shraddha P.; Hong, Song			14S,21R-Dihydroxydocosahexaenoic Acid Remedies Impaired Healing and Mesenchymal Stem Cell Functions in Diabetic Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; INCREASED ANGIOGENESIS; GROWTH-FACTORS; CDNA CLONING; EXPRESSION; BRAIN; 12R-LIPOXYGENASE; LIPOXYGENASE; REPAIR; MICE	Treatment of diabetes-impaired wound healing remains a major unresolved medical challenge. Here, we identified suppressed formation of a novel reparative lipid mediator 14S,21R-dihydroxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid (14S,21R-diHDHA) in cutaneous wounds of diabetic db/db mice. These results indicate that diabetes impedes the biosynthetic pathways of 14S,21R-diHDHA in skin wounds. Administration of exogenous 14S,21R-diHDHA to wounds in diabetic animals rescued healing and angiogenesis. When db/db mesenchymal stem cells (MSCs) were administered together with 14S,21R-diHDHA to wounds in diabetic animals, they coacted to accelerate wound re-epithelialization, granulation tissue formation, and synergistically improved vascularization. In the pivotal cellular processes of angiogenesis, 14S,21R-diHDHA enhanced VEGF release, vasculature formation, and migration of db/db dermal microvascular endothelial cells (DMVECs), as well as remedied paracrine angiogenic functions of db/db MSCs, including VEGF secretion and the promotion of DMVEC migration and vasculature formation. Our results show that 14S,21R-diHDHA activates the p38 MAPK pathway in wounds, db/db MSCs, and DMVECs. Overall, the impeded formation of 14S,21R-diHDHA described in this study suggests that diabetes could affect the generation of pro-healing lipid mediators in wound healing. By restoring wound healing and MSC functions, 14S,21R-diHDHA is a new lead for the development of better therapeutics used in treating wounds of diabetics.	[Tian, Haibin; Lu, Yan; Shah, Shraddha P.; Hong, Song] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Hong, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci Excellence, Lions Bldg,2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	shong@lsuhsc.edu			National Institutes of Health [1R01DK087800]; Neuroscience Center of Excellence, LSUHSC-NO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Center of Excellence, LSUHSC-NO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 1R01DK087800 (to S. H.) and by the Start-up Fund from the Neuroscience Center of Excellence, LSUHSC-NO (to S. H.).	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Basselin M, 2010, J LIPID RES, V51, P1049, DOI 10.1194/jlr.M002469; Bazan Nicolas G., 2008, P349; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cha ST, 2005, MICROVASC RES, V70, P198, DOI 10.1016/j.mvr.2005.08.002; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; CHEN XS, 1994, J BIOL CHEM, V269, P13979; ColvilleNash PR, 1997, MOL MED TODAY, V3, P14, DOI 10.1016/S1357-4310(96)10048-4; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Ding YX, 2000, AM J PHYSIOL-ENDOC M, V279, pE11, DOI 10.1152/ajpendo.2000.279.1.E11; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gronert K, 1999, METH MOL B, V120, P119; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Han XL, 2007, CURR OPIN MOL THER, V9, P586; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; Kampfer H, 2005, DIABETES, V54, P1543, DOI 10.2337/diabetes.54.5.1543; Kapoor M, 2006, CURR OPIN INVEST DR, V7, P418; KIM HY, 1990, PROSTAG OTH LIPID M, V40, P473, DOI 10.1016/0090-6980(90)90110-H; Kim IS, 2009, TISSUE ENG PT A, V15, P2411, DOI 10.1089/ten.tea.2008.0554; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Krieg P, 1998, BBA-LIPID LIPID MET, V1391, P7, DOI 10.1016/S0005-2760(97)00214-2; Kwon DS, 2008, INT WOUND J, V5, P453, DOI 10.1111/j.1742-481X.2007.00408.x; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; MARCUS AJ, 1984, P NATL ACAD SCI-BIOL, V81, P903, DOI 10.1073/pnas.81.3.903; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mezentsev A, 2002, J BIOL CHEM, V277, P18670, DOI 10.1074/jbc.M201143200; Montori VM, 2000, DIABETES CARE, V23, P1407, DOI 10.2337/diacare.23.9.1407; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; SCHWENK U, 1992, J BIOL CHEM, V267, P12482; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2000, J EXP MED, V192, pF5, DOI 10.1084/jem.192.3.F5; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shingel KI, 2008, J TISSUE ENG REGEN M, V2, P383, DOI 10.1002/term.101; Siebert M, 2001, BIOCHEM J, V355, P97, DOI 10.1042/0264-6021:3550097; STEFFENRUD S, 1987, BIOMED ENVIRON MASS, V14, P313, DOI 10.1002/bms.1200140704; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Swanson HI, 2004, CHEM-BIOL INTERACT, V149, P69, DOI 10.1016/j.cbi.2004.08.006; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang PY, 2006, PROSTAG LEUKOTR ESS, V75, P385, DOI 10.1016/j.plefa.2006.07.015; Yu ZY, 2006, ARCH BIOCHEM BIOPHYS, V455, P188, DOI 10.1016/j.abb.2006.09.002	68	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4443	4453		10.1074/jbc.M110.100388	http://dx.doi.org/10.1074/jbc.M110.100388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21112969	Green Published, hybrid			2022-12-27	WOS:000286975700044
J	Vasanth, S; ZeRuth, G; Kang, HS; Jetten, AM				Vasanth, Shivakumar; ZeRuth, Gary; Kang, Hong Soon; Jetten, Anton M.			Identification of Nuclear Localization, DNA Binding, and Transactivating Mechanisms of Kruppel-like Zinc Finger Protein Gli-Similar 2 (Glis2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; TRANSCRIPTION; REPRESSOR; ROLES; DIFFERENTIATION; EXPRESSION; APOPTOSIS; SEQUENCES; FIBROSIS; DISEASE	Gli-similar 1-3 (Glis1-3) constitute a subfamily of Kruppel-like zinc finger (ZF) transcription factors that are closely related to the Gli protein family. Mutations in GLIS2 are linked to nephronophthisis, a chronic kidney disease characterized by renal fibrosis and atrophy in children and young adults. Currently, very little information exists about the mechanism of action of Glis2, its target genes, or the signaling pathways that regulate its activity. In this study, we show that a region within ZF3 is required for the nuclear localization of Glis2. Analysis of Glis2 DNA binding demonstrated that Glis2 binds effectively to the consensus Glis binding sequence (GlisBS) (G/C)TGGGGGGT(A/C). Although Glis2 was unable to induce transactivation of a GlisBS-dependent reporter, it effectively inhibited the GlisBS-mediated transactivation by Gli1. Mutations that disrupt the tetrahedral configuration of each ZF within Glis2 abolished Glis2 binding to GlisBS and also abrogated its inhibition of Gli1-mediated transactivation. In contrast, Glis2 was able to activate the murine insulin-2 (Ins2) promoter by binding directly to two GlisBS elements located at -263 and -99 within the Ins2 promoter. Phosphomimetic mutation of Ser(245) inhibited the binding of Glis2 to GlisBS and dramatically affected its transactivation of the Ins2 promoter and its ability to inhibit GlisBS-dependent transactivation by Gli1. In this study, we demonstrate that Glis2 can function as a transcriptional activator and that post-translational modification within its DNA-binding domain can regulate its transcriptional activity. This control may play a critical role in the Glis2-dependent regulation of target genes and renal function.	[Vasanth, Shivakumar; ZeRuth, Gary; Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, Lab Resp Biol,NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), POB 12233,Mail Drop D2-01, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institutes of Health of the NIEHS [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIEHS (Z01-ES-100485).	Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES, V22, P1234, DOI 10.1359/JBMR.070503; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kramarenko II, 2010, MOL PHARMACOL, V78, P126, DOI 10.1124/mol.110.064840; Lamar E, 2001, DEVELOPMENT, V128, P1335; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; VORTKAMP A, 1995, DNA CELL BIOL, V14, P629, DOI 10.1089/dna.1995.14.629; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200	29	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4749	4759		10.1074/jbc.M110.165951	http://dx.doi.org/10.1074/jbc.M110.165951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127075	Green Published, hybrid			2022-12-27	WOS:000286975700073
J	Bryant, KJ; Bidgood, MJ; Lei, PW; Taberner, M; Salom, C; Kumar, V; Lee, L; Church, WB; Courtenay, B; Smart, BP; Gelb, MH; Cahill, MA; Graham, GG; McNeil, HP; Scott, KF				Bryant, Katherine J.; Bidgood, Matthew J.; Lei, Pei-Wen; Taberner, Megan; Salom, Caroline; Kumar, Vinod; Lee, Lawrence; Church, W. Bret; Courtenay, Brett; Smart, Brian P.; Gelb, Michael H.; Cahill, Michael A.; Graham, Garry G.; McNeil, H. Patrick; Scott, Kieran F.			A Bifunctional Role for Group IIA Secreted Phospholipase A(2) in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-TYPE RECEPTOR; FACTOR-KAPPA-B; PROSTAGLANDIN PRODUCTION; MAMMALIAN-CELLS; CYCLOOXYGENASE-2 EXPRESSION; PYRROLIDINE INHIBITORS; SYNOVIAL FIBROBLASTS; GROUP IB; ARTHRITIS; RELEASE	Human group IIA-secreted phospholipase A(2) (sPLA(2)-IIA) is an important regulator of cytokine-mediated inflammatory responses in both in vitro and in vivo models of rheumatoid arthritis (RA). However, treatment of RA patients with sPLA(2)-IIA inhibitors shows only transient benefit. Using an activityimpaired sPLA(2)-IIA mutant protein (H48Q), we show that up-regulation of TNF-dependent PGE(2) production and cyclooxygenase-2 (COX-2) induction by exogenous sPLA(2)-IIA in RA fibroblast-like synoviocytes (FLSs) is independent of its enzyme function. Selective cytosolic phospholipase A(2)-alpha (cPLA(2)-alpha) inhibitors abrogate TNF/sPLA(2)-IIA-mediated PGE(2) production without affecting COX-2 levels, indicating arachidonic acid (AA) flux to COX-2 occurs exclusively through TNF-mediated activation of cPLA(2)-alpha. Nonetheless, exogenous sPLA(2)-IIA, but not H48Q, stimulates both AA mobilization from FLSs and microparticle-derived AA release that is not used for COX-2-dependent PGE(2) production. sPLA(2)-IIA-mediated AA production is inhibited by pharmacological blockade of sPLA(2)-IIA but not cPLA(2)-alpha. Exogenous H48Q alone, like sPLA(2)-IIA, increases COX-2 protein levels without inducing PGE(2) production. Unlike TNF, sPLA(2)-IIA alone does not rapidly mobilize NF-kappa B or activate phosphorylation of p38 MAPK, two key regulators of COX-2 protein expression, but does activate the ERK1/2 pathway. Thus, sPLA(2)-IIA regulates AA flux through the cPLA(2)-alpha/COX-2 pathway in RA FLSs by up-regulating steady state levels of these biosynthetic enzymes through an indirect mechanism, rather than direct provision of substrate to the pathway. Inhibitors that have been optimized for their potency in enzyme activity inhibition alone may not adequately block the activity-independent function of sPLA(2)-IIA.	[Courtenay, Brett] St Vincents Private Hosp, Sydney, NSW 2010, Australia; [Kumar, Vinod; Graham, Garry G.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; Bidgood, Matthew J.; Lei, Pei-Wen; Taberner, Megan; Salom, Caroline; Scott, Kieran F.] Univ New S Wales, St Vincents Hosp, Sch Clin, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; McNeil, H. Patrick] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Lee, Lawrence; Church, W. Bret] Univ Sydney, Sydney, NSW 2006, Australia; [Cahill, Michael A.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Smart, Brian P.; Gelb, Michael H.] Univ Washington, Dept Chem & Biochem, Seattle, WA 98195 USA	University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Charles Sturt University; University of Washington; University of Washington Seattle	Scott, KF (corresponding author), Univ New S Wales, St Vincents Hosp, Sch Clin, Inflammat Res Lab, Darlinghurst, NSW 2010, Australia.	kieran.scott@unsw.edu.au	Church, William/H-6040-2013; CAHILL, Michael/J-8035-2012; Kumar, Vinod/AAM-3705-2020; Salom, Caroline/C-1761-2014; Bryant, Katherine/E-8574-2010	Church, William/0000-0002-8033-5518; CAHILL, Michael/0000-0002-8593-8844; Kumar, Vinod/0000-0002-7263-9917; Salom, Caroline/0000-0002-8986-9735; Bryant, Katherine/0000-0002-8686-623X; McNeil, Hugh Patrick/0000-0003-4336-2960; Lee, Lawrence/0000-0002-4453-4886; gelb, michael/0000-0001-7000-5219; Scott, Kieran/0000-0002-6012-4107	National Institutes of Health [HL50040, HL3625]; National Health and Medical Research Council [980263, 222870]; Cancer Council NSW [RG07-17]; Rebecca Cooper Foundation, Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003625, R01HL050040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Rebecca Cooper Foundation, Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL50040 and HL3625 (to M.H.G.), National Health and Medical Research Council Grants 980263 (to K.F.S. and P.M. Brooks) and 222870 (to K.F.S., G.G.G., and H.P.McN), Cancer Council NSW Grant RG07-17 (to K.F.S., G.G.G., Q.Dong, and P.J. Russell), and a grant from the Rebecca Cooper Foundation (to K.F.S.), Australia.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bidgood MJ, 2000, J IMMUNOL, V165, P2790, DOI 10.4049/jimmunol.165.5.2790; Boilard E, 2006, BIOCHEMISTRY-US, V45, P13203, DOI 10.1021/bi061376d; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200; Bradley JD, 2005, J RHEUMATOL, V32, P417; Chapdelaine Joan M., 1995, Arthritis and Rheumatism, V38, pS293; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; CISAR LA, 1993, CELL SIGNAL, V5, P463, DOI 10.1016/0898-6568(93)90086-2; Crofford LJ, 2005, J GENE MED, V7, P288, DOI 10.1002/jgm.661; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Hanasaki K, 2004, BIOL PHARM BULL, V27, P1165, DOI 10.1248/bpb.27.1165; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hughes-Fulford M, 2005, CARCINOGENESIS, V26, P1520, DOI 10.1093/carcin/bgi112; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jamal OS, 1998, ANN RHEUM DIS, V57, P550, DOI 10.1136/ard.57.9.550; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KUSHNER PJ, 1990, MOL ENDOCRINOL, V4, P1465, DOI 10.1210/mend-4-10-1465; Lehmann T, 2002, J RHEUMATOL, V29, P787; Lin MKS, 1996, J RHEUMATOL, V23, P1162; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; Min SY, 2004, J RHEUMATOL, V31, P875; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2004, BIOL PHARM BULL, V27, P1158, DOI 10.1248/bpb.27.1158; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; NUGTEREN DH, 1973, BIOCHIM BIOPHYS ACTA, V326, P448, DOI 10.1016/0005-2760(73)90145-8; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Pasztoi M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2697; REYNOLDS LJ, 1992, ANAL BIOCHEM, V204, P190, DOI 10.1016/0003-2697(92)90160-9; Santos LL, 2004, J RHEUMATOL, V31, P1038; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sawada H, 1999, EUR J BIOCHEM, V263, P826, DOI 10.1046/j.1432-1327.1999.00565.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200	61	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2492	2503		10.1074/jbc.M110.123927	http://dx.doi.org/10.1074/jbc.M110.123927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068383	Green Published, hybrid			2022-12-27	WOS:000286464300014
J	Qi, YN; Chuah, MLC; Dong, XM; Xie, KL; Luo, Z; Tang, K; Liang, ZX				Qi, Yaning; Chuah, Mary Lay Cheng; Dong, Xueming; Xie, Kailing; Luo, Zhen; Tang, Kai; Liang, Zhao-Xun			Binding of Cyclic Diguanylate in the Non-catalytic EAL Domain of FimX Induces a Long-range Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; PSEUDOMONAS-AERUGINOSA; ALCOHOL-DEHYDROGENASE; STRUCTURAL-ANALYSIS; TWITCHING MOTILITY; PROTEIN DOMAIN; PHOSPHODIESTERASE; MECHANISM; DEGRADATION; BACTERIA	FimX is a multidomain signaling protein required for type IV pilus biogenesis and twitching motility in the opportunistic pathogen Pseudomonas aeruginosa. FimX is localized to the single pole of the bacterial cell, and the unipolar localization is crucial for the correct assembly of type IV pili. FimX contains a non-catalytic EAL domain that lacks cyclic diguanylate (c-di-GMP) phosphodiesterase activity. It was shown that deletion of the EAL domain or mutation of the signature EVL motif affects the unipolar localization of FimX. However, it was not understood how the C-terminal EAL domain could influence protein localization considering that the localization sequence resides in the remote N-terminal region of the protein. Using hydrogen/deuterium exchange-coupled mass spectrometry, we found that the binding of c-di-GMP to the EAL domain triggers a long-range (similar to ca. 70 angstrom) conformational change in the N-terminal REC domain and the adjacent linker. In conjunction with the observation that mutation of the EVL motif of the EAL domain abolishes the binding of c-di-GMP, the hydrogen/deuterium exchange results provide a molecular explanation for the mediation of protein localization and type IV pilus biogenesis by c-di-GMP through a remarkable allosteric regulation mechanism.	[Qi, Yaning; Chuah, Mary Lay Cheng; Dong, Xueming; Xie, Kailing; Luo, Zhen; Tang, Kai; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zxliang@ntu.edu	Liang, Zhao-Xun/A-2191-2011; Dong, Xueming/M-2137-2017; Tang, Kai/A-2194-2011	Liang, Zhao-Xun/0000-0002-3128-1330; Dong, Xueming/0000-0001-8726-7565	Biomedical Research Council [06/1/22/19/464]; University Research Council [RG62/06]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); University Research Council	This work was supported by Biomedical Research Council Grant 06/1/22/19/464 (to Z.-X. L.) and University Research Council Grant RG62/06 (to K. T.).	Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Guhaniyogi J, 2008, J BACTERIOL, V190, P1419, DOI 10.1128/JB.01414-07; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Pasunooti S, 2010, J MOL CATAL B-ENZYM, V67, P98, DOI 10.1016/j.molcatb.2010.07.012; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	35	56	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2910	2917		10.1074/jbc.M110.196220	http://dx.doi.org/10.1074/jbc.M110.196220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098028	hybrid, Green Published			2022-12-27	WOS:000286464300055
J	Csepeggi, C; Jiang, M; Kojima, F; Crofford, LJ; Frolov, A				Csepeggi, Chad; Jiang, Min; Kojima, Fumiaki; Crofford, Leslie J.; Frolov, Andrey			Somatic Cell Plasticity and Niemann-Pick Type C2 Protein FIBROBLAST ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CHOLESTEROL TRAFFICKING; DENSITY-LIPOPROTEIN CHOLESTEROL; EPIDERMAL-GROWTH-FACTOR; DISEASE TYPE-C; RHEUMATOID-ARTHRITIS; STEM-CELLS; MYOFIBROBLAST DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; SYNOVIAL FIBROBLASTS; CARDIAC FIBROBLASTS	A growing body of evidence points toward activated fibroblasts, also known as myofibroblasts, as one of the leading mediators in several major human pathologies including proliferative fibrotic disorders, invasive tumor growth, rheumatoid arthritis, and atherosclerosis. Niemann-Pick Type C2 (NPC2) protein has been recently identified as a product of the second gene in NPC disease. It encodes ubiquitous, highly conserved, secretory protein with the poorly defined function. Here we show that NPC2 deficiency in human fibroblasts confers their activation. The activation phenomenon was not limited to fibroblasts as it was also observed in aortic smooth muscle cells upon silencing NPC2 gene by siRNA. More importantly, activated synovial fibroblasts isolated from patients with rheumatoid arthritis were also identified as NPC2-deficient at both the NPC2 mRNA and protein levels. The molecular mechanism responsible for activation of NPC2-null cells was shown to be a sustained phosphorylation of ERK 1/2 mitogen-activated protein kinase ( MAPK), which fulfills both the sufficient and necessary fibroblast activation criteria. All of these findings highlight a novel mechanism where NPC2 by negatively regulating ERK 1/2 MAPK phosphorylation may efficiently suppress development of maladaptive tissue remodeling and inflammation.	[Kojima, Fumiaki; Crofford, Leslie J.; Frolov, Andrey] Univ Kentucky, Div Rheumatol, Dept Internal Med, Lexington, KY 40536 USA; [Csepeggi, Chad; Jiang, Min; Frolov, Andrey] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University of Kentucky; University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Kentucky, Div Rheumatol, Dept Internal Med, 900 S Limestone St,Wethington Hlth Sci Bldg,Rm 45, Lexington, KY 40536 USA.	andrey.frolov@uky.edu	Crofford, Leslie J/J-8010-2013	Crofford, Leslie J/0000-0002-6347-5738	National Institutes of Health [RO1AR049010]; American Heart Association [SDG 023017N]; University of Cincinnati; Department of Internal Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Cincinnati; Department of Internal Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AR049010 (to L. J. C.). This work was also supported by American Heart Association Scientist Development Grant SDG 023017N, the University of Cincinnati Millennium Fund, and the Department of Internal Medicine Start-Up Fund (to A. F.).	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bjurulf B, 2008, MED SCI MONITOR, V14, pCS71; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Del Vecchio MA, 2001, ARTHRITIS RES, V3, P259, DOI 10.1186/ar311; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ebihara N, 2007, INVEST OPHTH VIS SCI, V48, P3069, DOI 10.1167/iovs.06-0968; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Faggin E, 1999, ARTERIOSCL THROM VAS, V19, P1393, DOI 10.1161/01.ATV.19.6.1393; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Gardai SJ, 2004, J BIOL CHEM, V279, P44695, DOI 10.1074/jbc.M405313200; Gillibert-Duplantier J, 2007, AM J PHYSIOL-GASTR L, V293, pG128, DOI 10.1152/ajpgi.00031.2007; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; GONG QQ, 1995, J BIOL CHEM, V270, P21672, DOI 10.1074/jbc.270.37.21672; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Haque S, 2008, CURR OPIN LIPIDOL, V19, P338, DOI 10.1097/MOL.0b013e328304b65f; Heo K, 2006, STEM CELLS, V24, P1549, DOI 10.1634/stemcells.2005-0458; Herrmann J, 2005, ARTERIOSCL THROM VAS, V25, P447, DOI 10.1161/01.ATV.0000152606.34120.97; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Kinnman N, 2000, LAB INVEST, V80, P697, DOI 10.1038/labinvest.3780073; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NAGAO S, 1986, J CUTAN PATHOL, V13, P261, DOI 10.1111/j.1600-0560.1986.tb01521.x; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Naz SM, 2007, BEST PRACT RES CL RH, V21, P871, DOI 10.1016/j.berh.2007.05.003; Okamura DM, 2009, J AM SOC NEPHROL, V20, P495, DOI 10.1681/ASN.2008010009; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Ospelt C, 2004, ANN RHEUM DIS, V63, P90, DOI 10.1136/ard.2004.028324; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schramek H, 1997, J BIOL CHEM, V272, P11426; Schramek H, 2003, AM J PHYSIOL-CELL PH, V285, pC652, DOI 10.1152/ajpcell.00463.2002; Schramek H, 1997, AM J PHYSIOL-CELL PH, V272, pC383, DOI 10.1152/ajpcell.1997.272.2.C383; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Srikanth K. N., 2005, Sarcoma, V9, P33, DOI 10.1080/13577140500090030; Stenmark KR, 2006, PHYSIOLOGY, V21, P134, DOI 10.1152/physiol.00053.2005; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Van Doornum S, 2002, ARTHRITIS RHEUM-US, V46, P862, DOI 10.1002/art.10089; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Verot L, 2007, CLIN GENET, V71, P320, DOI 10.1111/j.1399-0004.2007.00782.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Welch CL, 2007, CIRCULATION, V116, P2444, DOI 10.1161/CIRCULATIONAHA.107.701276; Wilcox JN, 2001, ANN NY ACAD SCI, V947, P68; Wilcox JN, 1996, INT J CARDIOL, V54, pS21, DOI 10.1016/S0167-5273(96)02811-2; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yamasaki S, 2002, CLIN EXP IMMUNOL, V129, P379, DOI 10.1046/j.1365-2249.2002.01876.x; Yanagimoto C, 2009, EXP CELL RES, V315, P119, DOI 10.1016/j.yexcr.2008.10.022; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje	92	12	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2078	2087		10.1074/jbc.M110.135897	http://dx.doi.org/10.1074/jbc.M110.135897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084287	hybrid, Green Published			2022-12-27	WOS:000286191500050
J	Hisano, Y; Kobayashi, N; Kawahara, A; Yamaguchi, A; Nishi, T				Hisano, Yu; Kobayashi, Naoki; Kawahara, Atsuo; Yamaguchi, Akihito; Nishi, Tsuyoshi			The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR EXPRESSION PROFILE; PROTEIN-COUPLED RECEPTORS; CANCER CELLS; SPHINGOSINE-1-PHOSPHATE LYASE; CERAMIDE SYNTHASES; MOLECULAR-CLONING; KINASE TYPE-2; PLATELETS; MIGRATION; RELEASE	FTY720 is a novel immunomodulating drug that can be phosphorylated inside cells; its phosphorylated form, FTY720-P, binds to a sphingosine 1-phosphate (S1P) receptor, S1P(1), and inhibits lymphocyte egress into the circulating blood. Although the importance of its pharmacological action has been well recognized, little is known about how FTY720-P is released from cells after its phosphorylation inside cells. Previously, we showed that zebrafish Spns2 can act as an S1P exporter from cells and is essential for zebrafish heart formation. Here, we demonstrate that human SPNS2 can transport several S1P analogues, including FTY720-P. Moreover, FTY720-P is transported by SPNS2 through the same pathway as S1P. This is the first identification of an FTY720-P transporter in cells; this finding is important for understanding FTY720 metabolism.	[Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; [Kobayashi, Naoki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba 2900193, Japan; [Kawahara, Atsuo] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University	Nishi, T (corresponding author), 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	tnishi@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Management Expenses Grants	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Management Expenses Grants	This study was supported by in part by the Management Expenses Grants for National Universities Corporations; a grant-in-aid for Scientific Research (S) (to A.Y.) and grants-in-aid for Scientific Research on Innovation and Scientific Research (C) (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Takeda Science Foundation (to T.N. and A.Y.).	Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, YONSEI MED J, V45, P991, DOI 10.3349/ymj.2004.45.6.991; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; Chiba K, 1998, J IMMUNOL, V160, P5037; Glickman M, 1999, MOL CELL NEUROSCI, V14, P141, DOI 10.1006/mcne.1999.0776; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kovarik JM, 2004, BRIT J CLIN PHARMACO, V57, P586, DOI 10.1111/j.1365-2125.2003.02065.x; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	41	108	112	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1758	1766		10.1074/jbc.M110.171116	http://dx.doi.org/10.1074/jbc.M110.171116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084291	Green Published, hybrid			2022-12-27	WOS:000286191500015
J	Frick, IM; Shannon, O; Akesson, P; Morgelin, M; Collin, M; Schmidtchen, A; Bjorck, L				Frick, Inga-Maria; Shannon, Oonagh; Akesson, Per; Morgelin, Matthias; Collin, Mattias; Schmidtchen, Artur; Bjorck, Lars			Antibacterial Activity of the Contact and Complement Systems Is Blocked by SIC, a Protein Secreted by Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; INNATE IMMUNITY; ANTIMICROBIAL PEPTIDES; INHIBITING PROTEIN; SURFACE PROTEIN; BINDING; IDENTIFICATION; ACTIVATION; COMPONENTS; KININOGENS	Recent studies have shown that activation of complement and contact systems results in the generation of antibacterial peptides. Streptococcus pyogenes, a major bacterial pathogen in humans, exists in > 100 different serotypes due to sequence variation in the surface-associated M protein. Cases of invasive and life-threatening S. pyogenes infections are commonly associated with isolates of the M1 serotype, and in contrast to the large majority of M serotypes, M1 isolates all secrete the SIC protein. Here, we show that SIC interferes with the activation of the contact system and blocks the activity of antibacterial peptides generated through complement and contact activation. This effect promotes the growth of S. pyogenes in human plasma, and in a mouse model of S. pyogenes sepsis, SIC enhances bacterial dissemination, results which help explain the high frequency of severe S. pyogenes infections caused by isolates of the M1 serotype.	[Frick, Inga-Maria; Shannon, Oonagh; Akesson, Per; Morgelin, Matthias; Collin, Mattias; Bjorck, Lars] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden	Lund University; Lund University	Frick, IM (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se	Collin, Mattias/C-6398-2009; Schmidtchen, Artur/F-9507-2015	Collin, Mattias/0000-0002-6166-7410; Shannon, Oonagh/0000-0001-8291-8189	Swedish Research Council [7480]; Foundations of Crafoord, Kock, Bergvall, and Osterlund; Royal Physiographic Society; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Crafoord, Kock, Bergvall, and Osterlund; Royal Physiographic Society; Hansa Medical AB	This work was supported by the Swedish Research Council (Project 7480), the Foundations of Crafoord, Kock, Bergvall, and Osterlund, the Royal Physiographic Society, and Hansa Medical AB.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Akesson P., 2010, MICROBIOLOGY    0812, DOI [10.1099/mic.0.039578-0, DOI 10.1099/MIC.0.039578-0]; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BENNASR A, 1995, BIOCHEM J, V305, P173, DOI 10.1042/bj3050173; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CHANG NS, 1992, BLOOD, V79, P2973; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; Fernie-King BA, 2001, IMMUNOLOGY, V103, P390, DOI 10.1046/j.1365-2567.2001.01249.x; Fernie-King BA, 2007, MICROBES INFECT, V9, P300, DOI 10.1016/j.micinf.2006.12.006; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FRICK IM, 1994, MOL MICROBIOL, V12, P143, DOI 10.1111/j.1365-2958.1994.tb01003.x; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hartas J, 1999, MICROB PATHOGENESIS, V26, P25, DOI 10.1006/mpat.1998.0244; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Hoe NP, 1999, NAT MED, V5, P924, DOI 10.1038/11369; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Minami M, 2009, FEMS MICROBIOL LETT, V298, P67, DOI 10.1111/j.1574-6968.2009.01696.x; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Musser JM, 1998, BIOMED RES REP, P185; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Sonesson A, 2007, BBA-BIOMEMBRANES, V1768, P346, DOI 10.1016/j.bbamem.2006.10.017; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Stone J. E., 1998, THESIS MISSOURI U SC; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	61	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1331	1340		10.1074/jbc.M110.178350	http://dx.doi.org/10.1074/jbc.M110.178350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068386	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000286005000045
J	Gupta, SC; Reuter, S; Phromnoi, K; Park, B; Hema, PS; Nair, M; Aggarwal, BB				Gupta, Subash C.; Reuter, Simone; Phromnoi, Kanokkarn; Park, Byoungduck; Hema, Padmanabhan S.; Nair, Mangalam; Aggarwal, Bharat B.			RETRACTED: Nimbolide Sensitizes Human Colon Cancer Cells to TRAIL through Reactive Oxygen Species- and ERK-dependent Up-regulation of Death Receptors, p53, and Bax (Retracted article. See vol. 291, pg. 16925, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NF-KAPPA-B; TREE AZADIRACHTA-INDICA; INDUCED APOPTOSIS; HYDROGEN-PEROXIDE; DOWN-REGULATION; MEDIATED APOPTOSIS; ALPHA KINASE; TUMOR-CELLS; DNA-DAMAGE; RESISTANCE	TNF-related apoptosis-inducing ligand (TRAIL) shows promise as a cancer treatment, but acquired tumor resistance to TRAIL is a roadblock. Here we investigated whether nimbolide, a limonoid, could sensitize human colon cancer cells to TRAIL. As indicated by assays that measure esterase activity, sub-G(1) fractions, mitochondrial activity, and activation of caspases, nimbolide potentiated the effect of TRAIL. This limonoid also enhanced expression of death receptors (DRs) DR5 and DR4 in cancer cells. Gene silencing of the receptors reduced the effect of limonoid on TRAIL-induced apoptosis. Using pharmacological inhibitors, we found that activation of ERK and p38 MAPK was required for DR up-regulation by nimbolide. Gene silencing of ERK abolished the enhancement of TRAIL-induced apoptosis. Moreover, our studies indicate that the limonoid induced reactive oxygen species production, which was required for ERK activation, up-regulation of DRs, and sensitization to TRAIL; these effects were mimicked by H2O2. In addition, nimbolide down-regulated cell survival proteins, including I-FLICE, cIAP-1, cIAP-2, Bcl-2, Bcl-xL, survivin, and X-linked inhibitor of apoptosis protein, and up-regulated the pro-apoptotic proteins p53 and Bax. Interestingly, p53 and Bax up-regulation by nimbolide was required for sensitization to TRAIL but not for DR up-regulation. Overall, our results indicate that nimbolide can sensitize colon cancer cells to TRAIL-induced apoptosis through three distinct mechanisms: reactive oxygen species- and ERK-mediated up-regulation of DR5 and DR4, downregulation of cell survival proteins, and up-regulation of p53 and Bax.	[Gupta, Subash C.; Reuter, Simone; Phromnoi, Kanokkarn; Park, Byoungduck; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA; [Hema, Padmanabhan S.; Nair, Mangalam] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013	Phromnoi, Kanokkarn/0000-0002-8003-6112	National Institutes of Health [CA016672, CA-124787-01A2]; Clayton Foundation for Research; Center for Targeted Therapy of the M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P01CA124787, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of the M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Support Grant CA016672 (to the M. D. Anderson Cancer Center) and National Institutes of Health Program Project Grant CA-124787-01A2. This work was also supported by a grant from the Clayton Foundation for Research (to B. B. A.) and a grant from the Center for Targeted Therapy of the M.D. Anderson Cancer Center.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anitha G, 2006, J ASIAN NAT PROD RES, V8, P445, DOI 10.1080/10286020500173267; [Anonymous], 1993, CA CAN J CLIN, V43, P47; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bratton SB, 2003, CELL DEATH DIFFER, V10, P4, DOI 10.1038/sj.cdd.4401176; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; HOLMAN RA, 1957, NATURE, V179, P1033, DOI 10.1038/1791033a0; JEFFREE GM, 1958, NATURE, V182, P892, DOI 10.1038/182892a0; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Kumar GH, 2009, INVEST NEW DRUG, V27, P246, DOI 10.1007/s10637-008-9170-z; Kwon D, 2008, BIOCHEM BIOPH RES CO, V372, P870, DOI 10.1016/j.bbrc.2008.05.148; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Moon DO, 2010, MOL CANCER THER, V9, P1583, DOI 10.1158/1535-7163.MCT-09-0942; Nair MS, 1997, PHYTOCHEMISTRY, V46, P1177, DOI 10.1016/S0031-9422(97)80006-4; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; PEZZUTO JM, 1986, NEW TRENDS NATURAL P, V26, P371; Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66; Roy MK, 2007, PHYTOTHER RES, V21, P245, DOI 10.1002/ptr.2058; Sastry BS, 2006, BIOORG MED CHEM LETT, V16, P4391, DOI 10.1016/j.bmcl.2006.05.105; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Siddiqui S, 1942, CURR SCI, V11, P278; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Takada Y, 2004, J BIOL CHEM, V279, P26287, DOI 10.1074/jbc.M400963200; Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang R, 2007, CANCER RES, V67, P7856, DOI 10.1158/0008-5472.CAN-07-0151; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161	47	82	87	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1134	1146		10.1074/jbc.M110.191379	http://dx.doi.org/10.1074/jbc.M110.191379			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078664	hybrid, Green Published			2022-12-27	WOS:000286005000024
J	Komati, H; Maharsy, W; Beauregard, J; Hayek, S; Nemer, M				Komati, Hiba; Maharsy, Wael; Beauregard, Janie; Hayek, Salim; Nemer, Mona			ZFP260 Is an Inducer of Cardiac Hypertrophy and a Nuclear Mediator of Endothelin-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; SERUM RESPONSE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIOMYOCYTE HYPERTROPHY; VENTRICULAR MYOCYTES; RAT CARDIOMYOCYTES; HYPERTENSIVE-RATS; NEURAL CREST; CELL-GROWTH	Pressure and volume overload induce hypertrophic growth of postnatal cardiomyocytes and genetic reprogramming characterized by reactivation of a subset of fetal genes. Despite intense efforts, the nuclear effectors of cardiomyocyte hypertrophy remain incompletely defined. Endothelin-1 (ET-1) plays an important role in cardiomyocyte growth and is involved in mediating the neurohormonal effects of mechanical stress. Here, we show that the phenylephrine-induced complex-1 (PEX1), also known as zinc finger transcription factor ZFP260, is essential for cardiomyocyte response to ET-1 as evidenced in cardiomyocytes with PEX1 knockdown. We found that ET-1 enhances PEX1 transcriptional activity via a PKC-dependent pathway which phosphorylates the protein and further potentiates its synergy with GATA4. Consistent with a role for PEX1 in cardiomyocyte hypertrophy, overexpression of PEX1 is sufficient to induce cardiomyocyte hypertrophy in vitro and in vivo. Importantly, transgenic mice with inducible PEX1 expression in the adult heart develop cardiac hypertrophy with preserved heart function. Together, the results identify a novel nuclear effector of ET-1 signaling and suggest that PEX1 may be a regulator of the early stages of cardiac hypertrophy.	[Komati, Hiba; Maharsy, Wael; Beauregard, Janie; Hayek, Salim; Nemer, Mona] Univ Ottawa, Lab Cardiac Dev & Differentiat, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Nemer, M (corresponding author), Univ Ottawa, Lab Cardiac Dev & Differentiat, Dept Biochem Microbiol & Immunol, 550 Rue Cumberland 246, Ottawa, ON K1N 6N5, Canada.	mona.nemer@uottawa.ca	Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X	Canadian Institutes of Health Research; Ottawa studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa studentship	This work was supported by grants from the Canadian Institutes of Health Research.; Supported in part by a University of Ottawa studentship.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Ammarguellat FZ, 2002, HYPERTENSION, V39, P679, DOI 10.1161/hy0202.103481; ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Charron F, 1999, MOL CELL BIOL, V19, P4355; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Debrus S, 2005, MOL CELL BIOL, V25, P8669, DOI 10.1128/MCB.25.19.8669-8682.2005; Dhaun N, 2008, HYPERTENSION, V52, P452, DOI 10.1161/HYPERTENSIONAHA.108.117366; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065; Keijzer R, 2001, DEVELOPMENT, V128, P503; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spieker L E, 2001, Heart Fail Rev, V6, P301, DOI 10.1023/A:1011456309039; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; WEI CM, 1994, CIRCULATION, V89, P1580, DOI 10.1161/01.CIR.89.4.1580; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Yang HH, 2002, DEVELOPMENT, V129, P2233; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	54	11	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1508	1516		10.1074/jbc.M110.162966	http://dx.doi.org/10.1074/jbc.M110.162966			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21051538	hybrid, Green Published			2022-12-27	WOS:000286005000063
J	Ushakov, DS; Caorsi, V; Ibanez-Garcia, D; Manning, HB; Konitsiotis, AD; West, TG; Dunsby, C; French, PM; Ferenczi, MA				Ushakov, Dmitry S.; Caorsi, Valentina; Ibanez-Garcia, Delisa; Manning, Hugh B.; Konitsiotis, Antonios D.; West, Timothy G.; Dunsby, Christopher; French, Paul M.; Ferenczi, Michael A.			Response of Rigor Cross-bridges to Stretch Detected by Fluorescence Lifetime Imaging Microscopy of Myosin Essential Light Chain in Skeletal Muscle Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY DOMAIN; CONTRACTION; ORIENTATION; SUBFRAGMENT-1; GENERATION; RESOLUTION; RELEASE; COMPLEX; BINDING; REGION	We applied fluorescence lifetime imaging microscopy to map the microenvironment of the myosin essential light chain (ELC) in permeabilized skeletal muscle fibers. Four ELC mutants containing a single cysteine residue at different positions in the C-terminal half of the protein (ELC-127, ELC-142, ELC-160, and ELC-180) were generated by site-directed mutagenesis, labeled with 7-diethylamino-3-((((2-iodoacetamido)ethyl)amino)carbonyl)coumarin, and introduced into permeabilized rabbit psoas fibers. Binding to the myosin heavy chain was associated with a large conformational change in the ELC. When the fibers were moved from relaxation to rigor, the fluorescence lifetime increased for all label positions. However, when 1% stretch was applied to the rigor fibers, the lifetime decreased for ELC-127 and ELC-180 but did not change for ELC-142 and ELC-160. The differential change of fluorescence lifetime demonstrates the shift in position of the C-terminal domain of ELC with respect to the heavy chain and reveals specific locations in the lever arm region sensitive to the mechanical strain propagating from the actin-binding site to the lever arm.	[Ushakov, Dmitry S.; Caorsi, Valentina; Ibanez-Garcia, Delisa; Konitsiotis, Antonios D.; West, Timothy G.; Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Manning, Hugh B.; Dunsby, Christopher; French, Paul M.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England	Imperial College London; Imperial College London	Ushakov, DS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	d.ushakov@imperial.ac.uk	Ferenczi, Michael/F-9510-2015; French, Paul/E-8649-2011; Ushakov, Dmitry/AAF-7914-2020	Ferenczi, Michael/0000-0002-0349-331X; Ushakov, Dmitry/0000-0001-7109-4217; French, Paul/0000-0002-0478-6755	Biotechnology and Biological Sciences Research Council [BB/E02/573/1]; Royal Society; UK Technology Strategy Board [CHBT/007/00030]; BBSRC [BB/I019448/1, BB/E021573/1] Funding Source: UKRI; MRC [G0601747] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021573/1, BB/I019448/1] Funding Source: researchfish; Medical Research Council [G0601747] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); UK Technology Strategy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E02/573/1), by a Royal Society Wolfson Research Merit Award (to P. M. F.) and by the UK Technology Strategy Board (Technology Award CHBT/007/00030).	Baumann BAJ, 2001, BIOCHEMISTRY-US, V40, P7868, DOI 10.1021/bi002731h; Borejdo J, 2002, BIOPHYS J, V82, p362A; Borejdo J, 2001, BIOCHEMISTRY-US, V40, P3796, DOI 10.1021/bi002527u; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dowling K, 1998, OPT LETT, V23, P810, DOI 10.1364/OL.23.000810; Garcia DI, 2007, BIOPHYS J, V93, P2091, DOI 10.1529/biophysj.106.096479; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V350, P497, DOI 10.1113/jphysiol.1984.sp015215; He ZH, 1999, J PHYSIOL-LONDON, V517, P839, DOI 10.1111/j.1469-7793.1999.0839s.x; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Huang W, 1998, EUR J BIOCHEM, V257, P457, DOI 10.1046/j.1432-1327.1998.2570457.x; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; Knowles AC, 2008, BIOPHYS J, V95, P3882, DOI 10.1529/biophysj.108.131508; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P9; Manning HB, 2008, J BIOPHOTONICS, V1, P494, DOI 10.1002/jbio.200810051; MARSH DJ, 1982, BIOCHEMISTRY-US, V21, P1925, DOI 10.1021/bi00537a035; Nelson MR, 1998, PROTEIN SCI, V7, P270; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Smyczynski C, 1997, BIOCHEMISTRY-US, V36, P13201, DOI 10.1021/bi970746i; Sweeney H. L., 1995, BIOPHYS J, V68, p112S; THIRLWELL H, 1994, BIOPHYS J, V67, P2436, DOI 10.1016/S0006-3495(94)80730-1; Ushakov D. S., 2008, Biofizika, V53, P950; WAGNER PD, 1977, J MOL BIOL, V109, P455, DOI 10.1016/S0022-2836(77)80023-5; West TG, 2009, BIOPHYS J, V96, P3281, DOI 10.1016/j.bpj.2009.01.016	29	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					842	850		10.1074/jbc.M110.149526	http://dx.doi.org/10.1074/jbc.M110.149526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056977	Green Published, hybrid			2022-12-27	WOS:000285782800083
J	Egawa, N; Yamamoto, K; Inoue, H; Hikawa, R; Nishi, K; Mori, K; Takahashi, R				Egawa, Naohiro; Yamamoto, Keisuke; Inoue, Haruhisa; Hikawa, Rie; Nishi, Katsunori; Mori, Kazutoshi; Takahashi, Ryosuke			The Endoplasmic Reticulum Stress Sensor, ATF6 alpha, Protects against Neurotoxin-induced Dopaminergic Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ATF6; PARKINSONS-DISEASE; RESPONSE-ELEMENT; OXIDATIVE STRESS; CELL-DEATH; BINDING-PROTEIN; ALPHA-SYNUCLEIN; P38; ACTIVATION; KINASE	Oxidative stress and endoplasmic reticulum (ER) stress are thought to contribute to the pathogenesis of various neurodegenerative diseases including Parkinson disease (PD), however, the relationship between these stresses remains unclear. ATF6 alpha is an ER-membrane-bound transcription factor that is activated by protein misfolding in the ER and functions as a critical regulator of ER quality control proteins in mammalian cells. The goal of this study was to explore the cause-effect relationship between oxidative stress and ER stress in the pathogenesis of neurotoxin-induced model of PD. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin known to produce oxidative stress, activated ATF6 alpha and increased ER chaperones and ER-associated degradation (ERAD) component in dopaminergic neurons. Importantly, MPTP induced formation of ubiquitin-immunopositive inclusions and loss of dopaminergic neurons more prominently in mice deficient in ATF6 alpha than in wild-type mice. Cultured cell experiments revealed that 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress not only promoted phosphorylation of p38 mitogen-activated protein kinase (p38MAPK) but also enhanced interaction between phosphorylated p38MAPK and ATF6 alpha, leading to increment in transcriptional activator activity of ATF6 alpha. Thus, our results revealed a link between oxidative stress and ER stress by showing the importance of ATF6 alpha in the protection of the dopaminergic neurons from MPTP that occurs through oxidative stress-induced activation of ATF6 alpha and p38MAPK-mediated enhancement of ATF6 alpha transcriptional activity.	[Egawa, Naohiro; Hikawa, Rie; Mori, Kazutoshi; Takahashi, Ryosuke] Japan Sci & Technol Corp, CREST, Tokyo, Japan; [Yamamoto, Keisuke; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Yamamoto, Keisuke] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Inoue, Haruhisa] Kyoto Univ, CiRA, Kyoto 6068507, Japan; [Nishi, Katsunori] Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; [Egawa, Naohiro; Hikawa, Rie; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); Kyoto University; Tokushima University; Kyoto University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Kyoto University	Takahashi, R (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	ryosuket@kuhp.kyoto-u.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Mori, Kazutoshi/K-6106-2015	Inoue, Haruhisa/0000-0003-4736-9537	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for scientific research on Priority Areas-Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grant-in-aid from the Ministry of Health, Labor, and Welfare of Japan.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Junn E, 2001, J NEUROCHEM, V78, P374, DOI 10.1046/j.1471-4159.2001.00425.x; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Shimoji M, 2005, MOL BRAIN RES, V134, P103, DOI 10.1016/j.molbrainres.2005.01.012; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yokoyama H, 2008, NEUROL SCI, V29, P293, DOI 10.1007/s10072-008-0986-2; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	35	101	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7947	7957		10.1074/jbc.M110.156430	http://dx.doi.org/10.1074/jbc.M110.156430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21131360	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000288013300025
J	Jepson, JEC; Savva, YA; Yokose, C; Sugden, AU; Sahin, A; Reenan, RA				Jepson, James E. C.; Savva, Yiannis A.; Yokose, Chio; Sugden, Arthur U.; Sahin, Asli; Reenan, Robert A.			Engineered Alterations in RNA Editing Modulate Complex Behavior in Drosophila REGULATORY DIVERSITY OF ADENOSINE DEAMINASE ACTING ON RNA (ADAR) TARGETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE COURTSHIP BEHAVIOR; HOMOLOGOUS RECOMBINATION; NERVOUS-SYSTEM; NEURAL CIRCUITRY; MELANOGASTER; GENE; FRUITLESS; SONG; INACTIVATION; EXPRESSION	Select proteins involved in electrical and chemical neurotransmission are re-coded at the RNA level via the deamination of particular adenosines to inosine by adenosine deaminases acting on RNA (ADARs). It has been hypothesized that this process, termed RNA editing, acts to "fine-tune" neurophysiological properties in animals and potentially downstream behavioral outputs. However, the extreme phenotypes resulting from deletions of adar loci have precluded investigations into the relationship between ADAR levels, target transcripts, and complex behaviors. Here, we engineer Drosophila hypomorphic for ADAR expression using homologous recombination. A substantial reduction in ADAR activity (> 80%) leads to altered circadian motor patterns and abnormal male courtship, although surprisingly, general locomotor coordination is spared. The altered phenotypic landscape in our adar hypomorph is paralleled by an unexpected dichotomous response of ADAR target transcripts, i.e. certain adenosines are minimally affected by dramatic ADAR reduction, whereas editing of others is severely curtailed. Furthermore, we use a novel reporter to map RNA editing activity across the nervous system, and we demonstrate that knockdown of editing in fruitless-expressing neurons is sufficient to modify the male courtship song. Our data demonstrate that network-wide temporal and spatial regulation of ADAR activity can tune the complex system of RNA-editing sites and modulate multiple ethologically relevant behavioral modalities.	[Jepson, James E. C.; Savva, Yiannis A.; Yokose, Chio; Sugden, Arthur U.; Sahin, Asli; Reenan, Robert A.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Reenan, RA (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, SFH Life Sci Bldg,185 Meeting St, Providence, RI 02912 USA.	Robert_Reenan@brown.edu		jepson, james/0000-0002-3357-2801; Yokose, Chio/0000-0001-7557-3303	Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Ellison Medical Foundation Senior Scholar award.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Grauso M, 2002, GENETICS, V160, P1519; HALL JC, 1979, GENETICS, V92, P437; Hanrahan CJ, 2000, GENETICS, V155, P1149; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ingleby L, 2009, J GEN PHYSIOL, V133, P17, DOI 10.1085/jgp.200810133; Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185; Jepson JEC, 2009, J BIOL CHEM, V284, P31391, DOI 10.1074/jbc.M109.035048; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Maggert Keith A., 2008, V420, P155, DOI 10.1007/978-1-59745-583-1_9; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcucci R, 2009, NUCLEIC ACIDS RES, V37, P1663, DOI 10.1093/nar/gkn1080; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Peixoto AA, 1998, GENETICS, V148, P827; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; Smith L A, 1998, J Neurogenet, V12, P227; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; VONSCHILCHER F, 1979, J COMP PHYSIOL, V129, P85, DOI 10.1007/BF00679915; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	43	56	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8325	8337		10.1074/jbc.M110.186817	http://dx.doi.org/10.1074/jbc.M110.186817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21078670	Green Published, hybrid			2022-12-27	WOS:000288013300061
J	Gao, S; Rao, VB				Gao, Song; Rao, Venigalla B.			Specificity of Interactions among the DNA-packaging Machine Components of T4-related Bacteriophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DOMAINS; SMALL TERMINASE; LARGE SUBUNIT; PROTEIN GP17; ATPASE; NUCLEASE; BINDING; LAMBDA; MOTOR; PURIFICATION	Tailed bacteriophages use powerful molecular motors to package the viral genome into a preformed capsid. Packaging at a rate of up to similar to 2000 bp/s and generating a power density twice that of an automobile engine, the phage T4 motor is the fastest and most powerful reported to date. Central to DNA packaging are dynamic interactions among the packaging components, capsid (gp23), portal (gp20), motor (gp17, large "terminase"), and regulator (gp16, small terminase), leading to precise orchestration of the packaging process, but the mechanisms are poorly understood. Here we analyzed the interactions between small and large terminases of T4-related phages. Our results show that the gp17 packaging ATPase is maximally stimulated by homologous, but not heterologous, gp16. Multiple interaction sites are identified in both gp16 and gp17. The specificity determinants in gp16 are clustered in the diverged N- and C-terminal domains (regions I-III). Swapping of diverged region(s), such as replacing C-terminal RB49 region III with that of T4, switched ATPase stimulation specificity. Two specificity regions, amino acids 37-52 and 290-315, are identified in or near the gp17-ATPase "transmission" subdomain II. gp16 binding at these sites might cause a conformational change positioning the ATPase-coupling residues into the catalytic pocket, triggering ATP hydrolysis. These results lead to a model in which multiple weak interactions between motor and regulator allow dynamic assembly and disassembly of various packaging complexes, depending on the functional state of the packaging machine. This might be a general mechanism for regulation of the phage packaging machine and other complex molecular machines.	[Gao, Song; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health, NIAID [R56AI081726]; National Science Foundation [MCB-0923873]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081726, R01AI081726] Funding Source: NIH RePORTER; Direct For Biological Sciences [0923873] Funding Source: National Science Foundation	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R56AI081726. This work was also supported by National Science Foundation Grant MCB-0923873.	Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CHAI SH, 1994, VIROLOGY, V202, P930, DOI 10.1006/viro.1994.1415; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DeLano W.L, PYMOL MOL GRAPHICS S; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goldberg E, 1983, MOL BIOL BACTERIOPHA, P32; Golz S, 1999, J MOL BIOL, V285, P1131, DOI 10.1006/jmbi.1998.2399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Kondabagil KR, 2006, J MOL BIOL, V358, P67, DOI 10.1016/j.jmb.2006.01.078; Kuebler D, 1998, J MOL BIOL, V281, P803, DOI 10.1006/jmbi.1998.1952; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Lin H, 1997, J BIOL CHEM, V272, P3495, DOI 10.1074/jbc.272.6.3495; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; LUFTIG RB, 1972, J VIROL, V10, P545, DOI 10.1128/JVI.10.3.545-554.1972; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tetart F, 2001, J BACTERIOL, V183, P358, DOI 10.1128/JB.183.1.358-366.2001; Tsay JM, 2010, J BIOL CHEM, V285, P24282, DOI 10.1074/jbc.M110.129395; van Duijn E, 2010, J AM SOC MASS SPECTR, V21, P971, DOI 10.1016/j.jasms.2009.12.010; Yang Q, 1999, BIOCHEMISTRY-US, V38, P465, DOI 10.1021/bi981271d; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107	46	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3944	3956		10.1074/jbc.M110.196907	http://dx.doi.org/10.1074/jbc.M110.196907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127059	Green Published, hybrid			2022-12-27	WOS:000286653200075
J	Horn, PJ; Ledbetter, NR; James, CN; Hoffman, WD; Case, CR; Verbeck, GF; Chapman, KD				Horn, Patrick J.; Ledbetter, Nicole R.; James, Christopher N.; Hoffman, William D.; Case, Charlene R.; Verbeck, Guido F.; Chapman, Kent D.			Visualization of Lipid Droplet Composition by Direct Organelle Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OIL BODIES; FATTY-ACIDS; IONIZATION; TRIACYLGLYCEROLS; FLUORESCENCE; EXTRACTION; MICROSCOPY; OLEOSINS; REVEALS; PLANTS	An expanding appreciation for the varied functions of neutral lipids in cellular organisms relies on a more detailed understanding of the mechanisms of lipid production and packaging into cytosolic lipid droplets (LDs). Conventional lipid profiling procedures involve the analysis of tissue extracts and consequently lack cellular or subcellular resolution. Here, we report an approach that combines the visualization of individual LDs, microphase extraction of lipid components from droplets, and the direct identification of lipid composition by nanospray mass spectrometry, even to the level of a single LD. The triacylglycerol (TAG) composition of LDs from several plant sources (mature cotton (Gossypium hirsutum) embryos, roots of cotton seedlings, and Arabidopsis thaliana seeds and leaves) were examined by direct organelle mass spectrometry and revealed the heterogeneity of LDs derived from different plant tissue sources. The analysis of individual LDs makes possible organellar resolution of molecular compositions and will facilitate new studies of LD biogenesis and functions, especially in combination with analysis of morphological and metabolic mutants. Furthermore, direct organelle mass spectrometry could be applied to the molecular analysis of other subcellular compartments and macromolecules.	[Verbeck, Guido F.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Ledbetter, Nicole R.; Hoffman, William D.; Verbeck, Guido F.] Univ N Texas, Dept Chem, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, 1155 Union Circle 305220, Denton, TX 76203 USA.	chapman@unt.edu	Verbeck, Guido/AAF-3774-2019; Hoffmann, William/M-9122-2016; Horn, Patrick/G-1013-2013	Verbeck, Guido/0000-0002-3317-9911; Hoffmann, William/0000-0002-7516-1437; Horn, Patrick/0000-0002-1057-4708; Chapman, Kent/0000-0003-0489-3072	Zyvex Instrument [GN1371]; University of North Texas [G33598]; United States Department of Energy [08-395, DE-SC0000797]	Zyvex Instrument; University of North Texas; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Zyvex Instrument Research Grant GN1371 and University of North Texas Faculty Research Grant G33598 (to G. F. V.).; Supported in part by Cotton Incorporated Research Grant 08-395 and Grant DE-SC0000797 from the United States Department of Energy. To whom correspondence should be addressed: University of North Texas, 1155 Union Circle #305220, Denton, TX 76203-5017. Tel.: 940-565-2969; Fax: 940-369-8656; E-mail: chapman@unt.edu.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brown JM, 2010, ANAL BIOCHEM, V398, P7, DOI 10.1016/j.ab.2009.10.044; Brunelle A, 2009, ANAL BIOANAL CHEM, V393, P31, DOI 10.1007/s00216-008-2367-3; Byrdwell WC, 2005, LIPIDS, V40, P383, DOI 10.1007/s11745-006-1398-9; CHAPMAN KD, 1991, J CELL BIOL, V115, P995, DOI 10.1083/jcb.115.4.995; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Cheng CF, 1998, ANAL CHEM, V70, P4417, DOI 10.1021/ac9805192; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; Dill AL, 2009, J CHROMATOGR B, V877, P2883, DOI 10.1016/j.jchromb.2008.12.058; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Ledbetter NL, 2010, J FORENSIC SCI, V55, P1218, DOI 10.1111/j.1556-4029.2010.01406.x; Leprince O, 1998, PLANTA, V204, P109, DOI 10.1007/s004250050236; Lisa M, 2008, J CHROMATOGR A, V1198, P115, DOI 10.1016/j.chroma.2008.05.037; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Robenek H, 2009, BBA-MOL CELL BIOL L, V1791, P408, DOI 10.1016/j.bbalip.2008.12.001; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; SCHMID KM, 1988, PHYTOCHEMISTRY, V27, P2831, DOI 10.1016/0031-9422(88)80672-1; SLACK CR, 1980, BIOCHEM J, V190, P551, DOI 10.1042/bj1900551; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; TZEN JTC, 1990, PLANT PHYSIOL, V94, P1282, DOI 10.1104/pp.94.3.1282; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Yang ZL, 2009, PLANT PHYSIOL, V150, P1981, DOI 10.1104/pp.109.140491; Zehethofer N, 2008, ANAL CHIM ACTA, V627, P62, DOI 10.1016/j.aca.2008.06.045; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	36	66	67	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3298	3306		10.1074/jbc.M110.186353	http://dx.doi.org/10.1074/jbc.M110.186353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118810	hybrid, Green Published			2022-12-27	WOS:000286653200015
J	Kodama, S; Negishi, M				Kodama, Susumu; Negishi, Masahiko			Pregnane X Receptor PXR Activates the GADD45 beta Gene, Eliciting the p38 MAPK Signal and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NUCLEAR RECEPTORS; CROSS-TALK; TGF-BETA; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; KINASE ACTIVATION; PROTEIN-KINASE; EXPRESSION; CAR	Pregnane X receptor (PXR) was originally characterized as a transcription factor that induces hepatic drug metabolism by activating cytochrome P450 genes. Here we have now demonstrated a novel function of PXR, that of eliciting p38 mitogen-activated protein kinase (MAPK) phosphorylation for cell migration. Upon xenobiotic activation of ectopic human PXR, human hepatocellular carcinoma HepG2 cells were found to exhibit increased phosphorylation of p38 MAPK and to subsequently change morphology and migrate. p38 MAPK was responsible for the regulation of these morphological changes and cell migration because the p38 MAPK inhibitor SB239063 repressed both. Prior to this phosphorylation, PXR directly activated the early response GADD45 beta gene by binding to a distal direct repeat 4 site of the GADD45 beta promoter. Ectopic expression of GADD45 beta increased p38 MAPK phosphorylation, whereas siRNA knockdown of GADD45 beta decreased the PXR-induced p38 MAPK phosphorylation, confirming that GADD45 beta can regulate PXR-induced p38 MAPK phosphorylation in HepG2 cells. These results indicate that PXR activates the GADD45 beta gene, increasing p38 MAPK phosphorylation, and leading HepG2 cells to change morphology and migrate. The GADD45 beta gene is a direct target for PXR, eliciting cell signals to regulate various cellular functions.	[Kodama, Susumu; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health through NIEHS [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZICES102445] Funding Source: NIH RePORTER	National Institutes of Health through NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant Z01ES1005-01 through the NIEHS.	Bakin AV, 2002, J CELL SCI, V115, P3193; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kakizaki S, 2008, CURR DRUG METAB, V9, P614, DOI 10.2174/138920008785821666; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Koyano S, 2004, DRUG METAB DISPOS, V32, P149, DOI 10.1124/dmd.32.1.149; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu X, 2010, J GASTROEN HEPATOL, V25, P420, DOI 10.1111/j.1440-1746.2009.05981.x; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Musch A, 2005, DIGESTION, V71, P78, DOI 10.1159/000084523; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Sipeki S, 1999, CELL SIGNAL, V11, P885, DOI 10.1016/S0898-6568(99)00060-1; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vairapandi M, 1996, ONCOGENE, V12, P2579; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Yamamoto Y, 2008, DRUG METAB DISPOS, V36, P1189, DOI 10.1124/dmd.108.020628; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001; Zhou J, 2008, MOL ENDOCRINOL, V22, P868, DOI 10.1210/me.2007-0197; Zucchini N, 2005, BBA-MOL CELL RES, V1745, P48, DOI 10.1016/j.bbamcr.2005.02.005	37	44	44	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3570	3578		10.1074/jbc.M110.179812	http://dx.doi.org/10.1074/jbc.M110.179812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127053	hybrid, Green Published			2022-12-27	WOS:000286653200041
J	Han, KD; Matsuura, A; Ahn, HC; Kwon, AR; Min, YH; Park, HJ; Won, HS; Park, SJ; Kim, DY; Lee, BJ				Han, Kyung-Doo; Matsuura, Atsushi; Ahn, Hee-Chul; Kwon, Ae-Ran; Min, Yu-Hong; Park, Hyo-Ju; Won, Hyung-Sik; Park, Sung-Jean; Kim, Do-Young; Lee, Bong-Jin			Functional Identification of Toxin-Antitoxin Molecules from Helicobacter pylori 26695 and Structural Elucidation of the Molecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MESSENGER-RNA INTERFERASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; TRANSCRIPTIONAL AUTOREPRESSION; CRYSTAL-STRUCTURE; YEFM ANTITOXIN; ACTIVE-SITE; PROTEIN; CLEAVAGE	Bacterial toxin-antitoxin (TA) systems are associated with many important cellular processes including antibiotic resistance and microorganism virulence. Here, we identify and structurally characterize TA molecules from the gastric pathogen, Helicobacter pylori. The HP0894 protein had been previously suggested, through our structural genomics approach, to be a putative toxin molecule. In this study, the intrinsic RNase activity and the bacterial cell growth-arresting activity of HP0894 were established. The RNA-binding surface was identified at three residue clusters: (Lys(8) and Ser(9)), (Lys(50)-Lys(54) and Glu(58)), and (Arg(80) and His(84)-Phe(88)). In particular, the -UA- and -CA- sequences in RNA were preferentially cleaved by HP0894, and residues Lys(52), Trp(53), and Ser(85)-Lys(87) were observed to be the main contributors to sequence recognition. The action of HP0894 could be inhibited by the HP0895 protein, and the HP0894-HP0895 complex formed an oligomer with a binding stoichiometry of 1:1. The N and C termini of HP0894 constituted the binding sites to HP0895. In contrast, the unstructured C-terminal region of HP0895 was responsible for binding to HP0894 and underwent a conformational change in the process. Finally, DNA binding activity was observed for both HP0895 and the HP0894-0895 complex but not for HP0894 alone. Taken together, it is concluded that the HP0894-HP0895 protein couple is a TA system in H. pylori, where HP0894 is a toxin with an RNase function, whereas HP0895 is an antitoxin functioning by binding to both the toxin and DNA.	[Han, Kyung-Doo; Matsuura, Atsushi; Kwon, Ae-Ran; Park, Hyo-Ju; Lee, Bong-Jin] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Ahn, Hee-Chul] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul 136791, South Korea; [Kwon, Ae-Ran; Min, Yu-Hong] Daegu Haany Univ, Dept Herbal Skin Care, Gyongsan 712715, Gyeongsangbuk, South Korea; [Won, Hyung-Sik] Konkuk Univ, Sch Med, Chungju 380701, Chungcheongbuk, South Korea; [Park, Sung-Jean] Gachon Univ, Sch Med & Sci, Grad Sch Med, Inchon 406799, South Korea; [Kim, Do-Young] Davidson Coll, Davidson, NC 28035 USA	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Daegu Haany University; Konkuk University; Konkuk University Medical Center; Gachon University; Davidson College	Lee, BJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Bong-Jin/AAQ-1609-2020	Lee, Bong-Jin/0000-0001-7896-2961	Korean government (Ministry of Education, Science and Technology (MEST) [20100001707]; New Drug Target [3700-20070095]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084420, A092006]; Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy	Korean government (Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); New Drug Target; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Foundation (NRF) of Korea Grant 20100001707 funded by the Korean government (Ministry of Education, Science and Technology (MEST)) and New Drug Target Discovery Grant 3700-20070095. This work was also supported by Grants A084420 and A092006 of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. This work was supported in part by the 2009 Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Cherny I, 2007, BIOCHEMISTRY-US, V46, P12152, DOI 10.1021/bi701037e; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Han KD, 2005, PROTEINS, V61, P1114, DOI 10.1002/prot.20691; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Lah J, 2003, J BIOL CHEM, V278, P14101, DOI 10.1074/jbc.M209855200; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson DN, 2005, NAT STRUCT MOL BIOL, V12, P282, DOI 10.1038/nsmb0405-282; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	46	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4842	4853		10.1074/jbc.M109.097840	http://dx.doi.org/10.1074/jbc.M109.097840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123184	Green Published, hybrid			2022-12-27	WOS:000286975700081
J	Sun, LY; Shi, L; Wang, F; Huangyang, PW; Si, WZ; Yang, J; Yao, Z; Shang, YF				Sun, Luyang; Shi, Lei; Wang, Feng; Huangyang, Peiwei; Si, Wenzhe; Yang, Jie; Yao, Zhi; Shang, Yongfeng			Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; COP9 SIGNALOSOME; UBIQUITIN LIGASE; CYTOPLASMIC LOCALIZATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; NUCLEAR EXPORT; C-MYC	The p53 tumor suppressor plays a central role in integrating cellular responses to various stresses. Tight regulation of p53 is thus essential for the maintenance of genome integrity and normal cell proliferation. Previously, we reported that JFK, the only Kelch domain-containing F-box protein in human, promotes ubiquitination and degradation of p53 and that unlike the other E3 ligases for p53, all of which possess an intrinsic ubiquitin ligase activity, JFK destabilizes p53 through the assembly of a Skp1-Cul1-F-box complex. Here, we report that the substrate recognition by JFK requires phosphorylation of p53 in its central core region by CSN (COP9 signalosome)associated kinase. Significantly, inhibition of CSN-associated kinase activity or knockdown of CSN5 impairs JFK-promoted p53 degradation, enhances p53-dependent transcription, and promotes cell growth suppression, G(1) arrest, and apoptosis. Moreover, we showed that JFK is transcriptionally regulated by p53 and forms an auto-regulatory negative feedback loop with p53. These data may shed new light on the functional connection between CSN, Skp1-Cul1-F-box ubiquitin ligase, and p53 and provide a molecular mechanism for the regulation of JFK-promoted p53 degradation.	[Yang, Jie; Yao, Zhi; Shang, Yongfeng] Tianjin Med Univ, Tianjin 300070, Peoples R China; [Sun, Luyang; Shi, Lei; Wang, Feng; Huangyang, Peiwei; Si, Wenzhe; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & translat Res, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China	Tianjin Medical University; Peking University	Yao, Z (corresponding author), Tianjin Med Univ, Tianjin 300070, Peoples R China.	yaozhi@tijmu.edu.cn	Huangyang, Peiwei/AAS-8905-2021; HUANG, YANGPEIWEI/AAS-7683-2021	HUANG, YANGPEIWEI/0000-0002-9131-3891	National Natural Science Foundation of China [30830032, 30921062, 81071673]; Ministry of Science and Technology of China [2007CB914503, 2011CB504204, 2009CB918903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y. S.) and 81071673 (to L. S.) from the National Natural Science Foundation of China and Grants 973 Program 2007CB914503 and 2011CB504204 (to Y. S.) and 2009CB918903 (to Z. Y.) from the Ministry of Science and Technology of China.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Corcoran CA, 2004, CANCER BIOL THER, V3, P721, DOI 10.4161/cbt.3.8.1068; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee EW, 2006, MOL CELLS, V22, P133; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang XP, 2003, PLANT CELL, V15, P1071, DOI 10.1105/tpc.009936; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504	50	18	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4226	4235		10.1074/jbc.M110.195115	http://dx.doi.org/10.1074/jbc.M110.195115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127074	Green Published, hybrid			2022-12-27	WOS:000286975700021
J	Mun, GI; Kim, IS; Lee, BH; Boo, YC				Mun, Gyeong In; Kim, In-San; Lee, Byung-Heon; Boo, Yong Chool			Endothelial Argininosuccinate Synthetase 1 Regulates Nitric Oxide Production and Monocyte Adhesion under Static and Laminar Shear Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; SYNTHASE EXPRESSION; DEPENDENT REGULATION; C-SRC; ARGININE; NO; CELLS; ACID; REGENERATION	Laminar shear stress (LSS) is known to increase endothelial nitric oxide (NO) production, which is essential for vascular health, through expression and activation of nitric oxide synthase 3 (NOS3). Recent studies demonstrated that LSS also increases the expression of argininosuccinate synthetase 1 (ASS1) that regulates the provision of L-arginine, the substrate of NOS3. It was thus hypothesized that ASS1 might contribute to vascular health by enhancing NO production in response to LSS. This hypothesis was pursued in the present study by modulating NOS3 and ASS1 levels in cultured endothelial cells. Exogenous expression of either NOS3 or ASS1 in human umbilical vein endothelial cells increased NO production and decreased monocyte adhesion stimulated by tumor necrosis factor-alpha (TNF-alpha). The latter effect of overexpressed ASS1 was reduced when human umbilical vein endothelial cells were co-treated with small interfering RNAs (siRNAs) for ASS1 or NOS3. SiRNAs of NOS3 and ASS1 attenuated the increase of NO production in human aortic endothelial cells stimulated by LSS (12 dynes.cm(-2)) for 24 h. LSS inhibited monocyte adhesion to human aortic endothelial cells stimulated by TNF-alpha, but this effect of LSS was abrogated by siRNAs of NOS3 and ASS1 that recovered the expression of vascular cell adhesion molecule-1. The current study suggests that the expression of ASS1 harmonized with that of NOS3 may be important for the optimized endothelial NO production and the prevention of the inflammatory monocyte adhesion to endothelial cells.	[Mun, Gyeong In; Boo, Yong Chool] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu 700422, South Korea; [Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol,Cell & Matrix Res Inst, Med Educ Program Human Resources BK21, Taegu 700422, South Korea	Kyungpook National University; Kyungpook National University	Boo, YC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Mol Med, 101 Dongindong 2 Ga, Taegu 700422, South Korea.	ycboo@knu.ac.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017	Boo, Yong Chool/0000-0001-9895-2066	Ministry of Education, Science and Technology, Republic of Korea [2009-0071171]; Ministry of Knowledge Economy, Republic of Korea [RTI 04-01-01]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea (Grant 2009-0071171) and by the Regional Technology Innovation Program of the Ministry of Knowledge Economy, Republic of Korea (Grant RTI 04-01-01).	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Boo YC, 2007, NITRIC OXIDE-BIOL CH, V16, P306, DOI 10.1016/j.niox.2006.09.004; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Brasse-Lagnel C, 2003, J BIOL CHEM, V278, P52504, DOI 10.1074/jbc.M306752200; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, p334A; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Cooke JP, 1997, CIRCULATION, V95, P311; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Duan WL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-16; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Hardy TA, 2002, FREE RADICAL BIO MED, V32, P122, DOI 10.1016/S0891-5849(01)00781-X; HATTORI Y, 1994, J BIOL CHEM, V269, P9405; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kim HJ, 2006, BIOCHEM BIOPH RES CO, V345, P1657, DOI 10.1016/j.bbrc.2006.05.090; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; McDonald KK, 1997, J BIOL CHEM, V272, P31213, DOI 10.1074/jbc.272.50.31213; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Mun GI, 2008, AM J PHYSIOL-HEART C, V295, pH1966, DOI 10.1152/ajpheart.00727.2008; Mun GI, 2010, AM J PHYSIOL-HEART C, V298, pH2102, DOI 10.1152/ajpheart.00835.2009; Mun GI, 2009, FREE RADICAL BIO MED, V47, P291, DOI 10.1016/j.freeradbiomed.2009.04.032; Padilla J, 2008, VASC MED, V13, P105, DOI 10.1177/1358863x07086671; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Szabados E, 1999, FREE RADICAL BIO MED, V27, P1103, DOI 10.1016/S0891-5849(99)00151-3; Tsao PS, 1996, CIRCULATION, V94, P1682, DOI 10.1161/01.CIR.94.7.1682; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624	48	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2536	2542		10.1074/jbc.M110.180489	http://dx.doi.org/10.1074/jbc.M110.180489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106532	Green Published, hybrid			2022-12-27	WOS:000286464300018
J	Snider, NT; Weerasinghe, SVW; Iniguez-Lluhi, JA; Herrmann, H; Omary, MB				Snider, Natasha T.; Weerasinghe, Sujith V. W.; Iniguez-Lluhi, Jorge A.; Herrmann, Harald; Omary, M. Bishr			Keratin Hypersumoylation Alters Filament Dynamics and Is a Marker for Human Liver Disease and Keratin Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE EPITHELIAL KERATINS; MODIFIER SUMO MODIFICATION; NUCLEAR-PORE COMPLEX; INTERMEDIATE-FILAMENTS; IN-VITRO; TRANSGENIC MICE; UBIQUITIN; PROTEIN; PHOSPHORYLATION; SUMOYLATION	Keratin polypeptide 8 (K8) associates noncovalently with its partners K18 and/or K19 to form the intermediate filament cytoskeleton of hepatocytes and other simple-type epithelial cells. Human K8, K18, and K19 variants predispose to liver disease, whereas site-specific keratin phosphorylation confers hepatoprotection. Because stress-induced protein phosphorylation regulates sumoylation, we hypothesized that keratins are sumoylated in an injury-dependent manner and that keratin sumoylation is an important regulatory modification. We demonstrate that K8/K18/K19, epidermal keratins, and vimentin are sumoylated in vitro. Upon transfection, K8, K18, and K19 are modified by poly-SUMO-2/3 chains on Lys-285/Lys-364 (K8), Lys-207/Lys-372 (K18), and Lys-208 (K19). Sumoylation affects filament organization and stimulus-induced keratin solubility and is partially inhibited upon mutation of one of three known K8 phosphorylation sites. Extensive sumoylation occurs in cells transfected with individual K8, K18, or K19 but is limited upon heterodimerization (K8/K18 or K8/K19) in the absence of stress. In contrast, keratin sumoylation is significantly augmented in cells and tissues during apoptosis, oxidative stress, and phosphatase inhibition. Poly-SUMO-2/3 conjugates are present in chronically injured but not normal, human, and mouse livers along with polyubiquitinated and large insoluble keratin-containing complexes. Notably, common human K8 liver disease-associated variants trigger keratin hypersumoylation with consequent diminished solubility. In contrast, modest sumoylation of wild type K8 promotes solubility. Hence, conformational changes induced by keratin natural mutations and extensive tissue injury result in K8/K18/K19 hypersumoylation, which retains keratins in an insoluble compartment, thereby limiting their cytoprotective function.	Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; [Herrmann, Harald] German Canc Res Ctr, Funct Architecture Cell Grp, D-69120 Heidelberg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ)	Snider, NT (corresponding author), 7720 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	nsnider@umich.edu		Omary, Bishr/0000-0002-8624-2347; Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health [DK52951]; University of Michigan [UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052951, R01DK052951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK52951 cells, respectively. Keratin post-translational modifications, (to M. B. O.) and by University of Michigan Postdoctoral Translational Scholars Program Award UL1RR024986 (to N. T. S.).	ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Ku NO, 2001, J BIOL CHEM, V276, P26792, DOI 10.1074/jbc.M103315200; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124	54	53	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2273	2284		10.1074/jbc.M110.171314	http://dx.doi.org/10.1074/jbc.M110.171314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21062750	Green Published, hybrid			2022-12-27	WOS:000286191500067
J	Wang, GY				Wang, Guangyu			The Inhibition Mechanism of Non-phosphorylated Ser(768) in the Regulatory Domain of Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; R-DOMAIN; ABC TRANSPORTER; PHOSPHORYLATION SITES; CHLORIDE CHANNEL; ATP BINDING; CFTR; PROTEIN; ACTIVATION; DIMERIZATION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette transporters but serves as a chloride channel dysfunctional in cystic fibrosis. The activity of CFTR is tightly controlled not only by ATP-driven dimerization of its nucleotide-binding domains but also by phosphorylation of a unique regulatory (R) domain by protein kinase A (PKA). The R domain has multiple excitatory phosphorylation sites, but Ser(737) and Ser(768) are inhibitory. The underlying mechanism is unclear. Here, sulfhydryl-specific cross-linking strategy was employed to demonstrate that Ser(768) or Ser(737) could interact with outwardly facing hydrophilic residues of cytoplasmic loop 3 regulating channel gating. Furthermore, mutation of these residues to alanines promoted channel opening by curcumin in an ATP-dependent manner even in the absence of PKA. However, mutation of Ser(768) and His(950) with different hydrogen bond donors or acceptors clearly changed ATP- and PKA-dependent channel activity no matter whether curcumin was present or not. More importantly, significant activation of a double mutant H950R/S768R needed only ATP. Finally, in vitro and in vivo single channel recordings suggest that Ser(768) may form a putative hydrogen bond with His950 of cytoplasmic loop 3 to prevent channel opening by ATP in the non-phosphorylated state and by subsequent cAMP-dependent phosphorylation. These observations support an electron cryomicroscopy-based structural model on which the R domain is closed to cytoplasmic loops regulating channel gating.	[Wang, Guangyu] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Wang, Guangyu] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Wang, Guangyu] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, GY (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, 1664 N Virginia St MS 318,Manville Med Bldg Rm 9, Reno, NV 89557 USA.	wangg@medicine.nevada.edu		Wang, Guangyu/0000-0002-5581-6926	National Institutes of Health [2R56DK056796-10]; American Heart Association [10SDG4120011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R56DK056796-10. This work was also supported by American Heart Association Grant 10SDG4120011 (to G. W.).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Vankeerberghen A, 1999, BIOCHEMISTRY-US, V38, P14988, DOI 10.1021/bi991520d; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang GY, 2010, J BIOL CHEM, V285, P40438, DOI 10.1074/jbc.M110.161497; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	34	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2171	2182		10.1074/jbc.M110.145540	http://dx.doi.org/10.1074/jbc.M110.145540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059651	hybrid, Green Published			2022-12-27	WOS:000286191500058
J	Zhang, HT; Zhou, R; Li, L; Chen, J; Chen, LL; Li, CJ; Ding, H; Yu, LA; Hu, LH; Jiang, HL; Shen, X				Zhang, Haitao; Zhou, Rong; Li, Li; Chen, Jing; Chen, Lili; Li, Chenjing; Ding, Hong; Yu, Liang; Hu, Lihong; Jiang, Hualiang; Shen, Xu			Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RXR; RAR; MODULATION; ACTIVATION; COMPLEX; CANCER; ACID	Retinoic X receptor (RXR) is a promising target for drug discovery against cancer and metabolic syndromes. Here, we identified a specific RXR alpha antagonist, danthron, from the traditional Chinese medicine rhubarb. Danthron repressed all tested RXR alpha-involved response element transcription, including the RXRE, PPRE, FXRE, and LXRE. Results from native PAGE and isothermal titration calorimetry (ITC)-based assays indicated that danthron bound to the tetrameric RXR alpha-LBD in a specific stoichimetric ratio, and such a binding could influence the corepressor SMRT affinity to the receptor. Additionally, a unique tetrameric structure of the apo-RXR alpha ligand-binding domain (LBD) was determined, which exhibited a larger tetramer interface and different ligand-binding pocket size compared with the one previously reported. Together with the biochemical and biophysical results, the determined crystal structure of danthron-soaked RXR alpha-LBD suggested a new mechanism for danthron antagonism to tetrameric RXR alpha. Moreover, the in vivo efficient improvement of insulin sensitivity by danthron was observed in diet-induced obese (DIO) mice. Thus, our findings were expected to supply new insights into the structural basis of RXR alpha antagonist for its further potential therapeutic application.	[Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Zhou, Rong; Li, Li; Shen, Xu] E China Univ Sci & Technol, Shanghai 200237, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology; Shanghai Jiao Tong University		simmhulh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Haitao/L-7612-2015	Zhang, Haitao/0000-0003-4879-2951	State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National Natural Science Foundation of China [30925040, 30890044, 10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; Science Foundation of Shanghai [08431902900]; E-Institutes of Shanghai Municipal Education Commission [E09013]; Foundation of Chinese Academy of Sciences [KSCX2-YW-R-168, SCX1-YW-02-2]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; Science Foundation of Shanghai(Natural Science Foundation of Shanghai); E-Institutes of Shanghai Municipal Education Commission; Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Program of Basic Research of China (Grants 2010CB912501, 2007CB914304, and 2009CB918502), the National Natural Science Foundation of China (Grants 30925040, 30890044, and 10979072), Key New Drug Creation and Manufacturing Program (2009ZX09301-001), the Science Foundation of Shanghai (Grant 08431902900), the E-Institutes of Shanghai Municipal Education Commission (Grant E09013), and the Foundation of Chinese Academy of Sciences (Grants KSCX2-YW-R-168 and SCX1-YW-02-2).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; DeLano W.L, PYMOL MOL GRAPHICS S; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gao Q, 2010, PLANTA MED, V76, P27, DOI 10.1055/s-0029-1185948; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Huang Q, 2007, MED RES REV, V27, P609, DOI 10.1002/med.20094; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P14263, DOI 10.1021/bi00043a034; Kersten S, 1998, J MOL BIOL, V284, P21, DOI 10.1006/jmbi.1998.2168; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kersten S, 1997, J BIOL CHEM, V272, P29759, DOI 10.1074/jbc.272.47.29759; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 2009, EXP MOL MED, V41, P648, DOI 10.3858/emm.2009.41.9.071; MANGELSDORF DJ, 1993, RECENT PROG HORM RES, V48, P99; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Sakaki J, 2007, BIOORG MED CHEM LETT, V17, P4804, DOI 10.1016/j.bmcl.2007.06.080; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Yotsumoto T, 2005, METABOLISM, V54, P573, DOI 10.1016/j.metabol.2004.11.013; Zhang L, 2008, J BIOL CHEM, V283, P5370, DOI 10.1074/jbc.M705566200	36	46	48	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1868	1875		10.1074/jbc.M110.166215	http://dx.doi.org/10.1074/jbc.M110.166215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084305	Green Published, hybrid			2022-12-27	WOS:000286191500027
J	Bhave, DP; Hong, JA; Lee, M; Jiang, W; Krebs, C; Carroll, KS				Bhave, Devayani P.; Hong, Jiyoung A.; Lee, Michael; Jiang, Wei; Krebs, Carsten; Carroll, Kate S.			Spectroscopic Studies on the [4Fe-4S] Cluster in Adenosine 5 '-Phosphosulfate Reductase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; ELECTRON-PARAMAGNETIC-RES; LYASE ACTIVATING ENZYME; ESCHERICHIA-COLI; 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; PSEUDOMONAS-AERUGINOSA; SULFATE REDUCTASE; CRYSTAL-STRUCTURE; ADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; REDOX POTENTIALS	Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase (MtAPR) is an iron-sulfur protein and a validated target to develop new antitubercular agents, particularly for the treatment of latent infection. The enzyme harbors a [4Fe-4S](2+) cluster that is coordinated by four cysteinyl ligands, two of which are adjacent in the amino acid sequence. The iron-sulfur cluster is essential for catalysis; however, the precise role of the [4Fe-4S] cluster in APR remains unknown. Progress in this area has been hampered by the failure to generate a paramagnetic state of the [4Fe-4S] cluster that can be studied by electron paramagnetic resonance spectroscopy. Herein, we overcome this limitation and report the EPR spectra of MtAPR in the [4Fe-4S](+) state. The EPR signal is rhombic and consists of two overlapping S = 1/2 species. Substrate binding to MtAPR led to a marked increase in the intensity and resolution of the EPR signal and to minor shifts in principle g values that were not observed among a panel of substrate analogs, including adenosine 5'-diphosphate. Using site-directed mutagenesis, in conjunction with kinetic and EPR studies, we have also identified an essential role for the active site residue Lys-144, whose side chain interacts with both the iron-sulfur cluster and the sulfate group of adenosine 5'-phosphosulfate. The implications of these findings are discussed with respect to the role of the iron-sulfur cluster in the catalytic mechanism of APR.	[Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hong, Jiyoung A.; Carroll, Kate S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lee, Michael; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Jiang, Wei; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Scripps Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carroll, KS (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way 2B2, Jupiter, FL 33458 USA.	kcarroll@scripps.edu	Krebs, Carsten/D-4773-2009; Bhave, Devayani/D-1915-2017	Krebs, Carsten/0000-0002-3302-7053; Bhave, Devayani/0000-0002-0773-9962; Hong, Jiyoung/0000-0002-0430-3290; Carroll, Kate/0000-0002-7624-9617	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087638] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM087638-03S1, R01 GM087638, R01 GM087638-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; ANTANAITIS BC, 1980, J BIOL CHEM, V255, P1204; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; Catrina I, 2007, J AM CHEM SOC, V129, P5760, DOI 10.1021/ja069111+; Chapman E, 2003, P NATL ACAD SCI USA, V100, P910, DOI 10.1073/pnas.0337638100; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Davydov R, 1999, BIOCHEMISTRY-US, V38, P4188, DOI 10.1021/bi982391o; Dey KR, 2010, TETRAHEDRON LETT, V51, P1329, DOI 10.1016/j.tetlet.2010.01.004; Dos Santos PC, 2008, P NATL ACAD SCI USA, V105, P11589, DOI 10.1073/pnas.0805713105; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; Engstrom M, 2000, CHEM PHYS LETT, V328, P483, DOI 10.1016/S0009-2614(00)00961-1; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; GILLUM WO, 1977, J AM CHEM SOC, V99, P584, DOI 10.1021/ja00444a044; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Kopriva S, 2007, J BIOL CHEM, V282, P22930, DOI 10.1074/jbc.M702522200; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; LANGEN R, 1992, J BIOL CHEM, V267, P25625; Lawrence CC, 1999, P NATL ACAD SCI USA, V96, P8979, DOI 10.1073/pnas.96.16.8979; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; LEYH TS, 1988, J BIOL CHEM, V263, P2409; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Noodleman L, 2002, CURR OPIN CHEM BIOL, V6, P259, DOI 10.1016/S1367-5931(02)00309-5; Noodleman L., 2008, WILEY ENCY CHEM BIOL, P1; Orme-Johnson W H, 1978, Methods Enzymol, V53, P268; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; RENOSTO F, 1984, J BIOL CHEM, V259, P2113; SATISHCHANDRAN C, 1992, BIOORG CHEM, V20, P107, DOI 10.1016/0045-2068(92)90031-W; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Yu ZH, 2008, BIOCHEMISTRY-US, V47, P12777, DOI 10.1021/bi801118f	56	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1216	1226		10.1074/jbc.M110.193722	http://dx.doi.org/10.1074/jbc.M110.193722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075841	Green Published, hybrid			2022-12-27	WOS:000286005000033
J	Kaufman, Y; Ma, L; Washington, I				Kaufman, Yardana; Ma, Li; Washington, Ilyas			Deuterium Enrichment of Vitamin A at the C20 Position Slows the Formation of Detrimental Vitamin A Dimers in Wild-type Rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; LIPOFUSCIN FLUOROPHORE; MOUSE MODEL; MACULAR DEGENERATION; VISUAL CYCLE; A2E; ACCUMULATION; INHIBITION; RPE; COMPONENT	Degenerative eye diseases are the most common causes of untreatable blindness. Accumulation of lipofuscin (granular deposits) in the retinal pigment epithelium (RPE) is a hallmark of major degenerative eye diseases such as Stargardt disease, Best disease, and age-related macular degeneration. The intrinsic reactivity of vitamin A leads to its dimerization and to the formation of pigments such as A2E, and is believed to play a key role in the formation of ocular lipofuscin. We sought a clinically pragmatic method to slow vitamin A dimerization as a means to elucidate the pathogenesis of macular degenerations and to develop a therapeutic intervention. We prepared vitamin A enriched with the stable isotope deuterium at carbon twenty (C20-D-3-vitamin A). Results showed that dimerization of deuterium-enriched vitamin A was considerably slower than that of vitamin A at natural abundance as measured in vitro. Administration of C20-D-3-vitamin A to wild-type rodents with no obvious genetic defects in vitamin A processing, slowed A2E biosynthesis. This study elucidates the mechanism of A2E biosynthesis and suggests that administration of C20-D-3-vitamin A may be a viable, long-term approach to retard vitamin A dimerization and by extension, may slow lipofuscin deposition and the progression of common degenerative eye diseases.	[Kaufman, Yardana; Ma, Li; Washington, Ilyas] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA	Columbia University	Washington, I (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA.	iw2101@columbia.edu		W, I/0000-0002-2238-7918	International Retinal Research Foundation; NATIONAL EYE INSTITUTE [R01EY021207] Funding Source: NIH RePORTER	International Retinal Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the International Retinal Research Foundation.	Avalle LB, 2004, EXP EYE RES, V78, P895, DOI 10.1016/j.exer.2003.10.023; Baehr W, 2003, VISION RES, V43, P2957, DOI 10.1016/j.visres.2003.10.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2001, BIOORG MED CHEM LETT, V11, P1533, DOI 10.1016/S0960-894X(01)00314-6; Bench BJ, 2006, J ORG CHEM, V71, P9458, DOI 10.1021/jo061763t; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BERGEN HR, 1988, J LABELLED COMPD RAD, V25, P11; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BRIDGES CDB, 1982, INVEST OPHTH VIS SCI, V22, P706; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Ervin R Bethene, 2004, Adv Data, P1; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gronemeyer H, 2001, CELL MOL BIOL LETT, V6, P3; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; ISLER O, 1949, HELV CHIM ACTA, V32, P489, DOI 10.1002/hlca.19490320218; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; PARDOEN JA, 1985, CAN J CHEM, V63, P1431, DOI 10.1139/v85-246; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; RADDING CM, 1956, J GEN PHYSIOL, V39, P923, DOI 10.1085/jgp.39.6.923; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Ribaya-Mercado JD, 2003, AM J CLIN NUTR, V77, P694, DOI 10.1093/ajcn/77.3.694; ROBERTS RD, 1980, J AM CHEM SOC, V102, P7054, DOI 10.1021/ja00543a027; Rodriguez-Otero J, 1999, J ORG CHEM, V64, P6842, DOI 10.1021/jo990881w; Rozanowski B, 2008, PHOTOCHEM PHOTOBIOL, V84, P650, DOI 10.1111/j.1751-1097.2007.00259.x; Saettel NJ, 2000, J ORG CHEM, V65, P2331, DOI 10.1021/jo991488t; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Schutt F, 2002, OPHTHALMOLOGE, V99, P861, DOI 10.1007/s00347-002-0672-3; Schutt F, 2001, OPHTHALMOLOGE, V98, P721, DOI 10.1007/s003470170078; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; SZWEDA LI, 1994, J BIOL CHEM, V269, P8712; Um SJ, 2004, CHEM PHARM BULL, V52, P501, DOI 10.1248/cpb.52.501; UNDERWOOD BA, 1970, AM J CLIN NUTR, V23, P1037; Vogel R., 2009, ANN M ASS RES VIS OP; Washington I, 2005, ANGEW CHEM INT EDIT, V44, P7097, DOI 10.1002/anie.200501346; Washington I, 2006, PHOTOCHEM PHOTOBIOL, V82, P1394, DOI 10.1562/2006-02-28-RA-828; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w	51	43	53	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7958	7965		10.1074/jbc.M110.178640	http://dx.doi.org/10.1074/jbc.M110.178640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21075840	Green Published, hybrid			2022-12-27	WOS:000288013300026
J	Cojocaru, M; Bouchard, A; Cloutier, P; Cooper, JJ; Varzavand, K; Price, DH; Coulombe, B				Cojocaru, Marilena; Bouchard, Annie; Cloutier, Philippe; Cooper, Jeff J.; Varzavand, Katayoun; Price, David H.; Coulombe, Benoit			Transcription Factor IIS Cooperates with the E3 Ligase UBR5 to Ubiquitinate the CDK9 Subunit of the Positive Transcription Elongation Factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TEFB-MEDIATED PHOSPHORYLATION; PROTEIN-INTERACTION NETWORK; TUMOR-SUPPRESSOR GENE; CLEAVAGE FACTOR TFIIS; FACTOR S-II; P-TEFB; HYPERPLASTIC-DISCS; SACCHAROMYCES-CEREVISIAE; PRODUCTIVE ELONGATION	Elongation of transcription by mammalian RNA polymerase II (RNAPII) is regulated by specific factors, including transcription factor IIS (TFIIS) and positive transcription elongation factor b (P-TEFb). We show that the E3 ubiquitin ligase UBR5 associates with the CDK9 subunit of positive transcription elongation factor b to mediate its polyubiquitination in human cells. TFIIS also binds UBR5 to stimulate CDK9 polyubiquitination. Co-localization of UBR5, CDK9, and TFIIS along specific regions of the gamma fibrinogen (gamma FBG) gene indicates that a ternary complex involving these factors participates in the transcriptional regulation of this gene. In support of this notion, overexpression of TFIIS not only modifies the ubiquitination pattern of CDK9 in vivo but also increases the association of CDK9 with various regions of the gamma FBG gene. Notably, the TFIIS-mediated increase in CDK9 loading is obtained during both basal and activated transcription of the gamma FBG gene. This increased CDK9 binding is paralleled by an increase in the recruitment of RNAPII along the gamma FBG gene and the phosphorylation of the C-terminal domain of the RNAPII largest subunit RPB1 on Ser-2, a known target of CDK9. Together, these results identify UBR5 as a novel E3 ligase that regulates transcription and define an additional function of TFIIS in the regulation of CDK9.	[Coulombe, Benoit] Inst Rech Clin Montreal, Gene Transcript & Prote Lab, Montreal, PQ H2W 1R7, Canada; [Cooper, Jeff J.; Varzavand, Katayoun; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Iowa	Coulombe, B (corresponding author), Inst Rech Clin Montreal, Gene Transcript & Prote Lab, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	benoit.coulombe@ircm.qc.ca		Price, David/0000-0002-5597-385X	Canadian Institutes for Health Research, Genome Canada, Genome Quebec; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Fonds de Recherche en Sante du Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	Canadian Institutes for Health Research, Genome Canada, Genome Quebec(Genome CanadaCanadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from the Canadian Institutes for Health Research, Genome Canada, Genome Quebec, the Natural Sciences and Engineering Research Council of Canada, and the Canadian Foundation for Innovation.; Recipient of studentships from the Canadian Institutes of Health Research and the Fonds de Recherche en Sante du Quebec.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Barboric M, 2005, J VIROL, V79, P11135, DOI 10.1128/JVI.79.17.11135-11141.2005; Brasier AR, 2008, CELL CYCLE, V7, P2661, DOI 10.4161/cc.7.17.6594; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ito T, 2006, MOL CELL BIOL, V26, P3194, DOI 10.1128/MCB.26.8.3194-3203.2006; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lindstrom DL, 2001, GENETICS, V159, P487; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Umehara T, 1995, GENE, V167, P297, DOI 10.1016/0378-1119(95)00634-6; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	48	32	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5012	5022		10.1074/jbc.M110.176628	http://dx.doi.org/10.1074/jbc.M110.176628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127351	Green Published, hybrid			2022-12-27	WOS:000287230600009
J	Carrasco-Marin, E; Fernandez-Prieto, L; Rodriguez-Del Rio, E; Madrazo-Toca, F; Reinheckel, T; Saftig, P; Alvarez-Dominguez, C				Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Reinheckel, Thomas; Saftig, Paul; Alvarez-Dominguez, Carmen			LIMP-2 Links Late Phagosomal Trafficking with the Onset of the Innate Immune Response to Listeria monocytogenes A ROLE IN MACROPHAGE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCOCEREBROSIDASE; MURINE MACROPHAGES; INTERFERON-GAMMA; RNAI SCREEN; CATHEPSIN-D; MATURATION; RECEPTOR; RECOGNITION; FUSION; CELLS	The innate immune response to Listeria monocytogenes depends on phagosomal bacterial degradation by macrophages. Here, we describe the role of LIMP-2, a lysosomal type III transmembrane glycoprotein and scavenger-like protein, in Listeria phagocytosis. LIMP-2-deficient mice display a macrophage-related defect in Listeria innate immunity. They produce less acute phase pro-inflammatory cytokines/chemokines, MCP-1, TNF-alpha, and IL-6 but normal levels of IL-12, IL-10, and IFN-gamma and a 25-fold increase in susceptibility to Listeria infection. This macrophage defect results in a low listericidal potential, poor response to TNF-alpha activation signals, impaired phago-lysosome transformation into antigen-processing compartments, and uncontrolled LM cytosolic growth that fails to induce normal levels of acute phase pro-inflammatory cytokines. LIMP-2 transfection of CHO cells confirmed that LIMP-2 participates in the degradation of Listeria within phagosomes, controls the late endosomal/lysosomal fusion machinery, and is linked to the activation of Rab5a. Therefore, the role of LIMP-2 appears to be connected to the TNF-alpha-dependent and early activation of Listeria macrophages through internal signals linking the regulation of late trafficking events with the onset of the innate Listeria immune response.	[Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Hosp Santa Cruz Liencres, Serv Inmunol, Liencres 39120, Cantabria, Spain; [Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Fdn Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Liencres 39120, Spain; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany	Hospital Universitario Marques de Valdecilla (HUMV); University of Kiel; University of Freiburg	Carrasco-Marin, E (corresponding author), Hosp Santa Cruz Liencres, Serv Inmunol, Barrio de las Mazas 17, Liencres 39120, Cantabria, Spain.	deicme@humv.es; psaftig@biochem.uni-kiel.de; calvarez@humv.es	Marin, Eugenio Carrasco/AAG-1578-2021; Saftig, Paul/A-7966-2010; Alvarez-Dominguez, Carmen/J-4675-2014; Reinheckel, Thomas/AAL-9761-2021	Marin, Eugenio Carrasco/0000-0002-3556-9227; Alvarez-Dominguez, Carmen/0000-0002-4585-6959; Reinheckel, Thomas/0000-0001-9866-9105	Fondo de Investigaciones Sanitarias [FIS-ISCIII-00/3073, PI01/3128, PI03-1009, PI07-0289, PI04-0324, CA06-0062]; Ministerio de Ciencia, Investigacion e Innovacion [BIO2002-0628, SAF-2006-08968, SAF2009-08695]; Deutsche Forschungsgemeinschaft [SA683/6-1]; Cluster of Excellence "Inflammation at Interfaces"; Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla [API09-SAF2009-08695]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia, Investigacion e Innovacion; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla	This work was supported in part by Fondo de Investigaciones Sanitarias Grants FIS-ISCIII-00/3073, PI01/3128, PI03-1009, and PI07-0289 (to E. C.-M.); grants from Ministerio de Ciencia, Investigacion e Innovacion (BIO2002-0628, SAF-2006-08968, and SAF2009-08695) and from Fondo de Investigaciones Sanitarias PI04-0324 (to C. A.-D.); Deutsche Forschungsgemeinschaft Grant SA683/6-1 and the Cluster of Excellence "Inflammation at Interfaces" (to P. S.); and Fondo de Investigaciones Sanitarias Contract CA06-0062 and Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla Grant API09-SAF2009-08695 (to L. F.-P.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; AlvarezDominguez C, 1997, INFECT IMMUN, V65, P78; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; BLUM JS, 1991, ADV EXP MED BIOL, V306, P281; Carrasco-Marin E, 2009, MOL MICROBIOL, V72, P668, DOI 10.1111/j.1365-2958.2009.06673.x; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; von Delwig A, 2005, SCAND J IMMUNOL, V62, P243, DOI 10.1111/j.1365-3083.2005.01664.x; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	41	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3332	3341		10.1074/jbc.M110.146761	http://dx.doi.org/10.1074/jbc.M110.146761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123180	hybrid, Green Published			2022-12-27	WOS:000286653200019
J	Novak, JF; Stirnberg, M; Roenneke, B; Marin, K				Novak, Jens F.; Stirnberg, Marit; Roenneke, Benjamin; Marin, Kay			A Novel Mechanism of Osmosensing, a Salt-dependent Protein-Nucleic Acid Interaction in the Cyanobacterium Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYLGLYCEROL-PHOSPHATE SYNTHASE; SP PCC-6803; ESCHERICHIA-COLI; COMPATIBLE SOLUTES; IN-VIVO; ACTIVATION; TREHALOSE; OSMOREGULATION; ACCUMULATION; STRESS	The de novo synthesis of compatible solutes is an essential part of the cellular osmotic stress response. Upon an osmotic challenge, it is regulated by the immediate biochemical activation of preformed enzymes and by activation of gene expression. Whereas the transcriptional response has been investigated intensively, the mechanisms by which enzymes are activated in osmotic stress situations are still elusive. Here, we address this topic for the moderately halotolerant cyanobacterium Synechocystis sp. PCC 6803, which synthesizes glucosylglycerol as a compatible solute. The key enzyme of the glucosylglycerol pathway (GgpS) is inhibited by nucleic acids in a sequence-and length-independent manner. The protein binds DNA, RNA, and heparin via a salt-dependent electrostatic interaction with the negatively charged backbone of the polyanions. Mechanistically, DNA binding to the enzyme causes noncompetitive inhibition of GgpS activity. The interaction of the enzyme and nucleic acids under in vivo conditions is indicated by the co-purification of both after cross-linking in Synechocystis cells. We propose a novel mechanism of activity regulation by the nonspecific salt-dependent binding of an enzyme to nucleic acids.	[Novak, Jens F.; Stirnberg, Marit; Roenneke, Benjamin; Marin, Kay] Univ Cologne, Inst Biochem, D-50547 Cologne, Germany	University of Cologne	Marin, K (corresponding author), Univ Cologne, Inst Biochem, Zuelpicher Str 47, D-50674 Cologne, Germany.	kay.marin@uni-koeln.de			International Max Planck Research School; Deutsche Forschungsgemeinschaft [MA 4159/1-1]	International Max Planck Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by an International Max Planck Research School fellowship.; Supported by Deutsche Forschungsgemeinschaft Grant MA 4159/1-1. To whom correspondence should be addressed: Inst. of Biochemistry, University of Cologne, Zuelpicher Str. 47, 50674 Cologne, Germany. Tel.: 49-221-470-6476; Fax: 49-221-470-5091; E-mail: kay.marin@uni-koeln.de.	BLUMWALD E, 1983, PLANT PHYSIOL, V73, P377, DOI 10.1104/pp.73.2.377; BOROWITZKA LJ, 1980, SCIENCE, V210, P650, DOI 10.1126/science.210.4470.650; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Cardoso FS, 2007, MICROBIOL-SGM, V153, P270, DOI 10.1099/mic.0.29262-0; Conrad H. E., 1998, HEPARIN BINDING PROT; da Costa M. S., 1998, V61, P117; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hagemann M, 1996, J PLANT PHYSIOL, V149, P746, DOI 10.1016/S0176-1617(96)80101-5; HAGEMANN M, 1994, CURR MICROBIOL, V28, P201, DOI 10.1007/BF01575962; HAGEMANN M, 1994, MICROBIOL-SGM, V140, P1427, DOI 10.1099/00221287-140-6-1427; Hagemann M, 2001, CURR MICROBIOL, V43, P278, DOI 10.1007/s002840010301; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; Jones LS, 2004, MOL CELL PROTEOMICS, V3, P746, DOI 10.1074/mcp.R400008-MCP200; Marin K, 2006, MICROBIOL-SGM, V152, P2023, DOI 10.1099/mic.0.28771-0; Morohoshi T, 2002, APPL ENVIRON MICROB, V68, P4107, DOI 10.1128/AEM.68.8.4107-4110.2002; Pan YT, 2002, EUR J BIOCHEM, V269, P6091, DOI 10.1046/j.1432-1033.2002.03327.x; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1016/0378-1097(85)90086-2; Schoor A, 1999, ARCH MICROBIOL, V171, P101, DOI 10.1007/s002030050684; Stirnberg M, 2007, MOL MICROBIOL, V63, P86, DOI 10.1111/j.1365-2958.2006.05495.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002	28	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3235	3241		10.1074/jbc.M110.157032	http://dx.doi.org/10.1074/jbc.M110.157032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123179	Green Published, hybrid			2022-12-27	WOS:000286653200008
J	Damiani, MJ; Nostedt, JJ; O'Neill, MA				Damiani, Michael J.; Nostedt, Jordan J.; O'Neill, Melanie A.			Impact of the N5-proximal Asn on the Thermodynamic and Kinetic Stability of the Semiquinone Radical in Photolyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; COUPLED ELECTRON-TRANSFER; FLAVIN MONONUCLEOTIDE-BINDING; NITRIC-OXIDE SYNTHASE; REDOX PROPERTIES; METHYLOPHILUS-METHYLOTROPHUS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; CRYPTOCHROME; PHOTORECEPTOR	Flavoproteins can dramatically adjust the thermodynamics and kinetics of electron transfer at their flavin cofactor. A versatile regulatory tool is proton transfer. Here, we demonstrate the significance of proton-coupled electron transfer to redox tuning and semiquinone (sq) stability in photolyases (PLs) and cryptochromes (CRYs). These light-responsive proteins share homologous overall architectures and FAD-binding pockets, yet they have evolved divergent functions that include DNA repair, photomorphogenesis, regulation of circadian rhythm, and magnetoreception. We report the first measurement of both FAD redox potentials for cyclobutane pyrimidine dimer PL (CPD-PL, Anacystis nidulans). These values, E-1(hq/sq) = -140 mV and E-2(sq/ox) = -219 mV, where hq is FAD hydroquinone and ox is oxidized FAD, establish that the sq is not thermodynamically stabilized (Delta E = E-2 - E-1 = -79 mV). Results with N386D CPD-PL support our earlier hypothesis of a kinetic barrier to sq oxidation associated with proton transfer. Both E-1 and E-2 are upshifted by similar to 100 mV in this mutant; replacing the N5-proximal Asn with Asp decreases the driving force for sq oxidation. However, this Asp alleviates the kinetic barrier, presumably by acting as a proton shuttle, because the sq in N386D CPD-PL oxidizes orders of magnitude more rapidly than wild type. These data clearly reveal, as suggested for plant CRYs, that an N5-proximal Asp can switch on proton transfer and modulate sq reactivity. However, the effect is context-dependent. More generally, we propose that PLs and CRYs tune the properties of their N5-proximal residue to adjust the extent of proton transfer, H-bonding patterns, and changes in protein conformation associated with electron transfer at the flavin.	[Damiani, Michael J.; Nostedt, Jordan J.; O'Neill, Melanie A.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	O'Neill, MA (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	maoneill@sfu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research (MSFHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR).	Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chen HC, 2008, BIOCHEMISTRY-US, V47, P13788, DOI 10.1021/bi800954h; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Damiani MJ, 2009, BIOCHEMISTRY-US, V48, P11399, DOI 10.1021/bi901371s; Dutton P L, 1978, Methods Enzymol, V54, P411; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Sokolowsky K, 2010, J PHYS CHEM B, V114, P7121, DOI 10.1021/jp102275r; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Xu L, 2008, BIOCHEMISTRY-US, V47, P8736, DOI 10.1021/bi800391j; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	47	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4382	4391		10.1074/jbc.M110.194696	http://dx.doi.org/10.1074/jbc.M110.194696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131361	Green Published, hybrid			2022-12-27	WOS:000286975700038
J	Ferrari, E; Tinti, M; Costa, S; Corallino, S; Nardozza, AP; Chatraryamontri, A; Ceol, A; Cesareni, G; Castagnoli, L				Ferrari, Emanuela; Tinti, Michele; Costa, Stefano; Corallino, Salvatore; Nardozza, Aurelio Pio; Chatraryamontri, Andrew; Ceol, Arnaud; Cesareni, Gianni; Castagnoli, Luisa			Identification of New Substrates of the Protein-tyrosine Phosphatase PTP1B by Bayesian Integration of Proteome Evidence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; INSULIN-RECEPTOR; PHOSPHORYLATION SITES; ADAPTER PROTEIN; IN-VIVO; TC-PTP; 1B; ACTIVATION; CELLS; GAB1	There is growing evidence that tyrosine phosphatases display an intrinsic enzymatic preference for the sequence context flanking the target phosphotyrosines. On the other hand, substrate selection in vivo is decisively guided by the enzyme-substrate connectivity in the protein interaction network. We describe here a system wide strategy to infer physiological substrates of protein-tyrosine phosphatases. Here we integrate, by a Bayesian model, proteome wide evidence about in vitro substrate preference, as determined by a novel high-density peptide chip technology, and "closeness" in the protein interaction network. This allows to rank candidate substrates of the human PTP1B phosphatase. Ultimately a variety of in vitro and in vivo approaches were used to verify the prediction that the tyrosine phosphorylation levels of five high-ranking substrates, PLC-gamma 1, Gab1, SHP2, EGFR, and SHP1, are indeed specifically modulated by PTP1B. In addition, we demonstrate that the PTP1B-mediated dephosphorylation of Gab1 negatively affects its EGF-induced association with the phosphatase SHP2. The dissociation of this signaling complex is accompanied by a decrease of ERK MAP kinase phosphorylation and activation.	[Ferrari, Emanuela; Tinti, Michele; Costa, Stefano; Corallino, Salvatore; Nardozza, Aurelio Pio; Chatraryamontri, Andrew; Ceol, Arnaud; Cesareni, Gianni; Castagnoli, Luisa] Univ Roma Tor Vergata, Dept Biol, I-00144 Rome, Italy; [Cesareni, Gianni] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Castagnoli, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00144 Rome, Italy.	cesareni@uniroma2.it; castagnoli@uniroma2.it	Ceol, Arnaud/H-3386-2012; Cesareni, Gianni/AAW-1382-2020	Ceol, Arnaud/0000-0001-9533-4246; Castagnoli, Luisa/0000-0001-5283-8671; Corallino, Salvatore/0000-0003-1911-6276; Tinti, Michele/0000-0002-0051-017X	Italian Association for Cancer Research (AIRC); Telethon; European Network of Excellence ENFIN	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); European Network of Excellence ENFIN	This work was supported by grants from the Italian Association for Cancer Research (AIRC), Telethon, and the European Network of Excellence ENFIN.	Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	45	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4173	4185		10.1074/jbc.M110.157420	http://dx.doi.org/10.1074/jbc.M110.157420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123182	Green Published, hybrid			2022-12-27	WOS:000286975700016
J	Kirabo, A; Embury, J; Kiss, R; Polgar, T; Gali, M; Majumder, A; Bisht, KS; Cogle, CR; Keseru, GM; Sayeski, PP				Kirabo, Annet; Embury, Jennifer; Kiss, Robert; Polgar, Timea; Gali, Meghanath; Majumder, Anurima; Bisht, Kirpal S.; Cogle, Christopher R.; Keseru, Gyoergy M.; Sayeski, Peter P.			The Stilbenoid Tyrosine Kinase Inhibitor, G6, Suppresses Jak2-V617F-mediated Human Pathological Cell Growth in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; POLYCYTHEMIA-VERA; JAK2 INHIBITOR; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATION; MURINE MODEL; MYELOFIBROSIS; APOPTOSIS; IDENTIFICATION; RESVERATROL	Using structure-based virtual screening, we previously identified a novel stilbenoid inhibitor of Jak2 tyrosine kinase named G6. Here, we hypothesized that G6 suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo. We found that G6 inhibited proliferation of the Jak2-V617F expressing human erythroleukemia (HEL) cell line by promoting marked cell cycle arrest and inducing apoptosis. The G6-dependent increase in apoptosis levels was concomitant with increased caspase 3/7 activity and cleavage of PARP. G6 also selectively inhibited phosphorylation of STAT5, a downstream signaling target of Jak2. Using a mouse model of Jak2-V617F-mediated hyperplasia, we found that G6 significantly decreased the percentage of blast cells in the peripheral blood, reduced splenomegaly, and corrected a pathologically low myeloid to erythroid ratio in the bone marrow by eliminating HEL cell engraftment in this tissue. In addition, drug efficacy correlated with the presence of G6 in the plasma, marrow, and spleen. Collectively, these data demonstrate that the stilbenoid compound, G6, suppresses Jak2-V617F-mediated aberrant cell growth. As such, G6 may be a potential therapeutic lead candidate against Jak2-mediated, human disease.	[Kirabo, Annet; Majumder, Anurima; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Embury, Jennifer] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kiss, Robert] Heriot Watt Univ, Dept Chem Engn, Edinburgh EH14 4A5, Midlothian, Scotland; [Polgar, Timea; Keseru, Gyoergy M.] Budapest Univ Technol & Econ, Dept Gen & Analyt Chem, H-1111 Budapest, Hungary; [Gali, Meghanath; Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Cogle, Christopher R.] Univ Florida, Coll Med, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Heriot Watt University; Budapest University of Technology & Economics; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, POB 100274, Gainesville, FL 32610 USA.	psayeski@ufl.edu	Cogle, Christopher/H-1746-2016; Polgár, Tímea/A-2089-2013	Cogle, Christopher/0000-0001-5422-6863; Polgár, Tímea/0000-0002-1367-6128; Keseru, Gyorgy M/0000-0003-1039-7809; Kiss, Robert/0000-0002-2879-6325	National Institutes of Health [R01-HL67277]; American Heart Association Greater Southeast Affiliate [0855361E]; University of Florida; University of Florida/Moffitt Cancer Center Collaborative Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Greater Southeast Affiliate(American Heart Association); University of Florida(University of Florida); University of Florida/Moffitt Cancer Center Collaborative Initiative(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL67277, an American Heart Association Greater Southeast Affiliate Grant in Aid (0855361E), a University of Florida Opportunity Fund Award, and a University of Florida/Moffitt Cancer Center Collaborative Initiative Award.	Antonysamy S, 2009, BIOORG MED CHEM LETT, V19, P279, DOI 10.1016/j.bmcl.2008.08.064; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kimura Y, 2005, IN VIVO, V19, P37; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larrosa M, 2003, J AGR FOOD CHEM, V51, P4576, DOI 10.1021/jf030073c; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lipka DB, 2008, MOL CANCER THER, V7, P1176, DOI 10.1158/1535-7163.MCT-07-2215; Majumder A, 2010, J BIOL CHEM, V285, P31399, DOI 10.1074/jbc.M110.168211; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Pardanani A, 2009, LEUKEMIA, V23, P1441, DOI 10.1038/leu.2009.50; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sayyah J, 2008, MOL CANCER THER, V7, P2308, DOI 10.1158/1535-7163.MCT-08-0279; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Swanson-Mungerson M, 2003, J ANTIMICROB CHEMOTH, V52, P152, DOI 10.1093/jac/dkg306; Szabo G, 2009, BIOORG MED CHEM LETT, V19, P3471, DOI 10.1016/j.bmcl.2009.05.010; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; Wadleigh Martha, 2010, Clin Adv Hematol Oncol, V8, P557; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	32	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4280	4291		10.1074/jbc.M110.200774	http://dx.doi.org/10.1074/jbc.M110.200774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127060	Green Published, hybrid			2022-12-27	WOS:000286975700027
J	Saito, A; Ochiai, K; Kondo, S; Tsumagari, K; Murakami, T; Cavener, DR; Imaizumi, K				Saito, Atsushi; Ochiai, Kimiko; Kondo, Shinichi; Tsumagari, Kenji; Murakami, Tomohiko; Cavener, Douglas R.; Imaizumi, Kazunori			Endoplasmic Reticulum Stress Response Mediated by the PERK-eIF2 alpha-ATF4 Pathway Is Involved in Osteoblast Differentiation Induced by BMP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLCOTT-RALLISON-SYNDROME; CIS-ACTING ELEMENT; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; INITIATION FACTOR-2-ALPHA; TRANSCRIPTION FACTOR; OSTEOCALCIN GENE; MESSENGER-RNA; KINASE; EXPRESSION	To avoid excess accumulation of unfolded proteins in the endoplasmic reticulum (ER), eukaryotic cells have signaling pathways from the ER to the cytosol or nucleus. These processes are collectively termed the ER stress response. Double stranded RNA activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK) is a major transducer of the ER stress response and directly phosphorylates eIF2 alpha, resulting in translational attenuation. Phosphorylated eIF2 alpha specifically promotes the translation of the transcription factor ATF4. ATF4 plays important roles in osteoblast differentiation and bone formation. Perk(-/-) mice are reported to exhibit severe osteopenia, and the phenotypes observed in bone tissues are very similar to those of Atf4(-/-) mice. However, the involvement of the PERK-eIF2 alpha-ATF4 signaling pathway in osteogenesis is unclear. Phosphorylated eIF2 alpha and ATF4 protein levels were attenuated in Perk(-/-) calvariae, and the gene expression levels of osteocalcin (Ocn) and bone sialoprotein (Bsp), which are targets for ATF4, were also down-regulated. Treatment of wild-type primary osteoblasts with BMP2, which is required for osteoblast differentiation, induced ER stress, leading to an increase in ATF4 protein expression levels. In contrast, the level of ATF4 in Perk(-/-) osteoblasts was severely diminished. The results indicate that PERK signaling is required for ATF4 activation during osteoblast differentiation. Perk(-/-) osteoblasts exhibited decreased alkaline phosphatase activities and delayed mineralized nodule formation relative to wild-type cultures. These abnormalities were almost completely restored by the introduction of ATF4 into Perk(-/-) osteoblasts. Taken together, ER stress occurs during osteoblast differentiation and activates the PERK-eIF2 alpha-ATF4 signaling pathway followed by the promotion of gene expression essential for osteogenesis, such as Ocn and Bsp.	[Saito, Atsushi; Kondo, Shinichi; Tsumagari, Kenji; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Div Genome Radiobiol & Med Sci, Dept Biochem, Hiroshima 7348553, Japan; [Ochiai, Kimiko; Murakami, Tomohiko] Miyazaki Univ, Fac Med, Dept Anat, Div Mol & Cellular Biol, Miyazaki 8891692, Japan; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Hiroshima University; University of Miyazaki; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Imaizumi, K (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348553, Japan.	imaizumi@hiroshima-u.ac.jp	Cavener, Douglas R/E-3524-2010		Japan Society for the Promotion of Science KAKENHI [22020030, 21790323, 21790174, 22800049]; Mochida Memorial Foundation for Medical and Pharmaceutical; Senri Life Science Foundation; Uehara Memorial Foundation; Toray Science Foundation; Takeda Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical; Senri Life Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI (Grants 22020030, 21790323, 21790174, and 22800049), the Mochida Memorial Foundation for Medical and Pharmaceutical, the Senri Life Science Foundation, The Uehara Memorial Foundation, the Toray Science Foundation, and the Takeda Science Foundation.	Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iyer S, 2004, ACTA PAEDIATR, V93, P1195, DOI 10.1080/08035250410029362; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	33	193	212	4	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4809	4818		10.1074/jbc.M110.152900	http://dx.doi.org/10.1074/jbc.M110.152900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135100	hybrid, Green Published			2022-12-27	WOS:000286975700078
J	Shinkyo, R; Guengerich, FP				Shinkyo, Raku; Guengerich, F. Peter			Cytochrome P450 7A1 Cholesterol 7 alpha-Hydroxylation INDIVIDUAL REACTION STEPS IN THE CATALYTIC CYCLE AND RATE-LIMITING FERRIC IRON REDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; BILE-ACID BIOSYNTHESIS; P450 REDUCTASE; OXIDATION REACTIONS; KINETIC-ANALYSIS; KEY ENZYME; BINDING; HYDROXYLATION; SUBSTRATE; 3A4	Cytochrome P450 (P450) 7A1 is well known as the cholesterol 7 alpha-hydroxylase, the first enzyme involved in bile acid synthesis from cholesterol. The human enzyme has been reported to have the highest catalytic activity of any mammalian P450. Analyses of individual steps of cholesterol 7 alpha-hydroxylation reaction revealed several characteristics of this reaction: (i) two-step binding of cholesterol to ferric P450, with an apparent K-d of 0.51 mu M, (ii) a rapid reduction rate in the presence of cholesterol (similar to 10 s(-1) for the fast phase), (iii) rapid formation of a ferrous P450-cholesterol-O-2 complex (29 s(-1)), (iv) the lack of a non-competitive kinetic deuterium isotope effect, (v) the lack of a kinetic burst, and (vi) the lack of a deuterium isotope effect when the reaction was initiated with the ferrous P450-cholesterol complex. A minimum kinetic model was developed and is consistent with all of the observed phenomena and the rates of cholesterol 7 alpha-hydroxylation and H2O and H2O2 formation. The results indicate that the first electron transfer step, although rapid, becomes rate-limiting in the overall P450 7A1 reaction. This is a different phenomenon compared with other P450s that have much lower rates of catalysis, attributed to the much more efficient substrate oxidation steps in this reaction.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Shinkyo, Raku/HIK-2997-2022		National Institutes of Health [R37 CA090426, P30 ES000267]; Eisai Co., Ltd.; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eisai Co., Ltd.(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and P30 ES000267 (to F. P. G.). This work was also supported by Eisai Co., Ltd. (to R. S.).	BERGSTROM S, 1958, J AM CHEM SOC, V80, P2337, DOI 10.1021/ja01542a081; Brunel JM, 2005, TETRAHEDRON-ASYMMETR, V16, P3036, DOI 10.1016/j.tetasy.2005.08.024; COREY EJ, 1959, J AM CHEM SOC, V81, P3127, DOI 10.1021/ja01521a053; CUNNINGHAM IM, 1974, J CHEM SOC PERK T 1, P2458, DOI 10.1039/p19740002458; Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200; DIEHL H, 1970, H-S Z PHYSIOL CHEM, V351, P1359, DOI 10.1515/bchm2.1970.351.2.1359; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; EINARSSON K, 1989, J LIPID RES, V30, P1477; ESTABROOK RW, 1971, METABOLISM, V20, P187, DOI 10.1016/0026-0495(71)90091-6; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; GIGON PL, 1969, MOL PHARMACOL, V5, P109; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 2002, J BIOL CHEM, V277, P33711, DOI 10.1074/jbc.M205146200; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Loughran PA, 2000, BIOCHEMISTRY-US, V39, P15110, DOI 10.1021/bi001522u; MAEDA Y, 1995, EUR J BIOCHEM, V228, P144, DOI 10.1111/j.1432-1033.1995.0144o.x; MARTIN KO, 1993, J LIPID RES, V34, P581; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; Mast N, 2005, BIOCHEMISTRY-US, V44, P3259, DOI 10.1021/bi047566a; Mueller Ernest J., 1995, P83; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Norlin M, 2000, J BIOL CHEM, V275, P34046, DOI 10.1074/jbc.M002663200; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OPRIAN DD, 1983, J BIOL CHEM, V258, P8684; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; Wilson WK, 1996, J LIPID RES, V37, P1529; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u	50	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4632	4643		10.1074/jbc.M110.193409	http://dx.doi.org/10.1074/jbc.M110.193409			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147774	hybrid, Green Published			2022-12-27	WOS:000286975700063
J	Duch, A; Palou, G; Jonsson, ZO; Palou, R; Calvo, E; Wohlschlegel, J; Quintana, DG				Duch, Alba; Palou, Gloria; Jonsson, Zophonias O.; Palou, Roger; Calvo, Enrique; Wohlschlegel, James; Quintana, David G.			A Dbf4 Mutant Contributes to Bypassing the Rad53-mediated Block of Origins of Replication in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S PHASE CHECKPOINT; DNA-REPLICATION; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DAMAGE; PHOSPHORYLATION; RAD53; PROGRESSION; SLD3	An intra-S phase checkpoint slows the rate of DNA replication in response to DNA damage and replication fork blocks in eukaryotic cells. In the budding yeast Saccharomyces cerevisiae, such down-regulation is achieved through the Rad53 kinase-dependent block of origins of replication. We have identified the Rad53 phosphorylation sites on Dbf4, the activator subunit of the essential S phase Dbf4-dependent kinase, and generated a non-phosphorylatable Dbf4 mutant (dbf4(7A)). We show here that dbf4(7A) is a bona fide intra-S phase checkpoint bypass allele that contributes to abrogating the Rad53 block of origin firing in response to genotoxic stress.	[Duch, Alba; Palou, Gloria; Palou, Roger; Quintana, David G.] Univ Autonoma Barcelona, Sch Med, Dept Biochem & Mol Biol, Biophys Unit, Bellaterra 08193, Catalonia, Spain; [Duch, Alba; Palou, Gloria; Palou, Roger; Quintana, David G.] Univ Autonoma Barcelona, Ctr Biophys Studies, Bellaterra 08193, Catalonia, Spain; [Jonsson, Zophonias O.; Wohlschlegel, James] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Calvo, Enrique] Ctr Nacl Invest Cardiovasc CNIC, Unidad Prote, Madrid 28029, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of California System; University of California Los Angeles; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Quintana, DG (corresponding author), Univ Autonoma Barcelona, Sch Med, Dept Biochem & Mol Biol, Biophys Unit, Bellaterra 08193, Catalonia, Spain.	davidg.quintana@uab.cat	Jónsson, Zophonías/E-1960-2015; Quintana, David G/M-5628-2018; Duch, Alba/AGI-1035-2022; Jónsson, Zophonías Oddur/AAO-1354-2020	Duch, Alba/0000-0001-6041-1360; Jónsson, Zophonías Oddur/0000-0001-5798-9647; Quintana, David G./0000-0002-4909-6686	National Institutes of Health [GM089778]; Ministerio de Ciencia e Innovacion [BFU2008-03778]; UCLA Jonsson Cancer Center; Ministerio de Educacion y Ciencia; Generalitat de Catalunya; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); UCLA Jonsson Cancer Center; Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089778 (to J.W.). This work was also supported by Grant BFU2008-03778 from the Ministerio de Ciencia e Innovacion (to D.G.Q.), the UCLA Jonsson Cancer Center (to J.W.), a Formacion de Personal Investigador fellowship from the Ministerio de Educacion y Ciencia (to A.D.), and a Formacio d'Investigadors fellowship from the Generalitat de Catalunya (to G.P.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Palou G, 2010, J BIOL CHEM, V285, P26431, DOI 10.1074/jbc.M110.138669; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	30	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2486	2491		10.1074/jbc.M110.190843	http://dx.doi.org/10.1074/jbc.M110.190843			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098477	hybrid, Green Published			2022-12-27	WOS:000286464300013
J	Zhong, SP; Machida, K; Tsukamoto, H; Johnson, DL				Zhong, Shuping; Machida, Keigo; Tsukamoto, Hide; Johnson, Deborah L.			Alcohol Induces RNA Polymerase III-dependent Transcription through c-Jun by Co-regulating TATA-binding Protein (TBP) and Brf1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENIC TRANSFORMATION; CELL-PROLIFERATION; INHIBITION; ACTIVATION; STRESS; TFIIIB; ELK-1; JNK1	Chronic alcohol consumption is associated with steatohepatitis and cirrhosis, enhancing the risk for hepatocellular carcinoma. RNA polymerase (pol) III transcribes a variety of small, untranslated RNAs, including tRNAs and 5S rRNAs, which determine the biosynthetic capacity of cells. Increased RNA pol III-dependent transcription, observed in transformed cells and human tumors, is required for oncogenic transformation. Given that alcohol consumption increases risk for liver cancer, we examined whether alcohol regulates this class of genes. Ethanol induces RNA pol III-dependent transcription in both HepG2 cells and primary mouse hepatocytes in a manner that requires ethanol metabolism and the activation of JNK1. This regulatory event is mediated, at least in part, through the ability of ethanol to induce expression of the TFIIIB components, Brf1, and the TATA-binding protein (TBP). Induction of TBP, Brf1, and RNA pol III-dependent gene expression is driven by enhanced c-Jun expression. Ethanol promotes a marked increase in the direct recruitment of c-Jun to TBP, Brf1, and tRNA gene promoters. Chronic alcohol administration in mice leads to enhanced expression of TBP, Brf1, tRNA, and 5S rRNA gene transcription in the liver. These alcohol-dependent increases are more pronounced in transgenic animals that express the HCV NS5A protein that display increased incidence of liver tumors. Together, these results identify a new class of genes that are regulated by alcohol through the co-regulation of TFIIIB components and define a central role for c-Jun in this process.	[Tsukamoto, Hide] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Tsukamoto, Hide] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Machida, Keigo] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Johnson, Deborah L.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Johnson, Deborah L.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhong, SP (corresponding author), 2011 Zonal Ave,HMR 605 MC 9097, Los Angeles, CA 90033 USA.	szhong@usc.edu			National Institutes of Health through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis [P50 AA011999]; National Institutes of Health [AA017288, CA108614]; NATIONAL CANCER INSTITUTE [R01CA108614, R01CA074138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R21AA017288] Funding Source: NIH RePORTER	National Institutes of Health through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AA011999 (to S.Z.) through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis and National Institutes of Health Grants AA017288 (to S.Z.) and CA108614 (to D.L.J.).	Cabarcas S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-74; Clemens DL, 2002, HEPATOLOGY, V35, P1196, DOI 10.1053/jhep.2002.32668; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Johnson DL, 2008, SCIENCE, V320, P461, DOI 10.1126/science.1158680; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SAS, 2000, MOL CELL BIOL, V20, P5000, DOI 10.1128/MCB.20.14.5000-5009.2000; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Nishitani Y, 2006, FEBS LETT, V580, P9, DOI 10.1016/j.febslet.2005.11.030; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06; Zhong SP, 2009, P NATL ACAD SCI USA, V106, P12682, DOI 10.1073/pnas.0904843106; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	27	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2393	2401		10.1074/jbc.M110.192955	http://dx.doi.org/10.1074/jbc.M110.192955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106530	hybrid, Green Published			2022-12-27	WOS:000286464300003
J	Wang, L; Payton, R; Dai, W; Lu, L				Wang, Ling; Payton, Reid; Dai, Wei; Lu, Luo			Hyperosmotic Stress-induced ATF-2 Activation through Polo-like Kinase 3 in Human Corneal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; C-JUN; TRANSCRIPTIONAL ACTIVATION; SERINE/THREONINE KINASE; PROTEIN-KINASES; APOPTOSIS; PHOSPHORYLATION; POLO-LIKE-KINASE-3; PROLIFERATION; INDUCTION	Elevated extracellular solute concentration (hyperosmotic stress) perturbs cell function and stimulates cell responses by evoking MAPK cascades and activating AP-1 transcription complex resulting in alterations of gene expression, cell cycle arrest, and apoptosis. The results presented here demonstrate that hyperosmotic stress elicited increases in ATF-2 phosphorylation through a novel Polo-like kinase 3 (Plk3) pathway in human corneal epithelial (HCE) cells. We found in hyperosmotic stress-induced HCE cells that Plk3 transferred to the nuclear compartment and was colocalized with ATF-2 in nuclei. Kinase activity of Plk3 was significantly activated by hyperosmotic stimulation. Further downstream, active Plk3 phosphorylated ATF-2 at the Thr-71 site in vivo and in vitro. Overexpression of Plk3 and its mutants enhanced hyperosmotic stress-induced ATF-2 phosphorylation. In contrast, suppression of Plk3 by knocking down Plk3 mRNA effectively diminished the effect of hyperosmotic stress-induced ATF-2 phosphorylation. The effect of hyperosmotic stress-induced activation of Plk3 on ATF-2 transcription factor function was also examined in CRE reporter-overexpressed HCE cells. Our results for the first time reveal that hyperosmotic stress can activate the Plk3 signaling pathway that subsequently regulates the AP-1 complex by directly phosphorylating ATF-2 independent from the effects of JNK and p38 activation.	[Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY 018343, CA074229]; NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015281, R01EY018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY 018343 (to L. L.) and CA074229 (to W. D.).	Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Carrillo RJ, 2010, J MOL BIOL, V396, P431, DOI 10.1016/j.jmb.2009.11.050; Conn CW, 2000, CANCER RES, V60, P6826; Corrales RM, 2008, CORNEA, V27, P574, DOI 10.1097/ICO.0b013e318165b19e; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DEUTSCH C, 1982, BIOCHIM BIOPHYS ACTA, V721, P262, DOI 10.1016/0167-4889(82)90078-7; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Huang ZB, 2004, J PHYSIOL-LONDON, V558, P181, DOI 10.1113/jphysiol.2004.065540; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Lee M, 2004, J BIOL CHEM, V279, P48692, DOI 10.1074/jbc.M403132200; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360	41	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1951	1958		10.1074/jbc.M110.166009	http://dx.doi.org/10.1074/jbc.M110.166009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098032	Green Published, hybrid			2022-12-27	WOS:000286191500036
J	Pham, CTN; Mitchell, LM; Huang, JL; Lubniewski, CM; Schall, OF; Killgore, JK; Pan, DPJ; Wickline, SA; Lanza, GM; Hourcade, DE				Pham, Christine T. N.; Mitchell, Lynne M.; Huang, Jennifer L.; Lubniewski, Christopher M.; Schall, Otto F.; Killgore, J. Kendall; Pan, Dipanjan; Wickline, Samuel A.; Lanza, Gregory M.; Hourcade, Dennis E.			Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; ALTERNATIVE PATHWAY; FUMAGILLIN NANOPARTICLES; TOXIC OXYGEN; IN-VIVO; 2 PARTS; LIPOSOMES; IMMUNOLOGY; CONVERTASE; MODEL	A wide variety of nanomaterials are currently being developed for use in the detection and treatment of human diseases. However, there is no systematic way to measure and predict the action of such materials in biological contexts. Lipid-encapsulated nanoparticles (NPs) are a class of nanomaterials that includes the liposomes, the most widely used and clinically proven type of NPs. Liposomes can, however, activate the complement system, an important branch of innate immunity, resulting in undesirable consequences. Here, we describe the complement response to lipid-encapsulated NPs that are functionalized on the surface with various lipid-anchored gadolinium chelates. We developed a quantitative approach to examine the interaction of NPs with the complement system using in vitro assays and correlating these results with those obtained in an in vivo mouse model. Our results indicate that surface functionalization of NPs with certain chemical structures elicits swift complement activation that is initiated by a natural IgM antibody and propagated via the classical pathway. The intensity of the response is dependent on the chemical structures of the lipid-anchored chelates and not zeta potential effects alone. Moreover, the extent of complement activation may be tempered by complement inhibiting regulatory proteins that bind to the surface of NPs. These findings represent a step forward in the understanding of the interactions between nanomaterials and the host innate immune response and provide the basis for a systematic structure-activity relationship study to establish guidelines that are critical to the future development of biocompatible nanotherapeutics.	[Hourcade, Dennis E.] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; [Pan, Dipanjan; Wickline, Samuel A.; Lanza, Gregory M.] Washington Univ, Sch Med, Div Cardiol, Dept Med, St Louis, MO 63110 USA; [Schall, Otto F.; Killgore, J. Kendall] Kereos Inc, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Pham, CTN (corresponding author), 660 S Euclid Ave,Box 8045, St Louis, MO 63110 USA.	cpham@dom.wustl.edu; dhourcad@dom.wustl.edu		Pan, Dipanjan/0000-0003-0175-4704	National Institutes of Health [AR056468, HL073646, CA119342, NS059302, HL094470, AI051436/AI051436S1]; National Institutes of Health/Food and Drug Administration [U01NS073457]; NATIONAL CANCER INSTITUTE [U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646, R01HL094470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302, U01NS073457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Food and Drug Administration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants AR056468 (to C. T. N. P.), HL073646 (to S. A. W.), CA119342 (to G. M. L.), NS059302 (to G. M. L.), HL094470 (to G. M. L.), and AI051436/AI051436S1 (to D. E. H.) and National Institutes of Health/Food and Drug Administration Grant U01NS073457 (to D. E. H.). S. A. W. and G. M. L. are scientific founders of Kereos, Inc., and minority shareholders (less than 5%).	Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786; ATKINSON JP, 1980, J IMMUNOL METHODS, V33, P351, DOI 10.1016/0022-1759(80)90005-8; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Caruthers SD, 2007, CURR OPIN BIOTECH, V18, P26, DOI 10.1016/j.copbio.2007.01.006; CHONN A, 1991, J IMMUNOL, V146, P4234; CUNNINGHAM CM, 1979, J IMMUNOL, V122, P1237; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Fischer MB, 1996, J IMMUNOL, V157, P549; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Harris TD, 2003, [No title captured], Patent No. [US6511648, 6511648]; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kraus D, 1998, INFECT IMMUN, V66, P399, DOI 10.1128/IAI.66.2.399-405.1998; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lanza GM, 1996, CIRCULATION, V94, P3334, DOI 10.1161/01.CIR.94.12.3334; Liszewski M.K., 1998, HUMAN COMPLEMENT SYS, P149; LUNDBERG C, 1987, AM J PATHOL, V128, P471; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rihova B, 2002, ADV DRUG DELIVER REV, V54, P653; Sadeghi MM, 2004, CIRCULATION, V110, P84, DOI 10.1161/01.CIR.0000133319.84326.70; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 1999, CIRCULATION, V99, P2302, DOI 10.1161/01.CIR.99.17.2302; TILL GO, 1986, FASEB J, V45, P13; TILL GO, 1982, J CLIN INVEST, V69, P1126, DOI 10.1172/JCI110548; TVEDTEN HW, 1985, AM J PATHOL, V119, P92; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Whaley K, 1985, METHODS COMPLEMENT C, P77; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Winter PM, 2008, JACC-CARDIOVASC IMAG, V1, P624, DOI 10.1016/j.jcmg.2008.06.003; WRIGHT SD, 1983, J EXP MED, V158, P2016, DOI 10.1084/jem.158.6.2016	37	55	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					123	130		10.1074/jbc.M110.180760	http://dx.doi.org/10.1074/jbc.M110.180760			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047788	hybrid, Green Published			2022-12-27	WOS:000285782800013
J	Schorn, C; Frey, B; Lauber, K; Janko, C; Strysio, M; Keppeler, H; Gaipl, US; Voll, RE; Springer, E; Munoz, LE; Schett, G; Herrmann, M				Schorn, Christine; Frey, Benjamin; Lauber, Kirsten; Janko, Christina; Strysio, Moritz; Keppeler, Hildegard; Gaipl, Udo S.; Voll, Reinhard E.; Springer, Eva; Munoz, Luis E.; Schett, Georg; Herrmann, Martin			Sodium Overload and Water Influx Activate the NALP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; GOUT; INTERLEUKIN-1-BETA; SYSTEM	The NALP3 inflammasome is activated by low intracellular potassium concentrations [K+](i), leading to the secretion of the proinflammatory cytokine IL-1 beta. However, the mechanism of [K+](i) lowering after phagocytosis of monosodium urate crystals is still elusive. Here, we propose that endosomes containing monosodium urate crystals fuse with acidic lysosomes. The low pH in the phagolysosome causes a massive release of sodium and raises the intracellular osmolarity. This process is balanced by passive water influx through aquaporins leading to cell swelling. This process dilutes [K+](i) to values below the threshold of 90 mM known to activate NALP3 inflammasomes without net loss of cytoplasmic potassium ions. In vitro, the inhibitors of lysosomal acidification (ammonium chloride, chloroquine) and of aquaporins (mercury chloride, phloretin) all significantly decreased the production of IL-1 beta. In vivo, only the pharmacological inhibitor of lysosome acidification chloroquine could be used which again significantly reduced the IL-1 beta production. As a translational aspect one may consider the use of chloroquine for the anti-inflammatory treatment of refractory gout.	[Voll, Reinhard E.; Munoz, Luis E.; Schett, Georg; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Frey, Benjamin; Gaipl, Udo S.; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Springer, Eva] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany; [Lauber, Kirsten] Univ Munich, Dept Radiat Oncol, D-81377 Munich, Germany; [Keppeler, Hildegard] Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Munich; Eberhard Karls University of Tubingen	Herrmann, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Krankenhausstr 12, D-91054 Erlangen, Germany.	Martin.Herrmann@uk-erlangen.de	Munoz, Luis E/E-7725-2010; herrmann, martin/AAT-9836-2020; Frey, Benjamin/D-9565-2017; Herrmann, Martin/A-9597-2013; Gaipl, Udo/AAE-1060-2020	Munoz, Luis E/0000-0002-5395-804X; Frey, Benjamin/0000-0001-6743-3351; Herrmann, Martin/0000-0002-0258-2484; Janko, Christina/0000-0001-5705-6329	Deutsche Forschungsgemeinschaft [GK SFB 643]; Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; University Clinic of Erlangen [09.10.15.1, 09.03.18.1]; K. und R. Wucherpfennigstiftung; Doktor Robert Pfleger Foundation; German Research Foundation [GA 1507/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; University Clinic of Erlangen; K. und R. Wucherpfennigstiftung; Doktor Robert Pfleger Foundation; German Research Foundation(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant GK SFB 643, the Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg and by Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Fond 09.10.15.1 of the University Clinic of Erlangen.; Supported by K. und R. Wucherpfennigstiftung.; Supported by the Doktor Robert Pfleger Foundation and by the German Research Foundation Grant GA 1507/1-1.; Supported by Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Fond 09.03.18.1 of the University Clinic of Erlangen.	Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; Celsus A. C., 1906, AULUS CORNELIUS CELS; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V127, P125, DOI 10.1016/j.vetimm.2008.09.028; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lo CJ, 2006, BIOPHYS J, V90, P357, DOI 10.1529/biophysj.105.071332; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2006, J CLIN INVEST, V116, P2073, DOI 10.1172/JCI29404; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Nilsson C, 2008, CLIN VACCINE IMMUNOL, V15, P585, DOI 10.1128/CVI.00161-07; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Peng Liming, 2001, Journal of West China University of Medical Sciences, V32, P602; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Roddy E, 2007, ANN RHEUM DIS, V66, P1374, DOI 10.1136/ard.2006.063768; ROGERS SW, 1988, J BIOL CHEM, V263, P19843; Schorn C, 2009, AUTOIMMUNITY, V42, P314, DOI 10.1080/08916930902832058; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Stamp LK, 2007, INTERN MED J, V37, P258, DOI 10.1111/j.1445-5994.2007.01315.x; Takeuchi K, 2008, CHEM SENSES, V33, P425, DOI 10.1093/chemse/bjn009	24	120	127	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					35	41		10.1074/jbc.M110.139048	http://dx.doi.org/10.1074/jbc.M110.139048			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051542	Green Published, hybrid			2022-12-27	WOS:000285782800004
J	Melo, FR; Waern, I; Ronnberg, E; Abrink, M; Lee, DM; Schlenner, SM; Feyerabend, TB; Rodewald, HR; Turk, B; Wernersson, S; Pejler, G				Melo, Fabio Rabelo; Waern, Ida; Ronnberg, Elin; Abrink, Magnus; Lee, David M.; Schlenner, Susan M.; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer; Turk, Boris; Wernersson, Sara; Pejler, Gunnar			A Role for Serglycin Proteoglycan in Mast Cell Apoptosis Induced by a Secretory Granule-mediated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE METHYL-ESTER; LYSOSOMAL MEMBRANE PERMEABILIZATION; DIPEPTIDYL PEPTIDASE-I; CARBOXYPEPTIDASE-A; T-LYMPHOCYTES; GRANZYME-B; CYTOTOXIC LYMPHOCYTES; DEATH; ACTIVATION; PROTEASES	Mast cell secretory granules (secretory lysosomes) contain large amounts of fully active proteases bound to serglycin proteoglycan. Damage to the granule membrane will thus lead to the release of serglycin and serglycin-bound proteases into the cytosol, which potentially could lead to proteolytic activation of cytosolic pro-apoptotic compounds. We therefore hypothesized that mast cells are susceptible to apoptosis induced by permeabilization of the granule membrane and that this process is serglycin-dependent. Indeed, we show that wild-type mast cells are highly sensitive to apoptosis induced by granule permeabilization, whereas serglycin-deficient cells are largely resistant. The reduced sensitivity of serglycin(-/-) cells to apoptosis was accompanied by reduced granule damage, reduced release of proteases into the cytosol, and defective caspase-3 activation. Mechanistically, the apoptosis-promoting effect of serglycin involved serglycin-dependent proteases, as indicated by reduced sensitivity to apoptosis and reduced caspase-3 activation in cells lacking individual mast cell-specific proteases. Together, these findings implicate serglycin proteoglycan as a novel player in mast cell apoptosis.	[Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, SE-75123 Uppsala, Sweden; [Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Lee, David M.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Lee, David M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schlenner, Susan M.; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Turk, Boris] Univ Ljubljana, Dept Biochem & Mol & Struct Biol, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ulm University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Pejler, G (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, SE-75123 Uppsala, Sweden.	Gunnar.Pejler@afb.slu.se	Ronnberg, Elin/ABA-8898-2020; Wernersson, Sara/D-4580-2011; Åbrink, Magnus/AAK-8346-2020; Wernersson, Sara/N-8830-2019; Melo, Fabio Rabelo/GQP-0844-2022; Schlenner, Susan/P-7905-2017	Ronnberg, Elin/0000-0002-4628-9968; Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Schlenner, Susan/0000-0002-8553-3388; Abrink, Magnus/0000-0002-1335-3927; Turk, Boris/0000-0002-9007-5764	National Institutes of Health [R01 AI 059746]; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Swedish Cancer Foundation; CAPES-Brazil; Vardal Foundation; Swedish Society of Medicine; Slovene Research Agency [P1-0140, J1-711]; European Research Council [FP7/2007-2013), 233074]; Deutsche Forschungsgemeinschaft [754-2-2]; Formas; King Gustaf V 80-Year Anniversary Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Swedish Cancer Foundation; CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Vardal Foundation; Swedish Society of Medicine; Slovene Research Agency(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Formas(Swedish Research Council Formas); King Gustaf V 80-Year Anniversary Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 059746. This work was also supported by grants from Swedish Research Council, Formas, King Gustaf V 80-Year Anniversary Fund, Torsten and Ragnar Soderberg Foundation, Swedish Cancer Foundation, CAPES-Brazil, Vardal Foundation, Swedish Society of Medicine, Slovene Research Agency Grants P1-0140 and J1-711, European Research Council (FP7/2007-2013)/ERC grant agreement no. 233074, and Deutsche Forschungsgemeinschaft 754-2-2.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Berent-Maoz B, 2006, J IMMUNOL, V176, P2272, DOI 10.4049/jimmunol.176.4.2272; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; CHARLEY M, 1986, J CLIN INVEST, V78, P1415, DOI 10.1172/JCI112730; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dragonetti A, 2000, J CELL SCI, V113, P3289; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Huang CF, 1998, J IMMUNOL, V160, P1910; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi Y, 2000, BIOCHEM BIOPH RES CO, V272, P687, DOI 10.1006/bbrc.2000.2836; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; Mirghomizadeh F, 2009, EXP CELL RES, V315, P3064, DOI 10.1016/j.yexcr.2009.07.019; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Pejler G, 1999, BIOCHEMISTRY-US, V38, P12187, DOI 10.1021/bi991046b; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; THIELE DL, 1986, J IMMUNOL, V136, P1038; Tran TM, 2009, APOPTOSIS, V14, P320, DOI 10.1007/s10495-009-0311-4; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; Wernersson S, 2009, J LEUKOCYTE BIOL, V85, P401, DOI 10.1189/jlb.1008670; Wolters PJ, 2000, AM J RESP CELL MOL, V22, P183, DOI 10.1165/ajrcmb.22.2.3767; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	56	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5423	5433		10.1074/jbc.M110.176461	http://dx.doi.org/10.1074/jbc.M110.176461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21123167	Green Published, hybrid			2022-12-27	WOS:000287230600051
J	Chi, CN; Bach, A; Engstrom, A; Stromgaard, K; Lundstrom, P; Ferguson, N; Jemth, P				Chi, Celestine N.; Bach, Anders; Engstrom, Ake; Stromgaard, Kristian; Lundstrom, Patrik; Ferguson, Neil; Jemth, Per			Biophysical Characterization of the Complex between Human Papillomavirus E6 Protein and Synapse-associated Protein 97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-SUPPRESSOR; PDZ-DOMAIN; HPV E6; POSTSYNAPTIC DENSITY; MEDIATED DEGRADATION; ADENOVIRUS E4-ORF1; BINDING MECHANISM; CERVICAL-CANCER; MOLECULAR-BASIS; CELL-LINES	The E6 protein of human papillomavirus (HPV) exhibits complex interaction patterns with several host proteins, and their roles in HPV-mediated oncogenesis have proved challenging to study. Here we use several biophysical techniques to explore the binding of E6 to the three PDZ domains of the tumor suppressor protein synapse-associated protein 97 (SAP97). All of the potential binding sites in SAP97 bind E6 with micromolar affinity. The dissociation rate constants govern the different affinities of HPV16 and HPV18 E6 for SAP97. Unexpectedly, binding is not mutually exclusive, and all three PDZ domains can simultaneously bind E6. Intriguingly, this quaternary complex has the same apparent hydrodynamic volume as the unliganded PDZ region, suggesting that a conformational change occurs in the PDZ region upon binding, a conclusion supported by kinetic experiments. Using NMR, we discovered a new mode of interaction between E6 and PDZ: a subset of residues distal to the canonical binding pocket in the PDZ(2) domain exhibited noncanonical interactions with the E6 protein. This is consistent with a larger proportion of the protein surface defining binding specificity, as compared with that reported previously.	[Lundstrom, Patrik] Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Ferguson, Neil] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	Linkoping University; Uppsala University; University of Copenhagen; University College Dublin	Lundstrom, P (corresponding author), Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.	patlu@ifm.liu.se; neil.ferguson@ucd.ie; Per.Jemth@imbim.uu.se		Bach, Anders/0000-0003-4305-9910; Stromgaard, Kristian/0000-0003-2206-4737	Swedish Research Council; Jeansson's Foundation; Clas Groschinskys Minnesfond; Science Foundation Ireland [07/SK/B1224, 09/YI/B1682]; University College Dublin	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeansson's Foundation; Clas Groschinskys Minnesfond; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College Dublin	This work was supported by funds from the Swedish Research Council (to P. J. and P. L.), Jeansson's Foundation (to P. J.), Clas Groschinskys Minnesfond (to P. J.), Science Foundation Ireland Awards 07/SK/B1224and 09/YI/B1682 (to N. F.), and a start-up award from University College Dublin (to N. F.).	ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chi CN, 2010, J BIOL CHEM, V285, P28252, DOI 10.1074/jbc.M110.124040; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; DEVILLIERS EM, 1987, LANCET, V2, P703; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fehrmann F, 2003, ONCOGENE, V22, P5201, DOI 10.1038/sj.onc.1206554; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P341, DOI 10.1021/bi602457q; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Liu YQ, 2008, FRONT BIOSCI-LANDMRK, V13, P121, DOI 10.2741/2664; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mammas IN, 2008, PATHOL ONCOL RES, V14, P345, DOI 10.1007/s12253-008-9056-6; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Niu XG, 2007, BIOCHEMISTRY-US, V46, P15042, DOI 10.1021/bi701303p; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Nomine Y, 2001, PROTEIN EXPRES PURIF, V23, P22, DOI 10.1006/prep.2001.1451; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Thomas M, 2001, ONCOGENE, V20, P5431, DOI 10.1038/sj.onc.1204719; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Thomas M, 2008, VIROLOGY, V376, P371, DOI 10.1016/j.virol.2008.03.021; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	47	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3597	3606		10.1074/jbc.M110.190264	http://dx.doi.org/10.1074/jbc.M110.190264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21113079	hybrid, Green Published			2022-12-27	WOS:000286653200044
J	Ertas, B; Kiger, L; Blank, M; Marden, MC; Burmester, T				Ertas, Beyhan; Kiger, Laurent; Blank, Miriam; Marden, Michael C.; Burmester, Thorsten			A Membrane-bound Hemoglobin from Gills of the Green Shore Crab Carcinus maenas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING PROPERTIES; GLOBIN-COUPLED SENSORS; MYRISTOYLATED PROTEINS; ARTHROPOD HEMOCYANINS; N-MYRISTOYLATION; EVOLUTION; NEUROGLOBIN; DROSOPHILA; MYOGLOBIN; CRUSTACEA	O-2 Most hemoglobins serve for the transport or storage of O-2. Although hemoglobins are widespread in "entomostracan" Crustacea, malacostracans harbor the copper-containing hemocyanin in their hemolymph. Usually, only one type of respiratory protein occurs within a single species. Here, we report the identification of a hemoglobin of the shore crab Carcinus maenas (Malacostraca, Brachyura). In contrast to the do-decameric hemocyanin of this species, C. maenas hemoglobin does not reside in the hemolymph but is restricted to the gills. Immunofluorescence studies and cell fractioning showed that C. maenas hemoglobin resides in the membrane of the chief cells of the gill. To the best of our knowledge, this is the first time that a membrane-bound hemoglobin has been identified in eukaryotes. Bioinformatic evaluation suggests that C. maenas hemoglobin is anchored in the membrane by N-myristoylation. Recombinant C. maenas hemoglobin has a hexacoordinate binding scheme at the Fe2+ and an oxygen affinity of P-50 = 0.5 Torr. A rapid autoxidation rate precludes a function as oxygen carrier. We rather speculate that, analogous to prokaryotic membrane-globins, C. maenas hemoglobin carries out enzymatic functions to protect the lipids in cell membrane from reactive oxygen species. Sequence comparisons and phylogenetic studies suggested that the ancestral arthropod hemoglobin was most likely an N-myristoylated protein that did not have an O-2 supply function. True respiratory hemoglobins of arthropods, however, evolved independently in chironomid midges and branchiopod crustaceans.	[Burmester, Thorsten] Univ Hamburg, Inst Zool, Bioctr Grindel, D-20146 Hamburg, Germany; Univ Hamburg, Zool Museum, D-20146 Hamburg, Germany; [Kiger, Laurent; Marden, Michael C.] INSERM, U779, F-94275 Le Kremlin Bicetre, France	University of Hamburg; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Bioctr Grindel, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Götting, Miriam/I-8222-2014; Marden, Michael/AAA-5923-2020; Kiger, Laurent/Q-1686-2018; Marden, Michael C/G-3139-2012; Burmester, Thorsten/I-7225-2013	Götting, Miriam/0000-0001-5336-1422; Marden, Michael C/0000-0002-5254-6385; Burmester, Thorsten/0000-0002-5772-7863	German Research Foundation (Deutsche Forschungsgemeinschaft) [Bu956/9]; INSERM	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work has been supported in part by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft Bu956/9) and INSERM.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERGTROM G, 1977, INSECT BIOCHEM, V7, P313, DOI 10.1016/0020-1790(77)90031-2; Bonamore A, 2003, BIOCHEMISTRY-US, V42, P5792, DOI 10.1021/bi0206311; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 1999, MOL BIOL EVOL, V16, P1809, DOI 10.1093/oxfordjournals.molbev.a026093; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; Burmester T, 2001, MOL BIOL EVOL, V18, P184, DOI 10.1093/oxfordjournals.molbev.a003792; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Burmester T, 2007, INSECT MOL BIOL, V16, P133, DOI 10.1111/j.1365-2583.2006.00706.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Di Giulio A, 2008, METHOD ENZYMOL, V436, P239, DOI 10.1016/S0076-6879(08)36013-3; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; FOX HM, 1957, NATURE, V179, P148, DOI 10.1038/179148a0; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; GOODMAN SH, 1990, CELL TISSUE RES, V260, P495, DOI 10.1007/BF00297229; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; Hankeln T, 2006, J INSECT PHYSIOL, V52, P701, DOI 10.1016/j.jinsphys.2006.03.010; Hardison R, 1998, J EXP BIOL, V201, P1099; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ILAN E, 1979, COMP BIOCHEM PHYS B, V63, P303, DOI 10.1016/0305-0491(79)90253-0; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Liu C, 2004, BIOCHEM BIOPH RES CO, V316, P1163, DOI 10.1016/j.bbrc.2004.02.170; MANGUM CP, 1983, BIOL CRUSTACEA, V5, P373; Marden MC, 2007, GENE, V398, P35, DOI 10.1016/j.gene.2007.01.036; MARKL J, 1979, J COMP PHYSIOL, V133, P167, DOI 10.1007/BF00691462; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; MARKL J, 1986, BIOL BULL, V171, P90, DOI 10.2307/1541909; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; OSMULSKI PA, 1986, COMP BIOCHEM PHYS B, V85, P701, DOI 10.1016/0305-0491(86)90166-5; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rinaldi AC, 2006, BIOCHEMISTRY-US, V45, P4069, DOI 10.1021/bi052277n; Sowa AW, 1998, P NATL ACAD SCI USA, V95, P10317, DOI 10.1073/pnas.95.17.10317; Terwilliger N. B., 2008, PROTEIN REV DIOXYGEN, P203; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; TERWILLIGER NB, 1991, STRUCTURE AND FUNCTION OF INVERTEBRATE OXYGEN CARRIERS, P59; Terwilliger NB, 1998, J EXP BIOL, V201, P1085; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	59	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3185	3193		10.1074/jbc.M110.160341	http://dx.doi.org/10.1074/jbc.M110.160341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118803	hybrid, Green Published			2022-12-27	WOS:000286653200002
J	Fletcher, CM; Coyne, MJ; Comstock, LE				Fletcher, C. Mark; Coyne, Michael J.; Comstock, Laurie E.			Theoretical and Experimental Characterization of the Scope of Protein O-Glycosylation in Bacteroides fragilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; TOPOLOGY; PREDICTION; SURFACE; STARCH; BLAST	Among bacterial species demonstrated to have protein O-glycosylation systems, that of Bacteroides fragilis and related species is unique in that extracytoplasmic proteins are glycosylated at serine or threonine residues within the specific three-amino acid motif D(S/T)(A/I/L/M/T/V). This feature allows for computational analysis of the proteome to identify candidate glycoproteins. With the criteria of a signal peptidase I or II cleavage site or a predicted transmembrane-spanning region and the presence of at least one glycosylation motif, we identified 1021 candidate glycoproteins of B. fragilis. In addition to the eight glycoproteins identified previously, we confirmed that another 12 candidate glycoproteins are in fact glycosylated. These included four glycoproteins that are predicted to localize to the inner membrane, a compartment not previously shown to include glycosylated proteins. In addition, we show that four proteins involved in cell division and chromosomal segregation, two of which are encoded by candidate essential genes, are glycosylated. To date, we have not identified any extracytoplasmic proteins containing a glycosylation motif that are not glycosylated. Therefore, based on the list of 1021 candidate glycoproteins, it is likely that hundreds of proteins, comprising more than half of the extracytoplasmic proteins of B. fragilis, are glycosylated. Site-directed mutagenesis of several glycoproteins demonstrated that all are glycosylated at the identified glycosylation motif. By engineering glycosylation motifs into a naturally unglycosylated protein, we are able to bring about site-specific glycosylation at the engineered sites, suggesting that this glycosylation system may have applications for glycoengineering.	[Fletcher, C. Mark; Coyne, Michael J.; Comstock, Laurie E.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			National Institutes of Health [AI067711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067711.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BOWLER LD, 1989, MOL MICROBIOL, V3, P1277, DOI 10.1111/j.1365-2958.1989.tb00278.x; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espitia C, 2010, MOL BIOSYST, V6, P775, DOI 10.1039/b916394h; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; GILL DR, 1987, MOL GEN GENET, V210, P504, DOI 10.1007/BF00327204; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gromiha MM, 2004, J COMPUT CHEM, V25, P762, DOI 10.1002/jcc.10386; HUG I, 2010, GLYCOBIOLOGY    0924, DOI DOI 10.1093/GLYC0B/CWQ148; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Jervis AJ, 2010, J BACTERIOL, V192, P5228, DOI 10.1128/JB.00211-10; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Martelli Pier Luigi, 2002, Bioinformatics, V18 Suppl 1, pS46; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	35	38	40	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3219	3226		10.1074/jbc.M110.194506	http://dx.doi.org/10.1074/jbc.M110.194506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115495	Green Published, hybrid			2022-12-27	WOS:000286653200006
J	Gangalum, RK; Atanasov, IC; Zhou, ZH; Bhat, SP				Gangalum, Rajendra K.; Atanasov, Ivo C.; Zhou, Z. Hong; Bhat, Suraj P.			alpha B-Crystallin Is Found in Detergent-resistant Membrane Microdomains and Is Secreted via Exosomes from Human Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; MACULAR DEGENERATION; MULTIPLE-SCLEROSIS; LIPID RAFTS; EXPRESSION; LENS; DRUSEN; MATURATION; PATHOLOGY; BIOMARKER	alpha B-crystallin (alpha B) is known as an intracellular Golgi membrane- associated small heat shock protein. Elevated levels of this protein have been linked with a myriad of neurodegenerative pathologies including Alzheimer disease, multiple sclerosis, and age-related macular degeneration. The membrane association of alpha B has been known for more than 3 decades, yet its physiological import has remained unexplained. In this investigation we show that alpha B is secreted from human adult retinal pigment epithelial cells via microvesicles (exosomes), independent of the endoplasmic reticulum-Golgi protein export pathway. The presence of alpha B in these lipoprotein structures was confirmed by its susceptibility to digestion by proteinase K only when exosomes were exposed to Triton X-100. Transmission electron microscopy was used to localize alpha B in immuno-gold- labeled intact and permeabilized microvesicles. The saucer- shaped exosomes, with a median diameter of 100-200 nm, were characterized by the presence of flotillin-1, alpha-enolase, and Hsp70, the same proteins that associate with detergent-resistant membrane microdomains (DRMs), which are known to be involved in their biogenesis. Notably, using polarized adult retinal pigment epithelial cells, we show that the secretion of alpha B is predominantly apical. Using OptiPrep gradients we demonstrate that alpha B resides in the DRM fraction. The secretion of alpha B is inhibited by the cholesterol-depleting drug, methyl beta-cyclodextrin, suggesting that the physiological function of this protein and the regulation of its export through exosomes may reside in its association with DRMs/lipid rafts.	[Bhat, Suraj P.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Gangalum, Rajendra K.; Bhat, Suraj P.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Atanasov, Ivo C.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, 100 Stein Plaza,Rm BH 623, Los Angeles, CA 90095 USA.	Bhat@jsei.ucla.edu	Zhou, Z Hong/HDN-0747-2022; Gangalum, Rajendra K/H-1369-2013	Gangalum, Rajendra K/0000-0002-8746-0266; Bhat, Suraj P/0000-0003-4707-5870	National Institutes of Health through NEI; National Institutes of Health [1S10RR23057]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER	National Institutes of Health through NEI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health grants, through the NEI (to S. P. B.). This work was also supported by National Institutes of Health Grant 1S10RR23057 (to the Electron Imaging Center for Nanomachines and Z. H. Z.). A preliminary account was presented at the Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL, May 3-7, 2009 (Bhat, S. P., Gangalum, R. K., and Jing, Z. (2009) Invest. Ophthalmol. Vis. Sci. 50, E-Abstr. 4183).	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Barbash O, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-2; Bhat SP, 2003, PROG DRUG RES, V60, P205; Bhat SP, 1999, EUR J CELL BIOL, V78, P143, DOI 10.1016/S0171-9335(99)80016-8; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; CHIESA R, 1989, CURR EYE RES, V8, P151, DOI 10.3109/02713688908995186; Chou YK, 2004, J NEUROSCI RES, V75, P516, DOI 10.1002/jnr.20000; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; Holcakova J, 2008, INT J BIOL MARKER, V23, P48, DOI 10.1177/172460080802300108; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; HU JG, 1994, INVEST OPHTH VIS SCI, V35, P3582; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KIBBELAAR MA, 1979, EXP EYE RES, V29, P679, DOI 10.1016/0014-4835(79)90024-1; Kozawa O, 2001, CELL STRESS CHAPERON, V6, P21, DOI 10.1379/1466-1268(2001)006<0021:BCALMW>2.0.CO;2; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; May CA, 2000, CURR EYE RES, V21, P588, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT588; McKechnie NM, 2003, INVEST OPHTH VIS SCI, V44, P2650, DOI 10.1167/iovs.02-0765; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; NISHIKAWA S, 1994, INVEST OPHTH VIS SCI, V35, P4159; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; THERY C, 2006, CURR PROTOC CELL BIO, V3; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; West KA, 2003, MOL CELL PROTEOMICS, V2, P37, DOI 10.1074/mcp.D200001-MCP200; Yaung J, 2007, MOL VIS, V13, P566	50	82	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3261	3269		10.1074/jbc.M110.160135	http://dx.doi.org/10.1074/jbc.M110.160135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097504	Green Published, hybrid			2022-12-27	WOS:000286653200011
J	Godinic-Mikulcic, V; Jaric, J; Hausmann, CD; Ibba, M; Weygand-Durasevic, I				Godinic-Mikulcic, Vlatka; Jaric, Jelena; Hausmann, Corinne D.; Ibba, Michael; Weygand-Durasevic, Ivana			An Archaeal tRNA-Synthetase Complex that Enhances Aminoacylation under Extreme Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGINYL-TRANSFER-RNA; PROTEIN-PROTEIN INTERACTIONS; THERMOAUTOTROPHICUM DELTA-H; METHIONYL-TRANSFER-RNA; MACROMOLECULAR ASSEMBLAGE; MULTIENZYME COMPLEX; YBAK PROTEIN; RAT-LIVER; IN-VITRO; COMPONENT	Aminoacyl-tRNA synthetases (aaRSs) play an integral role in protein synthesis, functioning to attach the correct amino acid with its cognate tRNA molecule. AaRSs are known to associate into higher-order multi-aminoacyl-tRNA synthetase complexes (MSC) involved in archaeal and eukaryotic translation, although the precise biological role remains largely unknown. To gain further insights into archaeal MSCs, possible protein-protein interactions with the atypical Methanothermobacter thermautotrophicus seryl-tRNA synthetase (MtSerRS) were investigated. Yeast two-hybrid analysis revealed arginyl-tRNA synthetase (MtArgRS) as an interacting partner of MtSerRS. Surface plasmon resonance confirmed stable complex formation, with a dissociation constant (K-D) of 250 nM. Formation of the MtSerRS.MtArgRS complex was further supported by the ability of GST-MtArgRS to co-purify MtSerRS and by coelution of the two enzymes during gel filtration chromatography. The MtSerRS.MtArgRS complex also contained tRNA(Arg), consistent with the existence of a stable ribonucleoprotein complex active in aminoacylation. Steady-state kinetic analyses revealed that addition of MtArgRS to MtSerRS led to an almost 4-fold increase in the catalytic efficiency of serine attachment to tRNA, but had no effect on the activity of MtArgRS. Further, the most pronounced improvements in the aminoacylation activity of MtSerRS induced by MtArgRS were observed under conditions of elevated temperature and osmolarity. These data indicate that formation of a complex between MtSerRS and MtArgRS provides a means by which methanogenic archaea can optimize an early step in translation under a wide range of extreme environmental conditions.	[Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Hausmann, Corinne D.; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Zagreb; University System of Ohio; Ohio State University	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	weygand@chem.pmf.hr		Godinic Mikulcic, Vlatka/0000-0003-0319-8035	National Institutes of Health [GM65183]; Ministry of Science, Education and Sports of the Republic of Croatia [119-0982913-1358]; Unity through Knowledge Fund (UKF) [10/07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Unity through Knowledge Fund (UKF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM65183), from the Ministry of Science, Education and Sports of the Republic of Croatia (Project 119-0982913-1358), and the Unity through Knowledge Fund (UKF, Project 10/07).	An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; BEC G, 1994, J BIOL CHEM, V269, P2086; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Bilokapic S, 2009, CROAT CHEM ACTA, V82, P493; Bilokapic S, 2009, J BIOL CHEM, V284, P10706, DOI 10.1074/jbc.M808501200; BREVET A, 1982, EUR J BIOCHEM, V124, P483; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; CIRAKOGLU B, 1985, BIOCHIM BIOPHYS ACTA, V829, P173, DOI 10.1016/0167-4838(85)90186-4; CIULLA R, 1994, J BACTERIOL, V176, P3177, DOI 10.1128/jb.176.11.3177-3187.1994; Deinert K, 2001, J BIOL CHEM, V276, P6000, DOI 10.1074/jbc.M008682200; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Frechin M, 2010, FEBS LETT, V584, P427, DOI 10.1016/j.febslet.2009.11.037; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; GOLDGUR Y, 1994, BIOCHEM MOL BIOL INT, V32, P1075; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lipman RSA, 2003, BIOCHEMISTRY-US, V42, P7487, DOI 10.1021/bi0344533; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mocibob M, 2008, ARCH BIOCHEM BIOPHYS, V470, P129, DOI 10.1016/j.abb.2007.11.014; Morales AJ, 1999, EMBO J, V18, P3475, DOI 10.1093/emboj/18.12.3475; Nomanbhoy T, 2001, NAT STRUCT BIOL, V8, P344, DOI 10.1038/86228; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Praetorius-Ibba M, 2005, J BIOL CHEM, V280, P26099, DOI 10.1074/jbc.M503539200; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rocak S, 2002, FEMS MICROBIOL LETT, V214, P101, DOI 10.1111/j.1574-6968.2002.tb11331.x; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; VENEMA RC, 1991, J BIOL CHEM, V266, P5298; Whelihan EF, 1997, EMBO J, V16, P2968, DOI 10.1093/emboj/16.10.2968; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Yuan J, 2010, FEBS LETT, V584, P2857, DOI 10.1016/j.febslet.2010.05.028; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	58	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3396	3404		10.1074/jbc.M110.168526	http://dx.doi.org/10.1074/jbc.M110.168526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098026	Green Published, hybrid			2022-12-27	WOS:000286653200026
J	Jenkins, RW; Idkowiak-Baldys, J; Simbari, F; Canals, D; Roddy, P; Riner, CD; Clarke, CJ; Hannun, YA				Jenkins, Russell W.; Idkowiak-Baldys, Jolanta; Simbari, Fabio; Canals, Daniel; Roddy, Patrick; Riner, Clarke D.; Clarke, Christopher J.; Hannun, Yusuf A.			A Novel Mechanism of Lysosomal Acid Sphingomyelinase Maturation REQUIREMENT FOR CARBOXYL-TERMINAL PROTEOLYTIC PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRICYCLIC ANTIDEPRESSANT DESIPRAMINE; DELTA-MEDIATED PHOSPHORYLATION; HUMAN-PLACENTA; LIVING CELLS; CATHEPSIN-D; PURIFICATION; HOMOGENEITY; FIBROBLASTS; ACTIVATION	Acid sphingomyelinase (aSMase) catalyzes the hydrolysis of sphingomyelin (SM) to form the bioactive lipid ceramide (Cer). Notably, aSMase exists in two forms: a zinc (Zn2+)-independent lysosomal aSMase (L-SMase) and a Zn2+-dependent secreted aSMase (S-SMase) that arise from alternative trafficking of a single protein precursor. Despite extensive investigation into the maturation and trafficking of aSMase, the exact identity of mature L-SMase has remained unclear. Here, we describe a novel mechanism of aSMase maturation involving C-terminal proteolytic processing within, or in close proximity to, endolysosomes. Using two different C-terminal-tagged constructs of aSMase (V5, DsRed), we demonstrate that aSMase is processed from a 75-kDa, Zn2+-activated proenzyme to a mature 65 kDa, Zn2+-independent L-SMase. L-SMase is recognized by a polyclonal Ab to aSMase, but not by anti-V5 or anti-DsRed antibodies, suggesting that the C-terminal tag is lost during maturation. Furthermore, indirect immunofluorescence staining demonstrated that mature L-SMase colocalized with the lysosomal marker LAMP1, whereas V5-aSMase localized to the Golgi secretory pathway. Moreover, V5-aSMase possessed Zn2+-dependent activity suggesting it may represent the common protein precursor of S-SMase and L-SMase. Importantly, the 65-kDa L-SMase, but not V5-aSMase, was sensitive to the lysosomotropic inhibitor desipramine, co-fractionated with lysosomes, and migrated at the same M-r as partially purified human aSMase. Finally, three aSMase mutants containing C-terminal Niemann-Pick mutations (R600H, R600P, Delta R608) exhibited defective proteolytic maturation. Taken together, these results demonstrate that mature L-SMase arises from C-terminal proteo-lytic processing of pro-aSMase and suggest that impaired C-terminal proteolysis may lead to severe defects in L-SMase function.	[Jenkins, Russell W.; Idkowiak-Baldys, Jolanta; Canals, Daniel; Roddy, Patrick; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Simbari, Fabio] Inst Adv Chem Catalonia CSIC, Dept Biomed Chem, Barcelona, Spain; [Riner, Clarke D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	Medical University of South Carolina; Consejo Superior de Investigaciones Cientificas (CSIC); University of Tennessee System; University of Tennessee Knoxville	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509C, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123	NCI, National Institutes of Health [P01 CA097132, GM08716]; American Heart Association [AHA 081509E]; Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Administrative Supplements Providing Summer Research Experiences for Students and Science Educators [HL043707-19S1]; National Institutes of Health NCI Medical University of South Carolina-Cancer Center [1P30 CA138313-01]; NATIONAL CANCER INSTITUTE [P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Administrative Supplements Providing Summer Research Experiences for Students and Science Educators; National Institutes of Health NCI Medical University of South Carolina-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA097132 from the NCI (to Y. A. H.), National Institutes of Health MSTP Training Grant GM08716 (to R. W. J.), American Heart Association Pre-doctoral Fellowship AHA 081509E (to R. W. J.), a Medical University of South Carolina Hollings Cancer Center Abney Foundation scholarship (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.), and Administrative Supplements Providing Summer Research Experiences for Students and Science Educators Grant HL043707-19S1 (to C. D. R.). The confocal core is supported in part by National Institutes of Health NCI Medical University of South Carolina-Cancer Center Support Grant 1P30 CA138313-01.	ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; ERICKSON AH, 1983, BIOCHEMISTRY-US, V22, P5201, DOI 10.1021/bi00291a021; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; He XX, 1999, BBA-PROTEIN STRUCT M, V1432, P251, DOI 10.1016/S0167-4838(99)00069-2; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; JONES CS, 1981, BIOCHEM J, V195, P373, DOI 10.1042/bj1950373; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; KURTH J, 1991, BIOL CHEM H-S, V372, P215, DOI 10.1515/bchm3.1991.372.1.215; Lansmann S, 1996, FEBS LETT, V399, P227, DOI 10.1016/S0014-5793(96)01331-2; Lansmann S, 2003, EUR J BIOCHEM, V270, P1076, DOI 10.1046/j.1432-1033.2003.03435.x; Lee CL, 2007, JPN J APPL PHYS 2, V46, pL457, DOI 10.1143/JJAP.46.L457; Lee CY, 2006, J LIPID RES, V47, P622, DOI 10.1194/jlr.M500487-JLR200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Pittis M G, 2004, Hum Mutat, V24, P186, DOI 10.1002/humu.9263; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; QUINTERN LE, 1991, METHOD ENZYMOL, V197, P536; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; QUINTERN LE, 1989, BIOCHIM BIOPHYS ACTA, V1003, P121, DOI 10.1016/0005-2760(89)90244-0; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; ROUSSON R, 1993, J IMMUNOL METHODS, V160, P199, DOI 10.1016/0022-1759(93)90178-A; SAKURAGAWA N, 1982, J BIOCHEM, V92, P637, DOI 10.1093/oxfordjournals.jbchem.a133974; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Takahashi I, 2005, TOHOKU J EXP MED, V206, P333, DOI 10.1620/tjem.206.333; Toomre D, 1999, J CELL SCI, V112, P21; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; YAMANAKA T, 1982, J NEUROCHEM, V38, P1753, DOI 10.1111/j.1471-4159.1982.tb06659.x; YONEZAWA S, 1988, J BIOL CHEM, V263, P16504; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; ZOU L, 1989, BIOTECHNOL APPL BIOC, V11, P217	43	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3777	3788		10.1074/jbc.M110.155234	http://dx.doi.org/10.1074/jbc.M110.155234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098024	hybrid, Green Published			2022-12-27	WOS:000286653200059
J	Soohoo, CY; Shi, R; Lee, TH; Huang, PY; Lu, KP; Zhou, XZ				Soohoo, Christina Y.; Shi, Rong; Lee, Tae Ho; Huang, Pengyu; Lu, Kun Ping; Zhou, Xiao Zhen			Telomerase Inhibitor PinX1 Provides a Link between TRF1 and Telomerase to Prevent Telomere Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN-CELLS; DNA-DAMAGE RESPONSE; CATALYTIC SUBUNIT; BINDING-PROTEIN; FISSION YEAST; LIFE-SPAN; HEPATOCELLULAR-CARCINOMA; CELLULAR SENESCENCE; HUMAN-CHROMOSOMES; HUMAN FIBROBLASTS	Telomere maintenance is essential for protecting chromosome ends. Aberrations in telomere length have been implicated in cancer and aging. Telomere elongation by human telomerase is inhibited in cis by the telomeric protein TRF1 and its associated proteins. However, the link between TRF1 and inhibition of telomerase elongation of telomeres remains elusive because TRF1 has no direct effect on telomerase activity. We have previously identified one Pin2/TRF1-interacting protein, PinX1, that has the unique property of directly binding and inhibiting telomerase catalytic activity (Zhou, X. Z., and Lu, K. P. (2001) Cell 107, 347-359). However, nothing is known about the role of the PinX1-TRF1 interaction in the regulation of telomere maintenance. By identifying functional domains and key amino acid residues in PinX1 and TRF1 responsible for the PinX1-TRF1 interaction, we show that the TRF homology domain of TRF1 interacts with a minimal 20-amino acid sequence of PinX1 via hydrophilic and hydrophobic interactions. Significantly, either disrupting this interaction by mutating the critical Leu-291 residue in PinX1 or knocking down endogenous TRF1 by RNAi abolishes the ability of PinX1 to localize to telomeres and to inhibit telomere elongation in cells even though neither has any effect on telomerase activity per se. Thus, the telomerase inhibitor PinX1 is recruited to telomeres by TRF1 and provides a critical link between TRF1 and telomerase inhibition to prevent telomere elongation and help maintain telomere homeostasis.	[Zhou, Xiao Zhen] Harvard Univ, Sch Med, Div Hematol Oncol,Beth Israel Deaconess Med Ctr, Canc Biol Program,Ctr Life Sci, Boston, MA 02115 USA; [Shi, Rong] So Med Univ, Inst Genet Engn, Guangzhou 510515, Guangdong, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Southern Medical University - China	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol,Beth Israel Deaconess Med Ctr, Canc Biol Program,Ctr Life Sci, Rm 0413, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu	Lee, Tae Ho/AAT-1721-2020		National Institutes of Health [R01CA122434]; NATIONAL CANCER INSTITUTE [R01CA122434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA122434 ( to X. Z. Z.).	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Banik SSR, 2004, J BIOL CHEM, V279, P51745, DOI 10.1074/jbc.M408131200; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Farazi PA, 2003, CANCER RES, V63, P5021; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guo CH, 2001, J UROLOGY, V166, P694, DOI 10.1016/S0022-5347(05)66045-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2002, J BIOL CHEM, V277, P7420, DOI 10.1074/jbc.M111365200; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Liao C, 2002, WORLD J GASTROENTERO, V8, P1050, DOI 10.3748/wjg.v8.i6.1050; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Oh BK, 2007, GENE, V400, P35, DOI 10.1016/j.gene.2007.05.015; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Qi L, 2003, CANCER RES, V63, P8188; Reaper PM, 2004, CELL CYCLE, V3, P543; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	106	32	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3894	3906		10.1074/jbc.M110.180174	http://dx.doi.org/10.1074/jbc.M110.180174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21119197	Green Published, hybrid			2022-12-27	WOS:000286653200070
J	Stalder, D; Barelli, H; Gautier, R; Macia, E; Jackson, CL; Antonny, B				Stalder, Daniele; Barelli, Helene; Gautier, Romain; Macia, Eric; Jackson, Catherine L.; Antonny, Bruno			Kinetic Studies of the Arf Activator Arno on Model Membranes in the Presence of Arf Effectors Suggest Control by a Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; PLECKSTRIN-HOMOLOGY DOMAINS; ADP-RIBOSYLATION FACTOR-1; COILED-COIL DOMAIN; SMALL G-PROTEINS; STRUCTURAL BASIS; PH DOMAIN; FAMILY; BINDING; SEC7	Proteins of the cytohesin/Arno/Grp1 family of Arf activators are positive regulators of the insulin-signaling pathway and control various remodeling events at the plasma membrane. Arno has a catalytic Sec7 domain, which promotes GDP to GTP exchange on Arf, followed by a pleckstrin homology (PH) domain. Previous studies have revealed two functions of the PH domain: inhibition of the Sec7 domain and membrane targeting. Interestingly, the Arno PH domain interacts not only with a phosphoinositide (phosphatidylinositol 4,5-bisphosphate or phosphatidylinositol 3,4,5-trisphosphate) but also with an activating Arf family member, such as Arf6 or Arl4. Using the full-length membrane-bound forms of Arf1 and Arf6 instead of soluble forms, we show here that the membrane environment dramatically affects the mechanism of Arno activation. First, Arf6-GTP stimulates Arno at nanomolar concentrations on liposomes compared with micromolar concentrations in solution. Second, mutations in the PH domain that abolish interaction with Arf6-GTP render Arno completely inactive when exchange reactions are reconstituted on liposomes but have no effect on Arno activity in solution. Third, Arno is activated by its own product Arf1-GTP in addition to a distinct activating Arf isoform. Consequently, Arno activity is strongly modulated by competition with Arf effectors. These results show that Arno behaves as a bistable switch, having an absolute requirement for activation by an Arf protein but, once triggered, becoming highly active through the positive feedback effect of Arf1-GTP. This property of Arno might provide an explanation for its function in signaling pathways that, once triggered, must move forward decisively.	[Stalder, Daniele; Barelli, Helene; Gautier, Romain; Macia, Eric; Antonny, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, F-06560 Valbonne, France; [Jackson, Catherine L.] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Macia, Eric/AAW-2964-2021; Jackson, Catherine/T-5688-2019; Jackson, Catherine/A-3421-2013; Antonny, Bruno/ABH-7434-2020	Jackson, Catherine/0000-0002-0843-145X; Antonny, Bruno/0000-0002-9166-8668; BARELLI, Helene/0000-0001-6376-863X; GAUTIER, Romain/0000-0001-6678-132X; macia, eric/0000-0003-3686-2000	Agence Nationale de la Recherche [ANR-08-BLAN-0060-01]; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by Agence Nationale de la Recherche Grant ANR-08-BLAN-0060-01.; Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	ALBERTY RA, 1953, J AM CHEM SOC, V75, P1928, DOI 10.1021/ja01104a045; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; El Annan J, 2004, AM J PHYSIOL-CELL PH, V286, pC768, DOI 10.1152/ajpcell.00250.2003; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Moss J, 2002, ARCH BIOCHEM BIOPHYS, V397, P156, DOI 10.1006/abbi.2001.2661; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217	58	57	57	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3873	3883		10.1074/jbc.M110.145532	http://dx.doi.org/10.1074/jbc.M110.145532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118813	Green Published, hybrid			2022-12-27	WOS:000286653200068
J	Yasmin, S; Andrews, SC; Moore, GR; Le Brun, NE				Yasmin, Samina; Andrews, Simon C.; Moore, Geoffrey R.; Le Brun, Nick E.			A New Role for Heme, Facilitating Release of Iron from the Bacterioferritin Iron Biomineral	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; HORSE SPLEEN FERRITIN; PSEUDOMONAS-AERUGINOSA; MAMMALIAN FERRITIN; AZOTOBACTER-VINELANDII; BACTERIAL FERRITIN; REDUCTION; FERROZINE; MOBILIZATION; BINDING	Bacterioferritin (BFR) from Escherichia coli is a member of the ferritin family of iron storage proteins and has the capacity to store very large amounts of iron as an Fe3+ mineral inside its central cavity. The ability of organisms to tap into their cellular stores in times of iron deprivation requires that iron must be released from ferritin mineral stores. Currently, relatively little is known about the mechanisms by which this occurs, particularly in prokaryotic ferritins. Here we show that the bis-Met-coordinated heme groups of E. coli BFR, which are not found in other members of the ferritin family, play an important role in iron release from the BFR iron biomineral: kinetic iron release experiments revealed that the transfer of electrons into the internal cavity is the rate-limiting step of the release reaction and that the rate and extent of iron release were significantly increased in the presence of heme. Despite previous reports that a high affinity Fe2+ chelator is required for iron release, we show that a large proportion of BFR core iron is released in the absence of such a chelator and further that chelators are not passive participants in iron release reactions. Finally, we show that the catalytic ferroxidase center, which is central to the mechanism of mineralization, is not involved in iron release; thus, core mineralization and release processes utilize distinct pathways.	Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Andrews, Simon C.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	University of East Anglia; University of Reading		n.le-brun@uea.ac.uk	Andrews, Simon C/H-4758-2019	Andrews, Simon C/0000-0003-4295-2686; Le Brun, Nick/0000-0001-9780-4061	United Kingdom Biotechnology and Biological Sciences Research Council [BB/D001943/1, BB/D002435/1]; Wellcome Trust; BBSRC [BB/D001943/1, BB/D002435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D002435/1, BB/D001943/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the United Kingdom Biotechnology and Biological Sciences Research Council Grants BB/D001943/1 (to N. E. L. B. and G. R. M.) and BB/D002435/1 (to S. C. A.) and a JIF grant from the Wellcome Trust.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Baaghil S, 2002, J CHEM SOC DALTON, P811, DOI 10.1039/b107288a; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; BOYER RF, 1988, J INORG BIOCHEM, V32, P171, DOI 10.1016/0162-0134(88)80025-4; Chasteen ND, 1998, MET IONS BIOL SYST, V35, P479; CHASTEEN ND, 1991, ANAL BIOCHEM, V195, P296, DOI 10.1016/0003-2697(91)90333-O; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; CHEESMAN MR, 1993, BIOCHEM J, V292, P47, DOI 10.1042/bj2920047; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; DeLano W.L, PYMOL MOL GRAPHICS S; Expert D, 2008, J BIOL CHEM, V283, P36564, DOI 10.1074/jbc.M807749200; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Fu XP, 2010, BIOCHEM J, V427, P313, DOI 10.1042/BJ20100015; FUNK F, 1985, EUR J BIOCHEM, V152, P167, DOI 10.1111/j.1432-1033.1985.tb09177.x; Garg RP, 1996, BIOCHEMISTRY-US, V35, P6297, DOI 10.1021/bi9600862; GIBBS CR, 1976, ANAL CHEM, V48, P1197, DOI 10.1021/ac50002a034; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; JACOBS DL, 1989, BIOCHEMISTRY-US, V28, P1650, DOI 10.1021/bi00430a033; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; KONTOGHIORGHES GJ, 1986, BIOCHEM J, V233, P299, DOI 10.1042/bj2330299; LAULHERE JP, 1993, BIOCHEM J, V290, P693, DOI 10.1042/bj2900693; Laulhere JP, 1996, BIOMETALS, V9, P303, DOI 10.1007/BF00817931; Lawson TL, 2009, BIOCHEMISTRY-US, V48, P9031, DOI 10.1021/bi900869x; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; MOORE GR, 1994, BIOCHEM J, V304, P493, DOI 10.1042/bj3040493; MOORE GR, 1992, J INORG BIOCHEM, V47, P175, DOI 10.1016/0162-0134(92)84063-S; Quail MA, 1996, BIOCHEM BIOPH RES CO, V229, P635, DOI 10.1006/bbrc.1996.1856; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Richards TD, 1996, J INORG BIOCHEM, V61, P1, DOI 10.1016/0162-0134(95)00029-1; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Sillen L, 1964, STABILITY CONSTANTS; SIRIVECH S, 1974, BIOCHEM J, V143, P311, DOI 10.1042/bj1430311; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STIEFEL EI, 1979, NATURE, V279, P81, DOI 10.1038/279081a0; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; THOMPSEN JC, 1984, ANAL CHEM, V56, P755, DOI 10.1021/ac00268a037; WATT GD, 1988, P NATL ACAD SCI USA, V85, P7457, DOI 10.1073/pnas.85.20.7457; WATT GD, 1985, P NATL ACAD SCI USA, V82, P3640, DOI 10.1073/pnas.82.11.3640; WATT GD, 1992, BIOCHEMISTRY-US, V31, P5672, DOI 10.1021/bi00139a035; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yang XK, 1996, BIOPHYS J, V71, P1587, DOI 10.1016/S0006-3495(96)79361-X; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f	57	45	47	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3473	3483		10.1074/jbc.M110.175034	http://dx.doi.org/10.1074/jbc.M110.175034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106523	Green Published, hybrid			2022-12-27	WOS:000286653200033
J	Gomes, C; Smith, SC; Youssef, MN; Zheng, JJ; Hagg, T; Hetman, M				Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal			RNA Polymerase 1-driven Transcription as a Mediator of BDNF-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; I TRANSCRIPTION; CORTICAL-NEURONS; DENDRITIC GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; DRIVEN TRANSCRIPTION; HIPPOCAMPAL-NEURONS; GENE-TRANSCRIPTION; NUCLEAR-FACTOR; TIF-IA	Neurite outgrowth is essential for development of the nervous system. Neurotrophins including BDNF are among extracellular signals that regulate neurite outgrowth. The ERK1/2 pathway contributes to intracellular signaling networks transducing the pro-neuritic effects of BDNF. In the nucleolus, RNA polymerase-1 (Pol1)-mediated transcription regulates ribosomal biogenesis, enabling cellular protein synthesis and growth. Hence, we tested the possibility that Pol1 is an effector for pro-neuritic signals such as BDNF. We report that Pol1-mediated nucleolar transcription was increased by BDNF in an ERK1/2-dependent manner in rat forebrain neurons. Conversely, in cultured hippocampal neurons, knockdown of a Pol1 coactivator, transcription initiation factor 1A (TIF1A), attenuated BDNF- or ERK1/2-induced neurite outgrowth. Also, upon overexpression, a constitutively active mutant of TIF1A strongly promoted neurite outgrowth, including increases in total neurite length and branching. Finally, overexpression of wild-type TIF1A enhanced the pro-neuritic effects of ERK1/2 activation. These observations indicate that the Pol1-mediated nucleolar transcription regulates neurite outgrowth and serves as a major pro-neuritic effector of the BDNF-activated ERK1/2 pathway. Thus, development of the nervous system appears critically dependent on the nucleolus.	[Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Hagg, Theo; Hetman, Michal] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Hetman, M (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR616, Louisville, KY 40292 USA.	michal.hetman@louisville.edu		Smith, Scott/0000-0003-2938-6202	National Institutes of Health [NS047341, RR015576]; National Science Foundation [IOS1021860]; Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare; University of Louisville School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047341] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021860] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare; University of Louisville School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047341 and RR015576 (to M. H.). This work was also supported by National Science Foundation Grant IOS1021860 (to M. H.), the Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare (to M. H. and T. H.), and the University of Louisville School of Medicine Summer Research Student Program (to M. N. Y.).	Bierhoff H, 2008, MOL CELL BIOL, V28, P4988, DOI 10.1128/MCB.00492-08; CLARK P, 1990, J COMP NEUROL, V302, P749, DOI 10.1002/cne.903020407; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hartwig CL, 2008, DEV NEUROBIOL, V68, P1225, DOI 10.1002/dneu.20655; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kinderman NB, 1998, J COMP NEUROL, V401, P205; LAFARGA M, 1985, DEV BRAIN RES, V22, P310, DOI 10.1016/0165-3806(85)90185-3; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Storer PD, 2003, J COMP NEUROL, V458, P326, DOI 10.1002/cne.10623; STOYKOVA AS, 1983, J NEUROCHEM, V41, P942, DOI 10.1111/j.1471-4159.1983.tb09038.x; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Szymanski J, 2009, BBA-MOL CELL RES, V1793, P1191, DOI 10.1016/j.bbamcr.2009.05.004; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	46	45	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4357	4363		10.1074/jbc.M110.170134	http://dx.doi.org/10.1074/jbc.M110.170134			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098478	hybrid, Green Published			2022-12-27	WOS:000286975700035
J	Lagerstedt, JO; Cavigiolio, G; Budamagunta, MS; Pagani, I; Voss, JC; Oda, MN				Lagerstedt, Jens O.; Cavigiolio, Giorgio; Budamagunta, Madhu S.; Pagani, Ioanna; Voss, John C.; Oda, Michael N.			Structure of Apolipoprotein A-I N Terminus on Nascent High Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOA-I; CHOLESTEROL; DOMAIN; CONFORMATION; STABILITY; LECITHIN; PHOSPHATIDYLCHOLINE; FUNCTIONALITY; MORPHOLOGY; EXPRESSION	Apolipoprotein A-I (apoA-I) is the major protein component of high density lipoproteins (HDL) and a critical element of cholesterol metabolism. To better elucidate the role of the apoA-I structure-function in cholesterol metabolism, the conformation of the apoA-I N terminus (residues 6-98) on nascent HDL was examined by electron paramagnetic resonance (EPR) spectroscopic analysis. A series of 93 apoA-I variants bearing single nitroxide spin label at positions 6-98 was reconstituted onto 9.6-nm HDL particles (rHDL). These particles were subjected to EPR spectral analysis, measuring regional flexibility and side chain solvent accessibility. Secondary structure was elucidated from side-chain mobility and molecular accessibility, wherein two major alpha-helical domains were localized to residues 6-34 and 50-98. We identified an unstructured segment (residues 35-39) and a beta-strand (residues 40-49) between the two helices. Residues 14, 19, 34, 37, 41, and 58 were examined by EPR on 7.8, 8.4, and 9.6 nm rHDL to assess the effect of particle size on the N-terminal structure. Residues 14, 19, and 58 showed no significant rHDL size-dependent spectral or accessibility differences, whereas residues 34, 37, and 41 displayed moderate spectral changes along with substantial rHDL size-dependent differences in molecular accessibility. We have elucidated the secondary structure of the N-terminal domain of apoA-I on 9.6 nm rHDL (residues 6-98) and identified residues in this region that are affected by particle size. We conclude that the inter-helical segment (residues 35-49) plays a role in the adaptation of apoA-I to the particle size of HDL.	[Cavigiolio, Giorgio; Pagani, Ioanna; Oda, Michael N.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Lund University; University of California System; University of California Davis	Oda, MN (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	moda@chori.org	Budamagunta, Madhu S/C-4628-2011; Lagerstedt, Jens/AAF-9567-2021; Pagani, Ioanna/E-7390-2012	Cavigiolio, Giorgio/0000-0002-1622-0628; Lagerstedt, Jens/0000-0002-4313-2666; Voss, John/0000-0001-9279-209X	National Institutes of Health [HL77268, HL78615]; Swedish Research Council; Petrus and Augusta Hedlund Foundation; Crafoord Foundation; Carl Trygger Foundation for Scientific Research; American Heart Association Scientist Development [0235222N]; Tobacco-related Disease Research Program of California [8KT-0021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078615, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Petrus and Augusta Hedlund Foundation; Crafoord Foundation; Carl Trygger Foundation for Scientific Research; American Heart Association Scientist Development(American Heart Association); Tobacco-related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77268 and HL78615. This work was also supported by grants from the Swedish Research Council, the Petrus and Augusta Hedlund Foundation, the Crafoord Foundation, the Carl Trygger Foundation for Scientific Research, and American Heart Association Scientist Development Grant 0235222N.; Supported by New Investigator Award 8KT-0021 from the Tobacco-related Disease Research Program of California.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Agree AKB, 2002, BBA-PROTEIN STRUCT M, V1594, P286, DOI 10.1016/S0167-4838(01)00317-X; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Corsico B, 2001, J BIOL CHEM, V276, P16978, DOI 10.1074/jbc.M011533200; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Fang YL, 2003, BIOCHEMISTRY-US, V42, P6881, DOI 10.1021/bi034152t; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; GLOMSET JA, 1968, J LIPID RES, V9, P155; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GOGONEA V, BIOCHEMISTRY, V49, P7323; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Klug CS, 1997, BIOCHEMISTRY-US, V36, P13027, DOI 10.1021/bi971232m; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MILLER GJ, 1975, LANCET, V1, P16; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, pE36; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1987, J LIPID RES, V28, P719; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oh KJ, 2000, METH MOL B, V145, P147; Panagotopulos SE, 2001, J BIOL CHEM, V276, P42965, DOI 10.1074/jbc.M106462200; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Smith LE, 2010, BBA-MOL CELL BIOL L, V1801, P64, DOI 10.1016/j.bbalip.2009.09.012; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SUBBAIAH PV, 1994, BIOCHEMISTRY-US, V33, P13259, DOI 10.1021/bi00249a012; Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52, DOI 10.5551/jat.E571; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537	58	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2966	2975		10.1074/jbc.M110.163097	http://dx.doi.org/10.1074/jbc.M110.163097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21047795	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286464300060
J	Cha, SK; Huang, CF; Ding, YX; Qi, XP; Huang, CL; Miller, RT				Cha, Seung-Kuy; Huang, Chunfa; Ding, Yaxian; Qi, Xiaoping; Huang, Chou-Long; Miller, R. Tyler			Calcium-sensing Receptor Decreases Cell Surface Expression of the Inwardly Rectifying K+ Channel Kir4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; RENAL ION-TRANSPORT; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; BARTTERS-SYNDROME; PLASMA-MEMBRANE; MUTATIONS; REABSORPTION; CAVEOLIN-1; KCNJ10	The Ca2+-sensing receptor (CaR) regulates salt and water transport in the kidney as demonstrated by the association of gain of function CaR mutations with a Bartter syndrome-like, salt-wasting phenotype, but the precise mechanism for this effect is not fully established. We found previously that the CaR interacts with and inactivates an inwardly rectifying K+ channel, Kir4.1, which is expressed in the distal nephron that contributes to the basolateral K+ conductance, and in which loss of function mutations are associated with a complex phenotype that includes renal salt wasting. We now find that CaR inactivates Kir4.1 by reducing its cell surface expression. Mutant CaRs reduced Kir4.1 cell surface expression and current density in HEK-293 cells in proportion to their signaling activity. Mutant, activated G alpha(q) reduced cell surface expression and current density of Kir4.1, and these effects were blocked by RGS4, a protein that blocks signaling via G alpha(i) and G alpha(q). Other alpha subunits had insignificant effects. Knockdown of caveolin-1 blocked the effect of G alpha(q) on Kir4.1, whereas knockdown of the clathrin heavy chain had no effect. CaR had no comparable effect on the renal outer medullary K+ channel, an apical membrane distal nephron K+ channel that is internalized by clathrin-coated vesicles. Co-immunoprecipitation studies showed that the CaR and Kir4.1 physically associate with caveolin-1 in HEK cells and in kidney extracts. Thus, the CaR decreases cell surface expression of Kir4.1 channels via a mechanism that involves G alpha(q) and caveolin. These results provide a novel molecular basis for the inhibition of renal NaCl transport by the CaR.	[Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Div Nephrol, Dept Med, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Miller, R. Tyler] Rammelkamp Ctr Res & Educ, Cleveland, OH 44109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Miller, RT (corresponding author), Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Div Nephrol, Dept Med, 10701 E Blvd 151 W, Cleveland, OH 44106 USA.	rtm4@case.edu			National Institutes of Health [DK-59985, DK-59530]; University of Texas Southwestern O'Brien Center [P30DK079328]; Veterans Affairs Merit Review; Leonard Rosenberg Research Foundation; Rammelkamp Center for Research and Education; Case Western Reserve University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059985, P30DK079328, R01DK059530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Center; Veterans Affairs Merit Review(US Department of Veterans Affairs); Leonard Rosenberg Research Foundation; Rammelkamp Center for Research and Education; Case Western Reserve University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59985 (to R.T.M.), DK-59530 (to C.-L.H.) and University of Texas Southwestern O'Brien Center grant P30DK079328. This was also supported by Veterans Affairs Merit Review grants (to C.H. and R.T.M.), the Leonard Rosenberg Research Foundation, and the Rammelkamp Center for Research and Education, Case Western Reserve University.	Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BONNARDEAUX A, 2000, KIDNEY, P1621; Breton S, 1998, J HISTOCHEM CYTOCHEM, V46, P205, DOI 10.1177/002215549804600209; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Desfleurs E, 1998, KIDNEY BLOOD PRESS R, V21, P401, DOI 10.1159/000025892; Ferreira MCD, 1998, AM J PHYSIOL-RENAL, V275, pF198, DOI 10.1152/ajprenal.1998.275.2.F198; Friedman PA, 1998, ANNU REV PHYSIOL, V60, P179, DOI 10.1146/annurev.physiol.60.1.179; Gamba G, 2009, PFLUG ARCH EUR J PHY, V458, P61, DOI 10.1007/s00424-008-0607-1; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Huang CF, 2007, CURR OPIN NEPHROL HY, V16, P437, DOI 10.1097/MNH.0b013e3282b974a6; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Huang C, 2010, CURR OPIN NEPHROL HY, V19, P106, DOI 10.1097/MNH.0b013e328332e7b2; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Motoyama HI, 2002, AM J PHYSIOL-RENAL, V283, pF399, DOI 10.1152/ajprenal.00346.2001; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ookata K, 2000, J AM SOC NEPHROL, V11, P1987, DOI 10.1681/ASN.V11111987; Pearce SHS, 1998, QJM-MON J ASSOC PHYS, V91, P5, DOI 10.1093/qjmed/91.1.5; PETERSON LN, 1990, AM J PHYSIOL, V259, pF122, DOI 10.1152/ajprenal.1990.259.1.F122; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Simon DB, 1998, CURR OPIN CELL BIOL, V10, P450, DOI 10.1016/S0955-0674(98)80057-4; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2	35	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1828	1835		10.1074/jbc.M110.160390	http://dx.doi.org/10.1074/jbc.M110.160390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084311	hybrid, Green Published			2022-12-27	WOS:000286191500023
J	Kroczynska, B; Joshi, S; Eklund, EA; Verma, A; Kotenko, SV; Fish, EN; Platanias, LC				Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Verma, Amit; Kotenko, Sergei V.; Fish, Eleanor N.; Platanias, Leonidas C.			Regulatory Effects of Ribosomal S6 Kinase 1 (RSK1) in IFN lambda Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; INTERFERON-LAMBDA; MAMMALIAN TARGET; INITIATION-FACTORS; DOCKING SITE; PHOSPHORYLATION; INHIBITOR; PATHWAYS; COMPLEX	Although the mechanisms of generation of signals that control transcriptional activation of Type III IFN (IFN lambda)-regulated genes have been identified, very little is known about the mechanisms by which the IFN lambda receptor generates signals for mRNA translation of IFN lambda-activated genes. We provide evidence that IFN lambda activates the p90 ribosomal protein S6 kinase 1 (RSK1) and its downstream effector, initiation factor eIF4B. Prior to its engagement by the IFN lambda receptor, the non-active form of RSK1 is present in a complex with the translational repressor 4E-BP1 in IFN lambda-sensitive cells. IFN lambda-inducible phosphorylation/activation of RSK1 results in its dissociation from 4E-BP1 at the same time that 4E-BP1 dissociates from eIF4E to allow formation of eIF4F and initiation of cap-dependent translation. Our studies demonstrate that such IFN lambda-dependent engagement of RSK1 is essential for up-regulation of p21(WAF1/CIP1) expression, suggesting a mechanism for generation of growth-inhibitory responses. Altogether, our data provide evidence for a critical role for the activated RSK1 in IFN lambda signaling.	[Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Verma, Amit] Albert Einstein Coll Med, Div Hematol Oncol, Dept Med, Bronx, NY 10461 USA; [Fish, Eleanor N.] Univ Toronto, Div Cell & Mol Biol, Toronto Res Inst, Univ Hlth Network, Toronto, ON M5G 2M1, Canada; [Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Kotenko, Sergei V.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA77816, AG029138, CA121192, HL082946, CA100579]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA100579, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, AG029138, CA121192, HL082946, and CA100579. This work was also supported by a Merit Review Grant from the Department of Veterans Affairs.	Altman JK, 2008, J BIOL CHEM, V283, P1992, DOI 10.1074/jbc.M705227200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hong SH, 2007, VIRUS RES, V126, P245, DOI 10.1016/j.virusres.2007.03.006; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katayama T, 2007, INT J ONCOL, V31, P613; Kaur S, 2008, CELL CYCLE, V7, P2112, DOI 10.4161/cc.7.14.6258; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kotenko SV, 2004, INT IMMUNOPHARMACOL, V4, P593, DOI 10.1016/j.intimp.2004.01.003; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krajcikova D, 2009, J BACTERIOL, V191, P3212, DOI 10.1128/JB.01807-08; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Li W, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155003; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	59	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1147	1156		10.1074/jbc.M110.183566	http://dx.doi.org/10.1074/jbc.M110.183566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075852	Green Published, hybrid			2022-12-27	WOS:000286005000025
J	Ng, DCH; Ng, IHW; Yeap, YYC; Badrian, B; Tsoutsman, T; McMullen, JR; Semsarian, C; Bogoyevitch, MA				Ng, Dominic C. H.; Ng, Ivan H. W.; Yeap, Yvonne Y. C.; Badrian, Bahareh; Tsoutsman, Tatiana; McMullen, Julie R.; Semsarian, Christopher; Bogoyevitch, Marie A.			Opposing Actions of Extracellular Signal-regulated Kinase (ERK) and Signal Transducer and Activator of Transcription 3 (STAT3) in Regulating Microtubule Stabilization during Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE DYSFUNCTION; PRESSURE-OVERLOAD; PROTEIN-KINASES; HEART-FAILURE; MYOCARDIAL-INFARCTION; MYOCYTE MORPHOLOGY; PATHWAY; RAT; INHIBITION; DYNAMICS	Excessive proliferation and stabilization of the microtubule (MT) array in cardiac myocytes can accompany pathological cardiac hypertrophy, but the molecular control of these changes remains poorly characterized. In this study, we examined MT stabilization in two independent murine models of heart failure and revealed increases in the levels of post-translationally modified stable MTs, which were closely associated with STAT3 activation. To explore the molecular signaling events contributing to control of the cardiac MT network, we stimulated cardiac myocytes with an alpha-adrenergic agonist phenylephrine (PE), and observed increased tubulin content without changes in detyrosinated (glutubulin) stable MTs. In contrast, the hypertrophic interleukin-6 (IL6) family cytokines increased both the glu-tubulin content and glu-MT density. When we examined a role for ERK in regulating cardiac MTs, we showed that the MEK/ERK-inhibitor U0126 increased glu-MT density in either control cardiac myocytes or following exposure to hypertrophic agents. Conversely, expression of an activated MEK1 mutant reduced glu-tubulin levels. Thus, ERK signaling antagonizes stabilization of the cardiac MT array. In contrast, inhibiting either JAK2 with AG490, or STAT3 signaling with Stattic or siRNA knockdown, blocked cytokine-stimulated increases in glu-MT density. Furthermore, the expression of a constitutively active STAT3 mutant triggered increased glu-MT density in the absence of hypertrophic stimulation. Thus, STAT3 activation contributes substantially to cytokine-stimulated glu-MT changes. Taken together, our results highlight the opposing actions of STAT3 and ERK pathways in the regulation of MT changes associated with cardiac myocyte hypertrophy.	[Ng, Dominic C. H.; Ng, Ivan H. W.; Yeap, Yvonne Y. C.; Bogoyevitch, Marie A.] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Badrian, Bahareh] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; [Tsoutsman, Tatiana; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW 2042, Australia; [McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Tsoutsman, Tatiana; Semsarian, Christopher] Univ Sydney, Cent Clin Sch, Sydney, NSW 2050, Australia	University of Melbourne; University of Western Australia; University of Sydney; Centenary Institute; Baker Heart and Diabetes Institute; University of Sydney	Ng, DCH (corresponding author), Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Badrian, Bahareh/0000-0001-5895-8498; Bogoyevitch, Marie/0000-0001-9745-3716	NHFA [G06P2517, G09M4435]; NHMRC [353592]	NHFA(National Heart Foundation of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in whole or in part, by NHFA Grants-in-aid (G06P2517, G09M4435; to D.C.H.N.) and NHMRC Project Grants (353592, to C.S. and 353592, to M.A.B.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Belmadani S, 2002, MOL CELL BIOCHEM, V237, P39, DOI 10.1023/A:1016554104209; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fassett JT, 2009, AM J PHYSIOL-HEART C, V297, pH523, DOI 10.1152/ajpheart.00462.2009; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Grounds HR, 2005, J CELL BIOCHEM, V95, P529, DOI 10.1002/jcb.20441; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hilfiker-Kleiner D, 2010, CIRCULATION, V122, P145, DOI 10.1161/CIRCULATIONAHA.109.933127; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Koide M, 2000, CIRCULATION, V102, P1045, DOI 10.1161/01.CIR.102.9.1045; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Mascareno E, 2000, MOL CELL BIOCHEM, V212, P171, DOI 10.1023/A:1007157126806; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Miyamoto T, 2004, BASIC RES CARDIOL, V99, P328, DOI 10.1007/s00395-004-0482-7; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng DCH, 2003, CARDIOVASC RES, V57, P333, DOI 10.1016/S0008-6363(02)00664-8; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; Ng DCH, 2008, CELL MOTIL CYTOSKEL, V65, P40, DOI 10.1002/cm.20242; Rothen-Rutishauser BM, 1998, J MOL CELL CARDIOL, V30, P19, DOI 10.1006/jmcc.1997.0596; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; WATKINS SC, 1987, CIRC RES, V60, P327, DOI 10.1161/01.RES.60.3.327; Webster Daniel R, 2002, Cardiovasc Toxicol, V2, P75, DOI 10.1385/CT:2:2:075; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1989, J CELL SCI, V92, P57; Willey CD, 2008, INT J BIOL SCI, V4, P184; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285	44	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1576	1587		10.1074/jbc.M110.128157	http://dx.doi.org/10.1074/jbc.M110.128157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056972	hybrid, Green Published			2022-12-27	WOS:000286005000070
J	Hochbaum, D; Barila, G; Ribeiro-Neto, F; Altschuler, DL				Hochbaum, Daniel; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			Radixin Assembles cAMP Effectors Epac and PKA into a Functional cAMP Compartment ROLE IN cAMP-DEPENDENT CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE ANCHORING PROTEIN; A TYPE-I; CYCLIC-AMP; RAP1 ACTIVATION; TERMINAL DOMAIN; ERM PROTEINS; EZRIN; DIFFUSION; SITE; RAS	cAMP is an ubiquitous second messenger. Localized areas with high cAMP concentration, i.e. cAMP microdomains, provide an elegant mechanism to generate signaling specificity and transduction efficiency. However, the mechanisms underlying cAMP effector targeting into these compartments is still unclear. Here we report the identification of radixin as a scaffolding unit for both cAMP effectors, Epac and PKA. This complex localizes in a submembrane compartment where cAMP synthesis occurs. Compartment disruption by shRNA and dominant negative approaches negatively affects cAMP action. Inhibition can be rescued by expression of Rap1b, a substrate for both Epac1 and PKA, but only in its GTP-bound and phosphorylated state. We propose that radixin scaffolds both cAMP effectors in a functional cAMP-sensing compartment for efficient signal transduction, using Rap1 as a downstream signal integrator.	[Hochbaum, Daniel; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 200 Lothrop St,W1346 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Hochbaum, Daniel/0000-0001-6387-7529	NCI, National Institutes of Health [CA071649]; NATIONAL CANCER INSTITUTE [R29CA071649, R01CA071649] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service Grant CA071649 from the NCI, National Institutes of Health.	ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Amieva MR, 1999, J CELL SCI, V112, P111; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Borland G, 2006, MOL PHARMACOL, V69, P374, DOI 10.1124/mol.105.016337; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gloerich M, 2010, MOL CELL BIOL, V30, P5421, DOI 10.1128/MCB.00463-10; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Metrich M, 2010, CELL SIGNAL, V22, P1459, DOI 10.1016/j.cellsig.2010.05.014; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	39	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					859	866		10.1074/jbc.M110.163816	http://dx.doi.org/10.1074/jbc.M110.163816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047789	Green Published, hybrid			2022-12-27	WOS:000285782800085
J	Sumandea, CA; Garcia-Cazarin, ML; Bozio, CH; Sievert, GA; Balke, CW; Sumandea, MP				Sumandea, C. Amelia; Garcia-Cazarin, Mary L.; Bozio, Catherine H.; Sievert, Gail A.; Balke, C. William; Sumandea, Marius P.			Cardiac Troponin T, a Sarcomeric AKAP, Tethers Protein Kinase A at the Myofilaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORING PROTEINS; REGULATORY SUBUNIT; SIGNAL-TRANSDUCTION; C PHOSPHORYLATION; MOUSE MYOCARDIUM; THIN-FILAMENTS; IN-VIVO; HEART; BINDING; MYOCYTES	Efficient and specific phosphorylation of PKA substrates, elicited in response to beta-adrenergic stimulation, require spatially confined pools of PKA anchored in proximity of its substrates. PKA-dependent phosphorylation of cardiac sarcomeric proteins has been the subject of intense investigations. Yet, the identity, composition, and function of PKA complexes at the sarcomeres have remained elusive. Here we report the identification and characterization of a novel sarcomeric AKAP (A-kinase anchoring protein), cardiac troponin T (cTnT). Using yeast two-hybrid technology in screening two adult human heart cDNA libraries, we identified the regulatory subunit of PKA as interacting with human cTnT bait. Immunoprecipitation studies show that cTnT is a dual specificity AKAP, interacting with both PKA-regulatory subunits type I and II. The disruptor peptide Ht31, but not Ht31P (control), abolished cTnT/PKA-R association. Truncations and point mutations identified an amphipathic helix domain in cTnT as the PKA binding site. This was confirmed by a peptide SPOT assay in the presence of Ht31 or Ht31P (control). Gelsolin-dependent removal of thin filament proteins also reduced myofilament-bound PKA-type II. Using a cTn exchange procedure that substitutes the endogenous cTn complex with a recombinant cTn complex we show that PKA-type II is troponin-bound in the myofilament lattice. Displacement of PKA-cTnT complexes correlates with a significant decrease in myofibrillar PKA activity. Taken together, our data propose a novel role for cTnT as a dual-specificity sarcomeric AKAP.	[Sumandea, C. Amelia; Garcia-Cazarin, Mary L.; Bozio, Catherine H.; Sievert, Gail A.; Balke, C. William; Sumandea, Marius P.] Univ Kentucky, Dept Physiol, Ctr Muscle Biol, Lexington, KY 40536 USA	University of Kentucky	Sumandea, MP (corresponding author), 426 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.	MariusSumandea@uky.edu			National Institutes of Health [HL071865, HL68733, AG032009]; Ruth L. Kirschstein National Research Service Award [HL82120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068733, R01HL071865, F32HL082120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071865, HL68733, and AG032009 and Ruth L. Kirschstein National Research Service Award HL82120 (to C. A. S.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colson BA, 2007, J MOL BIOL, V367, P36, DOI 10.1016/j.jmb.2006.12.063; DAVID H, 1979, J MOL CELL CARDIOL, V11, P631, DOI 10.1016/0022-2828(79)90377-8; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; DOSTMANN WRG, 1991, BIOCHEMISTRY-US, V30, P8710, DOI 10.1021/bi00099a032; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kawai M, 2006, J MUSCLE RES CELL M, V27, P455, DOI 10.1007/s10974-006-9075-4; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; Solaro RJ, 2009, IDRUGS, V12, P243; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Sumandea MP, 2009, BIOCHEMISTRY-US, V48, P7722, DOI 10.1021/bi900516n; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Trombitas K, 1997, AM J PHYSIOL-CELL PH, V273, pC662, DOI 10.1152/ajpcell.1997.273.2.C662; Trombitas K, 1997, J MUSCLE RES CELL M, V18, P345, DOI 10.1023/A:1018626210300; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	59	38	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					530	541		10.1074/jbc.M110.148684	http://dx.doi.org/10.1074/jbc.M110.148684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056973	Green Published, hybrid			2022-12-27	WOS:000285782800056
J	Wang, C; Kane, MA; Napoli, JL				Wang, Chao; Kane, Maureen A.; Napoli, Joseph L.			Multiple Retinol and Retinal Dehydrogenases Catalyze All-trans-retinoic Acid Biosynthesis in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; RELATIONAL MEMORY DEFICIT; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; VITAMIN-A-DEFICIENCY; HIPPOCAMPAL-NEURONS; BINDING-PROTEIN; ALDEHYDE DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; SYNAPTIC PLASTICITY	All-trans-retinoic acid (atRA) stimulates neurogenesis, dendritic growth of hippocampal neurons, and higher cognitive functions, such as spatial learning and memory formation. Although astrocyte-derived atRA has been considered a key factor in neurogenesis, little direct evidence identifies hippocampus cell types and the enzymes that biosynthesize atRA. Here we show that primary rat astrocytes, but not neurons, biosynthesize atRA using multiple retinol dehydrogenases (Rdh) of the short chain dehydrogenase/reductase gene family and retinaldehyde dehydrogenases (Raldh). Astrocytes secrete atRA into their medium; neurons sequester atRA. The first step, conversion of retinol into retinal, is rate-limiting. Neurons and astrocytes both synthesize retinyl esters and reduce retinal into retinol. siRNA knockdown indicates that Rdh10, Rdh2 (mRdh1), and Raldh1, -2, and -3 contribute to atRA production. Knockdown of the Rdh Dhrs9 increased atRA synthesis similar to 40% by increasing Raldh1 expression. Immunocytochemistry revealed cytosolic and nuclear expression of Raldh1 and cytosol and perinuclear expression of Raldh2. atRA autoregulated its concentrations by inducing retinyl ester synthesis via lecithin: retinol acyltransferase and stimulating its catabolism via inducing Cyp26B1. These data show that adult hippocampus astrocytes rely on multiple Rdh and Raldh to provide a paracrine source of atRA to neurons, and atRA regulates its own biosynthesis in astrocytes by directing flux of retinol. Observation of cross-talk between Dhrs9 and Raldh1 provides a novel mechanism of regulating atRA biosynthesis.	[Wang, Chao; Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu	Wang, Chao/A-4626-2016	Wang, Chao/0000-0003-0357-4096	National Institutes of Health [DK36870]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK36870.	Akita J, 2002, BRAIN RES, V954, P286, DOI 10.1016/S0006-8993(02)03356-5; ALLIOT F, 1988, DEV BRAIN RES, V44, P247, DOI 10.1016/0165-3806(88)90223-4; Asson-Batres MA, 2006, J COMP NEUROL, V496, P149, DOI 10.1002/cne.20904; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Brodeur H, 2003, J LIPID RES, V44, P303, DOI 10.1194/jlr.M200359-JLR200; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Chandrasekaran V, 2000, J NEUROBIOL, V42, P383, DOI 10.1002/(SICI)1097-4695(200003)42:4<383::AID-NEU1>3.0.CO;2-9; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Connor MJ, 1997, MOL CHEM NEUROPATHOL, V30, P239, DOI 10.1007/BF02815101; COOPER DL, 1993, ADV EXP MED BIOL, V328, P169; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; EDWARDS RB, 1992, EXP EYE RES, V54, P481, DOI 10.1016/0014-4835(92)90126-D; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Grun F, 2000, J BIOL CHEM, V275, P41210, DOI 10.1074/jbc.M007376200; Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; KLANN RC, 1982, CELL TISSUE KINET, V15, P473, DOI 10.1111/j.1365-2184.1982.tb01570.x; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; LABRECQUE J, 1993, BIOCHEM CELL BIOL, V71, P85, DOI 10.1139/o93-013; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Levison S. W., 2005, DEV NEUROBIOLOGY; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; McCaffery P, 2004, DEV BRAIN RES, V153, P233, DOI 10.1016/j.devbrainres.2004.09.003; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Napoli J. L., 2011, ENCY BIOL CHEM; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; ONG DE, 1988, J BIOL CHEM, V263, P5789; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Rexer BN, 2002, BIOL REPROD, V67, P1555, DOI 10.1095/biolreprod.102.007021; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rodnight R, 1997, BRAZ J MED BIOL RES, V30, P325, DOI 10.1590/S0100-879X1997000300005; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Ross AC, 2003, J NUTR, V133, p271S, DOI 10.1093/jn/133.1.271S; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shearer KD, 2010, J NEUROCHEM, V112, P246, DOI 10.1111/j.1471-4159.2009.06455.x; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soref CM, 2001, J BIOL CHEM, V276, P24194, DOI 10.1074/jbc.M100332200; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Toresson H, 1999, DEVELOPMENT, V126, P1317; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	72	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6542	6553		10.1074/jbc.M110.198382	http://dx.doi.org/10.1074/jbc.M110.198382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138835	hybrid, Green Published			2022-12-27	WOS:000287476400064
J	Sengle, G; Ono, RN; Sasaki, T; Sakai, LY				Sengle, Gerhard; Ono, Robert N.; Sasaki, Takako; Sakai, Lynn Y.			Prodomains of Transforming Growth Factor beta (TGF beta) Superfamily Members Specify Different Functions EXTRACELLULAR MATRIX INTERACTIONS AND GROWTH FACTOR BIOAVAILABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; PERLECAN; FIBRILLIN-1; DOMAIN; ACTIVATION; EXPRESSION; RECEPTORS; FIBULIN-2; MYOSTATIN; MEMBRANE	The specific functions of the prodomains of TGF beta superfamily members are largely unknown. Interactions are known between prodomains of TGF beta-1-3 and latent TGF beta-binding proteins and between prodomains of BMP-2, -4, -7, and -10 and GDF-5 and fibrillins, raising the possibility that latent TGF beta-binding proteins and fibrillins may mediate interactions with all other prodomains of this superfamily. This possibility is tested in this study. Results show that the prodomain of BMP-5 interacts with the N-terminal regions of fibrillin-1 and -2 in a site similar to the binding sites for other bone morphogenetic proteins. However, in contrast, the prodomain of GDF-8 (myostatin) interacts with the glycosaminoglycan side chains of perlecan. The binding site for the GDF-8 prodomain is likely the heparan sulfate chain present on perlecan domain V. These results support and extend the emerging concept that TGF beta superfamily prodomains target their growth factor dimers to extracellular matrix macromolecules. In addition, biochemical studies of prodomain.growth factor complexes were performed to identify inactive complexes. For some members of the superfamily, the prodomain is noncovalently associated with its growth factor dimer in an inactive complex; for others, the prodomain.growth factor complex is active, even though the prodomain is noncovalently associated with its growth factor dimer. Results show that the BMP-10 prodomain, in contrast to BMP-4, -5, and -7 prodomains, can inhibit the bioactivity of the BMP-10 growth factor and suggest that the BMP-10 complex is like TGF beta and GDF-8 complexes, which can be activated by cleavage of the associated prodomain.	[Sengle, Gerhard; Ono, Robert N.; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AR049698 (to L. Y. S.). This work was also supported by Shriners Hospitals for Children (to L. Y. S.).	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Costell M, 1996, FEBS LETT, V396, P127, DOI 10.1016/0014-5793(96)01082-4; Costell M, 1997, EUR J BIOCHEM, V243, P115, DOI 10.1111/j.1432-1033.1997.t01-1-00115.x; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hawke D. H., 1987, APPL BIOSYSTEMS USER; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Newfeld SJ, 1999, GENETICS, V152, P783; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; PAULSSON M, 1987, J MOL BIOL, V197, P297, DOI 10.1016/0022-2836(87)90125-2; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Schulze B, 1996, MATRIX BIOL, V15, P349, DOI 10.1016/S0945-053X(96)90138-9; Sengle G., 2008, PRIMER METABOLIC BON; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001	41	127	132	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5087	5099		10.1074/jbc.M110.188615	http://dx.doi.org/10.1074/jbc.M110.188615			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135108	Green Published, hybrid			2022-12-27	WOS:000287230600016
J	Kingston, IJ; Yung, JSY; Singleton, MR				Kingston, Isabel J.; Yung, Jasmine S. Y.; Singleton, Martin R.			Biophysical Characterization of the Centromere-specific Nucleosome from Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-A; CORE PARTICLE; FISSION YEAST; HISTONE H3; IN-VITRO; CHROMATIN; DNA; RECONSTITUTION; DEPOSITION; PROTEINS	The centromeric DNA of all eukaryotes is assembled upon a specialized nucleosome containing a histone H3 variant known as CenH3. Despite the importance and conserved nature of this protein, the characteristics of the centromeric nucleosome are still poorly understood. In particular, the stoichiometry and DNA-binding properties of the CenH3 nucleosome have been the subject of some debate. We have characterized the budding yeast centromeric nucleosome by biochemical and biophysical methods and show that it forms a stable octamer containing two copies of the Cse4 protein and wraps DNA in a left-handed supercoil, similar to the canonical H3 nucleosome. The DNA-binding properties of the recombinant nucleosome are identical to those observed in vivo demonstrating that the octameric structure is physiologically relevant.	[Kingston, Isabel J.; Singleton, Martin R.] Canc Res UK London Res Inst, Macromol Struct & Funct Lab, London WC2A 3LY, England; [Yung, Jasmine S. Y.] Univ London Imperial Coll Sci Technol & Med, Div Canc, Dept Surg & Canc, London SW7 2AZ, England	Cancer Research UK; Imperial College London	Singleton, MR (corresponding author), Canc Res UK London Res Inst, Macromol Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Martin.Singleton@cancer.org.uk		Singleton, Martin/0000-0001-5716-7715	Cancer Research UK; Cancer Research UK [15656] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dechassa ML, 2009, CELL, V138, P22, DOI 10.1016/j.cell.2009.06.037; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Muecke M, 2008, STRUCTURE, V16, P837, DOI 10.1016/j.str.2008.04.008; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	23	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4021	4026		10.1074/jbc.M110.189340	http://dx.doi.org/10.1074/jbc.M110.189340			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115484	hybrid, Green Published			2022-12-27	WOS:000286653200082
J	Lin, HH; Lai, SC; Chau, LY				Lin, Heng-Huei; Lai, Shao-Chuan; Chau, Lee-Young			Heme Oxygenase-1/Carbon Monoxide Induces Vascular Endothelial Growth Factor Expression via p38 Kinase-dependent Activation of Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR GENE; TRANSCRIPTIONAL REGULATION; CARBON-MONOXIDE; PROTEIN-KINASES; UP-REGULATION; PHOSPHORYLATION; ANGIOGENESIS; INDUCTION; HYPOXIA	Heme oxygenase-1 (HO-1) is a stress-inducible enzyme catalyzing the oxidative degradation of heme to free iron, CO, and biliverdin. Previous studies demonstrated that HO-1 overexpression promoted VEGF expression and angiogenesis in the ischemic heart. However, the underlying mechanism remained elusive. Here we show that adenovirus-mediated HO-1 transduction of rat primary cardiomyocytes and H9C2 myocytes resulted in significant induction of VEGF expression, and a similar effect was seen in cells directly exposed to CO gas or a CO-releasing compound, tricarbonyldichlororuthenium (II) dimer. HO-1/CO-induced VEGF expression was significantly suppressed by pharmacological inhibition of p38 kinase, but not of AKT, activation. VEGF promoter-luciferase reporter assays, electrophoretic mobility shift assays, supershift assay, and chromatin immunoprecipitation showed that CO-induced VEGF promoter activation requires the binding of the Sp1 transcriptional factor to a cis-regulatory sequence located at the VEGF promoter. Western blot analysis and immunostaining experiments demonstrated that HO-1/CO induced p38-dependent phosphorylation of Sp1 at Thr-453 and Thr-739 both in vitro and in vivo. Overexpression of Sp1 protein with an alanine mutation at Thr-453 or Thr-739 suppressed CO-induced Sp1 binding to the VEGF promoter and its transcriptional activation. Collectively, these data suggest that p38-dependent phosphorylation of Sp1 at Thr-453/Thr-739 is crucial for HO-1/CO-induced VEGF expression in myocytes.	[Lin, Heng-Huei; Lai, Shao-Chuan; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018	Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-96-2320-B-001-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from National Science Council of Taiwan Grant NSC-96-2320-B-001-001 and an investigatorship from the Academia Sinica (to L.-Y.C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Chang HJ, 2006, INT J ONCOL, V28, P135; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Duyndam MCA, 2003, J BIOL CHEM, V278, P6885, DOI 10.1074/jbc.M206320200; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Gao N, 2002, J BIOL CHEM, V277, P45041, DOI 10.1074/jbc.M202775200; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Volti GL, 2005, ANTIOXID REDOX SIGN, V7, P704, DOI 10.1089/ars.2005.7.704; Xiong SB, 2001, CANCER RES, V61, P1727; Yin YM, 2009, BIOMED PHARMACOTHER, V63, P429, DOI 10.1016/j.biopha.2009.04.045	29	50	53	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3829	3838		10.1074/jbc.M110.168831	http://dx.doi.org/10.1074/jbc.M110.168831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115498	Green Published, hybrid			2022-12-27	WOS:000286653200064
J	Lindsay, J; McDade, SS; Pickard, A; McCloskey, KD; McCance, DJ				Lindsay, Jaime; McDade, Simon S.; Pickard, Adam; McCloskey, Karen D.; McCance, Dennis J.			Role of Delta Np63 gamma in Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; EPIDERMAL MORPHOGENESIS; RETINOBLASTOMA PROTEIN; P63 EXPRESSION; BREAST-CANCER; P53 HOMOLOG; CELLS; MECHANISM; IDENTIFICATION; PROGRESSION	Although members of the p63 family of transcription factors are known for their role in the development and differentiation of epithelial surfaces, their function in cancer is less clear. Here, we show that depletion of the Delta Np63 alpha and beta isoforms, leaving only Delta Np63 gamma, results in epithelial to mesenchymal transition (EMT) in the normal breast cell line MCF10A. EMT can be rescued by the expression of the Delta Np63 alpha isoform. We also show that Delta Np63 gamma expressed in a background where all the other Delta Np63 are knocked down causes EMT with an increase in TGF beta-1, -2, and -3 and downstream effectors Smads2/3/4. In addition, a p63 binding site in intron 1 of TGF beta was identified. Inhibition of the TGF beta response with a specific inhibitor results in reversion of EMT in Delta Np63 alpha- and beta-depleted cells. In summary, we show that p63 is involved in inhibiting EMT and reduction of certain p63 isoforms may be important in the development of epithelial cancers.	[Lindsay, Jaime; McDade, Simon S.; Pickard, Adam; McCloskey, Karen D.; McCance, Dennis J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	McCance, DJ (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	d.mccance@qub.ac.uk	McDade, Simon/AAE-5031-2020; McDade, Simon S/E-5730-2017	McDade, Simon/0000-0002-3024-4773; McDade, Simon S/0000-0002-3024-4773; McCloskey, Karen/0000-0002-9135-9013; pickard, adam/0000-0001-9757-143X	Medical Research Council [MRC G0700754]; Medical Research Council [G0700754] Funding Source: researchfish; MRC [G0700754] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by Medical Research Council Grant MRC G0700754.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; CARNEY DN, 1985, CANCER RES, V45, P2913; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; De Rosa L, 2009, J BIOL CHEM, V284, P30574, DOI 10.1074/jbc.M109.049619; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Hay ED, 1995, ACTA ANAT, V154, P8; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Higashikawa K, 2009, INT J CANCER, V124, P2837, DOI 10.1002/ijc.24280; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; McDade SS, 2010, BIOCHEM SOC T, V38, P223, DOI 10.1042/BST0380223; Menges CW, 2006, CANCER RES, V66, P5555, DOI 10.1158/0008-5472.CAN-06-0499; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Park BJ, 2000, CANCER RES, V60, P3370; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Senoo M, 2001, BRIT J CANCER, V84, P1235, DOI 10.1054/bjoc.2000.1735; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; SOULE HD, 1990, CANCER RES, V50, P6075; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; VANDERHAEGEN BA, 1993, IN VITRO CELL DEV-AN, V29A, P180, DOI 10.1007/BF02634177; Wang XH, 2002, J UNIV SCI TECHNOL B, V9, P9; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wu GJ, 2005, CANCER RES, V65, P758; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	36	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3915	3924		10.1074/jbc.M110.162511	http://dx.doi.org/10.1074/jbc.M110.162511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127042	Green Published, hybrid			2022-12-27	WOS:000286653200072
J	Martins, IM; Cortes, JCG; Munoz, J; Moreno, MB; Ramos, M; Clemente-Ramos, JA; Duran, A; Ribas, JC				Martins, Ivone M.; Cortes, Juan C. G.; Munoz, Javier; Belen Moreno, M.; Ramos, Mariona; Clemente-Ramos, Jose A.; Duran, Angel; Ribas, Juan C.			Differential Activities of Three Families of Specific beta(1,3) Glucan Synthase Inhibitors in Wild-type and Resistant Strains of Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; CELL-WALL; NATURAL-PRODUCTS; FKS1 GENE; ECHINOCANDIN; SUBUNIT; SUSCEPTIBILITY; CASPOFUNGIN; HOMOLOG; MUTATIONS	Three specific beta(1,3) glucan synthase (GS) inhibitor families, papulacandins, acidic terpenoids, and echinocandins, have been analyzed in Schizosaccharomyces pombe wild-type and papulacandin-resistant cells and GS activities. Papulacandin and enfumafungin produced similar in vivo effects, different from that of echinocandins. Also, papulacandin was the strongest in vitro GS inhibitor (IC50 10(3)-10(4)-fold lower than with enfumafungin or pneumocandin), but caspofungin was by far the most efficient antifungal because of the following. 1) It was the only drug that affected resistant cells (minimal inhibitory concentration close to that of the wild type). 2) It was a strong inhibitor of wild-type GS (IC50 close to that of papulacandin). 3) It was the best inhibitor of mutant GS. Moreover, caspofungin showed a special effect for two GS inhibition activities, of high and low affinity, separated by 2 log orders, with no increase in inhibition. pbr1-8 and pbr1-6 resistances are due to single substitutions in the essential Bgs4 GS, located close to the resistance hot spot 1 region described in Saccharomyces and Candida Fks mutants. Bgs4(pbr1-8) contains the E700V change, four residues N-terminal from hot spot 1 defining a larger resistance hot spot 1-1 of 13 amino acids. Bgs4(pbr1-6) contains the W760S substitution, defining a new resistance hot spot 1-2. We observed spontaneous revertants of the spherical pbr1-6 phenotype and found that an additional A914V change is involved in the recovery of the wild-type cell shape, but it maintains the resistance phenotype. A better understanding of the mechanism of action of the antifungals available should help to improve their activity and to identify new antifungal targets.	[Martins, Ivone M.; Cortes, Juan C. G.; Munoz, Javier; Belen Moreno, M.; Ramos, Mariona; Clemente-Ramos, Jose A.; Duran, Angel; Ribas, Juan C.] Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Ribas, JC (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Edificio Dept,Rm 222,Campus Miguel de Unamuno, Salamanca 37007, Spain.	ribas@usal.es	Cortes, Juan Garcia/G-8773-2015; Ribas, Juan C/C-9864-2015; Martins, Ivone M/G-1752-2012	Cortes, Juan Garcia/0000-0002-2395-6668; Ribas, Juan C/0000-0001-6430-0895; Martins, Ivone M/0000-0002-3412-9377; Moreno, Maria Belen/0000-0002-5557-0575; Munoz-Garcia, Javier/0000-0002-2978-1192; Clemente-Ramos, Jose Angel/0000-0001-6872-6412	Ministerio de Educacion y Ciencia [BIO2006-13566]; Ministerio de Ciencia e Innovacion [BIO2009-10597]; Junta de Castilla y Leon, Spain [GR231]; Fundacao para a Ciencia e a Tecnologia, Portugal; Consejo Superior de Investigaciones Cientificas, Spain; Junta de Castilla y Leon, Spain; Ministerio de Ciencia e Innovacion, Spain	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Consejo Superior de Investigaciones Cientificas, Spain; Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Grants BIO2006-13566 from Ministerio de Educacion y Ciencia, BIO2009-10597 from Ministerio de Ciencia e Innovacion, and GR231 from Junta de Castilla y Leon, Spain.; Supported by a fellowship from Fundacao para a Ciencia e a Tecnologia, Portugal.; Supported by a fellowship from Consejo Superior de Investigaciones Cientificas, Spain.; Supported by a fellowship from Junta de Castilla y Leon, Spain.; Supported by a fellowship from Ministerio de Ciencia e Innovacion, Spain.	Alfa C, 1993, EXPT FISSION YEAST L; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Barrett D, 2002, BBA-MOL BASIS DIS, V1587, P224, DOI 10.1016/S0925-4439(02)00085-6; BARTIZAL K, 1992, ANTIMICROB AGENTS CH, V36, P1648, DOI 10.1128/AAC.36.8.1648; CASTRO C, 1995, J BACTERIOL, V177, P5732, DOI 10.1128/jb.177.20.5732-5739.1995; Chapman Stanley W, 2008, Trans Am Clin Climatol Assoc, V119, P197; Cleary JD, 2008, ANTIMICROB AGENTS CH, V52, P2263, DOI 10.1128/AAC.01568-07; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; DEMORA JF, 1991, ANTIMICROB AGENTS CH, V35, P2596, DOI 10.1128/AAC.35.12.2596; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; DOUGLAS CM, 1994, J BACTERIOL, V176, P5686, DOI 10.1128/JB.176.18.5686-5696.1994; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; EGEL R, 1984, CURR GENET, V8, P199, DOI 10.1007/BF00417816; ELSHERBEINI M, 1995, ANTIMICROB AGENTS CH, V39, P200, DOI 10.1128/AAC.39.1.200; Eschenauer Gregory, 2007, Ther Clin Risk Manag, V3, P71, DOI 10.2147/tcrm.2007.3.1.71; Fleischhacker M, 2008, EUR J CLIN MICROBIOL, V27, P127, DOI 10.1007/s10096-007-0411-4; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; KANG MS, 1986, CARBOHYD RES, V149, P13, DOI 10.1016/S0008-6215(00)90365-3; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Katiyar SK, 2009, ANTIMICROB AGENTS CH, V53, P1772, DOI 10.1128/AAC.00020-09; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kondoh O, 2002, J BIOL CHEM, V277, P41744, DOI 10.1074/jbc.M206734200; Kurtz MB, 1996, INFECT IMMUN, V64, P3244, DOI 10.1128/IAI.64.8.3244-3251.1996; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Montravers P, 2006, INT J ANTIMICROB AG, V27, P1, DOI 10.1016/j.ijantimicag.2005.11.002; Moreno MB, 2000, YEAST, V16, P861; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; RIBAS JC, 1991, J BACTERIOL, V173, P3456, DOI 10.1128/jb.173.11.3456-3462.1991; RIBAS JC, 1991, FEMS MICROBIOL LETT, V79, P263, DOI 10.1016/0378-1097(91)90096-S; Rocha EMF, 2007, ANTIMICROB AGENTS CH, V51, P4174, DOI 10.1128/AAC.00917-07; Sambrook J, 2001, MOL CLONING LAB MANU; Shao PL, 2007, INT J ANTIMICROB AG, V30, P487, DOI 10.1016/j.ijantimicag.2007.07.019; Stone EA, 2002, CLIN THER, V24, P351, DOI 10.1016/S0149-2918(02)85039-1; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Vicente MF, 2003, CLIN MICROBIOL INFEC, V9, P15, DOI 10.1046/j.1469-0691.2003.00489.x; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Wiederhold NR, 2007, CURR OPIN INFECT DIS, V20, P574, DOI 10.1097/QCO.0b013e3282f1be7f	52	35	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3484	3496		10.1074/jbc.M110.174300	http://dx.doi.org/10.1074/jbc.M110.174300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115488	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286653200034
J	Wu, FM; Nguyen, JV; Rankin, S				Wu, Frank M.; Nguyen, Judy V.; Rankin, Susannah			A Conserved Motif at the C Terminus of Sororin Is Required for Sister Chromatid Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ACETYLATION; PROTEIN; COMPLEX; ASSOCIATION; EXPRESSION; BINDING; SMC3; SCC2; WAPL	Sororin is a positive regulator of sister chromatid cohesion that interacts with the cohesin complex. Sororin is required for the increased stability of the cohesin complex on chromatin following DNA replication and sister chromatid cohesion during G(2). The mechanism by which sororin ensures cohesion is currently unknown. Because the primary sequence of sororin does not contain any previously characterized structural or functional motifs, we have undertaken a structure-function analysis of the sororin protein. Using a series of mutant derivatives of sororin, we show that the ability of sororin to bind to chromatin is separable from both its role in sister chromatid cohesion and its interaction with the cohesin complex. We also show that derivatives of sororin with deletions or mutations in the conserved C terminus fail to rescue the loss-of-cohesion phenotype caused by sororin RNAi and that these mutations also abrogate the association of sororin with the cohesin complex. Our data suggest that the interaction of the highly conserved motif at the C terminus of sororin with the cohesin complex is critical to its ability to mediate sister chromatid cohesion.	[Rankin, Susannah] Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Wu, Frank M.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73126 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rankin, S (corresponding author), Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Susannah-Rankin@omrf.org		Rankin, Susannah/0000-0002-4056-6610	National Institutes of Health through NCRR [RR016478]; Oklahoma Center for the Advancement of Science and Technology [HR06-175S]; J. Donald Capra predoctoral fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health through NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oklahoma Center for the Advancement of Science and Technology; J. Donald Capra predoctoral fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016478 through the NCRR. This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR06-175S.; Supported by a J. Donald Capra predoctoral fellowship.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Pfleger CM, 2000, GENE DEV, V14, P655; Rankin S, 2005, CELL CYCLE, V4, P1039, DOI 10.4161/cc.4.8.1926; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	22	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3579	3586		10.1074/jbc.M110.196758	http://dx.doi.org/10.1074/jbc.M110.196758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115494	Green Published, hybrid			2022-12-27	WOS:000286653200042
J	Mcnally, RS; Davis, BK; Clements, CM; Accavitti-Loper, MA; Mak, TW; Ting, JPY				Mcnally, R. Sean; Davis, Beckley K.; Clements, Casey M.; Accavitti-Loper, Mary Ann; Mak, Tak W.; Ting, Jenny P. -Y.			DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CARCINOMA; BREAST-CANCER; PARKINSONS-DISEASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; INTERLEUKIN-8; ANGIOGENESIS; METASTASIS; PROTECTS	Heightened DJ-1 (Park7) expression is associated with a reduction in chemotherapeutic-induced cell death and poor prognosis in several cancers, whereas the loss of DJ-1 function is found in a subgroup of Parkinson disease associated with neuronal death. This study describes a novel pathway by which DJ-1 modulates cell survival. Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1. Among these, Cezanne is a known deubiquitination enzyme that inhibits NF-kappa B activity. DJ-1/Cezanne interaction is confirmed by co-immunoprecipitation of over-expressed and endogenous proteins, maps to the amino-terminal 70 residues of DJ-1, and leads to the inhibition of the deubiquitinating activity of Cezanne. Microarray profiling of shRNA-transduced cells shows that DJ-1 and Cezanne regulate IL-8 and ICAM-1 expression in opposing directions. Similarly, DJ-1 enhances NF-kappa B nuclear translocation and cell survival, whereas Cezanne reduces these outcomes. Analysis of mouse Park7(-/-) primary cells confirms the regulation of ICAM-1 by DJ-1 and Cezanne. As NF-kappa B is important in cellular survival and transformation, IL-8 functions as an angiogenic factor and pro-survival signal, and ICAM-1 has been implicated in tumor progression, invasion, and metastasis; these data provide an additional modality by which DJ-1 controls cell survival and possibly tumor progression via interaction with Cezanne.	[Mcnally, R. Sean; Davis, Beckley K.; Clements, Casey M.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA; [Accavitti-Loper, Mary Ann] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ting, JPY (corresponding author), 450 West Dr,LCCC 22-004,CB 7295, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Clements, Casey M/X-6179-2019	Clements, Casey M/0000-0002-8634-7894	Lineberger Comprehensive Cancer Center; University Cancer Research Fund; UNC [5T32CA071341-15]; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [T32CA071341] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center; University Cancer Research Fund; UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Lineberger Comprehensive Cancer Center, the University Cancer Research Fund, and UNC Cancer Cell Biology Training Grant 5T32CA071341-15. This work was also supported by a grant from the Crohn's and Colitis Foundation of America (to B.K.D.).	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brown M, 2008, EXPERT OPIN THER TAR, V12, P1109, DOI 10.1517/14728222.12.9.1109 ; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Collins TS, 2000, CANCER IMMUNOL IMMUN, V49, P78, DOI 10.1007/s002620050605; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Karashima T, 2003, CLIN CANCER RES, V9, P2786; Ke JJ, 2006, WORLD J GASTROENTERO, V12, P3609, DOI 10.3748/wjg.v12.i22.3609; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; La Starza R, 2007, CANCER GENET CYTOGEN, V175, P73, DOI 10.1016/j.cancergencyto.2007.01.011; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; MacKeigan JP, 2003, CANCER RES, V63, P6928; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Millar HJ, 2008, CANCER EPIDEM BIOMAR, V17, P2180, DOI 10.1158/1055-9965.EPI-07-2915; MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ooe H, 2006, NEUROSCI LETT, V406, P165, DOI 10.1016/j.neulet.2006.06.067; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Rubie C, 2007, WORLD J GASTROENTERO, V13, P4996, DOI 10.3748/wjg.v13.i37.4996; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; TORII A, 1993, J SURG ONCOL, V53, P239, DOI 10.1002/jso.2930530410; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yuen HF, 2008, CANCER EPIDEM BIOMAR, V17, P3593, DOI 10.1158/1055-9965.EPI-08-0214; Zhang HY, 2008, ENDOCR-RELAT CANCER, V15, P535, DOI 10.1677/ERC-07-0195	51	55	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4098	4106		10.1074/jbc.M110.147371	http://dx.doi.org/10.1074/jbc.M110.147371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21097510	Green Published, hybrid			2022-12-27	WOS:000286975700008
J	Bassaganya-Riera, J; Guri, AJ; Lu, PY; Climent, M; Carbo, A; Sobral, BW; Horne, WT; Lewis, SN; Bevan, DR; Hontecillas, R				Bassaganya-Riera, Josep; Guri, Amir J.; Lu, Pinyi; Climent, Montse; Carbo, Adria; Sobral, Bruno W.; Horne, William T.; Lewis, Stephanie N.; Bevan, David R.; Hontecillas, Raquel			Abscisic Acid Regulates Inflammation via Ligand-binding Domain-independent Activation of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CYCLIC ADP-RIBOSE; TEMPERATURE-SIGNALING CASCADE; CONJUGATED LINOLEIC-ACID; C-LIKE PROTEIN-1; PPAR-GAMMA; GENE-EXPRESSION; ULCERATIVE-COLITIS; ADIPOSE-TISSUE; PROBE LEVEL	Abscisic acid (ABA) has shown efficacy in the treatment of diabetes and inflammation; however, its molecular targets and the mechanisms of action underlying its immunomodulatory effects remain unclear. This study investigates the role of peroxisome proliferator-activated receptor gamma (PPAR gamma) and lanthionine synthetase C-like 2 (LANCL2) as molecular targets for ABA. We demonstrate that ABA increases PPAR gamma reporter activity in RAW 264.7 macrophages and increases ppar gamma expression in vivo, although it does not bind to the ligand-binding domain of PPAR gamma. LANCL2 knockdown studies provide evidence that ABA-mediated activation of macrophage PPAR gamma is dependent on lancl2 expression. Consistent with the association of LANCL2 with G proteins, we provide evidence that ABA increases cAMP accumulation in immune cells. ABA suppresses LPS-induced prostaglandin E-2 and MCP-1 production via a PPAR gamma-dependent mechanism possibly involving activation of PPAR gamma and suppression of NF-kappa B and nuclear factor of activated T cells. LPS challenge studies in PPAR gamma-expressing and immune cell-specific PPAR gamma null mice demonstrate that ABA down-regulates toll-like receptor 4 expression in macrophages and T cells in vivo through a PPAR gamma-dependent mechanism. Global transcriptomic profiling and confirmatory quantitative RT-PCR suggest novel candidate targets and demonstrate that ABA treatment mitigates the effect of LPS on the expression of genes involved in inflammation, metabolism, and cell signaling, in part, through PPAR gamma. In conclusion, ABA decreases LPS-mediated inflammation and regulates innate immune responses through a bifurcating pathway involving LANCL2 and an alternative, ligand-binding domain-independent mechanism of PPAR gamma activation.	[Bassaganya-Riera, Josep; Guri, Amir J.; Lu, Pinyi; Climent, Montse; Carbo, Adria; Sobral, Bruno W.; Horne, William T.; Lewis, Stephanie N.; Hontecillas, Raquel] Virginia Polytech Inst & State Univ, Nutrit Immunol & Mol Med Grp, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lewis, Stephanie N.; Bevan, David R.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Polytech Inst & State Univ, Nutrit Immunol & Mol Med Grp, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu; rmagarzo@vt.edu	Lu, Pinyi/U-4513-2017; Sobral, Bruno/GVU-7637-2022; Climent, Montserrat/K-6490-2019	Sobral, Bruno/0000-0003-3908-577X; Climent, Montserrat/0000-0002-9029-7914; Lewis, Stephanie/0000-0001-8724-2069; Bevan, David/0000-0001-9974-1105	National Institutes of Health from National Center for Complementary and Alternative Medicine [5R01AT004308]; NIAID [HHSN272200900040C, HHSN272201000056C]; European Commission [224836]; Ramon y Cajal Program; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission(European CommissionEuropean Commission Joint Research Centre); Ramon y Cajal Program(Spanish Government); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AT004308 from National Center for Complementary and Alternative Medicine (to J. B.-R.), NIAID Contract HHSN272200900040C (to B. W. S.), and NIAID Contract HHSN272201000056C (to J. B.-R.). This work was also supported by European Commission Grant 224836, the Ramon y Cajal Program, and funds from the Nutritional Immunology and Molecular Medicine Laboratory.	Adolfsson O, 2001, J IMMUNOL, V167, P3809, DOI 10.4049/jimmunol.167.7.3809; Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Baillie RA, 1998, J LIPID RES, V39, P2048; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2010, CURR MED CHEM, V17, P467, DOI 10.2174/092986710790226110; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s; Chung SW, 2003, MOL PHARMACOL, V64, P1169, DOI 10.1124/mol.64.5.1169; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Guri AJ, 2010, CLIN NUTR, V29, P646, DOI 10.1016/j.clnu.2010.02.003; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim SR, 2005, MOL PHARMACOL, V68, P1568, DOI 10.1124/mol.105.017160; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; LU P, 2010, J MOL MODEL IN PRESS; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nechushtan H, 2009, ADV IMMUNOL, V103, P1, DOI 10.1016/S0065-2776(09)03001-6; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; O'Shea M, 2004, AM J CLIN NUTR, V79, p1199S, DOI 10.1093/ajcn/79.6.1199S; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; SAS Institute Inc, 2020, SAS STAT US GUID; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Szanto A, 2005, MOL PHARMACOL, V67, P1935, DOI 10.1124/mol.104.006445; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsavkelova E A, 2006, Prikl Biokhim Mikrobiol, V42, P261; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738; Yang TX, 2008, PPAR RES, V2008, DOI 10.1155/2008/943614; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	63	78	87	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2504	2516		10.1074/jbc.M110.160077	http://dx.doi.org/10.1074/jbc.M110.160077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21088297	Green Published, hybrid			2022-12-27	WOS:000286464300015
J	Herdendorf, TJ; Albrecht, DW; Benkovic, SJ; Nelson, SW				Herdendorf, Timothy J.; Albrecht, Dustin W.; Benkovic, Stephen J.; Nelson, Scott W.			Biochemical Characterization of Bacteriophage T4 Mre11-Rad50 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; DEPENDENT DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITIES; ESCHERICHIA-COLI; GENE-32 PROTEIN; MULTIPLE ROLES; MRE11 NUCLEASE; UVSW PROTEIN; RAD50	The Mre11-Rad50 complex (MR) from bacteriophage T4 (gp46/47) is involved in the processing of DNA double-strand breaks. Here, we describe the activities of the T4 MR complex and its modulation by proteins involved in homologous recombination. T4 Mre11 is a Rad50- and Mn2+-dependent dsDNA exonuclease and ssDNA endonuclease. ATP hydrolysis is required for the removal of multiple nucleotides via dsDNA exonuclease activity but not for the removal of the first nucleotide or for ssDNA endonuclease activity, indicating ATP hydrolysis is only required for repetitive nucleotide removal. By itself, Rad50 is a relatively inefficient ATPase, but the presence of Mre11 and dsDNA increases ATP hydrolysis by 20-fold. The ATP hydrolysis reaction exhibits positive cooperativity with Hill coefficients ranging from 1.4 for Rad50 alone to 2.4 for the Rad50-Mre11-DNA complex. Kinetic assays suggest that approximately four nucleotides are removed per ATP hydrolyzed. Directionality assays indicate that the prevailing activity is a 3' to 5' dsDNA exonuclease, which is incompatible with the proposed role of MR in the production of 3' ssDNA ends. Interestingly, we found that in the presence of a recombination mediator protein (UvsY) and ssDNA-binding protein (gp32), Mre11 is capable of using Mg2+ as a cofactor for its nuclease activity. Additionally, the Mg2+-dependent nuclease activity, activated by UvsY and gp32, results in the formation of endonuclease reaction products. These results suggest that gp32 and UvsY may alter divalent cation preference and facilitate the formation of a 3' ssDNA overhang, which is a necessary intermediate for recombination-mediated double-strand break repair.	[Benkovic, Stephen J.] Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA; [Herdendorf, Timothy J.; Albrecht, Dustin W.; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Iowa State University	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.	sjb1@psu.edu; swn@iastate.edu			National Institutes of Health [GM013306]; Carver Trust [10-3603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM013306 (to S.J.B.). This work was also supported by Carver Trust Young Investigator Grant 10-3603 (to S.W.N.) and by Iowa State University institutional support (to S.W.N.).	Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Belanger KG, 1998, MOL CELL, V2, P693, DOI 10.1016/S1097-2765(00)80167-7; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BERG JM, 1994, PRINCIPLES BIOINORGA, P103; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; George JW, 1996, GENETICS, V143, P1507; George JW, 2001, P NATL ACAD SCI USA, V98, P8290, DOI 10.1073/pnas.131007598; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; HINTON DM, 1986, J BIOL CHEM, V261, P5663; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; HOSODA J, 1974, FEBS LETT, V47, P338, DOI 10.1016/0014-5793(74)81043-4; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; LIELAUSIS A, 1963, COLD SPRING HARB SYM, P375; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; MOSIG G, 1968, COLD SPRING HARB SYM, V33, P361, DOI 10.1101/SQB.1968.033.01.042; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; MOSIG G, 1995, FEMS MICROBIOL REV, V17, P83, DOI 10.1111/j.1574-6976.1995.tb00190.x; MOSIG G, 1976, J VIROL, V17, P756, DOI 10.1128/JVI.17.3.756-761.1976; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; Nelson SW, 2009, VIRAL GENOME REPLICATION, P337, DOI 10.1007/b135974_16; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Sambrook J, 1989, MOL CLONING LAB MANU, V1 and 3; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stohr BA, 2002, GENETICS, V162, P1019; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	69	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2382	2392		10.1074/jbc.M110.178871	http://dx.doi.org/10.1074/jbc.M110.178871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081488	Green Published, hybrid			2022-12-27	WOS:000286464300002
J	Morishita, D; Takami, M; Yoshikawa, S; Katayama, R; Sato, S; Kukimoto-Niino, M; Umehara, T; Shirouzu, M; Sekimizu, K; Yokoyama, S; Fujita, N				Morishita, Daisuke; Takami, Miho; Yoshikawa, Seiko; Katayama, Ryohei; Sato, Shigeo; Kukimoto-Niino, Mutsuko; Umehara, Takashi; Shirouzu, Mikako; Sekimizu, Kazuhisa; Yokoyama, Shigeyuki; Fujita, Naoya			Cell-permeable Carboxyl-terminal p27(Kip1) Peptide Exhibits Anti-tumor Activity by Inhibiting Pim-1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CYTOPLASMIC LOCALIZATION; PROTEIN-KINASES; TUMOR-GROWTH; PHOSPHORYLATION; PROMOTES; BINDING; SPECIFICITY; OVEREXPRESSION; IDENTIFICATION	The incidence and death rate of prostate cancer is increasing rapidly. In addition, the low sensitivity of prostate cancer to chemotherapy makes it difficult to treat this condition. The serine/threonine kinase Pim-1 plays an important role in cell cycle progression and apoptosis inhibition, resulting in prostate tumorigenesis. Therefore, Pim-1 inhibition has been expected to be an attractive target for developing new anti-cancer drugs. However, no small compounds targeting Pim-1 have progressed to clinical use because of their lack of specificity. Here, we have reported a new cell-permeable Pim-1 inhibitory p27(Kip1) peptide that could interfere with the binding of Pim-1 to its substrates and act as an anti-cancer drug. The peptide could bind to Pim-1 and inhibit phosphorylation of endogenous p27(Kip1) and Bad by Pim-1. Treatment of prostate cancer with the peptide induces G(1) arrest and subsequently apoptosis in vitro. However, the peptide showed almost no growth inhibitory or apoptosis-inducing effects in normal cells. The peptide could inhibit tumor growth in in vivo prostate cancer xenograft models. Moreover, the peptide treatment could overcome resistance to taxol, one of the first line chemotherapeutic agents for prostate cancer, and a combination of the peptide with taxol synergistically inhibited prostate cancer growth in vivo. These results indicate that a Pim-1 inhibitory p27(Kip1) peptide could be developed as an anti-cancer drug against prostate cancer.	[Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan; [Yoshikawa, Seiko; Kukimoto-Niino, Mutsuko; Umehara, Takashi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Morishita, Daisuke; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; RIKEN; University of Tokyo; University of Tokyo	Fujita, N (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	naoya.fujita@jfcr.or.jp	Katayama, Ryohei/K-8537-2014; Umehara, Takashi/AHB-1730-2022; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Kukimoto-Niino, Mutsuko/C-6704-2017; Fujita, Naoya/A-7349-2010; Umehara, Takashi/N-5683-2015	Katayama, Ryohei/0000-0001-7394-895X; Umehara, Takashi/0000-0003-3464-2960; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Fujita, Naoya/0000-0002-9631-9264; Umehara, Takashi/0000-0003-3464-2960	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [22650238] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science, by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (to N. F.).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; CHENG HC, 1986, J BIOL CHEM, V261, P989; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; GLASS DB, 1986, J BIOL CHEM, V261, P2166; Holder S, 2007, BIOORGAN MED CHEM, V15, P6463, DOI 10.1016/j.bmc.2007.06.025; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Xu Y, 2005, J SURG ONCOL, V92, P326, DOI 10.1002/jso.20325; Yang LL, 2003, CANCER RES, V63, P831; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200	25	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2681	2688		10.1074/jbc.M109.092452	http://dx.doi.org/10.1074/jbc.M109.092452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062737	Green Published, hybrid			2022-12-27	WOS:000286464300034
J	Sauzeau, V; Carvajal-Gonzalez, JM; Riolobos, AS; Sevilla, MA; Menacho-Marquez, M; Roman, AC; Abad, A; Montero, MJ; Fernandez-Salguero, P; Bustelo, XR				Sauzeau, Vincent; Carvajal-Gonzalez, Jose M.; Riolobos, Adelaida S.; Sevilla, Maria A.; Menacho-Marquez, Mauricio; Roman, Angel C.; Abad, Antonio; Montero, Maria J.; Fernandez-Salguero, Pedro; Bustelo, Xose R.			Transcriptional Factor Aryl Hydrocarbon Receptor (Ahr) Controls Cardiovascular and Respiratory Functions by Regulating the Expression of the Vav3 Proto-oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIN-RECEPTOR; BLOOD-PRESSURE; NULL MICE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; CONSTITUTIVE EXPRESSION; NUCLEAR TRANSLOCATOR; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; AXON GUIDANCE; CDNA CLONING	Aryl hydrocarbon receptor (Ahr) is a transcriptional factor involved in detoxification responses to pollutants and in intrinsic biological processes of multicellular organisms. We recently described that Vav3, an activator of Rho/Rac GTPases, is an Ahr transcriptional target in embryonic fibroblasts. These results prompted us to compare the Ahr(-/-) and Vav3(-/-) mouse phenotypes to investigate the implications of this functional interaction in vivo. Here, we show that Ahr is important for Vav3 expression in kidney, lung, heart, liver, and brainstem regions. This process is not affected by the administration of potent Ahr ligands such as benzo[a]pyrene. We also report that Ahr- and Vav3-deficient mice display hypertension, tachypnea, and sympathoexcitation. The Ahr gene deficiency also induces the GABAergic transmission defects present in the Vav3(-/-) ventrolateral medulla, a main cardiorespiratory brainstem center. However, Ahr(-/-) mice, unlike Vav3-deficient animals, display additional defects in fertility, perinatal growth, liver size and function, closure, spleen size, and peripheral lymphocytes. These results demonstrate that Vav3 is a bona fide Ahr target that is in charge of a limited subset of the developmental and physiological functions controlled by this transcriptional factor. Our data also reveal the presence of sympathoexcitation and new cardiorespiratory defects in Ahr(-/-) mice.	[Carvajal-Gonzalez, Jose M.; Roman, Angel C.; Fernandez-Salguero, Pedro] Univ Extremadura, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain; [Sauzeau, Vincent; Sevilla, Maria A.; Menacho-Marquez, Mauricio; Abad, Antonio; Montero, Maria J.; Bustelo, Xose R.] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Salamanca 37007, Spain; [Riolobos, Adelaida S.; Sevilla, Maria A.; Montero, Maria J.] Univ Salamanca, Dept Fisiol & Farmacol, Salamanca 37007, Spain; [Riolobos, Adelaida S.] Univ Salamanca, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Fernandez-Salguero, P (corresponding author), Univ Extremadura, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain.	pmfersal@unex.es; xbustelo@usal.es	Bustelo, Xose R./AAD-2081-2022; Sevilla, M Angeles/J-8146-2017; S.Riolobos, Adelaida/B-3729-2017; Montero, María José MJ/C-3084-2018; Fernandez-Salguero, Pedro M./J-8437-2014; Sauzeau, Vincent/D-3548-2015; Bustelo, Xose R./A-9526-2010; Carvajal-Gonzalez, Jose Maria/ABC-6780-2020	Bustelo, Xose R./0000-0001-9398-6072; Sevilla, M Angeles/0000-0003-2960-8514; Montero, María José MJ/0000-0003-2125-0378; Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Bustelo, Xose R./0000-0001-9398-6072; Carvajal-Gonzalez, Jose Maria/0000-0001-6576-830X; Abad de Blas, Antonio Luis/0000-0001-8019-2775; Sauzeau, Vincent/0000-0002-6187-0312	National Institutes of Health [R01CA073735]; Spanish Ministry of Science and Innovation [SAF2009-07172, RD06/0020/0001, SAF2008-00462, RD06/0020/1016]; Castilla y Leon Autonomous Government [GR97]; Asociacion Espanola Contra el Cancer; Junta de Extremadura [GRU08012, GRU09001]; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Castilla y Leon Autonomous Government; Asociacion Espanola Contra el Cancer; Junta de Extremadura; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA073735. This work was also supported by Spanish Ministry of Science and Innovation Grants SAF2009-07172 and RD06/0020/0001, Castilla y Leon Autonomous Government Grant GR97, and the Asociacion Espanola Contra el Cancer (to X. R. B.), Spanish Ministry of Science and Innovation Grants SAF2008-00462 and RD06/0020/1016, and Junta de Extremadura Grants GRU08012 and GRU09001 (to P. F.-S.).	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200; Auyeung DJ, 2003, MOL PHARMACOL, V63, P119, DOI 10.1124/mol.63.1.119; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; BLESSING WW, 1988, AM J PHYSIOL, V254, pH686, DOI 10.1152/ajpheart.1988.254.4.H686; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; CHEVILLARD C, 1988, EUR J PHARMACOL, V147, P23, DOI 10.1016/0014-2999(88)90629-2; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; Flores O, 1998, EXP NEPHROL, V6, P39; FRANKIN BJ, 1996, MOUSE BRAIN STEREOTA; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; GONZALEZ FJ, 1985, NUCLEIC ACIDS RES, V13, P7269, DOI 10.1093/nar/13.20.7269; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Huang X, 2004, DEVELOPMENT, V131, P819, DOI 10.1242/dev.00959; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; KIMURA S, 1986, MOL CELL BIOL, V6, P1471, DOI 10.1128/MCB.6.5.1471; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Leung YK, 2002, BIOCHEM PHARMACOL, V63, P767, DOI 10.1016/S0006-2952(01)00902-9; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Movilla N, 1999, MOL CELL BIOL, V19, P7870; MUFTI NA, 1995, BIOCHEM BIOPH RES CO, V208, P144, DOI 10.1006/bbrc.1995.1316; Munzel PA, 2003, BIOCHEM PHARMACOL, V66, P841, DOI 10.1016/S0006-2952(03)00389-7; Nakata A, 2009, EMBO REP, V10, P622, DOI 10.1038/embor.2009.35; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Quevedo C, 2010, MOL BIOL CELL, V21, P1125, DOI 10.1091/mbc.E09-04-0292; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Sato S, 2008, TOXICOL APPL PHARM, V229, P10, DOI 10.1016/j.taap.2007.12.029; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2007, MOL BIOL CELL, V18, P943, DOI 10.1091/mbc.E06-09-0877; Sauzeau V, 2010, MOL BIOL CELL, V21, P4251, DOI 10.1091/mbc.E10-07-0639; Sauzeau V, 2010, J CLIN INVEST, V120, P315, DOI 10.1172/JCI38356; SAVAS U, 1994, J BIOL CHEM, V269, P14905; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; SHEN ZY, 1994, DNA CELL BIOL, V13, P763, DOI 10.1089/dna.1994.13.763; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Thrasher TN, 2005, AM J PHYSIOL-REG I, V288, pR819, DOI 10.1152/ajpregu.00813.2004; Tolentino-Silva FP, 2000, J APPL PHYSIOL, V89, P437, DOI 10.1152/jappl.2000.89.2.437; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yoshida S, 2002, CIRC J, V66, P197, DOI 10.1253/circj.66.197	70	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2896	2909		10.1074/jbc.M110.187534	http://dx.doi.org/10.1074/jbc.M110.187534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115475	Green Published, hybrid			2022-12-27	WOS:000286464300054
J	Martinez-Nunez, RT; Louafi, F; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Louafi, Fethi; Sanchez-Elsner, Tilman			The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor alpha 1 (IL13R alpha 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; INFLAMMATORY RESPONSE; DENDRITIC CELLS; DOWN-REGULATION; T-CELLS; ACTIVATION; MICE; EXPRESSION; ASTHMA; GENE	Macrophages play a central role in the balance and efficiency of the immune response and are at the interface between innate and adaptive immunity. Their phenotype is a delicate equilibrium between the M1 (classical, pro-Th-1) and M2 (alternative, pro-Th-2) profiles. This balance is regulated by cytokines such as interleukin 13 (IL-13), a typical pro-M2-Th-2 cytokine that has been related to allergic disease and asthma. IL-13 binds to IL-13 receptor alpha 1 (IL13R alpha 1), a component of the Type II IL-4 receptor, and exerts its effects by activating the transcription factor signal transducer and activator of transcription 6 (STAT6) through phosphorylation. MicroRNAs are short (similar to 22 nucleotide) inhibitory non-coding RNAs that block the translation or promote the degradation of their specific mRNA targets. By bioinformatics analysis, we found that microRNA-155 (miR-155) is predicted to target IL13R alpha 1. This suggested that miR-155 might be involved in the regulation of the M1/M2 balance in macrophages by modulating IL-13 effects. miR-155 has been implicated in the development of a healthy immune system and function as well as in the inflammatory pro-Th-1/M1 immune profile. Here we have shown that in human macrophages, miR-155 directly targets IL13R alpha 1 and reduces the levels of IL13R alpha 1 protein, leading to diminished activation of STAT6. Finally we also demonstrate that miR-155 affects the IL-13-dependent regulation of several genes (SOCS1, DC-SIGN, CCL18, CD23, and SERPINE) involved in the establishment of an M2/pro-Th-2 phenotype in macrophages. Our work shows a central role for miR-155 in determining the M2 phenotype in human macrophages.	[Martinez-Nunez, Rocio T.; Louafi, Fethi; Sanchez-Elsner, Tilman] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Infect Inflammat & Immun,JunkRNA Lab, Southampton SO16 6YD, Hants, England	University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	T.Sanchez-Elsner@soton.ac.uk		Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council (MRC) [G0801984]; Medical Research Council [G0801984] Funding Source: researchfish; MRC [G0801984] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) Grant G0801984 (to T.S.-E. and to F.L.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hogan SP, 1997, J CLIN INVEST, V99, P1329, DOI 10.1172/JCI119292; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Lee C, 2009, CLIN EXP ALLERGY, V39, P897, DOI 10.1111/j.1365-2222.2009.03217.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Watanabe Y, 2006, GENE, V365, P2, DOI 10.1016/j.gene.2005.09.035; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142	44	220	248	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1786	1794		10.1074/jbc.M110.169367	http://dx.doi.org/10.1074/jbc.M110.169367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097505	Green Published, hybrid			2022-12-27	WOS:000286191500018
J	Neumann, M; Seduk, F; Iobbi-Nivol, C; Leimkuhler, S				Neumann, Meina; Seduk, Farida; Iobbi-Nivol, Chantal; Leimkuehler, Silke			Molybdopterin Dinucleotide Biosynthesis in Escherichia coli IDENTIFICATION OF AMINO ACID RESIDUES OF MOLYBDOPTERIN DINUCLEOTIDE TRANSFERASES THAT DETERMINE SPECIFICITY FOR BINDING OF GUANINE OR CYTOSINE NUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; GUANINE DINUCLEOTIDE; CRYSTAL-STRUCTURE; CHAPERONE; MATURATION; COMPONENTS; DITHIOLENE; MECHANISM; REDUCTASE; INSIGHT	The molybdenum cofactor is modified by the addition of GMP or CMP to the C4' phosphate of molybdopterin forming the molybdopterin guanine dinucleotide or molybdopterin cytosine dinucleotide cofactor, respectively. The two reactions are catalyzed by specific enzymes as follows: the GTP: molybdopterin guanylyltransferase MobA and the CTP: molybdopterin cytidylyltransferase MocA. Both enzymes show 22% amino acid sequence identity and are specific for their respective nucleotides. Crystal structure analysis of MobA revealed two conserved motifs in the N-terminal domain of the protein involved in binding of the guanine base. Based on these motifs, we performed site-directed mutagenesis studies to exchange the amino acids to the sequence found in the paralogue MocA. Using a fully defined in vitro system, we showed that the exchange of five amino acids was enough to obtain activity with both GTP and CTP in either MocA or MobA. Exchange of the complete N-terminal domain of each protein resulted in the total inversion of nucleotide specificity activity, showing that the N-terminal domain determines nucleotide recognition and binding. Analysis of protein-protein interactions showed that the C-terminal domain of either MocA or MobA determines the specific binding to the respective acceptor protein.	[Neumann, Meina; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany; [Seduk, Farida; Iobbi-Nivol, Chantal] CNRS, Chim Bacterienne Lab, IFR88, F-13402 Marseille 20, France	University of Potsdam; Centre National de la Recherche Scientifique (CNRS)	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Neumann-Schaal, Meina/AAM-6389-2021	Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/6-1]; DAAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/6-1 and in part by DAAD PROCOPE program (to C.I.-N. and S.L.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Miller J.H., 1972, EXPT MOL GENETICS; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Rajagopalan K. V., 1996, CELLULAR MOL BIOL, P674; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	29	21	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1400	1408		10.1074/jbc.M110.155671	http://dx.doi.org/10.1074/jbc.M110.155671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081498	hybrid, Green Published			2022-12-27	WOS:000286005000052
J	Sliter, DA; Aguiar, M; Gygi, SP; Wojcikiewicz, RJH				Sliter, Danielle A.; Aguiar, Mike; Gygi, Steven P.; Wojcikiewicz, Richard J. H.			Activated Inositol 1,4,5-Trisphosphate Receptors Are Modified by Homogeneous Lys-48-and Lys-63-linked Ubiquitin Chains, but Only Lys-48-linked Chains Are Required for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ANAPHASE-PROMOTING COMPLEX; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; PROTEASOMAL DEGRADATION; PROTEIN UBIQUITINATION; CONJUGATING ENZYME; LIGASE	Inositol 1,4,5-trisphosphate (IP3) receptors (IP(3)Rs) are large, ubiquitously expressed, endoplasmic reticulum membrane proteins that form tetrameric IP3 and Ca2+-gated Ca2+ channels. Endogenous IP(3)Rs provide very appealing tools for studying the ubiquitin-proteasome pathway in intact mammalian cells because, upon activation, they are rapidly ubiquitinated and degraded. Using mass spectrometry, we previously examined the ubiquitination of IP(3)R1 in alpha T3-1 pituitary gonadotrophs and found that IP(3)R1 ubiquitination is highly complex, with receptors being modified at multiple sites by monoubiquitin and polyubiquitin chains formed through both Lys-48 and Lys-63 linkages (Sliter, D. A., Kubota, K., Kirkpatrick, D. S., Alzayady, K. J., Gygi, S. P., and Wojcikiewicz, R. J. H. (2008) J. Biol. Chem. 283, 35319-35328). Here, we have extended these studies to determine whether IP(3)R2 and IP(3)R3 are similarly modified and if ubiquitination is cell type-dependent. Using mass spectrometry and linkage-specific ubiquitin antibodies, we found that all IP3R types are subject to ubiquitination at approximately the same locations and that, independent of cell type, IP(3)Rs are modified by monoubiquitin and Lys-48- and Lys-63-linked ubiquitin chains, although in differing proportions. Remarkably, the attached Lys-48- and Lys-63-linked ubiquitin chains are homogeneous and are segregated to separate IP3R subunits, and Lys-48-linked ubiquitin chains, but not Lys-63-linked chains, are required for IP3R degradation. Together, these data provide unique insight into the complexities of ubiquitination of an endogenous ubiquitin-proteasome pathway substrate in unperturbed mammalian cells. Importantly, although Lys-48-linked ubiquitin chains appear to trigger proteasomal degradation, the presence of Lys-63-linked ubiquitin chains suggests that ubiquitination of IP(3)Rs may have physiological consequences beyond signaling for degradation.	[Sliter, Danielle A.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Aguiar, Mike; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health [DK049194, GM67945]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194, R01DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK049194 (to R. J. H. W.) and GM67945 (to S. P. G.). This work was also supported by the American Heart Association (to D. A. S.).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Goto E, 2010, J BIOL CHEM, V285, P35311, DOI 10.1074/jbc.M110.112763; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	55	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1074	1082		10.1074/jbc.M110.188383	http://dx.doi.org/10.1074/jbc.M110.188383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071436	Green Published, hybrid			2022-12-27	WOS:000286005000018
J	Boncela, J; Przygodzka, P; Papiewska-Pajak, I; Wyroba, E; Osinska, M; Cierniewski, CS				Boncela, Joanna; Przygodzka, Patrycja; Papiewska-Pajak, Izabela; Wyroba, Elzbieta; Osinska, Magdalena; Cierniewski, Czeslaw S.			Plasminogen Activator Inhibitor Type 1 Interacts with alpha 3 Subunit of Proteasome and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INTERMEDIATE-FILAMENT; TUMOR-GROWTH; PROTEIN; ANGIOGENESIS; PROTEOLYSIS; APOPTOSIS; UBIQUITIN; PROLIFERATION; DEGRADATION	Plasminogen activator inhibitor type-1 (PAI-1), a multifunctional protein, is an important physiological regulator of fibrinolysis, extracellular matrix homeostasis, and cell motility. Recent observations show that PAI-1 may also be implicated in maintaining integrity of cells, especially with respect to cellular proliferation or apoptosis. In the present study we provide evidence that PAI-1 interacts with proteasome and affects its activity. First, by using the yeast two-hybrid system, we found that the alpha 3 subunit of proteasome directly interacts with PAI-1. Then, to ensure that the PAI-1-proteasome complex is formed in vivo, both proteins were coimmunoprecipitated from endothelial cells and identified with specific antibodies. The specificity of this interaction was evidenced after transfection of HeLa cells with pCMV-PAI-1 and coimmunoprecipitation of both proteins with anti-PAI-1 antibodies. Subsequently, cellular distribution of the PAI-1-proteasome complexes was established by immunogold staining and electron microscopy analyses. Both proteins appeared in a diffuse cytosolic pattern but also could be found in a dense perinuclear and nuclear location. Furthermore, PAI-1 induced formation of aggresomes freely located in endothelial cytoplasm. Increased PAI-1 expression abrogated degradation of degron analyzed after cotransfection of HeLa cells with pCMV-PAI-1 and pd2EGFP-N1 and prevented degradation of p53 as well as I kappa B alpha, as evidenced both by confocal microscopy and Western immunoblotting.	[Papiewska-Pajak, Izabela; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-93232 Lodz, Poland; [Wyroba, Elzbieta; Osinska, Magdalena] Polish Acad Sci, Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl	Wyroba, Elzbieta/R-7525-2016; Wyroba, Elzbieta/P-4434-2019; Boncela, Joanna/AAU-4481-2020	Boncela, Joanna/0000-0001-8419-7012; Papiewska-Pajak, Izabela/0000-0001-6116-3418; Przygodzka, Patrycja/0000-0001-7529-8815	Polish Ministry of Science and Higher Education [N301 3386 33, N301 4392 38]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Projects N301 3386 33 (to J. B.) and N301 4392 38 (to C. S. C.).	ALIZADEH H, 1995, CURR EYE RES, V14, P449, DOI 10.3109/02713689509003755; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; BIANCHI E, 1995, INT J CANCER, V60, P597, DOI 10.1002/ijc.2910600505; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Boncela J, 2001, J BIOL CHEM, V276, P35305, DOI 10.1074/jbc.M104028200; CAJOT JF, 1990, P NATL ACAD SCI USA, V87, P6939, DOI 10.1073/pnas.87.18.6939; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Chen YB, 2006, ARTERIOSCL THROM VAS, V26, P1777, DOI 10.1161/01.ATV.0000227514.50065.2a; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Fay WP, 2007, ARTERIOSCL THROM VAS, V27, P1231, DOI 10.1161/ATVBAHA.107.140046; Gerards WLH, 1998, J MOL BIOL, V275, P113, DOI 10.1006/jmbi.1997.1429; Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC; Isogai C, 2001, CANCER RES, V61, P5587; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruithof E. K. O., 1983, PROGR FIBRINOLYSIS, V6, P356; KRUITHOF EKO, 1984, BLOOD, V64, P907; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Ma GPM, 2006, CARDIOVASC PATHOL, V15, P3, DOI 10.1016/j.carpath.2005.08.012; OLINKCOUX M, 1994, J CELL SCI, V107, P353; Pedroja BS, 2009, J BIOL CHEM, V284, P20708, DOI 10.1074/jbc.M109.018804; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; Sage E, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-19; Shu FJ, 2003, MOL CELL BIOCHEM, V254, P157, DOI 10.1023/A:1027317014159; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zoellner H, 1998, THROMB RES, V91, P209, DOI 10.1016/S0049-3848(98)00087-5; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	38	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6820	6831		10.1074/jbc.M110.173781	http://dx.doi.org/10.1074/jbc.M110.173781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135093	hybrid, Green Published			2022-12-27	WOS:000287476400089
J	Nagashima, K; Shumway, SD; Sathyanarayanan, S; Chen, AH; Dolinski, B; Xu, YY; Keilhack, H; Thi, N; Wiznerowicz, M; Li, LX; Lutterbach, BA; Chi, A; Paweletz, C; Allison, T; Yan, YW; Munshi, SK; Klippel, A; Kraus, M; Bobkova, EV; Deshmukh, S; Xu, ZW; Mueller, U; Szewczak, AA; Pan, BS; Richon, V; Pollock, R; Blume-Jensen, P; Northrup, A; Andersen, JN				Nagashima, Kumiko; Shumway, Stuart D.; Sathyanarayanan, Sriram; Chen, Albert H.; Dolinski, Brian; Xu, Youyuan; Keilhack, Heike; Thi Nguyen; Wiznerowicz, Maciej; Li, Lixia; Lutterbach, Bart A.; Chi, An; Paweletz, Cloud; Allison, Timothy; Yan, Youwei; Munshi, Sanjeev K.; Klippel, Anke; Kraus, Manfred; Bobkova, Ekaterina V.; Deshmukh, Sujal; Xu, Zangwei; Mueller, Uwe; Szewczak, Alexander A.; Pan, Bo-Sheng; Richon, Victoria; Pollock, Roy; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.			Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PHOSPHATIDYLINOSITOL 3-KINASE; STRUCTURAL MECHANISM; TUMOR-SUPPRESSOR; AGC KINASES; PROTEIN; ACTIVATION; PATHWAY; SPECIFICITY; MUTATIONS	Phosphoinositide-dependent kinase 1 (PDK1) is a critical activator of multiple prosurvival and oncogenic protein kinases and has garnered considerable interest as an oncology drug target. Despite progress characterizing PDK1 as a therapeutic target, pharmacological support is lacking due to the prevalence of nonspecific inhibitors. Here, we benchmark literature and newly developed inhibitors and conduct parallel genetic and pharmacological queries into PDK1 function in cancer cells. Through kinase selectivity profiling and x-ray crystallographic studies, we identify an exquisitely selective PDK1 inhibitor (compound 7) that uniquely binds to the inactive kinase conformation (DFG-out). In contrast to compounds 1-5, which are classical ATP-competitive kinase inhibitors (DFG-in), compound 7 specifically inhibits cellular PDK1 T-loop phosphorylation (Ser-241), supporting its unique binding mode. Interfering with PDK1 activity has minimal antiproliferative effect on cells growing as plastic-attached monolayer cultures (i.e. standard tissue culture conditions) despite reduced phosphorylation of AKT, RSK, and S6RP. However, selective PDK1 inhibition impairs anchorage-independent growth, invasion, and cancer cell migration. Compound 7 inhibits colony formation in a subset of cancer cell lines (four of 10) and primary xenograft tumor lines (nine of 57). RNAi-mediated knockdown corroborates the PDK1 dependence in cell lines and identifies candidate biomarkers of drug response. In summary, our profiling studies define a uniquely selective and cell-potent PDK1 inhibitor, and the convergence of genetic and pharmacological phenotypes supports a role of PDK1 in tumorigenesis in the context of three-dimensional in vitro culture systems.	[Nagashima, Kumiko; Shumway, Stuart D.; Sathyanarayanan, Sriram; Chen, Albert H.; Dolinski, Brian; Xu, Youyuan; Keilhack, Heike; Thi Nguyen; Wiznerowicz, Maciej; Li, Lixia; Lutterbach, Bart A.; Chi, An; Paweletz, Cloud; Klippel, Anke; Kraus, Manfred; Bobkova, Ekaterina V.; Deshmukh, Sujal; Xu, Zangwei; Mueller, Uwe; Szewczak, Alexander A.; Pan, Bo-Sheng; Richon, Victoria; Pollock, Roy; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.] Merck Res Labs, Boston, MA 02115 USA; [Allison, Timothy; Yan, Youwei; Munshi, Sanjeev K.] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company; Merck & Company	Andersen, JN (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, 44 Binney St, Boston, MA 02115 USA.	jannik_andersen@dfci.harvard.edu						Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Bilanges B, 2005, BIOCHEM J, V388, P573, DOI 10.1042/BJ20041956; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Boyle R. G., 2005, PCT Int. Appl., Patent No. [2005028474, WO 2005028474 A2]; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Edelman MJ, 2007, CLIN CANCER RES, V13, P2667, DOI 10.1158/1078-0432.CCR-06-1832; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Islam I, 2007, BIOORG MED CHEM LETT, V17, P3814, DOI 10.1016/j.bmcl.2007.04.071; Islam I, 2007, BIOORG MED CHEM LETT, V17, P3819, DOI 10.1016/j.bmcl.2007.05.060; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Kozina E., 2010, U.S. Patent, Patent No. [2010/0160309, 20100160309]; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Lind K. E., 2008, Patent No. 2008005457; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; SHOEMAKER RH, 1985, CANCER RES, V45, P2145; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Sternberger M, 2002, ANTISENSE NUCLEIC A, V12, P131, DOI 10.1089/108729002760220734; Sun DY, 2010, COMB CHEM HIGH T SCR, V13, P16, DOI 10.2174/138620710790218186; Tamguney T, 2008, EXP CELL RES, V314, P2299, DOI 10.1016/j.yexcr.2008.04.006; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; WALMSLEY DL, 2006, Patent No. 2006134318; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Welch S, 2007, GYNECOL ONCOL, V106, P305, DOI 10.1016/j.ygyno.2007.02.018; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	71	50	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6433	6448		10.1074/jbc.M110.156463	http://dx.doi.org/10.1074/jbc.M110.156463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21118801	hybrid, Green Published			2022-12-27	WOS:000287476400054
J	Bloom, J; Cristea, IM; Procko, AL; Lubkov, V; Chait, BT; Snyder, M; Cross, FR				Bloom, Joanna; Cristea, Ileana M.; Procko, Andrea L.; Lubkov, Veronica; Chait, Brian T.; Snyder, Michael; Cross, Frederick R.			Global Analysis of Cdc14 Phosphatase Reveals Diverse Roles in Mitotic Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEIN PHOSPHATASE; MICROTUBULE ORIENTATION; EXIT; ANAPHASE; LOCALIZATION; CYTOKINESIS	Cdc14 phosphatase regulates multiple events during anaphase and is essential for mitotic exit in budding yeast. Cdc14 is regulated in both a spatial and temporal manner. It is sequestered in the nucleolus for most of the cell cycle by the nucleolar protein Net1 and is released into the nucleus and cytoplasm during anaphase. To identify novel binding partners of Cdc14, we used affinity purification of Cdc14 and mass spectrometric analysis of interacting proteins from strains in which Cdc14 localization or catalytic activity was altered. To alter Cdc14 localization, we used a strain deleted for NET1, which causes full release of Cdc14 from the nucleolus. To alter Cdc14 activity, we generated mutations in the active site of Cdc14 (C283S or D253A), which allow binding of substrates, but not dephosphorylation, by Cdc14. Using this strategy, we identified new interactors of Cdc14, including multiple proteins involved in mitotic events. A subset of these proteins displayed increased affinity for catalytically inactive mutants of Cdc14 compared with the wild-type version, suggesting they are likely substrates of Cdc14. We have also shown that several of the novel Cdc14-interacting proteins, including Kar9 (a protein that orients the mitotic spindle) and Bni1 and Bnr1 (formins that nucleate actin cables and may be important for actomyosin ring contraction) are specifically dephosphorylated by Cdc14 in vitro and in vivo. Our findings suggest the dephosphorylation of the formins may be important for their observed localization change during exit from mitosis and indicate that Cdc14 targets proteins involved in wide-ranging mitotic events.	[Bloom, Joanna; Cristea, Ileana M.; Procko, Andrea L.; Lubkov, Veronica; Chait, Brian T.; Cross, Frederick R.] Rockefeller Univ, New York, NY 10065 USA; [Bloom, Joanna; Snyder, Michael] Yale Univ, New Haven, CT 06511 USA	Rockefeller University; Yale University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	fcross@rockefeller.edu		Lubkov, Veronica/0000-0002-5264-7549	National Institutes of Health; American Cancer Society [PF-06-017-01-CCG]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health (to F. R. C.) and a postdoctoral fellowship (PF-06-017-01-CCG) from the American Cancer Society (to J. B.).	Anderson VE, 2007, MOL BIOL CELL, V18, P2047, DOI 10.1091/mbc.E06-10-0918; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bailly E, 2003, J CELL SCI, V116, P4119, DOI 10.1242/jcs.00706; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bloom J, 2007, MOL CELL BIOL, V27, P842, DOI 10.1128/MCB.01069-06; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kikyo M, 1999, ONCOGENE, V18, P7046, DOI 10.1038/sj.onc.1203184; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lim HH, 2003, MOL BIOL CELL, V14, P4734, DOI 10.1091/mbc.E03-04-0238; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Maekawa H, 2004, GENE DEV, V18, P1709, DOI 10.1101/gad.298704; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Ross KE, 2004, DEV CELL, V6, P729, DOI 10.1016/S1534-5807(04)00128-5; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Surana U, 2002, BIOESSAYS, V24, P659, DOI 10.1002/bies.10106; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	68	54	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5434	5445		10.1074/jbc.M110.205054	http://dx.doi.org/10.1074/jbc.M110.205054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127052	Green Published, hybrid			2022-12-27	WOS:000287230600052
J	Fung, H; Demple, B				Fung, Hua; Demple, Bruce			Distinct Roles of Ape1 Protein in the Repair of DNA Damage Induced by Ionizing Radiation or Bleomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DOUBLE-STRAND-BREAK; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; HUMAN CELL-EXTRACTS; SINGLE-STRAND; ABASIC SITES; IN-VITRO; SACCHAROMYCES-CEREVISIAE; CLUSTERED DAMAGE; CANCER	Ionizing radiation (IR) and bleomycin (BLM) are used to treat various types of cancers. Both agents generate cytotoxic double strand breaks (DSB) and abasic (apurinic/apyrimidinic (AP)) sites in DNA. The human AP endonuclease Ape1 acts on abasic or 3'-blocking DNA lesions such as those generated by IR or BLM. We examined the effect of siRNA-mediated Ape1 suppression on DNA repair and cellular resistance to IR or BLM in human B-lymphoblastoid TK6 cells and HCT116 colon tumor cells. Partial Ape1 deficiency (similar to 30% of normal levels) sensitized cells more dramatically to BLM than to IR cytotoxicity. In both cases, expression of the unrelated yeast AP endonuclease, Apn1, largely restored resistance. Ape1 deficiency increased DNA AP site accumulation due to IR treatment but reduced the number of DSB. In contrast, for BLM, there were more DSB under Ape1 deficiency, with little change in the accumulation of AP sites. Although the role of Ape1 in generating DSB was greater for IR, the enzyme facilitated removal of AP sites, which may mitigate the cytotoxic effects of IR. In contrast, BLM generates scattered AP sites, and the DSB have 3'-phosphoglycolate termini that require Ape1 processing. These DSB persist under Ape1 deficiency. Apoptosis induced by BLM (but not by IR) under Ape1 deficiency was partially p53-dependent, more dramatically in TK6 than HCT116 cells. Thus, Ape1 suppression or inhibition may be a more efficacious adjuvant for BLM than for IR cancer therapy, particularly for tumors with a functional p53 pathway.	[Demple, Bruce] SUNY Stony Brook, Dept Pharmacol Sci, Sch Med, Stony Brook, NY 11794 USA; [Fung, Hua] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Dana-Farber Cancer Institute	Demple, B (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Sch Med, Stony Brook, NY 11794 USA.	bruce@pharm.stonybrook.edu			National Institutes of Health [R01 GM040000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM040000 (to B. D.).	Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chaudhry MA, 1999, BIOCHEM PHARMACOL, V57, P531, DOI 10.1016/S0006-2952(98)00327-X; CHEN CZ, 1989, ELECTROPHORESIS, V10, P318, DOI 10.1002/elps.1150100509; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Demple B, 2002, ONCOGENE, V21, P8926, DOI 10.1038/sj.onc.1206178; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; FADOK VA, 1992, J IMMUNOL, V148, P2207; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frosina G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/845396; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Georgakilas AG, 2004, NUCLEIC ACIDS RES, V32, P5609, DOI 10.1093/nar/gkh871; Ghotra VPS, 2009, INT J RADIAT BIOL, V85, P955, DOI 10.3109/09553000903242164; HENNER WD, 1983, J BIOL CHEM, V258, P711; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kingma PS, 1997, J BIOL CHEM, V272, P1148, DOI 10.1074/jbc.272.2.1148; LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033; Liu LL, 2002, CLIN CANCER RES, V8, P2985; Liu LL, 2003, MOL CANCER THER, V2, P1061; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Lomax ME, 2004, BIOCHEMISTRY-US, V43, P11017, DOI 10.1021/bi049560r; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; Milligan JR, 2002, INT J RADIAT BIOL, V78, P733, DOI 10.1080/09553000210140109; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; Pastwa E, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.16.e78; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; RAMOTAR D, 1993, J BIOL CHEM, V268, P20533; Robertson KA, 2001, CANCER RES, V61, P2220; Singh NP, 1997, MUTAT RES-DNA REPAIR, V383, P167, DOI 10.1016/S0921-8777(96)00056-0; SKOPEK TR, 1978, BIOCHEM BIOPH RES CO, V84, P411, DOI 10.1016/0006-291X(78)90185-7; Suh D, 1997, NUCLEIC ACIDS RES, V25, P2495, DOI 10.1093/nar/25.12.2495; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sutherland BM, 2002, RADIAT RES, V157, P611, DOI 10.1667/0033-7587(2002)157[0611:CDDIBX]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Willers H, 2004, BRIT J CANCER, V90, P1297, DOI 10.1038/sj.bjc.6601729; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xu YJ, 1998, J BIOL CHEM, V273, P28837, DOI 10.1074/jbc.273.44.28837; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yu YJ, 1997, ONCOGENE, V14, P1661, DOI 10.1038/sj.onc.1201026; Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	60	60	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4968	4977		10.1074/jbc.M110.146498	http://dx.doi.org/10.1074/jbc.M110.146498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21081487	Green Published, hybrid			2022-12-27	WOS:000287230600005
J	Yung, SC; Parenti, D; Murphy, PM				Yung, Sunny C.; Parenti, David; Murphy, Philip M.			Host Chemokines Bind to Staphylococcus aureus and Stimulate Protein A Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; SURFACE-PROTEINS; UNITED-STATES; CUTTING EDGE; CELL-WALL; ANTIMICROBIAL ACTIVITY; COMPLEMENT ACTIVATION; CUTANEOUS INFECTION; GAMMA-INTERFERON; AUGUST 2009	There are few examples of host signals that are beneficial to bacteria during infection. Here we found that 31 out of 42 host immunoregulatory chemokines were able to induce release of the virulence factor protein A (SPA) from a strain of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Detailed study of chemokine CXCL9 revealed that SPA release occurred through a post-translational mechanism and was inversely proportional to bacterial density. CXCL9 bound specifically to the cell membrane of CA-MRSA, and the related SPA-releasing chemokine CXCL10 bound to both cell wall and cell membrane. Clinical samples from patients infected with S. aureus and samples from a mouse model of CA-MRSA skin abscess all contained extracellular SPA. Further, SPA-releasing chemokines were present in mouse skin lesions infected with CA-MRSA. Our data identify a potential new mode of immune evasion, in which the pathogen exploits a host defense factor to release a virulence factor; moreover, chemokine binding may serve a scavenging function in immune evasion by S. aureus.	[Yung, Sunny C.; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Parenti, David] George Washington Univ, Dept Med, Med Ctr, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Rm 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov			Division of Intramural Research of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the NIAID, National Institutes of Health.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1071; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P941; [Anonymous], 2005, PRINCIPLES PRACTICE; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FOMENKO GA, 1980, ZH MIKROB EPID IMMUN, P57; FORSGREN A, 1970, Infection and Immunity, V2, P672; GALE EF, 1953, BIOCHEM J, V53, P493, DOI 10.1042/bj0530493; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2004, P NATL ACAD SCI USA, V101, P11392, DOI 10.1073/pnas.0404382101; GROV A, 1968, ACTA PATHOL MIC SC, V73, P400; Hartleib J, 2000, BLOOD, V96, P2149; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; LINDMARK R, 1977, EUR J BIOCHEM, V74, P623, DOI 10.1111/j.1432-1033.1977.tb11431.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; MOVITZ J, 1976, EUR J BIOCHEM, V68, P291, DOI 10.1111/j.1432-1033.1976.tb10788.x; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Otto M, 2001, PEPTIDES, V22, P1603, DOI 10.1016/S0196-9781(01)00495-8; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PARFENTJEV IA, 1964, J BACTERIOL, V88, P1, DOI 10.1002/path.1700880102; Patel M, 2009, CURR MOL MED, V9, P86, DOI 10.2174/156652409787314480; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; SANFORD BA, 1986, J CLIN MICROBIOL, V24, P131, DOI 10.1128/JCM.24.1.131-136.1986; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SPIKA JS, 1981, INFECT IMMUN, V34, P455, DOI 10.1128/IAI.34.2.455-460.1981; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VERBRUGH HA, 1979, IMMUNOLOGY, V37, P615; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	54	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5069	5077		10.1074/jbc.M110.195180	http://dx.doi.org/10.1074/jbc.M110.195180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138841	hybrid, Green Published			2022-12-27	WOS:000287230600014
J	Pifer, R; Benson, A; Sturge, CR; Yarovinsky, F				Pifer, Reed; Benson, Alicia; Sturge, Carolyn R.; Yarovinsky, Felix			UNC93B1 Is Essential for TLR11 Activation and IL-12-dependent Host Resistance to Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; CPG-DNA; IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; INNATE IMMUNITY; NUCLEIC-ACID; STRANDED-RNA; RECOGNITION; DISTINCT	Toll-like receptor (TLR) activation relies on biochemical recognition of microbial molecules and localization of the TLR within specific cellular compartments. Cell surface TLRs largely recognize bacterial membrane components, and intracellular TLRs are exclusively involved in sensing nucleic acids. Here we show that TLR11, an innate sensor for the Toxoplasma protein profilin, is an intracellular receptor that resides in the endoplasmic reticulum. The 12 membrane-spanning endoplasmic reticulum-resident protein UNC93B1 interacts directly with TLR11 and regulates the activation of dendritic cells in response to Toxoplasma gondii profilin and parasitic infection in vivo. A deficiency in functional UNC93B1 protein abolished TLR11-dependent IL-12 secretion by dendritic cells, attenuated Th1 responses against T. gondii, and dramatically enhanced susceptibility to the parasite. Our results reveal that the association with UNC93B1 and the intracellular localization of TLRs are not unique features of nucleic acid-sensing TLRs but is also essential for TLR11-dependent recognition of T. gondii profilin and for host protection against this parasite.	[Pifer, Reed; Benson, Alicia; Sturge, Carolyn R.; Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yarovinsky, F (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	felix.yarovinsky@utsouthwestern.edu		Yarovinsky, Felix/0000-0001-5825-8002; Reed, Pifer/0000-0002-9648-450X	National Institutes of Health [R01 AI085263, R21 AI079371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079371, R01AI085263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI085263 and R21 AI079371.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hunter CA, 2000, CURR OPIN IMMUNOL, V12, P413, DOI 10.1016/S0952-7915(00)00110-2; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McKee AS, 2004, J IMMUNOL, V173, P2632, DOI 10.4049/jimmunol.173.4.2632; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Triantafilou M, 2002, J CELL SCI, V115, P2603; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	47	80	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3307	3314		10.1074/jbc.M110.171025	http://dx.doi.org/10.1074/jbc.M110.171025			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097503	Green Published, hybrid			2022-12-27	WOS:000286653200016
J	Aoyagi, S; Archer, TK				Aoyagi, Sayura; Archer, Trevor K.			Differential Glucocorticoid Receptor-mediated Transcription Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; RNA-POLYMERASE; IN-VIVO; NUCLEAR RECEPTORS; BINDING; ACTIVATION; PROMOTER; GENOME; CELLS; SUPERFAMILY	Nuclear receptors such as the glucocorticoid receptor (GR) are ligand-dependent transcription factors that mediate transcription of target genes by recruiting factors that modulate chromatin structure. In this study, curcumin, a compound known to inhibit GR-mediated transcription, was used to examine the different mechanisms by which GR regulates transcription. The mechanisms of transcription regulation of metallothioneine-2A (MT2A) and solute carrier family 19 member 2 (SLC19A2), two GR target genes where the hormone-dependent gene activation is inhibited or unaffected by curcumin treatment, respectively, were analyzed by chromatin immunoprecipitation and RT-PCR experiments. The data suggest that the loss of hormone-dependent MT2A gene expression is due to the inhibition of continued transcription activity after initial assembly of the transcription machinery. In contrast, the hormone-dependent SLC19A2 gene expression is maintained because the continued transcription output after assembly of transcription machinery is unaffected by curcumin. These results suggest that the two GR target genes use alternate mechanisms to regulate expression levels at the level of continued transcription output after transcription machinery assembly.	[Aoyagi, Sayura; Archer, Trevor K.] NIEHS, Chromatin & Gene Express Sect, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Chromatin & Gene Express Sect, Mol Carcinogenesis Lab, NIH, 111 Alexander Dr,POB 12233,MD D4-01, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	National Institutes of Health of the NIEHS [Z01 ES071006-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Project Z01 ES071006-10 through the Intramural Research Program of the NIEHS (to T. K. A.).	Alonso-Gonzalez C, 2008, TOXICOL LETT, V181, P190, DOI 10.1016/j.toxlet.2008.07.021; Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kinyamu HK, 2008, ENVIRON MOL MUTAGEN, V49, P83, DOI 10.1002/em.20360; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; LAGANIE REJ, 2005, P NATL ACAD SCI USA, V102, P11651; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; MYMRYK JS, 1995, GENE DEV, V9, P1366, DOI 10.1101/gad.9.11.1366; MYMRYK JS, 1995, MOL ENDOCRINOL, V9, P1825, DOI 10.1210/me.9.12.1825; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; White RJ, 2010, TRENDS GENET, V26, P214, DOI 10.1016/j.tig.2010.02.004; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	38	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4610	4619		10.1074/jbc.M110.195040	http://dx.doi.org/10.1074/jbc.M110.195040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127044	Green Published, hybrid			2022-12-27	WOS:000286975700061
J	Costello, JL; Stead, JA; Feigenbutz, M; Jones, RM; Mitchell, P				Costello, Joe L.; Stead, Jonathan A.; Feigenbutz, Monika; Jones, Rebecca M.; Mitchell, Phil			The C-terminal Region of the Exosome-associated Protein Rrp47 Is Specifically Required for Box C/D Small Nucleolar RNA 3 '-Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; QUALITY-CONTROL; POLY(A) POLYMERASE; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; BIDIRECTIONAL PROMOTERS; EUKARYOTIC EXOSOME; BINDING-PROTEIN; YEAST NUCLEAR; CORE EXOSOME	Cells lacking the exosome-associated protein Rrp47 show similar defects in stable RNA processing to those observed in the absence of the catalytic subunit Rrp6, but the precise mechanism(s) by which Rrp47 functions together with Rrp6 remains unclear. Deletion complementation analyses defined an N-terminal region of Rrp47, largely coincident with the bioinformatically defined Sas10/C1D domain, which was sufficient for protein function in vivo. In vitro protein interaction studies demonstrated that this domain of Rrp47 binds the PMC2NT domain of Rrp6. Expression of the N-terminal domain of Rrp47 in yeast complemented most RNA-processing defects associated with the rrp47 Delta mutant but failed to complement the defect observed in 3'-end maturation of box C/D small nucleolar RNAs. Consistent with these results, protein capture assays revealed an interaction between the C-terminal region of Rrp47 and the small nucleolar ribonucleoproteins Nop56 and Nop58. Filter binding assays demonstrated that deletion of the lysine-rich sequence at the C terminus of Rrp47 blocked RNA binding in vitro. Furthermore, a protein mutated both at the C terminus and within the N-terminal domain showed a synergistic defect in RNA binding without impacting on its ability to interact with Rrp6. These studies provide evidence for a role of Rrp47 in registering a small nucleolar ribonucleoprotein particle assembly, functionally characterize the Sas10/C1D domain of Rrp47, and show that both the C terminus of Rrp47 and the N-terminal domain contribute to its RNA-binding activity.	[Costello, Joe L.; Stead, Jonathan A.; Feigenbutz, Monika; Jones, Rebecca M.; Mitchell, Phil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Mitchell, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.j.mitchell@shef.ac.uk		Jones, Rebecca M/0000-0002-5310-8475; Costello, Joseph/0000-0002-2867-1864; Stead, Jonathan/0000-0002-8133-3733; Mitchell, Phil/0000-0002-3178-0439	Biotechnology and Biological Sciences Research Council [BB/D001161]; Yorkshire Cancer Research; Wellcome Trust [088306/Z/09/Z]; University of Sheffield; BBSRC [BB/D001161/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001161/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); University of Sheffield; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Research Grant BB/D001161 (to J. A. S.), by Yorkshire Cancer Research and Wellcome Trust Research Grant 088306/Z/09/Z (to M. F.), by a Biotechnology and Biological Sciences Research Council Ph.D. studentship (to J. L. C.), and by a University of Sheffield Ph.D. studentship (to R. M. J.).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chapon C, 1997, RNA, V3, P1337; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kamakaka RT, 1998, GENETICS, V149, P903; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 2010, BIOCHEM SOC T, V38, P1088, DOI 10.1042/BST0381088; Nehls P, 1998, NUCLEIC ACIDS RES, V26, P1160, DOI 10.1093/nar/26.5.1160; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; PIPER PW, 1983, EMBO J, V2, P353, DOI 10.1002/j.1460-2075.1983.tb01430.x; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reinisch KM, 2007, CURR OPIN STRUC BIOL, V17, P209, DOI 10.1016/j.sbi.2007.03.012; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Synowsky SA, 2009, J MOL BIOL, V385, P1300, DOI 10.1016/j.jmb.2008.11.011; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wiederkehr T, 1998, RNA, V4, P1357, DOI 10.1017/S1355838298980955; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	55	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4535	4543		10.1074/jbc.M110.162826	http://dx.doi.org/10.1074/jbc.M110.162826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135092	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000286975700054
J	Ma, C; D'Mello, SR				Ma, Chi; D'Mello, Santosh R.			Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; NEURONAL APOPTOSIS; PROTECTS NEURONS; SURVIVAL; NEURODEGENERATION; TRANSCRIPTION; REPRESSION; DISEASE; HISTONE-DEACETYLASE-7; TOXICITY	Histone deacetylase (HDAC) 7 is a member of the HDAC family of deacetylases. Although some of the HDAC proteins have been shown to regulate neuronal survival and death, whether HDAC7 has a similar role is not known. In this study, we show that HDAC7 protects neurons from apoptosis. In cerebellar granule neurons (CGNs) primed to undergo apoptosis by low potassium treatment, expression of HDAC7 protein is reduced. Reduced expression is also observed in CGNs induced to die by pharmacological inhibition of the proteasome, in cortical neurons treated with homocysteic acid, and in the striatum of R6/2 transgenic mice, a commonly used genetic model of Huntington disease. Forced expression of HDAC7 in cultured CGNs blocks low potassium-induced death, and shRNA-mediated suppression of its expression induces death in otherwise healthy neurons. HDAC7-mediated neuroprotection does not require its catalytic domain and cannot be inhibited by chemical inhibitors of HDACs. Moreover, pharmacological inhibitors of the PI3K-Akt or Raf-MEK-ERK signaling pathways or that of PKA, PKC, and Ca2+/calmodulin-dependent protein kinase fail to reduce neuroprotection by HDAC7. We show that stimulation of c-jun expression, an essential feature of neuronal death, is prevented by HDAC7. shRNA-mediated suppression of HDAC7 expression leads to an increase in c-jun expression. Inhibition of c-jun expression by HDAC7 is mediated at the transcriptional level by its direct association with the c-jun gene promoter. Taken together, our results indicate that HDAC7 is a neuroprotective protein acting by a mechanism that is independent of its deacetylase activity but involving the inhibition of c-jun expression.	[Ma, Chi; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020	D'Mello, Santosh/0000-0002-7652-1334; , Chi/0000-0002-4171-0813	National Institutes of Health [NS047201, NS040408]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047201, R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047201 and NS040408.	Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Boutillier AL, 2002, ANN NY ACAD SCI, V973, P438, DOI 10.1111/j.1749-6632.2002.tb04679.x; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; D'Mello SR, 2000, J NEUROSCI RES, V59, P24, DOI 10.1002/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.3.CO;2-#; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Kao HY, 2000, GENE DEV, V14, P55; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kundel M, 2009, J NEUROSCI, V29, P13630, DOI 10.1523/JNEUROSCI.2910-08.2009; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Watson A, 1998, J NEUROSCI, V18, P751; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	35	62	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4819	4828		10.1074/jbc.M110.146860	http://dx.doi.org/10.1074/jbc.M110.146860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118817	Green Published, hybrid			2022-12-27	WOS:000286975700079
J	Tumusiime, S; Zhang, C; Overstreet, MS; Liu, ZC				Tumusiime, Sylvester; Zhang, Chen; Overstreet, Melissa S.; Liu, Zhengchang			Differential Regulation of Transcription Factors Stp1 and Stp2 in the Ssy1-Ptr3-Ssy5 Amino Acid Sensing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ACTIVATED PROTEOLYSIS; UBIQUITIN-LIGASE COMPLEX; SACCHAROMYCES-CEREVISIAE; ENDOPROTEOLYTIC ACTIVATION; SSY1P-PTR3P-SSY5P SENSOR; SCFGRR1 TARGETS; GENE-EXPRESSION; AGP1 GENE; YEAST; PROTEIN	Stp1 and Stp2 are two homologous transcription factors activated in response to extracellular amino acid stimuli. Here we show that both ubiquitin-dependent degradation of Stp1 and Stp2 and their intracellular localization are differentially regulated. We have found that the E2 ubiquitin-conjugating enzyme Cdc34 is required for degradation of both full-length and processed Stp1, but not Stp2. We have also found that Grr1, the F-box component of the SCFGrr1 E3 ubiquitin ligase, is the primary factor in degradation of full-length Stp1, whereas both Grr1 and Cdc4 are required for degradation of processed Stp1. Our localization studies showed that full-length Stp1 is localized both in the cytoplasm and at the cell periphery, whereas full-length Stp2 is localized only diffusely in the cytoplasm. We identified two nuclear localization signals of Stp1 and found that the N-terminal domain of Stp1 is required for localization of full-length Stp1 to the cell periphery. We also found that Stp2 is the primary factor involved in basal activation of target gene expression. Our results indicate that the functions of two seemingly redundant transcription factors can be separated by differential degradation and distinct cellular localization.	[Tumusiime, Sylvester; Zhang, Chen; Overstreet, Melissa S.; Liu, Zhengchang] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Zhang, Chen] Shanghai Univ Tradit Chinese Med, Dept Pathol, Shanghai 201203, Peoples R China	University of Louisiana System; University of New Orleans; Shanghai University of Traditional Chinese Medicine	Liu, ZC (corresponding author), 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	zliu5@uno.edu			University of New Orleans; Board of Regents of the State of Louisiana [LEQSF(2008-11)-RD-A-31]	University of New Orleans; Board of Regents of the State of Louisiana	This work was supported by the University of New Orleans and Board of Regents of the State of Louisiana Grant LEQSF(2008-11)-RD-A-31.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Amberg DC., 2005, METHODS YEAST GENETI; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Eckert-Boulet N, 2006, EUKARYOT CELL, V5, P174, DOI 10.1128/EC.5.1.174-179.2006; Eckert-Boulet N, 2004, YEAST, V21, P635, DOI 10.1002/yea.1120; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Forsberg H, 2001, MOL MICROBIOL, V42, P215, DOI 10.1046/j.1365-2958.2001.02627.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 2005, MOL BIOL CELL, V16, P4893, DOI 10.1091/mbc.E05-06-0516; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Poulsen P, 2005, EUKARYOT CELL, V4, P1116, DOI 10.1128/EC.4.6.1116-1124.2005; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	48	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4620	4631		10.1074/jbc.M110.195313	http://dx.doi.org/10.1074/jbc.M110.195313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127045	hybrid, Green Published			2022-12-27	WOS:000286975700062
J	Gianakopoulos, PJ; Mehta, V; Voronova, A; Cao, Y; Yao, ZZ; Coutu, J; Wang, XN; Waddington, MS; Tapscott, SJ; Skerjanc, IS				Gianakopoulos, Peter J.; Mehta, Virja; Voronova, Anastassia; Cao, Yi; Yao, Zizhen; Coutu, Josee; Wang, Xiaonan; Waddington, Michelle S.; Tapscott, Stephen J.; Skerjanc, Ilona S.			MyoD Directly Up-regulates Premyogenic Mesoderm Factors during Induction of Skeletal Myogenesis in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SATELLITE CELLS; ENHANCER FACTOR 2C; EMBRYONAL CARCINOMA-CELLS; P19 CELLS; DNA-BINDING; GENE-EXPRESSION; MOUSE EMBRYO; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; OTHERS EXPRESSION	Gain- and loss-of-function experiments have illustrated that the family of myogenic regulatory factors is necessary and sufficient for the formation of skeletal muscle. Furthermore, MyoD required cellular aggregation to induce myogenesis in P19 embryonal carcinoma stem cells. To determine the mechanism by which stem cells can be directed into skeletal muscle, a time course of P19 cell differentiation was examined in the presence and absence of exogenous MyoD. By quantitative PCR, the first MyoD up-regulated transcripts were the premyogenic mesoderm factors Meox1, Pax7, Six1, and Eya2 on day 4 of differentiation. Subsequently, the myoblast markers myogenin, MEF2C, and Myf5 were up-regulated, leading to skeletal myogenesis. These results were corroborated by Western blot analysis, showing up-regulation of Pax3, Six1, and MEF2C proteins, prior to myogenin protein expression. To determine at what stage a dominant-negative MyoD/EnR mutant could inhibit myogenesis, stable cell lines were created and examined. Interestingly, the premyogenic mesoderm factors, Meox1, Pax3/7, Six1, Eya2, and Foxc1, were down-regulated, and as expected, skeletal myogenesis was abolished. Finally, to identify direct targets of MyoD in this system, chromatin immunoprecipitation experiments were performed. MyoD was observed associated with regulatory regions of Meox1, Pax3/7, Six1, Eya2, and myogenin genes. Taken together, MyoD directs stem cells into the skeletal muscle lineage by binding and activating the expression of premyogenic mesoderm genes, prior to activating myoblast genes.	[Gianakopoulos, Peter J.; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Wang, Xiaonan; Skerjanc, Ilona S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Gianakopoulos, Peter J.; Waddington, Michelle S.; Skerjanc, Ilona S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Cao, Yi; Yao, Zizhen; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	University of Ottawa; Western University (University of Western Ontario); Fred Hutchinson Cancer Center	Skerjanc, IS (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	iskerjan@uottawa.ca	Skerjanc, Ilona/AAN-3318-2020; Voronova, Anastassia/GLR-8891-2022	Voronova, Anastassia/0000-0001-7504-1905; Yao, Zizhen/0000-0002-9361-5607; Tapscott, Stephen/0000-0002-0319-0968	Canadian Institutes of Health Research [MOP-84458]; Premier Research Excellence Award; Foundation for Gene and Cell Therapy; Canadian Institute of Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045113] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Premier Research Excellence Award; Foundation for Gene and Cell Therapy; Canadian Institute of Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Grant MOP-84458 from Canadian Institutes of Health Research (to I.S.S.).; Supported by a Premier Research Excellence Award in partnership with the Foundation for Gene and Cell Therapy.; Supported by a Canadian Institute of Aging investigator award.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Borycki AG, 1998, DEVELOPMENT, V125, P777; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Capdevila J, 1998, DEV BIOL, V193, P182, DOI 10.1006/dbio.1997.8806; COSSU G, 1983, DEV BIOL, V98, P520, DOI 10.1016/0012-1606(83)90382-2; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fan CM, 1997, DEV BIOL, V191, P160, DOI 10.1006/dbio.1997.8713; Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Huang J, 1996, MOL CELL BIOL, V16, P3893; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kume T, 2000, DEVELOPMENT, V127, P1387; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OLIVER G, 1995, DEVELOPMENT, V121, P693; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; PETROPOULOS H, 2002, THESIS U W ONTARIO L; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reecy JM, 1999, DEVELOPMENT, V126, P839; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rogerson PJ, 2002, FEBS LETT, V524, P134, DOI 10.1016/S0014-5793(02)03024-7; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Searcy RD, 1998, DEVELOPMENT, V125, P4461; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Wagner J, 2000, DEV BIOL, V228, P86, DOI 10.1006/dbio.2000.9921; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilton S, 1999, IN VITRO CELL DEV-AN, V35, P175; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Wyzykowski JC, 2002, MOL CELL BIOL, V22, P6199, DOI 10.1128/MCB.22.17.6199-6208.2002; Xu PX, 1997, DEVELOPMENT, V124, P219; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	97	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2517	2525		10.1074/jbc.M110.163709	http://dx.doi.org/10.1074/jbc.M110.163709			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078671	Green Published, hybrid			2022-12-27	WOS:000286464300016
J	Asano, R; Ikoma, K; Shimomura, I; Taki, S; Nakanishi, T; Umetsu, M; Kumagai, I				Asano, Ryutaro; Ikoma, Keiko; Shimomura, Ippei; Taki, Shintaro; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi			Cytotoxic Enhancement of a Bispecific Diabody by Format Conversion to Tandem Single-chain Variable Fragment (taFv) THE CASE OF THE hEx3 DIABODY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-BINDING; TUMOR-CELLS; V-H; MONOCLONAL-ANTIBODIES; SCFV MULTIMERS; FV FRAGMENT; CONSTRUCTION; LYSIS; ANTIBODY-528; ARRANGEMENT	Diabodies (Dbs) and tandem single-chain variable fragments (taFv) are the most widely used recombinant formats for constructing small bispecific antibodies. However, only a few studies have compared these formats, and none have discussed their binding kinetics and cross-linking ability. We previously reported the usefulness for cancer immunotherapy of a humanized bispecific Db (hEx3-Db) and its single-chain format (hEx3-scDb) that target epidermal growth factor receptor and CD3. Here, we converted hEx3-Db into a taFv format to investigate how format affects the function of a small bispecific antibody; our investigation included a cytotoxicity assay, surface plasmon resonance spectroscopy, thermodynamic analysis, and flow cytometry. The prepared taFv (hEx3-taFv) showed an enhanced cytotoxicity, which may be attributable to a structural superiority to the diabody format in cross-linking target cells but not to differences in the binding affinities of the formats. Comparable cross-linking ability for soluble antigens was observed among hEx3-Db, hEx3-scDb, and hEx3-taFv with surface plasmon resonance spectroscopy. Furthermore, drastic increases in cytotoxicity were found in the dimeric form of hEx3-taFv, especially when the two hEx3-taFv were covalently linked. Our results show that converting the format of small bispecific antibodies can improve their function. In particular, for small bispecific antibodies that target tumor and immune cells, a functional orientation that avoids steric hindrance in cross-linking two target cells may be important in enhancing the growth inhibition effect.	[Asano, Ryutaro; Ikoma, Keiko; Shimomura, Ippei; Taki, Shintaro; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016		Ministry of Education, Science, Sports, and Culture of Japan; New Energy and Industrial Technology Development Organization of Japan; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to R.A. and I.K.) and by grants from the New Energy and Industrial Technology Development Organization of Japan. This work was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Alt M, 1999, FEBS LETT, V454, P90, DOI 10.1016/S0014-5793(99)00782-6; Arakawa F, 1996, J BIOCHEM, V120, P657; Asano R, 2008, PROTEIN ENG DES SEL, V21, P597, DOI 10.1093/protein/gzn037; Asano R, 2008, J IMMUNOTHER, V31, P752, DOI 10.1097/CJI.0b013e3181849071; Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; Asano R, 2010, J BIOL CHEM, V285, P20844, DOI 10.1074/jbc.M110.120444; Asano R, 2010, FEBS J, V277, P477, DOI 10.1111/j.1742-4658.2009.07499.x; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Buhler P, 2008, CANCER IMMUNOL IMMUN, V57, P43, DOI 10.1007/s00262-007-0348-6; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; DeJonge J, 1995, MOL IMMUNOL, V32, P1405, DOI 10.1016/0161-5890(95)00089-5; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; Holliger P, 1997, CANCER IMMUNOL IMMUN, V45, P128, DOI 10.1007/s002620050414; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kipriyanov SM, 2003, J MOL BIOL, V330, P99, DOI 10.1016/S0022-2836(03)00526-6; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Korn T, 2004, J GENE MED, V6, P642, DOI 10.1002/jgm.555; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Le Gall F, 2004, J IMMUNOL METHODS, V285, P111, DOI 10.1016/j.jim.2003.11.007; Lu D, 2004, BIOCHEM BIOPH RES CO, V318, P507, DOI 10.1016/j.bbrc.2004.04.060; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; MALLENDER WD, 1994, J BIOL CHEM, V269, P199; McCall AM, 1999, MOL IMMUNOL, V36, P433, DOI 10.1016/S0161-5890(99)00057-7; Molhoj M, 2007, MOL IMMUNOL, V44, P1935, DOI 10.1016/j.molimm.2006.09.032; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; Power BE, 2003, PROTEIN SCI, V12, P734, DOI 10.1110/ps.0228503; RASO V, 1981, CANCER RES, V41, P2073; Robinson MK, 2005, CANCER RES, V65, P1471, DOI 10.1158/0008-5472.CAN-04-2008; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; Sundaresan G, 2003, J NUCL MED, V44, P1962; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; TRILL JJ, 1995, CURR OPIN BIOTECH, V6, P553, DOI 10.1016/0958-1669(95)80092-1; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	36	23	30	9	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1812	1818		10.1074/jbc.M110.172957	http://dx.doi.org/10.1074/jbc.M110.172957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097496	Green Published, hybrid			2022-12-27	WOS:000286191500021
J	Guderian, G; Peter, C; Wiesner, J; Sickmann, A; Schulze-Osthoff, K; Fischer, U; Grimmler, M				Guderian, Gernot; Peter, Christoph; Wiesner, Julia; Sickmann, Albert; Schulze-Osthoff, Klaus; Fischer, Utz; Grimmler, Matthias			RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; SMN COMPLEX; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC MATURATION; SPLICEOSOMAL SNRNPS; SUBUNIT PRECURSORS; ASSEMBLY PATHWAY; IN-VITRO; METHYLATION; NUCLEOLIN	Protein arginine methylation plays a critical role in differential gene expression through modulating protein-protein and protein-DNA/RNA interactions. Although numerous proteins undergo arginine methylation, only limited information is available on how protein arginine methyltransferases (PRMTs) identify their substrates. The human PRMT5 complex consists of PRMT5, WD45/MEP50 (WD repeat domain 45/methylosome protein 50), and pICln and catalyzes the symmetrical arginine dimethylation of its substrate proteins. pICln recruits the spliceosomal Sm proteins to the PRMT5 complex for methylation, which allows their subsequent loading onto snRNA to form small nuclear ribonucleoproteins. To understand how the PRMT5 complex is regulated, we investigated its biochemical composition and identified RioK1 as a novel, stoichiometric component of the PRMT5 complex. We show that RioK1 and pICln bind to PRMT5 in a mutually exclusive fashion. This results in a PRMT5-WD45/MEP50 core structure that either associates with pICln or RioK1 in distinct complexes. Furthermore, we show that RioK1 functions in analogy to pICln as an adapter protein by recruiting the RNA-binding protein nucleolin to the PRMT5 complex for its symmetrical methylation. The exclusive interaction of PRMT5 with either pICln or RioK1 thus provides the first mechanistic insight into how a methyltransferase can distinguish between its substrate proteins.	[Guderian, Gernot; Peter, Christoph; Fischer, Utz; Grimmler, Matthias] Univ Wurzburg, Bioctr, Dept Biochem, D-97074 Wurzburg, Germany; [Wiesner, Julia; Sickmann, Albert] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Prot Mass Spectrometry & Funct Prote Grp, D-97078 Wurzburg, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany	University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen	Grimmler, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, Obere Zahlbacherstr 63, D-55131 Mainz, Germany.	grimmler@uni-mainz.de	Peter, Christoph/ABB-4684-2020; Fischer, Utz/AAT-8422-2020; Schulze-Osthoff, Klaus/N-9025-2013; Fischer, Utz/A-4090-2016; Sickmann, Albert/A-1010-2011	Peter, Christoph/0000-0002-0048-2279; Fischer, Utz/0000-0002-1465-6591; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Fischer, Utz/0000-0002-1465-6591; Sickmann, Albert/0000-0002-2388-5265; Grimmler, Matthias/0000-0003-2860-3391	German Research Foundation (Deutsche Forschungsgemeinschaft) [Fi573/4-1]; families of spinal muscle atrophy (FSMA)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); families of spinal muscle atrophy (FSMA)	This work was supported by grants of the German Research Foundation (Deutsche Forschungsgemeinschaft Fi573/4-1) and families of spinal muscle atrophy (FSMA).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Herrmann F, 2004, J BIOL CHEM, V279, P48774, DOI 10.1074/jbc.M407332200; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mitulovic G, 2003, ANAL BIOANAL CHEM, V376, P946, DOI 10.1007/s00216-003-2047-2; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	50	94	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1976	1986		10.1074/jbc.M110.148486	http://dx.doi.org/10.1074/jbc.M110.148486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081503	Green Published, hybrid			2022-12-27	WOS:000286191500039
J	Harmat, V; Domokos, K; Menyhard, DK; Pallo, A; Szeltner, Z; Szamosi, I; Beke-Somfai, T; Naray-Szabo, G; Polgar, L				Harmat, Veronika; Domokos, Klarissza; Menyhard, Dora K.; Pallo, Anna; Szeltner, Zoltan; Szamosi, Ilona; Beke-Somfai, Tamas; Naray-Szabo, Gabor; Polgar, Laszlo			Structure and Catalysis of Acylaminoacyl Peptidase CLOSED AND OPEN SUBUNITS OF A DIMER OLIGOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROPYRUM-PERNIX K1; SERINE PROTEASE CATALYSIS; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; CRYSTAL-STRUCTURE; PYROCOCCUS-FURIOSUS; MECHANISM; ENDOPEPTIDASE; SPECIFICITY; TRIAD	Acylaminoacyl peptidase from Aeropyrum pernix is a homodimer that belongs to the prolyl oligopeptidase family. The monomer subunit is composed of one hydrolase and one propeller domain. Previous crystal structure determinations revealed that the propeller domain obstructed the access of substrate to the active site of both subunits. Here we investigated the structure and the kinetics of two mutant enzymes in which the aspartic acid of the catalytic triad was changed to alanine or asparagine. Using different substrates, we have determined the pH dependence of specificity rate constants, the rate-limiting step of catalysis, and the binding of substrates and inhibitors. The catalysis considerably depended both on the kind of mutation and on the nature of the substrate. The results were interpreted in terms of alterations in the position of the catalytic histidine side chain as demonstrated with crystal structure determination of the native and two mutant structures (D524N and D524A). Unexpectedly, in the homodimeric structures, only one subunit displayed the closed form of the enzyme. The other subunit exhibited an open gate to the catalytic site, thus revealing the structural basis that controls the oligopeptidase activity. The open form of the native enzyme displayed the catalytic triad in a distorted, inactive state. The mutations affected the closed, active form of the enzyme, disrupting its catalytic triad. We concluded that the two forms are at equilibrium and the substrates bind by the conformational selection mechanism.	[Harmat, Veronika; Menyhard, Dora K.; Beke-Somfai, Tamas; Naray-Szabo, Gabor] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; [Harmat, Veronika; Menyhard, Dora K.; Beke-Somfai, Tamas; Naray-Szabo, Gabor] Eotvos Lorand Univ, Inst Chem, HAS ELTE Prot Modeling Grp, H-1117 Budapest, Hungary; [Domokos, Klarissza; Szeltner, Zoltan; Szamosi, Ilona; Polgar, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Pallo, Anna] Hungarian Acad Sci, Chem Res Ctr, Dept Neurochem, H-1025 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Polgar, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, POB 7, H-1518 Budapest, Hungary.	polgar@enzim.hu	Beke-Somfai, Tamas/R-3970-2019; Beke-Somfai, Tamás/A-8383-2012; Harmat, Veronika/B-8033-2016; Pallo, Anna/B-6658-2009; Menyhárd, Dóra K./AAE-4527-2021	Beke-Somfai, Tamas/0000-0002-4788-3758; Beke-Somfai, Tamás/0000-0002-4788-3758; Harmat, Veronika/0000-0002-1866-9904; Menyhárd, Dóra K./0000-0002-0095-5531	OTKA [NK67800, F67937, K72973]; European Union [223077, 226716]; European Social Fund [TAMOP 4.2.1./B-09/KMR-2010-0003]; ICTP-ELETTRA Users Programme	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); ICTP-ELETTRA Users Programme	This work was supported by grants from the Hungarian Science Fund (OTKA NK67800, F67937, and K72973; European Union FP7 (223077 and 226716); the European Union and the European Social Fund (TAMOP 4.2.1./B-09/KMR-2010-0003); and the ICTP-ELETTRA Users Programme.	BACHOVCHIN WW, 1981, P NATL ACAD SCI-BIOL, V78, P7323, DOI 10.1073/pnas.78.12.7323; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; DeLano W.L, PYMOL MOL GRAPHICS S; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Fersht A, 1998, STRUCTURE MECH PROTE, P103; FERSHT AR, 1973, J MOL BIOL, V74, P137, DOI 10.1016/0022-2836(73)90103-4; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Harris MN, 2001, J BIOL CHEM, V276, P19310, DOI 10.1074/jbc.M010489200; Harwood VJ, 1997, J BACTERIOL, V179, P3613, DOI 10.1128/jb.179.11.3613-3618.1997; Hasebe T, 2001, J LEUKOCYTE BIOL, V69, P963; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; JAMES MNG, 1980, J MOL BIOL, V144, P43, DOI 10.1016/0022-2836(80)90214-4; JORDAN F, 1981, BIOCHEMISTRY-US, V20, P6366, DOI 10.1021/bi00525a013; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiss AL, 2004, FEBS LETT, V571, P17, DOI 10.1016/j.febslet.2004.06.054; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; KOSSIAKOFF AA, 1981, BIOCHEMISTRY-US, V20, P6462, DOI 10.1021/bi00525a027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R. J., 2001, GRAFIT VERSION 5 0; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Morty RE, 2002, J BACTERIOL, V184, P3329, DOI 10.1128/JB.184.12.3329-3337.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAYLOR SL, 1989, GENOMICS, V4, P355, DOI 10.1016/0888-7543(89)90342-X; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; POLGAR L, 1969, P NATL ACAD SCI USA, V64, P1335, DOI 10.1073/pnas.64.4.1335; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1972, ACTA BIOCHIMICA B A, V7, P29; POLGAR L, 1989, MECHANISMS PROTEASE, P87; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; SCALONI A, 1992, J LAB CLIN MED, V120, P546; SEGEL IH, 1975, ENZYME KINETICS, P72; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; St?cker, 1999, PROTEOLYTIC ENZYMES, P148, DOI 10.1007/978-3-642-59816-6; Szeltner Z, 2002, J BIOL CHEM, V277, P44597, DOI 10.1074/jbc.M207386200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V263, P139, DOI 10.1006/bbrc.1999.1289; ZERNER B, 1964, J AM CHEM SOC, V86, P3669, DOI 10.1021/ja01072a015	56	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1987	1998		10.1074/jbc.M110.169862	http://dx.doi.org/10.1074/jbc.M110.169862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084296	Green Published, hybrid			2022-12-27	WOS:000286191500040
J	Khurana, S; Chakraborty, S; Cheng, XW; Su, YT; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Cheng, Xiwen; Su, Yu-Ting; Kao, Hung-Ying			The Actin-binding Protein, Actinin Alpha 4 (ACTN4), Is a Nuclear Receptor Coactivator that Promotes Proliferation of MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; MOTIF; ALPHA-ACTININ-4; SPECIFICITY; EXPRESSION	Alpha actinins (ACTNs) are known for their ability to modulate cytoskeletal organization and cell motility by cross-linking actin filaments. We show here that ACTN4 harbors a functional LXXLL receptor interaction motif, interacts with nuclear receptors in vitro and in mammalian cells, and potently activates transcription mediated by nuclear receptors. Whereas overexpression of ACTN4 potentiates estrogen receptor alpha (ER alpha)-mediated transcription in transient transfection reporter assays, knockdown of ACTN4 decreases it. In contrast, histone deacetylase 7 (HDAC7) inhibits estrogen receptor alpha (ER alpha)-mediated transcription. Moreover, the ACTN4 mutant lacking the CaM (calmodulin)-like domain that is required for its interaction with HDAC7 fails to activate transcription by ER alpha. Chromatin immunoprecipitation (ChIP) assays demonstrate that maximal associations of ACTN4 and HDAC7 with the pS2 promoter are mutually exclusive. Knockdown of ACTN4 significantly decreases the expression of ER alpha target genes including pS2 and PR and also affects cell proliferation of MCF-7 breast cancer cells with or without hormone, whereas knockdown of HDAC7 exhibits opposite effects. Interestingly, overexpression of wild-type ACTN4, but not the mutants defective in interacting with ER alpha or HDAC7, results in an increase in pS2 and PR mRNA accumulation in a hormone-dependent manner. In summary, we have identified ACTN4 as a novel, atypical coactivator that regulates transcription networks to control cell growth.	[Khurana, Simran; Chakraborty, Sharmistha; Cheng, Xiwen; Su, Yu-Ting; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [R01 DK078965, HL093269]; Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965, HL093269, and the Pardee Foundation (to H.-Y.K.).	Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Huang SM, 2004, J MOL ENDOCRINOL, V32, P481, DOI 10.1677/jme.0.0320481; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	26	71	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1850	1859		10.1074/jbc.M110.162107	http://dx.doi.org/10.1074/jbc.M110.162107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078666	Green Published, hybrid			2022-12-27	WOS:000286191500025
J	Garcia, LL; Rivas-Marin, E; Floriano, B; Bernhardt, R; Ewen, KM; Reyes-Ramirez, F; Santero, E				Ledesma Garcia, Laura; Rivas-Marin, Elena; Floriano, Belen; Bernhardt, Rita; Ewen, Kerstin Maria; Reyes-Ramirez, Francisca; Santero, Eduardo			ThnY Is a Ferredoxin Reductase-like Iron-Sulfur Flavoprotein That Has Evolved to Function as a Regulator of Tetralin Biodegradation Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII NIFL; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; NITROGEN-FIXATION; CATABOLIC PATHWAY; NADP+ REDUCTASE; DIOXYGENASE; PURIFICATION; SYSTEM; STRAIN	Previous genetic studies in Sphingomonas macrogolitabida strain TFA have established that expression of genes involved in tetralin biodegradation (thn genes) requires the function of the LysR type activator ThnR and also ThnY. Sequence comparison indicated that ThnY is homologous to bacterial oxygenase-coupled NAD(P) H-dependent ferredoxin reductases. However, ThnY showed substitutions in highly conserved positions of the pyridine nucleotide binding domain of these ferredoxin reductases. ThnY expression is co-regulated with all other genes required for tetralin biodegradation, and presumably thnY is part of the thnCA3A4RY operon. ThnY has been purified, and its biochemical and functional properties were characterized. ThnY was found to be a monomeric orange-brown iron-sulfur flavoprotein (estimated mass of 37,000 Da) containing one non-covalently attached flavin adenine dinucleotide and one plant type ferredoxin 2Fe-2S cluster. It can be efficiently reduced by dithionite, but reduction by pyridine nucleotides was very poor. Consistently, ThnY-dependent reduction of cytochrome c, ferricyanide, or 2,6-dichloropheno-lindophenol using NAD(P) H as the electron donor was undetectable or very weak. The addition of ThnY to electrophoretic mobility shift assays containing ThnR and a probe bearing two thn divergent promoters resulted in a 3-fold increase in protein-DNA complex formation affinity, which indicates that ThnY directly promotes thn transcription activation by ThnR.	[Ledesma Garcia, Laura; Rivas-Marin, Elena; Floriano, Belen; Reyes-Ramirez, Francisca; Santero, Eduardo] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Bernhardt, Rita; Ewen, Kerstin Maria] Univ Saarland, D-66123 Saarbrucken, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Saarland University	Reyes-Ramirez, F (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.	freyram@upo.es	Rivas-Marín, Elena/B-6508-2016; Garcia, Laura Ledesma/AAA-6524-2021; Reyes-Ramirez, Francisca/L-3314-2014; Rivas-Marin, Elena/AAU-4036-2020; Floriano, Belen/K-7644-2014; Santero, Eduardo/K-6510-2014	Rivas-Marín, Elena/0000-0002-8696-8113; Garcia, Laura Ledesma/0000-0003-3276-2192; Reyes-Ramirez, Francisca/0000-0002-5120-8931; Rivas-Marin, Elena/0000-0002-8696-8113; Floriano, Belen/0000-0002-5326-7601; Santero, Eduardo/0000-0002-6111-7160	Spanish Ministry of Science and Innovation [BIO2008-01805, CSD2007-00005]; Andalusian Government [P05-CVI-131, P07-CVI-2518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Government	This work was supported by Spanish Ministry of Science and Innovation Grants BIO2008-01805 and CSD2007-00005 and Andalusian Government Grants P05-CVI-131 and P07-CVI-2518 (to L.L.G.).	ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; Aliverti A, 2008, ARCH BIOCHEM BIOPHYS, V474, P283, DOI 10.1016/j.abb.2008.02.014; Andujar E, 2003, MICROBIOL-SGM, V149, P1559, DOI 10.1099/mic.0.26034-0; Andujar E, 2000, J BACTERIOL, V182, P789, DOI 10.1128/JB.182.3.789-795.2000; Batie C. J., 1991, CHEM BIOCH FLAVOENZY, V3, P543; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; DORN E, 1974, ARCH MICROBIOL, V99, P61, DOI 10.1007/BF00696222; Dubbs JM, 2004, FEMS MICROBIOL REV, V28, P353, DOI 10.1016/j.femsre.2004.01.002; Elsen S, 2005, MOL MICROBIOL, V57, P17, DOI 10.1111/j.1365-2958.2005.04655.x; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; FETZNER S, 1992, J BACTERIOL, V174, P279, DOI 10.1128/jb.174.1.279-290.1992; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Garcia-Gonzalez V, 2009, FEMS MICROBIOL LETT, V300, P222, DOI 10.1111/j.1574-6968.2009.01784.x; Govantes F, 1996, J BACTERIOL, V178, P6817, DOI 10.1128/jb.178.23.6817-6823.1996; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heil G, 2002, MICROBIOL-SGM, V148, P2203, DOI 10.1099/00221287-148-7-2203; Hernaez MJ, 2000, J BACTERIOL, V182, P5448, DOI 10.1128/JB.182.19.5448-5453.2000; Hernaez MJ, 1999, APPL ENVIRON MICROB, V65, P1806; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; Huang JZ, 1998, J BACTERIOL, V180, P2736, DOI 10.1128/JB.180.10.2736-2743.1998; Karlsson A, 2002, J MOL BIOL, V318, P261, DOI 10.1016/S0022-2836(02)00039-6; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kovacikova G, 2004, MOL MICROBIOL, V53, P129, DOI 10.1111/j.1365-2958.2004.04121.x; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Little R, 2000, EMBO J, V19, P6041, DOI 10.1093/emboj/19.22.6041; Lopez-Sanchez A, 2010, APPL ENVIRON MICROB, V76, P110, DOI 10.1128/AEM.01846-09; Lopez-Sanchez A, 2009, MOL MICROBIOL, V73, P1086, DOI 10.1111/j.1365-2958.2009.06834.x; LOVENBERG W, 1973, IRON SULFUR PROTEINS, P214; MACHEROUX P, 1999, FLAVOPROTEIN PROTOCO, P1; Martinez-Perez O, 2004, J BACTERIOL, V186, P6101, DOI 10.1128/JB.186.18.6101-6109.2004; Martinez-Perez O, 2007, J BACTERIOL, V189, P3768, DOI 10.1128/JB.00057-07; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Nam JW, 2002, APPL ENVIRON MICROB, V68, P5882, DOI 10.1128/AEM.68.12.5882-5890.2002; Porrua O, 2007, MOL MICROBIOL, V66, P410, DOI 10.1111/j.1365-2958.2007.05927.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P5058; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6	50	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1709	1718		10.1074/jbc.M110.184648	http://dx.doi.org/10.1074/jbc.M110.184648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068394	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000286191500010
J	Liebscher, I; Muller, U; Teupser, D; Engemaier, E; Engel, KMY; Ritscher, L; Thor, D; Sangkuhl, K; Ricken, A; Wurm, A; Piehler, D; Schmutzler, S; Fuhrmann, H; Albert, FW; Reichenbach, A; Thiery, J; Schoneberg, T; Schulz, A				Liebscher, Ines; Mueller, Uwe; Teupser, Daniel; Engemaier, Eva; Engel, Kathrin M. Y.; Ritscher, Lars; Thor, Doreen; Sangkuhl, Katrin; Ricken, Albert; Wurm, Antje; Piehler, Daniel; Schmutzler, Sandra; Fuhrmann, Herbert; Albert, Frank W.; Reichenbach, Andreas; Thiery, Joachim; Schoeneberg, Torsten; Schulz, Angela			Altered Immune Response in Mice Deficient for the G Protein-coupled Receptor GPR34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V2 VASOPRESSIN RECEPTOR; CHEMOTACTIC MIGRATION; GLIAL-CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; INFLAMMATION; MACROPHAGES; PHENOTYPES; INFECTION	The X-chromosomal GPR34 gene encodes an orphan G(i) protein-coupled receptor that is highly conserved among vertebrates. To evaluate the physiological relevance of GPR34, we generated a GPR34-deficient mouse line. GPR34-deficient mice were vital, reproduced normally, and showed no gross abnormalities in anatomical, histological, laboratory chemistry, or behavioral investigations under standard housing. Because GPR34 is highly expressed in mononuclear cells of the immune system, mice were specifically tested for altered functions of these cell types. Following immunization with methylated BSA, the number of granulocytes and macrophages in spleens was significantly lower in GPR34-deficient mice as in wild-type mice. GPR34-deficient mice showed significantly increased paw swelling in the delayed type hypersensitivity test and higher pathogen burden in extrapulmonary tissues after pulmonary infection with Cryptococcus neoformans compared with wild-type mice. The findings in delayed type hypersensitivity and infection tests were accompanied by significantly different basal and stimulated TNF-alpha, GM-CSF, and IFN-gamma levels in GPR34-deficient animals. Our data point toward a functional role of GPR34 in the cellular response to immunological challenges.	[Sangkuhl, Katrin] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Teupser, Daniel; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Fac Med, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany; [Wurm, Antje; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, Fac Med, D-04103 Leipzig, Germany; [Mueller, Uwe; Piehler, Daniel] Univ Leipzig, Fac Vet Med, Inst Immunol, D-04103 Leipzig, Germany; [Schmutzler, Sandra; Fuhrmann, Herbert] Univ Leipzig, Fac Vet Med, Inst Biochem, D-04103 Leipzig, Germany; [Albert, Frank W.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society		schoberg@medizin.uni-leipzig.de	Grosche, Antje/N-1978-2014; Thor, Doreen/P-6778-2019; Reichenbach, Andreas/B-2510-2017; Liebscher, Ines/AAX-7478-2020; Engel, Kathrin M/AAQ-1309-2021	Grosche, Antje/0000-0003-0338-7530; Thor, Doreen/0000-0002-9522-5098; Liebscher, Ines/0000-0003-4480-8987; Engel, Kathrin M/0000-0003-0611-7042; Muller, Uwe/0000-0003-1502-9271; Albert, Frank/0000-0002-1380-8063	Deutsche Forschungsgemeinschaft [Scho 624/7-1, FOR 748]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant Scho 624/7-1, FOR 748.	Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; BELLINI F, 1990, BIOCHIM BIOPHYS ACTA, V1052, P216, DOI 10.1016/0167-4889(90)90079-S; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Black C A, 1999, Dermatol Online J, V5, P7; Boselt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005573; Boucher CA, 2001, J MED GENET, V38, P591, DOI 10.1136/jmg.38.9.591; Ceglarek U, 2002, CLIN CHEM LAB MED, V40, P693, DOI 10.1515/CCLM.2002.119; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; Iwashita M, 2009, J MED CHEM, V52, P5837, DOI 10.1021/jm900598m; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kleinschek MA, 2010, INT IMMUNOL, V22, P81, DOI 10.1093/intimm/dxp117; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Lee SY, 2008, BIOCHEM BIOPH RES CO, V374, P147, DOI 10.1016/j.bbrc.2008.06.117; LIVAK KJ, 2000, METHOD MOL BIOL, V132, P365; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; MODY CH, 1990, J IMMUNOL, V144, P1472; Mueller P, 2003, CLIN CHIM ACTA, V327, P47, DOI 10.1016/S0009-8981(02)00327-3; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; NOVAK A, 2008, 50 ANN M EXP DEC 6 2; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Park KS, 2006, MOL PHARMACOL, V69, P1066, DOI 10.1124/mol.105.018960; Park KS, 2005, BIOCHEM BIOPH RES CO, V333, P353, DOI 10.1016/j.bbrc.2005.05.109; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; Plyusnina I, 1997, PHYSIOL BEHAV, V61, P381, DOI 10.1016/S0031-9384(96)00445-3; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Rozen S, 2000, PRIMER3 WWW GEN USER; Schliebe N, 2008, AM J PHYSIOL-RENAL, V295, pF1177, DOI 10.1152/ajprenal.00465.2007; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 1999, BBA-GENE STRUCT EXPR, V1446, P57, DOI 10.1016/S0167-4781(99)00081-0; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Thor D, 2008, BIOCHEM J, V412, P103, DOI [10.1042/BJ20071366, 10.1042/bj20071366]; Uckermann O, 2004, GLIA, V45, P59, DOI 10.1002/glia.10305; WIGGLESWORTH MJ, 2006, FDN S P, P105; Wlodarska M, 2009, HAEMATOL-HEMATOL J, V94, P271; Wurm A, 2010, J NEUROCHEM, V112, P1261, DOI 10.1111/j.1471-4159.2009.06541.x; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	62	58	59	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2101	2110		10.1074/jbc.M110.196659	http://dx.doi.org/10.1074/jbc.M110.196659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097509	Green Published, hybrid			2022-12-27	WOS:000286191500052
J	Carriere, A; Romeo, Y; Acosta-Jaquez, HA; Moreau, J; Bonneil, E; Thibault, P; Fingar, DC; Roux, PP				Carriere, Audrey; Romeo, Yves; Acosta-Jaquez, Hugo A.; Moreau, Julie; Bonneil, Eric; Thibault, Pierre; Fingar, Diane C.; Roux, Philippe P.			ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; TUMOR-SUPPRESSOR COMPLEX; INITIATION-FACTOR 4E; RIBOSOMAL S6 KINASE; CELL-GROWTH; TUBEROUS SCLEROSIS; PROTEIN-PHOSPHORYLATION; MAMMALIAN TARGET; DOWNSTREAM TARGETS; IN-VIVO	The Ras/mitogen-activated protein kinase (MAPK) pathway regulates a variety of cellular processes by activating specific transcriptional and translational programs. Ras/MAPK signaling promotes mRNA translation and protein synthesis, but the exact molecular mechanisms underlying this regulation remain poorly understood. Increasing evidence suggests that the mammalian target of rapamycin (mTOR) plays an essential role in this process. Here, we show that Raptor, an essential scaffolding protein of the mTOR complex 1 (mTORC1), becomes phosphorylated on proline-directed sites following activation of the Ras/MAPK pathway. We found that ERK1 and ERK2 interact with Raptor in cells and mediate its phosphorylation in vivo and in vitro. Using mass spectrometry and phosphospecific antibodies, we found three proline-directed residues within Raptor, Ser(8), Ser(696), and Ser(863), which are directly phosphorylated by ERK1/2. Expression of phosphorylation-deficient alleles of Raptor revealed that phosphorylation of these sites by ERK1/2 normally promotes mTORC1 activity and signaling to downstream substrates, such as 4E-BP1. Our data provide a novel regulatory mechanism by which mitogenic and oncogenic activation of the Ras/MAPK pathway promotes mTOR signaling.	[Romeo, Yves; Moreau, Julie; Bonneil, Eric; Thibault, Pierre; Roux, Philippe P.] Univ Montreal, IRIC, Montreal, PQ H3C 3J7, Canada; [Carriere, Audrey; Romeo, Yves; Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada; [Acosta-Jaquez, Hugo A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roux, PP (corresponding author), Univ Montreal, IRIC, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	philippe.roux@umontreal.ca	Romeo, Yves/AAC-1669-2021; Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Thibault, Pierre/0000-0001-5993-0331; Carriere, Audrey/0000-0002-4277-7905	Terry Fox Foundation, Canadian Cancer Society Research Institute [018311]; Fondation pour la recherche en sante du Quebec; Cole Foundation; National Institutes of Health [R01 (DK-078135)]; American Diabetes Association; Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078135] Funding Source: NIH RePORTER	Terry Fox Foundation, Canadian Cancer Society Research Institute; Fondation pour la recherche en sante du Quebec; Cole Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Terry Fox Foundation Grant 018311 from the Canadian Cancer Society Research Institute. IRIC core facilities are supported by the Fondation pour la recherche en sante du Quebec.; Recipient of a fellowship from the Cole Foundation.; Supported by National Institutes of Health Grant R01 (DK-078135) and an American Diabetes Association Junior Faculty Award.; Holds a Canada Research Chair in Signal Transduction and Proteomics and a Career Development Award from the Human Frontier Science Program.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	65	168	173	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					567	577		10.1074/jbc.M110.159046	http://dx.doi.org/10.1074/jbc.M110.159046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21071439	Green Published, hybrid			2022-12-27	WOS:000285782800059
J	Aresta-Branco, F; Cordeiro, AM; Marinho, HS; Cyrne, L; Antunes, F; de Almeida, RFM				Aresta-Branco, Francisco; Cordeiro, Andre M.; Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando; de Almeida, Rodrigo F. M.			Gel Domains in the Plasma Membrane of Saccharomyces cerevisiae HIGHLY ORDERED, ERGOSTEROL-FREE, AND SPHINGOLIPID-ENRICHED LIPID RAFTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; MULTIPLE FUNCTIONS; CELL-SURFACE; FATTY-ACIDS; FLUORESCENCE; PHASE; METABOLISM; H2O2; PERMEABILITY; CHOLESTEROL	The plasma membrane of Saccharomyces cerevisiae was studied using the probes trans-parinaric acid and diphenylhexatriene. Diphenylhexatriene anisotropy is a good reporter of global membrane order. The fluorescence lifetimes of transparinaric acid are particularly sensitive to the presence and nature of ordered domains, but thus far they have not been measured in yeast cells. A long lifetime typical of the gel phase (>30 ns) was found in wild-type (WT) cells from two different genetic backgrounds, at 24 and 30 degrees C, providing the first direct evidence for the presence of gel domains in living cells. To understand their nature and location, the study of WT cells was extended to spheroplasts, the isolated plasma membrane, and liposomes from total lipid and plasma membrane lipid extracts (with or without ergosterol extraction by cyclodextrin). It is concluded that the plasma membrane is mostly constituted by ordered domains and that the gel domains found in living cells are predominantly at the plasma membrane and are formed by lipids. To understand their composition, strains with mutations in sphingolipid and ergosterol metabolism and in the glycosylphosphatidylinositol anchor remodeling pathway were also studied. The results strongly indicate that the gel domains are not ergosterol-enriched lipid rafts; they are mainly composed of sphingolipids, possibly inositol phosphorylceramide, and contain glycosylphosphatidylinositol-anchored proteins, suggesting an important role in membrane traffic and signaling, and interactions with the cell wall. The abundance of the sphingolipid-enriched gel domains was inversely related to the cellular membrane system global order, suggesting their involvement in the regulation of membrane properties.	[Aresta-Branco, Francisco; Cordeiro, Andre M.; Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando; de Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal; [Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando] Univ Lisbon, Dept Quim & Bioquim, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	de Almeida, RFM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Ed C8, P-1749016 Lisbon, Portugal.	Rodrigo.almeida@fc.ul.pt	Antunes, Fernando/A-1030-2009; Marinho, H. Susana/A-1357-2009; Cyrne, Luisa/A-1358-2009; Cordeiro, André/B-8310-2016; de Almeida, Rodrigo/D-8629-2012	Antunes, Fernando/0000-0002-4192-2840; Marinho, H. Susana/0000-0002-4625-2516; Cyrne, Luisa/0000-0002-0183-7713; Cordeiro, André/0000-0002-7299-8944; de Almeida, Rodrigo/0000-0002-9748-7083	Fundacao para a Ciencia e a Tecnologia, Portugal [PPCDT/BIA-MIC/59925/2004, PTDC/QUI-BIQ/104311/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants PPCDT/BIA-MIC/59925/2004 and PTDC/QUI-BIQ/104311/2008 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Asanov A, 2010, BBA-MOL CELL BIOL L, V1801, P147, DOI 10.1016/j.bbalip.2009.10.004; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bosson R, 2007, BIOCHEM SOC SYMP, V74, P199, DOI 10.1042/BSS2007c17; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Castro BM, 2007, BIOPHYS J, V93, P1639, DOI 10.1529/biophysj.107.107714; Castro BM, 2009, J BIOL CHEM, V284, P22978, DOI 10.1074/jbc.M109.026567; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; de Sampaio G, 1999, MOL MICROBIOL, V34, P247, DOI 10.1046/j.1365-2958.1999.01585.x; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folmer V, 2008, BBA-BIOMEMBRANES, V1778, P1141, DOI 10.1016/j.bbamem.2007.12.008; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; HEIDEPRIEM RW, 1992, J STEROID BIOCHEM, V43, P741, DOI 10.1016/0960-0760(92)90300-8; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Hsueh YW, 2007, BIOPHYS J, V92, P1606, DOI 10.1529/biophysj.106.097345; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Leber A, 1997, FEBS LETT, V411, P211, DOI 10.1016/S0014-5793(97)00692-3; Lentz B. R., 1988, MEMBRANE FLUIDITY AN, P13; LESTER RL, 1993, J BIOL CHEM, V268, P845; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MATEO CR, 1993, BIOPHYS J, V65, P2237, DOI 10.1016/S0006-3495(93)81257-8; MATEO CR, 1995, BIOPHYS J, V68, P978, DOI 10.1016/S0006-3495(95)80273-0; MATEO CR, 1991, EUR BIOPHYS J, V20, P41; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Obeid LA, 2002, BBA-MOL CELL BIOL L, V1585, P163, DOI 10.1016/S1388-1981(02)00337-2; Opekarova M, 2005, BBA-BIOMEMBRANES, V1711, P87, DOI 10.1016/j.bbamem.2005.02.015; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Pedroso N, 2009, FREE RADICAL BIO MED, V46, P289, DOI 10.1016/j.freeradbiomed.2008.10.039; Ragoonanan V, 2008, BBA-BIOMEMBRANES, V1778, P2283, DOI 10.1016/j.bbamem.2008.06.006; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SCHROEDER F, 1984, J NEUROCHEM, V43, P526, DOI 10.1111/j.1471-4159.1984.tb00931.x; SCHROEDER F, 1983, EUR J BIOCHEM, V132, P509, DOI 10.1111/j.1432-1033.1983.tb07391.x; SCHULTHESS G, 1995, MOL MEMBR BIOL, V12, P105, DOI 10.3109/09687689509038504; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Silva L, 2006, BIOPHYS J, V90, P3625, DOI 10.1529/biophysj.105.075408; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Swain E, 2002, J BIOL CHEM, V277, P26177, DOI 10.1074/jbc.M204115200; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200; WELTI R, 1981, J BIOL CHEM, V256, P7528; WOLF DE, 1995, MOL MEMBR BIOL, V12, P101, DOI 10.3109/09687689509038503; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	63	77	79	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5043	5054		10.1074/jbc.M110.154435	http://dx.doi.org/10.1074/jbc.M110.154435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127065	Green Published, hybrid			2022-12-27	WOS:000287230600012
J	Yip, CY; Harbour, ME; Jayawardena, K; Fearnley, IM; Sazanov, LA				Yip, Chui-ying; Harbour, Michael E.; Jayawardena, Kamburapola; Fearnley, Ian M.; Sazanov, Leonid A.			Evolution of Respiratory Complex I "SUPERNUMERARY" SUBUNITS ARE PRESENT IN THE alpha-PROTEOBACTERIAL ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYTOCHROME-C-OXIDASE; BOVINE HEART-MITOCHONDRIA; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; QUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; THERMUS-THERMOPHILUS; HYDROPHILIC DOMAIN; MASS-SPECTROMETRY	Modern alpha-proteobacteria are thought to be closely related to the ancient symbiont of eukaryotes, an ancestor of mitochondria. Respiratory complex I from alpha-proteobacteria and mitochondria is well conserved at the level of the 14 "core" subunits, consistent with that notion. Mitochondrial complex I contains the core subunits, present in all species, and up to 31 "supernumerary" subunits, generally thought to have originated only within eukaryotic lineages. However, the full protein composition of an alpha-proteobacterial complex I has not been established previously. Here, we report the first purification and characterization of complex I from the alpha-proteobacterium Paracoccus denitrificans. Single particle electron microscopy shows that the complex has a well defined L-shape. Unexpectedly, in addition to the 14 core subunits, the enzyme also contains homologues of three supernumerary mitochondrial subunits as follows: B17.2, AQDQ/18, and 13 kDa ( bovine nomenclature). This finding suggests that evolution of complex I via addition of supernumerary or "accessory" subunits started before the original endosymbiotic event that led to the creation of the eukaryotic cell. It also provides further confirmation that alpha-proteobacteria are the closest extant relatives of mitochondria.	[Yip, Chui-ying; Harbour, Michael E.; Jayawardena, Kamburapola; Fearnley, Ian M.; Sazanov, Leonid A.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Sazanov, LA (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Andersson SGE, 1999, CURR OPIN MICROBIOL, V2, P535, DOI 10.1016/S1369-5274(99)00013-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Dupuis A, 1998, BBA-BIOENERGETICS, V1364, P147, DOI 10.1016/S0005-2728(98)00025-5; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Giachini L, 2007, FEBS LETT, V581, P5645, DOI 10.1016/j.febslet.2007.11.019; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grivennikova VG, 2003, BBA-BIOENERGETICS, V1607, P79, DOI 10.1016/j.bbabio.2003.09.001; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; LUDWIG B, 1986, METHOD ENZYMOL, V126, P153; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; XU XM, 1993, BIOCHEMISTRY-US, V32, P968, DOI 10.1021/bi00054a030; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	53	68	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5023	5033		10.1074/jbc.M110.194993	http://dx.doi.org/10.1074/jbc.M110.194993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21115482	Green Published, hybrid			2022-12-27	WOS:000287230600010
J	Light, SH; Minasov, G; Shuvalova, L; Duban, ME; Caffrey, M; Anderson, WF; Lavie, A				Light, Samuel H.; Minasov, George; Shuvalova, Ludmilla; Duban, Mark-Eugene; Caffrey, Michael; Anderson, Wayne F.; Lavie, Arnon			Insights into the Mechanism of Type I Dehydroquinate Dehydratases from Structures of Reaction Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DEHYDROQUINASE; ACTIVE-SITE; SHIKIMATE PATHWAY; HIGH-THROUGHPUT; CATALYZED DEHYDRATION; ACID BIOSYNTHESIS; ENZYME; 3-DEHYDROQUINASE; PURIFICATION; INHIBITORS	The biosynthetic shikimate pathway consists of seven enzymes that catalyze sequential reactions to generate chorismate, a critical branch point in the synthesis of the aromatic amino acids. The third enzyme in the pathway, dehydroquinate dehydratase (DHQD), catalyzes the dehydration of 3-dehydroquinate to 3-dehydroshikimate. We present three crystal structures of the type I DHQD from the intestinal pathogens Clostridium difficile and Salmonella enterica. Structures of the enzyme with substrate and covalent pre- and post-dehydration reaction intermediates provide snapshots of successive steps along the type I DHQD-catalyzed reaction coordinate. These structures reveal that the position of the substrate within the active site does not appreciably change upon Schiff base formation. The intermediate state structures reveal a reaction state-dependent behavior of His-143 in which the residue adopts a conformation proximal to the site of catalytic dehydration only when the leaving group is present. We speculate that His-143 is likely to assume differing catalytic roles in each of its observed conformations. One conformation of His-143 positions the residue for the formation/hydrolysis of the covalent Schiff base intermediates, whereas the other conformation positions the residue for a role in the catalytic dehydration event. The fact that the shikimate pathway is absent from humans makes the enzymes of the pathway potential targets for the development of non-toxic antimicrobials. The structures and mechanistic insight presented here may inform the design of type I DHQD enzyme inhibitors.	[Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Light, Samuel H.; Minasov, George; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), 900 S Ashland Ave,MBRB Room 1108, Chicago, IL 60607 USA.	Lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Light, Sam/0000-0002-8074-1348; Minasov, George/0000-0001-5460-3462	National Institutes of Health through the NIAID [HHSN272200700058C]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN272200700058C (to W. F. A.) through the NIAID.; We thank Dr. Elisabetta Sabini for facilitating the communications with the groups involved in this work and Dr. Scott Peterson and Dr. Keehwan Kwon for providing DHQD expression clones. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported in part by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; BUTLER JR, 1974, J AM CHEM SOC, V96, P1617, DOI 10.1021/ja00812a069; CHAUDHURI S, 1986, BIOCHEM J, V239, P699, DOI 10.1042/bj2390699; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; DEKA RK, 1992, J BIOL CHEM, V267, P22237; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming I., 2010, MOL ORBITALS ORGANIC, P214; Godsey MH, 2007, PROTEIN SCI, V16, P1285, DOI 10.1110/ps.062674007; Gourley DG, 1999, NAT STRUCT BIOL, V6, P521; HANSON KR, 1963, P NATL ACAD SCI USA, V50, P981, DOI 10.1073/pnas.50.5.981; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KLEANTHOUS C, 1990, J BIOL CHEM, V265, P10929; KLEANTHOUS C, 1992, BIOCHEM J, V282, P687, DOI 10.1042/bj2820687; Le Sann C, 2004, MINI-REV MED CHEM, V4, P747; Lee WH, 2002, ACTA CRYSTALLOGR D, V58, P798, DOI 10.1107/S0907444902003918; LEECH AP, 1995, J BIOL CHEM, V270, P25827, DOI 10.1074/jbc.270.43.25827; LUMSDEN J, 1977, BIOCHEM J, V161, P599, DOI 10.1042/bj1610599; Marques MR, 2007, CURR DRUG TARGETS, V8, P445; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nichols CE, 2004, PROTEINS, V56, P625, DOI 10.1002/prot.20165; Noble M, 2006, BIOTECHNOL BIOENG, V95, P560, DOI 10.1002/bit.20772; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker EJ, 2000, BIOORG MED CHEM LETT, V10, P231, DOI 10.1016/S0960-894X(99)00660-5; POLLEY LD, 1978, BIOCHIM BIOPHYS ACTA, V526, P259, DOI 10.1016/0005-2744(78)90310-8; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; REILLY A, 1994, J BIOL CHEM, V269, P5523; Smith NN, 2008, ACTA CRYSTALLOGR F, V64, P886, DOI 10.1107/S1744309108028546; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; TURNER MJ, 1975, J CHEM SOC P1, V1, P52; VAZ ADN, 1975, J AM CHEM SOC, V97, P5914, DOI 10.1021/ja00853a046; WHITE PJ, 1990, BIOCHEM J, V265, P735, DOI 10.1042/bj2650735	35	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3531	3539		10.1074/jbc.M110.192831	http://dx.doi.org/10.1074/jbc.M110.192831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21087925	hybrid, Green Published			2022-12-27	WOS:000286653200038
J	Lin, YP; Kuo, CJ; Koleci, X; McDonough, SP; Chang, YF				Lin, Yi-Pin; Kuo, Chih-Jung; Koleci, Xhelil; McDonough, Sean P.; Chang, Yung-Fu			Manganese Binds to Clostridium difficile Fbp68 and Is Essential for Fibronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-LAYER PROTEINS; IMMUNOGLOBULIN-LIKE PROTEIN; TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS; MOLECULAR CHARACTERIZATION; PATHOGENIC LEPTOSPIRA; CALCIUM BINDS; GROEL HSP60; GENE; EXPRESSION	Clostridium difficile is an etiological agent of pseudomembranous colitis and antibiotic-associated diarrhea. Adhesion is the crucial first step in bacterial infection. Thus, in addition to toxins, the importance of colonization factors in C. difficile-associated disease is recognized. In this study, we identified Fbp68, one of the colonization factors that bind to fibronectin (Fn), as a manganese-binding protein (K-D = 52.70 +/- 1.97 nM). Furthermore, the conformation of Fbp68 changed dramatically upon manganese binding. Manganese binding can also stabilize the structure of Fbp68 as evidenced by the increased T-m measured by thermodenatured circular dichroism and differential scanning calorimetry (CD, T-m = 58-65 degrees C; differential scanning calorimetry, T-m = 59-66 degrees C). In addition, enhanced tolerance to protease K also suggests greatly improved stability of Fbp68 through manganese binding. Fn binding activity was found to be dependent on manganese due to the lack of binding by manganese-free Fbp68 to Fn. The C-terminal 194 amino acid residues of Fbp68 (Fbp68C) were discovered to bind to the N-terminal domain of Fn (Fbp68C-NTD, K-D = 233 +/- 10 nM, obtained from isothermal titration calorimetry). Moreover, adhesion of C. difficile to Caco-2 cells can be partially blocked if cells are pretreated with Fbp68C, and the binding of Fbp68C on Fn siRNA-transfected cells was significantly reduced. These results raise the possibility that Fbp68 plays a key role in C. difficile adherence on host cells to initiate infection.	[Lin, Yi-Pin; Kuo, Chih-Jung; Koleci, Xhelil; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu		Kuo, Chih-Jung/0000-0002-4988-5124	National Institutes of Health [N01-AI-30054]; NIAID, Department of Health and Human Services [ZC005-06, ZC008-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30054, Project ZC005-06 and ZC008-09 from NIAID, Department of Health and Human Services.	AINSWORTH S, 1975, BIOCHEM J, V145, P63, DOI 10.1042/bj1450063; Barondeau DP, 2004, CURR OPIN STRUC BIOL, V14, P765, DOI 10.1016/j.sbi.2004.10.012; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BORRIELLO SP, 1990, REV INFECT DIS, V12, pS185; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; CORTHIER G, 1989, INFECT IMMUN, V57, P3922, DOI 10.1128/IAI.57.12.3922-3927.1989; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; DAVIES HA, 1990, MICROB PATHOGENESIS, V9, P141, DOI 10.1016/0882-4010(90)90088-8; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; EVEILLARD M, 1993, MOL MICROBIOL, V7, P371, DOI 10.1111/j.1365-2958.1993.tb01129.x; Giesemann T, 2008, J MED MICROBIOL, V57, P690, DOI 10.1099/jmm.0.47742-0; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hesketh S, 2008, MOL CELL NEUROSCI, V37, P590, DOI 10.1016/j.mcn.2007.12.008; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; KARJALAINEN T, 1994, INFECT IMMUN, V62, P4347, DOI 10.1128/IAI.62.10.4347-4355.1994; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Karjalainen T, 2001, INFECT IMMUN, V69, P3442, DOI 10.1128/IAI.69.5.3442-3446.2001; Kelly CP, 1998, ANNU REV MED, V49, P375; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Poilane I, 1998, CAN J MICROBIOL, V44, P157, DOI 10.1139/cjm-44-2-157; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SEDDON SV, 1992, J MED MICROBIOL, V36, P307, DOI 10.1099/00222615-36-5-307; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi L, 2001, J BACTERIOL, V183, P7053, DOI 10.1128/JB.183.24.7053-7057.2001; SILVA JJ, 2001, BIOL CHEM ELEMENTS I, P402; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tasteyre A, 2000, MICROBIOL-SGM, V146, P957, DOI 10.1099/00221287-146-4-957; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vendrame F, 2006, J CLIN ENDOCR METAB, V91, P5064, DOI 10.1210/jc.2006-1358; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001	68	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3957	3969		10.1074/jbc.M110.184523	http://dx.doi.org/10.1074/jbc.M110.184523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21062746	Green Published, hybrid			2022-12-27	WOS:000286653200076
J	Ollivierre, JN; Sikora, JL; Beuning, PJ				Ollivierre, Jaylene N.; Sikora, Jacquelyn L.; Beuning, Penny J.			The Dimeric SOS Mutagenesis Protein UmuD Is Active as a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECA-MEDIATED CLEAVAGE; INTRINSICALLY UNSTRUCTURED PROTEINS; DAMAGE-INDUCED MUTAGENESIS; BETA-PROCESSIVITY CLAMP; ESCHERICHIA-COLI; DNA-POLYMERASE; TRANSLESION SYNTHESIS; PLASMID TP110; UV PROTECTION; INTACT UMUD	The homodimeric umuD gene products play key roles in regulating the cellular response to DNA damage in Escherichia coli. UmuD(2) is composed of 139-amino acid subunits and is up-regulated as part of the SOS response. Subsequently, damage-induced RecA.ssDNA nucleoprotein filaments mediate the slow self-cleavage of the N-terminal 24-amino acid arms yielding UmuD'(2). UmuD(2) and UmuD'(2) make a number of distinct protein-protein contacts that both prevent and facilitate mutagenic translesion synthesis. Wild-type UmuD(2) and UmuD'(2) form exceptionally tight dimers in solution; however, we show that the single amino acid change N41D generates stable, active UmuD and UmuD' monomers that functionally mimic the dimeric wild-type proteins. The UmuD N41D monomer is proficient for cleavage and interacts physically with DNA polymerase IV (DinB) and the beta clamp. Furthermore, the N41D variants facilitate UV-induced mutagenesis and promote overall cell viability. Taken together, these observations show that a monomeric form of UmuD retains substantial function in vivo and in vitro.	[Beuning, Penny J.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Beuning, Penny J.] Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Beuning, PJ (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave,102 Hurtig Hall, Boston, MA 02115 USA.	beuning@neu.edu			Camille and Henry Dreyfus Foundation; National Science Foundation [MCB-0845033]; Northeastern University Office of the Provost	Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); Northeastern University Office of the Provost	This work was supported by a New Faculty Award from the Camille and Henry Dreyfus Foundation (to P. J. B.), the National Science Foundation (CAREER Award, MCB-0845033 to P. J. B.), and the Northeastern University Office of the Provost.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], DYNAMICS BACTERIAL C; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BATTISTA JR, 1990, P NATL ACAD SCI USA, V87, P7190, DOI 10.1073/pnas.87.18.7190; Becherel OJ, 1999, J MOL BIOL, V294, P299, DOI 10.1006/jmbi.1999.3272; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, J BIOL CHEM, V281, P9633, DOI 10.1074/jbc.M511101200; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fang J, 2010, J MOL BIOL, V398, P40, DOI 10.1016/j.jmb.2010.02.040; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Foti JJ, 2010, J BIOL CHEM, V285, P23084, DOI 10.1074/jbc.M110.115774; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Freidberg E. C., 2005, DNA REPAIR MUTAGENES; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; GIMBLE FS, 1989, J MOL BIOL, V206, P29, DOI 10.1016/0022-2836(89)90521-4; GLAZEBROOK JA, 1986, J BACTERIOL, V168, P251, DOI 10.1128/jb.168.1.251-256.1986; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Gonzalez M, 2002, BIOESSAYS, V24, P141, DOI 10.1002/bies.10040; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Goodrich J., 2007, BINDING KINETICS MOL; Guzzo A, 1996, J BACTERIOL, V178, P7295, DOI 10.1128/jb.178.24.7295-7303.1996; HO C, 1993, J BACTERIOL, V175, P5411, DOI 10.1128/JB.175.17.5411-5419.1993; KULAEVA OI, 1995, J BACTERIOL, V177, P2737, DOI 10.1128/jb.177.10.2737-2743.1995; Lee MH, 1996, J BACTERIOL, V178, P7304, DOI 10.1128/jb.178.24.7304-7307.1996; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; LODWICK D, 1990, NUCLEIC ACIDS RES, V18, P5045, DOI 10.1093/nar/18.17.5045; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; McLenigan M, 1998, J BACTERIOL, V180, P4658, DOI 10.1128/JB.180.17.4658-4666.1998; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ohta T, 1999, J BACTERIOL, V181, P177, DOI 10.1128/JB.181.1.177-185.1999; Ollivierre JN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/947680; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Opperman T, 1996, J BACTERIOL, V178, P4400, DOI 10.1128/jb.178.15.4400-4411.1996; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; PERRY KL, 1985, P NATL ACAD SCI USA, V82, P4331, DOI 10.1073/pnas.82.13.4331; PERRY KL, 1982, NATURE, V300, P278, DOI 10.1038/300278a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Sambrook J., 2002, MOL CLONING LAB MANU; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; SHIBA T, 1990, MOL GEN GENET, V224, P169, DOI 10.1007/BF00271549; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; Singleton SF, 2002, PROTEIN EXPRES PURIF, V26, P476, DOI 10.1016/S1046-5928(02)00571-5; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2002, DNA REPAIR, V1, P77, DOI 10.1016/S1568-7864(01)00006-4; Sutton MD, 2002, P NATL ACAD SCI USA, V99, P5307, DOI 10.1073/pnas.082322099; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002	71	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3607	3617		10.1074/jbc.M110.167254	http://dx.doi.org/10.1074/jbc.M110.167254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118802	Green Published, hybrid			2022-12-27	WOS:000286653200045
J	Qi, H; Watanabe, T; Ku, HY; Liu, N; Zhong, M; Lin, HF				Qi, Hongying; Watanabe, Toshiaki; Ku, Hsueh-Yen; Liu, Na; Zhong, Mei; Lin, Haifan			The Yb Body, a Major Site for Piwi-associated RNA Biogenesis and a Gateway for Piwi Expression and Transport to the Nucleus in Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PIRNA BIOGENESIS; PLANARIAN STEM-CELLS; DROSOPHILA-MELANOGASTER; SELF-RENEWAL; FLAMENCO GENE; MALE GERMLINE; HIWI GENE; PROTEIN; ARMITAGE; HOMOLOG	Despite exciting progress in understanding the Piwi-interacting RNA (piRNA) pathway in the germ line, less is known about this pathway in somatic cells. We showed previously that Piwi, a key component of the piRNA pathway in Drosophila, is regulated in somatic cells by Yb, a novel protein containing an RNA helicase-like motif and a Tudor-like domain. Yb is specifically expressed in gonadal somatic cells and regulates piwi in somatic niche cells to control germ line and somatic stem cell self-renewal. However, the molecular basis of the regulation remains elusive. Here, we report that Yb recruits Armitage (Armi), a putative RNA helicase involved in the piRNA pathway, to the Yb body, a cytoplasmic sphere to which Yb is exclusively localized. Moreover, co-immunoprecipitation experiments show that Yb forms a complex with Armi. In Yb mutants, Armi is dispersed throughout the cytoplasm, and Piwi fails to enter the nucleus and is rarely detectable in the cytoplasm. Furthermore, somatic piRNAs are drastically diminished, and soma-expressing transposons are desilenced. These observations indicate a crucial role of Yb and the Yb body in piRNA biogenesis, possibly by regulating the activity of Armi that controls the entry of Piwi into the nucleus for its function. Finally, we discovered putative endo-siRNAs in the flamenco locus and the Yb dependence of their expression. These observations further implicate a role for Yb in transposon silencing via both the piRNA and endo-siRNA pathways.	Yale Univ, Sch Med, Stem Cell Ctr, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06511 USA	Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Stem Cell Ctr, 10 Amistad St, New Haven, CT 06509 USA.	haifan.lin@yale.edu	qi, hongying/G-7862-2012		National Institutes of Health [R01HD33760, DP1OD006825]; Mathers Award; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033760] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174418] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Award; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD33760 and DP1OD006825 (to H.L.). This work was also supported by the Mathers Award (to H.L.) and a fellowship from the Japan Society for the Promotion of Science (to T.W.).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Desset S, 2003, GENETICS, V164, P501; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Harris AN, 2001, DEVELOPMENT, V128, P2823; JOHNSON E, 1995, GENETICS, V140, P207; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; King FJ, 1999, DEVELOPMENT, V126, P1833; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; LIN HF, 1994, DEVELOPMENT, V120, P947; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	43	92	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3789	3797		10.1074/jbc.M110.193888	http://dx.doi.org/10.1074/jbc.M110.193888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106531	Green Published, hybrid			2022-12-27	WOS:000286653200060
J	Yamashita, H; Ueda, K; Kioka, N				Yamashita, Hiroshi; Ueda, Kazumitsu; Kioka, Noriyuki			WAVE2 Forms a Complex with PKA and Is Involved in PKA Enhancement of Membrane Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CELL-MIGRATION; ANCHORING PROTEINS; ACTIN REORGANIZATION; ARP2/3 COMPLEX; PHOSPHORYLATION; WASP; RAC; ACTIVATION; ADHESION	PKA contributes to many physiological processes, including glucose homeostasis and cell migration. The substrate specificity of PKA is low compared with other kinases; thus, complex formation with A-kinase-anchoring proteins is important for the localization of PKA in specific subcellular regions and the phosphorylation of specific substrates. Here, we show that PKA forms a complex with WAVE2 (Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2) in MDA-MB-231 breast cancer cells and mouse brain extracts. Two separate regions of WAVE2 are involved in WAVE2-PKA complex formation. This complex localizes to the leading edge of MDA-MB-231 cells. PKA activation results in enlargement of the membrane protrusion. WAVE2 depletion impairs PKA localization at membrane protrusions and the enlargement of membrane protrusion induced by PKA activation. Together, these results suggest that WAVE2 works as an A-kinase-anchoring protein that recruits PKA at membrane protrusions and plays a role in the enlargement of membrane protrusions induced by PKA activation.	[Yamashita, Hiroshi; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	nkioka@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by The Naito Foundation, a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, research fellowships from the Japan Society for the Promotion of Science for Young Scientists, and a grant from the Bio-oriented Technology Research Advancement Institution.	Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BUTT E, 1994, J BIOL CHEM, V269, P14509; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gustafsdottir SM, 2005, ANAL BIOCHEM, V345, P2, DOI 10.1016/j.ab.2005.01.018; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Mitsushima M, 2006, GENES CELLS, V11, P281, DOI 10.1111/j.1365-2443.2006.00932.x; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Rawe VY, 2004, HUM REPROD, V19, P2594, DOI 10.1093/humrep/deh513; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311	41	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3907	3914		10.1074/jbc.M110.145409	http://dx.doi.org/10.1074/jbc.M110.145409			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21119216	Green Published, hybrid			2022-12-27	WOS:000286653200071
J	Rathinavelan, T; Tang, C; De Guzman, RN				Rathinavelan, Thenmalarchelvi; Tang, Chun; De Guzman, Roberto N.			Characterization of the Interaction between the Salmonella Type III Secretion System Tip Protein SipD and the Needle Protein PrgI by Paramagnetic Relaxation Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; BURKHOLDERIA-PSEUDOMALLEI; SHIGELLA-FLEXNERI; NMR STRUCTURE; V-ANTIGEN; IPAD; VISUALIZATION; INJECTISOME; COMPLEX; DOMAIN	Many Gram-negative bacteria that cause major diseases and mortality worldwide require the type III secretion system (T3SS) to inject virulence proteins into their hosts and cause infections. A structural component of the T3SS is the needle apparatus, which consists of a base, an external needle, and a tip complex. In Salmonella typhimurium, the external needle is assembled by the polymerization of the needle protein PrgI. On top of this needle sits a tip complex, which is partly formed by the tip protein SipD. How SipD interacts with PrgI during the assembly of the T3SS needle apparatus remains unknown. The central region of PrgI forms an alpha-helical hairpin, whereas SipD has a long central coiled-coil, which is a defining structural feature of other T3SS tip proteins as well. Using NMR paramagnetic relaxation enhancement, we have identified a specific region on the SipD coiled-coil that interacts directly with PrgI. We present a model of how SipD might dock at the tip of the needle based on our paramagnetic relaxation enhancement results, thus offering new insight about the mechanism of assembly of the T3SS needle apparatus.	[Rathinavelan, Thenmalarchelvi; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Tang, Chun] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Phys & Atom Mol Phys, Wuhan 430071, Hubei Province, Peoples R China	University of Kansas; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	NIH [RR017708, R01AI074856]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants RR017708 and R01AI074856 (to R. N. D.).	Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mota LJ, 2006, TRENDS MICROBIOL, V14, P197, DOI 10.1016/j.tim.2006.02.010; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Wang Y, 2008, J BIOL CHEM, V283, P28297, DOI 10.1074/jbc.M804869200; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wang Y, 2010, BIOCHEMISTRY-US, V49, P4220, DOI 10.1021/bi100335u; Zhang L, 2007, J BIOL CHEM, V282, P32144, DOI 10.1074/jbc.M703403200; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	34	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4922	4930		10.1074/jbc.M110.159434	http://dx.doi.org/10.1074/jbc.M110.159434			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138848	Green Published, hybrid			2022-12-27	WOS:000286975700088
J	Weeks, SD; Grasty, KC; Hernandez-Cuebas, L; Loll, PJ				Weeks, Stephen D.; Grasty, Kimberly C.; Hernandez-Cuebas, Lisa; Loll, Patrick J.			Crystal Structure of a Josephin-Ubiquitin Complex EVOLUTIONARY RESTRAINTS ON ATAXIN-3 DEUBIQUITINATING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME; DIFFRACTION DATA; OXYANION HOLE; ATAXIN-3; DOMAIN; CHAINS; NEURODEGENERATION; PROTEASOME; MECHANISM	The Josephin domain is a conserved cysteine protease domain found in four human deubiquitinating enzymes: ataxin-3, the ataxin-3-like protein (ATXN3L), Josephin-1, and Josephin-2. Josephin domains from these four proteins were purified and assayed for their ability to cleave ubiquitin substrates. Reaction rates differed markedly both among the different proteins and for different substrates with a given protein. The ATXN3L Josephin domain is a significantly more efficient enzyme than the ataxin-3 domain despite their sharing 85% sequence identity. To understand the structural basis of this difference, the 2.6 angstrom x-ray crystal structure of the ATXN3L Josephin domain in complex with ubiquitin was determined. Although ataxin-3 and ATXN3L adopt similar folds, they bind ubiquitin in different, overlapping sites. Mutations were made in ataxin-3 at selected positions, introducing the corresponding ATXN3L residue. Only three such mutations are sufficient to increase the catalytic activity of the ataxin-3 domain to levels comparable with that of ATXN3L, suggesting that ataxin-3 has been subject to evolutionary restraints that keep its deubiquitinating activity in check.	[Weeks, Stephen D.; Grasty, Kimberly C.; Hernandez-Cuebas, Lisa; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Hernandez-Cuebas, Lisa] Drexel Univ, Coll Med, Grad Program Biochem, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Loll, PJ (corresponding author), 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	pat.loll@drexel.edu	Weeks, Stephen/N-4813-2019; Weeks, Stephen D/G-6150-2017	Weeks, Stephen/0000-0002-1360-0852; Weeks, Stephen D/0000-0002-1360-0852	National Institutes of Health (NINDS) [R01NS065140]; NIGMS, National Institutes of Health [GM-0080]; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065140] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS065140 (NINDS).; We gratefully acknowledge crystallization advice from Dr. Virginie Nahoum and thank Drs. Roger Greenberg, Randy Pittman, Shahri Raasi, and Wai-Kwan Tang for sharing reagents. Diffraction data were collected at the National Synchrotron Light Source, X6A beam line, funded by the NIGMS, National Institutes of Health under agreement GM-0080. The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the United States Department of Energy under contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hubener J, 2010, NEUROBIOL DIS, V38, P116, DOI 10.1016/j.nbd.2010.01.005; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1995, BIOCHEMISTRY-US, V34, P464, DOI 10.1021/bi00002a010; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Ovaa H, 2005, METHOD ENZYMOL, V399, P468, DOI 10.1016/S0076-6879(05)99032-0; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	49	36	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4555	4565		10.1074/jbc.M110.177360	http://dx.doi.org/10.1074/jbc.M110.177360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118805	Green Published, hybrid			2022-12-27	WOS:000286975700056
J	Wruck, CJ; Streetz, K; Pavic, G; Gotz, ME; Tohidnezhad, M; Brandenburg, LO; Varoga, D; Eickelberg, O; Herdegen, T; Trautwein, C; Cha, KM; Kan, YW; Pufe, T				Wruck, Christoph Jan; Streetz, Konrad; Pavic, Goran; Goetz, Mario E.; Tohidnezhad, Mersedeh; Brandenburg, Lars-Ove; Varoga, Deike; Eickelberg, Oliver; Herdegen, Thomas; Trautwein, Christian; Cha, Kaimin; Kan, Yuet Wai; Pufe, Thomas			Nrf2 Induces Interleukin-6 (IL-6) Expression via an Antioxidant Response Element within the IL-6 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED OXIDATIVE STRESS; LIVER-INJURY; MEDIATED EXPRESSION; GENE-EXPRESSION; CELLS; ACTIVATION; INDUCTION; PATHWAY; MICE; SURVIVAL	IL-6 gene expression is controlled by a promoter region containing multiple regulatory elements such as NF-kappa B, NF-IL6, CRE, GRE, and TRE. In this study, we demonstrated that TRE, found within the IL-6 promoter, is embedded in a functional antioxidant response element (ARE) matching an entire ARE consensus sequence. Further, point mutations of the ARE consensus sequence in the IL-6 promoter construct selectively eliminate ARE but not TRE activity. Nrf2 is a redox-sensitive transcription factor which provides cytoprotection against electrophilic and oxidative stress and is the most potent activator of ARE-dependent transcription. Using Nrf2 knock-out mice we demonstrate that Nrf2 is a potent activator of IL-6 gene transcription in vivo. Moreover, we show evidence that Nrf2 is the transcription factor that activates IL6 expression in a cholestatic hepatitis mouse model. Our findings suggest a possible role of IL-6 in oxidative stress defense and also give indication about an important function for Nrf2 in the regulation of hematopoietic and inflammatory processes.	[Wruck, Christoph Jan; Pavic, Goran; Tohidnezhad, Mersedeh; Brandenburg, Lars-Ove; Pufe, Thomas] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany; [Streetz, Konrad; Trautwein, Christian] Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany; [Goetz, Mario E.] Fed Inst Risk Assessment, Dept Expt Toxicol, D-14191 Berlin, Germany; [Varoga, Deike] Dept Orthopaed Trauma Surg, D-24105 Kiel, Germany; [Eickelberg, Oliver] Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr, Inst Lung Biol & Dis ILBD, D-81377 Neuherberg, Germany; [Eickelberg, Oliver] Helmholtz Zentrum Munchen, D-81377 Neuherberg, Germany; [Herdegen, Thomas] Univ Hosp Schleswig Holstein, Inst Pharmacol, D-24105 Kiel, Germany; [Cha, Kaimin] Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Federal Institute for Risk Assessment; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Hong Kong; University of California System; University of California San Francisco	Wruck, CJ (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany.	cwruck@ukaachen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Pavic, Goran/0000-0002-8104-1108	Deutsche Forschungsgemeinschaft [Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, SFB617]; Faculty of Medicine, RWTH Aachen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, RWTH Aachen	We acknowledge funding from the Deutsche Forschungsgemeinschaft Pu 214/3-2, Pu 214/4-2, and Pu 214/5-2, and SFB617. This research project was also supported by the START-Program of the Faculty of Medicine, RWTH Aachen.	Bernardi F, 2008, J OBSTET GYNAECOL RE, V34, P948, DOI 10.1111/j.1447-0756.2008.00803.x; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Bissonnette CJ, 2004, NEUROSCI LETT, V361, P40, DOI 10.1016/j.neulet.2004.01.005; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; de Araujo EG, 2009, ANN NY ACAD SCI, V1153, P57, DOI 10.1111/j.1749-6632.2008.03974.x; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Kida H, 2005, AM J PHYSIOL-LUNG C, V288, pL342, DOI 10.1152/ajplung.00016.2004; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee J, 2005, FASEB J, V19, pA955; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; Li Jiang, 2007, V399, P67, DOI 10.1007/978-1-59745-504-6_6; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; McMahon M, 2001, CANCER RES, V61, P3299; Nakajima A, 2002, FREE RADICAL BIO MED, V32, P1324, DOI 10.1016/S0891-5849(02)00845-6; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Plum W, 2010, AM J PATHOL, V176, P2236, DOI 10.2353/ajpath.2010.090469; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Simeonova PP, 1997, J IMMUNOL, V159, P3921; Streetz KL, 2003, GASTROENTEROLOGY, V125, P532, DOI 10.1016/S0016-5085(03)00901-6; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tacchini L, 2006, FREE RADICAL RES, V40, P1206, DOI 10.1080/10715760600885432; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Vassilakopoulos T, 2003, J APPL PHYSIOL, V94, P1025, DOI 10.1152/japplphysiol.00735.2002; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499; Wruck CJ, 2009, HISTOPATHOLOGY, V55, P102, DOI 10.1111/j.1365-2559.2009.03339.x; XIE T, 1995, J BIOL CHEM, V270, P6894, DOI 10.1074/jbc.270.12.6894; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720	49	99	101	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4493	4499		10.1074/jbc.M110.162008	http://dx.doi.org/10.1074/jbc.M110.162008			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127061	Green Published, hybrid			2022-12-27	WOS:000286975700049
J	Biswas, A; Mukherjee, S; Das, S; Shields, D; Chow, CW; Maitra, U				Biswas, Arunima; Mukherjee, Shaeri; Das, Supratik; Shields, Dennis; Chow, Chi Wing; Maitra, Umadas			Opposing Action of Casein Kinase 1 and Calcineurin in Nucleo-cytoplasmic Shuttling of Mammalian Translation Initiation Factor eIF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE HOMOLOG; RIBOSOME DISSOCIATION FACTOR; TRANSCRIPTION FACTOR; EUKARYOTIC TRANSLATION; NUCLEAR-LOCALIZATION; WHEAT-GERM; PROTEIN; SUBUNIT; YEAST; ACTIVATION	Eukaryotic initiation factor 6 (eIF6), a highly conserved protein from yeast to mammals, is essential for 60 S ribosome biogenesis and assembly. Both yeast and mammalian eIF6 are phosphorylated at Ser-174 and Ser-175 by the nuclear isoform of casein kinase 1 (CK1). The molecular basis of eIF6 phosphorylation, however, remains elusive. In the present work, we show that subcellular distribution of eIF6 in the nuclei and the cytoplasm of mammalian cells is mediated by dephosphorylation and phosphorylation, respectively. This nucleo-cytoplasmic shuttling is dependent on the phosphorylation status at Ser-174 and Ser-175 of eIF6. We demonstrate that Ca2+-activated calcineurin phosphatase binds to and promotes nuclear localization of eIF6. Increase in intracellular concentration of Ca2+ leads to rapid translocation of eIF6 from the cytoplasm to the nucleus, an event that is blocked by specific calcineurin inhibitors cyclosporin A or FK520. Nuclear export of eIF6 is regulated by phosphorylation at Ser-174 and Ser-175 by the nuclear isoform of CK1. Mutation of eIF6 at the phosphorylatable Ser-174 and Ser-175 to alanine or treatment of cells with the CK1 inhibitor, D4476 inhibits nuclear export of eIF6 and results in nuclear accumulation of eIF6. Together, these results establish eIF6 as a substrate for calcineurin and suggest a novel paradigm for calcineurin function in 60 S ribosome biogenesis via regulating the nuclear accumulation of eIF6.	[Biswas, Arunima; Mukherjee, Shaeri; Das, Supratik; Shields, Dennis; Maitra, Umadas] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Chow, Chi Wing] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Maitra, U (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	umadas.maitra@einstein.yu.edu			National Institutes of Health [GM15399]; NCI [P30CA13330]; Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM15399 from the National Institutes of Health, by Cancer Core Support Grant P30CA13330 from the NCI, and institutional support from the Albert Einstein College of Medicine.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Basu U, 2003, MOL CELL BIOL, V23, P6187, DOI 10.1128/MCB.23.17.6187-6199.2003; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; Ray P, 2008, J BIOL CHEM, V283, P9681, DOI 10.1074/jbc.M710294200; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; RUSSELL DW, 1980, ARCH BIOCHEM BIOPHYS, V201, P518, DOI 10.1016/0003-9861(80)90540-8; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712	37	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3129	3138		10.1074/jbc.M110.188565	http://dx.doi.org/10.1074/jbc.M110.188565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084295	Green Published, hybrid			2022-12-27	WOS:000286464300074
J	Burkhard, KA; Chen, FM; Shapiro, P				Burkhard, Kimberly A.; Chen, Fengming; Shapiro, Paul			Quantitative Analysis of ERK2 Interactions with Substrate Proteins ROLES FOR KINASE DOCKING DOMAINS AND ACTIVITY IN DETERMINING BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; RIBOSOMAL S6 KINASE; MAP KINASE; C-FOS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING ACTIVITY; MEDIATED INTERACTIONS; RAF/MEK/ERK PATHWAY; PTP-SL; PHOSPHORYLATION	Extracellular signal-regulated kinase-1 and -2 (ERK1/2) proteins regulate a variety of cellular functions, including cell proliferation and differentiation, by interacting with and phosphorylating substrate proteins. Two docking sites, common docking (CD/ED) domain and F-site recruitment site (FRS), on ERK proteins have been identified. Specific interactions with the CD/ED domain and the FRS occur with substrates containing a docking site for ERK and JNK, LXL (DEJL) motif (D-domain) and a docking site for ERK, FXF (DEF) motif (F-site), respectively. However, the relative contributions of the ERK docking sites in mediating substrate interactions that allow efficient phosphate transfer are largely unknown. In these studies, we provide a quantitative analysis of ERK2 interactions with substrates using surface plasmon resonance to measure real time protein-protein interactions. ERK2 interacted with ELK-1 (DEF and DEJL motifs), RSK-1 (DEJL motif), and c-Fos (DEF motif) with K-D values of 0.25, 0.15, and 0.97 mu M, respectively. CD/ED domain mutations inhibited interactions with ELK-1 and RSK-1 by 6-fold but had no effect on interactions with c-Fos. Select mutations in FRS residues differentially inhibited ELK-1 or c-Fos interactions with ERK2 but had little effect on RSK-1 interactions. Mutations in both the ED and FRS docking sites completely inhibited ELK-1 interactions but had no effect on interactions with stathmin, an ERK substrate whose docking site is unknown. The phosphorylation status of ERK2 did not affect interactions with RSK-1 or c-Fos but did inhibit interactions with ELK-1 and stathmin. These studies provide a quantitative evaluation of specific docking domains involved in mediating interactions between ERK2 and protein substrates and define the contributions of these interactions to phosphate transfer.	[Burkhard, Kimberly A.; Chen, Fengming; Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Shapiro, P (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St, Baltimore, MD 21201 USA.	pshapiro@rx.umaryland.edu			National Institutes of Health [CA120215]; NATIONAL CANCER INSTITUTE [R01CA120215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120215.	Ahn NG, 2009, NAT STRUCT MOL BIOL, V16, P1004, DOI 10.1038/nsmb1009-1004; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway K, 2005, BBA-PROTEINS PROTEOM, V1754, P316, DOI 10.1016/j.bbapap.2005.11.002; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen RH, 1996, ONCOGENE, V12, P1493; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; Cornish-Bowden A, 2001, METHODS, V24, P181, DOI 10.1006/meth.2001.1179; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Fernandes N, 2009, BIOCHEM BIOPH RES CO, V387, P414, DOI 10.1016/j.bbrc.2009.07.049; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Hoofnagle AN, 2004, BIOPHYS J, V86, P395, DOI 10.1016/S0006-3495(04)74115-6; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Lovric J, 1998, J BIOL CHEM, V273, P22848; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Martin MC, 2008, J BIOL CHEM, V283, P3854, DOI 10.1074/jbc.M705647200; McCubrey JA, 2008, CURR OPIN INVEST DR, V9, P614; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PHILLIPS SK, 2008, MOL BIOMETHODS HDB, P809; Polychronopoulos S, 2006, J BIOL CHEM, V281, P25601, DOI 10.1074/jbc.M605185200; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	56	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2477	2485		10.1074/jbc.M110.177899	http://dx.doi.org/10.1074/jbc.M110.177899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098038	Green Published, hybrid			2022-12-27	WOS:000286464300012
J	Rybakova, IN; Greaser, ML; Moss, RL				Rybakova, Inna N.; Greaser, Marion L.; Moss, Richard L.			Myosin Binding Protein C Interaction with Actin CHARACTERIZATION AND MAPPING OF THE BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; N-TERMINAL DOMAINS; MYBP-C; CARDIAC-MUSCLE; F-ACTIN; IN-VITRO; PHOSPHORYLATION; PURIFICATION; FILAMENTS; CRYSTALLIZATION	Myosin binding protein C (MyBPC) is a multidomain protein associated with the thick filaments of striated muscle. Although both structural and regulatory roles have been proposed for MyBPC, its interactions with other sarcomeric proteins remain obscure. The current study was designed to examine the actin-binding properties of MyBPC and to define MyBPC domain regions involved in actin interaction. Here, we have expressed full-length mouse cardiac MyBPC (cMyBPC) in a baculovirus system and shown that purified cMyBPC binds actin filaments with an affinity of 4.3 +/- 1.1 mu M and a 1: 1 molar ratio with regard to an actin protomer. The actin binding by cMyBPC is independent of protein phosphorylation status and is not significantly affected by the presence of tropomyosin and troponin on the actin filament. In addition, cMyBPC-actin interaction is not modulated by calmodulin. To determine the region of cMyBPC that is responsible for its interaction with actin, we have expressed and characterized five recombinant proteins encoding fragments of the cMyBPC sequence. Recombinant N-terminal fragments such as C0-C1, C0-C4, and C0-C5 cosediment with actin in a linear, nonsaturable manner. At the same time, MyBPC fragments lacking either the C0-C1 or C0-C4 region bind F-actin with essentially the same properties as full-length protein. Together, our results indicate that cMyBPC interacts with actin via a single, moderate affinity site localized to the C-terminal region of the protein. In contrast, certain basic regions of the N-terminal domains of MyBPC may act as small polycations and therefore bind actin via nonspecific electrostatic interactions.	[Rybakova, Inna N.; Moss, Richard L.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Greaser, Marion L.] Univ Wisconsin, Muscle Biol Lab, Dept Anim Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rybakova, IN (corresponding author), 601 Sci Dr, Madison, WI 53711 USA.	rybakova@physiology.wisc.edu	Greaser, Marion L/C-6147-2012	Greaser, Marion L/0000-0002-6583-9566	National Institutes of Health [R37HL82900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL082900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37HL82900 (to R. L. M.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Fougerousse F, 1998, CIRC RES, V82, P130; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Gautel M, 1998, CIRC RES, V82, P124; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Gordon AM, 1997, BIOPHYS J, V72, pWP199; Govada L, 2008, J MOL BIOL, V378, P387, DOI 10.1016/j.jmb.2008.02.044; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREASER ML, 1973, J BIOL CHEM, V248, P2125; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HARRIS SP, 2010, MYOFILAMENT CONTROL, P22; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HARTZELL HC, 1985, J CELL BIOL, V100, P208, DOI 10.1083/jcb.100.1.208; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; KENSLER RW, 2010, MYOFILAMENT CONTROL, P67; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Kurasawa M, 1999, MUSCLE NERVE, V22, P196, DOI 10.1002/(SICI)1097-4598(199902)22:2<196::AID-MUS7>3.0.CO;2-E; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Welikson RE, 2002, J CELL SCI, V115, P3517; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; YAMAMOTO K, 1986, FEBS LETT, V208, P123, DOI 10.1016/0014-5793(86)81545-9; ZHUO S, 1993, J BIOL CHEM, V268, P17754; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	42	61	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2008	2016		10.1074/jbc.M110.170605	http://dx.doi.org/10.1074/jbc.M110.170605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071444	Green Published, hybrid			2022-12-27	WOS:000286191500042
J	Thomas, AM; Harmer, SC; Khambra, T; Tinker, A				Thomas, Alison M.; Harmer, Stephen C.; Khambra, Tapsi; Tinker, Andrew			Characterization of a Binding Site for Anionic Phospholipids on KCNQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT-SYNDROME; RECEPTOR-MEDIATED INHIBITION; KCNQ2/KCNQ3 K+ CHANNELS; POTASSIUM CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE BINDING; STRUCTURAL DETERMINANTS; MUSCARINIC MODULATION; DISEASE PATHOGENESIS; PIP2 REGULATION	The KCNQ family of potassium channels underlie a repolarizing K+ current in the heart and the M-current in neurones. The assembly of KCNQ1 with KCNE1 generates the delayed rectifier current I-Ks in the heart. Characteristically these channels are regulated via G(q/11)-coupled receptors and the inhibition seen after phospholipase C activation is now thought to occur from membrane phosphatidylinositol (4,5)-bisphosphate (PIP2) depletion. It is not clear how KCNQ1 recognizes PIP2 and specifically which residues in the channel complex are important. Using biochemical techniques we identify a cluster of basic residues namely, Lys-354, Lys-358, Arg-360, and Lys-362, in the proximal C terminus as being involved in binding anionic phospholipids. The mutation of specific residues in combination, to alanine leads to the loss of binding to phosphoinositides. Functionally, the introduction of these mutations into KCNQ1 leads to shifts in the voltage dependence of channel activation toward depolarized potentials and reductions in current density. Additionally, the biophysical effects of the charge neutralizing mutations, which disrupt phosphoinositide binding, mirror the effects we see on channel function when we deplete cellular PIP2 levels through activation of a Gq/11-coupled receptor. Conversely, the addition of diC8-PIP2 to the wild-type channel, but not a PIP2 binding-deficient mutant, acts to shift the voltage dependence of channel activation toward hyperpolarized potentials and increase current density. In conclusion, we use a combined biochemical and functional approach to identify a cluster of basic residues important for the binding and action of anionic phospholipids on the KCNQ1/KCNE1 complex.	[Tinker, Andrew] UCL, Rayne Inst, BHF Labs, Dept Med, London WC1E 6JJ, England	University of London; King's College London; University College London	Tinker, A (corresponding author), UCL, Rayne Inst, BHF Labs, Dept Med, 5 Univ St, London WC1E 6JJ, England.	a.tinker@ucl.ac.uk	Harmer, Stephen/D-5512-2015	Harmer, Stephen/0000-0003-3909-6698	British Heart Foundation; British Heart Foundation [RG/10/10/28447] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DALEAU P, 1994, PFLUG ARCH EUR J PHY, V427, P553, DOI 10.1007/BF00374275; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Guy-David L, 2007, NEURON, V55, P537, DOI 10.1016/j.neuron.2007.08.001; Harmer SC, 2010, AM J PHYSIOL-CELL PH, V298, pC263, DOI 10.1152/ajpcell.00308.2009; Hernandez CC, 2008, J GEN PHYSIOL, V132, p20A; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 2007, J PHYSIOL-LONDON, V582, P903, DOI 10.1113/jphysiol.2007.132746; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	60	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2088	2100		10.1074/jbc.M110.153551	http://dx.doi.org/10.1074/jbc.M110.153551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084310	Green Published, hybrid			2022-12-27	WOS:000286191500051
J	Yoon, YJ; Kim, JA; Shin, KD; Shin, DS; Han, YM; Lee, YJ; Lee, JS; Kwon, BM; Han, DC				Yoon, Young Ju; Kim, Joo Ae; Shin, Ki Deok; Shin, Dae-Seop; Han, Young Min; Lee, Yu Jin; Lee, Jin Soo; Kwon, Byoung-Mog; Han, Dong Cho			KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ONCOGENE ADDICTION; DNA-BINDING ACTIVITY; GENE-EXPRESSION; HYDROGEN-PEROXIDE; HSP90 INHIBITORS; CANCER-CELLS; FACTOR HSF1; PHOSPHORYLATION; ACTIVATION; STRESS	Heat shock factor 1 (HSF1) is the master switch for heat shock protein (HSP) expression in eukaryotes. A synthetic chemical library was screened to identify inhibitors of HSF1 using a luciferase reporter under the control of a heat shock element. A compound named KRIBB11 (N-2-(1H-indazole-5-yl)-N-6-methyl-3-nitropyridine-2,6-diamine) was identified for its activity in abolishing the heat shock-induced luciferase activity with an IC50 of 1.2 mu mol/liter. When the cells were exposed to heat shock in the presence of KRIBB11, the induction of HSF1 downstream target proteins such as HSP27 and HSP70 was blocked. In addition, treatment of HCT-116 cells with KRIBB11 induced growth arrest and apoptosis. Markers of apoptosis, such as cleaved poly(ADP-ribose) polymerase, were detected after KRIBB11 treatment. Biotinyl-KRIBB11 was synthesized as an affinity probe for the identification of KRIBB11 target proteins. Using affinity chromatography and competition assays, KRIBB11 was shown to associate with HSF1 in vitro. Chromatin immuno-precipitation analysis showed that KRIBB11 inhibited HSF1-dependent recruitment of p-TEFb (positive transcription elongation factor b) to the hsp70 promoter. Finally, intraperitoneal treatment of nude mice with KRIBB11 at 50 mg/kg resulted in a 47.4% (p < 0.05) inhibition of tumor growth without body weight loss. Immunoblotting assays showed that the expression of HSP70 was lower in KRIBB11-treated tumor tissue than in control tissues. Because HSPs are expressed at high levels in a wide range of tumors, these results strengthen the rationale for targeting HSF1 in cancer therapy.	[Yoon, Young Ju; Kim, Joo Ae; Shin, Ki Deok; Shin, Dae-Seop; Han, Young Min; Lee, Yu Jin; Kwon, Byoung-Mog; Han, Dong Cho] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Kim, Joo Ae; Han, Young Min; Lee, Yu Jin; Kwon, Byoung-Mog; Han, Dong Cho] Univ Sci & Technol, Taejon 305806, South Korea; [Lee, Jin Soo] Dong Wha Pharmaceut Co Ltd, Yongin 446902, Gyeonggi Do, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, BM (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	kwonbm@kribb.re.kr; dchan@kribb.re.kr			KRIBB Research Initiative; National Chemical Genomics Research Program; Center for Biological Modulators of the 21st Century Frontier Research Program	KRIBB Research Initiative; National Chemical Genomics Research Program; Center for Biological Modulators of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the KRIBB Research Initiative Program, the National Chemical Genomics Research Program, and the Center for Biological Modulators of the 21st Century Frontier Research Program. Y.J. Yoon, J.S. Lee, B.-M. Kwon, and D.C. Han have applied for a patent using a part of this work.	AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Akagawa H, 1999, J ANTIBIOT, V52, P960, DOI 10.7164/antibiotics.52.960; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Elia G, 1996, CANCER RES, V56, P210; Garrido C, 1998, CANCER RES, V58, P5495; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Holmberg CI, 1998, J CELL SCI, V111, P3357; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Kim SA, 2005, J BIOL CHEM, V280, P12653, DOI 10.1074/jbc.M411908200; KINGSTON RE, 1986, MOL CELL BIOL, V6, P3180, DOI 10.1128/MCB.6.9.3180; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Lee SA, 2005, CANCER RES, V65, P3072, DOI 10.1158/0008-5472.CAN-04-2865; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Lis JT, 2000, GENE DEV, V14, P792; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mulholland PJ, 2001, ANN ONCOL, V12, P245, DOI 10.1023/A:1008372017097; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sanchez-Serrano I, 2006, NAT REV DRUG DISCOV, V5, P107, DOI 10.1038/nrd1959; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Seo JS, 1996, BIOCHEM BIOPH RES CO, V218, P582, DOI 10.1006/bbrc.1996.0103; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taylor DM, 2007, MOL CELL NEUROSCI, V34, P20, DOI 10.1016/j.mcn.2006.09.007; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yokota S, 2000, CANCER RES, V60, P2942; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	59	106	107	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1737	1747		10.1074/jbc.M110.179440	http://dx.doi.org/10.1074/jbc.M110.179440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078672	Green Published, hybrid			2022-12-27	WOS:000286191500013
J	Sephton, CF; Cenik, C; Kucukural, A; Dammer, EB; Cenik, B; Han, YH; Dewey, CM; Roth, FP; Herz, J; Peng, JM; Moore, MJ; Yu, G				Sephton, Chantelle F.; Cenik, Can; Kucukural, Alper; Dammer, Eric B.; Cenik, Basar; Han, YuHong; Dewey, Colleen M.; Roth, Frederick P.; Herz, Joachim; Peng, Junmin; Moore, Melissa J.; Yu, Gang			Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; MESSENGER-RNA; BINDING-PROTEIN; GENE-EXPRESSION; CFTR EXON-9; MUTATIONS; ALS; DISEASE	TAR DNA-binding protein 43 (TDP-43) is associated with a spectrum of neurodegenerative diseases. Although TDP-43 resembles heterogeneous nuclear ribonucleoproteins, its RNA targets and physiological protein partners remain unknown. Here we identify RNA targets of TDP-43 from cortical neurons by RNA immunoprecipitation followed by deep sequencing (RIP-seq). The canonical TDP-43 binding site (TG)(n) is 55.1-fold enriched, and moreover, a variant with adenine in the middle, (TG)(n)TA(TG)(m), is highly abundant among reads in our TDP-43 RIP-seq library. TDP-43 RNA targets can be divided into three different groups: those primarily binding in introns, in exons, and across both introns and exons. TDP-43 RNA targets are particularly enriched for Gene Ontology terms related to synaptic function, RNA metabolism, and neuronal development. Furthermore, TDP-43 binds to a number of RNAs encoding for proteins implicated in neurodegeneration, including TDP-43 itself, FUS/TLS, progranulin, Tau, and ataxin 1 and -2. We also identify 25 proteins that co-purify with TDP-43 from rodent brain nuclear extracts. Prominent among them are nuclear proteins involved in pre-mRNA splicing and RNA stability and transport. Also notable are two neuron-enriched proteins, methyl CpG-binding protein 2 and polypyrimidine tract-binding protein 2 (PTBP2). A PTBP2 consensus RNA binding motif is enriched in the TDP-43 RIP-seq library, suggesting that PTBP2 may co-regulate TDP-43 RNA targets. This work thus reveals the protein and RNA components of the TDP-43-containing ribonucleoprotein complexes and provides a framework for understanding how dysregulation of TDP-43 in RNA metabolism contributes to neurodegeneration.	[Dewey, Colleen M.; Herz, Joachim; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cenik, Can; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kucukural, Alper; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA 01655 USA; [Moore, Melissa J.] Howard Hughes Med Inst, Worcester, MA 01655 USA; [Dammer, Eric B.; Peng, Junmin] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Emory University	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu	Roth, Frederick P/H-6308-2011; Kucukural, Alper/AAJ-7758-2020; Dammer, Eric B/V-8652-2019; Kucukural, Alper/T-3563-2018; Han, YuHong/N-1461-2015; Peng, Junmin/N-2614-2018	Kucukural, Alper/0000-0001-9983-394X; Dammer, Eric B/0000-0003-2947-7606; Kucukural, Alper/0000-0001-9983-394X; Peng, Junmin/0000-0003-0472-7648; Roth, Frederick/0000-0002-6628-649X; Cenik, Can/0000-0001-6370-0889	National Institutes of Health [R01 AG029547, AG023104, HG004233, T32 NS007480, P30 NS055077]; Consortium for Frontotemporal Dementia Research; Welch Foundation; Ted Nash Long Life Foundation; Canadian Institute for Advanced Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, P30NS055077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029547, R01AG023104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Welch Foundation(The Welch Foundation); Ted Nash Long Life Foundation; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029547 and AG023104 (to G. Y.), HG004233 (to F. P. R.), T32 NS007480 (to E. B. D.), and P30 NS055077 (to J. P.). This work was also supported by the Consortium for Frontotemporal Dementia Research (to G. Y. and J. H.), the Welch Foundation (to G. Y.), the Ted Nash Long Life Foundation (to G. Y.), and a fellowship from the Canadian Institute for Advanced Research (to F. P. R.). M. J. M. is an HHMI investigator.	Aizawa H, 2010, ACTA NEUROPATHOL, V120, P75, DOI 10.1007/s00401-010-0678-x; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887	50	309	312	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1204	1215		10.1074/jbc.M110.190884	http://dx.doi.org/10.1074/jbc.M110.190884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21051541	Green Published, hybrid			2022-12-27	WOS:000286005000032
J	Zhang, LY; Zheng, YC; Callahan, B; Belfort, M; Liu, YZ				Zhang, Liyun; Zheng, Yuchuan; Callahan, Brian; Belfort, Marlene; Liu, Yangzhong			Cisplatin Inhibits Protein Splicing, Suggesting Inteins as Therapeutic Targets in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC SYSTEM; IN-VITRO; PLATINUM; PLATINATION; INTRONS; AGENTS; DRUGS; BCG	Mycobacterium tuberculosis harbors three protein splicing elements, called inteins, in critical genes and their protein products. Post-translational removal of the inteins occurs autocatalytically and is required for function of the respective M. tuberculosis proteins. Inteins are therefore potential targets for antimycobacterial agents. In this work, we report that the splicing activity of the intein present in the RecA recombinase of M. tuberculosis is potently inhibited by the anticancer drug cisplatin (cis-diamminedichloro-platinum(II)). This previously unrecognized activity of cisplatin was established using both an in vitro intein splicing assay, which yielded an IC50 of similar to 2 mu M, and a genetic reporter for intein splicing in Escherichia coli. Testing of related platinum(II) complexes indicated that the inhibition activity is highly structure-dependent, with cisplatin exhibiting the best inhibitory effect. Finally, we report that cisplatin is toxic toward M. tuberculosis with a minimum inhibitory concentration of similar to 40 mu M, and in genetic experiments conducted with the related Mycobacterium bovis bacillus Calmette-Guerrin (BCG) strain, we show that cisplatin toxicity can be mitigated by intein overexpression. We propose that cisplatin inhibits intein activity by modifying at least one conserved cysteine residue that is required for splicing. Together these results identify a novel active site inhibitor of inteins and validate inteins as viable targets for small molecule inhibition in mycobacteria.	Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Peoples R China; [Callahan, Brian; Belfort, Marlene] New York State Dept Hlth, Ctr Med Sci, Wadsworth Ctr, Albany, NY 12208 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; State University of New York (SUNY) System; Wadsworth Center	Liu, YZ (corresponding author), 96 Jinzhai Rd, Hefei 230026, Peoples R China.	liuyz@ustc.edu.cn	Zhang, Liyun/E-8123-2012; liu, yang/HHY-8583-2022; Liu, Yangzhong/D-5363-2009	Zhang, Liyun/0000-0003-1517-8808; Liu, Yangzhong/0000-0003-2891-7964; Belfort, Marlene/0000-0002-1592-5618; Callahan, Brian/0000-0003-4826-0162	Ministry of Education of China [707036]; National Science Foundation of China [20873135]; National Basic Research Program of China (973 Program) [2009CB918804]; National Institutes of Health [GM44844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044844] Funding Source: NIH RePORTER	Ministry of Education of China(Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (Grant 707036), the National Science Foundation of China (Grant 20873135), the National Basic Research Program of China (973 Program, 2009CB918804), and by National Institutes of Health Grant GM44844 (to M. B.).	Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; BELFORT M, 1984, J BACTERIOL, V160, P371, DOI 10.1128/JB.160.1.371-378.1984; Belfort M., 1998, U. S. Patent, Patent No. [5,795,731, 5795731]; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; DAVIS EO, 1994, EMBO J, V13, P699, DOI 10.1002/j.1460-2075.1994.tb06309.x; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Janin YL, 2007, BIOORGAN MED CHEM, V15, P2479, DOI 10.1016/j.bmc.2007.01.030; Kostova I, 2006, RECENT PAT ANTI-CANC, V1, P1, DOI 10.2174/157489206775246458; Li C, 2009, ANGEW CHEM INT EDIT, V48, P8497, DOI 10.1002/anie.200902948; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Miguel DC, 2009, J ANTIMICROB CHEMOTH, V63, P365, DOI 10.1093/jac/dkn509; Mills KV, 2001, J BIOL CHEM, V276, P10832, DOI 10.1074/jbc.M011149200; Mitchison DA, 2005, EUR RESPIR J, V25, P376, DOI 10.1183/09031936.05.00075704; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Naik PR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-230; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Paulus H, 2007, DRUG FUTURE, V32, P973, DOI 10.1358/dof.2007.032.11.1140690; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Reedijk J, 1999, CHEM REV, V99, P2499, DOI 10.1021/cr980422f; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Stordal B, 2007, CANCER TREAT REV, V33, P347, DOI 10.1016/j.ctrv.2007.01.009; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Thayer AM, 2010, CHEM ENG NEWS, V88, P24, DOI 10.1021/cen-v088n026.p024; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Weidt SK, 2007, CHEM COMMUN, P1719, DOI 10.1039/b701903c; Williams DS, 2007, INORG CHEM, V46, P2944, DOI 10.1021/ic062055t; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Xu MQ, 2005, CURR OPIN BIOTECH, V16, P440, DOI 10.1016/j.copbio.2005.06.012; Zhang LY, 2010, CHEM-EUR J, V16, P4297, DOI 10.1002/chem.200903584; Zhang LY, 2009, MOL BIOSYST, V5, P644, DOI 10.1039/b903144h	42	36	41	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1277	1282		10.1074/jbc.M110.171124	http://dx.doi.org/10.1074/jbc.M110.171124			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059649	Green Published, hybrid			2022-12-27	WOS:000286005000039
J	D'Adamo, MC; Shang, LJ; Imbrici, P; Brown, SDM; Pessia, M; Tucker, SJ				D'Adamo, M. Cristina; Shang, Lijun; Imbrici, Paola; Brown, Steve D. M.; Pessia, Mauro; Tucker, Stephen J.			Genetic Inactivation of Kcnj16 Identifies Kir5.1 as an Important Determinant of Neuronal PCO2/pH Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-COERULEUS NEURONS; HETEROMERIC KIR4.1-KIR5.1 CHANNELS; RECTIFIER K+ CHANNEL; POTASSIUM CHANNELS; CERULEUS NEURONS; FUNCTIONAL NEUROANATOMY; PH SENSITIVITY; KIR4.1; RAT; MODULATION	The molecular identity of ion channels which confer PCO2/pH sensitivity in the brain is unclear. Heteromeric Kir4.1/Kir5.1 channels are highly sensitive to inhibition by intracellular pH and are widely expressed in several brainstem nuclei involved in cardiorespiratory control, including the locus coeruleus. This has therefore led to a proposed role for these channels in neuronal CO2 chemosensitivity. To examine this, we generated mutant mice lacking the Kir5.1 (Kcnj16) gene. We show that although locus coeruleus neurons from Kcnj16((+/+)) mice rapidly respond to cytoplasmic alkalinization and acidification, those from Kcnj16((-/-)) mice display a dramatically reduced and delayed response. These results identify Kir5.1 as an important determinant of PCO2/pH sensitivity in locus coeruleus neurons and suggest that Kir5.1 may be involved in the response to hypercapnic acidosis.	[D'Adamo, M. Cristina; Imbrici, Paola; Pessia, Mauro] Univ Perugia, Sch Med, Sect Human Physiol, I-06100 Perugia, Italy; [Shang, Lijun; Tucker, Stephen J.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PT, England; [Shang, Lijun; Brown, Steve D. M.; Tucker, Stephen J.] Univ Oxford, OXION Initiat, Oxford OX1 3PT, England; [Brown, Steve D. M.] Med Res Council Harwell, Med Res Council, Mammalian Genet Unit, Didcot OX11 ORD, Oxon, England	University of Perugia; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Pessia, M (corresponding author), Univ Perugia, Sch Med, Sect Human Physiol, I-06100 Perugia, Italy.	pessia@unipg.it	Tucker, Stephen J./ABE-6741-2020; D'Adamo, Maria Cristina/AAD-3701-2022; Shang, Lijun/AAT-8172-2020; Tucker, Stephen J./ABE-7468-2020; imbrici, paola/J-6855-2018	Tucker, Stephen J./0000-0001-8996-2000; D'Adamo, Maria Cristina/0000-0002-6758-6064; Shang, Lijun/0000-0001-5925-5903; Tucker, Stephen J./0000-0001-8996-2000; imbrici, paola/0000-0001-9140-5350; Pessia, Mauro/0000-0002-2857-6795	Royal Society; COMPAGNIA di San Paolo (Turin); Ministero dell'Istruzione dell'Universita e della Ricerca FIRB [RBAU01TJ93]; PRIN; Fondazione Cassa di Risparmio di Perugia; MRC [MC_U142684175, MC_U142684172] Funding Source: UKRI; Medical Research Council [MC_U142684175, MC_U142684172] Funding Source: researchfish	Royal Society(Royal Society of London); COMPAGNIA di San Paolo (Turin)(Compagnia di San Paolo); Ministero dell'Istruzione dell'Universita e della Ricerca FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Royal Society (to S. J. T.) and the COMPAGNIA di San Paolo (Turin) "Programma Neuroscienze," Ministero dell'Istruzione dell'Universita e della Ricerca FIRB (RBAU01TJ93) and PRIN (to M. P.).; Recipient of a fellowship from Fondazione Cassa di Risparmio di Perugia.	BOND CT, 1994, RECEPTOR CHANNEL, V2, pU2; Buckler KJ, 2010, ADV EXP MED BIOL, V661, P15, DOI 10.1007/978-1-60761-500-2_2; Cui N, 2001, J CELL PHYSIOL, V189, P229, DOI 10.1002/jcp.10021; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Filosa JA, 2003, AM J PHYSIOL-CELL PH, V284, pC145, DOI 10.1152/ajpcell.00346.2002; Filosa JA, 2002, J PHYSIOL-LONDON, V541, P493, DOI 10.1113/jphysiol.2001.014142; Gargaglioni LH, 2010, RESP PHYSIOL NEUROBI, V173, P264, DOI 10.1016/j.resp.2010.04.024; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2005, J PHYSIOL-LONDON, V568, P715, DOI 10.1113/jphysiol.2005.095968; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Johnson SM, 2008, J APPL PHYSIOL, V105, P1301, DOI 10.1152/japplphysiol.90414.2008; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Oyamada Y, 1998, J PHYSIOL-LONDON, V513, P381, DOI 10.1111/j.1469-7793.1998.381bb.x; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Putnam RW, 2010, J APPL PHYSIOL, V108, P1796, DOI 10.1152/japplphysiol.01169.2009; Salvatore L, 1999, FEBS LETT, V449, P146, DOI 10.1016/S0014-5793(99)00420-2; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, pP3; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; WILLIAMS JT, 1984, MOL PHARMACOL, V26, P489; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33; Zhang XL, 2010, AM J PHYSIOL-CELL PH, V298, pC635, DOI 10.1152/ajpcell.00442.2009	39	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					192	198		10.1074/jbc.M110.189290	http://dx.doi.org/10.1074/jbc.M110.189290			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047793	Green Published, hybrid			2022-12-27	WOS:000285782800021
J	Liu, HL; Focia, PJ; He, XL				Liu, Heli; Focia, Pamela J.; He, Xiaolin			Homophilic Adhesion Mechanism of Neurofascin, a Member of the L1 Family of Neural Cell Adhesion Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING MODULE; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; MENTAL-RETARDATION; STRUCTURAL BASIS; HUMAN-DISEASE; MUTATIONS; DOMAINS; SPECIFICITY	The L1 family neural cell adhesion molecules play key roles in specifying the formation and remodeling of the neural network, but their homophilic interaction that mediates adhesion is not well understood. We report two crystal structures of a dimeric form of the headpiece of neurofascin, an L1 family member. The four N-terminal Ig-like domains of neurofascin form a horseshoe shape, akin to several other immunoglobulin superfamily cell adhesion molecules such as hemolin, axonin, and Dscam. The neurofascin dimer, captured in two crystal forms with independent packing patterns, reveals a pair of horseshoes in trans-synaptic adhesion mode. The adhesion interaction is mediated mostly by the second Ig-like domain, which features an intermolecular beta-sheet formed by the joining of two individual GFC beta-sheets and a large but loosely packed hydrophobic cluster. Mutagenesis combined with gel filtration assays suggested that the side chain hydrogen bonds at the intermolecular beta-sheet are essential for the homophilic interaction and that the residues at the hydrophobic cluster play supplementary roles. Our structures reveal a conserved homophilic adhesion mode for the L1 family and also shed light on how the pathological mutations of L1 affect its structure and function.	[Liu, Heli; Focia, Pamela J.; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	x-he@northwestern.edu			R. H. Lurie Comprehensive Cancer Center of Northwestern University; United States Department of Energy [W-31-109-Eng-38]	R. H. Lurie Comprehensive Cancer Center of Northwestern University; United States Department of Energy(United States Department of Energy (DOE))	We thank Xiaoyan Chen for assistance with cell culture and Zdzislaw Wawrzak for support with x-ray data collection. The Structural Biology Facility is supported by the R. H. Lurie Comprehensive Cancer Center of Northwestern University. Data were measured at the Life Sciences Collaborative Access Team beamline 21-ID-D at the Advanced Photon Source, Argonne National Laboratory, which is supported by United States Department of Energy Contract W-31-109-Eng-38.	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng L, 2004, MOL CELL NEUROSCI, V27, P522, DOI 10.1016/j.mcn.2004.08.005; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Nagem RAP, 2003, METHOD ENZYMOL, V374, P120, DOI 10.1016/S0076-6879(03)74005-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413	30	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					797	805		10.1074/jbc.M110.180281	http://dx.doi.org/10.1074/jbc.M110.180281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047790	hybrid, Green Published			2022-12-27	WOS:000285782800079
J	Muskett, FW; Thouta, S; Thomson, SJ; Bowen, A; Stansfeld, PJ; Mitcheson, JS				Muskett, Frederick W.; Thouta, Samrat; Thomson, Steven J.; Bowen, Alexander; Stansfeld, Phillip J.; Mitcheson, John S.			Mechanistic Insight into Human ether-a-go-go-related Gene (hERG) K+ Channel Deactivation Gating from the Solution Structure of the EAG Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; TORSION ANGLE DYNAMICS; HUMAN INWARD RECTIFIER; AMINO-TERMINAL DOMAIN; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; I-KR; MOLECULAR DETERMINANTS; XENOPUS OOCYTES; PAS DOMAIN	Human ether-a-go-go-related gene (hERG) K+ channels have a critical role in cardiac repolarization. hERG channels close (deactivate) very slowly, and this is vital for regulating the time course and amplitude of repolarizing current during the cardiac action potential. Accelerated deactivation is one mechanism by which inherited mutations cause long QT syndrome and potentially lethal arrhythmias. hERG deactivation is highly dependent upon an intact EAG domain (the first 135 amino acids of the N terminus). Importantly, deletion of residues 2-26 accelerates deactivation to a similar extent as removing the entire EAG domain. These and other experiments suggest the first 26 residues (NT1-26) contain structural elements required to slow deactivation by stabilizing the open conformation of the pore. Residues 26-135 form a Per-Arnt-Sim domain, but a structure for NT1-26 has not been forthcoming, and little is known about its site of interaction on the channel. In this study, we present an NMR structure for the entire EAG domain, which reveals that NT1-26 is structurally independent from the Per-Arnt-Sim domain and contains a stable amphipathic helix with one face being positively charged. Mutagenesis and electrophysiological studies indicate that neutralizing basic residues and breaking the amphipathic helix dramatically accelerate deactivation. Furthermore, scanning mutagenesis and molecular modeling studies of the cyclic nucleotide binding domain suggest that negatively charged patches on its cytoplasmic surface form an interface with the NT1-26 domain. We propose a model in which NT1-26 obstructs gating motions of the cyclic nucleotide binding domain to allosterically stabilize the open conformation of the pore.	[Muskett, Frederick W.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Thouta, Samrat; Thomson, Steven J.; Bowen, Alexander; Mitcheson, John S.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Stansfeld, Phillip J.] Univ Oxford, Oxford OX1 3QU, England	University of Leicester; University of Leicester; University of Oxford	Muskett, FW (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	fwm1@le.ac.uk; jm109@le.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Mitcheson, John/0000-0002-2683-2839; Thouta, Samrat/0000-0002-0460-6187	Biotechnology and Biological Sciences Research Council; Novartis Institutes for Biomedical Research, Horsham, UK; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novartis Institutes for Biomedical Research, Horsham, UK; Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Biotechnology and Biological Sciences Research Council Collaborative Awards in Science and Engineering Ph.D. studentship sponsored by Novartis Institutes for Biomedical Research, Horsham, UK.; Supported by the Wellcome Trust.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hancox JC, 1998, BIOCHEM BIOPH RES CO, V253, P719, DOI 10.1006/bbrc.1998.9837; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Muskett F. W., 2011, BIOMOL NMR IN PRESS; Muskett FW, 2003, BIOCHEMISTRY-US, V42, P15139, DOI 10.1021/bi030182k; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Roden DM, 1996, AM J CARDIOL, V78, P12, DOI 10.1016/S0002-9149(96)00448-1; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; YANG T, 1995, CIRCULATION, V91, P1799, DOI 10.1161/01.CIR.91.6.1799; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	61	76	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6184	6191		10.1074/jbc.M110.199364	http://dx.doi.org/10.1074/jbc.M110.199364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135103	Green Published, hybrid			2022-12-27	WOS:000287476400027
J	Wang, JF; Zurawski, TH; Meng, JH; Lawrence, G; Olango, WM; Finn, DP; Wheeler, L; Dolly, JO				Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary; Olango, Weredeselam M.; Finn, David P.; Wheeler, Larry; Dolly, J. Oliver			A Dileucine in the Protease of Botulinum Toxin A Underlies Its Long-lived Neuroparalysis TRANSFER OF LONGEVITY TO A NOVEL POTENTIAL THERAPEUTIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTOXIN-A; NEUROMUSCULAR-TRANSMISSION; NERVE-TERMINALS; SYNAPTOTAGMIN-I; SENSORY NEURONS; TRANSLOCATION; EXOCYTOSIS; PERSISTENCE; INHIBITION; INJECTION	Blockade of neurotransmitter release by botulinum neurotoxin type A (BoNT(A)) underlies the severe neuroparalytic symptoms of human botulism, which can last a few years. The structural basis for this remarkable persistence remains unclear. Herein, recombinant BoNT(A) was found to match the neurotoxicity of that from Clostridium botulinum, producing persistent cleavage of synaptosomal-associated protein of 25 kDa (SNAP-25) and neuromuscular paralysis. When two leucines near the C terminus of the protease light chain of A (LCA) were mutated, its inhibition of exocytosis was followed by fast recovery of intact SNAP-25 in cerebellar neurons and neuromuscular transmission in vivo. Deletion of 6-7 N terminus residues diminished BoNT(A) activity but did not alter the longevity of its SNAP-25 cleavage and neuromuscular paralysis. Furthermore, genetically fusing LCE to a BoNT(A) enzymically inactive mutant (BoTIM(A)) yielded a novel LCE-BoTIM(A) protein that targets neurons, and the BoTIM(A) moiety also delivers and stabilizes the inhibitory LCE, giving a potent and persistent cleavage of SNAP-25 with associated neuromuscular paralysis. Moreover, its neurotropism was extended to sensory neurons normally insensitive to BoNT(E). LCE-BoTIM(A)(AA) with the above-identified dileucine mutated gave transient neuromuscular paralysis similar to BoNT(E), reaffirming that these residues are critical for the persistent action of LCE-BoTIM(A) as well as BoNT(A). LCE-BoTIM(A) inhibited release of calcitonin gene-related peptide from sensory neurons mediated by transient receptor potential vanilloid type 1 and attenuated capsaicin-evoked nociceptive behavior in rats, following intraplantar injection. Thus, a long acting, versatile composite toxin has been developed with therapeutic potential for pain and conditions caused by overactive cholinergic nerves.	[Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary; Dolly, J. Oliver] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland; [Olango, Weredeselam M.; Finn, David P.] Natl Univ Ireland, Sch Med, Galway, Ireland; [Olango, Weredeselam M.; Finn, David P.] Natl Univ Ireland, Ctr Pain Res, Galway, Ireland; [Wheeler, Larry] Allergan Pharmaceut Inc, Irvine, CA 92623 USA	Dublin City University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; AbbVie; Allergan	Dolly, JO (corresponding author), Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland.	oliver.dolly@dcu.ie	Dolly, Oliver/G-1532-2012; Meng, Jianghui/H-4302-2014; Wang, Jiafu/AAX-9388-2020; Dolly, Oliver/ABH-6677-2020	Dolly, Oliver/0000-0002-0861-5320; Wang, Jiafu/0000-0002-3654-4400; Dolly, Oliver/0000-0002-0861-5320; Finn, David/0000-0001-6186-621X; Meng, Jianghui/0000-0002-3107-4200	Science Foundation Ireland; Irish Research Council for Science, Engineering and Technology; Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics"	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics"	This work was supported in part by a research professorship award from Science Foundation Ireland (to J. O. D.) and a grant to D. P. F., plus a studentship to W. M. O. from the Irish Research Council for Science, Engineering and Technology, and the Programme for Research in Third-Level Institutions Cycle four (PRTLI 4) Grant from the Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics."	Adler M, 2001, TOXICON, V39, P233, DOI 10.1016/S0041-0101(00)00120-3; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Barnes MP, 2007, CLINICAL USES OF BOTULINUM TOXINS, P1, DOI 10.1017/CBO9780511544842.001; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; Christoph T, 2007, NEUROCHEM INT, V50, P281, DOI 10.1016/j.neuint.2006.08.017; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Dolly JO, 2007, CLINICAL USES OF BOTULINUM TOXINS, P9, DOI 10.1017/CBO9780511544842.002; Dolly JO, 2009, CURR OPIN PHARMACOL, V9, P326, DOI 10.1016/j.coph.2009.03.004; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Jakubowski M, 2006, PAIN, V125, P286, DOI 10.1016/j.pain.2006.09.012; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Kim HY, 2009, PAIN, V145, P332, DOI 10.1016/j.pain.2009.06.035; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; Lawrence G, 2007, J PHARMACOL EXP THER, V320, P410, DOI 10.1124/jpet.106.108829; Lawrence GW, 2002, J CELL SCI, V115, P2791; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MAISEY EA, 1988, EUR J BIOCHEM, V177, P683, DOI 10.1111/j.1432-1033.1988.tb14423.x; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Meunier FA, 2003, MOL CELL NEUROSCI, V22, P454, DOI 10.1016/S1044-7431(02)00016-7; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Shi XR, 2009, J CELL BIOCHEM, V108, P660, DOI 10.1002/jcb.22300; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Witting N, 2000, PAIN, V84, P407, DOI 10.1016/S0304-3959(99)00231-6	39	63	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6375	6385		10.1074/jbc.M110.181784	http://dx.doi.org/10.1074/jbc.M110.181784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138836	hybrid, Green Published			2022-12-27	WOS:000287476400048
J	Chavez, A; Agrawal, V; Johnson, FB				Chavez, Alejandro; Agrawal, Vishesh; Johnson, F. Brad			Homologous Recombination-dependent Rescue of Deficiency in the Structural Maintenance of Chromosomes (Smc) 5/6 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; COMPLEMENTATION GROUP-M; STRAND-BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; PROTEINS PROMOTE; GENETIC-ANALYSIS; CROSSING-OVER; YEAST; HELICASE	The essential and evolutionarily conserved Smc5-Smc6 complex (Smc5/6) is critical for the maintenance of genome stability. Partial loss of Smc5/6 function yields several defects in DNA repair, which are rescued by inactivation of the homologous recombination (HR) machinery. Thus HR is thought to be toxic to cells with defective Smc5/6. Recent work has highlighted a role for Smc5/6 and the Sgs1 DNA helicase in preventing the accumulation of unresolved HR intermediates. Here we investigate how deletion of MPH1, encoding the orthologue of the human FANCM DNA helicase, rescues the DNA damage sensitivity of smc5/6 but not sgs1 Delta mutants. We find that MPH1 deletion diminishes accumulation of HR intermediates within both smc5/6 and sgs1 Delta cells, suggesting that MPH1 deletion is sufficient to decrease the use of template switch recombination (TSR) to bypass DNA lesions. We further explain how avoidance of TSR is nonetheless insufficient to rescue defects in sgs1 Delta mutants, by demonstrating a requirement for Sgs1, along with the post-replicative repair (PRR) and HR machinery, in a pathway that operates in mph1 Delta mutants. In addition, we map the region of Mph1 that binds Smc5, and describe a novel allele of MPH1 encoding a protein unable to bind Smc5 (mph1-Delta 60). Remarkably, mph1-Delta 60 supports normal growth and responses to DNA damaging agents, indicating that Smc5/6 does not simply restrain the recombinogenic activity of Mph1 via direct binding. These data as a whole highlight a role for Smc5/6 and	[Johnson, F. Brad] Univ Penn, Stellar Chance Labs 405A, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Cell & Mol Biol Grp, Sch Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Inst Aging, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Stellar Chance Labs 405A, Dept Pathol & Lab Med, Sch Med, 422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [R01-AG021521, P01-AG031862, T32-AG000255]; NATIONAL INSTITUTE ON AGING [P01AG031862, T32AG000255, R01AG021521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG021521 and P01-AG031862 (to F. B. J.) and T32-AG000255 (to A. C.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Frei C, 2000, GENE DEV, V14, P81; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee KY, 2008, MOL CELLS, V26, P5; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mullen JR, 2000, GENETICS, V154, P1101; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; PRAKASH S, 1977, GENETICS, V87, P229; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Scheller J, 2000, GENETICS, V155, P1069; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	50	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5119	5125		10.1074/jbc.M110.201608	http://dx.doi.org/10.1074/jbc.M110.201608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138837	Green Published, hybrid			2022-12-27	WOS:000287230600019
J	Froese, N; Kattih, B; Breitbart, A; Grund, A; Geffers, R; Molkentin, JD; Kispert, A; Wollert, KC; Drexler, H; Heineke, J				Froese, Natali; Kattih, Badder; Breitbart, Astrid; Grund, Andrea; Geffers, Robert; Molkentin, Jeffery D.; Kispert, Andreas; Wollert, Kai C.; Drexler, Helmut; Heineke, Joerg			GATA6 Promotes Angiogenic Function and Survival in Endothelial Cells by Suppression of Autocrine Transforming Growth Factor beta/Activin Receptor-like Kinase 5 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VITRO; ADHESION MOLECULE-1; DIFFERENTIATION; HEART; BETA; IDENTIFICATION; INHIBITOR	Understanding the transcriptional regulation of angiogenesis could lead to the identification of novel therapeutic targets. We showed here that the transcription factor GATA6 is expressed in different human primary endothelial cells as well as in vascular endothelial cells of mice in vivo. Activation of endothelial cells was associated with GATA6 nuclear translocation, chromatin binding, and enhanced GATA6-dependent transcriptional activation. siRNA-mediated down-regulation of GATA6 after growth factor stimulation led to a dramatically reduced capacity of macro-and microvascular endothelial cells to proliferate, migrate, or form capillary-like structures on Matrigel. Adenoviral overexpression of GATA6 in turn enhanced angiogenic function, especially in cardiac endothelial microvascular cells. Furthermore, GATA6 protected endothelial cells from undergoing apoptosis during growth factor deprivation. Mechanistically, down-regulation of GATA6 in endothelial cells led to increased expression of transforming growth factor (TGF) beta 1 and TGF beta 2, whereas enhanced GATA6 expression, accordingly, suppressed Tgfb1 promoter activity. High TGF beta 1/beta 2 expression in GATA6-depleted endothelial cells increased the activation of the activin receptor-like kinase 5 (ALK5) and SMAD2, and suppression of this signaling axis by TGF beta neutralizing antibody or ALK5 inhibition restored angiogenic function and survival in endothelial cells with reduced GATA6 expression. Together, these findings indicate that GATA6 plays a crucial role for endothelial cell function and survival, at least in part, by suppressing autocrine TGF beta expression and ALK5-dependent signaling.	[Froese, Natali; Kattih, Badder; Breitbart, Astrid; Grund, Andrea; Wollert, Kai C.; Drexler, Helmut; Heineke, Joerg] Hannover Med Sch, Klin Kardiol & Angiol, D-30625 Hannover, Germany; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Geffers, Robert] HCI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Dept Pediat, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA	Hannover Medical School; Hannover Medical School; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Heineke, J (corresponding author), Hannover Med Sch, Klin Kardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Heineke.Joerg@Mh-Hannover.de	Murakami, Iwanori/O-4913-2018	Murakami, Iwanori/0000-0001-7913-5327; Grund, Andrea/0000-0001-6423-7398; Molkentin, Jeffery/0000-0002-3558-6529	Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth [EXC 62/1]; Solvay Foundation; Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft [HE 3658/3-1]; Howard Hughes Medical Institute; National Institutes of Health	Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth; Solvay Foundation(Solvay SA); Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth (EXC 62/1, to J.H.), the Solvay Foundation (to J.H.), and the Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft HE 3658/3-1 (to J.H.).; Funded by grants from the Howard Hughes Medical Institute and the National Institutes of Health.	Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; German Z, 2000, J BIOL CHEM, V275, P8183, DOI 10.1074/jbc.275.11.8183; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Kessler T, 2010, RECENT RESULTS CANC, V180, P137, DOI 10.1007/978-3-540-78281-0_9; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mano T, 1999, CIRC RES, V84, P647, DOI 10.1161/01.RES.84.6.647; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakano N, 2007, J IMMUNOL, V178, P3067, DOI 10.4049/jimmunol.178.5.3067; Ochiai N, 2003, BLOOD, V102, P3349, DOI 10.1182/blood-2003-03-0851; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	38	23	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5680	5690		10.1074/jbc.M110.176925	http://dx.doi.org/10.1074/jbc.M110.176925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127043	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000287230600077
J	Qureshi, HY; Paudel, HK				Qureshi, Hamid Y.; Paudel, Hemant K.			Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser(262) and Destabilize Microtubule Cytoskeleton in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINERGIC-NEURONS; DISEASE; MICE; KINASE; GENE; MODEL; ASSOCIATION; DEMENTIA; SITES; COLOCALIZATION	In Parkinson disease (PD) brain, a progressive loss of dopaminergic neurons leads to dopamine depletion in the striatum and reduced motor function. Lewy bodies, the characteristic neuropathological lesions found in the brain of PD patients, are composed mainly of alpha-synuclein protein. Three point mutations in the alpha-synuclein gene are associated with familial PD. In addition, genome-wide association studies indicate that alpha-synuclein and Tau protein synergistically increase disease susceptibility in the human population. To determine the mechanism by which alpha-synuclein and Tau act together, we have used PD-causing neurotoxin MPTP and pathogenic alpha-synuclein mutants A30P, E46K, and A53T as models. We found that exposure of human neuroblastoma M17 cells to MPTP enhances the intracellular alpha-synuclein protein level, stimulates Tau protein phosphorylation at Ser(262), and induces apoptosis. In mouse brain, ablation of alpha-synuclein function significantly suppresses Tau phosphorylation at Ser(262). In vitro, alpha-synuclein binds to phosphorylated Ser(214) of Tau and stimulates PKA-catalyzed Tau phosphorylation at Ser(262). PD-associated alpha-synuclein mutations increase alpha-synuclein binding to Tau and stimulate Tau phosphorylation at Ser(262). In HEK-293 cells, alpha-synuclein and its all PD-associated mutants destabilize the microtubule cytoskeleton in a similar extent. In contrast, when co-expressed with Tau, these PD-associated mutants destabilize microtubules with significantly higher potency than WT. Our results demonstrate that alpha-synuclein is an in vivo regulator of Tau protein phosphorylation at Ser(262) and suggest that PD-associated risk factors such as environmental toxins and alpha-synuclein mutations promote Tau phosphorylation at Ser(262), causing microtubule instability, which leads to loss of dopaminergic neurons in PD brain.	McGill Univ, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada; National Scientific and Engineering Research Council of Canada (NSERC); Parkinson's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada; National Scientific and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson's Society of Canada	This work was supported in part by operating grants from Canadian Institute for Health Research, The Alzheimer's Society of Canada, and National Scientific and Engineering Research Council of Canada (NSERC).; Recipient of a postdoctoral fellowship from the Parkinson's Society of Canada.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Arima K, 1999, BRAIN RES, V843, P53, DOI 10.1016/S0006-8993(99)01848-X; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BOLLER F, 1980, ANN NEUROL, V7, P329, DOI 10.1002/ana.410070408; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cappelletti G, 2005, FEBS LETT, V579, P4781, DOI 10.1016/j.febslet.2005.07.058; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2003, ACTA NEUROPATHOL, V106, P243, DOI 10.1007/s00401-003-0726-x; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kim CY, 2008, J NEUROCHEM, V107, P303, DOI 10.1111/j.1471-4159.2008.05612.x; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuhn K, 2003, EUR J NEUROSCI, V17, P1, DOI 10.1046/j.1460-9568.2003.02408.x; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	65	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5055	5068		10.1074/jbc.M110.178905	http://dx.doi.org/10.1074/jbc.M110.178905			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127069	hybrid, Green Published			2022-12-27	WOS:000287230600013
J	Jia, LJ; Bickel, JS; Wu, JX; Morgan, MA; Li, H; Yang, J; Yu, XC; Chan, RC; Sun, Y				Jia, Lijun; Bickel, Jeremy S.; Wu, Jiaxue; Morgan, Meredith A.; Li, Hua; Yang, Jie; Yu, Xiaochun; Chan, Raymond C.; Sun, Yi			RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase Is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; CELL-CYCLE CONTROL; S-PHASE; DAMAGE CHECKPOINT; CULLIN PARTNERS; C. ELEGANS; HUMAN CDT1; REREPLICATION; PROTEOLYSIS; INHIBITOR	RBX1 (RING box protein 1), also known as ROC1 (Regulator of Cullin 1), is an essential component of SCF (Skp1/Cullins/F-box) E3 ubiquitin ligases, which target diverse proteins for proteasome-mediated degradation. Our recent study showed that RBX1 silencing triggered a DNA damage response (DDR) leading to G(2)-M arrest, senescence, and apoptosis, with the mechanism remaining elusive. Here, we show that, in human cancer cells, RBX1 silencing causes the accumulation of DNA replication licensing proteins CDT1 and ORC1, leading to DNA double-strand breaks, DDR, G(2) arrest, and, eventually, aneuploidy. Whereas CHK1 activation by RBX1 silencing is responsible for the G(2) arrest, enhanced DNA damage renders cancer cells more sensitive to radiation. In Caenorhabditis elegans, RBX-1 silencing causes CDT-1 accumulation, triggering DDR in intestinal cells, which is largely abrogated by simultaneous CDT-1 silencing. RBX-1 silencing also induces lethality during development of embryos and in adulthood. Thus, RBX1 E3 ligase is essential for the maintenance of mammalian genome integrity and the proper development and viability in C. elegans.	[Jia, Lijun; Morgan, Meredith A.; Li, Hua; Yang, Jie; Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA; [Bickel, Jeremy S.; Chan, Raymond C.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Jia, Lijun] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Wu, Jiaxue; Yu, Xiaochun; Chan, Raymond C.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; University of Michigan System; University of Michigan	Jia, LJ (corresponding author), Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA.	jialijun2002@yahoo.com.cn; rchan@umich.edu; sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287; Chan, Raymond/0000-0003-3397-2351	NCI [CA111554, CA118762]; Chinese National Nature Sciences Foundation [31071204]; Fudan University in China; NATIONAL CANCER INSTITUTE [R01CA111554, R01CA118762] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese National Nature Sciences Foundation; Fudan University in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111554 and CA118762 from NCI (to Y. S.). This work was also supported by Chinese National Nature Sciences Foundation Grant 31071204 and a grant from Fudan University in China (to L. J.).	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bickel JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001028; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Dutta A, 2007, NAT GENET, V39, P10, DOI 10.1038/ng0107-10; Gao MX, 2008, CELL DEATH DIFFER, V15, P1054, DOI 10.1038/cdd.2008.30; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2004, Methods Mol Biol, V280, P257; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Merlet J, 2010, DEVELOPMENT, V137, P3857, DOI 10.1242/dev.054866; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rialland M, 2002, J CELL SCI, V115, P1435; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Starostina NG, 2010, DEV CELL, V19, P753, DOI 10.1016/j.devcel.2010.10.013; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	52	41	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3379	3386		10.1074/jbc.M110.188425	http://dx.doi.org/10.1074/jbc.M110.188425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115485	Green Published, hybrid			2022-12-27	WOS:000286653200024
J	Zhou, HN; Brock, J; Casarotto, MG; Oakley, AJ; Board, PG				Zhou, Huina; Brock, Joseph; Casarotto, Marco G.; Oakley, Aaron J.; Board, Philip G.			Novel Folding and Stability Defects Cause a Deficiency of Human Glutathione Transferase Omega 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-AT-ONSET; S-TRANSFERASE; EQUILIBRIUM DENATURATION; ARSENIC METABOLISM; PARKINSON-DISEASE; ALZHEIMER-DISEASE; POLYMORPHISMS; GLUTATHIONE-TRANSFERASE-OMEGA-1-1; INTERMEDIATE; ALA140ASP	The polymorphic deletion of Glu-155 from human glutathione transferase omega1 (GSTO1-1) occurs in most populations. Although the recombinant Delta Glu-155 enzyme expressed in Escherichia coli is active, the deletion causes a deficiency of the active enzyme in vivo. The crystal structure and the folding/unfolding kinetics of the Delta Glu-155 variant were determined in order to investigate the cause of the rapid loss of the enzyme in human cells. The crystal structure revealed altered packing around the Glu-155 deletion, an increase in the predicted solvent-accessible area and a corresponding reduction in the buried surface area. This increase in solvent accessibility was consistent with an elevated Stern-Volmer constant. The unfolding of both the wild type and Delta Glu-155 enzyme in urea is best described by a three-state model, and there is evidence for the more pronounced population of an intermediate state by the Delta Glu-155 enzymes. Studies using intrinsic fluorescence revealed a free energy change around 14.4 kcal/mol for the wild type compared with around 8.6 kcal/mol for the Delta Glu-155 variant, which indicates a decrease in stability associated with the Glu-155 deletion. Urea induced unfolding of the wild type GSTO1-1 was reversible through an initial fast phase followed by a second slow phase. In contrast, the Delta Glu-155 variant lacks the slow phase, indicating a refolding defect. It is possible that in some conditions in vivo, the increased solvent-accessible area and the low stability of the Delta Glu-155 variant may promote its unfolding, whereas the refolding defect limits its refolding, resulting in GSTO1-1 deficiency.	[Zhou, Huina; Casarotto, Marco G.; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Brock, Joseph; Oakley, Aaron J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013; Brock, Joseph/P-6663-2018; Casarotto, Marco/D-8704-2011; Brock, Joseph/AAE-9483-2020	Oakley, Aaron/0000-0002-4764-014X; Brock, Joseph/0000-0003-3476-9478; Brock, Joseph/0000-0003-3476-9478; Casarotto, Marco/0000-0002-0571-7671	National Health and Medical Research Council [366731]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Project Grant 366731.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERHARDT J, 1995, EUR J BIOCHEM, V230, P614; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolsch H, 2007, STROKE, V38, P2847, DOI 10.1161/STROKEAHA.107.484162; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li YJ, 2006, NEUROBIOL AGING, V27, P1087, DOI 10.1016/j.neurobiolaging.2005.05.013; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Marnell LL, 2003, CHEM RES TOXICOL, V16, P1507, DOI 10.1021/tx034149a; Mukherjee B, 2006, DRUG METAB DISPOS, V34, P1237, DOI 10.1124/dmd.106.009613; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paiva L, 2008, PHARMACOGENET GENOM, V18, P1, DOI 10.1097/FPC.0b013e3282f29663; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Schmuck E, 2008, INT J BIOCHEM CELL B, V40, P2553, DOI 10.1016/j.biocel.2008.04.017; Szpikowska BK, 1996, ARCH BIOCHEM BIOPHYS, V335, P173, DOI 10.1006/abbi.1996.0495; Tanaka-Kagawa T, 2003, BIOCHEM BIOPH RES CO, V301, P516, DOI 10.1016/S0006-291X(02)03066-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Yu LZ, 2003, ENVIRON HEALTH PERSP, V111, P1421, DOI 10.1289/ehp.6420; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h	35	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4271	4279		10.1074/jbc.M110.197822	http://dx.doi.org/10.1074/jbc.M110.197822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21106529	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000286975700026
J	Chen, L; Romero, L; Chuang, SM; Tournier, V; Joshi, KK; Lee, JA; Kovvali, G; Madura, K				Chen, Li; Romero, Lizbeth; Chuang, Show-Mei; Tournier, Vincent; Joshi, Kishore Kumar; Lee, Jung Ah; Kovvali, Gopala; Madura, Kiran			Sts1 Plays a Key Role in Targeting Proteasomes to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; UBIQUITIN/PROTEASOME PATHWAY; PROTEIN-DEGRADATION; KARYOPHERIN-ALPHA; UBA DOMAINS; UBIQUITIN; RAD23; LOCALIZATION; YEAST	The evidence that nuclear proteins can be degraded by cytosolic proteasomes has received considerable experimental support. However, the presence of proteasome subunits in the nucleus also suggests that protein degradation could occur within this organelle. We determined that Sts1 can target proteasomes to the nucleus and facilitate the degradation of a nuclear protein. Specific sts1 mutants showed reduced nuclear proteasomes at the nonpermissive temperature. In contrast, high expression of Sts1 increased the levels of nuclear proteasomes. Sts1 targets proteasomes to the nucleus by interacting with Srp1, a nuclear import factor that binds nuclear localization signals. Deletion of the NLS in Sts1 prevented its interaction with Srp1 and caused proteasome mislocalization. In agreement with this observation, a mutation in Srp1 that weakened its interaction with Sts1 also reduced nuclear targeting of proteasomes. We reported that Sts1 could suppress growth and proteolytic defects of rad23 Delta rpn10 Delta. We show here that Sts1 suppresses a previously undetected proteasome localization defect in this mutant. Taken together, these findings explain the suppression of rad23 Delta rpn10 Delta by Sts1 and suggest that the degradation of nuclear substrates requires efficient proteasome localization.	[Chen, Li; Romero, Lizbeth; Chuang, Show-Mei; Tournier, Vincent; Joshi, Kishore Kumar; Lee, Jung Ah; Kovvali, Gopala; Madura, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), SPH-383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu		Tournier, Vincent/0000-0002-3971-1972; Chuang, Show-Mei/0000-0003-2986-0736	National Institutes of Health [CA083875]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA083875 (to K. M.).	Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Chandra A, 2010, J BIOL CHEM, V285, P8330, DOI 10.1074/jbc.M109.076786; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Cheong JK, 2008, J BIOL CHEM, V283, P11661, DOI 10.1074/jbc.M708365200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guerrero S., 2001, Innovative Food Science and Emerging Technologies, V2, P31, DOI 10.1016/S1466-8564(01)00020-0; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; Lambertson D, 1999, GENETICS, V153, P69; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stewart D, 2005, J VIROL, V79, P8773, DOI 10.1128/JVI.79.14.8773-8783.2005; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Yen HCS, 2003, J BIOL CHEM, V278, P30669, DOI 10.1074/jbc.M302093200	30	32	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3104	3118		10.1074/jbc.M110.135863	http://dx.doi.org/10.1074/jbc.M110.135863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075847	Green Published, hybrid			2022-12-27	WOS:000286464300072
J	Mathurin, K; Gallant, MA; Germain, P; Allard-Chamard, H; Brisson, J; Iorio-Morin, C; Fernandes, AD; Caron, MG; Laporte, SA; Parent, JL				Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Caron, Marc G.; Laporte, Stephane A.; Parent, Jean-Luc			An Interaction between L-prostaglandin D Synthase and Arrestin Increases PGD(2) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC SELENIUM-COMPOUNDS; LIPOCALIN-TYPE; BETA-ARRESTIN; D SYNTHETASE; RAT-BRAIN; INDUCIBLE CYCLOOXYGENASE; PPAR-GAMMA; RECEPTOR; ACTIVATION; D-2	L-type prostaglandin synthase (L-PGDS) produces PGD(2), a lipid mediator involved in neuromodulation and inflammation. Here, we show that L-PGDS and arrestin-3 (Arr3) interact directly and can be co-immunoprecipitated endogenously from MG-63 osteoblasts. Perinuclear L-PGDS/Arr3 co-localization is observed in PGD(2)-producing MG-63 cells and is induced by the addition of the L-PGDS substrate or co-expression of COX-2 in HEK293 cells. Inhibition of L-PGDS activity in MG-63 cells triggers redistribution of Arr3 and L-PGDS to the cytoplasm. Perinuclear localization of L-PGDS is detected in wild-type mouse embryonic fibroblasts (MEFs) but is more diffused in MEFs-arr-2(-/-) -arr-3(-/-). Arrestin-3 promotes PGD(2) production by L-PGDS in vitro. IL-1 beta-induced PGD(2) production is significantly lower in MEFs-arr-2(-/-) -arr-3(-/-) than in wild-type MEFs but can be rescued by expressing Arr2 or Arr3. A peptide corresponding to amino acids 86-100 of arrestin-3 derived from its L-PGDS binding domain stimulates L-PGDS-mediated PGD(2) production in vitro and in MG-63 cells. We report the first characterization of an interactor/modulator of a PGD(2) synthase and the identification of a new function for arrestin, which may open new opportunities for improving therapies for the treatment of inflammatory diseases.	[Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Ctr Rech Clin Etienne Lebel, Sherbrooke, PQ J1H 5N4, Canada; [Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Laporte, Stephane A.] McGill Univ, Hormones & Canc Res Unit, Dept Med, Montreal, PQ H3A 1A1, Canada; [Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A1, Canada	University of Sherbrooke; Duke University; McGill University; McGill University	Parent, JL (corresponding author), Univ Sherbrooke, Fac Med, Div Rheumatol, 3001,12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Jean-Luc.Parent@Usherbrooke.ca	Iorio-Morin, Christian/I-8696-2019; Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021; Allard-Chamard, H/J-2827-2019	Iorio-Morin, Christian/0000-0003-2995-7255; Laporte, Stephane/0000-0002-0633-543X; Allard-Chamard, H/0000-0001-7850-2658	Canadian Institutes of Health Research; Fonds de la recherche en sante du Quebec; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work was supported by a grant from Canadian Institutes of Health Research (to A. d. B. F. and J.- L. P.).; Recipient of studentships from the Fonds de la recherche en sante du Quebec.; Supported by fellowships from the Canadian Arthritis Network for part of this work.	Amirand C, 1998, J CELL SCI, V111, P3551; Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blodorn B, 1996, NEUROSCI LETT, V209, P117, DOI 10.1016/0304-3940(96)12614-8; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Farrell CJ, 2004, P NATL ACAD SCI USA, V101, P4625, DOI 10.1073/pnas.0306482101; Fujimori K, 2000, J BIOL CHEM, V275, P40511, DOI 10.1074/jbc.M007688200; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gerena RL, 2000, J ANDROL, V21, P848; Gietz R D, 2002, Methods Mol Biol, V185, P471; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Ide T, 2003, THROMB RES, V110, P311, DOI 10.1016/S0049-3848(03)00418-3; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; ITO S, 1989, PROSTAG LEUKOTR ESS, V37, P219, DOI 10.1016/0952-3278(89)90033-1; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Li L, 2006, CYTOKINE GROWTH F R, V17, P203, DOI 10.1016/j.cytogfr.2006.01.005; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mifflin RC, 2002, AM J PHYSIOL-CELL PH, V282, pC824, DOI 10.1152/ajpcell.00388.2001; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Nagasaka T, 2004, HISTOCHEM CELL BIOL, V121, P483, DOI 10.1007/s00418-004-0658-0; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; TAKAHATA R, 1993, BRAIN RES, V623, P65, DOI 10.1016/0006-8993(93)90010-K; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; UENO R, 1983, P NATL ACAD SCI-BIOL, V80, P1735, DOI 10.1073/pnas.80.6.1735; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1990, J BIOL CHEM, V265, P371; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294	59	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2696	2706		10.1074/jbc.M110.178277	http://dx.doi.org/10.1074/jbc.M110.178277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21112970	Green Published, hybrid			2022-12-27	WOS:000286464300036
J	Briknarova, K; Thomas, CJ; York, J; Nunberg, JH				Briknarova, Klara; Thomas, Celestine J.; York, Joanne; Nunberg, Jack H.			Structure of a Zinc-binding Domain in the Junin Virus Envelope Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; STABLE SIGNAL PEPTIDE; RECOMBINANT VACCINIA VIRUS; PH-INDUCED ACTIVATION; MEMBRANE-FUSION; GP-C; IDENTIFICATION; RECEPTOR; ARENAVIRUSES; MECHANISMS	Arenaviruses cause acute hemorrhagic fevers with high mortality. Entry of the virus into the host cell is mediated by the viral envelope glycoprotein, GPC. In contrast to other class I viral envelope glycoproteins, the mature GPC complex contains a cleaved stable signal peptide (SSP) in addition to the canonical receptor-binding (G1) and transmembrane fusion (G2) subunits. SSP is critical for intracellular transport of the GPC complex to the cell surface and for its membrane-fusion activity. Previous studies have suggested that SSP is retained in GPC through interaction with a zinc-binding domain (ZBD) in the cytoplasmic tail of G2. Here we used NMR spectroscopy to determine the structure of Junin virus (JUNV) ZBD (G2 residues 445-485) and investigate its interaction with a conserved Cys residue (Cys-57) in SSP. We show that JUNV ZBD displays a novel fold containing two zinc ions. One zinc ion is coordinated by His-447, His-449, Cys-455, and His-485. The second zinc ion is coordinated by His-459, Cys-467, and Cys-469 and readily accepts Cys-57 from SSP as the fourth ligand. Our studies describe the structural basis for retention of the unique SSP subunit and suggest a mechanism whereby SSP is positioned in the GPC complex to modulate pH-dependent membrane fusion.	[Briknarova, Klara] Univ Montana, Dept Chem & Biochem, Missoula, MT 59812 USA; [Briknarova, Klara; Thomas, Celestine J.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana	Briknarova, K (corresponding author), Univ Montana, Dept Chem & Biochem, 32 Campus Dr, Missoula, MT 59812 USA.	klara.briknarova@umontana.edu			National Institutes of Health [R01 AI074818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Research Grant R01 AI074818 (to J.H.N.).	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; BORROW P, 1994, VIROLOGY, V198, P1, DOI 10.1006/viro.1994.1001; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchmeier MJ, 2007, ARENAVIRIDAE VIRUSES; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Charrel RN, 2002, BIOCHEM BIOPH RES CO, V296, P1118, DOI 10.1016/S0006-291X(02)02053-3; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GHIRINGHELLI PD, 1991, J GEN VIROL, V72, P2129, DOI 10.1099/0022-1317-72-9-2129; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Lesburg CA, 1997, BIOCHEMISTRY-US, V36, P15780, DOI 10.1021/bi971296x; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MA L, 1995, PROTEIN SCI, V4, P1498, DOI 10.1002/pro.5560040807; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; Meyer BJ, 2002, CURR TOP MICROBIOL, V262, P139; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Saunders AA, 2007, J VIROL, V81, P5649, DOI 10.1128/JVI.02759-06; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wuthrich K, 1986, NMR PROTEINS NUCL AC; York J, 2005, VIROLOGY, V343, P267, DOI 10.1016/j.virol.2005.08.030; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; York J, 2007, J VIROL, V81, P13385, DOI 10.1128/JVI.01785-07; York J, 2007, VIROLOGY, V359, P72, DOI 10.1016/j.virol.2006.08.048; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2010, J VIROL, V84, P6119, DOI 10.1128/JVI.02700-09; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08	55	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1528	1536		10.1074/jbc.M110.166025	http://dx.doi.org/10.1074/jbc.M110.166025			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068387	Green Published, hybrid			2022-12-27	WOS:000286005000065
J	Aiga, M; Levinson, JN; Bamji, SX				Aiga, Mytyl; Levinson, Joshua N.; Bamji, Shernaz X.			N-cadherin and Neuroligins Cooperate to Regulate Synapse Formation in Hippocampal Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; SCAFFOLDING MOLECULE; INHIBITORY SYNAPSES; BETA-CATENIN; SYNAPTOGENESIS; PSD-95	Cadherins and neuroligins (NLs) represent two families of cell adhesion proteins that are essential for the establishment of synaptic connections in vitro; however, it remains unclear whether these proteins act in concert to regulate synapse density. Using a combination of overexpression and knockdown analyses in primary hippocampal neurons, we demonstrate that NL1 and N-cadherin promote the formation of glutamatergic synapses through a common functional pathway. Analysis of the spatial relationship between N-cadherin and NL1 indicates that in 14-day in vitro cultures, almost half of glutamatergic synapses are associated with both proteins, whereas only a subset of these synapses are associated with N-cadherin or NL1 alone. This suggests that NL1 and N-cadherin are spatially distributed in a manner that enables cooperation at synapses. In young cultures, N-cadherin clustering and its association with synaptic markers precede the clustering of NL1. Overexpression of N-cadherin at this time point enhances NL1 clustering and increases synapse density. Although N-cadherin is not sufficient to enhance NL1 clustering and synapse density in more mature cultures, knockdown of N-cadherin at later time points significantly attenuates the density of NL1 clusters and synapses. N-cadherin overexpression can partially rescue synapse loss in NL1 knockdown cells, possibly due to the ability of N-cadherin to recruit NL2 to glutamatergic synapses in these cells. We demonstrate that cadherins and NLs can act in concert to regulate synapse formation.	[Bamji, Shernaz X.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Bamji, SX (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	shernaz.bamji@ubc.ca						Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	34	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					851	858		10.1074/jbc.M110.176305	http://dx.doi.org/10.1074/jbc.M110.176305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056983	Green Published, hybrid			2022-12-27	WOS:000285782800084
J	Hong, Y; Jang, SW; Ye, KQ				Hong, Yi; Jang, Sung-Wuk; Ye, Keqiang			The N-terminal Fragment from Caspase-cleaved Serine/Arginine Protein-specific Kinase2 (SRPK2) Translocates into the Nucleus and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING FACTORS; MESSENGER-RNA; SR PROTEINS; PROTEOMIC ANALYSIS; MAMMALIAN-CELLS; RS DOMAIN; LOCALIZATION; IMPORT; PHOSPHORYLATION; TRANSPORTIN-SR2	SRPK2 belongs to a family of serine/arginine (SR) protein-specific kinases (SRPKs), which phosphorylate SR domain-containing proteins in the nuclear speckles and mediate the pre-mRNA splicing. Previous studies have shown that SRPK2 plays a pivotal role in cell proliferation and apoptosis. However, how SRPK2 is regulated during the apoptosis is unclear. Here, we show that SRPK2 is cleaved by caspases at Asp-139 and -403 residues. Its N terminus cleaved product translocates into the nucleus and promotes VP16-induced apoptosis. Akt phosphorylation of SRPK2 prevents its apoptotic cleavage by caspases. 14-3-3 beta, the binding partner of Akt-phosphorylated SRPK2, further protects it from degradation. Hence, our results suggest that the N-terminal domain of SRPK2 cleaved by caspases translocates into the nucleus, where it promotes chromatin condensation and apoptotic cell death.	[Hong, Yi; Jang, Sung-Wuk; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			NCI, National Institutes of Health [NS060680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060680] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant NS060680 from NCI, National Institutes of Health (to K. Y.).	CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang HY, 1999, GENOMICS, V57, P310, DOI 10.1006/geno.1999.5770; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	28	9	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					777	786		10.1074/jbc.M110.193441	http://dx.doi.org/10.1074/jbc.M110.193441			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056976	Green Published, hybrid			2022-12-27	WOS:000285782800077
J	He, KL; Sui, GZ; Xiong, HB; Broekman, MJ; Huang, BH; Marcus, AJ; Hajjar, KA				He, Kai-Li; Sui, Guangzhi; Xiong, Huabao; Broekman, M. Johan; Huang, Bihui; Marcus, Aaron J.; Hajjar, Katherine A.			Feedback Regulation of Endothelial Cell Surface Plasmin Generation by PKC-dependent Phosphorylation of Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PERIPHERAL MONOCYTES; PROTEIN-KINASE-C; IN-VITRO PHOSPHORYLATION; 5-LIPOXYGENASE PATHWAY; FIBRINOLYTIC RECEPTOR; THROMBOLYTIC THERAPY; EMBOLIC STROKE; ACTIVATION; BINDING; HETEROTETRAMER	In response to blood vessel injury, hemostasis is initiated by platelet activation, advanced by thrombin generation, and tempered by fibrinolysis. The primary fibrinolytic protease, plasmin, can be activated either on a fibrin-containing thrombus or on cells. Annexin A2 (A2) heterotetramer (A2.p11)(2) is a key profibrinolytic complex that assembles plasminogen and tissue plasminogen activator and promotes plasmin generation. We now report that, in endothelial cells, plasmin specifically induces activation of conventional PKC, which phosphorylates serine 11 and serine 25 of A2, triggering dissociation of the (A2.p11)(2) tetramer. The resulting free p11 undergoes ubiquitin-mediated proteasomal degradation, thus preventing further translocation of A2 to the cell surface. In vivo, pretreatment of A2(+/+) but not A2(-/-) mice with a conventional PKC inhibitor significantly reduced thrombosis in a carotid artery injury model. These results indicate that augmentation of fibrinolytic vascular surveillance by blockade of serine phosphorylation is A2-dependent. We also demonstrate that plasmin-induced phosphorylation of A2 requires both cleavage of A2 and activation of Toll-like receptor 4 on the cell surface. We propose that plasmin can limit its own generation by triggering a finely tuned "feedback" mechanism whereby A2 becomes serine-phosphorylated, dissociates from p11, and fails to translocate to the cell surface.	[He, Kai-Li; Huang, Bihui; Hajjar, Katherine A.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Broekman, M. Johan; Marcus, Aaron J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Marcus, Aaron J.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sui, Guangzhi] Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; [Xiong, Huabao] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Broekman, M. Johan; Marcus, Aaron J.] Vet Affairs New York Harbor Healthcare Syst, Thrombosis Res Lab, New York, NY 10010 USA	Cornell University; Cornell University; Cornell University; Yeshiva University; Icahn School of Medicine at Mount Sinai	Hajjar, KA (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave,Box 45, New York, NY 10065 USA.	khajjar@med.cornell.edu		Huang, Bihui/0000-0003-3084-7096	National Institutes of Health, NHLBI [HL042493, HL090895, HL046403, HL047073, HL089521]; Department of Veterans Affairs; Cancer Research and Treatment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042493, R37HL047073, R01HL090895, P01HL046403, R01HL089521, R01HL047073] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); Cancer Research and Treatment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL042493 and HL090895 (to K. A. H.), HL046403 (to K. A. H., A. J. M., and M. J. B.), and HL047073 and HL089521 (to A. J. M. and M. J. B.).; Recipient of a Merit Review Grant from the Department of Veterans Affairs and a grant from the Cancer Research and Treatment Fund.	Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Cesarman-Maus G, 2006, BLOOD, V107, P4375, DOI 10.1182/blood-2005-07-2636; Dassah M, 2009, GEN PHYSIOL BIOPHYS, V28, pF20; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; DUBOIS T, 1995, BIOCHEM J, V310, P243, DOI 10.1042/bj3100243; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAJJAR KA, 1990, J BIOL CHEM, V265, P2908; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar KA, 2010, WILLIAMS HEMATOLOGY, P2219; HALL SW, 1991, J BIOL CHEM, V266, P12329; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Jacovina AT, 2009, J CLIN INVEST, V119, P3384, DOI 10.1172/JCI39591; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassam G, 1998, J BIOL CHEM, V273, P4790, DOI 10.1074/jbc.273.8.4790; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; Peterson EA, 2003, J CELL SCI, V116, P2399, DOI 10.1242/jcs.00434; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Syrovets T, 1997, BLOOD, V89, P4574, DOI 10.1182/blood.V89.12.4574; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Tanaka Y, 2007, BRAIN RES, V1165, P135, DOI 10.1016/j.brainres.2007.06.039; THIEL C, 1992, J CELL SCI, V103, P733; Weide I, 1996, THROMB HAEMOSTASIS, V76, P561; WEIDE I, 1994, BLOOD, V83, P1941; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Zhu HH, 2010, J CEREBR BLOOD F MET, V30, P1137, DOI 10.1038/jcbfm.2009.279	51	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15428	15439		10.1074/jbc.M110.185058	http://dx.doi.org/10.1074/jbc.M110.185058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21115493	Green Published, hybrid			2022-12-27	WOS:000289788300072
J	Ikawa, M; Tokuhiro, K; Yamaguchi, R; Benham, AM; Tamura, T; Wada, I; Satouh, Y; Inoue, N; Okabe, M				Ikawa, Masahito; Tokuhiro, Keizo; Yamaguchi, Ryo; Benham, Adam M.; Tamura, Taku; Wada, Ikuo; Satouh, Yuhkoh; Inoue, Naokazu; Okabe, Masaru			Calsperin Is a Testis-specific Chaperone Required for Sperm Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; MOUSE SPERM; CALRETICULIN; CALNEXIN; CALMEGIN; IDENTIFICATION; DEFICIENT; ADAM3	Calnexin (CANX) and calreticulin (CALR) are homologous lectin chaperones located in the endoplasmic reticulum and cooperate to mediate nascent glycoprotein folding. In the testis, calmegin (CLGN) and calsperin (CALR3) are expressed as germ cell-specific counterparts of CANX and CALR, respectively. Here, we show that Calr3(-/-) males produced apparently normal sperm but were infertile because of defective sperm migration from the uterus into the oviduct and defective binding to the zona pellucida. Whereas CLGN was required for ADAM1A/ADAM2 dimerization and subsequent maturation of ADAM3, a sperm membrane protein required for fertilization, we show that CALR3 is a lectin-deficient chaperone directly required for ADAM3 maturation. Our results establish the client specificity of CALR3 and demonstrate that the germ cell-specific CALR-like endoplasmic reticulum chaperones have contrasting functions in the development of male fertility. The identification and understanding of the maturation mechanisms of key sperm proteins will pave the way toward novel approaches for both contraception and treatment of unexplained male infertility.	[Ikawa, Masahito; Tokuhiro, Keizo; Yamaguchi, Ryo; Benham, Adam M.; Satouh, Yuhkoh; Inoue, Naokazu; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yamaguchi, Ryo; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Satouh, Yuhkoh; Okabe, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Benham, Adam M.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Tamura, Taku; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Fukushima 9601295, Japan	Osaka University; Osaka University; Osaka University; Durham University; Fukushima Medical University	Ikawa, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ikawa@biken.osaka-u.ac.jp	Satouh, Yuhkoh/A-9917-2009; Tokuhiro, Keizo/HDM-4295-2022; Benham, Adam/AAC-6606-2019; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Satouh, Yuhkoh/0000-0001-9207-9374; ikawa, masahito/0000-0001-9859-6217; Tamura, Taku/0000-0001-6074-9273; Okabe, Masaru/0000-0002-0803-9044; Inoue, Naokazu/0000-0002-6187-8293; Benham, Adam/0000-0002-0919-7431; Wada, Ikuo/0000-0001-5668-6994	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20670006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hammarstrom P, 2009, FEBS LETT, V583, P2579, DOI 10.1016/j.febslet.2009.07.016; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue Naokazu, 2008, V475, P335, DOI 10.1007/978-1-59745-250-2_19; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2002, GENE, V291, P67, DOI 10.1016/S0378-1119(02)00540-1; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Persson S, 2002, GENE, V297, P151, DOI 10.1016/S0378-1119(02)00880-6; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; van Lith M, 2007, MOL BIOL CELL, V18, P2795, DOI 10.1091/mbc.E07-02-0147; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WATANABE D, 1995, FEBS LETT, V368, P509, DOI 10.1016/0014-5793(95)00729-S; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	44	95	105	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5639	5646		10.1074/jbc.M110.140152	http://dx.doi.org/10.1074/jbc.M110.140152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131354	Green Published, hybrid			2022-12-27	WOS:000287230600073
J	Kalhan, SC; Uppal, SO; Moorman, JL; Bennett, C; Gruca, LL; Parimi, PS; Dasarathy, S; Serre, D; Hanson, RW				Kalhan, Satish C.; Uppal, Sonal O.; Moorman, Jillian L.; Bennett, Carole; Gruca, Lourdes L.; Parimi, Prabhu S.; Dasarathy, Srinivasan; Serre, David; Hanson, Richard W.			Metabolic and Genomic Response to Dietary Isocaloric Protein Restriction in the Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SYNTHASE ACTIVITY; AMINO-ACID-METABOLISM; 3-PHOSPHOGLYCERATE DEHYDROGENASE; HUMAN-PREGNANCY; IN-VIVO; METHIONINE METABOLISM; TRANSCRIPTION FACTORS; SECRETORY PROTEINS; MAMMALIAN-CELLS; SKELETAL-MUSCLE	We have examined hepatic, genomic, and metabolic responses to dietary protein restriction in the non-pregnant Sprague-Dawley rat. Animals were pair-fed either a 6 or 24% casein-based diet for 7-10 days. At the end of the dietary period, a microarray analysis of the liver was performed, followed by validation of the genes of interest. The rates of appearance of phenylalanine, methionine, serine, and glucose and the contribution of pyruvate to serine and glucose were quantified using tracer methods. Plasma and tissue amino acid levels, enzyme activities, and metabolic intermediates were measured. Protein restriction resulted in significant differential expression of a number of genes involved in cell cycle, cell differentiation, transport, transcription, and metabolic processes. RTPCR showed that the expression of genes involved in serine biosynthesis and fatty acid oxidation was higher, and those involved in fatty acid synthesis and urea synthesis were lower in the liver of protein-restricted animals. Free serine and glycine levels were higher and taurine levels lower in all tissues examined. Tracer isotope studies showed an similar to 50% increase in serine de novo synthesis. Pyruvate was the primary (similar to 90%) source of serine in both groups. Transmethylation of methionine was significantly higher in the protein-restricted group. This was associated with a higher S-adenosylmethionine/S-adenosylhomocysteine ratio and lower cystathione beta-synthase and cystathionine gamma-lyase activity. Dietary isocaloric protein restriction results in profound changes in hepatic one-carbon metabolism within a short period. These may be related to high methylation demands placed on the organism and caused by possible changes in cellular osmolarity as a result of the efflux of the intracellular taurine.	Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Serre, David] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Kalhan, SC (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,NE40, Cleveland, OH 44195 USA.	sck@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK079937, DK58620]; Cleveland Clinic Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, R01DK079937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079937 (to S.C.K.) and DK58620 (to R.W.H.). This work was also supported by institutional support (to S.C.K.) from the Cleveland Clinic Foundation.	Achouri Y, 1999, BIOCHEM J, V344, P15, DOI 10.1042/0264-6021:3440015; ADIBI SA, 1973, AM J PHYSIOL, V225, P408, DOI 10.1152/ajplegacy.1973.225.2.408; Afolabi PR, 2004, AM J PHYSIOL-ENDOC M, V287, pE327, DOI 10.1152/ajpendo.00036.2004; BALLARD FJ, 1967, BIOCHEM J, V102, P952, DOI 10.1042/bj1020952; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BROSNAN JT, 1989, CAN J PHYSIOL PHARM, V67, P1058, DOI 10.1139/y89-167; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Courtney-Martin G, 2008, J NUTR, V138, P2172, DOI 10.3945/jn.108.093302; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; Dasarathy S, 2007, AM J PHYSIOL-GASTR L, V292, pG1105, DOI 10.1152/ajpgi.00529.2006; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; FRASCA V, 1988, BIOCHEMISTRY-US, V27, P8458, DOI 10.1021/bi00422a025; Fux R, 2005, AM J PHYSIOL-RENAL, V289, pF786, DOI 10.1152/ajprenal.00465.2004; Gaine PC, 2006, METABOLISM, V55, P501, DOI 10.1016/j.metabol.2005.10.012; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; GLAMOUR TS, 1995, AM J PHYSIOL-ENDOC M, V268, pE789, DOI 10.1152/ajpendo.1995.268.4.E789; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; Haussinger D, 1996, BIOCHEM J, V313, P697; HEINONEN K, 1973, BIOCHEM J, V136, P1011, DOI 10.1042/bj1361011; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ingenbleek Y, 2002, NUTRITION, V18, P40, DOI 10.1016/S0899-9007(01)00783-3; Jackson AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1179, DOI 10.1152/ajpgi.2001.281.5.G1179; Jun DY, 2008, GENE, V414, P106, DOI 10.1016/j.gene.2008.02.018; Kalhan SC, 2003, AM J PHYSIOL-ENDOC M, V284, pE733, DOI 10.1152/ajpendo.00167.2002; KALHAN SC, 1995, J MASS SPECTROM, V30, P1588, DOI 10.1002/jms.1190301111; Kalhan SC, 2001, AM J PHYSIOL-ENDOC M, V281, pE991, DOI 10.1152/ajpendo.2001.281.5.E991; Kalhan SC, 1998, AM J PHYSIOL-ENDOC M, V275, pE423, DOI 10.1152/ajpendo.1998.275.3.E423; Kang J, 1999, KIDNEY INT, V56, P452, DOI 10.1046/j.1523-1755.1999.00562.x; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; LARIVIERE F, 1992, AM J PHYSIOL, V263, pE173, DOI 10.1152/ajpendo.1992.263.1.E173; LARIVIERE F, 1994, METABOLISM, V43, P462, DOI 10.1016/0026-0495(94)90077-9; Ling PR, 2004, AM J PHYSIOL-REG I, V287, pR801, DOI 10.1152/ajpregu.00715.2003; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Mitoma J, 2004, GENE, V334, P15, DOI 10.1016/j.gene.2004.03.015; MUDD SH, 1965, J BIOL CHEM, V240, P4382; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; Ohuchi S, 2009, J NUTR SCI VITAMINOL, V55, P178, DOI 10.3177/jnsv.55.178; Ozanne SE, 1999, BIOCHEM SOC T, V27, P94, DOI 10.1042/bst0270094; Parimi PS, 2004, PEDIATR RES, V56, P423, DOI 10.1203/01.PDR.0000136277.10365.84; Parimi PS, 2003, PEDIATR RES, V53, P325, DOI [10.1203/01.PDR.0000047643.26484.48, 10.1203/00006450-200302000-00020]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao S, 2003, EUR J CLIN NUTR, V57, P531, DOI 10.1038/sj.ejcn.1601582; Reynolds RM, 2007, J CLIN ENDOCR METAB, V92, P2208, DOI 10.1210/jc.2007-0071; Rowling MJ, 2002, J NUTR, V132, P2545, DOI 10.1093/jn/132.9.2545; Shan J., 2010, PHYSL GENOM IN PRESS; SKETCHER RD, 1974, BRIT J NUTR, V32, P615, DOI 10.1079/BJN19740114; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; STIPANUK MH, 1979, J NUTR, V109, P2126, DOI 10.1093/jn/109.12.2126; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Yamamoto N, 1996, J NUTR SCI VITAMINOL, V42, P589, DOI 10.3177/jnsv.42.589; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	59	51	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5266	5277		10.1074/jbc.M110.185991	http://dx.doi.org/10.1074/jbc.M110.185991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147771	Green Published, hybrid			2022-12-27	WOS:000287230600035
J	Bucholc, M; Ciesielski, A; Goch, G; Anielska-Mazur, A; Kulik, A; Krzywinska, E; Dobrowolska, G				Bucholc, Maria; Ciesielski, Arkadiusz; Goch, Grazyna; Anielska-Mazur, Anna; Kulik, Anna; Krzywinska, Ewa; Dobrowolska, Grazyna			SNF1-related Protein Kinases 2 Are Negatively Regulated by a Plant-specific Calcium Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; BINDING PROTEINS; NITRIC-OXIDE; ION LUMINESCENCE; GENE-EXPRESSION; STRESS; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; CA2+	SNF1-related protein kinases 2 (SnRK2s) are plant-specific enzymes involved in environmental stress signaling and abscisic acid-regulated plant development. Here, we report that SnRK2s interact with and are regulated by a plant-specific calcium-binding protein. We screened a Nicotiana plumbaginifolia Matchmaker cDNA library for proteins interacting with Nicotiana tabacum osmotic stress-activated protein kinase (NtOSAK), a member of the SnRK2 family. A putative EF-hand calcium-binding protein was identified as a molecular partner of NtOSAK. To determine whether the identified protein interacts only with NtOSAK or with other SnRK2s as well, we studied the interaction of an Arabidopsis thaliana orthologue of the calcium-binding protein with selected Arabidopsis SnRK2s using a two-hybrid system. All kinases studied interacted with the protein. The interactions were confirmed by bimolecular fluorescence complementation assay, indicating that the binding occurs in planta, exclusively in the cytoplasm. Calcium binding properties of the protein were analyzed by fluorescence spectroscopy using Tb3+ as a spectroscopic probe. The calcium binding constant, determined by the protein fluorescence titration, was 2.5 +/- 0.9 x 10(5) M-1. The CD spectrum indicated that the secondary structure of the protein changes significantly in the presence of calcium, suggesting its possible function as a calcium sensor in plant cells. In vitro studies revealed that the activity of SnRK2 kinases analyzed is inhibited in a calcium-dependent manner by the identified calcium sensor, which we named SCS (SnRK2-interacting calcium sensor). Our results suggest that SCS is involved in response to abscisic acid during seed germination most probably by negative regulation of SnRK2s activity.	[Dobrowolska, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Ciesielski, Arkadiusz] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dobrowolska, G (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.	dobrowol@ibb.waw.pl	Kulik, Anna/AAG-6577-2020; Bucholc, Maria/ABF-5097-2020	Kulik, Anna/0000-0003-0073-0583; Bucholc, Maria/0000-0003-0237-1131; Dobrowolska, Grazyna/0000-0002-2598-9666; Ciesielski, Arkadiusz/0000-0003-3945-4723; Krzywinska, Ewa/0000-0003-2259-739X; Anielska-Mazur, Anna/0000-0003-3679-7595	Ministry of Science and Higher Education [N-N301-2540, 500/N-COST/2009/0]; European Union [COST FA0605]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	This work was supported by Ministry of Science and Higher Education Grants N-N301-2540 and 500/N-COST/2009/0 (to G. D.) and European Union Grant COST FA0605.	Akaboshi M, 2008, J MOL BIOL, V377, P246, DOI 10.1016/j.jmb.2008.01.006; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; Burza AM, 2006, J BIOL CHEM, V281, P34299, DOI 10.1074/jbc.M601977200; DADLEZ M, 1991, FEBS LETT, V282, P143, DOI 10.1016/0014-5793(91)80464-E; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gilroy S, 2001, NAT REV MOL CELL BIO, V2, P307, DOI 10.1038/35067109; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; HARMON AC, 2003, GRAVIT SPACE BIOL B, V16, P1; He Ping, 2007, Methods Mol Biol, V354, P1; HORROCKS WD, 1977, J AM CHEM SOC, V99, P2378, DOI 10.1021/ja00449a079; HORROCKS WD, 1980, J AM CHEM SOC, V102, P3650, DOI 10.1021/ja00530a069; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; James P, 1996, GENETICS, V144, P1425; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kelner A, 2004, PLANT PHYSIOL, V136, P3255, DOI 10.1104/pp.104.046151; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MARSDEN BJ, 1989, BIOCHEMISTRY-US, V28, P8839, DOI 10.1021/bi00448a024; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sokolovski S, 2005, PLANT J, V43, P520, DOI 10.1111/j.1365-313X.2005.02471.x; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Yamada H, 2004, BIOSCI BIOTECH BIOCH, V68, P1966, DOI 10.1271/bbb.68.1966; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188	56	34	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3429	3441		10.1074/jbc.M110.115535	http://dx.doi.org/10.1074/jbc.M110.115535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098029	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000286653200029
J	Ikeda, M; Andoo, A; Shimono, M; Takamatsu, N; Taki, A; Muta, K; Matsushita, W; Uechi, T; Matsuzaki, T; Kenmochi, N; Takata, K; Sasaki, S; Ito, K; Ishibashi, K				Ikeda, Masahiro; Andoo, Ayaka; Shimono, Mariko; Takamatsu, Natsuko; Taki, Asaka; Muta, Kanako; Matsushita, Wataru; Uechi, Tamayo; Matsuzaki, Toshiyuki; Kenmochi, Naoya; Takata, Kuniaki; Sasaki, Sei; Ito, Katsuaki; Ishibashi, Kenichi			The NPC Motif of Aquaporin-11, Unlike the NPA Motif of Known Aquaporins, Is Essential for Full Expression of Molecular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR INTRINSIC PROTEIN; WATER CHANNEL; MIP; MUTATIONS; CELLS; AQP11	The recently identified molecule aquaporin-11 (AQP11) has a unique amino acid sequence pattern that includes an Asn-Pro- Cys (NPC) motif, corresponding to the N-terminal Asn-Pro- Ala (NPA) signature motif of conventional AQPs. In this study, we examined the effect of the mutation of the NPC motif on the subcellular localization, oligomerization, and water permeability of AQP11 in transfected mammalian cells. Furthermore, the effect was also assessed using zebrafish. Site-directed mutation at the NPC motif did not affect the subcellular localization of AQP11 but reduced its oligomerization. A cell swelling assay revealed that cells expressing AQP11 with a mutated NPC motif had significantly lower osmotic water permeability than cells expressing wild-type AQP11. Zebrafish deficient in endogenous AQP11 showed a deformity in the tail region at an early stage of development. This phenotype was dramatically rescued by injection of human wild-type AQP11 mRNA, whereas the effect of mRNA for AQP11 with a mutated NPC motif was less marked. Although the NPA motif is known to be important for formation of water-permeable pores by conventional AQPs, our observations suggest that the corresponding NPC motif of AQP11 is essential for full expression of molecular function.	[Ikeda, Masahiro] Miyazaki Univ, Fac Agr, Dept Vet Pharmacol, Miyazaki 8892192, Japan; [Uechi, Tamayo; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki 8892192, Japan; [Matsuzaki, Toshiyuki; Takata, Kuniaki] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Maebashi, Gunma 3718511, Japan; [Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo 1138519, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo 2048588, Japan	University of Miyazaki; University of Miyazaki; Gunma University; Tokyo Medical & Dental University (TMDU); Meiji Pharmaceutical University	Ikeda, M (corresponding author), Miyazaki Univ, Fac Agr, Dept Vet Pharmacol, Gakuenkibanadai Nishi 1-1, Miyazaki 8892192, Japan.	a0d302u@cc.miyazaki-u.ac.jp	Kenmochi, Naoya/ABF-3564-2021	Ikeda, Masahiro/0000-0003-2539-8812	Japan Society for the Promotion of Science [17580259, 19580342]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 17580259 (to M. I.) and 19580342 (to M. I.).	Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Brand M, 1996, DEVELOPMENT, V123, P129; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Duchesne L, 2002, J BIOL CHEM, V277, P20598, DOI 10.1074/jbc.M201179200; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gorelick Daniel A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-14; Gu F, 2007, MOL VIS, V13, P1651; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Ishibashi K, 2009, J MED INVESTIG, V56, P312, DOI 10.2152/jmi.56.312; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kohli G, 2003, ENDOCRINOLOGY, V144, P1931, DOI 10.1210/en.2002-0126; Larsen HS, 2010, EUR J ORAL SCI, V118, P9, DOI 10.1111/j.1600-0722.2009.00708.x; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; MORRICAL SO, 2006, J AM SOC NEPHROL   S, V17, pA538; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005; Yeung CH, 2010, REPRODUCTION, V139, P209, DOI 10.1530/REP-09-0298	35	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3342	3350		10.1074/jbc.M110.180968	http://dx.doi.org/10.1074/jbc.M110.180968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118806	Green Published, hybrid			2022-12-27	WOS:000286653200020
J	Jang, YH; Min, DS				Jang, Young Hoon; Min, Do Sik			Nuclear Localization of Phospholipase D1 Mediates the Activation of Nuclear Protein Kinase C alpha and Extracellular Signal-regulated Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; LEUKEMIA-CELLS; EXPRESSION; MATRIX; TRANSLOCATION; TRANSDUCTION; METABOLISM; APOPTOSIS; INVASION; DOMAINS	Recent studies highlight the existence of a nuclear lipid metabolism related to cellular proliferation. However, the importance of nuclear phosphatidylcholine (PC) metabolism is poorly understood. Therefore, we were interested in nuclear PC as a source of second messengers and, particularly, nuclear localization of PC-specific phospholipase D (PLD). In the present study we have identified the nuclear localization sequence (NLS) of PLD1 whose mutation abolished its nuclear import. Recently, we reported that caspase-mediated cleavage of PLD1 generates the N-terminal fragment (NF-PLD1) and C-terminal fragment (CF-PLD1). Here we show that CF-PLD1 but not NF-PLD1, is exclusively imported into the nucleus via its functional NLS, whereas only some portions of intact PLD1 were localized into the nucleus. The NLS of intact PLD1 or CF-PLD1 is required for interaction with importin-beta, which is known to mediate nuclear import. The amount of intact PLD1 or CF-PLD1 translocated into nucleus is correlated with its binding affinity with importin-beta. Ultimately, nuclear localization of intact PLD1 but not CF-PLD1 mediates the activation of nuclear protein kinase C alpha and extracellular signal-regulated kinase signaling pathways. Taken together, we propose that nuclear localization of PLD1 via the NLS and its interaction with importin-beta may provide new insights on the functional role of nuclear PLD1 signaling.	[Jang, Young Hoon; Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Pusan National University	Min, DS (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr		Jang, Younghoon/0000-0002-5705-4945	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [0920050]; Translational Research Center for Protein Function Control, NSF, Republic of Korea [2009-0092960]; Korea government (MEST) [20100014590]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Translational Research Center for Protein Function Control, NSF, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National R&D Program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant 0920050, by Translational Research Center for Protein Function Control, NSF Grant 2009-0092960, Republic of Korea, and by National Research Foundation of Korea funded by the Korea government (MEST) Grant 20100014590.	Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; ALBI E, 1994, LIPIDS, V29, P715, DOI 10.1007/BF02538916; Antony P, 2003, FEBS LETT, V541, P93, DOI 10.1016/S0014-5793(03)00313-2; BALBOA MA, 1995, J BIOL CHEM, V270, P29843; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P905, DOI 10.1016/j.bbalip.2009.03.007; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gayral S, 2006, CIRC RES, V99, P132, DOI 10.1161/01.RES.0000232323.86227.8b; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Hunt AN, 2006, J CELL BIOCHEM, V97, P244, DOI 10.1002/jcb.20691; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Jang YH, 2008, CELL DEATH DIFFER, V15, P1782, DOI 10.1038/cdd.2008.111; JARPE MB, 1994, BIOCHEMISTRY-US, V33, P526, DOI 10.1021/bi00168a018; Kang DW, 2011, INT J CANCER, V128, P805, DOI 10.1002/ijc.25402; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Maraldi NM, 1999, J CELL PHYSIOL, V181, P203, DOI 10.1002/(SICI)1097-4652(199911)181:2<203::AID-JCP3>3.0.CO;2-O; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martelli AM, 1999, PROG LIPID RES, V38, P273, DOI 10.1016/S0163-7827(99)00009-0; Martelli AM, 2004, CELL MOL LIFE SCI, V61, P1143, DOI 10.1007/s00018-004-3414-7; Martelli AM, 1999, CANCER RES, V59, P3961; Min DS, 2001, NEUROPHARMACOLOGY, V41, P384, DOI 10.1016/S0028-3908(01)00070-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; NEITCHEVA T, 1995, INT J BIOCHEM CELL B, V27, P995, DOI 10.1016/1357-2725(95)00087-6; Neri LM, 2002, MOL BIOL CELL, V13, P947, DOI 10.1091/mbc.01-02-0086; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Tamiya-Koizumi K, 2002, J BIOCHEM, V132, P13, DOI 10.1093/oxfordjournals.jbchem.a003190; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	37	12	12	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4680	4689		10.1074/jbc.M110.162602	http://dx.doi.org/10.1074/jbc.M110.162602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21113078	Green Published, hybrid			2022-12-27	WOS:000286975700067
J	Meseguer, S; Mudduluru, G; Escamilla, JM; Allgayer, H; Barettino, D				Meseguer, Salvador; Mudduluru, Giridhar; Manuel Escamilla, Juan; Allgayer, Heike; Barettino, Domingo			MicroRNAs-10a and-10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-RISK NEUROBLASTOMA; NEURO-BLASTOMA CELLS; GENE-EXPRESSION; SIGNALING PATHWAY; MIRNA EXPRESSION; METASTASIS; INVASION; MIGRATION; ACTIVATION; PROTEINS	MicroRNAs (miRNAs) are an emerging class of non-coding endogenous RNAs involved in multiple cellular processes, including cell differentiation. Treatment with retinoic acid (RA) results in neural differentiation of neuroblastoma cells. We wanted to elucidate whether miRNAs contribute to the gene expression changes induced by RA in neuroblastoma cells and whether miRNA regulation is involved in the transduction of the RA signal. We show here that RA treatment of SH-SY5Y neuroblastoma cells results in profound changes in the expression pattern of miRNAs. Up to 42 different miRNA species significantly changed their expression (26 up-regulated and 16 down-regulated). Among them, the closely related miR-10a and -10b showed the most prominent expression changes. Induction of miR-10a and -10b by RA also could be detected in LA-N-1 neuroblastoma cells. Loss of function experiments demonstrated that miR-10a and -10b are essential mediators of RA-induced neuroblastoma differentiation and of the associated changes in migration, invasion, and in vivo metastasis. In addition, we found that the SR-family splicing factor SFRS1 (SF2/ASF) is a target for miR-10a -and -10b in HeLa and SH-SY5Y neuroblastoma cells. We show here that changes in miR10a and -10b expression levels may regulate SFRS1-dependent alternative splicing and translational functions. Taken together, our results give support to the idea that miRNA regulation plays a key role in RA-induced neuroblastoma cell differentiation. The discovery of SFRS1 as direct target of miR-10a and -10b supports the emerging functional interaction between two post-transcriptional mechanisms, microRNAs and splicing, in the neuronal differentiation context.	[Mudduluru, Giridhar; Allgayer, Heike] Heidelberg Univ, Mannheim Med Fac, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit DKFZ Heidelberg, D-68135 Mannheim, Germany; [Meseguer, Salvador; Manuel Escamilla, Juan; Barettino, Domingo] CSIC, Biol Hormone Act Unit, Dept Mol & Cellular Pathol & Therapy, Inst Biomed Valencia, E-46010 Valencia, Spain	Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Allgayer, H (corresponding author), Heidelberg Univ, Mannheim Med Fac, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit DKFZ Heidelberg, Theodor Kutzer Ufer 1-3, D-68135 Mannheim, Germany.	dbarettino@ibv.csic.es	Meseguer, Salvador/K-7137-2014; ESCAMILLA-HONRUBIA, JUAN MANUEL/L-5884-2014	Meseguer, Salvador/0000-0002-2718-4351; ESCAMILLA-HONRUBIA, JUAN MANUEL/0000-0003-0154-6569	Spanish former Ministry of Education and Science; Ministry of Science and Innovation [SAF2006-00647, SAF2007-60780]; Generalitat Valenciana [ACOMP 09/212]; Genoma Espana; Alfried Krupp von Bohlen und Halbach Foundation (Essen); Hella-Buhler-Foundation (Heidelberg); Dr. Ingrid zu Solms Foundatio (Frankfurt/Main); Hector Foundation (Weinheim); FRONTIER Excellence Initiative of the University of Heidelberg; Federal Ministry of Education and Research (BMBF), Germany; Walter Schulz Foundation, Munich, Germany; European Association for Cancer Research; Consejo Superior de Investigaciones Cientificas	Spanish former Ministry of Education and Science; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Genoma Espana; Alfried Krupp von Bohlen und Halbach Foundation (Essen); Hella-Buhler-Foundation (Heidelberg); Dr. Ingrid zu Solms Foundatio (Frankfurt/Main); Hector Foundation (Weinheim); FRONTIER Excellence Initiative of the University of Heidelberg; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Walter Schulz Foundation, Munich, Germany; European Association for Cancer Research; Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish former Ministry of Education and Science and Ministry of Science and Innovation Grants SAF2006-00647 and SAF2007-60780 and Generalitat Valenciana (ACOMP 09/212) and Genoma Espana (to D. B.) and by the Alfried Krupp von Bohlen und Halbach Foundation (Award for Young Full Professors) (Essen), Hella-Buhler-Foundation (Heidelberg), Dr. Ingrid zu Solms Foundatio (Frankfurt/Main), the Hector Foundation (Weinheim), the FRONTIER Excellence Initiative of the University of Heidelberg, the Federal Ministry of Education and Research (BMBF), Germany, and the Walter Schulz Foundation, Munich, Germany (to H. A.). This work was also supported by an European Association for Cancer Research training and travel fellowship award (to S. M.) for the purpose of training in microRNA research.; Recipient of a Consejo Superior de Investigaciones Cientificas I3P predoctoral fellowship/contract.	ALBINI A, 1987, CANCER RES, V47, P3239; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Giannini G, 1997, J BIOL CHEM, V272, P26693, DOI 10.1074/jbc.272.42.26693; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; INO M, 1986, DEV BRAIN RES, V30, P120, DOI 10.1016/0165-3806(86)90140-9; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Joshi S, 2006, ONCOGENE, V25, P240, DOI 10.1038/sj.onc.1209027; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laserna EJ, 2009, MOL ENDOCRINOL, V23, P1799, DOI 10.1210/me.2009-0165; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 2000, BRIT J CANCER, V83, P1121, DOI 10.1054/bjoc.2000.1430; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Mueller S, 2009, CURR ONCOL REP, V11, P431, DOI 10.1007/s11912-009-0059-6; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Petrocca F, 2009, RNA BIOL, V6, P335, DOI 10.4161/rna.6.3.9013; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; SIDELL N, 1982, J NATL CANCER I, V68, P589; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; TAHIRA T, 1991, ONCOGENE, V6, P2333; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; TSOKOS M, 1987, AM J PATHOL, V128, P484; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yamada S, 2007, NEUROREPORT, V18, P359, DOI 10.1097/WNR.0b013e32801299b4; Zijlstra A, 2002, CANCER RES, V62, P7083	85	87	92	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4150	4164		10.1074/jbc.M110.167817	http://dx.doi.org/10.1074/jbc.M110.167817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118818	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286975700014
J	Crawley, SW; Gharaei, MS; Ye, QL; Yang, YD; Raveh, B; London, N; Schueler-Furman, O; Jia, ZC; Cote, GP				Crawley, Scott W.; Gharaei, Mojdeh Samimi; Ye, Qilu; Yang, Yidai; Raveh, Barak; London, Nir; Schueler-Furman, Ora; Jia, Zongchao; Cote, Graham P.			Autophosphorylation Activates Dictyostelium Myosin II Heavy Chain Kinase A by Providing a Ligand for an Allosteric Binding Site in the alpha-Kinase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; PROTEIN-KINASE; CRYSTAL-STRUCTURE; ACTIN-BINDING; LOCALIZATION; PHOSPHORYLATION; IDENTIFICATION; DISCOIDEUM; FILAMENTS; TRPM7	Dictyostelium discoideum myosin II heavy chain kinase A (MHCK A), a member of the atypical alpha-kinase family, phosphorylates sites in the myosin II tail that block filament assembly. Here we show that the catalytic activity of A-CAT, the alpha-kinase domain of MHCKA (residues 552-841), is severely inhibited by the removal of a disordered C-terminal tail sequence (C-tail; residues 806-841). The key residue in the C-tail was identified as Thr(825), which was found to be constitutively autophosphorylated. Dephosphorylation of Thr(825) using shrimp alkaline phosphatase decreased A-CAT activity. The activity of a truncated A-CAT lacking Thr(825) could be rescued by Pi, phosphothreonine, and a phosphorylated peptide, but not by threonine, glutamic acid, aspartic acid, or an unphosphorylated peptide. These results focused attention on a Pi-binding pocket located in the C-terminal lobe of A-CAT. Mutational analysis demonstrated that the P-1-pocket was essential for A-CAT activity. Based on these results, it is proposed that autophosphorylation of Thr(825) activates ACAT by providing a covalently tethered ligand for the Pi-pocket. Ab initio modeling studies using the Rosetta FloppyTail and Flex-PepDock protocols showed that it is feasible for the phosphorylated Thr(825) to dock intramolecularly into the Pi-pocket. Allosteric activation is predicted to involve a conformational change in Arg(734), which bridges the bound Pi to Asp(762) in a key active site loop. Sequence alignments indicate that a comparable regulatory mechanism is likely to be conserved in Dictyostelium MHCKB-D and metazoan eukaryotic elongation factor-2 kinases.	[Crawley, Scott W.; Gharaei, Mojdeh Samimi; Ye, Qilu; Yang, Yidai; Jia, Zongchao; Cote, Graham P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Raveh, Barak; London, Nir; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Queens University - Canada; Hebrew University of Jerusalem	Cote, GP (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	coteg@queensu.ca	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362; London, Nir/0000-0003-2687-0699	Canadian Institutes of Health Research [MOP8603]; Heart and Stroke Foundation of Ontario [T6054]; Natural Sciences and Engineering Research Council of Canada [203705]; Israel Academy of Science and Humanities ISF [306/6]; USA-Israel Bi-national Science Foundation [2009418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Israel Academy of Science and Humanities ISF; USA-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation)	This work was supported in part by Canadian Institutes of Health Research Grant MOP8603 and Heart and Stroke Foundation of Ontario Grant T6054 (to G. P. C.), Natural Sciences and Engineering Research Council of Canada Grant 203705 (to Z.J.), the Israel Science Foundation funded by Israel Academy of Science and Humanities ISF Grant 306/6, and USA-Israel Bi-national Science Foundation Grant 2009418 (to O.S.-F.).	Betapudi V, 2005, MOL BIOL CELL, V16, P2248, DOI 10.1091/mbc.e04-07-0639; Betapudi V, 2009, TRAFFIC, V10, P1773, DOI 10.1111/j.1600-0854.2009.00992.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; COTE GP, 1987, J BIOL CHEM, V262, P1065; Crawley SW, 2008, BBA-PROTEINS PROTEOM, V1784, P908, DOI 10.1016/j.bbapap.2008.03.001; Crawley SW, 2009, BIOCHEM J, V420, P115, DOI 10.1042/BJ20081405; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De la Roche MA, 2002, J MUSCLE RES CELL M, V23, P703, DOI 10.1023/A:1024467426244; Egelhoff TT, 2005, J BIOL CHEM, V280, P2879, DOI 10.1074/jbc.M410803200; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; FUTEY LM, 1995, J BIOL CHEM, V270, P523, DOI 10.1074/jbc.270.2.523; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; KNECHT DA, 1995, DEV BIOL, V170, P434, DOI 10.1006/dbio.1995.1227; Kolman MF, 1997, J BIOL CHEM, V272, P16904, DOI 10.1074/jbc.272.27.16904; Kolman MF, 1996, J CELL BIOL, V132, P101, DOI 10.1083/jcb.132.1.101; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; LUCKVIELMETTER D, 1990, FEBS LETT, V269, P239, DOI 10.1016/0014-5793(90)81163-I; Luo X, 2001, J BIOL CHEM, V276, P17836, DOI 10.1074/jbc.M009366200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEDLEY QG, 1990, BIOCHEMISTRY-US, V29, P8992, DOI 10.1021/bi00490a016; MEDLEY QG, 1992, BIOCHIM BIOPHYS ACTA, V1175, P7, DOI 10.1016/0167-4889(92)90003-T; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagasaki A, 2002, MOL BIOL CELL, V13, p447A; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Russ M, 2006, BIOCHEM J, V395, P373, DOI 10.1042/BJ20051376; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Steimle PA, 2002, FEBS LETT, V516, P58, DOI 10.1016/S0014-5793(02)02494-8; Steimle PA, 2001, J BIOL CHEM, V276, P6853, DOI 10.1074/jbc.M008992200; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; VAILLANCOURT JP, 1988, J BIOL CHEM, V263, P10082; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219	50	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2607	2616		10.1074/jbc.M110.177014	http://dx.doi.org/10.1074/jbc.M110.177014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21071445	Green Published, hybrid			2022-12-27	WOS:000286464300026
J	Melendez, J; Grogg, M; Zheng, Y				Melendez, Jaime; Grogg, Matthew; Zheng, Yi			Signaling Role of Cdc42 in Regulating Mammalian Physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RHO-FAMILY GTPASES; GTP-BINDING PROTEINS; ACTIN RING FORMATION; CELL POLARITY; EPITHELIAL MORPHOGENESIS; NEURONAL DEVELOPMENT; CARDIAC-HYPERTROPHY; SPINDLE ORIENTATION; DIRECTED MIGRATION; DENDRITIC CELLS	Cdc42 is a member of the Rho GTPase family of intracellular molecular switches regulating multiple signaling pathways involved in actomyosin organization and cell proliferation. Knowledge of its signaling function in mammalian cells came mostly from studies using the dominant-negative or constitutively active mutant overexpression approach in the past 2 decades. Such an approach imposes a number of experimental limitations related to specificity, dosage, and/or clonal variability. Recent studies by conditional gene targeting of cdc42 in mice have revealed its tissue- and cell type-specific role and provide definitive information of the physiological signaling functions of Cdc42 in vivo.	[Melendez, Jaime; Grogg, Matthew; Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Melendez Rojel, Jaime/0000-0003-4711-864X	National Institutes of Health [R01 CA150547, R01 HL085362, P30 DK090971]; NATIONAL CANCER INSTITUTE [R01CA150547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA150547, R01 HL085362, and P30 DK090971. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2002, BIOESSAYS, V24, P602, DOI 10.1002/bies.10107; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chauhan BK, 2009, DEVELOPMENT, V136, P3657, DOI 10.1242/dev.042242; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Chuang TH, 1997, MOL BIOL CELL, V8, P1687, DOI 10.1091/mbc.8.9.1687; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Fuchs S, 2009, CELL STEM CELL, V4, P236, DOI 10.1016/j.stem.2009.01.017; Fukuda A, 2005, J BONE MINER RES, V20, P2245, DOI 10.1359/JBMR.050816; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Go MJ, 2005, DEV GROWTH DIFFER, V47, P225; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Lyubimova A, 2010, J CLIN INVEST, V120, P446, DOI 10.1172/JCI36478; Maddala R, 2008, DEV BIOL, V315, P217, DOI 10.1016/j.ydbio.2007.12.039; Maillet M, 2009, J CLIN INVEST, V119, P3079, DOI 10.1172/JCI37694; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mitchell DC, 2007, MOL VIS, V13, P1144; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Munoz-Descalzo S, 2007, INT J DEV BIOL, V51, P379, DOI 10.1387/ijdb.062250sm; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Na SQ, 1999, ONCOGENE, V18, P7966, DOI 10.1038/sj.onc.1203122; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Santos-Bredariol AS, 2002, J NEUROCYTOL, V31, P149, DOI 10.1023/A:1023997506760; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Schneeberger D, 2003, DEVELOPMENT, V130, P427, DOI 10.1242/dev.00248; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Servotte S, 2006, PROTOPLASMA, V229, P215, DOI 10.1007/s00709-006-0204-0; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Van Hengel J, 2008, GASTROENTEROLOGY, V134, P781, DOI 10.1053/j.gastro.2008.01.002; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wei L, 2002, DEVELOPMENT, V129, P1705; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Wu XW, 2006, MATRIX BIOL, V25, P466, DOI 10.1016/j.matbio.2006.09.001; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Yuan HX, 2009, HEPATOLOGY, V49, P240, DOI 10.1002/hep.22610	87	113	115	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2375	2381		10.1074/jbc.R110.200329	http://dx.doi.org/10.1074/jbc.R110.200329			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115489	Green Published, hybrid			2022-12-27	WOS:000286464300001
J	Noben-Trauth, K; Latoche, JR				Noben-Trauth, Konrad; Latoche, Joseph R.			Ectopic Mineralization in the Middle Ear and Chronic Otitis Media with Effusion Caused by RPL38 Deficiency in the Tail-short (Ts) Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; SENSORINEURAL HEARING-LOSS; RIBOSOMAL-PROTEIN S19; INNER-EAR; LABYRINTHITIS OSSIFICANS; CHOLESTEROL GRANULOMA; EXTRARIBOSOMAL FUNCTIONS; PLANAR POLARITY; EUSTACHIAN-TUBE; OTIC CAPSULE	Inflammation of the middle ear cavity (otitis media) and the abnormal deposition of bone at the otic capsule are common causes of conductive hearing impairment in children and adults. Although a host of environmental factors can contribute to these conditions, a genetic predisposition has an important role as well. Here, we analyze the Tail-short (Ts) mouse, which harbors a spontaneous semi-dominant mutation that causes skeletal defects and hearing loss. By genetic means, we show that the Ts phenotypes arise from an 18-kb deletion/insertion of the Rpl38 gene, encoding a ribosomal protein of the large subunit. We show that Ts mutants exhibit significantly elevated auditory-brain stem response thresholds and reduced distortion-product otoacoustic emissions, in the presence of normal endocochlear potentials and typical inner ear histology suggestive of a conductive hearing impairment. We locate the cause of the hearing impairment to the middle ear, demonstrating over-ossification at the round window ridge, ectopic deposition of cholesterol crystals in the middle ear cavity, enlarged Eustachian tube, and chronic otitis media with effusion all beginning at around 3 weeks after birth. Using specific antisera, we demonstrate that Rpl38 is an similar to 8-kDa protein that is predominantly expressed in mature erythrocytes. Finally, using an Rpl38 cDNA transgene, we rescue the Ts phenotypes. Together, these data present a previously uncharacterized combination of interrelated middle ear pathologies and suggest Rpl38 deficiency as a model to dissect the causative relationships between neo-ossification, cholesterol crystal deposition, and Eustachian tubes in the etiology of otitis media.	[Noben-Trauth, Konrad; Latoche, Joseph R.] NIDCD, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Noben-Trauth, K (corresponding author), 5 Res Ct, Rockville, MD 20850 USA.	nobentk@nidcd.nih.gov			National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000056] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Division of Intramural Research.	Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Benit L, 1997, J VIROL, V71, P5652; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; BROOKHOUSER PE, 1993, LARYNGOSCOPE, V103, P371, DOI 10.1002/lary.5541030402; BROTHERTON TW, 1979, BLOOD, V54, P673; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Cureoglu S, 2006, AM J OTOLARYNG, V27, P334, DOI 10.1016/j.amjoto.2005.11.001; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; DEOL MS, 1961, J EMBRYOL EXP MORPH, V6, P78; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ealy M, 2010, HEARING RES, V266, P70, DOI 10.1016/j.heares.2009.07.002; Eriksson PO, 2006, INT J MED MICROBIOL, V296, P501, DOI 10.1016/j.ijmm.2006.04.002; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Grossi PM, 2008, J NEUROSURG, V108, P357, DOI 10.3171/JNS/2008/108/2/0357; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; HAWKE M, 1975, ARCH OTOLARYNGOL, V101, P462; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; Ichimiya I, 1999, HEARING RES, V131, P128, DOI 10.1016/S0378-5955(99)00025-8; Ishijima J, 1998, GENOMICS, V49, P341, DOI 10.1006/geno.1998.5277; Jang CH, 2009, YONSEI MED J, V50, P585, DOI 10.3349/ymj.2009.50.4.585; Khan DC, 2000, HEARING RES, V142, P12, DOI 10.1016/S0378-5955(99)00221-X; KOTZIAS SA, 1985, AM J OTOL, V6, P490; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Munker G, 1981, Adv Otorhinolaryngol, V27, P138; Nabili V, 1999, LARYNGOSCOPE, V109, P931, DOI 10.1097/00005537-199906000-00017; NAGER GT, 1976, ANN OTO RHINOL LARYN, V85, P204, DOI 10.1177/000348947608500204; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; PARK K, 1992, AM J OTOLARYNG, V13, P93, DOI 10.1016/0196-0709(92)90005-E; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; PATERSON HF, 1980, J EXP ZOOL, V211, P247, DOI 10.1002/jez.1402110214; Pau H, 2005, LARYNGOSCOPE, V115, P116, DOI 10.1097/01.mlg.0000150693.31130.a0; RIFKIND RA, 1974, ANN NY ACAD SCI, V241, P113; SADE J, 1982, AM J OTOL, V3, P203; Saeboe-Larssen S, 1998, GENETICS, V148, P1215; SHER AE, 1971, ACTA OTO-LARYNGOL, P1; STEEL KP, 1987, HEARING RES, V28, P227, DOI 10.1016/0378-5955(87)90051-7; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thys M, 2009, OTOL NEUROTOL, V30, P1021, DOI 10.1097/MAO.0b013e3181a86509; Tinling SP, 2005, ANN OTO RHINOL LARYN, V114, P161, DOI 10.1177/000348940511400214; Tos M, 1989, Acta Otolaryngol Suppl, V457, P87; Uchida K, 1996, MAMM GENOME, V7, P481, DOI 10.1007/s003359900147; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu HX, 2009, OTOL NEUROTOL, V30, P579, DOI 10.1097/MAO.0b013e31819fe81c; Zheng QY, 2007, HEARING RES, V231, P23, DOI 10.1016/j.heares.2007.05.011; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046	62	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3079	3093		10.1074/jbc.M110.184598	http://dx.doi.org/10.1074/jbc.M110.184598			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062742	Green Published, hybrid			2022-12-27	WOS:000286464300070
J	Sugita, A; Kawai, S; Hayashibara, T; Amano, A; Ooshima, T; Michigami, T; Yoshikawa, H; Yoneda, T				Sugita, Atsushi; Kawai, Shinji; Hayashibara, Tetsuyuki; Amano, Atsuo; Ooshima, Takashi; Michigami, Toshimi; Yoshikawa, Hideki; Yoneda, Toshiyuki			Cellular ATP Synthesis Mediated by Type III Sodium-dependent Phosphate Transporter Pit-1 Is Critical to Chondrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED HYPOPHOSPHATEMIC MICE; BONE-INDUCING SUBSTANCE; D-RESISTANT RICKETS; GROWTH-PLATE; ENDOCHONDRAL OSSIFICATION; CHONDROCYTE APOPTOSIS; INORGANIC-PHOSPHATE; ELEMENTAL ANALYSIS; POTENTIAL ROLE; IN-VITRO	Disturbed endochondral ossification in X-linked hypophosphatemia indicates an involvement of P-i in chondrogenesis. We studied the role of the sodium-dependent P-i cotransporters (NPT), which are a widely recognized regulator of cellular P-i homeostasis, and the downstream events in chondrogenesis using Hyp mice, the murine homolog of human X-linked hypophosphatemia. Hyp mice showed reduced apoptosis and mineralization in hypertrophic cartilage. Hyp chondrocytes in culture displayed decreased apoptosis and mineralization compared with WT chondrocytes, whereas glycosaminoglycan synthesis, an early event in chondrogenesis, was not altered. Expression of the type III NPT Pit-1 and P-i uptake were diminished, and intracellular ATP levels were also reduced in parallel with decreased caspase-9 and caspase-3 activity in Hyp chondrocytes. The competitive NPT inhibitor phosphonoformic acid and ATP synthesis inhibitor 3-bromopyruvate disturbed endochondral ossification with reduced apoptosis in vivo and suppressed apoptosis and mineralization in conjunction with reduced P-i uptake and ATP synthesis in WT chondrocytes. Overexpression of Pit-1 in Hyp chondrocytes reversed P-i uptake and ATP synthesis and restored apoptosis and mineralization. Our results suggest that cellular ATP synthesis consequent to P-i uptake via Pit-1 plays an important role in chondrocyte apoptosis and mineralization, and that chondrogenesis is ATP-dependent.	[Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Biochem, Osaka 5941101, Japan; [Kawai, Shinji; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Osaka 5941101, Japan; [Hayashibara, Tetsuyuki; Ooshima, Takashi] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka 5941101, Japan; [Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Osaka 5941101, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Sugita, Atsushi; Yoshikawa, Hideki] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Yoneda, T (corresponding author), 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	tyoneda@dent.osaka-u.ac.jp	Michigami, Toshimi/AAU-2326-2021		Ministry of Education, Culture, Sports, Science, and Technology; Japanese Society for the Promotion of Science [A202290100]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the 21st Century COE Program entitled "Origination of Frontier BioDentistry" at Osaka University Graduate School of Dentistry, by the Ministry of Education, Culture, Sports, Science, and Technology, and by Grant-in-aid for Scientific Research A202290100 from the Japanese Society for the Promotion of Science (to T. Y.).	BOYDE A, 1980, HISTOCHEMISTRY, V69, P85, DOI 10.1007/BF00508369; Cecil DL, 2005, ARTHRITIS RHEUM-US, V52, P144, DOI 10.1002/art.20748; ECAROT B, 1992, J BONE MINER RES, V7, P523; Eguchi Y, 1999, CANCER RES, V59, P2174; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Fujita T, 2001, JPN J PHARMACOL, V85, P278, DOI 10.1254/jjp.85.278; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; Guicheux J, 2000, BONE, V27, P69, DOI 10.1016/S8756-3282(00)00302-1; Hayashibara T, 2007, J BONE MINER RES, V22, P1743, DOI 10.1359/JBMR.070709; Holm IA, 1997, AM J HUM GENET, V60, P790; Ishibashi K, 2002, AM J PHYSIOL-RENAL, V282, pF367, DOI 10.1152/ajprenal.00364.2000; JONES AR, 1995, CONTRACEPTION, V52, P317, DOI 10.1016/0010-7824(95)00217-X; KAKUTA S, 1985, CALCIFIED TISSUE INT, V37, P293, DOI 10.1007/BF02554877; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LoghmanAdham M, 1996, GEN PHARMACOL-VASC S, V27, P305, DOI 10.1016/0306-3623(95)02017-9; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Miao DS, 2004, BONE, V34, P638, DOI 10.1016/j.bone.2003.12.015; MONTESSUIT C, 1991, J BIOL CHEM, V266, P17791; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rowe PSN, 1996, BONE, V18, P159, DOI 10.1016/8756-3282(95)00458-0; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; SWENSON CL, 1991, CALCIFIED TISSUE INT, V48, P353, DOI 10.1007/BF02556155; TANAKA H, 1988, BONE MINER, V4, P237; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; WINTERS RW, 1958, MEDICINE, V37, P97, DOI 10.1097/00005792-195805000-00001; Wu LNY, 2002, J CELL BIOCHEM, V86, P475, DOI 10.1002/jcb.10240; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xu RH, 2005, CANCER RES, V65, P613; YOSHIKAWA H, 1985, BONE, V6, P235, DOI 10.1016/8756-3282(85)90006-7; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	45	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3094	3103		10.1074/jbc.M110.148403	http://dx.doi.org/10.1074/jbc.M110.148403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075853	Green Published, hybrid			2022-12-27	WOS:000286464300071
J	Woolls, HA; Lamanna, AC; Karbstein, K				Woolls, Heather A.; Lamanna, Allison C.; Karbstein, Katrin			Roles of Dim2 in Ribosome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KH-DOMAIN; RNA; CLEAVAGE; BINDING; IDENTIFICATION; ORGANIZATION; RECOGNITION; MODULES; 3'-END; SITES	In eukaryotes, ribosome assembly requires hundreds of conserved essential proteins not present in the mature particle. Despite their importance, the function of most factors remains unknown. This is because protein deletion often affects the composition of the entire particle. Additionally, many proteins are present in assembling ribosomes for extended times, which makes it difficult to pinpoint their role to a particular step. Here we have combined classical yeast biochemistry with experiments using recombinant proteins and RNA to study the role of Dim2 and its interaction with Nob1, the nuclease that generates the 3'-end of 18 S rRNA. Analysis of Dim2 mutants in which the interaction with Nob1 is disrupted demonstrates that this interaction between Dim2 and Nob1 is essential for optimal growth, and RNA binding experiments show that Dim2 increases Nob1 RNA affinity. Furthermore, our data indicate that Dim2 helps regulate Nob1 cleavage activity at the 3'-end of 18 S rRNA, as point mutants where this interaction is abolished in vitro accumulate pre-ribosomes containing Nob1 and 20 S rRNA in vivo. Interestingly, the site of interaction with Nob1 is mapped to the canonical RNA binding surface of a KH-like domain in Dim2, providing another example where an RNA-binding domain can be repurposed for protein interactions.	[Lamanna, Allison C.; Karbstein, Katrin] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Woolls, Heather A.; Karbstein, Katrin] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Lamanna, Allison C./0000-0003-0436-7494; Karbstein, Katrin/0000-0002-4034-1331	National Institutes of Health [R01-GM086451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM086451.	Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; CAMPBELL MG, 2011, PLOS ONE IN PRESS; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; TONE Y, 2002, GENE DEV, V16; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2008, RNA, V14, P2061, DOI 10.1261/rna.1176708; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	41	30	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2578	2586		10.1074/jbc.M110.191494	http://dx.doi.org/10.1074/jbc.M110.191494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075849	Green Published, hybrid			2022-12-27	WOS:000286464300023
J	Wu, K; Walukiewicz, HE; Glekas, GD; Ordal, GW; Rao, CV				Wu, Kang; Walukiewicz, Hanna E.; Glekas, George D.; Ordal, George W.; Rao, Christopher V.			Attractant Binding Induces Distinct Structural Changes to the Polar and Lateral Signaling Clusters in Bacillus subtilis Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; CHEMORECEPTOR MODIFICATION; HELICOBACTER-PYLORI; RECEPTOR; PROTEIN; CHEW; TRANSDUCTION; COMPLEX; GENES	Bacteria employ a modified two-component system for chemotaxis, where the receptors form ternary complexes with CheA histidine kinases and CheW adaptor proteins. These complexes are arranged in semi-ordered arrays clustered predominantly at the cell poles. The prevailing models assume that these arrays are static and reorganize only locally in response to attractant binding. Recent studies have shown, however, that these structures may in fact be much more fluid. We investigated the localization of the chemotaxis signaling arrays in Bacillus subtilis using immunofluorescence and live cell fluorescence microscopy. We found that the receptors were localized in clusters at the poles in most cells. However, when the cells were exposed to attractant, the number exhibiting polar clusters was reduced roughly 2-fold, whereas the number exhibiting lateral clusters distinct from the poles increased significantly. These changes in receptor clustering were reversible as polar localization was reestablished in adapted cells. We also investigated the dynamic localization of CheV, a hybrid protein consisting of an N-terminal CheW-like adaptor domain and a C-terminal response regulator domain that is known to be phosphorylated by CheA, using immunofluorescence. Interestingly, we found that CheV was localized predominantly at lateral clusters in unstimulated cells. However, upon exposure to attractant, CheV was found to be predominantly localized to the cell poles. Moreover, changes in CheV localization are phosphorylation-dependent. Collectively, these results suggest that the chemotaxis signaling arrays in B. subtilis are dynamic structures and that feedback loops involving phosphorylation may regulate the positioning of individual proteins.	[Wu, Kang; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Walukiewicz, Hanna E.; Glekas, George D.; Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	chris@scs.uiuc.edu			National Institutes of Health [GM054365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054365, R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054365 (to G. W. O. and C. V. R.).	Alexander RP, 2010, TRENDS MICROBIOL, V18, P494, DOI 10.1016/j.tim.2010.07.004; Besschetnova TY, 2008, P NATL ACAD SCI USA, V105, P12289, DOI 10.1073/pnas.0802868105; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Borrok MJ, 2008, ACS CHEM BIOL, V3, P101, DOI 10.1021/cb700211s; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Erbse AH, 2009, BIOCHEMISTRY-US, V48, P6975, DOI 10.1021/bi900641c; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; FUHRER DK, 1991, J BACTERIOL, V173, P7443, DOI 10.1128/jb.173.23.7443-7448.1991; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HANLON DW, 1992, J BIOL CHEM, V267, P12055; HANLON DW, 1994, J BIOL CHEM, V269, P14038; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Homma M, 2004, P NATL ACAD SCI USA, V101, P3462, DOI 10.1073/pnas.0306660101; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kirby JR, 2000, MOL MICROBIOL, V35, P44, DOI 10.1046/j.1365-2958.2000.01676.x; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Lai RZ, 2005, BIOCHEMISTRY-US, V44, P14298, DOI 10.1021/bi050567y; Lamanna AC, 2005, MOL MICROBIOL, V57, P774, DOI 10.1111/j.1365-2958.2005.04728.x; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Lowenthal AC, 2009, MICROBIOL-SGM, V155, P1181, DOI 10.1099/mic.0.021857-0; Lybarger SR, 2005, MOL MICROBIOL, V56, P1078, DOI 10.1111/j.1365-2958.2005.04593.x; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; Pereira Maristela, 2004, Genet Mol Res, V3, P92; Ping LY, 2008, MOL MICROBIOL, V69, P1427, DOI 10.1111/j.1365-2958.2008.06372.x; Pittman MS, 2001, MICROBIOL-SGM, V147, P2493, DOI 10.1099/00221287-147-9-2493; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; Rao CV, 2009, CONTRIB MICROBIOL, V16, P33, DOI 10.1159/000219372; ROSARIO MML, 1994, J BACTERIOL, V176, P2736, DOI 10.1128/JB.176.9.2736-2739.1994; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; Skidmore JM, 2000, J BACTERIOL, V182, P967, DOI 10.1128/JB.182.4.967-973.2000; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	56	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2587	2595		10.1074/jbc.M110.188664	http://dx.doi.org/10.1074/jbc.M110.188664			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098025	Green Published, hybrid			2022-12-27	WOS:000286464300024
J	Namkung, W; Phuan, PW; Verkman, AS				Namkung, Wan; Phuan, Puay-Wah; Verkman, A. S.			TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; PROTEIN; EXPRESSION; SECRETION; MECHANISMS; CFTR	TMEM16A (ANO1) functions as a calcium-activated chloride channel (CaCC). We developed pharmacological tools to investigate the contribution of TMEM16A to CaCC conductance in human airway and intestinal epithelial cells. A screen of similar to 110,000 compounds revealed four novel chemical classes of small molecule TMEM16A inhibitors that fully blocked TMEM16A chloride current with an IC50 < 10 mu M, without interfering with calcium signaling. Following structure-activity analysis, the most potent inhibitor, an aminophenylthiazole (T16A(inh)-A01), had an IC50 of similar to 1 mu M. Two distinct types of inhibitors were identified. Some compounds, such as tannic acid and the arylaminothiophene CaCCinh-A01, fully inhibited CaCC current in human bronchial and intestinal cells. Other compounds, including T16A(inh)-A01 and digallic acid, inhibited total CaCC current in these cells poorly, but blocked mainly an initial, agonist-stimulated transient chloride current. TMEM16A RNAi knockdown also inhibited mainly the transient chloride current. In contrast to the airway and intestinal cells, all TMEM16A inhibitors fully blocked CaCC current in salivary gland cells. We conclude that TMEM16A carries nearly all CaCC current in salivary gland epithelium, but is a minor contributor to total CaCC current in airway and intestinal epithelia. The small molecule inhibitors identified here permit pharmacological dissection of TMEM16A/CaCC function and are potential development candidates for drug therapy of hypertension, pain, diarrhea, and excessive mucus production.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [HL73856, DK72517, DK86125, DK35124, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086125, R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73856, DK72517, DK86125, DK35124, EB00415, and EY13574. This work was also supported by Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.	Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Flores CA, 2009, BRAZ J MED BIOL RES, V42, P993, DOI 10.1590/S0100-879X2009005000028; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Kahn MES, 2001, CLIN CANCER RES, V7, P343; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lee CH, 2010, ADV ANAT PATHOL, V17, P222, DOI 10.1097/PAP.0b013e3181d973c2; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Rufo PA, 2004, AM J PHYSIOL-CELL PH, V286, pC998, DOI 10.1152/ajpcell.00357.2003; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Storey S, 2008, NAT REV DRUG DISCOV, V7, P555, DOI 10.1038/nrd2603; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zeitlin PL, 2004, CHEST, V125, P143, DOI 10.1378/chest.125.1.143	30	266	286	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2365	2374		10.1074/jbc.M110.175109	http://dx.doi.org/10.1074/jbc.M110.175109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084298	Green Published, hybrid			2022-12-27	WOS:000286191500075
J	Ungethum, L; Kenis, H; Nicolaes, GA; Autin, L; Stoilova-McPhie, S; Reutelingsperger, CPM				Ungethum, Lisette; Kenis, Heidi; Nicolaes, Gerry A.; Autin, Ludovic; Stoilova-McPhie, Svetla; Reutelingsperger, Chris P. M.			Engineered Annexin A5 Variants Have Impaired Cell Entry for Molecular Imaging of Apoptosis Using Pretargeting Strategies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BINDING; 2-DIMENSIONAL CRYSTALLIZATION; CRYSTAL-STRUCTURE; PHOSPHATIDYLSERINE; CALCIUM; BIODISTRIBUTION; CRYSTALLOGRAPHY; RECOGNITION; MONOLAYERS; RESOLUTION	Phosphatidylserine ( PS) on apoptotic cells is a target for diagnosis and therapy using annexin A5 (anxA5). Pretargeting is a strategy developed to improve signal to background ratio for molecular imaging and to minimize undesired side effects of pharmacological and radiotherapy. Pretargeting relies on accessibility of the target finder on the surface of the target cell. anxA5 binds PS and crystallizes in a two-dimensional network covering the PS-expressing cell surface. Two-dimensional crystallization is the driving force for anxA5 internalization by PS-expressing cells. Here, we report structure/function analysis of anxA5 internalization. Guided by structural bioinformatics including protein-protein docking, we revealed that the amino acids Arg(63), Lys(70), Lys(101), Glu(138), Asp(139), and Asn(160) engage in intermolecular salt bridges within the anxA5 trimer, which is the basic building block of the two-dimensional network. Disruption of the salt bridges by site-directed mutagenesis does not affect PS binding but inhibits trimer formation and cell entry of surface-bound anxA5. The anxA5 variants with impaired internalization are superior molecular imaging agents in pretargeting strategies as compared with wild-type anxA5.	[Reutelingsperger, Chris P. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Autin, Ludovic] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Stoilova-McPhie, Svetla] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA	Maastricht University; Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston	Reutelingsperger, CPM (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	c.reutelingsperger@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Autin, Ludovic/0000-0002-2197-191X	VIDI [916-046-330]; Netherlands Organization for Scientific Research [910-48-617/5]; European Union [IVA-VLANED-1.20]	VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work was supported by VIDI Grant 916-046-330 and the INSERM/NWO Collaborative Grant 910-48-617/5 from the Netherlands Organization for Scientific Research ( to G. N.). This work was also supported by the European Union through the Euregional PACT II Grant from the Interreg IV program of Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20).	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Belhocine TZ, 2006, CURR CLIN PHARMACOL, V1, P129, DOI 10.2174/157488406776872541; Boersma HH, 2005, J NUCL MED, V46, P2035; Brisson A, 1999, J CRYST GROWTH, V196, P456, DOI 10.1016/S0022-0248(98)00834-3; Cauchon N, 2007, EUR J NUCL MED MOL I, V34, P247, DOI 10.1007/s00259-006-0199-y; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; Jeppesen B, 2008, J BIOL CHEM, V283, P6126, DOI 10.1074/jbc.M707637200; Kemerink GJ, 2003, J NUCL MED, V44, P947; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mo Y, 2003, J BIOL CHEM, V278, P2437, DOI 10.1074/jbc.M210286200; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Patel DR, 2005, BIOCHEMISTRY-US, V44, P2833, DOI 10.1021/bi047642+; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Rottey S, 2009, Q J NUCL MED MOL IM, V53, P127; Schutters K, 2010, APOPTOSIS, V15, P1072, DOI 10.1007/s10495-010-0503-y; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Stoylova SS, 1999, J BIOL CHEM, V274, P36573, DOI 10.1074/jbc.274.51.36573; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	30	17	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1903	1910		10.1074/jbc.M110.163527	http://dx.doi.org/10.1074/jbc.M110.163527			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078669	Green Published, hybrid			2022-12-27	WOS:000286191500031
J	Gibbings, S; Elkins, ND; Fitzgerald, H; Tiao, J; Weyman, ME; Shibao, G; Fini, MA; Wright, RM				Gibbings, Sophie; Elkins, Nancy D.; Fitzgerald, Hillary; Tiao, Janice; Weyman, Mari E.; Shibao, Gayle; Fini, Mehdi A.; Wright, Richard M.			Xanthine Oxidoreductase Promotes the Inflammatory State of Mononuclear Phagocytes through Effects on Chemokine Expression, Peroxisome Proliferator-activated Receptor-gamma Sumoylation, and HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC HEART-FAILURE; ALVEOLAR AIR SPACE; PPAR-GAMMA; OXIDATIVE STRESS; TRANSCRIPTIONAL ACTIVITY; ENDOTHELIAL DYSFUNCTION; MACROPHAGE ACTIVATION; SUPEROXIDE-DISMUTASE	The protective effects of pharmacological inhibitors of xanthine oxidoreductase (XOR) have implicated XOR in many inflammatory diseases. Nonetheless, the role played by XOR during inflammation is poorly understood. We previously observed that inhibition of XOR within the inflammatory mononuclear phagocytes (MNP) prevented neutrophil recruitment during adoptive transfer demonstrating the role of XOR in MNP-mediated neutrophil recruitment. To further explore the role of XOR in the inflammatory state of MNP, we studied MNP isolated from inflammatory lungs combined with analyses of MNP cell lines. We demonstrated that XOR activity was increased in inflammatory MNP following insufflation of Th-1 cytokines in vivo and that activity was specifically increased by MNP differentiation. Inhibition of XOR reduced levels of CINC-1 secreted by MNP. Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in purified rat lung MNP and MNP cell lines reflected both the presence of PPAR gamma isoforms and PPAR gamma SUMOylation, and XOR inhibitors increased levels of SUMO-PPAR gamma in MNP cell lines. Both ectopic overexpression of XOR cDNA and uric acid supplementation reduced SUMO-PPAR gamma in MNP cells. Levels of the M2 markers CD36, CD206, and arginase-1 were modulated by uric acid and oxonic acid, whereas siRNA to SUMO-1 or PIAS-1 also reduced arginase-1 in RAW264.7 cells. We also observed that HIF-1 alpha was increased by XOR inhibitors in inflammatory MNP and in MNP cell lines. These data demonstrate that XOR promotes the inflammatory state of MNP through effects on chemokine expression, PPAR gamma SUMOylation, and HIF-1 alpha and suggest that strategies for inhibiting XOR may be valuable in modulating lung inflammatory disorders.	[Elkins, Nancy D.; Weyman, Mari E.; Shibao, Gayle; Fini, Mehdi A.; Wright, Richard M.] Univ Colorado Denver, Webb Waring Ctr, Aurora, CO 80045 USA; [Fini, Mehdi A.; Wright, Richard M.] Univ Colorado Denver, Dept Med, Div Pulm Sci, Aurora, CO 80045 USA; [Gibbings, Sophie] Univ Bath, Dept Biochem, Bath BA2 7AY, Avon, England; [Fitzgerald, Hillary; Tiao, Janice] Princeton Univ, Dept Biochem, Princeton, NJ 08544 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Bath; Princeton University	Wright, RM (corresponding author), Univ Colorado Denver, Webb Waring Ctr, Aurora, CO 80045 USA.	richard.m.wright@UCDenver.edu			National Institutes of Health [HL-45582]; Robert and Helen Kleberg Foundation; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Helen Kleberg Foundation; American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-45582. This work was also supported in part by grants from The Robert and Helen Kleberg Foundation, Brian Fitzgerald (in honor of his son), and the American Cancer Society.	ADKINS WK, 1990, J APPL PHYSIOL, V69, P2012, DOI 10.1152/jappl.1990.69.6.2012; Ansari A, 2008, ALIMENT PHARM THER, V28, P749, DOI 10.1111/j.1365-2036.2008.03768.x; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Ayoub SS, 2009, MOL CELL BIOCHEM, V327, P101, DOI 10.1007/s11010-009-0048-y; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Becker J, 2006, FUND CLIN PHARMACOL, V20, P429, DOI 10.1111/j.1472-8206.2006.00425.x; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chinnaiyan AM, 2001, AM J PATHOL, V159, P1199, DOI 10.1016/S0002-9440(10)62505-9; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Davies John Q, 2005, Methods Mol Biol, V290, P91; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Desouza IA, 2005, BRIT J PHARMACOL, V146, P781, DOI 10.1038/sj.bjp.0706393; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Fini MA, 2008, J CELL BIOCHEM, V105, P1008, DOI 10.1002/jcb.21901; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Fukunari A, 2004, J PHARMACOL EXP THER, V311, P519, DOI 10.1124/jpet.104.070433; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; HELMKE RJ, 1989, IN VITRO CELL DEV B, V25, P44; Ichinose M, 2003, EUR RESPIR J, V22, P457, DOI 10.1183/09031936.03.00052002; Inkster ME, 2007, EUR J PHARMACOL, V561, P63, DOI 10.1016/j.ejphar.2006.12.029; Jaramillo M, 2004, J BIOL CHEM, V279, P52797, DOI 10.1074/jbc.M403823200; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Liu D, 2006, PHYSIOL RES, V55, P291, DOI 10.33549/physiolres.930822; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Maus U, 2001, AM J RESP CRIT CARE, V164, P406, DOI 10.1164/ajrccm.164.3.2009055; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pacheco P, 2007, J IMMUNOL, V179, P8500, DOI 10.4049/jimmunol.179.12.8500; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Parish RC, 2008, ANN PHARMACOTHER, V42, P1002, DOI 10.1345/aph.1K272; Parmley LA, 2007, BRIT J PHARMACOL, V152, P915, DOI 10.1038/sj.bjp.0707443; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pereda J, 2004, ANN SURG, V240, P108, DOI 10.1097/01.sla.0000129343.47774.89; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Prince Joseph E., 2003, Journal of Allergy and Clinical Immunology, V111, pS613; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Riaz AA, 2003, FREE RADICAL BIO MED, V35, P782, DOI 10.1016/S0891-5849(03)00405-2; Riaz AA, 2002, BRIT J SURG, V89, P1572, DOI 10.1046/j.1365-2168.2002.02279.x; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Sekundo W, 2001, EUR J OPHTHALMOL, V11, P264, DOI 10.1177/112067210101100309; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Shibata K, 1998, AM J RESP CRIT CARE, V158, P1578, DOI 10.1164/ajrccm.158.5.9804039; SIEMS WG, 1992, CELL MOL BIOL, V38, P189; Smith MR, 2007, PPAR RES, V2007, DOI 10.1155/2007/23812; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; Steinmuller C, 2000, AM J RESP CELL MOL, V22, P481, DOI 10.1165/ajrcmb.22.4.3336; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Wang XD, 2009, PULM PHARMACOL THER, V22, P318, DOI 10.1016/j.pupt.2009.01.004; Wright RM, 2004, AM J RESP CELL MOL, V30, P479, DOI 10.1165/rcmb.2003-0309OC; Xiang L, 2003, INFLAMM RES, V52, P353, DOI 10.1007/s00011-003-1184-6; Yakabi K, 2003, DIGEST DIS SCI, V48, P1081, DOI 10.1023/A:1023708511116; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang J, 2008, HYPERTENS RES, V31, P931, DOI 10.1291/hypres.31.931; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	93	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					961	975		10.1074/jbc.M110.150847	http://dx.doi.org/10.1074/jbc.M110.150847			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059659	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000286005000007
J	Sun, QM; Zhang, J; Fan, WL; Wong, KN; Ding, XJ; Chen, S; Zhong, Q				Sun, Qiming; Zhang, Jing; Fan, Weiliang; Wong, Kwun Ngok; Ding, Xiaojun; Chen, She; Zhong, Qing			The RUN Domain of Rubicon Is Important for hVps34 Binding, Lipid Kinase Inhibition, and Autophagy Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; BECLIN 1; SACCHAROMYCES-CEREVISIAE; PROTEIN; VPS34; MATURATION; ENDOSOME; UVRAG; RECRUITMENT; EFFECTOR	The class III phosphatidylinositol 3-kinase (PI3KC3) plays a central role in autophagy. Rubicon, a RUN domain-containing protein, is newly identified as a PI3KC3 subunit through its association with Beclin 1. Rubicon serves as a negative regulator of PI3KC3 and autophagosome maturation. The molecular mechanism underlying the PI3KC3 and autophagy inhibition by Rubicon is largely unknown. Here, we demonstrate that Rubicon interacts with the PI3KC3 catalytic subunit hVps34 via its RUN domain. The RUN domain contributes to the efficient inhibition of PI3KC3 lipid kinase activity by Rubicon. Furthermore, a Rubicon RUN domain deletion mutant fails to complement the autophagy deficiency in Rubicon-depleted cells. Hence, these results reveal a critical role of the Rubicon RUN domain in PI3KC3 and autophagy regulation.	[Sun, Qiming; Zhang, Jing; Fan, Weiliang; Wong, Kwun Ngok; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; [Ding, Xiaojun; Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of California System; University of California Berkeley; National Institute of Biological Sciences, Beijing	Zhong, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, 316 Barker Hall, Berkeley, CA 94720 USA.	qingzhong@berkeley.edu	Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X; Sun, Qiming/0000-0003-4988-9886	National Institutes of Health [RO1 CA133228]; Ellison Medical Foundation; Hellman Family Fund; NATIONAL CANCER INSTITUTE [R01CA133228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Hellman Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA133228 (to Q. Z.). The work was also supported by a New Investigator Award for Aging from the Ellison Medical Foundation and the Hellman Family Fund (to Q. Z.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	27	85	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					185	191		10.1074/jbc.M110.126425	http://dx.doi.org/10.1074/jbc.M110.126425			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21062745	Green Published, hybrid			2022-12-27	WOS:000285782800020
J	Naylor, J; Al-Shawaf, E; Mckeown, L; Manna, PT; Porter, KE; O'Regan, D; Muraki, K; Beech, DJ				Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Porter, Karen E.; O'Regan, David; Muraki, Katsuhiko; Beech, David J.			TRPC5 Channel Sensitivities to Antioxidants and Hydroxylated Stilbenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; CATION CHANNEL; RESVERATROL; RECEPTOR; CELL; STIMULATION; CURRENTS; AGONIST; INFLUX; WINE	Transient receptor potential canonical 5 (TRPC5) forms cationic channels that are polymodal sensors of factors including oxidized phospholipids, hydrogen peroxide, and reduced thioredoxin. The aim of this study was to expand knowledge of the chemical-sensing capabilities of TRPC5 by investigating dietary antioxidants. Human TRPC5 channels were expressed in HEK 293 cells and studied by patch clamp and intracellular Ca2+ recording. GFP- and HA-tagged channels were used to quantify plasma membrane localization. Gallic acid and vitamin C suppressed TRPC5 activity if it was evoked by exogenous hydrogen peroxide or lanthanide ions but not by lysophosphatidylcholine or carbachol. Catalase mimicked the effects, suggesting that lanthanide-evoked activity depended on endogenous hydrogen peroxide. Trans-resveratrol, by contrast, inhibited all modes of TRPC5, and its effect was additive with that of vitamin C, suggesting antioxidant-independent action. The IC50 was similar to 10 mu M. Diethylstilbestrol, a related hydroxylated stilbene, inhibited TRPC5 with a similar IC50, but its action contrasted sharply with that of resveratrol in outside-out membrane patches where diethylstilbestrol caused strong and reversible inhibition and resveratrol had no effect, suggesting indirect modulation by resveratrol. Resveratrol did not affect channel surface density, but its effect was calcium-sensitive, indicating an action via a calcium-dependent intermediate. The data suggest previously unrecognized chemical-sensing properties of TRPC5 through multiple mechanisms: (i) inhibition by scavengers of reactive oxygen species because a mode of TRPC5 activity depends on endogenous hydrogen peroxide; (ii) direct channel blockade by diethylstilbestrol; and (iii) indirect, antioxidant-independent inhibition by resveratrol.	[Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Beech, David J.] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Porter, Karen E.; Beech, David J.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [O'Regan, David] Leeds Gen Infirm, Dept Cardiac Surg, Leeds LS1 3EX, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	University of Leeds; University of Leeds; University of Leeds; Leeds General Infirmary; University of Leeds; Aichi Gakuin University	Beech, DJ (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	McKeown, Lynn/AAC-6037-2020	McKeown, Lynn/0000-0003-2326-7595; Beech, David/0000-0002-7683-9422; Manna, Paul Thomas/0000-0002-2260-2075	Wellcome Trust; Japan Society for the Promotion of Science (JSPS)	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by the Wellcome Trust and a Japan Society for the Promotion of Science (JSPS) International Collaboration Program grant.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Al-Shawaf E, 2010, ARTERIOSCL THROM VAS, V30, P1453, DOI 10.1161/ATVBAHA.110.205666; Beech D. J., 2007, V179, P109; Beech DJ, 2009, CELL CALCIUM, V45, P583, DOI 10.1016/j.ceca.2009.02.006; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dobrydneva Y, 1999, BRIT J PHARMACOL, V128, P149, DOI 10.1038/sj.bjp.0702749; Dobrydneva Y, 2010, J CARDIOVASC PHARM, V55, P522, DOI 10.1097/FJC.0b013e3181d64b33; Fauconneau B, 1997, LIFE SCI, V61, P2103, DOI 10.1016/S0024-3205(97)00883-7; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Goswami SK, 2009, CANCER LETT, V284, P1, DOI 10.1016/j.canlet.2009.01.041; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; Jiang L. H., 2011, CURRENT DRU IN PRESS; Lee KP, 2010, J BIOL CHEM, V285, P38666, DOI 10.1074/jbc.M110.155036; Nath AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004221; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukumar P, 2010, BIOCHEM BIOPH RES CO, V393, P50, DOI 10.1016/j.bbrc.2010.01.074; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Veurink M, 2005, PHARM WORLD SCI, V27, P139, DOI 10.1007/s11096-005-3663-z; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Wong CO, 2010, PFLUG ARCH EUR J PHY, V460, P121, DOI 10.1007/s00424-010-0823-3; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zakharov SI, 2004, MOL PHARMACOL, V66, P702; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	41	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5078	5086		10.1074/jbc.M110.196956	http://dx.doi.org/10.1074/jbc.M110.196956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127073	hybrid, Green Published			2022-12-27	WOS:000287230600015
J	Gupta, N; Ragsdale, SW				Gupta, Nirupama; Ragsdale, Stephen W.			Thiol-disulfide Redox Dependence of Heme Binding and Heme Ligand Switching in Nuclear Hormone Receptor Rev-erb beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CIRCADIAN CLOCK; OXIDATIVE STRESS; REGULATORY MOTIFS; CARBON-MONOXIDE; ESCHERICHIA-COLI; DNA-BINDING; PAS DOMAIN; PROTEIN; TRANSCRIPTION; ALPHA	Rev-erb beta is a heme-binding nuclear hormone receptor that represses a broad spectrum of target genes involved in regulating metabolism, the circadian cycle, and proinflammatory responses. Here, we demonstrate that a thiol-disulfide redox switch controls the interaction between heme and the ligand-binding domain of Rev-erb beta. The reduced dithiol state of Rev-erb beta binds heme 5-fold more tightly than the oxidized disulfide state. By means of site-directed mutagenesis and by UV-visible and EPR spectroscopy, we also show that the ferric heme of reduced (dithiol) Rev-erb beta can undergo a redox-triggered switch from imidazole/thiol ligation (via His-568 and Cys-384, based on a prior crystal structure) to His/neutral residue ligation upon oxidation to the disulfide form. On the other hand, we find that change in the redox state of iron has no effect on heme binding to the ligand-binding domain of the protein. The low dissociation constant for the complex between Fe3+ - or Fe2+-heme and the reduced dithiol state of the protein (K-d = similar to 20 nM) is in the range of the intracellular free heme concentration. We also determined that the Fe2+-heme bound to the ligand-binding domain of Rev-erb beta has high affinity for CO (K-d = 60 nM), which replaces one of the internal ligands when bound. We suggest that this thiol-disulfide redox switch is one mechanism by which oxidative stress is linked to circadian and/or metabolic imbalance. Heme dissociation from Rev-erb beta has been shown to derepress the expression of target genes in response to changes in intracellular redox conditions. We propose that oxidative stress leads to oxidation of cysteine(s), thus releasing heme from Rev-erb beta and altering its transcriptional activity.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	gupta, nirupama/H-2297-2012		National Institutes of Health [R21 HL089837, R01 HL102662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102662, R21HL089837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL089837 and R01 HL102662.	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P43; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; de Rosny E, 2008, BIOCHEMISTRY-US, V47, P13252, DOI 10.1021/bi801691b; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Downes M, 1996, NUCLEIC ACIDS RES, V24, P4379, DOI 10.1093/nar/24.22.4379; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Elswaifi Shaadi F., 2009, Infectious Disorders - Drug Targets, V9, P445; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Gupta N, 2008, J BIOL CHEM, V283, P28721, DOI 10.1074/jbc.M800630200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; Ignarro L. J., 2000, NITRIC OXIDE BIOL PA, P386; Inagaki S, 2005, J BIOL CHEM, V280, P3269, DOI 10.1074/jbc.M409884200; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito S, 2009, J INORG BIOCHEM, V103, P1380, DOI 10.1016/j.jinorgbio.2009.07.012; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kitanishi K, 2008, BIOCHEMISTRY-US, V47, P6157, DOI 10.1021/bi7023892; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; LIU SC, 1988, BLOOD, V71, P1755; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009; Ramakrishnan SN, 2009, BIOCHEM BIOPH RES CO, V388, P654, DOI 10.1016/j.bbrc.2009.08.045; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sharifian Akbar, 2005, J Circadian Rhythms, V3, P15, DOI 10.1186/1740-3391-3-15; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Steiner H, 1996, J BIOL CHEM, V271, P32605, DOI 10.1074/jbc.271.51.32605; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tanaka H, 2000, ONCOLOGY-BASEL, V59, P13, DOI 10.1159/000055282; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Terenzi H, 1996, PROTEIN EXPRES PURIF, V8, P313, DOI 10.1006/prep.1996.0106; Tsubaki M, 1997, J BIOL CHEM, V272, P23206, DOI 10.1074/jbc.272.37.23206; Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	83	76	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4392	4403		10.1074/jbc.M110.193466	http://dx.doi.org/10.1074/jbc.M110.193466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123168	Green Published, hybrid			2022-12-27	WOS:000286975700039
J	Nadanaka, S; Kinouchi, H; Taniguchi-Morita, K; Tamura, J; Kitagawa, H				Nadanaka, Satomi; Kinouchi, Hiroki; Taniguchi-Morita, Kayo; Tamura, Jun-ichi; Kitagawa, Hiroshi			Down-regulation of Chondroitin 4-O-Sulfotransferase-1 by Wnt Signaling Triggers Diffusion of Wnt-3a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; E-DISACCHARIDE EXPRESSION; CELL-SURFACE; MORPHOGEN GRADIENTS; TOUT-VELU; PROTEIN; GENE; SULFOTRANSFERASES; GLYCOSYLATION; BIOSYNTHESIS	During metazoan development, Wnt molecules are secreted from Wnt-producing cells, diffuse to target cells, and determine cell fates; therefore, Wnt secretion is tightly regulated. However, the molecular mechanisms controlling Wnt diffusion are not fully elucidated. The specific chondroitin sulfate (CS) structure synthesized by chondroitin-4-O-sulfotransferase- 1 (C4ST-1) binds to Wnt-3a with high affinity (Nadanaka, S., Ishida, M., Ikegami, M., and Kitagawa, H. (2008) J. Biol. Chem. 283, 27333-27343). In this study we tested whether Wnt signaling regulates sulfation patterns of cell-associated CS chains by suppressing expression of C4ST-1 to trigger release of Wnt molecules from Wnt-producing cells. C4ST-1 expression was dramatically reduced in L cells that stably expressed Wnt-3a (L-Wnt-3a cells) and had CS with low affinity for Wnt-3a. Forced expression of C4ST-1 in L-Wnt-3a cells inhibited diffusion of Wnt-3a due to structural alterations in CS chains mediated by C4ST-1. Furthermore, sustained Wnt signaling negatively regulated C4ST-1 expression in a cell-autonomous and non-cell autonomous fashion. These results demonstrated that C4ST-1 is a key downstream target of Wnt signaling that regulates Wnt diffusion from Wnt-producing cells.	[Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Taniguchi-Morita, Kayo; Tamura, Jun-ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390025, 20790081]	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Scientific Research Promotion Fund from the Japan Private School Promotion Foundation and Grant-in-aid for Scientific Research-B 21390025 (to H. Kitagawa), and Grant-in-aid for Young Scientists (B) 20790081 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. N.).	Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Rodriguez-Carballo E., 2010, J BONE MINE IN PRESS; Schmidt HH, 2004, ONCOGENE, V23, P6991, DOI 10.1038/sj.onc.1207934; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tamura J, 1997, CARBOHYD RES, V305, P43, DOI 10.1016/S0008-6215(97)00225-5; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Ueda Y, 2002, INT J CANCER, V99, P681, DOI 10.1002/ijc.10418; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	32	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4199	4208		10.1074/jbc.M110.155093	http://dx.doi.org/10.1074/jbc.M110.155093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123170	hybrid, Green Published			2022-12-27	WOS:000286975700018
J	Quach, JM; Walker, EC; Allan, E; Solano, M; Yokoyama, A; Kato, S; Sims, NA; Gillespie, MT; Martin, TJ				Quach, Julie M.; Walker, Emma C.; Allan, Elizabeth; Solano, Melissa; Yokoyama, Atsushi; Kato, Shigeaki; Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John			Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; INCREASES BONE-FORMATION; PARATHYROID-HORMONE PTH; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; ADIPOSE-TISSUE; ONCOSTATIN-M; PPAR-GAMMA; GENE-EXPRESSION; IN-VIVO	Osteoblasts and adipocytes are derived from common mesenchymal progenitor cells. The bone loss of osteoporosis is associated with altered progenitor differentiation from an osteoblastic to an adipocytic lineage. cDNA microarrays and quantitative real-time PCR (Q-PCR) were carried out in a differentiating mouse stromal osteoblastic cell line, Kusa 4b10, to identify gene targets of factors that stimulate osteoblast differentiation including parathyroid hormone (PTH) and gp130-binding cytokines, oncostatin M (OSM) and cardiotrophin-1 (CT-1). Zinc finger protein 467 (Zfp467) was rapidly down-regulated by PTH, OSM, and CT-1. Retroviral overexpression and RNA interference for Zfp467 in mouse stromal cells showed that this factor stimulated adipocyte formation and inhibited osteoblast commitment compared with controls. Regulation of adipocyte markers, including peroxisome proliferator-activated receptor (PPAR) gamma, C/EBP alpha, adiponectin, and resistin, and late osteoblast/osteocyte markers (osteocalcin and sclerostin) by Zfp467 was confirmed by Q-PCR. Intra-tibial injection of calvarial cells transduced with retroviral Zfp467 doubled the number of marrow adipocytes in C57Bl/6 mice compared with vector control-transduced cells, providing in vivo confirmation of a pro-adipogenic role of Zfp467. Furthermore, Zfp467 transactivated a PPAR-response element reporter construct and recruited a histone deacetylase complex. Thus Zfp467 is a novel co-factor that promotes adipocyte differentiation and suppresses osteoblast differentiation. This has relevance to therapeutic interventions in osteoporosis, including PTH-based therapies currently available, and may be of relevance for the use of adipose-derived stem cells for tissue engineering.	[Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Quach, Julie M.; Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John] St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Solano, Melissa; Gillespie, Matthew T.] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia; [Yokoyama, Atsushi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; Monash University; Prince Henry's Institute of Medical Research; University of Tokyo	Martin, TJ (corresponding author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.	jmartin@svi.edu.au	Yokoyama, Atsushi/W-3519-2019; Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Yokoyama, Atsushi/0000-0003-2842-4334; Gillespie, Matthew/0000-0001-6543-8909	National Health and Medical Research Council (Australia) [345401]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (Australia) Program Grant 345401 (to M. T. G., N. A. S., and T. J. M.).	Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI 10.1359/JBMR.080324; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Diallo EM, 2007, MOL CELL ENDOCRINOL, V264, P149, DOI 10.1016/j.mce.2006.11.004; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Duque G, 2009, EXP GERONTOL, V44, P183, DOI 10.1016/j.exger.2008.10.004; Fisher JL, 2002, CELL TISSUE RES, V307, P337, DOI 10.1007/s00441-001-0503-x; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282, DOI 10.1177/154411130401500504; GREENFIELD EM, 1993, J BONE MINER RES, V8, pS164; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Hozumi A, 2009, BIOCHEM BIOPH RES CO, V382, P780, DOI 10.1016/j.bbrc.2009.03.111; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Kerr JM, 2005, MOL CELL ENDOCRINOL, V238, P57, DOI 10.1016/j.mce.2005.03.004; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12; LOWE C, 1991, J BONE MINER RES, V6, P1277; Malaval L, 2005, J CELL PHYSIOL, V204, P585, DOI 10.1002/jcp.20312; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; MARTIN TJ, 1987, METHOD ENZYMOL, V145, P324; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakayama K, 2002, EMBO J, V21, P6174, DOI 10.1093/emboj/cdf596; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; ONYIA JE, 1995, BONE, V17, P479, DOI 10.1016/8756-3282(95)00332-2; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PEAR WS, 1996, CURRENT PROTOCOLS S, V36; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Rickard DJ, 2006, BONE, V39, P1361, DOI 10.1016/j.bone.2006.06.010; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sims NA, 2007, BONE, V40, pS126; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takagi K, 2008, J BONE MINER METAB, V26, P13, DOI 10.1007/s00774-007-0787-3; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Ueda Y, 2007, STEM CELLS, V25, P1356, DOI 10.1634/stemcells.2006-0811; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Walker EC, 2009, BONE, V44, pS32, DOI 10.1016/j.bone.2009.01.081; Walker EC, 2008, J BONE MINER RES, V23, pS377; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	76	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4186	4198		10.1074/jbc.M110.178251	http://dx.doi.org/10.1074/jbc.M110.178251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123171	hybrid, Green Published			2022-12-27	WOS:000286975700017
J	Egesten, A; Frick, IM; Morgelin, M; Olin, AI; Bjorck, L				Egesten, Arne; Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars			Binding of Albumin Promotes Bacterial Survival at the Epithelial Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCAL PROTEIN-G; IGG-BINDING; INNATE IMMUNITY; IDENTIFICATION; FOG; CHEMOKINES; MOLECULES; PYOGENES; STRAINS; REGIONS	Human serum albumin (HSA) is the dominating protein in human plasma. Many bacterial species, especially streptococci, express surface proteins that bind HSA with high specificity and affinity, but the biological consequences of these protein-protein interactions are poorly understood. Group G streptococci (GGS), carrying the HSA-binding protein G, colonize the skin and the mucosa of the upper respiratory tract, mostly without causing disease. In the case of bacterial invasion, pro-inflammatory cytokines are released that activate the epithelium to produce antibacterial peptides, in particular the chemokine MIG/CXCL9. In addition, the inflammation causes capillary leakage and extravasation of HSA and other plasma proteins, environmental changes at the epithelial surface to which the bacteria need to respond. In this study, we found that GGS adsorbed HSA from both saliva and plasma via binding to protein G and that HSA bound to protein G bound and inactivated the antibacterial MIG/CXCL9 peptide. Another surface protein of GGS, FOG, was found to mediate adherence of the bacteria to pharyngeal epithelial cells through interaction with glycosaminoglycans. This adherence was not affected by activation of the epithelium with a combination of IFN-gamma and TNF-alpha, leading to the production of MIG/CXCL9. However, at the activated epithelial surface, adherent GGS were protected against killing by MIG/CXCL9 through protein G-dependent HSA coating. The findings identify a previously unknown bacterial survival strategy that helps to explain the evolution of HSA-binding proteins among bacterial species of the normal human microbiota.	[Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars] Lund Univ, Dept Clin Sci, Sect Infect Med, SE-22185 Lund, Sweden; [Egesten, Arne; Olin, Anders I.] Lund Univ, Dept Clin Sci, Sect Resp Med & Allergol, SE-22185 Lund, Sweden; [Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars] Univ Lund Hosp, SE-22185 Lund, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Egesten, A (corresponding author), Lund Univ, BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	arne.egesten@med.lu.se			Swedish Research Council [7480, 20674]; Swedish Heart and Lung Foundation [20080246]; Medical Faculty at Lund University; Swedish Government Funds for Clinical Research (ALF); Foundations of Torsten; Ragnar Soderberg; Bergh; Crafoord; Greta and Johan Kock; Marianne and Marcus Wallenberg; Alfred Osterlund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty at Lund University; Swedish Government Funds for Clinical Research (ALF); Foundations of Torsten; Ragnar Soderberg; Bergh; Crafoord; Greta and Johan Kock; Marianne and Marcus Wallenberg; Alfred Osterlund	The work was supported by grants from the Swedish Research Council (Projects 7480 and 20674); the Swedish Heart and Lung Foundation (Project 20080246); the Medical Faculty at Lund University; the Swedish Government Funds for Clinical Research (ALF); and the Foundations of Torsten and Ragnar Soderberg, Bergh, Crafoord, Greta and Johan Kock, Marianne and Marcus Wallenberg, and Alfred Osterlund.	AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Boyle, 1990, BACTERIAL IMMUNOGLOB; CHRISTIE PJ, 1987, J BACTERIOL, V169, P2529, DOI 10.1128/jb.169.6.2529-2536.1987; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; deChateau M, 1996, P NATL ACAD SCI USA, V93, P8490, DOI 10.1073/pnas.93.16.8490; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; Dorosz J, 2010, J PHYS CHEM B, V114, P11053, DOI 10.1021/jp1052248; Edens HA, 2003, CURR OPIN HEMATOL, V10, P25, DOI 10.1097/00062752-200301000-00005; Edgerton M, 2000, Adv Dent Res, V14, P16; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; FAHNESTOCK SR, 1986, J BACTERIOL, V167, P870, DOI 10.1128/jb.167.3.870-880.1986; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hyland KA, 2009, FEMS IMMUNOL MED MIC, V55, P422, DOI 10.1111/j.1574-695X.2009.00540.x; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; KRONVALL G, 1979, INFECT IMMUN, V25, P1; MCDONALD DM, 1992, AM REV RESPIR DIS, V146, pS40, DOI 10.1164/ajrccm/146.5_Pt_2.S40; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Nitsche-Schmitz DP, 2007, J BIOL CHEM, V282, P17530, DOI 10.1074/jbc.M702612200; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nygren P A, 1988, J Mol Recognit, V1, P69, DOI 10.1002/jmr.300010204; PATTHY L, 1994, CURR OPIN STRUC BIOL, V4, P383, DOI 10.1016/S0959-440X(94)90108-2; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Raeder RH, 2000, J INFECT DIS, V181, P639, DOI 10.1086/315281; REIS KJ, 1984, J CLIN LAB IMMUNOL, V13, P75; SAMPSON PM, 1984, J APPL PHYSIOL, V57, P1648, DOI 10.1152/jappl.1984.57.6.1648; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sauty A, 1999, J IMMUNOL, V162, P3549; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sylvetsky N, 2002, AM J MED, V112, P622, DOI 10.1016/S0002-9343(02)01117-8; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002	46	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2469	2476		10.1074/jbc.M110.148171	http://dx.doi.org/10.1074/jbc.M110.148171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098039	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286464300011
J	Hu, LL; Wang, JN; Liu, Y; Zhang, Y; Zhang, LL; Kong, RR; Zheng, ZF; Du, XJ; Ke, Y				Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Ying; Zhang, Liangliang; Kong, Ruirui; Zheng, Zongfang; Du, Xiaojuan; Ke, Yang			A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; PROTEASOMAL DEGRADATION; CELL-CYCLE; RNA; MDM2; INHIBITION; PATHWAY; BIOGENESIS; RETROGENE; DEPLETION	Ribosome biogenesis is required for normal cell function, and aberrant ribosome biogenesis can lead to p53 activation. However, how p53 is activated by defects of ribosome biogenesis remains to be determined. Here, we identified human UTP14a as an SSU processome component by showing that hUTP14a is nucleolar, associated with U3 snoRNA and involved in 18 S rRNA processing. Interestingly, ectopic expression of hUTP14a resulted in a decrease and knockdown of hUTP14a led to an increase of p53 protein levels. We showed that hUTP14a physically interacts with p53 and functionally promotes p53 turn-over, and that hUTP14a promotion of p53 destabilization is sensitive to a proteasome inhibitor but independent of ubiquitination. Significantly, knockdown of hUTP14a led to cell cycle arrest and apoptosis. Our data identified a novel pathway for p53 activation through a defect in rRNA processing and suggest that a ribosome biogenesis factor itself could act as a sensor for nucleolar stress to regulate p53.	[Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Ying; Zhang, Liangliang; Kong, Ruirui; Zheng, Zongfang; Du, Xiaojuan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100191, Peoples R China; [Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Liangliang; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100191, Peoples R China; [Ke, Yang] Peking Univ, Sch Oncol, Genet Lab, Beijing Canc Hosp & Inst, Beijing 100142, Peoples R China; [Zhang, Ying; Kong, Ruirui; Zheng, Zongfang; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China	Peking University; Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Hlth Sci Ctr, Canc Res Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 30771224]; Key Construction Program of the National "985" Project [985-2-016-24]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131, 2006AA02A402]; National Basic Research Program of China (973 Program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National "985" Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grants No. 30571038 and 30771224), the Key Construction Program of the National "985" Project (Grant No. 985-2-016-24), Grants from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2008AA02Z131 and 2006AA02A402), and from the National Basic Research Program of China (973 Program) (Grant No. 2010CB529303).	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; PERRY RP, 1970, P NATL ACAD SCI USA, V65, P609, DOI 10.1073/pnas.65.3.609; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pluk H, 1998, MOL CELL BIOL, V18, P488, DOI 10.1128/MCB.18.1.488; Rohozinski J, 2006, BIOL REPROD, V74, P644, DOI 10.1095/biolreprod.105.046698; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Rohozinski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005064; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shetty G, 2008, ENDOCRINOLOGY, V149, P2773, DOI 10.1210/en.2007-1338; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Venema J, 1995, YEAST, V11, P1629, DOI 10.1002/yea.320111607; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	46	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3119	3128		10.1074/jbc.M110.157842	http://dx.doi.org/10.1074/jbc.M110.157842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078665	Green Published, hybrid			2022-12-27	WOS:000286464300073
J	Mehrotra, P; Riley, JP; Patel, R; Li, F; Voss, L; Goenka, S				Mehrotra, Purvi; Riley, Jonathan P.; Patel, Ravi; Li, Fang; Voss, Le'erin; Goenka, Shreevrat			PARP-14 Functions as a Transcriptional Switch for Stat6-dependent Gene Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY; AGGRESSIVE LYMPHOMA FAMILY; HISTONE VARIANT MACROH2A; INACTIVE X-CHROMOSOME; STAT6; COLLABORATOR; COACTIVATOR; EXPRESSION; DOMAINS; SIGNAL	A subset of poly ADP-ribose polymerases (PARP) that also contain macro domains regulate transcription. One such macro PARP, PARP-14 alters interleukin 4 (IL-4) and Stat6-dependent transcription. Stat6, activated by IL-4 plays an important role in T helper cell immunity and B cell responses. Here we define the mechanism by which PARP-14 regulates Stat6-activated transcription. Under non-stimulating conditions, PARP-14 recruits HDAC 2 and 3 to IL-4 responsive promoters. In the presence of IL-4, PARP-14 promotes efficient binding of Stat6 to its target genes. Moreover, HDAC 2 and 3 are released from the promoter with an IL-4 signal, this is aided by the ADP-ribosylation of the HDACs by PARP-14. The HDACs and PARP-14 get replaced by coactivators containing HAT activity. Based on these observations we put forth a mechanism in which PARP-14 functions as a transcriptional switch for Stat6-dependent gene induction. Thus, in the absence of a signal PARP-14 acts as a transcriptional repressor by recruiting HDACs. In contrast, in the presence of IL-4 the catalytic activity of PARP-14 facilitates Stat6 binding to the promoter, and release of HDACs so as to activate transcription.	Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Goenka, S (corresponding author), 1044 W Walnut Dr,R4 276, Indianapolis, IN 46202 USA.	goenkas@iupui.edu			National Institutes of Health [HL093105]; Showalter Foundation; Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Foundation; Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded, in whole or in part, by National Institutes of Health Grant HL093105, the Showalter Foundation Grant, and the Biomedical Research Grant awarded by the Indiana University School of Medicine.	Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Arimura A, 2004, J BIOL CHEM, V279, P31105, DOI 10.1074/jbc.M404428200; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chadwick BP, 2001, NUCLEIC ACIDS RES, V29, P2699, DOI 10.1093/nar/29.13.2699; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; McDonald C, 1999, J INTERF CYTOK RES, V19, P711, DOI 10.1089/107999099313550; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tinnell SB, 1998, INT IMMUNOL, V10, P1529, DOI 10.1093/intimm/10.10.1529; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653	26	106	108	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1767	1776		10.1074/jbc.M110.157768	http://dx.doi.org/10.1074/jbc.M110.157768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081493	Green Published, hybrid			2022-12-27	WOS:000286191500016
J	Nie, ZX; Merritt, A; Rouhi-Parkouhi, M; Tabernero, L; Garrod, D				Nie, Zhuxiang; Merritt, Anita; Rouhi-Parkouhi, Mansour; Tabernero, Lydia; Garrod, David			Membrane-impermeable Cross-linking Provides Evidence for Homophilic, Isoform-specific Binding of Desmosomal Cadherins in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DESMOGLEIN ISOFORMS; CYTOPLASMIC DOMAINS; ADHESION MOLECULES; PEMPHIGUS-VULGARIS; CRYSTAL-STRUCTURE; HUMAN-EPIDERMIS; CULTURED-CELLS; N-CADHERIN; CALCIUM	Desmosomes and adherens junctions are cadherin-based protein complexes responsible for cell-cell adhesion of epithelial cells. Type 1 cadherins of adherens junctions show specific homophilic adhesion that plays a major role in developmental tissue segregation. The desmosomal cadherins, desmocollin and desmoglein, occur as several different isoforms with overlapping expression in some tissues where different isoforms are located in the same desmosomes. Although adhesive binding of desmosomal cadherins has been investigated in a variety of ways, their interaction in desmosome-forming epithelial cells has not been studied. Here, using extracellular homobi-functional cross-linking, we provide evidence for homophilic and isoform-specific binding between the Dsc2, Dsc3, Dsg2, and Dsg3 isoforms in HaCaT keratinocytes and show that it represents trans interaction. Furthermore, the cross-linked adducts are present in the detergent-insoluble fraction, and electron microscopy shows that extracellular cross-linking probably occurs in desmosomes. We found no evidence for either heterophilic or cis interaction, but neither can be completely excluded by our data. Mutation of amino acid residues Trp-2 and Ala-80 that are important for trans interaction in classical cadherin adhesive binding abolished Dsc2 binding, indicating that these residues are also involved in desmosomal adhesion. These interactions of desmosomal cadherins may be of key importance for their ordered arrangement within desmosomes that we believe is essential for desmosomal adhesive strength and the maintenance of tissue integrity.	[Nie, Zhuxiang; Merritt, Anita; Rouhi-Parkouhi, Mansour; Tabernero, Lydia; Garrod, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Garrod, David] King Saud Univ, Riyadh 11451, Saudi Arabia	University of Manchester; King Saud University	Garrod, D (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.garrod@manchester.ac.uk	Tabernero, Lydia/F-3795-2018	Tabernero, Lydia/0000-0001-8867-455X; Garrod, David/0000-0003-0300-3947	Medical Research Council [G9630879, G0700074]; MRC [G0700074, G9630879] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grants G9630879 and G0700074.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; AMAGAI, 1994, J INVEST DERMATOL, V103, P608, DOI 10.1111/1523-1747.ep12397292; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Chidgey MAJ, 1996, J INVEST DERMATOL, V106, P689, DOI 10.1111/1523-1747.ep12345525; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; DUDEN R, 1988, J CELL BIOL, V107, P1049, DOI 10.1083/jcb.107.3.1049; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/212439; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Koeser J, 2003, EXP CELL RES, V285, P114, DOI 10.1016/S0014-4827(03)00016-8; Marcozzi C, 1998, J CELL SCI, V111, P495; MATTEY DL, 1990, J CELL SCI, V97, P689; MATTEY DL, 1986, J CELL SCI, V85, P113; Messenger AG, 2005, J INVEST DERMATOL, V125, P1077, DOI 10.1111/j.0022-202X.2005.23903.x; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Noe V, 1999, J CELL SCI, V112, P127; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; North AJ, 1999, J CELL SCI, V112, P4325; North AJ, 1996, P NATL ACAD SCI USA, V93, P7701, DOI 10.1073/pnas.93.15.7701; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; PARKER AE, 1991, J BIOL CHEM, V266, P10438; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; RAYNS DG, 1969, J CELL BIOL, V42, P322, DOI 10.1083/jcb.42.1.322; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shimizu A, 2005, J INVEST DERMATOL, V124, P984, DOI 10.1111/j.0022-202X.2005.23706.x; SHIMIZU H, 1995, J INVEST DERMATOL, V105, P153, DOI 10.1111/1523-1747.ep12316695; SKERROW CJ, 1989, J CELL SCI, V92, P667; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; VILELA MJ, 1995, J CELL SCI, V108, P1743; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2007, J MEMBRANE BIOL, V216, P83, DOI 10.1007/s00232-007-9037-9; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	66	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2143	2154		10.1074/jbc.M110.192245	http://dx.doi.org/10.1074/jbc.M110.192245			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098030	Green Published, hybrid			2022-12-27	WOS:000286191500056
J	Reed, AM; Husain, SZ; Thrower, E; Alexandre, M; Shah, A; Gorelick, FS; Nathanson, MH				Reed, Anamika M.; Husain, Sohail Z.; Thrower, Edwin; Alexandre, Martine; Shah, Ahsan; Gorelick, Fred S.; Nathanson, Michael H.			Low Extracellular pH Induces Damage in the Pancreatic Acinar Cell by Enhancing Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; CARDIAC RYANODINE RECEPTOR; INTRACELLULAR PH; SARCOPLASMIC-RETICULUM; ZYMOGEN ACTIVATION; LACTIC-ACIDOSIS; RELEASE CHANNEL; CA2+ RELEASE; NITRIC-OXIDE; DIABETIC-KETOACIDOSIS	Low extracellular pH (pHe) occurs in a number of clinical conditions and sensitizes to the development of pancreatitis. The mechanisms responsible for this sensitization are unknown. Because abnormal Ca2+ signaling underlies many of the early steps in the pathogenesis of pancreatitis, we evaluated the effect of decreasing pHe from 7.4 to 7.0 on Ca2+ signals in the acinar cell. Low pHe significantly increased the amplitude of cerulein-induced Ca2+ signals. The enhancement in amplitude was localized to the basolateral region of the acinar cell and was reduced by pretreatment with ryanodine receptor (RYR) inhibitors. Because basolateral RYRs also have been implicated in the pathogenesis of pancreatitis, we evaluated the effects of RYR inhibitors on pancreatitis responses in acidic conditions. RYR inhibitors significantly reduced the sensitizing effects of low pHe on zymogen activation and cellular injury. These findings suggest that enhanced RYR-mediated Ca2+ signaling in the basolateral region of the acinar cell is responsible for the injurious effects of low pHe on the exocrine pancreas.	[Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06515 USA; [Husain, Sohail Z.; Shah, Ahsan] Yale Univ, Dept Pediat, New Haven, CT 06515 USA	Yale University; Yale University	Reed, AM (corresponding author), 333 Cedar St,LMP 1080, New Haven, CT 06515 USA.	amc78@omega.med.yale.edu		Gorelick, Fred/0000-0001-8293-6803	American Gastroenterological Association; National Institutes of Health [T32 DK007356-31, R01 DK083327, R03 DK078707, K08 DK68116, DK34989, R01 DK54021, DK57751, DK45710, DK61747]; Children's Digestive Health and Nutrition Young Investigator award; Veterans Affairs merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, K08DK068116, R29DK045710, R01DK093491, R03DK078707, R01DK061747, K08DK090104, P30DK034989, P01DK057751, R01DK054021, T32DK007356, R01DK045710] Funding Source: NIH RePORTER	American Gastroenterological Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Digestive Health and Nutrition Young Investigator award; Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Gastroenterological Association Fellowship to Faculty Transition Award and National Institutes of Health Training Grant T32 DK007356-31 (to A. M. R.), National Institutes of Health Grants R01 DK083327, R03 DK078707, K08 DK68116, and DK34989 (to the Yale Liver Center), a Children's Digestive Health and Nutrition Young Investigator award (to S. Z. H.), National Institutes of Health Grant R01 DK54021 and a Veterans Affairs merit award (to F. S. G.), and National Institutes of Health Grants DK34989, DK57751, DK45710, and DK61747 (to M. H. N.).	ANTHONY BL, 1986, J NEUROCHEM, V46, P556, DOI 10.1111/j.1471-4159.1986.tb13003.x; ASSELIN J, 1983, BIOCHEM J, V216, P11, DOI 10.1042/bj2160011; Audia P, 2008, CLIN TOXICOL, V46, P164, DOI 10.1080/15563650701355314; Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Bultron G, 2008, J PEDIATR GASTR NUTR, V47, P370, DOI 10.1097/MPG.0b013e3181132252; CARTER KJ, 1987, AM J PHYSIOL, V253, pG690, DOI 10.1152/ajpgi.1987.253.5.G690; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Coghlan ME, 2001, CLIN INFECT DIS, V33, P1914, DOI 10.1086/323783; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Fitzsimmons TJ, 2000, BIOCHEM J, V351, P265, DOI 10.1042/0264-6021:3510265; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Guillaumes S, 1997, PANCREAS, V14, P262, DOI 10.1097/00006676-199704000-00007; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; LEACH SD, 1993, PANCREAS, V8, P64, DOI 10.1097/00006676-199301000-00013; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Leite MF, 1999, BIOCHEM J, V337, P305, DOI 10.1042/0264-6021:3370305; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Lokuta AJ, 1997, J BIOL CHEM, V272, P25333, DOI 10.1074/jbc.272.40.25333; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Menshikova EV, 2000, J CARDIOVASC PHARM, V36, P656, DOI 10.1097/00005344-200011000-00016; Morad M, 2000, ANTIOXID REDOX SIGN, V2, P1, DOI 10.1089/ars.2000.2.1-1; Mori S, 2008, MOD RHEUMATOL, V18, P634, DOI 10.1007/s10165-008-0106-4; MUALLEM S, 1989, AM J PHYSIOL, V257, pG917, DOI 10.1152/ajpgi.1989.257.6.G917; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; Muller Michael W, 2007, Pancreas, V35, pe30; Nair S, 2000, AM J GASTROENTEROL, V95, P2795, DOI 10.1016/S0002-9270(00)01981-X; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nishiguchi H, 1997, JPN J PHYSIOL, V47, P41, DOI 10.2170/jjphysiol.47.41; Noble MD, 2008, GUT, V57, P1566, DOI 10.1136/gut.2008.148551; Nyenwe EA, 2010, DIABETES CARE, V33, P1837, DOI 10.2337/dc10-0102; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Rodriguez P, 2003, J BIOL CHEM, V278, P38593, DOI 10.1074/jbc.C301180200; Rohra DK, 2003, LIFE SCI, V72, P1259; Speake T, 1998, J PHYSIOL-LONDON, V506, P415, DOI 10.1111/j.1469-7793.1998.415bw.x; Speake T, 1998, EUR J MORPHOL, V36, P165; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; STRAND MA, 1993, BIOCHIM BIOPHYS ACTA, V1175, P319, DOI 10.1016/0167-4889(93)90224-D; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; SZECOWKA J, 1985, REGUL PEPTIDES, V10, P71, DOI 10.1016/0167-0115(85)90001-1; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; WANG JX, 1992, NATURE, V359, P739, DOI 10.1038/359739a0; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yule DI, 1996, AM J PHYSIOL-CELL PH, V271, pC1285, DOI 10.1152/ajpcell.1996.271.4.C1285; Yule DI, 1997, J BIOL CHEM, V272, P9093; Zhou L, 2002, BIOCHEM BIOPH RES CO, V294, P1030, DOI 10.1016/S0006-291X(02)00599-5; Ziolo MT, 2001, AM J PHYSIOL-HEART C, V281, pH2295, DOI 10.1152/ajpheart.2001.281.6.H2295	71	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1919	1926		10.1074/jbc.M110.158329	http://dx.doi.org/10.1074/jbc.M110.158329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084290	Green Published, hybrid			2022-12-27	WOS:000286191500033
J	Fontanesi, F; Clemente, P; Barrientos, A				Fontanesi, Flavia; Clemente, Paula; Barrientos, Antoni			Cox25 Teams Up with Mss51, Ssc1, and Cox14 to Regulate Mitochondrial Cytochrome c Oxidase Subunit 1 Expression and Assembly in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE SYSTEM; HUMAN-CELLS; YEAST; PROTEIN; TRANSLATION; BIOGENESIS; MUTANTS; PRODUCT; ENZYMES; DENITRIFICANS	In the yeast Saccharomyces cerevisiae, mitochondrial cytochrome c oxidase (COX) biogenesis is translationally regulated. Mss51, a specific COX1 mRNA translational activator and Cox1 chaperone, drives the regulatory mechanism. During translation and post-translationally, newly synthesized Cox1 physically interacts with a complex of proteins involving Ssc1, Mss51, and Cox14, which eventually hand over Cox1 to the assembly pathway. This step is probably catalyzed by assembly chaperones such as Shy1 in a process coupled to the release of Ssc1-Mss51 from the complex. Impaired COX assembly results in the trapping of Mss51 in the complex, thus limiting its availability for COX1 mRNA translation. An exception is a null mutation in COX14 that does not affect Cox1 synthesis because the Mss51 trapping complexes become unstable, and Mss51 is readily available for translation. Here we present evidence showing that Cox25 is a new essential COX assembly factor that plays some roles similar to Cox14. A null mutation in COX25 by itself or in combination with other COX mutations does not affect Cox1 synthesis. Cox25 is an inner mitochondrial membrane intrinsic protein with a hydrophilic C terminus protruding into the matrix. Cox25 is an essential component of the complexes containing newly synthesized Cox1, Ssc1, Mss51, and Cox14. In addition, Cox25 is also found to interact with Shy1 and Cox5 in a complex that does not contain Mss51. These results suggest that once Ssc1-Mss51 are released from the Cox1 stabilization complex, Cox25 continues to interact with Cox14 and Cox1 to facilitate the formation of multisubunit COX assembly intermediates.	[Fontanesi, Flavia; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Clemente, Paula] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed,Alberto Sols Consejo Super Inv, E-28029 Madrid, Spain	University of Miami; University of Miami; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol & Biochem Mol Biol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu	Clemente, Paula/AAA-5768-2021	Fontanesi, Flavia/0000-0003-0509-3835; Clemente, Paula/0000-0002-6885-3750	National Institutes of Health [GM071775A]; Muscular Dystrophy Association; Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo; Universidad Autonoma de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo; Universidad Autonoma de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071775A (to A. B.). This work was also supported by a research grant from the Muscular Dystrophy Association (to A. B.) and a development grant from the Muscular Dystrophy Association (to F. F.).; Recipient of a research contract from the Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo and of a predoctoral fellowship for mobility from the Universidad Autonoma de Madrid (under the mentorship of Dr. Rafael Garesse).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Choquet Y, 2001, BIOCHEM SOC T, V29, P421, DOI 10.1042/BST0290421; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Maniatis T., 1982, MOL CLONING; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803	47	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					555	566		10.1074/jbc.M110.188805	http://dx.doi.org/10.1074/jbc.M110.188805			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21068384	hybrid, Green Published			2022-12-27	WOS:000285782800058
J	Tato, I; Bartrons, R; Ventura, F; Rosa, JL				Tato, Irantzu; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose			Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; MUSCLE PROTEIN-SYNTHESIS; FOXO TRANSCRIPTION FACTORS; ISOLATED RAT HEPATOCYTES; CELL-SURVIVAL; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; INSULIN-RESISTANCE; COLORECTAL-CANCER; IN-VIVO	The activity of mammalian target of rapamycin (mTOR) complexes regulates essential cellular processes, such as growth, proliferation, or survival. Nutrients such as amino acids are important regulators of mTOR complex 1 (mTORC1) activation, thus affecting cell growth, protein synthesis, and autophagy. Here, we show that amino acids may also activate mTOR complex 2 (mTORC2). This activation is mediated by the activity of class I PI3K and of Akt. Amino acids induced a rapid phosphorylation of Akt at Thr-308 and Ser-473. Whereas both phosphorylations were dependent on the presence of mTOR, only Akt phosphorylation at Ser-473 was dependent on the presence of rictor, a specific component of mTORC2. Kinase assays confirmed mTORC2 activation by amino acids. This signaling was functional, as demonstrated by the phosphorylation of Akt substrate FOXO3a. Interestingly, using different starvation conditions, amino acids can selectively activate mTORC1 or mTORC2. These findings identify a new signaling pathway used by amino acids underscoring the crucial importance of these nutrients in cell metabolism and offering new mechanistic insights.	[Tato, Irantzu; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, E-08907 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Rosa, JL (corresponding author), Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, Campus Bellvitge, E-08907 Barcelona, Spain.	joseluisrosa@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Bartrons, Ramon/0000-0001-9349-5847	Ministerio de Educacion y Ciencia (MEC) [BFU2008-02084/BMC]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020]; Generalitat de Catalunya [2009SGR1059]; Juan de la Cierva Program	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); Juan de la Cierva Program	This work was supported in part by Ministerio de Educacion y Ciencia (MEC) Grant BFU2008-02084/BMC, Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud Grant RD06/0020 and Generalitat de Catalunya Grant 2009SGR1059.; Supported by the Juan de la Cierva Program.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campbell LE, 1999, BIOCHEM J, V344, P433, DOI 10.1042/0264-6021:3440433; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Casas-Terradellas E, 2006, ELECTROPHORESIS, V27, P3935, DOI 10.1002/elps.200600141; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Krebs M, 2005, EUR J CLIN INVEST, V35, P351, DOI 10.1111/j.1365-2362.2005.01506.x; Kritchevsky D, 2001, J NUTR SCI VITAMINOL, V47, P13, DOI 10.3177/jnsv.47.13; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Mrkonjic M, 2009, BRIT J CANCER, V100, P1966, DOI 10.1038/sj.bjc.6605097; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Ruckle T, 2004, J MED CHEM, V47, P6921, DOI 10.1021/jm031112e; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Sadhu C, 2003, BIOCHEM BIOPH RES CO, V308, P764, DOI 10.1016/S0006-291X(03)01480-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao L, 2010, CELL DEATH DIFFER, V17, P1448, DOI 10.1038/cdd.2010.16; Yamaoka I, 2009, BIOCHEM BIOPH RES CO, V386, P252, DOI 10.1016/j.bbrc.2009.06.031; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	87	128	133	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6128	6142		10.1074/jbc.M110.166991	http://dx.doi.org/10.1074/jbc.M110.166991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21131356	hybrid, Green Published			2022-12-27	WOS:000287476400022
J	Zaferani, A; Vives, RR; van der Pol, P; Hakvoort, JJ; Navis, GJ; van Goor, H; Daha, MR; Lortat-Jacob, H; Seelen, MA; van den Born, J				Zaferani, Azadeh; Vives, Romain R.; van der Pol, Pieter; Hakvoort, Jelleke J.; Navis, Gerjan J.; van Goor, Harry; Daha, Mohamed R.; Lortat-Jacob, Hugues; Seelen, Marc A.; van den Born, Jacob			Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULES; BRUSH-BORDER; TUBULOINTERSTITIAL INJURY; PATHWAY ACTIVATION; BINDING; CELLS; PROTEOGLYCANS; DAMAGE; KIDNEY; GLYCOSAMINOGLYCANS	Properdin binds to proximal tubular epithelial cells (PTEC) and activates the complement system via the alternative pathway in vitro. Cellular ligands for properdin in the kidney have not yet been identified. Because properdin interacts with solid-phase heparin, we investigated whether heparan sulfate proteoglycans (HSPG) could be the physiological ligands of properdin. Kidneys from proteinuric rats showed colocalization of syndecan-1, a major epithelial HSPG, and properdin in the apical membranes of PTEC, which was not seen in control renal tissue. In vitro, PTEC did not constitutively express properdin. However, exogenous properdin binds to these cells in a dose-dependent fashion. Properdin binding was prevented by heparitinase pretreatment of the cells and was dose-dependently inhibited by exogenous heparin. ELISA and surface plasmon resonance spectroscopy (BIAcore) showed a strong dose-dependent interaction between heparan sulfate (HS) and properdin (K-d = 128 nM). Pretreatment of HSPG with heparitinase abolished this interaction in ELISA. Competition assays, using a library of HS-like polysaccharides, showed that sulfation pattern, chain length, and backbone composition determine the interaction of properdin with glycosaminogly-cans. Interestingly, two nonanticoagulant heparin derivatives inhibited properdin-HS interaction in ELISA and BIAcore. Incubation of PTEC with human serum as complement source led to complement activation and deposition of C3 on the cells. This C3 deposition is dependent on the binding of properdin to HS as shown by heparitinase pretreatment of the cells. Our data identify tubular HS as a novel docking platform for alternative pathway activation via properdin, which might play a role in proteinuric renal damage. Our study also suggests nonanticoagulant heparinoids may provide renoprotection in complement-dependent renal diseases.	[Zaferani, Azadeh; Hakvoort, Jelleke J.; Navis, Gerjan J.; Daha, Mohamed R.; Seelen, Marc A.; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Vives, Romain R.; Lortat-Jacob, Hugues] Univ Grenoble, Inst Biol Struct, F-38027 Grenoble, France; [van der Pol, Pieter; Daha, Mohamed R.] Leiden Univ, Dept Nephrol, NL-2300 RC Leiden, Netherlands; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9713 GZ Groningen, Netherlands	University of Groningen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Leiden University; Leiden University - Excl LUMC; University of Groningen	Zaferani, A (corresponding author), Expt Nephrol Lab, Antonius Deusinglaan 1,Fb-20, NL-9713 AV Groningen, Netherlands.	a.zaferani@med.umcg.nl	Vives, Romain/I-9372-2012; van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577	Dutch Kidney Foundation [NSN C03-6014]	Dutch Kidney Foundation	This work was supported by Dutch Kidney Foundation Grant NSN C03-6014.	BIANCONE L, 1994, KIDNEY INT, V45, P451, DOI 10.1038/ki.1994.59; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buelli S, 2009, KIDNEY INT, V75, P1050, DOI 10.1038/ki.2009.8; Burg M, 1997, LAB INVEST, V76, P505; CAMUSSI G, 1985, CLIN NEPHROL, V23, P134; CAMUSSI G, 1982, J IMMUNOL, V128, P1659; CAMUSSI G, 1983, ANN NY ACAD SCI, V420, P321, DOI 10.1111/j.1749-6632.1983.tb22219.x; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Ceol M, 2003, J NEPHROL, V16, P210; Ceol M, 2000, J AM SOC NEPHROL, V11, P2324, DOI 10.1681/ASN.V11122324; DANISHEF.V, 1965, BIOCHIM BIOPHYS ACTA, V101, P37; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARRIES TC, 1988, BIOCHEM J, V252, P47, DOI 10.1042/bj2520047; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Gottmann U, 2007, TRANSPL INT, V20, P542, DOI 10.1111/j.1432-2277.2007.00471.x; Gradowska Liliana, 1993, Archivum Immunologiae et Therapiae Experimentalis, V41, P133; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hsu SIH, 2003, J AM SOC NEPHROL, V14, pS186, DOI 10.1097/01.ASN.0000070032.58017.20; IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kemper C, 2008, MOL IMMUNOL, V45, P4048, DOI 10.1016/j.molimm.2008.06.034; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Matsuo S, 1998, NEPHROL DIAL TRANSPL, V13, P2723, DOI 10.1093/ndt/13.11.2723; Morita Y, 1997, J AM SOC NEPHROL, V8, P1363; MURATA K, 1975, CLIN CHIM ACTA, V63, P157; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; REJ RN, 1991, CARBOHYD RES, V210, P299, DOI 10.1016/0008-6215(91)80130-F; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Rook M, 2005, NEPHROL DIAL TRANSPL, V20, P59, DOI 10.1093/ndt/gfh579; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Sheerin NS, 1999, KIDNEY BLOOD PRESS R, V22, P47, DOI 10.1159/000025908; Siezenga MA, 2010, NEPHROL DIAL TRANSPL, V25, P1157, DOI 10.1093/ndt/gfp630; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Striker GE, 1997, KIDNEY INT, pS120; Tang S, 2002, KIDNEY BLOOD PRESS R, V25, P120, DOI 10.1159/000063520; van Timmeren MM, 2006, AM J PHYSIOL-RENAL, V291, pF456, DOI 10.1152/ajprenal.00403.2005; vanBruggen MCJ, 1996, KIDNEY INT, V50, P1555, DOI 10.1038/ki.1996.471; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wang JG, 2002, INFLAMM RES, V51, P435, DOI 10.1007/PL00012403; WEILER JM, 1992, J IMMUNOL, V148, P3210; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	50	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5359	5367		10.1074/jbc.M110.167825	http://dx.doi.org/10.1074/jbc.M110.167825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135110	hybrid, Green Published			2022-12-27	WOS:000287230600044
J	Abdelaziz, DH; Gavrilin, MA; Akhter, A; Caution, K; Kotrange, S; Abu Khweek, A; Abdulrahman, BA; Grandhi, J; Hassan, ZA; Marsh, C; Wewers, MD; Amer, AO				Abdelaziz, Dalia H.; Gavrilin, Mikhail A.; Akhter, Anwari; Caution, Kyle; Kotrange, Sheetal; Abu Khweek, Arwa; Abdulrahman, Basant A.; Grandhi, Jaykumar; Hassan, Zeinab A.; Marsh, Clay; Wewers, Mark D.; Amer, Amal O.			Apoptosis-associated Speck-like Protein (ASC) Controls Legionella pneumophila Infection in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HOST-CELL DEATH; LEGIONNAIRES-DISEASE; ACTIVATING ADAPTER; INFLAMMASOME; CASPASE-1; PHAGOSOME; BACTERIUM; FLAGELLIN; CARD	The ability of Legionella pneumophila to cause pneumonia is determined by its capability to evade the immune system and grow within human monocytes and their derived macrophages. Human monocytes efficiently activate caspase-1 in response to Salmonella but not to L. pneumophila. The molecular mechanism for the lack of inflammasome activation during L. pneumophila infection is unknown. Evaluation of the expression of several inflammasome components in human monocytes during L. pneumophila infection revealed that the expression of the apoptosis-associated speck-like protein (ASC) and the NOD-like receptor NLRC4 are significantly down-regulated in human monocytes. Exogenous expression of ASC maintained the protein level constant during L. pneumophila infection and conveyed caspase-1 activation and restricted the growth of the pathogen. Further depletion of ASC with siRNA was accompanied with improved NF-kappa B activation and enhanced L. pneumophila growth. Therefore, our data demonstrate that L. pneumophila manipulates ASC levels to evade inflammasome activation and grow in human monocytes. By targeting ASC, L. pneumophila modulates the inflammasome, the apoptosome, and NF-kappa B pathway simultaneously.	[Abdulrahman, Basant A.; Grandhi, Jaykumar; Marsh, Clay; Wewers, Mark D.; Amer, Amal O.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Abdulrahman, Basant A.; Grandhi, Jaykumar; Marsh, Clay; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Abdelaziz, Dalia H.; Abdulrahman, Basant A.; Hassan, Zeinab A.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Helwan, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University	Amer, AO (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Ctr Microbial Interface Biol, Biol Res Tower,460W 12th Ave,Rm 1014, Columbus, OH 43210 USA.	amal.amer@osumc.edu	Wewers, Mark/AAB-6202-2021; Amer, Amal/E-2643-2011	Abdulrahman, Basant/0000-0002-4970-6835; Gavrilin, Mikhail/0000-0003-2003-768X	National Institutes of Health [R01HL094586, R21AI083871]; American Lung Association [GRT00013604]; Egyptian Cultural and Educational Bureau; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094586 and R21AI083871. This work was also supported by Grant GRT00013604 from the American Lung Association.; Supported by the Egyptian Cultural and Educational Bureau.	Abdelaziz DH, 2010, INT J BIOCHEM CELL B, V42, P789, DOI 10.1016/j.biocel.2010.01.003; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amer AO, 2010, CELL MICROBIOL, V12, P140, DOI 10.1111/j.1462-5822.2009.01401.x; Bartfeld S, 2009, CELL MICROBIOL, V11, P1638, DOI 10.1111/j.1462-5822.2009.01354.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2001, INT J MED MICROBIOL, V291, P331, DOI 10.1078/1438-4221-00139; CORDES LG, 1979, LANCET, V2, P927; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Tilney LG, 2001, J CELL SCI, V114, P4637; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	42	55	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3203	3208		10.1074/jbc.M110.197681	http://dx.doi.org/10.1074/jbc.M110.197681			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097506	Green Published, hybrid			2022-12-27	WOS:000286653200004
J	Dong, LF; Jameson, VJA; Tilly, D; Cerny, J; Mahdavian, E; Marin-Hernandez, A; Hernandez-Esquivel, L; Rodriguez-Enriquez, S; Stursa, J; Witting, PK; Stantic, B; Rohlena, J; Truksa, J; Kluckova, K; Dyason, JC; Ledvina, M; Salvatore, BA; Moreno-Sanchez, R; Coster, MJ; Ralph, SJ; Smith, RAJ; Neuzil, J				Dong, Lan-Feng; Jameson, Victoria J. A.; Tilly, David; Cerny, Jiri; Mahdavian, Elahe; Marin-Hernandez, Alvaro; Hernandez-Esquivel, Luz; Rodriguez-Enriquez, Sara; Stursa, Jan; Witting, Paul K.; Stantic, Bela; Rohlena, Jakub; Truksa, Jaroslav; Kluckova, Katarina; Dyason, Jeffrey C.; Ledvina, Miroslav; Salvatore, Brian A.; Moreno-Sanchez, Rafael; Coster, Mark J.; Ralph, Stephen J.; Smith, Robin A. J.; Neuzil, Jiri			Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHERYL SUCCINATE; BREAST-CANCER CELLS; E ANALOGS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; BINDING SITE; DEHYDROGENASE; UBIQUINONE; ANTIOXIDANT; GROWTH	Mitochondrial complex II (CII) has been recently identified as a novel target for anti-cancer drugs. Mitochondrially targeted vitamin E succinate (MitoVES) is modified so that it is preferentially localized to mitochondria, greatly enhancing its pro-apoptotic and anti-cancer activity. Using genetically manipulated cells, MitoVES caused apoptosis and generation of reactive oxygen species (ROS) in CII-proficient malignant cells but not their CII-dysfunctional counterparts. MitoVES inhibited the succinate dehydrogenase (SDH) activity of CII with IC50 of 80 mu M, whereas the electron transfer from CII to CIII was inhibited with IC50 of 1.5 mu M. The agent had no effect either on the enzymatic activity of CI or on electron transfer from CI to CIII. Over 24 h, MitoVES caused stabilization of the oxygen-dependent destruction domain of HIF1 alpha fused to GFP, indicating promotion of the state of pseudohypoxia. Molecular modeling predicted the succinyl group anchored into the proximal CII ubiquinone (UbQ)-binding site and successively reduced interaction energies for serially shorter phytyl chain homologs of MitoVES correlated with their lower effects on apoptosis induction, ROS generation, and SDH activity. Mutation of the UbQ-binding Ser(68) within the proximal site of the CII SDHC subunit (S68A or S68L) suppressed both ROS generation and apoptosis induction by MitoVES. In vivo studies indicated that MitoVES also acts by causing pseudohypoxia in the context of tumor suppression. We propose that mitochondrial targeting of VES with an 11-carbon chain localizes the agent into an ideal position across the interface of the mitochondrial inner membrane and matrix, optimizing its biological effects as an anti-cancer drug.	[Neuzil, Jiri] Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Stantic, Bela] Griffith Univ, Inst Integrated & Intelligent Syst, Southport, Qld 4222, Australia; [Dyason, Jeffrey C.; Neuzil, Jiri] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia; [Jameson, Victoria J. A.; Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin 9016, New Zealand; [Tilly, David; Coster, Mark J.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Cerny, Jiri; Rohlena, Jakub; Truksa, Jaroslav; Kluckova, Katarina] Acad Sci Czech Republ, Inst Biotechnol, Prague 14220, Czech Republic; [Stursa, Jan; Ledvina, Miroslav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 14220, Czech Republic; [Mahdavian, Elahe; Salvatore, Brian A.] Louisiana State Univ, Dept Chem & Phys, Shreveport, LA 71115 USA; [Marin-Hernandez, Alvaro; Hernandez-Esquivel, Luz; Rodriguez-Enriquez, Sara; Moreno-Sanchez, Rafael] Natl Inst Cardiol, Dept Biochem, Mexico City 14080, DF, Mexico; [Witting, Paul K.] Univ Sydney, Sydney Med Sch, Bosch Res Inst, Discipline Pathol, Sydney, NSW 2006, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; Griffith University; University of Otago; Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; National Institute of Cardiology - Mexico; Bosch; University of Sydney	Neuzil, J (corresponding author), Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Griffith Hlth Inst, Griffith Univ Gold Coast Campus,Parklands Av, Southport, Qld 4222, Australia.	j.neuzil@griffith.edu.au	Truksa, Jaroslav/G-9454-2014; Coster, Mark/C-4621-2008; Witting, Paul/ABD-2053-2020; DONG, LANFENG/S-8805-2019; Kluckova, Katarina/H-4802-2014; Rohlena, Jakub/H-6699-2014; Ralph, Stephen J./AAE-4888-2019; Dyason, Jeffrey C/L-5534-2014; Witting, Paul/L-9786-2019; Kluckova, Katarina/ABF-2155-2020; Truksa, Jaroslav/AAB-5089-2020; Černý, Jiří/I-4733-2012; Neuzil, Jiri/H-7204-2014; Moreno-Sanchez, Rafael/A-3158-2011; Stursa, Jan/J-4255-2014; RODRIGUEZ-ENRIQUEZ, SARA/I-8376-2017	Truksa, Jaroslav/0000-0002-8967-7354; Coster, Mark/0000-0002-0910-6819; Witting, Paul/0000-0003-2237-7004; Kluckova, Katarina/0000-0002-9693-7708; Rohlena, Jakub/0000-0001-5427-6502; Ralph, Stephen J./0000-0002-4335-092X; Truksa, Jaroslav/0000-0002-8967-7354; Černý, Jiří/0000-0002-1969-9304; Neuzil, Jiri/0000-0002-2478-2460; Moreno-Sanchez, Rafael/0000-0002-9587-7184; Dong, Lanfeng/0000-0002-9857-6352; RODRIGUEZ-ENRIQUEZ, SARA/0000-0002-0822-1233; Tilly, David/0000-0002-4859-961X; Marin-Hernandez, Alvaro/0000-0002-7968-7225	Australian Research Council; Cancer Council Queensland; National Breast Cancer Foundation; Grant Agency of the Czech Republic [204/08/0811, P301/10/1937]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA500520702, KJB500970904, KAN200520703]; Griffith Health Institute; Otago University Research Grants Committee; Consejo Nacional de Ciencia y Tecnologia-Mexico [80534, 20675]; National Institutes of Health, NCRR [P20RR016456]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Griffith Health Institute; Otago University Research Grants Committee; Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Australian Research Council, the Cancer Council Queensland, the National Breast Cancer Foundation, Grant Agency of the Czech Republic Grants 204/08/0811 and P301/10/1937, Grant Agency of the Academy of Sciences of the Czech Republic Grants IAA500520702, KJB500970904, and KAN200520703) (to J. N.), the Griffith Health Institute (to L.-F.D.), the Otago University Research Grants Committee (to R. A. J. S.), Consejo Nacional de Ciencia y Tecnologia-Mexico Grants 80534 and 20675 (to R.M.-S. and S. R.-E.), and National Institutes of Health, NCRR, Grant P20RR016456 (to E. M. and B. A. S.).	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BIASSUTTO L, 2010, MITOCHONDRI IN PRESS; Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001; Cervera AM, 2008, CANCER RES, V68, P4058, DOI 10.1158/0008-5472.CAN-07-5580; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2007, CANCER RES, V67, P11906, DOI 10.1158/0008-5472.CAN-07-3034; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hahn T, 2006, CANCER RES, V66, P9374, DOI 10.1158/0008-5472.CAN-06-2403; Hawkins BJ, 2010, J BIOL CHEM, V285, P26494, DOI 10.1074/jbc.M110.143164; Hayden EC, 2008, NATURE, V455, P158; Ishii T, 2005, CANCER RES, V65, P203; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jasso-Chavez R, 2001, ARCH BIOCHEM BIOPHYS, V390, P295, DOI 10.1006/abbi.2001.2353; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lawson KA, 2003, MOL CANCER THER, V2, P437; Lemarie A, 2009, MITOCHONDRION, V9, P254, DOI 10.1016/j.mito.2009.03.004; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Malafa MP, 2002, SURGERY, V131, P85, DOI 10.1067/msy.2002.119191; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Neuzil J, 2001, BRIT J CANCER, V84, P87, DOI 10.1054/bjoc.2000.1559; Neuzil J, 2007, MOL ASPECTS MED, V28, P607, DOI 10.1016/j.mam.2007.02.003; Neuzil J, 2007, REDOX REP, V12, P148, DOI 10.1179/135100007X200227; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; OOSTVEEN FG, 1995, J BIOL CHEM, V270, P26104, DOI 10.1074/jbc.270.44.26104; Peczkowska M, 2008, NAT CLIN PRACT ENDOC, V4, P111, DOI 10.1038/ncpendmet0726; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prochazka L, 2010, APOPTOSIS, V15, P782, DOI 10.1007/s10495-010-0482-z; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shiau CW, 2006, J BIOL CHEM, V281, P11819, DOI 10.1074/jbc.M511015200; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Stapelberg M, 2005, J BIOL CHEM, V280, P25369, DOI 10.1074/jbc.M414498200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Twombly R, 2005, J NATL CANCER I, V97, P330, DOI 10.1093/jnci/97.5.330; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Weber T, 2002, CLIN CANCER RES, V8, P863; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yu WP, 2003, CANCER RES, V63, P2483	71	149	156	1	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3717	3728		10.1074/jbc.M110.186643	http://dx.doi.org/10.1074/jbc.M110.186643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21059645	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286653200054
J	Li, DJ; D'Angelo, L; Chavez, M; Woulfe, DS				Li, Dongjun; D'Angelo, Lauren; Chavez, Massiel; Woulfe, Donna S.			Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT PHOSPHORYLATION; BETA-ARRESTINS; ACTIVATION; SRC; MICE; AGGREGATION; THROMBIN; KINASE; PATHWAYS; ROLES	Arrestins can facilitate desensitization or signaling by G protein-coupled receptors (GPCR) in many cells, but their roles in platelets remain uncharacterized. Because of recent reports that arrestins can serve as scaffolds to recruit phosphatidylinositol-3 kinases (PI3K)s to GPCRs, we sought to determine whether arrestins regulate PI3K-dependent Akt signaling in platelets, with consequences for thrombosis. Co-immuno-precipitation experiments demonstrate that arrestin-2 associates with p85 PI3K alpha/beta subunits in thrombin-stimulated platelets, but not resting cells. The association is inhibited by inhibitors of P2Y12 and Src family kinases (SFKs). The function of arrestin-2 in platelets is agonist-specific, as PAR4-dependent Akt phosphorylation and fibrinogen binding were reduced in arrestin-2 knock-out platelets compared with WT controls, but ADP-stimulated signaling to Akt and fibrinogen binding were unaffected. ADP receptors regulate arrestin recruitment to PAR4, because co-immunoprecipitates of arrestin-2 with PAR4 are disrupted by inhibitors of P2Y1 or P2Y12. P2Y1 may regulate arrestin-2 recruitment to PAR4 through protein kinase C (PKC) activation, whereas P2Y12 directly interacts with PAR4 and therefore, may help to recruit arrestin-2 to PAR4. Finally, arrestin2(-/-) mice are less sensitive to ferric chloride-induced thrombosis than WT mice, suggesting that arrestin-2 can regulate thrombus formation in vivo. In conclusion, arrestin-2 regulates PAR4-dependent signaling pathways, but not responses to ADP alone, and contributes to thrombus formation in vivo.	[Li, Dongjun; D'Angelo, Lauren; Chavez, Massiel; Woulfe, Donna S.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	University of Delaware	Woulfe, DS (corresponding author), Univ Delaware, Dept Biol Sci, Rm 329 Wolf Hall,105 Green, Newark, DE 19716 USA.	dswoulfe@udel.edu			National Institutes of Health [R01 HL081241]; Pennsylvania Tobacco Formula Fund [080-37807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Formula Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL081241 and Pennsylvania Tobacco Formula Fund Grant 080-37807.	Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Conner DA, 1997, CIRC RES, V81, P1021; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Goel R, 2004, J BIOL CHEM, V279, P6701, DOI 10.1074/jbc.M308753200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Guidetti GF, 2008, J BIOL CHEM, V283, P28795, DOI 10.1074/jbc.M801588200; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; TORTI M, 1992, BIOCHEM BIOPH RES CO, V186, P440, DOI 10.1016/S0006-291X(05)80827-7; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	34	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3805	3814		10.1074/jbc.M110.118018	http://dx.doi.org/10.1074/jbc.M110.118018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106537	Green Published, hybrid			2022-12-27	WOS:000286653200062
J	Singh, K; Chaturvedi, R; Barry, DP; Coburn, LA; Asim, M; Lewis, ND; Piazuelo, MB; Washington, MK; Vitek, MP; Wilson, KT				Singh, Kshipra; Chaturvedi, Rupesh; Barry, Daniel P.; Coburn, Lori A.; Asim, Mohammad; Lewis, Nuruddeen D.; Piazuelo, M. Blanca; Washington, M. Kay; Vitek, Michael P.; Wilson, Keith T.			The Apolipoprotein E-Mimetic Peptide COG112 Inhibits NF-kappa B Signaling, Proinflammatory Cytokine Expression, and Disease Activity in Murine Models of Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CITROBACTER-RODENTIUM INFECTION; NITRIC-OXIDE SYNTHASE; INTESTINAL INFLAMMATION; CROHNS-DISEASE; TNF-ALPHA; MACROPHAGE APOPTOSIS; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS; HOST-DEFENSE	Inflammatory bowel disease (IBD), consisting of Crohn's disease and ulcerative colitis, is a source of substantial morbidity and remains difficult to treat. New strategies for beneficial anti-inflammatory therapies would be highly desirable. Apolipoprotein (apo) E has immunomodulatory effects and synthetically derived apoE-mimetic peptides are beneficial in models of sepsis and neuroinflammation. We have reported that the antennapedia-linked apoE-mimetic peptide COG112 inhibits the inflammatory response to the colitis-inducing pathogen Citrobacter rodentium in vitro by inhibiting NF-kappa B activation. We now determined the effect of COG112 in mouse models of colitis. Using C. rodentium as an infection model, and dextran sulfate sodium (DSS) as an injury model, mice were treated with COG112 by intraperitoneal injection. With C. rodentium, COG112 improved the clinical parameters of survival, body weight, colon weight, and histologic injury. With DSS, COG112 ameliorated the loss of body weight, reduction in colon length, and histologic injury, whether administered concurrently with induction of colitis, during induction plus recovery, or only during the recovery phase of disease. In both colitis models, COG112 inhibited colon tissue inducible nitric-oxide synthase (iNOS), KC, TNF-alpha, IFN-gamma, and IL-17 mRNA expression, and reduced nuclear translocation of NF-kappa B, as determined by immunoblot and immunofluorescence confocal microscopy. I kappa B kinase (IKK) activity was also reduced, which is necessary for activation of the canonical NF-kappa B pathway. Isolated colonic epithelial cells exhibited marked attenuation of expression of iNOS and the CXC chemokines KC and MIP-2. These studies indicate that apoE-mimetic peptides such as COG112 are novel potential therapies for IBD.	[Wilson, Keith T.] Vanderbilt Univ, Sch Med, Med Ctr, Div Gastroenterol,Dept Med, Nashville, TN 37232 USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Lewis, Nuruddeen D.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Singh, Kshipra; Chaturvedi, Rupesh; Coburn, Lori A.; Asim, Mohammad; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wilson, KT (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr, Div Gastroenterol,Dept Med, 1030C MRB IV,2215 Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008	Barry, Daniel P/0000-0002-3972-3914; Lewis, Nuruddeen/0000-0002-1233-6607; Vitek, Michael/0000-0001-8140-8048; Wilson, Keith/0000-0003-4421-1830; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health [R41DK075161, R01DK053620, R01AT004821, 3R01AT004821S1, P01CA028842, F31GM083500, T32CA009592, T32DK007673, P30DK058404]; Office of Medical Research, Dept. of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA009592, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, P30DK058404, R41DK075161, R01DK053620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R41DK075161 (to K. T. W. and M. P. V.), R01DK053620, R01AT004821, and 3R01AT004821S1 (to K. T. W.), P01CA028842 (to K. T. W.), F31GM083500 (to N. D. L), T32CA009592 (N. D. L.), T32DK007673 (D. P. B.), the Flow Cytometry Core, and the Cell Imaging Core of the Vanderbilt University Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404; and a Merit Review Grant from the Office of Medical Research, Dept. of Veterans Affairs (to K. T. W.).	Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Clark M, 2007, GASTROENTEROLOGY, V133, P312, DOI 10.1053/j.gastro.2007.05.006; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; D'Haens GR, 1999, ITAL J GASTROENTEROL, V31, P519; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DOMEK MJ, 1995, SCAND J GASTROENTERO, V30, P1089, DOI 10.3109/00365529509101612; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hacker H., 2006, SCI STKE, V13; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hyams JS, 2000, J PEDIATR-US, V137, P192, DOI 10.1067/mpd.2000.107161; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kim YH, 2008, INT IMMUNOPHARMACOL, V8, P1695, DOI 10.1016/j.intimp.2008.08.003; Kirman I, 2004, EUR J GASTROEN HEPAT, V16, P639, DOI 10.1097/01.meg.0000108345.41221.c2; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mouser JF, 1999, CLIN THER, V21, P932; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Murthy S, 1999, ALIMENT PHARM THER, V13, P251; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Present DH, 1999, ALIMENT PHARM THERAP, V13, P23, DOI 10.1046/j.1365-2036.1999.00026.x; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Van Oosten MV, 2001, J BIOL CHEM, V276, P8820, DOI 10.1074/jbc.M009915200; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470	67	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3839	3850		10.1074/jbc.M110.176719	http://dx.doi.org/10.1074/jbc.M110.176719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115487	Green Published, hybrid			2022-12-27	WOS:000286653200065
J	Schwetz, TA; Norring, SA; Ednie, AR; Bennett, ES				Schwetz, Tara A.; Norring, Sarah A.; Ednie, Andrew R.; Bennett, Eric S.			Sialic Acids Attached to O-Glycans Modulate Voltage-gated Potassium Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAGAS HEART-DISEASE; U-TYPE INACTIVATION; SODIUM-CHANNEL; K+ CHANNELS; LINKED GLYCOSYLATION; CONGENITAL DISORDERS; N-GLYCOSYLATION; NA+ CHANNEL; MUCIN-TYPE; VENTRICULAR MYOCYTES	Neuronal, cardiac, and skeletal muscle action potentials are produced and conducted through the highly regulated activity of several types of voltage-gated ion channels. Voltage-gated potassium (K-v) channels are responsible for action potential repolarization. Glycans can be attached to glycoproteins through N-and O-linkages. Previous reports described the impact of N-glycans on voltage-gated ion channel function. Here, we show that sialic acids attached through O-linkages modulate gating of K(v)2.1, K(v)4.2, and K(v)4.3. The conductance-voltage (G-V) relationships for each isoform were shifted uniquely by a depolarizing 8-16 mV under conditions of reduced sialylation. The data indicate that sialic acids modulate K-v channel activation through apparent electrostatic mechanisms that promote channel activity. Voltage-dependent steady-state inactivation was unaffected by changes in sialylation. N-Linked sialic acids cannot be responsible for the G-V shifts because K(v)4.2 and K(v)4.3 cannot be N-glycosylated, and immunoblot analysis confirmed K(v)2.1 is not N-glycosylated. Glycosidase gel shift analysis suggested that K(v)2.1, K(v)4.2, and K(v)4.3 were O-glycosylated and sialylated. To confirm this, azide-modified sugar residues involved specifically in O-glycan and sialic acid biosynthesis were shown to incorporate into all three K-v channel isoforms using Cu(I)-catalyzed cycloaddition chemistry. Together, the data indicate that sialic acids attached to O-glycans uniquely modulate gating of three K-v channel isoforms that are not N-glycosylated. These data provide the first evidence that external O-glycans, with core structures distinct from N-glycans in type and number of sugar residues, can modulate K-v channel function and thereby contribute to changes in electrical signaling that result from regulated ion channel expression and/or O-glycosylation.	[Schwetz, Tara A.; Norring, Sarah A.; Ednie, Andrew R.; Bennett, Eric S.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Bennett, Eric S.] Univ S Florida, Coll Med, Program Neurosci, Tampa, FL 33612 USA; [Bennett, Eric S.] Univ S Florida, Coll Med, Program Cardiovasc Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Bennett, ES (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, 12901 Bruce B Downs Blvd,MDC 8, Tampa, FL 33612 USA.	esbennet@health.usf.edu			American Heart Association; James and Esther King Biomedical Research Program	American Heart Association(American Heart Association); James and Esther King Biomedical Research Program	This work was supported by an American Heart Association predoctoral fellowship (to T. A. S.), an American Heart Association grant-in-aid (to E. S. B.), and Bridge and Challenge grants from the James and Esther King Biomedical Research Program (to E. S. B.).	Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Bertil H., 2001, ION CHANNELS EXCITAB; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Bustamante JM, 2005, INT J CARDIOL, V102, P211, DOI 10.1016/j.ijcard.2004.05.014; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; Colbert CM, 1999, J NEUROSCI, V19, P8163; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; HILLE B, 1975, J PHYSIOL-LONDON, V250, pP34; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Johnson D, 2006, J BIOL CHEM, V281, P25875, DOI 10.1074/jbc.M605060200; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Klemic KG, 2001, BIOPHYS J, V81, P814, DOI 10.1016/S0006-3495(01)75743-8; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Leroy JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.pdr.0000246802.57692.ea; LIBBY P, 1986, J CLIN INVEST, V77, P127, DOI 10.1172/JCI112266; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lvov A, 2009, J BIOL CHEM, V284, P28276, DOI 10.1074/jbc.M109.028761; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Plotnikov AN, 2004, CIRCULATION, V110, P489, DOI 10.1161/01.CIR.0000137823.64947.52; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; SHI GY, 1994, J BIOL CHEM, V269, P23204; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Sternick EB, 2006, J CARDIOVASC ELECTR, V17, P113, DOI 10.1111/j.1540-8167.2005.00315.x; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Yacoub S, 2008, HEART, V94, P244, DOI 10.1136/hrt.2007.132316; Yoshida M, 2010, BIOCHEM BIOPH RES CO, V396, P304, DOI 10.1016/j.bbrc.2010.04.088; Yoshida M, 2009, FEBS LETT, V583, P2225, DOI 10.1016/j.febslet.2009.05.050; ZHANG JF, 1992, NEURON, V9, P97, DOI 10.1016/0896-6273(92)90224-2; Zhu J, 2003, BIOCHEM J, V375, P769, DOI 10.1042/BJ20030517	66	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4123	4132		10.1074/jbc.M110.171322	http://dx.doi.org/10.1074/jbc.M110.171322			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115483	Green Published, hybrid			2022-12-27	WOS:000286975700011
J	Thompson, MG; Foley, DA; Swartzentruber, KG; Colley, KJ				Thompson, Matthew G.; Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.			Sequences at the Interface of the Fifth Immunoglobulin Domain and First Fibronectin Type III Repeat of the Neural Cell Adhesion Molecule Are Critical for Its Polysialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; NERVOUS-SYSTEM; HUMAN POLYSIALYLTRANSFERASE; GLYCAN POLYSIALYLATION; BRAIN-DEVELOPMENT; WILMS TUMOR; RAT-BRAIN; ST8SIA II; N-CAM; NCAM	Polysialic acid is an anti-adhesive glycan that modifies a select group of mammalian proteins. The primary substrate of the polysialyltransferases (polySTs) is the neural cell adhesion molecule (NCAM). Polysialic acid negatively regulates cell adhesion, is required for proper brain development, and is expressed in specific areas of the adult brain where it promotes on-going cell migration and synaptic plasticity. The first fibronectin type III repeat (FN1) of NCAM is required for polysialylation of the N-glycans on the adjacent immunoglobulin-like domain (Ig5), and acidic residues on the surface of FN1 play a role in polyST recognition. Recent work demonstrated that the FN1 domain from the unpolysialylated olfactory cell adhesion molecule (OCAM) was able to partially replace NCAM FN1 (Foley, D. A., Swartzentruber, K. G., Thompson, M. G., Mendiratta, S. S., and Colley, K. J. (2010) J. Biol. Chem. 285, 35056-35067). Here we demonstrate that individually replacing three identical regions shared by NCAM and OCAM FN1, (PSSP503)-P-500 (PSSP), (526)GGVPI(530) (GGVPI), and (580)NGKG(583) (NGKG), dramatically reduces NCAM polysialylation. In addition, we show that the polyST, ST8SiaIV/PST, specifically binds NCAM and that this binding requires the FN1 domain. Replacing the FN1 PSSP sequences and the acidic patch residues decreases NCAM-polyST binding, whereas replacing the GGVPI and NGKG sequences has no effect. The location of GGVPI and NGKG in loops that flank the Ig5-FN1 linker and the proximity of PSSP to this linker suggest that GGVPI and NGKG sequences may be critical for stabilizing the Ig5-FN1 linker, whereas PSSP may play a dual role maintaining the Ig5-FN1 interface and a polyST recognition site.	[Thompson, Matthew G.; Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZUBER C, 1992, J BIOL CHEM, V267, P9965	50	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4525	4534		10.1074/jbc.M110.200386	http://dx.doi.org/10.1074/jbc.M110.200386			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131353	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000286975700053
J	Choi, S; Kim, W; Chung, J				Choi, Sekyu; Kim, Wonho; Chung, Jongkyeong			Drosophila Salt-inducible Kinase (SIK) Regulates Starvation Resistance through cAMP-response Element-binding Protein (CREB)-regulated Transcription Coactivator (CRTC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS RESISTANCE; RAPID-DETERMINATION; GENE-EXPRESSION; CREB; ABLATION; FAMILY; TORC2	Salt-inducible kinase (SIK), one of the AMP-activated kinase (AMPK)-related kinases, has been suggested to play important functions in glucose homeostasis by inhibiting the cAMP-response element-binding protein (CREB)-regulated transcription coactivator (CRTC). To examine the role of SIK in vivo, we generated Drosophila SIK mutant and found that the mutant flies have higher amounts of lipid and glycogen stores and are resistant to starvation. Interestingly, SIK transcripts are highly enriched in the brain, and we found that neuron-specific expression of exogenous SIK fully rescued lipid and glycogen storage phenotypes as well as starvation resistance of the mutant. Using genetic and biochemical analyses, we demonstrated that CRTC Ser-157 phosphorylation by SIK is critical for inhibiting CRTC activity in vivo. Furthermore, double mutants of SIK and CRTC became sensitive to starvation, and the Ser-157 phosphomimetic mutation of CRTC reduced lipid and glycogen levels in the SIK mutant, suggesting that CRTC mediates the effects of SIK signaling. Collectively, our results strongly support the importance of the SIK-CRTC signaling axis that functions in the brain to maintain energy homeostasis in Drosophila.	[Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Choi, Sekyu; Kim, Wonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Sekyu; Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, San 56-1 Sillim Dong, Seoul 151742, South Korea.	jkc@snu.ac.kr		Choi, Sekyu/0000-0003-2928-0942	Korean Ministry of Education, Science and Technology [2010-0018291]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Creative Research Initiatives Grant 2010-0018291 from the Korean Ministry of Education, Science and Technology.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5	30	36	39	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2658	2664		10.1074/jbc.C110.119222	http://dx.doi.org/10.1074/jbc.C110.119222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21127058	Green Published, hybrid			2022-12-27	WOS:000286464300031
J	Lefevre, J; Chernov, KG; Joshi, V; Delga, S; Toma, F; Pastre, D; Curmi, PA; Savarin, P				Lefevre, Julien; Chernov, Konstantin G.; Joshi, Vandana; Delga, Stephanie; Toma, Flavio; Pastre, David; Curmi, Patrick A.; Savarin, Philippe			The C Terminus of Tubulin, a Versatile Partner for Cationic Molecules BINDING OF TAU, POLYAMINES, AND CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MICROTUBULE-ASSOCIATED PROTEINS; BETA-TUBULIN; STRUCTURAL BASIS; ALPHA-TUBULIN; IN-VITRO; SITES; NMR; POLYMERIZATION; DOMAIN	The C-terminal region of tubulin is involved in multiple aspects of the regulation of microtubule assembly. To elucidate the molecular mechanisms of this regulation, we study here, using different approaches, the interaction of Tau, spermine, and calcium, three representative partners of the tubulin C-terminal region, with a peptide composed of the last 42 residues of alpha 1a-tubulin. The results show that their binding involves overlapping amino acid stretches in the C-terminal tubulin region: amino acid residues 421-441 for Tau, 430-432 and 444-451 for spermine, and 421-443 for calcium. Isothermal titration calorimetry, NMR, and cosedimentation experiments show that Tau and spermine have similar micromolar binding affinities, whereas their binding stoichiometry differs (C-terminal tubulin peptide/spermine stoichiometry 1: 2, and C-terminal tubulin peptide/Tau stoichiometry 8: 1). Interestingly, calcium, known as a negative regulator of microtubule assembly, can compete with the binding of Tau and spermine with the C-terminal domain of tubulin and with the positive effect of these two partners on microtubule assembly in vitro. This observation opens up the possibility that calcium may participate in the regulation of microtubule assembly in vivo through direct (still unknown) or indirect mechanism (displacement of microtubule partners). The functional importance of this part of tubulin was also underlined by the observation that an alpha-tubulin mutant deleted from the last 23 amino acid residues does not incorporate properly into the microtubule network of HeLa cells. Together, these results provide a structural basis for a better understanding of the complex interactions and putative competition of tubulin cationic partners with the C-terminal region of tubulin.	[Lefevre, Julien; Chernov, Konstantin G.; Joshi, Vandana; Delga, Stephanie; Toma, Flavio; Pastre, David; Curmi, Patrick A.; Savarin, Philippe] Univ Evry Val dEssonne, INSERM, U829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Curmi, PA (corresponding author), Univ Evry Val dEssonne, INSERM, U829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France.	pcurmi@univ-evry.fr; philippe.savarin@univ-evry.fr	CURMI, Patrick/G-4036-2013; Pastre, David/B-2958-2014; joshi, vandana/GWR-3119-2022	Pastre, David/0000-0002-3348-9514; joshi, vandana/0000-0001-7853-6583; CURMI, Patrick A./0000-0001-5045-8501				Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; ANDERSON PJ, 1985, BIOCHEM BIOPH RES CO, V132, P147, DOI 10.1016/0006-291X(85)91000-9; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Doi H, 2003, BIOSCI BIOTECH BIOCH, V67, P1643, DOI 10.1271/bbb.67.1643; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jimenez MA, 1999, PROTEIN SCI, V8, P788; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; Joe PA, 2009, J BIOL CHEM, V284, P4283, DOI 10.1074/jbc.M807491200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kar S, 2003, FEBS LETT, V539, P34, DOI 10.1016/S0014-5793(03)00181-9; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; KUZNETSOV SA, 1978, FEBS LETT, V95, P343, DOI 10.1016/0014-5793(78)81026-6; Landino LM, 2004, J BIOL CHEM, V279, P35101, DOI 10.1074/jbc.M405471200; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; LITTLE M, 1988, COMP BIOCHEM PHYS B, V90, P655, DOI 10.1016/0305-0491(88)90320-3; LOBERT S, 1993, CELL MOTIL CYTOSKEL, V25, P282, DOI 10.1002/cm.970250308; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MACCIONI RB, 1986, EUR J BIOCHEM, V156, P375, DOI 10.1111/j.1432-1033.1986.tb09593.x; Mechulam A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000255; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Patel MM, 2005, BIOPHYS J, V88, P2089, DOI 10.1529/biophysj.104.052100; PONSTINGL H, 1981, P NATL ACAD SCI-BIOL, V78, P2757, DOI 10.1073/pnas.78.5.2757; PONSTINGL H, 1979, NATURE, V282, P423, DOI 10.1038/282423a0; PONSTINGL H, 1981, COLD SPRING HARB SYM, V46, P191; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Savarin P, 2010, BIOCHEM J, V430, P151, DOI 10.1042/BJ20091811; SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SERRANO L, 1986, J BIOL CHEM, V261, P7076; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; SOLOMON F, 1977, BIOCHEMISTRY-US, V16, P358, DOI 10.1021/bi00622a003; STROMBERG E, 1994, CELL MOTIL CYTOSKEL, V28, P59, DOI 10.1002/cm.970280106; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n	66	42	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3065	3078		10.1074/jbc.M110.144089	http://dx.doi.org/10.1074/jbc.M110.144089			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062741	Green Published, hybrid			2022-12-27	WOS:000286464300069
J	Shah, CA; Wang, H; Bei, L; Platanias, LC; Eklund, EA				Shah, Chirag A.; Wang, Hao; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.			HoxA10 Regulates Transcription of the Gene Encoding Transforming Growth Factor beta 2 (TGF beta 2) in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; DNA-BINDING; IN-VITRO; ACTIVATES TRANSCRIPTION; PROGENITOR CELLS; EXPRESSION; LEUKEMIA; MLL; DIFFERENTIATION	HoxA10 is a homeodomain transcription factor that is maximally expressed in myeloid progenitor cells. HoxA10 is over-expressed in a poor prognosis subset of human acute myeloid leukemia (AML) and in vivo overexpression of HoxA10 in murine bone marrow induces myeloid leukemia. HoxA10 contributes to myeloid progenitor expansion and differentiation block, but few target genes have been identified that explain the influence of HoxA10 on these processes. The current study identifies the gene encoding transforming growth factor beta 2 (TGF beta 2) as a HoxA10 target gene. We found that HoxA10 activated TGF beta 2 transcription by interacting with tandem cis elements in the promoter. We also determined that HoxA10 overexpression in myeloid progenitor cells increased Tgf beta 2 production by the cells. Tgf beta 2 stimulates proliferation of hematopoietic stem and progenitor cells. Therefore, these studies identified autocrine stimulation of myeloid progenitors by Tgf beta 2 as one mechanism by which HoxA10 expands this population. Because HoxA proteins had not been previously known to influence expression of pro-proliferative cytokines, this has implications for understanding molecular mechanisms involved in progenitor expansion and the pathobiology of AML.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterns Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterns Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717 and a Veterns Affairs Merit Review grant (to E.A.E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lee SW, 2006, J CELL BIOCHEM, V98, P981, DOI 10.1002/jcb.20773; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; PAREKH T, 1994, J IMMUNOL, V152, P2456; Salzman SA, 2002, CYTOKINES CELL MOL T, V7, P31, DOI 10.1080/13684730216400; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Szymkowiak CH, 2000, CYTOKINE, V12, P397, DOI 10.1006/cyto.1999.0572; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	44	36	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3161	3176		10.1074/jbc.M110.183251	http://dx.doi.org/10.1074/jbc.M110.183251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087928	Green Published, hybrid			2022-12-27	WOS:000286464300077
J	Chan, YC; Khanna, S; Roy, S; Sen, CK				Chan, Yuk Cheung; Khanna, Savita; Roy, Sashwati; Sen, Chandan K.			miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR ETS-1; GROWTH-FACTOR; E-CADHERIN; CANCER-CELLS; MATRIX METALLOPROTEINASES; MICRORNA EXPRESSION; GENE-EXPRESSION; REPRESSORS ZEB1; ANGIOTENSIN-II	The miR-200 family plays a crucial role in epithelial to mesenchymal transition via controlling cell migration and polarity. We hypothesized that miR-200b, one miR-200 family member, could regulate angiogenic responses via modulating endothelial cell migration. Delivery of the miR-200b mimic in human microvascular endothelial cells (HMECs) suppressed the angiogenic response, whereas miR-200b-depleted HMECs exhibited elevated angiogenesis in vitro, as evidenced by Matrigel (R) tube formation and cell migration. Using in silico studies, miR target reporter assay, and Western blot analysis revealed that v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1), a crucial angiogenesis-related transcription factor, serves as a novel direct target of miR-200b. Knocking down endogenous Ets-1 simulated an anti-angiogenic response of the miR-200b mimic-transfected cells. Certain Ets-1-associated genes, namely matrix metalloproteinase 1 and vascular endothelial growth factor receptor 2, were negatively regulated by miR-200b. Overexpression of Ets-1 rescued miR-200b-dependent impairment in angiogenic response and suppression of Ets-1-associated gene expression. Both hypoxia as well as HIF-1 alpha stabilization inhibited miR-200b expression and elevated Ets-1 expression. Experiments to identify how miR-200b modulates angiogenesis under a low oxygen environment illustrated that hypoxia-induced miR-200b down-regulation derepressed Ets-1 expression to promote angiogenesis. This study provides the first evidence that hypoxia-sensitive miR-200b is involved in induction of angiogenesis via directly targeting Ets-1 in HMECs.	[Chan, Yuk Cheung; Khanna, Savita; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sen, CK (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	chandan.sen@osumc.edu	Sen, Chandan K/A-8762-2013; Roy, sashwati/E-3990-2011; Khanna, Savita/E-3378-2011		National Institutes of Health [GM077185, GM069589]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, R01GM077185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077185 and GM069589 (to C. K. S.).	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen ZQ, 1997, CANCER RES, V57, P2013; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Forough R, 2006, J VASC RES, V43, P327, DOI 10.1159/000093198; GLASSBERG MK, 1992, J APPL PHYSIOL, V72, P1681, DOI 10.1152/jappl.1992.72.5.1681; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Jackson CJ, 1997, INT J BIOCHEM CELL B, V29, P1167, DOI 10.1016/S1357-2725(97)00061-7; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Kappel A, 2000, BLOOD, V96, P3078; Khanna S, 2006, FREE RADICAL BIO MED, V40, P2147, DOI 10.1016/j.freeradbiomed.2006.02.010; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Ono K, 2002, BRIT J CANCER, V86, P1803, DOI 10.1038/sj.bjc.6600307; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pearse DD, 2008, AM J PHYSIOL-RENAL, V294, pF1094, DOI 10.1152/ajprenal.00458.2007; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x; Roy S, 2007, DNA CELL BIOL, V26, P627, DOI 10.1089/dna.2007.0617; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sachidanandam K, 2006, EXP BIOL MED, V231, P1016; Sen CK, 2009, J VASC RES, V46, P527, DOI 10.1159/000226221; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Watanabe D, 2004, AM J PATHOL, V164, P1827, DOI 10.1016/S0002-9440(10)63741-8; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang BS, 1996, MOL CELL BIOL, V16, P538	52	195	205	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2047	2056		10.1074/jbc.M110.158790	http://dx.doi.org/10.1074/jbc.M110.158790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081489	Green Published, hybrid			2022-12-27	WOS:000286191500047
J	Marinis, JM; Homer, CR; McDonald, C; Abbott, DW				Marinis, Jill M.; Homer, Craig R.; McDonald, Christine; Abbott, Derek W.			A Novel Motif in the Crohn's Disease Susceptibility Protein, NOD2, Allows TRAF4 to Down-regulate Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; MEKK4; RECOGNITION; ASSOCIATION; RECEPTOR; BINDING; COMMON; RIP2	The Crohn's disease and early onset sarcoidosis susceptibility protein, NOD2, coordinates innate immune signaling pathways. Because dysregulation of this coordination can lead to inflammatory disease, maintaining appropriate activation of the NOD2 signaling pathway is paramount in immunologic homeostasis. In this work, we identify the atypical tumor necrosis factor-associated factor (TRAF) family member, TRAF4, as a key negative regulator of NOD2 signaling. TRAF4 inhibits NOD2-induced NF-kappa B activation and directly binds to NOD2 to inhibit NOD2-induced bacterial killing. We find that two consecutive glutamate residues in NOD2 are required for interaction with TRAF4 and inhibition of NOD2 signaling because mutation of these residues abrogated both TRAF4 binding and inhibition of NOD2. This work identifies a novel negative regulator of NOD2 signaling. Additionally, it defines a TRAF4 binding motif within NOD2 involved in termination of innate immune signaling responses.	[Marinis, Jill M.; Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA; [Homer, Craig R.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Abbott, DW (corresponding author), 2103 Cornell Rd,6533 WRB, Cleveland, OH 44106 USA.	dwa4@case.edu		Abbott, Derek/0000-0003-4387-8094; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health (NIH) [R01GM86550-01, 5T32GM008056-28, R01DK082437]; Burroughs Wellcome Career Award for Biomedical Scientists [10061206.01]; Gerald and Nancy Goldberg; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award for Biomedical Scientists(Burroughs Wellcome Fund); Gerald and Nancy Goldberg; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01GM86550-01 (to D. W. A.), NIH Cell and Molecular Biology Training Grant 5T32GM008056-28 (to J. M. M.), and NIH Research Grant R01DK082437 (to C. M.). This work was also supported by Burroughs Wellcome Career Award for Biomedical Scientists 10061206.01 (to D. W. A.) and the generosity of Gerald and Nancy Goldberg (to C. M.).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Chung JY, 2002, J CELL SCI, V115, P679; Clark NM, 2008, CURR BIOL, V18, P1402, DOI 10.1016/j.cub.2008.07.084; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Ogura Y, 2003, GENOMICS, V81, P369, DOI 10.1016/S0888-7543(03)00027-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Xu YX, 2002, J BIOL CHEM, V277, P28051, DOI 10.1074/jbc.M202665200; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P736, DOI 10.1002/ibd.21144; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	41	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1938	1950		10.1074/jbc.M110.189308	http://dx.doi.org/10.1074/jbc.M110.189308			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097508	Green Published, hybrid			2022-12-27	WOS:000286191500035
J	Tsuda, E; Yang, HB; Nishimura, T; Uehara, Y; Sakai, T; Furutani, M; Koshiba, T; Hirose, M; Nozaki, H; Murphy, AS; Hayashi, K				Tsuda, Etsuko; Yang, Haibing; Nishimura, Takeshi; Uehara, Yukiko; Sakai, Tatsuya; Furutani, Masahiko; Koshiba, Tomokazu; Hirose, Masakazu; Nozaki, Hiroshi; Murphy, Angus S.; Hayashi, Ken-ichiro			Alkoxy-auxins Are Selective Inhibitors of Auxin Transport Mediated by PIN, ABCB, and AUX1 Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS HYPOCOTYLS; MAIZE COLEOPTILES; CHEMICAL GENOMICS; ROOT GRAVITROPISM; GENE-EXPRESSION; TWISTED DWARF1; PROTEIN; PLANT; EFFLUX; INFLUX	Polar auxin movement is a primary regulator of programmed and plastic plant development. Auxin transport is highly regulated at the cellular level and is mediated by coordinated transport activity of plasma membrane-localized PIN, ABCB, and AUX1/LAX transporters. The activity of these transporters has been extensively analyzed using a combination of pharmacological inhibitors, synthetic auxins, and knock-out mutants in Arabidopsis. However, efforts to analyze auxin-dependent growth in other species that are less tractable to genetic manipulation require more selective inhibitors than are currently available. In this report, we characterize the inhibitory activity of 5-alkoxy derivatives of indole 3-acetic acid and 7-alkoxy derivatives of naphthalene 1-acetic acid, finding that the hexyloxy and benzyloxy derivatives act as potent inhibitors of auxin action in plants. These alkoxy-auxin analogs inhibit polar auxin transport and tropic responses associated with asymmetric auxin distribution in Arabidopsis and maize. The alkoxy-auxin analogs inhibit auxin transport mediated by AUX1, PIN, and ABCB proteins expressed in yeast. However, these analogs did not inhibit or activate SCFTIR1 auxin signaling and had no effect on the subcellular trafficking of PIN proteins. Together these results indicate that alkoxy-auxins are inactive auxin analogs for auxin signaling, but are recognized by PIN, ABCB, and AUX1 auxin transport proteins. Alkoxy-auxins are powerful new tools for analyses of auxin-dependent development.	[Hirose, Masakazu; Nozaki, Hiroshi; Hayashi, Ken-ichiro] Okayama Univ Sci, Dept Biochem, Okayama 7000005, Japan; [Yang, Haibing; Murphy, Angus S.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Nishimura, Takeshi; Koshiba, Tomokazu] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Uehara, Yukiko] RIKEN Plant Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Sakai, Tatsuya] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Furutani, Masahiko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Okayama University of Science; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tokyo Metropolitan University; RIKEN; Niigata University; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Hayashi, K (corresponding author), Okayama Univ Sci, Dept Biochem, 1-1 Ridai Cho, Okayama 7000005, Japan.	hayashi@dbc.ous.ac.jp	Sakai, Tatsuya/A-8909-2010; Furutani, Masahiko/AAM-7080-2021; Furutani, Masahiko/P-2112-2015; Hayashi, Ken-ichiro/AAP-3513-2021	Sakai, Tatsuya/0000-0002-1589-6247; Hayashi, Ken-ichiro/0000-0002-9812-2801; Furutani, Masahiko/0000-0002-6620-5151; Nishimura, Takeshi/0000-0002-1813-2832; Koshiba, Tomokazu/0000-0001-9264-4775	Japan Ministry of Education, Culture, Sports, Science and Technology; United States Department of Energy [DE-FG02-06ER15804]; Grants-in-Aid for Scientific Research [22570058] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); United States Department of Energy(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by a grant from Japan Ministry of Education, Culture, Sports, Science and Technology (to K. H.) and United States Department of Energy Grant DE-FG02-06ER15804 (to A. S. M.).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2008, P NATL ACAD SCI USA, V105, P4489, DOI 10.1073/pnas.0711414105; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hayashi K, 2003, J BIOL CHEM, V278, P23797, DOI 10.1074/jbc.M300299200; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Imhoff V, 2000, PLANTA, V210, P580, DOI 10.1007/s004250050047; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; KATEKAR GF, 1977, PLANT PHYSIOL, V60, P826, DOI 10.1104/pp.60.6.826; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; Mori Y, 2005, PLANT SCI, V168, P467, DOI 10.1016/j.plantsci.2004.09.010; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagashima A, 2008, PLANT J, V53, P516, DOI 10.1111/j.1365-313X.2007.03358.x; Nishimura T, 2006, PLANTA, V224, P1427, DOI 10.1007/s00425-006-0311-3; Nishimura T, 2009, PLANT CELL PHYSIOL, V50, P1874, DOI 10.1093/pcp/pcp129; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; OKADA K, 1992, AUST J PLANT PHYSIOL, V19, P439, DOI 10.1071/PP9920439; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Oono Y, 2003, PLANT PHYSIOL, V133, P1135, DOI 10.1104/pp.103.027847; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Peer WA, 2009, PLANT CELL, V21, P1693, DOI 10.1105/tpc.108.059634; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Soeno K, 2010, PLANT CELL PHYSIOL, V51, P524, DOI 10.1093/pcp/pcq032; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamazoe A, 2005, PLANT PHYSIOL, V139, P779, DOI 10.1104/pp.105.068924; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	54	46	47	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2354	2364		10.1074/jbc.M110.171165	http://dx.doi.org/10.1074/jbc.M110.171165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084292	hybrid, Green Published			2022-12-27	WOS:000286191500074
J	Hong, SY; Kim, OK; Kim, SG; Yang, MS; Park, CM				Hong, Shin-Young; Kim, Ok-Kyoung; Kim, Sang-Gyu; Yang, Moon-Sik; Park, Chung-Mo			Nuclear Import and DNA Binding of the ZHD5 Transcription Factor Is Modulated by a Competitive Peptide Inhibitor in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER; SIGNAL-TRANSDUCTION; SUBCELLULAR-LOCALIZATION; HOMEODOMAIN PROTEINS; GENE; LOOP; EXPRESSION; RESPONSES; THALIANA; HELIX	Competitive inhibition of transcription factors by small proteins is an intriguing component of gene regulatory networks in both animals and plants. The small interfering proteins possess limited sequence homologies to specific transcription factors but lack one or more protein motifs required for transcription factor activities. They interfere with the activities of transcription factors, such as DNA binding and transcriptional activation, by forming nonfunctional heterodimers. A potential example is the Arabidopsis MIF1 (mini zinc finger 1) protein consisting of 101 residues. It has a zinc finger domain but lacks other protein motifs normally present in transcription factors. In this work, we show that MIF1 and its functional homologues physically interact with a group of zinc finger homeodomain (ZHD) transcription factors, such as ZHD5, that regulate floral architecture and leaf development. Gel mobility shift assays revealed that MIF1 blocks the DNA binding activity of ZHD5 homodimers by competitively forming MIF1-ZHD5 heterodimers. Accordingly, the transcriptional activation activity of ZHD5 was significantly suppressed by MIF1 coexpressed transiently in Arabidopsis protoplasts. Notably, MIF1 also prevents ZHD5 from nuclear localization. Although ZHD5 was localized exclusively in the nucleus, it was scattered throughout the cytoplasm when MIF1 was coexpressed. Transgenic plants overexpressing the ZHD5 gene (35S:ZHD5) exhibited accelerated growth with larger leaves. Consistent with the negative regulation of ZHD5 by MIF1, the 35S:ZHD5 phenotypes were diminished by MIF1 coexpression. These observations indicate that MIF1 regulates the ZHD5 activities in a dual step manner:nuclear import and DNA binding.	[Hong, Shin-Young; Kim, Ok-Kyoung; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea; [Kim, Sang-Gyu] Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany; [Yang, Moon-Sik] Chonbuk Natl Univ, Div Biol Sci, Jeonju 561756, South Korea; [Yang, Moon-Sik] Chonbuk Natl Univ, Res Inst Bioact Mat, Jeonju 561756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Max Planck Society; Jeonbuk National University; Jeonbuk National University	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Park, Chung-Mo/B-6175-2012; Kim, Sang-Gyu/T-5925-2017; Hong, Shin-Young/H-2954-2016	Hong, Shin-Young/0000-0003-3031-2753	Brain Korea 21 Biogreen 21 [20080401034001]; National Research Laboratory; Plant Signaling Network Research Center; National Research Foundation of Korea [2009-0087317, 2007-03415]; Agricultural R & D Promotion Center [309017-5]; Korea Ministry for Food, Agriculture, Forestry, and Fisheries	Brain Korea 21 Biogreen 21(Rural Development Administration (RDA), Republic of Korea); National Research Laboratory(Korea Science and Engineering Foundation); Plant Signaling Network Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Agricultural R & D Promotion Center; Korea Ministry for Food, Agriculture, Forestry, and Fisheries	This work was supported by Brain Korea 21 Biogreen 21 Grant 20080401034001 and National Research Laboratory Programs and by grants from the Plant Signaling Network Research Center, the National Research Foundation of Korea (2009-0087317 and 2007-03415), and the Agricultural R & D Promotion Center (309017-5), Korea Ministry for Food, Agriculture, Forestry, and Fisheries.	BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Chariot A, 1999, BIOCHEM PHARMACOL, V58, P1851, DOI 10.1016/S0006-2952(99)00234-8; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; CHRISTIANSON AMK, 1993, NUCLEIC ACIDS RES, V21, P4416, DOI 10.1093/nar/21.18.4416; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Connolly JP, 1999, NUCLEIC ACIDS RES, V27, P1182, DOI 10.1093/nar/27.4.1182; Crawford KM, 2001, PLANT PHYSIOL, V125, P1802, DOI 10.1104/pp.125.4.1802; Duby A., 1987, CURRENT PROTOCOLS MO, P1; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Furlong EEM, 1996, J BIOL CHEM, V271, P29688, DOI 10.1074/jbc.271.47.29688; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Hu W, 2008, J INTEGR PLANT BIOL, V50, P1031, DOI 10.1111/j.1744-7909.2008.00681.x; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim H, 2005, PLANT CELL, V17, P888, DOI 10.1105/tpc.104.028829; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P4305, DOI 10.1073/pnas.85.12.4305; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LEE KAW, 1992, J CELL SCI, V103, P9; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LUEHRSEN KR, 1992, METHOD ENZYMOL, V216, P397; Miller J. H, 1972, EXPT MOL GENETICS; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Park HC, 2007, NUCLEIC ACIDS RES, V35, P3612, DOI 10.1093/nar/gkm273; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Resnekov O., 1996, NATO ASI SER, P267; Rozen S, 2000, Methods Mol Biol, V132, P365; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Seo PJ, 2010, BIOCHEM J, V427, P359, DOI 10.1042/BJ20091762; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sicard A, 2008, PLANT J, V55, P415, DOI 10.1111/j.1365-313X.2008.03520.x; Smith GE, 2003, MOL BIOL REP, V30, P199, DOI 10.1023/A:1026330907065; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; WHITESIDE ST, 1993, J CELL SCI, V104, P949; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yun J, 2008, PLANT SIGNAL BEHAV, V3, P615, DOI 10.4161/psb.3.9.6225; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	68	58	78	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1659	1668		10.1074/jbc.M110.167692	http://dx.doi.org/10.1074/jbc.M110.167692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059647	hybrid, Green Published			2022-12-27	WOS:000286005000078
J	Lejon, S; Thong, SY; Murthy, A; AlQarni, S; Murzina, NV; Blobel, GA; Laue, ED; Mackay, JP				Lejon, Sara; Thong, Sock Yue; Murthy, Andal; AlQarni, Saad; Murzina, Natalia V.; Blobel, Gerd A.; Laue, Ernest D.; Mackay, Joel P.			Insights into Association of the NuRD Complex with FOG-1 from the Crystal Structure of an RbAp48.FOG-1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELER MI-2-BETA; TRANSCRIPTIONAL REPRESSION; HISTONE H3; MI-2/NURD COMPLEX; GENE-EXPRESSION; RECOGNITION; REGULATOR; PROTEINS; BINDING; RECRUITS	Chromatin-modifying complexes such as the NuRD complex are recruited to particular genomic sites by gene-specific nuclear factors. Overall, however, little is known about the molecular basis for these interactions. Here, we present the 1.9 angstrom resolution crystal structure of the NuRD subunit RbAp48 bound to the 15 N-terminal amino acids of the GATA-1 cofactor FOG-1. The FOG-1 peptide contacts a negatively charged binding pocket on top of the RbAp48 beta-propeller that is distinct from the binding surface used by RpAp48 to contact histone H4. We further show that RbAp48 interacts with the NuRD subunit MTA-1 via a surface that is distinct from its FOG-binding pocket, providing a first glimpse into the way in which NuRD assembly facilitates interactions with cofactors. Our RbAp48 center dot FOG-1 structure provides insight into the molecular determinants of FOG-1-dependent association with the NuRD complex and into the links between transcription regulation and nucleosome remodeling.	[Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thong, Sock Yue; AlQarni, Saad; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Cambridge; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Laue, ED (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	e.d.laue@bioc.cam.ac.uk; joel.mackay@sydney.edu.au	Alqarni, Saad/AAH-2502-2020; Mackay, Joel/D-6834-2011	Mackay, Joel/0000-0001-7508-8033; Laue, Ernest/0000-0002-7476-4148	National Institutes of Health [DK058044]; Australian National Health and Medical Research Council; Wellcome Trust, United Kingdom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK058044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, United Kingdom(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK058044. This work was also supported by grants from the Australian National Health and Medical Research Council and the Wellcome Trust, United Kingdom.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Henikoff S, 2003, NATURE, V423, P814, DOI 10.1038/423814a; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moon HE, 2007, ONCOL REP, V18, P1311; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; TOH Y, 1994, J BIOL CHEM, V269, P22958; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	44	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1196	1203		10.1074/jbc.M110.195842	http://dx.doi.org/10.1074/jbc.M110.195842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047798	Green Published, hybrid			2022-12-27	WOS:000286005000031
J	Clausing, E; Mayer, A; Chanarat, S; Muller, B; Germann, SM; Cramer, P; Lisby, M; Strasser, K				Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Germann, Susanne M.; Cramer, Patrick; Lisby, Michael; Straesser, Katja			The Transcription Elongation Factor Bur1-Bur2 Interacts with Replication Protein A and Maintains Genome Stability during Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; RNA-POLYMERASE-II; DNA-DAMAGE; IN-VIVO; HISTONE MODIFICATION; BUR1 KINASE; S-PHASE; COMPLEX; YEAST; REPAIR	Multiple DNA-associated processes such as DNA repair, replication, and recombination are crucial for the maintenance of genome integrity. Here, we show a novel interaction between the transcription elongation factor Bur1-Bur2 and replication protein A (RPA), the eukaryotic single-stranded DNA-binding protein with functions in DNA repair, recombination, and replication. Bur1 interacted via its C-terminal domain with RPA, and bur1-Delta C mutants showed a deregulated DNA damage response accompanied by increased sensitivity to DNA damage and replication stress as well as increased levels of persisting Rad52 foci. Interestingly, the DNA damage sensitivity of an rfa1 mutant was suppressed by bur1 mutation, further underscoring a functional link between these two protein complexes. The transcription elongation factor Bur1-Bur2 interacts with RPA and maintains genome integrity during DNA replication stress.	[Germann, Susanne M.; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Cramer, Patrick; Straesser, Katja] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Cramer, Patrick; Straesser, Katja] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany	University of Copenhagen; University of Munich; University of Munich	Lisby, M (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloees Vej 5, DK-2200 Copenhagen N, Denmark.	mlisby@bio.ku.dk; strasser@lmb.uni-muenchen.de	Mayer, Andreas/AAA-5173-2021; Lisby, Michael/K-9814-2014; Germann, Susanne Manuela/K-9062-2014; Chanarat, Sittinan/M-6810-2018	Lisby, Michael/0000-0002-4830-5247; Germann, Susanne Manuela/0000-0002-4737-8452; Chanarat, Sittinan/0000-0001-6267-0040; Strasser, Katja/0000-0003-3533-5516; Mayer, Andreas/0000-0002-4532-9382	Deutscher Akademischer Austausch Dienst; European Molecular Biology Organization; Fonds der Chemischen Industrie; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; European Research Council; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 646, Sonderforschungsbereich Transregio 5]; Nanoinitiative Munich (NIM); Elitenetzwerk Bayern; Jung Stiftung	Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanoinitiative Munich (NIM); Elitenetzwerk Bayern; Jung Stiftung	This work was supported by the Deutscher Akademischer Austausch Dienst (to S. M. G.); Sonderforschungsbereich 646, the European Molecular Biology Organization Young Investigator Programme, and the Fonds der Chemischen Industrie (to K. S.); the Danish Agency for Science, Technology and Innovation, the Villum Kann Rasmussen Foundation, and the European Research Council (to M. L.); and the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 646, Sonderforschungsbereich Transregio 5, the Nanoinitiative Munich (NIM), the Elitenetzwerk Bayern, the Jung Stiftung, and the Fonds der Chemischen Industrie (to P. C.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liao C, 2007, MOL PHARMACOL, V71, P416, DOI 10.1124/mol.106.030494; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	37	15	15	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41665	41674		10.1074/jbc.M110.193292	http://dx.doi.org/10.1074/jbc.M110.193292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21075850	Green Published, hybrid			2022-12-27	WOS:000285622600054
J	Bomble, YJ; Beckham, GT; Matthews, JF; Nimlos, MR; Himmel, ME; Crowley, MF				Bomble, Yannick J.; Beckham, Gregg T.; Matthews, James F.; Nimlos, Mark R.; Himmel, Michael E.; Crowley, Michael F.			Modeling the Self-assembly of the Cellulosome Enzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM CELLULOSOME; INTEGRATING PROTEIN CIPA; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE CBHA; DISORDERED PROTEIN; INTRINSIC DISORDER; ENERGY LANDSCAPE; STRUCTURAL BASIS; DOCKERIN DOMAIN; ENDOGLUCANASE	Most bacteria use free enzymes to degrade plant cell walls in nature. However, some bacteria have adopted a different strategy wherein enzymes can either be free or tethered on a protein scaffold forming a complex called a cellulosome. The study of the structure and mechanism of these large macromolecular complexes is an active and ongoing research topic, with the goal of finding ways to improve biomass conversion using cellulosomes. Several mechanisms involved in cellulosome formation remain unknown, including how cellulosomal enzymes assemble on the scaffoldin and what governs the population of cellulosomes created during self-assembly. Here, we present a coarse-grained model to study the self-assembly of cellulosomes. The model captures most of the physical characteristics of three cellulosomal enzymes (Cel5B, CelS, and CbhA) and the scaffoldin (CipA) from Clostridium thermocellum. The protein structures are represented by beads connected by restraints to mimic the flexibility and shapes of these proteins. From a large simulation set, the assembly of cellulosomal enzyme complexes is shown to be dominated by their shape and modularity. The multimodular enzyme, CbhA, binds statistically more frequently to the scaffoldin than CelS or Cel5B. The enhanced binding is attributed to the flexible nature and multimodularity of this enzyme, providing a longer residence time around the scaffoldin. The characterization of the factors influencing the cellulosome assembly process may enable new strategies to create designers cellulosomes.	[Bomble, Yannick J.; Matthews, James F.; Himmel, Michael E.; Crowley, Michael F.] Colorado Sch Mines, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.; Nimlos, Mark R.] Colorado Sch Mines, Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Bomble, Yannick J.; Nimlos, Mark R.; Himmel, Michael E.; Crowley, Michael F.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Beckham, Gregg T.; Himmel, Michael E.] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA	Colorado School of Mines; Colorado School of Mines; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of Colorado System; University of Colorado Boulder	Bomble, YJ (corresponding author), Colorado Sch Mines, Biosci Ctr, Golden, CO 80401 USA.	Yannick.Bomble@nrel.gov; Michael.Crowley@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000	Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center; DOE Bioenergy Research Center; DOE Office of Science ASCR SciDAC; Texas Advanced Computing Center Ranger cluster under National Science Foundation [MCB090159]; National Science Foundation; National Renewable Energy Laboratory	Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center(United States Department of Energy (DOE)); DOE Bioenergy Research Center(United States Department of Energy (DOE)); DOE Office of Science ASCR SciDAC; Texas Advanced Computing Center Ranger cluster under National Science Foundation; National Science Foundation(National Science Foundation (NSF)); National Renewable Energy Laboratory(United States Department of Energy (DOE))	This work was supported by the Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center, a DOE Bioenergy Research Center, and by the DOE Office of Science ASCR SciDAC program.; We thank the Texas Advanced Computing Center Ranger cluster under National Science Foundation Teragrid Grant MCB090159. We thank Qi Xu for helpful discussions. Access to PONDR (R) was provided by Molecular Kinetics. Computational time for this research was supported in part by the Golden Energy Computing Organization at the Colorado School of Mines using resources acquired with financial assistance from the National Science Foundation and the National Renewable Energy Laboratory.	Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Bellesia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3108461; Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040; BHAT S, 1994, INT J BIOL MACROMOL, V16, P335, DOI 10.1016/0141-8130(94)90066-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782; CHAUVAUX S, 1990, BIOCHEM J, V265, P261, DOI 10.1042/bj2650261; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Ciruela A, 1998, FEBS LETT, V422, P221, DOI 10.1016/S0014-5793(97)01590-1; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; GREPINET O, 1986, NUCLEIC ACIDS RES, V14, P1791, DOI 10.1093/nar/14.4.1791; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hills RD, 2009, INT J MOL SCI, V10, P889, DOI 10.3390/ijms10030889; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kataeva I, 1997, BIOCHEM J, V326, P617, DOI 10.1042/bj3260617; Kataeva IA, 2004, PROTEIN ENG DES SEL, V17, P759, DOI 10.1093/protein/gzh094; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kivenson A, 2010, BIOPHYS J, V99, P619, DOI 10.1016/j.bpj.2010.04.035; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; KRUUS K, 1995, P NATL ACAD SCI USA, V92, P9254, DOI 10.1073/pnas.92.20.9254; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07; Morag E, 1996, J BIOTECHNOL, V51, P235, DOI 10.1016/S0168-1656(96)01601-X; Nguyen HD, 2007, NANO LETT, V7, P338, DOI 10.1021/nl062449h; Nguyen HD, 2009, J AM CHEM SOC, V131, P2606, DOI 10.1021/ja807730x; Noach I, 2009, J MOL BIOL, V391, P86, DOI 10.1016/j.jmb.2009.06.006; Oehler S, 2010, J MOL BIOL, V395, P242, DOI 10.1016/j.jmb.2009.10.056; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Schwartz R, 1998, BIOPHYS J, V75, P2626, DOI 10.1016/S0006-3495(98)77708-2; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Strodel B, 2008, J CHEM THEORY COMPUT, V4, P657, DOI 10.1021/ct700305w; Strodel B, 2007, J AM CHEM SOC, V129, P16005, DOI 10.1021/ja075346p; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; WU JHD, 1988, BIOCHEMISTRY-US, V27, P1703, DOI 10.1021/bi00405a048; Xu JC, 2009, PROTEIN SCI, V18, P949, DOI 10.1002/pro.105; Zverlov VV, 1998, J BACTERIOL, V180, P3091, DOI 10.1128/JB.180.12.3091-3099.1998	71	37	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5614	5623		10.1074/jbc.M110.186031	http://dx.doi.org/10.1074/jbc.M110.186031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21098021	Green Published, hybrid			2022-12-27	WOS:000287230600071
J	Machwe, A; Lozada, E; Wold, MS; Li, GM; Orren, DK				Machwe, Amrita; Lozada, Enerlyn; Wold, Marc S.; Li, Guo-Min; Orren, David K.			Molecular Cooperation between the Werner Syndrome Protein and Replication Protein A in Relation to Replication Fork Blockage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ROTHMUND-THOMSON-SYNDROME; S-PHASE; SYNDROME HELICASE; CELL-CYCLE; BIOCHEMICAL-CHARACTERIZATION; ANNEALING ACTIVITIES; RPA PHOSPHORYLATION; HUMAN RECQ5-BETA; BINDING PROTEIN	The premature aging and cancer-prone disease Werner syndrome is caused by loss of function of the RecQ helicase family member Werner syndrome protein (WRN). At the cellular level, loss of WRN results in replication abnormalities and chromosomal aberrations, indicating that WRN plays a role in maintenance of genome stability. Consistent with this notion, WRN possesses annealing, exonuclease, and ATPase-dependent helicase activity on DNA substrates, with particularly high affinity for and activity on replication and recombination structures. After certain DNA-damaging treatments, WRN is recruited to sites of blocked replication and co-localizes with the human single-stranded DNA-binding protein replication protein A (RPA). In this study we examined the physical and functional interaction between WRN and RPA specifically in relation to replication fork blockage. Co-immunoprecipitation experiments demonstrated that damaging treatments that block DNA replication substantially increased association between WRN and RPA in vivo, and a direct interaction between purified WRN and RPA was confirmed. Furthermore, we examined the combined action of RPA (unmodified and hyperphosphorylation mimetic) and WRN on model replication fork and gapped duplex substrates designed to bind RPA. Even with RPA bound stoichiometrically to this gap, WRN efficiently catalyzed regression of the fork substrate. Further analysis showed that RPA could be displaced from both substrates by WRN. RPA displacement by WRN was independent of its ATPase-and helicase-dependent remodeling of the fork. Taken together, our results suggest that, upon replication blockage, WRN and RPA functionally interact and cooperate to help properly resolve replication forks and maintain genome stability.	[Machwe, Amrita; Lozada, Enerlyn; Li, Guo-Min; Orren, David K.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Li, Guo-Min; Orren, David K.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Kentucky; University of Kentucky; University of Iowa	Orren, DK (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, 356 Hlth Sci Res Bldg,1095 VAD, Lexington, KY 40536 USA.	dkorre2@uky.edu		Li, Guo-Min/0000-0002-9842-4578; Wold, Marc/0000-0002-4580-1624	National Institutes of Health [R01 CA113371]; NIA [AG027258]; NIA, National Institutes of Health [R01 AG026534]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258, R01AG026534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA113371 and by AG027258 (NIA) (to D. K. O.).; Supported in part by NIA, National Institutes of Health Grant R01 AG026534.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Anantha RW, 2009, CELL CYCLE, V8, P357, DOI 10.4161/cc.8.3.7496; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; MITSIS PG, 1995, DEV BIOL, V170, P445, DOI 10.1006/dbio.1995.1228; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Oakley GG, 2001, MOL BIOL CELL, V12, P1199, DOI 10.1091/mbc.12.5.1199; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rodriguez-Lopez AM, 2002, AGING CELL, V1, P30, DOI 10.1046/j.1474-9728.2002.00002.x; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; STATES JC, 1993, CARCINOGENESIS, V14, P1643, DOI 10.1093/carcin/14.8.1643; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	74	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3497	3508		10.1074/jbc.M110.105411	http://dx.doi.org/10.1074/jbc.M110.105411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107010	Green Published, hybrid			2022-12-27	WOS:000286653200035
J	Morrone, A; McCully, ME; Bryan, PN; Brunori, M; Daggett, V; Gianni, S; Travaglini-Allocatelli, C				Morrone, Angela; McCully, Michelle E.; Bryan, Philip N.; Brunori, Maurizio; Daggett, Valerie; Gianni, Stefano; Travaglini-Allocatelli, Carlo			The Denatured State Dictates the Topology of Two Proteins with Almost Identical Sequence but Different Native Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FOLDING TRANSITION-STATE; CHYMOTRYPSIN INHIBITOR-2; HOMOLOGOUS PROTEINS; SECONDARY STRUCTURE; NUCLEIC-ACIDS; ALPHA-HELIX; PATHWAY; INTERMEDIATE; MECHANISM	The protein folding problem is often studied by comparing the mechanisms of proteins sharing the same structure but different sequence. The recent design of the two proteins G(A)88 and G(B)88, displaying different structures and functions while sharing 88% sequence identity (49 out of 56 amino acids), allows the unique opportunity for a complementary approach. At which stage of its folding pathway does a protein commit to a given topology? Which residues are crucial in directing folding mechanisms to a given structure? By using a combination of biophysical and computational techniques, we have characterized the folding of both G(A)88 and G(B)88. We show that, contrary to expectation, G(B)88, characterized by a native alpha+beta fold, displays in the denatured state a content of native-like helical structure greater than G(A)88, which is all-alpha in its native state. Both experiments and simulations indicate that such residual structure may be tuned by changing pH. Thus, despite the high sequence identity, the folding pathways for these two proteins appear to diverge as early as in the denatured state. Our results suggest a mechanism whereby protein topology is committed very early along the folding pathway, being imprinted in the residual structure of the denatured state.	[McCully, Michelle E.; Daggett, Valerie] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [McCully, Michelle E.; Daggett, Valerie] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Morrone, Angela; Brunori, Maurizio; Gianni, Stefano; Travaglini-Allocatelli, Carlo] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol CNR, I-00185 Rome, Italy; [Morrone, Angela; Brunori, Maurizio; Gianni, Stefano; Travaglini-Allocatelli, Carlo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Bryan, Philip N.] Univ Maryland, Dept Bioengn, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Daggett, V (corresponding author), Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA.	daggett@u.washington.edu; stefano.gianni@uniroma1.it	gianni, stefano/C-8536-2009	Travaglini-Allocatelli, Carlo/0000-0001-8735-1126; Brunori, Maurizio/0000-0002-7795-1635; Gianni, Stefano/0000-0003-1653-1925	Italian Ministero dell'Istruzione dell'Universita e della Ricerca [2007B57EAB_004, 20074TJ3ZB_005, RBRN07BMCT_007]; National Institutes of Health [GM50789, GM062154]; Department of Defense through the National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050789, R01GM062154, R01GM050789] Funding Source: NIH RePORTER	Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense through the National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by grants from the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (Grants 2007B57EAB_004, 20074TJ3ZB_005, and RBRN07BMCT_007). This work was supported, in whole or in part, by National Institutes of Health Grants GM50789 (to V. D.) and GM062154 (to P. N. B.). This work was also supported by a grant from the Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program (to M. E. M.) for the MD studies.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; [Anonymous], 2005, SCIENCE, V309, P78; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548; Davidson AR, 2008, P NATL ACAD SCI USA, V105, P2759, DOI 10.1073/pnas.0800030105; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; He Y, 2008, P NATL ACAD SCI USA, V105, P14412, DOI 10.1073/pnas.0805857105; Hubner IA, 2006, J MOL BIOL, V359, P1075, DOI 10.1016/j.jmb.2006.04.015; Ivarsson Y, 2008, PROTEIN ENG DES SEL, V21, P155, DOI 10.1093/protein/gzm077; Ivarsson Y, 2009, J AM CHEM SOC, V131, P11727, DOI 10.1021/ja900438b; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levitt M, 1997, J PHYS CHEM B, V101, P5051, DOI 10.1021/jp964020s; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Li AJ, 1996, J MOL BIOL, V257, P412, DOI 10.1006/jmbi.1996.0172; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; ROSE GD, 1994, PROTEINS, V19, P1, DOI 10.1002/prot.340190102; Ruan B, 2004, BIOCHEMISTRY-US, V43, P14539, DOI 10.1021/bi048177j; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scott KA, 2007, BIOCHEMISTRY-US, V46, P1545, DOI 10.1021/bi061904l; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; White GWN, 2005, J MOL BIOL, V350, P757, DOI 10.1016/j.jmb.2005.05.005; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550	48	35	35	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3863	3872		10.1074/jbc.M110.155911	http://dx.doi.org/10.1074/jbc.M110.155911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118804	Green Published, hybrid			2022-12-27	WOS:000286653200067
J	Juang, YT; Rauen, T; Wang, Y; Ichinose, K; Benedyk, K; Tenbrock, K; Tsokos, GC				Juang, Yuang-Taung; Rauen, Thomas; Wang, Ying; Ichinose, Kunihiro; Benedyk, Konrad; Tenbrock, Klaus; Tsokos, George C.			Transcriptional Activation of the cAMP-responsive Modulator Promoter in Human T Cells Is Regulated by Protein Phosphatase 2A-mediated Dephosphorylation of SP-1 and Reflects Disease Activity in Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT MODULATOR; IL-2 PRODUCTION; EXPRESSION; BINDING; CREM	Systemic lupus erythematosus (SLE) is a complex autoimmune disease with numerous abnormalities recorded at the cellular, molecular, and genetic level. Expression of the basic leucine zipper transcription factor cAMP-responsive element modulator (CREM)alpha was reported to be abnormally increased in T cells from SLE patients. CREM alpha suppresses IL-2 and T cell receptor xi chain gene transcription by direct binding to the respective promoters. Here, we show that increased CREM expression is the result of enhanced promoter activity. DNA binding analyses reveal direct binding of transcription factor specificity protein-1 (SP-1) to the CREM promoter resulting in enhanced transcriptional activity and increased CREM expression. Protein phosphatase 2A is known to activate SP-1 through dephosphorylation at its serine residue 59. Our results show that nuclei from SLE T cells contain lower levels of Ser(59)-phosphorylated SP-1 protein and a stronger SP-1 binding to the CREM promoter. We conclude that protein phosphatase 2A accounts for enhanced SP-1 dephosphorylation at Ser(59) in SLE T cells. More importantly, CREM promoter activity mirrors reliably disease activity in SLE patients, underscoring its potential role as a biomarker for the prediction of flares in SLE patients.	[Juang, Yuang-Taung; Rauen, Thomas; Ichinose, Kunihiro; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol,Sch Med, Boston, MA 02115 USA; [Wang, Ying] Walter Reed Army Inst Res, Dept Cellular Injury, Silver Spring, MD 20910 USA; [Benedyk, Konrad; Tenbrock, Klaus] Univ Aachen, Rhein Westfael TH, Dept Pediat, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol,Sch Med, CLS-937,330 Brookline Ave, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Ichinose, Kunihiro/I-2126-2019	tsokos, george C/0000-0001-9589-2360; Ichinose, Kunihiro/0000-0001-8794-7106	National Institutes of Health [AI42269, AI68787]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; Internationales Zentrum fur Klinische Forschung Munster [FG5]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Internationales Zentrum fur Klinische Forschung Munster; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI42269 and AI68787 (to G.C.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T.R.) and Internationales Zentrum fur Klinische Forschung Munster Grant FG5 (to K.T.).	Della Fazia MA, 1998, FEBS LETT, V434, P33, DOI 10.1016/S0014-5793(98)00944-2; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iliopoulos AG, 1996, SEMIN ARTHRITIS RHEU, V25, P318, DOI 10.1016/S0049-0172(96)80018-7; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Vicart A, 2006, J MOL BIOL, V364, P897, DOI 10.1016/j.jmb.2006.09.036	20	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1795	1801		10.1074/jbc.M110.166785	http://dx.doi.org/10.1074/jbc.M110.166785			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097497	Green Published, hybrid			2022-12-27	WOS:000286191500019
J	Fernandez, MM; Cho, S; De Marzi, MC; Kerzic, MC; Robinson, H; Mariuzza, RA; Malchiodi, EL				Fernandez, Marisa M.; Cho, Sangwoo; De Marzi, Mauricio C.; Kerzic, Melissa C.; Robinson, Howard; Mariuzza, Roy A.; Malchiodi, Emilio L.			Crystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a Mouse T-cell Receptor beta Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; AFFINITY MATURATION; BACTERIAL SUPERANTIGENS; 3-DIMENSIONAL STRUCTURE; BINDING; ZINC; ARCHITECTURE; RECOGNITION; INVOLVEMENT; ACTIVATION	Superantigens (SAgs) are bacterial or viral toxins that bind MHC class II (MHC-II) molecules and T-cell receptor (TCR) in a nonconventional manner, inducing T-cell activation that leads to inflammatory cytokine production, which may result in acute toxic shock. In addition, the emerging threat of purpura fulminans and community-associated meticillin-resistant Staphylococcus aureus emphasizes the importance of a better characterization of SAg binding to their natural ligands that may allow the development of reagents to neutralize their action. The three-dimensional structure of the complex between a mouse TCR beta chain (mV beta 8.2) and staphylococcal enterotoxin G (SEG) at 2.0 angstrom resolution revealed a binding site that does not conserve the "hot spots" present in mV beta 8.2-SEC2, mV beta 8.2-SEC3, mV beta 8.2-SEB, and mV beta 8.2-SPEA complexes. Analysis of the mV beta 8.2-SEG interface allowed us to explain the higher affinity of this complex compared with the others, which may account for the early activation of T-cells bearing mV beta 8.2 by SEG. This mode of interaction between SEG and mV beta 8.2 could be an adaptive advantage to bestow on the pathogen a faster rate of colonization of the host.	[Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Inmunidad Humoral Prof Ricardo Marg, RA-1113 Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Cho, Sangwoo; Kerzic, Melissa C.; Mariuzza, Roy A.; Malchiodi, Emilio L.] Univ Maryland, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Fernandez, Marisa M.; Cho, Sangwoo; Kerzic, Melissa C.; Mariuzza, Roy A.; Malchiodi, Emilio L.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [De Marzi, Mauricio C.] Univ Nacl Lujan, Dept Ciencias Basicas, RA-6700 Buenos Aires, DF, Argentina; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; United States Department of Energy (DOE); Brookhaven National Laboratory	Mariuzza, RA (corresponding author), 9600 Gudelsky Dr, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov; emalchio@ffyb.uba.ar		Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907	National Institutes of Health [AI36900, AI073654]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 38293, 450]; National Multiple Sclerosis Society [RG2747]; Offices of Biological and Environmental Research; Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the National Institutes of Health; Fogarty International Center [TW007972]; International Centre for Genetic Engineering and Biotechnology [CRP/ARG09-02]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073654, R01AI036900, R37AI036900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Offices of Biological and Environmental Research; Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Genetic Engineering and Biotechnology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36900 and AI073654. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnica Grant PICT 38293 (to E. L. M.) and 450 (to M. M. F.); and National Multiple Sclerosis Society Grant RG2747 (to R. A. M.). Financial support for use of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy and from the National Center for Research Resources of the National Institutes of Health.; Supported by the Fogarty International Center (TW007972) and International Centre for Genetic Engineering and Biotechnology (CRP/ARG09-02).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks MC, 2003, J INFECT DIS, V187, P77, DOI 10.1086/345874; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Brocke S, 1998, SEMIN IMMUNOL, V10, P57, DOI 10.1006/smim.1997.0105; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; Fernandez MM, 2007, PROTEINS, V68, P389, DOI 10.1002/prot.21388; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jarraud S, 1999, J CLIN MICROBIOL, V37, P2446, DOI 10.1128/JCM.37.8.2446-2449.1999; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Madakamutil LT, 2003, J IMMUNOL, V170, P2985, DOI 10.4049/jimmunol.170.6.2985; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Munson SH, 1998, INFECT IMMUN, V66, P3337, DOI 10.1128/IAI.66.7.3337-3348.1998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papageorgiou AC, 1999, EMBO J, V18, P9, DOI 10.1093/emboj/18.1.9; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Renno T, 1999, J IMMUNOL, V162, P6312; Roussel A, 1997, NAT STRUCT BIOL, V4, P635, DOI 10.1038/nsb0897-635; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sundberg E, 1999, NAT STRUCT BIOL, V6, P123; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Yang JY, 2003, J BIOL CHEM, V278, P50412, DOI 10.1074/jbc.M306848200; Yarwood JM, 2000, FEMS MICROBIOL LETT, V192, P1, DOI 10.1016/S0378-1097(00)00400-6	41	11	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1189	1195		10.1074/jbc.M110.142471	http://dx.doi.org/10.1074/jbc.M110.142471			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059660	Green Published, hybrid			2022-12-27	WOS:000286005000030
J	Sinnett-Smith, J; Rozengurt, N; Kui, R; Huang, C; Rozengurt, E				Sinnett-Smith, James; Rozengurt, Nora; Kui, Robert; Huang, Carlos; Rozengurt, Enrique			Protein Kinase D1 Mediates Stimulation of DNA Synthesis and Proliferation in Intestinal Epithelial IEC-18 Cells and in Mouse Intestinal Crypts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP SER(744); SIGNAL-TRANSDUCTION PATHWAY; PLECKSTRIN HOMOLOGY DOMAIN; D PKD ACTIVATION; NF-KAPPA-B; PHORBOL ESTERS; G(Q)-COUPLED RECEPTORS; LYSOPHOSPHATIDIC ACID; SWISS 3T3-CELLS; IN-VIVO	We examined whether protein kinase D1 (PKD1), the founding member of a new protein kinase family, plays a critical role in intestinal epithelial cell proliferation. Our results demonstrate that PKD1 activation is sustained, whereas that of PKD2 is transient in intestinal epithelial IEC-18 stimulated with the G(q)-coupled receptor agonists angiotensin II or vasopressin. PKD1 gene silencing utilizing small interfering RNAs dramatically reduced DNA synthesis and cell proliferation in IEC-18 cells stimulated with G(q)-coupled receptor agonists. To clarify the role of PKD1 in intestinal epithelial cell proliferation in vivo, we generated transgenic mice that express elevated PKD1 protein in the intestinal epithelium. Transgenic PKD1 exhibited constitutive catalytic activity and phosphorylation at the activation loop residues Ser(744) and Ser(748) and on the autophosphorylation site, Ser(916). To examine whether PKD1 expression stimulates intestinal cell proliferation, we determined the rate of crypt cell DNA synthesis by detection of 5-bromo-2-deoxyuridine incorporated into the nuclei of crypt cells of the ileum. Our results demonstrate a significant increase (p < 0.005) in DNA-synthesizing cells in the crypts of two independent lines of PKD1 transgenic mice as compared with non-transgenic littermates. Morphometric analysis showed a significant increase in the length and in the total number of cells per crypt in the transgenic PKD1 mice as compared with the non-transgenic littermates (p < 0.01). Thus, transgenic PKD1 signaling increases the number of cells per crypt by stimulating the rate of crypt cell proliferation. Collectively, our results indicate that PKD1 plays a role in promoting cell proliferation in intestinal epithelial cells both in vitro and in vivo.	[Rozengurt, Enrique] Univ Calif Los Angeles, Sch Med, Dept Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Inst Mol Biol, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [R0- 1 DK 55003, R0- 1 DK56930, P30 DK41301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK055003, R01DK056930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R0- 1 DK 55003, R0- 1 DK56930, and P30 DK41301 (to E. R.).	Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P1011; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; BROOKS SF, 1991, EMBO J, V10, P2497, DOI 10.1002/j.1460-2075.1991.tb07789.x; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; Guha S, 2002, CANCER RES, V62, P1632; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Rey O, 2003, J CELL PHYSIOL, V196, P483, DOI 10.1002/jcp.10323; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; Simon TC, 1997, J BIOL CHEM, V272, P10652; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	55	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					511	520		10.1074/jbc.M110.167528	http://dx.doi.org/10.1074/jbc.M110.167528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051537	Green Published, hybrid			2022-12-27	WOS:000285782800054
J	Edderkaoui, M; Nitsche, C; Zheng, L; Pandol, SJ; Gukovsky, I; Gukovskaya, AS				Edderkaoui, Mouad; Nitsche, Claudia; Zheng, Ling; Pandol, Stephen J.; Gukovsky, Ilya; Gukovskaya, Anna S.			NADPH Oxidase Activation in Pancreatic Cancer Cells Is Mediated through Akt-dependent Up-regulation of p22(phox)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AORTIC SMOOTH-MUSCLE; FACTOR-I RECEPTOR; ENDOTHELIAL-CELLS; GROWTH; NOX4; APOPTOSIS; ALPHA; EXPRESSION; GENERATION	We recently showed that Nox4 NADPH oxidase is highly expressed in pancreatic ductal adenocarcinoma and that it is activated by growth factors and plays a pro-survival, antiapoptotic role. Here we investigate the mechanisms through which insulin-like growth factor I and serum (FBS) activate NADPH oxidase in pancreatic cancer (PaCa) cells. We show that in PaCa cells, NADPH oxidase is composed of Nox4 and p22(phox) catalytic subunits, which are both required for NADPH oxidase activity. Insulin-like growth factor I and FBS activate NADPH oxidase through transcriptional up-regulation of p22(phox). This involves activation of the transcription factor NF-kappa B mediated by Akt kinase. Up-regulation of p22(phox) by the growth factors results in increased Nox4-p22(phox) complex formation and activation of NADPH oxidase. This mechanism is different from that for receptor-induced activation of phagocytic NADPH oxidase, which is mediated by phosphorylation of its regulatory subunits. Upregulation of p22(phox) represents a novel pro-survival mechanism through which growth factors and Akt inhibit apoptosis in PaCa cells.	[Gukovskaya, Anna S.] Vet Affairs Greater Los Angeles Healthcare Syst, W Los Angeles Healthcare Ctr, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Gukovskaya, AS (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, W Los Angeles Healthcare Ctr, 11301 Wilshire Blvd,Bldg 258,Rm 340, Los Angeles, CA 90073 USA.	agukovsk@ucla.edu		Edderkaoui, Mouad/0000-0002-2549-8242; Gukovskaya, Anna/0000-0003-3737-5335	National Institutes of Health through NCI [R01CA119025]; NCCAM [AT003960]; Department of Veterans Affairs Merit Review; CURE-Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE [R01CA119025] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P01AT003960] Funding Source: NIH RePORTER	National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); CURE-Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA119025 through the NCI (to A. S. G.) and AT003960 through the NCCAM (to S. J. P.). This study was also supported by the Department of Veterans Affairs Merit Review (to A. S. G.) and the CURE-Digestive Diseases Research Center Pilot and Feasibility Award (to M. E.).	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Dusi S, 2001, EUR J IMMUNOL, V31, P929, DOI 10.1002/1521-4141(200103)31:3<929::AID-IMMU929>3.0.CO;2-M; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Min YF, 2003, CANCER RES, V63, P6432; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Mouria M, 2002, INT J CANCER, V98, P761, DOI 10.1002/ijc.10202; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023	32	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7779	7787		10.1074/jbc.M110.200063	http://dx.doi.org/10.1074/jbc.M110.200063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21118808	Green Published, hybrid			2022-12-27	WOS:000288013300009
J	Haglund, L; Tillgren, V; Addis, L; Wenglen, C; Recklies, A; Heinegard, D				Haglund, Lisbet; Tillgren, Viveka; Addis, Laura; Wenglen, Christina; Recklies, Anneliese; Heinegard, Dick			Identification and Characterization of the Integrin alpha(2)beta(1) Binding Motif in Chondroadherin Mediating Cell Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE MATRIX PROTEIN; RICH REPEAT PROTEIN; COLLAGEN; RECOGNITION; EXPRESSION; RECEPTOR; SURFACE; DOMAIN; PROTEOGLYCANS; ADHESION	Chondroadherin is a leucine-rich repeat protein known to mediate adhesion of isolated cells via the integrin alpha(2)beta(1) and to interact with collagen. In this work, we show that cell adhesion to chondroadherin leads to activation of MAPKs but does not result in cell spreading and division. This is in contrast to the spreading and dividing of cells grown on collagen, although the binding is mediated via the same alpha(2)beta(1) receptor. We identified a cell binding motif, CQLRGLRRWLEAK(318) by mass spectrometry after protease digestion of chondroadherin. Cells adhering to the synthetic peptide CQLRGLRRWLEAK(318) remained round, as was observed when they bound to the intact protein. The peptide added in solution was able to inhibit cell adhesion to the intact protein in a dose-dependent manner and was also verified to bind to the alpha(2)beta(1) integrin. A cyclic peptide, CQLRGLRRWLEAKASRPDATC(326), mimicking the structural constraints of this sequence in the intact protein, showed similar efficiency in inhibiting binding to chondroadherin. The unique peptide motif responsible for cellular binding is primarily located in the octamer sequence LRRWLEAK(318). Binding of cells to the active peptide or to chondroadherin immobilized on cell culture plates rapidly induces intracellular signaling (i.e. ERK phosphorylation). Thus, chondroadherin interaction with cells may be central for maintaining the adult chondrocyte phenotype and cartilage homeostasis. The peptides, particularly the more stable cyclic peptide, open new opportunities to modulate cell behavior in situations of tissue pathology.	[Haglund, Lisbet; Tillgren, Viveka; Addis, Laura; Wenglen, Christina; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden; [Recklies, Anneliese] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada	Lund University; McGill University	Heinegard, D (corresponding author), Lund Univ, Dept Clin Sci Lund, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Addis, Laura/R-1385-2016; Haglund, Lisbet/N-3095-2013	Addis, Laura/0000-0001-8455-4278; Haglund, Lisbet/0000-0002-1288-2149	Swedish Research Council; King Gustaf V: 80 Years Fund; Crafoord Foundation for Research in Rheumatology; Greta and Johan Kock's Foundations; Royal Physiographic Society; Osterlund Foundation; ANAMAR; IngaBritt and Arne Lundbergs Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V: 80 Years Fund; Crafoord Foundation for Research in Rheumatology; Greta and Johan Kock's Foundations; Royal Physiographic Society; Osterlund Foundation; ANAMAR; IngaBritt and Arne Lundbergs Research Foundation	This work was supported by the Swedish Research Council, King Gustaf V: 80 Years Fund, the Crafoord Foundation for Research in Rheumatology, Greta and Johan Kock's Foundations, the Royal Physiographic Society, the Osterlund Foundation, and ANAMAR. Funding of mass spectrometers was through a grant from the IngaBritt and Arne Lundbergs Research Foundation. A patent application has been submitted for use of the identified active peptides to modulate cell activity.	Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Hagg P, 1998, J BIOL CHEM, V273, P15590, DOI 10.1074/jbc.273.25.15590; HARDINGHAM TE, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P5; HEINEGARD D, 1985, BIOCHEM J, V225, P95, DOI 10.1042/bj2250095; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Makihira S, 1999, J BIOL CHEM, V274, P11417, DOI 10.1074/jbc.274.16.11417; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mansson B, 2001, ANN RHEUM DIS, V60, P27, DOI 10.1136/ard.60.1.27; MAROUDAS A, 1968, BIOPHYS J, V8, P575, DOI 10.1016/S0006-3495(68)86509-9; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; RECKLIES AD, 1992, ARTHRITIS RHEUM, V35, P1510, DOI 10.1002/art.1780351215; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; SOMMARIN Y, 1983, BIOCHEM J, V214, P777, DOI 10.1042/bj2140777; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200	30	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3925	3934		10.1074/jbc.M110.161141	http://dx.doi.org/10.1074/jbc.M110.161141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127050	hybrid, Green Published			2022-12-27	WOS:000286653200073
J	Karlberg, H; Tan, YJ; Mirazimi, A				Karlberg, Helen; Tan, Yee-Joo; Mirazimi, Ali			Induction of Caspase Activation and Cleavage of the Viral Nucleocapsid Protein in Different Cell Types during Crimean-Congo Hemorrhagic Fever Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MAMMALIAN-CELLS; DEATH; EXPRESSION; REPLICATION; DISEASE; BIOLOGY	Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of similar to 80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.	[Karlberg, Helen; Mirazimi, Ali] Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; [Karlberg, Helen; Mirazimi, Ali] Karolinska Inst, Inst Microbiol Tumor & Cell Biol, SE-17772 Stockholm, Sweden; [Tan, Yee-Joo] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	Swedish Institute for Infectious Disease Control; Karolinska Institutet; National University of Singapore	Mirazimi, A (corresponding author), Inst Infect Dis Control, SE-17182 Solna, Sweden.	Ali.Mirazimi@smi.se		Tan, Yee-Joo/0000-0002-2278-4497; , Ali/0000-0003-2371-6055	Swedish Medical Research Council [K2010-57X-0349-01-3]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported in part by Swedish Medical Research Council Grant K2010-57X-0349-01-3 (to A.M.).	Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013; Akhmatova Nelly K, 2003, Russ J Immunol, V8, P37; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Bray Mike, 2006, Expert Rev Anti Infect Ther, V4, P917, DOI 10.1586/14787210.4.6.917; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Gadaleta P, 2002, VIRUS RES, V86, P87, DOI 10.1016/S0168-1702(02)00049-7; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hardestam J, 2005, J MED VIROL, V76, P234, DOI 10.1002/jmv.20347; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Kang JI, 1999, VIROLOGY, V264, P99, DOI 10.1006/viro.1999.9896; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Ontiveros SJ, 2010, VIROLOGY, V401, P165, DOI 10.1016/j.virol.2010.02.018; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; TARODI B, 1994, VIROLOGY, V201, P404, DOI 10.1006/viro.1994.1309; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Zhirnov OP, 1999, J VIROL, V73, P10158, DOI 10.1128/JVI.73.12.10158-10163.1999; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	35	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3227	3234		10.1074/jbc.M110.149369	http://dx.doi.org/10.1074/jbc.M110.149369			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123175	hybrid, Green Published			2022-12-27	WOS:000286653200007
J	Kashyap, V; Gudas, LJ; Brenet, F; Funk, P; Viale, A; Scandura, JM				Kashyap, Vasundhra; Gudas, Lorraine J.; Brenet, Fabienne; Funk, Patricia; Viale, Agnes; Scandura, Joseph M.			Epigenomic Reorganization of the Clustered Hox Genes in Embryonic Stem Cells Induced by Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN SUZ12; RESPONSE ELEMENTS; IN-VIVO; DEVELOPMENTAL REGULATORS; INDUCED DIFFERENTIATION; FUNCTIONAL-ANALYSIS; MOUSE DEVELOPMENT; EARLY HINDBRAIN	Retinoic acid (RA) regulates clustered Hox gene expression during embryogenesis and is required to establish the anterior- posterior body plan. Using mutant embryonic stem cell lines deficient in the RA receptor gamma(RAR gamma) or Hoxa1 3'-RA-responsive element, we studied the kinetics of transcriptional and epigenomic patterning responses to RA. RAR gamma is essential for RA-induced Hox transcriptional activation, and deletion of its binding site in the Hoxa1 enhancer attenuates transcriptional and epigenomic activation of both Hoxa and Hoxb gene clusters. The kinetics of epigenomic reorganization demonstrate that complete erasure of the polycomb repressive mark H3K27me3 is not necessary to initiate Hox transcription. RAR gamma is not required to establish the bivalent character of Hox clusters, but RA/RAR gamma signaling is necessary to erase H3K27me3 from activated Hox genes during embryonic stem cell differentiation. Highly coordinated, long range epigenetic Hox cluster reorganization is closely linked to transcriptional activation and is triggered by RAR gamma located at the Hoxa1 3'-RA-responsive element.	[Gudas, Lorraine J.; Brenet, Fabienne; Funk, Patricia; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Scandura, JM (corresponding author), Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA.	jms2003@med.cornell.edu	Brenet, Fabienne/R-1881-2016; Kashyap, Vasundhra/H-8970-2019	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X	National Institutes of Health [R01CA043796]; Department of Defense [W81XWH-08-1-0317]; Cornell Belfer Family startup funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cornell Belfer Family startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043796 (to L.J.G.). This work was also supported by Cornell Belfer Family startup funds (to J.M.S.).; Supported in part by Department of Defense Predoctoral Award W81XWH-08-1-0317.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Atkinson SP, 2008, STEM CELLS, V26, P1174, DOI 10.1634/stemcells.2007-0497; Barrow JR, 2000, DEVELOPMENT, V127, P933; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dupe V, 1997, DEVELOPMENT, V124, P399; FRASCH M, 1995, DEVELOPMENT, V121, P957; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Ghyselinck NB, 1997, INT J DEV BIOL, V41, P425; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang D, 1998, DEVELOPMENT, V125, P3235; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Oosterveen T, 2003, J BIOL CHEM, V278, P24103, DOI 10.1074/jbc.M300774200; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pfeifer GP, 2009, SEMIN CANCER BIOL, V19, P181, DOI 10.1016/j.semcancer.2009.02.008; POPPERL H, 1993, MOL CELL BIOL, V13, P257; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roelen BAJ, 2002, MECH DEVELOP, V119, P81, DOI 10.1016/S0925-4773(02)00329-5; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Studer M, 1998, DEVELOPMENT, V125, P1025; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Thompson JR, 1998, DEV DYNAM, V211, P97, DOI 10.1002/(SICI)1097-0177(199801)211:1<97::AID-AJA9>3.3.CO;2-M; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; ZHANG MB, 1994, DEVELOPMENT, V120, P2431; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	94	75	76	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3250	3260		10.1074/jbc.M110.157545	http://dx.doi.org/10.1074/jbc.M110.157545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21087926	Green Published, hybrid			2022-12-27	WOS:000286653200010
J	Ma, YJ; Doni, A; Skjoedt, MO; Honore, C; Arendrup, M; Mantovani, A; Garred, P				Ma, Ying Jie; Doni, Andrea; Skjoedt, Mikkel-Ole; Honore, Christian; Arendrup, Maiken; Mantovani, Alberto; Garred, Peter			Heterocomplexes of Mannose-binding Lectin and the Pentraxins PTX3 or Serum Amyloid P Component Trigger Cross-activation of the Complement System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNITY; INVASIVE CANDIDIASIS; A-CHAIN; RECOGNITION; PATHWAY; FICOLIN-2; BACTERIA; DISEASE; HEAD	The long pentraxin 3 (PTX3), serum amyloid P component (SAP), and C-reactive protein belong to the pentraxin family of pattern recognition molecules involved in tissue homeostasis and innate immunity. They interact with C1q from the classical complement pathway. Whether this also occurs via the analogous mannose-binding lectin (MBL) from the lectin complement pathway is unknown. Thus, we investigated the possible interaction between MBL and the pentraxins. We report that MBL bound PTX3 and SAP partly via its collagen-like domain but not C-reactive protein. MBL-PTX3 complex formation resulted in recruitment of C1q, but this was not seen for the MBL-SAP complex. However, both MBL-PTX3 and MBL-SAP complexes enhanced C4 and C3 deposition and opsonophagocytosis of Candida albicans by polymorphonuclear leukocytes. Interaction between MBL and PTX3 led to communication between the lectin and classical complement pathways via recruitment of C1q, whereas SAP-enhanced complement activation occurs via a hitherto unknown mechanism. Taken together, MBL-pentraxin heterocomplexes trigger cross-activation of the complement system.	[Ma, Ying Jie; Skjoedt, Mikkel-Ole; Honore, Christian; Garred, Peter] Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark; [Doni, Andrea; Mantovani, Alberto] Ist Ricovero & Cura Carattere Sci, Ist Clin Humanitas, Lab Immunol & Inflammat, I-20089 Milan, Italy; [Arendrup, Maiken] Statens Serum Inst, Unit Mycol, DK-2300 Copenhagen, Denmark; [Mantovani, Alberto] Univ Milan, Dept Translat Med, I-20089 Milan, Italy	Rigshospitalet; University of Copenhagen; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Humanitas Research Hospital; Statens Serum Institut; University of Milan	Garred, P (corresponding author), Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Jie, Ying/AAJ-4697-2021; Mantovani, Alberto/HCI-7449-2022	Jie, Ying/0000-0003-4003-2579; Mantovani, Alberto/0000-0001-5578-236X; Doni, Andrea/0000-0001-9203-5814; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Honore, Christian/0000-0003-4846-1319; Arendrup, Maiken Cavling/0000-0002-4747-0144; Garred, Peter/0000-0002-2876-8586	Benzon Foundation; Lundbeck foundation; Carlsberg Foundation; Rigshospitalet; Capital Region of Denmark; Novo Nordisk Foundation; European Commission; Telethon; Italian Ministry of Health	Benzon Foundation; Lundbeck foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Rigshospitalet; Capital Region of Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from The Benzon Foundation, The Lundbeck foundation, The Carlsberg Foundation, Rigshospitalet, The Capital Region of Denmark, The Novo Nordisk Foundation, The European Commission (Project Tolerage), Telethon, and the Italian Ministry of Health.	Arendrup MC, 2008, CLIN MICROBIOL INFEC, V14, P487, DOI 10.1111/j.1469-0691.2008.01954.x; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; de Haas CJC, 2000, INFECT IMMUN, V68, P1753, DOI 10.1128/IAI.68.4.1753-1759.2000; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Koneti A, 2008, INFECT IMMUN, V76, P994, DOI 10.1128/IAI.01185-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Tanio M, 2009, MOL IMMUNOL, V47, P215, DOI 10.1016/j.molimm.2009.09.032; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; YING SC, 1993, J IMMUNOL, V150, P169; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	44	95	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3405	3417		10.1074/jbc.M110.190637	http://dx.doi.org/10.1074/jbc.M110.190637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106539	Green Published, hybrid			2022-12-27	WOS:000286653200027
J	Verbruggen, P; Ruf, M; Blakqori, G; Overby, AK; Heidemann, M; Eick, D; Weber, F				Verbruggen, Paul; Ruf, Marius; Blakqori, Gjon; Oeverby, Anna K.; Heidemann, Martin; Eick, Dirk; Weber, Friedemann			Interferon Antagonist NSs of La Crosse Virus Triggers a DNA Damage Response-like Degradation of Transcribing RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN NSS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; RIG-I; GENE-EXPRESSION; TRANSCRIPTIONAL ELONGATION; PROTEASOMAL DEGRADATION; INDUCED UBIQUITINATION; ANTIVIRAL RESPONSES; VIRAL ENCEPHALITIS	La Crosse encephalitis virus (LACV) is a mosquito-borne member of the negative-strand RNA virus family Bunyaviridae. We have previously shown that the virulence factor NSs of LACV is an efficient inhibitor of the antiviral type I interferon system. A recombinant virus unable to express NSs (rLACVdelNSs) strongly induced interferon transcription, whereas the corresponding wt virus (rLACV) suppressed it. Here, we show that interferon induction by rLACVdelNSs mainly occurs through the signaling pathway leading from the pattern recognition receptor RIG-I to the transcription factor IRF-3. NSs expressed by rLACV, however, acts downstream of IRF-3 by specifically blocking RNA polymerase II-dependent transcription. Further investigations revealed that NSs induces proteasomal degradation of the mammalian RNA polymerase II subunit RPB1. NSs thereby selectively targets RPB1 molecules of elongating RNA polymerase II complexes, the so-called IIo form. This phenotype has similarities to the cellular DNA damage response, and NSs was indeed found to transactivate the DNA damage response gene pak6. Moreover, NSs expressed by rLACV boosted serine 139 phosphorylation of histone H2A. X, one of the earliest cellular reactions to damaged DNA. However, other DNA damage response markers such as up-regulation and serine 15 phosphorylation of p53 or serine 1524 phosphorylation of BRCA1 were not triggered by LACV infection. Collectively, our data indicate that the strong suppression of interferon induction by LACV NSs is based on a shutdown of RNA polymerase II transcription and that NSs achieves this by exploiting parts of the cellular DNA damage response pathway to degrade IIo-borne RPB1 subunits.	[Weber, Friedemann] Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [Verbruggen, Paul; Ruf, Marius; Blakqori, Gjon; Oeverby, Anna K.; Weber, Friedemann] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-79008 Freiburg, Germany; [Heidemann, Martin; Eick, Dirk] Ctr Integrated Prot Sci, Helmholtz Ctr Environm Hlth, Dept Mol Epigenet, D-81377 Munich, Germany	Philipps University Marburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Weber, F (corresponding author), Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	friedemann.weber@staff.uni-marburg.de	Weber, Friedemann/AAB-3425-2019	Weber, Friedemann/0000-0001-9737-337X	 [We2616/2-3];  [SFB 593];  [SFB-Transregio5]	; ; 	This work was supported by Grants We2616/2-3 and SFB 593 (to F. W.) and SFB-Transregio5 (to D.E.).	Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; *CDCP, 2005, CONF PROB CAL SER VI; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Clement JQ, 1999, RNA, V5, P206, DOI 10.1017/S1355838299981190; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Heine GF, 2008, J BIOL CHEM, V283, P9555, DOI 10.1074/jbc.M707700200; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KOLAKOFSKY D, 1987, COLD SPRING HARB SYM, V52, P373, DOI 10.1101/SQB.1987.052.01.043; KONTERMANN RE, 1995, BIOL CHEM H-S, V376, P473, DOI 10.1515/bchm3.1995.376.8.473; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Leonard VHJ, 2006, J VIROL, V80, P9667, DOI 10.1128/JVI.00822-06; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; RAJU R, 1988, J VIROL, V62, P27, DOI 10.1128/JVI.62.1.27-32.1988; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Rodriguez A, 2009, J VIROL, V83, P11166, DOI 10.1128/JVI.01439-09; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Thomas D, 2004, J BIOL CHEM, V279, P31471, DOI 10.1074/jbc.M400938200; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114	81	65	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3681	3692		10.1074/jbc.M110.154799	http://dx.doi.org/10.1074/jbc.M110.154799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118815	Green Published, hybrid			2022-12-27	WOS:000286653200051
J	Leung, CCY; Gong, ZH; Chen, JJ; Glover, JNM				Leung, Charles Chung Yun; Gong, Zihua; Chen, Junjie; Glover, J. N. Mark			Molecular Basis of BACH1/FANCJ Recognition by TopBP1 in DNA Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSERINE/THREONINE-BINDING DOMAINS; C-TERMINAL DOMAINS; BRCT DOMAINS; STRUCTURAL BASIS; FANCONI-ANEMIA; PHOSPHOPEPTIDE RECOGNITION; CONFORMATIONAL-CHANGE; BACH1 PHOSPHOPEPTIDE; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE	The diverse roles of TopBP1 in DNA replication and checkpoint signaling are associated with the scaffolding ability of TopBP1 to initiate various protein-protein interactions. The recognition of the BACH1/FANCJ helicase by TopBP1 is critical for the activation of the DNA replication checkpoint at stalled replication forks and is facilitated by the C-terminal tandem BRCT7/8 domains of TopBP1 and a phosphorylated Thr(1133) binding motif in BACH1. Here we provide the structural basis for this interaction through analysis of the x-ray crystal structures of TopBP1 BRCT7/8 both free and in complex with a BACH1 phospho-peptide. In contrast to canonical BRCT-phospho-peptide recognition, TopBP1 BRCT7/8 undergoes a dramatic conformational change upon BACH1 binding such that the two BRCT repeats pivot about the central BRCT-BRCT interface to provide an extensive and deep peptide-binding cleft. Additionally, we provide the first structural mechanism for Thr(P) recognition among BRCT domains. Together with systematic mutagenesis studies, we highlight the role of key contacts in governing the unique specificity of the TopBP1-BACH1 interaction.	[Leung, Charles Chung Yun; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Gong, Zihua; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Alberta; University of Texas System; UTMD Anderson Cancer Center	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Classen, Scott/AAY-8176-2020		National Institutes of Health [CA92584, CA089239]; Canadian Cancer Society; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92584 (to J. N. M. G.) and CA089239 (to J. C.). This work was also supported by grants from the Canadian Cancer Society and the Howard Hughes Medical Institute International Scholar program (to J. N. M. G.).	Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burrows AE, 2008, GENE DEV, V22, P1416, DOI 10.1101/gad.1685108; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cescutti R, 2010, EMBO J, V29, P3723, DOI 10.1038/emboj.2010.238; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huo YG, 2010, BIOCHEM BIOPH RES CO, V401, P401, DOI 10.1016/j.bbrc.2010.09.066; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Leung CCY, 2010, PROTEIN SCI, V19, P162, DOI 10.1002/pro.290; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nomine Y, 2008, BIOCHEMISTRY-US, V47, P9866, DOI 10.1021/bi702247d; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; RAPPAS M, 2010, NUCL ACIDS IN PRESS; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wollmann Y, 2007, J CELL BIOCHEM, V102, P171, DOI 10.1002/jcb.21292; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	70	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4292	4301		10.1074/jbc.M110.189555	http://dx.doi.org/10.1074/jbc.M110.189555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127055	Green Published, hybrid			2022-12-27	WOS:000286975700028
J	Shi, ZC; Cai, ZY; Sanchez, A; Zhang, TT; Wen, S; Wang, J; Yang, JH; Fu, SB; Zhang, DK				Shi, Zhongcheng; Cai, Zhenyu; Sanchez, Amir; Zhang, Tingting; Wen, Shu; Wang, Jun; Yang, Jianhua; Fu, Songbin; Zhang, Dekai			A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; PATTERN-RECOGNITION; ANTIVIRAL RESPONSE; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; STRANDED-RNA; RIG-I; ACTIVATION; PROTEIN; INFECTION	Toll-like receptors (TLRs) are the key molecular sensors used by the mammalian innate immune system to detect various types of pathogens. Tlr13 is a novel and uncharacterized member of the mammalian TLR family. Here we report the cloning and characterization of tlr13. Tlr13 is predominantly expressed in the spleen, particularly in dendritic cells and macrophages. Tlr13 appears to activate a MyD88- and TAK1-dependent TLR signaling pathway, inducing the activation of NF-kappa B. This receptor can also activate type 1 interferon through IRF7. Furthermore, Tlr13 seems to be another intracellular TLR. Remarkably, cells expressing tlr13 fail to respond to known TLR ligands but instead respond specifically to vesicular stomatitis virus. Cells with the knockdown of tlr13 are highly susceptible to vesicular stomatitis virus infection. Thus, these results provide an important insight into the potential role of the novel Toll-like receptor tlr13 in the recognition of viral infection.	[Shi, Zhongcheng; Fu, Songbin] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China; [Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Yang, Jianhua] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Harbin Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Texas Children's Cancer Center	Fu, SB (corresponding author), Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China.	fusb@ems.hrbmu.edu.cn; dzhang@ibt.tamhsc.edu			National Institutes of Health [AI085164]; Texas AM University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AM University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI085164 (to D. Z.). This study was also supported by Texas A&M University (to D. Z.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burger-Kentischer A, 2010, J IMMUNOL METHODS, V358, P93, DOI 10.1016/j.jim.2010.03.020; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Shi ZC, 2009, J BIOL CHEM, V284, P20540, DOI 10.1074/jbc.M109.022541; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	30	119	145	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4517	4524		10.1074/jbc.M110.159590	http://dx.doi.org/10.1074/jbc.M110.159590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131352	Green Published, hybrid			2022-12-27	WOS:000286975700052
J	Meen, AJ; Oynebraten, I; Reine, TM; Duelli, A; Svennevig, K; Pejler, G; Jenssen, T; Kolset, SO				Meen, Astri J.; Oynebraten, Inger; Reine, Trine M.; Duelli, Annette; Svennevig, Katja; Pejler, Gunnar; Jenssen, Trond; Kolset, Svein O.			Serglycin Is a Major Proteoglycan in Polarized Human Endothelial Cells and Is Implicated in the Secretion of the Chemokine GRO alpha/CXCL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN UMBILICAL VEIN; CHONDROITIN SULFATE; HEPARAN-SULFATE; MAST-CELL; HEMATOPOIETIC-CELLS; GRANULE INTEGRITY; IN-VITRO; EXPRESSION; ALPHA; STORAGE	Proteoglycan (PG) expression was studied in primary human umbilical vein endothelial cells (HUVEC). RT-PCR analyses showed that the expression of the PG serglycin core protein was much higher than that of the extracellular matrix PG decorin and the cell surface PG syndecan-1. PG biosynthesis was further studied by biosynthetic [S-35] sulfate labeling of polarized HUVEC. Interestingly, a major part of S-35-PGs was secreted to the apical medium. A large portion of these PGs was trypsin-resistant, a typical feature of serglycin. The trypsin-resistant PGs were mainly of the chondroitin/dermatan sulfate type but also contained a minor heparan sulfate component. Secreted serglycin was identified by immunoprecipitation as a PG with a core protein of similar to 30 kDa. Serglycin was furthermore shown to be present in perinuclear regions and in two distinct types of vesicles throughout the cytoplasm using immunocytochemistry. To search for possible serglycin partner molecules, HUVEC were stained for the chemokine growth-related oncogene alpha(GRO alpha/CXCL1). Co-localization with serglycin could be demonstrated, although not in all vesicles. Serglycin did not show overt co-localization with tissue-type plasminogen activator-positive vesicles. When PG biosynthesis was abrogated using benzyl-beta-D-xyloside, serglycin secretion was decreased, and the number of vesicles with co-localized serglycin and GRO alpha was reduced. The level of GRO alpha in the apical medium was also reduced after xyloside treatment. Together, these findings indicate that serglycin is a major PG in human endothelial cells, mainly secreted to the apical medium and implicated in chemokine secretion.	[Oynebraten, Inger] Univ Oslo, Inst Immunol, Rikshosp, N-0424 Oslo, Norway; [Meen, Astri J.; Reine, Trine M.; Svennevig, Katja; Kolset, Svein O.] Univ Oslo, Dept Nutr, N-0316 Oslo, Norway; [Duelli, Annette; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, S-75123 Uppsala, Sweden; [Jenssen, Trond] Natl Hosp Norway, Kidney Sect, Dept Internal Med, Oslo Univ Hosp, N-0027 Oslo, Norway; [Jenssen, Trond] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway	University of Oslo; National Hospital Norway; University of Oslo; Swedish University of Agricultural Sciences; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso	Oynebraten, I (corresponding author), Univ Oslo, Inst Immunol, Rikshosp, Box 4950, N-0424 Oslo, Norway.	inger.oynebraten@rr-research.no; s.o.kolset@medisin.uio.no	Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676	Throne Holst Foundation; Helse Sor-Ost; Norwegian Cancer Society; Swedish Research Council	Throne Holst Foundation; Helse Sor-Ost; Norwegian Cancer Society(Norwegian Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Throne Holst Foundation, Helse Sor-Ost, the Norwegian Cancer Society and the Swedish Research Council.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Braga T, 2009, MOL IMMUNOL, V46, P422, DOI 10.1016/j.molimm.2008.10.019; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Falkowska-Hansen B, 2006, MOL CELL BIOCHEM, V287, P43, DOI 10.1007/s11010-005-9024-3; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; Kolset SO, 1999, J CELL SCI, V112, P1797; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Liu DG, 2001, HISTOCHEM J, V33, P621, DOI 10.1023/A:1016398200087; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Prydz K, 2009, GLYCOCONJUGATE J, V26, P1117, DOI 10.1007/s10719-009-9232-2; Raats CJI, 1999, J AM SOC NEPHROL, V10, P1689; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; Suzuki D, 2002, NEPHRON, V92, P564, DOI 10.1159/000064110; Svennevig K, 2008, PERFUSION-UK, V23, P165, DOI 10.1177/0267659108098215; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; Valiyaveettil M, 2004, MOL BIOCHEM PARASIT, V134, P115, DOI 10.1016/j.molbiopara.2003.11.009; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Yasuo T, 2008, J REPROD IMMUNOL, V78, P1, DOI 10.1016/j.jri.2007.09.002; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2636	2647		10.1074/jbc.M110.151944	http://dx.doi.org/10.1074/jbc.M110.151944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075844	Green Published, hybrid			2022-12-27	WOS:000286464300029
J	Rousselet, E; Benjannet, S; Hamelin, J; Canuel, M; Seidah, NG				Rousselet, Estelle; Benjannet, Suzanne; Hamelin, Josee; Canuel, Maryssa; Seidah, Nabil G.			The Proprotein Convertase PC7 UNIQUE ZYMOGEN ACTIVATION AND TRAFFICKING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; IN-VITRO; PROHORMONE CONVERTASES; ENDOPLASMIC-RETICULUM; FLUOROGENIC PEPTIDES; POTENT INHIBITORS; FURIN; PROTEIN; GLYCOPROTEIN; PROSEGMENT	The zymogen activation mechanism and physiological functions of the most ancient and highly conserved basic amino acid-specific proprotein convertase 7 (PC7) are not known. Herein, we characterized the biosynthesis, subcellular localization, and trafficking of the membrane-bound full-length rat and human PC7. The prosegment of PC7 is primarily secreted alone as a non-inhibitory protein via the conventional, Golgi-dependent, secretory pathway. Mature PC7 is partially sulfated and thus reaches the cell surface via the conventional route. However, a fraction of PC7 reaches the cell surface through a brefeldin A-and COPII-independent unconventional secretory pathway. The latter trafficking may explain the rapid (< 10 min) transit of a fraction of PC7 from the ER to the cell surface. Electron microscopy further confirmed the localization of PC7 to the cell surface of HEK293 cells. Within the cytosolic tail, only two cysteines (Cys(699) and Cys(704)) are palmitoylated, but this modification does not affect the choice of trafficking pathway. Swapping the transmembrane-cytosolic tail (TMCT) sequences of the convertases Furin and PC7 revealed that PC7(TMCT-Furin) is much more sulfated and hence traffics more efficiently through the conventional secretory pathway. In contrast, the Furin(TMCT-PC7) is no longer sulfated and thus reaches the cell surface by the unconventional pathway. Because trafficking of PC7(CT-Furin) and Furin(CT-PC7) resemble their wild type counterparts, we deduce that the transmembrane domain of PC7 regulates the sorting of PC7 toward the unconventional secretory pathway. In conclusion, PC7 is distinct from other proprotein convertases in its zymogen activation, subcellular localization, and trafficking.	[Rousselet, Estelle; Benjannet, Suzanne; Hamelin, Josee; Canuel, Maryssa; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	CIHR [MOP-44363]; Strauss Foundation; Canada Chair [216684]	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by CIHR Grants MOP-44363, a Strauss Foundation grant, and a Canada Chair Grant 216684.	ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Baldwin TA, 2002, J BIOL CHEM, V277, P50333, DOI 10.1074/jbc.M209075200; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bhattacharjya S, 2000, BIOCHEMISTRY-US, V39, P2868, DOI 10.1021/bi9923961; Blais V, 2002, FEBS LETT, V524, P43, DOI 10.1016/S0014-5793(02)02998-8; BOS CR, 1995, J BIOL CHEM, V270, P665, DOI 10.1074/jbc.270.2.665; Canaff L, 1999, ENDOCRINOLOGY, V140, P3633, DOI 10.1210/en.140.8.3633; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Khatib AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011438; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Meerabux J, 1996, CANCER RES, V56, P448; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, BRAIN RES, V848, pA14; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; SEIDAH NG, 2011, ANN NEW YOR IN PRESS; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wouters S, 1999, FEBS LETT, V456, P97, DOI 10.1016/S0014-5793(99)00938-2; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	59	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2728	2738		10.1074/jbc.M110.192344	http://dx.doi.org/10.1074/jbc.M110.192344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075846	Green Published, hybrid			2022-12-27	WOS:000286464300039
J	Zhang, YW; Rudnick, G				Zhang, Yuan-Wei; Rudnick, Gary			Myristoylation of cGMP-dependent Protein Kinase Dictates Isoform Specificity for Serotonin Transporter Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL CHORIOCARCINOMA CELLS; OBSESSIVE-COMPULSIVE DISORDER; CYCLIC-GMP; NITRIC-OXIDE; RAT-BRAIN; IN-VITRO; PHOSPHORYLATION; ACTIVATION; RECEPTORS; STIMULATION	By transporting serotonin (5-HT) into neurons and other cells, serotonin transporter (SERT) modulates the action of 5-HT at cell surface receptors. SERT itself is modulated by several processes, including the cGMP signaling pathway. Activation of SERT by cGMP requires the cGMP-dependent protein kinase (PKG). Here we show that in HeLa cells lacking endogenous PKG, expression of PKGI alpha or PKGI beta was required for 8-bromoguanosine-3',5'-cyclic monophosphate (8-Br-cGMP) to stimulate SERT phosphorylation and 5-HT influx. Catalytically inactive PKG mutants and wild-type PKGII did not support this stimulation. However, a mutant PKGII (G2A) that was not myristoylated substituted for functional PKGI, suggesting that myristoylation and subsequent membrane association blocked productive interaction with SERT. PKG also influenced SERT expression and localization. PKGI isoforms increased total and cell surface SERT levels, and PKGII decreased cell surface SERT without altering total expression. Remarkably, these changes did not require 8-Br-cGMP or functional kinase activity and were also observed with a SERT mutant resistant to activation by PKG. Both PKGI alpha and PKGI beta formed detergent-stable complexes with SERT, and this association did not require catalytic activity. The nonmyr-istoylated PKGII G2A mutant stimulated SERT expression similar to PKGI isoforms. These results suggest multiple mechanisms by which PKG can modulate SERT and demonstrate that the functional difference between PKG isoforms results from myristoylation of PKGII.	[Zhang, Yuan-Wei; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251	National Institutes of Health [DA008213]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA008213 (to G.R.).	Bauman AL, 2000, J NEUROSCI, V20, P7571; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; De Vente J, 2001, NEUROSCIENCE, V108, P27, DOI 10.1016/S0306-4522(01)00401-8; Delorme R, 2005, MOL PSYCHIATR, V10, P1059, DOI 10.1038/sj.mp.4001728; ELHUSSEINI AED, 1995, J NEUROCHEM, V64, P2814; Gambaryan S, 2003, J BIOL CHEM, V278, P29640, DOI 10.1074/jbc.M302143200; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Hoenderop JGJ, 1999, P NATL ACAD SCI USA, V96, P6084, DOI 10.1073/pnas.96.11.6084; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Lincoln T M, 1995, Adv Pharmacol, V34, P305; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; RAMAMOORTHY S, 1993, J BIOL CHEM, V268, P21626; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200; Zhu CB, 2004, EUR J PHARMACOL, V504, P1, DOI 10.1016/j.ejphar.2004.09.023; Zhu CB, 2007, J PHARMACOL EXP THER, V322, P332, DOI 10.1124/jpet.107.121665	38	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2461	2468		10.1074/jbc.M110.203935	http://dx.doi.org/10.1074/jbc.M110.203935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097501	hybrid, Green Published			2022-12-27	WOS:000286464300010
J	Noda, M; Doi, Y; Liang, JF; Kawanokuchi, J; Sonobe, Y; Takeuchi, H; Mizuno, T; Suzumura, A				Noda, Mariko; Doi, Yukiko; Liang, Jianfeng; Kawanokuchi, Jun; Sonobe, Yoshifumi; Takeuchi, Hideyuki; Mizuno, Tetsuya; Suzumura, Akio			Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ACTIVATED MICROGLIA; MOUSE MODEL; RAT-BRAIN; TRANSCRIPTION FACTORS; SOLUBLE FRACTALKINE; CHEMOKINE RECEPTORS; APOPTOTIC NEURONS; UP-REGULATION; IN-VIVO	Glutamate-induced excito-neurotoxicity likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases. Microglial clearance of dying neurons and associated debris is essential to maintain healthy neural networks in the central nervous system. In fact, the functions of microglia are regulated by various signaling molecules that are produced as neurons degenerate. Here, we show that the soluble CX3C chemokine fractalkine (sFKN), which is secreted from neurons that have been damaged by glutamate, promotes microglial phagocytosis of neuronal debris through release of milk fat globule-EGF factor 8, a mediator of apoptotic cell clearance. In addition, sFKN induces the expression of the antioxidant enzyme heme oxygenase-1 (HO-1) in microglia in the absence of neurotoxic molecule production, including NO, TNF, and glutamate. sFKN treatment of primary neuron-microglia co-cultures significantly attenuated glutamate-induced neuronal cell death. Using several specific MAPK inhibitors, we found that sFKN-induced heme oxygenase-1 expression was primarily mediated by activation of JNK and nuclear factor erythroid 2-related factor 2. These results suggest that sFKN secreted from glutamate-damaged neurons provides both phagocytotic and neuroprotective signals.	[Noda, Mariko; Doi, Yukiko; Liang, Jianfeng; Kawanokuchi, Jun; Sonobe, Yoshifumi; Takeuchi, Hideyuki; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Mizuno, T (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	tmizuno@riem.nagoya-u.ac.jp		Noda, Mariko/0000-0002-6066-1359; Takeuchi, Hideyuki/0000-0001-5912-7581	National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; New Energy and Industrial Technology Development Organization (NEDO)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO), a Grant-in-aid for the global COE program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants from the Ministry of Health, Labor and Welfare of Japan, and the New Energy and Industrial Technology Development Organization (NEDO).	Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BOCCHINI V, 1988, INT J DEV NEUROSCI, V6, P525, DOI 10.1016/0736-5748(88)90060-3; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438, DOI 10.1111/paa.1999.111.5.438; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim TS, 2008, NEUROSCI LETT, V436, P196, DOI 10.1016/j.neulet.2008.03.019; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Li QB, 2007, LIFE SCI, V80, P1087, DOI 10.1016/j.lfs.2006.11.043; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Napoli I, 2009, GLIA, V57, P1660, DOI 10.1002/glia.20878; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pappolla MA, 1998, AM J PATHOL, V152, P871; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Surh YJ, 2009, ARCH PHARM RES, V32, P1163, DOI 10.1007/s12272-009-1807-8; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H., 2010, CLIN EXP NEUROIMMUNO, V1, P12, DOI [10.1111/j.1759-1961.2009.00001.x, DOI 10.1111/J.1759-1961.2009.00001.X]; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Yasui Y, 2007, BIOL PHARM BULL, V30, P443, DOI 10.1248/bpb.30.443	49	108	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2308	2319		10.1074/jbc.M110.169839	http://dx.doi.org/10.1074/jbc.M110.169839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071446	hybrid, Green Published			2022-12-27	WOS:000286191500070
J	Robbins, P				Robbins, Phil			Stents, Statins, and Other Dumb Luck	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CHITIN SYNTHASE; O-ANTIGEN; BIOSYNTHESIS; CHLORAMPHENICOL; INTERMEDIATE; YEAST; GENE		Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA	Boston University	Robbins, P (corresponding author), Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.	robbinsp@bu.edu		Robbins, Phillips/0000-0002-5121-1524				BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; GOTTLIEB D, 1956, J BACTERIOL, V72, P153, DOI 10.1128/JB.72.2.153-156.1956; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; MELLADO E, 1995, MOL GEN GENET, V246, P353, DOI 10.1007/BF00288608; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; ROBBINS PW, 1958, J BIOL CHEM, V233, P681; ROBBINS PW, 1962, BIOCHEMISTRY-US, V1, P323, DOI 10.1021/bi00908a020; ROBBINS PW, 1977, CELL, V12, P893, DOI 10.1016/0092-8674(77)90153-2; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; WRIGHT A, 1965, P NATL ACAD SCI USA, V54, P235, DOI 10.1073/pnas.54.1.235; WRIGHT A, 1967, P NATL ACAD SCI USA, V57, P1798, DOI 10.1073/pnas.57.6.1798	12	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1669	1674		10.1074/jbc.X110.205633	http://dx.doi.org/10.1074/jbc.X110.205633			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098482	Green Published, hybrid			2022-12-27	WOS:000286191500006
J	Lalle, M; Curra, C; Ciccarone, F; Pace, T; Cecchetti, S; Fantozzi, L; Ay, B; Breton, CB; Ponzi, M				Lalle, Marco; Curra, Chiara; Ciccarone, Fabio; Pace, Tomasino; Cecchetti, Serena; Fantozzi, Luca; Ay, Bernhard; Breton, Catherine Braun; Ponzi, Marta			Dematin, a Component of the Erythrocyte Membrane Skeleton, Is Internalized by the Malaria Parasite and Associates with Plasmodium 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; DEPENDENT PROTEIN-KINASE; INFECTED ERYTHROCYTES; EXPORTED PROTEINS; HOST ERYTHROCYTE; STREPTOLYSIN-O; GLYCOPHORIN-C; FALCIPARUM; PHOSPHORYLATION; BINDING	The malaria parasite invades the terminally differentiated erythrocytes, where it grows and multiplies surrounded by a parasitophorous vacuole. Plasmodium blood stages translocate newly synthesized proteins outside the parasitophorous vacuole and direct them to various erythrocyte compartments, including the cytoskeleton and the plasma membrane. Here, we show that the remodeling of the host cell directed by the parasite also includes the recruitment of dematin, an actin-binding protein of the erythrocyte membrane skeleton and its repositioning to the parasite. Internalized dematin was found associated with Plasmodium 14-3-3, which belongs to a family of conserved multitask molecules. We also show that, in vitro, the dematin-14-3-3 interaction is strictly dependent on phosphorylation of dematin at Ser(124) and Ser(333), belonging to two 14-3-3 putative binding motifs. This study is the first report showing that a component of the erythrocyte spectrin-based membrane skeleton is recruited by the malaria parasite following erythrocyte infection.	[Lalle, Marco; Curra, Chiara; Ciccarone, Fabio; Pace, Tomasino; Fantozzi, Luca; Ponzi, Marta] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Ay, Bernhard] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Breton, Catherine Braun] Univ Montpellier 2, F-34095 Montpellier, France	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Montpellier	Ponzi, M (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	marta.ponzi@iss.it	CICCARONE, FABIO/K-4225-2016; Lalle, Marco/O-2287-2015; Cecchetti, Serena/N-1061-2015; Ciccarone, Fabio/AAR-9128-2021	Lalle, Marco/0000-0001-5168-2150; Cecchetti, Serena/0000-0002-3601-176X; Ciccarone, Fabio/0000-0002-2425-2240; Ponzi, Marta/0000-0003-0936-3548; Curra, Chiara/0000-0001-7851-1087	European Commission [242095]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the European Commission Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 242095.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Al-Khedery B, 1999, MOL BIOCHEM PARASIT, V102, P117, DOI 10.1016/S0166-6851(99)00090-0; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; BEHARI R, 1994, EXP PARASITOL, V79, P250, DOI 10.1006/expr.1994.1088; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Chishti AH, 1996, BLOOD, V87, P3462, DOI 10.1182/blood.V87.8.3462.bloodjournal8783462; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cortes A, 2004, BLOOD, V104, P2961, DOI 10.1182/blood-2004-06-2136; Dat MHQ, 2000, PARASITE IMMUNOL, V22, P535, DOI 10.1046/j.1365-3024.2000.00333.x; Dhermy D, 2007, CURR OPIN HEMATOL, V14, P198, DOI 10.1097/MOH.0b013e3280d21afd; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOSEY MM, 1976, BIOCHEMISTRY-US, V15, P1561, DOI 10.1021/bi00652a029; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Muro AF, 2000, BLOOD, V95, P3978; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; PLUT DA, 1978, EUR J BIOCHEM, V82, P333, DOI 10.1111/j.1432-1033.1978.tb12027.x; READ LK, 1991, MOL BIOCHEM PARASIT, V45, P109, DOI 10.1016/0166-6851(91)90032-2; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Sudo A, 2008, MOL BIOCHEM PARASIT, V160, P138, DOI 10.1016/j.molbiopara.2008.03.011; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trasarti E, 2007, MOL BIOCHEM PARASIT, V152, P159, DOI 10.1016/j.molbiopara.2006.12.010; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	43	25	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1227	1236		10.1074/jbc.M110.194613	http://dx.doi.org/10.1074/jbc.M110.194613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21084299	Green Published, hybrid			2022-12-27	WOS:000286005000034
J	Nogues, L; Salcedo, A; Mayor, F; Penela, P				Nogues, Laura; Salcedo, Alicia; Mayor, Federico, Jr.; Penela, Petronila			Multiple Scaffolding Functions of beta-Arrestins in the Degradation of G Protein-coupled Receptor Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; ERK ACTIVATION; MDM2; GRKS; UBIQUITINATION; EXPRESSION; ROLES; TRAFFICKING; BETA-ARRESTIN-2; INTERACTOME	G protein-coupled receptor kinase 2 (GRK2) plays a fundamental role in the regulation of G protein-coupled receptors (GPCRs), and changes in GRK2 expression levels can have an important impact on cell functions. GRK2 is known to be degraded by the proteasome pathway. We have shown previously that beta-arrestins participate in enhanced kinase turnover upon GPCR stimulation by facilitating GRK2 phosphorylation by c-Src or by MAPK or by recruiting the Mdm2 E3 ubiquitin ligase to the receptor complex. In this report, we have investigated how such diverse beta-arrestin scaffold functions are integrated to modulate GRK2 degradation. Interestingly, we found that in the absence of GPCR activation, beta-arrestins do not perform an adaptor role for GRK2/Mdm2 association, but rather compete with GRK2 for direct Mdm2 binding to regulate basal kinase turnover. Upon agonist stimulation, beta-arrestins-mediated phosphorylation of GRK2 at serine 670 by MAPK facilitates Mdm2-mediated GRK2 degradation, whereas c-Src-dependent phosphorylation would support the action of an undetermined beta-arrestin-recruited ligase in the absence of GPCR activation. The ability of beta-arrestins to play different scaffold functions would allow coordination of both Mdm2-dependent and-independent processes aimed at the specific modulation of GRK2 turnover in different signaling contexts.	[Penela, Petronila] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid 28049, Spain; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Penela, P (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid 28049, Spain.	ppenela@cbm.uam.es	Mayor, Federico/N-7644-2016	Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Educacion y Ciencia [SAF2008-00552]; Fundacion Mutua Madrilena; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Comunidad de Madrid and Universidad Autonoma de Madrid [CCG08-UAM/BIO-4452]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Comunidad de Madrid and Universidad Autonoma de Madrid	This work was supported by Ministerio de Educacion y Ciencia Grant SAF2008-00552, Fundacion Mutua Madrilena, Fundacion Ramon Areces, the Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III Grant RD06-0014/0037, Comunidad de Madrid Grant S-SAL-0159-2006 (to F.M., Jr.), and Comunidad de Madrid and Universidad Autonoma de Madrid Grant CCG08-UAM/BIO-4452 (to P.P.).	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bezard E, 2005, NEUROBIOL DIS, V18, P323, DOI 10.1016/j.nbd.2004.10.005; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Chen ZG, 2003, CELL SIGNAL, V15, P843, DOI 10.1016/S0898-6568(03)00056-1; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Gu L, 2003, FEBS LETT, V544, P218, DOI 10.1016/S0014-5793(03)00502-7; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Lombardi MS, 2004, STROKE, V35, P981, DOI 10.1161/01.STR.0000121644.82596.7e; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, ENDOCRINOLOGY, V142, P987, DOI 10.1210/en.142.3.987; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2008, EMBO J, V27, P1206, DOI 10.1038/emboj.2008.55; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676	44	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1165	1173		10.1074/jbc.M110.203406	http://dx.doi.org/10.1074/jbc.M110.203406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081496	Green Published, hybrid			2022-12-27	WOS:000286005000027
J	Palmer, MT; Lee, YK; Maynard, CL; Oliver, JR; Bikle, DD; Jetten, AM; Weaver, CT				Palmer, Matthew T.; Lee, Yun Kyung; Maynard, Craig L.; Oliver, James R.; Bikle, Daniel D.; Jetten, Anton M.; Weaver, Casey T.			Lineage-specific Effects of 1,25-Dihydroxyvitamin D-3 on the Development of Effector CD4 T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; ROR-GAMMA; TGF-BETA; IN-VITRO; TRANSCRIPTIONAL REGULATION; INTESTINAL INFLAMMATION; MEDIATED PATHOLOGY; SKIN INFLAMMATION	Vitamin D deficiency is implicated in autoimmune disease. We therefore evaluated the effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25-D-3), the active form of vitamin D, on the development of T helper 1 (Th1), Th17, and Th9 cells, which are implicated in the pathogenesis of different types of autoimmunity. 1,25-D-3 compromised the development of Th17 and Th9 cells, including IL-22-expressing cells while simultaneously increasing the frequency of IL-10-competent cells. Relative to Th17 and Th9 cells, the effects of 1,25-D-3 on Th1 cells were modest, reflecting the significantly reduced levels of the receptor for vitamin D in this lineage. The use of cells deficient in IL-10 or antibodies that block IL-10 signaling abolished the inhibitory effect of 1,25-D-3 on Th9 cells but had no effect on inhibition of Th17 cell frequencies. Thus, the induction of IL-10 in cultures of Th9 cells is an important mechanism by which 1,25-D-3 compromises Th9 development but does not explain inhibition of Th17 cells. A survey of select representatives of the Th17 transcriptome revealed that the levels of mRNA that encode ROR gamma t, IL-17A, IL-17F, IL-23R, and IL-22, were reduced by 1,25-D-3, whereas IL-21 and aryl hydrocarbon receptor mRNA remained unchanged. These data suggest that vitamin D deficiency may promote autoimmunity by favoring the inordinate production of Th17 and Th9 cells at the expense of regulatory IL-10-producing T cells.	[Palmer, Matthew T.; Lee, Yun Kyung; Maynard, Craig L.; Oliver, James R.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Bikle, Daniel D.] Univ Calif San Francisco, Ctr Vet Med, Dept Med, San Francisco, CA 94121 USA; [Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, BBRB 870,845 19th St S, Birmingham, AL 35294 USA.	cweaver@uab.edu	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445; Weaver, Casey/0000-0002-2180-1793	National Institutes of Health [AI035783, AI057956, DK064400]; Crohn's and Colitis Foundation of America;  [AR053458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057956, R21AI035783, R01AI035783, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053458, R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI035783, AI057956, and DK064400 (to C. T. W.) and Postdoctoral Training Grant AR053458. This work was also supported by a Crohn's and Colitis Foundation of America fellowship (to M. T. P.).	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Ehrchen J, 2007, FASEB J, V21, P3208, DOI 10.1096/fj.06-7261com; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; FOURNIER C, 1990, CLIN IMMUNOL IMMUNOP, V54, P53, DOI 10.1016/0090-1229(90)90005-B; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOSOMI J, 1983, ENDOCRINOLOGY, V113, P1950, DOI 10.1210/endo-113-6-1950; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim WC, 2005, NAT CLIN PRACT GASTR, V2, P308, DOI 10.1038/ncpgasthep0215; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MATHIEU C, 1992, DIABETES, V41, P1491, DOI 10.2337/diabetes.41.11.1491; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meyer T, 2000, P NATL ACAD SCI USA, V97, P9197, DOI 10.1073/pnas.150246097; Moan J, 2008, P NATL ACAD SCI USA, V105, P668, DOI 10.1073/pnas.0710615105; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; NIEVES J, 1994, NEUROLOGY, V44, P1687, DOI 10.1212/WNL.44.9.1687; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vidal M, 2002, MOL CELL BIOL, V22, P2777, DOI 10.1128/MCB.22.8.2777-2787.2002; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	63	160	172	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					997	1004		10.1074/jbc.M110.163790	http://dx.doi.org/10.1074/jbc.M110.163790			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047796	Green Published, hybrid			2022-12-27	WOS:000286005000010
J	Tasseva, G; Cole, L; Vance, JE				Tasseva, Guergana; Cole, Laura; Vance, Jean E.			N-Myc and SP Regulate Phosphatidylserine Synthase-1 Expression in Brain and Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; HAMSTER OVARY CELLS; LOOP-HELIX PROTEINS; TRANSCRIPTIONAL ENHANCER FACTOR-4; DNA-BINDING PROTEINS; C-MYC; CYCLE PROGRESSION; GENE-EXPRESSION; NERVOUS-SYSTEM; LIPID RELEASE	Phosphatidylserine (PS) is an essential constituent of biological membranes and plays critical roles in apoptosis and cell signaling. Because no information was available on transcriptional mechanisms that regulate PS biosynthesis in mammalian cells, we investigated the regulation of expression of the mouse PS synthase-1 (Pss1) gene. The Pss1 core promoter was characterized in vitro and in vivo through gel shift and chromatin immunoprecipitation assays. Transcription factor-binding sites, such as a GC-box cluster that binds Sp1/Sp3/Sp4 and N-Myc, and a degenerate E-box motif that interacts with Tal1 and E47, were identified. Pss1 transactivation was higher in brain of neonatal mice than in other tissues, consistent with brain being a major site of expression of Pss1 mRNA and PSS1 activity. Enzymatic assays revealed that PSS1 activity is enriched in primary cortical astrocytes compared with primary cortical neurons. Site-directed mutagenesis of binding sites within the Pss1 promoter demonstrated that Sp and N-Myc synergistically activate Pss1 expression in astrocytes. Chromatin immunoprecipitation indicated that Sp1, Sp3, and Sp4 interact with a common DNA binding site on the promoter. Reduction in levels of Sp1, Sp3, or N-Myc proteins by RNA interference decreased promoter activity. In addition, disruption of Sp/DNA binding with mithramycin significantly reduced Pss1 expression and PSS1 enzymatic activity, underscoring the essential contribution of Sp factors in regulating PSS1 activity. These studies provide the first analysis of mechanisms that regulate expression of a mammalian Pss gene in brain.	[Tasseva, Guergana; Cole, Laura; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Tasseva, Guergana; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Cole, Laura] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research.	Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Bradley CK, 2006, EUR J NEUROSCI, V23, P1677, DOI 10.1111/j.1460-9568.2006.04712.x; Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200; CHENG JT, 1993, ONCOGENE, V8, P677; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; DiNapoli MR, 1997, J IMMUNOL, V158, P1810; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gagne J, 1996, BRAIN RES, V740, P337, DOI 10.1016/S0006-8993(96)00897-9; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Goracci G, 1976, Adv Exp Med Biol, V72, P123; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; Hubscher H. G., 1959, BIOCHIM BIOPHYS ACTA, V36, P518; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; KANFER JN, 1988, FEBS LETT, V240, P101, DOI 10.1016/0014-5793(88)80347-8; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; KUGE O, 1991, J BIOL CHEM, V266, P24184; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Le Goff W, 2003, J LIPID RES, V44, P1322, DOI 10.1194/jlr.M200425-JLR200; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Mozzi R, 2003, NEUROCHEM RES, V28, P195, DOI 10.1023/A:1022412831330; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Parisi F, 2007, NUCLEIC ACIDS RES, V35, P1098, DOI 10.1093/nar/gkl1157; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 1999, BIOCHEM J, V342, P57, DOI 10.1042/0264-6021:3420057; Stone SJ, 1998, J BIOL CHEM, V273, P7293, DOI 10.1074/jbc.273.13.7293; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; Sugimoto H, 2005, J BIOL CHEM, V280, P40857, DOI 10.1074/jbc.M503578200; Sugimoto H, 2003, J BIOL CHEM, V278, P19716, DOI 10.1074/jbc.M301590200; Sugimoto H, 2001, J BIOL CHEM, V276, P12338, DOI 10.1074/jbc.M100090200; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Van Eekelen JAM, 2003, NEUROSCIENCE, V122, P421, DOI 10.1016/S0306-4522(03)00571-2; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WATADA H, 1995, GENE, V153, P255, DOI 10.1016/0378-1119(94)00765-K; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhu L, 2009, GENE, V447, P51, DOI 10.1016/j.gene.2009.07.014; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	82	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1061	1073		10.1074/jbc.M110.158709	http://dx.doi.org/10.1074/jbc.M110.158709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068393	hybrid, Green Published			2022-12-27	WOS:000286005000017
J	Kurasin, M; Valjamae, P				Kurasin, Mihhail; Vaeljamaee, Priit			Processivity of Cellobiohydrolases Is Limited by the Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; SERRATIA-MARCESCENS; HUMICOLA-INSOLENS; PHANEROCHAETE-CHRYSOSPORIUM; 1.9-ANGSTROM RESOLUTION; CRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; AROMATIC RESIDUES; STRUCTURAL BASIS; BINDING DOMAIN	Processive cellobiohydrolases (CBHs) are the key components of fungal cellulase systems. Despite the wealth of structural data confirming the processive mode of action, little quantitative information on the processivity of CBHs is available. Here, we developed a method for measuring cellulase processivity. Sensitive fluorescence detection of enzyme-generated insoluble reducing groups on cellulose after labeling with diaminopyridine enabled quantification of the number of reducing-end exo-mode and endo-mode initiations. Both CBHs TrCel7A from Trichoderma reesei and PcCel7D from Phanerochaete chrysosporium employed reducing-end exo- and endo-mode initiation in parallel. Processivity values measured for TrCel7A and PcCel7D on cellulose hydrolysis were more than an order of magnitude lower than the values of intrinsic processivity that were found from the ratio of catalytic constant (k(cat)) and dissociation rate constant (k(off)). We propose that the length of the obstacle-free path available for a processive run on cellulose chain limits the processivity of CBHs on cellulose. TrCel7A and PcCel7D differed in their k(off) values, whereas the k(cat) values were similar. Furthermore, the k(off) values for endoglucanases (EGs) were much higher than the k(off) values for CBHs, whereas the k(cat) values for EGs and CBHs were within the same order of magnitude. These results suggest that the value of k(off) may be the primary target for the selection of cellulases.	[Kurasin, Mihhail; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51014 Tartu, Estonia	University of Tartu	Valjamae, P (corresponding author), Vanemuise 46-138, EE-51014 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	European Commission [213139]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (FP7/2007-2013, Grant 213139).	ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Armand S, 1997, J BIOL CHEM, V272, P2709, DOI 10.1074/jbc.272.5.2709; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; HAKANSSON U, 1978, BIOCHIM BIOPHYS ACTA, V524, P385; HENRISSAT B, 1998, CELLULOSE COMMUN, V5, P84; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; HOSHINO E, 1993, J BIOCHEM-TOKYO, V114, P230, DOI 10.1093/oxfordjournals.jbchem.a124159; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Lemoine M, 2009, BIOCHEM J, V419, P545, DOI 10.1042/BJ20080619; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Nutt A, 1998, EUR J BIOCHEM, V258, P200, DOI 10.1046/j.1432-1327.1998.2580200.x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varrot A, 1999, BIOCHEMISTRY-US, V38, P8884, DOI 10.1021/bi9903998; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	55	193	197	4	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					169	177		10.1074/jbc.M110.161059	http://dx.doi.org/10.1074/jbc.M110.161059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051539	hybrid, Green Published			2022-12-27	WOS:000285782800018
J	Ouyang, JY; Parakhia, RA; Ochs, RS				Ouyang, Jiangyong; Parakhia, Rahulkumar A.; Ochs, Raymond S.			Metformin Activates AMP Kinase through Inhibition of AMP Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; GLYCOGEN-SYNTHESIS; COMPLEX I; INSULIN; LKB1; METABOLISM; TRANSPORT; PHOSPHORYLATION	The mechanism for how metformin activates AMPK (AMP-activated kinase) was investigated in isolated skeletal muscle L6 cells. A widely held notion is that inhibition of the mitochondrial respiratory chain is central to the mechanism. We also considered other proposals for metformin action. As metabolic pathway markers, we focused on glucose transport and fatty acid oxidation. We also confirmed metformin actions on other metabolic processes in L6 cells. Metformin stimulated both glucose transport and fatty acid oxidation. The mitochondrial Complex I inhibitor rotenone also stimulated glucose transport but it inhibited fatty acid oxidation, independently of metformin. The peroxynitrite generator 3-morpholinosydnonimine stimulated glucose transport, but inhibited fatty acid oxidation. Addition of the nitric oxide precursor arginine to cells did not affect glucose transport. These studies differentiate metformin from inhibition of mitochondrial respiration and from active nitrogen species. Knockdown of adenylate kinase also failed to affect metformin stimulation of glucose transport. Hence, any means of increase in ADP appears not to be involved in the metformin mechanism. Knockdown of LKB1, an upstream kinase and AMPK activator, did not affect metformin action. Having ruled out existing proposals, we suggest a new one: metformin might increase AMP through inhibition of AMP deaminase (AMPD). We found that metformin inhibited purified AMP deaminase activity. Furthermore, a known inhibitor of AMPD stimulated glucose uptake and fatty acid oxidation. Both metformin and the AMPD inhibitor suppressed ammonia accumulation by the cells. Knockdown of AMPD obviated metformin stimulation of glucose transport. We conclude that AMPD inhibition is the mechanism of metformin action.	[Parakhia, Rahulkumar A.; Ochs, Raymond S.] St Johns Univ, Dept Pharmaceut Sci, Sch Pharm, Queens, NY 11439 USA; [Ouyang, Jiangyong] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA	Saint John's University; New York University	Ochs, RS (corresponding author), St Johns Univ, Dept Pharmaceut Sci, Sch Pharm, Queens, NY 11439 USA.	ochsr@stjohns.edu	Nili, Mona/P-5570-2016					ASHBY B, 1978, J BIOL CHEM, V253, P8728; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bertrand L., 2006, AM J PHYSL HEART CIR; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Borkowski T, 2008, NUCLEOS NUCLEOT NUCL, V27, P867, DOI 10.1080/15257770802146536; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; CUENDET GS, 1976, J CLIN INVEST, V58, P1078, DOI 10.1172/JCI108559; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Erion MD, 1999, J AM CHEM SOC, V121, P308, DOI 10.1021/ja983153j; Fediuc S, 2008, J CELL PHYSIOL, V215, P392, DOI 10.1002/jcp.21321; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Halimi S, 2006, DIABETES METAB, V32, P555, DOI 10.1016/S1262-3636(07)70309-9; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; Hanisch F, 2008, J NEUROL, V255, P318, DOI 10.1007/s00415-008-0530-6; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hoek JB, 2006, GASTROENTEROLOGY, V131, P974, DOI 10.1053/j.gastro.2006.07.033; IBSEN KH, 1961, CANCER RES, V21, P829; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2004, DIABETES, V53, pA63; Kalsi KK, 2003, CARDIOVASC RES, V59, P678, DOI 10.1016/S0008-6363(03)00497-8; Kang J, 2001, AM J PHYSIOL-ENDOC M, V280, pE428, DOI 10.1152/ajpendo.2001.280.3.E428; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kotel'nikova AV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P816, DOI 10.1023/A:1010229216652; KUN E, 1966, MOL PHARMACOL, V2, P481; Lee W. J., 2009, KOREAN DIABETES J, V33, P198, DOI DOI 10.4093/KDJ.2009.33.3.198; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; LOWENSTEIN JM, 1990, INT J SPORTS MED, V11, pS37, DOI 10.1055/s-2007-1024853; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parakhia RA, 2009, FASEB J, V23; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Schimmack G, 2006, DIABETES OBES METAB, V8, P591, DOI 10.1111/j.1463-1326.2005.00561.x; Segu VBG, 1998, METABOLISM, V47, P824, DOI 10.1016/S0026-0495(98)90120-2; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SMILEY KL, 1967, J BIOL CHEM, V242, P2502; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Wingertzahn MA, 1999, P SOC EXP BIOL MED, V221, P234, DOI 10.1046/j.1525-1373.1999.d01-81.x; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	62	160	181	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					1	11		10.1074/jbc.M110.121806	http://dx.doi.org/10.1074/jbc.M110.121806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059655	Green Published, hybrid			2022-12-27	WOS:000285782800001
J	Wang, SS; Zheng, YX				Wang, Shusheng; Zheng, Yixian			Identification of a Novel Dynein Binding Domain in Nudel Essential for Spindle Pole Organization in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; LIS1; PROTEIN; COMPLEX; BEHAVIOR; MITOSIS	The nuclear distribution protein E (NudE) and nuclear distribution protein E-like (Nudel or Ndel1) interact with both lissencephaly 1 (Lis1) and dynein. These interactions are thought to be essential for dynein function. Previous studies have shown that the highly conserved N terminus of NudE/Nudel directly binds to Lis1, and such binding is critical for dynein activity. By contrast, although the C terminus of NudE/Nudel was reported to bind to dynein, the functional significance of this binding has remained unclear. Using the sperm-mediated spindle assembly assay in Xenopus egg extracts and extensive mutagenesis studies, we have identified a highly conserved dynein binding domain within the first 80 amino acids of Nudel. We further demonstrate that the dynein intermediate chain in the dynein complex is directly involved in this interaction. Importantly, we show that both the dynein and Lis1 binding domains of Nudel are required for spindle pole organization. Finally, we report that spindle defects caused by immuno-depletion of Nudel could be rescued by a 1-fold increase of Lis1 concentration in Xenopus egg extracts. This suggests that an important function of the N terminus of Nudel is to facilitate the interaction between Lis1 and dynein during spindle assembly. Together, our findings open up new avenues to further decipher the mechanism of dynein regulation by Nudel and Lis1.	Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Zheng, YX (corresponding author), 3520 San Martin Dr, Baltimore, MD 21218 USA.	zheng@ciwemb.edu			National Institutes of Health [GM56312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56312.	Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Ma LW, 2009, ADV ENG MATER, V11, pB267, DOI 10.1002/adem.200900149; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771	24	37	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					587	593		10.1074/jbc.M110.181578	http://dx.doi.org/10.1074/jbc.M110.181578			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056974	Green Published, hybrid			2022-12-27	WOS:000285782800061
J	Liu, LQ; Parameswaran, S; Liu, J; Kim, S; Wojcik, EJ				Liu, Liqiong; Parameswaran, Sreeja; Liu, Jing; Kim, Sunyoung; Wojcik, Edward J.			Loop 5-directed Compounds Inhibit Chimeric Kinesin-5 Motors IMPLICATIONS FOR CONSERVED ALLOSTERIC MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTROPY-ENTHALPY COMPENSATION; TRITYL-L-CYSTEINE; SMALL-MOLECULE INHIBITOR; SPINDLE PROTEIN KSP; MITOTIC KINESIN; MICROTUBULE-BINDING; ATP HYDROLYSIS; HUMAN EG5; MONASTROL; LIGAND	The human Eg5 (HsEg5) protein is unique in its sensitivity to allosteric agents even among phylogenetic kin. For example, S-trityl-L-cysteine (STC) and monastrol are HsEg5 inhibitors that bind to a surface pocket created by the L5 loop, but neither compound inhibits the Drosophila Kinesin-5 homologue (Klp61F). Herein we ask whether or not drug sensitivity can be designed into Klp61F. Two chimeric Klp61F motor domains were engineered, bacterially expressed, and purified to test this idea. We report that effector binding can elicit a robust allosteric response comparable with HsEg5 in both motor domain chimeras. Furthermore, isothermal titration calorimetry confirms that the Klp61F chimeras have de novo binding affinities for both STC and monastrol. These data show that the mechanism of intramolecular communication between the three ligand binding sites is conserved in the Kinesin-5 family, and reconstitution of a drug binding cassette within the L5 pocket is sufficient to restore allosteric inhibition. However, the two compounds were not equivalent in their allosteric inhibition. This surprising disparity in the response between the chimeras to monastrol and STC suggests that there is more than one allosteric communication network for these effectors.	[Liu, Liqiong; Parameswaran, Sreeja; Liu, Jing; Kim, Sunyoung; Wojcik, Edward J.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wojcik, EJ (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	ewojci@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350, R01GM066328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. J. W.). This work was also supported by a Louisiana Board of Regents grant (to S. K.).	Bharatham K, 2008, J COMPUT AID MOL DES, V22, P925, DOI 10.1007/s10822-008-9229-0; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2004, BIOCHEMISTRY-US, V43, P13072, DOI 10.1021/bi049264e; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Cox CD, 2008, J MED CHEM, V51, P4239, DOI 10.1021/jm800386y; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Fisicaro E, 2004, PHYS CHEM CHEM PHYS, V6, P4156, DOI 10.1039/b404327h; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Gallicchio E, 1998, J AM CHEM SOC, V120, P4526, DOI 10.1021/ja974061h; Garcia-Saez I, 2007, J BIOL CHEM, V282, P9740, DOI 10.1074/jbc.M608883200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lakamper S, 2010, J MOL BIOL, V399, P1, DOI 10.1016/j.jmb.2010.03.009; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lewis JA, 2008, CURR OPIN CHEM BIOL, V12, P269, DOI 10.1016/j.cbpa.2008.02.014; Luo LS, 2004, BIOCHEMISTRY-US, V43, P15258, DOI 10.1021/bi048282t; Luo LS, 2008, J AM CHEM SOC, V130, P7584, DOI 10.1021/ja710889h; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marshall CG, 2009, ARCH BIOCHEM BIOPHYS, V484, P1, DOI 10.1016/j.abb.2009.01.015; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Roecker AJ, 2007, BIOORG MED CHEM LETT, V17, P5677, DOI 10.1016/j.bmcl.2007.07.074; Schiemann K, 2010, BIOORG MED CHEM LETT, V20, P1491, DOI 10.1016/j.bmcl.2010.01.110; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Sheth PR, 2010, BIOCHEMISTRY-US, V49, P8350, DOI 10.1021/bi1005283; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhang B, 2008, BIOCHEM BIOPH RES CO, V372, P565, DOI 10.1016/j.bbrc.2008.05.074; Zhang XY, 2007, J AM CHEM SOC, V129, P3812, DOI 10.1021/ja069098t; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067	58	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6201	6210		10.1074/jbc.M110.154989	http://dx.doi.org/10.1074/jbc.M110.154989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21127071	Green Published, hybrid			2022-12-27	WOS:000287476400029
J	Balla, A; Erdelyi, LS; Soltesz-Katona, E; Balla, T; Varnai, P; Hunyady, L				Balla, Andras; Erdelyi, Laszlo Sandor; Soltesz-Katona, Eszter; Balla, Tamas; Varnai, Peter; Hunyady, Laszlo			Demonstration of Angiotensin II-induced Ras Activation in the trans-Golgi Network and Endoplasmic Reticulum Using Bioluminescence Resonance Energy Transfer-based Biosensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; COUPLED RECEPTOR ENDOCYTOSIS; GTP-BINDING PROTEINS; SMOOTH-MUSCLE-CELLS; SIGNAL-TRANSDUCTION; LIVING CELLS; LIVE CELLS; H-RAS; K-RAS; PLASMA-MEMBRANE	Previous studies have demonstrated that molecules of the Ras signaling pathway are present in intracellular compartments, including early endosomes, the endoplasmic reticulum (ER), and the Golgi, and suggested that mitogens can regulate Ras activity in these endomembranes. In this study, we investigated the effect of angiotensin II (AngII) on intracellular Ras activity in living HEK293 cells expressing angiotensin type 1 receptors (AT(1)-Rs) using newly developed bioluminescence resonance energy transfer biosensors. To investigate the subcellular localization of AngII-induced Ras activation, we targeted our probes to various intracellular compartments, such as the trans-Golgi network (TGN), the ER, and early endosomes. Using these biosensors, we detected AngII-induced Ras activation in the TGN and ER, but not in early endosomes. In cells expressing a cytoplasmic tail deletion AT(1)-R mutant, the AngII-induced response was enhanced, suggesting that receptor internalization and beta-arrestin binding are not required for AngII-induced Ras activation in endomembranes. Although we were able to demonstrate EGF-induced Ras activation in the plasma membrane and TGN, but not in other endomembranes, AG1478, an EGF receptor inhibitor, did not affect the AngII-induced response, suggesting that the latter is independent of EGF receptor transactivation. AngII was unable to stimulate Ras activity in the studied compartments in cells expressing a G protein coupling-deficient AT(1)R mutant ((DRY127)-D-125 to (125)AAY(127)). These data suggest that AngII can stimulate Ras activity in the TGN and ER with a G protein-dependent mechanism, which does not require beta-arrestin-mediated signaling, receptor internalization, and EGF receptor transactivation.	[Balla, Andras; Erdelyi, Laszlo Sandor; Soltesz-Katona, Eszter; Varnai, Peter; Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Balla, Tamas] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA; [Hunyady, Laszlo] Semmelweis Univ, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Hungarian Acad Sci, H-1444 Budapest, Hungary	Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Semmelweis University; Hungarian Academy of Sciences	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	hunyady@eok.sote.hu	Soltész-Katona, Eszter/H-1897-2019	Soltész-Katona, Eszter/0000-0002-9054-740X; Balla, Tamas/0000-0002-9077-3335; Balla, Andras/0000-0002-6450-2793	Hungarian Scientific Research Fund OTKA [NK72661]; Hungarian Ministry of Public Health (ETT) [337/2009]; National Development Agency of Hungary (NFU TAMOP) [4.2.2-08/1/KMR]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Public Health (ETT); National Development Agency of Hungary (NFU TAMOP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by Hungarian Scientific Research Fund (OTKA) Grant NK72661, Hungarian Ministry of Public Health (ETT) Grant 337/2009, and National Development Agency of Hungary (NFU TAMOP) Grant 4.2.2-08/1/KMR.	Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; BALMFORTH AJ, 1995, EUR J PHARM-MOLEC PH, V291, P135, DOI 10.1016/0014-2999(95)90089-6; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2005, METHODS, V37, P138, DOI 10.1016/j.ymeth.2005.05.022; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fukano T, 2007, CELL STRUCT FUNCT, V32, P9, DOI 10.1247/csf.06019; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hunyady L, 1999, J AM SOC NEPHROL, V10, pS47; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Ohtsu H, 2006, HYPERTENSION, V48, P534, DOI 10.1161/01.HYP.0000237975.90870.eb; Olivares-Reyes JA, 2001, J BIOL CHEM, V276, P37761; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Smith RD, 1998, MOL ENDOCRINOL, V12, P634, DOI 10.1210/me.12.5.634; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; Varnai P, 2007, PFLUG ARCH EUR J PHY, V455, P69, DOI 10.1007/s00424-007-0270-y; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5319	5327		10.1074/jbc.M110.176933	http://dx.doi.org/10.1074/jbc.M110.176933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21062747	Green Published, hybrid			2022-12-27	WOS:000287230600040
J	Artz, JD; Wernimont, AK; Dunford, JE; Schapira, M; Dong, AP; Zhao, Y; Lew, J; Russell, RGG; Ebetino, FH; Oppermann, U; Hui, R				Artz, Jennifer D.; Wernimont, Amy K.; Dunford, James E.; Schapira, Matthieu; Dong, Aiping; Zhao, Yong; Lew, Jocelyne; Russell, R. Graham G.; Ebetino, F. Hal; Oppermann, Udo; Hui, Raymond			Molecular Characterization of a Novel Geranylgeranyl Pyrophosphate Synthase from Plasmodium Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; NITROGEN-CONTAINING BISPHOSPHONATES; PRODUCT CHAIN-LENGTH; CRYSTAL-STRUCTURE; IN-VITRO; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; POTENT INHIBITORS; MECHANISM; GROWTH	We present here a study of a eukaryotic trans-prenylsynthase from the malaria pathogen Plasmodium vivax. Based on the results of biochemical assays and contrary to previous indications, this enzyme catalyzes the production of geranylgeranyl pyrophosphate (GGPP) rather than farnesyl pyrophosphate (FPP). Structural analysis shows that the product length is constrained by a hydrophobic cavity formed primarily by a set of residues from the same subunit as the product as well as at least one other from the dimeric partner. Furthermore, Plasmodium GGPP synthase (GGPPS) can bind nitrogen-containing bisphosphonates (N-BPs) strongly with the energetically favorable cooperation of three Mg2+, resulting in inhibition by this class of compounds at IC50 concentrations below 100 nM. In contrast, human and yeast GGPPSs do not accommodate a third magnesium atom in the same manner, resulting in their insusceptibility to N-BPs. This differentiation is in part attributable to a deviation in a conserved motif known as the second aspartate-rich motif: whereas the aspartates at the start and end of the five-residue motif in FFPP synthases and P. vivax GGPPSs both participate in the coordination of the third Mg2+, an asparagine is featured as the last residue in human and yeast GGPPSs, resulting in a different manner of interaction with nitrogen-containing ligands.	[Lew, Jocelyne; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Dunford, James E.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Dunford, James E.; Russell, R. Graham G.; Oppermann, Udo] Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Ebetino, F. Hal] Procter & Gamble Pharmaceut Inc, Mason, OH 45040 USA	University of Toronto; Structural Genomics Consortium; University of Oxford; University of Oxford; University of Toronto; Procter & Gamble	Hui, R (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St,MaRS South Tower, Toronto, ON M5G 1L7, Canada.	raymond.hui@utoronto.ca	Artz, Jennifer/G-5515-2014	Artz, Jennifer/0000-0003-0500-6156; Russell, Robert Graham G/0000-0002-4136-1828; Dunford, James/0000-0002-9932-4042	Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada through Ontario Genomics Institute, GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust [1097737]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through Ontario Genomics Institute, GlaxoSmithKline(Genome CanadaCanada Foundation for InnovationGlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.(Ministry of Research and Innovation, OntarioMerck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Petrus and Augusta Hedlund's Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust (all to the Structural Genomics Consortium, registered charity number 1097737).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Artz JD, 2008, CHEM BIOL, V15, P1296, DOI 10.1016/j.chembiol.2008.10.017; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Chakrabarti D, 1998, MOL BIOCHEM PARASIT, V94, P175, DOI 10.1016/S0166-6851(98)00065-6; Chakrabarti D, 2002, J BIOL CHEM, V277, P42066, DOI 10.1074/jbc.M202860200; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen CKM, 2008, J MED CHEM, V51, P5594, DOI 10.1021/jm800325y; Clastre M, 2007, EXP PARASITOL, V116, P375, DOI 10.1016/j.exppara.2007.02.002; Dunford JE, 2008, J MED CHEM, V51, P2187, DOI 10.1021/jm7015733; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Ghosh S, 2004, J MED CHEM, V47, P175, DOI 10.1021/jm030084x; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Ling Y, 2007, J BIOL CHEM, V282, P30804, DOI 10.1074/jbc.M703178200; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Moreno B, 2001, BIOCHEM BIOPH RES CO, V284, P632, DOI 10.1006/bbrc.2001.5009; Mukkamala D, 2008, J MED CHEM, V51, P7827, DOI 10.1021/jm8009074; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; REED BC, 1975, BIOCHEMISTRY-US, V14, P50, DOI 10.1021/bi00672a009; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Singh AP, 2010, ANTIMICROB AGENTS CH, V54, P2987, DOI 10.1128/AAC.00198-10; Szabo CM, 2002, J MED CHEM, V45, P2185, DOI 10.1021/jm010412y; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011	30	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3315	3322		10.1074/jbc.M109.027235	http://dx.doi.org/10.1074/jbc.M109.027235			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084289	Green Published, hybrid			2022-12-27	WOS:000286653200017
J	Beckman, JD; Chen, CS; Nguyen, J; Thayanithy, V; Subramanian, S; Steer, CJ; Vercellotti, GM				Beckman, Joan D.; Chen, Chunseng; Nguyen, Julia; Thayanithy, Venugopal; Subramanian, Subbaya; Steer, Clifford J.; Vercellotti, Gregory M.			Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REPRESSOR BACH1; SICKLE-CELL-DISEASE; OXIDATIVE STRESS; CARBON-MONOXIDE; MESSENGER-RNAS; MICRORNAS; INFLAMMATION; MICE; DEFICIENCY; INDUCTION	Heme oxygenase-1 (HO-1) enzyme plays a critical role in metabolizing the excess heme generated during hemolysis. Our previous studies suggested that during intravascular hemolysis the expression of HO-1 protein is not sufficient to reduce the oxidative burden of free heme in the vasculature. This led us to hypothesize that a post-translational mechanism of control exists for HO-1 expression. Micro-RNAs (miRNA) affect gene expression by post-transcriptional gene regulation of transcripts. We performed in silico analysis for the human HMOX1-3' untranslated region (3' UTR) and identified candidate miRNA binding sites. Two candidate miRNAs, miR-377 and miR-217, were cloned and co-transfected with a luciferase vector containing the human HMOX1-3'UTR region. The combination of miR-377 and miR-217 produced a 58% reduction in HMOX1-3'UTR luciferase reporter expression compared with controls. The same constructs were then used to assess how overexpression of miR-217 and miR-377 affected HO-1 levels after induction with hemin. Cells transfected with the combination of miR-377 and miR-217 exhibited no change in HMOX1 mRNA levels, but a significant reduction in HMOX1 (HO-1) protein expression and enzyme activity compared with non-transfected hemin-stimulated controls. Transfection with either miR-377 or miR-217 alone did not produce a significant decrease in HO-1 protein expression or enzyme activity. Knockdown of miR-217 and miR-377 in combination leads to up-regulation of HO-1 protein. Exposure to hemin induced a significant reduction in miR-217 expression and a trend toward decreased miR-377 expression in two different cells lines. In summary, these data suggests that the combination of miR-377 and miR-217 help regulate HO-1 protein expression in the presence of hemin.	[Vercellotti, Gregory M.] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Vercellotti, GM (corresponding author), Rm D495 Mayo,MMC 480,420 Delaware St SE, Minneapolis, MN 55455 USA.	verce001@umn.edu	Thayanithy, Venugopal/C-2777-2013; Beckman, Joan/V-2579-2019; Beckman, Joan/D-4174-2015	Beckman, Joan/0000-0001-7903-944X; Beckman, Joan/0000-0001-7903-944X; Subramanian, Subbaya/0000-0002-2544-480X	NIA [F30AG030909]; NHLBI [R01 HL67367, P01HL055552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067367, P01HL055552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030909] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F30AG030909 from the NIA (to J. D. B.) and R01 HL67367 and P01HL055552 from the NHLBI (to G. M. V. and R. P. Hebbel).	BALLA G, 1991, LAB INVEST, V64, P648; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Beckman JD, 2009, AM J PHYSIOL-HEART C, V297, pH1243, DOI 10.1152/ajpheart.00327.2009; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hinton A, 2010, STEM CELLS DEV, V19, P797, DOI 10.1089/scd.2009.0224; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x	43	73	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3194	3202		10.1074/jbc.M110.148726	http://dx.doi.org/10.1074/jbc.M110.148726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106538	Green Published, hybrid			2022-12-27	WOS:000286653200003
J	Bocik, WE; Sircar, A; Gray, JJ; Tolman, JR				Bocik, William E.; Sircar, Aroop; Gray, Jeffrey J.; Tolman, Joel R.			Mechanism of Polyubiquitin Chain Recognition by the Human Ubiquitin Conjugating Enzyme Ube2g2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; NMR-SPECTROSCOPY; PROTEIN; BINDING; GP78; PROTEASOME; SITE; CONFORMATIONS; ROSETTADOCK	Ube2g2 is a human ubiquitin conjugating (E2) enzyme involved in the endoplasmic reticulum-associated degradation pathway, which is responsible for the identification and degradation of unfolded and misfolded proteins in the endoplasmic reticulum compartment. The Ube2g2-specific role is the assembly of Lys-48-linked polyubiquitin chains, which constitutes a signal for proteasomal degradation when attached to a substrate protein. NMR chemical shift perturbation and paramagnetic relaxation enhancement approaches were employed to characterize the binding interaction between Ube2g2 and ubiquitin, Lys-48-linked diubiquitin, and Lys-63-linked diubiquitin. Results demonstrate that ubiquitin binds to Ube2g2 with an affinity of 90 mu M in two different orientations that are rotated by 180 degrees in models generated by the RosettaDock modeling suite. The binding of Ube2g2 to Lys-48- and Lys-63-linked diubiquitin is primarily driven by interactions with individual ubiquitin subunits, with a clear preference for the subunit containing the free Lys-48 or Lys-63 side chain (i.e. the distal subunit). This preference is particularly striking in the case of Lys-48-linked diubiquitin, which exhibits an similar to 3-fold difference in affinities between the two ubiquitin subunits. This difference can be attributed to the partial steric occlusion of the subunit whose Lys-48 side chain is involved in the isopeptide linkage. As such, these results suggest that Lys-48-linked polyubiquitin chains may be designed to bind certain proteins like Ube2g2 such that the terminal ubiquitin subunit carrying the reactive Lys-48 side chain can be positioned properly for chain elongation regardless of chain length.	[Bocik, William E.; Gray, Jeffrey J.; Tolman, Joel R.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Bocik, William E.; Gray, Jeffrey J.; Tolman, Joel R.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Gray, JJ (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	jgray@jhu.edu; tolman@jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Bocik, William/0000-0002-0183-7051; Chen, Lu/0000-0002-9580-8576	National Institutes of Health [T32GM008403, GM075310-04S1, GM078221]; UCB SA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075310, R01GM078221, T32GM008403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCB SA(UCB Pharma SA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008403 (to W. E. B.), GM075310-04S1 (to J. R. T.), and GM078221 (to J. J. G.). This work was also supported by UCB SA (to A. S., J. J. G., and J. R. T.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard T.D., 2004, SPARKY 3; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; KALBITZER H, 2007, PROTEIN REV, V5, P189; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lewis LK, 2010, BIOTECHNIQUES, V48, P297, DOI 10.2144/000113387; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	46	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3981	3991		10.1074/jbc.M110.189050	http://dx.doi.org/10.1074/jbc.M110.189050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098018	Green Published, hybrid			2022-12-27	WOS:000286653200078
J	Bajaj, MS; Ogueli, GI; Kumar, Y; Vadivel, K; Lawson, G; Shanker, S; Schmidt, AE; Bajaj, SP				Bajaj, Madhu S.; Ogueli, Godwin I.; Kumar, Yogesh; Vadivel, Kanagasabai; Lawson, Gregory; Shanker, Sreejesh; Schmidt, Amy E.; Bajaj, S. Paul			Engineering Kunitz Domain 1 (KD1) of Human Tissue Factor Pathway Inhibitor-2 to Selectively Inhibit Fibrinolysis PROPERTIES OF KD1-L17R VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PROTEASE-INHIBITOR; PLASMA KALLIKREIN; TRANEXAMIC ACID; CARDIAC-SURGERY; PHAGE DISPLAY; ITERATIVE OPTIMIZATION; HEREDITARY ANGIOEDEMA; PROTEINASE-INHIBITORS; PROTEOLYTIC CLEAVAGE	Tissue factor pathway inhibitor-2 (TFPI-2) inhibits factor XIa, plasma kallikrein, and factor VIIa/tissue factor; accordingly, it has been proposed for use as an anticoagulant. Full-length TFPI-2 or its isolated first Kunitz domain (KD1) also inhibits plasmin; therefore, it has been proposed for use as an antifibrinolytic agent. However, the anticoagulant properties of TFPI-2 or KD1 would diminish its antifibrinolytic function. In this study, structure-based investigations and analysis of the serine protease profiles revealed that coagulation enzymes prefer a hydrophobic residue at the P2' position in their substrates/inhibitors, whereas plasmin prefers a positively charged arginine residue at the corresponding position in its substrates/inhibitors. Based upon this observation, we changed the P2' residue Leu-17 in KD1 to Arg (KD1-L17R) and compared its inhibitory properties with wild-type KD1 (KD1-WT). Both WT and KD1-L17R were expressed in Escherichia coli, folded, and purified to homogeneity. N-terminal sequences and mass spectra confirmed proper expression of KD1-WT and KD1-L17R. Compared with KD1-WT, the KD1-L17R did not inhibit factor XIa, plasma kallikrein, or factor VIIa/tissue factor. Furthermore, KD1-L17R inhibited plasmin with similar to 6-fold increased affinity and effectively prevented plasma clot fibrinolysis induced by tissue plasminogen activator. Similarly, in a mouse liver laceration bleeding model, KD1-L17R was similar to 8-fold more effective than KD1-WT in preventing blood loss. Importantly, in this bleeding model, KD1-L17R was equally or more effective than aprotinin or tranexamic acid, which have been used as antifibrinolytic agents to prevent blood loss during major surgery/trauma. Furthermore, as compared with aprotinin, renal toxicity was not observed with KD1-L17R.	[Bajaj, Madhu S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Ogueli, Godwin I.; Kumar, Yogesh; Vadivel, Kanagasabai; Shanker, Sreejesh; Schmidt, Amy E.; Bajaj, S. Paul] Univ Calif Los Angeles, Orthopaed Hosp, Prot Chem Lab, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Ogueli, Godwin I.; Kumar, Yogesh; Vadivel, Kanagasabai; Shanker, Sreejesh; Schmidt, Amy E.; Bajaj, S. Paul] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Lawson, Gregory] Univ Calif Los Angeles, Div Lab Anim Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bajaj, MS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Pulm & Crit Care Med, Box 951690, Los Angeles, CA 90095 USA.	mbajaj@mednet.ucla.edu; pbajaj@mednet.ucla.edu	KUMAR, YOGESH/GXN-1220-2022	Vadivel, Kanagasabai/0000-0003-3777-9540	National Institutes of Health [R21HL89661, RO1HL36365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036365, R21HL089661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL89661 and RO1HL36365.	Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Beaufort N, 2004, FEBS LETT, V574, P89, DOI 10.1016/j.febslet.2004.08.009; Beierlein W, 2005, ANN THORAC SURG, V79, P741, DOI 10.1016/j.athoracsur.2004.03.072; BEITH JG, 1984, BIOCHEM MEDICA, V32, P287; BOOTH NA, 2006, HEMOSTASIS THROMBOSI, P365; Breuer T, 2009, EUR J CARDIO-THORAC, V35, P167, DOI 10.1016/j.ejcts.2008.09.038; Caballero T, 2006, J ALLERGY CLIN IMMUN, V117, P476, DOI 10.1016/j.jaci.2005.10.045; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Colman R, 2006, HEMOSTASIS THROMBOSI, P107; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; DAVIE EW, 2006, HEMOSTASIS THROMBOSI, P21; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; DENNIS MS, 1995, J BIOL CHEM, V270, P25411, DOI 10.1074/jbc.270.43.25411; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Ebisch IMW, 2007, FERTIL STERIL, V87, P619, DOI 10.1016/j.fertnstert.2006.07.1510; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GROH J, 1993, INFUSIONSTHER TRANSF, V4, P173; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Helland R, 1999, J MOL BIOL, V287, P923, DOI 10.1006/jmbi.1999.2654; Hervio LS, 2000, CHEM BIOL, V7, P443, DOI 10.1016/S1074-5521(00)00125-3; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Immer FF, 2008, HEART SURG FORUM, V11, pE9, DOI 10.1532/HSF98.20071149; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; KISIEL W, 2008, Patent No. 7432238; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lehmann A, 2008, EXPERT OPIN BIOL TH, V8, P1187, DOI [10.1517/14712598.8.8.1187, 10.1517/14712598.8.8.1187 ]; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Markland W, 1996, BIOCHEMISTRY-US, V35, P8058, DOI 10.1021/bi952629y; Markland W, 1996, BIOCHEMISTRY-US, V35, P8045, DOI 10.1021/bi9526286; MCSWEENEY PLH, 1993, FOOD BIOTECHNOL, V7, P143, DOI 10.1080/08905439309549853; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murkin JM, 2010, ANESTH ANALG, V110, P350, DOI 10.1213/ANE.0b013e3181c92b23; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; Ohri SK, 2001, PERFUSION-UK, V16, P199, DOI 10.1177/026765910101600305; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Plow EF, 2004, TRENDS CARDIOVAS MED, V14, P180, DOI 10.1016/j.tcm.2004.04.001; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; Royston D, 2007, EUR J ANAESTH, V24, P6, DOI 10.1017/S0265021506001955; Sambrook J, 2001, MOL CLONING LAB MANU; Samis JA, 2000, BLOOD, V95, P943, DOI 10.1182/blood.V95.3.943.003k34_943_951; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; SPRECHER CA, 1998, Patent No. 5728674; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; TAKAGI T, 1975, BIOCHEMISTRY-US, V14, P940, DOI 10.1021/bi00676a010; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	75	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4329	4340		10.1074/jbc.M110.191163	http://dx.doi.org/10.1074/jbc.M110.191163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115497	Green Published, hybrid			2022-12-27	WOS:000286975700032
J	Shloush, J; Vlassov, JE; Engson, I; Duan, SL; Saridakis, V; Dhe-Paganon, S; Raught, B; Sheng, Y; Arrowsmith, CH				Shloush, Jonathan; Vlassov, John E.; Engson, Ian; Duan, Shili; Saridakis, Vivian; Dhe-Paganon, Sirano; Raught, Brian; Sheng, Yi; Arrowsmith, Cheryl H.			Structural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; EMBRYONIC LETHALITY; TUMOR-SUPPRESSOR; IN-VIVO; MDM2-DEFICIENT MICE; DNA-DAMAGE; COMPLEX; PATHWAY; CANCER; DEGRADATION	The tumor suppressor p53 maintains genome stability and prevents malignant transformation by promoting cell cycle arrest and apoptosis. Both Mdm2 and Pirh2 have been shown to ubiquitylate p53 through their RING domains, thereby targeting p53 for proteasomal degradation. Using structural and functional analyses, here we show that the Pirh2 RING domain differs from the Mdm2 RING domain in its oligomeric state, surface charge distribution, and zinc coordination scheme. Pirh2 also possesses weaker E3 ligase activity toward p53 and directs ubiquitin to different residues on p53. NMR and mutagenesis studies suggest that whereas Pirh2 and Mdm2 share a conserved E2 binding site, the seven C-terminal residues of the Mdm2 RING directly contribute to Mdm2 E3 ligase activity, a feature unique to Mdm2 and absent in the Pirh2 RING domain. This comprehensive analysis of the Pirh2 and Mdm2 RING domains provides structural and mechanistic insight into p53 regulation by its E3 ligases.	[Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Duan, Shili; Raught, Brian; Arrowsmith, Cheryl H.] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sheng, Y (corresponding author), Rm 103 FS,4700 Keele St, Toronto, ON M3J 1P3, Canada.	yisheng@yorku.ca; carrow@uhnres.utoronto.ca		Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Cancer Society; National Cancer Institute of Canada; Canada Research Chairs program; Ontario Ministry of Health and Long Term Care; Leukemia and Lymphoma Society of Canada; Banting Research Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chairs program(Canada Research Chairs); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Leukemia and Lymphoma Society of Canada; Banting Research Foundation	This work was supported by funding from the Canadian Cancer Society, the National Cancer Institute of Canada (to C. H. A.), the Canada Research Chairs program (to C. H. A.), the Ontario Ministry of Health and Long Term Care (to B. R.), the Leukemia and Lymphoma Society of Canada (a postdoctoral fellowship) (to Y. S.), and the Banting Research Foundation (to Y. S.).	BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; Billeter M, 1995, J BIOMOL NMR, V5, P1; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dang JJ, 2002, CANCER RES, V62, P1222; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; LUNA RMD, 1995, NATURE, V378, P203; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2004, CELL CYCLE, V3, P900; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Topisirovic I, 2009, P NATL ACAD SCI USA, V106, P12676, DOI 10.1073/pnas.0900596106; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	63	27	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4796	4808		10.1074/jbc.M110.157669	http://dx.doi.org/10.1074/jbc.M110.157669			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21084285	hybrid, Green Published			2022-12-27	WOS:000286975700077
J	Trikha, P; Sharma, N; Opavsky, R; Reyes, A; Pena, C; Ostrowski, MC; Roussel, MF; Leone, G				Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Ostrowski, Michael C.; Roussel, Martine F.; Leone, Gustavo			E2f1-3 Are Critical for Myeloid Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; CELLULAR PROLIFERATION; S-PHASE; C-MYC; RETINOBLASTOMA GENE; GROWTH ARREST; C/EBP-ALPHA; TRANSCRIPTION; EXPRESSION; CSF-1	Hematopoietic development involves the coordinated activity of differentiation and cell cycle regulators. In current models of mammalian cell cycle control, E2f activators (E2f1, E2f2, and E2f3) are portrayed as the ultimate transcriptional effectors that commit cells to enter and progress through S phase. Using conditional gene knock-out strategies, we show that E2f1-3 are not required for the proliferation of early myeloid progenitors. Rather, these E2fs are critical for cell survival and proliferation at two distinct steps of myeloid development. First, E2f1-3 are required as transcriptional repressors for the survival of CD11b(+) myeloid progenitors, and then they are required as activators for the proliferation of CD11b(+) macrophages. In bone marrow macrophages, we show that E2f1-3 respond to CSF1-Myc mitogenic signals and serve to activate E2f target genes and promote their proliferation. Together, these findings expose dual functions for E2f1-3 at distinct stages of myeloid development in vivo, first as repressors in cell survival and then as activators in cell proliferation. In summary, this work places E2f1-3 in a specific signaling cascade that is critical for myeloid development in vivo.	[Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Coll Med & Publ Hlth, Columbus, OH 43210 USA; [Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Ostrowski, Michael C.] Ohio State Univ, Dept Mol Cellular Biochem, Coll Med & Publ Hlth, Columbus, OH 43210 USA; [Roussel, Martine F.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA; [Roussel, Martine F.] St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Leone, G (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, 12th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	Trikha, Prashant/B-5897-2012; Roussel, Martine F/F-1469-2016; Ostrowski, Michael/H-3108-2011	Roussel, Martine F/0000-0002-1740-8139; Ostrowski, Michael/0000-0003-2948-6297	National Institutes of Health [R01CA85619, R01CA82259, R01HD04470, P01CA097189, R01CA053271, CA71907, CA91765, CA 106196-06]; American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA085619, T32CA106196, P01CA071907, R01CA082259, R01CA053271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA85619, R01CA82259, R01HD04470, and P01CA097189 (to G. L.); R01CA053271 and P01CA097189 (to M. C. O.); and CA71907 and CA91765. This work was also supported by the American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital (to M. F. R.).; Recipient of National Institutes of Health T32 Fellowship CA 106196-06.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Humbert PO, 2000, GENE DEV, V14, P690; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; ROUSSEL MF, 1994, J CELL SCI, P105; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	48	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4783	4795		10.1074/jbc.M110.182733	http://dx.doi.org/10.1074/jbc.M110.182733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115501	hybrid, Green Published			2022-12-27	WOS:000286975700076
J	Whichard, ZL; Motter, AE; Stein, PJ; Corey, SJ				Whichard, Zakary L.; Motter, Adilson E.; Stein, Peter J.; Corey, Seth J.			Slowly Produced MicroRNAs Control Protein Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY-ANALYSIS; TRANSFER-RNA; TRANSLATION; RIBOSOME; EXPRESSION; MECHANISM; TARGETS; BINDING; OUTPUT; MODEL	Proteins are the primary agents of function in biological systems, and their levels are critical control elements, reflecting the interplay between transcription, translation, and protein degradation. Here, we consider the role of microRNAs (miRNAs) in the post-transcriptional regulation of protein synthesis. To determine their impact on protein concentration, we constructed a mechanistic model consisting of four state variables and nine kinetic parameters that account for transcript sequestration and degradation via miRNA-mRNA complex formation. Our dynamical model predicts that, even when present in low copy number, miRNAs can exert potent effects on protein concentration. Sensitivity analysis of the steady-state solution indicates that miRNA synthesis commonly acts to fine-tune protein concentrations. However, the same analysis shows that for a small subset of miRNA-mRNA pairs characterized by slowly produced miRNAs, the miRNA synthesis rate is the dominant control element. Our model equations provide a tool to evaluate the importance of particular miRNAs on their target proteins and promote the development of miRNA-based therapies that target proteins associated with cancer, inflammation, and metabolic disorders.	[Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Childrens Mem Hosp, Dept Pediat, Chicago, IL 60611 USA; [Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Childrens Mem Hosp, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Motter, Adilson E.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Motter, Adilson E.] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University	Corey, SJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Lurie 5-107,303 E Super St, Chicago, IL 60611 USA.	s-corey@northwestern.edu		Motter, Adilson E./0000-0003-1794-4828	National Institutes of Health [R01HL080052, R01CA108922]; National Cancer Institute [1U54CA143869-01]; Children's Memorial Hospital/Northwestern University; J. P. McCarthy Foundation; NATIONAL CANCER INSTITUTE [U54CA143869, R01CA108922] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Memorial Hospital/Northwestern University; J. P. McCarthy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01HL080052 and R01CA108922, National Cancer Institute Grant 1U54CA143869-01, Children's Memorial Hospital/Northwestern University, and a J. P. McCarthy Foundation award (to S. J. C.).	Altuvia S, 2000, P NATL ACAD SCI USA, V97, P9824, DOI 10.1073/pnas.97.18.9824; Altuvia S, 2004, J BACTERIOL, V186, P6679, DOI 10.1128/JB.186.20.6679-6680.2004; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan K., 2000, SENSITIVITY ANAL; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2007, BIOPHYS J, V93, pL52, DOI 10.1529/biophysj.107.118448; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Nissan T, 2008, RNA, V14, P1480, DOI 10.1261/rna.1072808; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; OLOFSSON SO, 1987, AM HEART J, V113, P446, DOI 10.1016/0002-8703(87)90612-0; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Scherer S., 2008, SHORT GUIDE HUMAN GE; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207	36	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4742	4748		10.1074/jbc.M110.166348	http://dx.doi.org/10.1074/jbc.M110.166348			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21051536	Green Published, hybrid			2022-12-27	WOS:000286975700072
J	Ben-Yona, A; Bendahan, A; Kanner, BI				Ben-Yona, Assaf; Bendahan, Annie; Kanner, Baruch I.			A Glutamine Residue Conserved in the Neurotransmitter: Sodium: Symporters Is Essential for the Interaction of Chloride with the GABA Transporter GAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ION-BINDING; SUBTYPE-A; IDENTIFICATION; SITE; PERMEATION	Neurotransmitter: sodium symporters are crucial for efficient synaptic transmission. The transporter GAT-1 mediates electrogenic cotransport of GABA, sodium, and chloride. The presence of chloride enables the transporter to couple the transport of the neurotransmitter to multiple sodium ions, thereby enabling its accumulation against steep concentration gradients. Here we study the functional impact of mutations of the putative chloride-binding residues on transport by GAT-1, with the emphasis on a conserved glutamine residue. In contrast to another putative chloride coordinating residue, Ser331, where mutation to glutamate led to chloride-independent GABA transport, the Q291E mutant was devoid of any transport activity, despite substantial expression at the plasma membrane. Low but significant transport activity was observed with substitution mutants with small side chains such as Q291S/A/G. Remarkably, when these mutations were combined with the S331E mutation, transport was increased significantly, even though the activity of the S331E single mutant was only similar to 25% of that of wild type GAT-1. Transport by these double mutants was largely chloride-independent. Like mutants of other putative chloride coordinating residues, the apparent affinity of the active Gln-291 single mutants for chloride was markedly reduced along with a change their anion selectivity. In addition to the interaction of the transporter with chloride, Gln-291 is also required at an additional step during transport. Electrophysiological analysis of the Q291N and Q291S mutants, expressed in Xenopus laevis oocytes, is consistent with the idea that this additional step is associated with the gating of the transporter.	[Ben-Yona, Assaf; Bendahan, Annie; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission)	This work was supported by grants from the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KANNER BI, 1994, J EXP BIOL, V196, P237; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	31	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2826	2833		10.1074/jbc.M110.149732	http://dx.doi.org/10.1074/jbc.M110.149732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098479	hybrid, Green Published			2022-12-27	WOS:000286464300048
J	Darshi, M; Mendiola, VL; Mackey, MR; Murphy, AN; Koller, A; Perkins, GA; Ellisman, MH; Taylor, SS				Darshi, Manjula; Mendiola, Vincent L.; Mackey, Mason R.; Murphy, Anne N.; Koller, Antonius; Perkins, Guy A.; Ellisman, Mark H.; Taylor, Susan S.			ChChd3, an Inner Mitochondrial Membrane Protein, Is Essential for Maintaining Crista Integrity and Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; COILED-COIL; ELECTRON TOMOGRAPHY; ASSEMBLY PATHWAY; MAMMALIAN-CELLS; OUTER-MEMBRANE; MORPHOLOGY; IMPORT; FUSION	The mitochondrial inner membrane (IM) serves as the site for ATP production by hosting the oxidative phosphorylation complex machinery most notably on the crista membranes. Disruption of the crista structure has been implicated in a variety of cardiovascular and neurodegenerative diseases. Here, we characterize ChChd3, a previously identified PKA substrate of unknown function (Schauble, S., King, C. C., Darshi, M., Koller, A., Shah, K., and Taylor, S. S. (2007) J. Biol. Chem. 282, 14952-14959), and show that it is essential for maintaining crista integrity and mitochondrial function. In the mitochondria, ChChd3 is a peripheral protein of the IM facing the intermembrane space. RNAi knockdown of ChChd3 in HeLa cells resulted in fragmented mitochondria, reduced OPA1 protein levels and impaired fusion, and clustering of the mitochondria around the nucleus along with reduced growth rate. Both the oxygen consumption and glycolytic rates were severely restricted. Ultrastructural analysis of these cells revealed aberrant mitochondrial IM structures with fragmented and tubular cristae or loss of cristae, and reduced crista membrane. Additionally, the crista junction opening diameter was reduced to 50% suggesting remodeling of cristae in the absence of ChChd3. Analysis of the ChChd3-binding proteins revealed that ChChd3 interacts with the IM proteins mitofilin and OPA1, which regulate crista morphology, and the outer membrane protein Sam50, which regulates import and assembly of beta-barrel proteins on the outer membrane. Knockdown of ChChd3 led to almost complete loss of both mitofilin and Sam50 proteins and alterations in several mitochondrial proteins, suggesting that ChChd3 is a scaffolding protein that stabilizes protein complexes involved in maintaining crista architecture and protein import and is thus essential for maintaining mitochondrial structure and function.	[Darshi, Manjula; Koller, Antonius; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Mendiola, Vincent L.; Mackey, Mason R.; Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mendiola, Vincent L.; Mackey, Mason R.; Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Murphy, Anne N.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Leichtag 415, La Jolla, CA 92093 USA.	staylor@ucsd.edu	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902; Mendiola, Vincent Louie/0000-0001-5287-0743; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health [P01 DK54441, P21 RR04050]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 (to S. S. T.) and P21 RR04050 (to M. H. E.).	Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Dreger M, 2005, J PROTEOME RES, V4, P238, DOI 10.1021/pr049870w; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavazis AN, 2009, AM J PHYSIOL-HEART C, V297, pH144, DOI 10.1152/ajpheart.01278.2008; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Odgren PR, 1996, J CELL SCI, V109, P2253; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Perkins GA, 1997, J STRUCT BIOL, V120, P219, DOI 10.1006/jsbi.1997.3920; Perkins GA, 2001, J NEUROSCI RES, V66, P857, DOI 10.1002/jnr.10050; Perkins G, 2009, EXP NEUROL, V218, P183, DOI 10.1016/j.expneurol.2009.05.021; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yamaguchi R, 2009, BBA-BIOENERGETICS, V1787, P963, DOI 10.1016/j.bbabio.2009.02.005; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	52	223	238	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2918	2932		10.1074/jbc.M110.171975	http://dx.doi.org/10.1074/jbc.M110.171975			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081504	Green Published, hybrid			2022-12-27	WOS:000286464300056
J	Merz, A; Long, G; Hiet, MS; Brugger, B; Chlanda, P; Andre, P; Wieland, F; Krijnse-Locker, J; Bartenschlager, R				Merz, Andreas; Long, Gang; Hiet, Marie-Sophie; Bruegger, Britta; Chlanda, Petr; Andre, Patrice; Wieland, Felix; Krijnse-Locker, Jacomine; Bartenschlager, Ralf			Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; LOW-DENSITY; APOLIPOPROTEIN-E; IN-VIVO; REPLICATION; CULTURE; CHOLESTEROL; SECRETION; INFECTION; RECEPTOR	A hallmark of hepatitis C virus (HCV) particles is their association with host cell lipids, most notably lipoprotein components. It is thought that this property accounts for the low density of virus particles and their large heterogeneity. However, the composition of infectious virions and their biochemical and morphological properties are largely unknown. We developed a system in which the envelope glycoprotein E2 was N-terminally tagged with a FLAG epitope. This virus, designated Jc1E2(FLAG), produced infectivity titers to wild type levels and allowed affinity purification of virus particles that were analyzed for their protein and lipid composition. By using mass spectrometry, we found the lipid composition of Jc1E2FLAG particles to resemble the one very low-and low density-lipoprotein with cholesteryl esters accounting for almost half of the total HCV lipids. Thus, HCV particles possess a unique lipid composition that is very distinct from all other viruses analyzed so far and from the human liver cells in which HCV was produced. By electron microscopy (EM), we found purified Jc1E2FLAG particles to be heterogeneous, mostly spherical structures, with an average diameter of about 73 nm. Importantly, the majority of E2-containing particles also contained apoE on their surface as assessed by immuno-EM. Taken together, we describe a rapid and efficient system for the production of large quantities of affinity-purified HCV allowing a comprehensive analysis of the infectious virion, including the determination of its lipid composition.	[Krijnse-Locker, Jacomine; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Bruegger, Britta; Wieland, Felix] Heidelberg Univ, Heidelberg Univ Biochem Ctr, D-69120 Heidelberg, Germany; [Chlanda, Petr] EMBL Heidelberg, Struct Computat Biol Programme, D-69117 Heidelberg, Germany; [Andre, Patrice] Univ Lyon, INSERM, U851, F-69365 Lyon 07, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf_bartenschlager@med.uni-heidelberg.de	Chlanda, Petr/AAK-6368-2021; André, Patrice/M-8139-2014; Locker, Jacomine Krijnse/AAX-1185-2020; Locker, Jacomine Krijnse/E-1009-2016; Bartenschlager, Ralf/L-2582-2015	Chlanda, Petr/0000-0002-7782-2139; André, Patrice/0000-0002-5834-7395; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft Sonderforschungsbereich [638]; Teilprojekt [A5]; European Research Council [233130]; European Union (Marie Curie Training Network EI-HCV) [MRTN-CT-2006-035599 EI-HCV]; Deutsche Forschungsgemeinschaft [SFB TRR83]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG)); Teilprojekt; European Research Council(European Research Council (ERC)European Commission); European Union (Marie Curie Training Network EI-HCV)(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 638, Teilprojekt A5 (to R. B.).; Supported in part by European Research Council Grant 233130.; Supported by a grant from the European Union (Marie Curie Training Network EI-HCV, Contract MRTN-CT-2006-035599 EI-HCV).; Supported by Grant SFB TRR83 from the Deutsche Forschungsgemeinschaft.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; BARTENSCHLAGER R, 2011, TRENDS MICR IN PRESS; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Bruss V, 2004, VIRUS RES, V106, P199, DOI 10.1016/j.virusres.2004.08.016; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; HUI DY, 1981, J BIOL CHEM, V256, P5646; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koivusalo M, 2001, J LIPID RES, V42, P663; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; SATOH O, 1990, J LIPID RES, V31, P1293; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SCHLESINGER HR, 1973, J VIROL, V12, P1028, DOI 10.1128/JVI.12.5.1028-1030.1973; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Takahashi H, 2010, BIOCHEM BIOPH RES CO, V395, P565, DOI 10.1016/j.bbrc.2010.04.081; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038	76	272	283	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3018	3032		10.1074/jbc.M110.175018	http://dx.doi.org/10.1074/jbc.M110.175018			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21056986	Green Published, hybrid			2022-12-27	WOS:000286464300065
J	Tomasiak, TM; Archuleta, TL; Andrell, J; Luna-Chavez, C; Davis, TA; Sarwar, M; Ham, AJ; McDonald, WH; Yankovskaya, V; Stern, HA; Johnston, JN; Maklashina, E; Cecchini, G; Iverson, TM				Tomasiak, Thomas M.; Archuleta, Tara L.; Andrell, Juni; Luna-Chavez, Cesar; Davis, Tyler A.; Sarwar, Maruf; Ham, Amy J.; McDonald, W. Hayes; Yankovskaya, Victoria; Stern, Harry A.; Johnston, Jeffrey N.; Maklashina, Elena; Cecchini, Gary; Iverson, Tina M.			Geometric Restraint Drives On- and Off-pathway Catalysis by the Escherichia coli Menaquinol:Fumarate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA DEHYDROGENASE; AMINO-ACID OXIDASE; FUMARATE REDUCTASE; ACTIVE-SITE; COMPLEX-II; SUCCINATE-DEHYDROGENASE; CRYSTAL-STRUCTURES; 3-NITROPROPIONIC ACID; RESPIRATORY COMPLEX; LIVER MITOCHONDRIA	Complex II superfamily members catalyze the kinetically difficult interconversion of succinate and fumarate. Due to the relative simplicity of complex II substrates and their similarity to other biologically abundant small molecules, substrate specificity presents a challenge in this system. In order to identify determinants for on-pathway catalysis, off-pathway catalysis, and enzyme inhibition, crystal structures of Escherichia coli menaquinol: fumarate reductase (QFR), a complex II superfamily member, were determined bound to the substrate, fumarate, and the inhibitors oxaloacetate, glutarate, and 3-nitropropionate. Optical difference spectroscopy and computational modeling support a model where QFR twists the dicarboxylate, activating it for catalysis. Orientation of the C2-C3 double bond of activated fumarate parallel to the C(4a)-N5 bond of FAD allows orbital overlap between the substrate and the co-factor, priming the substrate for nucleophilic attack. Off-pathway catalysis, such as the conversion of malate to oxaloacetate or the activation of the toxin 3-nitropropionate may occur when inhibitors bind with a similarly activated bond in the same position. Conversely, inhibitors that do not orient an activatable bond in this manner, such as glutarate and citrate, are excluded from catalysis and act as inhibitors of substrate binding. These results support a model where electronic interactions via geometric constraint and orbital steering underlie catalysis by QFR.	[Luna-Chavez, Cesar; Yankovskaya, Victoria; Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Andrell, Juni] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Ham, Amy J.; McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Davis, Tyler A.; Johnston, Jeffrey N.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Johnston, Jeffrey N.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Sarwar, Maruf; Stern, Harry A.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); MRC Laboratory Molecular Biology; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester; University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA.	gary.cecchini@ucsf.edu; tina.iverson@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016; Johnston, Jeff/AAW-1271-2021	McDonald, W. Hayes/0000-0002-3510-426X; Johnston, Jeff/0000-0002-0885-636X	National Institutes of Health (NIH) [GM61606, GM079419, GM084333, P30 ES000267, T32 GM65086]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NIGMS; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Vanderbilt Core Grant in Vision Research [P30EY008126]; Department of Veterans Affairs; Ellison Medical Foundation [AG-NS-0325]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079419, T32GM065086, R01GM084333, R01GM061606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Vanderbilt Core Grant in Vision Research; Department of Veterans Affairs(US Department of Veterans Affairs); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM61606 (to G. C.), GM079419 (to T. M. I.), and GM084333 (to J. N. J.) and a pilot award funded by NIH Grant P30 ES000267 (to T. M. I.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program, and NIGMS, NIH. Use of the LS-CAT beamline at the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. A portion of this work used facilities that were supported by the Vanderbilt Core Grant in Vision Research (P30EY008126). Part of this work is based upon research conducted at the European Synchrotron Radiation Facility. This work was supported by the Department of Veterans Affairs and by Ellison Medical Foundation Grant AG-NS-0325 (to T. M. I.).; Supported by National Institutes of Health Grant T32 GM65086 (Chemistry-Biology Interface training grant).	ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAL MF, 1993, J NEUROSCI, V13, P4181; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; Benson TE, 1997, BIOCHEMISTRY-US, V36, P806, DOI 10.1021/bi962221g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH MT, 1951, J BIOL CHEM, V188, P685; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; COLES CJ, 1979, J BIOL CHEM, V254, P5161; DAFFORN A, 1971, P NATL ACAD SCI USA, V68, P2463, DOI 10.1073/pnas.68.10.2463; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; HALL LH, 1987, BIOCHEMISTRY-US, V26, P7401, DOI 10.1021/bi00397a031; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kolker S, 2004, J INHERIT METAB DIS, V27, P805, DOI 10.1023/B:BOLI.0000045762.37248.28; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Luna-Chavez C, 2000, PROTEIN EXPRES PURIF, V19, P188, DOI 10.1006/prep.2000.1238; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Miura R, 1996, J BIOCHEM-TOKYO, V119, P512; MORRIS MP, 1954, SCIENCE, V119, P322, DOI 10.1126/science.119.3088.322; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHINA Y, 1995, J BIOCHEM-TOKYO, V118, P614, DOI 10.1093/oxfordjournals.jbchem.a124954; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1993, CCP4 STUDY WEEKEND D, P56; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Reid GA, 2000, BBA-BIOENERGETICS, V1459, P310, DOI 10.1016/S0005-2728(00)00166-3; Shen B, 2010, NATURE, V465, P1027, DOI 10.1038/nature09125; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	51	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3047	3056		10.1074/jbc.M110.192849	http://dx.doi.org/10.1074/jbc.M110.192849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098488	hybrid, Green Published			2022-12-27	WOS:000286464300067
J	Wang, J; Wu, JW; Wang, ZX				Wang, Jue; Wu, Jia-Wei; Wang, Zhi-Xin			Mechanistic Studies of the Autoactivation of PAK2 A TWO-STEP MODEL OF CIS INITIATION FOLLOWED BY TRANS AMPLIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP AUTOPHOSPHORYLATION; KINASE GAMMA-PAK; P21-ACTIVATED KINASE; PROTEIN-KINASE; SUBSTRATE REACTION; ASSAYS; PHOSPHORYLATION; CONFORMATION; CDC42	Protein kinase activation, via autophosphorylation of the activation loop, is a common regulatory mechanism in phosphorylation- dependent signaling cascades. Despite the prevalence of this reaction and its importance in biological regulation, the molecular mechanisms of autophosphorylation are poorly understood. In this study, we developed a kinetic approach to distinguish quantitatively between cis- and trans-pathways in an autocatalytic reaction. Using this method, we have undertaken a detailed kinetic analysis for the autoactivation mechanism of p21-activated protein kinase 2 (PAK2). PAK2 is regulated in vivo and in vitro by small GTP-binding proteins, Cdc42 and Rac. Full activation of PAK2 requires autophosphorylation of the conserved threonine, Thr(402), in the activation loop of its catalytic kinase domain. Analyses of the time courses of substrate reaction during PAK2 autoactivation suggest that autophosphorylation of Thr(402) in PAK2 obeys a two-step mechanism of cis initiation, followed by trans amplification. The unphosphorylated PAK2 undergoes an intramolecular (cis) autophosphorylation on Thr(402) to produce phosphorylated PAK2, and this newly formed active PAK2 then phosphorylates other PAK2 molecules at Thr(402) in an intermolecular (trans) manner. Based on the kinetic equation derived, all microscopic kinetic constants for the cis and trans autophosphorylation have been estimated quantitatively. The advantage of the new method is not only its usefulness in the study of fast activation reactions, but its convenience in the study of substrate effects on modification reaction. It would be particularly useful when the regulatory mechanism of the autophosphorylation reaction toward certain enzymes is being assessed.	[Wang, Jue; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Acad Sinica, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, ZX (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Roche R&D Center (China) Ltd., MOST [2006CB503900, 2007CB914400]; NSFC [30770476]	Roche R&D Center (China) Ltd., MOST; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the RRDCC basic research grant of Roche R&D Center (China) Ltd., MOST Grants 2006CB503900 and 2007CB914400, and NSFC Grant 30770476.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Stevens WK, 1999, BIOCHEMISTRY-US, V38, P5968, DOI 10.1021/bi990426u; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; TSOU CL, 1988, ADV ENZYMOL RAMB, V61, P381; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121	28	11	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2689	2695		10.1074/jbc.M110.156505	http://dx.doi.org/10.1074/jbc.M110.156505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098037	Green Published, hybrid			2022-12-27	WOS:000286464300035
J	Chi, YY; Zhang, CY; Zong, HL; Hong, Y; Kong, XF; Liu, HO; Zou, WY; Wang, YL; Yun, XJ; Gu, JX				Chi, Yayun; Zhang, Chunyi; Zong, Hongliang; Hong, Yi; Kong, Xiangfei; Liu, Haiou; Zou, Weiying; Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin			Thr-370 Is Responsible for CDK11(p58) Autophosphorylation, Dimerization, and Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-CYCLE; ANDROGEN RECEPTOR; DOWN-REGULATION; MAP KINASE; APOPTOSIS; ACTIVATION; PROMOTES; PHOSPHORYLATION; TRANSLOCATION	CDK11(p58), a member of the p34(cdc2)-related kinase family, is associated with cell cycle progression, tumorigenesis, and proapoptotic signaling. It is also required for the maintenance of chromosome cohesion, the maturation of centrosome, the formation of bipolar spindle, and the completion of mitosis. Here we identified that CDK11(p58) interacted with itself to form homodimers in cells, whereas D224N, the kinase-dead mutant, failed to form homodimers. CDK11(p58) was autophosphorylated, and the main functions of CDK11(p58), such as kinase activity, transactivation of nuclear receptors, and proapoptotic signal transduction, were dependent on its autophosphorylation. Furthermore, the in vitro kinase assay indicated that CDK11(p58) was autophosphorylated at Thr-370. By mutagenesis, we created CDK11(p58) T370A and CDK11(p58) T370D, which mimic the dephosphorylated and phosphorylated forms of CDK11(p58), respectively. The T370A mutant could not form dimers and be phosphorylated by the wild type CDK11(p58) and finally lost the kinase activity. Further functional research revealed that T370A failed to repress the transactivition of androgen receptor and enhance the cell apoptosis. Overall, our data indicated that Thr-370 is responsible for the autophosphorylation, dimerization, and kinase activity of CDK11(p58). Moreover, Thr-370 mutants might affect CDK11(p58)-mediated signaling pathways.	[Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China; [Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Chi, Yayun] Fudan Univ, Canc Hosp, Res Ctr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Gu, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Gene Res, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	jxgu@shmu.edu.cn	Zong, Hongliang/F-9366-2013	Zong, Hongliang/0000-0002-5855-5733; Gu, Jianxin/0000-0002-7454-6722	National Natural Scientific Foundation of China [30770426, 30930025, 30900266, J0730860]; Shanghai Leading Academic Discipline Project [B110]; State Key Project Specialized for Infectious Diseases [2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02, 2008ZX10004-014]; National Basic Research Program of China (973 Program) [2010CB912100, 2010CB912104]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); State Key Project Specialized for Infectious Diseases; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Scientific Foundation of China Grants 30770426, 30930025, and 30900266; Shanghai Leading Academic Discipline Project (B110); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China Grant J0730860; State Key Project Specialized for Infectious Diseases Grants 2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02, and 2008ZX10004-014; and National Basic Research Program of China (973 Program) Grants 2010CB912100 and 2010CB912104.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Ariza ME, 1999, J BIOL CHEM, V274, P28505, DOI 10.1074/jbc.274.40.28505; Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Cai MM, 2002, MOL CELL BIOCHEM, V238, P49, DOI 10.1023/A:1019950819784; Chen C, 2006, FEBS LETT, V580, P813, DOI 10.1016/j.febslet.2005.12.097; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Chi YY, 2009, BIOCHEM BIOPH RES CO, V386, P493, DOI 10.1016/j.bbrc.2009.06.061; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kong XF, 2009, J BIOCHEM, V146, P417, DOI 10.1093/jb/mvp089; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; Li ZJ, 2005, BIOCHEM BIOPH RES CO, V327, P628, DOI 10.1016/j.bbrc.2004.12.047; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Trembley JH, 2004, PROG NUCLEIC ACID RE, V77, P263, DOI 10.1016/S0079-6603(04)77007-5; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Yun XJ, 2007, MOL CELL BIOCHEM, V304, P213, DOI 10.1007/s11010-007-9502-x; Zhang SW, 2002, J BIOL CHEM, V277, P35314, DOI 10.1074/jbc.M202179200; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	28	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1748	1757		10.1074/jbc.M110.107367	http://dx.doi.org/10.1074/jbc.M110.107367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078675	hybrid, Green Published			2022-12-27	WOS:000286191500014
J	Nagai, S; Okazaki, M; Segawa, H; Bergwitz, C; Dean, T; Potts, JT; Mahon, MJ; Gardella, TJ; Juppner, H				Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald			Acute Down-regulation of Sodium-dependent Phosphate Transporter NPT2a Involves Predominantly the cAMP/PKA Pathway as Revealed by Signaling-selective Parathyroid Hormone Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; C ACTIVATION DOMAIN; RECEPTOR; COTRANSPORTER; MUTATIONS; HYPERCALCIURIA; BINDING; REGION; SITES; CELLS	The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor (PTHR1) in cells of the renal proximal tubule mediates the reduction in membrane expression of the sodium-dependent P-i co-transporters, NPT2a and NPT2c, and thus suppresses the re-uptake of P-i from the filtrate. In most cell types, the liganded PTHR1 activates G alpha(S)/adenylyl cyclase/cAMP/PKA (cAMP/PKA) and G alpha(q/11)/phospholipase C/phosphatidylinositol 1,4,5-trisphosphate (IP3)/Ca2+/PKC (IP3/PKC) signaling pathways, but the relative roles of each pathway in mediating renal regulation P-i transport remain uncertain. We therefore explored the signaling mechanisms involved in PTH-dependent regulation of NPT2a function using potent, long-acting PTH analogs, M-PTH(1-28) (where M = Ala(1,12), Aib(3), Gln(10), Har(11), Trp(14), and Arg(19)) and its position 1-modified variant, Trp(1)-M-PTH(1-28), designed to be phospholipase C-deficient. In cell-based assays, both M-PTH(1-28) and Trp(1)-M-PTH(1-28) exhibited potent and prolonged cAMP responses, whereas only M-PTH(1-28) was effective in inducing IP3 and intracellular calcium responses. In opossum kidney cells, a clonal cell line in which the PTHR1 and NPT2a are endogenously expressed, M-PTH(1-28) and Trp(1)-M-PTH( 1-28) each induced reductions in P-32 uptake, and these responses persisted for more than 24 h after ligand wash-out, whereas that of PTH(1-34) was terminated by 4 h. When injected into wild-type mice, both M-modified PTH analogs induced prolonged reductions in blood P-i levels and commensurate reductions in NPT2a expression in the renal brush border membrane. Our findings suggest that the acute down-regulation of NPT2a expression by PTH ligands involves mainly the cAMP/PKA signaling pathway and are thus consistent with the elevated blood P-i levels seen in pseudohypoparathyroid patients, in whom G alpha(s)-mediated signaling in renal proximal tubule cells is defective.	[Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Dept Pediat, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Med, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Juppner, H (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Thier 10,50 Blossum St, Boston, MA 02114 USA.	hjueppner@partners.org						Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; BELL NH, 1972, J CLIN INVEST, V51, P816, DOI 10.1172/JCI106876; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bisello A, 2002, J BIOL CHEM, V277, P38524, DOI 10.1074/jbc.M202544200; COLE JA, 1988, ENDOCRINOLOGY, V122, P2981, DOI 10.1210/endo-122-6-2981; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4022, DOI 10.1210/jc.2005-2840; Jankowski M, 2001, KIDNEY BLOOD PRESS R, V24, P1, DOI 10.1159/000054198; JOUISHOMME H, 1992, ENDOCRINOLOGY, V130, P53, DOI 10.1210/en.130.1.53; JOUISHOMME H, 1994, J BONE MINER RES, V9, P943; Levine LM., 2001, PARATHYROIDS BASIC C, P807; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Shimizu M, 2002, BIOCHEMISTRY-US, V41, P13224, DOI 10.1021/bi026162k; Shimizu M, 2001, ENDOCRINOLOGY, V142, P3068, DOI 10.1210/en.142.7.3068; Shimizu N, 2004, J BONE MINER RES, V19, P2078, DOI 10.1359/JBMR.040914; Takasu H, 1996, ENDOCRINOLOGY, V137, P5537, DOI 10.1210/en.137.12.5537; Tenenhouse HS, 2007, J STEROID BIOCHEM, V103, P572, DOI 10.1016/j.jsbmb.2006.12.090; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Whitfield JF, 2001, J BONE MINER RES, V16, P441, DOI 10.1359/jbmr.2001.16.3.441	30	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1618	1626		10.1074/jbc.M110.198416	http://dx.doi.org/10.1074/jbc.M110.198416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047792	Green Published, hybrid			2022-12-27	WOS:000286005000074
J	Sheridan, JT; Worthington, EN; Yu, KA; Gabriel, SE; Hartzell, HC; Tarran, R				Sheridan, John T.; Worthington, Erin N.; Yu, Kuai; Gabriel, Sherif E.; Hartzell, H. Criss; Tarran, Robert			Characterization of the Oligomeric Structure of the Ca2+-activated Cl- Channel Ano1/TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RESONANCE ENERGY-TRANSFER; ACTIVATED CHLORIDE CHANNEL; PDZ BINDING MOTIF; PLASMA-MEMBRANE; SENSORY NEURONS; LIVING CELLS; K+ CHANNELS; CALCIUM; PROTEIN	Members of the Anoctamin (Ano)/TMEM16A family have recently been identified as essential subunits of the Ca2+-activated chloride channel (CaCC). For example, Ano1 is highly expressed in multiple tissues including airway epithelia, where it acts as an apical conduit for transepithelial Cl- secretion and helps regulate lung liquid homeostasis and mucus clearance. However, little is known about the oligomerization of this protein in the plasma membrane. Thus, utilizing mCherry- and eGFP-tagged Ano1 constructs, we conducted biochemical and Forster resonance energy transfer (FRET)-based experiments to determine the quaternary structure of Ano1. FRET and co-immunoprecipitation studies revealed that tagged Ano1 subunits directly associated before they reached the plasma membrane. This association was not altered by changes in cytosolic Ca2+, suggesting that this is a fixed interaction. To determine the oligomeric structure of Ano1, we performed chemical cross-linking, non-denaturing PAGE, and electromobility shift assays, which revealed that Ano1 exists as a dimer. These data are the first to probe the quaternary structure of Ano1. Understanding the oligomeric nature of Ano1 is an essential step in the development of therapeutic drugs that could be useful in the treatment of cystic fibrosis.	Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Worthington, Erin N.; Gabriel, Sherif E.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Yu, Kuai; Hartzell, H. Criss] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University		tarran@med.unc.edu			National Institutes of Health [HL084934, HL034322, EY0148852, GM60448]; Cystic Fibrosis Foundation; Children's Healthcare of Atlanta Center for Cystic Fibrosis Research; Howard Hughes Medical Institute Med-Into-Grad University; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934, P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Healthcare of Atlanta Center for Cystic Fibrosis Research; Howard Hughes Medical Institute Med-Into-Grad University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084934, HL034322, EY0148852, and GM60448, the Cystic Fibrosis Foundation, and the Children's Healthcare of Atlanta Center for Cystic Fibrosis Research.; Supported in part by the Howard Hughes Medical Institute Med-Into-Grad University of North Carolina Program in Translational Medicine.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Duan DY, 2009, J PHYSIOL-LONDON, V587, P2163, DOI 10.1113/jphysiol.2008.165860; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JOHNSON LG, 1995, J CLIN INVEST, V95, P1377, DOI 10.1172/JCI117789; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kuo MMC, 2007, P NATL ACAD SCI USA, V104, P2151, DOI 10.1073/pnas.0609085104; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Wei L, 2001, PFLUG ARCH EUR J PHY, V442, P280, DOI 10.1007/s004240100531; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Xiao QH, 2009, J PHYSIOL-LONDON, V587, P4379, DOI 10.1113/jphysiol.2009.176800; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	48	94	99	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1381	1388		10.1074/jbc.M110.174847	http://dx.doi.org/10.1074/jbc.M110.174847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056985	hybrid, Green Published			2022-12-27	WOS:000286005000050
J	Fleming, FE; Graham, KL; Takada, Y; Coulson, BS				Fleming, Fiona E.; Graham, Kate L.; Takada, Yoshikazu; Coulson, Barbara S.			Determinants of the Specificity of Rotavirus Interactions with the alpha 2 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ADHESION SITE; I-DOMAIN; ECHOVIRUS 1; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODIES; MEMBRANE PENETRATION; DIFFERENT MECHANISMS; COLLAGEN RECEPTOR; LIGAND SEQUENCES; RHESUS ROTAVIRUS	The human alpha 2 beta 1 integrin binds collagen and acts as a cellular receptor for rotaviruses and human echovirus 1. These ligands require the inserted (I) domain within the alpha 2 subunit of alpha 2 beta 1 for binding. Previous studies have identified the binding sites for collagen and echovirus 1 in the alpha 2 I domain. We used CHO cells expressing mutated alpha 2 beta 1 to identify amino acids involved in binding to human and animal rotaviruses. Residues where mutation affected rotavirus binding were located in several exposed loops and adjacent regions of the alpha 2 I domain. Binding by all rotaviruses was eliminated by mutations in the activation-responsive alpha C-alpha 6 and alpha F helices. This is a novel feature that distinguishes rotavirus from other alpha 2 beta 1 ligands. Mutation of residues that co-ordinate the metal ion (Ser-153, Thr-221, and Glu-256 in alpha 2 and Asp-130 in beta 1) and nearby amino acids (Ser-154, Gln-215, and Asp-219) also inhibited rotavirus binding. The importance of most of these residues was greatest for binding by human rotaviruses. These mutations inhibit collagen binding to alpha 2 beta 1 (apart from Glu-256) but do not affect echovirus binding. Overall, residues where mutation affected both rotavirus and collagen recognition are located at one side of the metal ion-dependent adhesion site, whereas those important for collagen alone cluster nearby. Mutations eliminating rotavirus and echovirus binding are distinct, consistent with the respective preference of these viruses for activated or inactive alpha 2 beta 1. In contrast, rotavirus and collagen utilize activated alpha 2 beta 1 and show an overlap in alpha 2 beta 1 residues important for binding.	[Fleming, Fiona E.; Graham, Kate L.; Coulson, Barbara S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA	University of Melbourne; University of California System; University of California Davis	Coulson, BS (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Gate 11, Parkville, Vic 3010, Australia.	barbarac@unimelb.edu.au		Coulson, Barbara/0000-0002-2110-8147; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [1R01CA131015-01A2]; National Health and Medical Research Council of Australia (NHMRC) [350252, 350253, 509006, 628319]; NATIONAL CANCER INSTITUTE [R01CA131015, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA131015-01A2 (to Y. T.) and Grants 350252, 350253, 509006, and 628319 (to B. S. C.) from the National Health and Medical Research Council of Australia (NHMRC).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; BASS DM, 1991, VIROLOGY, V183, P602, DOI 10.1016/0042-6822(91)90989-O; BERGELSON JM, 1994, CELL ADHES COMMUN, V2, P455, DOI 10.3109/15419069409004455; BERGELSON JM, 1993, J CLIN INVEST, V92, P232, DOI 10.1172/JCI116555; Blanchard H, 2007, J MOL BIOL, V367, P1215, DOI 10.1016/j.jmb.2007.01.028; Ciarlet M, 2002, J VIROL, V76, P1109, DOI 10.1128/JVI.76.3.1109-1123.2002; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; Coulson B. S., 1997, LEUKOCYTE TYPING; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; COULSON BS, 1993, J CLIN MICROBIOL, V31, P1; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; EDELMAN JM, 1994, CELL ADHES COMMUN, V2, P131, DOI 10.3109/15419069409004432; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931; Graham KL, 2006, J GEN VIROL, V87, P1275, DOI 10.1099/vir.0.81580-0; Graham KL, 2005, J GEN VIROL, V86, P3397, DOI 10.1099/vir.0.81102-0; Graham KL, 2004, J VIROL, V78, P11786, DOI 10.1128/JVI.78.21.11786-11797.2004; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Halasz P, 2008, J VIROL, V82, P148, DOI 10.1128/JVI.01980-07; Haselhorst T, 2009, NAT CHEM BIOL, V5, P91, DOI 10.1038/nchembio.134; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jafri M, 2008, AM J PHYSIOL-GASTR L, V295, pG16, DOI 10.1152/ajpgi.00442.2007; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; KALJOT KT, 1988, J VIROL, V62, P1136, DOI 10.1128/JVI.62.4.1136-1144.1988; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Kirkwood CD, 1998, J VIROL, V72, P9348, DOI 10.1128/JVI.72.11.9348-9352.1998; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Londrigan SL, 2003, J VIROL, V77, P9486, DOI 10.1128/JVI.77.17.9486-9501.2003; Ludert JE, 1996, J VIROL, V70, P487, DOI 10.1128/JVI.70.1.487-493.1996; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; OCONNELL PJ, 1991, IMMUNOL CELL BIOL, V69, P103, DOI 10.1038/icb.1991.16; Pellicci DG, 2005, J IMMUNOL, V175, P4416, DOI 10.4049/jimmunol.175.7.4416; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TENCHINI ML, 1993, CELL ADHES COMMUN, V1, P55, DOI 10.3109/15419069309095681; Trask S. D., J VIROL, V84, P1764; Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Yoder JD, 2006, EMBO J, V25, P1559, DOI 10.1038/sj.emboj.7601034; Zarate S, 2000, VIROLOGY, V278, P50, DOI 10.1006/viro.2000.0660	63	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6165	6174		10.1074/jbc.M110.142992	http://dx.doi.org/10.1074/jbc.M110.142992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138834	Green Published, hybrid			2022-12-27	WOS:000287476400025
J	Bonilla, M; Denicola, A; Marino, SM; Gladyshev, VN; Salinas, G				Bonilla, Mariana; Denicola, Ana; Marino, Stefano M.; Gladyshev, Vadim N.; Salinas, Gustavo			Linked Thioredoxin-Glutathione Systems in Platyhelminth Parasites ALTERNATIVE PATHWAYS FOR GLUTATHIONE REDUCTION AND DEGLUTATHIONYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRASSICEPS METACESTODE CYSTICERCI; FUNCTIONALLY RELATED PROTEINS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; S-NITROSOGLUTATHIONE; SCHISTOSOMA-MANSONI; GLUTAREDOXIN 3; NMR STRUCTURE; SELENOCYSTEINE; MITOCHONDRIAL	In most organisms, thioredoxin (Trx) and/or glutathione (GSH) systems are essential for redox homeostasis and deoxyribonucleotide synthesis. Platyhelminth parasites have a unique and simplified thiol-based redox system, in which the selenoprotein thioredoxin-glutathione reductase (TGR), a fusion of a glutaredoxin (Grx) domain to canonical thioredoxin reductase domains, is the sole enzyme supplying electrons to oxidized glutathione (GSSG) and Trx. This enzyme has recently been validated as a key drug target for flatworm infections. In this study, we show that TGR possesses GSH-independent deglutathionylase activity on a glutathionylated peptide. Furthermore, we demonstrate that deglutathionylation and GSSG reduction are mediated by the Grx domain by a monothiolic mechanism and that the glutathionylated TGR intermediate is resolved by selenocysteine. Deglutathionylation and GSSG reduction via Grx domain, but not Trx reduction, are inhibited at high [GSSG]/[GSH] ratios. We found that Trxs (cytosolic and mitochondrial) provide alternative pathways for deglutathionylation and GSSG reduction. These pathways are operative at high [GSSG]/[GSH] and function in a complementary manner to the Grx domain-dependent one. Despite the existence of alternative pathways, the thioredoxin reductase domains of TGR are an obligate electron route for both the Grx domain-and the Trx-dependent pathways. Overall, our results provide an explanation for the unique array of thiol-dependent redox pathways present in parasitic platyhelminths. Finally, we found that TGR is inhibited by 1-hydroxy-2-oxo-3-(N-3-methyl-aminopropyl)-3-methyl-1-triazene (NOC-7), giving further evidence for NO donation as a mechanism of action for oxadiazole N-oxide TGR inhibitors. Thus, NO donors aimed at TGR could disrupt the entire redox homeostasis of parasitic flatworms.	[Bonilla, Mariana; Salinas, Gustavo] Univ Republica, Catedra Inmunol, Fac Quim, Fac Ciencias,Inst Higiene, Montevideo 11600, Uruguay; [Denicola, Ana] Univ Repupl, Lab Fisicoquim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Salinas, G (corresponding author), Univ Republica, Catedra Inmunol, Fac Quim, Fac Ciencias,Inst Higiene, Avda Navarro 3051,Piso 2, Montevideo 11600, Uruguay.	gsalin@fq.edu.uy	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016; Denicola, Ana/0000-0002-5181-9708; Bonilla, Mariana/0000-0002-9206-345X	National Institutes of Health [1R03TW008588-01, GM065204]; Uruguayan Research Council [PDT 63- 105]; PEDECIBA/ANII (Uruguay); Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay); FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uruguayan Research Council; PEDECIBA/ANII (Uruguay); Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health FIRCA Grant 1R03TW008588-01 (to G. S.) and Grant GM065204 (to V. N. G.). This study was also supported by Grants PDT 63- 105 from the Uruguayan Research Council (to G. S.), and PEDECIBA/ANII (Uruguay) and Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay) postgraduate fellowships (to M. B.).	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2010, J BIOL CHEM, V285, P32557, DOI 10.1074/jbc.M110.141960; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bar-Noy S, 2001, FREE RADICAL BIO MED, V30, P51, DOI 10.1016/S0891-5849(00)00448-2; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Greetham D, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-3; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA1; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Xia B, 2001, J MOL BIOL, V310, P907, DOI 10.1006/jmbi.2001.4721; XIA TH, 1992, PROTEIN SCI, V1, P310	39	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4959	4967		10.1074/jbc.M110.170761	http://dx.doi.org/10.1074/jbc.M110.170761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21051543	Green Published, hybrid			2022-12-27	WOS:000287230600004
J	Patel, A; Vought, VE; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			A Novel Non-SET Domain Multi-subunit Methyltransferase Required for Sequential Nucleosomal Histone H3 Methylation by the Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS DOSAGE COMPENSATION; SACCHAROMYCES-CEREVISIAE; LYSINE METHYLTRANSFERASES; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; PRODUCT SPECIFICITY; ANGSTROM RESOLUTION; TRITHORAX FAMILY; CATALYTIC DOMAIN; STRUCTURAL BASIS	Gene expression within the context of eukaryotic chromatin is regulated by enzymes that catalyze histone lysine methylation. Histone lysine methyltransferases that have been identified to date possess the evolutionarily conserved SET or Dot1-like domains. We previously reported the identification of a new multi-subunit histone H3 lysine 4 methyltransferase lacking homology to the SET or Dot1 family of histone lysine methyltransferases. This enzymatic activity requires a complex that includes WRAD (WDR5, RbBP5, Ash2L, and DPY-30), a complex that is part of the MLL1 (mixed lineage leukemia protein-1) core complex but that also exists independently of MLL1 in the cell. Here, we report that the minimal complex required for WRAD enzymatic activity includes WDR5, RbBP5, and Ash2L and that DPY-30, although not required for enzymatic activity, increases the histone substrate specificity of the WRAD complex. We also show that WRAD requires zinc for catalytic activity, displays Michaelis-Menten kinetics, and is inhibited by S-adenosylhomocysteine. In addition, we demonstrate that WRAD preferentially methylates lysine 4 of histone H3 within the context of the H3/H4 tetramer but does not methylate nucleosomal histone H3 on its own. In contrast, we find that MLL1 and WRAD are required for nucleosomal histone H3 methylation, and we provide evidence suggesting that each plays distinct structural and catalytic roles in the recognition and methylation of a nucleosome substrate. Our results indicate that WRAD is a new H3K4 methyltransferase with functions that include regulating the substrate and product specificities of the MLL1 core complex.	[Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			National Institutes of Health [R01CA140522]; American Cancer Society [RSG-09-245-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 (to M. S. C.). This work was also supported by Research Scholar Grant RSG-09-245-01-DMC from the American Cancer Society (to M. S. C.).	Adamson AL, 1996, GENETICS, V144, P621; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; CHANDRASEKHARAN MB, MOL CELL BIOL, V30, P3216; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Flaus A, 2004, EMBO J, V23, P343, DOI 10.1038/sj.emboj.7600047; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Gori F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P338; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Krajewski WA, 2010, BIOCHEM BIOPH RES CO, V397, P112, DOI 10.1016/j.bbrc.2010.05.080; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; LAWRENCE F, 1990, PROTEIN METHYLATION, P305; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang JH, 2001, J MOL MED, V79, P399, DOI 10.1007/s001090100222; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yates JA, 2010, FEBS LETT, V584, P689, DOI 10.1016/j.febslet.2010.01.022; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	82	56	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3359	3369		10.1074/jbc.M110.174524	http://dx.doi.org/10.1074/jbc.M110.174524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106533	Green Published, hybrid			2022-12-27	WOS:000286653200022
J	Wahlgren, WY; Pal, G; Kardos, J; Porrogi, P; Szenthe, B; Patthy, A; Graf, L; Katona, G				Wahlgren, Weixiao Yuan; Pal, Gabor; Kardos, Jozsef; Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo; Katona, Gergely			The Catalytic Aspartate Is Protonated in the Michaelis Complex Formed between Trypsin and an in Vitro Evolved Substrate-like Inhibitor A REFINED MECHANISM OF SERINE PROTEASE ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; BARRIER HYDROGEN-BOND; ALPHA-LYTIC PROTEASE; ATOMIC-RESOLUTION; PEPTIDE-BOND; 3-DIMENSIONAL STRUCTURE; PHAGE-DISPLAY; CHYMOTRYPSIN; ANGSTROM; TRIAD	The mechanism of serine proteases prominently illustrates how charged amino acid residues and proton transfer events facilitate enzyme catalysis. Here we present an ultrahigh resolution (0.93 angstrom) x-ray structure of a complex formed between trypsin and a canonical inhibitor acting through a substrate-like mechanism. The electron density indicates the protonation state of all catalytic residues where the catalytic histidine is, as expected, in its neutral state prior to the acylation step by the catalytic serine. The carboxyl group of the catalytic aspartate displays an asymmetric electron density so that the O-delta 2-C gamma bond appears to be a double bond, with O-delta 2 involved in a hydrogen bond to His-57 and Ser-214. Only when Asp-102 is protonated on O-delta 1 atom could a density functional theory simulation reproduce the observed electron density. The presence of a putative hydrogen atom is also confirmed by a residual mF(obs) - DFcalc density above 2.5 sigma next to O-delta 1. As a possible functional role for the neutral aspartate in the active site, we propose that in the substrate-bound form, the neutral aspartate residue helps to keep the pK(a) of the histidine sufficiently low, in the active neutral form. When the histidine receives a proton during the catalytic cycle, the aspartate becomes simultaneously negatively charged, providing additional stabilization for the protonated histidine and indirectly to the tetrahedral intermediate. This novel proposal unifies the seemingly conflicting experimental observations, which were previously seen as either supporting the charge relay mechanism or the neutral pK(a) histidine theory.	[Pal, Gabor; Kardos, Jozsef; Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Katona, Gergely] Univ Gothenburg, Dept Chem, S-40530 Gothenburg, Sweden; [Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo] Hungarian Acad Sci, Biotechnol Lab, Chem Res Ctr, H-1117 Budapest, Hungary	Eotvos Lorand University; University of Gothenburg; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Graf, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary.	graf@elte.hu; gergely.katona@chem.gu.se	Yuan Wahlgren, Weixiao/D-5589-2011; Katona, Gergely/B-3491-2008; Pal, Gabor/A-6244-2009; Kardos, József/J-1035-2017	Katona, Gergely/0000-0002-2031-8716; Pal, Gabor/0000-0001-7868-7971; Kardos, József/0000-0002-2135-2932	Swedish Science Research Council; Harald and Greta Jeanssons Foundation; OTKA [68408, 81950]; Janos Bolyai Research Fellowship	Swedish Science Research Council; Harald and Greta Jeanssons Foundation; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by the Swedish Science Research Council, the Harald and Greta Jeanssons Foundation, and OTKA Grants 68408 and 81950.; Supported by the Janos Bolyai Research Fellowship Program.	Ahmed HU, 2007, ACTA CRYSTALLOGR D, V63, P906, DOI 10.1107/S0907444907029976; Ash EL, 1997, SCIENCE, V278, P1128, DOI 10.1126/science.278.5340.1128; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Born M, 1920, Z PHYS, V1, P45, DOI 10.1007/BF01881023; Burgess SG, 2008, BIOCHEMISTRY-US, V47, P5168, DOI 10.1021/bi800127d; COREY DR, 1992, J AM CHEM SOC, V114, P4905, DOI 10.1021/ja00038a067; DeLano W.L, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; ELROD JP, 1980, J AM CHEM SOC, V102, P3917, DOI 10.1021/ja00531a039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; FINKENSTADT WR, 1967, J BIOL CHEM, V242, P771; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; Frey PA, 2004, J PHYS ORG CHEM, V17, P511, DOI 10.1002/poc.769; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Fuhrmann CN, 2004, J MOL BIOL, V338, P999, DOI 10.1016/j.jmb.2004.03.018; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; KOEPPE RE, 1976, BIOCHEMISTRY-US, V15, P3450, DOI 10.1021/bi00661a009; KOSSIAKOFF AA, 1981, BIOCHEMISTRY-US, V20, P6462, DOI 10.1021/bi00525a027; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Liu B, 2006, J BIOL CHEM, V281, P24024, DOI 10.1074/jbc.M600495200; Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; MARKLEY JL, 1978, BIOCHEMISTRY-US, V17, P4627, DOI 10.1021/bi00615a008; MARKLEY JL, 1976, J MOL BIOL, V102, P487, DOI 10.1016/0022-2836(76)90330-2; MATTHEWS BW, 1967, NATURE, V214, P652, DOI 10.1038/214652a0; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; ROBILLARD G, 1972, J MOL BIOL, V71, P507, DOI 10.1016/0022-2836(72)90366-X; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Schmidt A, 2003, J BIOL CHEM, V278, P43357, DOI 10.1074/jbc.M306944200; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHOTTON D M, 1970, Nature (London), V225, P802, DOI 10.1038/225802a0; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Uritski A, 2009, J PHYS CHEM C, V113, P10285, DOI 10.1021/jp901971q; Vrielink A, 2003, CURR OPIN STRUC BIOL, V13, P709, DOI 10.1016/j.sbi.2003.10.012; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Wurtele M, 2000, ACTA CRYSTALLOGR D, V56, P520, DOI 10.1107/S0907444900000299; You TJ, 1995, BIOPHYS J, V69, P1721, DOI 10.1016/S0006-3495(95)80042-1; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	65	20	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3587	3596		10.1074/jbc.M110.161604	http://dx.doi.org/10.1074/jbc.M110.161604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097875	hybrid, Green Published			2022-12-27	WOS:000286653200043
J	Liu, TA; Zhang, HT; Liu, FY; Wu, QY; Shen, X; Yang, Q				Liu, Tian; Zhang, Haitao; Liu, Fengyi; Wu, Qingyue; Shen, Xu; Yang, Qing			Structural Determinants of an Insect beta-N-Acetyl-D-hexosaminidase Specialized as a Chitinolytic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; LOBES GENE ENCODES; TAY-SACHS-DISEASE; MOLECULAR-CLONING; OSTRINIA-FURNACALIS; TMG-CHITOTRIOMYCIN; CRYSTAL-STRUCTURE; SANDHOFF-DISEASE; PLASMA-MEMBRANE; SF9 CELLS	beta-N-Acetyl-D-hexosaminidase has been postulated to have a specialized function. However, the structural basis of this specialization is not yet established. OfHex1, the enzyme from the Asian corn borer Ostrinia furnacalis (one of the most destructive pests) has previously been reported to function merely in chitin degradation. Here the vital role of OfHex1 during the pupation of O. furnacalis was revealed by RNA interference, and the crystal structures of OfHex1 and OfHex1 complexed with TMG-chitotriomycin were determined at 2.1 angstrom. The mechanism of selective inhibition by TMG-chitotriomycin was related to the existence of the +1 subsite at the active pocket of OfHex1 and a key residue, Trp(490), at this site. Mutation of Trp(490) to Ala led to a 2,277-fold decrease in sensitivity toward TMG-chitotriomycin as well as an 18-fold decrease in binding affinity for the substrate (GlcNAc)(2). Although the overall topology of the catalytic domain of OfHex1 shows a high similarity with the human and bacterial enzymes, OfHex1 is distinguished from these enzymes by large conformational changes linked to an "open-close" mechanism at the entrance of the active site, which is characterized by the "lid" residue, Trp(448). Mutation of Trp(448) to Ala or Phe resulted in a more than 1,000-fold loss in enzyme activity, due mainly to the effect on k(cat). The current work has increased our understanding of the structure-function relationship of OfHex1, shedding light on the structural basis that accounts for the specialized function of beta-N-acetyl-D-hexosaminidase as well as making the development of species-specific pesticides a likely reality.	[Liu, Tian; Liu, Fengyi; Wu, Qingyue; Yang, Qing] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116024, Peoples R China; [Yang, Qing] E China Univ Sci & Technol, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China; [Zhang, Haitao; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, E Inst, Shanghai Municipal Educ Commiss, Sch Med, Shanghai 200025, Peoples R China	Dalian University of Technology; East China University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Shanghai Municipal Education Commission (SHMEC)	Shen, X (corresponding author), 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	xshen@mail.shcnc.ac.cn; qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Zhang, Haitao/L-7612-2015; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Zhang, Haitao/0000-0003-4879-2951; Liu, Tian/0000-0001-9768-5496	National Key Project for Basic Research [2010CB126100, 2009CB918502, 2010CB912501]; Program for New Century Excellent Talents in University; East China University of Science and Technology, Shanghai, China; National Natural Science Foundation of China [10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; E-Institutes of Shanghai Municipal Education Commission [E09013]	National Key Project for Basic Research(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); East China University of Science and Technology, Shanghai, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; E-Institutes of Shanghai Municipal Education Commission	This work is supported by National Key Project for Basic Research Grants 2010CB126100, 2009CB918502, and 2010CB912501; the Program for New Century Excellent Talents in University; the National Special Fund for State Key Laboratory of Bioreactor Engineering (East China University of Science and Technology, Shanghai, China); National Natural Science Foundation of China Grant 10979072; Key New Drug Creation and Manufacturing Program Grant 2009ZX09301-001; and E-Institutes of Shanghai Municipal Education Commission Grant E09013.	Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cattaneo F, 2006, GLYCOBIOLOGY, V16, P786, DOI 10.1093/glycob/cwl007; Cattaneo F, 2002, INSECT BIOCHEM MOLEC, V32, P929, DOI 10.1016/S0965-1748(02)00031-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; He Y, 2009, CARBOHYD RES, V344, P627, DOI 10.1016/j.carres.2008.12.007; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Intra J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-214; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Miranda PV, 2000, MOL HUM REPROD, V6, P699, DOI 10.1093/molehr/6.8.699; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2007, BIOSCI BIOTECH BIOCH, V71, P1626, DOI 10.1271/bbb.60705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Usuki H, 2008, J AM CHEM SOC, V130, P4146, DOI 10.1021/ja077641f; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; Yang Y, 2009, J AM CHEM SOC, V131, P12076, DOI 10.1021/ja9055245	35	75	89	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4049	4058		10.1074/jbc.M110.184796	http://dx.doi.org/10.1074/jbc.M110.184796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21106526	Green Published, hybrid			2022-12-27	WOS:000286975700003
J	Liu, AYC; Mathur, R; Mei, N; Langhammer, CG; Babiarz, B; Firestein, BL				Liu, Alice Y. C.; Mathur, Rohan; Mei, Newton; Langhammer, Christopher G.; Babiarz, Bruce; Firestein, Bonnie L.			Neuroprotective Drug Riluzole Amplifies the Heat Shock Factor 1 (HSF1)- and Glutamate Transporter 1 (GLT1)-dependent Cytoprotective Mechanisms for Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSCRIPTION FACTOR; NEURODEGENERATIVE DISEASES; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; GENE-EXPRESSION; HUMAN HSF1; STRESS; ACID	Heat shock factor 1 (HSF1) mediates the cellular response to stress to increase the production of heat shock protein (HSP) chaperones for proper protein folding, trafficking, and degradation; failure of this homeostatic mechanism likely contributes to neurodegeneration. We show that the neuroprotective drug riluzole increased the amount of HSF1 in NG108-15 neuroprogenitor cells by slowing the specific turnover of HSF1 and supporting a more robust and sustained activation of HSF1. Using Hsp70-luciferase as a functional readout of the activity of HSF1, we show that riluzole amplified the heat shock induction of the reporter gene with an optimal increase at 1 mu M. Immunocytochemical staining and Western blot quantitation of HSP70 in NG108-15 neuroprogenitor cells and embryonic spinal cord neurons provided corroborative evidence that riluzole amplified the HSF1-dependent regulation of HSP70 expression. Parallel studies on the GLT1 glutamate transporter showed that riluzole increased GLT1-reporter and GLT1 protein expression and that the increase was enhanced by heat shock and coincident with the increased expression of HSP70 and HSP90. This result is consistent with the anti-glutamatergic profile of riluzole and the presence of multiple heat shock elements on the GLT1 gene promoter, suggesting that riluzole may modulate GLT1 expression through HSF1. The increased HSP chaperones and GLT1 transporter blunted glutamate-induced and N-methyl D-aspartate receptor-mediated excitotoxic death. In summary, we show that riluzole increased the amount and activity of HSF1 to boost the expression of HSPs and GLT1 for neuroprotection under stress.	[Liu, Alice Y. C.; Mathur, Rohan; Mei, Newton; Langhammer, Christopher G.; Babiarz, Bruce; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Liu, AYC (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, 604 Allison Rd, Piscataway, NJ 08854 USA.	liu@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565; Mei, Newton/0000-0001-8240-5113; Mathur, Rohan/0000-0001-5246-8543; Liu, Alice Y./0000-0002-6984-1671	National Science Foundation [MCB0240009]; New Jersey Commission on Spinal Cord Research [05-3037-SCR-E-0, 07A-019-SCR1]	National Science Foundation(National Science Foundation (NSF)); New Jersey Commission on Spinal Cord Research	This work was supported in part by grants from the Busch Biomedical Research Grant Program, National Science Foundation Grant MCB0240009 (to A. Y. C. L.), and New Jersey Commission on Spinal Cord Research Grants 05-3037-SCR-E-0 (to A. Y. C. L.) and 07A-019-SCR1 (to B. L. F.).	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bryson HM, 1996, DRUGS, V52, P549, DOI 10.2165/00003495-199652040-00010; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Cotto JJ, 1997, J CELL SCI, V110, P2925; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; ESTEVEZ AG, 1995, EUR J PHARMACOL, V280, P47, DOI 10.1016/0014-2999(95)00186-O; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Frizzo MED, 2004, CELL MOL NEUROBIOL, V24, P123, DOI 10.1023/B:CEMN.0000012717.37839.07; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fumagalli E, 2008, EUR J PHARMACOL, V578, P171, DOI 10.1016/j.ejphar.2007.10.023; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Ishiyama T, 2004, BRAIN RES, V1019, P226, DOI 10.1016/j.brainres.2004.06.002; Jensen LT, 2008, CELL STRESS CHAPERON, V13, P177, DOI 10.1007/s12192-008-0020-x; Jolly C, 1997, J CELL SCI, V110, P2935; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lips J, 2000, ANESTHESIOLOGY, V93, P1303, DOI 10.1097/00000542-200011000-00025; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NIRENBERG M, 1983, SCIENCE, V222, P794, DOI 10.1126/science.6314503; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sakurai H, 2007, J BIOL CHEM, V282, P13334, DOI 10.1074/jbc.M611801200; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864	53	46	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2785	2794		10.1074/jbc.M110.158220	http://dx.doi.org/10.1074/jbc.M110.158220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098017	Green Published, hybrid			2022-12-27	WOS:000286464300044
J	Markandeya, YS; Fahey, JM; Pluteanu, F; Cribbs, LL; Balijepalli, RC				Markandeya, Yogananda S.; Fahey, Jonathan M.; Pluteanu, Florentina; Cribbs, Leanne L.; Balijepalli, Ravi C.			Caveolin-3 Regulates Protein Kinase A Modulation of the Ca(v)3.2 (alpha(1H)) T-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; VENTRICULAR MYOCYTES; CARDIAC-HYPERTROPHY; SMOOTH-MUSCLE; HUMAN HEART; EXPRESSION; CELLS; LOCALIZATION; COMPONENT; RECEPTOR		[Balijepalli, Ravi C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Cellular & Mol Arrhythmia Res Program, Madison, WI 53706 USA; [Pluteanu, Florentina; Cribbs, Leanne L.] Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA	University of Wisconsin System; University of Wisconsin Madison; Loyola University Chicago	Balijepalli, RC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Cellular & Mol Arrhythmia Res Program, B370,1300 Univ Ave, Madison, WI 53706 USA.	rcb@medicine.wisc.edu	Pluteanu, Florentina/R-8630-2018	Pluteanu, Florentina/0000-0003-0743-0129	American Heart Association [0730010N]	American Heart Association(American Heart Association)	This work was supported by Scientist Development Grant 0730010N from the American Heart Association (to R.C.B.).	ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Ball CJ, 2009, HYPERTENSION, V53, P654, DOI 10.1161/HYPERTENSIONAHA.108.125831; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Beetz N, 2009, CARDIOVASC RES, V84, P396, DOI 10.1093/cvr/cvp251; Bossuyt J, 2002, ANN NY ACAD SCI, V976, P197; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Brueggemann LI, 2005, AM J PHYSIOL-HEART C, V288, pH923, DOI 10.1152/ajpheart.01126.2003; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 2001, CIRC RES, V88, P403; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Kikuchi T, 2005, J CARDIOVASC PHARM, V45, P204, DOI 10.1097/01.fjc.0000152029.53997.57; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Koga A, 2003, HYPERTENSION, V42, P213, DOI 10.1161/01.HYP.0000082926.08268.5D; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee JH, 1999, J NEUROSCI, V19, P1912; Lenglet S, 2002, ENDOCRINOLOGY, V143, P1748, DOI 10.1210/en.143.5.1748; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; NUSS HB, 1994, J PHYSIOL-LONDON, V479, P265, DOI 10.1113/jphysiol.1994.sp020294; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Ostadal B, 1999, PHYSIOL REV, V79, P635, DOI 10.1152/physrev.1999.79.3.635; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; Rangel A, 2010, MOL PHARMACOL, V77, P202, DOI 10.1124/mol.109.058727; Ratajczak P, 2005, J APPL PHYSIOL, V99, P244, DOI 10.1152/japplphysiol.01292.2004; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Vassort G, 2006, CELL CALCIUM, V40, P205, DOI 10.1016/j.ceca.2006.04.025; Wagoner LE, 1996, CIRCULATION, V93, P111, DOI 10.1161/01.CIR.93.1.111; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wolfe JT, 2002, J PHYSIOL-LONDON, V538, P343, DOI 10.1113/jphysiol.2001.012839; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; You HT, 2010, MOL PHARMACOL, V77, P211, DOI 10.1124/mol.109.059022	71	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2433	2444		10.1074/jbc.M110.182550	http://dx.doi.org/10.1074/jbc.M110.182550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084288	Green Published, hybrid			2022-12-27	WOS:000286464300007
J	Gruner, I; Fradrich, C; Bottger, LH; Trautwein, AX; Jahn, D; Hartig, E				Gruner, Ines; Fraedrich, Claudia; Boettger, Lars H.; Trautwein, Alfred X.; Jahn, Dieter; Haertig, Elisabeth			Aspartate 141 Is the Fourth Ligand of the Oxygen-sensing [4Fe-4S](2+) Cluster of Bacillus subtilis Transcriptional Regulator Fnr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSSBAUER-SPECTROSCOPY; PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; DNA-BINDING; FERREDOXIN; PROTEINS	The Bacillus subtilis redox regulator Fnr controls genes of the anaerobic metabolism in response to low oxygen tension. An unusual structure for the oxygen-sensing [4Fe-4S](2+) cluster was detected by a combination of genetic experiments with UV-visible and Mossbauer spectroscopy. Asp-141 was identified as the fourth iron-sulfur cluster ligand besides three Cys residues. Exchange of Asp-141 with Ala abolished functional in vivo complementation of an fnr knock-out strain by the mutagenized fnr gene and in vitro DNA binding of the recombinant regulator FnrD141A. In contrast, substitution of Asp-141 with Cys preserved [4Fe-4S](2+) structure and regulator function.	[Gruner, Ines; Fraedrich, Claudia; Jahn, Dieter; Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Boettger, Lars H.; Trautwein, Alfred X.] Univ Lubeck, Inst Phys, D-23538 Lubeck, Germany	Braunschweig University of Technology; University of Lubeck	Hartig, E (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	e.haertig@tu-bs.de	Böttger, Lars/G-3570-2010	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [Ha3456-1/3]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant Ha3456-1/3 and the Fonds der Chemischen Industrie.	BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRITT RD, 1991, BIOCHEMISTRY-US, V30, P1892, DOI 10.1021/bi00221a023; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Imai T, 2001, J BIOCHEM, V130, P649, DOI 10.1093/oxfordjournals.jbchem.a003030; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MATZANKE BF, 1989, EUR J BIOCHEM, V183, P371, DOI 10.1111/j.1432-1033.1989.tb14938.x; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Schunemann V, 2000, REP PROG PHYS, V63, P263, DOI 10.1088/0034-4885/63/3/202; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004	19	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2017	2021		10.1074/jbc.M110.191940	http://dx.doi.org/10.1074/jbc.M110.191940			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068385	Green Published, hybrid			2022-12-27	WOS:000286191500043
J	Mokkapati, S; Fleger-Weckmann, A; Bechtel, M; Koch, M; Breitkreutz, D; Mayer, U; Smyth, N; Nischt, R				Mokkapati, Sharada; Fleger-Weckmann, Anja; Bechtel, Manuela; Koch, Manuel; Breitkreutz, Dirk; Mayer, Ulrike; Smyth, Neil; Nischt, Roswitha			Basement Membrane Deposition of Nidogen 1 but Not Nidogen 2 Requires the Nidogen Binding Module of the Laminin gamma 1 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-LIKE MOTIF; EPITHELIAL MORPHOGENESIS; GLOBULAR DOMAINS; EXPRESSION; SKIN; ADHESION; PROTEIN; CELLS; PROLIFERATION; COMPONENTS	The nidogen-laminin interaction is proposed to play a key role in basement membrane (BM) assembly. However, though there are similarities, the phenotypes in mice lacking nidogen 1 and 2 (nidogen double null) differ to those of mice lacking the nidogen binding module (gamma 1III4) of the laminin gamma 1 chain. This indicates different cell- and tissue-specific functions for nidogens and their interaction with laminin and poses the question of whether the phenotypes in nidogen double null mice are caused by the loss of the laminin-nidogen interaction or rather by other unknown nidogen functions. To investigate this, we analyzed BMs, in particular those in the skin of mice lacking the nidogen binding module. In contrast to nidogen double null mice, all skin BMs in gamma 1III4-deficient mice appeared normal. Furthermore, although nidogen 1 deposition was strongly reduced, nidogen 2 appeared unchanged. Mice with additional deletion of the laminin gamma 3 chain, which contains a gamma 1-like nidogen binding module, showed a further reduction of nidogen 1 in the dermoepidermal BM; however, this again did not affect nidogen 2. This demonstrates that in vivo only nidogen 1 deposition is critically dependent on the nidogen binding modules of the laminin gamma 1 and gamma 3 chains, whereas nidogen 2 is independently recruited either by binding to an alternative site on laminin or to other BM proteins.	[Mokkapati, Sharada; Fleger-Weckmann, Anja; Bechtel, Manuela; Nischt, Roswitha] Univ Hosp Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Koch, Manuel] Univ Cologne, Inst Oral & Musculoskeletal Biol, Fac Med, Ctr Biochem,Ctr Mol Med Cologne,Ctr Dent Med, D-5000 Cologne 41, Germany; [Breitkreutz, Dirk] German Canc Res Ctr, Div A110 A080, D-69120 Heidelberg, Germany; [Mayer, Ulrike] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Smyth, Neil] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England	University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); University of East Anglia; University of Southampton	Nischt, R (corresponding author), Univ Hosp Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	Roswitha.Nischt@uni-koeln.de	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; Smyth, Neil/0000-0002-3734-2149; Mayer, Ulrike/0000-0003-2328-0052	Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne [NI 304/11-1]; Maria Pesch Stiftung; Medical Research Council (MRC) [BJ10R141]; MRC [G0501515] Funding Source: UKRI; Medical Research Council [G0501515] Funding Source: researchfish	Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne(German Research Foundation (DFG)); Maria Pesch Stiftung; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne (to R. N.) and Grant NI 304/11-1 (to R. N.). This work was also supported by the Maria Pesch Stiftung (to R. N.). N. S. is funded by the Medical Research Council (MRC) through grant BJ10R141.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004; BICKENBACH JR, 1995, J INVEST DERMATOL, V104, P405, DOI 10.1111/1523-1747.ep12665896; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Gerharz M, 2007, WOUND REPAIR REGEN, V15, P105, DOI 10.1111/j.1524-475X.2006.00191.x; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; Kadoya Y, 1997, DEVELOPMENT, V124, P683; Kikkawa Y, 2004, EXP CELL RES, V300, P94, DOI 10.1016/j.yexcr.2004.06.031; Kimura N, 1998, EXP CELL RES, V241, P36, DOI 10.1006/excr.1998.4016; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; McMillan JR, 2003, J HISTOCHEM CYTOCHEM, V51, P1299, DOI 10.1177/002215540305101007; Miosge N, 2000, HISTOCHEM CELL BIOL, V113, P115, DOI 10.1007/s004180050014; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; Niessen CM, 1996, J CELL SCI, V109, P1695; Nischt R, 2007, J INVEST DERMATOL, V127, P545, DOI 10.1038/sj.jid.5700562; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Pouliot N, 2002, EXP DERMATOL, V11, P387, DOI 10.1034/j.1600-0625.2002.110501.x; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tomakidi P, 1999, DIFFERENTIATION, V64, P263, DOI 10.1046/j.1432-0436.1999.6450263.x; Tunggal J, 2003, J CELL SCI, V116, P803, DOI 10.1242/jcs.00293; Willem M, 2002, DEVELOPMENT, V129, P2711	42	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1911	1918		10.1074/jbc.M110.149864	http://dx.doi.org/10.1074/jbc.M110.149864			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084308	Green Published, hybrid			2022-12-27	WOS:000286191500032
J	Bancells, C; Benitez, S; Ordonez-Llanos, J; Oorni, K; Kovanen, PT; Milne, RW; Sanchez-Quesada, JL				Bancells, Cristina; Benitez, Sonia; Ordonez-Llanos, Jordi; Oorni, Katariina; Kovanen, Petri T.; Milne, Ross W.; Sanchez-Quesada, Jose L.			Immunochemical Analysis of the Electronegative LDL Subfraction Shows That Abnormal N-terminal Apolipoprotein B Conformation Is Involved in Increased Binding to Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCLONAL-ANTIBODIES; RECEPTOR; B-100; AGGREGATION; PARTICLES; EPITOPES; PLASMA; CELLS; SITE	Electronegative LDL (LDL(-)) is a minor subfraction of modified LDL present in plasma. Among its atherogenic characteristics, low affinity to the LDL receptor and high binding to arterial proteoglycans (PGs) could be related to abnormalities in the conformation of its main protein, apolipoprotein B-100 (apoB-100). In the current study, we have performed an immunochemical analysis using monoclonal antibody (mAb) probes to analyze the conformation of apoB-100 in LDL(-). The study, performed with 28 anti-apoB-100 mAbs, showed that major differences of apoB-100 immunoreactivity between native LDL and LDL(-) concentrate in both terminal extremes. The mAbs Bsol 10, Bsol 14 (which recognize the amino-terminal region), Bsol 2, and Bsol 7 (carboxyl-terminal region) showed increased immunoreactivity in LDL(-), suggesting that both terminal extremes are more accessible in LDL(-) than in native LDL. The analysis of in vitro-modified LDLs, including LDL lipolyzed with sphingomyelinase (SMase-LDL) or phospholipase A(2) (PLA(2)-LDL) and oxidized LDL (oxLDL), suggested that increased amino-terminal immunoreactivity was related to altered conformation due to aggregation. This was confirmed when the aggregated subfractions of LDL(-) (agLDL(-)) and oxLDL (ag-oxLDL) were isolated and analyzed. Thus, Bsol 10 and Bsol 14 immunoreactivity was high in SMase-LDL, ag-oxLDL, and agLDL(-). The altered amino-terminal apoB-100 conformation was involved in the increased PG binding affinity of agLDL(-) because Bsol 10 and Bsol 14 blocked its high PG-binding. These observations suggest that an abnormal conformation of the amino-terminal region of apoB-100 is responsible for the increased PG binding affinity of agLDL(-).	[Bancells, Cristina; Benitez, Sonia; Ordonez-Llanos, Jordi; Sanchez-Quesada, Jose L.] Hosp Santa Creu & Sant Pau, Dept Biochem, Biomed Res Inst IIB St Pau, Barcelona 08025, Spain; [Bancells, Cristina; Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Cerdanyola Del Valles 08193, Catalonia, Spain; [Oorni, Katariina; Kovanen, Petri T.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Milne, Ross W.] Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON K1Y 4W7, Canada	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Wihuri Research Institute; University of Ottawa; University of Ottawa Heart Institute	Bancells, C (corresponding author), Hosp Santa Creu & Sant Pau, Dept Biochem, Res Inst, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	cbancells@santpau.cat; RMilne@ottawaheart.ca; jsanchezq@santpau.cat	Oorni, Katariina/G-2484-2011; Ordonez-Llanos, Jorge/N-1126-2019; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jordi/B-4961-2011; Ordonez-Llanos, Jorge/A-9335-2010	Oorni, Katariina/0000-0002-9525-0250; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jordi/0000-0003-4896-5832; Bancells, Cristina/0000-0003-4819-218X; Sanchez-Quesada, Jose Luis/0000-0003-0224-591X	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS)) [PI06/0500, PI09/0160]; Heart and Stroke Foundation of Canada [T6110]; Spanish Ministry of Education and Science (MEC) [AP-2004-1468]; ISCIII/FIS [CP04/0110, CP06/0220]	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS))(Instituto de Salud Carlos IIISpanish Government); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Spanish Ministry of Education and Science (MEC)(Spanish Government); ISCIII/FIS(Instituto de Salud Carlos III)	This work was supported by Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS)) Grants PI06/0500 and PI09/0160 and from the Heart and Stroke Foundation of Canada (Grant T6110).; Recipient of Predoctoral Fellowship AP-2004-1468 from the Spanish Ministry of Education and Science (MEC).; Supported by ISCIII/FIS CP04/0110.; Supported by ISCIII/FIS CP06/0220.	Asatryan L, 2005, J LIPID RES, V46, P115, DOI 10.1194/jlr.M400306-JLR200; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Bancells C, 2008, BIOCHEMISTRY-US, V47, P8186, DOI 10.1021/bi800537h; Bancells C, 2010, J BIOL CHEM, V285, P32425, DOI 10.1074/jbc.M110.139691; Bancells C, 2009, J LIPID RES, V50, P446, DOI 10.1194/jlr.M800318-JLR200; Benitez S, 2004, ATHEROSCLEROSIS, V177, P299, DOI 10.1016/j.atherosclerosis.2004.07.027; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; Benitez S, 2007, BBA-MOL CELL BIOL L, V1771, P613, DOI 10.1016/j.bbalip.2007.03.001; Benitez S, 2006, BBA-MOL CELL BIOL L, V1761, P1014, DOI 10.1016/j.bbalip.2006.03.020; Blanco FJ, 2010, J LIPID RES, V51, P1560, DOI 10.1194/jlr.D002642; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Demuth K, 1996, ARTERIOSCL THROM VAS, V16, P773, DOI 10.1161/01.ATV.16.6.773; Flood C, 2002, J BIOL CHEM, V277, P32228, DOI 10.1074/jbc.M204053200; Goldberg IJ, 1998, J BIOL CHEM, V273, P35355, DOI 10.1074/jbc.273.52.35355; Gustafsson M, 2004, CURR OPIN LIPIDOL, V15, P505, DOI 10.1097/00041433-200410000-00003; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; HOFF HF, 1992, J BIOL CHEM, V267, P602; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, pA593; MILNE R, 1989, J BIOL CHEM, V264, P19754; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Parasassi T, 2001, FREE RADICAL BIO MED, V31, P82, DOI 10.1016/S0891-5849(01)00555-X; PEASE RJ, 1990, J BIOL CHEM, V265, P553; READE R, 1989, AM J NEPHROL, V9, P110, DOI 10.1159/000167948; Sanchez-Quesada JL, 1999, AM J CARDIOL, V84, P655, DOI 10.1016/S0002-9149(99)00411-7; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Sanchez-Quesada JL, 2002, J LIPID RES, V43, P699; Sanchez-Quesada JL, 2001, J CLIN ENDOCR METAB, V86, P3243, DOI 10.1210/jc.86.7.3243; Segrest JP, 2001, J LIPID RES, V42, P1346; Sevanian A, 1997, J LIPID RES, V38, P419; Wang XY, 1998, P NATL ACAD SCI USA, V95, P7643, DOI 10.1073/pnas.95.13.7643; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301; Witztum JL, 1997, ANN NY ACAD SCI, V811, P88, DOI 10.1111/j.1749-6632.1997.tb51992.x; ZAWADZKI Z, 1991, J LIPID RES, V32, P243; ZAWADZKI Z, 1989, J LIPID RES, V30, P885; Ziegler O, 1996, DIABETES METAB, V22, P179; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	41	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1125	1133		10.1074/jbc.M110.175315	http://dx.doi.org/10.1074/jbc.M110.175315			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078674	Green Published, hybrid			2022-12-27	WOS:000286005000023
J	Im, SS; Kim, MY; Kwon, SK; Kim, TH; Bae, JS; Kim, H; Kim, KS; Oh, GT; Ahn, YH				Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Oh, Goo-Taeg; Ahn, Yong-Ho			Peroxisome Proliferator-activated Receptor alpha Is Responsible for the Up-regulation of Hepatic Glucose-6-phosphatase Gene Expression in Fasting and db/db Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; RAT-LIVER GLUCOSE-6-PHOSPHATASE; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; INSULIN-RESISTANCE; CATALYTIC SUBUNIT; H4IIE CELLS; TRANSCRIPTIONAL COACTIVATOR; NUCLEAR FACTOR-4-ALPHA	Glucose-6-phosphatase (G6Pase) is a key enzyme that is responsible for the production of glucose in the liver during fasting or in type 2 diabetes mellitus (T2DM). During fasting or in T2DM, peroxisome proliferator-activated receptor alpha (PPAR alpha) is activated, which may contribute to increased hepatic glucose output. However, the mechanism by which PPAR alpha up-regulates hepatic G6Pase gene expression in these states is not well understood. We evaluated the mechanism by which PPAR alpha up-regulates hepatic G6Pase gene expression in fasting and T2DM states. In PPAR alpha-null mice, both hepatic G6Pase and phosphoenolpyruvate carboxykinase levels were not increased in the fasting state. Moreover, treatment of primary cultured hepatocytes with Wy14,643 or fenofibrate increased the G6Pase mRNA level. In addition, we have localized and characterized a PPAR-responsive element in the promoter region of the G6Pase gene. Chromatin immunoprecipitation (ChIP) assay revealed that PPAR alpha binding to the putative PPAR-responsive element of the G6Pase promoter was increased in fasted wild-type mice and db/db mice. These results indicate that PPAR alpha is responsible for glucose production through the up-regulation of hepatic G6Pase gene expression during fasting or T2DM animal models.	[Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Kim, Tae-Hyun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Seoul 120752, South Korea; [Im, Seung-Soon] Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Oh, Goo-Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Lab Cardiovasc Genom, Seoul 120750, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sanford Burnham Prebys Medical Discovery Institute; Ewha Womans University	Ahn, YH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 134 Shinchon Dong, Seoul 120752, South Korea.	yha111@yuhs.ac	Kim, Hail/C-5608-2018; Oh, Goo Taeg/AAQ-9995-2021; AHN, Yong Ho/H-6712-2017; Kim, Hail/C-1849-2011	AHN, Yong Ho/0000-0002-4133-0757; Kim, Hail/0000-0002-6652-1349; Kim, Kyung-sup/0000-0001-8483-8537	Ministry of Education, Science, and Technology [2009-0080655]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A091014]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology Grant 2009-0080655 (Y.-H. A.) and by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Grant A091014 (M.-Y. K.).	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Asayama K, 1999, MOL CELL BIOCHEM, V194, P227, DOI 10.1023/A:1006930513476; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bihan H, 2005, FEBS LETT, V579, P2284, DOI 10.1016/j.febslet.2005.03.020; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim HJ, 2003, DIABETES, V52, pA290; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Massillon D, 2003, J BIOL CHEM, V278, P40694, DOI 10.1074/jbc.M303182200; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Metzger S, 1997, AM J PHYSIOL-ENDOC M, V273, pE262, DOI 10.1152/ajpendo.1997.273.2.E262; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roe C. R., 1995, METABOLIC MOL BASES, P1501; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Schoonjans K, 1996, J LIPID RES, V37, P907; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sugden MC, 2004, DIABETES, V53, pS71, DOI 10.2337/diabetes.53.2007.S71; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Suh HN, 2008, AM J PHYSIOL-CELL PH, V295, pC1518, DOI 10.1152/ajpcell.00368.2008; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Xu C, 2007, J NUTR, V137, P554, DOI 10.1093/jn/137.3.554; YANUKAKASHLES O, 1994, MOL CELL BIOL, V14, P7124, DOI 10.1128/MCB.14.11.7124; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	59	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1157	1164		10.1074/jbc.M110.157875	http://dx.doi.org/10.1074/jbc.M110.157875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081500	Green Published, hybrid			2022-12-27	WOS:000286005000026
J	Zhang, XX; Yu, HJ; Lou, JR; Zheng, J; Zhu, H; Popescu, NI; Lupu, F; Lind, SE; Ding, WQ				Zhang, Xiaoxi; Yu, Haijun; Lou, Jessica R.; Zheng, Jie; Zhu, Hua; Popescu, Narcis-Ioan; Lupu, Florea; Lind, Stuart E.; Ding, Wei-Qun			MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TUMOR ANGIOGENESIS; MESSENGER-RNA; LUNG CANCERS; METASTASIS; INVASION; RECEPTOR; ACTIVATION; PHENOTYPE; CLUSTER	Tissue factor has been recognized as a regulator of tumor angiogenesis and metastasis. The tissue factor gene is selectively expressed in highly invasive breast cancer cells, and the mechanisms regulating tissue factor expression in these cells remain unclear. This study demonstrates that microRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells, providing a molecular basis for the selective expression of the tissue factor gene. Tissue factor protein was barely detectable in MCF-7, T47D, and ZR-75-1 cells (less invasive breast lines) but was expressed at a significantly higher level in MDA-MB-231 and BT-20 cells (invasive breast lines) as assayed by Western blot. The tissue factor gene promoter was activated, and forced expression of tissue factor cDNA was achieved in MCF-7 cells, implying that the 3'-UTR of the tissue factor transcript is responsible for the suppression of tissue factor expression. Bioinformatics analysis predicted microRNA-binding sites for miR-19, miR-20, and miR-106b in the 3'-UTR of the tissue factor transcript. Reporter gene assay using the TF-3'-UTR luciferase reporter construct confirmed that the 3'-UTR negatively regulates gene expression in MCF-7 cells, an effect reversed by deletion of the miR-19-binding site. Application of the miR-19 inhibitor induces endogenous tissue factor expression in MCF-7 cells, and overexpression of miR-19 down-regulates tissue factor expression in MDA-MB-231 cells. RT-PCR analysis using cDNA made from Ago2-immunoprecipitated RNA samples confirmed that Ago2 binds preferentially to tissue factor 3'-UTR in MCF-7 cells, as compared with MDA-MB-231 cells, consistent with the observation that miR-19 levels are higher in MCF-7 cells.	[Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zhu, Hua; Popescu, Narcis-Ioan; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Lind, Stuart E.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Lind, Stuart E.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 975 NE 10th St,BRC 411A, Oklahoma City, OK 73104 USA.	weiqun-ding@ouhsc.edu	Lupu, Florea/C-3162-2009; Lupu, Florea/AAV-3257-2021	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Popescu, Narcis/0000-0002-4809-9885	Susan G. Komen for the Cure Foundation [KG081083]; Oklahoma Center for the Advancement of Science and Technology [HR09-025]	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Oklahoma Center for the Advancement of Science and Technology	This work was supported by Susan G. Komen for the Cure Foundation Grant KG081083 and Oklahoma Center for the Advancement of Science and Technology Grant HR09-025.	AHERN SM, 1993, J BIOL CHEM, V268, P2154; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 1999, J BIOL CHEM, V274, P32225, DOI 10.1074/jbc.274.45.32225; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ding WQ, 2004, MOL CANCER THER, V3, P1109; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127; Koomagi R, 1998, INT J CANCER, V79, P19, DOI 10.1002/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.3.CO;2-9; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Ngo CV, 2007, INT J CANCER, V120, P1261, DOI 10.1002/ijc.22426; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Sawada M, 1999, BRIT J CANCER, V79, P472, DOI 10.1038/sj.bjc.6690073; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Steitz JA, 2009, BIOCHEM SOC T, V37, P931, DOI 10.1042/BST0370931; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Tsopanoglou NE, 2007, SEMIN THROMB HEMOST, V33, P680, DOI 10.1055/s-2007-991535; Tuller ER, 2009, MOL PHARMACOL, V76, P588, DOI 10.1124/mol.109.057430; Ueno T, 2000, BRIT J CANCER, V83, P164; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wojtukiewicz MZ, 2001, NEOPLASIA, V3, P371, DOI 10.1038/sj.neo.7900184; Yu JL, 2004, SEMIN THROMB HEMOST, V30, P21; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou JN, 1998, MOL CARCINOGEN, V21, P234, DOI 10.1002/(SICI)1098-2744(199804)21:4<234::AID-MC2>3.0.CO;2-K	44	102	117	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1429	1435		10.1074/jbc.M110.146530	http://dx.doi.org/10.1074/jbc.M110.146530			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059650	Green Published, hybrid			2022-12-27	WOS:000286005000055
J	Zienicke, B; Chen, LY; Khawn, H; Hammam, MAS; Kinoshita, H; Reichert, J; Ulrich, AS; Inomata, K; Lamparter, T				Zienicke, Benjamin; Chen, Li-Yi; Khawn, Htoi; Hammam, Mostafa A. S.; Kinoshita, Hideki; Reichert, Johannes; Ulrich, Anne S.; Inomata, Katsuhiko; Lamparter, Tilman			Fluorescence of Phytochrome Adducts with Synthetic Locked Chromophores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSS CERATODON-PURPUREUS; AGROBACTERIUM-TUMEFACIENS; CYANOBACTERIUM SYNECHOCYSTIS; BILIVERDIN DERIVATIVES; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; BACTERIAL PHYTOCHROME; SIGNAL-TRANSDUCTION; SPECTRAL PROPERTIES; CRYSTAL-STRUCTURE	We performed steady state fluorescence measurements with phytochromes Agp1 and Agp2 of Agrobacterium tumefaciens and three mutants in which photoconversion is inhibited. These proteins were assembled with the natural chromophore biliverdin (BV), with phycoerythrobilin (PEB), which lacks a double bond in the ring C-D-connecting methine bridge, and with synthetic bilin derivatives in which the ring C-D-connecting methine bridge is locked. All PEB and locked chromophore adducts are photoinactive. According to fluorescence quantum yields, the adducts may be divided into four different groups: wild type BV adducts exhibiting a weak fluorescence, mutant BV adducts with about 10-fold enhanced fluorescence, adducts with locked chromophores in which the fluorescence quantum yields are around 0.02, and PEB adducts with a high quantum yield of around 0.5. Thus, the strong fluorescence of the PEB adducts is not reached by the locked chromophore adducts, although the photoconversion energy dissipation pathway is blocked. We therefore suggest that ring D of the bilin chromophore, which contributes to the extended pi-electron system of the locked chromophores, provides an energy dissipation pathway that is independent on photoconversion.	[Chen, Li-Yi; Khawn, Htoi; Hammam, Mostafa A. S.; Kinoshita, Hideki; Inomata, Katsuhiko] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan; [Zienicke, Benjamin; Lamparter, Tilman] KIT, Inst Bot, D-76131 Karlsruhe, Germany; [Reichert, Johannes; Ulrich, Anne S.] KIT, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany	Kanazawa University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Inomata, K (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan.	inomata@se.kanazawa-u.ac.jp; tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013; Hammam, Mostafa/M-6126-2016; Ulrich, Anne S/H-5519-2013	Lamparter, Tilman/0000-0003-4327-9737; Hammam, Mostafa/0000-0003-4299-2231; Ulrich, Anne S/0000-0001-5571-9483	Deutsche Forschungsgemeinschaft [B2, Sfb 498]; Graduiertenforderung des Landes Baden Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenforderung des Landes Baden Wurttemberg	This work was supported by Grant B2 from the Deutsche Forschungsgemeinschaft, Sfb 498, and a grant from the Graduiertenforderung des Landes Baden Wurttemberg (to B. Z.).	ALEKABI H, 1986, PHOTOCHEM PHOTOBIOL, V44, P433, DOI 10.1111/j.1751-1097.1986.tb04690.x; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Bose G, 2004, BIOPHYS J, V87, P2013, DOI 10.1529/biophysj.103.038521; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; Chen LY, 2009, CHEM LETT, V38, P602, DOI 10.1246/cl.2009.602; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Giraud E, 2008, PHOTOSYNTH RES, V97, P141, DOI 10.1007/s11120-008-9323-0; Hammam MAS, 2006, B CHEM SOC JPN, V79, P1561, DOI 10.1246/bcsj.79.1561; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Khawn H, 2008, CHEM LETT, V37, P198, DOI 10.1246/cl.2008.198; Kinoshita H, 2005, CHEM LETT, V34, P800, DOI 10.1246/cl.2005.800; Krieger A, 2008, J PHOTOCH PHOTOBIO B, V93, P16, DOI 10.1016/j.jphotobiol.2008.07.001; KUFER W, 1983, ISRAEL J CHEM, V23, P233; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 1997, PLANT CELL PHYSIOL, V38, P51, DOI 10.1093/oxfordjournals.pcp.a029084; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; McDonagh AF, 1979, PORPHYRINS; Montgomery BL, 2007, MOL MICROBIOL, V64, P16, DOI 10.1111/j.1365-2958.2007.05622.x; Murphy JT, 1997, CURR BIOL, V7, P870, DOI 10.1016/S0960-9822(06)00375-7; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Oberpichler I, 2006, FEBS LETT, V580, P437, DOI 10.1016/j.febslet.2005.12.035; Otto H, 2003, BIOCHEMISTRY-US, V42, P5885, DOI 10.1021/bi026946y; PETRIER C, 1981, TETRAHEDRON LETT, V22, P855, DOI 10.1016/0040-4039(81)80014-7; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Sambrook J, 2001, MOL CLONING LAB MANU; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHNEIDER S, 1994, J PHOTOCH PHOTOBIO B, V26, P75, DOI 10.1016/1011-1344(94)85038-0; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sineshchekov V, 2002, J PHOTOCH PHOTOBIO B, V67, P39, DOI 10.1016/S1011-1344(02)00282-8; SINESHCHEKOV VA, 1995, BBA-BIOENERGETICS, V1228, P125, DOI 10.1016/0005-2728(94)00173-3; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104	57	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1103	1113		10.1074/jbc.M110.155143	http://dx.doi.org/10.1074/jbc.M110.155143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071442	Green Published, hybrid			2022-12-27	WOS:000286005000021
J	Marland, JRK; Pan, DX; Buttery, PC				Marland, Jamie R. K.; Pan, DingXin; Buttery, Philip C.			Rac GTPase-activating Protein (Rac GAP) alpha 1-Chimaerin Undergoes Proteasomal Degradation and Is Stabilized by Diacylglycerol Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; DENDRITIC SPINES; KINASE-C; UBIQUITIN LIGASE; HIPPOCAMPAL-NEURONS; RHO GTPASES; ALPHA-2-CHIMAERIN; BETA-2-CHIMAERIN; BINDING; MECHANISM	alpha 1-Chimaerin is a neuron-specific member of the Rho GTPase-activating protein family that selectively inactivates the small GTPase Rac. It is known to regulate the structure of dendrites and dendritic spines. We describe here that under basal conditions alpha 1-chimaerin becomes polyubiquitinated and undergoes rapid proteasomal degradation. This degradation is partly dependent on the N-terminal region that is unique to this isoform. Mimicking diacylglycerol (DAG) signaling with a phorbol ester stabilizes endogenous alpha 1-chimaerin against degradation and causes accumulation of the protein. The stabilization requires phorbol ester binding via the C1 domain of the protein and is independent of PKC activity. In addition, overexpression of a constitutively active Rac1 mutant is sufficient to cause an accumulation of alpha 1-chimaerin through a phospholipase C-dependent mechanism, showing that endogenous DAG signaling can also stabilize the protein. These results suggest that signaling via DAG may regulate the abundance of alpha 1-chimaerin under physiological conditions, providing a new model for understanding how its activity could be controlled.	[Marland, Jamie R. K.; Pan, DingXin; Buttery, Philip C.] Univ Cambridge, Ctr Brain Repair, Cambridge CB2 0PY, England	University of Cambridge	Buttery, PC (corresponding author), Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	pcb10@cam.ac.uk	Pan, Dingxin/AAE-1205-2021	Marland, Jamie/0000-0001-6442-082X	Alzheimer's Research Trust; Medical Research Council; Alzheimers Research UK [ART-PPG2007B-1] Funding Source: researchfish	Alzheimer's Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by an Alzheimer's Research Trust pilot grant (to P. C. B.) and by a Medical Research Council studentship (to J. R. K. M.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MANSER E, 1992, J BIOL CHEM, V267, P16025; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Takeuchi S, 2009, FEBS LETT, V583, P1237, DOI 10.1016/j.febslet.2009.03.032; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750	46	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					199	207		10.1074/jbc.M110.166728	http://dx.doi.org/10.1074/jbc.M110.166728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056981	Green Published, hybrid			2022-12-27	WOS:000285782800022
J	Yanaka, S; Sano, E; Naruse, N; Miura, K; Futatsumori-Sugai, M; Caaveiro, JMM; Tsumoto, K				Yanaka, Saeko; Sano, Emiko; Naruse, Norio; Miura, Kin-ichiro; Futatsumori-Sugai, Mutsumi; Caaveiro, Jose M. M.; Tsumoto, Kouhei			Non-core Region Modulates Interleukin-11 Signaling Activity GENERATION OF AGONIST AND ANTAGONIST VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING SITES; CYTOKINE-RECEPTOR; CHEMICAL-MODIFICATION; CRYSTAL-STRUCTURE; FUSION-PROTEIN; GP130; GLYCOSYLATION; IDENTIFICATION; RECOGNITION; RECOMBINANT	Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four alpha-helices. We have investigated the region of hIL-11 that does not belong to the alpha-helical bundle motif, and that for the purpose of brevity we have termed "non-core region." The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini alpha-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.	[Yanaka, Saeko; Sano, Emiko; Miura, Kin-ichiro; Futatsumori-Sugai, Mutsumi; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Sano, Emiko; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Kashiwa, Chiba 2778562, Japan; [Naruse, Norio] Proteios Inc, Kamakura, Kanagawa 2488555, Japan	University of Tokyo; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp	Yanaka, Saeko/AAW-5301-2020; Caaveiro, Jose/J-2790-2013; Yanaka, Saeko/AAU-4487-2020	Yanaka, Saeko/0000-0002-3513-5701; Caaveiro, Jose/0000-0001-5568-2369; 	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for general research from the Japan Society for the Promotion of Science (to K. T.).	Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Bhatia M, 2007, LEUKEMIA LYMPHOMA, V48, P9, DOI 10.1080/10428190600909115; Bhatia Prakash K., 1999, V64, P155; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; CZUPRYN MJ, 1995, J BIOL CHEM, V270, P978, DOI 10.1074/jbc.270.2.978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dela Cruz CS, 2004, J EXP MED, V199, P503, DOI 10.1084/jem.20031205; Du XX, 1997, AM J PHYSIOL-GASTR L, V272, pG545, DOI 10.1152/ajpgi.1997.272.3.G545; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Feng YQ, 1999, BIOCHEMISTRY-US, V38, P4553, DOI 10.1021/bi982224o; Futatsumori-Sugai M., 2010, COMMUN, V391, P931; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Harmegnies D, 2003, BIOCHEM J, V375, P23, DOI 10.1042/BJ20030459; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; JENKINS N, 1994, ENZYME MICROB TECH, V16, P354, DOI 10.1016/0141-0229(94)90149-X; Karow J, 1996, BIOCHEM J, V318, P489, DOI 10.1042/bj3180489; Kaye J A, 1998, Stem Cells, V16 Suppl 2, P207; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Nicola NA, 1999, ADV PROTEIN CHEM, V52, P1; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; OHEDA M, 1990, J BIOL CHEM, V265, P11432; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Peeters K, 2008, DRUG DISCOV TODAY, V13, P798, DOI 10.1016/j.drudis.2008.06.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflanz S, 1999, FEBS LETT, V450, P117, DOI 10.1016/S0014-5793(99)00477-9; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; Sands BE, 2002, ALIMENT PHARM THERAP, V16, P399, DOI 10.1046/j.1365-2036.2002.01179.x; SANO E, 1987, CELL STRUCT FUNCT, V12, P509, DOI 10.1247/csf.12.509; SCAHILL SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4654, DOI 10.1073/pnas.80.15.4654; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takagi A, 2007, J CONTROL RELEASE, V119, P271, DOI 10.1016/j.jconrel.2007.03.009; Tan HD, 2005, BIOTECHNOL LETT, V27, P905, DOI 10.1007/s10529-005-7179-3; Trepicchio WL, 1998, ANN NY ACAD SCI, V856, P12, DOI 10.1111/j.1749-6632.1998.tb08308.x; Underhill-Day N, 2003, ENDOCRINOLOGY, V144, P3406, DOI 10.1210/en.2002-0144; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616	55	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8085	8093		10.1074/jbc.M110.152561	http://dx.doi.org/10.1074/jbc.M110.152561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21138838	Green Published, hybrid			2022-12-27	WOS:000288013300039
J	Lee, KH; Liu, YJ; Biswas, A; Ogawa, C; Kobayashi, KS				Lee, Kyoung-Hee; Liu, Yuen-Joyce; Biswas, Amlan; Ogawa, Chikako; Kobayashi, Koichi S.			A Novel Aminosaccharide Compound Blocks Immune Responses by Toll-like Receptors and Nucleotide-binding Domain, Leucine-rich Repeat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BLAU-SYNDROME; BACTERIAL PEPTIDOGLYCAN; REGULATORY ROLES; CARD15 MUTATIONS; CROHNS-DISEASE; CUTTING EDGE; MURINE MODEL; STRANDED-RNA	Toll-like receptors (TLRs) and nucleotide-binding domain, leucine-rich repeat (NLR) proteins are two major forms of innate immune receptors that trigger inflammatory responses by various biological mechanisms such as cytokine production, recruitment of inflammatory cells, or activation of adaptive immunity. Although the innate immune system is designed to fight against infectious pathogens, excessive activation of TLR or NLR signaling pathways may lead to unwarranted inflammation with hazardous outcomes, including septic shock or inflammatory diseases. As part of the search for effective therapeutics to regulate these responses, here we show that a novel aminosaccharide compound, named DFK1012, inhibits immune responses caused by TLR and NLR activation. Treatment with DFK1012, but not its derivatives DFK845 or DFK846, strongly inhibited pro-inflammatory cytokine production upon stimulation via either TLR or NLR proteins in macrophages. Importantly, we have not observed cytotoxicity in any range of its working concentration. Treatment with DFK1012 did not interfere with TLR- or NLR-induced activation of p38 and JNK, phosphorylation/degradation of I kappa B, and subsequent nuclear translocation of NF-kappa B subunit p65, suggesting that the inhibitory activity of DFK1012 is not due to the suppression of downstream signaling. Indeed, DFK1012 did not impair transcription of pro-inflammatory cytokine genes but rather promoted post-translational degradation of pro-inflammatory cytokines. Therefore, DFK1012 is a novel anti-inflammatory compound that drives proteolysis of proinflammatory cytokines induced by TLR and NLR stimulation. DFK1012 may represent a novel class of potential therapeutic agents aimed at the treatment of inflammatory disorders.	[Lee, Kyoung-Hee; Liu, Yuen-Joyce; Biswas, Amlan; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ogawa, Chikako] Eisai Res Inst, Andover, MA 01810 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Eisai Co Ltd	Kobayashi, KS (corresponding author), 1420A,44 Binney St, Boston, MA 02115 USA.	Koichi_Kobayashi@dfci.harvard.edu		Liu, Yuen-Joyce/0000-0003-1772-0082; Kobayashi, Koichi/0000-0003-2930-0114	Eisai Research Institute under Dana-Farber Cancer Institute [2696, CRF 734]; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	Eisai Research Institute under Dana-Farber Cancer Institute; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Eisai Research Institute under the Sponsored Research Agreement (Dana-Farber Cancer Institute Agreement Number Reference 2696/Eisai Research Institute CRF 734).; A recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Berdeli A, 2005, J MOL MED, V83, P535, DOI 10.1007/s00109-005-0677-x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3656, DOI 10.1016/j.bmcl.2008.04.042; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Hoshino K, 1999, J IMMUNOL, V162, P3749; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEDZHITOV R, 1997, INT IMMUNOL, V91, P317; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rose CD, 2005, J RHEUMATOL, V32, P373; Schmidt C, 2006, NAT BIOTECHNOL, V24, P230, DOI 10.1038/nbt0306-230; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Solomon KA, 1997, J IMMUNOL, V159, P4524; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wardowska A, 2009, VACCINE, V27, P369, DOI 10.1016/j.vaccine.2008.11.017; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	59	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5727	5735		10.1074/jbc.M110.108001	http://dx.doi.org/10.1074/jbc.M110.108001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138842	Green Published, hybrid			2022-12-27	WOS:000287230600081
J	Adebiyi, A; Narayanan, D; Jaggar, JH				Adebiyi, Adebowale; Narayanan, Damodaran; Jaggar, Jonathan H.			Caveolin-1 Assembles Type 1 Inositol 1,4,5-Trisphosphate Receptors and Canonical Transient Receptor Potential 3 Channels into a Functional Signaling Complex in Arterial Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERIES; CHOLESTEROL DEPLETION; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; SKELETAL-MUSCLE; CA2+ RELEASE; CONTRACTION; ACTIVATION; PROTEINS; MICE	Physical coupling of sarcoplasmic reticulum (SR) type 1 inositol 1,4,5-trisphosphate receptors (IP(3)R1) to plasma membrane canonical transient receptor potential 3 (TRPC3) channels activates a cation current (I-Cat) in arterial smooth muscle cells that induces vasoconstriction. However, structural components that enable IP(3)R1 and TRPC3 channels to communicate locally are unclear. Caveolae are plasma membrane microdomains that can compartmentalize proteins. Here, we tested the hypothesis that caveolae and specifically caveolin-1 (cav-1), a caveolae scaffolding protein, facilitate functional IP(3)R1 to TRPC3 coupling in smooth muscle cells of resistance-size cerebral arteries. Methyl-beta-cyclodextrin (M beta CD), which disassembles caveolae, reduced IP3-induced I-Cat activation in smooth muscle cells and vasoconstriction in pressurized arteries. Cholesterol replenishment reversed these effects. Cav-1 knockdown using shRNA attenuated IP3-induced vasoconstriction, but did not alter TRPC3 and IP(3)R1 expression. A synthetic peptide corresponding to the cav-1 scaffolding domain (CSD) sequence (amino acids 82-101) also attenuated IP3-induced I-Cat activation and vasoconstriction. A cav-1 antibody co-immunoprecipitated cav-1, TRPC3, and IP(3)R1 from cerebral artery lysate. ImmunoFRET indicated that cav-1, TRPC3 channels and IP(3)R1 are spatially co-localized in arterial smooth muscle cells. IP(3)R1 and TRPC3 channel spatial localization was disrupted by M beta CD and a CSD peptide. Cholesterol replenishment re-established IP(3)R1 and TRPC3 channel close spatial proximity. Taken together, these data indicate that in arterial smooth muscle cells, cav-1 co-localizes SR IP(3)R1 and plasma membrane TRPC3 channels in close spatial proximity thereby enabling IP3-induced physical coupling of these proteins, leading to I-Cat generation and vasoconstriction.	[Adebiyi, Adebowale; Narayanan, Damodaran; Jaggar, Jonathan H.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Jaggar, JH (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	jjaggar@uthsc.edu		Adebiyi, Adebowale/0000-0002-7033-1871	National Institutes of Health [R01 HL67061, HL094378, K01 HL096411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094378, K01HL096411, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grants R01 HL67061 and HL094378 (to J. H. J.), and K01 HL096411 (to A. A.).	Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Adebiyi A, 2007, AM J PHYSIOL-HEART C, V292, pH1584, DOI 10.1152/ajpheart.00584.2006; Adebiyi A, 2010, CIRC RES, V106, P1603, DOI 10.1161/CIRCRESAHA.110.216804; Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; Albert AP, 2009, CURR MED CHEM, V16, P1158, DOI 10.2174/092986709787581815; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Christian AE, 1997, J LIPID RES, V38, P2264; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Dubroca C, 2007, CARDIOVASC RES, V73, P190, DOI 10.1016/j.cardiores.2006.10.020; Flemming R, 2002, J PHYSIOL-LONDON, V543, P455, DOI 10.1113/jphysiol.2002.023366; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; Launikonis BS, 2001, J PHYSIOL-LONDON, V534, P71, DOI 10.1111/j.1469-7793.2001.00071.x; LESH RE, 1995, CIRC RES, V77, P220, DOI 10.1161/01.RES.77.2.220; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu M, 2005, J PHYSIOL-LONDON, V566, P161, DOI 10.1113/jphysiol.2005.088260; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; MORGAN JP, 1984, PFLUG ARCH EUR J PHY, V400, P338, DOI 10.1007/BF00581571; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Patel HH, 2007, FASEB J, V21, P2970, DOI 10.1096/fj.07-8424com; Potocnik SJ, 2007, J VASC RES, V44, P292, DOI 10.1159/000101451; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Shaw L, 2006, CARDIOVASC RES, V69, P825, DOI 10.1016/j.cardiores.2005.12.016; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhao GL, 2008, AM J PHYSIOL-CELL PH, V295, pC1376, DOI 10.1152/ajpcell.00362.2008; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	41	62	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4341	4348		10.1074/jbc.M110.179747	http://dx.doi.org/10.1074/jbc.M110.179747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098487	Green Published, hybrid			2022-12-27	WOS:000286975700033
J	Dong, JY; Sereno, A; Snyder, WB; Miller, BR; Tamraz, S; Doern, A; Favis, M; Wu, XF; Tran, H; Langley, E; Joseph, I; Boccia, A; Kelly, R; Wortham, K; Wang, Q; Berquist, L; Huang, F; Gao, SRX; Zhang, Y; Lugovskoy, A; Martin, S; Gouvis, H; Berkowitz, S; Chiang, G; Reff, M; Glaser, SM; Hariharan, K; Demarest, SJ				Dong, Jianying; Sereno, Arlene; Snyder, William B.; Miller, Brian R.; Tamraz, Susan; Doern, Adam; Favis, Michael; Wu, Xiufeng; Tran, Hon; Langley, Emma; Joseph, Ingrid; Boccia, Antonio; Kelly, Rebecca; Wortham, Kathleen; Wang, Qin; Berquist, Lisa; Huang, Flora; Gao, Sharon X.; Zhang, Ying; Lugovskoy, Alexey; Martin, Shelly; Gouvis, Heather; Berkowitz, Steven; Chiang, Gisela; Reff, Mitchell; Glaser, Scott M.; Hariharan, Kandasamy; Demarest, Stephen J.			Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; MULTIPLE DISEASE MEDIATORS; HAMSTER OVARY CELLS; MONOCLONAL-ANTIBODIES; DOMAIN INTERACTIONS; ESCHERICHIA-COLI; CANCER-CELLS; STABILITY; FRAGMENTS; BINDING	Bispecific antibodies (BsAbs) target multiple epitopes on the same molecular target or different targets. Although interest in BsAbs has persisted for decades, production of stable and active BsAbs has hindered their clinical evaluation. Here, we describe the production and characterization of tetravalent IgG-like BsAbs that combine the activities of allosteric and competitive inhibitors of the type-I insulin-like growth factor receptor (IGF-1R). The BsAbs, which were engineered for thermal stability, express well, demonstrate favorable biophysical properties, and recognize both epitopes on IGF-1R. Only one BsAb with a unique geometry, denoted BIIB4-5scFv, was capable of engaging all four of its binding arms simultaneously. All the BsAbs (especially BIIB4-5scFv) demonstrated enhanced ligand blocking over the single monoclonal antibodies (mAbs), particularly at high ligand concentrations. The pharmacokinetic profiles of two IgG-like BsAbs were tested in nude mice and shown to be comparable with that of the parental mAbs. The BsAbs, especially BIIB4-5scFv, demonstrated an improved ability to reduce the growth of multiple tumor cell lines and to inhibit ligand-induced IGF-1R signaling in tumor cells over the parental mAbs. BIIB4-5scFv also led to superior tumor growth inhibition over its parental mAbs in vivo. In summary, BsAbs that bridge multiple inhibitory mechanisms against a single target may generally represent a more effective strategy for intervention in oncology or other indications compared with traditional mAb therapy.	[Dong, Jianying; Demarest, Stephen J.] Biogen Idec Inc, Dept Prot Chem, San Diego, CA 92122 USA	Biogen	Dong, JY (corresponding author), Biogen Idec Inc, Dept Prot Chem, San Diego, CA 92122 USA.	jianying_dong@yahoo.com; kdemarest7@gmail.com						ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fedi P., 2000, HOLLAND FREI CANC ME, P33; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; GLENNIE MJ, 1987, J IMMUNOL, V139, P2367; HEISS MM, 2010, INT J CANCER, DOI DOI 10.1002/IJC.25423; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; JACOBS S, 1986, ENDOCRINOLOGY, V118, P223, DOI 10.1210/endo-118-1-223; Jordan JL, 2009, PROTEINS, V77, P832, DOI 10.1002/prot.22502; Kontermann RE, 2010, CURR OPIN MOL THER, V12, P176; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Majors BS, 2008, BIOTECHNOL BIOENG, V101, P567, DOI 10.1002/bit.21917; Majors BS, 2008, J BIOTECHNOL, V138, P103, DOI 10.1016/j.jbiotec.2008.08.003; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Miller Brian R., 2009, V525, P279, DOI 10.1007/978-1-59745-554-1_14; Muller D, 2007, CURR OPIN MOL THER, V9, P319; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qu ZX, 2008, BLOOD, V111, P2211, DOI 10.1182/blood-2007-08-110072; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STAERZ UD, 1986, P NATL ACAD SCI USA, V83, P1453, DOI 10.1073/pnas.83.5.1453; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wang N, 2009, PROTEINS, V76, P99, DOI 10.1002/prot.22319; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	52	30	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4703	4717		10.1074/jbc.M110.184317	http://dx.doi.org/10.1074/jbc.M110.184317			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123183	hybrid, Green Published			2022-12-27	WOS:000286975700069
J	Guth, E; Thommen, M; Weber-Ban, E				Guth, Ethan; Thommen, Michael; Weber-Ban, Eilika			Mycobacterial Ubiquitin-like Protein Ligase PafA Follows a Two-step Reaction Pathway with a Phosphorylated Pup Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI GLUTAMINE-SYNTHETASE; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; IN-VIVO; TUBERCULOSIS; PROTEASOME; PHOSPHATE; MECHANISM; SITE; MICE	In Mycobacterium tuberculosis, the enzyme PafA is responsible for the activation and conjugation of the proteasome-targeting molecule Pup to protein substrates. As the proteasomal pathway has been shown to be vital to the persistence of M. tuberculosis, understanding the reaction mechanism of PafA is critical to the design of antituberculous agents. In this study, we have developed novel techniques to study the activity of PafA and have characterized fundamental features of the reaction mechanism. We show that PafA catalyzes a two-step reaction mechanism proceeding through a gamma-glutamyl phosphate-mixed anhydride intermediate that is formed on the C-terminal glutamate of Pup before transfer of Pup to the substrate acceptor lysine. SDS-PAGE analysis of formation of the phosphorylated intermediate revealed that the rate of Pup activation matched the maximal steady-state rate of product formation in the overall reaction and suggested that Pup activation was rate-limiting when all substrates were present at saturating concentrations. Following activation, both ADP and the phosphorylated intermediate remained associated with the enzyme awaiting nucleophilic attack by a lysine residue of the target protein. The PafA reaction mechanism appeared to be noticeably biased toward the stable activation of Pup in the absence of additional substrate and required very low concentrations of ATP and Pup relative to other carboxylate-amine/ammonia ligase family members. The bona fide nucleophilic substrate PanB showed a 3 orders of magnitude stronger affinity than free lysine, promoting Pup conjugation to occur close to the rate limit of activation with physiologically relevant concentrations of substrate.	[Guth, Ethan; Thommen, Michael; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Thommen, Michael/0000-0001-5760-0697; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation; ETH; National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH(ETH Zurich); National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation	This work was supported by the Swiss National Science Foundation, the National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation, an ETH research grant, and an ETH postdoctoral fellowship (to E. G.).	Abell LM, 1995, BIOCHEMISTRY-US, V34, P16695, DOI 10.1021/bi00051a018; ALIBHAI M, 1994, BIOCHEMISTRY-US, V33, P682, DOI 10.1021/bi00169a008; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; CLARK DD, 1985, BIOCHEMISTRY-US, V24, P5147, DOI 10.1021/bi00340a029; Clemente MT, 1999, EUR J BIOCHEM, V264, P453, DOI 10.1046/j.1432-1327.1999.00636.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; HILDEBRAND JG, 1969, J BIOL CHEM, V244, P2606; Horiuchi KY, 2001, BIOCHEMISTRY-US, V40, P6450, DOI 10.1021/bi002599l; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; KRISHNASWAMY R, 1960, J BIOL CHEM, V235, pPC39; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; MEEK TD, 1982, BIOCHEMISTRY-US, V21, P2158, DOI 10.1021/bi00538a027; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; NISHIMURA JS, 1964, J BIOL CHEM, V239, P2553; NISHIMURA JS, 1963, J BIOL CHEM, V238, P1179; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; SEKURA R, 1977, J BIOL CHEM, V252, P2606; SEKURA R, 1977, J BIOL CHEM, V252, P2599; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x	38	68	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4412	4419		10.1074/jbc.M110.189282	http://dx.doi.org/10.1074/jbc.M110.189282			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21081505	Green Published, hybrid			2022-12-27	WOS:000286975700041
J	Duan, L; Motchoulski, N; Danzer, B; Davidovich, I; Shariat-Madar, Z; Levenson, VV				Duan, Lei; Motchoulski, Natalia; Danzer, Brian; Davidovich, Irina; Shariat-Madar, Zia; Levenson, Victor V.			Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIESTROGEN RESISTANCE; ENDOCRINE THERAPY; PROLYL OLIGOPEPTIDASE; PROTEIN-KINASE; TAMOXIFEN; DEATH; MACROAUTOPHAGY; INHIBITION; MECHANISMS; SENSITIVITY	Endocrine therapy with tamoxifen (TAM) significantly improves outcomes for patients with estrogen receptor-positive breast cancer. However, intrinsic (de novo) or acquired resistance to TAM occurs in a significant proportion of treated patients. To identify genes involved in resistance to TAM, we introduced full-length cDNA expression library into estrogen receptor-positive MCF7 cells and exposed them to a cytotoxic dose of 4-hydroxytamoxifen (4OHTAM). Four different library inserts were isolated from surviving clones. Re-introduction of the genes individually into naive MCF7 cells made them resistant to 4OHTAM. Cells overexpressing these genes had an increase in acidic autophagic vacuoles induced by 4OHTAM, suggesting their role in autophagy. One of them, prolylcarboxypeptidase (PRCP), was investigated further. Overexpression of PRCP increased cell proliferation, boosted several established markers of autophagy, including expression of LC3-2, sequestration of monodansylcadaverine, and proteolysis of BSA in an ER-alpha dependent manner, and increased resistance to 4OHTAM. Conversely, knockdown of endogenous PRCP in MCF7 cells increased cell sensitivity to 4OHTAM and at the same time decreased cell proliferation and expression of LC3-2, sequestration of monodansylcadaverine, and proteolysis of BSA. Inhibition of enzymatic activity of PRCP enhanced 4OHTAM-induced cytotoxicity in MCF7 cells. Cells with acquired resistance to 4OHTAM exhibited increased PRCP activity, although inhibition of PRCP prevented development of 4OHTAM resistance in parental MCF7 cells and restored response to 4OHTAM in MCF7 cells with acquired resistance to 4OHTAM. Thus, we have for the first time identified PRCP as a resistance factor for 4OHTAM resistance in estrogen receptor-positive breast cancer cells.	[Duan, Lei; Danzer, Brian; Levenson, Victor V.] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA; [Motchoulski, Natalia; Davidovich, Irina] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA	Rush University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Mississippi	Levenson, VV (corresponding author), Rush Univ, Med Ctr, Dept Radiat Oncol, 1750 W Harrison St, Chicago, IL 60612 USA.	victor_levenson@rush.edu			NCRR [P20RR021929]; Susan G. Komen Breast Cancer Foundation [BCTR 0100916, BCTR 0504311]; Department of Defense [W81XWH-07-1-0505]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104932] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR021929 from NCRR (to Z. S.-M.). This work was also supported by Susan G. Komen Breast Cancer Foundation Grants BCTR 0100916 and BCTR 0504311 (to V. V. L.) and Department of Defense Grant W81XWH-07-1-0505 (to V. V. L.).	Adamo V, 2007, ANN ONCOL, V18, P53, DOI 10.1093/annonc/mdm225; ARAFAH BM, 1986, CANCER RES, V46, P3268; Arpino G, 2009, ONCOLOGY-BASEL, V77, P23, DOI 10.1159/000258493; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Brodie A, 2010, J STEROID BIOCHEM, V118, P283, DOI 10.1016/j.jsbmb.2009.09.004; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Jordan VC, 2004, CANCER CELL, V5, P207, DOI 10.1016/S1535-6108(04)00059-5; Kim SK, 2008, FREE RADICAL BIO MED, V45, P537, DOI 10.1016/j.freeradbiomed.2008.05.011; Levenson AS, 1997, CANCER RES, V57, P3071; Liang XH, 2001, CANCER RES, V61, P3443; LIEN EA, 1989, CANCER RES, V49, P2175; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273; Mele DA, 2009, CELL CYCLE, V8, P2425, DOI 10.4161/cc.8.15.9144; Miyoshi Y, 2010, BREAST CANCER-TOKYO, V17, P86, DOI 10.1007/s12282-009-0177-x; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; ODYA CE, 1978, J BIOL CHEM, V253, P5927; Poole R, 2007, CURR OPIN ONCOL, V19, P564, DOI 10.1097/CCO.0b013e3282f1c523; Purohit A, 2002, STEROIDS, V67, P979, DOI 10.1016/S0039-128X(02)00046-6; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; REDDEL RR, 1985, CANCER RES, V45, P1525; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shariat-Madar Z, 2005, AM J PHYSIOL-HEART C, V289, pH2697, DOI 10.1152/ajpheart.00715.2005; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734	45	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2864	2876		10.1074/jbc.M110.143271	http://dx.doi.org/10.1074/jbc.M110.143271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087932	hybrid, Green Published			2022-12-27	WOS:000286464300052
J	Lefort, CT; Wojciechowski, K; Hocking, DC				Lefort, Craig T.; Wojciechowski, Katherine; Hocking, Denise C.			N-cadherin Cell-Cell Adhesion Complexes Are Regulated by Fibronectin Matrix Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UVOMORULIN-CATENIN COMPLEX; ADHERENS JUNCTIONS; SMOOTH-MUSCLE; CYCLE PROGRESSION; MEDIATED ADHESION; PHYSICAL STATE; FIBROBLASTS; GROWTH; MORPHOGENESIS; INTEGRINS	Fibronectin is a principal component of the extracellular matrix. Soluble fibronectin molecules are assembled into the extracellular matrix as insoluble, fibrillar strands via a cell-dependent process. In turn, the interaction of cells with the extracellular matrix form of fibronectin stimulates cell functions critical for tissue repair. Cross-talk between cell-cell and cell-extracellular matrix adhesion complexes is essential for the organization of cells into complex, functional tissue during embryonic development and tissue remodeling. Here, we demonstrate that fibronectin matrix assembly affects the organization, composition, and function of N-cadherin-based adherens junctions. Using fibronectin-null mouse embryonic myofibro-blasts, we identified a novel quaternary complex composed of N-cadherin, beta-catenin, tensin, and actin that exists in the absence of a fibronectin matrix. In the absence of fibronectin, homophilic N-cadherin ligation recruited both tensin and alpha 5 beta 1 integrins into nascent cell-cell adhesions. Initiation of fibronectin matrix assembly disrupted the association of tensin and actin with N-cadherin, released alpha 5 beta 1 integrins and tensin from cell-cell contacts, stimulated N-cadherin reorganization into thin cellular protrusions, and decreased N-cadherin adhesion. Fibronectin matrix assembly has been shown to recruit alpha 5 beta 1 integrins and tensin into fibrillar adhesions. Taken together, these studies suggest that tensin serves as a common cytoskeletal link for integrin- and cadherin-based adhesions and that the translocation of alpha 5 beta 1 integrins from cell-cell contacts into fibrillar adhesions during fibronectin matrix assembly is a novel mechanism by which cell-cell and cell-matrix adhesions are coordinated.	Univ Rochester, Sch Med & Dent, Dept Biomed Engn, Rochester, NY 14642 USA; [Wojciechowski, Katherine; Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hocking, DC (corresponding author), Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	denise_hocking@urmc.rochester.edu	Hocking, Denise/H-7903-2012	Hocking, Denise/0000-0003-2337-0357	National Institutes of Health [EB008368, GM081513, T32HL066988]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EB008368 and GM081513.; Supported by National Institutes of Health Grant T32HL066988 and a pre-doctoral fellowship from the American Heart Association. Present address: La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.	Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; BOCKHOLT SM, 1992, EXP CELL RES, V203, P39, DOI 10.1016/0014-4827(92)90037-9; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BROWN S, 1976, J SUPRAMOL STR CELL, V5, P119, DOI 10.1002/jss.400050203; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; El Sayegh TY, 2007, FEBS LETT, V581, P167, DOI 10.1016/j.febslet.2006.12.029; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gui LQ, 2006, J BIOL CHEM, V281, P34816, DOI 10.1074/jbc.M608611200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Jones M, 2002, ARTERIOSCL THROM VAS, V22, P1972, DOI 10.1161/01.ATV.0000036416.14084.5A; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; LINASK KK, 1988, DEV BIOL, V129, P315, DOI 10.1016/0012-1606(88)90378-8; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LO SH, 1994, J BIOL CHEM, V269, P22310; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; NORTH AJ, 1993, J CELL BIOL, V120, P1159, DOI 10.1083/jcb.120.5.1159; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pierres A, 2007, FEBS LETT, V581, P1841, DOI 10.1016/j.febslet.2007.03.077; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YONEMURA S, 1995, J CELL SCI, V108, P127; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	66	31	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3149	3160		10.1074/jbc.M110.115733	http://dx.doi.org/10.1074/jbc.M110.115733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084302	Green Published, hybrid			2022-12-27	WOS:000286464300076
J	Ota, R; Kotani, T; Yamashita, M				Ota, Ryoma; Kotani, Tomoya; Yamashita, Masakane			Biochemical Characterization of Pumilio1 and Pumilio2 in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYTOPLASMIC POLYADENYLATION; CELL-CYCLE; MEIOTIC MATURATION; BINDING PROTEINS; TEMPORAL CONTROL; MAP KINASE; PUM2 GENES; IDENTIFICATION; ACTIVATION	Precise control of the timing of translational activation of dormant mRNAs stored in oocytes is required for normal progression of oocyte maturation. We previously showed that Pumilio1 (Pum1) is specifically involved in the translational control of cyclin B1 mRNA during Xenopus oocyte maturation, in cooperation with cytoplasmic polyadenylation element-binding protein (CPEB). It was reported that another Pumilio, Pumilio2 (Pum2), exists in Xenopus oocytes and that this protein regulates the translation of RINGO mRNA, together with Deleted in Azoospermia-like protein (DAZL). In this study, we characterized Pum1 and Pum2 biochemically by using newly produced antibodies that discriminate between them. Pum1 and Pum2 are bound to several key proteins involved in translational control of dormant mRNAs, including CPEB and DAZL, in immature oocytes. However, Pum1 and Pum2 themselves have no physical interaction. Injection of anti-Pum1 or anti-Pum2 antibody accelerated CPEB phosphorylation, cyclin B1 translation, and oocyte maturation. Pum1 phosphorylation coincides with the dissociation of CPEB from Pum1 and the translational activation of cyclin B1 mRNA, a target of Pum1, whereas Pum2 phosphorylation occurred at timing earlier than that for Pum1. Some, but not all, of cyclin B1 mRNAs release the deadenylase PARN during oocyte maturation, whereas Pum1 remains associated with the mRNA. On the basis of these findings, we discuss the functions of Pum1 and Pum2 in translational control of mRNAs during oocyte maturation.	[Kotani, Tomoya; Yamashita, Masakane] Hokkaido Univ, Fac Sci, Dept Biol Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Fac Sci, Grad Sch Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Yamashita, M (corresponding author), North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	myama@sci.hokudai.ac.jp	Yamashita, Masakane/A-4556-2012	Yamashita, Masakane/0000-0002-3696-451X; Kotani, Tomoya/0000-0003-1930-6635	Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [23770196, 23013001] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to R. O.).	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Git A, 2009, RNA, V15, P1121, DOI 10.1261/rna.1195709; HIRAI T, 1992, MOL REPROD DEV, V33, P131, DOI 10.1002/mrd.1080330204; Kim JS, 2006, J HYPERTENS, V24, pS177; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; Kurisaki I, 2007, CELL TISSUE RES, V327, P33, DOI 10.1007/s00441-006-0260-y; Lee JY, 2008, MOL REPROD DEV, V75, P184, DOI 10.1002/mrd.20765; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Ota R, 2008, ZOOL SCI, V25, P773, DOI 10.2108/zsj.25.773; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Sakamoto I, 1998, DEV BIOL, V195, P60, DOI 10.1006/dbio.1997.8835; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; TANAKA T, 1995, DEV GROWTH DIFFER, V37, P387, DOI 10.1046/j.1440-169X.1995.t01-3-00005.x; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; Wang YY, 2008, DEV BIOL, V317, P454, DOI 10.1016/j.ydbio.2008.02.033; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yasuda K, 2010, DEV BIOL, V348, P76, DOI 10.1016/j.ydbio.2010.09.015	40	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2853	2863		10.1074/jbc.M110.155523	http://dx.doi.org/10.1074/jbc.M110.155523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098481	Green Published, hybrid			2022-12-27	WOS:000286464300051
J	Hu, JH; Mukhopadhyay, A; Craig, AWB				Hu, Jinghui; Mukhopadhyay, Alka; Craig, Andrew W. B.			Transducer of Cdc42-dependent Actin Assembly Promotes Epidermal Growth Factor-induced Cell Motility and Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; FORMIN-BINDING PROTEIN-17; WASP-WIP COMPLEX; N-WASP; CARCINOMA-CELLS; CORTACTIN PHOSPHORYLATION; FIBROBLAST MIGRATION; COLLECTIVE INVASION; BAR PROTEINS	Toca-1 (transducer of Cdc42-dependent actin assembly) interacts with the Cdc42.N-WASP and Abi1.Rac.WAVE F-actin branching pathways that function in lamellipodia formation and cell motility. However, the potential role of Toca-1 in these processes has not been reported. Here, we show that epidermal growth factor (EGF) induces Toca-1 localization to lamellipodia, where it co-localizes with F-actin and Arp2/3 complex in A431 epidermoid carcinoma cells. EGF also induces tyrosine phosphorylation of Toca-1 and interactions with N-WASP and Abi1. Stable knockdown of Toca-1 expression by RNA interference has no effect on cell growth, EGF receptor expression, or internalization. However, Toca-1 knockdown cells display defects in EGF-induced filopodia and lamellipodial protrusions compared with control cells. Further analyses reveal a role for Toca-1 in localization of Arp2/3 and Abi1 to lamellipodia. Toca-1 knockdown cells also display a significant defect in EGF-induced motility and invasiveness. Taken together, these results implicate Toca-1 in coordinating actin assembly within filopodia and lamellipodia to promote EGF-induced cell migration and invasion.	[Craig, Andrew W. B.] Queens Univ, Dept Biochem, Canc Res Inst, Kingston, ON K7L 3N6, Canada; Queens Univ, Canc Biol & Genet Div, Canc Res Inst, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Craig, AWB (corresponding author), Queens Univ, Dept Biochem, Canc Res Inst, Kingston, ON K7L 3N6, Canada.	andrew.craig@queensu.ca	Craig, Andrew/G-2312-2017; Craig, Andrew/AAC-6923-2019	Craig, Andrew/0000-0002-2039-2393; Craig, Andrew/0000-0002-2039-2393	Canadian Cancer Society Research Institute; Canadian Institutes for Health Research (CIHR) at Queen's University; Canadian Breast Cancer Foundation-Ontario Chapter	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR) at Queen's University(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation-Ontario Chapter	This work was supported by a grant from the Canadian Cancer Society Research Institute (to A. W. B. C.). Salary support was provided by the Canadian Institutes for Health Research (CIHR) training program in cancer research at Queen's University (to J. H.), Canadian Breast Cancer Foundation-Ontario Chapter (to J. H.), and a CIHR New Investigator award (to A. W. B. C.).	Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Fuchs U, 2001, P NATL ACAD SCI USA, V98, P8756, DOI 10.1073/pnas.121433898; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hu JH, 2009, CELL SIGNAL, V21, P1686, DOI 10.1016/j.cellsig.2009.07.007; Huang YT, 2002, INT J CANCER, V99, P505, DOI 10.1002/ijc.10373; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Suetsugu S, 2009, FEBS LETT, V583, P3401, DOI 10.1016/j.febslet.2009.10.019; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098	61	34	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2261	2272		10.1074/jbc.M110.157974	http://dx.doi.org/10.1074/jbc.M110.157974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21062739	Green Published, hybrid			2022-12-27	WOS:000286191500066
J	Liu, KD; Cho, YY; Yao, K; Nadas, J; Kim, DJ; Cho, EJ; Lee, MH; Pugliese, A; Zhang, JSA; Bode, AM; Dong, ZM; Dong, ZG				Liu, Kangdong; Cho, Yong-Yeon; Yao, Ke; Nadas, Janos; Kim, Dong Joon; Cho, Eun-Jin; Lee, Mee-Hyun; Pugliese, Angelo; Zhang, Jishuai; Bode, Ann M.; Dong, Ziming; Dong, Zigang			Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-1; ELEMENT-BINDING PROTEIN; GENOME-WIDE ANALYSIS; GENE ACTIVATION; MAPK PATHWAY; HISTONE H3; FACTOR-I; PHOSPHORYLATION; KINASE; RSK2	RSK2 is a widely expressed serine/threonine kinase, and its activation enhances cell proliferation. Here, we report that ATF1 is a novel substrate of RSK2 and that RSK2-ATF1 signaling plays an important role in EGF-induced neoplastic cell transformation. RSK2 phosphorylated ATF1 at Ser-63 and enhanced ATF1 transcriptional activity. Docking experiments using the crystal structure of the RSK2 N-terminal kinase domain combined with in vitro pulldown assays demonstrated that eriodictyol, a flavanone found in fruits, bound with the N-terminal kinase domain of RSK2 to inhibit RSK2 N-terminal kinase activity. In cells, eriodictyol inhibited phosphorylation of ATF1 but had no effect on the phosphorylation of RSK, MEK1/2, ERK1/2, p38 or JNKs, indicating that eriodictyol specifically suppresses RSK2 signaling. Furthermore, eriodictyol inhibited RSK2-mediated ATF1 transactivation and tumor promoter-induced transformation of JB6 Cl41 cells. Eriodictyol or knockdown of RSK2 or ATF1 also suppressed Ras-mediated focus formation. Overall, these results indicate that RSK2-ATF1 signaling plays an important role in neoplastic cell transformation and that eriodictyol is a novel natural compound for suppressing RSK2 kinase activity.	[Pugliese, Angelo; Zhang, Jishuai; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Liu, Kangdong; Yao, Ke; Dong, Ziming] Zhengzhou Univ, Basic Med Coll, Zhengzhou 450001, Peoples R China	University of Minnesota System; Zhengzhou University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Kim, Dong Joon/AAL-8967-2020; pugliese, angelo/C-1729-2008	Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA111536, CA120388, CA077646, R37CA081064, ES016548]; The Hormel Foundation; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA077646, R01CA111536, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, National Institutes of Health Grants CA111536, CA120388, CA077646, R37CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BROWN AD, 1995, ONCOGENE, V10, P1749; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Clavin M, 2007, J ETHNOPHARMACOL, V112, P585, DOI 10.1016/j.jep.2007.04.007; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kang SM, 2009, MOL CELL BIOL, V29, P2105, DOI 10.1128/MCB.00998-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZD, 2009, FEBS LETT, V583, P1999, DOI 10.1016/j.febslet.2009.05.013; LIU F, 1993, J BIOL CHEM, V268, P6714; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nebreda AR, 1999, SCIENCE, V286, P1309, DOI 10.1126/science.286.5443.1309; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; *SCHROG SUIT, 2009, IND FIT DOCK PROT GL; Shimomura A, 1996, J BIOL CHEM, V271, P17957, DOI 10.1074/jbc.271.30.17957; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	40	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2057	2066		10.1074/jbc.M110.147306	http://dx.doi.org/10.1074/jbc.M110.147306			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098035	Green Published, hybrid			2022-12-27	WOS:000286191500048
J	Bala, S; Marcos, M; Kodys, K; Csak, T; Catalano, D; Mandrekar, P; Szabo, G				Bala, Shashi; Marcos, Miguel; Kodys, Karen; Csak, Timea; Catalano, Donna; Mandrekar, Pranoti; Szabo, Gyongyi			Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor alpha (TNF alpha) Production via Increased mRNA Half-life in Alcoholic Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHRONIC ETHANOL EXPOSURE; RAT KUPFFER CELLS; NONALCOHOLIC STEATOHEPATITIS; 3'-UNTRANSLATED REGION; INFLAMMATORY RESPONSE; CHOLINE-DEFICIENT; CONTROLLED-TRIAL; HUMAN MONOCYTES	Activation of Kupffer cells (KCs) by gut-derived lipopolysaccharide (LPS) and Toll-Like Receptors 4 (TLR4)-LPS-mediated increase in TNF alpha production has a central role in the pathogenesis of alcoholic liver disease. Micro-RNA (miR)-125b, miR-146a, and miR-155 can regulate inflammatory responses to LPS. Here we evaluated the involvement of miRs in alcohol-induced macrophage activation. Chronic alcohol treatment in vitro resulted in a time-dependent increase in miR-155 but not miR-125b or miR-146a levels in RAW 264.7 macrophages. Furthermore, alcohol pretreatment augmented LPS-induced miR-155 expression in macrophages. We found a linear correlation between alcohol-induced increase in miR-155 and TNF alpha induction. In a mouse model of alcoholic liver disease, we found a significant increase in both miR-155 levels and TNF alpha production in isolated KCs when compared with pair-fed controls. The mechanistic role of miR-155 in TNF alpha regulation was indicated by decreased TNF alpha levels in alcohol-treated macrophages after inhibition of miR-155 and by increased TNF alpha production after miR-155 overexpression, respectively. We found that miR-155 affected TNF alpha mRNA stability because miR-155 inhibition decreased whereas miR-155 overexpression increased TNF alpha mRNA half-life. Using the NF-kappa B inhibitors, MG-132 or Bay11-7082, we demonstrated that NF-kappa B activation mediated the up-regulation of miR-155 by alcohol in KCs. In conclusion, our novel data demonstrate that chronic alcohol consumption increases miR-155 in macrophages via NF-kappa B and the increased miR-155 contributes to alcohol-induced elevation in TNF alpha production via increased mRNA stability.	[Bala, Shashi; Marcos, Miguel; Kodys, Karen; Csak, Timea; Catalano, Donna; Mandrekar, Pranoti; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Marcos, Miguel/B-3550-2008	Marcos, Miguel/0000-0003-1269-4487	National Institutes of Health [AA011576, AA008577]; Alfonso Martin Escudero Foundation, Spain; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576, R01AA008577, R01AA017986, R29AA008577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfonso Martin Escudero Foundation, Spain; Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA011576 and AA008577 (to G.S.). This work was also supported by a scholarship from the Alfonso Martin Escudero Foundation, Spain (to M.M.).; We thank Jan Petrasek and Odette Taha for help in animal work. Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were used for this study.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Gaetke LM, 2003, J AM COLL NUTR, V22, P415, DOI 10.1080/07315724.2003.10719325; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Han J, 1990, Eur Cytokine Netw, V1, P71; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hill DB, 2000, J LAB CLIN MED, V135, P387, DOI 10.1067/mlc.2000.106451; Hill DB, 1999, CLIN BIOCHEM, V32, P563, DOI 10.1016/S0009-9120(99)00056-9; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Menon KVN, 2004, AM J GASTROENTEROL, V99, P255, DOI 10.1111/j.1572-0241.2004.04034.x; Nagy LE, 2004, ALCOHOL, V33, P229, DOI 10.1016/j.alcohol.2004.09.002; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romics L, 2005, ALCOHOL CLIN EXP RES, V29, P1018, DOI 10.1097/01.ALC.0000167744.60838.4A; Romics L, 2004, HEPATOLOGY, V40, P376, DOI 10.1002/hep.20304; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thakur V, 2007, J GASTROEN HEPATOL, V22, pS53, DOI 10.1111/j.1440-1746.2006.04650.x; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang EH, 1997, CANCER RES, V57, P5426; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9	52	301	318	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1436	1444		10.1074/jbc.M110.145870	http://dx.doi.org/10.1074/jbc.M110.145870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062749	Green Published, hybrid			2022-12-27	WOS:000286005000056
J	Choi, HS; Su, WM; Morgan, JM; Han, GS; Xu, Z; Karanasios, E; Siniossoglou, S; Carman, GM				Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Karanasios, Eleftherios; Siniossoglou, Symeon; Carman, George M.			Phosphorylation of Phosphatidate Phosphatase Regulates Its Membrane Association and Physiological Functions in Saccharomyces cerevisiae IDENTIFICATION OF SER602, THR723, AND SER744 AS THE SITES PHOSPHORYLATED BY CDC28 (CDK1)-ENCODED CYCLIN-DEPENDENT KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHY FLD MUTATION; PHOSPHOLIPID BIOSYNTHESIS; PROTEIN-PHOSPHORYLATION; ACID PHOSPHATASE; LIPID-METABOLISM; SHUTTLE VECTORS; GLOBAL ANALYSIS; CTP SYNTHETASE; YEAST; GENE	The Saccharomyces cerevisiae PAH1-encoded phosphatidate phosphatase (PAP) catalyzes the penultimate step in the synthesis of triacylglycerol and plays a role in the transcriptional regulation of phospholipid synthesis genes. PAP is phosphorylated at multiple Ser and Thr residues and is dephosphorylated for in vivo function by the Nem1p-Spo7p protein phosphatase complex localized in the nuclear/endoplasmic reticulum membrane. In this work, we characterized seven previously identified phosphorylation sites of PAP that are within the Ser/Thr-Pro motif. When expressed on a low copy plasmid, wild type PAP could not complement the pah1 Delta mutant in the absence of the Nem1p-Spo7p complex. However, phosphorylation-deficient PAP (PAP-7A) containing alanine substitutions for the seven phosphorylation sites bypassed the requirement of the phosphatase complex and complemented the pah1 Delta nem1 Delta mutant phenotypes, such as temperature sensitivity, nuclear/endoplasmic reticulum membrane expansion, decreased triacylglycerol synthesis, and derepression of INO1 expression. Subcellular fractionation coupled with immunoblot analysis showed that PAP-7A was highly enriched in the membrane fraction. In fluorescence spectroscopy analysis, the PAP-7A showed tighter association with phospholipid vesicles than wild type PAP. Using site-directed mutagenesis of PAP, we identified Ser(602), Thr(723), and Ser(744), which belong to the seven phosphorylation sites, as the sites phosphorylated by the CDC28 (CDK1)-encoded cyclin-dependent kinase. Compared with the dephosphorylation mimic of the seven phosphorylation sites, alanine substitution for Ser(602), Thr(723), and/or Ser(744) had a partial effect on circumventing the requirement for the Nem1p-Spo7p complex.	[Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Karanasios, Eleftherios; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [GM-50679]; Medical Research Council [G0701446]; MRC [G0701446] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 (to G.M.C.). This work was also supported by Medical Research Council Grant G0701446 (to S.S.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CASALS C, 1993, BIOCHEM J, V296, P585, DOI 10.1042/bj2960585; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CULBERTSON MR, 1975, GENETICS, V80, P23; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	71	88	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1486	1498		10.1074/jbc.M110.155598	http://dx.doi.org/10.1074/jbc.M110.155598			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081492	Green Published, hybrid			2022-12-27	WOS:000286005000061
J	Groisman, B; Shenkman, M; Ron, E; Lederkremer, GZ				Groisman, Bella; Shenkman, Marina; Ron, Efrat; Lederkremer, Gerardo Z.			Mannose Trimming Is Required for Delivery of a Glycoprotein from EDEM1 to XTP3-B and to Late Endoplasmic Reticulum-associated Degradation Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; ASIALOGLYCOPROTEIN RECEPTOR SUBUNITS; UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED PROTEINS; SUGAR CHAINS; MRH DOMAIN; N-GLYCANS; MEMBRANE	Although the trimming of alpha 1,2-mannose residues from precursor N-linked oligosaccharides is an essential step in the delivery of misfolded glycoproteins to endoplasmic reticulum (ER)-associated degradation (ERAD), the exact role of this trimming is unclear. EDEM1 was initially suggested to bind N-glycans after mannose trimming, a role presently ascribed to the lectins OS9 and XTP3-B, because of their in vitro affinities for trimmed oligosaccharides. We have shown before that ER mannosidase I (ERManI) is required for the trimming and concentrates together with the ERAD substrate and ERAD machinery in the pericentriolar ER-derived quality control compartment (ERQC). Inhibition of mannose trimming prevents substrate accumulation in the ERQC. Here, we show that the mannosidase inhibitor kifunensine or ERManI knockdown do not affect binding of an ERAD substrate glycoprotein to EDEM1. In contrast, substrate association with XTP3-B and with the E3 ubiquitin ligases HRD1 and SCFFbs2 was inhibited. Consistently, whereas the ERAD substrate partially colocalized upon proteasomal inhibition with EDEM1, HRD1, and Fbs2 at the ERQC, colocalization was repressed by mannosidase inhibition in the case of the E3 ligases but not for EDEM1. Interestingly, association and colocalization of the substrate with Derlin-1 was independent of mannose trimming. The HRD1 adaptor protein SEL1L had been suggested to play a role in N-glycan-dependent substrate delivery to OS9 and XTP3-B. However, substrate association with XTP3-B was still dependent on mannose trimming upon SEL1L knockdown. Our results suggest that mannose trimming enables delivery of a substrate glycoprotein from EDEM1 to late ERAD steps through association with XTP3-B.	[Groisman, Bella; Shenkman, Marina; Ron, Efrat; Lederkremer, Gerardo Z.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il		Lederkremer, Gerardo/0000-0002-9857-7152	Israel Science Foundation [1229/07]; German-Israeli Project Cooperation (DIP)	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (DIP)	This work was supported by grants from the Israel Science Foundation (1229/07) and German-Israeli Project Cooperation (DIP).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Ayalon-Soffer M, 1999, J CELL SCI, V112, P3309; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Frenkel Z, 2004, MOL BIOL CELL, V15, P2133, DOI 10.1091/mbc.E03-12-0899; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Groisman B, 2006, ISRAEL J CHEM, V46, P189, DOI 10.1560/2QPD-9WP9-NCYK-58X3; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Jakob CA, 2001, EMBO REP, V2, P423; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shenkman M, 2000, J BIOL CHEM, V275, P2845, DOI 10.1074/jbc.275.4.2845; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Yamaguchi D, 2010, GLYCOBIOLOGY, V20, P348, DOI 10.1093/glycob/cwp182; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2623, DOI 10.1271/bbb.70074; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735; Zuber C, 2007, P NATL ACAD SCI USA, V104, P4407, DOI 10.1073/pnas.0700154104	54	46	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1292	1300		10.1074/jbc.M110.154849	http://dx.doi.org/10.1074/jbc.M110.154849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062743	Green Published, hybrid			2022-12-27	WOS:000286005000041
J	Misra, UK; Payne, S; Pizzo, SV				Misra, Uma K.; Payne, Sturgis; Pizzo, Salvatore V.			Ligation of Prostate Cancer Cell Surface GRP78 Activates a Proproliferative and Antiapoptotic Feedback Loop A ROLE FOR SECRETED PROSTATE-SPECIFIC ANTIGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL DOMAIN; NF-KAPPA-B; SIGNAL-TRANSDUCTION; RECEPTOR; ALPHA(2)-MACROGLOBULIN; EXPRESSION; PROTEIN; PSA; ALPHA-2-MACROGLOBULIN; ANTIBODIES	GRP78, a well characterized chaperone in the endoplasmic reticulum, is critical to the unfolded protein response. More recently, it has been identified on the cell surface, where it has many roles. On cancer cells, it functions as a signaling receptor coupled to proproliferative/antiapoptotic and promigratory mechanisms. In the current study, we demonstrate that ligation of prostate cancer cell surface GRP78 by its natural ligand, activated alpha(2)-macroglobulin (alpha M-2*), results in a 2-3-fold up-regulation in the synthesis of prostate-specific antigen (PSA). The PSA is secreted into the medium as an active proteinase, where it binds to native alpha M-2. The resultant alpha M-2.PSA complexes bind to GRP78, causing a 1.5-2-fold increase in the activation of MEK1/2, ERK1/2, S6K, and Akt, which is coupled with a 2-3-fold increase in DNA and protein synthesis. PSA is a marker for the progression of prostate cancer, but its mechanistic role in the disease is unclear. The present studies suggest that PSA may be involved in a signal transduction-dependent feedback loop, whereby it promotes a more aggressive behavior by human prostate cancer cells.	[Misra, Uma K.; Payne, Sturgis; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	Pizzo001@mc.duke.edu			National Institutes of Health [CA 131235]; NATIONAL CANCER INSTITUTE [R01CA131235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 131235.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Asplin IR, 2000, ARCH BIOCHEM BIOPHYS, V383, P135, DOI 10.1006/abbi.2000.2052; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gurova KV, 2002, ONCOGENE, V21, P153, DOI 10.1038/sj.onc.1205001; Ito K, 2009, INT J UROL, V16, P458, DOI 10.1111/j.1442-2042.2009.02293.x; Kanoh W, 2001, ANTICANCER RES, V21, P551; Kanoh Y, 2001, ONCOL REP, V8, P515; Kanoh Y, 2008, J CLIN LAB ANAL, V22, P302, DOI 10.1002/jcla.20260; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; LeBeau AM, 2009, BIOCHEMISTRY-US, V48, P3490, DOI 10.1021/bi9001858; Leman ES, 2009, J CELL BIOCHEM, V108, P3, DOI 10.1002/jcb.22227; Lin VK, 2005, PROSTATE, V63, P299, DOI 10.1002/pros.20183; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2010, BIOCHEM BIOPH RES CO, V392, P538, DOI 10.1016/j.bbrc.2010.01.058; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2010, BIOCHEM BIOPH RES CO, V391, P272, DOI 10.1016/j.bbrc.2009.11.048; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; OHTANI H, 1985, ONCOLOGY, V42, P341, DOI 10.1159/000226060; Otto A, 1998, J UROLOGY, V159, P297, DOI 10.1016/S0022-5347(01)64085-0; Payne H., 2010, UROL ONCOL-SEMIN ORI, DOI [10.1016/j.urolone.2009.11.003, DOI 10.1016/J.UROLONE.2009.11.003]; Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395; Wu S. M., 2000, HEMOSTASIS THROMBOSI, P367	36	57	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1248	1259		10.1074/jbc.M110.129767	http://dx.doi.org/10.1074/jbc.M110.129767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056970	Green Published, hybrid			2022-12-27	WOS:000286005000036
J	Benjamin, JJR; Poon, PP; Lewis, SM; Auger, A; Wong, TA; Singer, RA; Johnston, GC				Benjamin, Jeremy J. R.; Poon, Pak P.; Lewis, Stephen M.; Auger, Andreanne; Wong, Tania A.; Singer, Richard A.; Johnston, Gerald C.			The Yeast Arf GTPase-activating Protein Age1 Is Regulated by Phospholipase D for Post-Golgi Vesicular Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; RETRIEVAL; BINDING; FAMILY; GCS1; COATOMER; VESICLES; SUBUNIT	Vesicular transport shuttles cargo among intracellular compartments. Several stages of vesicular transport are mediated by the small GTPase Arf, which is controlled in a cycle of GTP binding and hydrolysis by Arf guanine-nucleotide exchange factors and Arf GTPase-activating proteins (ArfGAPs), respectively. In budding yeast the Age2 + Gcs1 ArfGAP pair facilitates post-Golgi transport. We have found the AGE1 gene, encoding another ArfGAP, can in high gene-copy number alleviate the temperature sensitivity of cells carrying mutations affecting the Age2 + Gcs1 ArfGAP pair. Moreover, increased AGE1 gene dosage compensates for the complete absence of the otherwise essential Age2 + Gcs1 ArfGAP pair. Increased dosage of SFH2, encoding a phosphatidylinositol transfer protein, also allows cell growth in the absence of the Age2 + Gcs1 pair, but good growth in this situation requires Age1. The ability of Age1 to overcome the need for Age2 + Gcs1 depends on phospholipase D activity that regulates lipid composition. We show by direct assessment of Age1 ArfGAP activity that Age1 is regulated by lipid composition and can provide ArfGAP function for post-Golgi transport.	[Johnston, Gerald C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Poon, Pak P.; Auger, Andreanne; Singer, Richard A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University	Johnston, GC (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.	g.c.johnston@dal.ca	Lewis, Stephen/E-5533-2010	Lewis, Stephen/0000-0001-9537-5822	Canadian Institutes of Health Research [MOP-64293]; Beatrice Hunter Cancer Research Institute; The Terry Fox Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; The Terry Fox Foundation	This work was supported by Grant MOP-64293 from the Canadian Institutes of Health Research (to G.C.J. and R.A.S.).; Supported by a trainee award from The Beatrice Hunter Cancer Research Institute with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at Canadian Institutes of Health Research.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; ARCHAMBAULT J, 1992, MOL GEN GENET, V232, P408, DOI 10.1007/BF00266244; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Huber I, 2001, METHOD ENZYMOL, V329, P307; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SIKORSKI RS, 1989, GENETICS, V122, P19; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Wong TA, 2005, P NATL ACAD SCI USA, V102, P12777, DOI 10.1073/pnas.0506156102; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792	34	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5187	5196		10.1074/jbc.M110.185108	http://dx.doi.org/10.1074/jbc.M110.185108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135091	Green Published, hybrid			2022-12-27	WOS:000287230600027
J	Cabrera, R; Baez, M; Pereira, HM; Caniuguir, A; Garratt, RC; Babul, J				Cabrera, Ricardo; Baez, Mauricio; Pereira, Humberto M.; Caniuguir, Andres; Garratt, Richard C.; Babul, Jorge			The Crystal Complex of Phosphofructokinase-2 of Escherichia coli with Fructose-6-phosphate KINETIC AND STRUCTURAL ANALYSIS OF THE ALLOSTERIC ATP INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE; REGULATORY PROPERTIES; DOMAIN MOTIONS; BINDING; MECHANISM; KINASE; AGGREGATION; TRANSITIONS; MUTAGENESIS; PHOSPHATE	Substrate inhibition by ATP is a regulatory feature of the phosphofructokinases isoenzymes from Escherichia coli (Pfk-1 and Pfk-2). Under gluconeogenic conditions, the loss of this regulation in Pfk-2 causes substrate cycling of fructose-6-phosphate (fructose-6-P) and futile consumption of ATP delaying growth. In the present work, we have broached the mechanism of ATP-induced inhibition of Pfk-2 from both structural and kinetic perspectives. The crystal structure of Pfk-2 in complex with fructose-6-P is reported to a resolution of 2 angstrom. The comparison of this structure with the previously reported inhibited form of the enzyme suggests a negative interplay between fructose-6-P binding and allosteric binding of MgATP. Initial velocity experiments show a linear increase of the apparent K-0.5 for fructose-6-P and a decrease in the apparent k(cat) as a function of MgATP concentration. These effects occur simultaneously with the induction of a sigmoidal kinetic behavior (n(H) of approximately 2). Differences and resemblances in the patterns of fructose-6-P binding and the mechanism of inhibition are discussed for Pfk-1 and Pfk-2, as an example of evolutionary convergence, because these enzymes do not share a common ancestor.	[Cabrera, Ricardo; Baez, Mauricio; Caniuguir, Andres; Babul, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Pereira, Humberto M.; Garratt, Richard C.] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil	Universidad de Chile; Universidade de Sao Paulo	Cabrera, R (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Casilla 653, Santiago, Chile.	ricabrer@uchile.cl	Cabrera, Ricardo/H-8132-2014; garratt, richard c/F-6921-2011; Pereira, Humberto M/J-7824-2016; Inbeqmedi, Inct/I-1929-2013; 4, INCT/H-4499-2013; Baez, Mauricio/H-7517-2013	Pereira, Humberto M/0000-0002-8652-6729; garratt, richard/0000-0002-2016-3179; Cabrera, Ricardo/0000-0002-8896-3172	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile [FONDECYT 1090336]; CEPID; FAPESP; CNPq	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile; CEPID; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Comision Nacional de Investigacion Cientifica y Tecnologica Grant FONDECYT 1090336, Chile, and by funds from the following brazilian institutions: CEPID and INCT programs of FAPESP and CNPq (to R.C.G. and H.M.P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ATKINSON DE, 1965, J BIOL CHEM, V240, P757; BABUL J, 1978, J BIOL CHEM, V253, P4350; Baez M, 2008, FEBS LETT, V582, P1907, DOI 10.1016/j.febslet.2008.05.011; Baez M, 2007, BIOCHEMISTRY-US, V46, P6141, DOI 10.1021/bi7002247; Baez M, 2009, FEBS LETT, V583, P2054, DOI 10.1016/j.febslet.2009.05.034; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BERGER SA, 1991, BIOCHEMISTRY-US, V30, P8477, DOI 10.1021/bi00098a027; Cabrera R, 2003, J BIOL CHEM, V278, P12913, DOI 10.1074/jbc.M212137200; Cabrera R, 2008, J MOL BIOL, V383, P588, DOI 10.1016/j.jmb.2008.08.029; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; CAMPOS G, 1984, J BIOL CHEM, V259, P6147; Cornish-Bowden A., 2004, FUNDAMENTAL ENZYME K, P88; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; Fenton AW, 2003, BIOCHEMISTRY-US, V42, P12676, DOI 10.1021/bi0349221; Guixe V, 1998, BIOCHEMISTRY-US, V37, P13269, DOI 10.1021/bi980576p; GUIXE V, 1988, ARCH BIOCHEM BIOPHYS, V264, P519, DOI 10.1016/0003-9861(88)90317-7; JOHNSON JL, 1992, BIOCHEMISTRY-US, V31, P11510, DOI 10.1021/bi00161a032; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KOTLARZ D, 1981, EUR J BIOCHEM, V117, P569; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parducci RE, 2006, BIOCHEMISTRY-US, V45, P9291, DOI 10.1021/bi060026o; Reinhart GD, 2004, METHOD ENZYMOL, V380, P187; Segel I. H., 1975, ENZYME KINETICS, pxxii; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; Torres JC, 1997, BIOCHEM J, V327, P675; Wang XJ, 2001, BIOCHEMISTRY-US, V40, P3938, DOI 10.1021/bi002709o; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weber G., 1992, PROTEIN INTERACTIONS, P31; WYMAN J, 1965, J MOL BIOL, V11, P631, DOI 10.1016/S0022-2836(65)80017-1	40	21	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5774	5783		10.1074/jbc.M110.163162	http://dx.doi.org/10.1074/jbc.M110.163162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147773	Green Published, hybrid			2022-12-27	WOS:000287230600086
J	Chigaev, A; Wu, Y; Williams, DB; Smagley, Y; Sklar, LA				Chigaev, Alexandre; Wu, Yang; Williams, D. Bart; Smagley, Yelena; Sklar, Larry A.			Discovery of Very Late Antigen-4 (VLA-4, alpha(4)beta(1) Integrin) Allosteric Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; REAL-TIME ANALYSIS; MONOCLONAL-ANTIBODIES; CONFORMATIONAL REGULATION; CHEMOKINE RECEPTOR; ADHESION MOLECULES; CXCR4 ANTAGONIST; STROMAL CELLS; STEM-CELLS; MOBILIZATION	Integrins are cell adhesion receptors that mediate cell-to-cell, or cell-to-extracellular matrix adhesion. They represent an attractive target for treatment of multiple diseases. Two classes of small molecule integrin inhibitors have been developed. Competitive antagonists bind directly to the integrin ligand binding pocket and thus disrupt the ligand-receptor interaction. Allosteric antagonists have been developed primarily for alpha(L)beta(2)-integrin (LFA-1, lymphocyte function-associated antigen-1). Here we present the results of screening the Prestwick Chemical Library using a recently developed assay for the detection of alpha(4)beta(1)-integrin allosteric antagonists. Secondary assays confirmed that the compounds identified: 1) do not behave like competitive (direct) antagonists; 2) decrease ligand binding affinity for VLA-4 similar to 2 orders of magnitude; 3) exhibit antagonistic properties at low temperature. In a cell based adhesion assay in vitro, the compounds rapidly disrupted cellular aggregates. In accord with reports that VLA-4 antagonists in vivo induce mobilization of hematopoietic progenitors into the peripheral blood, we found that administration of one of the compounds significantly increased the number of colony-forming units in mice. This effect was comparable to AMD3100, a well known progenitor mobilizing agent. Because all the identified compounds are structurally related, previously used, or currently marketed drugs, this result opens a range of therapeutic possibilities for VLA-4-related pathologies.	Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Chigaev, A (corresponding author), MSC08 4630,915 Camino Salud, Albuquerque, NM 87131 USA.	achigaev@salud.unm.edu; lsklar@salud.unm.edu	Chigaev, Alexandre/A-3103-2010	Chigaev, Alexandre/0000-0002-7726-638X	National Institutes of Health [U54 MH084690, HL081062]; Leukemia and Lymphoma Society [7388-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 MH084690 and HL081062 and the Leukemia and Lymphoma Society Grant 7388-06.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Berger JR, 2006, NEUROL RES, V28, P299, DOI 10.1179/016164106X98198; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Bonig H, 2009, STEM CELLS, V27, P836, DOI 10.1002/stem.9; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; CHEDID L, 1954, CR SOC BIOL, V148, P1039; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655; Dijkgraaf I, 2009, FRONT BIOSCI-LANDMRK, V14, P887, DOI 10.2741/3284; Edwards BS, 2000, J IMMUNOL, V165, P404, DOI 10.4049/jimmunol.165.1.404; FIEVE RR, 1966, ARCH GEN PSYCHIAT, V15, P529; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Kenakin T, 2004, MOL INTERV, V4, P222, DOI 10.1124/mi.4.4.6; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; MATTHEWS N, 1995, BIOCHEM PHARMACOL, V50, P1053, DOI 10.1016/0006-2952(95)00240-Z; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Njus BH, 2009, ASSAY DRUG DEV TECHN, V7, P507, DOI 10.1089/adt.2009.0203; Oostendorp RAJ, 1997, LEUKEMIA LYMPHOMA, V24, P423, DOI 10.3109/10428199709055581; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; Pollmacher T, 2000, J PSYCHIATR RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; Ramirez P, 2009, BLOOD, V114, P1340, DOI 10.1182/blood-2008-10-184721; Rigal E, 2009, M S-MED SCI, V25, P1135, DOI 10.1051/medsci/200925121135; ROUDEBUSH RE, 1991, INT J IMMUNOPHARMACO, V13, P961, DOI 10.1016/0192-0561(91)90049-D; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Shen WW, 1999, COMPR PSYCHIAT, V40, P407, DOI 10.1016/S0010-440X(99)90082-2; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sklar LA, 2002, ANNU REV BIOPH BIOM, V31, P97, DOI 10.1146/annurev.biophys.31.082901.134406; Sudeshna G, 2010, EUR J PHARMACOL, V648, P6, DOI 10.1016/j.ejphar.2010.08.045; SURMAN OS, 1993, PSYCHOSOMATICS, V34, P139, DOI 10.1016/S0033-3182(93)71904-0; Thanacoody HKR, 2007, BRIT J CLIN PHARMACO, V64, P566, DOI 10.1111/j.1365-2125.2007.03021.x; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Woodside DG, 2008, BIODRUGS, V22, P85, DOI 10.2165/00063030-200822020-00002; Yoneda T, 2000, J Orthop Sci, V5, P75, DOI 10.1007/s007760050012; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3	51	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5455	5463		10.1074/jbc.M110.162636	http://dx.doi.org/10.1074/jbc.M110.162636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131351	hybrid, Green Published			2022-12-27	WOS:000287230600054
J	Foster, JD; Vaughan, RA				Foster, James D.; Vaughan, Roxanne A.			Palmitoylation Controls Dopamine Transporter Kinetics, Degradation, and Protein Kinase C-dependent Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; PLASMA-MEMBRANE; MEDIATED PALMITOYLATION; INDUCED TRAFFICKING; TERMINAL RESIDUES; MOLECULAR-CLONING; GABA(A) RECEPTORS; CELL-LINES; ENDOCYTOSIS; SUBSTRATE	Palmitoylation is a lipid modification that confers diverse functions to target proteins and is a contributing factor for many neuronal diseases. In this study, we demonstrate using [H-3] palmitic acid labeling and acyl-biotinyl exchange that native and expressed dopamine transporters (DATs) are palmitoylated, and using the palmitoyl acyltransferase inhibitor 2-bromopalmitate (2BP), we identify several associated functions. Treatment of rat striatal synaptosomes with 2BP using lower doses or shorter times caused robust inhibition of transport V-max that occurred with no losses of DAT protein or changes in DAT surface levels, indicating that acute loss of palmitoylation leads to reduction of transport kinetics. Treatment of synaptosomes or cells with 2BP using higher doses or longer times resulted in DAT protein losses and production of transporter fragments, implicating palmitoylation in regulation of transporter degradation. Site-directed mutagenesis indicated that palmitoylation of rat DAT occurs at Cys-580 at the intracellular end of transmembrane domain 12 and at one or more additional unidentified site(s). Cys-580 mutation also led to production of transporter degradation fragments and to increased phorbol ester-induced down-regulation, further supporting palmitoylation in opposing DAT turnover and in opposing protein kinase C-mediated regulation. These results identify S-palmitoylation as a major regulator of DAT properties that could significantly impact acute and long term dopamine transport capacity.	[Foster, James D.; Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Vaughan, RA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, 501 N Columbia Rd,Stop 9037, Grand Forks, ND 58202 USA.	rvaughan@medicine.nodak.edu			NIDA, National Institutes of Health [R01 DA13147]; University of North Dakota faculty seed; National Center for Research Resources INBRE Program [P20 RR016741]; University of North Dakota;  [ND EPSCoR IIG]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013147] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of North Dakota faculty seed; National Center for Research Resources INBRE Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of North Dakota; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA13147 (to R.A.V.) from the NIDA. This work was also supported by Grant ND EPSCoR IIG (to R.A.V. and J.D.F.), a University of North Dakota faculty seed grant (to J.D.F.), and National Center for Research Resources INBRE Program Grant P20 RR016741 (to the University of North Dakota).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Bannon M. J., 1998, PSYCHOPHARMACOLOGY 4; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P589, DOI 10.1113/jphysiol.1975.sp010949; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1992, MOL PHARMACOL, V42, P383; GU H, 1994, J BIOL CHEM, V269, P7124; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jackson C. S., 1996, CURRENT PROTOCOLS PR, P141211; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; KIMMICH GA, 1994, AM J PHYSIOL-CELL PH, V267, pC1119; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Plasek J, 1996, J PHOTOCH PHOTOBIO B, V33, P101, DOI 10.1016/1011-1344(96)07283-1; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Richards TL, 2009, J NEUROCHEM, V108, P1575, DOI 10.1111/j.1471-4159.2009.05910.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 2005, J NEUROSCI METH, V143, P33, DOI 10.1016/j.jneumeth.2004.09.022; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Woehler A, 2009, GLYCOCONJUGATE J, V26, P749, DOI 10.1007/s10719-008-9187-8; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010	69	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5175	5186		10.1074/jbc.M110.187872	http://dx.doi.org/10.1074/jbc.M110.187872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118819	Green Published, hybrid			2022-12-27	WOS:000287230600026
J	Janganan, TK; Zhang, L; Bavro, VN; Matak-Vinkovic, D; Barrera, NP; Burton, MF; Steel, PG; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Zhang, Li; Bavro, Vassiliy N.; Matak-Vinkovic, Dijana; Barrera, Nelson P.; Burton, Matthew F.; Steel, Patrick G.; Robinson, Carol V.; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.			Opening of the Outer Membrane Protein Channel in Tripartite Efflux Pumps Is Induced by Interaction with the Membrane Fusion Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO FITNESS; MULTIDRUG EFFLUX; NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSPORTER ACRB; SYSTEM; RESISTANCE; TOLC; MECHANISM	The multiple transferable resistance (MTR) pump, from Neisseria gonorrhoeae, is typical of the specialized machinery used to translocate drugs across the inner and outer membranes of Gram-negative bacteria. It consists of a tripartite complex composed of an inner-membrane transporter, MtrD, a periplasmic membrane fusion protein, MtrC, and an outermembrane channel, MtrE. We have expressed the components of the pump in Escherichia coli and used the antibiotic vancomycin, which is too large to cross the outer-membrane by passive diffusion, to test for opening of the MtrE channel. Cells expressing MtrCDE are not susceptible to vancomycin, indicating that the channel is closed; but become susceptible to vancomycin in the presence of transported substrates, consistent with drug-induced opening of the MtrE channel. A mutational analysis identified residues Asn-198, Glu-434, and Gln-441, lining an intraprotomer groove on the surface of MtrE, to be important for pump function; mutation of these residues yielded cells that were sensitive to vancomycin. Pull-down assays and micro-calorimetry measurements indicated that this functional impairment is not due to the inability of MtrC to interact with the MtrE mutants; nor was it due to the MtrE mutants adopting an open conformation, because cells expressing these MtrE mutants alone are relatively insensitive to vancomycin. However, cells expressing the MtrE mutants with MtrC are sensitive to vancomycin, indicating that residues lining the intra-protomer groove control opening of the MtrE channel in response to binding of MtrC.	[Janganan, Thamarai K.; Zhang, Li; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Matak-Vinkovic, Dijana; Barrera, Nelson P.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Burton, Matthew F.; Steel, Patrick G.] Univ Durham, Dept Chem, Sci Labs, Durham DH1 3LE, England; [Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Durham University; University of Oxford; University of Cambridge; Durham University; University of Oxford; University of Oxford	Walmsley, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	a.r.walmsley@durham.ac.uk	Janganan, Thamarai/AAQ-8705-2020; Steel, Patrick/G-3187-2012; Bavro, Vassiliy/I-4846-2019	Steel, Patrick/0000-0002-2493-5826; Bavro, Vassiliy/0000-0003-2330-8924; robinson, carol/0000-0001-7829-5505; Barrera, Nelson/0000-0001-7825-1406	BSAC (British Society for Antimicrobial Chemotherapy); Wellcome Trust; EU; BBSRC	BSAC (British Society for Antimicrobial Chemotherapy); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BSAC (British Society for Antimicrobial Chemotherapy) and the Wellcome Trust (to M. I. B.-W. and A. R. W.). This work was also supported in part by a Marie Curie Fellowship from the EU (to V. N. B.), the Wellcome Trust (to C. V. R.), and the BBSRC (to N. P. B., D. M.-V., and C. V. R.).	Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Elkins CA, 2003, J BACTERIOL, V185, P5349, DOI 10.1128/JB.185.18.5349-5356.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Rouquette C, 1999, MOL MICROBIOL, V33, P651, DOI 10.1046/j.1365-2958.1999.01517.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCUDAMORE RA, 1979, ANTIMICROB AGENTS CH, V15, P820, DOI 10.1128/AAC.15.6.820; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Vediyappan G, 2006, J BACTERIOL, V188, P3757, DOI 10.1128/JB.00038-06; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Warner DM, 2007, J INFECT DIS, V196, P1804, DOI 10.1086/522964; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457	48	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5484	5493		10.1074/jbc.M110.187658	http://dx.doi.org/10.1074/jbc.M110.187658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21115481	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000287230600058
J	Schildknecht, S; Pape, R; Muller, N; Robotta, M; Marquardt, A; Burkle, A; Drescher, M; Leist, M				Schildknecht, Stefan; Pape, Regina; Mueller, Nathalie; Robotta, Marta; Marquardt, Andreas; Buerkle, Alexander; Drescher, Malte; Leist, Marcel			Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MICROGLIAL ACTIVATION; TYROSINE NITRATION; OXIDATIVE STRESS; UP-REGULATION; DOPAMINERGIC NEURODEGENERATION; PROSTANOID SYNTHESIS; ALZHEIMERS-DISEASE; LATERAL-SCLEROSIS; SUBSTANTIA-NIGRA	Minocycline prevents oxidative protein modifications and damage in disease models associated with inflammatory glial activation and oxidative stress. Although the drug has been assumed to act by preventing the up-regulation of proinflammatory enzymes, we probed here its direct chemical interaction with reactive oxygen species. The antibiotic did not react with superoxide or (NO)-N-center dot radicals, but peroxynitrite (PON) was scavenged in the range of similar to 1 mu M minocycline and below. The interaction of pharmacologically relevant minocycline concentrations with PON was corroborated in several assay systems and significantly exceeded the efficacy of other antibiotics. Minocycline was degraded during the reaction with PON, and the resultant products lacked antioxidant properties. The antioxidant activity of minocycline extended to cellular systems, because it prevented neuronal mitochondrial DNA damage and glutathione depletion. Maintenance of neuronal viability under PON stress was shown to be solely dependent on direct chemical scavenging by minocycline. We chose alpha-synuclein (ASYN), known from Parkinsonian pathology as a biologically relevant target in chemical and cellular nitration reactions. Submicromolar concentrations of minocycline prevented tyrosine nitration of ASYN by PON. Mass spectrometric analysis revealed that minocycline impeded nitrations more effectively than methionine oxidations and dimerizations of ASYN, which are secondary reactions under PON stress. Thus, PON scavenging at low concentrations is a novel feature of minocycline and may help to explain its pharmacological activity.	[Schildknecht, Stefan; Pape, Regina; Leist, Marcel] Univ Konstanz, Dept Vitro Toxicol & Biomed, Fac Biol, D-78457 Constance, Germany; [Mueller, Nathalie; Buerkle, Alexander] Univ Konstanz, Dept Mol Toxicol, Fac Biol, D-78457 Constance, Germany; [Robotta, Marta; Drescher, Malte] Univ Konstanz, Emmy Noether EPR Grp, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Mass Spectrometry Facil, Fac Chem, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz	Schildknecht, S (corresponding author), Univ Konstanz, Dept Vitro Toxicol & Biomed, Fac Biol, POB M657, D-78457 Constance, Germany.	Stefan.Schildknecht@uni-konstanz.de	Leist, Marcel/D-2133-2010; Drescher, Malte/B-2578-2012	Leist, Marcel/0000-0002-3778-8693; 	Doerenkamp-Zbinden foundation; Land Baden-Wurttemberg; KoRS-CB; IRTG [1331]; Deutsche Forschungsgemeinschaft	Doerenkamp-Zbinden foundation; Land Baden-Wurttemberg; KoRS-CB; IRTG; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Doerenkamp-Zbinden foundation, the Land Baden-Wurttemberg, KoRS-CB, IRTG 1331, and the Deutsche Forschungsgemeinschaft.	Agostini S, 2010, GASTROENTEROLOGY, V139, P553, DOI 10.1053/j.gastro.2010.03.046; Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Brades S, 2009, GASTROENTEROLOGY, V136, P1339, DOI 10.1053/j.gastro.2008.12.044; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cho Y, 2009, NEUROTOX RES, V16, P361, DOI 10.1007/s12640-009-9078-1; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Falsig J, 2008, J NEUROSCI RES, V86, P1434, DOI 10.1002/jnr.21590; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Fillpovic R, 2008, EXP NEUROL, V211, P41, DOI 10.1016/j.expneurol.2007.12.024; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gieseler A, 2009, BIOCHEM PHARMACOL, V77, P888, DOI 10.1016/j.bcp.2008.11.003; Goulden V, 1996, BRIT J DERMATOL, V134, P693, DOI 10.1111/j.1365-2133.1996.tb06972.x; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Imam SZ, 2001, ANN NY ACAD SCI, V939, P366; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jope RS, 2000, ARCH BIOCHEM BIOPHYS, V376, P365, DOI 10.1006/abbi.2000.1728; KASS GEN, 1988, ARCH BIOCHEM BIOPHYS, V260, P789, DOI 10.1016/0003-9861(88)90509-7; KELLY RG, 1967, TOXICOL APPL PHARM, V11, P171, DOI 10.1016/0041-008X(67)90036-1; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Koch H, 2001, J INVEST DERMATOL, V117, P892, DOI 10.1046/j.0022-202x.2001.01513.x; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; Perrin D, 2000, ARCH BIOCHEM BIOPHYS, V377, P266, DOI 10.1006/abbi.2000.1787; PRYOR WA, 1994, P NATL ACAD SCI USA, V91, P11173, DOI 10.1073/pnas.91.23.11173; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Schildknecht S, 2008, FASEB J, V22, P215, DOI 10.1096/fj.06-8015com; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; Schildknecht S, 2009, ARCH BIOCHEM BIOPHYS, V484, P183, DOI 10.1016/j.abb.2008.10.023; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; Wang CX, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-2; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Whiteman M, 1997, FREE RADICAL RES, V26, P49, DOI 10.3109/10715769709097783; Wilkins A, 2004, NEURON GLIA BIOL, V1, P297, DOI 10.1017/S1740925X05000104; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	54	85	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4991	5002		10.1074/jbc.M110.169565	http://dx.doi.org/10.1074/jbc.M110.169565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21081502	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000287230600007
J	Acharya, P; Liao, MX; Engel, JC; Correia, MA				Acharya, Poulomi; Liao, Mingxiang; Engel, Juan C.; Correia, Maria Almira			Liver Cytochrome P450 3A Endoplasmic Reticulum-associated Degradation A MAJOR ROLE FOR THE p97 AAA ATPase IN CYTOCHROME P450 3A EXTRACTION INTO THE CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; VALOSIN-CONTAINING PROTEIN; MOTILITY FACTOR-RECEPTOR; HMG-COA REDUCTASE; AAA-ATPASE; RAT HEPATOCYTES; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; UBIQUITIN LIGASES	The CYP3A subfamily of hepatic cytochromes P450, being engaged in the metabolism and clearance of > 50% of clinically relevant drugs, can significantly influence therapeutics and drug-drug interactions. Our characterization of CYP3A degradation has indicated that CYPs 3A incur ubiquitin-dependent proteasomal degradation (UPD) in an endoplasmic reticulum (ER)-associated degradation (ERAD) process. Cytochromes P450 are monotopic hemoproteins N-terminally anchored to the ER membrane with their protein bulk readily accessible to the cytosolic proteasome. Given this topology, it was unclear whether they would require the AAA-ATPase p97 chaperone complex that retrotranslocates/dislocates ubiquitinated ER-integral and luminal proteins into the cytosol for proteasomal delivery. To assess the in vivo relevance of this p97-CYP3A association, we used lentiviral shRNAs to silence p97 (80% mRNA and 90% protein knockdown relative to controls) in sandwich-cultured rat hepatocytes. This extensive hepatic p97 knockdown remarkably had no effect on cellular morphology, ER stress, and/or apoptosis, despite the well recognized strategic p97 roles in multiple important cellular processes. However, such hepatic p97 knockdown almost completely abrogated CYP3A extraction into the cytosol, resulting in a significant accumulation of parent and ubiquitinated CYP3A species that were firmly ER-tethered. Little detectable CYP3A accumulated in the cytosol, even after concomitant inhibition of proteasomal degradation, thereby documenting a major role of p97 in CYP3A extraction and delivery to the 26 S proteasome during its UPD/ERAD. Intriguingly, the accumulated parent CYP3A was functionally active, indicating that p97 can regulate physiological CYP3A content and thus influence its clinically relevant function.	[Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Box 2280,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [DK26506, GM44037]; NIDDK, National Institutes of Health [P30DK26743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026506, P30DK026743, R56DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26506 and GM44037.; We gratefully thank Chris Her (University of California San Francisco (UCSF) Liver Center Cell and Tissue Biology Core Facility) (Dr. J. J. Maher, Director) for hepatocyte isolation and Ahalya Sriskandarajan (UCSF) for able technical assistance in some of these studies. We also thank Dr. Alex Y. So (Keith Yamamoto laboratory, UCSF) for generous advice and training in the use of lentiviral shRNAi technology and Dr. Michelle Flanniken (Raul Andino laboratory, UCSF) for technical advice. We also acknowledge the UCSF Liver Center Core on Cell and Tissue Biology (supported by NIDDK, National Institutes of Health, Grant P30DK26743).	Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BROWN CA, 1989, J BIOL CHEM, V264, P4442; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Han XM, 2005, J PHARMACOL EXP THER, V314, P128, DOI 10.1124/jpet.105.084699; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; KEMPER B, 1989, DRUG METAB REV, V20, P811, DOI 10.3109/03602538909103580; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCormack T, 1997, J BIOL CHEM, V272, P26103, DOI 10.1074/jbc.272.42.26103; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; SAKAGUCHI M, 1993, FRONTIERS BIOTRANSFO, V8, P59; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; Szczena-Skorupa E, 2008, EXPERT OPIN DRUG MET, V4, P123, DOI 10.1517/17425255.4.2.123; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VERGERES G, 1989, BIOCHEMISTRY-US, V28, P3650, DOI 10.1021/bi00435a005; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	90	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3815	3828		10.1074/jbc.M110.186981	http://dx.doi.org/10.1074/jbc.M110.186981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107009	hybrid, Green Published			2022-12-27	WOS:000286653200063
J	Buhrman, G; Kumar, VSS; Cirit, M; Haugh, JM; Mattos, C				Buhrman, Greg; Kumar, V. S. Senthil; Cirit, Murat; Haugh, Jason M.; Mattos, Carla			Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURES; QUANTITATIVE-ANALYSIS; TRANSITION-STATE; PROTEIN-KINASE; BINDING; SWITCH; ACTIVATION; HYDROLYSIS	Ras is a key signal transduction protein in the cell. Mutants of Gly(12) and Gln(61) impair GTPase activity and are found prominently in cancers. In wild type Ras-GTP, an allosteric switch promotes disorder to order transition in switch II, placing Gln(61) in the active site. We show that the "on" and "off" conformations of the allosteric switch can also be attained in RasG12V and RasQ61L. Although both mutants have similarly impaired active sites in the on state, RasQ61L stabilizes an anti- catalytic conformation of switch II in the off state of the allosteric switch when bound to Raf. This translates into more potent activation of the MAPK pathway involving Ras, Raf kinase, MEK, and ERK (Ras/Raf/MEK/ERK) in cells transfected with RasQ61L relative to RasG12V. This differential is not observed in the Raf-independent pathway involving Ras, phosphoinositide 3-kinase (PI3K), and Akt (Ras/PI3K/Akt). Using a combination of structural analysis, hydrolysis rates, and experiments in NIH-3T3 cells, we link the allosteric switch to the control of signaling in the Ras/Raf/MEK/ERK pathway, supporting a GTPase-activating protein-independent model for duration of the Ras-Raf complex.	[Mattos, Carla] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Cirit, Murat; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mattos, C (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Box 7622,128 Polk Hall, Raleigh, NC 27695 USA.	carla_mattos@ncsu.edu		Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [R01-CA096867, R56-CA096867]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA096867, R56CA096867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA096867 and R56-CA096867.; Kathleen Davis and Susan Fetics made the RasG12V and RasQ61L mutants of the full-length protein inserted into the pBM-IRES-Puro vector for expression in NIH-3T3 cells. Stephanie Holsenbeck made the truncated RasG12V mutant in pET21a. Use of the Advanced Photon Source at the Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buhrman G, 2003, STRUCTURE, V11, P747, DOI 10.1016/S0969-2126(03)00128-X; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; JOHN J, 1989, J BIOL CHEM, V264, P13086; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MINATO T, 1994, J BIOL CHEM, V269, P20845; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4	40	61	61	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3323	3331		10.1074/jbc.M110.193854	http://dx.doi.org/10.1074/jbc.M110.193854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098031	Green Published, hybrid			2022-12-27	WOS:000286653200018
J	Ma, L; Dong, FM; Denis, M; Feng, Y; Wang, MD; Zha, XH				Ma, Loretta; Dong, Fumin; Denis, Maxime; Feng, Ying; Wang, Ming-Dong; Zha, Xiaohui			Ht31, a Protein Kinase A Anchoring Inhibitor, Induces Robust Cholesterol Efflux and Reverses Macrophage Foam Cell Formation through ATP-binding Cassette Transporter A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGIER-DISEASE; ABCA1; ATHEROSCLEROSIS; MICE; MICROPARTICLES; TRAFFICKING; DEFICIENCY; MUTATIONS; MEMBRANE; HDL	Macrophage foam cell is the predominant cell type in atherosclerotic lesions. Removal of excess cholesterol from macrophages thus offers effective protection against atherosclerosis. Here we report that a protein kinase A (PKA)-anchoring inhibitor, st-Ht31, induces robust cholesterol/phospholipid efflux, and ATP-binding cassette transporter A1 (ABCA1) greatly facilitates this process. Remarkably, we found that st-Ht31 completely reverses foam cell formation, and this process is ABCA1-dependent. The reversal is also accompanied by the restoration of well modulated inflammatory response to LPS. There is no detectable toxicity associated with st-Ht31, even when cells export up to 20% cellular cholesterol per hour. Using FRET-based PKA biosensors in live cells, we provide evidence that st-Ht31 drives cholesterol efflux by elevating PKA activity specifically in the cytoplasm. Furthermore, ABCA1 facilitates st-Ht31 uptake. This allows st-Ht31 to effectively remove cholesterol from ABCA1-expressing cells. We speculate that de-anchoring of PKA offers a novel therapeutic strategy to remove excess cholesterol from lipid-laden lesion macrophages.	[Dong, Fumin; Denis, Maxime; Feng, Ying; Zha, Xiaohui] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Ma, Loretta; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Wang, Ming-Dong] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Zha, XH (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada.	xzha@ohri.ca			Canadian Institutes of Health Research; Ontario Graduate Scholarship in Science and Technology; Canada Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology; Canada Graduate Scholarship	This work is supported in part by a grant from Canadian Institutes of Health Research.; Supported by an Ontario Graduate Scholarship in Science and Technology and a Canada Graduate Scholarship.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; CARR DW, 1992, J BIOL CHEM, V267, P13376; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fitzgerald ML, 2002, J MOL MED, V80, P271, DOI 10.1007/s00109-001-0318-y; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Hayon T, 2003, LEUKEMIA LYMPHOMA, V44, P1957, DOI 10.1080/1042819031000116607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schillace RV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004807; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	27	24	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3370	3378		10.1074/jbc.M110.173666	http://dx.doi.org/10.1074/jbc.M110.173666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106522	hybrid, Green Published			2022-12-27	WOS:000286653200023
J	Marois, L; Pare, G; Vaillancourt, M; Rollet-Labelle, E; Naccache, PH				Marois, Louis; Pare, Guillaume; Vaillancourt, Myriam; Rollet-Labelle, Emmanuelle; Naccache, Paul H.			Fc gamma RIIIb Triggers Raft-dependent Calcium Influx in IgG-mediated Responses in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE PHOSPHORYLATION; LIPID RAFTS; LIGAND-BINDING; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; ANCHORED PROTEINS; RECEPTOR FUNCTION; IMMUNE-COMPLEXES	Human neutrophils constitutively express a unique combination of Fc gamma Rs, namely Fc gamma RIIa and Fc gamma RIIIb. Numerous lines of evidence support the concept that these Fc gamma Rs generate only partially characterized intracellular signals. However, despite the fact that both receptors are likely to be engaged simultaneously in a physiological setting, no recent publications have investigated the distinct, although partially convergent, results of their joint activation in IgG-dependent responses. To examine the significance of the co-expression of Fc gamma RIIa and Fc gamma RIIIb on human neutrophils, we analyzed the neutrophil responses to stimuli that engage these Fc gamma Rs, namely the phagocytosis of human IgG-opsonized zymosan and the responses to heat-aggregated IgGs. Blocking antibodies to either Fc gamma R significantly decreased the phagocytic index and the stimulated production of superoxide anions. Both receptors are required for optimal IgG-dependent responses by human neutrophils. On the other hand, only blocking antibodies to Fc gamma RIIIb, but not to Fc gamma RIIa, inhibited the mobilization of calcium in response to heat-aggregated IgGs. Furthermore, phagocytosis of IgG-opsonized zymosan by human neutrophils required an extracellular influx of calcium that was blocked only by antibodies against Fc gamma RIIIb. We also observed that this calcium influx as well as the IgG-dependent phagocytosis were dependent on the integrity of the plasma membrane detergent-resistant microdomains to which both isoforms were recruited following stimulation by heat-aggregated IgGs. These data clarify the mechanisms that regulate the Fc gamma Rs constitutively expressed on human neutrophils, describe a specific contribution of Fc gamma RIIIb at the level of the mobilization of calcium, and provide evidence for a crucial role of detergent-resistant microdomains in this process.	[Marois, Louis; Pare, Guillaume; Vaillancourt, Myriam; Rollet-Labelle, Emmanuelle; Naccache, Paul H.] Univ Laval, Dept Microbiol Infectiol & Immunol, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol,Ctr Rech,Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University	Rollet-Labelle, E (corresponding author), Univ Laval, Dept Microbiol Infectiol & Immunol, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol,Ctr Rech,Fac Med, 2705 Blvd Laurier,Rm T1-49, Quebec City, PQ G1V 4G2, Canada.	emmanuelle.rollet@crchul.ulaval.ca		Marois, Louis/0000-0002-1567-5583	Canadian Institutes of Health Research; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by grants from the Canadian Institutes of Health Research.; Recipient of a Canadian Arthritis Network Graduate Award and a Canadian Institutes of Health Research Doctoral Research Award.	Alves CMOS, 2008, CLIN RHEUMATOL, V27, P701, DOI 10.1007/s10067-007-0768-x; Barabe F, 2002, J IMMUNOL, V168, P4042, DOI 10.4049/jimmunol.168.8.4042; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Belostocki K, 2005, CLIN IMMUNOL, V117, P78, DOI 10.1016/j.clim.2005.07.001; BIANCHINI L, 1993, J BIOL CHEM, V268, P3357; Bournazos S, 2009, J IMMUNOL, V182, P8026, DOI 10.4049/jimmunol.0900107; Chuang FYS, 2000, J IMMUNOL, V164, P350, DOI 10.4049/jimmunol.164.1.350; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; EDBERG JC, 1994, J IMMUNOL, V152, P5826; Edberg JC, 1998, J BIOL CHEM, V273, P8071, DOI 10.1074/jbc.273.14.8071; Fernandes MJG, 2006, BIOCHEM J, V393, P351, DOI 10.1042/BJ20050129; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Fossati G, 2002, ANN RHEUM DIS, V61, P13, DOI 10.1136/ard.61.1.13; Fossati G, 2002, ARTHRITIS RHEUM, V46, P1351, DOI 10.1002/art.10230; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; HUNTER S, 1994, P NATL ACAD SCI USA, V91, P10232, DOI 10.1073/pnas.91.21.10232; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Katsumata O, 2001, J IMMUNOL, V167, P5814, DOI 10.4049/jimmunol.167.10.5814; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Kwiatkowska K, 2001, EUR J IMMUNOL, V31, P989, DOI 10.1002/1521-4141(200104)31:4<989::AID-IMMU989>3.0.CO;2-V; Lamberti Y, 2008, MICROB PATHOGENESIS, V44, P501, DOI 10.1016/j.micpath.2008.01.002; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Nagarajan S, 2000, BLOOD, V95, P1069, DOI 10.1182/blood.V95.3.1069.003k14_1069_1077; Nagarajan S, 2005, J IMMUNOL, V174, P5423, DOI 10.4049/jimmunol.174.9.5423; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; NAZIRUDDIN B, 1992, J IMMUNOL, V149, P3702; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; PETROSKI RJ, 1979, AM J PHYSIOL, V237, pC43, DOI 10.1152/ajpcell.1979.237.1.C43; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; PORGES AJ, 1994, J IMMUNOL, V153, P1271; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Rivas-Fuentes S, 2010, CELL IMMUNOL, V263, P114, DOI 10.1016/j.cellimm.2010.03.006; ROLLET E, 1994, J IMMUNOL, V153, P353; Rollet-Labelle E, 2004, BIOCHEM J, V381, P919, DOI 10.1042/BJ20031808; SAGE SO, 1990, BIOCHEM J, V265, P915, DOI 10.1042/bj2650915; SALMON JE, 1991, J IMMUNOL, V146, P997; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Selvaraj P, 2004, IMMUNOL RES, V29, P219, DOI 10.1385/IR:29:1-3:219; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; St-Onge M, 2010, FASEB J, V24, P2116, DOI 10.1096/fj.09-146167; Strzelecka-Kiliszek A, 2004, MOL MEMBR BIOL, V21, P101, DOI 10.1080/09687680310001639094; Van Laethem F., 2002, Current Molecular Medicine (Hilversum), V2, P557; VOSSEBELD PJM, 1995, J BIOL CHEM, V270, P10671, DOI 10.1074/jbc.270.18.10671; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161	61	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3509	3519		10.1074/jbc.M110.169516	http://dx.doi.org/10.1074/jbc.M110.169516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123174	Green Published, hybrid			2022-12-27	WOS:000286653200036
J	Nothmann, D; Leinenweber, A; Torres-Salazar, D; Kovermann, P; Hotzy, J; Gameiro, A; Grewer, C; Fahlke, C				Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Gameiro, Armanda; Grewer, Christof; Fahlke, Christoph			Hetero-oligomerization of Neuronal Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; CHLORIDE CHANNEL; EAAC1; STOICHIOMETRY; TRANSLOCATION; EXCHANGERS; BARTTIN; INJURY	Excitatory amino acid transporters (EAATs) mediate the uptake of glutamate into neuronal and glial cells of the mammalian central nervous system. Two transporters expressed primarily in glia, EAAT1 and EAAT2, are crucial for glutamate homeostasis in the adult mammalian brain. Three neuronal transporters (EAAT3, EAAT4, and EAAT5) appear to have additional functions in regulating and processing cellular excitability. EAATs are assembled as trimers, and the existence of multiple isoforms raises the question of whether certain isoforms can form hetero-oligomers. Co-expression and pull-down experiments of various glutamate transporters showed that EAAT3 and EAAT4, but neither EAAT1 and EAAT2, nor EAAT2 and EAAT3 are capable of co-assembling into heterotrimers. To study the functional consequences of hetero-oligomerization, we co-expressed EAAT3 and the serine-dependent mutant R501C EAAT4 in HEK293 cells and Xenopus laevis oocytes and studied glutamate/serine transport and anion conduction using electrophysiological methods. Individual subunits transport glutamate independently of each other. Apparent substrate affinities are not affected by hetero-oligomerization. However, polarized localization in Madin-Darby canine kidney cells was different for homo-and hetero-oligomers. EAAT3 inserts exclusively into apical membranes of Madin-Darby canine kidney cells when expressed alone. Co-expression with EAAT4 results in additional appearance of basolateral EAAT3. Our results demonstrate the existence of heterotrimeric glutamate transporters and provide novel information about the physiological impact of EAAT oligomerization.	[Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany; [Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA	Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Albers, Thomas/A-9082-2012; Kovermann, Peter/AAF-4411-2020; Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918; Torres-Salazar, Delany/0000-0002-6789-9810	National Institutes of Health [R01-NS049335-05]; Deutsche Forschungsgemeinschaft [FA301/6, FA301/9]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-NS049335-05 (to C. G.). This work was also supported by Deutsche Forschungsgemeinschaft Grants FA301/6 and 9 (to Ch. F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Cheng CL, 2002, J NEUROSCI, V22, P10643; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Furuta A, 1997, J NEUROSCI, V17, P8363; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 2001, BRAIN RES, V914, P196, DOI 10.1016/S0006-8993(01)02802-5; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	39	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3935	3943		10.1074/jbc.M110.187492	http://dx.doi.org/10.1074/jbc.M110.187492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127051	Green Published, hybrid			2022-12-27	WOS:000286653200074
J	Dave, RH; Saengsawang, W; Lopus, M; Dave, S; Wilson, L; Rasenick, MM				Dave, Rahul H.; Saengsawang, Witchuda; Lopus, Manu; Dave, Sonya; Wilson, Leslie; Rasenick, Mark M.			A Molecular and Structural Mechanism for G Protein-mediated Microtubule Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; TRANSDUCIN ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; GTPASE ACTIVITY; TUBULIN GTPASE; GAMMA-SUBUNIT; NMR ANALYSIS; LIPID RAFTS	The heterotrimeric, G protein-coupled receptor-associated G protein, G alpha(s), binds tubulin with nanomolar affinity and disrupts microtubules in cells and in vitro. Here we determine that the activated form of G alpha(s) binds tubulin with a K-D of 100 nM, stimulates tubulin GTPase, and promotes microtubule dynamic instability. Moreover, the data reveal that the alpha 3-beta 5 region of G alpha(s) is a functionally important motif in the G alpha(s)-mediated microtubule destabilization. Indeed, peptides corresponding to that region of G alpha(s) mimic G alpha(s) protein in activating tubulin GTPase and increase microtubule dynamic instability. We have identified specific mutations in peptides or proteins that interfere with this process. The data allow for a model of the G alpha(s)/tubulin interface in which G alpha(s) binds to the microtubule plus-end and activates the intrinsic tubulin GTPase. This model illuminates both the role of tubulin as an "effector" (e.g. adenylyl cyclase) for G alpha(s) and the role of G alpha(s) as a GTPase activator for tubulin. Given the ability of G alpha(s) to translocate intra-cellularly in response to agonist activation, G alpha(s) may play a role in hormone- or neurotransmitter-induced regulation of cellular morphology.	[Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Dave, Rahul H.] Univ Illinois, Med Scientist Training Program, Chicago, IL 60612 USA; [Lopus, Manu; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lopus, Manu; Wilson, Leslie] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Dave, Sonya] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Vanderbilt University	Rasenick, MM (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott,M-C 901, Chicago, IL 60612 USA.	raz@uic.edu	Lopus, Manu/C-8470-2012	Lopus, Manu/0000-0002-4829-3960	National Institutes of Health [NS 13560, T32-HL007692, MH 39595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 13560 (to M. L. and L. W.), T32-HL007692 (to R. H. D.), and MH 39595 (to W. S. and M. M. R.). This work was also supported by AbdulRazzaq Al-Siddiqi.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bianchi M, 2009, SYNAPSE, V63, P359, DOI 10.1002/syn.20614; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Chen YB, 2001, J BIOL CHEM, V276, P45751, DOI 10.1074/jbc.M107191200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; Donati RJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1238, DOI 10.1038/sj.npp.1300697; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Layden BT, 2008, BBA-MOL CELL RES, V1783, P964, DOI 10.1016/j.bbamcr.2008.02.017; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LOPUS M, 2009, WILEY ENCY CHEM BIOL, V3, P153; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; MARGOLIS RL, 1977, P NATL ACAD SCI USA, V74, P3466, DOI 10.1073/pnas.74.8.3466; Mejillano MR, 1996, ARCH BIOCHEM BIOPHYS, V336, P130, DOI 10.1006/abbi.1996.0540; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; MURPHY DB, 1982, METHOD CELL BIOL, V24, P31; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Roychowdhury S, 2008, FEBS J, V275, P4654, DOI 10.1111/j.1742-4658.2008.06614.x; Skiba NP, 2000, METHOD ENZYMOL, V315, P502; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Smrcka AV, 2010, P NATL ACAD SCI USA, V107, P639, DOI 10.1073/pnas.0909503107; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; van Rossum D, 1999, J NEUROCHEM, V72, P962, DOI 10.1046/j.1471-4159.1999.0720962.x; WANG N, 1990, J BIOL CHEM, V265, P1239; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yan K, 1996, J NEUROCHEM, V66, P1489; Yenjerla M, 2010, METHOD CELL BIOL, V95, P189, DOI 10.1016/S0091-679X(10)95011-5; Yenjerla M, 2010, J ALZHEIMERS DIS, V19, P1377, DOI 10.3233/JAD-2010-1335; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4319	4328		10.1074/jbc.M110.196436	http://dx.doi.org/10.1074/jbc.M110.196436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21112971	Green Published, hybrid			2022-12-27	WOS:000286975700031
J	Higashi, K; Tomigahara, Y; Shiraki, H; Miyata, K; Mikami, T; Kimura, T; Moro, T; Inagaki, Y; Kaneko, H				Higashi, Kiyoshi; Tomigahara, Yoshitaka; Shiraki, Hiroaki; Miyata, Kaori; Mikami, Toshiyuki; Kimura, Toru; Moro, Tadashi; Inagaki, Yutaka; Kaneko, Hideo			A Novel Small Compound That Promotes Nuclear Translocation of YB-1 Ameliorates Experimental Hepatic Fibrosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; DEPENDENT TRANSCRIPTIONAL ACTIVATION; COLLAGEN GENE-EXPRESSION; BOX-BINDING-PROTEIN; RAT-LIVER FIBROSIS; FACTOR SUPPRESSES; STELLATE CELLS; MESSENGER-RNA; BETA; EXPORT	Transforming growth factor-beta (TGF-beta) is considered to be a major factor contributing to liver fibrosis. We have previously shown that nuclear translocation of YB-1 antagonizes the TGF-beta/Smad3 signaling in regulating collagen gene expression. More recently, we have demonstrated that the novel small compound HSc025 promotes nuclear translocation of YB-1, resulting in the improvement of skin and pulmonary fibrosis. Here, we presented evidence as to the mechanism by which HSc025 stimulates nuclear translocation of YB-1 and the pharmacological effects of HSc025 on a murine model of hepatic fibrosis. A proteomics approach and binding assays using HSc025-immobilized resin showed that HSc025 binds to the amino acid sequence within the C-tail region of YB-1. In addition, immunoprecipitation experiments and glutathione S-transferase pulldown assays identified poly(A)-binding protein (PABP) as one of the cytoplasmic anchor proteins of YB-1. HSc025 directly binds to YB-1 and interrupts its interaction with PABP, resulting in accelerated nuclear translocation of YB-1. Transfection of cells with PABP siRNA promoted nuclear translocation of YB-1 and subsequently inhibited basal and TGF-beta-stimulated collagen gene expression. Moreover, HSc025 significantly suppressed collagen gene expression in cultured activated hepatic stellate cells. Oral administration of HSc025 to mice with carbon tetrachloride-induced hepatic fibrosis improved liver injury as well as the degree of hepatic fibrosis. Altogether, the results provide a novel insight into therapy for organ fibrosis using YB-1 modulators.	[Higashi, Kiyoshi; Tomigahara, Yoshitaka; Shiraki, Hiroaki; Miyata, Kaori; Kaneko, Hideo] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Mikami, Toshiyuki; Kimura, Toru] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Osaka 5548558, Japan; [Moro, Tadashi; Inagaki, Yutaka] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan; [Moro, Tadashi] Minophagen Pharmaceut Co Ltd, Res Lab, Zama 2280002, Japan	Sumitomo Chem Co Ltd; Dainippon Sumitomo Pharmaceutical Company; Tokai University	Higashi, K (corresponding author), 1-98,Kasugadenaka 3 Chome,Konohana Ku, Osaka 5548558, Japan.	higashik2@sc.sumitomo-chem.co.jp		HIGASHI, KIYOSHI/0000-0003-3577-0526	Sumitomo Chemical Co. Ltd.	Sumitomo Chemical Co. Ltd.(Sumitomo Chem Co Ltd)	K. Higashi, Y. Tomigahara, H. Shiraki, K. Miyata, and H. Kaneko are employees of Sumitomo Chemical Co. Ltd., and T. Mikami and T. Kimura are employees of Dainippon Sumitomo Pharma Co. Ltd. Sumitomo Chemical Ltd. has applied for patents to use HSc025 and its analog as antifibrotic drugs. A part of the pharmacological studies of HSc025 was conducted by Y. Inagaki at Tokai University, which is supported by a research grant from Sumitomo Chemical Co. Ltd.	Albanis E, 2006, AM J TRANSPLANT, V6, P12, DOI 10.1111/j.1600-6143.2005.01143.x; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; CZAJA MJ, 1989, HEPATOLOGY, V10, P795, DOI 10.1002/hep.1840100508; Date M, 2000, GUT, V46, P719, DOI 10.1136/gut.46.5.719; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Duh JL, 1995, J BIOL CHEM, V270, P30499, DOI 10.1074/jbc.270.51.30499; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Hasegawa M, 2009, ARTHRITIS RHEUM-US, V60, P3465, DOI 10.1002/art.24934; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; HIRAYAMA C, 1970, BIOCHEM J, V118, P229, DOI 10.1042/bj1180229; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inagaki Y, 2005, GASTROENTEROLOGY, V129, P259, DOI 10.1053/j.gastro.2005.03.088; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; Kawada N, 1996, DIGEST DIS SCI, V41, P1022, DOI 10.1007/BF02091547; KAWAGUCHI H, 1995, J MOL CELL CARDIOL, V27, P201, DOI 10.1016/S0022-2828(08)80019-3; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MATSUDA Y, 1995, J BIOCHEM-TOKYO, V118, P643, DOI 10.1093/oxfordjournals.jbchem.a124958; Matsumoto K, 2005, MOL CELL BIOL, V25, P1779, DOI 10.1128/MCB.25.5.1779-1792.2005; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Sakaida I, 1998, J HEPATOL, V28, P471, DOI 10.1016/S0168-8278(98)80322-X; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Tamura T, 2003, BIOCONJUGATE CHEM, V14, P1222, DOI 10.1021/bc034099l; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328	31	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4485	4492		10.1074/jbc.M110.151936	http://dx.doi.org/10.1074/jbc.M110.151936			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115500	hybrid, Green Published			2022-12-27	WOS:000286975700048
J	Lalle, M; Camerini, S; Cecchetti, S; Fantauzzi, CB; Crescenzi, M; Pozio, E				Lalle, Marco; Camerini, Serena; Cecchetti, Serena; Fantauzzi, Claudia Blasetti; Crescenzi, Marco; Pozio, Edoardo			Giardia Duodenalis 14-3-3 Protein Is Polyglycylated by a Tubulin Tyrosine Ligase-like Member and Deglycylated by Two Metallocarboxypeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; POSTTRANSLATIONAL POLYGLYCYLATION; CARBOXYPEPTIDASE YSCS; ALPHA-TUBULIN; BETA-TUBULIN; LAMBLIA; EXPRESSION; ENZYME; GENE; MICROTUBULES	The flagellated protozoan Giardia duodenalis is a parasite of the upper part of the small intestine of mammals, including humans, and an interesting biological model. Giardia harbors a single 14-3-3 isoform, a multifunctional protein family, that is modified at the C terminus by polyglycylation, an unusual post-translational modification consisting of the covalent addition of one or multiple glycines on the gamma-carboxyl groups of specific glutamic acids. Polyglycylation affects the intracellular localization of g14-3-3, as the shortening of the polyglycine chain is correlated with a partial relocalization of 14-3-3 inside the nuclei during encystation. In this work we demonstrate that the gTTLL3, a member of the tubulin tyrosine ligase-like family, is the enzyme responsible for the 14-3-3 polyglycylation. We also identify two metallopeptidases of the M20 family, here termed gDIP1 (giardial dipeptidase 1) and gDIP2, as enzymes able to shorten the g14-3-3 polyglycine tail both in vivo and in vitro. Finally, we show that the ectopic expression of gDIP2 alters the g14-3-3 localization and strongly hampers the cyst formation. In conclusion, we have identified a polyglycylase and two deglycylases that act in concert to modulate the stage-dependent glycylation status of the multifunctional regulatory g14-3-3 protein in G. duodenalis.	[Lalle, Marco; Fantauzzi, Claudia Blasetti; Pozio, Edoardo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Camerini, Serena; Cecchetti, Serena; Crescenzi, Marco] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Camerini, Serena/A-4637-2017; Lalle, Marco/O-2287-2015; Crescenzi, Marco/J-3603-2018; Cecchetti, Serena/N-1061-2015	Camerini, Serena/0000-0001-6131-4335; Lalle, Marco/0000-0001-5168-2150; Crescenzi, Marco/0000-0003-0156-1494; Cecchetti, Serena/0000-0002-3601-176X	European Commission [SANCO/2006/FOODSAFETY/032]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission Contract SANCO/2006/FOODSAFETY/032.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alonso-del-Rivero M, 2009, FEBS J, V276, P4875, DOI 10.1111/j.1742-4658.2009.07187.x; Barrett AJ, 2003, BIOL CHEM, V384, P873, DOI 10.1515/BC.2003.098; BORDALLO J, 1991, FEBS LETT, V283, P27, DOI 10.1016/0014-5793(91)80546-F; Bre MH, 1996, J CELL SCI, V109, P727; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; Campanati L, 1999, BIOL CELL, V91, P499, DOI 10.1016/S0248-4900(00)88206-4; COLOMBO S, 1995, J BACTERIOL, V177, P5561, DOI 10.1128/jb.177.19.5561-5566.1995; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; FEELY DE, 1982, EXP PARASITOL, V53, P145, DOI 10.1016/0014-4894(82)90100-X; FELIX F, 1966, BIOCHIM BIOPHYS ACTA, V122, P127, DOI 10.1016/0926-6593(66)90096-8; FRIEND DS, 1966, J CELL BIOL, V29, P317, DOI 10.1083/jcb.29.2.317; Henrich B., 2004, HDB PROTEOLYTIC ENZY, P951; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Midlej V, 2009, PARASITOL INT, V58, P72, DOI 10.1016/j.parint.2008.11.002; MINTON NP, 1983, J BACTERIOL, V156, P1222, DOI 10.1128/JB.156.3.1222-1227.1983; Mori S, 2005, BBA-PROTEINS PROTEOM, V1748, P26, DOI 10.1016/j.bbapap.2004.12.001; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOSER P, 1970, INT J PROT RES, V2, P191; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Rawlings N. D., 2004, HDB PROTEOLYTIC ENZY, P231; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sousa MC, 2001, CLIN DIAGN LAB IMMUN, V8, P258; SPORMANN DO, 1991, EUR J BIOCHEM, V197, P399, DOI 10.1111/j.1432-1033.1991.tb15924.x; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Suarez-Rendueles P., 2004, HDB PROTEOLYTIC ENZY, P950; Thompson RCA, 2000, INT J PARASITOL, V30, pV; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vanderheyden PML, 2006, FUND CLIN PHARMACOL, V20, P613, DOI 10.1111/j.1472-8206.2006.00444.x; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Weber K, 1997, FEBS LETT, V419, P87, DOI 10.1016/S0014-5793(97)01436-1; WINIECKAKRUSNELL J, 1995, EUR J CLIN MICROBIOL, V14, P218, DOI 10.1007/BF02310359; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Wouters MA, 2001, J MOL BIOL, V314, P1191, DOI 10.1006/jmbi.2000.5161	47	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4471	4484		10.1074/jbc.M110.181511	http://dx.doi.org/10.1074/jbc.M110.181511			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135098	Green Published, hybrid			2022-12-27	WOS:000286975700047
J	Ralat, LA; Guo, Q; Ren, M; Funke, T; Dickey, DM; Potter, LR; Tang, WJ				Ralat, Luis A.; Guo, Qing; Ren, Min; Funke, Todd; Dickey, Deborah M.; Potter, Lincoln R.; Tang, Wei-Jen			Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL TRIPEPTIDE; RAT; RECEPTORS; ENDOPEPTIDASE-24.11; DEGRADATION; SUBSTRATE; RECOGNITION; NEPRILYSIN; INSULYSIN; CLEAVAGE	Natriuretic peptides (NPs) are cyclic vasoactive peptide hormones with high therapeutic potential. Three distinct NPs (ANP, BNP, and CNP) can selectively activate natriuretic peptide receptors, NPR-A and NPR-B, raising the cyclic GMP (cGMP) levels. Insulin-degrading enzyme (IDE) was found to rapidly cleave ANP, but the functional consequences of such cleavages in the cellular environment and the molecular mechanism of recognition and cleavage remain unknown. Here, we show that reducing expression levels of IDE profoundly alters the response of NPR-A and NPR-B to the stimulation of ANP, BNP, and CNP in cultured cells. IDE rapidly cleaves ANP and CNP, thus inactivating their ability to raise intracellular cGMP. Conversely, reduced IDE expression enhances the stimulation of NPR-A and NPR-B by ANP and CNP, respectively. Instead of proteolytic inactivation, IDE cleavage can lead to hyperactivation of BNP toward NPR-A. Conversely, decreasing IDE expression reduces BNP-mediated signaling. Additionally, the cleavages of ANP and BNP by IDE render them active with NPR-B and a reduction of IDE expression diminishes the ability of ANP and BNP to stimulate NPR-B. Our kinetic and crystallographic analyses offer the molecular basis for the selective degradation of NPs and their variants by IDE. Furthermore, our studies reveal how IDE utilizes its catalytic chamber and exosite to engulf and bind up to two NPs leading to biased stochastic, non-sequential cleavages and the ability of IDE to switch its substrate selectivity. Thus, the evolutionarily conserved IDE may play a key role in modulating and reshaping the strength and duration of NP-mediated signaling.	[Ralat, Luis A.; Guo, Qing; Ren, Min; Funke, Todd; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM81539, F32 GM87093, 5T32HL07237-33, R21HL093402-01]; U.S. Dept. of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402, T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539, F32GM087093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM81539 (to W.-J. T.), F32 GM87093 (to L. A. R.), 5T32HL07237-33 (to T. F.), and R21HL093402-01 (to L. R. P.).; We thank the staff of APS SBC for help in data collection. The use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Office of Basic Energy Sciences, under Contract No. W-31-109-ENG-38. The use of the proteomics service facility was supported by Chicago Biomedical Consortium.	CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Dickey DM, 2009, J BIOL CHEM, V284, P19196, DOI 10.1074/jbc.M109.010777; DUCKWORTH WC, 1989, AM J PHYSIOL, V256, pE208, DOI 10.1152/ajpendo.1989.256.2.E208; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; JOHNSON GR, 1989, J BIOL CHEM, V264, P11637; JOHNSON GR, 1990, BIOCHEM BIOPH RES CO, V167, P110, DOI 10.1016/0006-291X(90)91737-D; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; MULLER D, 1992, BIOCHEMISTRY-US, V31, P11138; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; NUSSENZVEIG DR, 1990, J BIOL CHEM, V265, P20952; Pankow K, 2007, CIRC RES, V101, P875, DOI 10.1161/CIRCRESAHA.107.153585; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; SAXENHOFER H, 1990, AM J PHYSIOL, V259, pF832, DOI 10.1152/ajprenal.1990.259.5.F832; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; SEYMOUR AA, 1991, J PHARMACOL EXP THER, V256, P1002; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHIMEKAKE Y, 1992, FEBS LETT, V309, P185, DOI 10.1016/0014-5793(92)81091-Y; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; TOLL L, 1991, BIOCHEM BIOPH RES CO, V175, P886, DOI 10.1016/0006-291X(91)91648-V; VANNESTE Y, 1990, BIOCHEM J, V269, P801, DOI 10.1042/bj2690801; WEBB RL, 1989, J CARDIOVASC PHARM, V14, P285, DOI 10.1097/00005344-198908000-00015	31	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4670	4679		10.1074/jbc.M110.173252	http://dx.doi.org/10.1074/jbc.M110.173252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098034	hybrid, Green Published			2022-12-27	WOS:000286975700066
J	Sever-Chroneos, Z; Krupa, A; Davis, J; Hasan, M; Yang, CH; Szeliga, J; Herrmann, M; Hussain, M; Geisbrecht, BV; Kobzik, L; Chroneos, ZC				Sever-Chroneos, Zvjezdana; Krupa, Agnieszka; Davis, Jeremy; Hasan, Misbah; Yang, Ching-Hui; Szeliga, Jacek; Herrmann, Mathias; Hussain, Muzafar; Geisbrecht, Brian V.; Kobzik, Lester; Chroneos, Zissis C.			Surfactant Protein A (SP-A)-mediated Clearance of Staphylococcus aureus Involves Binding of SP-A to the Staphylococcal Adhesin Eap and the Macrophage Receptors SP-A Receptor 210 and Scavenger Receptor Class A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ADHERENCE PROTEIN; TUMOR-NECROSIS-FACTOR; HOST-CELL INVASION; PULMONARY SURFACTANT; MYCOBACTERIUM-TUBERCULOSIS; CHEMOKINE PRODUCTION; STREPTOCOCCUS-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; ALVEOLAR MACROPHAGES; POTENTIAL MECHANISM	Staphylococcus aureus causes life-threatening pneumonia in hospitals and deadly superinfection during viral influenza. The current study investigated the role of surfactant protein A (SP-A) in opsonization and clearance of S. aureus. Previous studies showed that SP-A mediates phagocytosis via the SP-A receptor 210 (SP-R210). Here, we show that SP-R210 mediates binding and control of SP-A-opsonized S. aureus by macrophages. We determined that SP-A binds S. aureus through the extracellular adhesin Eap. Consequently, SP-A enhanced macrophage uptake of Eap-expressing (Eap(+)) but not Eap-deficient (Eap(-)) S. aureus. In a reciprocal fashion, SP-A failed to enhance uptake of Eap(+) S. aureus in peritoneal Raw264.7 macrophages with a dominant negative mutation (SP-R210(DN)) blocking surface expression of SP-R210. Accordingly, WT mice cleared infection with Eap(+) but succumbed to sublethal infection with Eap-S. aureus. However, SP-R210(DN) cells compensated by increasing non-opsonic phagocytosis of Eap(+) S. aureus via the scavenger receptor scavenger receptor class A (SR-A), while non-opsonic uptake of Eap(+) S. aureus was impaired. Macrophages express two isoforms: SP-R210(L) and SP-R210(S). The results show that WT alveolar macrophages are distinguished by expression of SP-R210(L), whereas SR-A(-/-) alveolar macrophages are deficient in SP-R210(L) expressing only SP-R210(S). Accordingly, SR-A(-/-) mice were highly susceptible to both Eap(+) and Eap(-) S. aureus. The lungs of susceptible mice generated abnormal inflammatory responses that were associated with impaired killing and persistence of S. aureus infection in the lung. In conclusion, alveolar macrophage SP-R210(L) mediates recognition and killing of SP-A-opsonized S. aureus in vivo, coordinating inflammatory responses and resolution of S. aureus pneumonia through interaction with SR-A.	[Sever-Chroneos, Zvjezdana; Krupa, Agnieszka; Davis, Jeremy; Hasan, Misbah; Yang, Ching-Hui; Szeliga, Jacek; Chroneos, Zissis C.] Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, Tyler, TX 75708 USA; [Herrmann, Mathias] Univ Hosp Saarland, D-66421 Homburg, Germany; [Hussain, Muzafar] Univ Hosp Munster, Div Cell Biol & Biophys, D-48129 Munster, Germany; [Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Universitatsklinikum des Saarlandes; University of Munster; University of Missouri System; University of Missouri Kansas City; Harvard University; Harvard T.H. Chan School of Public Health	Chroneos, ZC (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, 11937 US Hwy 271, Tyler, TX 75708 USA.	zissis.chroneos@uthct.edu	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; , Zissis/0000-0002-9841-7917; Krupa, Agnieszka/0000-0003-1303-4608	National Institutes of Health [HL068127, ES11008, AI071028]; Potts Memorial Foundation; Juvenile Diabetes Research Foundation; University of Texas Health Science Center at Tyler research council; Federal Ministry for Research and Technology [01KI07103]; Deutsche Forschungsgemeinschaft [1850/7-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Potts Memorial Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of Texas Health Science Center at Tyler research council; Federal Ministry for Research and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068127 (to Z.C.C.), ES11008 (to L.K.), and AI071028 (to B.V.G.). This work was also supported by the Potts Memorial Foundation (to Z.C.C.), the Juvenile Diabetes Research Foundation (to Z.C.C.), and University of Texas Health Science Center at Tyler research council grants (to Z.S.-C.).; Supported by Federal Ministry for Research and Technology Grant 01KI07103 and by Deutsche Forschungsgemeinschaft Grant 1850/7-2.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Athanasopoulos AN, 2006, BLOOD, V107, P2720, DOI 10.1182/blood-2005-08-3140; Banerjee S, 2010, J BIOL CHEM, V285, P2665, DOI 10.1074/jbc.M109.060822; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; Canadas O, 2008, BIOPHYS J, V95, P3287, DOI 10.1529/biophysj.108.137323; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Chimote G, 2008, J COLLOID INTERF SCI, V328, P288, DOI 10.1016/j.jcis.2008.08.022; Chroneos ZC, 1996, J BIOL CHEM, V271, P16375, DOI 10.1074/jbc.271.27.16375; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; COONROD JD, 1984, J CLIN INVEST, V74, P1269, DOI 10.1172/JCI111537; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Gil M, 2009, J BIOL CHEM, V284, P7495, DOI 10.1074/jbc.M808643200; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Harraghy N, 2003, MICROBIOL-SGM, V149, P2701, DOI 10.1099/mic.0.26465-0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Hussain M, 2001, CLIN DIAGN LAB IMMUN, V8, P1271, DOI 10.1128/CDLI.8.6.1271-1276.2001; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Inden K, 2009, MICROBES INFECT, V11, P245, DOI 10.1016/j.micinf.2008.11.013; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Kowanko IC, 1996, INFECT IMMUN, V64, P3435, DOI 10.1128/IAI.64.8.3435-3437.1996; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lin YL, 2007, J BIOL CHEM, V282, P4653, DOI 10.1074/jbc.M608552200; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; McElroy MC, 2002, INFECT IMMUN, V70, P3865, DOI 10.1128/IAI.70.7.3865-3873.2002; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; MCNEELY TB, 1993, J INFECT DIS, V167, P91, DOI 10.1093/infdis/167.1.91; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; NUGENT KM, 1982, INFECT IMMUN, V36, P1185, DOI 10.1128/IAI.36.3.1185-1191.1982; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Rivera-Marrero CA, 2002, AM J PHYSIOL-LUNG C, V282, pL546, DOI 10.1152/ajplung.00175.2001; Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Samten B, 2008, J LEUKOCYTE BIOL, V84, P115, DOI 10.1189/jlb.1207835; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Szeliga J, 2005, ANAL BIOCHEM, V346, P179, DOI 10.1016/j.ab.2005.07.021; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van de Wetering JK, 2001, J INFECT DIS, V184, P1143, DOI 10.1086/323746; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; VIA DP, 1989, J LIPID RES, V30, P1515; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wang ZD, 2008, TUBERCULOSIS, V88, P178, DOI 10.1016/j.tube.2007.11.003; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Weikert LF, 2000, AM J PHYSIOL-LUNG C, V279, pL216, DOI 10.1152/ajplung.2000.279.2.L216; Weikert LF, 1997, AM J PHYSIOL-LUNG C, V272, pL989, DOI 10.1152/ajplung.1997.272.5.L989; WRIGHT SD, 1984, J CELL BIOL, V99, P336, DOI 10.1083/jcb.99.1.336; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Xie CP, 2006, J EXP MED, V203, P985, DOI 10.1084/jem.20051681; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	105	50	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4854	4870		10.1074/jbc.M110.125567	http://dx.doi.org/10.1074/jbc.M110.125567			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123169	Green Published, hybrid			2022-12-27	WOS:000286975700082
J	Bier, C; Knauer, SK; Klapthor, A; Schweitzer, A; Rekik, A; Kramer, OH; Marschalek, R; Stauber, RH				Bier, Carolin; Knauer, Shirley K.; Klapthor, Alexander; Schweitzer, Andrea; Rekik, Alexander; Kraemer, Oliver H.; Marschalek, Rolf; Stauber, Roland H.			Cell-based Analysis of Structure-Function Activity of Threonine Aspartase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPORT FACTOR FAMILY; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; PROTEIN STABILITY; FUSION PROTEIN; MLL; COMPLEX; LEUKEMIA; TASPASE1; SURVIVIN	Taspase1 is a threonine protease responsible for cleaving intracellular substrates. As such, (de) regulated Taspase1 function is expected not only to be vital for ordered development but may also be relevant for disease. However, the full repertoires of Taspase1 targets as well as the exact biochemical requirements for its efficient and substrate-specific cleavage are not yet resolved. Also, no cellular assays for this protease are currently available, hampering the exploitation of the (patho)biological relevance of Taspase1. Here, we developed highly efficient cell-based translocation biosensor assays to probe Taspase1 trans-cleavage in vivo. These modular sensors harbor variations of Taspase1 cleavage sites and localize to the cytoplasm. Expression of Taspase1 but not of inactive Taspase1 mutants or of unrelated proteases triggers proteolytic cleavage and nuclear accumulation of the biosensors. Employing our assay combined with scanning mutagenesis, we identified the sequence and spatial requirements for efficient Taspase1 processing in liquid and solid tumor cell lines. Collectively, our results defined an improved Taspase1 consensus recognition sequence, Q(3)(F/I/L/V)D-2(1) down arrow G(1)' X-2' D-3' D-4', allowing the first genome-wide bioinformatic identification of the human Taspase1 degradome. Among the 27 most likely Taspase1 targets are cytoplasmic but also nuclear proteins, such as the up-stream stimulatory factor 2 (USF2) or the nuclear RNA export factors 2/5 (NXF2/5). Cleavage site recognition and proteolytic processing of selected targets were verified in the context of the biosensor and for the full-length proteins. We provide novel mechanistic insights into the function and bona fide targets of Taspase1 allowing for a focused investigation of the (patho)biological relevance of this type 2 asparaginase.	[Stauber, Roland H.] Univ Hosp Mainz, Mol & Cellular Oncol Mainzer Screening Ctr, D-55101 Mainz, Germany; [Knauer, Shirley K.] Univ Duisburg Essen, Ctr Med Biotechnol, Inst Mol Biol, D-45117 Essen, Germany; [Kraemer, Oliver H.] Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, D-07745 Jena, Germany; [Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmaceut Biol ZAFES, D-60438 Frankfurt, Germany	University Hospital Mainz; University of Duisburg Essen; Friedrich Schiller University of Jena; Goethe University Frankfurt		bier@uni-mainz.de; shirley.knauer@uni-due.de; rstauber@uni-mainz.de	Krämer, Oliver H/L-9266-2015; Marschalek, Rolf/D-3404-2011; Knauer, Shirley K/E-7931-2012	Krämer, Oliver H/0000-0003-3973-045X; Marschalek, Rolf/0000-0003-4870-3445; Knauer, Shirley K/0000-0003-4321-0924; Stauber, Roland/0000-0002-1341-4523	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen [DFG KN973/1-1, DFG INST371/5-1FUGG]; Mainz Screening Center; Dr. Krieg; Inneruniversity; MAIFOR	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen; Mainz Screening Center; Dr. Krieg; Inneruniversity; MAIFOR	This work was supported by German Cancer Aid Grant FKZ102362 (to R. H. S. and R. M.), Head and Neck Cancer Foundation (to C. B.), Wilhelm-Sander Foundation, Funds of the Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen Grants DFG KN973/1-1 and DFG INST371/5-1FUGG, Mainz Screening Center, donation from Dr. Krieg, and the Inneruniversity and MAIFOR Mainz Support Program.	Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Chen N, 2006, ONCOGENE, V25, P579, DOI 10.1038/sj.onc.1209079; DAHLQUIST KD, 2004, CURR PROTOC BIOINFOR, P1; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fetz V, 2009, SENSORS-BASEL, V9, P5423, DOI 10.3390/s90705423; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Gaussmann A, 2007, ONCOGENE, V26, P3352, DOI 10.1038/sj.onc.1210125; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Heger P, 2001, TRAFFIC, V2, P544, DOI 10.1034/j.1600-0854.2001.20804.x; Hoiby T, 2007, BBA-GENE STRUCT EXPR, V1769, P429, DOI 10.1016/j.bbaexp.2007.04.008; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2007, CELL CYCLE, V6, P1502; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2006, LEUKEMIA, V20, P777, DOI 10.1038/sj.leu.2404150; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Taki T, 2005, ONCOGENE, V24, P5191, DOI 10.1038/sj.onc.1208711; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van Deursen D, 2009, BBA-MOL CELL BIOL L, V1791, P229, DOI 10.1016/j.bbalip.2009.01.017; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	48	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3007	3017		10.1074/jbc.M110.161646	http://dx.doi.org/10.1074/jbc.M110.161646			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084304	hybrid, Green Published			2022-12-27	WOS:000286464300064
J	Kieseritzky, G; Knapp, EW				Kieseritzky, Gernot; Knapp, Ernst-Walter			Charge Transport in the ClC-type Chloride-Proton Anti-porter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION CENTERS; /H+ EXCHANGE TRANSPORTER; PROKARYOTIC HOMOLOG; ELECTRON-TRANSFER; PROTEINS; CHANNELS; ANTIPORTER; MECHANISM; DYNAMICS; SYSTEMS	The first chloride transporter identified in the superfamily of ClC chloride channels was from Escherichia coli (EClC) (Accardi, A., and Miller, C. (2004) Nature 427, 803-807). Pathways, energetics, and mechanism of proton and chloride translocation and their coupling are up to now unclear. To bridge the hydrophobic gap of proton transport, we modeled four stable buried waters into both subunits of the WT EClC structure. Together they form a "water wire" connecting Glu-203 with the chloride at the central site, which in turn connects to Glu-148, the hypothetical proton exit site. Assuming the transient production of hydrochloride in the central chloride binding site of EClC, the water wire could establish a transmembrane proton transport pathway starting from Glu-203 all the way downstream onto Glu-148. We demonstrated by electrostatic and quantum chemical computations that protonation of the central chloride is energetically feasible. We characterized all chloride occupancies and protonation states possibly relevant for the proton-chloride transport cycle in EClC and constructed a working model. Accordingly, EClC evolves through states involving up to two excess protons and between one and three chlorides, which was required to fulfill the experimentally observed 2: 1 stoichiometry. We show that the Y445F and E203H mutants of EClC can operate similarly, thus explaining why they exhibit almost WT activity levels. The proposed mechanism of coupled chloride-proton transport in EClC is consistent with available experimental data and allows predictions on the importance of specific amino acids, which may be probed by mutation experiments.	[Kieseritzky, Gernot; Knapp, Ernst-Walter] Free Univ Berlin, Inst Chem, D-14195 Berlin, Germany	Free University of Berlin	Knapp, EW (corresponding author), Free Univ Berlin, Inst Chem, Fabeckstr 36A, D-14195 Berlin, Germany.	knapp@chemie.fu-berlin.de	Knapp, Ernst-Walter/AAH-6720-2021; Knapp, Ernst-Walter/E-4493-2010	Knapp, Ernst-Walter/0000-0002-2858-0460; Knapp, Ernst-Walter/0000-0002-2858-0460	German National Academic Foundation; Volkswagen Foundation	German National Academic Foundation; Volkswagen Foundation(Volkswagen)	This work was supported by the German National Academic Foundation and the Volkswagen Foundation.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Day TJF, 2002, J CHEM PHYS, V117, P5839, DOI 10.1063/1.1497157; de Grotthuss C, 1806, ANN CHIM, V58, P54; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2003, J BIOL CHEM, V278, P52002, DOI 10.1074/jbc.M306434200; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kieseritzky G, 2008, J COMPUT CHEM, V29, P2575, DOI 10.1002/jcc.20999; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; KNAPP EW, 1980, CHEM PHYS, V46, P215, DOI 10.1016/0301-0104(80)85096-8; Kuang ZF, 2007, PROTEINS, V68, P26, DOI 10.1002/prot.21441; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nguitragool W, 2007, P NATL ACAD SCI USA, V104, P20659, DOI 10.1073/pnas.0708639104; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; ROBERTSON JL, 2010, NATURE IN PRESS; ROBINSON RA, 1971, ANAL CHEM, V43, P969, DOI 10.1021/ac60302a030; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SCHRODINGER L, 2009, JAGUAR, V7; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Voigt P, 2003, J BIOL CHEM, V278, P51993, DOI 10.1074/jbc.M307560200; Voth GA, 2006, ACCOUNTS CHEM RES, V39, P143, DOI 10.1021/ar0402098; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang D, 2009, BIOPHYS J, V97, P121, DOI 10.1016/j.bpj.2009.04.038; WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008; WARSHEL A, 1991, COMPUTER MODELING CH, P46; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2976	2986		10.1074/jbc.M110.163246	http://dx.doi.org/10.1074/jbc.M110.163246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21059656	Green Published, hybrid			2022-12-27	WOS:000286464300061
J	Sasaki, CY; Ghosh, P; Longo, DL				Sasaki, Carl Y.; Ghosh, Paritosh; Longo, Dan L.			Recruitment of RelB to the Csf2 Promoter Enhances RelA-mediated Transcription of Granulocyte-Macrophage Colony-stimulating Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CHROMATIN IMMUNOPRECIPITATION; NF-KAPPA-B2 P100; IKK-ALPHA; ACTIVATION; GENE; PHOSPHORYLATION; KINASE; SERINE-536	Tumor necrosis factor (TNF) induces expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) but lymphotoxin beta (LT beta) does not. Here we report that priming of cells with agonistic LT beta receptor antibody synergistically enhanced TNF-induced GM-CSF expression. The LT beta priming process was not due to an increase in TNF-mediated nuclear translocation of p65, p65 DNA binding, or NF-kappa B transactivational activity. The synergistic effect of LT beta priming was not observed with other TNF-responsive genes such as Ccl2 or RelB, which suggested that this effect was not a general increase in TNF signaling. Furthermore, RelB and p65 were both independently recruited to the GM-CSF promoter when cells were primed with LT beta followed by TNF treatment. As a consequence, an increase in both chromatin accessibility and the recruitment of RNA polymerase II were observed to the GMCSF promoter. Taken together, these findings suggested that LT beta signaling amplified TNF-mediated GM-CSF expression by facilitating chromatin access and the co-recruitment of RNA polymerase II to increase gene transcription. Moreover, the novel priming process described here underscores the complexity of the interactions between the classical and alternative NF-kappa B signaling pathways.	[Sasaki, Carl Y.; Ghosh, Paritosh; Longo, Dan L.] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sasaki, CY (corresponding author), NIA, Immunol Lab, NIH, 251 Bay View Blvd,Suite 100, Baltimore, MD 21224 USA.	sasakic@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000426] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the NIA, National Institutes of Health.	Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Brettingham-Moore KH, 2008, NUCLEIC ACIDS RES, V36, P2639, DOI 10.1093/nar/gkn117; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; OSBORNE CS, 1995, J IMMUNOL, V155, P226; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Rudolph D, 2000, GENE DEV, V14, P854; Saito T, 2010, BIOCHEM BIOPH RES CO, V391, P235, DOI 10.1016/j.bbrc.2009.11.039; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sasaki CY, 2007, CANCER RES, V67, P11218, DOI 10.1158/0008-5472.CAN-07-0922; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	35	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1093	1102		10.1074/jbc.M110.119438	http://dx.doi.org/10.1074/jbc.M110.119438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071440	hybrid, Green Published			2022-12-27	WOS:000286005000020
J	Sasaki, Y; Milbrandt, J				Sasaki, Yo; Milbrandt, Jeffrey			Axonal Degeneration Is Blocked by Nicotinamide Mononucleotide Adenylyltransferase (Nmnat) Protein Transduction into Transected Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; WALLERIAN DEGENERATION; ADENINE-DINUCLEOTIDE; LENTIVIRAL VECTORS; SELF-DESTRUCTION; IN-VIVO; GENE; NEURODEGENERATION; GLYCOPROTEIN; EXPRESSION	Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wld(s)) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provides an opportunity to develop novel agents to treat axonal damage.	[Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, HOPE Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [NS070053, AG13730, NS065053]; Muscular Dystrophy Association [10040]; Craig H. Neilsen Foundation [124030]; National Institutes of Health Neuroscience Blueprint Center [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065053, P30NS057105, R21NS070053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Craig H. Neilsen Foundation; National Institutes of Health Neuroscience Blueprint Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS070053 (to J.M.), AG13730 (to J.M.), NS065053 (to A. DiAntonio and J.M.). This work was also supported by Muscular Dystrophy Association Grants 10040 (to J.M.) and Craig H. Neilsen Foundation Grant 124030 (to J.M.). The authors and Washington University may derive benefit from a licensing agreement with Sirtris Pharmaceuticals, which did not provide any support for this work.; We thank Kelli Simburger, Amy Strickland, Amber Neilson, and Tim Fahrner for experimental assistance and members of the Milbrandt laboratory and Aaron DiAntonio for comments on the manuscript and helpful discussions. We thank Michael Whitt, University of Tennessee Health Science Center, for the VSV-G antibody. The HOPE Center for Neurological Disorders of Washington University was supported by National Institutes of Health Neuroscience Blueprint Center Core Grant P30 NS057105.	Abe A, 1998, J VIROL, V72, P6159, DOI 10.1128/JVI.72.7.6159-6163.1998; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Hammarstedt M, 2004, J VIROL, V78, P5686, DOI 10.1128/JVI.78.11.5686-5697.2004; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	18	52	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41211	41215		10.1074/jbc.C110.193904	http://dx.doi.org/10.1074/jbc.C110.193904			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21071441	hybrid, Green Published			2022-12-27	WOS:000285622600006
J	Andersen, JT; Pehrson, R; Tolmachev, V; Daba, MB; Abrahmsen, L; Ekblad, C				Andersen, Jan Terje; Pehrson, Rikard; Tolmachev, Vladimir; Daba, Muluneh Bekele; Abrahmsen, Lars; Ekblad, Caroline			Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; I-RELATED RECEPTOR; INTERSTITIAL EXCLUSION; ANTIBODY FRAGMENTS; FUSION PROTEIN; CONTINUOUS-INFUSION; AFFIBODY MOLECULE; IGG HOMEOSTASIS; THERAPEUTICS; EXPRESSION	The therapeutic and diagnostic efficiency of engineered small proteins, peptides, and chemical drug candidates is hampered by short in vivo serum half-life. Thus, strategies to tailor their biodistribution and serum persistence are highly needed. An attractive approach is to take advantage of the exceptionally long circulation half-life of serum albumin or IgG, which is attributed to a pH-dependent interaction with the neonatal Fc receptor (FcRn) rescuing these proteins from intracellular degradation. Here, we present molecular evidence that a minimal albumin binding domain (ABD) derived from streptococcal protein G can be used for efficient half-life extension by indirect targeting of FcRn. We show that ABD, and ABD recombinantly fused to an Affibody molecule, in complex with albumin does not interfere with the strictly pH-dependent FcRn-albumin binding kinetics. The same result was obtained in the presence of IgG. An in vivo study performed in rat confirmed that the clinically relevant human epidermal growth factor 2 (HER2)-targeting Affibody molecule fused to ABD has a similar half-life and biodistribution profile as serum albumin. The proof-of-concept described may be broadly applicable to extend the in vivo half-life of short lived biological or chemical drugs ultimately resulting in enhanced therapeutic or diagnostic efficiency, a more favorable dosing regimen, and improved patient compliance.	[Pehrson, Rikard; Tolmachev, Vladimir; Abrahmsen, Lars; Ekblad, Caroline] Affibody AB, SE-11251 Stockholm, Sweden; Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Tolmachev, Vladimir] Uppsala Univ, Rudbeck Lab, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden	University of Oslo; University of Oslo; Uppsala University	Ekblad, C (corresponding author), Affibody AB, Lindhagensgatan 133, SE-11251 Stockholm, Sweden.	caroline.ekblad@affibody.com	Tolmachev, Vladimir/I-3076-2012; Tolmachev, Vladimir/T-3722-2017; Tolmachev, Vladimir/U-3107-2019; Andersen, Jan Terje/AAB-6209-2020	Tolmachev, Vladimir/0000-0002-6122-1734; Tolmachev, Vladimir/0000-0002-6122-1734; Andersen, Jan Terje/0000-0003-1710-1628	Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo; The Norwegian Research Council	Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo; The Norwegian Research Council(Research Council of Norway)	This work was supported by grants from the Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo (to J.T.A.) and The Norwegian Research Council (to J.T.A.).	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2009, RECOMBINANT ANTIBODIES FOR IMMUNOTHERAPY, P293, DOI 10.1017/CBO9780511596773.023; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Aunoble B, 2000, INT J ONCOL, V16, P567; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Konig T, 1998, J IMMUNOL METHODS, V218, P73, DOI 10.1016/S0022-1759(98)00112-4; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; NYGREN PA, 1991, VACCINES, V91, P363; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orlova A, 2006, J NUCL MED, V47, P512; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Stork R, 2009, J BIOL CHEM, V284, P25612, DOI 10.1074/jbc.M109.027078; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; WIIG H, 1994, AM J PHYSIOL, V266, pH212, DOI 10.1152/ajpheart.1994.266.1.H212; WIIG H, 1992, AM J PHYSIOL, V263, pH1222, DOI 10.1152/ajpheart.1992.263.4.H1222; Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627, DOI 10.1152/ajpheart.2000.278.5.H1627; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	52	122	144	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5234	5241		10.1074/jbc.M110.164848	http://dx.doi.org/10.1074/jbc.M110.164848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138843	hybrid, Green Published			2022-12-27	WOS:000287230600032
J	Chiu, J; Tactacan, CM; Tan, SX; Lin, RCY; Wouters, MA; Dawes, IW				Chiu, Joyce; Tactacan, Carole M.; Tan, Shi-Xiong; Lin, Ruby C. Y.; Wouters, Merridee A.; Dawes, Ian W.			Cell Cycle Sensing of Oxidative Stress in Saccharomyces cerevisiae by Oxidation of a Specific Cysteine Residue in the Transcription Factor Swi6p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT-MUTAGENESIS SLIM; START-SPECIFIC TRANSCRIPTION; LINOLEIC-ACID HYDROPEROXIDE; MAP KINASE PATHWAY; REGULATORY ASSOCIATIONS; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; BUDDING YEAST; IDENTIFICATION; MECHANISMS	Yeast cells begin to bud and enter the S phase when growth conditions are favorable during the G(1) phase. When subjected to some oxidative stresses, cells delay entry at G(1), allowing repair of cellular damage. Hence, oxidative stress sensing is coordinated with the regulation of cell cycle. We identified a novel function of the cell cycle regulator of Saccharomyces cerevisiae, Swi6p, as a redox sensor through its cysteine residue at position 404. When alanine was substituted at this position, the resultant mutant, C404A, was sensitive to several reactive oxygen species and oxidants including linoleic acid hydroperoxide, the superoxide anion, and diamide. This mutant lost the ability to arrest in G(1) phase upon treatment with lipid hydroperoxide. The Cys-404 residue of Swi6p in wild-type cells was oxidized to a sulfenic acid when cells were subjected to linoleic acid hydroperoxide. Mutation of Cys-404 to Ala abolished the down-regulation of expression of the G(1) cyclin genes CLN1, CLN2, PCL1, and PCL2 that occurred when cells of the wild type were exposed to the lipid hydroperoxide. In conclusion, oxidative stress signaling for cell cycle regulation occurs through oxidation of the G(1)/S-speicific transcription factor Swi6p and consequently leads to suppression of the expression of G(1) cyclins and a delay in cells entering the cell cycle.	[Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Wouters, Merridee A.] Victor Chang Cardiac Res Inst, Struct & Computat Biol Program, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Dawes, IW (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Chiu, Joyce/H-7772-2017; Tan, Shi-Xiong/Y-3728-2019; Lin, Ruby CY/A-1636-2009; Wouters, Merridee/D-2046-2012; Wouters, Merridee A/G-2481-2015	Chiu, Joyce/0000-0001-8910-8664; Lin, Ruby CY/0000-0003-4163-511X; Wouters, Merridee A/0000-0002-2121-912X; Tan, Shi-Xiong/0000-0002-0020-2572	Australian Research Council; National Health and Medical Research Council Peter Doherty; University of New South Wales	Australian Research Council(Australian Research Council); National Health and Medical Research Council Peter Doherty; University of New South Wales	This work was supported by discovery grants from Australian Research Council (to I.W.D.) and National Health and Medical Research Council Peter Doherty and University of New South Wales vice-chancellor's post-doctoral fellowships (to R.C.Y.L.).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alic N, 2001, MOL BIOL CELL, V12, P1801, DOI 10.1091/mbc.12.6.1801; Barrera G, 2005, BIOFACTORS, V24, P151, DOI 10.1002/biof.5520240118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; Fong CS, 2008, FEMS YEAST RES, V8, P386, DOI 10.1111/j.1567-1364.2007.00349.x; Foord R, 1999, NAT STRUCT BIOL, V6, P157; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Gutteridge J. M., 1999, FREE RADICAL BIO MED, P36; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neely MD, 2005, BRAIN RES, V1037, P90, DOI 10.1016/j.brainres.2004.12.027; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, p371A; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102	57	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5204	5214		10.1074/jbc.M110.172973	http://dx.doi.org/10.1074/jbc.M110.172973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147769	Green Published, hybrid			2022-12-27	WOS:000287230600029
J	Ranji, A; Shkriabai, N; Kvaratskhelia, M; Musier-Forsyth, K; Boris-Lawrie, K				Ranji, Arnaz; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen			Features of Double-stranded RNA-binding Domains of RNA Helicase A Are Necessary for Selective Recognition and Translation of Complex mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEINS; VIRUS TYPE-1; REPORTER RNA; FAMILY; INTERACTS; RETROVIRUSES; EXPRESSION; NUCLEOLIN; SEQUENCE; DSRNA	The DExH protein RNA helicase A (RHA) plays numerous roles in cell physiology, and post-transcriptional activation of gene expression is a major role among them. RHA selectively activates translation of complex cellular and retroviral mRNAs. Although RHA requires interaction with structural features of the 5'-UTR of these target mRNAs, the molecular basis of their translation activation by RHA is poorly understood. RHA contains a conserved ATPase-dependent helicase core that is flanked by two alpha-beta-beta-beta-alpha double-stranded RNA-binding domains at the N terminus and repeated arginine-glycine residues at the C terminus. The individual recombinant N-erminal, centralhelicase, and C-terminal domains were evaluated for their ability to specifically interact with cognate RNAs by in vitro biochemical measurements and mRNA translation assays in cells. The results demonstrate that N-terminal residues confer selective interaction with retroviral and junD target RNAs. Conserved lysine residues in the distal alpha-helix of the double-stranded RNA-binding domains are necessary to engage structural features of retroviral and junD 5'-UTRs. Exogenous expression of the N terminus coprecipitates junD mRNA and inhibits the translation activity of endogenous RHA. The results indicate that the molecular basis for the activation of translation by RHA is recognition of target mRNA by the N-terminal domain that tethers the ATP-dependent helicase for rearrangement of the complex 5'-UTR.	[Ranji, Arnaz; Boris-Lawrie, Kathleen] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Ranji, Arnaz; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ranji, Arnaz; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Ranji, Arnaz; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Boris-Lawrie, K (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.	boris-lawrie.1@osu.edu	Boris-Lawrie, Kathleen/AAB-8953-2020	Boris-Lawrie, Kathleen/0000-0001-6366-6270	National Institutes of Health Grants [RO1CA108882, P30CA100730, RO1GM065056]; Ohio State University Comprehensive Cancer Center [P01CA16058]; Ohio State University College of Veterinary Medicine; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA108882, P01CA100730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065056] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center; Ohio State University College of Veterinary Medicine(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA108882 (to K.B.- L.), P30CA100730 (to K.B.- L. and M.K.), RO1GM065056 (to K.M.- F.), and P01CA16058 (to the Ohio State University Comprehensive Cancer Center). This work was also supported by a Glenn Barber predoctoral fellowship from the Ohio State University College of Veterinary Medicine (to A.R.).	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Butsch M, 1999, J VIROL, V73, P4847, DOI 10.1128/JVI.73.6.4847-4855.1999; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Guenard F, 2009, J HUM GENET, V54, P152, DOI 10.1038/jhg.2009.6; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hull S, 2002, J VIROL, V76, P10211, DOI 10.1128/JVI.76.20.10211-10218.2002; Lebars I, 2001, EMBO J, V20, P7250, DOI 10.1093/emboj/20.24.7250; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Nagel R, 2000, RNA, V6, P1142, DOI 10.1017/S1355838200000431; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Stello T, 1999, NUCLEIC ACIDS RES, V27, P4823, DOI 10.1093/nar/27.24.4823; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a	37	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5328	5337		10.1074/jbc.M110.176339	http://dx.doi.org/10.1074/jbc.M110.176339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21123178	Green Published, hybrid			2022-12-27	WOS:000287230600041
J	Dellisanti, CD; Hanson, SM; Chen, L; Czajkowski, C				Dellisanti, Cosma D.; Hanson, Sonya M.; Chen, Lin; Czajkowski, Cynthia			Packing of the Extracellular Domain Hydrophobic Core Has Evolved to Facilitate Pentameric Ligand-gated Ion Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GAMMA-AMINOBUTYRIC-ACID; X-RAY-STRUCTURE; BINDING-PROTEIN; CRYSTAL-STRUCTURE; GATING MECHANISM; PARTIAL AGONISTS; STABILITY; ACTIVATION; MUTATIONS	Protein function depends on conformational flexibility and folding stability. Loose packing of hydrophobic cores is not infrequent in proteins, as the enhanced flexibility likely contributes to their biological function. Here, using experimental and computational approaches, we show that eukaryotic pentameric ligand-gated ion channels are characterized by loose packing of their extracellular domain beta-sandwich cores, and that loose packing contributes to their ability to rapidly switch from closed to open channel states in the presence of ligand. Functional analyses of GABA(A) receptors show that increasing the beta-core packing disrupted GABA-mediated currents, with impaired GABA efficacy and slowed GABA current activation and desensitization. We propose that loose packing of the hydrophobic beta-core developed as an evolutionary strategy aimed to facilitate the allosteric mechanisms of eukaryotic pentameric ligand-gated ion channels.	[Dellisanti, Cosma D.; Czajkowski, Cynthia] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA; [Hanson, Sonya M.; Chen, Lin] Univ So Calif 90089, Los Angeles, CA 90089 USA	University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), 601 Sci Dr,Rm 135, Madison, WI 53711 USA.	czajkowski@physiology.wisc.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199	NIGMS NIH HHS [R01 GM064642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cheng XL, 2009, BIOPHYS J, V96, P4502, DOI 10.1016/j.bpj.2009.03.018; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Chothia C, 2009, BIOCHEM J, V419, P15, DOI 10.1042/BJ20090122; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; ERIKSSON AE, 1993, J MOL BIOL, V229, P747, DOI 10.1006/jmbi.1993.1077; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; JACKSON MB, 1982, J NEUROSCI, V2, P889; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Olano LR, 2004, J AM CHEM SOC, V126, P7991, DOI 10.1021/ja049701c; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; SANDBERG WS, 1991, P NATL ACAD SCI USA, V88, P1706, DOI 10.1073/pnas.88.5.1706; SANDBERG WS, 1989, SCIENCE, V245, P54, DOI 10.1126/science.2787053; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; WILLIAMS MA, 1994, PROTEIN SCI, V3, P1224, DOI 10.1002/pro.5560030808	64	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3658	3670		10.1074/jbc.M110.156851	http://dx.doi.org/10.1074/jbc.M110.156851			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098036	Green Published, hybrid			2022-12-27	WOS:000286653200049
J	Hayashida, A; Amano, S; Park, PW				Hayashida, Atsuko; Amano, Shiro; Park, Pyong Woo			Syndecan-1 Promotes Staphylococcus aureus Corneal Infection by Counteracting Neutrophil-mediated Host Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PSEUDOMONAS-AERUGINOSA; EPITHELIAL-CELLS; VIRULENCE FACTOR; ALPHA-TOXIN; BETA-TOXIN; BACTERIAL KERATITIS; LUNG INJURY; BINDING; INFILTRATION	Many microbial pathogens subvert cell surface heparan sulfate proteoglycans (HSPGs) to infect host cells in vitro. The significance of HSPG-pathogen interactions in vivo, however, remains to be determined. In this study, we examined the role of syndecan-1, a major cell surface HSPG of epithelial cells, in Staphylococcus aureus corneal infection. We found that syndecan-1 null (Sdc1(-/-)) mice significantly resist S. aureus corneal infection compared with wild type (WT) mice that express abundant syndecan-1 in their corneal epithelium. However, syndecan-1 did not bind to S. aureus, and syndecan-1 was not required for the colonization of cultured corneal epithelial cells by S. aureus, suggesting that syndecan-1 does not mediate S. aureus attachment to corneal tissues in vivo. Instead, S. aureus induced the shedding of syndecan-1 ectodomains from the surface of corneal epithelial cells. Topical administration of purified syndecan-1 ectodomains or heparan sulfate (HS) significantly increased, whereas inhibition of syndecan-1 shedding significantly decreased the bacterial burden in corneal tissues. Furthermore, depletion of neutrophils in the resistant Sdc1(-/-) mice increased the corneal bacterial burden to that of the susceptible WT mice, suggesting that syndecan-1 moderates neutrophils to promote infection. We found that syndecan-1 does not affect the infiltration of neutrophils into the infected cornea but that purified syndecan-1 ectodomain and HS significantly inhibit neutrophil-mediated killing of S. aureus. These data suggest a previously unknown bacterial subversion mechanism where S. aureus exploits the capacity of syndecan-1 ectodomains to inhibit neutrophil-mediated bacterial killing mechanisms in an HS-dependent manner to promote its pathogenesis in the cornea.	[Hayashida, Atsuko; Park, Pyong Woo] Harvard Univ, Childrens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Amano, Shiro] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Tokyo	Park, PW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Med, 320 Longwood Ave,Enders 461, Boston, MA 02115 USA.	pyong.park@childrens.harvard.edu		Park, Pyong Woo/0000-0002-7979-4979	National Institutes of Health [R01 HL94613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL94613.	Bartlett AH, 2007, MOL CELLS, V24, P153; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chen HB, 1997, INVEST OPHTH VIS SCI, V38, P381; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Gao C, 2002, MOL CANCER RES, V1, P12; Girgis DO, 2005, INVEST OPHTH VIS SCI, V46, P2064, DOI 10.1167/iovs.04-0897; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Henry-Stanley MJ, 2003, MED MICROBIOL IMMUN, V192, P107, DOI 10.1007/s00430-002-0165-7; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Jett BD, 2002, DNA CELL BIOL, V21, P397, DOI 10.1089/10445490260099683; Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002; Khan S, 2007, J LEUKOCYTE BIOL, V81, P315, DOI 10.1189/jlb.0506344; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIANG OD, 1992, INFECT IMMUN, V60, P899, DOI 10.1128/IAI.60.3.899-906.1992; LIMBERG M B, 1991, American Journal of Ophthalmology, V112, p2S; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.01143.x; McCormick CC, 2009, INVEST OPHTH VIS SCI, V50, P2848, DOI 10.1167/iovs.08-3157; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; PARK PW, 1991, J BIOL CHEM, V266, P23399; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; PEREIRA HA, 1993, P NATL ACAD SCI USA, V90, P4733, DOI 10.1073/pnas.90.10.4733; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sack RA, 2001, BIOSCIENCE REP, V21, P463, DOI 10.1023/A:1017943826684; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	58	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3288	3297		10.1074/jbc.M110.185165	http://dx.doi.org/10.1074/jbc.M110.185165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127056	Green Published, hybrid			2022-12-27	WOS:000286653200014
J	Durpes, MC; Hardy-Dessources, MD; El Nemer, W; Picot, J; Lemonne, N; Elion, J; Decastel, M				Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; El Nemer, Wassim; Picot, Julien; Lemonne, Nathalie; Elion, Jacques; Decastel, Monique			Activation State of alpha 4 beta 1 Integrin on Sickle Red Blood Cells Is Linked to the Duffy Antigen Receptor for Chemokines(DARC) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(4)BETA(1) INTEGRIN; ERYTHROCYTE ADHERENCE; CLINICAL SEVERITY; ADHESION; ENDOTHELIUM; RETICULOCYTES; INTERLEUKIN-8; MECHANISMS; SEQUENCE	In sickle cell anemia, reticulocytes express enhanced levels of alpha 4 beta 1 integrin that interact mainly with vascular cell adhesion molecule-1 and fibronectin, promoting vaso-occlusion. These interactions are known to be highly sensitive to the inflammatory chemokine IL-8. The Duffy antigen receptor for chemokines (DARC) modulates the function of inflammatory processes. However, the link between alpha 4 beta 1 activation by chemokines and DARC erythroid expression is not or poorly explored. Therefore, the capacity of alpha 4 beta 1 to mediate Duffy-negative and Duffy-positive sickle reticulocyte (SRe) adhesion to immobilized vascular cell adhesion molecule-1 and fibronectin was evaluated. Using static adhesion assays, we found that, under basal conditions, Duffy-positive SRe adhesion was 2-fold higher than that of Duffy-negative SRes. Incubating the cells with IL-8 or RANTES (regulated on activation normal T cell expressed and secreted) increased Duffy-positive SRe adhesion only, whereas Mn2+ increased cell adhesion independently of the Duffy phenotype. Flow cytometry analyses performed with anti-beta 1 and anti-alpha 4 antibodies, including a conformation-sensitive one, in the presence or absence of IL-8, revealed that Duffy-positive and Duffy-negative SRes displayed similar erythroid alpha 4 beta 1 expression levels, but with distinct activation states. IL-8 did not affect alpha 4 beta 1 affinity in Duffy-positive SRes but induced its clustering as corroborated by immunofluorescence microscopy. Our results indicate that in Duffy-negative SRes alpha 4 beta 1 integrin is constitutively expressed in a low affinity state, whereas in Duffy-positive SRes alpha 4 beta 1 is expressed in a higher chemokine-sensitive affinity state. This activation state associated with DARC RBC expression may influence the intensity of the inflammatory responses encountered in sickle cell anemia and participate in its interindividual clinical expression variability.	[Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; Elion, Jacques; Decastel, Monique] INSERM, UMR S763, F-97159 Pointe A Pitre, Guadeloupe, France; [Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; Elion, Jacques; Decastel, Monique] Univ Antilles Guyane, F-97159 Pointe A Pitre, Guadeloupe, France; [El Nemer, Wassim; Picot, Julien] INSERM, UMR S665, F-75015 Paris, France; [El Nemer, Wassim; Picot, Julien] Univ Paris Diderot, F-75013 Paris, France; [El Nemer, Wassim; Picot, Julien] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Lemonne, Nathalie] Ctr Hosp Univ Pointe A Pitre, Unite Transversale, Ctr Drepanocytose CRMR SDM Antilles Guyane, F-97159 Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe	Decastel, M (corresponding author), Univ Antilles Guyane, Hop RICOU, CHU Pointe A Pitre, INSERM,UMR S763,CNRS,SD401, F-97159 Pointe A Pitre, Guadeloupe, France.	moniquedecastel@yahoo.fr	Elion, Jacques/A-1048-2014; , Hardy-dessources/K-9189-2017; Nemer, Wassim El/N-4247-2017	Elion, Jacques/0000-0002-8407-1783; , Hardy-dessources/0000-0003-0861-3648; Nemer, Wassim El/0000-0001-8184-427X	Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche; Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche	Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from Region Guadeloupe, Fond Social Europeen and Association Francaise d'Hematologie (to M.-C. D.) and from the Agence Nationale de la Recherche (SCADHESION 2007).	Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Brittain JE, 2008, TRANSFUS CLIN BIOL, V15, P19, DOI 10.1016/j.tracli.2008.03.013; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Cartron JP, 1998, VOX SANG, V74, P29, DOI 10.1111/j.1423-0410.1998.tb05397.x; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; Duits AJ, 1998, EUR J HAEMATOL, V61, P302; Durpes MC, 2010, BLOOD CELL MOL DIS, V44, P219, DOI 10.1016/j.bcmd.2010.02.001; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; Etienne-Julan M, 2004, HAEMATOLOGICA, V89, P863; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; GEE BE, 1995, BLOOD, V85, P268, DOI 10.1182/blood.V85.1.268.bloodjournal851268; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hebbel RP, 1997, J CLIN INVEST, V100, pS83; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Kumar A, 1996, BLOOD, V88, P4348; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Lee K, 2001, BLOOD, V98, P966, DOI 10.1182/blood.V98.4.966; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; Montes RAO, 2002, AM J HEMATOL, V70, P216, DOI 10.1002/ajh.10145; Nebor D, 2010, CLIN IMMUNOL, V136, P116, DOI 10.1016/j.clim.2010.02.023; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; Schnog JB, 2000, CLIN IMMUNOL, V96, P264, DOI 10.1006/clim.2000.4884; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; Walmet PS, 2003, AM J HEMATOL, V73, P215, DOI 10.1002/ajh.10360; WAUTIER JL, 1985, AM J HEMATOL, V19, P121, DOI 10.1002/ajh.2830190203; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Yazdanbakhsh K, 2000, TRANSFUSION, V40, P310, DOI 10.1046/j.1537-2995.2000.40030310.x	33	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3057	3064		10.1074/jbc.M110.173229	http://dx.doi.org/10.1074/jbc.M110.173229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21088296	hybrid, Green Published			2022-12-27	WOS:000286464300068
J	Zou, CB; Butler, PL; Coon, TA; Smith, RM; Hammen, G; Zhao, YT; Chen, BB; Mallampalli, RK				Zou, Chunbin; Butler, Phillip L.; Coon, Tiffany A.; Smith, Rebecca M.; Hammen, Gary; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.			LPS Impairs Phospholipid Synthesis by Triggering beta-Transducin Repeat-containing Protein (beta-TrCP)-mediated Polyubiquitination and Degradation of the Surfactant Enzyme Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (LPCAT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; GLYCOGEN-SYNTHASE KINASE-3; ADULT-RAT LUNG; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; REGULATORY ENZYME; CELLS; PHOSPHORYLATION; EXPRESSION; PHOSPHATIDYLCHOLINE; TRANSCRIPTION	Acyl-CoA: lysophosphatidylcholine acyltransferase 1 (LPCAT1) is a relatively newly described and yet indispensable enzyme needed for generation of the bioactive surfactant phospholipid, dipalmitoylphosphatidylcholine (DPPtdCho). Here, we show that lipopolysaccharide (LPS) causes LPCAT1 degradation using the Skp1-Cullin-F-box ubiquitin E3 ligase component, beta-transducin repeat-containing protein (beta-TrCP), that polyubiquitinates LPCAT1, thereby targeting the enzyme for proteasomal degradation. LPCAT1 was identified as a phosphoenzyme as Ser(178) within a phosphodegron was identified as a putative molecular recognition site for glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylation that recruits beta-TrCP docking within the enzyme. beta-TrCP ubiquitinates LPCAT1 at an acceptor site (Lys(221)), as substitution of Lys(221) with Arg abrogated LPCAT1 polyubiquitination. LPS profoundly reduced immunoreactive LPCAT1 levels and impaired lung surfactant mechanics, effects that were overcome by siRNA to beta-TrCP and GSK-3 beta or LPCAT1 gene transfer, respectively. Thus, LPS appears to destabilize the LPCAT1 protein by GSK-3 beta-mediated phosphorylation within a canonical phosphodegron for beta-TrCP docking and site-specific ubiquitination. LPCAT1 is the first lipogenic substrate for beta-TrCP, and the results suggest that modulation of the GSK-3 beta-SCF beta(TrCP) E3 ligase effector pathway might be a unique strategy to optimize dipalmitoylphosphatidylcholine levels in sepsis.	[Mallampalli, Rama K.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Hammen, Gary] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Mallampalli, RK (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Acute Lung Injury Ctr Excellence, 628 NW Montefiore,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	NHLBI NIH HHS [HL098174, R01 HL091916, R01 HL098174, HL096376, R01 HL096376, R01 HL091916-02, R01 HL097376, HL097376] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096376, R01HL091916, R01HL097376, R01HL098174] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Liberman Z, 2008, AM J PHYSIOL-ENDOC M, V294, pE1169, DOI 10.1152/ajpendo.00050.2008; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MASON RJ, 1980, J BIOL CHEM, V255, P5101; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Wang CY, 2009, MOL BIOL CELL, V20, P4153, DOI 10.1091/mbc.E09-02-0174; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	26	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2719	2727		10.1074/jbc.M110.192377	http://dx.doi.org/10.1074/jbc.M110.192377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068446	hybrid, Green Published			2022-12-27	WOS:000286464300038
J	Cheng, HM; Rashid, S; Yu, ZX; Yoshizumi, A; Hwang, EL; Brodsky, B				Cheng, Haiming; Rashid, Shayan; Yu, Zhuoxin; Yoshizumi, Ayumi; Hwang, Eileen; Brodsky, Barbara			Location of Glycine Mutations within a Bacterial Collagen Protein Affects Degree of Disruption of Triple-helix Folding and Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS IMPERFECTA; I COLLAGEN; MOLECULAR-STRUCTURE; MUTANT COLLAGEN; MODEL; DOMAIN; ENZYMES; CHAINS	The hereditary bone disorder osteogenesis imperfecta is often caused by missense mutations in type I collagen that change one Gly residue to a larger residue and that break the typical (Gly-Xaa-Yaa)(n) sequence pattern. Site-directed mutagenesis in a recombinant bacterial collagen system was used to explore the effects of the Gly mutation position and of the identity of the residue replacing Gly in a homogeneous collagen molecular population. Homotrimeric bacterial collagen proteins with a Gly-to-Arg or Gly-to-Ser replacement formed stable triple-helix molecules with a reproducible 2 degrees C decrease in stability. All Gly replacements led to a significant delay in triple-helix folding, but a more dramatic delay was observed when the mutation was located near the N terminus of the triple-helix domain. This highly disruptive mutation, close to the globular N-terminal trimerization domain where folding is initiated, is likely to interfere with triple-helix nucleation. A positional effect of mutations was also suggested by trypsin sensitivity for a Gly-to-Arg replacement close to the triple-helix N terminus but not for the same replacement near the center of the molecule. The significant impact of the location of a mutation on triple-helix folding and conformation could relate to the severe consequences of mutations located near the C terminus of type I and type III collagens, where trimerization occurs and triple-helix folding is initiated.	[Cheng, Haiming; Rashid, Shayan; Yu, Zhuoxin; Yoshizumi, Ayumi; Hwang, Eileen; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	barbara.brodsky@tufts.edu	Yu, Zhuoxin/L-1512-2013; Cheng, Haiming/AAU-7243-2020	Cheng, Haiming/0000-0002-1686-5354; Hwang, Eileen/0000-0003-0161-6977	National Institutes of Health [GM60048, T32 GM008360]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048, T32GM008360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.) and Training Grant T32 GM008360 (to E. H.). This work was also supported by a China Scholarship Council fellowship (to H. C.).	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRYAN MA, 2010, BIOPOLYMERS     0318, DOI DOI 10.1002/BIP.21432; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Byers P H, 1995, Connect Tissue Res, V31, P257, DOI 10.3109/03008209509010818; Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Kelly JW, 2001, PHILOS T R SOC B, V356, P157; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Ramachandran G N., 1967, TREATISE COLLAGEN; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	30	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2041	2046		10.1074/jbc.M110.153965	http://dx.doi.org/10.1074/jbc.M110.153965			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071452	Green Published, hybrid			2022-12-27	WOS:000286191500046
J	Lawrence, MC; Naziruddin, B; Levy, MF; Jackson, A; Mcglynn, K				Lawrence, Michael C.; Naziruddin, Bashoo; Levy, Marlon F.; Jackson, Andrew; Mcglynn, Kathleen			Calcineurin/Nuclear Factor of Activated T Cells and MAPK Signaling Induce TNF-alpha Gene Expression in Pancreatic Islet Endocrine Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RENAL-TRANSPLANT RECIPIENTS; NONOBESE DIABETIC MICE; TRANSCRIPTION FACTOR NFAT; CYTOKINE MESSENGER-RNA; BETA-CELL; DENDRITIC CELLS; NOD MICE; CYCLOSPORINE-A; NUCLEAR FACTOR	Cytokines contribute to pancreatic islet inflammation, leading to impaired glucose homeostasis and diabetic diseases. A plethora of data shows that proinflammatory cytokines are produced in pancreatic islets by infiltrating mononuclear immune cells. Here, we show that pancreatic islet alpha cells and beta cells express tumor necrosis factor-alpha (TNF-alpha) and other cytokines capable of promoting islet inflammation when exposed to interleukin-1 beta (IL-1 beta). Cytokine expression by beta cells was dependent on calcineurin (CN)/nuclear factor of activated T cells (NFAT) and MAPK signaling. NFAT associated with the TNF-alpha promoter in response to stimuli and synergistically activated promoter activity with ATF2 and c-Jun. In contrast, the beta-cell-specific transcriptional activator MafA could repress NFAT-mediated TNF-alpha gene expression whenever C/EBP-beta was bound to the promoter. NFAT differentially regulated the TNF-alpha gene depending upon the expression and MAPK-dependent activation of interacting basic leucine zipper partners in beta cells. Both p38 and JNK were required for induction of TNF-alpha mRNA and protein expression. Collectively, the data show that glucose and IL-1 beta can activate signaling pathways, which control induction and repression of cytokines in pancreatic endocrine cells. Thus, by these mechanisms, pancreatic beta cells themselves may contribute to islet inflammation and their own immunological destruction in the pathogenesis of diabetes.	[Lawrence, Michael C.; Mcglynn, Kathleen] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Naziruddin, Bashoo; Levy, Marlon F.] Baylor Univ, Med Ctr, Baylor Reg Transplant Inst, Dallas, TX 75246 USA; [Jackson, Andrew] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; Yale University	Lawrence, MC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Michael.Lawrence@UTSouthwestern.edu	Jackson, Andrew M/C-1426-2008	Jackson, Andrew M/0000-0002-8620-8544	National Institutes of Health [DK55310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310 (to Melanie H. Cobb).	Abdullah HI, 2006, AM J PHYSIOL-RENAL, V290, pF1110, DOI 10.1152/ajprenal.00223.2005; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Al-Uzri A, 2001, TRANSPLANTATION, V72, P1020, DOI 10.1097/00007890-200109270-00007; Araujo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132; ARGILES JM, 1994, HORM METAB RES, V26, P447, DOI 10.1055/s-2007-1001730; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cardozo AK, 2003, J PROTEOME RES, V2, P553, DOI 10.1021/pr034029o; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cho Y, 2003, SLEEP, V26, pA362; Chow CW, 1999, MOL CELL BIOL, V19, P2300; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dahlen E, 1998, J IMMUNOL, V160, P3585; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; el-Nawawy A, 1998, Indian J Pediatr, V65, P455, DOI 10.1007/BF02761143; El-Sheikh A, 1999, J AUTOIMMUN, V12, P109, DOI 10.1006/jaut.1998.0264; GEPTS W, 1978, DIABETES, V27, P251, DOI 10.2337/diab.27.1.S251; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; GRANELLIPIPERNO A, 1990, J EXP MED, V172, P1869, DOI 10.1084/jem.172.6.1869; GRANELLIPIPERNO A, 1990, J EXP MED, V171, P533, DOI 10.1084/jem.171.2.533; Green EA, 2000, IMMUNITY, V12, P459, DOI 10.1016/S1074-7613(00)80198-3; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; Hanley S, 2006, TRANSPLANTATION, V82, P813, DOI 10.1097/01.tp.0000234787.05789.23; Heit JJ, 2007, BIOESSAYS, V29, P1011, DOI 10.1002/bies.20644; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Ishizuka N, 1999, METABOLISM, V48, P1485, DOI 10.1016/S0026-0495(99)90234-2; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kagi D, 1999, J IMMUNOL, V162, P4598; KAYE RE, 1992, P NATL ACAD SCI USA, V89, P8542, DOI 10.1073/pnas.89.18.8542; Krentz AJ, 2001, TRANSPLANTATION, V72, P1593; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; Lee LF, 2005, P NATL ACAD SCI USA, V102, P15995, DOI 10.1073/pnas.0508122102; LeeperWoodford SK, 1997, AM J PHYSIOL-ENDOC M, V273, pE433, DOI 10.1152/ajpendo.1997.273.2.E433; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Maes BD, 2001, TRANSPLANTATION, V72, P1655, DOI 10.1097/00007890-200111270-00014; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MEHTA V, 1993, LYMPHOKINE CYTOK RES, V12, P255; MEHTA VK, 1994, EUR J ENDOCRINOL, V130, P208, DOI 10.1530/eje.0.1300208; Movahedi B, 2004, DIABETOLOGIA, V47, P998, DOI 10.1007/s00125-004-1426-3; Pakala SV, 1999, J EXP MED, V189, P1053, DOI 10.1084/jem.189.7.1053; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rabinovitch A, 1989, Reg Immunol, V2, P77; Rabinovitch A, 1996, DIABETES, V45, P749, DOI 10.2337/diabetes.45.6.749; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Rabinovitch A, 2003, ADV EXP MED BIOL, V520, P159; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Rajagopalan G, 2003, DIABETES, V52, P342, DOI 10.2337/diabetes.52.2.342; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rieneck K, 2000, APMIS, V108, P855, DOI 10.1111/j.1600-0463.2000.tb00009.x; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; SVENSSON U, 1995, MOL IMMUNOL, V32, P157, DOI 10.1016/0161-5890(94)00107-C; TOCCI MJ, 1989, J IMMUNOL, V143, P718; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsiotra PC, 2001, INT J OBESITY, V25, P1018, DOI 10.1038/sj.ijo.0801657; Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Viola JPB, 1997, MEM I OSWALDO CRUZ, V92, P147, DOI 10.1590/S0074-02761997000800020; VOORBIJ HAM, 1989, DIABETES, V38, P1623, DOI 10.2337/diabetes.38.12.1623; Weir M, 2001, TRANSPL P, V33, p23S, DOI 10.1016/S0041-1345(01)02231-X; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; Yazdani-Biuki B, 2004, EUR J CLIN INVEST, V34, P641, DOI 10.1111/j.1365-2362.2004.01390.x; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; ZIEGLER AG, 1992, J AUTOIMMUN, V5, P571, DOI 10.1016/0896-8411(92)90154-I	88	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1025	1036		10.1074/jbc.M110.158675	http://dx.doi.org/10.1074/jbc.M110.158675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059644	hybrid, Green Published			2022-12-27	WOS:000286005000013
J	Liu, SH; Hatano, B; Zhao, MH; Yen, CC; Kang, K; Reilly, SM; Gangl, MR; Gorgun, C; Balschi, JA; Ntambi, JM; Lee, CH				Liu, Sihao; Hatano, Ben; Zhao, Minghui; Yen, Chen-Chung; Kang, Kihwa; Reilly, Shannon M.; Gangl, Matthew R.; Gorgun, Cem; Balschi, James A.; Ntambi, James M.; Lee, Chih-Hao			Role of Peroxisome Proliferator-activated Receptor delta/beta in Hepatic Metabolic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-DELTA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEIN-KINASE; TRIGLYCERIDE SYNTHESIS; TARGETED DISRUPTION; GLUCOSE-HOMEOSTASIS; FATTY-ACIDS; IKK-BETA; GENE	Pharmacological activation of peroxisome proliferator-activated receptor delta/beta (PPAR delta/beta) improves glucose handling and insulin sensitivity. The target tissues of drug actions remain unclear. We demonstrate here that adenovirus-mediated liver-restricted PPAR delta activation reduces fasting glucose levels in chow-and high fat-fed mice. This effect is accompanied by hepatic glycogen and lipid deposition as well as up-regulation of glucose utilization and de novo lipogenesis pathways. Promoter analyses indicate that PPAR delta regulates hepatic metabolic programs through both direct and indirect transcriptional mechanisms partly mediated by its co-activator, PPAR gamma co-activator-1 beta. Assessment of the lipid composition reveals that PPAR delta increases the production of monounsaturated fatty acids, which are PPAR activators, and reduces that of saturated FAs. Despite the increased lipid accumulation, adeno-PPAR delta-infected livers exhibit less damage and show a reduction in JNK stress signaling, suggesting that PPAR delta-regulated lipogenic program may protect against lipotoxicity. The altered substrate utilization by PPAR delta also results in a secondary effect on AMP-activated protein kinase activation, which likely contributes to the glucose-lowering activity. Collectively, our data suggest that PPAR delta controls hepatic energy substrate homeostasis by coordinated regulation of glucose and fatty acid metabolism, which provide a molecular basis for developing PPAR delta agonists to manage hyperglycemia and insulin resistance.	[Gangl, Matthew R.; Gorgun, Cem; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Genet & Complex Dis,Div Biol Sci, Boston, MA 02115 USA; [Zhao, Minghui; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Dept Biochem, Madison, WI 53706 USA; [Yen, Chen-Chung; Balschi, James A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Physiol NMR Core Lab, Boston, MA 02115 USA; [Yen, Chen-Chung; Balschi, James A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, CH (corresponding author), 665 Huntington Ave,Bldg 1,Rm 207, Boston, MA 02115 USA.	clee@hsph.harvard.edu	Reilly, Shannon Marie/ABB-6473-2021; liu, sihao/A-8823-2015	Reilly, Shannon Marie/0000-0003-0412-2446; liu, sihao/0000-0002-4188-3693	National Institutes of Health [HL46033, DK062388, DK075046]; Japan Self Defense Forces Central Hospital; National Institutes of Health NIEHS [T32 ES07155]; American Heart Association; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046033, R29HL046033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388, R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645, T32ES007155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Self Defense Forces Central Hospital; National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46033 (to J. A. B.), DK062388 (to J. M. N.), and DK075046 (to C.-H. L.). This work was also supported by funds from the Japan Self Defense Forces Central Hospital (to B. H.), National Institutes of Health NIEHS Training Grant T32 ES07155 (to S. M. R.), and by the American Heart Association and American Diabetes Association (to C.-H. L.).	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; PAGLIASSOTTI MJ, 1992, ANNU REV PHYSIOL, V54, P847, DOI 10.1146/annurev.physiol.54.1.847; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Staels B, 2006, CURR MED RES OPIN, V22, pS27, DOI 10.1185/030079906X112732; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	48	107	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1237	1247		10.1074/jbc.M110.138115	http://dx.doi.org/10.1074/jbc.M110.138115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059653	Green Published, hybrid			2022-12-27	WOS:000286005000035
J	Shakya, A; Kang, JS; Chumley, J; Williams, MA; Tantin, D				Shakya, Arvind; Kang, Jinsuk; Chumley, Jeffrey; Williams, Matthew A.; Tantin, Dean			Oct1 Is a Switchable, Bipotential Stabilizer of Repressed and Inducible Transcriptional States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HOMEOBOX GENE CDX2; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; T-CELLS; OCT-1-DEFICIENT MICE; INTERACTION NETWORK; AUTOIMMUNE-DISEASE; PROMOTER ACTIVITY; HUMAN FIBROBLASTS	Little is known regarding how the Oct1 transcription factor regulates target gene expression. Using murine fibroblasts and two target genes, Polr2a and Ahcy, we show that Oct1 recruits the Jmjd1a/KDM3A lysine demethylase to catalyze the removal of the inhibitory histone H3K9 dimethyl mark and block repression. Using purified murine T cells and the Il2 target locus, and a colon cancer cell line and the Cdx2 target locus, we show that Oct1 recruits the NuRD chromatin-remodeling complex to promote a repressed state, but in a regulated manner can switch to a different capacity and mediate Jmjd1a recruitment to block repression. These findings indicate that Oct1 maintains repression through a mechanism involving NuRD and maintains poised gene expression states through an antirepression mechanism involving Jmjd1a. We propose that, rather than acting as a primary trigger of gene activation or repression, Oct1 is a switchable stabilizer of repressed and inducible states.	[Shakya, Arvind; Kang, Jinsuk; Chumley, Jeffrey; Williams, Matthew A.; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Tantin, D (corresponding author), Univ Utah, Sch Med, Dept Pathol, JMRB 5700B, Salt Lake City, UT 84112 USA.	dean.tantin@path.utah.edu		Shakya, Arvind/0000-0001-7993-6159; Williams, Matthew/0000-0002-4721-4482	National Institutes of Health through the NCI [1R21CA141009]; American Cancer Society [GMC-115196.]; NATIONAL CANCER INSTITUTE [R21CA141009] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA141009 through the NCI. This work was also supported by American Cancer Society Grant GMC-115196.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertolino E, 2002, MOL CELL, V10, P397, DOI 10.1016/S1097-2765(02)00597-X; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Cron RQ, 2001, GENES IMMUN, V2, P464, DOI 10.1038/sj.gene.6363811; dela Paz NG, 2007, J BIOL CHEM, V282, P8424, DOI 10.1074/jbc.M606923200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Duncliffe KN, 1997, IMMUNITY, V6, P175, DOI 10.1016/S1074-7613(00)80424-0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gervaziev YV, 2010, INT J IMMUNOGENET, V37, P13, DOI 10.1111/j.1744-313X.2009.00883.x; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jin TR, 2001, J BIOL CHEM, V276, P14752, DOI 10.1074/jbc.M008277200; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; KAUSHANSKY K, 1994, J IMMUNOL, V152, P1812; Kiesler P, 2009, HUM MOL GENET, V18, P4513, DOI 10.1093/hmg/ddp411; Krueger F, 2009, CELL SIGNAL, V21, P1846, DOI 10.1016/j.cellsig.2009.07.020; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Riedt T, 2009, BLOOD, V113, P4049, DOI 10.1182/blood-2008-12-196634; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; SHEN LY, 1993, MOL CELL BIOL, V13, P3530, DOI 10.1128/MCB.13.6.3530; SMITH KA, 1992, CURR OPIN IMMUNOL, V4, P271, DOI 10.1016/0952-7915(92)90076-Q; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Suh E, 1996, MOL CELL BIOL, V16, P619; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tantin D, 2002, MOL CELL BIOL, V22, P1460, DOI 10.1128/MCB.22.5.1460-1473.2002; THEVENIN C, 1993, J BIOL CHEM, V268, P5949; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PX, 2009, J BIOL CHEM, V284, P26456, DOI 10.1074/jbc.M109.030668; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wu GD, 1997, J BIOL CHEM, V272, P2396; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zabel MD, 2002, J IMMUNOL, V168, P3341, DOI 10.4049/jimmunol.168.7.3341; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	66	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					450	459		10.1074/jbc.M110.174045	http://dx.doi.org/10.1074/jbc.M110.174045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051540	hybrid, Green Published			2022-12-27	WOS:000285782800048
J	Chavali, PL; Saini, RKR; Matsumoto, Y; Agren, H; Funa, K				Chavali, Pavithra Lakshminarasimhan; Saini, Ravi Kanth Rao; Matsumoto, Yoshiki; Agren, Hans; Funa, Keiko			Nuclear Orphan Receptor TLX Induces Oct-3/4 for the Survival and Maintenance of Adult Hippocampal Progenitors upon Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; INDUCED DEDIFFERENTIATION; EXPRESSION; GENE; DIFFERENTIATION; TRANSCRIPTION; NEUROGENESIS; PLURIPOTENCY; ACTIVATION; MECHANISM	Hypoxia promotes neural stem cell proliferation, the mechanism of which is poorly understood. Here, we have identified the nuclear orphan receptor TLX as a mediator for proliferation and pluripotency of neural progenitors upon hypoxia. We found an enhanced early protein expression of TLX under hypoxia potentiating sustained proliferation of neural progenitors. Moreover, TLX induction upon hypoxia in differentiating conditions leads to proliferation and a stem cell-like phenotype, along with coexpression of neural stem cell markers. Following hypoxia, TLX is recruited to the Oct-3/4 proximal promoter, augmenting the gene transcription and promoting progenitor proliferation and pluripotency. Knockdown of Oct-3/4 significantly reduced TLX-mediated proliferation, highlighting their interdependence in regulating the progenitor pool. Additionally, TLX synergizes with basic FGF to sustain cell viability upon hypoxia, since the knockdown of TLX along with the withdrawal of growth factor results in cell death. This can be attributed to the activation of Akt signaling pathway by TLX, the depletion of which results in reduced proliferation of progenitor cells. Cumulatively, the data presented here demonstrate a new role for TLX in neural stem cell proliferation and pluripotency upon hypoxia.	[Chavali, Pavithra Lakshminarasimhan; Saini, Ravi Kanth Rao; Matsumoto, Yoshiki; Funa, Keiko] Univ Gothenburg, Inst Biomed, Dept Med Chem & Cell Biol, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Agren, Hans] Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Funa, K (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Chem & Cell Biol, Sahlgrenska Acad, Box 440,Medicinaregatan 9A, SE-40530 Gothenburg, Sweden.	keiko.funa@gu.se	MATSUMOTO, Yoshiki/AAW-8516-2020; Agren, Hans/H-7715-2016	MATSUMOTO, Yoshiki/0000-0002-8620-2863; Lakshminarasimhan Chavali, Pavithra/0000-0002-7525-5230	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Research Foundation; Hjalmar Svensson Foundation; ALF Funds at the Vastra Gotaland Region; Assar Gabrielson Foundation, Sweden; Swedish Institute, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Research Foundation; Hjalmar Svensson Foundation; ALF Funds at the Vastra Gotaland Region; Assar Gabrielson Foundation, Sweden; Swedish Institute, Sweden	This work was supported in part by grants from the Swedish Research Council, Swedish Cancer Society, Swedish Childhood Cancer Research Foundation, Hjalmar Svensson Foundation, ALF Funds at the Vastra Gotaland Region, and in part by Assar Gabrielson Foundation, Sweden.; Recipient of visiting researchers grant from the Swedish Institute, Sweden. To whom correspondence may be addressed: Institute of Biomedicine, Dept. of Medical Chemistry and Cell Biology, Sahlgrenska Academy, University of Gothenburg, Box 440, Medicinaregatan 9A, SE 405 30 Gothenburg, Sweden. Tel.: 46-31-786-3151; E-mail: pavithrachavali@anatcell.gu.se.	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Blaud M, 2004, J MOL BIOL, V339, P1049, DOI 10.1016/j.jmb.2004.04.035; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chin JH, 2009, BIOCHEM BIOPH RES CO, V388, P247, DOI 10.1016/j.bbrc.2009.07.165; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; Helczynska K, 2003, CANCER RES, V63, P1441; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Iwahara N, 2009, BIOCHEM BIOPH RES CO, V386, P671, DOI 10.1016/j.bbrc.2009.06.103; Jogi A, 2003, CANCER LETT, V197, P145, DOI 10.1016/S0304-3835(03)00095-8; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kobayashi M, 2000, MOL CELL BIOL, V20, P8731, DOI 10.1128/MCB.20.23.8731-8739.2000; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Rodrigues CAV, 2010, BIOTECHNOL BIOENG, V106, P260, DOI 10.1002/bit.22648; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Stenman JM, 2003, J NEUROSCI, V23, P10568; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	44	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9393	9404		10.1074/jbc.M110.167445	http://dx.doi.org/10.1074/jbc.M110.167445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21135096	Green Published, hybrid			2022-12-27	WOS:000288247700068
J	Chaix, A; Lopez, S; Voisset, E; Gros, L; Dubreuil, P; De Sepulveda, P				Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Gros, Laurent; Dubreuil, Patrice; De Sepulveda, Paulo			Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; FACTOR RECEPTOR/C-KIT; C-KIT; SIGNAL TRANSDUCER; WILD-TYPE; SERINE PHOSPHORYLATION; JUXTAMEMBRANE DOMAIN; MITOCHONDRIAL STAT3; PKC-DELTA	Mutations in the c-kit gene occur in the vast majority of mastocytosis. In adult patients as well as in the cell line derived from mast cell neoplasms, the mutations occur almost exclusively at amino acid 816 within the kinase domain of KIT. Among the downstream effectors of KIT signaling, STAT3 and STAT5 have been shown to be critical for cell proliferation elicited by the KIT-Asp(816) mutant protein. However, little is known about the mechanisms of activation of STAT proteins. In this study, we identify and clarify the contribution of various STAT kinases in two widely used neoplastic mast cell lines, P815 and HMC-1. We show that STAT1, -3, and -5 proteins are activated downstream of the KIT-Asp(816) mutant. All three STAT proteins are located in the nucleus and are phosphorylated on serine residues. KIT-Asp(816) mutant can directly phosphorylate STATs on the activation-specific tyrosine residues in vitro. However, within cells, SRC family kinases and JAKs diversely contribute to tyrosine phosphorylation of STAT proteins downstream of the KIT mutant. Using a panel of inhibitors, we provide evidence for the implication or exclusion of serine/threonine kinases as responsible for serine phosphorylation of STAT1, -3, and -5 in the two cell lines. Finally, we show that only STAT5 is transcriptionally active in these cells. This suggests that the contribution of STAT1 and STAT3 downstream of KIT mutant is independent of their transcription factor function.	[De Sepulveda, Paulo] Ctr Rech Cancerol Marseille, U891, INSERM, F-13273 Marseille 9, France; [Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Dubreuil, Patrice; De Sepulveda, Paulo] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Dubreuil, Patrice; De Sepulveda, Paulo] Univ Aix Marseille 2, F-13009 Marseille, France; [Gros, Laurent] AB Sci, F-75008 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	De Sepulveda, P (corresponding author), Ctr Rech Cancerol Marseille, U891, INSERM, 27 Blvd Lei Roure,BP30059, F-13273 Marseille 9, France.	paulo.de-sepulveda@inserm.fr	dubreuil, patrice/F-5346-2011; Voisset, Edwige/GSE-5113-2022; Dubreuil, Patrice/V-4816-2019; Voisset, Edwige/AAM-3503-2021; LOPEZ, SOPHIE/R-1917-2016; De sepulveda, paulo/K-6043-2015	dubreuil, patrice/0000-0003-1155-1150; Voisset, Edwige/0000-0002-0943-4847; Dubreuil, Patrice/0000-0003-1155-1150; Voisset, Edwige/0000-0002-0943-4847; LOPEZ, SOPHIE/0000-0002-5009-5533; De sepulveda, paulo/0000-0001-8295-5414	La Ligue Contre le Cancer; l'Institut National du Cancer; l'Agence Nationale de la Recherche ANR-M-RAR; Ministere de la Recherche/Ecole Normale Superieure; Association pour la Recherche sur le Cancer; Societe Francaise d'Hematologie; Agence Nationale de la Recherche; INSERM-Region Provence Alpes Cote d'Azur	La Ligue Contre le Cancer(Ligue nationale contre le cancer); l'Institut National du Cancer(Institut National du Cancer (INCA) France); l'Agence Nationale de la Recherche ANR-M-RAR(French National Research Agency (ANR)); Ministere de la Recherche/Ecole Normale Superieure(Ministry of Research, France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Societe Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM-Region Provence Alpes Cote d'Azur(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Provence-Alpes-Cote d'Azur)	This work was supported in part by La Ligue Contre le Cancer (label Ligue 2008), l'Institut National du Cancer, and l'Agence Nationale de la Recherche ANR-M-RAR.; Recipient of Ph.D. fellowships from Ministere de la Recherche/Ecole Normale Superieure and Association pour la Recherche sur le Cancer and financial support from Societe Francaise d'Hematologie.; Supported by Agence Nationale de la Recherche.; Supported by INSERM-Region Provence Alpes Cote d'Azur, Association pour la Recherche sur le Cancer, and Societe Francaise d'Hematologie.	Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DeBerry C, 1997, BIOCHEM J, V327, P73, DOI 10.1042/bj3270073; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gartsbein M, 2006, J CELL SCI, V119, P470, DOI 10.1242/jcs.02744; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; HOCKE GM, 1995, CYTOKINE, V7, P491, DOI 10.1006/cyto.1995.0067; Jelacic T, 2005, BLOOD, V105, P1923, DOI 10.1182/blood-2004-04-1450; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Pan J, 2007, BLOOD, V109, P315, DOI 10.1182/blood-2006-04-013805; Paukku K, 2000, BIOCHEM J, V345, P759, DOI 10.1042/0264-6021:3450759; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Tyner JW, 2008, BLOOD, V111, P2238, DOI 10.1182/blood-2007-06-097253; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	58	50	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5956	5966		10.1074/jbc.M110.182642	http://dx.doi.org/10.1074/jbc.M110.182642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135090	Green Published, hybrid			2022-12-27	WOS:000287476400003
J	Jaremko, L; Jaremko, M; Elfaki, I; Mueller, JW; Ejchart, A; Bayer, P; Zhukov, I				Jaremko, Lukasz; Jaremko, Mariusz; Elfaki, Imadeldin; Mueller, Jonathan W.; Ejchart, Andrzej; Bayer, Peter; Zhukov, Igor			Structure and Dynamics of the First Archaeal Parvulin Reveal a New Functionally Important Loop in Parvulin-type Prolyl Isomerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR RELAXATION MEASUREMENTS; MITOTIC REGULATOR HPIN1; TORSION ANGLE DYNAMICS; BACKBONE DYNAMICS; BACILLUS-SUBTILIS; SUBSTRATE-BINDING; ESCHERICHIA-COLI; N-15 RELAXATION; CHEMICAL-SHIFTS; PROTEIN	Parvulins are a group of peptidyl-prolyl isomerases (PPIases) responsible for important biological processes in all kingdoms of life. The PinA protein from the psychrophilic archaeon Cenarchaeum symbiosum is a parvulin-like PPIase. Due to its striking similarity to the human parvulins Pin1 and Par14, PinA constitutes an interesting subject for structural and functional studies. Here, we present the first high resolution NMR structure of an archaeal parvulin, PinA, based on 1798 conformational restraints. Structure calculation yields an ensemble of 20 convergent low energy structures with a backbone r.m.s.d. value of 0.6 angstrom within the secondary structure elements. The overall fold of PinA comprises the beta-alpha(3)-beta-alpha-beta(2) fold typical for all parvulin structures known so far, but with helix III being a short 3(10)-helix. A detailed comparison of this high resolution structure of the first archaeal PinA protein with bacterial and eukaryotic parvulin PPIase structures reveals an atypically large catalytic binding site. This feature provides an explanation for cold-adapted protein function. Moreover, the residues in and around 3(10)-helix III exhibit strong intramolecular dynamics on a microsecond to millisecond timescale and display structural heterogeneity within the NMR ensemble. A putative peptide ligand was found for PinA by phage display and was used for H-1-N-15-HSQC titrations. Again, the flexible region around 3(10)-helix III as well as residues of the peptide binding pocket showed the strongest chemical shift perturbations upon peptide binding. The local flexibility of this region also was modulated by ligand binding. A glycine and two positively charged residues are conserved in most parvulin proteins in this flexible loop region, which may be of general functional importance for parvulin-type PPIases.	[Elfaki, Imadeldin; Mueller, Jonathan W.; Bayer, Peter] Univ Duisburg Essen, Inst Struct & Med Biochem, Ctr Med Biotechnol, ZMB, D-45117 Essen, Germany; [Jaremko, Lukasz; Jaremko, Mariusz; Ejchart, Andrzej; Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Zhukov, Igor] Natl Inst Chem, Slovenian NMR Ctr, SI-1000 Ljubljana, Slovenia; [Jaremko, Lukasz] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland; [Zhukov, Igor] EN FIST Ctr Excellence, SI-1000 Ljubljana, Slovenia	University of Duisburg Essen; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; National Institute of Chemistry - Slovenia; University of Warsaw	Bayer, P (corresponding author), Univ Duisburg Essen, Inst Struct & Med Biochem, Ctr Med Biotechnol, ZMB, Univ Str 2, D-45117 Essen, Germany.	peter.bayer@uni-due.de; igor.zhukov@ki.si	Jaremko, Lukasz/A-3101-2009; Elfaki, Imadeldin/AER-0062-2022; Jaremko, Lukasz/GQB-5017-2022; Bayer, Peter/B-8803-2009; Mueller, Jonathan Wolf/D-1632-2010; Zhukov, Igor/J-4069-2015	Jaremko, Lukasz/0000-0001-7684-9359; Bayer, Peter/0000-0003-0435-7202; Mueller, Jonathan Wolf/0000-0003-1212-189X; Zhukov, Igor/0000-0002-9912-1018; Jaremko, Mariusz/0000-0002-0787-702X	Polish Ministry of Science and Higher Education [N301 07131/2159, IP2010014570]; Slovenian Research Agency [P1-0242-0104]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported in part by Polish Ministry of Science and Higher Education Grant N301 07131/2159, Slovenian Research Agency Grant P1-0242-0104 (to I. Z.), Polish Ministry of Science and Higher Education luventus Plus program (project nr IP2010014570, to L. J.).	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding KY, 2004, J AM CHEM SOC, V126, P6232, DOI 10.1021/ja049049l; Fushman D., 2003, BIONMR DRUG RES; Ghalebani L, 2008, J MAGN RESON, V195, P1, DOI 10.1016/j.jmr.2008.07.025; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Kazimierczuk K, 2008, J AM CHEM SOC, V130, P5404, DOI 10.1021/ja800622p; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozminski W, 2005, J BIOMOL NMR, V31, P87, DOI 10.1007/s10858-004-7563-7; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Maruyama T, 2004, FRONT BIOSCI-LANDMRK, V9, P1680, DOI 10.2741/1361; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Mueller JW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Suzuki Y, 2004, EUR J BIOCHEM, V271, P1372, DOI 10.1111/j.1432-1033.2004.04049.x; Tossavainen H, 2006, FEBS LETT, V580, P1822, DOI 10.1016/j.febslet.2006.02.042; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wong KB, 1997, J MOL BIOL, V268, P494, DOI 10.1006/jmbi.1997.0989; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Ye KQ, 2002, EUR J BIOCHEM, V269, P5182, DOI 10.1046/j.1432-1033.2002.03222.x; Yongye AB, 2010, J COMPUT AID MOL DES, V24, P675, DOI 10.1007/s10822-010-9365-1	51	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6554	6565		10.1074/jbc.M110.160713	http://dx.doi.org/10.1074/jbc.M110.160713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138844	Green Published, hybrid			2022-12-27	WOS:000287476400065
J	Usuki, F; Yamashita, A; Fujimura, M				Usuki, Fusako; Yamashita, Akio; Fujimura, Masatake			Post-transcriptional Defects of Antioxidant Selenoenzymes Cause Oxidative Stress under Methylmercury Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; THIOREDOXIN REDUCTASE; GLUTATHIONE-PEROXIDASE; SIGNALING PATHWAYS; MERCURY TOXICITY; CELL-LINES; SELENIUM; EBSELEN; SUBSTRATE; MECHANISM	Methylmercury (MeHg) toxicity is a continuous environmental problem to human health. The critical role of oxidative stress in the pathogenesis of MeHg cytotoxicity has been clarified, but the molecular mechanisms underlying MeHg-mediated oxidative stress remain to be elucidated. Here we demonstrate a post-transcriptional effect of MeHg on antioxidant selenoenzymes by using a MeHg-susceptible cell line. MeHg-induced selenium deficiency leads to failure of the recoding of a UGA codon for selenocysteine and results in degradation of the major antioxidant selenoenzyme glutathione peroxidase 1 (GPx1) mRNA by nonsense-mediated mRNA decay (NMD), a cellular mechanism that detects the premature termination codon (PTC) located 5'-upstream of the last exon-exon junction and degrades PTC-containing mRNAs. In contrast, thioredoxin reductase 1 (TrxR1), another antioxidant selenoenzyme of the thioredoxin system, was likely skipped by NMD because of a UGA codon in the last exon. However, TrxR1 activity was decreased despite mRNA up-regulation, which was probably due to the synthesis of aberrant TrxR1 protein without selenocysteine. Changes in selenoenzyme GPx1 and TrxR1 mRNAs were observed earlier than was the incidence of oxidative stress and up-regulation of other antioxidant enzyme mRNAs. Results indicated that the MeHg-induced relative selenium-deficient condition affects the major antioxidant selenoenzymes GPx1 and TrxR1 through a post-transcriptional effect, resulting in the disturbance of cellular redox systems and the incidence of oxidative stress. Treatment with ebselen, a seleno-organic compound, effectively suppressed oxidative stress and protected cells against MeHg-induced relative selenium deficiency and cytotoxicity.	Natl Inst Minamata Dis, Dept Clin Med, Minamata 8670008, Japan; [Fujimura, Masatake] Natl Inst Minamata Dis, Dept Basic Med Sci, Minamata 8670008, Japan; [Yamashita, Akio] Yokohama City Univ, Dept Microbiol & Mol Biodef Res, Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Akio] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; Japan Science & Technology Agency (JST)	Usuki, F (corresponding author), 4058-18 Hama, Minamata 8670008, Japan.	usuki@nimd.go.jp			KAKENHI [20591015]; Japan Society for the Promotion of Science; Japan Science and Technology Corporation; Yokohama Foundation for Advancement of Medical Science	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Yokohama Foundation for Advancement of Medical Science	This study was supported in part by KAKENHI (20591015) (to F. U.). This work was also supported in part by grants from the Japan Society for the Promotion of Science (to A. Y.), from the Japan Science and Technology Corporation (to A. Y.), and from the Yokohama Foundation for Advancement of Medical Science (to A. Y.).	BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; DAVIS LE, 1994, ANN NEUROL, V35, P680, DOI 10.1002/ana.410350608; Farina M, 2004, TOXICOL LETT, V146, P227, DOI 10.1016/j.toxlet.2003.10.001; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HIROTA Y, 1980, TOXICOL APPL PHARM, V53, P174, DOI 10.1016/0041-008X(80)90394-4; Imura N, 1986, Dev Toxicol Environ Sci, V12, P115; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NISHIKIDO N, 1987, TOXICOL APPL PHARM, V88, P322, DOI 10.1016/0041-008X(87)90207-9; NOBUNAGA T, 1979, TOXICOL APPL PHARM, V47, P79, DOI 10.1016/0041-008X(79)90074-7; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Park ST, 1996, NEUROTOXICOLOGY, V17, P37; SATOH H, 1985, TOXICOL LETT, V25, P199; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; SUGIURA Y, 1978, BIOINORG CHEM, V9, P167, DOI 10.1016/S0006-3061(00)80288-4; Usuki F, 1998, NEUROREPORT, V9, P2291, DOI 10.1097/00001756-199807130-00027; Usuki F, 2004, ACTA NEUROPATHOL, V108, P1, DOI 10.1007/s00401-004-0844-0; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; Usuki F, 2001, J HEALTH SCI, V47, P162, DOI 10.1248/jhs.47.162; Usuki F, 2000, BIOCHEM BIOPH RES CO, V267, P739, DOI 10.1006/bbrc.1999.2026; Usuki F, 2008, NEUROTOXICOLOGY, V29, P22, DOI 10.1016/j.neuro.2007.08.011; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Watanabe C, 1999, NEUROTOXICOL TERATOL, V21, P83, DOI 10.1016/S0892-0362(98)00036-1; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209; Yee S, 1996, NEUROTOXICOLOGY, V17, P17; YEE S, 1994, EXP MOL PATHOL, V60, P188, DOI 10.1006/exmp.1994.1017; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; [No title captured]	39	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6641	6649		10.1074/jbc.M110.168872	http://dx.doi.org/10.1074/jbc.M110.168872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21106535	hybrid, Green Published			2022-12-27	WOS:000287476400072
J	Salem, T; Mazzella, A; Barberini, ML; Wengier, D; Motillo, V; Parisi, G; Muschietti, J				Salem, Tamara; Mazzella, Agustina; Laura Barberini, Maria; Wengier, Diego; Motillo, Viviana; Parisi, Gustavo; Muschietti, Jorge			Mutations in Two Putative Phosphorylation Motifs in the Tomato Pollen Receptor Kinase LePRK2 Show Antagonistic Effects on Pollen Tube Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR CELL-GROWTH; TIP GROWTH; IN-VIVO; ARABIDOPSIS; GERMINATION; COMPLEX; DOMAIN; SITES; ROP; ACTIVATION	The tip-growing pollen tube is a useful model for studying polarized cell growth in plants. We previously characterized LePRK2, a pollen-specific receptor-like kinase from tomato (1). Here, we showed that LePRK2 is present as multiple phosphorylated isoforms in mature pollen membranes. Using comparative sequence analysis and phosphorylation site prediction programs, we identified two putative phosphorylation motifs in the cytoplasmic juxtamembrane (JM) domain. Site-directed mutagenesis in these motifs, followed by transient overexpression in tobacco pollen, showed that both motifs have opposite effects in regulating pollen tube length. Relative to LePRK2-eGFP pollen tubes, alanine substitutions in residues of motif I, Ser(277)/Ser(279)/Ser(282), resulted in longer pollen tubes, but alanine substitutions in motif II, Ser(304)/Ser(307)/Thr(308), resulted in shorter tubes. In contrast, phosphomimicking aspartic substitutions at these residues gave reciprocal results, that is, shorter tubes with mutations in motif I and longer tubes with mutations in motif II. We conclude that the length of pollen tubes can be negatively and positively regulated by phosphorylation of residues in motif I and II respectively. We also showed that LePRK2-eGFP significantly decreased pollen tube length and increased pollen tube tip width, relative to eGFP tubes. The kinase activity of LePRK2 was relevant for this phenotype because tubes that expressed a mutation in a lysine essential for kinase activity showed the same length and width as the eGFP control. Taken together, these results suggest that LePRK2 may have a central role in pollen tube growth through regulation of its own phosphorylation status.	[Salem, Tamara; Mazzella, Agustina; Laura Barberini, Maria; Wengier, Diego; Muschietti, Jorge] Consejo Nacl Invest Cient & Tecn, Inst Ingn Genet & Biol Mol INGEBI, RA-1428 Buenos Aires, DF, Argentina; [Muschietti, Jorge] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, RA-1428 Buenos Aires, DF, Argentina; [Motillo, Viviana; Parisi, Gustavo] Univ Nacl Quilmes, Ctr Estudios & Invest, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Muschietti, J (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Ingn Genet & Biol Mol INGEBI, RA-1428 Buenos Aires, DF, Argentina.	prometeo@dna.uba.ar		parisi, gustavo/0000-0001-7444-1624; Muschietti, Jorge/0000-0002-5719-4833; , Maria Agustina/0000-0001-6205-3085	Universidad de Buenos Aires [UBACYT-X109]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2005-31656, PICT2007-01976]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-CONICET-5545]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Grants Universidad de Buenos Aires UBACYT-X109, Agencia Nacional de Promocion Cientifica y Tecnologica PICT2005-31656, PICT2007-01976, and Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP-CONICET-5545 (to J.M.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cai G, 2009, J EXP BOT, V60, P495, DOI 10.1093/jxb/ern321; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chen CYH, 2003, PLANT CELL, V15, P237, DOI 10.1105/tpc.007153; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2003, J EXP BOT, V54, P73, DOI 10.1093/jxb/54.380.73; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Kim HU, 2002, PLANT MOL BIOL, V50, P1, DOI 10.1023/A:1016077014583; Klahre U, 2006, PLANT J, V46, P1018, DOI 10.1111/j.1365-313X.2006.02757.x; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Shichrur K, 2006, TRENDS PLANT SCI, V11, P57, DOI 10.1016/j.tplants.2005.12.001; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wengier D, 2003, P NATL ACAD SCI USA, V100, P6860, DOI 10.1073/pnas.0631728100; Wengier DL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-33; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zhang D, 2008, PLANT PHYSIOL, V148, P1368, DOI 10.1104/pp.108.124420; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	37	14	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4882	4891		10.1074/jbc.M110.147512	http://dx.doi.org/10.1074/jbc.M110.147512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131355	Green Published, hybrid			2022-12-27	WOS:000286975700084
J	Moore, MD; Cookson, J; Coventry, VK; Sproat, B; Rabe, L; Cranston, RD; McGowan, I; James, W				Moore, Michael D.; Cookson, Jonathan; Coventry, Veronica K.; Sproat, Brian; Rabe, Lorna; Cranston, Ross D.; McGowan, Ian; James, William			Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases IMPLICATIONS FOR RNA-BASED THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; R5 STRAINS; STRUCTURAL-CHARACTERIZATION; MICROBICIDES; BINDS	RNA-based drugs are an emerging class of therapeutics. They have the potential to regulate proteins, chromatin, as well as bind to specific proteins of interest in the form of aptamers. These aptamers are protected from nuclease attack by chemical modifications that enhance their stability for in vivo usage. However, nucleases are ubiquitous, and as we have yet to characterize the entire human microbiome it is likely that many nucleases are yet to be identified. Any novel, unusual enzymes present in vivo might reduce the efficacy of RNA-based therapeutics, even when they are chemically modified. We have previously identified an RNA-based aptamer capable of neutralizing a broad spectrum of clinical HIV-1 isolates and are developing it as a vaginal and rectal microbicide candidate. As a first step we addressed aptamer stability in the milieu of proteins present in these environments. Here we uncover a number of different nucleases that are able to rapidly degrade 2'-F-modified RNA. We demonstrate that the aptamer can be protected from the nuclease(s) present in the vaginal setting, without affecting its antiviral activity, by replacement of key positions with 2'-O-Me-modified nucleotides. Finally, we show that the aptamer can be protected from all nucleases present in both vaginal and rectal compartments using Zn2+ cations. In conclusion we have derived a stable, antiviral RNA-based aptamer that could form the basis of a pre-exposure microbicide or be a valuable addition to the current tenofovir-based microbicide candidate undergoing clinical trials.	[Moore, Michael D.; Cookson, Jonathan; Coventry, Veronica K.; James, William] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rabe, Lorna; Cranston, Ross D.; McGowan, Ian] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Sproat, Brian] Chemconsilium GCV, B-2221 Booischot, Belgium	University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Moore, MD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kenny.moore@path.ox.ac.uk	M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; james, william/H-4289-2013	M, Ian/0000-0002-6470-8476; james, william/0000-0002-2506-1198; Cranston, Ross/0000-0002-2687-6217	National Institutes of Health from the NIAID [DMID U01 AI066734]; National Center for Research Resources [1 UL1 RR024153]; MRC [G0401610] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066734] Funding Source: NIH RePORTER; Medical Research Council [G0401610] Funding Source: researchfish	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DMID U01 AI066734 from the NIAID and National Center for Research Resources, Clinical and Translational Science Award 1 UL1 RR024153.	Ashihara E, 2010, CURR DRUG TARGETS, V11, P345, DOI 10.2174/138945010790711897; Cohen C, 2008, VIROLOGY, V381, P46, DOI 10.1016/j.virol.2008.08.025; de Campos WRL, 2009, ANTIMICROB AGENTS CH, V53, P3056, DOI 10.1128/AAC.01502-08; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2005, RNA, V11, P873, DOI 10.1261/rna.7205405; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; James W, 2007, J GEN VIROL, V88, P351, DOI 10.1099/vir.0.82442-0; Joubert MK, 2010, BIOCHEMISTRY-US, V49, P5880, DOI 10.1021/bi100301k; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KASS EH, 1989, REV INFECT DIS, V11, pS167; Katakowski JA, 2010, CURR OPIN MOL THER, V12, P192; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Khati M, 2010, J CLIN PATHOL, V63, P480, DOI 10.1136/jcp.2008.062786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; OOSTERLINCK W, 1991, UROL RES, V19, P265, DOI 10.1007/BF00305309; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Sayer N, 2002, BIOCHEM BIOPH RES CO, V293, P924, DOI 10.1016/S0006-291X(02)00308-X; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; SHIMAYAMA T, 1993, NUCLEIC ACIDS RES, V21, P2605, DOI 10.1093/nar/21.11.2605; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	27	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2526	2535		10.1074/jbc.M110.178426	http://dx.doi.org/10.1074/jbc.M110.178426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106536	hybrid, Green Published			2022-12-27	WOS:000286464300017
J	Pillai, SM; Meredith, D				Pillai, Samyuktha Muralidharan; Meredith, David			SLC36A4 (hPAT4) Is a High Affinity Amino Acid Transporter When Expressed in Xenopus laevis Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; SMALL-INTESTINE; L-TRYPTOPHAN; RAT PAT2; MEMBRANE; SYSTEM; ABSORPTION; NUTRIENT; CARRIER	The SLC36 family of transporters consists of four genes, two of which, SLC36A1 and SLC36A2, have been demonstrated to code for human proton-coupled amino acid transporters or hPATs. Here we report the characterization of the fourth member of the family, SLC36A4 or hPAT4, which when expressed in Xenopus laevis oocytes also encodes a plasma membrane amino acid transporter, but one that is not proton-coupled and has a very high substrate affinity for the amino acids proline and tryptophan. hPAT4 in Xenopus oocytes mediated sodium-independent, electroneutral uptake of [H-3] proline, with the highest rate of uptake when the uptake medium pH was 7.4 and an affinity of 3.13 mu M. Tryptophan was also an excellently transported substrate with a similarly high affinity (1.72 mu M). Other amino acids that inhibited [H-3] proline were isoleucine (K-i 0.23 mM), glutamine (0.43 mM), methionine (0.44 mM), and alanine (1.48 mM), and with lower affinity, glycine, threonine, and cysteine (K-i > 5mM for all). Of the amino acids directly tested for transport, only proline, tryptophan, and alanine showed significant uptake, whereas glycine and cysteine did not. Of the non-proteogenic amino acids and drugs tested, only sarcosine produced inhibition (K-i 1.09 mM), whereas gamma-aminobutyric acid (GABA), beta-alanine, L-Dopa, D-serine, and delta-aminolevulinic acid were without effect on [H-3] proline uptake. This characterization of hPAT4 as a very high affinity/low capacity non-proton-coupled amino acid transporter raises questions about its physiological role, especially as the transport characteristics of hPAT4 are very similar to the Drosophila orthologue PATH, an amino acid "transceptor" that plays a role in nutrient sensing.	[Pillai, Samyuktha Muralidharan; Meredith, David] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England	Oxford Brookes University	Meredith, D (corresponding author), Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England.	dmeredith@brookes.ac.uk	Meredith, David/F-3664-2010		School of Life Sciences, Oxford Brookes University	School of Life Sciences, Oxford Brookes University	This work was supported by a scholarship from the School of Life Sciences, Oxford Brookes University (to S.M.P.).	Abbot EL, 2006, BRIT J PHARMACOL, V147, P298, DOI 10.1038/sj.bjp.0706557; Anderson CMH, 2010, J PHARMACOL EXP THER, V332, P220, DOI 10.1124/jpet.109.159822; Anderson CMH, 2004, GASTROENTEROLOGY, V127, P1410, DOI 10.1053/j.gastro.2004.08.017; Bermingham JR, 2004, MAMM GENOME, V15, P114, DOI 10.1007/s00335-003-2319-3; Bevington A, 2002, EUR J CLIN INVEST, V32, P590, DOI 10.1046/j.1365-2362.2002.01038.x; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boll M, 2003, MOL MEMBR BIOL, V20, P261, DOI 10.1080/0968768031000100759; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2006, PFLUG ARCH EUR J PHY, V451, P511, DOI 10.1007/s00424-005-1481-8; Chen Z, 2003, BIOCHEM BIOPH RES CO, V304, P747, DOI 10.1016/S0006-291X(03)00648-X; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; DEVES R, 1989, PROC R SOC SER B-BIO, V237, P85, DOI 10.1098/rspb.1989.0038; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Foltz M, 2004, EUR J BIOCHEM, V271, P3340, DOI 10.1111/j.1432-1033.2004.04268.x; Frolund S, 2010, BRIT J PHARMACOL, V159, P1339, DOI 10.1111/j.1476-5381.2009.00620.x; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Javitt Daniel C, 2002, Curr Opin Investig Drugs, V3, P1067; Kennedy DJ, 2005, BRIT J PHARMACOL, V144, P28, DOI 10.1038/sj.bjp.0706029; Larsen M, 2009, BRIT J PHARMACOL, V157, P1380, DOI 10.1111/j.1476-5381.2009.00253.x; Meredith D, 2004, J BIOL CHEM, V279, P15795, DOI 10.1074/jbc.M313922200; Metzner L, 2006, AMINO ACIDS, V31, P111, DOI 10.1007/s00726-005-0314-6; Metzner L, 2005, FASEB J, V19, P1468, DOI 10.1096/fj.05-3683com; Metzner L, 2009, MOL PHARMACEUT, V6, P1006, DOI 10.1021/mp9000684; NEWEY H, 1964, J PHYSIOL-LONDON, V170, P328, DOI 10.1113/jphysiol.1964.sp007334; Reynolds B, 2007, BIOCHEM SOC T, V35, P1215, DOI 10.1042/BST0351215; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 2000, BRIT J PHARMACOL, V129, P457, DOI 10.1038/sj.bjp.0703069	32	32	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2455	2460		10.1074/jbc.M110.172403	http://dx.doi.org/10.1074/jbc.M110.172403			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097500	Green Published, hybrid			2022-12-27	WOS:000286464300009
J	Mercer, AE; Copple, IM; Maggs, JL; O'Neill, PM; Park, BK				Mercer, Amy E.; Copple, Ian M.; Maggs, James L.; O'Neill, Paul M.; Park, B. Kevin			The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG DIHYDROARTEMISININ DHA; PLASMODIUM-FALCIPARUM; IN-VIVO; IRON-METABOLISM; DEPLETED CELL; CANCER-CELLS; APOPTOSIS; ACTIVATION; DNA; ARTESUNATE	The artemisinin compounds are the frontline drugs for the treatment of drug-resistant malaria. They are selectively cytotoxic to mammalian cancer cell lines and have been implicated as neurotoxic and embryotoxic in animal studies. The endoperoxide functional group is both the pharmacophore and toxicophore, but the proposed chemical mechanisms and targets of cytotoxicity remain unclear. In this study we have used cell models and quantitative drug metabolite analysis to define the role of the mitochondrion and cellular heme in the chemical and molecular mechanisms of cell death induced by artemisinin compounds. HeLa rho(0) cells, which are devoid of a functioning electron transport chain, were used to demonstrate that actively respiring mitochondria play an essential role in endoperoxide-induced cytotoxicity (artesunate IC50 values, 48 h: HeLa cells, 6 +/- 3 mu M; and HeLa rho(0) cells, 34 +/- 5 mu M) via the generation of reactive oxygen species and the induction of mitochondrial dysfunction and apoptosis but do not have any role in the reductive activation of the endoperoxide to cytotoxic carbon-centered radicals. However, using chemical modulators of heme synthesis (succinylacetone and protoporphyrin IX) and cellular iron content (holotransferrin), we have demonstrated definitively that free or protein-bound heme is responsible for intracellular activation of the endoperoxide group and that this is the chemical basis of cytotoxicity (IC50 value and biomarker of bioactivation levels, respectively: 10 beta-(p-fluorophenoxy)dihydroartemisinin alone, 0.36 +/- 0.20 mu M and 11 +/- 5%; and with succinylacetone, > 100 mu M and 2 +/- 5%).	[Mercer, Amy E.; Copple, Ian M.; Maggs, James L.; Park, B. Kevin] Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England; [O'Neill, Paul M.] Univ Liverpool, Dept Chem, Liverpool L69 3GE, Merseyside, England	University of Liverpool; University of Liverpool	Mercer, AE (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Sherrington Bldgs, Liverpool L69 3GE, Merseyside, England.	aemercer@liv.ac.uk	Chadwick, Amy E/D-8633-2015	Chadwick, Amy E/0000-0002-7399-8655; Copple, Ian/0000-0003-4101-1913	Medical Research Council; European Union; MRC [G0700654] Funding Source: UKRI; Medical Research Council [G0700654] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by funds from the Medical Research Council (to A. E. M.) and the European Union (to I. M. C.) as part of the FP7 framework.	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Atamna H, 2002, ARCH BIOCHEM BIOPHYS, V397, P345, DOI 10.1006/abbi.2001.2671; Berman PA, 1997, FREE RADICAL BIO MED, V22, P1283, DOI 10.1016/S0891-5849(96)00508-4; Berridge MV, 1998, PROTOPLASMA, V205, P74, DOI 10.1007/BF01279296; Cazelles J, 2002, J ORG CHEM, V67, P609, DOI 10.1021/jo010688d; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2001, INT J ONCOL, V18, P767; Ferraresi R, 2008, CYTOM PART A, V73A, P528, DOI 10.1002/cyto.a.20544; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GREENSTOCK CL, 1975, BIOCHIM BIOPHYS ACTA, V396, P11, DOI 10.1016/0005-2728(75)90184-X; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Jefford CW, 2007, DRUG DISCOV TODAY, V12, P487, DOI 10.1016/j.drudis.2007.04.009; JIANG JB, 1985, AM J TROP MED HYG, V34, P424, DOI 10.4269/ajtmh.1985.34.424; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Laffan SB, 2006, BIRTH DEFECTS RES A, V76, P329; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Longo M, 2008, REPROD TOXICOL, V25, P433, DOI 10.1016/j.reprotox.2008.02.004; Longo M, 2006, REPROD TOXICOL, V22, P797, DOI 10.1016/j.reprotox.2006.08.001; Lu JJ, 2008, CANCER BIOL THER, V7, P1017, DOI 10.4161/cbt.7.7.6035; MAENO Y, 1993, AM J TROP MED HYG, V49, P485, DOI 10.4269/ajtmh.1993.49.485; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Mercer AE, 2009, TOXICOL APPL PHARM, V239, P297, DOI 10.1016/j.taap.2009.05.027; Mercer AE, 2009, CURR OPIN DRUG DISC, V12, P125; Miyoshi N, 2008, BBA-MOL BASIS DIS, V1782, P566, DOI 10.1016/j.bbadis.2008.07.002; Muller O, 2009, LANCET, V374, P1419, DOI 10.1016/S0140-6736(09)61857-2; NASS MMK, 1970, P NATL ACAD SCI USA, V67, P1926, DOI 10.1073/pnas.67.4.1926; Nicotera P, 1998, TOXICOL LETT, V103, P139; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; O'Neill PM, 2001, J MED CHEM, V44, P58, DOI 10.1021/jm000987f; Park BK, 1998, BRIT J CLIN PHARMACO, V46, P521, DOI 10.1046/j.1365-2125.1998.00838.x; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Ponka P, 1997, BLOOD, V89, P1; Posner GH, 2006, EXPERT OPIN THER PAT, V16, P1665, DOI 10.1517/13543776.16.12.1665; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Robert A, 2002, CHEM COMMUN, P414, DOI 10.1039/b110817b; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Singh NP, 2004, ANTICANCER RES, V24, P2277; Stocks PA, 2007, ANGEW CHEM INT EDIT, V46, P6278, DOI 10.1002/anie.200604697; Taylor SM, 2009, NEW ENGL J MED, V361, P1807, DOI 10.1056/NEJMc091737; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Toovey S, 2006, TOXICOL LETT, V166, P95, DOI 10.1016/j.toxlet.2006.06.001; Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582; World Health Organization, 2003, WHOCDSMAL20031094; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472	57	117	126	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					987	996		10.1074/jbc.M110.144188	http://dx.doi.org/10.1074/jbc.M110.144188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059641	Green Published, hybrid			2022-12-27	WOS:000286005000009
J	Pinto, JR; Reynaldo, DP; Parvatiyar, MS; Dweck, D; Liang, J; Jones, MA; Sorenson, MM; Potter, JD				Pinto, Jose Renato; Reynaldo, Daniel P.; Parvatiyar, Michelle S.; Dweck, David; Liang, Jingsheng; Jones, Michelle A.; Sorenson, Martha M.; Potter, James D.			Strong Cross-bridges Potentiate the Ca2+ Affinity Changes Produced by Hypertrophic Cardiomyopathy Cardiac Troponin C Mutants in Myofilaments A FAST KINETIC APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; MAGNESIUM BINDING-SITES; RABBIT PSOAS FIBERS; T I79N MUTATION; SKELETAL-MUSCLE; CALCIUM-BINDING; TRANSGENIC MICE; FUNCTIONAL-CHARACTERIZATION; DILATED CARDIOMYOPATHY; MOUSE MODEL	This spectroscopic study examined the steady-state and kinetic parameters governing the cross-bridge effect on the increased Ca2+ affinity of hypertrophic cardiomyopathy-cardiac troponin C (HCM-cTnC) mutants. Previously, we found that incorporation of the A8V and D145E HCM-cTnC mutants, but not E134D into thin filaments (TFs), increased the apparent Ca2+ affinity relative to TFs containing the WT protein. Here, we show that the addition of myosin subfragment 1 (S1) to TFs reconstituted with these mutants in the absence of MgATP(2-), the condition conducive to rigor cross-bridge formation, further increased the apparent Ca2+ affinity. Stopped-flow fluorescence techniques were used to determine the kinetics of Ca2+ dissociation (k(off)) from the cTnC mutants in the presence of TFs and S1. At a high level of complexity (i.e. TF + S1), an increase in the Ca2+ affinity and decrease in k(off) was achieved for the A8V and D145E mutants when compared with WT. Therefore, it appears that the cTnC Ca2+ off-rate is most likely to be affected rather than the Ca2+ on rate. At all levels of TF complexity, the results obtained with the E134D mutant reproduced those seen with the WT protein. We conclude that strong cross-bridges potentiate the Ca2+-sensitizing effect of HCM-cTnC mutants on the myofilament. Finally, the slower k(off) from the A8V and D145E mutants can be directly correlated with the diastolic dysfunction seen in these patients.	[Pinto, Jose Renato; Reynaldo, Daniel P.; Parvatiyar, Michelle S.; Dweck, David; Liang, Jingsheng; Jones, Michelle A.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Reynaldo, Daniel P.; Sorenson, Martha M.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Ciencias Saude, BR-21941902 Rio De Janeiro, Brazil	University of Miami; Universidade Federal do Rio de Janeiro	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rm 6083 R-189,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Pinto, Jose Renato/0000-0001-9092-4976; Pereira Reynaldo, Daniel/0000-0003-2531-2097; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [AR050199, HL042325, NS064821]; American Heart Association [AHA 0825368E, AHA 09POST2300030]; Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042325, R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050199, HL042325, and NS064821 (to J. D. P.). This work was also supported by postdoctoral fellowships from the American Heart Association AHA 0825368E (to J. R. P.) and AHA 09POST2300030 (to M. S. P.) and Brazilian agencies Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ) (to M. M. S.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to M. M. S. and D. P. R., both affiliated with the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem).	Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Iorga B, 2008, CARDIOVASC RES, V77, P676, DOI 10.1093/cvr/cvm113; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; KAWAI M, 1987, PFLUG ARCH EUR J PHY, V408, P1, DOI 10.1007/BF00581833; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Maron BJ, 2007, CARDIOL CLIN, V25, P399, DOI 10.1016/j.ccl.2007.07.006; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Neulen A, 2009, BASIC RES CARDIOL, V104, P751, DOI 10.1007/s00395-009-0038-y; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; SMITH L, 1994, J BIOL CHEM, V269, P9857; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; Wang Y, 2002, J APPL PHYSIOL, V92, P2409, DOI 10.1152/japplphysiol.00376.2001; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	50	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1005	1013		10.1074/jbc.M110.168583	http://dx.doi.org/10.1074/jbc.M110.168583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056975	hybrid, Green Published			2022-12-27	WOS:000286005000011
J	Balendiran, GK; Sawaya, MR; Schwarz, FP; Ponniah, G; Cuckovich, R; Verma, M; Cascio, D				Balendiran, Ganesaratnam K.; Sawaya, Michael R.; Schwarz, Frederick P.; Ponniah, Gomathinayagam; Cuckovich, Richard; Verma, Malkhey; Cascio, Duilio			The Role of Cys-298 in Aldose Reductase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC COMPLICATIONS; HUMAN-ERYTHROCYTE; BINDING-SITE; ACTIVATION; MECHANISM; INVOLVEMENT; INHIBITION; CONSTANTS; SORBITOL; PATHWAY	Diabetic tissues are enriched in an "activated" form of human aldose reductase (hAR), a NADPH-dependent oxidoreductase involved in sugar metabolism. Activated hAR has reduced sensitivity to potential anti-diabetes drugs. The C298S mutant of hAR reproduces many characteristics of activated hAR, although it differs from wild-type hAR only by the replacement of a single sulfur atom with oxygen. Isothermal titration calorimetry measurements revealed that the binding constant of NADPH to the C298S mutant is decreased by a factor of two, whereas that of NADP(+) remains the same. Similarly, the heat capacity change for the binding of NADPH to the C298S mutant is twice increased; however, there is almost no difference in the heat capacity change for binding of the NADP(+) to the C298S. X-ray crystal structures of wild-type and C298S hAR reveal that the side chain of residue 298 forms a gate to the nicotinamide pocket and is more flexible for cysteine compared with serine. Unlike Cys-298, Ser-298 forms a hydrogen bond with Tyr-209 across the nicotinamide ring, which inhibits movements of the nicotinamide. We hypothesize that the increased polarity of the oxidized nicotinamide weakens the hydrogen bond potentially formed by Ser-298, thus, accounting for the relatively smaller effect of the mutation on NADP(+) binding. The effects of the mutant on catalytic rate constants and binding constants for various substrates are the same as for activated hAR. It is, thus, further substantiated that activated hAR arises from oxidative modification of Cys-298, a residue near the nicotinamide binding pocket.	[Balendiran, Ganesaratnam K.; Cuckovich, Richard] Youngstown State Univ, Dept Chem, Youngstown, OH 44555 USA; [Sawaya, Michael R.; Cascio, Duilio] UCLA DOE, Los Angeles, CA 90095 USA; [Schwarz, Frederick P.] Natl Inst Stand & Technol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; [Ponniah, Gomathinayagam] Merck & Co Inc, Lebanon, NH 03766 USA; [Verma, Malkhey] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University System of Ohio; Youngstown State University; United States Department of Energy (DOE); University of California System; University of California Los Angeles; National Institute of Standards & Technology (NIST) - USA; Merck & Company; University of Manchester	Balendiran, GK (corresponding author), Youngstown State Univ, Dept Chem, WBSH 6017,1 Univ Plaza, Youngstown, OH 44555 USA.	pl_note@yahoo.com			Office of Biological and Environmental Research, United States Department of Energy; National Institutes of Health, National Center for Research Resources, Biomedical; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases [DK085496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK085496] Funding Source: NIH RePORTER	Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank David Eisenberg and Todd Yeates for use of their facilities, Peter Kasvinsky and the Youngstown State University Graduate School, for encouragement and support the staff at Synchrotron Radiation Laboratory beamline 9-1 and Advanced Light Source beamline 8.2.2 for expert assistance, and Dino Moras and Alberto Podjarny for the gift of the His-tag recombinant hAR overexpression cells. Data collection facilities at the Stanford Synchrotron Radiation Laboratory are funded by The Office of Biological and Environmental Research, United States Department of Energy, the National Institutes of Health, National Center for Research Resources, Biomedical, and the National Institute of General Medical Sciences.; This study was supported by Grant DK085496 from the National Institute of Diabetes and Digestive and Kidney Diseases.	Balendiran GK, 2005, BIOCHEM PHARMACOL, V70, P1653, DOI 10.1016/j.bcp.2005.06.029; BOHREN KM, 1993, ADV EXP MED BIOL, V328, P267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cappiello M, 1996, J BIOL CHEM, V271, P33539, DOI 10.1074/jbc.271.52.33539; Caprio S, 1997, DIABETOLOGIA, V40, pB78, DOI 10.1007/s001250051411; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; DELCORSO A, 1987, BIOCHEM BIOPH RES CO, V148, P369, DOI 10.1016/0006-291X(87)91120-X; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLYNN TG, 1982, BIOCHEM PHARMACOL, V31, P2705, DOI 10.1016/0006-2952(82)90123-X; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; GREENE DA, 1987, NEW ENGL J MED, V316, P599; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; GRIMSHAW CE, 1990, BIOCHEMISTRY-US, V29, P9947, DOI 10.1021/bi00494a027; Grimshaw CE, 1996, ARCH BIOCHEM BIOPHYS, V327, P89, DOI 10.1006/abbi.1996.0096; GRIMSHAW CE, 1989, BIOCHEMISTRY-US, V28, P5343, DOI 10.1021/bi00439a006; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; JASPAN J, 1986, DRUGS, V32, P23, DOI 10.2165/00003495-198600322-00007; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU SQ, 1992, BIOCHEM PHARMACOL, V44, P2427, DOI 10.1016/0006-2952(92)90693-D; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newfield RS, 1997, DIABETOLOGIA, V40, pB62, DOI 10.1007/BF03168189; NISHIMURA C, 1991, BIOCHIM BIOPHYS ACTA, V1078, P171, DOI 10.1016/0167-4838(91)99006-E; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; SRIVASTAVA SK, 1986, METABOLISM, V35, P114, DOI 10.1016/0026-0495(86)90199-X; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P7222, DOI 10.1073/pnas.82.21.7222; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	39	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6336	6344		10.1074/jbc.M110.154195	http://dx.doi.org/10.1074/jbc.M110.154195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21084309	hybrid, Green Published			2022-12-27	WOS:000287476400044
J	Zigrino, P; Nischt, R; Mauch, C				Zigrino, Paola; Nischt, Roswitha; Mauch, Cornelia			The Disintegrin-like and Cysteine-rich domains of ADAM-9 Mediate Interactions between Melanoma Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG INTEGRIN ALPHA-6-BETA-1; GROWTH-FACTOR; COLLAGEN-I; ADHESION; METALLOPROTEINASES; EXPRESSION; PROTEIN; CANCER; INVASION; BINDING	A characteristic of malignant cells is their capacity to invade their surrounding and to metastasize to distant organs. During these processes, proteolytic activities of tumor and stromal cells modify the extracellular matrix to produce a microenvironment suitable for their growth and migration. In recent years the family of ADAM proteases has been ascribed important roles in these processes. ADAM-9 is expressed in human melanoma at the tumor-stroma border where direct or indirect interactions between tumor cells and fibroblasts occur. To analyze the role of ADAM-9 for the interaction between melanoma cells and stromal fibroblasts, we produced the recombinant disintegrin-like and cysteine-rich domain of ADAM-9 (DC-9). Melanoma cells and human fibroblasts adhered to immobilized DC-9 in a Mn2+-dependent fashion suggesting an integrin-mediated process. Inhibition studies showed that adhesion of fibroblasts was mediated by several beta 1 integrin receptors independent of the RGD and ECD recognition motif. Furthermore, interaction of fibroblasts and high invasive melanoma cells with soluble recombinant DC-9 resulted in enhanced expression of MMP-1 and MMP-2. Silencing of ADAM-9 in melanoma cells significantly reduced cell adhesion to fibroblasts. Ablation of ADAM-9 in fibroblasts almost completely abolished these cellular interactions and melanoma cell invasion in vitro. In summary, these results suggest that ADAM-9 expression plays an important role in mediating cell-cell contacts between fibroblasts and melanoma cells and that these interactions contribute to proteolytic activities required during invasion of melanoma cells.	Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany	University of Cologne; University of Cologne	Zigrino, P (corresponding author), Univ Hosp Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	Paola.Zigrino@uni-koeln.de		Zigrino, Paola/0000-0002-7470-0064	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund)	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund)	This work was supported by the Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund, to P. Z. and C. M.).	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; Charrier L, 2007, J BIOL CHEM, V282, P16948, DOI 10.1074/jbc.M700158200; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Heino J, 1996, INT J CANCER, V65, P717, DOI 10.1002/(SICI)1097-0215(19960315)65:6<717::AID-IJC1>3.3.CO;2-P; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517; Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Kurschat P, 2002, J PATHOL, V197, P179, DOI 10.1002/path.1080; Loffek S, 2006, EUR J CELL BIOL, V85, P1167, DOI 10.1016/j.ejcb.2006.07.003; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Namba K, 2001, CELL IMMUNOL, V213, P104, DOI 10.1006/cimm.2001.1873; Nath D, 2000, J CELL SCI, V113, P2319; Nath D, 1999, J CELL SCI, V112, P579; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Schlondorff J, 1999, J CELL SCI, V112, P3603; Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Wandel E, 2000, EXP DERMATOL, V9, P34, DOI 10.1034/j.1600-0625.2000.009001034.x; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	41	42	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6801	6807		10.1074/jbc.M110.168617	http://dx.doi.org/10.1074/jbc.M110.168617			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135106	Green Published, hybrid			2022-12-27	WOS:000287476400087
J	Dhennin-Duthille, I; Nyga, R; Yahiaoui, S; Gouilleux-Gruart, V; Regnier, A; Lassoued, K; Gouilleux, F				Dhennin-Duthille, Isabelle; Nyga, Remy; Yahiaoui, Saliha; Gouilleux-Gruart, Valerie; Regnier, Aline; Lassoued, Kaiss; Gouilleux, Fabrice			The Tumor Suppressor hTid1 Inhibits STAT5b Activity via Functional Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE SIGNAL-TRANSDUCTION; EPIDERMAL-GROWTH-FACTOR; ALPHA-HELICAL REGION; HUMAN DNAJ PROTEIN; TRANSACTIVATION DOMAIN; HUMAN HOMOLOG; LYMPHOID DEVELOPMENT; NEGATIVE REGULATORS; HEMATOPOIETIC-CELLS; ACTIVATED STAT5A	STAT5a and -5b (signal transducers and activators of transcription 5a and 5b) proteins play an essential role in hematopoietic cell proliferation and survival and are frequently constitutively active in hematologic neoplasms and solid tumors. Because STAT5a and STAT5b differ mainly in the carboxylterminal transactivation domain, we sought to identify new proteins that bind specifically to this domain by using a bacterial two-hybrid screening. We isolated hTid1, a human DnaJ protein that acts as a tumor suppressor in various solid tumors. hTid1 interacts specifically with STAT5b but not with STAT5a in hematopoietic cell lines. This interaction involves the cysteine-rich region of the hTid1 DnaJ domain. We also demonstrated that hTid1 negatively regulates the expression and transcriptional activity of STAT5b and suppresses the growth of hematopoietic cells transformed by an oncogenic form of STAT5b. Our findings define hTid1 as a novel partner and negative regulator of STAT5b.	[Dhennin-Duthille, Isabelle; Nyga, Remy; Yahiaoui, Saliha; Gouilleux-Gruart, Valerie; Regnier, Aline; Lassoued, Kaiss; Gouilleux, Fabrice] Univ Picardie Jules Verne, INSERM, UFR Med, U925, F-80036 Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Lassoued, K (corresponding author), Univ Picardie Jules Verne, INSERM, UFR Med, U925, 3 Rue Louvels, F-80036 Amiens, France.	kaiss.lassoued@sa.u-picardie.fr; fabrice.gouilleux@univ-tours.fr		Gouilleux, Fabrice/0000-0001-6047-1718	INSERM; Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie; Ministere de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie(Fondation ARC pour la Recherche sur le CancerRegion Hauts-de-France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by INSERM, Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie.; Supported by the "Ministere de la Recherche."	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Chen YH, 2006, BLOOD, V108, P566, DOI 10.1182/blood-2005-12-4777; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Gu L, 2010, AM J PATHOL, V176, P1959, DOI 10.2353/ajpath.2010.090653; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Kaymer M, 1997, GENE, V204, P91, DOI 10.1016/S0378-1119(97)00528-3; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Kieslinger M, 2000, GENE DEV, V14, P232; Kile BT, 2001, INT J HEMATOL, V73, P292, DOI 10.1007/BF02981953; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lanvin O, 2004, ONCOGENE, V23, P3040, DOI 10.1038/sj.onc.1207450; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liang QC, 2009, CANCER LETT, V273, P164, DOI 10.1016/j.canlet.2008.08.011; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Mizuki M, 2000, BLOOD, V96, p680A; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Qian J, 2010, GASTROENTEROLOGY, V138, P1418, DOI 10.1053/j.gastro.2009.10.044; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Santos SCR, 2000, ONCOGENE, V19, P1164, DOI 10.1038/sj.onc.1203418; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Syken J, 2003, ONCOGENE, V22, P4636, DOI 10.1038/sj.onc.1206569; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tan SH, 2008, ENDOCR-RELAT CANCER, V15, P367, DOI 10.1677/ERC-08-0013; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Torregroza I, 2006, BIOCHEM J, V393, P311, DOI 10.1042/BJ20050785; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Xi SC, 2003, CANCER RES, V63, P6763; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yin X, 2001, GENE, V278, P201, DOI 10.1016/S0378-1119(01)00720-X; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	65	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5034	5042		10.1074/jbc.M110.155903	http://dx.doi.org/10.1074/jbc.M110.155903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21106534	Green Published, hybrid			2022-12-27	WOS:000287230600011
J	Tremp, AZ; Dessens, JT				Tremp, Annie Z.; Dessens, Johannes T.			Malaria IMC1 Membrane Skeleton Proteins Operate Autonomously and Participate in Motility Independently of Cell Shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE TOXOPLASMA-GONDII; PLASMODIUM-BERGHEI; APICOMPLEXAN PARASITES; INTERMEDIATE-FILAMENTS; GLIDING MOTILITY; MOSQUITO MIDGUT; XIV MYOSIN; LIFE-CYCLE; INVASION; CYTOSKELETON	Plasmodium IMC1 (inner membrane complex 1) proteins comprise components of the subpellicular network, a lattice of intermediate filaments that form a structural part of the pellicle in the zoite stages of malaria parasites. Family members IMC1a and IMC1b are differentially expressed in sporozoites and ookinetes, respectively, but have functionally equivalent roles affecting cell morphology, strength, motility, and infectivity. Because of the coincident effects of previous imc1 gene disruptions on both zoite shape and locomotion, it has been impossible to ascribe a direct involvement in motility to these proteins. We show here that a third family member, IMC1h, has a distinct differential expression pattern and localizes to the pellicle of both ookinetes and sporozoites. Knock-out of IMC1h mimics the loss-of-function phenotypes of IMC1a and IMC1b in their respective life stages, indicating that IMC1 proteins could be operating co-dependently. By generating double null mutant parasites for IMC1h and IMC1b, we tested this hypothesis: double knock-out exacerbated the phenotypes of the single knock-outs in terms of ookinete strength, motility, and infectivity but did not further affect ookinete morphology. These findings provide the first genetic evidence that IMC1 proteins can function independently of each other and contribute to gliding motility independently of cell shape.	[Tremp, Annie Z.; Dessens, Johannes T.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Dessens, JT (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	johannes.dessens@lshtm.ac.uk		Dessens, Johannes/0000-0002-2070-6073; Tremp, Annie/0000-0003-4042-9074	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Matuschewski Kai, 2008, V47, P110; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Saeed S, 2010, MOL BIOCHEM PARASIT, V170, P49, DOI 10.1016/j.molbiopara.2009.11.008; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Vernick KD, 1999, EXP PARASITOL, V91, P362, DOI 10.1006/expr.1998.4388; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	43	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5383	5391		10.1074/jbc.M110.187195	http://dx.doi.org/10.1074/jbc.M110.187195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21098480	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000287230600047
J	Konson, A; Pradeep, S; D'Acunto, CW; Seger, R				Konson, Alexander; Pradeep, Sunila; D'Acunto, Cosimo Walter; Seger, Rony			RETRACTED: Pigment Epithelium-derived Factor and Its Phosphomimetic Mutant Induce JNK-dependent Apoptosis and p38-mediated Migration Arrest (Retracted article. See vol. 292, pg. 8849, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ANTI-ANGIOGENIC ACTIVITY; HUMAN ENDOTHELIAL-CELLS; FACTOR EXPRESSION; TUMOR-GROWTH; FACTOR PEDF; PPAR-GAMMA; ACTIVATION; INHIBITION; RECEPTOR; KINASE	Pigment epithelium-derived factor (PEDF) is a potent endogenous inhibitor of angiogenesis and a promising anticancer agent. We have previously shown that PEDF can be phosphorylated and that distinct phosphorylations differentially regulate its physiological functions. We also demonstrated that triple phosphomimetic mutant (EEE-PEDF), has significantly increased antiangiogenic activity and is much more efficient than WT-PEDF in inhibiting neovascularization and tumor growth. The enhanced antiangiogenic effect was associated with a direct ability to facilitate apoptosis of tumor-residing endothelial cells (ECs), and subsequently, disruption of intratumoral vascularization. In the present report, we elucidated the molecular mechanism by which EEE-PEDF exerts more profound effects at the cellular level. We found that EEE-PEDF suppresses EC proliferation due to caspase-3-dependent apoptosis and also inhibits migration of the EC much better than WT-PEDF. Although WT-PEDF and EEE-PEDF did not affect proliferation and did not induce apoptosis of cancer cells, these agents efficiently inhibited cancer cell motility, with EEE-PEDF showing a stronger effect. The stronger activity of EEE-PEDF was correlated with a better binding to laminin receptors. Furthermore, the proapoptotic and antimigratory activities of WT-PEDF and EEE-PEDF were found regulated by differential activation of two distinct MAPK pathways, namely JNK and p38, respectively. We show that JNK and p38 phosphorylation is much higher in cells treated with EEE-PEDF. JNK leads to apoptosis of ECs, whereas p38 leads to anti-migratory effect in both EC and cancer cells. These results reveal the molecular signaling mechanism by which the phosphorylated PEDF exerts its stronger antiangiogenic, antitumor activities.	[Konson, Alexander; Pradeep, Sunila; D'Acunto, Cosimo Walter; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Seger, R (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, POB 26, IL-76100 Rehovot, Israel.	rony.seger@weizmann.ac.il			Israeli Ministry of Industry and Trade; Horowitz Foundation; Phyllis and Joseph Gurwin Fund for Scientific Advancement; EU [LSHC CT-2006-037731]	Israeli Ministry of Industry and Trade; Horowitz Foundation; Phyllis and Joseph Gurwin Fund for Scientific Advancement; EU(European Commission)	This work was supported by grants from the Israeli Ministry of Industry and Trade (Nofar program), the Horowitz Foundation, the Phyllis and Joseph Gurwin Fund for Scientific Advancement and the EU Sixth Framework Program (GROWTHSTOP, LSHC CT-2006-037731).	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Biyashev D, 2010, J BIOL CHEM, V285, P13517, DOI 10.1074/jbc.M110.117374; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chen HB, 2008, BIOCHEM BIOPH RES CO, V369, P718, DOI 10.1016/j.bbrc.2008.02.100; Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188; Crawford SE, 2001, J CELL SCI, V114, P4421; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Ek ETH, 2007, CLIN EXP METASTAS, V24, P93, DOI 10.1007/s10585-007-9062-1; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; ENNIS BW, 1991, CANCER INVEST, V9, P553, DOI 10.3109/07357909109018953; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; Hu YL, 1999, AM J PHYSIOL-HEART C, V277, pH1593, DOI 10.1152/ajpheart.1999.277.4.H1593; Hutchings H, 2002, BIOCHEM BIOPH RES CO, V294, P764, DOI 10.1016/S0006-291X(02)00548-X; Konson A, 2010, CANCER RES, V70, P6247, DOI 10.1158/0008-5472.CAN-10-0434; Maik-Rachline G, 2006, BLOOD, V107, P2745, DOI 10.1182/blood-2005-06-2547; Maik-Rachline G, 2005, BLOOD, V105, P670, DOI 10.1182/blood-2004-04-1569; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 2005, J STRUCT BIOL, V151, P130, DOI 10.1016/j.jsb.2005.05.005; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JJ, 2005, DIABETES, V54, P243, DOI 10.2337/diabetes.54.1.243; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S1525-0016(03)00128-X; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Yafai Y, 2007, GLIA, V55, P642, DOI 10.1002/glia.20495; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474; Zhang LJ, 2006, INT J MOL MED, V17, P937	48	28	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3540	3551		10.1074/jbc.M110.151548	http://dx.doi.org/10.1074/jbc.M110.151548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21059648	Green Published, hybrid			2022-12-27	WOS:000286653200039
J	Terao, M; Fratelli, M; Kurosaki, M; Zanetti, A; Guarnaccia, V; Paroni, G; Tsykin, A; Lupi, M; Gianni, M; Goodall, GJ; Garattini, E				Terao, Mineko; Fratelli, Maddalena; Kurosaki, Mami; Zanetti, Adriana; Guarnaccia, Valeria; Paroni, Gabriela; Tsykin, Anna; Lupi, Monica; Gianni, Maurizio; Goodall, Gregory J.; Garattini, Enrico			Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells BIOLOGICAL CORRELATES AND MOLECULAR TARGETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; TUMOR-SUPPRESSOR GENE; CANCER-CELLS; MICRORNA-21 TARGETS; MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK; PROSTATE-CANCER; EXPRESSION; ALPHA; APOPTOSIS	Retinoids are promising agents for the treatment/prevention of breast carcinoma. We examined the role of microRNAs in mediating the effects of all-trans-retinoic acid (ATRA), which suppresses the proliferation of estrogen receptor-positive (ER alpha(+)) breast carcinoma cells, such as MCF-7, but not estrogen receptor-negative cells, such as MDA-MB-231. We found that pro-oncogenic miR-21 is selectively induced by ATRA in ER alpha(+) cells. Induction of miR-21 counteracts the anti-proliferative action of ATRA but has the potentially beneficial effect of reducing cell motility. In ER alpha(+) cells, retinoid-dependent induction of miR-21 is due to increased transcription of the MIR21 gene via ligand-dependent activation of the nuclear retinoid receptor, RAR alpha. RAR alpha is part of the transcription complex present in the 5'-flanking region of the MIR21 gene. The receptor binds to two functional retinoic acid-responsive elements mapping upstream of the transcription initiation site. Silencing of miR-21 enhances ATRA-dependent growth inhibition and senescence while reverting suppression of cell motility afforded by the retinoid. Up-regulation of miR-21 results in retinoid-dependent inhibition of the established target, maspin. Knockdown and overexpression of maspin in MCF-7 cells indicates that the protein is involved in ATRA-induced growth inhibition and contributes to the ATRA-dependent anti-motility responses. Integration between whole genome analysis of genes differentially regulated by ATRA in MCF-7 and MDA-MB-231 cells, prediction of miR-21 regulated genes, and functional studies led to the identification of three novel direct miR-21 targets: the pro-inflammatory cytokine IL1B, the adhesion molecule ICAM-1 and PLAT, the tissue-type plasminogen activator. Evidence for ICAM-1 involvement in retinoid-dependent inhibition of MCF-7 cell motility is provided.	[Terao, Mineko; Fratelli, Maddalena; Kurosaki, Mami; Zanetti, Adriana; Guarnaccia, Valeria; Paroni, Gabriela; Lupi, Monica; Gianni, Maurizio; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy; [Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Tsykin, Anna; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre for Cancer Biology; SA Pathology; University of Adelaide	Garattini, E (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	egarattini@marionegri.it	Garattini, Enrico/AAI-1998-2019; KUROSAKI, Mami/ABG-2224-2020; adriana, zanetti/ABA-1189-2020; Fratelli, Maddalena/AAA-6446-2020; Terao, Mineko/AAA-6415-2020; Paroni, Gabriela/J-4848-2018; Gianni, Maurizio/ABG-6322-2020; terao, mineko/AAU-8089-2020; Lupi, Monica/AAH-5704-2019	KUROSAKI, Mami/0000-0001-8231-713X; adriana, zanetti/0000-0002-5825-9707; Fratelli, Maddalena/0000-0002-1769-3427; Terao, Mineko/0000-0002-9976-9869; Paroni, Gabriela/0000-0003-0132-0869; Gianni, Maurizio/0000-0002-6945-708X; Tsykin, Anna/0000-0001-5965-6803; Goodall, Gregory/0000-0003-1294-0692; Lupi, Monica/0000-0002-9835-7870; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana Ricerca contro il Cancro; Ministero della Universita e della Ricerca; Fondazione "Italo Monzino"; Fondazione "Negri-Weizmann"	Associazione Italiana Ricerca contro il Cancro; Ministero della Universita e della Ricerca; Fondazione "Italo Monzino"; Fondazione "Negri-Weizmann"	This work was supported by the Associazione Italiana Ricerca contro il Cancro, Ministero della Universita e della Ricerca, Fondazione "Italo Monzino," and Fondazione "Negri-Weizmann."	Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; DeClerck YA, 1997, ADV EXP MED BIOL, V425, P89; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Elgort MG, 1996, MOL ENDOCRINOL, V10, P477, DOI 10.1210/me.10.5.477; ERICKSON CA, 1989, J EXP ZOOL, V251, P123, DOI 10.1002/jez.1402510203; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fu HY, 2006, BIOCHEM BIOPH RES CO, V343, P1009, DOI 10.1016/j.bbrc.2006.02.176; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Gianni M, 1996, BLOOD, V87, P1520, DOI 10.1182/blood.V87.4.1520.bloodjournal8741520; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Joensuu KM, 2009, HUM PATHOL, V40, P1143, DOI 10.1016/j.humpath.2009.02.006; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Mandal S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-181; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marchetti M, 2003, HAEMATOLOGICA, V88, P895; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mologni L, 1999, BLOOD, V93, P1045, DOI 10.1182/blood.V93.3.1045.403k22_1045_1061; Nwankwo JO, 2002, ANTICANCER RES, V22, P4129; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parrella E, 2006, MOL PHARMACOL, V70, P909, DOI 10.1124/mol.106.023614; Patel JB, 2007, BRIT J CANCER, V96, P1204, DOI 10.1038/sj.bjc.6603705; Plumb LA, 2004, METH MOLEC MED, V88, P165; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Rickles FR, 2009, THROMB RES, V123, pS16, DOI 10.1016/S0049-3848(09)70004-0; RISHI AK, 1995, CANCER RES, V55, P4999; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Uray IP, 2006, EXPERT OPIN INV DRUG, V15, P1583, DOI 10.1517/13543784.15.12.1583; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Zhu WY, 1999, CANCER RES, V59, P85; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	67	74	81	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4027	4042		10.1074/jbc.M110.184994	http://dx.doi.org/10.1074/jbc.M110.184994			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21131358	Green Published, hybrid			2022-12-27	WOS:000286653200083
J	Wang, E; Mueller, WF; Hertel, KJ; Cambi, F				Wang, Erming; Mueller, William F.; Hertel, Klemens J.; Cambi, Franca			G Run-mediated Recognition of Proteolipid Protein and DM20 5 ' Splice Sites by U1 Small Nuclear RNA Is Regulated by Context and Proximity to the Splice Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; COMPLEX-FORMATION; 5'-SPLICE SITES; SR PROTEINS; ENHANCER; INTRON; OLIGODENDROCYTES; BINDS; EXON; ATP	Highly conserved G runs, G1M2 and ISE, regulate the proteolipid protein (PLP)/DM20 ratio. We have investigated recruitment of U1 small nuclear ribonuclear protein (snRNP) by G1M2 and ISE and examined the effect of splice site strength, distance, and context on G run function. G1M2 is necessary for initial recruitment of U1snRNP to the DM20 5' splice site independent of the strength of the splice site. G1M2 regulates E complex formation and supports DM20 splicing when functional U1snRNP is reduced. By contrast, the ISE is not required for the initial recruitment of U1snRNP to the PLP 5' splice site. However, in close proximity to either the DM20 or the PLP 5' splice site, the ISE recruits U1snRNP to both splice sites. The ISE enhances DM20 splicing, whereas close to the PLP 5' splice site, it inhibits PLP splicing. Splicing enhancement and inhibition are mediated by heterogeneous nuclear ribonuclear protein (hnRNP)H/F. The data show that recognition of the DM20 5' splice site depends on G run-mediated recruitment of U1snRNA, whereas a complex interaction between the ISE G runs, context and position determines the functional outcome on splicing. The data suggest that different mechanisms underlie G run-mediated recognition of 5' splice sites and that context and position play a critical role.	[Cambi, Franca] Univ Kentucky, Dept Neurol, KY Clin L445, Lexington, KY 40536 USA; [Mueller, William F.; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of Kentucky; University of California System; University of California Irvine	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, KY Clin L445, Lexington, KY 40536 USA.	franca.cambi@uky.edu		Hertel, Klemens/0000-0002-7560-9529	National Institutes of Health [RO1NS053905, RO1GM62287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS053905 (to F.C.) and RO1GM62287 (to K.J.H.).	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Dhir A, 2010, EMBO J, V29, P749, DOI 10.1038/emboj.2009.397; Du H, 2001, RNA, V7, P133, DOI 10.1017/S1355838201001844; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hastings ML, 2001, RNA, V7, P859, DOI 10.1017/S1355838201002084; Hobson GM, 2006, HUM MUTAT, V27, P69, DOI 10.1002/humu.20276; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Hwang DY, 1996, GENE DEV, V10, P338, DOI 10.1101/gad.10.3.338; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Ladd AN, 2002, GENOME BIOL, V3; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; MADHANI HD, 1994, ANNU REV GENET, V28, P1; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; NUSSINOV R, 1987, BIOCHIM BIOPHYS ACTA, V910, P261, DOI 10.1016/0167-4781(87)90119-9; NUSSINOV R, 1988, J THEOR BIOL, V133, P73, DOI 10.1016/S0022-5193(88)80025-0; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Vouyiouklis DA, 2000, J NEUROCHEM, V74, P940, DOI 10.1046/j.1471-4159.2000.0740940.x; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101	44	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4059	4071		10.1074/jbc.M110.199927	http://dx.doi.org/10.1074/jbc.M110.199927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127064	Green Published, hybrid			2022-12-27	WOS:000286975700004
J	Bodnar, M; Wang, H; Riedel, T; Hintze, S; Kato, E; Fallah, G; Groger-Arndt, H; Giniatullin, R; Grohmann, M; Hausmann, R; Schmalzing, G; Illes, P; Rubini, P				Bodnar, Mandy; Wang, Haihong; Riedel, Thomas; Hintze, Stefan; Kato, Erzsebet; Fallah, Ghada; Groeger-Arndt, Helke; Giniatullin, Rashid; Grohmann, Marcus; Hausmann, Ralf; Schmalzing, Guenther; Illes, Peter; Rubini, Patrizia			Amino Acid Residues Constituting the Agonist Binding Site of the Human P2X3 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; C-TERMINAL DOMAIN; ATP-BINDING; ION-CHANNEL; PURINERGIC RECEPTORS; EXTRACELLULAR LOOP; CYSTEINE RESIDUES; CELL-SURFACE; KINASE-C; DESENSITIZATION	Homomeric P2X3 receptors are present in sensory ganglia and participate in pain perception. Amino acid (AA) residues were replaced in the four supposed nucleotide binding segments (NBSs) of the human (h) P2X3 receptor by alanine, and these mutants were expressed in HEK293 cells and Xenopus laevis oocytes. Patch clamp and two-electrode voltage clamp measurements as well as the Ca2+ imaging technique were used to compare the concentration-response curves of the selective P2X1,3 agonist alpha, beta-methylene ATP obtained at the wild-type P2X3 receptor and its NBS mutants. Within these NBSs, certain Gly (Gly-66), Lys (Lys-63, Lys-176, Lys-284, Lys-299), Asn (Asn-177, Asn-279), Arg (Arg-281, Arg-295), and Thr (Thr-172) residues were of great importance for a full agonist response. However, the replacement of further AAs in the NBSs by Ala also appeared to modify the amplitude of the current and/or [Ca2+] i responses, although sometimes to a minor degree. The agonist potency decrease was additive after the simultaneous replacement of two adjacent AAs by Ala (K65A/G66A, F171A/T172A, N279A/F280A, F280A/R281A) but was not altered after Ala substitution of two non-adjacent AAs within the same NBS (F171A/N177A). SDS-PAGE in the Cy5 cell surface-labeled form demonstrated that the mutants appeared at the cell surface in oocytes. Thus, groups of AAs organized in NBSs rather than individual amino acids appear to be responsible for agonist binding at the hP2X3 receptor. These NBSs are located at the interface of the three subunits forming a functional receptor.	[Groeger-Arndt, Helke; Grohmann, Marcus; Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Fallah, Ghada; Hausmann, Ralf; Schmalzing, Guenther] Rhein Westfal TH Aachen Univ, Dept Mol Pharmacol, Univ Hosp, D-52074 Aachen, Germany; [Giniatullin, Rashid] AI Virtanen Inst, Dept Neurobiol, Kuopio 70211, Finland	Leipzig University; RWTH Aachen University; RWTH Aachen University Hospital	Illes, P (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	Peter.Illes@medizin.uni-leipzig.de	Giniatullin, Rashid/Y-9687-2018; Riedel, Thomas/A-5079-2012	Giniatullin, Rashid/0000-0002-1580-6280	Deutsche Forschungsgemeinschaft [IL 20/11-3, WI 1674/4-1, IL20/18-2]; Volkswagen Foundation [I/82 940]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grants IL 20/11-3; WI 1674/4-1; and IL20/18-2) and the Volkswagen Foundation (Grant I/82 940).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chizh BA, 2001, PHARMACOL REV, V53, P553; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Fischer W, 2007, EUR J PHARMACOL, V576, P7, DOI 10.1016/j.ejphar.2007.07.068; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Freist W, 1998, FEBS LETT, V434, P61, DOI 10.1016/S0014-5793(98)00958-2; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Gerevich Z, 2007, J BIOL CHEM, V282, P33949, DOI 10.1074/jbc.M705840200; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; He ML, 2002, MOL PHARMACOL, V62, P1187, DOI 10.1124/mol.62.5.1187; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Mager PP, 2006, EXPERT OPIN DRUG DIS, V1, P303, DOI 10.1517/17460441.1.4.303; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nakazawa K, 2005, EUR J PHARMACOL, V518, P107, DOI 10.1016/j.ejphar.2005.06.018; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; SCHMALZING G, 1991, BIOCHEM J, V279, P329, DOI 10.1042/bj2790329; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Sokolova E, 2004, BRIT J PHARMACOL, V141, P1048, DOI 10.1038/sj.bjp.0705701; Stanchev D, 2006, NEUROSCI LETT, V393, P78, DOI 10.1016/j.neulet.2005.09.045; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Wirkner K, 2005, J NEUROSCI, V25, P7734, DOI 10.1523/JNEUROSCI.2028-05.2005; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhou Z, 1998, BIOCHEM BIOPH RES CO, V252, P541, DOI 10.1006/bbrc.1998.9689	53	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2739	2749		10.1074/jbc.M110.167437	http://dx.doi.org/10.1074/jbc.M110.167437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098022	hybrid, Green Published			2022-12-27	WOS:000286464300040
J	Murakawa, T; Machida, Y; Hayashi, H				Murakawa, Takeshi; Machida, Yasuhiro; Hayashi, Hideyuki			Product-assisted Catalysis as the Basis of the Reaction Specificity of Threonine Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; MECHANISM; ENZYMES; VINYLGLYCINE; SERINE; AMINOTRANSFERASE; CYSTATHIONINE; DEHYDRATASE; SYNTHETASE; INHIBITORS	Threonine synthase (TS), which is a pyridoxal 5 '-phosphate (PLP)-dependent enzyme, catalyzes the elimination of the gamma-phosphate group from O-phospho-L-homoserine (OPHS) and the subsequent addition of water at C beta to form L-threonine. The catalytic course of TS is the most complex among the PLP enzymes, and it is an intriguing problem how the elementary steps are controlled in TS to carry out selective reactions. When L-vinylglycine was added to Thermus thermophilus HB8 TS in the presence of phosphate, L-threonine was formed with k(cat) and reaction specificity comparable with those when OPHS was used as the substrate. However, in the absence of phosphate or when sulfate was used in place of phosphate, only the side reaction product-alpha-ketobutyrate, was formed. Global analysis of the spectral changes in the reaction of TS with L-threonine showed that compared with the more acidic sulfate ion, the phosphate ion decreased the energy levels of the transition states of the addition of water at the C beta of the PLP-alpha-aminocrotonate aldimine (AC) and the transaldimination to form L-threonine. The x-ray crystallographic analysis of TS complexed with an analog for AC gave a distinct electron density assigned to the phosphate ion derived from the solvent near the C beta of the analog. These results indicated that the phosphate ion released from OPHS by gamma-elimination acts as the base catalyst for the addition of water at C beta of AC, thereby providing the basis of the reaction specificity. The phosphate ion is also considered to accelerate the protonation/deprotonation at C gamma	[Murakawa, Takeshi; Machida, Yasuhiro; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Fac Med, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Hayashi, H (corresponding author), Osaka Med Coll, Dept Biochem, Fac Med, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	hayashi@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [21570120, 91445990]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research 21570120 (to H. H.) and 91445990 (to T. M.) from the Japan Society for the Promotion of Science.	ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Covarrubias AS, 2008, J MOL BIOL, V381, P622, DOI 10.1016/j.jmb.2008.05.086; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; ESAKI N, 1977, FEBS LETT, V84, P309, DOI 10.1016/0014-5793(77)80713-8; Feng L, 2000, BIOCHEMISTRY-US, V39, P2436, DOI 10.1021/bi9922704; FLAVIN M, 1960, J BIOL CHEM, V235, P1112; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Garrido-Franco M, 2002, J BIOL CHEM, V277, P12396, DOI 10.1074/jbc.M108734200; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hur O, 2002, BIOCHEMISTRY-US, V41, P9991, DOI 10.1021/bi025568u; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Jhee KH, 2001, BIOCHEMISTRY-US, V40, P10873, DOI 10.1021/bi011087j; JOHNSTON M, 1979, BIOCHEMISTRY-US, V18, P1729, DOI 10.1021/bi00576a015; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Laber B, 1999, EUR J BIOCHEM, V263, P212, DOI 10.1046/j.1432-1327.1999.00487.x; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; MADSEN BC, 1981, ANAL CHEM, V53, P1924, DOI 10.1021/ac00235a046; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOCKEL B, 1992, J BACTERIOL, V174, P8065; Omi R, 2003, J BIOL CHEM, V278, P46035, DOI 10.1074/jbc.M308065200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; TONEY MD, 1993, BIOCHEMISTRY-US, V32, P1471, DOI 10.1021/bi00057a010	27	10	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2774	2784		10.1074/jbc.M110.186205	http://dx.doi.org/10.1074/jbc.M110.186205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084312	hybrid, Green Published			2022-12-27	WOS:000286464300043
J	Schmidt, DR; Schmidt, S; Holmstrom, SR; Makishima, M; Yu, RT; Cummins, CL; Mangelsdorf, DJ; Kliewer, SA				Schmidt, Daniel R.; Schmidt, Samuel; Holmstrom, Sam R.; Makishima, Makoto; Yu, Ruth T.; Cummins, Carolyn L.; Mangelsdorf, David J.; Kliewer, Steven A.			AKR1B7 Is Induced by the Farnesoid X Receptor and Metabolizes Bile Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VAS-DEFERENS; FEEDBACK-REGULATION; NUCLEAR RECEPTOR; URSODEOXYCHOLIC ACID; LIVER; MICE; FXR; CARCINOGENESIS; IDENTIFICATION; EXPRESSION	Although bile acids are crucial for the absorption of lipophilic nutrients in the intestine, they are cytotoxic at high concentrations and can cause liver damage and promote colorectal carcinogenesis. The farnesoid X receptor (FXR), which is activated by bile acids and abundantly expressed in enterohepatic tissues, plays a crucial role in maintaining bile acids at safe concentrations. Here, we show that FXR induces expression of Akr1b7 (aldo-keto reductase 1b7) in murine small intestine, colon, and liver by binding directly to a response element in the Akr1b7 promoter. We further show that AKR1B7 metabolizes 3-keto bile acids to 3 beta-hydroxy bile acids that are less toxic to cultured cells than their 3 alpha-hydroxy precursors. These findings reveal a feed-forward, protective pathway operative in murine enterohepatic tissues wherein FXR induces AKR1B7 to detoxify bile acids.	[Schmidt, Daniel R.; Schmidt, Samuel; Holmstrom, Sam R.; Makishima, Makoto; Cummins, Carolyn L.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Schmidt, Daniel R.; Cummins, Carolyn L.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yu, Ruth T.] Salk Inst Biol Sci, Gene Express Lab, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Salk Institute	Mangelsdorf, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu; steven.kliewer@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796; Yu, Ruth/0000-0002-9527-9627; Cummins, Carolyn/0000-0001-7603-6577	Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-588]; National Institutes of Health [CA114109, GM007062]; Nuclear Receptor Signaling Atlas (NURSA); NATIONAL CANCER INSTITUTE [R01CA114109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Receptor Signaling Atlas (NURSA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (to D.J.M.), the Robert A. Welch Foundation (I-1275 to D.J. M. and I-588 to S.A.K.), the National Institutes of Health (CA114109 to S.A.K.), Nuclear Receptor Signaling Atlas (NURSA), and National Institutes of Health Pharmacological Sciences Training Grant GM007062.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cheng JB, 2003, FALK SYMP, V129, P1; EARNEST DL, 1994, CANCER RES, V54, P5071; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Hofmann AF, 2009, CLIN GASTROENTEROL H, V7, P1151, DOI 10.1016/j.cgh.2009.07.026; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lefrancois-Martinez AM, 1999, J BIOL CHEM, V274, P32875, DOI 10.1074/jbc.274.46.32875; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Liu MJ, 2009, MOL PHARMACOL, V76, P604, DOI 10.1124/mol.109.057455; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Narisawa T, 1999, J EXP CLIN CANC RES, V18, P259; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; RODA A, 1983, J BIOL CHEM, V258, P6362; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schmidt DR, 2008, NUTR REV, V66, pS88, DOI 10.1111/j.1753-4887.2008.00092.x; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Val P, 2002, ENDOCRINOLOGY, V143, P3435, DOI 10.1210/en.2002-220293; Vergnes L, 2003, J LIPID RES, V44, P503, DOI 10.1194/jlr.M200399-JLR200; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078	33	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2425	2432		10.1074/jbc.M110.181230	http://dx.doi.org/10.1074/jbc.M110.181230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081494	Green Published, hybrid			2022-12-27	WOS:000286464300006
J	Collinson, EJ; Wimmer-Kleikamp, S; Gerega, SK; Yang, YH; Parish, CR; Dawes, IW; Stocker, R				Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Gerega, Sebastien K.; Yang, Yee Hwa; Parish, Christopher R.; Dawes, Ian W.; Stocker, Roland			The Yeast Homolog of Heme Oxygenase-1 Affords Cellular Antioxidant Protection via the Transcriptional Regulation of Known Antioxidant Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROBE LEVEL DATA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SULFOXIDE REDUCTASE; HYDROGEN-PEROXIDE; IRON DEPRIVATION; CELLS; EXPRESSION; BILIRUBIN	Heme oxygenase-1 (HO-1) degrades heme and protects cells from oxidative challenge. This antioxidant activity is thought to result from the HO-1 enzymatic activity, manifested by a decrease in the concentration of the pro-oxidant substrate heme, and an increase in the antioxidant product bilirubin. Using a global transcriptional approach, and yeast as a model, we show that HO-1 affords cellular protection via up-regulation of transcripts encoding enzymes involved in cellular antioxidant defense, rather than via its oxygenase activity. Like mammalian cells, yeast responds to oxidative stress by expressing its HO-1 homolog and, compared with the wild type, heme oxygenase-null mutant cells have increased sensitivity toward oxidants that is rescued by overexpression of human HO-1 or its yeast homolog. Increased oxidant sensitivity of heme oxygenase-null mutant cells is explained by a decrease in the expression of the genes encoding gamma-glutamylcysteine synthetase, glutathione peroxidase, catalase, and methionine sulfoxide reductase, because overexpression of any of these genes affords partial, and overexpression of all four genes provides complete, protection to the null mutant. Genes encoding antioxidant enzymes represent only a small portion of the 480 differentially expressed transcripts in heme oxygenase-null mutants. Transcriptional regulation may be explained by the nuclear localization of heme oxygenase observed in oxidant-challenged cells. Our results challenge the notion that HO-1 functions simply as a catabolic and antioxidant enzyme. They indicate much broader functions for HO-1, the unraveling of which may help explain the multiple biological responses reported in animals as a result of altered HO-1 expression.	[Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Stocker, Roland] Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia; [Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Stocker, Roland] Univ Sydney, Sydney Med Sch, Bosch Inst, Sydney, NSW 2006, Australia; [Yang, Yee Hwa] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Sydney; Australian National University; John Curtin School of Medical Research; University of New South Wales Sydney	Stocker, R (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia.	roland.stocker@sydney.edu.au	Yang, Jean YH/D-2920-2015; Stocker, Roland/AAV-4489-2021	Yang, Jean YH/0000-0002-5271-2603; Parish, Christopher/0000-0001-7740-0430	Australian Research Council [DP0988470]; University of Sydney Medical Foundation; National Health & Medical Research Council of Australia (NHMRC) [455395]; Sydney Medical School; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney Medical Foundation(University of Sydney); National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; University of Sydney(University of Sydney)	This work was supported by the Australian Research Council DP0988470, University of Sydney Medical Foundation, and the National Health & Medical Research Council of Australia (NHMRC) Program Grant 455395.; Supported by a NHMRC CJ Martin Fellowship and an Early Career Grant of the Sydney Medical School.; Supported by a NHMRC Senior Principal Research Fellowship and a University of Sydney Professorial Fellowship. To whom correspondence should be addressed: Centre for Vascular Research, School of Medical Sciences (Pathology) and Bosch Institute, Sydney Medical School, University of Sydney, Sydney, NSW 2006. Tel.: 61-2-9036-3207; Fax: 61-2-90363038; E-mail:roland.stocker@sydney.edu.au.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; CHANG SW, 1988, J APPL PHYSIOL, V65, P358, DOI 10.1152/jappl.1988.65.1.358; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim DY, 2006, JPN J APPL PHYS 2, V45, pL74, DOI 10.1143/JJAP.45.L74; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kwast KE, 1998, J EXP BIOL, V201, P1177; LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lushchak V, 2005, ARCH BIOCHEM BIOPHYS, V441, P35, DOI 10.1016/j.abb.2005.06.010; MAINES MD, 1986, J BIOL CHEM, V261, P411; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200	46	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2205	2214		10.1074/jbc.M110.187062	http://dx.doi.org/10.1074/jbc.M110.187062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081499	Green Published, hybrid			2022-12-27	WOS:000286191500061
J	Jin, ZN; Deval, J; Johnson, KA; Swinney, DC				Jin, Zhinan; Deval, Jerome; Johnson, Kenneth A.; Swinney, David C.			Characterization of the Elongation Complex of Dengue Virus RNA Polymerase ASSEMBLY, KINETICS OF NUCLEOTIDE INCORPORATION, AND FIDELITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; DNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRAL-RNA; IN-VITRO; MECHANISM; REPLICATION; NS5B; DISCRIMINATION; TEMPERATURE	Dengue virus (DENV) infects 50-100 million people worldwide per year, causing severe public health problems. DENV RNA-dependent RNA polymerase, an attractive target for drug development, catalyzes de novo replication of the viral genome in three phases: initiation, transition, and elongation. The aim of this work was to characterize the mechanism of nucleotide addition catalyzed by the polymerase domain of DENV serotype 2 during elongation using transient kinetic methods. We measured the kinetics of formation of the elongation complex containing the polymerase and a double-stranded RNA by pre-incubation experiments. The elongation complex assembly is slow, following a one-step binding mechanism with an association rate of 0.0016 +/- 0.0001 mu M(-1)s(-1) and a dissociation rate of 0.00020 +/- 0.00005 s(-1) at 37 degrees C. The elongation complex assembly is 6 times slower at 30 degrees C and requires Mg2+ during preincubation. The assembled elongation complex incorporates a correct nucleotide, GTP, to the primer with a K-d of 275 +/- 52 mu M and k(pol) of 18 +/- 1 s(-1). The fidelity of the polymerase is 1/34,000, 1/59,000, 1/135,000 for misincorporation of UTP, ATP, and CTP opposite CMP in the template, respectively. The fidelity of DENV polymerase is comparable with HIV reverse transcriptase and the poliovirus polymerase. This work reports the first description of presteady-state kinetics and fidelity for an RNA-dependent RNA polymerase from the Flaviviridae family.	[Jin, Zhinan; Deval, Jerome; Swinney, David C.] Roche Palo Alto LLC, Virol DTA, Palo Alto, CA 94034 USA; [Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	Roche Holding; University of Texas System; University of Texas Austin	Swinney, DC (corresponding author), iRND3, Inst Rare & Neglected Dis Drug Discovery, 1514 Ridge Rd, Belmont, CA 94002 USA.	david.swinney@iRND3.org	jin, zhinan/D-4217-2013		Roche Postdoc fellowship	Roche Postdoc fellowship	Supported by a Roche Postdoc fellowship.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Beaulieu PL, 2009, EXPERT OPIN THER PAT, V19, P145, DOI 10.1517/13543770802672598; Benzaghou I, 2004, J BIOL CHEM, V279, P49755, DOI 10.1074/jbc.M409657200; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	49	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2067	2077		10.1074/jbc.M110.162685	http://dx.doi.org/10.1074/jbc.M110.162685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078673	hybrid, Green Published			2022-12-27	WOS:000286191500049
J	Murai, T; Maruyama, Y; Mio, K; Nishiyama, H; Suga, M; Sato, C				Murai, Toshiyuki; Maruyama, Yuusuke; Mio, Kazuhiro; Nishiyama, Hidetoshi; Suga, Mitsuo; Sato, Chikara			Low Cholesterol Triggers Membrane Microdomain-dependent CD44 Shedding and Suppresses Tumor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIPID RAFTS; MATRIX-METALLOPROTEINASE; ADAM10; RECEPTOR; CLEAVAGE; BETA; GLYCOPROTEIN; ACTIVATION; DEPLETION	CD44 is a cell surface adhesion molecule for hyaluronan and is implicated in tumor invasion and metastasis. Proteolytic cleavage of CD44 plays a critical role in the migration of tumor cells and is regulated by factors present in the tumor microenvironment, such as hyaluronan oligosaccharides and epidermal growth factor. However, molecular mechanisms underlying the proteolytic cleavage on membranes remain poorly understood. In this study, we demonstrated that cholesterol depletion with methyl-beta-cyclodextrin, which disintegrates membrane lipid rafts, enhances CD44 shedding mediated by a disintegrin and metalloproteinase 10 (ADAM10) and that cholesterol depletion disorders CD44 localization to the lipid raft. We also evaluated the effect of long term cholesterol reduction using a statin agent and demonstrated that statin enhances CD44 shedding and suppresses tumor cell migration on a hyaluronan-coated substrate. Our results indicate that membrane lipid organization regulates CD44 shedding and propose a possible molecular mechanism by which cholesterol reduction might be effective for preventing and treating the progression of malignant tumors.	[Murai, Toshiyuki] Osaka Univ, Grad Sch Med, Div Prevent & Environm Med, Dept Immunol & Microbiol, Suita, Osaka 5650871, Japan; [Maruyama, Yuusuke; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Nishiyama, Hidetoshi; Suga, Mitsuo] JEOL Ltd, Adv Technol Div, Tokyo 1968558, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Jeol Ltd; JEOL Japan	Murai, T (corresponding author), Osaka Univ, Grad Sch Med, Div Prevent & Environm Med, Dept Immunol & Microbiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	murai@orgctl.med.osaka-u.ac.jp	Sato, Chikara/M-7183-2016; Mio, Kazuhiro/L-7488-2018	Sato, Chikara/0000-0001-5543-4496; Mio, Kazuhiro/0000-0002-1655-8231	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alfandari D, 2009, SEMIN CELL DEV BIOL, V20, P153, DOI 10.1016/j.semcdb.2008.09.006; Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BOURGUIGNON LYW, 1991, J BIOL CHEM, V266, P11761; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Gliemroth J, 2003, NEUROSURG REV, V26, P117, DOI 10.1007/s10143-003-0258-9; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lokeshwar VB, 1997, CANCER RES, V57, P773; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mio K, 2000, J BIOL CHEM, V275, P32413, DOI 10.1074/jbc.M005428200; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Nishiyama H, 2010, J STRUCT BIOL, V169, P438, DOI 10.1016/j.jsb.2010.01.005; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; TARONE G, 1984, J CELL BIOL, V99, P512, DOI 10.1083/jcb.99.2.512; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Wu HL, 2009, ACTA CRYSTALLOGR E, V65, pO1014, DOI 10.1107/S1600536809012781; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	51	120	125	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1999	2007		10.1074/jbc.M110.184010	http://dx.doi.org/10.1074/jbc.M110.184010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21087933	Green Published, hybrid			2022-12-27	WOS:000286191500041
J	Wang, W; Zhu, JQ; Springer, TA; Luo, BH				Wang, Wei; Zhu, Jieqing; Springer, Timothy A.; Luo, Bing-Hao			Tests of Integrin Transmembrane Domain Homo-oligomerization during Integrin Ligand Binding and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAINS; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; CELL-MEMBRANES; ALPHA-SUBUNIT; OUTSIDE-IN; ACTIVATION; ALPHA-IIB-BETA-3; ALPHA(IIB)BETA(3)	Integrin transmembrane (TM) and/or cytoplasmic domains play a critical role in integrin bidirectional signaling. Although it has been shown that TM and/or cytoplasmic alpha and beta domains associate in the resting state and separation of these domains is required for both inside-out and outside-in signaling, the role of TM homomeric association remains elusive. Formation of TM homo-oligomers was observed in micelles and bacterial membranes previously, and it has been proposed that homomeric association is important for integrin activation and clustering. This study addresses whether integrin TM domains form homo-oligomers in mammalian cell membranes using cysteine scanning mutagenesis. Our results show that TM homomeric interaction does not occur before or after soluble ligand binding or during inside-out activation. In addition, even though the cysteine mutants and the heterodimeric disulfide-bounded mutant could form clusters after adhering to immobilized ligand, the integrin TM domains do not form homo-oligomers, suggesting that integrin TM homomeric association is not critical for integrin clustering or outside-in signaling. Therefore, integrin TM homo-oligomerization is not required for integrin activation, ligand binding, or signaling.	[Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Zhu, Jieqing; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Zhu, Jieqing; Springer, Timothy A.] Childrens Hosp, Boston, MA 02115 USA	Louisiana State University System; Louisiana State University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital	Luo, BH (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	luo@lsu.edu			American Heart Association [10GRNT3960011]; Louisiana Board of Regents [LEQSF(2009-12)-RD-A07]	American Heart Association(American Heart Association); Louisiana Board of Regents	This work was supported by American Heart Association Grant 10GRNT3960011 and Louisiana Board of Regents Grant LEQSF(2009-12)-RD-A07.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; DU XP, 1993, J BIOL CHEM, V268, P23087; Gottschalk KE, 2004, STRUCTURE, V12, P1109, DOI 10.1016/j.str.2004.02.039; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Hantgan RR, 2004, BBA-PROTEINS PROTEOM, V1700, P19, DOI 10.1016/j.bbapap.2004.03.011; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Imai Y, 2008, BLOOD, V112, P5007, DOI 10.1182/blood-2008-03-144543; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li R, 2004, BIOCHEM SOC T, V32, P412, DOI 10.1042/BST0320412; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Lin X, 2006, PROTEINS, V63, P16, DOI 10.1002/prot.20882; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; SACHEZMADRID F, 1999, EMBO J, V18, P501; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang W, 2010, J CELL BIOCHEM, V109, P447, DOI 10.1002/jcb.22427; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Whitlock BB, 2000, J CELL BIOL, V151, P1305, DOI 10.1083/jcb.151.6.1305; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	58	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1860	1867		10.1074/jbc.M110.193797	http://dx.doi.org/10.1074/jbc.M110.193797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081497	Green Published, hybrid			2022-12-27	WOS:000286191500026
J	Brouwers, O; Niessen, PM; Ferreira, I; Miyata, T; Scheffer, PG; Teerlink, T; Schrauwen, P; Brownlee, M; Stehouwer, CD; Schalkwijk, CG				Brouwers, Olaf; Niessen, Petra M.; Ferreira, Isabel; Miyata, Toshio; Scheffer, Peter G.; Teerlink, Tom; Schrauwen, Patrick; Brownlee, Michael; Stehouwer, Coen D.; Schalkwijk, Casper G.			Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLASMA-PROTEIN; LIPID-PEROXIDATION; MITOCHONDRIAL PROTEINS; CELLS; INHIBITION; KIDNEY; DAMAGE; N-EPSILON-(CARBOXYMETHYL)LYSINE; N-EPSILON-(CARBOXYETHYL)LYSINE; AMINOGUANIDINE	The reactive advanced glycation end product (AGE) precursor methylglyoxal (MGO) and MGO-derived AGEs are associated with diabetic vascular complications and also with an increase in oxidative stress. Glyoxalase-I (GLO-I) transgenic rats were used to explore whether overexpression of this MGO detoxifying enzyme reduces levels of AGEs and oxidative stress in a rat model of diabetes. Rats were made diabetic with streptozotocin, and after 12 weeks, plasma and multiple tissues were isolated for analysis of AGEs, carbonyl stress, and oxidative stress. GLO-I activity was significantly elevated in multiple tissues of all transgenic rats compared with wild-type (WT) littermates. Streptozotocin treatment resulted in a 5-fold increase in blood glucose concentrations irrespective of GLO-I overexpression. Levels of MGO, glyoxal, 3-deoxyglucosone, AGEs, and oxidative stress markers nitrotyrosine, malondialdehyde, and F2-isoprostane were elevated in the diabetic WT rats. In diabetic GLO-I rats, glyoxal and MGO composite scores were significantly decreased by 81%, and plasma AGEs and oxidative stress markers scores were significantly decreased by similar to 50%. Hyperglycemia induced a decrease in protein levels of the mitochondrial oxidative phosphorylation complex in the gastrocnemius muscle, which was accompanied by an increase in the lipid peroxidation product 4-hydroxy-2-nonenal, and this was counteracted by GLO-I overexpression. This study shows for the first time in an in vivo model of diabetes that GLO-I overexpression reduces hyperglycemia-induced levels of carbonyl stress, AGEs, and oxidative stress. The reduction of oxidative stress by GLO-I overexpression directly demonstrates the link between glycation and oxidative stress.	[Brouwers, Olaf; Niessen, Petra M.; Ferreira, Isabel; Stehouwer, Coen D.; Schalkwijk, Casper G.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gen Internal Med,Lab Metab & Vasc Med, NL-6202 AZ Maastricht, Netherlands; [Miyata, Toshio] Tohoku Univ, Ctr Translat & Adv Res, Sendai, Miyagi 9808575, Japan; [Scheffer, Peter G.; Teerlink, Tom] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1007 MB Amsterdam, Netherlands; [Schrauwen, Patrick] Maastricht Univ, Med Ctr, Dept Human Biol, NL-6200 MD Maastricht, Netherlands; [Brownlee, Michael] Albert Einstein Coll Med, Int Ctr Diabet Complicat Res, Bronx, NY 10461 USA	Maastricht University; Tohoku University; Vrije Universiteit Amsterdam; Maastricht University; Yeshiva University; Albert Einstein College of Medicine	Schalkwijk, CG (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Div Gen Internal Med,Lab Metab & Vasc Med, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.	C.Schalkwijk@maastrichtuniversity.nl	Ferreira, Isabel/B-6033-2008; Miyata, Toshio/A-4872-2010; Stehouwer, Coen/AAB-3435-2021	Ferreira, Isabel/0000-0003-1434-0607; schrauwen, patrick/0000-0002-0973-847X; Stehouwer, Coen/0000-0001-8752-3223; Schalkwijk, Casper G/0000-0003-0190-2690	Dutch Diabetes Foundation [2005.11.013]; Netherlands Heart Foundation [2006T050]	Dutch Diabetes Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported in part by Dutch Diabetes Foundation Grant 2005.11.013.; Supported by Netherlands Heart Foundation Post-doctoral Research Grant 2006T050.	Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Biswas S, 1997, BIOCHEM J, V323, P343, DOI 10.1042/bj3230343; Brouwers O, 2010, DIABETOLOGIA, V53, P989, DOI 10.1007/s00125-010-1677-0; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2006, CURR OPIN LIPIDOL, V17, P510, DOI 10.1097/01.mol.0000245256.17764.fb; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; de Kerkhof JV, 2004, NEPHROL DIAL TRANSPL, V19, P910, DOI 10.1093/ndt/gfh004; Drel VR, 2006, FREE RADICAL BIO MED, V40, P1454, DOI 10.1016/j.freeradbiomed.2005.12.034; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Ihm SH, 1999, METABOLISM, V48, P1141, DOI 10.1016/S0026-0495(99)90128-2; Inagi R, 2002, KIDNEY INT, V62, P679, DOI 10.1046/j.1523-1755.2002.00488.x; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kedziora-Kornatowska K, 1998, BIOCHEM MOL BIOL INT, V46, P577; Marti R, 1997, CLIN CHEM, V43, P1010; MCLELLAN AC, 1993, ANAL BIOCHEM, V211, P37, DOI 10.1006/abio.1993.1229; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Miyata T, 2001, KIDNEY INT, V60, P2351, DOI 10.1046/j.1523-1755.2001.00051.x; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Reddy VP, 2006, DRUG DISCOV TODAY, V11, P646, DOI 10.1016/j.drudis.2006.05.016; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Roest M, 2008, J CLIN LIPIDOL, V2, P298, DOI 10.1016/j.jacl.2008.06.004; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Sakamoto H, 2000, BLOOD, V95, P3214, DOI 10.1182/blood.V95.10.3214; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Scheijen JLJM, 2009, J CHROMATOGR B, V877, P610, DOI 10.1016/j.jchromb.2009.01.022; Schindhelm RK, 2007, DIABETES CARE, V30, P1789, DOI 10.2337/dc06-2585; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Teerlink T, 2004, CLIN CHEM, V50, P1222, DOI 10.1373/clinchem.2004.031286; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; YAYLAYAN VA, 1994, CRIT REV FOOD SCI, V34, P321, DOI 10.1080/10408399409527667	36	171	176	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1374	1380		10.1074/jbc.M110.144097	http://dx.doi.org/10.1074/jbc.M110.144097			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056979	Green Published, hybrid			2022-12-27	WOS:000286005000049
J	Gumiero, A; Metcalfe, CL; Pearson, AR; Raven, EL; Moody, PCE				Gumiero, Andrea; Metcalfe, Clive L.; Pearson, Arwen R.; Raven, Emma Lloyd; Moody, Peter C. E.			Nature of the Ferryl Heme in Compounds I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; X-RAY-ABSORPTION; HORSERADISH-PEROXIDASE; ASCORBATE PEROXIDASE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; AUTOCATALYTIC FORMATION; SUBSTRATE-BINDING; MYOGLOBIN; SPECTROSCOPY	Heme enzymes are ubiquitous in biology and catalyze a vast array of biological redox processes. The formation of high valent ferryl intermediates of the heme iron (known as Compounds I and Compound II) is implicated for a number of catalytic heme enzymes, but these species are formed only transiently and thus have proved somewhat elusive. In consequence, there has been conflicting evidence as to the nature of these ferryl intermediates in a number of different heme enzymes, in particular the precise nature of the bond between the heme iron and the bound oxygen atom. In this work, we present high resolution crystal structures of both Compound I and Compound II intermediates in two different heme peroxidase enzymes, cytochrome c peroxidase and ascorbate peroxidase, allowing direct and accurate comparison of the bonding interactions in the different intermediates. A consistent picture emerges across all structures, showing lengthening of the ferryl oxygen bond (and presumed protonation) on reduction of Compound I to Compound II. These data clarify long standing inconsistencies on the nature of the ferryl heme species in these intermediates.	[Gumiero, Andrea; Metcalfe, Clive L.; Raven, Emma Lloyd] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Pearson, Arwen R.] Univ Leeds, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Moody, Peter C. E.] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leeds; University of Leicester; University of Leicester	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Henry Wellcome Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; peter.moody@le.ac.uk	Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238; Pearson, Arwen/0000-0001-8499-7490; Metcalfe, Clive/0000-0002-7856-8574; Raven, Emma/0000-0002-1643-8694	Leverhulme Trust; ESRF [MX1088, MX310]; Biotechnology and Biological Sciences Research Council [BB/H001905/1, BB/C001184/1] Funding Source: researchfish; BBSRC [BB/H001905/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); ESRF; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Leverhulme Trust (to E. L. R./P. C. E. M.) and ESRF Grants MX1088 and Diamond MX310.	Badyal SK, 2008, BIOCHEMISTRY-US, V47, P4403, DOI 10.1021/bi702337n; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bonagura CA, 2003, BIOCHEMISTRY-US, V42, P5600, DOI 10.1021/bi034058c; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; CHANCE B, 1984, ARCH BIOCHEM BIOPHYS, V235, P596, DOI 10.1016/0003-9861(84)90234-0; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1259, DOI 10.1021/bi00354a010; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; Davydov R, 2008, BIOCHEMISTRY-US, V47, P5147, DOI 10.1021/bi702514d; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Dunford H. B., 2010, PEROXIDASES CATALASE; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; GOODIN DB, 1991, BIOCHEMISTRY-US, V30, P4953, DOI 10.1021/bi00234a017; Green MT, 2009, CURR OPIN CHEM BIOL, V13, P84, DOI 10.1016/j.cbpa.2009.02.028; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Hersleth H. P., 2010, BIOCH BIOPH IN PRESS; Hersleth HP, 2002, J BIOL INORG CHEM, V7, P299, DOI 10.1007/s007750100296; Ho R.Y.N., 1995, ACTIVE OXYGEN BIOCH, P1, DOI [10.1007/978-94-011-0609-2_1, DOI 10.1007/978-94-011-0609-2_1]; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Metcalfe CL, 2004, J AM CHEM SOC, V126, P16242, DOI 10.1021/ja048242c; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Montellano P. R. O. d., 2005, CYTOCHROME P450 STRU; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newcomb M, 2008, P NATL ACAD SCI USA, V105, P8179, DOI 10.1073/pnas.0708299105; Paithankar KS, 2010, ACTA CRYSTALLOGR D, V66, P381, DOI 10.1107/S0907444910006724; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; PENNERHAHN JE, 1983, J BIOL CHEM, V258, P2761; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P13269, DOI 10.1021/bi7015316; Pond AE, 1998, INORG CHIM ACTA, V276, P250; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Stone KL, 2005, P NATL ACAD SCI USA, V102, P16563, DOI 10.1073/pnas.0507069102; Unno M, 2007, J AM CHEM SOC, V129, P13394, DOI 10.1021/ja076108x; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	48	83	85	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1260	1268		10.1074/jbc.M110.183483	http://dx.doi.org/10.1074/jbc.M110.183483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062738	Green Published, hybrid			2022-12-27	WOS:000286005000037
J	Karantzali, E; Lekakis, V; Ioannou, M; Hadjimichael, C; Papamatheakis, J; Kretsovali, A				Karantzali, Efthimia; Lekakis, Vassilios; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph; Kretsovali, Androniki			Sall1 Regulates Embryonic Stem Cell Differentiation in Association with Nanog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; KIDNEY DEVELOPMENT; GENE-EXPRESSION; CAUSATIVE GENE; MURINE HOMOLOG; TRANSCRIPTIONAL NETWORK; DEACETYLASE COMPLEX; PLURIPOTENCY; REPRESSION; HETEROCHROMATIN	Sall1 is a multi-zinc finger transcription factor that regulates kidney organogenesis. It is considered to be a transcriptional repressor, preferentially localized on heterochromatin. Mutations or deletions of the human SALL1 gene are associated with the Townes-Brocks syndrome. Despite its high expression, no function was yet assigned for Sall1 in embryonic stem (ES) cells. In the present study, we show that Sall1 is expressed in a differentiation-dependent manner and physically interacts with Nanog and Sox2, two components of the core pluripotency network. Genome-wide mapping of Sall1-binding loci has identified 591 genes, 80% of which are also targeted by Nanog. A large proportion of these genes are related to self-renewal and differentiation. Sall1 positively regulates and synergizes with Nanog for gene transcriptional regulation. In addition, our data show that Sall1 suppresses the ectodermal and mesodermal differentiation. Specifically, the induction of the gastrulation markers T brachyury, Goosecoid, and Dkk1 and the neuroectodermal markers Otx2 and Hand1 was inhibited by Sall1 overexpression during embryoid body differentiation. These data demonstrate a novel role for Sall1 as a member of the transcriptional network that regulates stem cell pluripotency.	[Karantzali, Efthimia; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph; Kretsovali, Androniki] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Karantzali, Efthimia; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph] Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; [Lekakis, Vassilios] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University System of Maryland; University of Maryland College Park	Kretsovali, A (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece.	kretsova@imbb.forth.gr		Ioannou, Marilia/0000-0001-7384-902X	European Union [LSHG-CT 2003-503494]; IMBB	European Union(European Commission); IMBB	This work was supported by the European Union FP6 I. P. FunGenES Grant LSHG-CT 2003-503494 and IMBB intramural funding (to A. K.).	Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; de Celis JF, 1999, DEVELOPMENT, V126, P2653; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kohlhase J, 2003, J MED GENET, V40; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Netzer C, 2006, BBA-MOL BASIS DIS, V1762, P386, DOI 10.1016/j.bbadis.2005.12.005; Ng JH, 2008, MUTAT RES-FUND MOL M, V647, P52, DOI 10.1016/j.mrfmmm.2008.08.009; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Nishinakamura R, 2006, J PHYSIOL SCI, V56, P131, DOI 10.2170/physiolsci.M95; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Ott T, 2001, MECH DEVELOP, V101, P203, DOI 10.1016/S0925-4773(00)00552-9; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamamoto C, 2010, HYPERTENS RES, V33, P143, DOI 10.1038/hr.2009.195; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	53	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1037	1045		10.1074/jbc.M110.170050	http://dx.doi.org/10.1074/jbc.M110.170050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062744	hybrid, Green Published			2022-12-27	WOS:000286005000014
J	Li, Y; Liu, XQ; Wu, YY; Xu, Z; Li, HQ; Griffith, LC; Zhou, Y				Li, Yong; Liu, Xinqiu; Wu, Yuying; Xu, Zhe; Li, Hongqin; Griffith, Leslie C.; Zhou, Yi			Intracellular Regions of the Eag Potassium Channel Play a Critical Role in Generation of Voltage-dependent Currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; LONG QT SYNDROME; K+ CHANNELS; CRYSTAL-STRUCTURE; ION CHANNELS; DROSOPHILA; TEMPERATURE; ACTIVATION; EXPRESSION; FAMILY	Folding, assembly, and trafficking of ion channels are tightly controlled processes and are important for biological functions relevant to health and disease. Here, we report that functional expression of the Eag channel is temperature-sensitive by a mechanism that is independent of trafficking or surface targeting of the channel protein. Eag channels in cells grown at 37 degrees C exhibit voltage-evoked gating charge movements but fail to conduct K+ ions. By mutagenesis and chimeric channel studies, we show that the N- and C-terminal regions are involved in controlling a step after movement of the voltage sensor, as well as in regulating biophysical properties of the Eag channel. Synthesis and assembly of Eag at high temperature disrupt the ability of these domains to carry out their function. These results suggest an important role of the intracellular regions in the generation of Eag currents.	[Li, Yong; Liu, Xinqiu; Wu, Yuying; Xu, Zhe; Li, Hongqin; Zhou, Yi] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Li, Yong; Liu, Xinqiu] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Griffith, Leslie C.] Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	State University System of Florida; Florida State University; Shanghai Jiao Tong University; Brandeis University; Brandeis University	Li, Y (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	liyong68@shsmu.edu.cn; yzhou@fsu.edu	Li, Yong/ABB-5588-2021	Griffith, Leslie/0000-0003-3164-9876	National Institutes of Health [NS50355, GM54408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grant (to Irwin B. Levitan) and Grants NS50355 (to Y.Z.) and GM54408 (to L.C.G.).	BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brown CR, 1997, J BIOENERG BIOMEMBR, V29, P491, DOI 10.1023/A:1022491124939; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Ju M, 2006, BIOCHEM BIOPH RES CO, V342, P1088, DOI 10.1016/j.bbrc.2006.02.062; Lansdell SJ, 1997, J NEUROCHEM, V68, P1812; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Liu XQ, 2010, CHANNELS, V4, P311, DOI 10.4161/chan.4.4.12329; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Perrin MJ, 2008, PROG BIOPHYS MOL BIO, V98, P137, DOI 10.1016/j.pbiomolbio.2008.10.006; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Schmeisser H, 2006, J INTERF CYTOK RES, V26, P866, DOI 10.1089/jir.2006.26.866; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Suda N, 1997, J GEN PHYSIOL, V109, P619, DOI 10.1085/jgp.109.5.619; Sun XX, 2009, MOL CELL NEUROSCI, V40, P338, DOI 10.1016/j.mcn.2008.11.005; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Szabo I, 2000, BIOCHEM BIOPH RES CO, V274, P130, DOI 10.1006/bbrc.2000.3095; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wilson GF, 1998, J BIOL CHEM, V273, P6389, DOI 10.1074/jbc.273.11.6389; Wray D, 2004, EUR BIOPHYS J BIOPHY, V33, P194, DOI 10.1007/s00249-003-0363-2; Wray D, 2009, EUR BIOPHYS J BIOPHY, V38, P271, DOI 10.1007/s00249-008-0357-1; Yang K, 2005, FEBS LETT, V579, P4113, DOI 10.1016/j.febslet.2005.06.039; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zhang JS, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-24; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1389	1399		10.1074/jbc.M110.184077	http://dx.doi.org/10.1074/jbc.M110.184077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059657	Green Published, hybrid			2022-12-27	WOS:000286005000051
J	Mitra, PS; Basu, NK; Basu, M; Chakraborty, S; Saha, T; Owens, IS				Mitra, Partha S.; Basu, Nikhil K.; Basu, Mousumi; Chakraborty, Sunit; Saha, Tapas; Owens, Ida S.			Regulated Phosphorylation of a Major UDP-glucuronosyltransferase Isozyme by Tyrosine Kinases Dictates Endogenous Substrate Selection for Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER PATIENTS; COMET ASSAY; DNA-DAMAGE; CELLS; SRC; ESTRADIOL; EXPRESSION; METABOLITES; ESTROGENS; ESTRONE	Whereas UDP-glucuronosyltransferase-2B7 is widely distributed in different tissues, it preferentially detoxifies genotoxic 4-OH-estradiol and 4-OH-estrone (4-OHE1) with barely detectable 17 beta-estradiol (E-2) conversion following expression in COS-1 cells. Consistent with the UDP-glucuronosyltransferase requirement for regulated phosphorylation, we discovered that 2B7 requires Src-dependent tyrosine phosphorylation. Y236F-2B7 and Y438F-2B7 mutants were null and 90% inactive, respectively, when expressed in COS-1. We demonstrated that 2B7 incorporated immunoprecipitable [P-33] orthophosphate and that 2B7His, previously expressed in SYF-(Src, Yes, Fyn)(-/-) cells, was Src-supported or phosphorylated under in vitro conditions. Unexpectedly, 2B7 expressed in SYF-/- and SYF+/- cells metabolized 4-OHE1 at 10- and 3-fold higher rates, respectively, than that expressed in COS-1, and similar analysis showed that E-2 metabolism was 16- and 9-fold higher than in COS-1. Because anti-Tyr(P)-438-2B7 detected Tyr(P)-438-2B7 in each cell line, results indicated that unidentified tyrosine kinase(s) (TKs) phosphorylated 2B7 in SYF-/-. 2B7-transfected COS-1 treated with increasing concentrations of the Src-specific inhibitor PP2 down-regulated 4-OHE1 glucuronidation reaching 60% maximum while simultaneously increasing E-2 metabolism linearly. This finding indicated that increasing PP2 inhibition of Src allows increasing E-2 metabolism caused by 2B7 phosphorylation by unidentified TK(s). Importantly, 2B7 expressed in SYF-/- is more competent at metabolizing E-2 in cellulo than 2B7 expressed in COS-1. To confirm Src-controlled 2B7 prevents toxicity, we showed that 2B7-transfected COS-1 efficiently protected against 4-OH-E-1-mediated depurination. Finally, our results indicate that Src-dependent phosphorylation of 2B7 allows metabolism of 4-OHE1, but not E-2, in COS-1, whereas non-Src-phosphorylated 2B7 metabolizes both chemicals. Importantly, we determined that 2B7 substrate selection is not fixed but varies depending upon the TK(s) that carry out its required phosphorylation.	[Mitra, Partha S.; Basu, Nikhil K.; Basu, Mousumi; Chakraborty, Sunit; Owens, Ida S.] NICHHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Saha, Tapas] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Basu, M (corresponding author), NICHHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bldg 10,Rm 9D-42, Bethesda, MD 20892 USA.	basun@mail.nih.gov; owens@mail.nih.gov			National Institutes of Health NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Basu NK, 2008, J BIOL CHEM, V283, P23048, DOI 10.1074/jbc.M800032200; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2004, J BIOL CHEM, V279, P1429, DOI 10.1074/jbc.M306439200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Buitrago C, 2000, J CELL BIOCHEM, V79, P274, DOI 10.1002/1097-4644(20001101)79:2<274::AID-JCB100>3.0.CO;2-R; Burger DM, 2008, CLIN PHARMACOL THER, V84, P698, DOI 10.1038/clpt.2008.106; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Dutton G., 1980, GLUCURONIDATION DRUG, P3; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Gestl SA, 2002, AM J PATHOL, V160, P1467, DOI 10.1016/S0002-9440(10)62572-2; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Kerman K, 2007, ANAL CHIM ACTA, V588, P26, DOI 10.1016/j.aca.2007.02.001; Kim H, 2005, ONCOGENE, V24, P5629, DOI 10.1038/sj.onc.1208718; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; MACKENZIE PI, 1984, ARCH BIOCHEM BIOPHYS, V231, P487, DOI 10.1016/0003-9861(84)90412-0; Mitra PS, 2009, BIOCHEM BIOPH RES CO, V382, P651, DOI 10.1016/j.bbrc.2009.03.054; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Newman DK, 2009, J THROMB HAEMOST, V7, P195, DOI 10.1111/j.1538-7836.2009.03369.x; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orlow I, 2008, J CLIN ONCOL, V26, P3560, DOI 10.1200/JCO.2007.13.2654; Paquette B, 2005, INT J CANCER, V113, P706, DOI 10.1002/ijc.20647; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, BIOCHEMISTRY-US, V31, P3409, DOI 10.1021/bi00128a015; RITTER JK, 1990, J BIOL CHEM, V265, P7900; Rivera GM, 2009, MOL CELL, V36, P525, DOI 10.1016/j.molcel.2009.10.025; Thibaudeau J, 2006, CANCER RES, V66, P125, DOI 10.1158/0008-5472.CAN-05-2857; Volak LP, 2010, XENOBIOTICA, V40, P306, DOI 10.3109/00498251003596817; Wells PG, 2004, DRUG METAB DISPOS, V32, P281, DOI 10.1124/dmd.32.3.281; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	36	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1639	1648		10.1074/jbc.M110.165126	http://dx.doi.org/10.1074/jbc.M110.165126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056984	Green Published, hybrid			2022-12-27	WOS:000286005000076
J	Stuart, SF; Leatherbarrow, RJ; Willison, KR				Stuart, Sarah F.; Leatherbarrow, Robin J.; Willison, Keith R.			A Two-step Mechanism for the Folding of Actin by the Yeast Cytosolic Chaperonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC CHAPERONIN; CCT; INTERACTS; PROTEIN; STATE	Actin requires the chaperonin containing TCP1 (CCT), a hexadecameric ATPase essential for cell viability in eukaryotes, to fold to its native state. Following binding of unfolded actin to CCT, the cavity of the chaperone closes and actin is folded and released in an ATP-dependent folding cycle. In yeast, CCT forms a ternary complex with the phosducin-like protein PLP2p to fold actin, and together they can return nascent or chemically denatured actin to its native state in a pure in vitro folding assay. The complexity of the CCT-actin system makes the study of the actin folding mechanism technically challenging. We have established a novel spectroscopic assay through selectively labeling the C terminus of yeast actin with acrylodan and observe significant changes in the acrylodan fluorescence emission spectrum as actin is chemically unfolded and then refolded by the chaperonin. The variation in the polarity of the environment surrounding the fluorescent probe during the unfolding/folding processes has allowed us to monitor actin as it folds on CCT. The rate of actin folding at a range of temperatures and ATP concentrations has been determined for both wild type CCT and a mutant CCT, CCT4anc2, defective in folding actin in vivo. Binding of the non-hydrolysable ATP analog adenosine 5'-(beta,gamma-imino)-triphosphate to the ternary complex leads to 3-fold faster release of actin from CCT following addition of ATP, suggesting a two-step folding process with a conformational change occurring upon closure of the cavity and a subsequent final folding step involving packing of the C terminus to the native-like state.	[Stuart, Sarah F.; Leatherbarrow, Robin J.] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England; [Stuart, Sarah F.; Willison, Keith R.] Inst Canc Res, Sect Cell & Mol Biol, London SW3 6JB, England	Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Willison, KR (corresponding author), 237 Fulham Rd, London SW3 6JB, England.	keith.willison@icr.ac.uk	Leatherbarrow, Robin J/H-3070-2014	Leatherbarrow, Robin J/0000-0001-8193-5964	Engineering and Physical Sciences Research Council through the Institute of Chemical Biology	Engineering and Physical Sciences Research Council through the Institute of Chemical Biology(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Engineering and Physical Sciences Research Council through the Institute of Chemical Biology.	Altschuler GM, 2009, FEBS LETT, V583, P782, DOI 10.1016/j.febslet.2009.01.031; Altschuler GM, 2008, J R SOC INTERFACE, V5, P1391, DOI 10.1098/rsif.2008.0185; Altschuler GM, 2005, J MOL BIOL, V353, P385, DOI 10.1016/j.jmb.2005.07.062; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; McCormack EA, 2001, J STRUCT BIOL, V135, P198, DOI 10.1006/jsbi.2001.4385; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Stirling PC, 2007, MOL BIOL CELL, V18, P2336, DOI 10.1091/mbc.E07-01-0069; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P5083, DOI 10.1021/bi062093o; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yasunaga T, 2001, J BIOCHEM-TOKYO, V129, P201, DOI 10.1093/oxfordjournals.jbchem.a002844	24	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					178	184		10.1074/jbc.M110.166256	http://dx.doi.org/10.1074/jbc.M110.166256			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056978	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000285782800019
J	Weems, J; Olson, AL				Weems, Juston; Olson, Ann Louise			Class II Histone Deacetylases Limit GLUT4 Gene Expression during Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE GLUCOSE-TRANSPORTER; MYOCYTE ENHANCER FACTOR-2; TRANSCRIPTIONAL REPRESSION; BINDING PROTEIN; ADIPOSE-TISSUE; MESSENGER-RNA; DB/DB MICE; PROMOTER; MEF2; ACTIVATION	Insulin-dependent glucose homeostasis is highly sensitive to the levels of insulin-responsive glucose transporter 4 (GLUT4) expression in adipocytes. The level of GLUT4 protein expression is highly dependent on the rate of GLUT4 gene transcription. GLUT4 gene transcription is decreased in a variety of physiologic states of insulin resistance including type 2 diabetes, obesity, and prolonged fasting. GLUT4 gene expression in adipocytes is differentiation-dependent, with full expression delayed until late in the differentiation program. In this paper, we have tested the hypothesis that differentiation-dependent GLUT4 gene expression in 3T3-L1 adipocytes is dependent on the nuclear concentration of a class II histone deacetylase (HDAC) protein, HDAC5. We have tested this hypothesis by reducing the levels of class II HDACs in the nuclear compartment of 3T3-L1 preadipocytes using two experimental approaches. First, preadipocytes were treated with phenylephrine, an alpha-adrenergic receptor agonist, to drive HDACS out of the nuclear compartment. Also, the class II HDAC concentrations were reduced using siRNA knockdown. In each case, reduction of nuclear class II HDAC concentration resulted in increased expression of endogenous GLUT4 mRNA in preadipocytes. Together, our data indicate that class II HDAC expression is the major regulatory mechanism for inhibiting GLUT4 expression in the predifferentiated state.	[Weems, Juston; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,BMSB 964, Oklahoma City, OK 73190 USA.	ann-olson@ouhsc.edu			National Institutes of Health [DK081545]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081545, R01DK081545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081545.	Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Brozinick JT, 2001, DIABETES, V50, P593, DOI 10.2337/diabetes.50.3.593; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; FLORESRIVEROS JR, 1993, BIOCHEM BIOPH RES CO, V194, P1148, DOI 10.1006/bbrc.1993.1942; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GERRITS PM, 1993, J BIOL CHEM, V268, P640; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Oshel KM, 2000, J BIOL CHEM, V275, P23666, DOI 10.1074/jbc.M001452200; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	39	37	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					460	468		10.1074/jbc.M110.157107	http://dx.doi.org/10.1074/jbc.M110.157107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047791	hybrid, Green Published			2022-12-27	WOS:000285782800049
J	Zaika, O; Zhang, J; Shapiro, MS				Zaika, Oleg; Zhang, Jie; Shapiro, Mark S.			Combined Phosphoinositide and Ca2+ Signals Mediating Receptor Specificity toward Neuronal Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; RAT SYMPATHETIC NEURONS; PHOSPHOLIPASE-C; K+ CHANNELS; MUSCARINIC-RECEPTOR; CALCIUM CHANNELS; KCNQ CHANNELS; BINDING PROTEIN; SENSORY NEURONS; IP3 RECEPTOR	Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates Ca2+ (I-Ca) and M-type K+ currents in superior cervical ganglion sympathetic neurons. In those cells, M-1 muscarinic and AT(1) angiotensin types do not elicit Ca-i(2+) signals and suppress both currents via depletion of PIP2, whereas the B-2 bradykinin and P2Y purinergic types elicit robust IP3-mediated [Ca2+](i) rises and neither deplete PIP2 nor inhibit I-Ca. We have suggested that this specificity arises from differential Ca-i(2+) signals underlying receptor-specific stimulation of PIP2 synthesis by phosphatidylinositol (PI) 4-kinase. Here, we investigate which PI 4-kinase isoform underlies this signal, whether stimulation of PI 4-phosphate 5-kinase is also required, and the origin of receptor-specific Ca-i(2+) signals. Recordings of I-Ca were used as a PIP2 "biosensor." In control, stimulation of M-1, but not B-2 or P2Y, receptors robustly suppressed I-Ca. However, when PI 4-kinase III beta, diacylglycerol kinase, Rho, or Rho-kinase was blocked, agonists of all three receptors robustly suppressed I-Ca. Overexpression of exogenous M-1 receptors yielded large [Ca2+](i) rises by muscarinic agonist, and transfection of wildtype IRBIT decreased Ca-i(2+) signals, whereas dominant negative IRBIT-S68A had little effect on B-2 or P2Y responses but greatly increased muscarinic responses. We conclude that overlaid on microdomain organization is IRBIT, setting a "threshold" for [IP3], assisting in fidelity of receptor specificity.	[Zaika, Oleg; Zhang, Jie; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, MS 7756,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu			National Institutes of Health, NINDS [R01 NS43394, ARRA R01 NS065138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394, R01NS065138] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants R01 NS43394 and ARRA R01 NS065138 (to M. S. S.).	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brown SA, 2008, BIOPHYS J, V95, P1795, DOI 10.1529/biophysj.108.130195; Calvert JA, 2004, BRIT J PHARMACOL, V143, P525, DOI 10.1038/sj.bjp.0705959; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; DECOURCELLES DD, 1989, J BIOL CHEM, V264, P3274; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Filippov AK, 2006, J NEUROSCI, V26, P9340, DOI 10.1523/JNEUROSCI.2635-06.2006; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gamper Nikita, 2006, V337, P27; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; LASSING I, 1990, FEBS LETT, V262, P231, DOI 10.1016/0014-5793(90)80197-Q; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu LW, 2008, J CELL PHYSIOL, V216, P91, DOI 10.1002/jcp.21378; Loew LM, 2007, J PHYSIOL-LONDON, V582, P945, DOI 10.1113/jphysiol.2007.132860; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mitra-Ganguli T, 2009, J GEN PHYSIOL, V134, P385, DOI 10.1085/jgp.200910204; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; SEKAR MC, 1984, BIOCHEM J, V223, P527, DOI 10.1042/bj2230527; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Weernink PAO, 2007, BBA-BIOMEMBRANES, V1768, P888, DOI 10.1016/j.bbamem.2006.09.012; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	92	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					830	841		10.1074/jbc.M110.166033	http://dx.doi.org/10.1074/jbc.M110.166033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051544	hybrid, Green Published			2022-12-27	WOS:000285782800082
J	Moore, B; Miles, AJ; Guerra-Giraldez, C; Simpson, P; Iwata, M; Wallace, BA; Matthews, SJ; Smith, DF; Brown, KA				Moore, Benjamin; Miles, Andrew J.; Guerra-Giraldez, Cristina; Simpson, Peter; Iwata, Momi; Wallace, B. A.; Matthews, Stephen J.; Smith, Deborah F.; Brown, Katherine A.			Structural Basis of Molecular Recognition of the Leishmania Small Hydrophilic Endoplasmic Reticulum-associated Protein (SHERP) at Membrane Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; PROTOZOAN PARASITE LEISHMANIA; BOUND ALPHA-SYNUCLEIN; REGULATED GENE FAMILY; VACUOLAR H+-ATPASE; SECONDARY STRUCTURE; DONOVANI PROMASTIGOTES; UNILAMELLAR VESICLES; THERMUS-THERMOPHILUS; SUBUNIT ARRANGEMENT	The 57-residue small hydrophilic endoplasmic reticulum-associated protein (SHERP) shows highly specific, stage-regulated expression in the non-replicative vector-transmitted stages of the kinetoplastid parasite, Leishmania major, the causative agent of human cutaneous leishmaniasis. Previous studies have demonstrated that SHERP localizes as a peripheral membrane protein on the cytosolic face of the endoplasmic reticulum and on outer mitochondrial membranes, whereas its high copy number suggests a critical function in vivo. However, the absence of defined domains or identifiable orthologues, together with lack of a clear phenotype in transgenic parasites lacking SHERP, has limited functional understanding of this protein. Here, we use a combination of biophysical and biochemical methods to demonstrate that SHERP can be induced to adopt a globular fold in the presence of anionic lipids or SDS. Cross-linking and binding studies suggest that SHERP has the potential to form a complex with the vacuolar type H+-ATPase. Taken together, these results suggest that SHERP may function in modulating cellular processes related to membrane organization and/or acidification during vector transmission of infective Leishmania.	[Simpson, Peter; Iwata, Momi; Matthews, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England; [Moore, Benjamin; Brown, Katherine A.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Miles, Andrew J.; Wallace, B. A.] Univ London Birkbeck Coll, Dept Crystallog, Inst Struct & Mol Biol, London WC1E 7HX, England; [Guerra-Giraldez, Cristina; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5YW, N Yorkshire, England; [Iwata, Momi] Diamond Light Source Ltd, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Brown, Katherine A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Imperial College London; Imperial College London; University of London; Birkbeck University London; University of York - UK; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Texas System; University of Texas Austin	Matthews, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk; deborah.smith@york.ac.uk; k.brown@imperial.ac.uk	Guerra-Giraldez, Cristina/AAK-8596-2020; Wallace, B A/C-3753-2008	Guerra-Giraldez, Cristina/0000-0002-9287-9838; Simpson, Pete/0000-0002-2679-9303; Wallace, B A/0000-0001-9649-5092; Matthews, Steve/0000-0003-0676-0927	United Kingdom Biotechnology and Biological Science Research Council; Wellcome Trust [077503, 079819, 085464, 068779]; SRCD; European Union [RII3-CT-2004-506008]; BBSRC [BB/G530417/1] Funding Source: UKRI; MRC [G0800038] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530417/1] Funding Source: researchfish; Medical Research Council [G0800038] Funding Source: researchfish	United Kingdom Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SRCD; European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the United Kingdom Biotechnology and Biological Science Research Council (to K.A.B., D.F.S., and B.A.W.); Wellcome Trust Program Grant 077503 (to D.F.S.) and Program Grant 079819 and Equipment Grant 085464 (to S.J.M.); and SRCD beamtime grants (to B.A.W. and K.A.B.).; Supported by Wellcome Trust Traveling Fellowship 068779. Present address: Dept. de Microbiologia, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima 31, Peru.; Access to the CD1 beamline at the Institute for Synchrotron Studies is acknowledged under the European Union Integrated Infrastructure Initiative (I3), Integrated Activity on Synchrotron and Free Electron Laser Science (IA-SFS), contract RII3-CT-2004-506008. NMR spectra were recorded at the Medical Research Council Biomedical NMR Centre (Mill Hill, UK). We thank Dr. G. Kelly and Dr. T. A. Frankiel for assistance in data recording.	ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BEACH DH, 1979, J PARASITOL, V65, P203, DOI 10.2307/3280147; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Boucher J, 2004, J LIPID RES, V45, P849, DOI 10.1194/jlr.M300431-JLR200; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fossi M, 2005, J MAGN RESON, V175, P92, DOI 10.1016/j.jmr.2005.03.020; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Knuepfer E, 2001, BIOCHEM J, V356, P335, DOI 10.1042/0264-6021:3560335; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-507; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McKean PG, 1997, MOL BIOCHEM PARASIT, V85, P221, DOI 10.1016/S0166-6851(97)02829-6; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Meier S, 2002, J BIOMOL NMR, V24, P351, DOI 10.1023/A:1021609207024; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Qi J, 2007, J BIOENERG BIOMEMBR, V39, P423, DOI 10.1007/s10863-007-9116-8; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1985, J IMMUNOL, V135, P564; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sadlova J, 2010, CELL MICROBIOL, V12, P1765, DOI 10.1111/j.1462-5822.2010.01507.x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Sreerama N, 1999, PROTEIN SCI, V8, P370; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wang GS, 1997, BIOCHEMISTRY-US, V36, P13657, DOI 10.1021/bi971151q; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200	78	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9246	9256		10.1074/jbc.M110.130427	http://dx.doi.org/10.1074/jbc.M110.130427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21106528	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000288247700055
J	Poland, PA; Rondanino, C; Kinlough, CL; Heimburg-Molinaro, J; Arthur, CM; Stowell, SR; Smith, DF; Hughey, RP				Poland, Paul A.; Rondanino, Christine; Kinlough, Carol L.; Heimburg-Molinaro, Jamie; Arthur, Connie M.; Stowell, Sean R.; Smith, Dave F.; Hughey, Rebecca P.			Identification and Characterization of Endogenous Galectins Expressed in Madin Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED MDCK CELLS; BLOOD-GROUP ANTIGENS; BIOSYNTHETIC-PATHWAY; APICAL TRAFFICKING; N-GLYCAN; MUC1; PROTEINS; LECTINS; BINDING; SURFACE	Madin Darby canine kidney (MDCK) cells are a well characterized epithelial cell line used to study mechanisms of polarized delivery. As glycans on apically expressed proteins have been identified as targeting signals, and crosslinking by the abundant galectin-3 has been implicated in the mechanism of glycan-dependent sorting, we wanted to identify other members of the galectin (Gal) family expressed in MDCK cells. By analyzing intron-exon boundaries, we identified canine genes that were highly homologous to mammalian Gal-1, 2, 3, 4, 7, 8, 9, and 12, and galectin-related HSPC159 and GRIFIN. Transcripts for Gal-2 and -12 were not detected in MDCK cells, but we found transcript levels for Gal-3 > Gal-9 > Gal-8 > Gal-1 Gal-4 > Gal-7. Canine Gal-1, -2, -3, -4, -7, -8, -9, and -12 were cloned and expressed in Escherichia coli as GST fusion proteins to characterize binding specificities on arrays of synthetic glycans on glass slides from Core H of the NIH Consortium for Functional Glycomics. Individual expression of the N-terminal (GST-Gal-9N) and C-terminal (GST-Gal-9C) carbohydrate recognition domains greatly improved protein yield and the ability to characterize Gal-9 binding on the array. Canine galectins differentially bound sulfated disaccharides as well as human blood groups A, B, and H on both N-glycans and linear glycan structures on the array. Analysis of GST-Gal-1, -3, -4, -7, -8, -9N, and -9C binding to immunopurified human MUC1 expressed in MDCK cells revealed a preference for binding GST-Gal-3 and -9, which interestingly reflects the two most abundant galectins expressed in MDCK cells.	[Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Heimburg-Molinaro, Jamie; Arthur, Connie M.; Stowell, Sean R.; Smith, Dave F.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, S-933 Scaife Hall, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu	Rondanino, Christine/S-6880-2018	Rondanino, Christine/0000-0002-1100-9401	National Institutes of Health [DK054787, GM85448, GM62116]; Genzyme Renal Innovations Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054787 (to R. P. H.), GM85448 (to D. F. S.), and Genzyme Renal Innovations Program (to R. P. H.).; We thank Sandra Gendler for the CT-2 antibody, and Ora Weisz and Rick Cummings for helpful discussions. Glycan microarray data were obtained through the Protein-Glycan Interaction Core (Core H) of the Consortium for Functional Glycomics supported by National Institutes of Health Grant GM62116.	Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Cummings RD, 2009, GALECTINS; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Markova V, 2006, INT J MOL MED, V18, P65; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Varki A., 2009, ESSENTIALS GLYCOBIOL; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	42	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6780	6790		10.1074/jbc.M110.179002	http://dx.doi.org/10.1074/jbc.M110.179002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21127048	hybrid, Green Published			2022-12-27	WOS:000287476400085
J	Ramani, VC; Yang, Y; Ren, YS; Nan, L; Sanderson, RD				Ramani, Vishnu C.; Yang, Yang; Ren, Yongsheng; Nan, Li; Sanderson, Ralph D.			Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RECEPTOR C-MET; MULTIPLE-MYELOMA; TUMOR-GROWTH; BONE-MARROW; 4-KRINGLE ANTAGONIST; OSTEOCLAST FORMATION; IN-VITRO; INTERLEUKIN-11; SYNDECAN-1	Hepatocyte growth factor (HGF) is a heparin-binding cytokine that enhances growth, motility, and angiogenesis of many tumor types, including multiple myeloma where it is often highly expressed. However, little is known regarding what controls HGF level and activity in these tumors. Evaluation of bone marrow biopsies from myeloma patients revealed a strong positive correlation between the levels of HGF and heparanase, an endoglucuronidase known to promote aggressive tumor behavior. In vitro, addition of recombinant heparanase to myeloma cells or transfection of myeloma cell lines with the cDNA for heparanase significantly increased tumor cell expression and secretion of biologically active HGF. Shed syndecan-1, whose levels in myeloma are also enhanced by heparanase expression, binds to secreted HGF. This syndecan-1-HGF complex is active as shown by its ability to stimulate paracrine signaling via c-Met, the cell surface receptor for HGF. Surprisingly, heparanase enzyme activity was not required for up-regulation of HGF expression by the tumor cells. This is in contrast to the heparanase-mediated enhanced syndecan-1 shedding, which does require activity of the enzyme. This suggests that two different functional domains within the heparanase enzyme (the enzyme active site and a separate site) contribute to events leading to enhanced HGF signaling. These findings demonstrate a novel mechanism driving the HGF pathway whereby heparanase stimulates an increase in both HGF expression and syndecan-1 shedding to enhance HGF signaling. This work also provides further mechanistic insight into the dynamic role of heparanase in driving aggressive tumor progression.	[Ramani, Vishnu C.; Yang, Yang; Ren, Yongsheng; Nan, Li; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Metab Bone Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu	nan, li li/HHM-7022-2022		National Institutes of Health [CA135075, CA138340]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075, R01CA151538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by Multiple Myeloma Research Foundation research fellow award (to V. C. R.) and Multiple Myeloma Research Foundation senior research award (to Y. Y.).	Abdallah BM, 2005, CALCIFIED TISSUE INT, V76, P90, DOI 10.1007/s00223-004-0074-4; Ahlen J, 2002, BONE, V31, P242, DOI 10.1016/S8756-3282(02)00784-6; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borset M, 2000, BLOOD, V96, P2528; Borset M, 1999, LEUKEMIA LYMPHOMA, V32, P249, DOI 10.3109/10428199909167385; Borset M, 1996, BLOOD, V88, P3998, DOI 10.1182/blood.V88.10.3998.bloodjournal88103998; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; COOPER CS, 1992, ONCOGENE, V7, P3; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hill PA, 1998, ENDOCRINOLOGY, V139, P1564, DOI 10.1210/en.139.4.1564; Hjertner O, 1999, BLOOD, V94, P3883; HUGHES FJ, 1993, CALCIFIED TISSUE INT, V53, P362, DOI 10.1007/BF01351844; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kelly T, 2003, CANCER RES, V63, P8749; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Kuba K, 2000, CANCER RES, V60, P6737; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Matsumoto K, 2003, CANCER SCI, V94, P321, DOI 10.1111/j.1349-7006.2003.tb01440.x; Morrissey C, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-148; NAKA D, 1992, J BIOL CHEM, V267, P20114; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Rajgopal R, 2006, J BIOL CHEM, V281, P20780, DOI 10.1074/jbc.M600169200; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Seidel C, 1998, BLOOD, V91, P806, DOI 10.1182/blood.V91.3.806.806_806_812; Shaughnessy SG, 2002, CYTOKINE, V20, P78, DOI 10.1006/cyto.2002.1981; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yap TA, 2010, MOL CANCER THER, V9, P1077, DOI 10.1158/1535-7163.MCT-10-0122; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729	52	94	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6490	6499		10.1074/jbc.M110.183277	http://dx.doi.org/10.1074/jbc.M110.183277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21131364	Green Published, hybrid			2022-12-27	WOS:000287476400059
J	Pesce, A; Nardini, M; Dewilde, S; Capece, L; Marti, MA; Congia, S; Salter, MD; Blouin, GC; Estrin, DA; Ascenzi, P; Moens, L; Bolognesi, M; Olson, JS				Pesce, Alessandra; Nardini, Marco; Dewilde, Sylvia; Capece, Luciana; Marti, Marcelo A.; Congia, Sonia; Salter, Mallory D.; Blouin, George C.; Estrin, Dario A.; Ascenzi, Paolo; Moens, Luc; Bolognesi, Martino; Olson, John S.			Ligand Migration in the Apolar Tunnel of Cerebratulus lacteus Mini-Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; DISTAL HISTIDINE; NEMERTEAN WORM; NERVE GLOBINS; HEME-PROTEINS; RESP MODEL; O-2 ENTRY; BINDING; CAVITIES; AFFINITY	The large apolar tunnel traversing the mini-hemoglobin from Cerebratulus lacteus (CerHb) has been examined by x-ray crystallography, ligand binding kinetics, and molecular dynamic simulations. The addition of 10 atm of xenon causes loss of diffraction in wild-type (wt) CerHbO(2) crystals, but Leu-86(G12)Ala CerHbO(2), which has an increased tunnel volume, stably accommodates two discrete xenon atoms: one adjacent to Leu-86(G12) and another near Ala-55(E18). Molecular dynamics simulations of ligand migration in wt CerHb show a low energy pathway through the apolar tunnel when Leu or Ala, but not Phe or Trp, is present at the 86(G12) position. The addition of 10-15 atm of xenon to solutions of wt CerHbCO and L86A CerHbCO causes 2-3-fold increases in the fraction of geminate ligand recombination, indicating that the bound xenon blocks CO escape. This idea was confirmed by L86F and L86W mutations, which cause even larger increases in the fraction of geminate CO rebinding, 2-5-fold decreases in the bimolecular rate constants for ligand entry, and large increases in the computed energy barriers for ligand movement through the apolar tunnel. Both the addition of xenon to the L86A mutant and oxidation of wt CerHb heme iron cause the appearance of an out Gln-44(E7) conformer, in which the amide side chain points out toward the solvent and appears to lower the barrier for ligand escape through the E7 gate. However, the observed kinetics suggest little entry and escape (<= 25%) through the E7 pathway, presumably because the in Gln-44(E7) conformer is thermodynamically favored.	[Salter, Mallory D.; Blouin, George C.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Capece, Luciana; Marti, Marcelo A.; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Dept Quim Inorgan Analit & Quim Fis, Buenos Aires, DF, Argentina; [Ascenzi, Paolo] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Elect Microscopy, I-00146 Rome, Italy	Rice University; University of Genoa; University of Milan; University of Antwerp; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Roma Tre University; Roma Tre University	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St, Houston, TX 77005 USA.	olson@rice.edu	Pesce, Alessandra/A-3660-2015; Estrin, Dario/AAY-7549-2020; Bolognesi, Martino/B-7924-2017; Nardini, Marco/B-7842-2017	Bolognesi, Martino/0000-0002-9253-5170; Estrin, Dario/0000-0002-5006-7225; Olson, John/0000-0002-0760-5403; Nardini, Marco/0000-0002-3718-2165; Marti, Marcelo/0000-0002-7911-9340	National Institutes of Health [GM035649, HL047020]; Italian Ministry of University and Scientific Research; University of Milano [RBLA03B3KC]; Universidad de Buenos Aires [08-X625, X076]; Agencia de Promocion Cientifica y Tecnologica [07-1650, 06-25667]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5218]; Guggenheim Foundation fellowship; Welch Foundation [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Milano; Universidad de Buenos Aires(University of Buenos Aires); Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Guggenheim Foundation fellowship; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020 (to J.S.O.). This work was also supported by grants from the Italian Ministry of University and Scientific Research (FIRB Project "Biologia Strutturale, "RBLA03B3KC) and from the University of Milano (to M. B.), Universidad de Buenos Aires Grants 08-X625 (to M.A.M.) and X076 (to D.A.E.), Agencia de Promocion Cientifica y Tecnologica Grants 07-1650 (to M.A.M.) and 06-25667 (to D.A.E.), Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 5218 and a Guggenheim Foundation fellowship (to D.A.E.), and Robert A. Welch Foundation Grant C-0612 (to J.S.O.).	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; Hundahl C, 2006, FEBS J, V273, P1323, DOI 10.1111/j.1742-4658.2006.05158.x; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach A. R., 2001, MOL MODELLING PRINCI, P581; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Marti MA, 2006, PROTEINS, V62, P641, DOI 10.1002/prot.20822; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; MIMS MP, 1983, J BIOL CHEM, V258, P4219; Moschetti T, 2009, BIOPHYS J, V97, P1700, DOI 10.1016/j.bpj.2009.05.059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3; Pesce A, 2001, ACTA CRYSTALLOGR D, V57, P1897, DOI 10.1107/S0907444901015815; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; SCHOENBORN BP, 1965, NATURE, V208, P760, DOI 10.1038/208760a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	42	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5347	5358		10.1074/jbc.M110.169045	http://dx.doi.org/10.1074/jbc.M110.169045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147768	hybrid, Green Published			2022-12-27	WOS:000287230600043
J	ter Beek, J; Duurkens, RH; Erkens, GB; Slotboom, DJ				ter Beek, Josy; Duurkens, Ria H.; Erkens, Guus B.; Slotboom, Dirk Jan			Quaternary Structure and Functional Unit of Energy Coupling Factor (ECF)-type Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLED GENE-EXPRESSION; ABC TRANSPORTERS; LACTOCOCCUS-LACTIS; MEMBRANE-PROTEINS; LIGHT-SCATTERING; BINDING; BACTERIA; PROKARYOTES; AFFINITY; SYSTEMS	ATP-binding cassette (ABC) transporters mediate transport of diverse substrates across membranes. We have determined the quaternary structure and functional unit of the recently discovered ECF-type (energy coupling factor) of ABC transporters, which is widespread among prokaryotes. ECF transporters are protein complexes consisting of a conserved energizing module (two peripheral ATPases and the integral membrane protein EcfT) and a non-conserved integral membrane protein responsible for substrate specificity (S-component). S-components for different substrates are often unrelated in amino acid sequence but may associate with the same energizing module. Here, the energizing module from Lactococcus lactis was shown to form stable complexes with each of the eight predicted S-components found in the organism. The quaternary structures of three of these complexes were determined by light scattering. EcfT, the two ATPases (EcfA and EcfA`), and the S-components were found to be present in a 1:1:1:1 ratio. The complexes were reconstituted in proteoliposomes and shown to mediate ATP-dependent transport. ECF-type transporters are the smallest known ABC transporters.	[ter Beek, Josy; Duurkens, Ria H.; Erkens, Guus B.; Slotboom, Dirk Jan] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen	Slotboom, DJ (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a toptalent grant from the Netherlands Organisation for Scientific Research (NWO) (to J. t. B.) and a vidi grant from the NWO (to D. J. S.).	Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	20	42	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5471	5475		10.1074/jbc.M110.199224	http://dx.doi.org/10.1074/jbc.M110.199224			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135102	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000287230600056
J	Bessadok, A; Garcia, E; Jacquet, H; Martin, S; Garrigues, A; Loiseau, N; Andre, F; Orlowski, S; Vivaudou, M				Bessadok, Anis; Garcia, Elisabeth; Jacquet, Helene; Martin, Solenne; Garrigues, Alexia; Loiseau, Nicolas; Andre, Francois; Orlowski, Stephane; Vivaudou, Michel			Recognition of Sulfonylurea Receptor (ABCC8/9) Ligands by the Multidrug Resistance Transporter P-glycoprotein (ABCB1) FUNCTIONAL SIMILARITIES BASED ON COMMON STRUCTURAL FEATURES BETWEEN TWO MULTISPECIFIC ABC PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; 3-DIMENSIONAL STRUCTURES; MAXIMUM-LIKELIHOOD; PROTEIN STRUCTURES; MOLECULAR-BASIS; DRUG-BINDING; OPENERS; MODEL; MODULATORS; PROGRAMS	ATP-sensitive K+ (K-ATP) channels are the target of a number of pharmacological agents, blockers like hypoglycemic sulfonylureas and openers like the hypotensive cromakalim and diazoxide. These agents act on the channel regulatory subunit, the sulfonylurea receptor (SUR), which is an ABC protein with homologies to P-glycoprotein (P-gp). P-gp is a multidrug transporter expressed in tumor cells and in some healthy tissues. Because these two ABC proteins both exhibit multispecific recognition properties, we have tested whether SUR ligands could be substrates of P-gp. Interaction with P-gp was assayed by monitoring ATPase activity of P-gp-enriched vesicles. The blockers glibenclamide, tolbutamide, and meglitinide increased ATPase activity, with a rank order of potencies that correlated with their capacity to block K-ATP channels. P-gp ATPase activity was also increased by the openers SR47063 (a cromakalim analog), P1075 (a pinacidil analog), and diazoxide. Thus, these molecules bind to P-gp (although with lower affinities than for SUR) and are possibly transported by P-gp. Competition experiments among these molecules as well as with typical P-gp substrates revealed a structural similarity between drug binding domains in the two proteins. To rationalize the observed data, we addressed the molecular features of these proteins and compared structural models, computerized by homology from the recently solved structures of murine P-gp and bacterial ABC transporters MsbA and Sav1866. Considering the various residues experimentally assigned to be involved in drug binding, we uncovered several hot spots, which organized spatially in two main binding domains, selective for SR47063 and for glibenclamide, in matching regions of both P-gp and SUR.	[Bessadok, Anis; Martin, Solenne; Garrigues, Alexia; Andre, Francois; Orlowski, Stephane] CEA Saclay, CNRS, URA 2096, Serv Bioenerget Biol Struct & Mecanismes,iBiTec S, F-91191 Gif Sur Yvette, France; [Garcia, Elisabeth; Jacquet, Helene; Vivaudou, Michel] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France; [Loiseau, Nicolas] INRA, UR66, Lab Pharmacol Toxicol, F-31027 Toulouse, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE	Orlowski, S (corresponding author), CEA Saclay, CNRS, URA 2096, Serv Bioenerget Biol Struct & Mecanismes,iBiTec S, F-91191 Gif Sur Yvette, France.	stephane.orlowski@cea.fr; michel.vivaudou@ibs.fr	ANDRE, François/E-5555-2015; Le Discorde, Magali/A-5127-2009; LOISEAU, Nicolas/ADN-2394-2022; Vivaudou, Michel/C-5338-2008	Le Discorde, Magali/0000-0001-5126-0900; LOISEAU, Nicolas/0000-0003-3783-0879; Vivaudou, Michel/0000-0002-9777-3127	Ligue Nationale de Recherche contre le Cancer; Les Amis des Sciences; SPI-Bio; ARC	Ligue Nationale de Recherche contre le Cancer; Les Amis des Sciences; SPI-Bio; ARC(Australian Research Council)	Supported by studentships from the "Ligue Nationale de Recherche contre le Cancer" and "Les Amis des Sciences." Present address: Commissariat a l'Energie Atomique/Cadarache, IBEB-LEMS, 13108 St. Paul Lez Durance, France.; Supported by studentships from SPI-Bio and ARC. Present address: Bio-predic, Parc d'Affaires de la Breteche, Batiment B1, 35760 Saint-Gregoire, France.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Avendano C, 2002, CURR MED CHEM, V9, P159, DOI 10.2174/0929867023371175; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coghlan MJ, 2001, J MED CHEM, V44, P1627, DOI 10.1021/jm000484+; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; de Wet H, 2010, FEBS J, V277, P2654, DOI [10.1111/j.1742-4658.2010.07675.x, 10.1111/j.1742-464X.2010.07675.x]; Dorschner H, 1999, MOL PHARMACOL, V55, P1060; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forestier C, 1996, J GEN PHYSIOL, V107, P489, DOI 10.1085/jgp.107.4.489; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Garrigos M, 1997, EUR J BIOCHEM, V244, P664, DOI 10.1111/j.1432-1033.1997.00664.x; GARRIGOS M, 1993, BIOCHEM BIOPH RES CO, V196, P1034, DOI 10.1006/bbrc.1993.2355; Garrigues A, 2002, MOL PHARMACOL, V62, P1288, DOI 10.1124/mol.62.6.1288; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gribble FM, 2002, BIOCHEM SOC T, V30, P333, DOI 10.1042/bst0300333; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jahangir A, 2005, J MOL CELL CARDIOL, V39, P99, DOI 10.1016/j.yjmcc.2005.04.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le T, 1999, MOL MEMBR BIOL, V16, P173, DOI 10.1080/096876899294634; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Loffler-Walz C, 1998, BRIT J PHARMACOL, V123, P1395, DOI 10.1038/sj.bjp.0701756; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Megard I, 2002, BRAIN RES, V927, P153, DOI 10.1016/S0006-8993(01)03337-6; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2005, MOL PHARMACOL, V67, P1026, DOI 10.1124/mol.104.008698; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pascaud C, 1998, BIOCHEM J, V333, P351, DOI 10.1042/bj3330351; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	68	25	27	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3552	3569		10.1074/jbc.M110.155200	http://dx.doi.org/10.1074/jbc.M110.155200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098040	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000286653200040
J	Bosch, DE; Kimple, AJ; Sammond, DW; Muller, RE; Miley, MJ; Machius, M; Kuhlman, B; Willard, FS; Siderovski, DP				Bosch, Dustin E.; Kimple, Adam J.; Sammond, Deanne W.; Muller, Robin E.; Miley, Michael J.; Machius, Mischa; Kuhlman, Brian; Willard, Francis S.; Siderovski, David P.			Structural Determinants of Affinity Enhancement between GoLoco Motifs and G-Protein alpha Subunit Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESIGN; PINS; FLUORESCENCE; ACTIVATION; MUTATIONS; HOMOLOG; DISPLAY	GoLoco motif proteins bind to the inhibitory G(i) subclass of G-protein alpha subunits and slow the release of bound GDP; this interaction is considered critical to asymmetric cell division and neuro-epithelium and epithelial progenitor differentiation. To provide protein tools for interrogating the precise cellular role(s) of GoLoco motif/G alpha(i) complexes, we have employed structure-based protein design strategies to predict gain-of-function mutations that increase GoLoco motif binding affinity. Here, we describe fluorescence polarization and isothermal titration calorimetry measurements showing three predicted G alpha(i1) point mutations, E116L, Q147L, and E245L; each increases affinity for multiple GoLoco motifs. A component of this affinity enhancement results from a decreased rate of dissociation between the G alpha mutants and GoLoco motifs. For G alpha(Q147L)(i1), affinity enhancement was seen to be driven by favorable changes in binding enthalpy, despite reduced contributions from binding entropy. The crystal structure of G(alpha i1)(Q147L) bound to the RGS14 GoLoco motif revealed disorder among three peptide residues surrounding a well defined Leu-147 side chain. Monte Carlo simulations of the peptide in this region showed a sampling of multiple backbone conformations in contrast to the wild-type complex. We conclude that mutation of Glu-147 to leucine creates a hydrophobic surface favorably buried upon GoLoco peptide binding, yet the hydrophobic Leu-147 also promotes flexibility among residues 511-513 of the RGS14 GoLoco peptide.	[Willard, Francis S.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sammond, Deanne W.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Willard, FS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	francis.willard@gmail.com; dsiderov@med.unc.edu	, PEP-MX Core/AGV-4051-2022; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Kimple, Adam/0000-0003-1670-8401; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01 CA127152, F30 MH074266, T32 GM008719]; NATIONAL CANCER INSTITUTE [R01CA127152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH074266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA127152 (to D. P. S.), F30 MH074266 (to A. J. K.), and T32 GM008719 (to D. E. B. and A. J. K.).	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Brady GP, 1997, CURR OPIN STRUC BIOL, V7, P215, DOI 10.1016/S0959-440X(97)80028-0; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hahn KM, 2010, NAT METHODS, V7, P595, DOI 10.1038/nmeth0810-595; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Iscru E, 2009, MOL CELL NEUROSCI, V40, P62, DOI 10.1016/j.mcn.2008.09.002; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao BM, 2005, NAT BIOTECHNOL, V23, P191, DOI 10.1038/nbt1064; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sammond DW, 2010, PROTEINS, V78, P1055, DOI 10.1002/prot.22631; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Woodnutt G, 2008, CURR OPIN DRUG DISC, V11, P754; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	42	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3351	3358		10.1074/jbc.M110.190496	http://dx.doi.org/10.1074/jbc.M110.190496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115486	Green Published, hybrid			2022-12-27	WOS:000286653200021
J	Holland, S; Coste, O; Zhang, DD; Pierre, SC; Geisslinger, G; Scholich, K				Holland, Sabrina; Coste, Ovidiu; Zhang, Dong Dong; Pierre, Sandra C.; Geisslinger, Gerd; Scholich, Klaus			The Ubiquitin Ligase MYCBP2 Regulates Transient Receptor Potential Vanilloid Receptor 1 (TRPV1) Internalization through Inhibition of p38 MAPK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM DEPRESSION; THERMAL NOCICEPTION; ADENYLYL CYCLASES; FORMATION REVEALS; SYNAPTIC GROWTH; MICE LACKING; MYOSIN-VI; PAM; ACTIVATION	The E3 ubiquitin ligase MYCBP2 negatively regulates neuronal growth, synaptogenesis, and synaptic strength. More recently it was shown that MYCBP2 is also involved in receptor and ion channel internalization. We found that mice with a MYCBP2-deficiency in peripheral sensory neurons show prolonged thermal hyperalgesia. Loss of MYCBP2 constitutively activated p38 MAPK and increased expression of several proteins involved in receptor trafficking. Surprisingly, loss of MYCBP2 inhibited internalization of transient receptor potential vanilloid receptor 1 (TRPV1) and prevented desensitization of capsaicin-induced calcium increases. Lack of desensitization, TRPV internalization and prolonged hyperalgesia were reversed by inhibition of p38 MAPK. The effects were TRPV-specific, since neither mustard oil-induced desensitization nor behavioral responses to mechanical stimuli were affected. In summary, we show here for the first time that p38 MAPK activation can inhibit activity-induced ion channel internalization and that MYCBP2 regulates internalization of TRPV1 in peripheral sensory neurons as well as duration of thermal hyperalgesia through p38 MAPK.	[Holland, Sabrina; Coste, Ovidiu; Zhang, Dong Dong; Pierre, Sandra C.; Geisslinger, Gerd; Scholich, Klaus] Klinikum Goethe Univ Frankfurt, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scholich, K (corresponding author), Klinikum Goethe Univ Frankfurt, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Scholich@em.uni-frankfurt.de		Holland, Sabrina M/0000-0003-4805-1803	DFG [SCHO817-3]; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF)	DFG(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF)	This work was supported by the DFG Grant SCHO817-3 and the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF).	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Mizushima T, 2005, PAIN, V113, P51, DOI 10.1016/j.pain.2004.09.038; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Yang HT, 2002, DEV BRAIN RES, V136, P35, DOI 10.1016/S0165-3806(02)00311-5; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	58	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3671	3680		10.1074/jbc.M110.154765	http://dx.doi.org/10.1074/jbc.M110.154765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098484	Green Published, hybrid			2022-12-27	WOS:000286653200050
J	Ladiwala, ARA; Dordick, JS; Tessier, PM				Ladiwala, Ali Reza A.; Dordick, Jonathan S.; Tessier, Peter M.			Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid beta through Three Independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; METHYLENE-BLUE; IN-VITRO; ALZHEIMERS-DISEASE; PROTEIN OLIGOMERS; FIBRIL FORMATION; SHEET STRUCTURES; ALPHA-SYNUCLEIN; TANNIC-ACID; AGGREGATION	In protein conformational disorders ranging from Alzheimer to Parkinson disease, proteins of unrelated sequence misfold into a similar array of aggregated conformers ranging from small oligomers to large amyloid fibrils. Substantial evidence suggests that small, prefibrillar oligomers are the most toxic species, yet to what extent they can be selectively targeted and remodeled into non-toxic conformers using small molecules is poorly understood. We have evaluated the conformational specificity and remodeling pathways of a diverse panel of aromatic small molecules against mature soluble oligomers of the A beta 42 peptide associated with Alzheimer disease. We find that small molecule antagonists can be grouped into three classes, which we herein define as Class I, II, and III molecules, based on the distinct pathways they utilize to remodel soluble oligomers into multiple conformers with reduced toxicity. Class I molecules remodel soluble oligomers into large, off-pathway aggregates that are non-toxic. Moreover, Class IA molecules also remodel amyloid fibrils into the same off-pathway structures, whereas Class IB molecules fail to remodel fibrils but accelerate aggregation of freshly disaggregated A beta. In contrast, a Class II molecule converts soluble A beta oligomers into fibrils, but is inactive against disaggregated and fibrillar A beta. Class III molecules disassemble soluble oligomers (as well as fibrils) into low molecular weight species that are non-toxic. Strikingly, A beta non-toxic oligomers (which are morphologically indistinguishable from toxic soluble oligomers) are significantly more resistant to being remodeled than A beta soluble oligomers or amyloid fibrils. Our findings reveal that relatively subtle differences in small molecule structure encipher surprisingly large differences in the pathways they employ to remodel A beta soluble oligomers and related aggregated conformers.	Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tessier, PM (corresponding author), 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	Alzheimer's Association [NIRG-08-90967]	Alzheimer's Association(Alzheimer's Association)	This work was supported by the Alzheimer's Association Grant NIRG-08-90967 (to P.M.T.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amijee H, 2009, J ALZHEIMERS DIS, V17, P33, DOI 10.3233/JAD-2009-1044; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Boye-Harnasch M, 2006, J BIOTECHNOL, V125, P222, DOI 10.1016/j.jbiotec.2006.03.006; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DISANTO AR, 1972, J PHARM SCI, V61, P1086, DOI 10.1002/jps.2600610710; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; KUPFER A, 1994, LANCET, V343, P763, DOI 10.1016/S0140-6736(94)91839-2; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Meng XY, 2009, BIOCHEMISTRY-US, V48, P8206, DOI 10.1021/bi900506b; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Riviere C, 2009, NEUROCHEM RES, V34, P1120, DOI 10.1007/s11064-008-9883-6; Roberts BE, 2008, NAT STRUCT MOL BIOL, V15, P544, DOI 10.1038/nsmb0608-544; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	61	147	150	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3209	3218		10.1074/jbc.M110.173856	http://dx.doi.org/10.1074/jbc.M110.173856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098486	Green Published, hybrid			2022-12-27	WOS:000286653200005
J	Dominguez, V; Raimondi, C; Somanath, S; Bugliani, M; Loder, MK; Edling, CE; Divecha, N; da Silva-Xavier, G; Marselli, L; Persaud, SJ; Turner, MD; Rutter, GA; Marchetti, P; Falasca, M; Maffucci, T				Dominguez, Veronica; Raimondi, Claudio; Somanath, Sangeeta; Bugliani, Marco; Loder, Merewyn K.; Edling, Charlotte E.; Divecha, Nullin; da Silva-Xavier, Gabriela; Marselli, Lorella; Persaud, Shanta J.; Turner, Mark D.; Rutter, Guy A.; Marchetti, Piero; Falasca, Marco; Maffucci, Tania			Class II Phosphoinositide 3-Kinase Regulates Exocytosis of Insulin Granules in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-UPTAKE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; MUSCLE-CELLS; SECRETION; ISLETS; PATHWAY; MICE; P110-GAMMA; MODULATION	Phosphoinositide 3-kinases (PI3Ks) are critical regulators of pancreatic beta cell mass and survival, whereas their involvement in insulin secretion is more controversial. Furthermore, of the different PI3Ks, the class II isoforms were detected in beta cells, although their role is still not well understood. Here we show that down-regulation of the class II PI3K isoform PI3K-C2 alpha specifically impairs insulin granule exocytosis in rat insulinoma cells without affecting insulin content, the number of insulin granules at the plasma membrane, or the expression levels of key proteins involved in insulin secretion. Proteolysis of synaptosomal-associated protein of 25 kDa, a process involved in insulin granule exocytosis, is impaired in cells lacking PI3K-C2 alpha. Finally, our data suggest that the mRNA for PI3K-C2 alpha may be down-regulated in islets of Langerhans from type 2 diabetic compared with non-diabetic individuals. Our results reveal a critical role for PI3K-C2 alpha in beta cells and suggest that down-regulation of PI3K-C2 alpha may be a feature of type 2 diabetes.	[Maffucci, Tania] Queen Mary Univ London, Inositide Signalling Grp, Barts & London Sch Med & Dent, Ctr Diabet,Blizard Inst Cell & Mol Sci, London E1 2AT, England; [Bugliani, Marco; Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56100 Pisa, Italy; [Loder, Merewyn K.; da Silva-Xavier, Gabriela; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London SW7 2AZ, England; [Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Persaud, Shanta J.] Kings Coll London, Diabet Res Grp, London SE1 1UL, England	University of London; Queen Mary University London; University of Pisa; Imperial College London; Paterson Institute for Cancer Research; University of Manchester; University of London; King's College London	Maffucci, T (corresponding author), Queen Mary Univ London, Inositide Signalling Grp, Barts & London Sch Med & Dent, Ctr Diabet,Blizard Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	t.maffucci@qmul.ac.uk	Raimondi, Claudio/AAJ-4335-2020; Bugliani, Marco/I-3168-2019; Persaud, Shanta/AAH-3200-2021; Marchetti, Piero/J-7439-2013; Falasca, Marco/S-4020-2016	Raimondi, Claudio/0000-0002-1419-6855; Bugliani, Marco/0000-0002-1744-1561; Marchetti, Piero/0000-0003-4907-0635; Turner, Mark/0000-0001-7175-1053; Falasca, Marco/0000-0002-9801-7235; Marselli, Lorella/0000-0002-6698-2962; divecha, nullin/0000-0001-9695-6039; Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X; Persaud, Shanta/0000-0002-4933-5958	Barts and The London Charity [430/647, RAB/06/PHD/12]; Diabetes Research & Wellness Foundation; Diabetes UK [BDA: 09/0003971]; Pancreatic Cancer Research Fund; Wellcome Trust; Medical Research Council; European Union; Juvenile Diabetes Research Foundation; Diabetes UK [09/0003971] Funding Source: researchfish; Medical Research Council [G0401641] Funding Source: researchfish; MRC [G0401641] Funding Source: UKRI	Barts and The London Charity; Diabetes Research & Wellness Foundation; Diabetes UK(Diabetes UK); Pancreatic Cancer Research Fund; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Barts and The London Charity Grant 430/647, Diabetes Research & Wellness Foundation, and Diabetes UK Grant BDA: 09/0003971 (all to T. M.).; Supported by Barts and The London Charity Grants 430/647 (to T. M.) and RAB/06/PHD/12 (to M. D. T.).; Supported by the Pancreatic Cancer Research Fund (to M. F.).; Supported by grants from The Wellcome Trust, Medical Research Council, European Union (FP6 "Savebeta"), Juvenile Diabetes Research Foundation, and Diabetes UK.; Supported by grants from the European Union (FP6 "EURODIA").	[Anonymous], 1995, Diabetes, V44, P1249; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Bugliani M, 2009, ISLETS, V1, P106, DOI 10.4161/isl.1.2.9142; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Daimon M, 2008, BIOCHEM BIOPH RES CO, V365, P466, DOI 10.1016/j.bbrc.2007.10.180; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Del Prato S, 2007, DIABETES-METAB RES, V23, P518, DOI 10.1002/dmrr.770; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; HAGIWARA S, 1995, BIOCHEM BIOPH RES CO, V214, P51, DOI 10.1006/bbrc.1995.2255; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Logie LJ, 2005, MOL GENET METAB, V85, P54, DOI 10.1016/j.ymgme.2005.01.003; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Muller D, 2007, DIABETOLOGIA, V50, P1239, DOI 10.1007/s00125-007-0671-7; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ng SKL, 2009, BIOCHEM BIOPH RES CO, V387, P310, DOI 10.1016/j.bbrc.2009.07.013; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; Rutter GA, 2008, FRONT HORM RES, V36, P118, DOI 10.1159/000115360; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; Zawalich WS, 2000, J ENDOCRINOL, V166, P111, DOI 10.1677/joe.0.1660111; Zawalich WS, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740247	54	96	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4216	4225		10.1074/jbc.M110.200295	http://dx.doi.org/10.1074/jbc.M110.200295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127054	hybrid, Green Published			2022-12-27	WOS:000286975700020
J	Ma, DD; Zhang, R; Sun, Y; Rios, HF; Haruyama, N; Han, XL; Kulkarni, AB; Qin, CL; Feng, JQ				Ma, Dedong; Zhang, Rong; Sun, Yao; Rios, Hector F.; Haruyama, Naoto; Han, Xianglong; Kulkarni, Ashok B.; Qin, Chunlin; Feng, Jian Q.			A Novel Role of Periostin in Postnatal Tooth Formation and Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; TRANSFORMING GROWTH-FACTOR-BETA-1; SIBLING PROTEINS; PERIODONTAL-LIGAMENT; ENAMEL DEFECTS; NULL MUTATION; MOUSE TEETH; BONE; MICE; SIALOPHOSPHOPROTEIN	Periostin plays multiple functions during development. Our previous work showed a critical role of this disulfide-linked cell adhesion protein in maintenance of periodontium integrity in response to occlusal load. In this study, we attempted to address whether this mechanical response molecule played a direct role in postnatal tooth development. Our key findings are 1) periostin is expressed in preodontoblasts, and odontoblasts; and the periostin-null incisor displayed a massive increase in dentin formation after mastication; 2) periostin is also expressed in the ameloblast cells, and an enamel defect is identified in both the adult-null incisor and molar; 3) deletion of periostin leads to changes in expression profiles of many non-collagenous protein such as DSPP, DMP1, BSP, and OPN in incisor dentin; 4) the removal of a biting force leads to reduction of mineralization, which is partially prevented in periostin-null mice; and 6) both in vitro and in vivo data revealed a direct regulation of periostin by TGF-beta 1 in dentin formation. In conclusion, periostin plays a novel direct role in controlling postnatal tooth formation, which is required for the integrity of both enamel and dentin.	[Ma, Dedong] Shandong Univ, Dept Resp Med, Qilu Hosp, Jinan 250012, Peoples R China; [Ma, Dedong; Zhang, Rong; Sun, Yao; Han, Xianglong; Qin, Chunlin; Feng, Jian Q.] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Zhang, Rong] Fourth Mil Med Univ, Dept Operat Dent & Endodont, Sch Stomatol, Xian 710032, Peoples R China; [Rios, Hector F.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Haruyama, Naoto; Kulkarni, Ashok B.] NIDCR, Funct Genom Sect, NIH, Bethesda, MD 20892 USA	Shandong University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Air Force Military Medical University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Feng, JQ (corresponding author), Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	jfeng@bcd.tamhsc.edu	Haruyama, Naoto/D-1993-2011	Haruyama, Naoto/0000-0001-6225-5816	National Institutes of adhesive molecule [NIH/NIDCR DE015209, DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092, R01DE018486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of adhesive molecule; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of adhesive molecule highly expressed in the PDL, is essential for Health (NIH/NIDCR DE015209 (to J. Q. F.), and DE005092 (to C. Q.)).	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; BENES AJ, 1985, J CELL SCI, V75, P35; BOWERS GN, 1975, CLIN CHEM, V21, P1988; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; DSouza RN, 1995, CONNECT TISSUE RES, V32, P41, DOI 10.3109/03008209509013704; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Haruyama N, 2006, EUR J ORAL SCI, V114, P30, DOI 10.1111/j.1600-0722.2006.00276.x; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; MICHAELI Y, 1968, J DENT RES, V47, P633, DOI 10.1177/00220345680470042101; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; NILSSON BE, 1971, CLIN ORTHOP RELAT R, P179; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Risnes S, 1996, Adv Dent Res, V10, P261; Risnes S, 1995, CONNECT TISSUE RES, V32, P183, DOI 10.3109/03008209509013722; SKOBE Z, 1993, J DENT RES, V72, P46, DOI 10.1177/00220345930720010601; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sreenath TL, 2003, GENESIS, V35, P94, DOI 10.1002/gene.10170; Sreenath TL, 1999, INT J DEV BIOL, V43, P509; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509	36	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4302	4309		10.1074/jbc.M110.140202	http://dx.doi.org/10.1074/jbc.M110.140202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131362	Green Published, hybrid			2022-12-27	WOS:000286975700029
J	Mukherjee, PK; Wiest, A; Ruiz, N; Keightley, A; Moran-Diez, ME; McCluskey, K; Pouchus, YF; Kenerley, CM				Mukherjee, Prasun K.; Wiest, Aric; Ruiz, Nicolas; Keightley, Andrew; Moran-Diez, Maria E.; McCluskey, Kevin; Pouchus, Yves Francois; Kenerley, Charles M.			Two Classes of New Peptaibols Are Synthesized by a Single Non-ribosomal Peptide Synthetase of Trichoderma virens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-FORMING PEPTAIBOLS; SECONDARY METABOLISM; ADENYLATION DOMAINS; FUNGAL METABOLITES; MASS-SPECTROMETRY; FUTURE-PROSPECTS; PEPTAIBIOTICS; BIOSYNTHESIS; ANTIBIOTICS; HYPOCREA	Peptaibols are a group of small peptides having a high alpha-aminoisobutyric acid (Aib) content and produced by filamentous fungi, especially by the members of the genus Trichoderma (anamorph Hypocrea). These antibiotics are economically important for their anti-microbial and anti-cancer properties as well as ability to induce systemic resistance in plants against microbial invasion. In this study we present sequences of two classes (11-residue and 14-residue) of peptaibols produced by the biocontrol fungus Trichoderma virens. Of the 35 11-residue peptaibols sequenced, 18 are hitherto not described, and all the 53 14-residue sequences described by us here are new. We have also identified a peptaibol synthetase (non-ribosomal peptide synthetase, NRPS) with 14 complete modules in the genome of this fungus and disruption of this single gene (designated as tex2) resulted in the loss of both the classes of peptaibols. We, thus present here an unprecedented case where a single NRPS encodes for two classes of peptaibols. The new peptaibols identified here could have applications as therapeutic agents for the management of human and plant health.	[Mukherjee, Prasun K.; Moran-Diez, Maria E.; Kenerley, Charles M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Mukherjee, Prasun K.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India; [Wiest, Aric; McCluskey, Kevin] Univ Missouri, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA; [Ruiz, Nicolas; Pouchus, Yves Francois] Univ Nantes, Fac Pharm, MMS EA 2160, F-44000 Nantes, France; [Keightley, Andrew] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Texas A&M University System; Texas A&M University College Station; Bhabha Atomic Research Center (BARC); University of Missouri System; University of Missouri Kansas City; Nantes Universite; University of Missouri System; University of Missouri Kansas City	Kenerley, CM (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	c-kenerley@tamu.edu	Moran-Diez, Maria E/A-9461-2017	Moran-Diez, Maria E/0000-0003-0253-5669	National Research Initiative [2008-35319-04470]	National Research Initiative(United States Department of Agriculture (USDA))	This project was supported by the National Research Initiative Competitive Grants Program Grant 2008-35319-04470 (to C. M. K.).	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Becker D, 1997, LIEBIGS ANN-RECL, P767; Berg A, 2003, J PEPT SCI, V9, P810, DOI 10.1002/psc.498; Bode HB, 2006, J IND MICROBIOL BIOT, V33, P577, DOI 10.1007/s10295-006-0082-7; Brotman Y, 2010, CURR BIOL, V20, pR390, DOI 10.1016/j.cub.2010.02.042; Chutrakul C, 2008, CHEM BIODIVERS, V5, P1694, DOI 10.1002/cbdv.200890158; Daniel JFD, 2007, NAT PROD REP, V24, P1128, DOI 10.1039/b618086h; Degenkolb T, 2003, J PEPT SCI, V9, P666, DOI 10.1002/psc.497; Degenkolb T, 2008, CHEM BIODIVERS, V5, P1817, DOI 10.1002/cbdv.200890171; Degenkolb T, 2008, CHEM BIODIVERS, V5, P693, DOI 10.1002/cbdv.200890066; Degenkolb T, 2008, CHEM BIODIVERS, V5, P671, DOI 10.1002/cbdv.200890064; Degenkolb T, 2006, J AGR FOOD CHEM, V54, P7047, DOI 10.1021/jf060788q; Duclohier H, 2007, CHEM BIODIVERS, V4, P1023, DOI 10.1002/cbdv.200790094; Engelberth J, 2000, ANGEW CHEM INT EDIT, V39, P1860, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1860::AID-ANIE1860>3.0.CO;2-F; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; IIDA A, 1995, CHEM PHARM BULL, V43, P392, DOI 10.1248/cpb.43.392; Komon-Zelazowska M, 2007, EUKARYOT CELL, V6, P2332, DOI 10.1128/EC.00143-07; Krause C, 2007, CHEM BIODIVERS, V4, P1083, DOI 10.1002/cbdv.200790098; Kubicek CP, 2007, CHEM BIODIVERS, V4, P1068, DOI 10.1002/cbdv.200790097; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Maddau L, 2009, MICROBIOL-SGM, V155, P3371, DOI 10.1099/mic.0.030916-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; Mohamed-Benkada M, 2006, RAPID COMMUN MASS SP, V20, P1176, DOI 10.1002/rcm.2430; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; MUKHERJEE PK, 2008, SOIL BIOL SERIES; Neuhof T, 2007, MICROBIOL-SGM, V153, P3417, DOI 10.1099/mic.0.2007/006692-0; Peltola J, 2004, APPL ENVIRON MICROB, V70, P4996, DOI 10.1128/AEM.70.8.4996-5004.2004; Pruksakorn P, 2010, BIOORG MED CHEM LETT, V20, P3658, DOI 10.1016/j.bmcl.2010.04.100; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; REBUFFAT S, 1995, J CHEM SOC P1, V14, P1849; Ren JW, 2009, J NAT PROD, V72, P1036, DOI 10.1021/np900190w; Ruiz N, 2007, PEPTIDES, V28, P1351, DOI 10.1016/j.peptides.2007.05.012; Sang Yongming, 2008, Animal Health Research Reviews, V9, P227, DOI 10.1017/S1466252308001497; SANSOM MSP, 1993, Q REV BIOPHYS, V26, P365, DOI 10.1017/S0033583500002833; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-26; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; Szekeres A., 2005, Acta Microbiologica et Immunologica Hungarica, V52, P137, DOI 10.1556/AMicr.52.2005.2.2; THOMAS MD, 1989, CURR GENET, V15, P415, DOI 10.1007/BF00376798; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Vizcaino JA, 2006, FOLIA MICROBIOL, V51, P114, DOI 10.1007/BF02932165; WADA S, 1995, CHEM PHARM BULL, V43, P910; Weckwerth W, 2000, J BIOL CHEM, V275, P17909, DOI 10.1074/jbc.M001084200; Wei MC, 2010, CURR ORG CHEM, V14, P1433, DOI 10.2174/138527210791616759; Wei XY, 2005, CAN J MICROBIOL, V51, P423, DOI 10.1139/W05-006; Wenzel SC, 2006, ANGEW CHEM INT EDIT, V45, P2296, DOI 10.1002/anie.200503737; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2005, CHEMBIOCHEM, V6, P375, DOI 10.1002/cbic.200400282; Wiest A, 2002, J BIOL CHEM, V277, P20862, DOI 10.1074/jbc.M201654200; Yun BS, 2000, TETRAHEDRON LETT, V41, P1429, DOI 10.1016/S0040-4039(99)02308-4; Zocher R, 1997, ADV MICROB PHYSIOL, V38, P85	54	65	68	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4544	4554		10.1074/jbc.M110.159723	http://dx.doi.org/10.1074/jbc.M110.159723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123172	Green Published, hybrid			2022-12-27	WOS:000286975700055
J	Pirie, CM; Hackel, BJ; Rosenblum, MG; Wittrup, KD				Pirie, Christopher M.; Hackel, Benjamin J.; Rosenblum, Michael G.; Wittrup, K. Dane			Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; SINGLE-CHAIN IMMUNOTOXIN; CARCINOEMBRYONIC ANTIGEN; PSEUDOMONAS EXOTOXIN; MONOCLONAL-ANTIBODIES; QUANTITATIVE-ANALYSIS; SYNTHESIS INHIBITION; CYTOTOXIC ACTIVITY; COLORECTAL-CANCER; DIPHTHERIA-TOXIN	Gelonin-based immunotoxins vary widely in their cytotoxic potency as a function of antigen density, target cell internalization and trafficking kinetics, and conjugate properties. We have synthesized novel gelonin immunotoxins using two different binding scaffold types (single-chain antibody variable fragments and fibronectin domains) targeting two different tumor antigens (carcinoembryonic antigen and EGF receptor). Constructs were characterized using an antigen-negative cell line (HT-1080), cell lines positive for each antigen (HT-1080(CEA) for carcinoembryonic antigen and A431 for EGF receptor), and a cell line positive for both antigens (HT-29). Immunotoxins exhibited K-d values between 8 and 15 nM and showed 20-2000-fold enhanced cytotoxicity compared with gelonin (IC50 similar to 0.25-30 nM versus 500 nM). Using quantitative fluorescence flow cytometry, we measured internalization of gelonin (via pinocytosis) and gelonin-based immunotoxins (via antigen-dependent, receptor-mediated endocytosis). Results were matched with cytotoxicity measurements made at equivalent concentration and exposures. Unexpectedly, when matched internalization and cytotoxicity data were combined, a conserved internalized cytotoxicity curve was generated that was common across experimental conditions. Considerable variations in antigen expression, trafficking kinetics, extracellular immunotoxin concentration, and exposure time were all found to collapse to a single potency curve on the basis of internalized immunotoxin. Fifty percent cytotoxicity occurred when similar to 5 x 10(6) toxin molecules were internalized regardless of the mechanism of uptake. Cytotoxicity observed at a threshold internalization was consistent with the hypothesis that endosomal escape is a common, highly inefficient, rate-limiting step following internalization by any means tested. Methods designed to enhance endosomal escape might be utilized to improve the potency of gelonin-based immunotoxins.	[Pirie, Christopher M.; Wittrup, K. Dane] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Hackel, Benjamin J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Wittrup, K. Dane] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Rosenblum, Michael G.] Univ Texas Houston, MD Anderson Canc Ctr, Immunopharmacol & Targeted Therapy Lab, Dept Expt Therapeut, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Wittrup, KD (corresponding author), 400 Main St,E19-551, Cambridge, MA 02142 USA.	wittrup@mit.edu			National Institutes of Health [CA96504, CA101830]; Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA101830, R01CA096504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA96504 and CA101830. This work was also supported by a pilot project grant from the Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence and by National Science Foundation graduate research fellowships (to C. M. P. and B. J. H.).	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Akamatsu Y, 1998, CLIN CANCER RES, V4, P2825; AVILA AD, 1989, INT J CANCER, V43, P926, DOI 10.1002/ijc.2910430533; Beers R, 2000, CLIN CANCER RES, V6, P2835; Boehm MK, 2000, BIOCHEM J, V346, P519, DOI 10.1042/0264-6021:3460519; Chan MC, 1999, CANCER IMMUNOL IMMUN, V47, P321, DOI 10.1007/s002620050537; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chiron MF, 1997, J BIOL CHEM, V272, P31707, DOI 10.1074/jbc.272.50.31707; Convertine AJ, 2009, J CONTROL RELEASE, V133, P221, DOI 10.1016/j.jconrel.2008.10.004; Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579; DiMassimo AM, 1997, BRIT J CANCER, V75, P822, DOI 10.1038/bjc.1997.147; Du X, 2008, CANCER RES, V68, P6300, DOI 10.1158/0008-5472.CAN-08-0461; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GOLDMACHER VS, 1989, J CELL PHYSIOL, V141, P222, DOI 10.1002/jcp.1041410129; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Keller J, 2001, J CONTROL RELEASE, V74, P259, DOI 10.1016/S0168-3659(01)00329-7; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, METH MOL B, V352, P95; KONDO T, 1988, J BIOL CHEM, V263, P9470; Kraeber-Bodere F, 2006, J NUCL MED, V47, P247; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kreitman RJ, 2009, J CLIN ONCOL, V27, P2983, DOI 10.1200/JCO.2008.20.2630; LAMBERT JM, 1985, J BIOL CHEM, V260, P2035; LEVIN LV, 1987, CANCER IMMUNOL IMMUN, V24, P202; Liu Z., 2010, ASCR 101 ANN M WASH; MAY RD, 1991, CELL IMMUNOL, V135, P490, DOI 10.1016/0008-8749(91)90292-J; NEVILLE DM, 1989, J BIOL CHEM, V264, P14653; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; PREIJERS FWMB, 1988, BRIT J HAEMATOL, V70, P289, DOI 10.1111/j.1365-2141.1988.tb02484.x; Rathore D, 1996, BIOCHEM BIOPH RES CO, V222, P58, DOI 10.1006/bbrc.1996.0697; REITER Y, 1994, J BIOL CHEM, V269, P18327; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Rosenblum MG, 2003, CANCER RES, V63, P3995; ROSENBLUM MG, 1995, J INTERF CYTOK RES, V15, P547, DOI 10.1089/jir.1995.15.547; Schmidt MM, 2008, CANCER IMMUNOL IMMUN, V57, P1879, DOI 10.1007/s00262-008-0518-1; SCOTT CF, 1987, INT J IMMUNOPHARMACO, V9, P211, DOI 10.1016/0192-0561(87)90096-8; SEETHARAM S, 1991, J BIOL CHEM, V266, P17376; Sharma SK, 2005, CLIN CANCER RES, V11, P814; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STIRPE F, 1980, J BIOL CHEM, V255, P6947; Thompson J, 2001, PROTEIN ENG, V14, P1035, DOI 10.1093/protein/14.12.1035; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Wegener WA, 2000, J NUCL MED, V41, P1016; Wenning LA, 1999, BIOTECHNOL BIOENG, V62, P562; Wenning LA, 1998, BIOTECHNOL BIOENG, V57, P484, DOI 10.1002/(SICI)1097-0290(19980220)57:4<484::AID-BIT13>3.0.CO;2-C; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; YAZDI PT, 1994, CANCER RES, V54, P6387; Zhang M, 2007, ANTICANCER RES, V27, P35	50	60	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4165	4172		10.1074/jbc.M110.186973	http://dx.doi.org/10.1074/jbc.M110.186973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138845	hybrid, Green Published			2022-12-27	WOS:000286975700015
J	Sousa, IP; Carvalho, CAM; Ferreira, DF; Weissmuller, G; Rocha, GM; Silva, JL; Gomes, AMO				Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Ferreira, Davis F.; Weissmueller, Gilberto; Rocha, Gustavo M.; Silva, Jerson L.; Gomes, Andre M. O.			Envelope Lipid-packing as a Critical Factor for the Biological Activity and Stability of Alphavirus Particles Isolated from Mammalian and Mosquito Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; SINDBIS VIRUS; IMMUNODEFICIENCY-VIRUS; MEMBRANE CHOLESTEROL; INFLUENZA-VIRUS; LAURDAN FLUORESCENCE; PLASMA-MEMBRANE; LOW-PH; ENTRY; PROTEINS	Alphaviruses are enveloped arboviruses. The viral envelope is derived from the host cell and is positioned between two icosahedral protein shells (T = 4). Because the viral envelope contains glycoproteins involved in cell recognition and entry, the integrity of the envelope is critical for the success of the early events of infection. Differing levels of cholesterol in different hosts leads to the production of alphaviruses with distinct levels of this sterol loaded in the envelope. Using Mayaro virus, a New World alphavirus, we investigated the role of cholesterol on the envelope of alphavirus particles assembled in either mammalian or mosquito cells. Our results show that although quite different in their cholesterol content, Mayaro virus particles obtained from both cells share a similar high level of lateral organization in their envelopes. This organization, as well as viral stability and infectivity, is severely compromised when cholesterol is depleted from the envelope of virus particles isolated from mammalian cells, but virus particles isolated from mosquito cells are relatively unaffected by cholesterol depletion. We suggest that it is not cholesterol itself, but rather the organization of the viral envelope, that is critical for the biological activity of alphaviruses.	[Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21341902 Rio De Janeiro, Brazil; [Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21341902 Rio De Janeiro, Brazil; [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, BR-21341902 Rio De Janeiro, Brazil; [Weissmueller, Gilberto; Rocha, Gustavo M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21341902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gomes, AMO (corresponding author), Ave Carlos Chagas Filho,373 CCS Rm E1-008,Cidade, BR-21941902 Rio De Janeiro, Brazil.	amog@bioqmed.ufrj.br	Sousa, ivanildo/ABC-1067-2020; Sousa, Ivanildo/HCH-7825-2022; Gomes, Andre M.O./C-4009-2014; Ferreira, Davis/D-9356-2014; SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014	Sousa, Ivanildo/0000-0003-1840-3302; Gomes, Andre M.O./0000-0003-1052-8004; SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; Carvalho, Carlos/0000-0001-6615-1387	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	The work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio (FUJB), Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX).	Bagatolli LA, 2003, METHOD ENZYMOL, V360, P481; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Clayton RB, 1964, J LIPID RES, V15, P3; Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009; He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10; Huang HL, 2006, J GEN VIROL, V87, P277, DOI 10.1099/vir.0.81551-0; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; LUUKKONEN A, 1976, BIOCHIM BIOPHYS ACTA, V450, P109, DOI 10.1016/0005-2760(76)90082-5; LUUKKONEN A, 1977, VIROLOGY, V78, P331, DOI 10.1016/0042-6822(77)90105-2; MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57; MEZENCIO JMS, 1993, MEM I OSWALDO CRUZ, V88, P299, DOI 10.1590/S0074-02761993000200020; MOORE NF, 1976, J VIROL, V19, P126, DOI 10.1128/JVI.19.1.126-135.1976; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Polozov IV, 2004, BIOPHYS J, V87, P1741, DOI 10.1529/biophysj.104.040725; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; RECEVEUR MC, 2010, EUROSURVEILLANCE, V15, pP11; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SEFTON BM, 1974, J MOL BIOL, V90, P343, DOI 10.1016/0022-2836(74)90378-7; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070; Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	49	16	17	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1730	1736		10.1074/jbc.M110.198002	http://dx.doi.org/10.1074/jbc.M110.198002			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075845	hybrid, Green Published			2022-12-27	WOS:000286191500012
J	Iftikhar, M; Hurtado, P; Bais, MV; Wigner, N; Stephens, DN; Gerstenfeld, LC; Trackman, PC				Iftikhar, Mussadiq; Hurtado, Paola; Bais, Manish V.; Wigner, Nate; Stephens, Danielle N.; Gerstenfeld, Louis C.; Trackman, Philip C.			Lysyl Oxidase-like-2 (LOXL2) Is a Major Isoform in Chondrocytes and Is Critically Required for Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATIVE CARTILAGE REPAIR; TUMOR-SUPPRESSOR ACTIVITY; CHONDROGENIC CELL-LINE; ARTICULAR-CARTILAGE; COLLAGEN NETWORK; GROWTH-FACTOR; MECHANICAL-PROPERTIES; PROPEPTIDE DOMAIN; FRACTURE CALLUS; BONE-FORMATION	The lysyl oxidase family is made up of five members: lysyl oxidase (LOX) and lysyl oxidase-like 1-4 (LOXL1-LOXL4). All members share conserved C-terminal catalytic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and more divergent propeptide regions. LOX family enzyme activities catalyze the final enzymatic conversion required for the formation of normal biosynthetic collagen and elastin cross-links. The importance of lysyl oxidase enzyme activity to normal bone development has long been appreciated, but regulation and roles for specific LOX isoforms in bone formation in vivo is largely unexplored. Fracture healing recapitulates aspects of endochondral bone development. The present study first investigated the expression of all LOX isoforms in fracture healing. A remarkable coincidence of LOXL2 expression with the chondrogenic phase of fracture healing was found, prompting more detailed analyses of LOXL2 expression in normal growth plates, and LOXL2 expression and function in developing ATDC5 chondrogenic cells. Data show that LOXL2 is expressed by pre-hypertrophic and hypertrophic chondrocytes in vivo, and that LOXL2 expression is regulated in vitro as a function of chondrocyte differentiation. Moreover, LOXL2 knockdown studies in vitro show that LOXL2 expression is required for ATDC5 chondrocyte cell line differentiation through regulation of SNAIL and SOX9, important transcription factors that control chondrocyte differentiation. Taken together, data provide evidence that LOXL2, like LOX, is a multifunctional protein. LOXL2 promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation.	[Iftikhar, Mussadiq; Hurtado, Paola; Bais, Manish V.; Stephens, Danielle N.; Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA; [Bais, Manish V.; Wigner, Nate; Gerstenfeld, Louis C.] Boston Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02118 USA	Boston University; Boston University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St,W-201, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; /0000-0002-0477-1211; Bais, Manish/0000-0003-4198-7377; Buckley, Paola/0000-0002-7501-8753	National Institutes of Health, NIDCR [R01 DE 14066]; National Institutes of Health, NIAMS [P01AR049920, AR044927]; Dept. of Defense [DAMD17-03-1-0576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049920, R01AR044927, R56AR044927, R29AR044927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dept. of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants NIDCR R01 DE 14066 (to P. C. T.) and NIAMS P01AR049920 and AR044927 (to L. C. G.), and the Dept. of Defense Grant DAMD17-03-1-0576 (to L. C. G.).	Ahsan T, 1999, J ORTHOPAED RES, V17, P850, DOI 10.1002/jor.1100170610; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Ford JL, 2004, J ORTHOP RES, V22, P368, DOI 10.1016/j.orthres.2003.08.010; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2006, J HISTOCHEM CYTOCHEM, V54, P1215, DOI 10.1369/jhc.6A6959.2006; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Ito H, 2001, J BIOL CHEM, V276, P24023, DOI 10.1074/jbc.M100861200; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kagan HM, 1986, REGULATION MATRIX AC, P321; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; LEES S, 1990, CONNECT TISSUE RES, V24, P95, DOI 10.3109/03008209009152426; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; McGowan KB, 2005, J ORTHOP RES, V23, P594, DOI 10.1016/j.orthres.2004.02.015; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Nakatani S, 2007, BIOL PHARM BULL, V30, P433, DOI 10.1248/bpb.30.433; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; SELYE H., 1957, REV CANADIENNE BIOL, V16, P1; TANG SS, 1983, J BIOL CHEM, V258, P4331; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776	51	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					909	918		10.1074/jbc.M110.155622	http://dx.doi.org/10.1074/jbc.M110.155622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071451	Green Published, hybrid			2022-12-27	WOS:000286005000002
J	Laaberki, MH; Pfeffer, J; Clarke, AJ; Dworkin, J				Laaberki, Maria-Halima; Pfeffer, John; Clarke, Anthony J.; Dworkin, Jonathan			O-Acetylation of Peptidoglycan Is Required for Proper Cell Separation and S-layer Anchoring in Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL POLYSACCHARIDE; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PEPTIDOGLYCAN; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE; ENTEROCOCCUS-FAECALIS; LYSOZYME RESISTANCE; MUREIN HYDROLASES; ESCHERICHIA-COLI; LYTIC ACTIVITY	O-Acetylation of the MurNAc moiety of peptidoglycan is typically associated with bacterial resistance to lysozyme, a muramidase that serves as a central component of innate immunity. Here, we report that the peptidoglycan of Bacillus anthracis, the etiological agent of anthrax, is O-acetylated and that, unusually, this modification is produced by two unrelated families of O-acetyltransferases. Also, in contrast to other bacteria, O-acetylation of B. anthracis peptidoglycan is combined with N-deacetylation to confer resistance of cells to lysozyme. Activity of the Pat O-acetyltransferases is required for the separation of the daughter cells following bacterial division and for anchoring of one of the major S-layer proteins. Our results indicate that peptidoglycan O-acetylation modulates endogenous muramidase activity affecting the cell-surface properties and morphology of this important pathogen.	Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Pfeffer, John; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Columbia University; University of Guelph	Dworkin, J (corresponding author), 701 W 168th St,Rm 1218, New York, NY 10032 USA.	jonathan.dworkin@columbia.edu	Laaberki, Maria-Halima/M-6369-2014	Laaberki, Maria-Halima/0000-0001-5796-5995	National Institutes of Health [AI76841]; Irma; Canadian Institutes of Health Research [MOP 81223]; Natural Sciences and Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI76841 and an Irma T. Hirschl Scholar award (to J.D.), by operating Grant MOP 81223 (to A. J. C.) from the Canadian Institutes of Health Research, and by a postgraduate scholarship (PGS D) (to J. P.) from the Natural Sciences and Research Council of Canada.	Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Clarke A. J., 2000, GLYCOMICROBIOLOGY; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Dommett R, 2005, MOL IMMUNOL, V42, P903, DOI 10.1016/j.molimm.2004.12.004; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Dunn AK, 2003, APPL ENVIRON MICROB, V69, P1197, DOI 10.1128/AEM.69.2.1197-1205.2003; Franklin MJ, 2004, J BACTERIOL, V186, P4759, DOI 10.1128/JB.186.14.4759-4773.2004; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; KEMPER MA, 1993, J BACTERIOL, V175, P5690, DOI 10.1128/JB.175.17.5690-5696.1993; Laaberki MH, 2008, J BACTERIOL, V190, P6197, DOI 10.1128/JB.00623-08; Langer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003706; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Rollins SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001824; ROSENTHAL RS, 1983, INFECT IMMUN, V40, P903, DOI 10.1128/IAI.40.3.903-911.1983; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Shatalin KY, 2005, FEMS MICROBIOL LETT, V245, P315, DOI 10.1016/j.femsle.2005.03.029; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Strating H, 2001, ANAL BIOCHEM, V291, P149, DOI 10.1006/abio.2001.5007; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	52	57	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5278	5288		10.1074/jbc.M110.183236	http://dx.doi.org/10.1074/jbc.M110.183236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135105	Green Published, hybrid			2022-12-27	WOS:000287230600036
J	Papadopoulos, C; Arato, K; Lilienthal, E; Zerweck, J; Schutkowski, M; Chatain, N; Muller-Newen, G; Becker, W; de la Luna, S				Papadopoulos, Chrisovalantis; Arato, Krisztina; Lilienthal, Eva; Zerweck, Johannes; Schutkowski, Mike; Chatain, Nicolas; Mueller-Newen, Gerhard; Becker, Walter; de la Luna, Susana			Splice Variants of the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 4 (DYRK4) Differ in Their Subcellular Localization and Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENE-EXPRESSION; APOPTOTIC RESPONSE; GLYCOGEN-SYNTHASE; SERINE RESIDUE; CELL-SURVIVAL; DNA-DAMAGE; FAMILY; ACTIVATION; SUBSTRATE	Dual specificity tyrosine phosphorylation-regulated kinases, DYRKs, are a family of conserved protein kinases that play key roles in the regulation of cell differentiation, proliferation, and survival. Of the five mammalian DYRKs, DYRK4 is the least studied family member. Here, we show that several splice variants of DYRK4 are expressed in tissue-specific patterns and that these variants have distinct functional capacities. One of these variants contains a nuclear localization signal in its extended N terminus that mediates its interaction with importin alpha 3 and alpha 5 and that is capable of targeting a heterologous protein to the nucleus. Consequently, the nucleocytoplasmic mobility of this variant differs from that of a shorter isoform in live cell imaging experiments. Other splicing events affect the catalytic domain, including a three-amino acid deletion within subdomain XI that markedly reduces the enzymatic activity of DYRK4. We also show that autophosphorylation of a tyrosine residue within the activation loop is necessary for full DYRK4 kinase activity, a defining feature of the DYRK family. Finally, by comparing the phosphorylation of an array of 720 peptides, we show that DYRK1A, DYRK2, and DYRK4 differ in their target recognition sequence and that preference for an arginine residue at position P - 3 is a feature of DYRK1A but not of DYRK2 and DYRK4. Therefore, we highlight the use of subcellular localization as an important regulatory mechanism for DYRK proteins, and we propose that substrate specificity could be a source of functional diversity among DYRKs.	[Papadopoulos, Chrisovalantis; Arato, Krisztina; de la Luna, Susana] Univ Pompeu Fabra, Genes & Dis Program, Ctr Genom Regulat, Barcelona 08003, Spain; [Papadopoulos, Chrisovalantis; Lilienthal, Eva; Becker, Walter] Rheinisch Westfael Tech Hsch Aachen Univ, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany; [Arato, Krisztina; de la Luna, Susana] Ctr Invest Biomed Red Enfermedades Raras, Barcelona 08003, Spain; [Chatain, Nicolas; Mueller-Newen, Gerhard] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Biochem, D-52074 Aachen, Germany; [Zerweck, Johannes; Schutkowski, Mike] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Saale, Germany; [de la Luna, Susana] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); RWTH Aachen University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; RWTH Aachen University; Martin Luther University Halle Wittenberg; ICREA	de la Luna, S (corresponding author), Ctr Regulacio Genom CRG, Dr Aiguader 88, Barcelona 08003, Spain.	susana.luna@crg.es	Becker, Walter/B-8889-2008; Arató, Krisztina/AAB-6057-2019; Arató, Krisztina/M-7505-2015; de la Luna, Susana/E-9553-2015	Becker, Walter/0000-0002-0347-4768; Arató, Krisztina/0000-0003-0366-0998; Arató, Krisztina/0000-0003-0366-0998; de la Luna, Susana/0000-0001-7765-916X; Schutkowski, MIke/0000-0003-0919-7076	Spanish Ministry of Science and Innovation [BFU2007-61043, BFU2010-15347]; Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya [2009SGR1464]; Deutsche Forschungsgemeinschaft [SFB 542, B12, Z1, BE-1967/2-1]; German Academic Exchange Service DAAD; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya(Generalitat de Catalunya); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Innovation Grant BFU2007-61043 and BFU2010-15347 (to S. L.), Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya Grant 2009SGR1464 (to S. L.), Deutsche Forschungsgemeinschaft SFB 542, Projects B12 and Z1 (to G. M.-N.) and BE-1967/2-1 (to W. B.), and the German Academic Exchange Service DAAD doctoral fellowship (to C. P.).	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Alvarez M, 2007, MOL BIOL CELL, V18, P1167, DOI 10.1091/mbc.E06-08-0668; Aranda S., 2011, FASEB J IN PRESS; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Kassis S, 2000, BIOCHEM J, V348, P263, DOI 10.1042/0264-6021:3480263; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kinstrie R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000579; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leder S, 2003, BIOCHEM J, V372, P881, DOI 10.1042/BJ20030182; Lee K, 2000, CANCER RES, V60, P3631; Leypoldt F, 2001, J NEUROCHEM, V76, P806, DOI 10.1046/j.1471-4159.2001.00079.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Nakai Kenta, 2007, V390, P429; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Raich WB, 2003, GENETICS, V163, P571; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sacher F, 2007, MOL CELL ENDOCRINOL, V267, P80, DOI 10.1016/j.mce.2006.12.041; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Sitz JH, 2004, MOL CELL BIOL, V24, P5821, DOI 10.1128/MCB.24.13.5821-5834.2004; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021	48	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5494	5505		10.1074/jbc.M110.157909	http://dx.doi.org/10.1074/jbc.M110.157909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127067	Green Published, hybrid			2022-12-27	WOS:000287230600059
J	Shirakawa, T; Kawazoe, Y; Tsujikawa, T; Jung, DJ; Sato, S; Uesugi, M				Shirakawa, Takashi; Kawazoe, Yoshinori; Tsujikawa, Tomoko; Jung, Dongju; Sato, Shin-ichi; Uesugi, Motonari			Deactivation of STAT6 through Serine 707 Phosphorylation by JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASE; C-JUN; DNA-BINDING; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INTERLEUKIN-4-INDUCED TRANSCRIPTION; MAMMALIAN-CELLS; KAPPA-B; IL-4	Signal transducer and activator of transcription 6 (STAT6), which plays a critical role in immune responses, is activated by interleukin-4 (IL-4). Activity of STAT family members is regulated primarily by tyrosine phosphorylations and possibly also by serine phosphorylations. Here, we report a previously undescribed serine phosphorylation of STAT6, which is activated by cell stress or by the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta). Our analyses suggest that Ser-707 is phosphorylated by c-Jun N-terminal kinase (JNK). Phosphorylation decreases the DNA binding ability of IL-4-stimulated STAT6, thereby inhibiting the transcription of STAT6-responsive genes. Inactivation of STAT6 by JNK-dependent Ser-707 phosphorylation may be one mechanism of controlling the balance between IL-1 beta and IL-4 signals.	[Kawazoe, Yoshinori; Tsujikawa, Tomoko; Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Shirakawa, Takashi; Jung, Dongju; Sato, Shin-ichi; Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Uesugi, M (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	uesugi@scl.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020		JSPS [21310140, 20611007]; Uehara Memorial Foundation; Naito Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	This work was supported in part by grants from JSPS (21310140, to M. U., and 20611007, to Y. K.), the Uehara Memorial Foundation (to M. U.), and the Naito Foundation (to S. S.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Cowley DO, 2000, GENE DEV, V14, P366; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Golks A, 2008, EMBO REP, V9, P748, DOI 10.1038/embor.2008.129; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; GUPTA RK, 1995, J PEDIATR-US, V126, P389, DOI 10.1016/S0022-3476(95)70454-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Losman JA, 1999, J IMMUNOL, V162, P3770; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL SW, 1994, NEW ZEAL MED J, V107, P434; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Uciechowski P, 1996, FEBS LETT, V394, P273, DOI 10.1016/0014-5793(96)00967-2; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Yamagishi S, 2001, J BIOL CHEM, V276, P5129, DOI 10.1074/jbc.M007258200; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	58	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4003	4010		10.1074/jbc.M110.168435	http://dx.doi.org/10.1074/jbc.M110.168435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123173	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000286653200080
J	Bairwa, NK; Mohanty, BK; Stamenova, R; Curcio, MJ; Bastia, D				Bairwa, Narendra K.; Mohanty, Bidyut K.; Stamenova, Radostina; Curcio, M. Joan; Bastia, Deepak			The Intra-S Phase Checkpoint Protein Tof1 Collaborates with the Helicase Rrm3 and the F-box Protein Dia2 to Maintain Genome Stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REGULATES DNA-REPLICATION; TRANSFER-RNA GENES; MRC1; DAMAGE; YEAST; FORK; COMPLEXES; REPAIR; TY1	The intra-S phase checkpoint protein complex Tof1/Csm3 of Saccharomyces cerevisiae antagonizes Rrm3 helicase to modulate replication fork arrest not only at the replication termini of rDNA but also at strong nonhistone protein binding sites throughout the genome. We investigated whether these checkpoint proteins acted either antagonistically or synergistically with Rrm3 in mediating other important functions such as maintenance of genome stability. High retromobility of a normally quiescent retrovirus-like transposable element Ty1 of S. cerevisiae is a form of genome instability, because the transposition events induce mutations. We measured the transposition of Ty1 in various genetic backgrounds and discovered that Tof1 suppressed excessive retromobility in collaboration with either Rrm3 or the F-box protein Dia2. Although both Rrm3 and Dia2 are believed to facilitate fork movement, fork stalling at DNA-protein complexes did not appear to be a major contributor to enhancement of retromobility. Absence of the aforementioned proteins either individually or in pair-wise combinations caused karyotype changes as revealed by the altered migrations of the individual chromosomes in pulsed field gels. The mobility changes were RNase H-resistant and therefore, unlikely to have been caused by extensive R loop formation. These mutations also resulted in alterations of telomere lengths. However, the latter changes could not fully account for the magnitude of the observed karyotypic alterations. We conclude that unlike other checkpoint proteins that are known to be required for elevated retromobility, Tof1 suppressed high frequency retrotransposition and maintained karyotype stability in collaboration with the aforementioned proteins.	[Bairwa, Narendra K.; Mohanty, Bidyut K.; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Curcio, M. Joan] Wadsworth Ctr, Mol Genet Lab, Albany, NY 12208 USA; [Stamenova, Radostina] SUNY Albany, Dept Biomed Sci, New York, NY 12208 USA	Medical University of South Carolina; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu		Curcio, M. Joan/0000-0001-5361-3909	National Institutes of Health [GM049264, GM049264-17S1, GM52072]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264, R01GM052072, R29GM052072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049264 and GM049264-17S1 (to D.B.) and by GM52072 (to M.J.C.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Bessler JB, 2004, GENETICS, V168, P1205, DOI 10.1534/genetics.104.028035; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; CHRISTMAN MF, 1993, P NATL ACAD SCI USA, V90, P7637, DOI 10.1073/pnas.90.16.7637; Curcio MJ, 2007, MOL CELL BIOL, V27, P8874, DOI 10.1128/MCB.01095-07; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Foss EJ, 2001, GENETICS, V157, P567; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Mou ZM, 2006, GENETICS, V172, P2157, DOI 10.1534/genetics.105.054072; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Razidlo DF, 2008, DNA REPAIR, V7, P633, DOI 10.1016/j.dnarep.2008.01.009; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; Scholes DT, 2001, GENETICS, V159, P1449; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Stamenova R, 2009, GENETICS, V182, P711, DOI 10.1534/genetics.109.104208; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004	44	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2445	2454		10.1074/jbc.M110.189456	http://dx.doi.org/10.1074/jbc.M110.189456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087929	hybrid, Green Published			2022-12-27	WOS:000286464300008
J	Brown, BL; Wood, TK; Peti, W; Page, R				Brown, Breann L.; Wood, Thomas K.; Peti, Wolfgang; Page, Rebecca			Structure of the Escherichia coli Antitoxin MqsA (YgiT/b3021) Bound to Its Gene Promoter Reveals Extensive Domain Rearrangements and the Specificity of Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MULTIDRUG TOLERANCE; NUCLEIC-ACID; TOXIN; COMPLEX; MECHANISMS; PROTEIN; RECOGNITION; RESISTANCE; OPERON	Bacterial cultures, especially biofilms, produce a small number of persister cells, a genetically identical subpopulation of wild type cells that are metabolically dormant, exhibit multidrug tolerance, and are highly enriched in bacterial toxins. The gene most highly up-regulated in Escherichia coli persisters is mqsR, a ribonuclease toxin that, along with mqsA, forms a novel toxin.antitoxin (TA) system. Like all known TA systems, both the MqsR.MqsA complex and MqsA alone regulate their own transcription. Despite the importance of TA systems in persistence and biofilms, very little is known about how TA modules, and antitoxins in particular, bind and recognize DNA at a molecular level. Here, we report the crystal structure of MqsA bound to a 26-bp fragment from the mqsRA promoter. We show that MqsA binds DNA predominantly via its C-terminal helix-turn-helix domain, with direct binding of recognition helix residues Asn(97) and Arg(101) to the DNA major groove. Unexpectedly, the structure also revealed that the MqsA N-terminal domain interacts with the DNA phosphate backbone. This results in a more than 105 degrees rotation of the N-terminal domains between the free and complexed states, an unprecedented rearrangement for an antitoxin. The structure also shows that MqsA bends the DNA by more than 55 degrees in order to achieve symmetrical binding. Finally, using a combination of biochemical and NMR studies, we show that the DNA sequence specificity of MqsA is mediated by direct readout.	[Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Brown, Breann L.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Wood, Thomas K.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA	Brown University; Brown University; Texas A&M University System; Texas A&M University College Station	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box GE-4, Providence, RI 02912 USA.	rebecca_page@brown.edu	Wood, Thomas/GWZ-2481-2022; Peti, Wolfgang/L-3492-2014	Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X	National Institutes of Health [F31 NS062630]; National Science Foundation [MCB-0952550]; Offices of Biological and Environmental Research; Offices of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research; Offices of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant F31 NS062630 (to B. L. B.). This work was also supported by National Science Foundation CAREER Award MCB-0952550 (to R. P.).; Data for this study were measured at beamline X25 of the National Synchrotron Light Source (supported principally by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and by the National Center for Research Resources of the National Institutes of Health).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brown BL, 2010, ACTA CRYSTALLOGR F, V66, P1060, DOI 10.1107/S1744309110028617; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Cos P, 2010, CURR PHARM DESIGN, V16, P2279, DOI 10.2174/138161210791792868; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DEFEYTER R, 1989, MOL GEN GENET, V218, P481, DOI 10.1007/BF00332413; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HIRAGA S, 1986, J BACTERIOL, V166, P100, DOI 10.1128/jb.166.1.100-104.1986; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lawson CL, 2008, RSC BIOMOL SCI, P66; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Little EJ, 2008, STRUCTURE, V16, P1828, DOI 10.1016/j.str.2008.09.009; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos E, 2007, BIOMOL NMR ASSIGM, V1, P217, DOI 10.1007/s12104-007-9060-x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904	58	50	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2285	2296		10.1074/jbc.M110.172643	http://dx.doi.org/10.1074/jbc.M110.172643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068382	hybrid, Green Published			2022-12-27	WOS:000286191500068
J	Mattera, R; Boehm, M; Chaudhuri, R; Prabhu, Y; Bonifacino, JS				Mattera, Rafael; Boehm, Markus; Chaudhuri, Rittik; Prabhu, Yogikala; Bonifacino, Juan S.			Conservation and Diversification of Dileucine Signal Recognition by Adaptor Protein (AP) Complex Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; LINKED MENTAL-RETARDATION; VIRUS TYPE-1 NEF; CD4 DOWN-REGULATION; CLATHRIN ADAPTER; SORTING SIGNALS; GAMMA-ADAPTIN; HIV-1 NEF; STRUCTURAL EXPLANATION; APPENDAGE DOMAIN	The clathrin-associated, heterotetrameric adaptor protein (AP) complexes, AP-1, AP-2, and AP-3, recognize signals in the cytosolic domains of transmembrane proteins, leading to their sorting to endosomes, lysosomes, lysosome-related organelles, and/or the basolateral membrane of polarized epithelial cells. One type of signal, referred to as "dileucine-based," fits the consensus motif (D/E)XXXL(L/I). Previous biochemical analyses showed that (D/E)XXXL(L/I) signals bind to a combination of two subunits of each AP complex, namely the AP-1 gamma-sigma 1, AP-2 alpha-sigma 2, and AP-3 delta-sigma 3 hemicomplexes, and structural studies revealed that an imperfect variant of this motif lacking the (D/E) residue binds to a site straddling the interface of alpha and sigma 2. Herein, we report mutational and binding analyses showing that canonical (D/E)XXXL(L/I) signals bind to this same site on AP-2, and to similar sites on AP-1 and AP-3. The strength and amino acid requirements of different interactions depend on the specific signals and AP complexes involved. We also demonstrate the occurrence of diverse AP-1 heterotetramers by combinatorial assembly of various gamma and sigma 1 subunit isoforms encoded by different genes. These AP-1 variants bind (D/E)XXXL(L/I) signals with marked preferences for certain sequences, implying that they are not functionally equivalent. Our results thus demonstrate that different AP complexes share a conserved binding site for (D/E)XXXL(L/I) signals. However, the characteristics of the binding site on each complex vary, providing for the specific recognition of a diverse repertoire of (D/E)XXXL(L/I) signals.	[Mattera, Rafael; Boehm, Markus; Chaudhuri, Rittik; Prabhu, Yogikala; Bonifacino, Juan S.] NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BONIFACINO JS, 2001, CURR PROTOC CELL BIO, V1; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chuang E, 1997, J IMMUNOL, V159, P144; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Li W, 2010, CLEFT PALATE-CRAN J, V47, P566, DOI 10.1597/09-145; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Owen DJ, 2001, TRAFFIC, V2, P105, DOI 10.1034/j.1600-0854.2001.020205.x; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saillour Y, 2007, J MED GENET, V44, P739, DOI 10.1136/jmg.2007.051334; Simmen T, 1999, J CELL SCI, V112, P45; Stephens DJ, 1997, J BIOL CHEM, V272, P14104, DOI 10.1074/jbc.272.22.14104; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	56	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2022	2030		10.1074/jbc.M110.197178	http://dx.doi.org/10.1074/jbc.M110.197178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097499	hybrid, Green Published			2022-12-27	WOS:000286191500044
J	Renigunta, A; Renigunta, V; Saritas, T; Decher, N; Mutig, K; Waldegger, S				Renigunta, Aparna; Renigunta, Vijay; Saritas, Turgay; Decher, Niels; Mutig, Kerim; Waldegger, Siegfried			Tamm-Horsfall Glycoprotein Interacts with Renal Outer Medullary Potassium Channel ROMK2 and Regulates Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIATED ESCHERICHIA-COLI; UROMODULIN STORAGE DISEASES; THICK ASCENDING LIMB; PROTEIN; EXPRESSION; MICE; GENE; TRANSPORT; MUTATIONS; ER	Tamm-Horsfall glycoprotein (THGP) or Uromodulin is a membrane protein exclusively expressed along the thick ascending limb (TAL) and early distal convoluted tubule (DCT) of the nephron. Mutations in the THGP encoding gene result in Familial Juvenile Hyperuricemic Nephropathy (FJHN), Medullary Cystic Kidney Disease type 2 (MCKD-2), and Glomerulocystic Kidney Disease (GCKD). The physicochemical and biological properties of THGP have been studied extensively, but its physiological function in the TAL remains obscure. We performed yeast two-hybrid screening employing a human kidney cDNA library and identified THGP as a potential interaction partner of the renal outer medullary potassium channel (ROMK2), a key player in the process of salt reabsorption along the TAL. Functional analysis by electrophysiological techniques in Xenopus oocytes showed a strong increase in ROMK current amplitudes when co-expressed with THGP. The effect of THGP was specific for ROMK2 and did not influence current amplitudes upon co-expression with Kir2.x, inward rectifier potassium channels related to ROMK. Single channel conductance and open probability of ROMK2 were not altered by co-expression of THGP, which instead increased surface expression of ROMK2 as determined by patch clamp analysis and luminometric surface quantification, respectively. Despite preserved interaction with ROMK2, disease-causing THGP mutants failed to increase its current amplitude and surface expression. THGP(-/-) mice exhibited increased ROMK accumulation in intracellular vesicular compartments when compared with WT animals. Therefore, THGP modulation of ROMK function confers a new role of THGP on renal ion transport and may contribute to salt wasting observed in FJHN/MCKD-2/GCKD patients.	[Renigunta, Aparna; Waldegger, Siegfried] Univ Marburg, Childrens Hosp, Dept Pediat Nephrol, D-35043 Marburg, Germany; [Renigunta, Vijay; Decher, Niels] Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; [Saritas, Turgay; Mutig, Kerim] Charite, Inst Anat, D-13353 Berlin, Germany	Philipps University Marburg; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Renigunta, A (corresponding author), Univ Marburg, Childrens Hosp, Dept Pediat Nephrol, Baldingerstr, D-35043 Marburg, Germany.	renigunt@med.uni-marburg.de; siegfried.waldegger@med.uni-marburg.de	Turgay, Saritas/AAH-5127-2020; Mutig, Kerim/L-9010-2017; Decher, Niels/AAF-5002-2020	Turgay, Saritas/0000-0002-6691-9218; Mutig, Kerim/0000-0001-9006-5112; 	Deutsche Forschungsgemeinschaft (DFG) [SFB-593]; P. E. Kempkes Foundation [15/06, 10/08]; Rhoen AG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); P. E. Kempkes Foundation; Rhoen AG	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB-593), Rhoen AG, and P. E. Kempkes Foundation (Grants 15/06 and 10/08, to A. R.).	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho M, 2002, BRAZ J MED BIOL RES, V35, P1165, DOI 10.1590/S0100-879X2002001000009; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; Devuyst O, 2005, NEPHROL DIAL TRANSPL, V20, P1290, DOI 10.1093/ndt/gfh851; DULAWA J, 1988, EUR J CLIN INVEST, V18, P87, DOI 10.1111/j.1365-2362.1988.tb01171.x; Gersch M, 2006, NEPHROL DIAL TRANSPL, V21, P2028, DOI 10.1093/ndt/gfk081; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lu M, 2004, AM J PHYSIOL-RENAL, V286, pF490, DOI 10.1152/ajprenal.00305.2003; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; MORISHIGE K, 1993, FEBS LETT, V336, P375, DOI 10.1016/0014-5793(93)80840-Q; Nakanishi H, 2007, J CELL SCI, V120, P908, DOI 10.1242/jcs.03405; Okamoto M, 2006, J BIOL CHEM, V281, P4013, DOI 10.1074/jbc.M504684200; ORSKOV I, 1980, LANCET, V1, P887; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sachs AN, 2008, AM J PHYSIOL-RENAL, V295, pF1799, DOI 10.1152/ajprenal.90510.2008; Schmitt R, 2004, HISTOCHEM CELL BIOL, V121, P319, DOI 10.1007/s00418-004-0638-4; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Takiue Y, 2008, BIOL PHARM BULL, V31, P405, DOI 10.1248/bpb.31.405; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Wolf MTF, 2003, KIDNEY INT, V64, P1580, DOI 10.1046/j.1523-1755.2003.00269.x; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	41	79	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2224	2235		10.1074/jbc.M110.149880	http://dx.doi.org/10.1074/jbc.M110.149880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081491	Green Published, hybrid			2022-12-27	WOS:000286191500063
J	Park, SH; Jiang, R; Piao, SF; Zhang, B; Kim, EH; Kwon, HM; Jin, XL; Lee, BL; Ha, NC				Park, Sun Hee; Jiang, Rui; Piao, Shunfu; Zhang, Bing; Kim, Eun-Hye; Kwon, Hyun-Mi; Jin, Xiao Ling; Lee, Bok Luel; Ha, Nam-Chul			Structural and Functional Characterization of a Highly Specific Serpin in the Insect Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTALLOGRAPHIC ANALYSIS; CRYSTAL-STRUCTURE; HEPARIN PENTASACCHARIDE; SERINE-PROTEASE; HOST-DEFENSE; FACTOR IXA; ANTITHROMBIN; ACTIVATION; MECHANISM; RECOGNITION	The Toll signaling pathway, an essential innate immune response in invertebrates, is mediated via the serine protease cascade. Once activated, the serine proteases are irreversibly inactivated by serine protease inhibitors (serpins). Recently, we identified three serpin-serine protease pairs that are directly involved in the regulation of Toll signaling cascade in a large beetle, Tenebrio molitor. Of these, the serpin SPN48 was cleaved by its target serine protease, Spatzle-processing enzyme, at a noncanonical P1 residue of the serpin's reactive center loop. To address this unique cleavage, we report the crystal structure of SPN48, revealing that SPN48 exhibits a native conformation of human antithrombin, where the reactive center loop is partially inserted into the center of the largest beta-sheet of SPN48. The crystal structure also shows that SPN48 has a putative heparin-binding site that is distinct from those of the mammalian serpins. Ensuing biochemical studies demonstrate that heparin accelerates the inhibition of Spatzle-processing enzyme by a proximity effect in targeting the SPN48. Our finding provides the molecular mechanism of how serpins tightly regulate innate immune responses in invertebrates.	[Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea	Pusan National University; Pusan National University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.	brlee@pusan.ac.kr; hnc@pusan.ac.kr	Jiang, Rui/F-9248-2011	Jiang, Rui/0000-0002-5580-9822	Pusan National University [PNU-2008-0596-000]	Pusan National University(Pusan National University)	This work was supported by Bio-Scientific Research Grant PNU-2008-0596-000 from Pusan National University (to N.C.H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chai KX, 1997, BBA-GENE STRUCT EXPR, V1353, P277, DOI 10.1016/S0167-4781(97)00100-0; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Park SH, 2010, ACTA CRYSTALLOGR F, V66, P198, DOI 10.1107/S1744309109053147; Pearce MC, 2008, PROTEIN SCI, V17, P2127, DOI 10.1110/ps.037234.108; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao S, 2005, BBA-PROTEINS PROTEOM, V1752, P103, DOI 10.1016/j.bbapap.2005.05.008; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; PRATT CW, 1993, BLOOD COAGUL FIBRIN, V4, P479, DOI 10.1097/00001721-199306000-00013; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Robertson AS, 2006, J BIOL CHEM, V281, P26437, DOI 10.1074/jbc.M606085200; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; Walenga JM, 2002, EXPERT OPIN INV DRUG, V11, P397, DOI 10.1517/13543784.11.3.397; WALENGA JM, 1988, THROMB RES, V52, P553, DOI 10.1016/0049-3848(88)90128-4; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039	44	24	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1567	1575		10.1074/jbc.M110.144006	http://dx.doi.org/10.1074/jbc.M110.144006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047786	hybrid, Green Published			2022-12-27	WOS:000286005000069
J	Sheikh, SZ; Kobayashi, T; Matsuoka, K; Onyiah, JC; Plevy, SE				Sheikh, Shehzad Z.; Kobayashi, Taku; Matsuoka, Katsuyoshi; Onyiah, Joseph C.; Plevy, Scott E.			Characterization of an Interferon-stimulated Response Element (ISRE) in the Il23a Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA; IL-23 P19; T-CELLS; MURINE MACROPHAGES; ULCERATIVE-COLITIS; GENE-EXPRESSION; DENDRITIC CELLS; C-REL; INTERLEUKIN-12	We have demonstrated previously that IFN-gamma plays a protective role in the initiation of chronic intestinal inflammation through attenuation of Toll-like receptor-mediated IL-23 induction in macrophages. Here, an interferon-stimulated response element (ISRE) is identified in a region of conserved nucleotide sequences in the Il23a promoter. This ISRE mediated, in part, Il23a promoter induction by LPS and inhibition of LPS-induced activity by IFN-gamma. LPS and IFN-gamma recruit interferon regulatory factors (IRFs) to the Il23a ISRE in murine bone marrow-derived macrophages (BMMs). Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter. Consequently, IRF-1(-/-) mice were more susceptible to colonic injury by trinitrobenzenesulfonic acid, and IL-10/IRF-1 double-deficient (IL-10/IRF-1(-/-)) mice demonstrated more severe colonic inflammation compared with IL-10(-/-) mice. The severity of colitis in both models correlated with increased colonic IL-23. CD11b(+) lamina propria mononuclear cells, comprising predominantly macrophages, were identified as the major source of IL-23 in colitis-prone mice. Basal and heat-killed Escherichia coli-stimulated levels of Il23a were increased in IL-10/IRF-1(-/-) compared with WT and IL-10(-/-) colonic CD11b(+) lamina propria mononuclear cells. In conclusion, these experiments characterize IRF-ISRE interactions on the Il23a promoter, which have in vivo relevance as a homeostatic checkpoint in chronic intestinal inflammation.	Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Plevy, SE (corresponding author), CB 7032,7341C MBRB,103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	scott_plevy@med.unc.edu	Matsuoka, Katsuyoshi/AAB-1580-2022; Kobayashi, Taku/AAO-6437-2020	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Kobayashi, Taku/0000-0002-2073-4234	National Institutes of Health [RO1 DK54452]; Gastroenterology Research Training Grant [T32 DK007737, P30 DK034987]; National Research Service [F32 DK083186]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, F32DK083186, T32DK007737, R01DK054452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gastroenterology Research Training Grant; National Research Service; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by, in whole or in part, by National Institutes of Health Grant RO1 DK54452 (to S. E. P.), Gastroenterology Research Training Grant T32 DK007737 (to S. Z. S. and J. C. O.), and Grant P30 DK034987 (to the Center for Gastrointestinal Biology and Disease, Immunotechnologies, Gnotobiotic, and Histology Cores). This work was also supported by National Research Service Award F32 DK083186 (to S. Z. S.) and a Crohn's and Colitis Foundation of America Research fellowship award (to K. M.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kelchtermans H, 2007, J LEUKOCYTE BIOL, V81, P1044, DOI 10.1189/jlb.0806486; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Mahler M, 2002, INFLAMM BOWEL DIS, V8, P347; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reinhard C, 2006, INFLAMM BOWEL DIS, V12, P227, DOI 10.1097/01.MIB.0000202413.16360.a1; Sheikh SZ, 2010, J IMMUNOL, V184, P4069, DOI 10.4049/jimmunol.0903600; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vermeire K, 1997, J IMMUNOL, V158, P5507; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	26	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1174	1180		10.1074/jbc.M110.147884	http://dx.doi.org/10.1074/jbc.M110.147884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21097874	hybrid, Green Published			2022-12-27	WOS:000286005000028
J	Waning, DL; Lehman, JA; Batuello, CN; Mayo, LD				Waning, David L.; Lehman, Jason A.; Batuello, Christopher N.; Mayo, Lindsey D.			c-Abl Phosphorylation of Mdm2 Facilitates Mdm2-Mdmx Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TYROSINE KINASE; P53 ACTIVATION; DEGRADATION; ATM; PROTEIN; UBIQUITINATION; STABILIZATION; APOPTOSIS; HDMX	Mdm2 and Mdmx are oncoproteins that have essential yet nonredundant roles in development and function as part of a multicomponent ubiquitinating complex that targets p53 for proteasomal degradation. However, in response to DNA damage, Mdm2 and Mdmx are phosphorylated and protect p53 through various mechanisms. It has been predicted that Mdm2-Mdmx complex formation modulates Mdm2 ligase activity, yet the mechanism that promotes formation of Mdm2-Mdmx complexes is unknown. Here, we show that optimal Mdm2-Mdmx complex formation requires c-Abl phosphorylation of Mdm2 both in vitro and in vivo. In addition, Abl phosphorylation of Mdm2 is required for efficient ubiquitination of Mdmx in vitro, and eliminating c-Abl signaling, using c-Abl(-/-) knock-out murine embryonic fibroblasts, led to a decrease in Mdmx ubiquitination. Further, p53 levels are not induced as efficiently in c-Abl(-/-) murine embryonic fibroblasts following DNA damage. Overall, these results define a direct link between genotoxic stress-activated c-Abl kinase signaling and Mdm2-Mdmx complex formation. Our results add an important regulatory mechanism for the activation of p53 in response to DNA damage.	[Waning, David L.; Lehman, Jason A.; Mayo, Lindsey D.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Batuello, Christopher N.; Mayo, Lindsey D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Mayo, LD (corresponding author), 980 W Walnut,Bldg R3,Rm C548, Indianapolis, IN 46202 USA.	ldmayo@iupui.edu			National Institutes of Health [CA109262]; NATIONAL CANCER INSTITUTE [R21CA205437, R01CA109262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109262 (to L. D. M.).	Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Buchdunger E, 1996, CANCER RES, V56, P100; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Ma Yongxian, 2000, Molecular Cell Biology Research Communications, V3, P122, DOI 10.1006/mcbr.2000.0201; Mancini F, 2004, J BIOL CHEM, V279, P8169, DOI 10.1074/jbc.M311793200; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Momand J, 1996, ONCOGENE, V12, P2279; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; Zhang XN, 2009, CANCER RES, V69, P7960, DOI 10.1158/0008-5472.CAN-09-0634; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	35	24	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					216	222		10.1074/jbc.M110.183012	http://dx.doi.org/10.1074/jbc.M110.183012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21081495	Green Published, hybrid			2022-12-27	WOS:000285782800024
J	Rodrigues, JF; Mathias-Santos, C; Sbrogio-Almeida, ME; Amorim, JH; Cabrera-Crespo, J; Balan, A; Ferreira, LCS				Rodrigues, Juliana F.; Mathias-Santos, Camila; Sbrogio-Almeida, Maria Elisabete; Amorim, Jaime H.; Cabrera-Crespo, Joaquim; Balan, Andrea; Ferreira, Luis C. S.			Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLTRANSFERASE ACTIVITY; CHOLERA-TOXIN; MUCOSAL ADJUVANTS; B-SUBUNIT; A-SUBUNIT; IMMUNOGENICITY; RESPONSES; BINDING; MUTANT; SITE	Heat-labile toxins (LTs) have ADP-ribosylation activity and induce the secretory diarrhea caused by enterotoxigenic Escherichia coli (ETEC) strains in different mammalian hosts. LTs also act as adjuvants following delivery via mucosal, parenteral, or transcutaneous routes. Previously we have shown that LT produced by human-derived ETEC strains encompass a group of 16 polymorphic variants, including the reference toxin (LT1 or hLT) produced by the H10407 strain and one variant that is found mainly among bacterial strains isolated from pigs (LT4 or pLT). Herein, we show that LT4 ( with six polymorphic sites in the A (K4R, K213E, and N238D) and B (S4T, A46E, and E102K) subunits) displays differential in vitro toxicity and in vivo adjuvant activities compared with LT1. One in vitro generated LT mutant (LTK4R), in which the lysine at position 4 of the A subunit was replaced by arginine, showed most of the LT4 features with an similar to 10-fold reduction of the cytotonic effects, ADP-ribosylation activity, and accumulation of intracellular cAMP in Y1 cells. Molecular dynamic studies of the A subunit showed that the K4R replacement reduces the N-terminal region flexibility and decreases the catalytic site crevice. Noticeably, LT4 showed a stronger Th1-biased adjuvant activity with regard to LT1, particularly concerning activation of cytotoxic CD8(+) T lymphocytes when delivered via the intranasal route. Our results further emphasize the relevance of LT polymorphism among human-derived ETEC strains that may impact both the pathogenicity of the bacterial strain and the use of these toxins as potential vaccine adjuvants.	[Ferreira, Luis C. S.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Vaccine Dev Lab, BR-05508000 Sao Paulo, Brazil; [Sbrogio-Almeida, Maria Elisabete; Cabrera-Crespo, Joaquim] Butantan Inst, Technol Dev Div, BR-05503900 Sao Paulo, Brazil; [Balan, Andrea] Res Ctr Energy & Mat, Natl Lab Biosci, BR-13084971 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Ferreira, LCS (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Vaccine Dev Lab, BR-05508000 Sao Paulo, Brazil.	lcsf@usp.br	Rodrigues, Juliana/AAC-3512-2019; Ferreira, Luis Carlos S/M-3954-2014; Balan, Andrea/D-1891-2014; Amorim, Jaime Henrique/O-9222-2017; Cabrera-Crespo, Joaquin/D-3183-2015	Ferreira, Luis Carlos S/0000-0002-4883-1693; Balan, Andrea/0000-0001-6199-3198; Amorim, Jaime Henrique/0000-0002-0623-2879; Cabrera-Crespo, Joaquin/0000-0002-1457-6786	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants.	[Anonymous], 1998, PYM; Arce S, 2005, INFECT IMMUN, V73, P2718, DOI 10.1128/IAI.73.5.2718-2727.2005; BACK E, 1979, J CLIN MICROBIOL, V10, P791; Braga CJM, 2008, BRAZ J MICROBIOL, V39, P44, DOI 10.1590/S1517-838220080001000011; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; de Haan L, 1998, IMMUNOL CELL BIOL, V76, P270, DOI 10.1046/j.1440-1711.1998.00745.x; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser SA, 2003, INFECT IMMUN, V71, P1527, DOI 10.1128/IAI.71.3.1527-1537.2003; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Hagiwara Y, 2001, VACCINE, V19, P1652, DOI 10.1016/S0264-410X(00)00412-6; Hajishengallis G, 2005, J DENT RES, V84, P1104, DOI 10.1177/154405910508401205; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIRST TR, 1999, COMPREHENSIVE SOURCE, P104; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; HONDA T, 1981, INFECT IMMUN, V34, P337, DOI 10.1128/IAI.34.2.337-340.1981; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614, DOI 10.1128/JCM.22.4.614-619.1985; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lasaro MA, 2008, J BACTERIOL, V190, P2400, DOI 10.1128/JB.00988-07; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEONG J, 1985, INFECT IMMUN, V48, P73, DOI 10.1128/IAI.48.1.73-77.1985; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; MACKLER B, 1967, METHOD ENZYMOL, V10, P261; MEKALANOS JJ, 1978, INFECT IMMUN, V20, P552, DOI 10.1128/IAI.20.2.552-558.1978; Nashar TO, 1996, P NATL ACAD SCI USA, V93, P226, DOI 10.1073/pnas.93.1.226; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Partidos CD, 1999, IMMUNOL LETT, V67, P209, DOI 10.1016/S0165-2478(99)00013-9; PIZZA M, 1994, J EXP MED, V180, P2147, DOI 10.1084/jem.180.6.2147; PIZZA M, 1994, MOL MICROBIOL, V14, P51, DOI 10.1111/j.1365-2958.1994.tb01266.x; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Simmons CP, 1999, J IMMUNOL, V163, P6502; Simmons CP, 2001, SCAND J IMMUNOL, V53, P218, DOI 10.1046/j.1365-3083.2001.00884.x; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; TSUJI T, 1982, INFECT IMMUN, V38, P444, DOI 10.1128/IAI.38.2.444-448.1982; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; VANDENAKKER F, 1995, BIOCHEMISTRY-US, V34, P10996, DOI 10.1021/bi00035a005; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; YOST DA, 1981, J BIOL CHEM, V256, P3647; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	54	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5222	5233		10.1074/jbc.M110.173682	http://dx.doi.org/10.1074/jbc.M110.173682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135101	hybrid, Green Published			2022-12-27	WOS:000287230600031
J	Dong, LJ; Zhang, XY; Fu, XA; Zhang, XZ; Gao, XJ; Zhu, MY; Wang, XT; Yang, ZX; Jensen, ON; Saarikettu, J; Yao, Z; Silvennoinen, O; Yang, J				Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Zhang, Xianzhi; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Jensen, Ole Norregaard; Saarikettu, Juha; Yao, Zhi; Silvennoinen, Olli; Yang, Jie			PTB-associated Splicing Factor (PSF) Functions as a Repressor of STAT6-mediated Ig epsilon Gene Transcription by Recruitment of HDAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVELY ACTIVE STAT6; JAK-3 JANUS KINASE; RNA-POLYMERASE-II; HISTONE ACETYLATION; SIGNAL TRANSDUCER; RECEPTOR; ACTIVATION; EXPRESSION; IL-4; COACTIVATOR	Regulation of transcription requires cooperation between sequence-specific transcription factors and numerous coregulatory proteins. In IL-4/IL-13 signaling several coactivators for STAT6 have been identified, but the molecular mechanisms of STAT6-mediated gene transcription are still not fully understood. Here we identified by proteomic approach that the PTB-associated splicing factor (PSF) interacts with STAT6. In intact cells the interaction was observed only after IL-4 stimulation. The IL-4-induced tyrosine phosphorylation of both STAT6 and PSF is a prerequisite for the efficient association of the two proteins. Functional analysis demonstrated that ectopic expression of PSF resulted in inhibition of STAT6-mediated transcriptional activation and mRNA expression of the Ig epsilon germline heavy chain gene, whereas knockdown of PSF increased the STAT6-mediated responses. PSF recruited histone deacetylase 1 (HDAC1) to the STAT6 transcription complex, which resulted in reduction of H3 acetylation at the promoter regions of Ig heavy chain germline Ig epsilon and inhibition of STAT6-mediated transcription. In addition, the HDACs inhibitor trichostatin A (TSA) enhanced H3 acetylation, and reverted the PSF-mediated transcriptional repression of Ig epsilon gene transcription. In summary, these results identify PSF as a repressor of STAT6-mediated transcription that functions through recruitment of HDAC to the STAT6 transcription complex, and delineates a novel regulatory mechanism of IL-4 signaling that may have implications in the pathogenesis of allergic diseases and pharmacological HDAC inhibition in lymphomas.	[Zhang, Xianzhi; Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Jensen, Ole Norregaard] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Basic Med Coll, Dept Immunol, Tianjin 300070, Peoples R China; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Minist China, Key Lab Educ, Tianjin 300070, Peoples R China; [Fu, Xiao; Gao, Xingjie; Wang, Xinting; Yang, ZhenXia; Yang, Jie] Tianjin Med Univ, Lab Mol Immunol, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China	Tampere University; Tampere University Hospital; University of Southern Denmark; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Silvennoinen, O (corresponding author), Univ Tampere, Tampere Univ Hosp, Inst Med Technol, Biokatu 8, FI-33014 Tampere, Finland.	olli.silvennoinen@uta.fi; yangj@tijmu.edu.cn	Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528	Ministry of Science and Technology of China [2007AA02Z115]; NSFC [90919032, 30970562, 30670441]; 973 program [2009CB918903]; Specialized Fund for the Doctoral Program of Higher Education [20091202110001]; Tianjin Educational Committee Foundation [2008ZD01]; Tianjin Municipal Science and Technology Commission [08ZCGHHZ01900, 08JCYBJC07700]; Medical Research Council of Academy of Finland; Finnish Foundation for Cancer Research; Pirkanmaa Hospital District Research Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Specialized Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Educational Committee Foundation; Tianjin Municipal Science and Technology Commission; Medical Research Council of Academy of Finland(Academy of Finland); Finnish Foundation for Cancer Research; Pirkanmaa Hospital District Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation	This work was supported by the 863 project of the Ministry of Science and Technology of China Grants 2007AA02Z115, NSFC Grants 90919032, 30970562, and 30670441, 973 program Grant 2009CB918903, Specialized Fund for the Doctoral Program of Higher Education Grant 20091202110001, Tianjin Educational Committee Foundation Grant 2008ZD01, Tianjin Municipal Science and Technology Commission Grants 08ZCGHHZ01900 and 08JCYBJC07700, Medical Research Council of Academy of Finland, Finnish Foundation for Cancer Research, Pirkanmaa Hospital District Research Foundation, Sigrid Juselius Foundation, and the Tampere Tuberculosis Foundation.	An Woojin, 2007, Subcell Biochem, V41, P351; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Bruns HA, 2006, CRIT REV ONCOL HEMAT, V57, P245, DOI 10.1016/j.critrevonc.2005.08.005; Buglio D, 2008, BLOOD, V112, P1424, DOI 10.1182/blood-2008-01-133769; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kaplan MH, 2007, BLOOD, V110, P4367, DOI 10.1182/blood-2007-06-098244; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Lutz M, 2000, BIOCHEM SOC T, V28, P386, DOI 10.1042/0300-5127:0280386; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Sehra S, 2008, J IMMUNOL, V180, P3551, DOI 10.4049/jimmunol.180.5.3551; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shen CH, 2001, J IMMUNOL, V166, P411, DOI 10.4049/jimmunol.166.1.411; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Valineva T, 2006, NUCLEIC ACIDS RES, V34, P3938, DOI 10.1093/nar/gkl539; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; WARREN WD, 1995, J IMMUNOL, V155, P5637; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	37	19	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3451	3459		10.1074/jbc.M110.168377	http://dx.doi.org/10.1074/jbc.M110.168377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106524	Green Published, hybrid			2022-12-27	WOS:000286653200031
J	Gieseking, S; Bergen, K; Di Pasquale, F; Diederichs, K; Welte, W; Marx, A				Gieseking, Sonja; Bergen, Konrad; Di Pasquale, Francesca; Diederichs, Kay; Welte, Wolfram; Marx, Andreas			Human DNA Polymerase beta Mutations Allowing Efficient Abasic Site Bypass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; APURINIC APYRIMIDINIC SITES; ACTIVE-SITE; CELLULAR-TRANSFORMATION; TRANSLESION SYNTHESIS; MISMATCH-EXTENSION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; MUTATOR MUTANT; AMINO-ACID	The DNA of every cell in the human body gets damaged more than 50,000 times a day. The most frequent damages are abasic sites. This kind of damage blocks proceeding DNA synthesis by several DNA polymerases that are involved in DNA replication and repair. The mechanistic basis for the incapability of these DNA polymerases to bypass abasic sites is not clarified. To gain insights into the mechanistic basis, we intended to identify amino acid residues that govern for the pausing of DNA polymerase beta when incorporating a nucleotide opposite to abasic sites. Human DNA polymerase beta was chosen because it is a well characterized DNA polymerase and serves as model enzyme for studies of DNA polymerase mechanisms. Moreover, it acts as the main gap-filling enzyme in base excision repair, and human tumor studies suggest a link between DNA polymerase beta and cancer. In this study we employed high throughput screening of a library of more than 11,000 human DNA polymerase beta variants. We identified two mutants that have increased ability to incorporate a nucleotide opposite to an abasic site. We found that the substitutions E232K and T233I promote incorporation opposite the lesion. In addition to this feature, the variants have an increased activity and a lower fidelity when processing nondamaged DNA. The mutations described in this work are located in well characterized regions but have not been reported before. A crystallographic structure of one of the mutants was obtained, providing structural insights.	[Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Chem, D-78464 Constance, Germany; Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Biol, D-78464 Constance, Germany	University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Chem, Univ Str 10, D-78464 Constance, Germany.	andreas.marx@uni-konstanz.de			Deutsche Forschungsgemeinschaft [SPP1170]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within SPP1170.	ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; CASASFINET JR, 1992, BIOCHEMISTRY-US, V31, P10272, DOI 10.1021/bi00157a014; Clairmont CA, 1999, P NATL ACAD SCI USA, V96, P9580, DOI 10.1073/pnas.96.17.9580; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Efrati E, 1997, J BIOL CHEM, V272, P2559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Idriss HT, 2002, INT J BIOCHEM CELL B, V34, P321, DOI 10.1016/S1357-2725(01)00131-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kosa JL, 1999, J BIOL CHEM, V274, P3851, DOI 10.1074/jbc.274.6.3851; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; KUMAR A, 1990, J BIOL CHEM, V265, P2124; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Minnick DT, 1996, J BIOL CHEM, V271, P24954, DOI 10.1074/jbc.271.40.24954; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Saul R L, 1986, Basic Life Sci, V38, P529; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Starcevic D, 2004, CELL CYCLE, V3, P998; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Strerath M, 2007, CHEMBIOCHEM, V8, P395, DOI 10.1002/cbic.200600337; Summerer D, 2005, ANGEW CHEM INT EDIT, V44, P4712, DOI 10.1002/anie.200500047; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1	59	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4011	4020		10.1074/jbc.M110.176826	http://dx.doi.org/10.1074/jbc.M110.176826			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107011	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000286653200081
J	Mabilleau, G; Chappard, D; Sabokbar, A				Mabilleau, Guillaume; Chappard, Daniel; Sabokbar, Afsie			Role of the A20-TRAF6 Axis in Lipopolysaccharide-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TOLL-LIKE RECEPTOR; BONE-RESORPTION; RHEUMATOID-ARTHRITIS; IN-VITRO; DEFECTIVE INTERLEUKIN-1; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; ACTIVATION	Bacterial lipopolysaccharide (LPS) has long been suggested as a potent inducer of bone loss in vivo despite controversial effects on osteoclast precursors. Recently, the role of the deubiquitinating protease A20 in regulating the LPS response in various organs was reported. In the present study, we investigated whether A20 is expressed in osteoclast cultures in response to RANKL or LPS and whether this protein plays a role in osteoclast formation and activation. Human peripheral blood mononuclear cells were cultured in the presence of M-CSF +/- RANKL +/- LPS. Although LPS induced the formation of multinucleated TRAP-positive cells expressing OSCAR, cathepsin K, and the calcitonin receptor, these cells were not capable of lacunar resorption. Release of TNF-alpha was noted in LPS-treated cultures, and the addition of a neutralizing anti-TNF-alpha antibody abrogated osteoclast formation in these cultures. A20 appeared to be a late-expressed gene in LPS-treated cultures and was associated with TRAF6 degradation and NF-kappa B inhibition. Silencing of A20 restored TRAF6 expression and NF-kappa B activation and resulted in increased bone resorption in LPS-treated cultures. A20 appeared important in the control of bone resorption and could represent a therapeutic target to treat patients with bone resorption associated with inflammatory diseases.	[Mabilleau, Guillaume] Univ Angers, INSERM, Fac Med, Inst Biol Sante,LHEA,U922, F-49933 Angers 09, France; Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Oxford	Mabilleau, G (corresponding author), Univ Angers, INSERM, Fac Med, Inst Biol Sante,LHEA,U922, 4 Rue Larrey, F-49933 Angers 09, France.	guillaume.mabilleau@univ-angers.fr	Daniel, chappard/AFK-4857-2022; Daniel, chappard/AAG-3528-2022; Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X	National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit; Diabetes UK-R.D. Lawrence	National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit; Diabetes UK-R.D. Lawrence(Diabetes UK)	This work was supported by the National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit.; Recipient of a Diabetes UK-R.D. Lawrence research fellowship. To whom correspondence should be addressed: INSERM, U922, LHEA, Institut de Biologie en Sante, 4 Rue Larrey, 49933 Angers Cedex 09, France. Tel.: 33-0-244688349; Fax: 33-0-241735886; E-mail: guillaume.mabilleau@univangers.fr.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Edwards JR, 2006, ARTHRITIS RHEUM-US, V54, P1451, DOI 10.1002/art.21821; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mabilleau G, 2008, DIABETOLOGIA, V51, P1035, DOI 10.1007/s00125-008-0992-1; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; O'Reilly SM, 2003, BIOCHEM BIOPH RES CO, V303, P586, DOI 10.1016/S0006-291X(03)00389-9; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	47	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3242	3249		10.1074/jbc.M110.150300	http://dx.doi.org/10.1074/jbc.M110.150300			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127049	Green Published, hybrid			2022-12-27	WOS:000286653200009
J	Brams, M; Gay, EA; Saez, JC; Guskov, A; van Elk, R; van der Schors, RC; Peigneur, S; Tytgat, J; Strelkov, SV; Smit, AB; Yakel, JL; Ulens, C				Brams, Marijke; Gay, Elaine A.; Saez, Jose Colon; Guskov, Albert; van Elk, Rene; van der Schors, Roel C.; Peigneur, Steve; Tytgat, Jan; Strelkov, Sergei V.; Smit, August B.; Yakel, Jerrel L.; Ulens, Chris			Crystal Structures of a Cysteine-modified Mutant in Loop D of Acetylcholine-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; AGONIST BINDING; AMINO-ACIDS; CONFORMATIONAL-CHANGES; EXTRACELLULAR DOMAIN; STRUCTURE VALIDATION; NICOTINIC RECEPTORS; GABA(A) RECEPTOR; VOLTAGE-SENSOR	Covalent modification of alpha 7 W55C nicotinic acetylcholine receptors (nAChR) with the cysteine-modifying reagent [2-(trimethylammonium) ethyl] methanethiosulfonate (MTSET+) produces receptors that are unresponsive to acetylcholine, whereas methyl methanethiolsulfonate (MMTS) produces enhanced acetylcholine-gated currents. Here, we investigate structural changes that underlie the opposite effects of MTSET+ and MMTS using acetylcholine-binding protein (AChBP), a homolog of the extracellular domain of the nAChR. Crystal structures of Y53C AChBP show that MT-SET+-modification stabilizes loop C in an extended conformation that resembles the antagonist-bound state, which parallels our observation that MTSET+ produces unresponsive W55C nAChRs. The MMTS-modified mutant in complex with acetylcholine is characterized by a contracted C-loop, similar to other agonist-bound complexes. Surprisingly, we find two acetylcholine molecules bound in the ligand-binding site, which might explain the potentiating effect of MMTS modification in W55C nAChRs. Unexpectedly, we observed in the MMTS-Y53C structure that ten phosphate ions arranged in two rings at adjacent sites are bound in the vestibule of AChBP. We mutated homologous residues in the vestibule of alpha 1 GlyR and observed a reduction in the single channel conductance, suggesting a role of this site in ion permeation. Taken together, our results demonstrate that targeted modification of a conserved aromatic residue in loop D is sufficient for a conformational switch of AChBP and that a defined region in the vestibule of the extracellular domain contributes to ion conduction in an-ion-selective Cys-loop receptors.	[Ulens, Chris] KULeuven, Lab Struct Neurobiol, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Peigneur, Steve; Tytgat, Jan] KULeuven, Toxicol Lab, B-3000 Louvain, Belgium; [Strelkov, Sergei V.] KULeuven, Lab Biocrystallog, B-3000 Louvain, Belgium; [Gay, Elaine A.; Saez, Jose Colon; Yakel, Jerrel L.] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [van Elk, Rene; van der Schors, Roel C.; Smit, August B.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Guskov, Albert] Nanyang Technol Univ, Div Struct & Computat Biol, Singapore 138673, Singapore	KU Leuven; KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Vrije Universiteit Amsterdam; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ulens, C (corresponding author), KULeuven, Lab Struct Neurobiol, Dept Mol Cell Biol, Herestr 49,PB 601, B-3000 Louvain, Belgium.	chris.ulens@med.kuleuven.be	Guskov, Albert/G-1286-2016; Strelkov, Sergei V/G-7425-2014; Smit, August B/E-8410-2011	Guskov, Albert/0000-0003-2340-2216; Strelkov, Sergei V/0000-0001-7189-4652; Peigneur, Steve/0000-0003-0504-5702; Colon-Saez, Jose/0000-0003-4913-0300; Tytgat, Jan/0000-0003-1778-6022; Yakel, Jerrel/0000-0001-5463-674X	National Institutes of Health, NIEHS; FWO-Vlaanderen [G.0330.06, G.0257.08]; Belgian Federal Science Policy Office [P6/31]; EU [2020288]; KULeuven Onderzoekstoelage [OT/08/048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090089] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FWO-Vlaanderen(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); EU(European Commission); KULeuven Onderzoekstoelage(KU Leuven); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIEHS (to E. A. G., J. C. S., and J. L. Y.), by Grants FWO-Vlaanderen (G.0330.06, G.0257.08), and the Belgian Federal Science Policy Office, Interuniversity Attraction Poles program (P6/31) (to J. T.), EU FP7 2020288 NeuroCypres (to C. U., A. B. S., and R. C. vd. S.), and KULeuven Onderzoekstoelage OT/08/048 (to S. V. S. and C. U.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bricogne G, 2009, BUSTER VERSION 2 8 0; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hanson SM, 2008, J MED CHEM, V51, P7243, DOI 10.1021/jm800889m; Hibbs RE, 2006, J MOL NEUROSCI, V30, P73, DOI 10.1385/JMN:30:1:73; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Suryanarayanan A, 2005, BIOCHEMISTRY-US, V44, P9140, DOI 10.1021/bi050661e; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	52	41	41	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4420	4428		10.1074/jbc.M110.188730	http://dx.doi.org/10.1074/jbc.M110.188730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115477	Green Published, hybrid			2022-12-27	WOS:000286975700042
J	Li, JM; Wang, JJ; Zhang, SX				Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.			Preconditioning with Endoplasmic Reticulum Stress Mitigates Retinal Endothelial Inflammation via Activation of X-box Binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; OXYGEN-INDUCED RETINOPATHY; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BARRIER BREAKDOWN; MACULAR EDEMA; ER STRESS; GROWTH-FACTOR; P-SELECTIN; TNF-ALPHA	Endoplasmic reticulum (ER) stress is widely implicated in various pathological conditions such as diabetes. Previously, we reported that enhanced ER stress contributes to inflammation and vascular damage in diabetic and ischemia-induced retinopathy. However, the exact role of the signaling pathways activated by ER stress in vascular inflammation remains poorly understood. In the present study, we investigated the role of X-box binding protein 1 (XBP1) in retinal adhesion molecule expression, leukostasis, and vascular leakage. Exposure of human retinal endothelial cells to low dose ER stress inducers resulted in a robust activation of XBP1 but did not affect inflammatory gene expression. However, ER stress preconditioning almost completely abolished TNF-alpha-elicited NF-kappa B activation and adhesion molecule ICAM-1 and VCAM-1 expression. Pharmaceutical inhibition of XBP1 activation or knockdown of XBP1 by siRNA markedly attenuated the effects of preconditioning on inflammation. Moreover, loss of XBP1 led to an increase in ICAM-1 and VCAM-1 expression. Conversely, overexpression of spliced XBP1 attenuated TNF-alpha-induced phosphorylation of IKK, I kappa B alpha, and NF-kappa B p65, accompanied by decreased NF-kappa B activity and reduced adhesion molecule expression. Finally, in vivo studies show that activation of XBP1 by ER stress preconditioning prevents TNF-alpha-induced ICAM-1 and VCAM-1 expression, leukostasis, and vascular leakage in mouse retinas. These results collectively indicate a protective effect of ER stress preconditioning against retinal endothelial inflammation, which is likely through activation of XBP1-mediated unfolded protein response (UPR) and inhibition of NF-kappa B activation.	[Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA; [Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhang, SX (corresponding author), 941 Stanton L Young Blvd,BSEB331A, Oklahoma City, OK 73104 USA.	xin-zhang@ouhsc.edu	li, jingming/J-5760-2012	li, jingming/0000-0003-2300-8614	National Institutes of Health [EY019949, P20RR024215]; Juvenile Diabetes Research Foundation [5-2009-475]; Oklahoma Center for the Advancement of Science and Technology [HR07-167, HR10-060]; American Health Assistance Foundation [M2010088]; Harold Hamm Oklahoma Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for the Advancement of Science and Technology; American Health Assistance Foundation(BrightFocus Foundation); Harold Hamm Oklahoma Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019949 and P20RR024215. This work was also supported by Research Award 5-2009-475 from the Juvenile Diabetes Research Foundation, Research Grants HR07-167 and HR10-060 from the Oklahoma Center for the Advancement of Science and Technology, Research Grant M2010088 from the American Health Assistance Foundation, and the Dr. William Talley Research Award from the Harold Hamm Oklahoma Diabetes Center.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Aiello LP, 2000, KIDNEY INT, V58, pS113, DOI 10.1046/j.1523-1755.2000.07718.x; Bayat H, 2008, ARTERIOSCL THROM VAS, V28, P127, DOI 10.1161/ATVBAHA.107.150250; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; De La Cruz MDJP, 2004, DIABETES-METAB RES, V20, P91; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Gardner TW, 2008, CURR DIABETES REP, V8, P263, DOI 10.1007/s11892-008-0047-5; Hayakawa K, 2008, BIOCHEM BIOPH RES CO, V365, P47, DOI 10.1016/j.bbrc.2007.10.115; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2009, MOL VIS, V15, P1418; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kawamura T, 2008, J ANTIBIOT, V61, P312, DOI 10.1038/ja.2008.44; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mori K, 2002, INVEST OPHTH VIS SCI, V43, pU956; Mullins RF, 2006, MOL VIS, V12, P224; Norman MU, 2008, J LEUKOCYTE BIOL, V84, P68, DOI 10.1189/jlb.1107796; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Shestakova MV, 2002, TERAPEVT ARKH, V74, P24; TANG SB, 1995, GRAEF ARCH CLIN EXP, V233, P21, DOI 10.1007/BF00177781; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zhang SX, 2005, CURR EYE RES, V30, P681, DOI 10.1080/02713680590934102; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	42	88	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4912	4921		10.1074/jbc.M110.199729	http://dx.doi.org/10.1074/jbc.M110.199729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138840	Green Published, hybrid			2022-12-27	WOS:000286975700087
J	Sultan, A; Nesslany, F; Violet, M; Begard, S; Loyens, A; Talahari, S; Mansuroglu, Z; Marzin, D; Sergeant, N; Humez, S; Colin, M; Bonnefoy, E; Buee, L; Galas, MC				Sultan, Audrey; Nesslany, Fabrice; Violet, Marie; Begard, Severine; Loyens, Anne; Talahari, Smail; Mansuroglu, Zeyni; Marzin, Daniel; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Bonnefoy, Eliette; Buee, Luc; Galas, Marie-Christine			Nuclear Tau, a Key Player in Neuronal DNA Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GEL-ELECTROPHORESIS ASSAY; HUMAN NEUROBLASTOMA-CELLS; ALZHEIMERS-DISEASE; COMET ASSAY; HEAT-SHOCK; IN-VITRO; PROTEIN; PHOSPHORYLATION; DAMAGE; BRAIN	Tau, a neuronal protein involved in neurodegenerative disorders such as Alzheimer disease, which is primarily described as a microtubule-associated protein, has also been observed in the nuclei of neuronal and non-neuronal cells. However, the function of the nuclear form of Tau in neurons has not yet been elucidated. In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus. These results highlight a novel role for nuclear Tau as a key player in early stress response.	[Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] INSERM, UMR837, F-59045 Lille, France; [Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Univ Lille 2, Jean Pierre Aubert Res Ctr, Inst Med Predict & Rech Therapeut, Fac Med Pole Rech, Lille, France; [Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] CHU Lille, F-59037 Lille, France; [Nesslany, Fabrice; Talahari, Smail; Marzin, Daniel] Inst Pasteur, Lab Toxicol Genet, F-59019 Lille, France; [Mansuroglu, Zeyni; Bonnefoy, Eliette] Univ Paris 05, CNRS, FRE 3235, F-75270 Paris 06, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Galas, MC (corresponding author), INSERM, U837, 1 Rue Michel Polonovski, F-59045 Lille, France.	marie-christine.galas@inserm.fr	Sergeant, Nicolas/O-5467-2017; BUEE, Luc/B-3126-2010; LICEND, CEMND/F-1296-2015; Galas, Marie-Christine/AAL-9812-2020	Sergeant, Nicolas/0000-0003-1448-124X; BUEE, Luc/0000-0002-6261-4230; Galas, Marie-Christine/0000-0002-3766-7103; Colin, Morvane/0000-0003-0611-4167	Inserm; CNRS; IMPRT; University Lille 2; Region Nord/Pas-de-Calais; Fonds Europeen de Development Regional; DN2M; ANR [ANR-08-MNPS002/AMYTOXTAU]; European Community MEMOSAD [200611]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); IMPRT; University Lille 2; Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Fonds Europeen de Development Regional; DN2M; ANR(French National Research Agency (ANR)); European Community MEMOSAD	This work was supported by Inserm, CNRS, IMPRT, University Lille 2, Region Nord/Pas-de-Calais, Fonds Europeen de Development Regional, DN2M, as well as grants from ANR-08-MNPS002/AMYTOXTAU and from the European Community MEMOSAD (FP7 Contract 200611).	ASHBY J, 1995, MUTAGENESIS, V10, P85, DOI 10.1093/mutage/10.2.85; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Coppede F, 2009, CURR ALZHEIMER RES, V6, P36, DOI 10.2174/156720509787313970; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Daniel S, 2008, BBA-MOL CELL RES, V1783, P1003, DOI 10.1016/j.bbamcr.2008.01.014; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; GREENWOOD JA, 1995, EXP CELL RES, V220, P332, DOI 10.1006/excr.1995.1323; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; HELLMAN B, 1995, MUTAT RES-DNA REPAIR, V336, P123, DOI 10.1016/0921-8777(94)00047-A; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Hua Q, 2002, PROTEIN PEPTIDE LETT, V9, P349, DOI 10.2174/0929866023408652; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Karuppagounder SS, 2008, NEUROCHEM RES, V33, P1365, DOI 10.1007/s11064-008-9594-z; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Lemay J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-47; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Merk O, 1999, ENVIRON MOL MUTAGEN, V33, P167, DOI 10.1002/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Padmaraju V, 2010, NEUROCHEM INT, V57, P51, DOI 10.1016/j.neuint.2010.04.013; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; Roque A, 2004, NUCLEIC ACIDS RES, V32, P6111, DOI 10.1093/nar/gkh945; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Rutten BPF, 2007, NEUROBIOL AGING, V28, P91, DOI 10.1016/j.neurobiolaging.2005.10.019; Sestili P, 2006, MUTAT RES-GEN TOX EN, V607, P205, DOI 10.1016/j.mrgentox.2006.04.018; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shanavas A, 2000, P NATL ACAD SCI USA, V97, P14139, DOI 10.1073/pnas.97.26.14139; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Xu SL, 2006, BIOCHEM BIOPH RES CO, V342, P330, DOI 10.1016/j.bbrc.2006.01.148; Yoshimura Y, 2003, NEUROSCI LETT, V353, P185, DOI 10.1016/j.neulet.2003.09.037; Zhao QL, 2006, FREE RADICAL BIO MED, V40, P1131, DOI 10.1016/j.freeradbiomed.2005.10.064	51	262	272	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4566	4575		10.1074/jbc.M110.199976	http://dx.doi.org/10.1074/jbc.M110.199976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131359	hybrid, Green Published			2022-12-27	WOS:000286975700057
J	Chan, P; Gabay, M; Wright, FA; Kan, W; Oner, SS; Lanier, SM; Smrcka, AV; Blumer, JB; Tall, GG				Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Kan, Wei; Oner, Sukru S.; Lanier, Stephen M.; Smrcka, Alan V.; Blumer, Joe B.; Tall, Gregory G.			Purification of Heterotrimeric G Protein alpha Subunits by GST-Ric-8 Association PRIMARY CHARACTERIZATION OF PURIFIED G alpha(olf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; ASYMMETRIC CELL-DIVISION; PHOSPHOLIPASE-C-BETA; CONFORMATIONAL-CHANGES; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; CORTICAL LOCALIZATION; GUANINE-NUCLEOTIDES; LIMITED PROTEOLYSIS	Ric-8A and Ric-8B are nonreceptor G protein guanine nucleotide exchange factors that collectively bind the four subfamilies of G protein alpha subunits. Co-expression of G alpha subunits with Ric-8A or Ric-8B in HEK293 cells or insect cells greatly promoted G alpha protein expression. We exploited these characteristics of Ric-8 proteins to develop a simplified method for recombinant G protein alpha subunit purification that was applicable to all G alpha subunit classes. The method allowed production of the olfactory adenylyl cyclase stimulatory protein G alpha(olf) for the first time and unprecedented yield of G alpha(q) and G alpha(13). G alpha subunits were co-expressed with GST-tagged Ric-8A or Ric-8B in insect cells. GST-Ric-8-G alpha complexes were isolated from whole cell detergent lysates with glutathione-Sepharose. G alpha subunits were dissociated from GST-Ric-8 with GDP-AlF4- (GTP mimicry) and found to be > 80% pure, bind guanosine 5 '-[gamma -thio]triphosphate (GTP gamma S), and stimulate appropriate G protein effector enzymes. A primary characterization of G alpha(olf) showed that it binds GTP gamma S at a rate marginally slower than G alpha(s short) and directly activates adenylyl cyclase isoforms 3, 5, and 6 with less efficacy than G alpha(s short).	[Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Kan, Wei; Smrcka, Alan V.; Tall, Gregory G.] Univ Rochester, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Oner, Sukru S.; Lanier, Stephen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of Rochester; Medical University of South Carolina	Tall, GG (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	gregory_tall@urmc.rochester.edu	Oner, Sukru/K-8032-2012	Oner, Sukru/0000-0002-8864-7356; Kan, Wei/0000-0002-6830-6714; Blumer, Joe/0000-0002-0020-3815; Lanier, Stephen/0000-0002-2740-7607; Chan, PuiYee/0000-0002-9133-9506	National Institutes of Health [GM088242, GM053536, GM086510, NS24821, DA025896]; New York State Stem Cell Science [C024307]; National Institute on Drug Abuse [T32 DA07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081772, R01GM053536, R01GM088242, R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896, T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM088242 (to G. G. T.), GM053536 (to A. V. S.), GM086510 (to J. B. B.), and NS24821 and DA025896 (to S. M. L.). This work was also supported by New York State Stem Cell Science Grant C024307 (to G. G. T.) and National Institute on Drug Abuse Grant T32 DA07232 (to P. C.).	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Biddlecome GH, 1996, J BIOL CHEM, V271, P33705; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HALLIDAY KR, 1984, J BIOL CHEM, V259, P516; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HEPLER JR, 1994, METHOD ENZYMOL, V237, P191; HUDSON TH, 1981, J BIOL CHEM, V256, P1459; JONES DT, 1990, J BIOL CHEM, V265, P2671; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KOZASA T, 1999, PROTEINS TECHNIQUES, P23; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lehmann DM, 2007, METHOD ENZYMOL, V434, P29, DOI 10.1016/S0076-6879(07)34003-2; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nagai Y, 2010, J BIOL CHEM, V285, P11114, DOI 10.1074/jbc.M109.063313; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SINGER WD, 1994, J BIOL CHEM, V269, P19796; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SVOBODA P, 1994, EUR J BIOCHEM, V224, P455, DOI 10.1111/j.1432-1033.1994.00455.x; SVOBODA P, 1992, EUR J BIOCHEM, V208, P693, DOI 10.1111/j.1432-1033.1992.tb17236.x; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; WINSLOW JW, 1986, J BIOL CHEM, V261, P7571; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	47	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2625	2635		10.1074/jbc.M110.178897	http://dx.doi.org/10.1074/jbc.M110.178897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115479	Green Published, hybrid			2022-12-27	WOS:000286464300028
J	Lin, WY; Wu, GY; Li, SY; Weinberg, EM; Kumthip, K; Peng, LF; Mendez-Navarro, J; Chen, WC; Jilg, N; Zhao, H; Goto, K; Zhang, LL; Brockman, MA; Schuppan, D; Chung, RT				Lin, Wenyu; Wu, Guoyang; Li, Shaoyong; Weinberg, Ethan M.; Kumthip, Kattareeya; Peng, Lee F.; Mendez-Navarro, Jorge; Chen, Wen-Chi; Jilg, Nikolaus; Zhao, Hong; Goto, Kaku; Zhang, Leiliang; Brockman, Mark A.; Schuppan, Detlef; Chung, Raymond T.			HIV and HCV Cooperatively Promote Hepatic Fibrogenesis via Induction of Reactive Oxygen Species and NF kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS CORE PROTEIN; INDUCED LIVER FIBROSIS; C VIRUS; STELLATE CELLS; MITOCHONDRIAL INJURY; OXIDATIVE STRESS; GENE-EXPRESSION; RAT-LIVER; ACTIVATION; REPLICATION	HIV/HCV coinfection leads to accelerated hepatic fibrosis progression, with higher rates of cirrhosis, liver failure, and liver death than does HCV mono-infection. However, the pro-fibrogenic role of HIV on hepatocytes and hepatic stellate cells (HSC) has not been fully clarified. We hypothesized that HIV, HCV induce liver fibrosis through altered regulation of the production of extracellular matrix and matrix metalloproteinases. We examined the fibrogenesis- and fibrolysis-related gene activity in LX2 HSC and Huh7.5.1 cells in the presence of inactivated CXCR4 and CCR5 HIV, as well as HCV JFH1 virus. The role of reactive oxygen species (ROS) upon fibrosis gene expression was assessed using the ROS inhibitor. Fibrosis-related transcripts including procollagen alpha 1(I) (CoL1A), TIMP1, and MMP3 mRNA were measured by qPCR. TIMP1 and MMP3 protein expression were assessed by ELISA. We found that inactivated CXCR4 HIV and CCR5 HIV increased CoL1A, and TIMP1 expression in both HSC and Huh7.5.1 cells; the addition of JFH1 HCV further increased CoL1A and TIMP1 expression. CXCR4 HIV and CCR5 HIV induced ROS production in HSC and Huh7.5.1 cells which was further enhanced by JFH1 HCV. The ROS inhibitor DPI abrogated HIV -and HCV-induced CoL1A and TIMP1 expression. HIV and HCV-induced CoL1A and TIMP1 expression were also blocked by NF kappa B siRNA. Our data provide further evidence that HIV and HCV independently regulate hepatic fibrosis progression through the generation of ROS; this regulation occurs in an NF kappa B-dependent fashion. Strategies to limit the viral induction of oxidative stress are warranted to inhibit fibrogenesis.	[Mendez-Navarro, Jorge; Chen, Wen-Chi; Jilg, Nikolaus; Zhao, Hong; Goto, Kaku; Zhang, Leiliang] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02114 USA; [Wu, Guoyang] Xiamen Univ, Hepatobiliary Surg Dept, Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Li, Shaoyong; Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Brockman, Mark A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Xiamen University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Simon Fraser University	Chung, RT (corresponding author), MA Gen Hosp, Gastrointestinal Unit, Warren 1007, Boston, MA 02114 USA.	rtchung@partners.org	LI, Shaoyong/D-1052-2013; Jilg, Nikolaus/GON-5240-2022; Weinberg, Ethan Michael/AAH-8009-2019; Brockman, Mark/D-1669-2016	Weinberg, Ethan Michael/0000-0002-5605-8995; Kumthip, Kattareeya/0000-0001-7028-7607; Brockman, Mark/0000-0001-6432-1426	National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study; National Institutes of Health [AI069939, AI082630, AI066313U19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313, U19AI082630, R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study Grant (to W. L.), and National Institutes of Health Grants AI069939 (to R. T. C.), AI082630 (to R. T. C.), and AI066313U19 (to D. S.).	Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Blackard JT, 2006, J INTERF CYTOK RES, V26, P834, DOI 10.1089/jir.2006.26.834; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; CASINI A, 1994, LIFE SCI, V55, P1311, DOI 10.1016/0024-3205(94)00763-2; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kim SM, 2007, AM J PHYSIOL-RENAL, V292, pF415, DOI 10.1152/ajprenal.00317.2006; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; MILANI S, 1990, GASTROENTEROLOGY, V98, P175, DOI 10.1016/0016-5085(90)91307-R; MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117; Miura K, 2008, HEPATOLOGY, V48, p789A; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Pascual-Pareja JF, 2009, AIDS, V23, P971, DOI 10.1097/QAD.0b013e328329f994; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sherman KE, 2007, HEPATOLOGY, V45, P1566, DOI 10.1002/hep.21722; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Urtasun R, 2009, GASTROENTEROLOGY, V136, P1410, DOI 10.1053/j.gastro.2008.12.065; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	46	80	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2665	2674		10.1074/jbc.M110.168286	http://dx.doi.org/10.1074/jbc.M110.168286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098019	Green Published, hybrid			2022-12-27	WOS:000286464300032
J	Wan, XP; Dennis, AT; Obejero-Paz, C; Overholt, JL; Heredia-Moya, J; Kirk, KL; Ficker, E				Wan, Xiaoping; Dennis, Adrienne T.; Obejero-Paz, Carlos; Overholt, Jeffrey L.; Heredia-Moya, Jorge; Kirk, Kenneth L.; Ficker, Eckhard			Oxidative Inactivation of the Lipid Phosphatase Phosphatase and Tensin Homolog on Chromosome Ten (PTEN) as a Novel Mechanism of Acquired Long QT Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR PTEN; GROWTH-FACTOR-I; ARSENIC TRIOXIDE; PHOSPHATIDYLINOSITOL 3-KINASE; CARDIAC REPOLARIZATION; CA2+ CHANNEL; KINASE-C; CELLS	The most common cause of cardiac side effects of pharmaco-therapy is acquired long QT syndrome, which is characterized by abnormal cardiac repolarization and most often caused by direct blockade of the cardiac potassium channel human ether a-go-go-related gene (hERG). However, little is known about therapeutic compounds that target ion channels other than hERG. We have discovered that arsenic trioxide (As2O3), a very potent antineoplastic compound for the treatment of acute promyelocytic leukemia, is proarrhythmic via two separate mechanisms: a well characterized inhibition of hERG/I-Kr trafficking and a poorly understood increase of cardiac calcium currents. We have analyzed the latter mechanism in the present study using biochemical and electrophysiological methods. We find that oxidative inactivation of the lipid phosphatase PTEN by As2O3 enhances cardiac calcium currents in the therapeutic concentration range via a PI3K alpha-dependent increase in phosphatidylinositol 3,4,5-triphosphate (PIP3) production. In guinea pig ventricular myocytes, even a modest reduction in PTEN activity is sufficient to increase cellular PIP3 levels. Under control conditions, PIP3 levels are kept low by PTEN and do not affect calcium current amplitudes. Based on pharmacological experiments and intracellular infusion of PIP3, we propose that in guinea pig ventricular myocytes, PIP3 regulates calcium currents independently of the protein kinase Akt along a pathway that includes a secondary oxidation-sensitive target. Overall, our report describes a novel form of acquired long QT syndrome where the target modified by As2O3 is an intracellular signaling cascade.	[Wan, Xiaoping; Dennis, Adrienne T.; Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Obejero-Paz, Carlos] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Overholt, Jeffrey L.] Winston Salem State Univ, Dept Life Sci, Winston Salem, NC 27110 USA; [Heredia-Moya, Jorge; Kirk, Kenneth L.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Winston-Salem State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ficker, E (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	eficker@metrohealth.org		Heredia-Moya, Jorge/0000-0001-7620-9140	National Institutes of Health [HL71789]; NIDDK, National Institutes of Health; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL71789 (to E. F.) and intramural funds of NIDDK, National Institutes of Health (to J. H.-M. and K. L. K.). This work was also supported by a grant from the American Heart Association (to J. L. O.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Chiang CE, 2002, BLOOD, V100, P2249, DOI 10.1182/blood-2002-02-0598; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; Delbono O, 1997, J NEUROSCI, V17, P6918; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Holleran JL, 2003, ANAL BIOCHEM, V323, P19, DOI 10.1016/j.ab.2003.08.030; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kuryshev YA, 2006, MOL PHARMACOL, V69, P1216, DOI 10.1124/mol.105.019281; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Laurent A, 2005, CANCER RES, V65, P948; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Lu ZJ, 2007, DIABETES, V56, P2780, DOI 10.2337/db06-1629; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Ohnishi K, 2000, ANN INTERN MED, V133, P881, DOI 10.7326/0003-4819-133-11-200012050-00012; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Siu CW, 2006, BLOOD, V108, P103, DOI 10.1182/blood-2006-01-0054; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Unnikrishnan D, 2001, BLOOD, V97, P1514, DOI 10.1182/blood.V97.5.1514; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475	45	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2843	2852		10.1074/jbc.M110.125526	http://dx.doi.org/10.1074/jbc.M110.125526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097842	hybrid, Green Published			2022-12-27	WOS:000286464300050
J	Mittal, R; Krishnan, S; Gonzalez-Gomez, I; Prasadarao, NV				Mittal, Rahul; Krishnan, Subramanian; Gonzalez-Gomez, Ignacio; Prasadarao, Nemani V.			Deciphering the Roles of Outer Membrane Protein A Extracellular Loops in the Pathogenesis of Escherichia coli K1 Meningitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BACTERIAL-MENINGITIS; NEONATAL MENINGITIS; TRANSMEMBRANE DOMAIN; DENDRITIC CELLS; STRAIN RS218; OMPA; EXPRESSION; INVASION; BETA	Outer membrane protein A (OmpA) has been implicated as an important virulence factor in several Gram-negative bacterial infections such as Escherichia coli K1, a leading cause of neonatal meningitis associated with significant mortality and morbidity. In this study, we generated E. coli K1 mutants that express OmpA in which three or four amino acids from various extracellular loops were changed to alanines, and we examined their ability to survive in several immune cells. We observed that loop regions 1 and 2 play an important role in the survival of E. coli K1 inside neutrophils and dendritic cells, and loop regions 1 and 3 are needed for survival in macrophages. Concomitantly, E. coli K1 mutants expressing loop 1 and 2 mutations were unable to cause meningitis in a newborn mouse model. Of note, mutations in loop 4 of OmpA enhance the severity of the pathogenesis by allowing the pathogen to survive better in circulation and to produce high bacteremia levels. These results demonstrate, for the first time, the roles played by different regions of extracellular loops of OmpA of E. coli K1 in the pathogenesis of meningitis and may help in designing effective preventive strategies against this deadly disease.	[Mittal, Rahul; Krishnan, Subramanian; Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Div Infect Dis, Dept Pediat, Los Angeles, CA 90027 USA; [Gonzalez-Gomez, Ignacio] Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Prasadarao, NV (corresponding author), Childrens Hosp Los Angeles, Div Infect Dis, Dept Pediat, MS 51,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	pnemani@chla.usc.edu	Krishnan, Subramanian/K-5032-2019	Krishnan, Subramanian/0000-0001-5780-7452	National Institutes of Health [AI40567, NS73115]; Saban Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040567, R29AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saban Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40567 and NS73115 (to N. V. P.). This work was also supported by Saban Research Institute research career development fellowship (to R. M.).	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980; Boyer-Mariotte S, 2008, J ANTIMICROB CHEMOTH, V62, P1472, DOI 10.1093/jac/dkn362; BRAUN V, 1972, EUR J BIOCHEM, V28, P51, DOI 10.1111/j.1432-1033.1972.tb01883.x; Criss AK, 2008, CELL MICROBIOL, V10, P2257, DOI 10.1111/j.1462-5822.2008.01205.x; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; Dubois D, 2009, EMERG INFECT DIS, V15, P1988, DOI 10.3201/eid1512.090928; Fagan RP, 2008, INFECT IMMUN, V76, P1135, DOI 10.1128/IAI.01327-07; Houdouin V, 2008, CLIN MICROBIOL INFEC, V14, P685, DOI 10.1111/j.1469-0691.2008.02019.x; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim K S, 2000, Subcell Biochem, V33, P47; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Koebnik R, 1999, J MOL BIOL, V285, P1801, DOI 10.1006/jmbi.1998.2405; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Ling M, 1998, BLOOD, V92, P4764, DOI 10.1182/blood.V92.12.4764.424k03_4764_4770; LUO Y, 2001, CURR PROTOC IMMUNOL, V3; Maruvada R, 2008, IMMUNOLOGY, V124, P265, DOI 10.1111/j.1365-2567.2007.02764.x; Mittal R, 2008, J IMMUNOL, V181, P2672, DOI 10.4049/jimmunol.181.4.2672; Mittal R, 2010, J IMMUNOL, V185, P2998, DOI 10.4049/jimmunol.1001296; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Mittal R, 2010, AM J PATHOL, V176, P1292, DOI 10.2353/ajpath.2010.090851; Mittal R, 2009, FEMS IMMUNOL MED MIC, V57, P156, DOI 10.1111/j.1574-695X.2009.00591.x; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Nudelman Y, 2009, DRUGS, V69, P2577, DOI 10.2165/11530590-000000000-00000; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Power ML, 2006, APPL ENVIRON MICROB, V72, P7930, DOI 10.1128/AEM.01040-06; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Sidjabat HE, 2010, J ANTIMICROB CHEMOTH, V65, P1301, DOI 10.1093/jac/dkq098; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; SOKURENKO EV, 1994, J BACTERIOL, V176, P748, DOI 10.1128/jb.176.3.748-755.1994; Subramanian K, 2008, J APPL MICROBIOL, V105, P715, DOI 10.1111/j.1365-2672.2008.03800.x; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x	49	40	42	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2183	2193		10.1074/jbc.M110.178236	http://dx.doi.org/10.1074/jbc.M110.178236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071448	hybrid, Green Published			2022-12-27	WOS:000286191500059
J	Oommen, S; Gupta, SK; Vlahakis, NE				Oommen, Saji; Gupta, Shiv K.; Vlahakis, Nicholas E.			Vascular Endothelial Growth Factor A (VEGF-A) Induces Endothelial and Cancer Cell Migration through Direct Binding to Integrin alpha 9 beta 1 IDENTIFICATION OF A SPECIFIC alpha 9 beta 1 BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RECEPTOR-BINDING; TYROSINE KINASE; MICE LACKING; ANGIOGENESIS; INTEGRIN-ALPHA-9-BETA-1; ACTIVATION; DOMAIN; ALPHA(4)BETA(1); ALPHA(9)BETA(1)	Integrin alpha 9 beta 1 mediates accelerated cell adhesion and migration through interactions with a number of diverse extracellular ligands. We have shown previously that it directly binds the vascular endothelial growth factors (VEGF) A, C, and D and contributes to VEGF-induced angiogenesis and lymphangiogenesis. Until now, the alpha 9 beta 1 binding site in VEGF has not been identified. Here, we report that the three-amino acid sequence, EYP, encoded by exon 3 of VEGF-A is essential for binding of VEGF to integrin alpha 9 beta 1 and induces adhesion and migration of endothelial and cancer cells. EYP is specific for alpha 9 beta 1 binding and neither requires nor activates VEGFR-2, the cognate receptor for VEGF-A. Following binding to EYP, integrin alpha 9 beta 1 transduces cell migration through direct activation of the integrin signaling intermediates Src and focal adhesion kinase. This interaction is biologically important because it mediates in vitro endothelial cell tube formation, wound healing, and cancer cell invasion. These novel findings identify EYP as a potential site for directed pharmacotherapy.	[Oommen, Saji; Gupta, Shiv K.; Vlahakis, Nicholas E.] Mayo Clin, Thorac Dis Res Unit, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Mayo Clinic	Vlahakis, NE (corresponding author), Mayo Clin, Thorac Dis Res Unit, Div Pulm & Crit Care Med, 200 1st St SW, Rochester, MN 55905 USA.	Vlahakis.nicholas@mayo.edu			National Institutes of Health [K08HL076455-05]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI Research Grant K08HL076455-05 from the National Institutes of Health (to N. E. V.). This work was also supported by a Mayo Foundation Research grant (to N. E. V.).	Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Gupta SK, 2010, CELL ADHES MIGR, V4, P194, DOI 10.4161/cam.4.2.10900; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214	42	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1083	1092		10.1074/jbc.M110.175158	http://dx.doi.org/10.1074/jbc.M110.175158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071450	hybrid, Green Published			2022-12-27	WOS:000286005000019
J	Carrillo, LD; Froemming, JA; Mahal, LK				Carrillo, Luz D.; Froemming, Joshua A.; Mahal, Lara K.			Targeted in Vivo O-GlcNAc Sensors Reveal Discrete Compartment-specific Dynamics during Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PROTEIN-KINASE; NUCLEAR-LOCALIZATION; ACTIVATION DOMAIN; PHOSPHORYLATION; MEMBRANE; EXPORT; TRANSFERASE; REPORTER	beta-O-N-acetyl-D-glucosamine (O-GlcNAc) is a post-translational modification involved in a plethora of biological systems ranging from cellular stress to insulin signaling. This modification shares many hallmarks with phosphorylation, including its dynamic cycling onto a host of proteins such as transcription factors, kinases, and phosphatases, and regulation of cellular functions, including cell signaling. Herein, we report the development of an improved genetically based O-GlcNAc FRET sensor and compartmentalized targeted variants for the characterization of the spatiotemporal dynamics of O-GlcNAc. During serum-stimulated signal transduction, rapid increases in O-GlcNAc activity were observed at both the plasma membrane and the nucleus, with a concomitant decrease detected in the cytoplasm. These findings suggest the existence of compartment specific dynamics for O-GlcNAc in response to signal-inducing stimuli, pointing to complex regulation of this modification. In addition, inhibition of the PI3K pathway by wortmannin abolished the O-GlcNAc response, suggesting that the activity observed is modulated downstream of the PI3K pathway. Taken together, our data argues that O-GlcNAc is a rapidly induced component of signaling and that the interplay between O-GlcNAc and kinase signaling may be more akin to the complex relationship between kinase pathways.	[Carrillo, Luz D.; Froemming, Joshua A.; Mahal, Lara K.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Mahal, Lara K.] NYU, Dept Chem, New York, NY 10003 USA	University of Texas System; University of Texas Austin; New York University	Mahal, LK (corresponding author), 100 Washington Sq E,Rm 1001, New York, NY 10003 USA.	lkmahal@nyu.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	American Heart Association [0755146Y]; Alfred P. Sloan Foundation	American Heart Association(American Heart Association); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Financial Support for this work came from the American Heart Association (Grant-in-aid, 0755146Y) and the Alfred P. Sloan Foundation.	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Carrillo LD, 2006, J AM CHEM SOC, V128, P14768, DOI 10.1021/JA065835+; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Nanashima N, 2005, J BIOL CHEM, V280, P43010, DOI 10.1074/jbc.M509481200; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; SAARELA S, 1995, J BACTERIOL, V177, P1477, DOI 10.1128/jb.177.6.1477-1484.1995; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tanskanen J, 2001, J BACTERIOL, V183, P512, DOI 10.1128/JB.183.2.512-519.2001; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	44	25	25	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6650	6658		10.1074/jbc.M110.191627	http://dx.doi.org/10.1074/jbc.M110.191627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138847	Green Published, hybrid			2022-12-27	WOS:000287476400073
J	Florek, P; Levdikov, VM; Blagova, E; Lebedev, AA; Skrabana, R; Resetarova, S; Pavelcikova, P; Barak, I; Wilkinson, AJ				Florek, Patrik; Levdikov, Vladimir M.; Blagova, Elena; Lebedev, Andrey A.; Skrabana, Rostislav; Resetarova, Stanislava; Pavelcikova, Pamela; Barak, Imrich; Wilkinson, Anthony J.			The Structure and Interactions of SpoIISA and SpoIISB, a Toxin-Antitoxin System in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-GRAPHICS; STATIONARY-PHASE; DIFFRACTION DATA; GAF DOMAIN; EXPRESSION; COMPLEX; PROTEIN	Spore formation in Bacillus subtilis begins with an asymmetric cell division, following which differential gene expression is established by alternative compartment-specific RNA polymerase sigma factors. The spoIISAB operon of B. subtilis was identified as a locus whose mutation leads to increased activity of the first sporulation-specific sigma factor, sigma(F). Inappropriate spoIISA expression causes lysis of vegetatively growing B. subtilis cells and Escherichia coli cells when expressed heterologously, effects that are countered by co-expression of spoIISB, identifying SpoIISA-SpoIISB as a toxin-antitoxin system. SpoIISA has three putative membrane-spanning segments and a cytoplasmic domain. Here, the crystal structure of a cytoplasmic fragment of SpoIISA (CSpoIISA) in complex with SpoIISB has been determined by selenomethionine-multiwavelength anomalous dispersion phasing to 2.5 angstrom spacing, revealing a CSpoIISA(2) . SpoIISB(2) heterotetramer. CSpoIISA has a single domain alpha/beta structure resembling a GAF domain with an extended alpha-helix at its N terminus. The two CSpoIISA protomers form extensive interactions through an intermolecular four-helix bundle. Each SpoIISB chain is highly extended and lacking tertiary structure. The SpoIISB chains wrap around the CSpoIISA dimer, forming extensive interactions with both CSpoIISA protomers. CD spectroscopy experiments indicate that SpoIISB is a natively disordered protein that adopts structure only in the presence of CSpoIISA, whereas surface plasmon resonance experiments revealed that the CSpoIISA . SpoIISB complex is stable with a dissociation constant in the nanomolar range. The results are interpreted in relation to sequence conservation and mutational data, and possible mechanisms of cell killing by SpoIISA are discussed.	[Resetarova, Stanislava; Pavelcikova, Pamela; Barak, Imrich] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551 45, Slovakia; [Levdikov, Vladimir M.; Blagova, Elena; Lebedev, Andrey A.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Skrabana, Rostislav] Slovak Acad Sci, Inst Neuroimmunol, Bratislava 84510 45, Slovakia	Slovak Academy of Sciences; University of York - UK; Slovak Academy of Sciences	Barak, I (corresponding author), Slovak Acad Sci, Inst Mol Biol, Bratislava 84551 45, Slovakia.	Imrich.Barak@savba.sk; ajw@ysbl.york.ac.uk	Rešetárová, Stanislava/ABA-8823-2020; Barak, Imrich/H-7285-2019; Levdikov, Vladimir/AAA-6139-2022; Skrabana, Rostislav/T-7382-2019	Barak, Imrich/0000-0002-3690-404X; Skrabana, Rostislav/0000-0001-8200-5275; Wilkinson, Anthony/0000-0003-4577-9479; Levdikov, Vladimir/0000-0003-3041-1049	Slovak Academy of Sciences [2/0016/10]; Slovak Research and Development Agency [APVT-51-0278, LPP-0218-06]; European Science Foundation [ESF-EC-0106]; Wellcome Trust [082829/Z/07/Z]	Slovak Academy of Sciences(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); European Science Foundation(European Science Foundation (ESF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Grant 2/0016/10 from the Slovak Academy of Sciences, by grants from the Slovak Research and Development Agency under Contracts APVT-51-0278 and LPP-0218-06, by a European Science Foundation Grant ESF-EC-0106, and by Grant 082829/Z/07/Z from the Wellcome Trust.	Adler E, 2001, J BACTERIOL, V183, P3574, DOI 10.1128/JB.183.12.3574-3581.2001; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Dewey JS, 2010, P NATL ACAD SCI USA, V107, P2219, DOI 10.1073/pnas.0914030107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florek P, 2008, FEMS MICROBIOL LETT, V278, P177, DOI 10.1111/j.1574-6968.2007.00984.x; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Harwood C.R., 1990, MOL BIOL METHODS BAC; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Ju JL, 1998, J BACTERIOL, V180, P1673, DOI 10.1128/JB.180.7.1673-1681.1998; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ramakrishnan V, 1997, METHOD ENZYMOL, V276, P538, DOI 10.1016/S0076-6879(97)76077-4; Resetarova S, 2010, RES MICROBIOL, V161, P750, DOI 10.1016/j.resmic.2010.09.005; Savva CG, 2008, MOL MICROBIOL, V69, P784, DOI 10.1111/j.1365-2958.2008.06298.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SEVCIK J, 1991, ACTA CRYSTALLOGR B, V47, P240, DOI 10.1107/S0108768190009569; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Steil L, 2005, MICROBIOL-SGM, V151, P399, DOI 10.1099/mic.0.27493-0; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	53	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6808	6819		10.1074/jbc.M110.172429	http://dx.doi.org/10.1074/jbc.M110.172429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147767	Green Published, hybrid			2022-12-27	WOS:000287476400088
J	Riese, MJ; Grewal, J; Das, J; Zou, T; Patil, V; Chakraborty, AK; Koretzky, GA				Riese, Matthew J.; Grewal, Jashanpreet; Das, Jayajit; Zou, Tao; Patil, Vineet; Chakraborty, Arup K.; Koretzky, Gary A.			Decreased Diacylglycerol Metabolism Enhances ERK Activation and Augments CD8(+) T Cell Functional Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBL-B; KINASE-ZETA; HOMEOSTATIC PROLIFERATION; RAS ACTIVATION; IN-VIVO; POSITIVE SELECTION; ANTIGEN; PROTEIN; ALPHA; NAIVE	Modulation of T cell receptor signal transduction in CD8(+) T cells represents a novel strategy toward enhancing the immune response to tumor. Recently, levels of guanine exchange factors, RasGRP and SOS, within T cells have been shown to represent a key determinant in the regulation of the analog to the digital activation threshold of Ras. One important for regulating activation levels of RasGRP is diacylglycerol (DAG), and its levels are influenced by diacylglycerol kinase-zeta (DGK zeta), which metabolizes DAG into phosphatidic acid, terminating DAG-mediated Ras signaling. We sought to determine whether DGK zeta-deficient CD8(+) T cells demonstrated enhanced in vitro responses in a manner predicted by the current model of Ras activation and to evaluate whether targeting this threshold confers enhanced CD8(+) T cell responsiveness to tumor. We observed that DGK zeta-deficient CD8(+) T cells conform to most predictions of the current model of how RasGRP levels influence Ras activation. But our results differ in that the EC50 value of stimulation is not altered for any T cell receptor stimulus, a finding that suggests a further degree of complexity to how DGK zeta deficiency affects signals important for Ras and ERK activation. Additionally, we found that DGK zeta-deficient CD8(+) T cells demonstrate enhanced responsiveness in a subcutaneous lymphoma model, implicating the analog to a digital conversion threshold as a novel target for potential therapeutic manipulation.	[Koretzky, Gary A.] Univ Penn, Dept Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Riese, Matthew J.] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Dept Med, Div Rheumatol, Philadelphia, PA 19104 USA; [Das, Jayajit] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Das, Jayajit] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Koretzky, Gary A.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA 02129 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Koretzky, GA (corresponding author), 413 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Das, Jayajit/E-2951-2011; Das, Jayajit/AAD-8502-2022; Koretzky, Gary/AAU-5381-2021	Das, Jayajit/0000-0001-9649-4698; Riese, Matthew/0000-0002-2423-0017	National Institutes of Health; NATIONAL CANCER INSTITUTE [K08CA151893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Chakraborty AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pt2; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; DiSpirito JR, 2010, CELL RES, V20, P13, DOI 10.1038/cr.2009.140; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg J, 2003, J IMMUNOL, V170, P228, DOI 10.4049/jimmunol.170.1.228; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnson KG, 1999, J IMMUNOL, V162, P3802; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Norment AM, 2003, J IMMUNOL, V170, P1141, DOI 10.4049/jimmunol.170.3.1141; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shamim M, 2007, J IMMUNOL, V179, P7233, DOI 10.4049/jimmunol.179.11.7233; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Van Kampen NG, 1992, STOCHASTIC PROCESSES; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Yi TL, 2008, CURR ONCOL REP, V10, P114, DOI 10.1007/s11912-008-0019-6; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	46	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5254	5265		10.1074/jbc.M110.171884	http://dx.doi.org/10.1074/jbc.M110.171884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138839	hybrid, Green Published			2022-12-27	WOS:000287230600034
J	Yano, M; Watanabe, K; Yamamoto, T; Ikeda, K; Senokuchi, T; Lu, MH; Kadomatsu, T; Tsukano, H; Ikawa, M; Okabe, M; Yamaoka, S; Okazaki, T; Umehara, H; Gotoh, T; Song, WJ; Node, K; Taguchi, R; Yamagata, K; Oike, Y				Yano, Masato; Watanabe, Ken; Yamamoto, Tadashi; Ikeda, Kazutaka; Senokuchi, Takafumi; Lu, Meihong; Kadomatsu, Tsuyoshi; Tsukano, Hiroto; Ikawa, Masahito; Okabe, Masaru; Yamaoka, Shohei; Okazaki, Toshiro; Umehara, Hisanori; Gotoh, Tomomi; Song, Wen-Jie; Node, Koichi; Taguchi, Ryo; Yamagata, Kazuya; Oike, Yuichi			Mitochondrial Dysfunction and Increased Reactive Oxygen Species Impair Insulin Secretion in Sphingomyelin Synthase 1-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; PANCREATIC BETA-CELLS; SPHINGOLIPID METABOLISM; CERAMIDE; APOPTOSIS; PROTEINS; DETERMINANTS; TRAFFICKING; INHIBITION; SENESCENCE	Sphingomyelin synthase 1 (SMS1) catalyzes the conversion of ceramide to sphingomyelin. Here, we generated and analyzed SMS1-null mice. SMS1-null mice exhibited moderate neonatal lethality, reduced body weight, and loss of fat tissues mass, suggesting that they might have metabolic abnormality. Indeed, analysis on glucose metabolism revealed that they showed severe deficiencies in insulin secretion. Isolated mutant islets exhibited severely impaired ability to release insulin, dependent on glucose stimuli. Further analysis indicated that mitochondria in mutant islet cells cannot up-regulate ATP production in response to glucose. We also observed additional mitochondrial abnormalities, such as hyperpolarized membrane potential and increased levels of reactive oxygen species (ROS) in mutant islets. Finally, when SMS1-null mice were treated with the anti-oxidant N-acetyl cysteine, we observed partial recovery of insulin secretion, indicating that ROS overproduction underlies pancreatic beta-cell dysfunction in SMS1-null mice. Altogether, our data suggest that SMS1 is important for controlling ROS generation, and that SMS1 is required for normal mitochondrial function and insulin secretion in pancreatic beta-cells.	[Yano, Masato; Yamamoto, Tadashi; Kadomatsu, Tsuyoshi; Tsukano, Hiroto; Gotoh, Tomomi; Oike, Yuichi] Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Senokuchi, Takafumi; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan; [Lu, Meihong; Song, Wen-Jie] Kumamoto Univ, Fac Life Sci, Dept Sensory & Cognit Physiol, Kumamoto 8608556, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan; [Yamamoto, Tadashi; Node, Koichi] Saga Univ, Dept Cardiovasc & Renal Med, Saga 8498501, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Res Inst Microbial Dis & Pharmaceut Sci, Osaka 5650871, Japan; [Yamaoka, Shohei; Okazaki, Toshiro] Tottori Univ, Div Clin Lab Med & Hematol Oncol, Fac Med, Tottori 6838503, Japan; [Umehara, Hisanori] Kanazawa Med Univ, Dept Hematol & Immunol, Ishikawa 9200293, Japan	Kumamoto University; Kumamoto University; Kumamoto University; National Center for Geriatrics & Gerontology; Saga University; University of Tokyo; Osaka University; Tottori University; Kanazawa Medical University	Yano, M (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto 8608556, Japan.	myano@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Watanabe, Ken/I-3960-2013; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Watanabe, Ken/0000-0003-0664-3915; ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044; Song, Wen-Jie/0000-0003-2909-3098	Ministry of Education, Science, Technology, Sports, and Culture of Japan [19790215, 22116009]; Japan Society for the Promotion of Science [22659156]; Takeda Science Foundation; Inamori Foundation	Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported by Grants-in-Aid 19790215 (to M. Y.), and 22116009 (to Y. O.) from the Ministry of Education, Science, Technology, Sports, and Culture of Japan, by Grant-in-Aid 22659156 (to Y. O.) from the Japan Society for the Promotion of Science, and by grants-in-aid from the Takeda Science Foundation and Inamori Foundation (to M. Y.).	Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Separovic D, 2008, EXP CELL RES, V314, P1860, DOI 10.1016/j.yexcr.2008.02.008; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; WOLLHEIM CB, 1990, METHOD ENZYMOL, V192, P188; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000; Yano M, 2007, EXP CELL RES, V313, P3767, DOI 10.1016/j.yexcr.2007.07.031; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	48	106	109	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3992	4002		10.1074/jbc.M110.179176	http://dx.doi.org/10.1074/jbc.M110.179176			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115496	Green Published, hybrid			2022-12-27	WOS:000286653200079
J	Delarasse, C; Auger, R; Gonnord, P; Fontaine, B; Kanellopoulos, JM				Delarasse, Cecile; Auger, Rodolphe; Gonnord, Pauline; Fontaine, Bertrand; Kanellopoulos, Jean M.			The Purinergic Receptor P2X7 Triggers alpha-Secretase-dependent Processing of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; P2X(7) RECEPTOR; ALZHEIMER-DISEASE; EXTRACELLULAR ATP; MICE LACKING; LIPID RAFTS; MOUSE MODEL; CELL-DEATH; L-SELECTIN; RELEASE	The amyloid precursor protein (APP) is cleaved by beta- and gamma-secretases to generate the beta-amyloid (A beta) peptides, which are present in large amounts in the amyloid plaques of Alzheimer disease (AD) patient brains. Non-amyloidogenic processing of APP by alpha-secretases leads to proteolytic cleavage within the A beta peptide sequence and shedding of the soluble APP ectodomain (sAPP alpha), which has been reported to be endowed with neuroprotective properties. In this work, we have shown that activation of the purinergic receptor P2X7 (P2X7R) stimulates sAPP alpha release from mouse neuroblastoma cells expressing human APP, from human neuroblastoma cells and from mouse primary astrocytes or neural progenitor cells. sAPP alpha shedding is inhibited by P2X7R antagonists or knockdown of P2X7R with specific small interfering RNA (siRNA) and is not observed in neural cells from P2X7R-deficient mice. P2X7R-dependent APP-cleavage is independent of extracellular calcium and strongly inhibited by hydroxamate-based metalloprotease inhibitors, TAPI-2 and GM6001. However, knockdown of a disintegrin and metalloproteinase-9 (ADAM9), ADAM10 and ADAM17 by specific siRNA, known to have alpha-secretase activity, does not block the P2X7R-dependent non-amyloidogenic pathway. Using several specific pharmacological inhibitors, we demonstrate that the mitogen-activated protein kinase modules Erk1/2 and JNK are involved in P2X7R-dependent alpha-secretase activity. Our study suggests that P2X7R, which is expressed in hippocampal neurons and glial cells, is a potential therapeutic target in AD.	[Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Lab Activat Cellulaire & Transduct Signaux, F-91405 Orsay, France; [Delarasse, Cecile; Fontaine, Bertrand] INSERM, CRICM, UMR S975, F-75013 Paris, France; [Delarasse, Cecile; Fontaine, Bertrand] Univ Paris 06, F-75013 Paris, France; [Delarasse, Cecile; Fontaine, Bertrand] CNRS, UMR7225, F-75013 Paris, France; [Delarasse, Cecile; Auger, Rodolphe; Gonnord, Pauline; Kanellopoulos, Jean M.] Univ Paris 11, F-91405 Orsay, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Kanellopoulos, JM (corresponding author), Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Lab Activat Cellulaire & Transduct Signaux, Batiment 430, F-91405 Orsay, France.	jean.kanellopoulos@u-psud.fr	Delarasse, Cecile/K-8234-2017	Delarasse, Cecile/0000-0001-9739-4306	Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche [ANR-07-BLAN-0089-02]; Association France Alzheimer; Neuropole de Recherche francilien (NeRF); ANR	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association France Alzheimer; Neuropole de Recherche francilien (NeRF); ANR(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Agence Nationale pour la Recherche (ANR-07-BLAN-0089-02), Association France Alzheimer, and Neuropole de Recherche francilien (NeRF).; Supported by ANR.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Bandyopadhyay S, 2007, CURR MED CHEM, V14, P2848, DOI 10.2174/092986707782360060; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Carroll WA, 2009, PURINERG SIGNAL, V5, P63, DOI 10.1007/s11302-008-9110-6; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fuller S, 2009, EXPERT REV NEUROTHER, V9, P1585, DOI 10.1586/ERN.09.111; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Haring R, 1998, J NEUROCHEM, V71, P2094; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Ma GZ, 2005, J NEUROSCI RES, V80, P683, DOI 10.1002/jnr.20515; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Papp L, 2007, BIOCHEM BIOPH RES CO, V355, P568, DOI 10.1016/j.bbrc.2007.02.014; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Robert SJ, 2001, J BIOL CHEM, V276, P44881, DOI 10.1074/jbc.M109008200; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	66	78	94	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2596	2606		10.1074/jbc.M110.200618	http://dx.doi.org/10.1074/jbc.M110.200618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081501	hybrid, Green Published			2022-12-27	WOS:000286464300025
J	Ruffieux-Daidie, D; Staub, O				Ruffieux-Daidie, Dorothee; Staub, Olivier			Intracellular Ubiquitylation of the Epithelial Na+ Channel Controls Extracellular Proteolytic Channel Activation via Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; GAMMA-SUBUNIT; LIDDLES-SYNDROME; ESSENTIAL-HYPERTENSION; UBIQUITIN LIGASE; SERINE PROTEASES; XENOPUS-OOCYTES; RAT-KIDNEY; ENAC	The epithelial Na+ channel ENaC is a key player in the maintenance of whole body Na+ balance, and consequently of blood pressure. It is tightly regulated by numerous signaling pathways including ubiquitylation via the ubiquitin-protein ligase Nedd4-2. This mechanism is itself under the control of several kinases, which phosphorylate Nedd4-2, thereby interfering with ENaC/Nedd4-2 interaction, or by Usp2-45, which binds to and deubiquitylates ENaC. Another, different regulatory mechanism concerns the proteolytic activation of ENaC, during which the channel is cleaved on its luminal side by intracellular convertases such as furin, and further activated by extracellular proteases such as CAP-1. This process is regulated as well but the underlying mechanisms are not understood. Previously, evidence was provided that the ubiquitylation status of ENaC may affect the cleavage of the channel. When ubiquitylation of ENaC was reduced, either by co-expressing Usp2-45, or mutating either the ENaC PY-motifs (i.e. the binding sites for Nedd4-2) or intracellular lysines (i.e. ubiquitylation sites), the level of channel cleavage was increased. Here we demonstrate that lysine-mutated ENaC channels are not ubiquitylated at the cell surface, are preferentially cleaved, and Usp2-45 does not affect their cleavage efficiency. We further show by limited proteolysis that the intracellular ubiquitylation status of ENaC affects the extracellular conformation of alpha ENaC, by demonstrating that non-ubiquitylated channels are more efficiently cleaved when treated with extracellularly added trypsin or chymotrypsin. These results present a new paradigm in which an intracellular, post-translational modification (e.g. ubiquitylation) of a transmembrane protein can affect its extracellular conformation.	[Ruffieux-Daidie, Dorothee; Staub, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Staub, O (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Olivier.Staub@unil.ch			Swiss National Science Foundation [31003A_125422/1]; Leducq Foundation (Transatlantic Network on Hypertension); Swiss Kidney Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leducq Foundation (Transatlantic Network on Hypertension)(Leducq Foundation); Swiss Kidney Foundation	This work was supported by the Swiss National Science Foundation (31003A_125422/1), by the Leducq Foundation (Transatlantic Network on Hypertension), and by the Swiss Kidney Foundation.	Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Dahlberg J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000432; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fava C, 2006, KIDNEY INT, V70, P562, DOI 10.1038/sj.ki.5001590; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Tanswell AK, 1998, AM J PHYSIOL-LUNG C, V275, pL452, DOI 10.1152/ajplung.1998.275.3.L452; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wen H, 2008, CLIN EXP HYPERTENS, V30, P87, DOI 10.1080/10641960801949909; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	36	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2416	2424		10.1074/jbc.M110.176156	http://dx.doi.org/10.1074/jbc.M110.176156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084303	Green Published, hybrid			2022-12-27	WOS:000286464300005
J	Gorski, JP; Huffman, NT; Chittur, S; Midura, RJ; Black, C; Oxford, J; Seidah, NG				Gorski, Jeff P.; Huffman, Nichole T.; Chittur, Sridar; Midura, Ronald J.; Black, Claudine; Oxford, Julie; Seidah, Nabil G.			Inhibition of Proprotein Convertase SKI-1 Blocks Transcription of Key Extracellular Matrix Genes Regulating Osteoblastic Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; ENDOPLASMIC-RETICULUM STRESS; BONE ACIDIC GLYCOPROTEIN-75; UBIQUITIN-PROTEASOME PATHWAY; COENZYME-A SYNTHASE; IN-VITRO; SQUALENE SYNTHASE; CYSTEINE PROTEASE; SITE-1 PROTEASE; COLLAGEN GENE	Mineralization, a characteristic phenotypic property of osteoblastic lineage cells, was blocked by 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF) and decanoyl-Arg-Arg-Leu-Leu-chloromethyl ketone (dec-RRLL-cmk), inhibitors of SKI-1 (site 1; subtilisin kexin like-1) protease. Because SKI-1 is required for activation of SREBP and CREB (cAMP-response element-binding protein)/ATF family transcription factors, we tested the effect of these inhibitors on gene expression. AEBSF decreased expression of 140 genes by 1.5-3.0-fold including Phex, Dmp1, COL1A1, COL11A1, and fibronectin. Direct comparison of AEBSF and dec-RRLL-cmk, a more specific SKI-1 inhibitor, demonstrated that expression of Phex, Dmp1, COL11A1, and fibronectin was reduced by both, whereas COL1A2 and HMGCS1 were reduced only by AEBSF. AEBSF and decRRLL-cmk decreased the nuclear content of SKI-1-activated forms of transcription factors SREBP-1, SREBP-2, and OASIS. In contrast to AEBSF, the actions of dec-RRLL-cmk represent the sum of its direct actions on SKI-1 and indirect actions on caspase-3. Specifically, dec-RRLL-cmk reduced intracellular caspase-3 activity by blocking the formation of activated 19-kDa caspase-3. Conversely, overexpression of SKI-1-activated SREBP-1a and CREB-H in UMR106-01 osteoblastic cells increased the number of mineralized foci and altered their morphology to yield mineralization nodules, respectively. In summary, SKI-1 regulates the activation of transmembrane transcription factor precursors required for expression of key genes required for mineralization of osteoblastic cultures in vitro and bone formation in vivo. Our results indicate that the differentiated phenotype of osteoblastic cells and possibly osteocytes depends upon the non-apoptotic actions of SKI-1.	[Gorski, Jeff P.] Univ Missouri, Sch Dent, Ctr Excellence Study Musculoskeletal & Dent Tissu, Bone Biol Program,Dept Oral Biol, Kansas City, MO 64108 USA; [Chittur, Sridar] SUNY Albany, Ctr Funct Genom, Rensselaer, NY 12144 USA; [Midura, Ronald J.] Cleveland Clin, Lerner Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Oxford, Julie] Boise State Univ, Dept Biol, Boise, ID 83725 USA; [Seidah, Nabil G.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R, Canada	University of Missouri System; University of Missouri Kansas City; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Cleveland Clinic Foundation; Idaho; Boise State University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Ctr Excellence Study Musculoskeletal & Dent Tissu, Bone Biol Program,Dept Oral Biol, 650 E 25th St, Kansas City, MO 64108 USA.	gorskij@umkc.edu	/W-2676-2019; Oxford, Julia Thom/AAH-2842-2019; Seidah, Nabil/I-3596-2013	Oxford, Julia Thom/0000-0002-4850-3569; Seidah, Nabil/0000-0001-6503-9342	National Institutes of Health (NIAMS) [R01-052775]; University of Missouri-Kansas City Center of Excellence for Mineralized Tissues; University of Missouri Research Board	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Missouri-Kansas City Center of Excellence for Mineralized Tissues; University of Missouri Research Board	This work was supported, in whole or in part, by National Institutes of Health Grant R01-052775 (NIAMS; to J.P.G.). This work was also supported by University of Missouri-Kansas City Center of Excellence for Mineralized Tissues and the University of Missouri Research Board (to J.P.G.).	Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chandhoke TK, 2008, BONE, V43, P101, DOI 10.1016/j.bone.2008.03.012; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Dixon PH, 1998, J CLIN ENDOCR METAB, V83, P3615, DOI 10.1210/jc.83.10.3615; Dooley KA, 1999, J BIOL CHEM, V274, P5285, DOI 10.1074/jbc.274.9.5285; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gondret F, 2001, J LIPID RES, V42, P106; Gorski JP, 2009, CELLS TISSUES ORGANS, V189, P25, DOI 10.1159/000151723; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Guan GM, 1997, J BIOL CHEM, V272, P10295; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Higgins ME, 2001, J LIPID RES, V42, P1939; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; Hunter I, 2001, J BONE MINER RES, V16, P466, DOI 10.1359/jbmr.2001.16.3.466; Inoue J, 1998, J BIOCHEM-TOKYO, V123, P1191; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501; Liu XS, 1996, J BIOL CHEM, V271, P13371, DOI 10.1074/jbc.271.23.13371; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Michaelson JE, 2002, AM J PHYSIOL-LUNG C, V282, pL291, DOI 10.1152/ajplung.00445.2000; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Park IC, 2000, INT J ONCOL, V16, P1243; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Ruchon AF, 2000, J BONE MINER RES, V15, P1440, DOI 10.1359/jbmr.2000.15.8.1440; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Singh LP, 2001, DIABETES, V50, P2355, DOI 10.2337/diabetes.50.10.2355; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082; Wang CY, 2009, J BIOL CHEM, V284, P7100, DOI 10.1074/jbc.M805898200; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; Webb SJ, 1999, FASEB J, V13, P339, DOI 10.1096/fasebj.13.2.339; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	66	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1836	1849		10.1074/jbc.M110.151647	http://dx.doi.org/10.1074/jbc.M110.151647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075843	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000286191500024
J	Kalwa, H; Michel, T				Kalwa, Hermann; Michel, Thomas			The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT CROSS-LINKING; SIGNALING PATHWAYS; KINASE-C; N-WASP; SUBCELLULAR-LOCALIZATION; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CARCINOMA-CELLS; LIPID DOMAINS; NITRIC-OXIDE	The MARCKS protein (myristoylated alanine-rich C kinase substrate) is an actin-and calmodulin-binding protein that is expressed in many mammalian tissues. The role of MARCKS in endothelial signaling responses is incompletely understood. We found that siRNA-mediated knockdown of MARCKS in cultured endothelial cells abrogated directed cell movement in a wound healing assay. We used biochemical and cell imaging approaches to explore the role of MARCKS in endothelial signal transduction pathways activated by insulin. Insulin treatment of vascular endothelial cells promoted the dose-and time-dependent phosphorylation of MARCKS. Cell imaging and hydrodynamic approaches revealed that MARCKS is targeted to plasmalemmal caveolae and undergoes subcellular translocation in response to insulin. Insulin treatment promoted an increase in levels of the signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) in plasmalemmal caveolae. The insulin-stimulated increase in caveolar PIP2 was blocked by siRNA-mediated knockdown of MARCKS, as determined using both biochemical assays and imaging studies using FRET-based PIP2 biosensors. The critical role of PIP2 in MARCKS responses was explored by examining the PIP2- and actin-binding proteins Arp2/3 and N-WASP. Insulin promoted the rapid and robust phosphorylation of both N-WASP and Arp2/3, but these phosphorylation responses were markedly attenuated by siRNA-mediated MARCKS knockdown. Moreover, MARCKS knockdown effectively abrogated N-WASP activation in response to insulin, as determined using a FRET-based N-WASP activity biosensor. Taken together, these studies show that MARCKS plays a key role in insulin-dependent endothelial signaling to PIP2 and is a critical determinant of actin assembly and directed cell movement in the vascular endothelium.	[Kalwa, Hermann; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), 75 Francis St,Thorn Bldg 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Kalwa, Hermann/ABG-2323-2021		National Institutes of Health [GM36259, HL48743, HL46457]; Fonds National de la Recherche (Luxembourg) [PDR-09-002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche (Luxembourg)(Luxembourg National Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36259, HL48743, and HL46457 (to T. M.). This work was also supported by Postdoctoral Fellowship PDR-09-002 from the Fonds National de la Recherche (Luxembourg) (to H. K.).	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Baron AD, 2002, J DIABETES COMPLICAT, V16, P92, DOI 10.1016/S1056-8727(01)00209-4; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cho SJ, 2001, BIOCHEM BIOPH RES CO, V283, P273, DOI 10.1006/bbrc.2001.4773; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Jiang ZY, 2003, J BIOL CHEM, V278, P31964, DOI 10.1074/jbc.M303314200; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; ROBINSON PJ, 1993, ANAL BIOCHEM, V210, P172, DOI 10.1006/abio.1993.1169; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Soderholm J, 2005, CHEM BIOL, V12, P263, DOI 10.1016/j.chembiol.2005.03.001; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	41	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2320	2330		10.1074/jbc.M110.196022	http://dx.doi.org/10.1074/jbc.M110.196022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097841	Green Published, hybrid			2022-12-27	WOS:000286191500071
J	Miethke, M; Pierik, AJ; Peuckert, F; Seubert, A; Marahiel, MA				Miethke, Marcus; Pierik, Antonio J.; Peuckert, Florian; Seubert, Andreas; Marahiel, Mohamed A.			Identification and Characterization of a Novel-type Ferric Siderophore Reductase from a Gram-positive Extremophile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CHARACTERIZATION; ESCHERICHIA-COLI; IRON-TRANSPORT; FERRIOXAMINE-B; SACCHAROMYCES-CEREVISIAE; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PROTEIN	Iron limitation is one major constraint of microbial life, and a plethora of microbes use siderophores for high affinity iron acquisition. Because specific enzymes for reductive iron release in Gram-positives are not known, we searched Firmicute genomes and found a novel association pattern of putative ferric siderophore reductases and uptake genes. The reductase from the schizokinen-producing alkaliphile Bacillus halodurans was found to cluster with a ferric citrate-hydroxamate uptake system and to catalyze iron release efficiently from Fe[III]-dicitrate, Fe[III]-schizokinen, Fe[III]-aerobactin, and ferrichrome. The gene was hence named fchR for ferric citrate and hydroxamate reductase. The tightly bound [2Fe-2S] cofactor of FchR was identified by UV-visible, EPR, CD spectroscopy, and mass spectrometry. Iron release kinetics were determined with several substrates by using ferredoxin as electron donor. Catalytic efficiencies were strongly enhanced in the presence of an iron-sulfur scaffold protein scavenging the released ferrous iron. Competitive inhibition of FchR was observed with Ga(III)-charged siderophores with K-i values in the micromolar range. The principal catalytic mechanism was found to couple increasing K-m and K-D values of substrate binding with increasing k(cat) values, resulting in high catalytic efficiencies over a wide redox range. Physiologically, a chromosomal fchR deletion led to strongly impaired growth during iron limitation even in the presence of ferric siderophores. Inductively coupled plasma-MS analysis of Delta fchR revealed intracellular iron accumulation, indicating that the ferric substrates were not efficiently metabolized. We further show that FchR can be efficiently inhibited by redox-inert siderophore mimics in vivo, suggesting that substrate-specific ferric siderophore reductases may present future targets for microbial pathogen control.	Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; [Pierik, Antonio J.] Univ Marburg, Inst Zytobiol & Zytopathol, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg		miethke@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie.	Abergel RJ, 2009, J AM CHEM SOC, V131, P12682, DOI 10.1021/ja903051q; Adjimani JP, 1997, J INORG BIOCHEM, V66, P247, DOI 10.1016/S0162-0134(96)00221-8; Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; BATIE CJ, 1981, J BIOL CHEM, V256, P7756; Bernstein LR, 1998, PHARMACOL REV, V50, P665; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYERS BR, 1967, J BACTERIOL, V93, P286, DOI 10.1128/JB.93.1.286-294.1967; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; COVES J, 1993, BIOCHEM BIOPH RES CO, V192, P1403, DOI 10.1006/bbrc.1993.1572; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; DYKES J, 1982, ARCH BIOCHEM BIOPHYS, V218, P46, DOI 10.1016/0003-9861(82)90319-8; EMERY T, 1986, BIOCHEMISTRY-US, V25, P4629, DOI 10.1021/bi00364a026; Fischbach MA, 2005, P NATL ACAD SCI USA, V102, P571, DOI 10.1073/pnas.0408463102; Froissard M, 2007, TRAFFIC, V8, P1601, DOI 10.1111/j.1600-0854.2007.00627.x; GILLAM AH, 1981, ANAL CHEM, V53, P841, DOI 10.1021/ac00229a023; Gilmour R, 1997, J BACTERIOL, V179, P863, DOI 10.1128/jb.179.3.863-870.1997; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Harrington JM, 2009, BIOMETALS, V22, P679, DOI 10.1007/s10534-009-9233-4; HARRIS WR, 1979, J AM CHEM SOC, V101, P2722, DOI 10.1021/ja00504a038; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kim L, 1996, GENE, V181, P71, DOI 10.1016/S0378-1119(96)00466-0; Kragl C, 2007, EUKARYOT CELL, V6, P1278, DOI 10.1128/EC.00066-07; LESUISSE E, 1995, ANAL BIOCHEM, V226, P375, DOI 10.1006/abio.1995.1239; Lin H, 2005, J AM CHEM SOC, V127, P11075, DOI 10.1021/ja0522027; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; Matzanke BF, 2004, BIOCHEMISTRY-US, V43, P1386, DOI 10.1021/bi0357661; McMillan DGG, 2010, APPL ENVIRON MICROB, V76, P6955, DOI 10.1128/AEM.01393-10; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Miethke M, 2010, ANTIMICROB AGENTS CH, V54, P1580, DOI 10.1128/AAC.01158-09; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Muller K, 1998, EUR J BIOCHEM, V258, P1001, DOI 10.1046/j.1432-1327.1998.2581001.x; MULLIS KB, 1971, BIOCHEMISTRY-US, V10, P4894, DOI 10.1021/bi00802a010; Namba K, 2010, CHEM REC, V10, P140, DOI 10.1002/tcr.200900028; NELSON M, 1992, BIOMETALS, V5, P37, DOI 10.1007/BF01079696; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; Poole RK, 1997, MICROBIOL-SGM, V143, P1557, DOI 10.1099/00221287-143-5-1557; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; Riboldi GP, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-3; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; Spasojevic I, 1999, INORG CHEM, V38, P449, DOI 10.1021/ic980635n; Storey EP, 2006, BIOMETALS, V19, P637, DOI 10.1007/s10534-006-9001-7; STULKE J, 1993, J GEN MICROBIOL, V139, P2041, DOI 10.1099/00221287-139-9-2041; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; TUFANO TP, 1981, BIOCHIM BIOPHYS ACTA, V668, P420, DOI 10.1016/0005-2795(81)90176-8; USAMI R, 1990, STARCH-STARKE, V42, P230, DOI 10.1002/star.19900420607; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WAWROUSEK EF, 1982, J INORG BIOCHEM, V17, P169, DOI 10.1016/S0162-0134(00)80097-5; Xia M, 2007, CURR MICROBIOL, V55, P71, DOI 10.1007/s00284-007-0023-3; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zhu MG, 2005, MICROBIOL-SGM, V151, P2363, DOI 10.1099/mic.0.27888-0	79	20	21	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2245	2260		10.1074/jbc.M110.192468	http://dx.doi.org/10.1074/jbc.M110.192468			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21051545	Green Published, hybrid			2022-12-27	WOS:000286191500065
J	Yokogawa, M; Osawa, M; Takeuchi, K; Mase, Y; Shimada, I				Yokogawa, Mariko; Osawa, Masanori; Takeuchi, Koh; Mase, Yoko; Shimada, Ichio			NMR Analyses of the G beta gamma Binding and Conformational Rearrangements of the Cytoplasmic Pore of G Protein-activated Inwardly Rectifying Potassium Channel 1 (GIRK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; CROSS-SATURATION; SUBUNITS; IDENTIFICATION; COMPLEXES; DOMAIN; SITES; RECTIFICATION; RESIDUES	G protein-activated inwardly rectifying potassium channel (GIRK) plays crucial roles in regulating heart rate and neuronal excitability in eukaryotic cells. GIRK is activated by the direct binding of heterotrimeric G protein beta gamma subunits (G beta gamma) upon stimulation of G protein-coupled receptors, such as M2 acetylcholine receptor. The binding of G beta gamma to the cytoplasmic pore (CP) region of GIRK causes structural rearrangements, which are assumed to open the transmembrane ion gate. However, the crucial residues involved in the G beta gamma binding and the structural mechanism of GIRK gating have not been fully elucidated. Here, we have characterized the interaction between the CP region of GIRK and G beta gamma, by ITC and NMR. The ITC analyses indicated that four G beta gamma molecules bind to a tetramer of the CP region of GIRK with a dissociation constant of 250 mu M. The NMR analyses revealed that the G beta gamma binding site spans two neighboring subunits of the GIRK tetramer, which causes conformational rearrangements between subunits. A possible binding mode and mechanism of GIRK gating are proposed.	[Yokogawa, Mariko; Osawa, Masanori; Takeuchi, Koh; Mase, Yoko; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Tokyo 1130033, Japan; [Yokogawa, Mariko] Japan Biol Informat Consortium JBiC, Tokyo 1350064, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Tokyo 1350064, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Takeuchi, Koh/B-4971-2010; Osawa, Masanori/GRS-5726-2022	Takeuchi, Koh/0000-0002-6227-4627; Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a Grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, and Technology (to M. O. and I. S.), and a grant from Takeda Science Foundation (to M. O.).	Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Corey S, 2001, J BIOL CHEM, V276, P11409, DOI 10.1074/jbc.M100058200; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	31	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2215	2223		10.1074/jbc.M110.160754	http://dx.doi.org/10.1074/jbc.M110.160754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075842	Green Published, hybrid			2022-12-27	WOS:000286191500062
J	Spessott, W; Uliana, A; Maccioni, HJF				Spessott, Waldo; Uliana, Andrea; Maccioni, Hugo J. F.			Cog2 Null Mutant CHO Cells Show Defective Sphingomyelin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-MEDIATED ENDOCYTOSIS; NORMAL GOLGI FUNCTION; CONGENITAL DISORDER; GLYCOSPHINGOLIPID SYNTHESIS; RETROGRADE TRANSPORT; HELA-CELLS; COMPLEX; GLYCOSYLATION; PROTEIN	The COG (conserved oligomeric Golgi complex) is a Golgi-associated tethering complex involved in retrograde trafficking of multiple Golgi enzymes. COG deficiencies lead to misorganization of the Golgi, defective trafficking of glycosylation enzymes, and abnormal N-, O- and ceramide-linked oligosaccharides. Here, we show that in Cog2 null mutant ldlC cells, the content of sphingomyelin (SM) is reduced to similar to 25% of WT cells. Sphingomyelin synthase (SMS) activity is essentially normal in ldlC cells, but in contrast with the typical Golgi localization in WT cells, in ldlC cells, transfected SMS1 localizes to vesicular structures scattered throughout the cytoplasm, which show almost no signal of co-transfected ceramide transfer protein (CERT). Cog2 transfection restores SM formation and the typical SMS1 Golgi localization phenotype. Adding exogenous N-6-[(7-nitrobenzo-2-oxa-1,3-diazol-4-yl) amino]hexanoyl-4-d-erythro-sphingosine (C-6-NBD-ceramide) to ldlC cell cultures results in normal SM formation. Endogenous ceramide levels were 3-fold higher in ldlC cells than in WT cells, indicating that Golgi misorganization caused by Cog2 deficiency affects the delivery of ceramide to sites of SM synthesis by SMS1. Considering the importance of SM as a structural component of membranes, this finding is also worth of consideration in relation to a possible contribution to the clinical phenotype of patients suffering congenital disorders of glycosylation type II.	[Spessott, Waldo; Uliana, Andrea; Maccioni, Hugo J. F.] Univ Nacl Cordoba, CONICET, Fac Ciencias Quim, Dept Quim Biol,CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Maccioni, HJF (corresponding author), Haya Torre S-N, RA-5000 Cordoba, Argentina.	maccioni@dqb.fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba [PICT 2006-01239]; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grant PICT 2006-01239 from Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba.; Recipients of Consejo Nacional de Investigaciones Cientificas y Tecnicas fellowships.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bruinsma P, 2004, J BIOL CHEM, V279, P39814, DOI 10.1074/jbc.M405500200; Chandran S, 2008, TRAFFIC, V9, P1894, DOI 10.1111/j.1600-0854.2008.00810.x; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DANIOTTI JL, 1991, J NEUROCHEM, V57, P2054, DOI 10.1111/j.1471-4159.1991.tb06421.x; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2009, BBA-MOL BASIS DIS, V1792, P896, DOI 10.1016/j.bbadis.2008.10.020; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; PODOS SD, 1994, J CELL BIOL, V127, P679, DOI 10.1083/jcb.127.3.679; Reynders E, 2009, HUM MOL GENET, V18, P3244, DOI 10.1093/hmg/ddp262; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Spessott W., 2010, J NEUROCHEM IN PRESS; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Vasile E, 2006, EXP CELL RES, V312, P3132, DOI 10.1016/j.yexcr.2006.06.005; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	46	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41472	41482		10.1074/jbc.M110.150011	http://dx.doi.org/10.1074/jbc.M110.150011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047787	Green Published, hybrid			2022-12-27	WOS:000285622600033
J	Alvarez, MN; Peluffo, G; Piacenza, L; Radi, R				Noel Alvarez, Mara; Peluffo, Gonzalo; Piacenza, Luca; Radi, Rafael			Intraphagosomal Peroxynitrite as a Macrophage-derived Cytotoxin against Internalized Trypanosoma cruzi CONSEQUENCES FOR OXIDATIVE KILLING AND ROLE OF MICROBIAL PEROXIREDOXINS IN INFECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-TYROSINE NITRATION; NADPH-OXIDASE; MURINE MACROPHAGES; REACTIVE OXYGEN; IFN-GAMMA; POLYMORPHONUCLEAR LEUKOCYTES; LUMINOL CHEMILUMINESCENCE; PERITONEAL-MACROPHAGES; MEDIATED CYTOTOXICITY	Macrophage-derived radicals generated by the NADPH oxidase complex and inducible nitric-oxide synthase (iNOS) participate in cytotoxic mechanisms against microorganisms. Nitric oxide ((NO)-N-center dot) plays a central role in the control of acute infection by Trypanosoma cruzi, the causative agent of Chagas disease, and we have proposed that much of its action relies on macrophage-derived peroxynitrite (ONOO- + ONOOH) formation, a strong oxidant arising from the reaction of (NO)-N-center dot with superoxide radical (O-2(radical anion)). Herein, we have shown that internalization of T. cruzi trypomastigotes by macrophages triggers the assembly of the NADPH oxidase complex to yield O-2(radical anion) during a 60-90-min period. This does not interfere with IFN-gamma-dependent iNOS induction and a sustained (NO)-N-center dot production (similar to 24 h). The major mechanism for infection control via reactive species formation occurred when (NO)-N-center dot and O-2(radical anion) were produced simultaneously, generating intraphagosomal peroxynitrite levels compatible with microbial killing. Moreover, biochemical and ultrastructural analysis confirmed cellular oxidative damage and morphological disruption in internalized parasites. Overexpression of cytosolic tryparedoxin peroxidase in T. cruzi neutralized macrophage-derived peroxynitrite-dependent cytotoxicity to parasites and favored the infection in an animal model. Collectively, the data provide, for the first time, direct support for the action of peroxynitrite as an intraphagosomal cytotoxin against pathogens and the premise that microbial peroxiredoxins facilitate infectivity via decomposition of macrophage-derived peroxynitrite.	[Radi, Rafael] Univ Republica, Dpto Bioquim, Fac Med, Montevideo 11800, Uruguay; Univ Republica, Ctr Free Rad & Biomed Res, Fac Med, Montevideo 11800, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Radi, R (corresponding author), Univ Republica, Dpto Bioquim, Fac Med, Avda Gen Flores 2125, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy			Howard Hughes Medical Institute; International Centre for Genetic Engineering and Biotechnology; Fondo Clemente Estable (Programa de Desarrollo Tecnologico); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica	Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Centre for Genetic Engineering and Biotechnology; Fondo Clemente Estable (Programa de Desarrollo Tecnologico); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica	This work was supported by grants from the Howard Hughes Medical Institute and the International Centre for Genetic Engineering and Biotechnology (to R. R.), the Fondo Clemente Estable (Programa de Desarrollo Tecnologico) (to L. P.), and the Comision Sectorial de Investigacion Cientifica, Universidad de la Republica (to M. N. A.).	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015; Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BAEHNER RL, 1976, BLOOD, V48, P309; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; BAXTER MA, 1983, IMMUNOLOGY, V48, P657; Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brito C, 1999, J IMMUNOL, V162, P3356; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cape JL, 2009, ARCH BIOCHEM BIOPHYS, V484, P190, DOI 10.1016/j.abb.2009.01.010; Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996; CARDONI RL, 1984, CELL IMMUNOL, V86, P518, DOI 10.1016/0008-8749(84)90407-6; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Castro L, 1996, ARCH BIOCHEM BIOPHYS, V333, P179, DOI 10.1006/abbi.1996.0379; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DENICOLA A, 1993, ARCH BIOCHEM BIOPHYS, V304, P279, DOI 10.1006/abbi.1993.1350; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; Pineyro MD, 2011, ARCH BIOCHEM BIOPHYS, V507, P287, DOI 10.1016/j.abb.2010.12.014; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gomez-Mejiba SE, 2010, J BIOL CHEM, V285, P20062, DOI 10.1074/jbc.M109.086579; Gookin JL, 2005, INFECT IMMUN, V73, P3929, DOI 10.1128/IAI.73.7.3929-3936.2005; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Guinazu N, 2007, INT J PARASITOL, V37, P1243, DOI 10.1016/j.ijpara.2007.03.010; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; James PE, 1998, J LEUKOCYTE BIOL, V64, P78, DOI 10.1002/jlb.64.1.78; KIERSZENBAUM F, 1974, J IMMUNOL, V112, P1839; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; MCCABE RE, 1990, J IMMUNOL, V144, P2384; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nauser T, 2002, J PHYS CHEM A, V106, P4084, DOI 10.1021/jp025518z; Oliveira MAP, 2000, EXP PARASITOL, V95, P96, DOI 10.1006/expr.2000.4523; Palazzolo-Ballance AM, 2007, BIOCHEMISTRY-US, V46, P7536, DOI 10.1021/bi700123s; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2001, P NATL ACAD SCI USA, V98, P7301, DOI 10.1073/pnas.121520398; Piacenza L, 2008, BIOCHEM J, V410, P359, DOI 10.1042/BJ20071138; Piacenza L, 2009, CURR OPIN MICROBIOL, V12, P415, DOI 10.1016/j.mib.2009.06.011; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REED SG, 1987, J EXP MED, V166, P1734, DOI 10.1084/jem.166.6.1734; RIMOLDI MT, 1981, IMMUNOLOGY, V42, P521; Roman-Campos D, 2009, BASIC RES CARDIOL, V104, P238, DOI 10.1007/s00395-009-0776-x; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Roychowdhury S, 2002, GLIA, V38, P103, DOI 10.1002/glia.10024; RUBBO H, 1994, J BIOL CHEM, V269, P26066; RUBBO H, 1994, ARCH BIOCHEM BIOPHYS, V308, P96, DOI 10.1006/abbi.1994.1014; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Stempin CC, 2008, ACTA TROP, V106, P119, DOI 10.1016/j.actatropica.2008.02.004; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Szabo C, 1996, FREE RADICAL BIO MED, V21, P855, DOI 10.1016/0891-5849(96)00170-0; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TANAKA Y, 1983, INFECT IMMUN, V41, P1322, DOI 10.1128/IAI.41.3.1322-1331.1983; Thomson L, 2003, ARCH BIOCHEM BIOPHYS, V412, P55, DOI 10.1016/S0003-9861(02)00745-2; TORRICO F, 1991, J IMMUNOL, V146, P3626; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; VILLALTA F, 1983, J IMMUNOL, V131, P1504; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; WIRTH JJ, 1982, J IMMUNOL, V129, P2759; Wrona M, 2005, FREE RADICAL BIO MED, V38, P262, DOI 10.1016/j.freeradbiomed.2004.10.022; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Zago MP, 2008, INFECT IMMUN, V76, P443, DOI 10.1128/IAI.00400-07; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	100	168	171	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6627	6640		10.1074/jbc.M110.167247	http://dx.doi.org/10.1074/jbc.M110.167247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21098483	Green Published, hybrid			2022-12-27	WOS:000287476400071
J	Chen, HK; Ji, ZS; Dodson, SE; Miranda, RD; Rosenblum, CI; Reynolds, IJ; Freedman, SB; Weisgraber, KH; Huang, YD; Mahley, RW				Chen, Hung-Kai; Ji, Zhong-Sheng; Dodson, Sara E.; Miranda, Rene D.; Rosenblum, Charles I.; Reynolds, Ian J.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.			Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR CINGULATE CORTEX; CYTOCHROME-C-OXIDASE; E TYPE-4 ALLELE; AMYLOID-BETA; OXIDATIVE STRESS; NEURONAL CELLS; EXPRESSION; BRAIN; DYSFUNCTION; ENERGY	Apolipoprotein (apo) E4 is the major genetic risk factor for late-onset Alzheimer disease (AD). ApoE4 assumes a pathological conformation through an intramolecular interaction mediated by Arg-61 in the amino-terminal domain and Glu-255 in the carboxyl-terminal domain, referred to as apoE4 domain interaction. Because AD is associated with mitochondrial dysfunction, we examined the effect of apoE4 domain interaction on mitochondrial respiratory function. Steady-state amounts of mitochondrial respiratory complexes were examined in neurons cultured from brain cortices of neuron-specific enolase promoter-driven apoE3 (NSE-apoE3) or apoE4 (NSEapoE4) transgenic mice. All subunits of mitochondrial respiratory complexes assessed were significantly lower in NSEapoE4 neurons compared with NSE-apoE3 neurons. However, no significant differences in levels of mitochondrial complexes were detected between astrocytes expressing different apoE isoforms driven by the glial fibrillary acidic protein promoter, leading to our conclusion that the effect of apoE4 is neuron specific. In neuroblastoma Neuro-2A (N2A) cells, apoE4 expression reduced the levels of mitochondrial respiratory complexes I, IV, and V. Complex IV enzymatic activity was also decreased, lowering mitochondrial respiratory capacity. Mutant apoE4 ( apoE4-Thr-61) lacking domain interaction did not induce mitochondrial dysfunction in N2A cells, indicating that the effect is specific to apoE4-expressing cells and dependent on domain interaction. Consistent with this finding, treatment of apoE4-expressing N2A cells with a small molecule that disrupts apoE4 domain interaction restored mitochondrial respiratory complex IV levels. These results suggest that pharmacological intervention with small molecules that disrupt apoE4 domain interaction is a potential therapeutic approach for apoE4-carrying AD subjects.	[Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Chen, Hung-Kai; Ji, Zhong-Sheng; Dodson, Sara E.; Miranda, Rene D.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Ctr Translat Res, San Francisco, CA 95158 USA; [Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Rosenblum, Charles I.] Merck Res Labs, Rahway, NJ 07065 USA; [Reynolds, Ian J.] Merck Res Labs, West Point, PA 19486 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Merck & Company	Mahley, RW (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	rmahley@gladstone.ucsf.edu	Reynolds, Ian/C-4358-2008; Reynolds, Ian Jeffery/ABH-3197-2020	Reynolds, Ian/0000-0003-3028-5070; Chen, Hung-Kai/0000-0002-2169-4924	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This work was supported in part by Merck Research Laboratories.	Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buttini M, 1999, J NEUROSCI, V19, P4867; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1989, ARTERIOSCLEROSIS, V9, pI14; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu PT, 2006, NEUROBIOL DIS, V21, P256, DOI 10.1016/j.nbd.2005.07.004; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	49	128	132	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5215	5221		10.1074/jbc.M110.151084	http://dx.doi.org/10.1074/jbc.M110.151084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118811	Green Published, hybrid			2022-12-27	WOS:000287230600030
J	Liu, ZH; Shan, M; Li, L; Lu, L; Meng, S; Chen, C; He, YX; Jiang, SB; Zhang, LQ				Liu, Zhonghua; Shan, Mei; Li, Li; Lu, Lu; Meng, Shu; Chen, Cheng; He, Yuxian; Jiang, Shibo; Zhang, Linqi			In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to Sifuvirtide, a Novel HIV-1 Fusion Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CCR5 MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEIN; SYNTHETIC PEPTIDES; POTENT INHIBITORS; CRYSTAL-STRUCTURE; ENTRY INHIBITORS; ATOMIC-STRUCTURE; CORE STRUCTURE; SPIKE PROTEIN	Sifuvirtide, a novel fusion inhibitor against human immunodeficiency virus type I (HIV-1), which is more potent than enfuvirtide (T20) in cell culture, is currently under clinical investigation for the treatment of HIV-1 infection. We now report that in vitro selection of HIV-1 variants resistant to sifuvirtide in the presence of increasing concentrations of sifuvirtide has led to several specific mutations in the gp41 region that had not been previously reported. Many of these substitutions were confined to the N-terminal heptad repeat region at positions 37, 38, 41, and 43, either singly or in combination. A downstream substitution at position 126 (N126K) in the C-terminal heptad repeat region was also found. Site-directed mutagenesis studies have further identified the critical amino acid substitutions and combinations thereof in conferring the resistant genotypes. Furthermore, the mutant viruses demonstrated variable degrees of cross-resistance to enfuvirtide, some of which are preferentially more resistant to sifuvirtide. Impaired infectivity was also found for many of the mutant viruses. Biophysical and structural analyses of the key substitutions have revealed several potential novel mechanisms against sifuvirtide. Our results may help to predict potential resistant patterns in vivo and facilitate the further clinical development and therapeutic utility of sifuvirtide.	[Liu, Zhonghua; Shan, Mei; Li, Li; Meng, Shu; He, Yuxian; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; [Liu, Zhonghua; Shan, Mei; Li, Li; Meng, Shu; He, Yuxian; Zhang, Linqi] Peking Union Med Coll, Beijing 100730, Peoples R China; [Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Chen, Cheng; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York Blood Center; Tsinghua University	Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	lu, lu/HGA-0894-2022; ZHANG, LIN/GYD-9123-2022; lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health [AI046221]; Chinese Ministry of Science and Technology [2006CB504200]; Chinese Natural Science Foundation [30825035]; Tsinghua University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tsinghua University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S. J.). This work was also supported by National Basic Research Program (also called the 973 Program) of the Chinese Ministry of Science and Technology Grant 2006CB504200 (to L. Z.), National Outstanding Youth Award of the Chinese Natural Science Foundation 30825035 (to L. Z.), and a grant from the Tsinghua University Initiative Scientific Research Program and Tsinghua Yue-Yuen Medical Sciences Fund (to L. Z.).	Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; Jacobson JM, 2008, J INFECT DIS, V198, P1345, DOI 10.1086/592169; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V269, P641, DOI 10.1006/bbrc.1999.1972; Katritzky AR, 2009, J MED CHEM, V52, P7631, DOI 10.1021/jm900450n; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Liu K, 2008, J MED CHEM, V51, P7843, DOI 10.1021/jm800869t; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Lombardi S, 1996, VIROLOGY, V220, P274, DOI 10.1006/viro.1996.0315; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; RAPAPORT D, 1995, EMBO J, V14, P5524, DOI 10.1002/j.1460-2075.1995.tb00239.x; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEM BIOPH RES CO, V315, P664, DOI 10.1016/j.bbrc.2004.01.115; Zhu Y, 2010, J VIROL, V84, P9359, DOI 10.1128/JVI.00644-10	48	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3277	3287		10.1074/jbc.M110.199323	http://dx.doi.org/10.1074/jbc.M110.199323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098485	Green Published, hybrid			2022-12-27	WOS:000286653200013
J	Sasaki, D; Fujihashi, M; Okuyama, N; Kobayashi, Y; Noike, M; Koyama, T; Miki, K				Sasaki, Daisuke; Fujihashi, Masahiro; Okuyama, Naomi; Kobayashi, Yukiko; Noike, Motoyoshi; Koyama, Tanetoshi; Miki, Kunio			Crystal Structure of Heterodimeric Hexaprenyl Diphosphate Synthase from Micrococcus luteus B-P 26 Reveals That the Small Subunit Is Directly Involved in the Product Chain Length Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL PYROPHOSPHATE SYNTHASE; CATALYTICALLY ACTIVE COMPLEX; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; SULFOLOBUS-SOLFATARICUS; DETERMINATION MECHANISM; ESSENTIAL COMPONENTS; STRUCTURE VALIDATION; CONSERVED ASPARTATE; ELONGATING ENZYMES	Hexaprenyl diphosphate synthase from Micrococcus luteus B-P 26 (Ml-HexPPs) is a heterooligomeric type trans-prenyltransferase catalyzing consecutive head-to-tail condensations of three molecules of isopentenyl diphosphates (C-5) on a farnesyl diphosphate (FPP; C-15) to form an (all-E) hexaprenyl diphosphate (HexPP; C-30). Ml-HexPPs is known to function as a heterodimer of two different subunits, small and large subunits called HexA and HexB, respectively. Compared with homooligomeric trans-prenyltransferases, the molecular mechanism of heterooligomeric trans-prenyltransferases is not yet clearly understood, particularly with respect to the role of the small subunits lacking the catalytic motifs conserved in most known trans-prenyltransferases. We have determined the crystal structure of Ml-HexPPs both in the substrate-free form and in complex with 7,11-dimethyl-2,6,10-dodecatrien-1-yl diphosphate ammonium salt (3-DesMe-FPP), an analog of FPP. The structure of HexB is composed of mostly antiparallel alpha-helices joined by connecting loops. Two aspartate-rich motifs (designated the first and second aspartate-rich motifs) and the other characteristic motifs in HexB are located around the diphosphate part of 3-DesMe-FPP. Despite the very low amino acid sequence identity and the distinct polypeptide chain lengths between HexA and HexB, the structure of HexA is quite similar to that of HexB. The aliphatic tail of 3-DesMe-FPP is accommodated in a large hydrophobic cleft starting from HexB and penetrating to the inside of HexA. These structural features suggest that HexB catalyzes the condensation reactions and that HexA is directly involved in the product chain length control in cooperation with HexB.	[Sasaki, Daisuke; Fujihashi, Masahiro; Okuyama, Naomi; Kobayashi, Yukiko; Miki, Kunio] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Noike, Motoyoshi; Koyama, Tanetoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kyoto University; Tohoku University	Miki, K (corresponding author), Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [B-024]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Global Centers of Excellence program "International Center for Integrated Research and Advanced Education in Materials Science" of the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant B-024.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Artz JD, 2008, CHEM BIOL, V15, P1296, DOI 10.1016/j.chembiol.2008.10.017; BLANCHARD L, 1993, GENE, V125, P185, DOI 10.1016/0378-1119(93)90326-X; Burke C, 2004, ARCH BIOCHEM BIOPHYS, V422, P52, DOI 10.1016/j.abb.2003.12.003; Burke C, 2002, J BIOL CHEM, V277, P3141, DOI 10.1074/jbc.M105900200; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Cao R, 2008, PROTEINS, V73, P431, DOI 10.1002/prot.22066; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Christianson DW, 2007, SCIENCE, V316, P60, DOI 10.1126/science.1141630; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; FUJII H, 1983, FEBS LETT, V161, P257, DOI 10.1016/0014-5793(83)81020-5; FUJII H, 1982, J BIOL CHEM, V257, P4610; Fujikura K, 2008, BIOSCI BIOTECH BIOCH, V72, P851, DOI 10.1271/bbb.70723; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Guo RT, 2004, BIOCHEMISTRY-US, V43, P7678, DOI 10.1021/bi036336d; Hemmi H, 2003, EUR J BIOCHEM, V270, P2186, DOI 10.1046/j.1432-1033.2003.03583.x; Hemmi H, 2002, BIOCHEM BIOPH RES CO, V297, P1096, DOI 10.1016/S0006-291X(02)02348-3; Hirooka K, 2000, EUR J BIOCHEM, V267, P4520, DOI 10.1046/j.1432-1327.2000.01502.x; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; ITO M, 1987, BIOCHEMISTRY-US, V26, P4745, DOI 10.1021/bi00389a022; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Kloer DP, 2006, BIOCHEMISTRY-US, V45, P15197, DOI 10.1021/bi061572k; KOIKETAKESHITA A, 1995, J BIOL CHEM, V270, P18396, DOI 10.1074/jbc.270.31.18396; KOYAMA T, 1995, BIOCHEM BIOPH RES CO, V212, P681, DOI 10.1006/bbrc.1995.2022; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; Koyama T, 1999, BIOSCI BIOTECH BIOCH, V63, P1671, DOI 10.1271/bbb.63.1671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang J, 1998, PROTEINS, V33, P1; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao JH, 2006, J AM CHEM SOC, V128, P14485, DOI 10.1021/ja061737c; MARRERO PF, 1992, J BIOL CHEM, V267, P21873; Miyagi Y, 2007, J BIOCHEM, V142, P377, DOI 10.1093/jb/mvm144; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaki M, 2001, BIOORG MED CHEM LETT, V11, P2157, DOI 10.1016/S0960-894X(01)00391-2; Noike M, 2008, FEBS J, V275, P3921, DOI 10.1111/j.1742-4658.2008.06538.x; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Ohnuma S, 1996, J BIOL CHEM, V271, P18831, DOI 10.1074/jbc.271.31.18831; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Ohnuma S, 1998, J BIOL CHEM, V273, P26705, DOI 10.1074/jbc.273.41.26705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Rodan Gideon A., 2002, Current Molecular Medicine (Hilversum), V2, P571, DOI 10.2174/1566524023362104; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; SAGAMI H, 1992, ARCH BIOCHEM BIOPHYS, V297, P314, DOI 10.1016/0003-9861(92)90678-P; SAGAMI H, 1994, J BIOL CHEM, V269, P20561; SAGAMI H, 1981, BIOCHEM INT, V3, P669; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Shimizu N, 1998, J BACTERIOL, V180, P1578, DOI 10.1128/JB.180.6.1578-1581.1998; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Sun HY, 2005, J BACTERIOL, V187, P8137, DOI 10.1128/JB.187.23.8137-8148.2005; TAKAHASHI I, 1980, J BIOL CHEM, V255, P4539; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Wang W, 2008, J MOL BIOL, V381, P129, DOI 10.1016/j.jmb.2008.05.060; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; YOSHIDA I, 1987, BIOCHEMISTRY-US, V26, P6840, DOI 10.1021/bi00395a038; YOSHIDA I, 1989, BIOCHEM BIOPH RES CO, V160, P448, DOI 10.1016/0006-291X(89)92453-4; YOSHIDA I, 1989, BIOCHIM BIOPHYS ACTA, V995, P138, DOI 10.1016/0167-4838(89)90072-1; ZHANG DL, 1993, ANAL BIOCHEM, V213, P356, DOI 10.1006/abio.1993.1432; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhang YW, 2000, BIOCHEMISTRY-US, V39, P12717, DOI 10.1021/bi001311p; Zhang YW, 1998, BIOCHEMISTRY-US, V37, P13411, DOI 10.1021/bi972926y; Zhang YW, 1999, BIOCHEMISTRY-US, V38, P14638, DOI 10.1021/bi9913653; Zhang YW, 1997, J BACTERIOL, V179, P1417, DOI 10.1128/jb.179.4.1417-1419.1997	87	16	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3729	3740		10.1074/jbc.M110.147991	http://dx.doi.org/10.1074/jbc.M110.147991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21068379	Green Published, hybrid			2022-12-27	WOS:000286653200055
J	Shen, XA; Ying, HY; Qiu, Y; Park, JS; Shyam, R; Chi, ZL; Iwata, T; Yue, BYJT				Shen, Xiang; Ying, Hongyu; Qiu, Ye; Park, Jeong-Seok; Shyam, Rajalekshmy; Chi, Zai-Long; Iwata, Takeshi; Yue, Beatrice Y. J. T.			Processing of Optineurin in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; OPEN-ANGLE GLAUCOMA; AUTOPHAGY-LYSOSOME PATHWAY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; TRABECULAR MESHWORK; HUNTINGTONS-DISEASE; MAMMALIAN-CELLS; ALPHA-SYNUCLEIN; PAGETS-DISEASE	Optineurin is a gene linked to amyotrophic lateral sclerosis, Paget disease of bone, and glaucoma, a major blinding disease. Mutations such as E50K were identified in glaucoma patients. We investigated herein the involvement of ubiquitin-proteasome pathway (UPP) and autophagy, two major routes for protein clearance, in processing of optineurin in a retinal ganglion cell model line RGC5 and neuronal PC12 cells. It was found that the endogenous optineurin level in neuronal cells was increased by treatment of proteasomal inhibitor but not by autophagic and lysosomal inhibitors. Multiple bands immunoreactive to anti-ubiquitin were seen in the optineurin pulldown, indicating that optineurin was ubiquitinated. In cells overexpressing wild type and E50K optineurin, the level of the proteasome regulatory beta 5 subunit (PSMB5, indicative of proteasome activity) was reduced, whereas that for autophagy marker microtubule-associated protein 1 light chain 3 was enhanced compared with controls. Autophagosome formation was detected by electron microscopy. The foci formed after optineurin transfection were increased upon treatment of an autophagic inhibitor but were decreased by treatment of an inducer, rapamycin. Moreover, the level of optineurin-triggered apoptosis was reduced by rapamycin. This study thus provides compelling evidence that in a normal homeostatic situation, the turnover of endogenous optineurin involves mainly UPP. When optineurin is up-regulated or mutated, the UPP function is compromised, and autophagy comes into play. A decreased PSMB5 level and an induced autophagy were also demonstrated in vivo in retinal ganglion cells of E50K transgenic mice, validating and making relevant the in vitro findings.	[Shen, Xiang; Ying, Hongyu; Qiu, Ye; Park, Jeong-Seok; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.] Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Chicago, IL 60612 USA; [Chi, Zai-Long; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo 1528902, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, 1855 W Taylor St, Chicago, IL 60612 USA.	beatyue@uic.edu	Chi, Zai-Long/L-1523-2019	Shyam, Rajalekshmy/0000-0003-2154-4173	National Institutes of Health, NEI [EY018828, EY005628, EY003890]; Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [EY01792]; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018828, EY005628, and EY003890 from NEI (to B. Y. J. T. Y.) and Core Grant EY01792. This work was also supported by Ministry of Health, Labor, and Welfare and Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. I.).	Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bao XH, 2010, INT J MOL MED, V25, P493, DOI 10.3892/ijmm_00000369; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Caballero M, 2004, BIOCHEM BIOPH RES CO, V323, P1048, DOI 10.1016/j.bbrc.2004.08.195; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Huang Y, 2007, EXP EYE RES, V85, P659, DOI 10.1016/j.exer.2007.07.020; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Normando EM, 2009, EXP EYE RES, V89, P446, DOI 10.1016/j.exer.2009.05.004; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Vittitow JL, 2002, BIOCHEM BIOPH RES CO, V298, P67, DOI 10.1016/S0006-291X(02)02395-1; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	67	67	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3618	3629		10.1074/jbc.M110.175810	http://dx.doi.org/10.1074/jbc.M110.175810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21059646	hybrid, Green Published			2022-12-27	WOS:000286653200046
J	Wyatt, D; Malik, R; Vesecky, AC; Marchese, A				Wyatt, Debra; Malik, Rohit; Vesecky, Alissa C.; Marchese, Adriano			Small Ubiquitin-like Modifier Modification of Arrestin-3 Regulates Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; SUMO MODIFICATION; CLATHRIN ADAPTER; STRUCTURAL BASIS; PROTEIN; SUMOYLATION; COMPLEX; ACTIVATION; INTERACTS	Nonvisual arrestins are regulated by direct post-translational modifications, such as phosphorylation, ubiquitination, and nitrosylation. However, whether arrestins are regulated by other post-translational modifications remains unknown. Here we show that nonvisual arrestins are modified by small ubiquitin-like modifier 1 (SUMO-1) upon activation of beta(2)-adrenergic receptor (beta(2)AR). Lysine residues 295 and 400 in arrestin-3 fall within canonical SUMO consensus sites, and mutagenic analysis reveals that Lys-400 represents the main SUMOylation site. Depletion of the SUMO E2 modifying enzyme Ubc9 blocks arrestin-3 SUMOylation and attenuates beta(2)AR internalization, suggesting that arrestin SUMOylation mediates G protein-coupled receptor endocytosis. Consistent with this, expression of a SUMO-deficient arrestin mutant failed to promote beta(2)AR internalization as compared with wild-type arrestin-3. Our data reveal an unprecedented role for SUMOylation in mediating GPCR endocytosis and provide novel mechanistic insight into arrestin function and regulation.	[Marchese, Adriano] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol, Maywood, IL 60153 USA; [Malik, Rohit; Marchese, Adriano] Loyola Univ Chicago, Stritch Sch Med, Program Mol Biol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Marchese, A (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		Malik, Rohit/0000-0003-4537-3452	National Institutes of Health [GM75159, DA026040]; American Heart Association [0910098G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM75159 and DA026040 (to A. M.). This work was also supported by Predoctoral Fellowship 0910098G from the American Heart Association (to R. M.).	Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	36	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3884	3893		10.1074/jbc.M110.152116	http://dx.doi.org/10.1074/jbc.M110.152116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118812	hybrid, Green Published			2022-12-27	WOS:000286653200069
J	Busam, RD; Thorsell, AG; Flores, A; Hammarstrom, M; Persson, C; Obrink, B; Hallberg, BM				Busam, Robert D.; Thorsell, Ann-Gerd; Flores, Alex; Hammarstrom, Martin; Persson, Camilla; Obrink, Bjorn; Hallberg, B. Martin			Structural Basis of Tumor Suppressor in Lung Cancer 1 (TSLC1) Binding to Differentially Expressed in Adenocarcinoma of the Lung (DAL-1/4.1B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION-MOLECULE; CRYSTAL-STRUCTURE; PROTEIN 4.1R; FERM DOMAIN; CELL-ADHESION; RECOGNITION; INTERACTS; GENE; TAIL	Perturbed cell adhesion mechanisms are crucial for tumor invasion and metastasis. A cell adhesion protein, TSLC1 (tumor suppressor in lung cancer 1), is inactivated in a majority of metastatic cancers. DAL-1 (differentially expressed in adenocarcinoma of the lung protein), another tumor suppressor, binds through its FERM domain to the TSLC1 C-terminal, 4.1 glycophorin C-like, cytoplasmic domain. However, the molecular basis for this interaction is unknown. Here, we describe the crystal structure of a complex between the DAL-1 FERM domain and a portion of the TSLC1 cytoplasmic domain. DAL-1 binds to TSLC1 through conserved residues in a well defined hydrophobic pocket in the structural C-lobe of the DAL-1 FERM domain. From the crystal structure, it is apparent that Tyr(406) and Thr(408) in the TSLC1 cytoplasmic domain form the most important interactions with DAL-1, and this was also confirmed by surface plasmon resonance studies. Our results refute earlier exon deletion experiments that indicated that glycophorin C interacts with the alpha-lobe of 4.1 FERM domains.	[Busam, Robert D.; Thorsell, Ann-Gerd; Flores, Alex; Hammarstrom, Martin; Persson, Camilla] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Obrink, Bjorn; Hallberg, B. Martin] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet		Martin.Hallberg@ki.se	Hallberg, B. Martin/C-5361-2009	Hallberg, B. Martin/0000-0002-6781-0345	Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Wenner Foundation; Gren Foundation; Swedish Research Council [20073772, 20064211]; Swedish Cancer Foundation [07 0629]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Wenner Foundation; Gren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; Supported by the Wenner-Gren Foundations.; Supported by grants from the Swedish Research Council (Grant 20073772) and the Swedish Cancer Foundation (Grant 07 0629). Junior Research Fellow of The Swedish Research Council (Grant 20064211).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bernkopf DB, 2008, EXPERT OPIN THER TAR, V12, P845, DOI 10.1517/14728222.12.7.845 ; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Kusunoki H, 2009, PROTEINS, V76, P255, DOI 10.1002/prot.22405; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Surace EI, 2006, J ANDROL, V27, P816, DOI 10.2164/jandrol.106.000398; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Tran YK, 1999, CANCER RES, V59, P35; Watabe K, 2003, HISTOL HISTOPATHOL, V18, P1321, DOI 10.14670/HH-18.1321; Yageta M, 2002, CANCER RES, V62, P5129; Yu TX, 2002, BIOCHEM J, V365, P783, DOI 10.1042/BJ20020060	45	20	25	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4511	4516		10.1074/jbc.M110.174011	http://dx.doi.org/10.1074/jbc.M110.174011			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131357	hybrid, Green Published			2022-12-27	WOS:000286975700051
J	Chakravarty, AK; Shuman, S				Chakravarty, Anupam K.; Shuman, Stewart			RNA 3 '-Phosphate Cyclase (RtcA) Catalyzes Ligase-like Adenylylation of DNA and RNA 5 '-Monophosphate Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; HELA-CELL EXTRACT; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; NICK RECOGNITION; LIGATION; ENZYME; INTERMEDIATE; SPECIFICITY; ADENYLATE	RNA 3'-phosphate cyclase (Rtc) enzymes are a widely distributed family that catalyze the synthesis of RNA 2',3'-cyclic phosphate ends via an ATP-dependent pathway comprising three nucleotidyl transfer steps: reaction of Rtc with ATP to form a covalent Rtc-(histidinyl-N)-AMP intermediate and release PPi; transfer of AMP from Rtc to an RNA 3'-phosphate to form an RNA(3')pp(5')A intermediate; and attack by the terminal nucleoside O2' on the 3'-phosphate to form an RNA 2',3'-cyclic phosphate product and release AMP. The chemical transformations of the cyclase pathway resemble those of RNA and DNA ligases, with the key distinction being that ligases covalently adenylylate 5'-phosphate ends en route to phosphodiester synthesis. Here we show that the catalytic repertoire of RNA cyclase overlaps that of ligases. We report that Escherichia coli RtcA catalyzes adenylylation of 5'-phosphate ends of DNA or RNA strands to form AppDNA and AppRNA products. The polynucleotide 5' modification reaction requires the His(309) nucleophile, signifying that it proceeds through a covalent RtcA-AMP intermediate. We established this point directly by demonstrating transfer of [P-32] AMP from RtcA to a pDNA strand. RtcA readily adenylylated the 5'-phosphate at a 5'-PO4/3'-OH nick in duplex DNA but was unable to covert the nicked DNA-adenylate to a sealed phosphodiester. Our findings raise the prospect that cyclization of RNA 3'-ends might not be the only biochemical pathway in which Rtc enzymes participate; we discuss scenarios in which the 5'-adenylyltransferase of RtcA might play a role.	[Chakravarty, Anupam K.; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330.	Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1990, METHOD ENZYMOL, V181, P499; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; REINBERG D, 1985, J BIOL CHEM, V260, P6088; SHUMAN S, 1995, VIROLOGY, V211, P73, DOI 10.1006/viro.1995.1380; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tanaka N, 2009, RNA, V15, P1865, DOI 10.1261/rna.1771509; VICENTE O, 1988, EUR J BIOCHEM, V176, P431, DOI 10.1111/j.1432-1033.1988.tb14300.x	25	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4117	4122		10.1074/jbc.M110.196766	http://dx.doi.org/10.1074/jbc.M110.196766			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098490	hybrid, Green Published			2022-12-27	WOS:000286975700010
J	LaLonde, DP; Bretscher, A				LaLonde, David P.; Bretscher, Anthony			The UBX Protein SAKS1 Negatively Regulates Endoplasmic Reticulum-associated Degradation and p97-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; PEPTIDE-N-GLYCANASE; AAA ATPASE P97/VCP; DEUBIQUITINATING ENZYME; UBIQUITIN; P97; ER; COMPLEX; DOMAIN; POLYUBIQUITIN	Endoplasmic reticulum-associated degradation (ERAD) is an essential quality control process whereby misfolded proteins are exported from the endoplasmic reticulum and degraded by the proteasome in the cytosol. The ATPase p97 acts as an essential component of this process by providing the force needed for retrotranslocation and by serving as a processing station for the substrate once in the cytosol. Proteins containing the ubiquitin regulatory X (UBX) ubiquitin-like domain function as adaptors for p97 through their direct binding with the amino terminus of the ATPase. We demonstrate that the UBX protein SAKS1 is able to act as an adaptor for p97 that negatively modulates ERAD. This requires the ability of SAKS1 to bind both polyubiquitin and p97. Moreover, the association between SAKS1 and p97 is positively regulated by polyubiquitin binding of the UBX protein. SAKS1 also negatively impacts the p97-dependent processing required for degradation of a cytosolic, non-ERAD, substrate. We find SAKS1 is able to protect polyubiquitin from the activity of deubiquitinases, such as ataxin-3, that are necessary for efficient ERAD. Thus, SAKS1 inhibits protein degradation mediated by p97 complexes in the cytosol with a component of the mechanism being the ability to shield polyubiquitin chains from ubiquitin-processing factors.	[LaLonde, David P.; Bretscher, Anthony] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University	LaLonde, DP (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, 434 Weill Hall, Ithaca, NY 14853 USA.	DPL36@cornell.edu			National Institutes of Health [GM036652]; NRSA [GM080847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036652, F32GM080847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM036652 (to A. B.) and NRSA Postdoctoral Fellowship GM080847 (to D. P. L.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ishibashi T, 2005, J BIOCHEM, V137, P617, DOI 10.1093/jb/mvi074; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; McNeill H, 2004, BIOCHEM J, V384, P391, DOI 10.1042/BJ20041498; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu-Baer F, 2010, MOL CELL BIOL, V30, P2787, DOI 10.1128/MCB.01056-09; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864	40	25	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4892	4901		10.1074/jbc.M110.158030	http://dx.doi.org/10.1074/jbc.M110.158030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135095	Green Published, hybrid			2022-12-27	WOS:000286975700085
J	Mengeling, BJ; Phan, TQ; Goodson, ML; Privalsky, ML				Mengeling, Brenda J.; Phan, Theresa Q.; Goodson, Michael L.; Privalsky, Martin L.			Aberrant Corepressor Interactions Implicated in PML-RAR alpha and PLZF-RAR alpha Leukemogenesis Reflect an Altered Recruitment and Release of Specific NCoR and SMRT Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR HORMONE-RECEPTORS; RETINOIC ACID RECEPTORS; TRANSCRIPTION FACTOR; DNA RECOGNITION; X-RECEPTOR; HELIX 12; BINDING; RXR; REPRESSION	Human acute promyelocytic leukemia is causally linked to chromosomal translocations that generate chimeric retinoic acid receptor-alpha proteins (x-RAR alpha fusions). Wild-type RAR alpha is a transcription factor that binds to the SMRT/NCoR family of corepressors in the absence of hormone but releases from corepressor and binds coactivators in response to retinoic acid. In contrast, the x-RAR alpha fusions are impaired for corepressor release and operate in acute promyelocytic leukemia as dominant-negative inhibitors of wild-type RAR alpha. We report that the two most common x-RAR alpha fusions, PML-RAR alpha and PLZF-RAR alpha, have gained the ability to recognize specific splice variants of SMRT and NCoR that are poorly recognized by RAR alpha. These differences in corepressor specificity between the normal and oncogenic receptors are further magnified in the presence of a retinoid X receptor heteromeric partner. The ability of retinoids to fully release corepressor from PML-RAR alpha differs for the different splice variants, a phenomenon relevant to the requirement for supraphysiological levels of this hormone in differentiation therapy of leukemic cells. We propose that this shift in the specificity of the x-RAR alpha fusions to a novel repertoire of corepressors contributes to the dominant-negative and oncogenic properties of these oncoproteins and helps explain previously paradoxical aspects of their behavior.	[Mengeling, Brenda J.; Phan, Theresa Q.; Goodson, Michael L.; Privalsky, Martin L.] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu	Goodson, Michael L/G-4175-2010	Goodson, Michael/0000-0002-3464-490X	National Institutes of Health [RO1DK53528]; National Institute of General Medical Sciences [T32-GM007377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK53528.; Supported in part by Public Health Service Predoctoral Training Award T32-GM007377 from the National Institute of General Medical Sciences.	ALLENBY G, 1994, J BIOL CHEM, V269, P16689; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Collins SJ, 2008, CURR OPIN HEMATOL, V15, P346, DOI 10.1097/MOH.0b013e3283007edf; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; Hauksdottir H, 2001, CELL GROWTH DIFFER, V12, P85; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Jonas BA, 2007, MOL ENDOCRINOL, V21, P1924, DOI 10.1210/me.2007-0035; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; LANOTTE M, 1991, BLOOD, V77, P1080; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; Lin BC, 1997, J BIOL CHEM, V272, P9860; Lin RJ, 2000, MOL CELL, V5, P821, DOI 10.1016/S1097-2765(00)80322-6; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209; Ordentlich P, 2001, CURR TOP MICROBIOL, V254, P101; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Phan TQ, 2010, MOL CELL ENDOCRINOL, V319, P88, DOI 10.1016/j.mce.2009.11.010; Privalsky M. L, 2008, NR COREGULATORS HUMA, P243; Redner RL, 2002, LEUKEMIA, V16, P1927, DOI 10.1038/sj.leu.2402720; Rosen MD, 2009, MOL ENDOCRINOL, V23, P1183, DOI 10.1210/me.2009-0126; Short S, 2005, BIOCHEM BIOPH RES CO, V334, P845, DOI 10.1016/j.bbrc.2005.06.175; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Sutanto MM, 2006, MOL CELL ENDOCRINOL, V259, P43, DOI 10.1016/j.mce.2006.08.004; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	48	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4236	4247		10.1074/jbc.M110.200964	http://dx.doi.org/10.1074/jbc.M110.200964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131350	Green Published, hybrid			2022-12-27	WOS:000286975700022
J	Severin, S; Pollitt, AY; Navarro-Nunez, L; Nash, CA; Mourao-Sa, D; Eble, JA; Senis, YA; Watson, SP				Severin, Sonia; Pollitt, Alice Y.; Navarro-Nunez, Leyre; Nash, Craig A.; Mourao-Sa, Diego; Eble, Johannes A.; Senis, Yotis A.; Watson, Steve P.			Syk-dependent Phosphorylation of CLEC-2 A NOVEL MECHANISM OF HEM-IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; SRC FAMILY KINASES; GLYCOPROTEIN-VI; PLATELET ACTIVATION; PHOSPHATASE CD148; CRYSTAL-STRUCTURE; B-CELL; LYN; ASSOCIATION; PODOPLANIN	The C-type lectin-like receptor CLEC-2 signals via phosphorylation of a single cytoplasmic YXXL sequence known as a hem-immunoreceptor tyrosine-based activation motif (hemITAM). In this study, we show that phosphorylation of CLEC-2 by the snake toxin rhodocytin is abolished in the absence of the tyrosine kinase Syk but is not altered in the absence of the major platelet Src family kinases, Fyn, Lyn, and Src, or the tyrosine phosphatase CD148, which regulates the basal activity of Src family kinases. Further, phosphorylation of CLEC-2 by rhodocytin is not altered in the presence of the Src family kinase inhibitor PP2, even though PLC gamma 2 phosphorylation and platelet activation are abolished. A similar dependence of phosphorylation of CLEC-2 on Syk is also seen in response to stimulation by an IgG mAb to CLEC-2, although interestingly CLEC-2 phosphorylation is also reduced in the absence of Lyn. These results provide the first definitive evidence that Syk mediates phosphorylation of the CLEC-2 hemITAM receptor with Src family kinases playing a critical role further downstream through the regulation of Syk and other effector proteins, providing a new paradigm in signaling by YXXL-containing receptors.	[Severin, Sonia; Pollitt, Alice Y.; Navarro-Nunez, Leyre; Nash, Craig A.; Senis, Yotis A.; Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Mourao-Sa, Diego] Lincolns Inn Fields Labs, Immunobiol Lab, Canc Res UK, London Res Inst, London WC2A 3PX, England; [Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med, D-60590 Frankfurt, Germany	University of Birmingham; Cancer Research UK; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Severin, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	s.severin@bham.ac.uk	Severin, Sonia/M-5276-2014; Navarro Nuñez, Leyre/C-7093-2013; Watson, Stephen P/Q-6292-2016; Senis, Yotis/AAD-7183-2021	Navarro Nuñez, Leyre/0000-0001-7115-8065; Watson, Stephen P/0000-0002-7846-7423; Mourao, Diego/0000-0001-6618-6969; Pollitt, Alice/0000-0001-8706-5154; SEVERIN, Sonia/0000-0002-1566-2619; Senis, Yotis/0000-0002-0947-9957	British Heart Foundation [PG/06/129/21681]; Wellcome Trust [088410]; Spanish Ministry of Education [EX2009_0242]; Deutsche Forschungsgemeinschaft [SFB/TR23, A8]; British Heart Foundation [FS/08/034/25085] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); British Heart Foundation(British Heart Foundation)	Supported by British Heart Foundation Grant PG/06/129/21681.; Supported by Wellcome Trust Grant 088410.; Supported by the Spanish Ministry of Education (EX2009_0242).; Supported by Deutsche Forschungsgemeinschaft Grant SFB/TR23 Project A8.	Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bori-Sanz T, 2003, J BIOL CHEM, V278, P35914, DOI 10.1074/jbc.M301826200; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Hooley E, 2008, BIOCHEMISTRY-US, V47, P7831, DOI 10.1021/bi800528t; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Lannutti BJ, 2003, EXP HEMATOL, V31, P1268, DOI 10.1016/j.exphem.2003.09.009; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schmaier AA, 2009, P NATL ACAD SCI USA, V106, P21167, DOI 10.1073/pnas.0906436106; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Sobanov Y, 2001, EUR J IMMUNOL, V31, P3493, DOI 10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Watson AA, 2008, PROTEIN SCI, V17, P1611, DOI 10.1110/ps.035568.108; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	41	80	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4107	4116		10.1074/jbc.M110.167502	http://dx.doi.org/10.1074/jbc.M110.167502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098033	Green Published, hybrid			2022-12-27	WOS:000286975700009
J	Shpilman, M; Niv-Spector, L; Katz, M; Varol, C; Solomon, G; Ayalon-Soffer, M; Boder, E; Halpern, Z; Elinav, E; Gertler, A				Shpilman, Michal; Niv-Spector, Leonora; Katz, Meirav; Varol, Chen; Solomon, Gili; Ayalon-Soffer, Michal; Boder, Eric; Halpern, Zamir; Elinav, Eran; Gertler, Arieh			Development and Characterization of High Affinity Leptins and Leptin Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR ANTAGONISTS; LARGE-SCALE PREPARATION; YEAST SURFACE DISPLAY; BINDING-SITE-III; GROWTH-HORMONE; BREAST-CANCER; RECOMBINANT HUMAN; OVINE; EXPRESSION; CELLS	Leptin is a pleiotropic hormone acting both centrally and peripherally. It participates in a variety of biological processes, including energy metabolism, reproduction, and modulation of the immune response. So far, structural elements affecting leptin binding to its receptor remain unknown. We employed random mutagenesis of leptin, followed by selection of high affinity mutants by yeast surface display and discovered that replacing residue Asp-23 with a non-negatively charged amino acid leads to dramatically enhanced affinity of leptin for its soluble receptor. Rational mutagenesis of Asp-23 revealed the D23L substitution to be most effective. Coupling the Asp-23 mutation with alanine mutagenesis of three amino acids (L39A/D40A/F41A) previously reported to convert leptin into antagonist resulted in potent antagonistic activity. These novel superactive mouse and human leptin antagonists (D23L/L39A/D40A/F41A), termed SMLA and SHLA, respectively, exhibited over 60-fold increased binding to leptin receptor and 14-fold higher antagonistic activity in vitro relative to the L39A/D40A/F41A mutants. To prolong and enhance in vivo activity, SMLA and SHLA were monopegylated mainly at the N terminus. Administration of the pegylated SMLA to mice resulted in a remarkably rapid, significant, and reversible 27-fold more potent increase in body weight (as compared with pegylated mouse leptin antagonist), because of increased food consumption. Thus, recognition and mutagenesis of Asp-23 enabled construction of novel compounds that induce potent and reversible central and peripheral leptin deficiency. In addition to enhancing our understanding of leptin interactions with its receptor, these antagonists enable in vivo study of the role of leptin in metabolic and immune processes and hold potential for future therapeutic use in disease pathologies involving leptin.	[Gertler, Arieh] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Katz, Meirav; Varol, Chen; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Katz, Meirav; Varol, Chen; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Ayalon-Soffer, Michal] Bioline Innovat, IL-91450 Jerusalem, Israel; [Boder, Eric] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Tennessee System; University of Tennessee Knoxville	Gertler, A (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, POB 12, IL-76100 Rehovot, Israel.	gertler@agri.huji.ac.il	Elinav, Eran/ABE-8881-2020; Varol, Chen/ABH-6487-2020; Boder, Eric T./E-9635-2015; Elinav, Eran/C-8077-2011; Varol, Chen/AAW-4202-2021	Elinav, Eran/0000-0002-5775-2110; Boder, Eric T./0000-0003-4095-5680; 	Israel Science Foundation [521/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation Grant 521/07 (to A. G. and E. E.).	Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Elinav E., 2009, LEPTIN LEPTIN ANTAGO, P133; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Frankenberry KA, 2006, INT J ONCOL, V28, P985; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gertler A, 1998, FEBS LETT, V422, P137, DOI 10.1016/S0014-5793(97)01613-X; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; Gertler A, 2007, NAT MED, V13, P18, DOI 10.1038/nm0107-18; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Holness MJ, 1999, MOL CELL ENDOCRINOL, V157, P11, DOI 10.1016/S0303-7207(99)00126-4; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; MEILHOC E, 1990, BIO-TECHNOL, V8, P223, DOI 10.1038/nbt0390-223; Muller AF, 2004, J CLIN ENDOCR METAB, V89, P1503, DOI 10.1210/jc.2002-022049; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Raver N, 2002, GEN COMP ENDOCR, V126, P52, DOI 10.1006/gcen.2001.7766; Raver N, 2000, PROTEIN EXPRES PURIF, V19, P30, DOI 10.1006/prep.2000.1202; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Raymond CK, 1999, BIOTECHNIQUES, V26, P134, DOI 10.2144/99261rr02; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Siegmund B, 2002, GASTROENTEROLOGY, V122, pA86; Somasundar P, 2004, J SURG RES, V118, P71, DOI 10.1016/j.jss.2004.01.017; Udagawa J, 2006, ENDOCRINOLOGY, V147, P647, DOI 10.1210/en.2005-0791; van der Lely AJ, 2006, NEUROENDOCRINOLOGY, V83, P264, DOI 10.1159/000095537; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	40	108	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4429	4442		10.1074/jbc.M110.196402	http://dx.doi.org/10.1074/jbc.M110.196402			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21119198	Green Published, hybrid			2022-12-27	WOS:000286975700043
J	Zanotti, S; Smerdel-Ramoya, A; Canalis, E				Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto			Reciprocal Regulation of Notch and Nuclear Factor of Activated T-cells (NFAT) c1 Transactivation in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; BONE-FORMATION; TRANSCRIPTIONAL REPRESSION; SIGNALING PATHWAYS; CAUSES OSTEOPENIA; RNA INTERFERENCE; QUANTITATIVE PCR; MAMMALIAN-CELLS; PRIMARY TARGET; DIFFERENTIATION	Notch are transmembrane receptors involved in the determination of cell fate. Nuclear factor of activated T-cells (NFAT) c are transcription factors that control cell differentiation and function. We tested whether Notch and NFAT signaling pathways interacted in osteoblastic cells. Notch signaling was induced in ST-2 cells using vectors expressing Notch1 intracellular domain (NICD), and in Rosa(Notch) osteoblastic cells by Cre recombinase-mediated excision of a loxP-flanked STOP cassette cloned between the Rosa26 promoter and NICD. NFATc1 was induced in Rosa(Notch) osteoblastic cells by transducing an adenoviral vector expressing constitutively active NFATc1. Notch inhibited NFAT transactivation and NFATc1 transcription. In ST-2 cells, suppression of NFAT transactivation by Notch was reversed by constitutively active cGMP-dependent protein kinase type II. NFATc1 inhibited the transactivation of Notch target genes, and competed for binding to DNA with the Notch interacting protein Epstein-Barr virus latency C promoter binding factor-1, suppressor of hairless, Lag-1 (CSL). Co-immunoprecipitation and confocal microscopy demonstrated that NFATc1 and CSL interacted. Studies on the effects of NICD and NFATc1 on the differentiation and function of osteoblastic cells demonstrated that NICD and NFATc1 inhibited expression of osteoblast gene markers in Rosa(Notch) osteoblasts, but only NICD suppressed the commitment of bone marrow stromal cells to the osteoblastic lineage. In conclusion, NICD and NFATc1 reciprocally inhibit their signaling pathways, and form a regulatory network to control their activity in osteoblasts.	[Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			NIDDK [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Canalis E, 2005, J Endocrinol Invest, V28, P3; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Chow W, 2008, EXP CELL RES, V314, P2919, DOI 10.1016/j.yexcr.2008.07.010; Cohen TV, 2004, J NEUROCHEM, V90, P1059, DOI 10.1111/j.1471-4159.2004.02564.x; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; NELSON JA, 1987, MOL CELL BIOL, V7, P4125, DOI 10.1128/MCB.7.11.4125; NYE JS, 1994, DEVELOPMENT, V120, P2421; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Pan L, 2005, J BIOL CHEM, V280, P20860, DOI 10.1074/jbc.M414618200; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shen TS, 2007, J PHYSIOL-LONDON, V579, P535, DOI 10.1113/jphysiol.2006.120048; Sokal R. R, 1981, BIOMETRY; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tang L, 2002, CELL BIOL INT, V26, P75, DOI 10.1006/cbir.2001.0812; Vaandrager AB, 2003, J BIOL CHEM, V278, P28651, DOI 10.1074/jbc.M303699200; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	71	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4576	4588		10.1074/jbc.M110.161893	http://dx.doi.org/10.1074/jbc.M110.161893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131365	hybrid, Green Published			2022-12-27	WOS:000286975700058
J	Andreotti, G; Vitale, RM; Avidan-Shpalter, C; Amodeo, P; Gazit, E; Motta, A				Andreotti, Giuseppina; Vitale, Rosa Maria; Avidan-Shpalter, Carmit; Amodeo, Pietro; Gazit, Ehud; Motta, Andrea			Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMON-CALCITONIN; SECONDARY STRUCTURE; ALPHA-HELIX; PROTEIN AGGREGATION; DYNAMIC PROPERTIES; NMR-SPECTROSCOPY; BETA PEPTIDE; FIBRILLOGENESIS; OLIGOMERIZATION; DETERMINANTS	Irreversible aggregation limits bioavailability and therapeutic activity of protein-based drugs. Here we show that an aggregation-resistant mutant can be engineered by structural homology with a non-amyloidogenic analogue and that the aggregation-resistant variant may act as an inhibitor. This strategy has successfully been applied to the amyloidogenic human calcitonin (hCT). Including only five residues from the non-amyloidogenic salmon calcitonin (sCT), we obtained a variant, polar human calcitonin (phCT), whose solution structure was shown by CD, NMR, and calculations to be practically identical to that of sCT. phCT was also observed to be a potent amyloidogenesis inhibitor of hCT when mixed with it in a 1:1 ratio. Fibrillation studies of phCT and the phCT-hCT mixture mimicked the sCT behavior in the kinetics and shapes of the fibrils with a dramatic reduction with respect to hCT. Finally, the effect of phCT alone and of the mixture on the intracellular cAMP level in T47D cells confirmed for the mutant and the mixture their calcitonin-like activity, exhibiting stimulation effects identical to those of sCT, the current therapeutic form. The strategy followed appears to be suitable to develop new forms of hCT with a striking reduction of aggregation and improved activity. Finally, the inhibitory properties of the aggregation-resistant analogue, if confirmed for other amyloidogenic peptides, may favor a new strategy for controlling fibril formation in a variety of human diseases.	[Andreotti, Giuseppina; Vitale, Rosa Maria; Amodeo, Pietro; Motta, Andrea] CNR, Ist Chim Biomol, Comprensorio Olivetti, I-80078 Pozzuoli, Naples, Italy; [Avidan-Shpalter, Carmit; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Tel Aviv University	Motta, A (corresponding author), CNR, Ist Chim Biomol, Comprensorio Olivetti, Edificio A,Via Campi Flegrei 34, I-80078 Pozzuoli, Naples, Italy.	andrea.motta@icb.cnr.it	Vitale, Rosa Maria/AAY-1522-2020; ANDREOTTI, GIUSEPPINA/AAX-8952-2020; Gazit, Ehud/C-3715-2011; Amodeo, Pietro/P-1800-2015; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019	Vitale, Rosa Maria/0000-0001-9243-1307; ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; Gazit, Ehud/0000-0001-5764-1720; Amodeo, Pietro/0000-0002-6439-7575; Gazit, Ehud/0000-0001-5764-1720; Motta, Andrea/0000-0002-8643-658X	DIP, German-Israeli Project Cooperation	DIP, German-Israeli Project Cooperation	This research was partly funded by DIP, German-Israeli Project Cooperation.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Amodeo P, 1999, J BIOMOL NMR, V13, P161, DOI 10.1023/A:1008365322148; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; ANDREOTTI G, Patent No. 2007000481; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; ARVINTE T, 1993, J BIOL CHEM, V268, P6408; ARVINTE T, 1996, CIBA F SYMP, V199, P90; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Beaudreuil J, 2000, BONE, V27, P161, DOI 10.1016/S8756-3282(00)00305-7; Case D, 2006, AMBER 9; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; FELETTI C, 1979, NEPHRON, V24, P85, DOI 10.1159/000181689; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GRAUER A, 1993, HORM METAB RES, V25, P486, DOI 10.1055/s-2007-1002156; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; KANAORI K, 1995, BIOCHEMISTRY-US, V34, P12138, DOI 10.1021/bi00038a006; Kazantzis A, 2002, EUR J BIOCHEM, V269, P780, DOI 10.1046/j.0014-2956.2001.02689.x; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMP SJ, 1981, J BIOL CHEM, V256, P2269; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Manicourt D.-H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P285; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MORAN J, 1978, P NATL ACAD SCI USA, V75, P3984, DOI 10.1073/pnas.75.8.3984; MORELLI MAC, 1992, J BIOMOL NMR, V2, P335, DOI 10.1007/BF01874812; Moriarty DF, 1998, BIOCHEM BIOPH RES CO, V245, P344, DOI 10.1006/bbrc.1998.8425; Motta A, 1998, PROTEINS, V32, P314, DOI 10.1002/(SICI)1097-0134(19980815)32:3<314::AID-PROT7>3.3.CO;2-J; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rodan G. A., 2002, PRINCIPLES BONE BIOL, P1423; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Rymer DL, 2001, J BIOL CHEM, V276, P2523, DOI 10.1074/jbc.M005800200; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Schmidt MC, 1998, BIOCHEMISTRY-US, V37, P16582, DOI 10.1021/bi981219h; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Shtainfeld A, 2010, BIOCHEMISTRY-US, V49, P5299, DOI 10.1021/bi1002713; SIMMERLING CL, 1999, AMBER 6; SINGER FR, 1972, J CLIN INVEST, V51, P2331, DOI 10.1172/JCI107044; SLETTEN K, 1976, J EXP MED, V143, P993, DOI 10.1084/jem.143.4.993; Stipani V, 2001, BIOPHYS J, V81, P3332, DOI 10.1016/S0006-3495(01)75966-8; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; WADA S, 1995, ENDOCRINOLOGY, V136, P2611, DOI 10.1210/en.136.6.2611; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; YAMAMOTO Y, 1982, JPN J PHARMACOL, V32, P1013, DOI 10.1254/jjp.32.1013; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	74	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2707	2718		10.1074/jbc.M110.182014	http://dx.doi.org/10.1074/jbc.M110.182014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078667	Green Published, hybrid			2022-12-27	WOS:000286464300037
J	Brenneis, C; Coste, O; Altenrath, K; Angioni, C; Schmidt, H; Schuh, CD; Zhang, DD; Henke, M; Weigert, A; Brune, B; Rubin, B; Nusing, R; Scholich, K; Geisslinger, G				Brenneis, Christian; Coste, Ovidiu; Altenrath, Kai; Angioni, Carlo; Schmidt, Helmut; Schuh, Claus-Dieter; Zhang, Dong Dong; Henke, Marina; Weigert, Andreas; Bruene, Bernhard; Rubin, Barry; Nusing, Rolf; Scholich, Klaus; Geisslinger, Gerd			Anti-inflammatory Role of Microsomal Prostaglandin E Synthase-1 in a Model of Neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; E RECEPTOR SUBTYPES; RAT SPINAL-CORD; INNATE IMMUNITY; PAIN HYPERSENSITIVITY; ISCHEMIC TOLERANCE; LIGAND-BINDING; MESSENGER-RNA; NEONATAL-RAT; LIPOPOLYSACCHARIDE	A major immunological response during neuroinflammation is the activation of microglia, which subsequently release proinflammatory mediators such as prostaglandin E-2 (PGE(2)). Besides its proinflammatory properties, cyclooxygenase-2 (COX-2)-derived PGE(2) has been shown to exhibit anti-inflammatory effects on innate immune responses. Here, we investigated the role of microsomal PGE(2) synthase-1 (mPGES-1), which is functionally coupled to COX-2, in immune responses using a model of lipopolysaccharide (LPS)-induced spinal neuroinflammation. Interestingly, we found that activation of E-prostanoid (EP)2 and EP4 receptors, but not EP1, EP3, PGI(2) receptor (IP), thromboxane A(2) receptor (TP), PGD(2) receptor (DP), and PGF(2) receptor (FP), efficiently blocked LPS-induced tumor necrosis factor alpha (TNF alpha) synthesis and COX-2 and mPGES-1 induction as well as prostaglandin synthesis in spinal cultures. In vivo, spinal EP2 receptors were up-regulated in microglia in response to intrathecally injected LPS. Accordingly, LPS priming reduced spinal synthesis of TNF alpha, interleukin 1 beta (IL-1 beta), and prostaglandins in response to a second intrathecal LPS injection. Importantly, this reduction was only seen in wild-type but not in mPGES-1-deficient mice. Furthermore, intrathecal application of EP2 and EP4 agonists as well as genetic deletion of EP2 significantly reduced spinal TNF alpha and IL-1 beta synthesis in mPGES-1 knock-out mice after LPS priming. These data suggest that initial inflammation prepares the spinal cord for a negative feedback regulation by mPGES-1- derived PGE(2) followed by EP2 activation, which limits the synthesis of inflammatory mediators during chronic inflammation. Thus, our data suggest a role of mPGES-1-derived PGE(2) in resolution of neuroinflammation.	[Zhang, Dong Dong; Henke, Marina; Nusing, Rolf; Geisslinger, Gerd] Klinikum Goethe Univ Frankfurt, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany; [Weigert, Andreas; Bruene, Bernhard] Klinikum Goethe Univ Frankfurt, ZAFES, Inst Biochem 1, D-60590 Frankfurt, Germany; [Rubin, Barry] Univ Toronto, Div Vasc Surg, Toronto, ON M5S 1A1, Canada	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Toronto	Geisslinger, G (corresponding author), Klinikum Goethe Univ Frankfurt, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	geisslinger@em.uni-frankfurt.de	Weigert, Andreas/E-6540-2010; Schuh, Claus D/G-9032-2013	Weigert, Andreas/0000-0002-7529-1952; 	Deutsche Forschungsgemeinschaft [GE695]; LOEWE Lipid Signaling Forschungszentrum Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt	This work was supported by Deutsche Forschungsgemeinschaft Grant GE695 and the LOEWE Lipid Signaling Forschungszentrum Frankfurt.	ARMSTRONG RA, 1989, BRIT J PHARMACOL, V97, P657, DOI 10.1111/j.1476-5381.1989.tb12001.x; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; Brenneis C, 2008, J CELL MOL MED, V12, P639, DOI 10.1111/j.1582-4934.2007.00110.x; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Choi JS, 2006, CELL TISSUE RES, V324, P203, DOI 10.1007/s00441-005-0121-0; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kawamura T, 1997, LIFE SCI, V61, P2111, DOI 10.1016/S0024-3205(97)00884-9; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Lin HY, 2010, STROKE, V41, P1543, DOI 10.1161/STROKEAHA.109.574004; Lin HY, 2009, PEDIATR RES, V66, P254, DOI 10.1203/PDR.0b013e3181b0d336; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Montine TJ, 2002, J NEUROCHEM, V83, P463, DOI 10.1046/j.1471-4159.2002.01157.x; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039; Noda M, 2007, J NEUROCHEM, V101, P397, DOI 10.1111/j.1471-4159.2006.04339.x; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pierre S, 2008, MOL CELL PROTEOMICS, V7, P2475, DOI 10.1074/mcp.M800201-MCP200; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Reinold H, 2005, J CLIN INVEST, V115, P673; Sacco S, 1998, J NEUROCHEM, V71, P2063; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Scholich K, 2006, TRENDS PHARMACOL SCI, V27, P399, DOI 10.1016/j.tips.2006.06.001; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Shen AG, 2009, NEUROCHEM RES, V34, P333, DOI 10.1007/s11064-008-9780-z; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; TAFFET SM, 1989, CELL IMMUNOL, V120, P291, DOI 10.1016/0008-8749(89)90198-6; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	52	57	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2331	2342		10.1074/jbc.M110.157362	http://dx.doi.org/10.1074/jbc.M110.157362			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075851	hybrid, Green Published			2022-12-27	WOS:000286191500072
J	Stogios, PJ; Shakya, T; Evdokimova, E; Savchenko, A; Wright, GD				Stogios, Peter J.; Shakya, Tushar; Evdokimova, Elena; Savchenko, Alexei; Wright, Gerard D.			Structure and Function of APH(4)-Ia, a Hygromycin B Resistance Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINETIC MECHANISM; PHOSPHOTRANSFERASE; PURIFICATION; SUBSTRATE; TRANSLOCATION; ENTEROCOCCUS; SELECTIVITY; SEQUENCE; GENE	The aminoglycoside phosphotransferase (APH) APH(4)-Ia is one of two enzymes responsible for bacterial resistance to the atypical aminoglycoside antibiotic hygromycin B (hygB). The crystal structure of APH(4)-Ia enzyme was solved in complex with hygB at 1.95A resolution. The APH(4)-Ia structure adapts a general two-lobe architecture shared by other APH enzymes and eukaryotic kinases, with the active site located at the interdomain cavity. The enzyme forms an extended hydrogen bond network with hygB primarily through polar and acidic side chain groups. Individual alanine substitutions of seven residues involved in hygB binding did not have significant effect on APH(4)-Ia enzymatic activity, indicating that the binding affinity is spread across a distributed network. hygB appeared as the only substrate recognized by APH(4)-Ia among the panel of 14 aminoglycoside compounds. Analysis of the active site architecture and the interaction with the hygB molecule demonstrated several unique features supporting such restricted substrate specificity. Primarily the APH(4)-Ia substrate-binding site contains a cluster of hydrophobic residues that provides a complementary surface to the twisted structure of the substrate. Similar to APH(2 '') enzymes, the APH(4)-Ia is able to utilize either ATP or GTP for phosphoryl transfer. The defined structural features of APH(4)-Ia interactions with hygB and the promiscuity in regard to ATP or GTP binding could be exploited for the design of novel aminoglycoside antibiotics or inhibitors of this enzyme.	[Wright, Gerard D.] McMaster Univ, MDCL 2301, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	McMaster University; University of Toronto	Wright, GD (corresponding author), McMaster Univ, MDCL 2301, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Stogios, Peter/0000-0001-8663-1425; Wright, Gerard/0000-0002-9129-7131	National Institutes of Health [HHSN272200700058C]; Canadian Institutes of Health Research [MT-13536]; Canada Research Chairs program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN272200700058C (to A. S.). This work was also supported by Canadian Institutes of Health Research Grant MT-13536 (to G. D. W.) and the Canada Research Chairs program (to G. D. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P14115, DOI 10.1021/bi00251a021; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; PON NG, 1967, ANAL BIOCHEM, V19, P272, DOI 10.1016/0003-2697(67)90163-7; RAO RN, 1983, ANTIMICROB AGENTS CH, V24, P689, DOI 10.1128/AAC.24.5.689; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; SIREGAR JJ, 1995, BIOCHEMISTRY-US, V34, P12681, DOI 10.1021/bi00039a026; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZALACAIN M, 1987, EUR J BIOCHEM, V162, P419, DOI 10.1111/j.1432-1033.1987.tb10618.x; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	39	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1966	1975		10.1074/jbc.M110.194266	http://dx.doi.org/10.1074/jbc.M110.194266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084294	hybrid, Green Published			2022-12-27	WOS:000286191500038
J	Szmola, R; Bence, M; Carpentieri, A; Szabo, A; Costello, CE; Samuelson, J; Sahin-Toth, M				Szmola, Richard; Bence, Melinda; Carpentieri, Andrea; Szabo, Andras; Costello, Catherine E.; Samuelson, John; Sahin-Toth, Miklos			Chymotrypsin C Is a Co-activator of Human Pancreatic Procarboxypeptidases A1 and A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SERINE PROTEINASE-INHIBITOR; SITE-DIRECTED MUTAGENESIS; HEREDITARY PANCREATITIS; BOVINE PROCARBOXYPEPTIDASE; ACTIVATION PATHWAY; 3-DIMENSIONAL STRUCTURE; ENZYMATIC SPECIFICITY; TRYPTIC ACTIVATION; CARBOXYPEPTIDASE-A	Human digestive carboxypeptidases CPA1, CPA2, and CPB1 are secreted by the pancreas as inactive proenzymes containing a 94-96-amino acid-long propeptide. Activation of procarboxypeptidases is initiated by proteolytic cleavage at the C-terminal end of the propeptide by trypsin. Here, we demonstrate that subsequent cleavage of the propeptide by chymotrypsin C (CTRC) induces a nearly 10-fold increase in the activity of trypsin-activated CPA1 and CPA2, whereas CPB1 activity is unaffected. Other human pancreatic proteases such as chymotrypsin B1, chymotrypsin B2, chymotrypsin-like enzyme-1, elastase 2A, elastase 3A, or elastase 3B are inactive or markedly less effective at promoting procarboxypeptidase activation. On the basis of these observations, we propose that CTRC is a physiological co-activator of proCPA1 and proCPA2. Furthermore, the results confirm and extend the notion that CTRC is a key regulator of digestive zymogen activation.	[Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Costello, Catherine E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Costello, Catherine/0000-0003-1594-5122; Samuelson, John/0000-0001-9533-3040; Carpentieri, Andrea/0000-0002-1944-5355	National Institutes of Health [R01 DK082412, R01 DK082412-S2, R01 DK058088, R01 AI44070, P41 RR010888, S10 RR020946]; Rosztoczy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888, S10RR020946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosztoczy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412, R01 DK082412-S2 (American Recovery and Reinvestment Act), R01 DK058088 (to M.S.-T.), R01 AI44070 (to J.S.), P41 RR010888 (to C.E.C.), S10 RR020946 (to J. Zaia). This work was also supported by a scholarship from the Rosztoczy Foundation (to M.B.).	AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; BROWN JR, 1961, P NATL ACAD SCI USA, V47, P1554, DOI 10.1073/pnas.47.10.1554; CATASUS L, 1992, BIOCHEM J, V287, P299, DOI 10.1042/bj2870299; CATASUS L, 1995, J BIOL CHEM, V270, P6651, DOI 10.1074/jbc.270.12.6651; CHAPUS C, 1987, EUR J BIOCHEM, V166, P379, DOI 10.1111/j.1432-1033.1987.tb13526.x; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; IIOAKAMA K, 1985, BIOCHIM BIOPHYS ACTA, V831, P249, DOI 10.1016/0167-4838(85)90042-1; KEILDLOUHA V, 1972, BIOCHIM BIOPHYS ACTA, V276, P531, DOI 10.1016/0005-2744(72)91013-3; KELLER PJ, 1958, J BIOL CHEM, V230, P905; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; LACKO AG, 1970, BIOCHEMISTRY-US, V9, P4680; Laethem RM, 1996, ARCH BIOCHEM BIOPHYS, V332, P8, DOI 10.1006/abbi.1996.0310; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Mock WL, 2002, BIOORG MED CHEM LETT, V12, P1193, DOI 10.1016/S0960-894X(02)00128-2; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; OPPEZZO O, 1994, EUR J BIOCHEM, V222, P55, DOI 10.1111/j.1432-1033.1994.tb18841.x; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; PASCUAL R, 1989, EUR J BIOCHEM, V179, P609, DOI 10.1111/j.1432-1033.1989.tb14590.x; PETERSON LM, 1976, BIOCHEMISTRY-US, V15, P2501, DOI 10.1021/bi00657a001; PHILLIPS MA, 1990, J BIOL CHEM, V265, P20692; PHILLIPS MA, 1992, PROTEIN SCI, V1, P517; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P3535, DOI 10.1074/jbc.273.6.3535; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; UREN JR, 1972, BIOCHEMISTRY-US, V11, P4483, DOI 10.1021/bi00774a010; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; VENDRELL J, 1992, BIOL CHEM H-S, V373, P387, DOI 10.1515/bchm3.1992.373.2.387; VENDRELL J, 1990, J BIOL CHEM, V265, P6949; VILLEGAS V, 1995, PROTEIN SCI, V4, P1792, DOI 10.1002/pro.5560040914; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	41	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1819	1827		10.1074/jbc.M110.187369	http://dx.doi.org/10.1074/jbc.M110.187369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098023	hybrid, Green Published			2022-12-27	WOS:000286191500022
J	Tsukada, T; Kotlyanskaya, L; Huynh, R; Desai, B; Novak, SM; Kajava, AV; Gregorio, CC; Kostyukova, AS				Tsukada, Takehiro; Kotlyanskaya, Lucy; Huynh, Robert; Desai, Brinda; Novak, Stefanie M.; Kajava, Andrey V.; Gregorio, Carol C.; Kostyukova, Alla S.			Identification of Residues within Tropomodulin-1 Responsible for Its Localization at the Pointed Ends of the Actin Filaments in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPOMYOSIN BINDING; CAPPING PROTEIN; STRIATED-MUSCLE; DOMAINS; LENGTH; HEART; DYNAMICS; LEADS; MICE	Tropomodulin is a tropomyosin-dependent actin filament capping protein involved in the structural formation of thin filaments and in the regulation of their lengths through its localization at the pointed ends of actin filaments. The disordered N-terminal domain of tropomodulin contains three functional sites: two tropomyosin-binding and one tropomyosin-dependent actin-capping sites. The C-terminal half of tropomodulin consists of one compact domain containing a tropomyosin-independent actin-capping site. Here we determined the structural properties of tropomodulin-1 that affect its roles in cardiomyocytes. To explore the significance of individual tropomyosin-binding sites, GFP-tropomodulin-1 with single mutations that destroy each tropomyosin-binding site was expressed in cardiomyocytes. We demonstrated that both sites are necessary for the optimal localization of tropomodulin-1 at thin filament pointed ends, with site 2 acting as the major determinant. To investigate the functional properties of the tropomodulin C-terminal domain, truncated versions of GFP-tropomodulin-1 were expressed in cardiomyocytes. We discovered that the leucine-rich repeat (LRR) fold and the C-terminal helix are required for its proper targeting to the pointed ends. To investigate the structural significance of the LRR fold, we generated three mutations within the C-terminal domain (V232D, F263D, and L313D). Our results show that these mutations affect both tropomyosin-independent actin-capping activity and pointed end localization, most likely by changing local conformations of either loops or side chains of the surfaces involved in the interactions of the LRR domain. Studying the influence of these mutations individually, we concluded that, in addition to the tropomyosin-independent actin-capping site, there appears to be another regulatory site within the tropomodulin C-terminal domain.	[Tsukada, Takehiro; Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Tsukada, Takehiro; Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Kotlyanskaya, Lucy; Huynh, Robert; Desai, Brinda; Kostyukova, Alla S.] Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Kajava, Andrey V.] Univ Montpellier 1 & 2, CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	University of Arizona; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Gregorio, CC (corresponding author), Univ Arizona, Dept Cell Biol & Anat, 1656 E Mabel St, Tucson, AZ 85724 USA.	gregorio@arizona.edu; kostyuas@umdnj.edu	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Huynh, Robert/0000-0003-3056-5830	National Institutes of Health [HL083146, 5R25GM62584, GM081688]; American Heart Association [0825870G]; University of Medicine; Dentistry of New Jersey Foundation; Schering Plough Corp.; Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081688, R25GM062584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Medicine; Dentistry of New Jersey Foundation; Schering Plough Corp.(Merck & CompanySchering Plough Corporation); Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL083146 (to C. C. G.), National Institutes of Health IMSD Fellowship 5R25GM62584 (to S. M. N.), and National Institutes of Health Grant GM081688 (to A. S. K.). This work was also supported by American Heart Association Grant 0825870G to (T. T.) and University of Medicine and Dentistry of New Jersey Foundation grants (to A. S. K.).; Supported by the University of Medicine and Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program, supported in part by Schering Plough Corp.	Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FASMAN GD, 1989, PRACTICAL HDB BIOCH, P84; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujisawa T, 2001, FEBS LETT, V498, P67, DOI 10.1016/S0014-5793(01)02498-X; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kong KY, 2004, J BIOL CHEM, V279, P30856, DOI 10.1074/jbc.M302845200; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; Ono Y, 2005, DEV BIOL, V282, P336, DOI 10.1016/j.ydbio.2005.03.015; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167	30	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2194	2204		10.1074/jbc.M110.186924	http://dx.doi.org/10.1074/jbc.M110.186924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078668	Green Published, hybrid			2022-12-27	WOS:000286191500060
J	Resseguie, ME; da Costa, KA; Galanko, JA; Patel, M; Davis, IJ; Zeisel, SH				Resseguie, Mary E.; da Costa, Kerry-Ann; Galanko, Joseph A.; Patel, Mukund; Davis, Ian J.; Zeisel, Steven H.			Aberrant Estrogen Regulation of PEMT Results in Choline Deficiency-associated Liver Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRANSFERASE GENE; NEURAL-TUBE DEFECTS; DIETARY REQUIREMENTS; CHIP-CHIP; TRANSCRIPTION; NUTRIENT; PHOSPHATIDYLCHOLINE; SUSCEPTIBILITY; POLYMORPHISM; EXPRESSION	When dietary choline is restricted, most men and postmenopausal women develop multiorgan dysfunction marked by hepatic steatosis (choline deficiency syndrome (CDS)). However, a significant subset of premenopausal women is protected from CDS. Because hepatic PEMT (phosphatidylethanolamine N-methyltransferase) catalyzes de novo biosynthesis of choline and this gene is under estrogenic control, we hypothesized that there are SNPs in PEMT that disrupt the hormonal regulation of PEMT and thereby put women at risk for CDS. In this study, we performed transcript-specific gene expression analysis, which revealed that estrogen regulates PEMT in an isoform-specific fashion. Locus-wide SNP analysis identified a risk-associated haplotype that was selectively associated with loss of hormonal activation. Chromatin immunoprecipitation, analyzed by locus-wide microarray studies, comprehensively identified regions of estrogen receptor binding in PEMT. The polymorphism (rs12325817) most highly linked with the development of CDS (p < 0.00006) was located within 1 kb of the critical estrogen response element. The risk allele failed to bind either the estrogen receptor or the pioneer factor FOXA1. These data demonstrate that allele-specific ablation of estrogen receptor-DNA interaction in the PEMT locus prevents hormone-inducible PEMT expression, conferring risk of CDS in women.	[Zeisel, Steven H.] Inst Nutr Res, Sch Publ Hlth, Kannapolis, NC 28081 USA; [Resseguie, Mary E.; da Costa, Kerry-Ann; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Galanko, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Patel, Mukund; Davis, Ian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Patel, Mukund; Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), Inst Nutr Res, Sch Publ Hlth, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu		Davis, Ian/0000-0002-1552-0960	National Institutes of Health [DK55865, AG09525, DK56350, DK 034987]; V Foundation for Cancer Research; Rita Allen Foundation; Corn-Hammond Fund for Pediatric Oncology; Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Rita Allen Foundation; Corn-Hammond Fund for Pediatric Oncology; Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and AG09525 (to S. Z.) and DK56350 (to the University of North Carolina at Chapel Hill Nutrition Obesity Research Center).; Supported by National Institutes of Health Grants DK 034987 and DK 056350.; Supported by the V Foundation for Cancer Research, the Rita Allen Foundation, and Corn-Hammond Fund for Pediatric Oncology.; Supported by Mead Johnson Nutritionals, Balchem, and the Egg Nutrition Research Center and serves on advisory boards for Dupont and Solae. To whom correspondence should be addressed: Nutrition Research Institute, 500 Laureate Way, Kannapolis, NC 28081. Fax: 704-250-5001; E-mail: steven_zeisel@unc.edu.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barkhem T, 1997, J STEROID BIOCHEM, V62, P53, DOI 10.1016/S0960-0760(97)00017-4; BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P205, DOI 10.1016/0006-3002(61)90745-4; Buchman AL, 2001, JPEN-PARENTER ENTER, V25, P260, DOI 10.1177/0148607101025005260; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; da Costa KA, 2006, FASEB J, V20, pA606; Dong H, 2007, J HEPATOL, V46, P915, DOI 10.1016/j.jhep.2006.12.012; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Jensen LJ, 2007, FASEB J, V21, pA519; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Mattick S, 1997, J STEROID BIOCHEM, V60, P285, DOI 10.1016/S0960-0760(96)00198-7; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCMAHON KE, 1985, CLIN CHIM ACTA, V149, P1, DOI 10.1016/0009-8981(85)90267-0; *NAT AC SCI US I M, 1998, CHOL DIET REF INT FO, V1, P390; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Resseguie ME, 2007, FASEB J, V21, pA61; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Rozen S, 2000, Methods Mol Biol, V132, P365; SAS Institute Inc, 1996, SAS STATSOFTWARE CHA; Shaw GM, 2009, EPIDEMIOLOGY, V20, P714, DOI 10.1097/EDE.0b013e3181ac9fe7; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; ZEISEL SH, 1995, J NUTR, V125, P3049; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	41	67	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1649	1658		10.1074/jbc.M110.106922	http://dx.doi.org/10.1074/jbc.M110.106922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059658	Green Published, hybrid			2022-12-27	WOS:000286005000077
J	Jurgensen, S; Antonio, LL; Mussi, GEA; Brito-Moreira, J; Bomfim, TR; De Felice, FG; Garrido-Sanabria, ER; Cavalheiro, EA; Ferreira, ST				Juergensen, Sofia; Antonio, Leandro L.; Mussi, Gabriela E. A.; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Garrido-Sanabria, Emilio R.; Cavalheiro, Esper A.; Ferreira, Sergio T.			Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-beta Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; DEPENDENT MECHANISM; PERISYNAPTIC SITES; SURFACE EXPRESSION; ALZHEIMERS-DISEASE; SECRETED OLIGOMERS; PLASTICITY; TRAFFICKING; GLUR1	Soluble oligomers of the amyloid-beta peptide (A beta Os) accumulate in the brains of Alzheimer disease (AD) patients and are implicated in synapse failure and early memory loss in AD. A beta Os have been shown to impact synapse function by inhibiting long term potentiation, facilitating the induction of long term depression and inducing internalization of both AMPA and NMDA glutamate receptors, critical players in plasticity mechanisms. Because activation of dopamine D1/D5 receptors plays important roles in memory circuits by increasing the insertion of AMPA and NMDA receptors at synapses, we hypothesized that selective activation of D1/D5 receptors could protect synapses from the deleterious action of A beta Os. We show that SKF81297, a selective D1/D5 receptor agonist, prevented the reduction in surface levels of AMPA and NMDA receptors induced by A beta Os in hippocampal neurons in culture. Protection by SKF81297 was abrogated by the specific D1/D5 antagonist, SCH23390. Levels of AMPA receptor subunit GluR1 phosphorylated at Ser(845), which regulates AMPA receptor association with the plasma membrane, were reduced in a calcineurin-dependent manner in the presence of A beta Os, and treatment with SKF81297 prevented this reduction. Establishing the functional relevance of these findings, SKF81297 blocked the impairment of long term potentiation induced by A beta Os in hippocampal slices. Results suggest that D1/D5 receptors may be relevant targets for development of novel pharmacological approaches to prevent synapse failure in AD.	[Juergensen, Sofia; Mussi, Gabriela E. A.; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-1944590 Rio De Janeiro, Brazil; [Antonio, Leandro L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Dept Expt Neurol, BR-04023900 Sao Paulo, Brazil; [Garrido-Sanabria, Emilio R.] Univ Texas Brownsville, Ctr Biomed Studies, Dept Biol Sci, Brownsville, TX 78520 USA	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas Rio Grande Valley	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, CCS IBqM, BR-21941590 Rio De Janeiro, Brazil.	ferreira@bioqmed.ufrj.br	Cavalheiro, Esper A/I-3084-2016; Cavalheiro, Esper A/F-4325-2014; Neurociencia, Inct/I-1011-2013; Cavalheiro, Esper/N-3985-2019; De Felice, Fernanda G/M-1074-2017; Ferreira, Sergio/AAZ-1576-2020	Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro, Esper/0000-0002-0854-3582; Ferreira, Sergio/0000-0001-7160-9866	National Institutes of Health [5SC1NS063950-04, 3SC1NS063950-03S1]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico; Instituto Nacional de Neurociencia Translacional; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS063950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Neurociencia Translacional; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5SC1NS063950-04 and 3SC1NS063950-03S1 (to E. R. G.-S.). This work was also supported by grants from Conselho Nacional de Desenvolvimento Cientifico Tecnologico, Instituto Nacional de Neurociencia Translacional, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to S. T. F.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to E. A. C.); and Human Frontier Science Program (to F. G. D. F.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen QS, 2002, NEUROBIOL LEARN MEM, V77, P354, DOI 10.1006/nlme.2001.4034; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Mockett BG, 2007, J NEUROSCI, V27, P2918, DOI 10.1523/JNEUROSCI.0838-06.2007; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rui YF, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-10; Sanabria ERG, 2002, BRAIN RES BULL, V59, P47, DOI 10.1016/S0361-9230(02)00837-7; Schaeffer EL, 2009, PROG NEURO-PSYCHOPH, V33, P1087, DOI 10.1016/j.pnpbp.2009.06.024; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder GL, 1998, J NEUROSCI, V18, P10297; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; WALS P, 1998, P NATL ACAD SCI USA, V95, P6448; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	63	71	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3270	3276		10.1074/jbc.M110.177790	http://dx.doi.org/10.1074/jbc.M110.177790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115476	Green Published, hybrid			2022-12-27	WOS:000286653200012
J	Shlyakhtenko, LS; Lushnikov, AY; Li, M; Lackey, L; Harris, RS; Lyubchenko, YL				Shlyakhtenko, Luda S.; Lushnikov, Alexander Y.; Li, Ming; Lackey, Lela; Harris, Reuben S.; Lyubchenko, Yuri L.			Atomic Force Microscopy Studies Provide Direct Evidence for Dimerization of the HIV Restriction Factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; DNA; DEAMINASE; PROTEINS; GAG; HYPERMUTATION; DYNAMICS; VIRIONS; COMPLEX	APOBEC3G (A3G) is an antiviral protein that binds RNA and single-stranded DNA (ssDNA). The oligomerization state of A3G is likely to be influenced by these nucleic acid interactions. We applied the power of nanoimaging atomic force microscopy technology to characterize the role of ssDNA in A3G oligomerization. We used recombinant human A3G prepared from HEK-293 cells and specially designed DNA substrates that enable free A3G to be distinguished unambiguously from DNA-bound protein complexes. This DNA substrate can be likened to a molecular ruler because it consists of a 235-bp double-stranded DNA visual tag spliced to a 69-nucleotide ssDNA substrate. This hybrid substrate enabled us to use volume measurements to determine A3G stoichiometry in both free and ssDNA-bound states. We observed that free A3G is primarily monomeric, whereas ssDNA-complexed A3G is mostly dimeric. A3G stoichiometry increased slightly with the addition of Mg2+, but dimers still predominated when Mg2+ was depleted. A His-248/His-250 Zn2+-mediated intermolecular bridge was observed in a catalytic domain crystal structure (Protein Data Bank code 3IR2); however, atomic force microscopy analyses showed that the stoichiometry of the A3G-ssDNA complexes changed insignificantly when these residues were mutated to Ala. We conclude that A3G exchanges between oligomeric forms in solution with monomers predominating and that this equilibrium shifts toward dimerization upon binding ssDNA.	[Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Li, Ming; Lackey, Lela; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Lyubchenko, YL (corresponding author), 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Lackey, Lela/0000-0003-2163-4005	National Institutes of Health [AI064046, P01 GM091743, SIG 1S10 SS023400]; National Science Foundation [PHY-0615590]; NATO [SFP-983204]; Nebraska Research Initiative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064046, T32AI083196, R56AI064046, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATO(NATO (North Atlantic Treaty Organisation)); Nebraska Research Initiative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064046 (to R. S. H.) and P01 GM091743 (to R. S. H. and Y. L. L.). This work was also supported by National Science Foundation Grant PHY-0615590 (to Y. L. L.), NATO Grant SFP-983204 (to Y. L. L.), a Nebraska Research Initiative Grant (to Y. L. L.), and a National Science Foundation doctoral scholarship (to L. L.). The AFM experiments were performed in the University of Nebraska Nanoimaging Core Facility with the use of AFM instruments purchased with National Institutes of Health Support Grant SIG 1S10 SS023400.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Brar SS, 2008, DNA REPAIR, V7, P77, DOI 10.1016/j.dnarep.2007.08.002; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; HANSMA HG, 1995, BIOPHYS J, V68, P1672, DOI 10.1016/S0006-3495(95)80343-7; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hultquist JF, 2009, FUTURE VIROL, V4, P605, DOI 10.2217/FVL.09.59; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Kataoka Naoyuki, 2008, V488, P357, DOI 10.1007/978-1-60327-475-3_23; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Lushnikov AY, 2006, BIOCHEMISTRY-US, V45, P152, DOI 10.1021/bi051767c; Lushnikov AY, 2004, NUCLEIC ACIDS RES, V32, P4704, DOI 10.1093/nar/gkh810; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	48	67	67	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3387	3395		10.1074/jbc.M110.195685	http://dx.doi.org/10.1074/jbc.M110.195685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123176	hybrid, Green Published			2022-12-27	WOS:000286653200025
J	Agbor, TA; Cheong, A; Comerford, KM; Scholz, CC; Bruning, U; Clarke, A; Cummins, EP; Cagney, G; Taylor, CT				Agbor, Terence A.; Cheong, Alex; Comerford, Katrina M.; Scholz, Carsten C.; Bruning, Ulrike; Clarke, Ambrose; Cummins, Eoin P.; Cagney, Gerard; Taylor, Cormac T.			Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROTEIN SUMOYLATION; INDUCIBLE FACTOR-1; SUMO; EXPRESSION; CELLS; HIF-1; RESPONSES; CYTOPROTECTION; RESPIRATION	Under conditions of hypoxia, most eukaryotic cells undergo a shift in metabolic strategy, which involves increased flux through the glycolytic pathway. Although this is critical for bioenergetic homeostasis, the underlying mechanisms have remained incompletely understood. Here, we report that the induction of hypoxia-induced glycolysis is retained in cells when gene transcription or protein synthesis are inhibited suggesting the involvement of additional post-translational mechanisms. Post-translational protein modification by the small ubiquitin related modifier-1 (SUMO-1) is induced in hypoxia and mass spectrometric analysis using yeast cells expressing tap-tagged Smt3 (the yeast homolog of mammalian SUMO) revealed hypoxia-dependent modification of a number of key glycolytic enzymes. Overexpression of SUMO-1 in mammalian cancer cells resulted in increased hypoxia-induced glycolysis and resistance to hypoxia-dependent ATP depletion. Supporting this, non-transformed cells also demonstrated increased glucose uptake upon SUMO-1 overexpression. Conversely, cells overexpressing the de-SUMOylating enzyme SENP-2 failed to demonstrate hypoxia-induced glycolysis. SUMO-1 overexpressing cells demonstrated focal clustering of glycolytic enzymes in response to hypoxia leading us to hypothesize a role for SUMOylation in promoting spatial re-organization of the glycolytic pathway. In summary, we hypothesize that SUMO modification of key metabolic enzymes plays an important role in shifting cellular metabolic strategies toward increased flux through the glycolytic pathway during periods of hypoxic stress.	[Taylor, Cormac T.] Univ Coll Dublin, Coll Life Sci, Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland; [Agbor, Terence A.] Univ Massachusetts, Sch Med, Dept Mol Genet, Worcester, MA 01655 USA; [Agbor, Terence A.] Univ Massachusetts, Sch Med, Dept Microbiol, Worcester, MA 01655 USA	University College Dublin; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Taylor, CT (corresponding author), Univ Coll Dublin, Coll Life Sci, Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Scholz, Carsten C./P-3185-2019; Cheong, Alex/E-5049-2011; Cummins, Eoin/S-7554-2019	Scholz, Carsten C./0000-0001-6579-8015; Cheong, Alex/0000-0003-2482-9078; Cummins, Eoin/0000-0002-9346-8299; Cagney, Gerard/0000-0001-7189-9496; Taylor, Cormac/0000-0002-0946-1247	Science Foundation Ireland; European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission)	This work was supported by grants from the Science Foundation Ireland and European Union Marie Curie Action.	Agbor TA, 2008, BIOCHEM SOC T, V36, P445, DOI 10.1042/BST0360445; Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Lee YJ, 2006, BIOCHEM SOC T, V34, P1295, DOI 10.1042/BST0341295; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RACKER E, 1972, AM SCI, V60, P56; Sagar GDV, 2007, MOL CELL BIOL, V27, P4774, DOI 10.1128/MCB.00283-07; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Spoden GA, 2009, J CELL BIOCHEM, V107, P293, DOI 10.1002/jcb.22125; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Ulrich HD, 2007, CELL, V131, P446, DOI 10.1016/j.cell.2007.10.026; Vigodner M, 2009, CELL TISSUE RES, V336, P277, DOI 10.1007/s00441-009-0775-0; Wilson V. G., 2005, SCI STKE, V290, P32; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601	39	46	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4718	4726		10.1074/jbc.M110.115931	http://dx.doi.org/10.1074/jbc.M110.115931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123177	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000286975700070
J	Deville, K; Gold, VAM; Robson, A; Whitehouse, S; Sessions, RB; Baldwin, SA; Radford, SE; Collinson, I				Deville, Karine; Gold, Vicki A. M.; Robson, Alice; Whitehouse, Sarah; Sessions, Richard B.; Baldwin, Stephen A.; Radford, Sheena E.; Collinson, Ian			The Oligomeric State and Arrangement of the Active Bacterial Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE CONFORMATIONAL-CHANGE; PROTEIN-CONDUCTING CHANNEL; DIMERIC SECA ATPASE; ESCHERICHIA-COLI; TRANSLATING RIBOSOME; PRECURSOR PROTEINS; COMPLEX SECYEG; MEMBRANE; BINDING; DISSOCIATION	Protein secretion in bacteria is driven through the ubiquitous SecYEG complex by the ATPase SecA. The structure of SecYEG alone or as a complex with SecA in detergent reveal a monomeric heterotrimer enclosing a central protein channel, yet in membranes it is dimeric. We have addressed the functional significance of the oligomeric status of SecYEG in protein translocation using single molecule and ensemble methods. The results show that while monomers are sufficient for the SecA-and ATP-dependent association of SecYEG with pre-protein, active transport requires SecYEG dimers arranged in the back-to-back conformation. Molecular modeling of this dimeric structure, in conjunction with the new functional data, provides a rationale for the presence of both active and passive copies of SecYEG in the functional translocon.	[Gold, Vicki A. M.; Robson, Alice; Whitehouse, Sarah; Sessions, Richard B.; Collinson, Ian] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Deville, Karine; Radford, Sheena E.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Bristol; University of Leeds; University of Leeds; University of Leeds	Collinson, I (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	ian.collinson@bristol.ac.uk		Robson, Alice/0000-0003-3338-2626; Collinson, Ian/0000-0002-3931-0503; Sessions, Richard/0000-0003-0320-0895; Gold, Vicki/0000-0002-6908-0745; Radford, Sheena/0000-0002-3079-8039	BBSRC [BB/F002343/1]; Wellcome Trust [080705/Z/06/Z];  [084452];  [082140]; Biotechnology and Biological Sciences Research Council [BB/F002343/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (Project Grant BB/F002343/1, to I. C.), Wellcome Trust Studentship Project Grant 080705/Z/06/Z (to K. D.) and Project Grant 084452 (to I. C.), and Equipment Grant 082140 (to I. C.) for the bioreactor.	Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; GELL C, 2006, HDB SINGLE MOL FLUOR; Gold VAM, 2007, J BIOL CHEM, V282, P17424, DOI 10.1074/jbc.M702066200; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	36	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4659	4669		10.1074/jbc.M110.175638	http://dx.doi.org/10.1074/jbc.M110.175638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21056980	Green Published, hybrid			2022-12-27	WOS:000286975700065
J	Farrow, MA; Kim, EY; Wolinsky, SM; Sheehy, AM				Farrow, Melissa A.; Kim, Eun-Young; Wolinsky, Steven M.; Sheehy, Ann M.			NFAT and IRF Proteins Regulate Transcription of the Anti-HIV Gene, APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTIDINE DEAMINASE; DENDRITIC CELLS; VIF PROTEIN; ENZYME APOBEC3G; EDITING ENZYME; B-CELLS; EXPRESSION; ACTIVATION; HYPERMUTATION	The human cytidine deaminase APOBEC3G (A3G) is an innate restriction factor that inhibits human immunodeficiency virus, type 1 (HIV-1) replication. Regulation of A3G gene expression plays an important role in this suppression. Currently, an understanding of the mechanism of this gene regulation is largely unknown. Here, we have identified and characterized a TATA-less core promoter with an NFAT/IRF-4 composite binding site that confers cell type-specific transcriptional regulation. We found that A3G expression is critically dependent on NFATc1/NFATc2 and IRF-4. When either NFATc1 or NFATc2 and IRF-4 were co-expressed, A3G promoter activity was observed in cells that normally lack A3G expression and expression was not detected in the presence of the individual factors. This induced A3G expression allowed normally permissive CEMss cells to adopt a nonpermissive state, able to resist an HIV-1 Delta vif challenge. This represents the first reporting of manipulating the restrictive state of a cell type via gene regulation. Identification of NFAT and IRF family members as critical regulators of A3G expression offers important insight into the transcriptional control mechanisms that regulate innate immune responses and identifies specific targets for therapeutic intervention aimed at effectively boosting our natural immunity, in the form of a host defensive factor, against HIV-1.	[Farrow, Melissa A.; Sheehy, Ann M.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Kim, Eun-Young; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	College of the Holy Cross; Northwestern University; Feinberg School of Medicine	Sheehy, AM (corresponding author), Coll Holy Cross, Dept Biol, 1 Coll St, Worcester, MA 01610 USA.	asheehy@holycross.edu	Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697; Kim, Eunyoung/0000-0002-7436-7396	Richard and Susan Smith Family Foundation; Center for AIDS Research at the University of Massachusetts [P30AI42845]; National Institutes of Health [AI071766-01, AI-3070072]; Elizabeth Glaser Pediatric AIDS Foundation [PF-77521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, F32AI071766, S15AI030700] Funding Source: NIH RePORTER	Richard and Susan Smith Family Foundation; Center for AIDS Research at the University of Massachusetts; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Richard and Susan Smith Family Foundation (to A.M.S.), by Grant P30AI42845 from the Center for AIDS Research at the University of Massachusetts, by National Institutes of Health Grants AI071766-01 (to A.M.S.) and AI-3070072 (to S.M.W.), and by Elizabeth Glaser Pediatric AIDS Foundation Grant PF-77521 (to M.A.F.).	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Badran BM, 2002, J BIOL CHEM, V277, P47136, DOI 10.1074/jbc.M206330200; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Farrow MA, 2008, FUTURE MICROBIOL, V3, P145, DOI 10.2217/17460913.3.2.145; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Luo H, 2010, MOL IMMUNOL, V47, P1383, DOI 10.1016/j.molimm.2010.02.016; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Nagulapalli S, 2002, MOL CELL BIOL, V22, P7337, DOI 10.1128/MCB.22.20.7337-7350.2002; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Wang YJ, 2009, J NEUROIMMUNOL, V206, P14, DOI 10.1016/j.jneuroim.2008.10.003; Ying SC, 2007, ACTA BIOCH BIOPH SIN, V39, P297, DOI 10.1111/j.1745-7270.2007.00275.x; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	47	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2567	2577		10.1074/jbc.M110.154377	http://dx.doi.org/10.1074/jbc.M110.154377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078663	Green Published, hybrid			2022-12-27	WOS:000286464300022
J	Sumitomo, T; Nakata, M; Higashino, M; Jin, YJ; Terao, Y; Fujinaga, Y; Kawabata, S				Sumitomo, Tomoko; Nakata, Masanobu; Higashino, Miharu; Jin, Yingji; Terao, Yutaka; Fujinaga, Yukako; Kawabata, Shigetada			Streptolysin S Contributes to Group A Streptococcal Translocation across an Epithelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; TIGHT JUNCTION; HYALURONIC-ACID; REGULATORY SYSTEM; VIRULENCE FACTORS; GENE-EXPRESSION; E-CADHERIN; TNF-ALPHA; PYOGENES; INVASION	Group A Streptococcus pyogenes (GAS) is a human pathogen that causes local suppurative infections and severe invasive diseases. Systemic dissemination of GAS is initiated by bacterial penetration of the epithelial barrier of the pharynx or damaged skin. To gain insight into the mechanism by which GAS penetrates the epithelial barrier, we sought to identify both bacterial and host factors involved in the process. Screening of a transposon mutant library of a clinical GAS isolate recovered from an invasive episode allowed identification of streptolysin S (SLS) as a novel factor that facilitates the translocation of GAS. Of note, the wild type strain efficiently translocated across the epithelial monolayer, accompanied by a decrease in transepithelial electrical resistance and cleavage of transmembrane junctional proteins, including occludin and E-cadherin. Loss of integrity of intercellular junctions was inhibited after infection with a deletion mutant of the sagA gene encoding SLS, as compared with those infected with the wild type strain. Interestingly, following GAS infection, calpain was recruited to the plasma membrane along with E-cadherin. Moreover, bacterial translocation and destabilization of the junctions were partially inhibited by a pharmacological calpain inhibitor or genetic interference with calpain. Our data indicate a potential function of SLS that facilitates GAS invasion into deeper tissues via degradation of epithelial intercellular junctions in concert with the host cysteine protease calpain.	[Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Jin, Yingji; Fujinaga, Yukako] Osaka Univ, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp		Terao, Yutaka/0000-0002-4450-5583; Nakata, Masanobu/0000-0003-1686-5415	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20791336]; MEXT [18073011, 2189048, 19791343]; Japan Society for the Promotion of Science (JSPS) [20390465]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research for Young Scientists (B) 20791336 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to T. S.); Grant-in-Aid for Scientific Research on Priority Areas 18073011 from MEXT (to S. K.); Grant-in-Aid for Scientific Research (B) 20390465 from the Japan Society for the Promotion of Science (JSPS) (to S. K.); Grant-in-Aid for Scientific Research for Young Scientists (A) 2189048 from MEXT (to Y. T.); and Grant-in-Aid for Scientific Research for Young Scientists (B) 19791343 from MEXT (to M. N.).	Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carr A, 2001, J BIOL CHEM, V276, P41790, DOI 10.1074/jbc.M107401200; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Cleary P P, 2000, Subcell Biochem, V33, P137; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kawabata S, 1999, MICROB PATHOGENESIS, V27, P71, DOI 10.1006/mpat.1999.0283; Klenk M, 2005, CELL MICROBIOL, V7, P1237, DOI 10.1111/j.1462-5822.2005.00548.x; Klenk M, 2007, ISME J, V1, P678, DOI 10.1038/ismej.2007.54; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Lin A, 2009, INFECT IMMUN, V77, P5190, DOI 10.1128/IAI.00420-09; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Mariadason JM, 2002, CANCER RES, V62, P4791; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; McKay DM, 1997, J IMMUNOL, V159, P2382; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; NIDA K, 1983, J BACTERIOL, V155, P1156, DOI 10.1128/JB.155.3.1156-1161.1983; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Podbielski A, 2003, INT J MED MICROBIOL, V293, P179, DOI 10.1078/1438-4221-00253; Rios-Doria J, 2005, PROSTATE, V63, P259, DOI 10.1002/pros.20179; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wessels MR, 2005, J INFECT DIS, V192, P13, DOI 10.1086/430625	59	55	58	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2750	2761		10.1074/jbc.M110.171504	http://dx.doi.org/10.1074/jbc.M110.171504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084306	Green Published, hybrid			2022-12-27	WOS:000286464300041
J	Tikhonov, DB; Zhorov, BS				Tikhonov, Denis B.; Zhorov, Boris S.			Possible Roles of Exceptionally Conserved Residues around the Selectivity Filters of Sodium and Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW INACTIVATION; MOLECULAR LOCALIZATION; AROMATIC RESIDUE; HOMOLOGY MODEL; NUCLEIC-ACIDS; CA2+ CHANNEL; BINDING-SITE; MU-CONOTOXIN; NA+ CHANNEL; FORCE-FIELD	In the absence of x-ray structures of sodium and calcium channels their homology models are used to rationalize experimental data and design new experiments. A challenge is to model the outer-pore region that folds differently from potassium channels. Here we report a new model of the outer-pore region of the NaV1.4 channel, which suggests roles of highly conserved residues around the selectivity filter. The model takes from our previous study (Tikhonov, D. B., and Zhorov, B. S. (2005) Biophys. J. 88, 184-197) the general disposition of the P-helices, selectivity filter residues, and the outer carboxylates, but proposes new intra-and inter-domain contacts that support structural stability of the outer pore. Glycine residues downstream from the selectivity filter are proposed to participate in knob-into-hole contacts with the P-helices and S6s. These contacts explain the adapted tetrodotoxin resistance of snakes that feed on toxic prey through valine substitution of isoleucine in the P-helix of repeat IV. Polar residues five positions upstream from the selectivity filter residues form H-bonds with the ascending-limb backbones. Exceptionally conserved tryptophans are engaged in inter-repeat H-bonds to form a ring whose pi-electrons would facilitate passage of ions from the outer carboxylates to the selectivity filter. The outer-pore model of CaV1.2 derived from the NaV1.4 model is also stabilized by the ring of exceptionally conservative tryptophans and H-bonds between the P-helices and ascending limbs. In this model, the exceptionally conserved aspartate downstream from the selectivity-filter glutamate in repeat II facilitates passage of calcium ions to the selectivity-filter ring through the tryptophan ring. Available experimental data are discussed in view of the models.	[Tikhonov, Denis B.; Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia; McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 325, Canada	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; McMaster University	Zhorov, BS (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019; Tikhonov, Denis/AAK-9148-2020	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-53229]; RAS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); RAS(Russian Academy of SciencesRegione Sardegna)	This study was supported by grants from Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research (MOP-53229) (to B. S. Z.), and by a grant from the RAS Program Molecular and Cell Biology (to D. B. T.).	BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Carbonneau E, 2002, PFLUG ARCH EUR J PHY, V445, P18, DOI 10.1007/s00424-002-0887-9; CHAHINE M, 1992, BIOPHYS J, V62, P37, DOI 10.1016/S0006-3495(92)81771-X; CHEN LQ, 1992, FEBS LETT, V309, P253, DOI 10.1016/0014-5793(92)80783-D; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P825, DOI 10.1007/s00249-009-0561-7; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P839, DOI 10.1007/s00249-009-0574-2; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Durell SR, 2001, BIOCHEM BIOPH RES CO, V281, P741, DOI 10.1006/bbrc.2001.4408; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ikeda T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768063; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Santarelli VP, 2007, BIOPHYS J, V93, P2341, DOI 10.1529/biophysj.107.106856; Santarelli VP, 2007, J BIOL CHEM, V282, P8044, DOI 10.1074/jbc.M611334200; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; TANG SQ, 1993, J BIOL CHEM, V268, P13026; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tsang SY, 2005, MOL PHARMACOL, V67, P424, DOI 10.1124/mol.67.2.424; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Yamagishi T, 2001, J GEN PHYSIOL, V118, P171, DOI 10.1085/jgp.118.2.171; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484	38	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2998	3006		10.1074/jbc.M110.175406	http://dx.doi.org/10.1074/jbc.M110.175406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081490	hybrid, Green Published			2022-12-27	WOS:000286464300063
J	Giorgetti, S; Raimondi, S; Pagano, K; Relini, A; Bucciantini, M; Corazza, A; Fogolari, F; Codutti, L; Salmona, M; Mangione, P; Colombo, L; De Luigi, A; Porcari, R; Gliozzi, A; Stefani, M; Esposito, G; Bellotti, V; Stoppini, M				Giorgetti, Sofia; Raimondi, Sara; Pagano, Katiuscia; Relini, Annalisa; Bucciantini, Monica; Corazza, Alessandra; Fogolari, Federico; Codutti, Luca; Salmona, Mario; Mangione, Palma; Colombo, Lino; De Luigi, Ada; Porcari, Riccardo; Gliozzi, Alessandra; Stefani, Massimo; Esposito, Gennaro; Bellotti, Vittorio; Stoppini, Monica			Effect of Tetracyclines on the Dynamics of Formation and Destructuration of beta 2-Microglobulin Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; IN-VITRO; BETA(2)-MICROGLOBULIN; SPECTROSCOPY; AGGREGATION; NMR; TOXICITY; SUPPRESSION; DOXYCYCLINE; OLIGOMERS	The discovery of methods suitable for the conversion in vitro of native proteins into amyloid fibrils has shed light on the molecular basis of amyloidosis and has provided fundamental tools for drug discovery. We have studied the capacity of a small library of tetracycline analogues to modulate the formation or destructuration of beta 2-microglobulin fibrils. The inhibition of fibrillogenesis of the wild type protein was first established in the presence of 20% trifluoroethanol and confirmed under a more physiologic environment including heparin and collagen. The latter conditions were also used to study the highly amyloidogenic variant, P32G. The NMR analysis showed that doxycycline inhibits beta 2-microglobulin self-association and stabilizes the native-like species through fast exchange interactions involving specific regions of the protein. Cell viability assays demonstrated that the drug abolishes the natural cytotoxic activity of soluble beta 2-microglobulin, further strengthening a possible in vivo therapeutic exploitation of this drug. Doxycycline can disassemble preformed fibrils, but the IC50 is 5-fold higher than that necessary for the inhibition of fibrillogenesis. Fibril destructuration is a dynamic and time-dependent process characterized by the early formation of cytotoxic protein aggregates that, in a few hours, convert into non-toxic insoluble material. The efficacy of doxycycline as a drug against dialysis-related amyloidosis would benefit from the ability of the drug to accumulate just in the skeletal system where amyloid is formed. In these tissues, the doxycycline concentration reaches values several folds higher than those resulting in inhibition of amyloidogenesis and amyloid destructuration in vitro.	[Mangione, Palma; Bellotti, Vittorio; Stoppini, Monica] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Pagano, Katiuscia; Corazza, Alessandra; Fogolari, Federico; Codutti, Luca; Esposito, Gennaro] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Relini, Annalisa; Corazza, Alessandra; Fogolari, Federico; Gliozzi, Alessandra; Esposito, Gennaro; Bellotti, Vittorio; Stoppini, Monica] INBB, I-00136 Rome, Italy; [Relini, Annalisa; Gliozzi, Alessandra] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Bucciantini, Monica; Stefani, Massimo] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Salmona, Mario; De Luigi, Ada] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Colombo, Lino] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy	University of Pavia; University of Udine; University of Genoa; University of Florence; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Dipartimento Biochim, Via Taramelli 3B, I-27100 Pavia, Italy.	vbellot@unipv.it	De Luigi, Ada/ABF-7913-2020; Relini, Annalisa/AHC-3105-2022; Bellotti, Vittorio/A-6201-2014; Pagano, Katiuscia/AAB-9495-2020; salmona, mario/ABI-4066-2020; Giorgetti, Sofia/AAD-4341-2019; salmona, mario/AAA-7116-2020; Corazza, Alessandra/AGB-1457-2022	De Luigi, Ada/0000-0001-7907-7139; Bellotti, Vittorio/0000-0001-8678-662X; Giorgetti, Sofia/0000-0001-9438-6511; salmona, mario/0000-0002-9098-9873; Corazza, Alessandra/0000-0003-2272-1928; STEFANI, MASSIMO/0000-0002-4490-1922; bucciantini, monica/0000-0002-5243-9301; pagano, katiuscia/0000-0002-0462-2056; Fogolari, Federico/0000-0001-9862-250X; Mangione, Palma/0000-0003-0260-1400; RELINI, ANNALISA/0000-0002-4040-9279	Italian Ministry of University, Research and Instruction (MIUR); European Union (EU) [LSHM-CT-2005-037525]; Fondazione Cariplo [2007.5151, 2009-2543]	Italian Ministry of University, Research and Instruction (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union (EU)(CGIAREuropean Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of University, Research and Instruction (MIUR) (projects FIRB and PRIN), the European Union (EU) (EURAMY Project LSHM-CT-2005-037525), and the Fondazione Cariplo (2007.5151 and 2009-2543).	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Aitken JF, 2010, DIABETES, V59, P161, DOI 10.2337/db09-0548; Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bellotti V, 2007, ANN MED, V39, P200, DOI 10.1080/07853890701206887; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; De Lorenzi E, 2004, CURR MED CHEM, V11, P1065; De Luigi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001888; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Gordon J, 2003, INT J CANCER, V103, P316, DOI 10.1002/ijc.10828; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JEENER J, 1979, J CHEM PHYS, V71, P286; Jerschow A, 1998, J MAGN RESON, V132, P13, DOI 10.1006/jmre.1998.1400; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Menaa C, 2008, KIDNEY INT, V73, P1275, DOI 10.1038/ki.2008.100; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Saikali Zeina, 2003, Anticancer Drugs, V14, P773; Tagliavini F, 2000, J MOL BIOL, V300, P1309, DOI 10.1006/jmbi.2000.3840; Verdone G, 2009, J BIOMOL NMR, V43, P79, DOI 10.1007/s10858-008-9290-y; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2008, CLIN NEPHROL, V70, P496; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	41	77	81	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2121	2131		10.1074/jbc.M110.178376	http://dx.doi.org/10.1074/jbc.M110.178376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068391	hybrid, Green Published			2022-12-27	WOS:000286191500054
J	Haurat, MF; Aduse-Opoku, J; Rangarajan, M; Dorobantu, L; Gray, MR; Curtis, MA; Feldman, MF				Haurat, M. Florencia; Aduse-Opoku, Joseph; Rangarajan, Minnie; Dorobantu, Loredana; Gray, Murray R.; Curtis, Michael A.; Feldman, Mario F.			Selective Sorting of Cargo Proteins into Bacterial Membrane Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS W50; GRAM-NEGATIVE BACTERIA; POLYACRYLAMIDE-GELS; STRUCTURAL-ANALYSIS; VIRULENCE FACTORS; STRAIN W50; LIPOPOLYSACCHARIDE; IDENTIFICATION; ANTIGEN; POLYSACCHARIDE	In contrast to the well established multiple cellular roles of membrane vesicles in eukaryotic cell biology, outer membrane vesicles (OMV) produced via blebbing of prokaryotic membranes have frequently been regarded as cell debris or microscopy artifacts. Increasingly, however, bacterial membrane vesicles are thought to play a role in microbial virulence, although it remains to be determined whether OMV result from a directed process or from passive disintegration of the outer membrane. Here we establish that the human oral pathogen Porphyromonas gingivalis has a mechanism to selectively sort proteins into OMV, resulting in the preferential packaging of virulence factors into OMV and the exclusion of abundant outer membrane proteins from the protein cargo. Furthermore, we show a critical role for lipopolysaccharide in directing this sorting mechanism. The existence of a process to package specific virulence factors into OMV may significantly alter our current understanding of host-pathogen interactions.	[Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dorobantu, Loredana; Gray, Murray R.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2E9, Canada; [Aduse-Opoku, Joseph; Rangarajan, Minnie; Curtis, Michael A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London E1 2AT, England	University of Alberta; University of Alberta; University of London; Queen Mary University London	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Aduse-Opoku, Joseph/CAF-0056-2022; Haurat, M Florencia/ABA-2634-2020; Feldman, Mario/A-2637-2014	Haurat, M Florencia/0000-0001-7569-2783; Feldman, Mario/0000-0003-4497-0976; opoku, anita/0000-0001-7243-8157; Gray, Murray/0000-0003-2431-7312; Curtis, Mike A/0000-0002-1563-9953	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Centre for Carbohydrate Science; Canada Foundation for Innovation; University of Alberta; Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research; Medical Research Council [G0501478]; MRC [G0501478] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Centre for Carbohydrate Science; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Alberta Ingenuity Centre for Carbohydrate Science, the Canada Foundation for Innovation, the University of Alberta, the Alberta Ingenuity Fund, the Alberta Heritage Foundation for Medical Research (to M. F. F.), Medical Research Council Grant G0501478 (to M. A. C.), and the Natural Sciences and Engineering Research Council of Canada (to M. R. G.).	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; CURTIS MA, 1991, ORAL MICROBIOL IMMUN, V6, P321, DOI 10.1111/j.1399-302X.1991.tb00502.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Duncan L, 2004, MICROB PATHOGENESIS, V36, P319, DOI 10.1016/j.micpath.2004.02.004; Ellen AF, 2009, EXTREMOPHILES, V13, P67, DOI 10.1007/s00792-008-0199-x; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hanley SA, 1999, INFECT IMMUN, V67, P1157, DOI 10.1128/IAI.67.3.1157-1171.1999; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kawai F, 2006, GENES GENET SYST, V81, P69, DOI 10.1266/ggs.81.69; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Marolda Cristina L., 2006, V347, P237; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MILLAR DJ, 1993, FEMS IMMUNOL MED MIC, V7, P211, DOI 10.1111/j.1574-695X.1993.tb00401.x; Murakami Y, 2004, MICROBIOL IMMUNOL, V48, P561, DOI 10.1111/j.1348-0421.2004.tb03552.x; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Paramonov N, 2001, EUR J BIOCHEM, V268, P4698, DOI 10.1046/j.1432-1327.2001.02397.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Veith PD, 2001, EUR J BIOCHEM, V268, P4748, DOI 10.1046/j.1432-1327.2001.02399.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i	50	193	198	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1269	1276		10.1074/jbc.M110.185744	http://dx.doi.org/10.1074/jbc.M110.185744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056982	Green Published, hybrid			2022-12-27	WOS:000286005000038
J	Mironova, E; Peti-Peterdi, J; Bugaj, V; Stockand, JD				Mironova, Elena; Peti-Peterdi, Janos; Bugaj, Vladislav; Stockand, James D.			Diminished Paracrine Regulation of the Epithelial Na+ Channel by Purinergic Signaling in Mice Lacking Connexin 30	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT; SODIUM-CHANNEL; APICAL MONOCILIA; TRANSPORT; MECHANISMS; MEMBRANE; NEPHRON; KIDNEY; CELLS; ALDOSTERONE	We tested whether ATP release through Connexin 30 (Cx30) is part of a local purinergic regulatory system intrinsic to the aldosterone-sensitive distal nephron (ASDN) important for proper control of sodium excretion; if changes in sodium intake influence ATP release via Cx30; and if this allows a normal ENaC response to changes in systemic sodium levels. In addition, we define the consequences of disrupting ATP regulation of ENaC in Cx30(-/-) mice. Urinary ATP levels in wildtype mice increase with sodium intake, being lower and less dependent on sodium intake in Cx30(-/-) mice. Loss of inhibitory ATP regulation causes ENaC activity to be greater in Cx30(-/-) versus wild-type mice, particularly with high sodium intake. This results from compromised ATP release rather than end-organ resistance: ENaC in Cx30(-/-) mice responds to exogenous ATP. Thus, loss of paracrine ATP feedback regulation of ENaC in Cx30(-/-) mice disrupts normal responses to changes in sodium intake. Consequently, ENaC is hyperactive in Cx30(-/-) mice lowering sodium excretion particularly during increases in sodium intake. Clamping mineralocorticoids high in Cx30(-/-) mice fed a high sodium diet causes a marked decline in renal sodium excretion. This is not the case in wildtype mice, which are capable of undergoing aldosterone-escape. This loss of the ability of ENaC to respond to changes in sodium levels contributes to salt-sensitive hypertension in Cx30(-/-) mice.	[Mironova, Elena; Bugaj, Vladislav; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Peti-Peterdi, Janos] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Texas System; University of Texas Health San Antonio; University of Southern California	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7756 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01DK59594]; American Heart Association (AHA) [0640054N, 0640056N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594, R01DK064324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK59594 (to J. D. S.) and the American Heart Association (AHA) Established Investigator Awards 0640054N (to J. D. S.) and 0640056N (to J. P. P.).	AUGUST JT, 1958, J CLIN INVEST, V37, P1549, DOI 10.1172/JCI103747; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; MATSUZAKI T, 1992, Heart and Vessels, V7, P1, DOI 10.1007/BF01745861; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Olteanu D, 2006, AM J PHYSIOL-CELL PH, V290, pC952, DOI 10.1152/ajpcell.00339.2005; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; RELMAN AS, 1952, YALE J BIOL MED, V24, P540; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Rieg TM, 2007, FASEB J, V21, pA437; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SAKMANN B, 1983, SINGLE CHANNEL RECOR; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Verrey F, 2000, KIDNEY INT, V57, P1277, DOI 10.1046/j.1523-1755.2000.00962.x	30	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1054	1060		10.1074/jbc.M110.176552	http://dx.doi.org/10.1074/jbc.M110.176552			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075848	Green Published, hybrid			2022-12-27	WOS:000286005000016
J	Sileikyte, J; Petronilli, V; Zulian, A; Dabbeni-Sala, F; Tognon, G; Nikolov, P; Bernardi, P; Ricchelli, F				Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Dabbeni-Sala, Federica; Tognon, Giuseppe; Nikolov, Peter; Bernardi, Paolo; Ricchelli, Fernanda			Regulation of the Inner Membrane Mitochondrial Permeability Transition by the Outer Membrane Translocator Protein (Peripheral Benzodiazepine Receptor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; RAT-BRAIN MITOCHONDRIA; CYTOCHROME-C RELEASE; AUTORADIOGRAPHIC LOCALIZATION; PHOTODYNAMIC-ACTION; PROTOPORPHYRIN-IX; OXIDATIVE STRESS; PORE COMPLEX; CELL-DEATH; 18 KDA	We studied the properties of the permeability transition pore (PTP) in rat liver mitochondria and in mitoplasts retaining inner membrane ultrastructure and energy-linked functions. Like mitochondria, mitoplasts readily underwent a permeability transition following Ca2+ uptake in a process that maintained sensitivity to cyclosporin A. On the other hand, major differences between mitochondria and mitoplasts emerged in PTP regulation by ligands of the outer membrane translocator protein of 18 kDa, TSPO, formerly known as the peripheral benzodiazepine receptor. Indeed, (i) in mitoplasts, the PTP could not be activated by photo-oxidation after treatment with dicarboxylic porphyrins endowed with protoporphyrin IX configuration, which bind TSPO in intact mitochondria; and (ii) mitoplasts became resistant to the PTP-inducing effects of N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide and of other selective ligands of TSPO. Thus, the permeability transition is an inner membrane event that is regulated by the outer membrane through specific interactions with TSPO.	[Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Dabbeni-Sala, Federica] Univ Padua, Dept Pharmacol & Anesthesiol, I-35121 Padua, Italy; [Tognon, Giuseppe; Ricchelli, Fernanda] Univ Padua, Consiglio Nazl Ric Inst Biomed Technol, I-35121 Padua, Italy; [Tognon, Giuseppe; Ricchelli, Fernanda] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Nikolov, Peter] Bulgarian Acad Sci, Inst Organ Chem, Sofia 1000, Bulgaria	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua; University of Padua; Bulgarian Academy of Sciences	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it; rchielli@bio.unipd.it	Petronilli, Valeria/C-3558-2015; Bernardi, Paolo/C-3656-2008	Petronilli, Valeria/0000-0003-4026-6404; Bernardi, Paolo/0000-0001-9187-3736; Sileikyte, Justina/0000-0002-6795-6344	Consiglio Nazionale delle Ricerche; Ministry for University and Research (MIUR/FIRB) [CINECA RBAU01YL5R]; Universita di Padova Progetto Strategico; Fondazione Cariparo, Padova, Italy	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); Ministry for University and Research (MIUR/FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Universita di Padova Progetto Strategico; Fondazione Cariparo, Padova, Italy(Fondazione Cariparo)	This work was supported in part by grants from the Consiglio Nazionale delle Ricerche within the framework of Italy-Bulgaria (BAN) bilateral cooperation, by the Ministry for University and Research (MIUR/FIRB CINECA RBAU01YL5R and PRIN), and the Universita di Padova Progetto Strategico "Models of Mitochondrial Diseases."; Supported by a fellowship from the Fondazione Cariparo, Padova, Italy. Performed this work in partial fulfillment of the requirements for a Ph.D.	ANHOLT RRH, 1985, J PHARMACOL EXP THER, V233, P517; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; BEATRICE MC, 1984, J BIOL CHEM, V259, P1279; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Beutner G, 1996, FEBS LETT, V396, P189, DOI 10.1016/0014-5793(96)01092-7; Castedo M, 2002, J EXP MED, V196, P1121, DOI 10.1084/jem.20021758; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; DESOUZA EB, 1985, ENDOCRINOLOGY, V116, P567, DOI 10.1210/endo-116-2-567; Galiegue S, 2003, CURR MED CHEM, V10, P1563, DOI 10.2174/0929867033457223; GARNIER M, 1994, MOL PHARMACOL, V45, P201; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HIRSCH JD, 1989, MOL PHARMACOL, V35, P164; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Jayakumar AR, 2002, J NEUROCHEM, V83, P1226, DOI 10.1046/j.1471-4159.2002.01261.x; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krueger KE, 1995, BBA-REV BIOMEMBRANES, V1241, P453, DOI 10.1016/0304-4157(95)00016-X; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Li JY, 2007, EUR J PHARMACOL, V560, P117, DOI 10.1016/j.ejphar.2006.12.027; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Moreno G, 2001, ARCH BIOCHEM BIOPHYS, V386, P243, DOI 10.1006/abbi.2000.2200; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Petronilli V, 2009, BBA-BIOENERGETICS, V1787, P897, DOI 10.1016/j.bbabio.2009.03.014; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rao VLR, 1997, EUR J PHARMACOL, V340, P89, DOI 10.1016/S0014-2999(97)01395-2; RICCHELLI F, 1993, PHOTOCHEM PHOTOBIOL, V58, P53, DOI 10.1111/j.1751-1097.1993.tb04903.x; RICCHELLI F, 1995, J PHOTOCH PHOTOBIO B, V29, P109, DOI 10.1016/1011-1344(95)07155-U; Ricchelli F, 1999, BIOCHEMISTRY-US, V38, P9295, DOI 10.1021/bi9900828; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875, DOI 10.1093/oxfordjournals.jbchem.a124790; TOMOV TC, 1986, J BIOCHEM BIOPH METH, V13, P29, DOI 10.1016/0165-022X(86)90005-9; VERMA A, 1988, MOL PHARMACOL, V34, P800; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070	54	87	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1046	1053		10.1074/jbc.M110.172486	http://dx.doi.org/10.1074/jbc.M110.172486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062740	Green Published, hybrid			2022-12-27	WOS:000286005000015
J	Guo, H; Friedman, AD				Guo, Hong; Friedman, Alan D.			Phosphorylation of RUNX1 by Cyclin-dependent Kinase Reduces Direct Interaction with HDAC1 and HDAC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBF-BETA-SMMHC; MYOSIN HEAVY-CHAIN; CELL-CYCLE; ADULT HEMATOPOIESIS; ACUTE-LEUKEMIA; PROLIFERATION; BINDING; ONCOPROTEINS; PROGRESSION; EXPRESSION	RUNX1 regulates formation of the definitive hematopoietic stem cell and its subsequent lineage maturation, and mutations of RUNX1 contribute to leukemic transformation. Phosphorylation of Ser-48, Ser-303, and Ser-424 by cyclin-dependent kinases (cdks) increases RUNX1 trans-activation activity without perturbing p300 interaction. We now find that endogenous RUNX1 interacts with endogenous HDAC1 or HDAC3. Mutation of the three RUNX1 serines to aspartic acid reduces co-immunoprecipitation with HDAC1 or HDAC3 when expressed in 293T cells; mutation of these three serines to alanine increases HDAC interaction, and mutation of each serine individually to aspartic acid also reduces these interactions. GST-RUNX1 isolated from bacterial extracts bound in vitro translated HDAC1 or HDAC3, and these interactions were weakened by mutation of Ser-48, Ser-303, and Ser-424 to aspartic acid. The ability of RUNX1 phosphorylation and not only serine to aspartic acid conversion to reduce HDAC1 binding was demonstrated using wild-type GST-RUNX1 phosphorylated in vitro using cdk1/cyclinB and by exposure of 293T cells transduced with RUNX1 and HDAC1 to roscovitine, a cdk inhibitor. Finally, RUNX1 or RUNX1(tripleD), in which Ser-48, Ser-303, and Ser-424 are mutated to aspartic acid, stimulated proliferation of transduced, lineage-negative murine marrow progenitors more potently than did RUNX1(tripleA), in which these serines are mutated to alanine, suggesting that stimulation of RUNX1 trans-activation by cdk-mediated reduction in HDAC interaction increases marrow progenitor cell proliferation.	[Guo, Hong; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21231 USA	Johns Hopkins University	Friedman, AD (corresponding author), CRB 1 Rm 253,1650 Orleans St, Baltimore, MD 21231 USA.	afriedm2@jhmi.edu			National Institutes of Health [R01CA098805, U01HL099775, U01HL100397]; Maryland Stem Cell Research Foundation; NATIONAL CANCER INSTITUTE [R01CA098805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA098805, U01HL099775, and U01HL100397. This work was also supported by a grant from the Maryland Stem Cell Research Foundation (to A. D. F.).	Bee T, 2009, BLOOD CELL MOL DIS, V43, P35, DOI 10.1016/j.bcmd.2009.03.011; Bernardin F, 2002, CANCER BIOL THER, V1, P492, DOI 10.4161/cbt.1.5.163; Bernardin F, 2002, CANCER RES, V62, P3904; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Burel SA, 2001, MOL CELL BIOL, V21, P5577, DOI 10.1128/MCB.21.16.5577-5590.2001; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; D'Costa J, 2005, LEUKEMIA, V19, P921, DOI 10.1038/sj.leu.2403755; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; FINER MH, 1994, BLOOD, V83, P43; Friedman AD, 1999, LEUKEMIA, V13, P1932, DOI 10.1038/sj.leu.2401590; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Kagoshima H, 2007, DEVELOPMENT, V134, P3905, DOI 10.1242/dev.008276; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Niini T, 2000, HAEMATOLOGICA, V85, P362; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Yang YD, 2002, CANCER RES, V62, P2232; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	33	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					208	215		10.1074/jbc.M110.149013	http://dx.doi.org/10.1074/jbc.M110.149013			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059642	hybrid, Green Published			2022-12-27	WOS:000285782800023
J	Perez-Cadahia, B; Drobic, B; Espino, PS; He, SH; Mandal, S; Healy, S; Davie, JR				Perez-Cadahia, Beatriz; Drobic, Bojan; Espino, Paula S.; He, Shihua; Mandal, Soma; Healy, Shannon; Davie, James R.			Role of MSK1 in the Malignant Phenotype of Ras-transformed Mouse Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED PHOSPHORYLATION; HISTONE H3 PHOSPHORYLATION; CELL-TRANSFORMATION; MITOGEN; CANCER; AP-1; ACTIVATION; KINASE-1; PATHWAY; CYCLOOXYGENASE-2	Activated by the RAS-MAPK signaling pathway, MSK1 is recruited to immediate-early gene (IEG) regulatory regions, where it phosphorylates histone H3 at Ser-10 or Ser-28. Chromatin remodelers and modifiers are then recruited by 14-3-3 proteins, readers of phosphoserine marks, leading to the occupancy of IEG promoters by the initiation-engaged form of RNA polymerase II and the onset of transcription. In this study, we show that this mechanism of IEG induction, initially elucidated in parental 10T1/2 murine fibroblast cells, applies to metastatic Hras1-transformed Ciras-3 cells. As the RAS-MAPK pathway is constitutively activated in Ciras-3 cells, MSK1 activity and phosphorylated H3 steady-state levels are elevated. We found that steady-state levels of the IEG products AP-1 and COX-2 were also elevated in Ciras-3 cells. When MSK1 activity was inhibited or MSK1 expression was knocked down in Ciras-3 cells, the induction of IEG expression and the steady-state levels of COX-2, FRA-1, and JUN were greatly reduced. Furthermore, MSK1 knockdown Ciras-3 cells lost their malignant phenotype, as reflected by the absence of anchorage-independent growth.	[Perez-Cadahia, Beatriz; Drobic, Bojan; Espino, Paula S.; He, Shihua; Mandal, Soma; Healy, Shannon; Davie, James R.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888	Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Manitoba Health Research Council; Canada Research Chair; Canadian Cancer Society Research Institute Terry Fox Foundation	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Cancer Society Research Institute Terry Fox Foundation	This work was supported by grants from the Canadian Cancer Society Research Institute, the Canadian Institutes of Health Research, and the Manitoba Health Research Council and by a Canada Research Chair (to J. R. D.), a Canadian Cancer Society Research Institute Terry Fox Foundation studentship (to B. D.), a Manitoba Health Research Council fellowship (to B. P.-C.), and a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada graduate scholarship (to P. S. E.).	Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BOS JL, 1989, CANCER RES, V49, P4682; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, 2004, CANCER RES, V64, P9076, DOI 10.1158/0008-5472.CAN-04-2369; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2009, GENE CHROMOSOME CANC, V48, P397, DOI 10.1002/gcc.20649; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; EGAN SE, 1987, MOL CELL BIOL, V7, P830, DOI 10.1128/MCB.7.2.830; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Roze E, 2008, FASEB J, V22, P1083, DOI 10.1096/fj.07-9814; Sahin M, 2009, ANGIOLOGY, V60, P242, DOI 10.1177/0003319708318378; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strelkov IS, 2002, CANCER RES, V62, P75; Tange S, 2009, BIOCHEM BIOPH RES CO, V386, P588, DOI 10.1016/j.bbrc.2009.06.082; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002	29	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					42	49		10.1074/jbc.M110.156687	http://dx.doi.org/10.1074/jbc.M110.156687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21071437	hybrid, Green Published			2022-12-27	WOS:000285782800005
J	Barsony, J; Sugimura, Y; Verbalis, JG				Barsony, Julia; Sugimura, Yoshihisa; Verbalis, Joseph G.			Osteoclast Response to Low Extracellular Sodium and the Mechanism of Hyponatremia-induced Bone Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; OXIDATIVE STRESS; RECEPTOR ACTIVATOR; ASCORBIC-ACID; REDOX REGULATION; IN-VIVO; TRANSPORT; RANKL; DIFFERENTIATION; CALCIUM	Our recent animal and human studies revealed that chronic hyponatremia is a previously unrecognized cause of osteoporosis that is associated with increased osteoclast numbers in a rat model of the human disease of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We used cellular and molecular approaches to demonstrate that sustained low extracellular sodium ion concentrations ([Na+]) directly stimulate osteoclastogenesis and resorptive activity and to explore the mechanisms underlying this effect. Assays on murine preosteoclastic RAW 264.7 cells and on primary bone marrow monocytes both indicated that lowering the medium [Na+] dose-dependently increased osteoclast formation and resorptive activity. Low [Na+], rather than low osmolality, triggered these effects. Chronic reduction of [Na+] dose-dependently decreased intracellular calcium without depleting endoplasmic reticulum calcium stores. Moreover, we found that reduction of [Na+] dose-dependently decreased cellular uptake of radiolabeled ascorbic acid, and reduction of ascorbic acid in the culture medium mimicked the osteoclastogenic effect of low [Na+]. We also detected downstream effects of reduced ascorbic acid uptake, namely evidence of hyponatremia-induced oxidative stress. This was manifested by increased intracellular free oxygen radical accumulation and proportional changes in protein expression and phosphorylation, as indicated by Western blot analysis from cellular extracts and by increased serum 8-hydroxy-2'-deoxyguanosine levels in vivo in rats. Our results therefore reveal novel sodium signaling mechanisms in osteoclasts that may serve to mobilize sodium from bone stores during prolonged hyponatremia, thereby leading to a resorptive osteoporosis in patients with SIADH.	[Barsony, Julia; Sugimura, Yoshihisa; Verbalis, Joseph G.] Georgetown Univ, Div Endocrinol & Metab, Washington, DC 20007 USA	Georgetown University	Barsony, J (corresponding author), Georgetown Univ, Div Endocrinol & Metab, 4000 Reservoir Rd NW,D-233, Washington, DC 20007 USA.	jb394@georgetown.edu	Sugimura, Yoshihisa/Q-8716-2019		National Institutes of Health [Z01-DK060050, R01-AG029477]; Yamanouchi Pharma America (Paramus, NJ); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yamanouchi Pharma America (Paramus, NJ); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01-DK060050 and Extramural Grant R01-AG029477. This work was also supported by a research grant from Yamanouchi Pharma America (Paramus, NJ).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BERGSTROM WH, 1954, J CLIN INVEST, V33, P867, DOI 10.1172/JCI102959; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Blair HC, 2006, REV ENDOCR METAB DIS, V7, P23, DOI 10.1007/s11154-006-9010-4; CHRISTENSEN O, 1987, NATURE, V330, P66, DOI 10.1038/330066a0; DATTA HK, 1990, BIOCHEM BIOPH RES CO, V167, P183, DOI 10.1016/0006-291X(90)91748-H; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; FRANCESCHI RT, 1995, AM J PHYSIOL-CELL PH, V268, pC1430, DOI 10.1152/ajpcell.1995.268.6.C1430; Gupta A, 1997, J CLIN INVEST, V100, P538, DOI 10.1172/JCI119563; Huber DM, 2001, ENDOCRINOLOGY, V142, P3800, DOI 10.1210/en.142.9.3800; KELLY MEM, 1994, J PHYSIOL-LONDON, V475, P377, DOI 10.1113/jphysiol.1994.sp020079; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Kim HJ, 2006, FREE RADICAL BIO MED, V40, P1483, DOI 10.1016/j.freeradbiomed.2005.10.066; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Komarova SV, 2001, CURR PHARM DESIGN, V7, P637, DOI 10.2174/1381612013397799; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li JP, 2007, ENDOCRINOLOGY, V148, P2116, DOI 10.1210/en.2006-1321; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; PERKINS SL, 1994, BONE, V15, P65, DOI 10.1016/8756-3282(94)90893-1; Perry SF, 2006, J EXP BIOL, V209, P4591, DOI 10.1242/jeb.02558; Riihonen R, 2010, MATRIX BIOL, V29, P287, DOI 10.1016/j.matbio.2010.01.003; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakuta Koichi, 2002, Osaka City Medical Journal, V48, P29; Sandhu HS, 2009, INT UROL NEPHROL, V41, P733, DOI 10.1007/s11255-009-9585-2; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Seeliger E, 2006, AM J PHYSIOL-REG I, V290, pR1429, DOI 10.1152/ajpregu.00676.2005; Sharif-Naeini R, 2008, KIDNEY INT, V73, P811, DOI 10.1038/sj.ki.5002788; SHIOI A, 1994, CALCIFIED TISSUE INT, V55, P387, DOI 10.1007/BF00299320; Shui C, 2002, CALCIFIED TISSUE INT, V71, P437, DOI 10.1007/s00223-001-1138-3; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Skerry T. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P166; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Tsuzuki T, 2000, JPN J PHYSIOL, V50, P67, DOI 10.2170/jjphysiol.50.67; Verbalis JG, 2007, J AM SOC NEPHROL, V18, P3056, DOI 10.1681/ASN.2007070825; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211; Xu Y, 2010, ANTIOXID REDOX SIGN, V13, P27, DOI 10.1089/ars.2009.2886; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Zhang Y, 2005, APOPTOSIS, V10, P545, DOI 10.1007/s10495-005-1885-0	51	123	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10864	10875		10.1074/jbc.M110.155002	http://dx.doi.org/10.1074/jbc.M110.155002			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21135109	Green Published, hybrid			2022-12-27	WOS:000288547000100
J	Qiu, Y; Stavreva, DA; Luo, Y; Indrawan, A; Chang, MR; Hager, GL				Qiu, Yi; Stavreva, Diana A.; Luo, Yi; Indrawan, Anindya; Chang, Myron; Hager, Gordon L.			Dynamic Interaction of HDAC1 with a Glucocorticoid Receptor-regulated Gene Is Modulated by the Activity State of the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; CHROMATIN DYNAMICS; TRANSCRIPTION; TRAFFICKING; INHIBITION; EXCHANGE; ALPHA	Although histone deacetylases (HDACs) are normally considered as co-repressors, HDAC1 has been identified as a coactivator for the glucocorticoid receptor (GR) (Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., Adkins, N. L., Stavreva, D. A., Wiench, M., Georgel, P. T., Schiltz, R. L., and Hager, G. L. (2006) Mol. Cell 22, 669-679). Furthermore, HDAC1 is acetylated, and its acetylation level is linked to the transcription state of a GR-induced promoter (mouse mammary tumor virus). GR is also known to interact dynamically with regulatory elements in living cells (McNally, J. G., Muller, W. G., Walker, D., Wolford, R., and Hager, G. L. (2000) Science 287, 1262-1265). However, HDAC1 dynamics have never been studied. We demonstrate here that HDAC1 also exchanges rapidly with promoter chromatin, and its exchange rate is significantly modulated during the development of promoter activity. Prior to induction, HDAC1 mobility was retarded compared with the exchange rate for GR. HDAC1 mobility then increased substantially, coordinately with the peak of promoter activity. At later time points, promoter activity was severely repressed, and HDAC1 mobility returned to the rate of exchange observed for the uninduced promoter. Thus, alterations of the exchange rates of HDAC1 at the promoter are correlated with the activity state of the promoter. These findings provide direct evidence for the functional role of highly mobile transcription factor complexes in transcription regulation.	[Qiu, Yi; Luo, Yi] Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Chang, Myron] Univ Florida, Dept Epidemiol & Hlth Policy Res, Div Biostat, Gainesville, FL 32610 USA; [Stavreva, Diana A.; Indrawan, Anindya; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hager, GL (corresponding author), Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Rm 356,2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu; hagerg@exchange.nih.gov	Stavreva, Diana/AAW-8964-2020	, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674-01]; Bankhead-Coley Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC005450, ZIABC010027] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and Grant R01 HL095674-01 (to Y. Q.). This work was also supported by the Bankhead-Coley Research Foundation (to Y. Q.).	Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874	27	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7641	7647		10.1074/jbc.M110.185488	http://dx.doi.org/10.1074/jbc.M110.185488			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21127047	Green Published, hybrid			2022-12-27	WOS:000287737300077
J	Guerrero, F; Sedoud, A; Kirilovsky, D; Rutherford, AW; Ortega, JM; Roncel, M				Guerrero, Fernando; Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William; Ortega, Jose M.; Roncel, Mercedes			A High Redox Potential Form of Cytochrome c(550) in Photosystem II from Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; OXYGEN EVOLUTION; C-TYPE; GENE; MANGANESE; COMPLEX; BINDING; PHOTOACTIVATION; CYANOBACTERIA; RESOLUTION	Cytochrome c(550) (cyt c(550)) is a component of photosystem II (PSII) from cyanobacteria, red algae, and some other eukaryotic algae. Its physiological role remains unclear. In the present work, measurements of the midpoint redox potential (E-m) were performed using intact PSII core complexes preparations from a histidine-tagged PSII mutant strain of the thermophilic cyanobacterium Thermosynechococcus (T.) elongatus. When redox titrations were done in the absence of redox mediators, an E-m value of +200 mV was obtained for cyt c(550). This value is similar to 300 mV more positive than that previously measured in the presence of mediators (E-m = -80 mV). The shift from the high potential form (E-m = +200 mV) to the low potential form (E-m = -80 mV) of cyt c(550) is attributed to conformational changes, triggered by the reduction of a component of PSII that is sequestered and out of equilibrium with the medium, most likely the Mn4Ca cluster. This reduction can occur when reduced low potential redox mediators are present or under highly reducing conditions even in the absence of mediators. Based on these observations, it is suggested that the E-m of +200 mV obtained without mediators could be the physiological redox potential of the cyt c(550) in PSII. This value opens the possibility of a redox function for cyt c(550) in PSII.	[Roncel, Mercedes] Univ Seville, Inst Bioquim Vegetal & Fotosintesis, CSIC, Seville 41092, Spain; [Guerrero, Fernando; Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William] Commissariat Energie Atom, Inst Biol & Technol Saclay iBiTec S, F-91191 Gif Sur Yvette, France; [Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William] Ctr Natl Rech Sci, URA 2096, F-91191 Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Roncel, M (corresponding author), Univ Seville, Inst Bioquim Vegetal & Fotosintesis, CSIC, Americo Vespucio 49, Seville 41092, Spain.	mroncel@us.es	RONCEL, MERCEDES/G-3035-2015; Rutherford, Alfred W/A-7831-2019; Ortega, José María/O-7697-2014; Kirilovsky, Diana/I-2359-2014	RONCEL, MERCEDES/0000-0001-8749-7432; Rutherford, Alfred W/0000-0002-3124-154X; Ortega, José María/0000-0002-7841-3687; Kirilovsky, Diana/0000-0003-2146-3103; Guerrero, Fernando/0000-0003-2215-3115	Ministry of Education and Culture of Spain [BFU2007-68107-C02-01/BMC]; Andalusia Government [PAI CVI-261]; EU/Energy Network [212508]	Ministry of Education and Culture of Spain(Spanish Government); Andalusia Government; EU/Energy Network(European Commission)	This work was supported by grants from the Ministry of Education and Culture of Spain (BFU2007-68107-C02-01/BMC, cofinanced by FEDER), and Andalusia Government (PAI CVI-261) and the EU/Energy Network project SOLAR-H2 (FP7 Contract 212508).	ALAM J, 1984, BIOCHIM BIOPHYS ACTA, V766, P317, DOI 10.1016/0005-2728(84)90247-0; Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CHENIAE GM, 1972, PLANT PHYSIOL, V50, P87, DOI 10.1104/pp.50.1.87; Clark W. M., 1960, OXIDATION REDUCTION; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Dutton P L, 1978, Methods Enzymol, V54, P411; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frazao C, 2001, J BIOL INORG CHEM, V6, P324, DOI 10.1007/s007750100208; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOGANSON CW, 1990, BIOCHIM BIOPHYS ACTA, V1016, P203, DOI 10.1016/0005-2728(90)90059-D; HOGANSON CW, 1991, BIOCHIM BIOPHYS ACTA, V1057, P399, DOI 10.1016/S0005-2728(05)80154-9; HOLTON RW, 1963, SCIENCE, V142, P234, DOI 10.1126/science.142.3589.234; Ishikita H, 2005, FEBS LETT, V579, P3190, DOI 10.1016/j.febslet.2005.05.004; JOHNSON GN, 1995, BBA-BIOENERGETICS, V1229, P202, DOI 10.1016/0005-2728(95)00003-2; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; KANG C, 1994, FEBS LETT, V344, P5, DOI 10.1016/0014-5793(94)00341-6; KASSNER RJ, 1972, P NATL ACAD SCI USA, V69, P2263, DOI 10.1073/pnas.69.8.2263; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P599, DOI 10.1093/pcp/pce074; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; KIENZL PF, 1983, FEBS LETT, V162, P76, DOI 10.1016/0014-5793(83)81052-7; Kirilovsky D, 2004, J BIOL CHEM, V279, P52869, DOI 10.1074/jbc.M408206200; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; KROGMANN DW, 1991, BIOCHIM BIOPHYS ACTA, V1058, P35, DOI 10.1016/S0005-2728(05)80264-6; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MEI R, 1991, BIOCHEMISTRY-US, V30, P7836, DOI 10.1021/bi00245a025; MIYAO M, 1991, BIOCHEMISTRY-US, V30, P5379, DOI 10.1021/bi00236a008; Morand L.Z., 1994, MOL BIOL CYANOBACTER, P381; Moser CC, 2005, PHOTOCH PHOTOBIO SCI, V4, P933, DOI 10.1039/b507352a; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; NAVARRO JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P46, DOI 10.1006/abbi.1995.1202; NISHIYAMA Y, 1994, PLANT PHYSIOL, V105, P1313, DOI 10.1104/pp.105.4.1313; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; Sawaya MR, 2001, BIOCHEMISTRY-US, V40, P9215, DOI 10.1021/bi002679p; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; TAMURA N, 1985, BIOCHIM BIOPHYS ACTA, V809, P245, DOI 10.1016/0005-2728(85)90068-4; Vrettos JS, 2001, J BIOL INORG CHEM, V6, P708, DOI 10.1007/s007750100249; Wilson G S, 1978, Methods Enzymol, V54, P396; Wirtz M, 2000, FARADAY DISCUSS, V116, P221, DOI 10.1039/b001520m; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	45	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5985	5994		10.1074/jbc.M110.170126	http://dx.doi.org/10.1074/jbc.M110.170126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135104	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000287476400006
J	Chetrit, D; Barzilay, L; Horn, G; Bielik, T; Smorodinsky, NI; Ehrlich, M				Chetrit, David; Barzilay, Lior; Horn, Galit; Bielik, Tom; Smorodinsky, Nechama I.; Ehrlich, Marcelo			Negative Regulation of the Endocytic Adaptor Disabled-2 (Dab2) in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MYOSIN-VI; COATED PITS; MITOTIC PHOSPHORYLATION; MICROTUBULE DYNAMICS; PROTEIN; BINDING; MEMBRANE; CELLS; CARGO	Mitotic cells undergo extensive changes in shape and size through the altered regulation and function of their membrane trafficking machinery. Disabled 2 (Dab2), a multidomain cargo-specific endocytic adaptor and a mediator of signal transduction, is a potential integrator of trafficking and signaling. Dab2 binds effectors of signaling and trafficking that localize to different intracellular compartments. Thus, differential localization is a putative regulatory mechanism of Dab2 function. Furthermore, Dab2 is phosphorylated in mitosis and is thus regulated in the cell cycle. However, a detailed description of the intracellular localization of Dab2 in the different phases of mitosis and an understanding of the functional consequences of its phosphorylation are lacking. Here, we show that Dab2 is progressively displaced from the membrane in mitosis. This phenomenon is paralleled by a loss of co-localization with clathrin. Both phenomena culminate in metaphase/anaphase and undergo partial recovery in cytokinesis. Treatment with 2-methoxyestradiol, which arrests cells at the spindle assembly checkpoint, induces the same effects observed in metaphase cells. Moreover, 2-methoxyestradiol also induced Dab2 phosphorylation and reduced Dab2/clathrin interactions, endocytic vesicle motility, clathrin exchange dynamics, and the internalization of a receptor endowed with an NPXY endocytic signal. Serine/threonine to alanine mutations, of residues localized to the central region of Dab2, attenuated its phosphorylation, reduced its membrane displacement, and maintained its endocytic abilities in mitosis. We propose that the negative regulation of Dab2 is part of an accommodation of the cell to the altered physicochemical conditions prevalent in mitosis, aimed at allowing endocytic activity throughout the cell cycle.	[Ehrlich, Marcelo] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Horn, Galit; Bielik, Tom; Smorodinsky, Nechama I.] Tel Aviv Univ, Alec & Myra Marmot Hybridoma Unit, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation [1122/06]	Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israel Science Foundation Grant 1122/06.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Attalla H, 1996, BIOCHEM BIOPH RES CO, V228, P467, DOI 10.1006/bbrc.1996.1683; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borlido J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003115; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; Cho SY, 2000, BIOCHEM J, V352, P645, DOI 10.1042/0264-6021:3520645; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huang CH, 2007, CELL SIGNAL, V19, P1339, DOI 10.1016/j.cellsig.2007.01.019; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; JORDAN MA, 1992, J CELL SCI, V102, P401; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Karam JA, 2007, CLIN CANCER RES, V13, P4400, DOI 10.1158/1078-0432.CCR-07-0287; Kariya K, 2000, J BIOL CHEM, V275, P18399, DOI 10.1074/jbc.M000521200; KEYDAR I, 1989, P NATL ACAD SCI USA, V86, P1362, DOI 10.1073/pnas.86.4.1362; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kowanetz K, 2003, FEBS LETT, V554, P81, DOI 10.1016/S0014-5793(03)01111-6; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Moskowitz HS, 2005, MOL BIOL CELL, V16, P1769, DOI 10.1091/mbc.E04-08-0739; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Pribluda VS, 2000, CANCER METAST REV, V19, P173, DOI 10.1023/A:1026543018478; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; PYPAERT M, 1987, EUR J CELL BIOL, V45, P23; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Xu XX, 1998, ONCOGENE, V16, P1561, DOI 10.1038/sj.onc.1201678; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	73	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5392	5403		10.1074/jbc.M110.161851	http://dx.doi.org/10.1074/jbc.M110.161851			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21097498	Green Published, hybrid			2022-12-27	WOS:000287230600048
J	Van Itallie, CM; Mitic, LL; Anderson, JM				Van Itallie, Christina M.; Mitic, Laura L.; Anderson, James M.			Claudin-2 Forms Homodimers and Is a Component of a High Molecular Weight Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; TIGHT-JUNCTION LOCALIZATION; BIOCHEMICAL-CHARACTERIZATION; PLASMA-MEMBRANE; OCCLUDIN; BARRIER; PALMITOYLATION; SOLUBILIZATION; PERMEABILITY; TRICELLULIN	Tight junctions are multiprotein complexes that form the fundamental physiologic and anatomic barrier between epithelial and endothelial cells, yet little information is available about their molecular organization. To begin to understand how the transmembrane proteins of the tight junction are organized into multiprotein complexes, we used blue native-PAGE (BN-PAGE) and cross-linking techniques to identify complexes extracted from MDCK II cells and mouse liver. In nonionic detergent extracts from MDCK II cells, the tight junction integral membrane protein claudin-2 was preferentially isolated as a homodimer, whereas claudin-4 was monomeric. Analysis of the interactions between chimeras of claudin-2 and -4 are consistent with the transmembrane domains of claudin-2 being responsible for dimerization, and mutational analysis followed by cross-linking indicated that the second transmembrane domains were arranged in close proximity in homodimers. BN-PAGE of mouse liver membrane identified a relatively discrete high molecular weight complex containing at least claudin-1, claudin-2, and occludin; the difference in the protein complex sizes between cultured cells and tissues may reflect differences in tight junction protein or lipid composition or post-translational modifications. Our results suggest that BN-PAGE may be a useful tool in understanding tight junction structure.	Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Mitic, Laura L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill	Van Itallie, CM (corresponding author), NHLBI, NIH, Bldg 50,Rm 4530, Bethesda, MD 20892 USA.	Christina.VanItallie@nih.gov		Anderson, James/0000-0003-2765-7996	National Institutes of Health [RO1 DK45134]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK45134.	Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Azem A, 2010, BBA-PROTEINS PROTEOM, V1804, P768, DOI 10.1016/j.bbapap.2009.11.024; Babusiak M, 2007, PROTEOMICS, V7, P121, DOI 10.1002/pmic.200600382; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; BOONE CW, 1969, J CELL BIOL, V41, P378, DOI 10.1083/jcb.41.2.378; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kiss A, 2008, MOL BIOL CELL, V19, P4042, DOI 10.1091/mbc.E08-04-0394; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mrsny RJ, 2008, AM J PATHOL, V172, P905, DOI 10.2353/ajpath.2008.070698; PAYNE JW, 1973, BIOCHEM J, V135, P867, DOI 10.1042/bj1350867; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; STEVENSON BR, 1984, J CELL BIOL, V98, P1209, DOI 10.1083/jcb.98.4.1209; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275	44	61	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3442	3450		10.1074/jbc.M110.195578	http://dx.doi.org/10.1074/jbc.M110.195578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098027	Green Published, hybrid			2022-12-27	WOS:000286653200030
J	Bertoni, A; Giuliano, P; Galgani, M; Rotoli, D; Ulianich, L; Adornetto, A; Santillo, MR; Porcellini, A; Avvedimento, VE				Bertoni, Alessandra; Giuliano, Paola; Galgani, Mario; Rotoli, Deborah; Ulianich, Luca; Adornetto, Annagrazia; Santillo, Maria Rosaria; Porcellini, Antonio; Avvedimento, Vittorio Enrico			Early and Late Events Induced by PolyQ-expanded Proteins IDENTIFICATION OF A COMMON PATHOGENIC PROPERTY OF POLYQ-EXPANDED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIPID RAFTS; NEUROBLASTOMA-CELLS; NADPH OXIDASES; NOX FAMILY; HUNTINGTIN; TRANSCRIPTION; PROTEASOME; SYSTEM; ROS	To find a common pathogenetic trait induced by polyQ-expanded proteins, we have used a conditional expression system in PC12 cells to tune the expression of these proteins and analyze the early and late consequences of their expression. We find that expression for 3 h of a polyQ-expanded protein stimulates cellular reactive oxygen species (ROS) levels and significantly reduces the mitochondrial electrochemical gradient. 24-36 h later, ROS induce DNA damage and activation of the checkpoint kinase, ATM. DNA damage signatures are reversible and persist as long as polyQ-expanded proteins are expressed. Transcription of neural and stress response genes is down-regulated in these cells. Selective inhibition of ATM or histone deacetylase rescues transcription and restores the expression of silenced genes. Eventually, after 1 week, the expression of polyQ-expanded protein also induces endoplasmic reticulum stress. As to the primary mechanism responsible for ROS generation, we find that polyQ-expanded proteins, including native Ataxin-2 and Huntingtin, are selectively sequestered in the lipid raft membrane compartment and interact with gp91, the membrane NADPH-oxidase subunit. Selective inhibition of NADPH oxidase or silencing of H-Ras signaling dissolves the aggregates and eliminates DNA damage. We suggest that targeting of the polyQ-expanded proteins to the lipid rafts activates the resident NADPH oxidase. This triggers a signal linking H-Ras, ROS, and ERK1/2 that maintains and propagates the ROS wave to the nucleus. This mechanism may represent the common pathogenetic signature of all polyQ-expanded proteins independently of the specific context or the function of the native wild type protein.	[Avvedimento, Vittorio Enrico] Univ Naples Federico II, Sch Med, Dept Mol & Cellular Biol & Pathol, I-80131 Naples, Italy; [Rotoli, Deborah; Ulianich, Luca] CNR, Inst Endocrinol & Expt Oncol, I-80125 Naples, Italy; [Adornetto, Annagrazia; Santillo, Maria Rosaria] Univ Naples Federico II, Sch Med, Physiol Unit, Dept Neurosci, I-80131 Naples, Italy; [Porcellini, Antonio] Univ Molise, Dept Hlth Sci, I-86100 Campobasso, Italy; [Porcellini, Antonio] Univ Naples Federico II, Dept Struct & Funct Biol, I-80126 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Molise; University of Naples Federico II	Porcellini, A (corresponding author), Univ Campobasso, Dept Hlth Sci, Via De Sanctis, I-86100 Campobasso, Italy.	Antonio.Porcellini@unimol.it; avvedim@unina.it	Rotoli, Deborah/AAB-3237-2022; Ulianich, Luca/ABD-2530-2020; Porcellini, Antonio/E-1900-2011; Porcellini, Antonio/AAC-6097-2019; Galgani, Mario/AAC-3298-2022; Adornetto, Annagrazia/AAG-5467-2020	Rotoli, Deborah/0000-0001-9760-4211; Porcellini, Antonio/0000-0001-6882-9518; Adornetto, Annagrazia/0000-0003-1869-2642; Galgani, Mario/0000-0001-8414-1676	Associazione Italiana per la Ricerca sul Cancro and CariVerona	Associazione Italiana per la Ricerca sul Cancro and CariVerona(Fondazione AIRC per la ricerca sul cancro)	This work supported in part by Associazione Italiana per la Ricerca sul Cancro and CariVerona.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Calabresi P, 1998, ANN NEUROL, V43, P586, DOI 10.1002/ana.410430506; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Guo C, 2007, CELL SIGNAL, V19, P504, DOI 10.1016/j.cellsig.2006.08.001; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hsiao HY, 2010, MOL NEUROBIOL, V41, P248, DOI 10.1007/s12035-009-8097-5; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Reiner A, 2003, MOL NEUROBIOL, V28, P259, DOI 10.1385/MN:28:3:259; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Sim S, 2005, J IMMUNOL, V174, P4279, DOI 10.4049/jimmunol.174.7.4279; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829	53	52	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4727	4741		10.1074/jbc.M110.156521	http://dx.doi.org/10.1074/jbc.M110.156521			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115499	Green Published, hybrid			2022-12-27	WOS:000286975700071
J	Liu, B; Moloney, A; Meehan, S; Morris, K; Thomas, SE; Serpell, LC; Hider, R; Marciniak, SJ; Lomas, DA; Crowther, DC				Liu, Beinan; Moloney, Aileen; Meehan, Sarah; Morris, Kyle; Thomas, Sally E.; Serpell, Louise C.; Hider, Robert; Marciniak, Stefan J.; Lomas, David A.; Crowther, Damian C.			Iron Promotes the Toxicity of Amyloid beta Peptide by Impeding Its Ordered Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; DROSOPHILA MODEL; BINDING; CHEMISTRY; METALS; COPPER; DAMAGE; IONS	We have previously shown that overexpressing subunits of the iron-binding protein ferritin can rescue the toxicity of the amyloid beta (A beta) peptide in our Drosophila model system. These data point to an important pathogenic role for iron in Alzheimer disease. In this study, we have used an iron-selective chelating compound and RNAi-mediated knockdown of endogenous ferritin to further manipulate iron in the brain. We confirm that chelation of iron protects the fly from the harmful effects of A beta. To understand the pathogenic mechanisms, we have used biophysical techniques to see how iron affects A beta aggregation. We find that iron slows the progression of the A beta peptide from an unstructured conformation to the ordered cross-beta fibrils that are characteristic of amyloid. Finally, using mammalian cell culture systems, we have shown that iron specifically enhances A beta toxicity but only if the metal is present throughout the aggregation process. These data support the hypothesis that iron delays the formation of well ordered aggregates of A beta and so promotes its toxicity in Alzheimer disease.	[Liu, Beinan; Moloney, Aileen; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Marciniak, Stefan J.; Lomas, David A.; Crowther, Damian C.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Meehan, Sarah] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Morris, Kyle; Serpell, Louise C.] Univ Sussex, Dept Biochem, Sch Life Sci, Falmer BN1 6PD, Sussex, England; [Hider, Robert] Kings Coll London, Dept Biol Chem, Pharmaceut Sci Res Div, London WC2R 2LS, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Sussex; University of London; King's College London	Crowther, DC (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	dcc26@cam.ac.uk	Marciniak, Stefan J/F-1855-2010	Hider, Robert/0000-0003-1330-5797; Serpell, Louise/0000-0001-9335-7751; Morris, Kyle L/0000-0002-1717-8134; Marciniak, Stefan/0000-0001-8472-7183	MRC (UK); Engineering and Physical Sciences Research Council (EPSRC) (UK); Diabetes UK; Alzheimers Research UK [ART-ESG2010-3, ART-SRF2010-2, ART-PhD2006-5] Funding Source: researchfish; Medical Research Council [G0601840, G0901786, MC_G1000734, G0700990] Funding Source: researchfish; MRC [G0601840, G0700990, MC_G1000734, G0901786] Funding Source: UKRI	MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC) (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diabetes UK(Diabetes UK); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the MRC (UK), Engineering and Physical Sciences Research Council (EPSRC) (UK), and Diabetes UK.	Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Makin O. Sumner, 2004, V299, P67; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wan L., 2010, FREE RADIC IN PRESS; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101	33	148	156	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4248	4256		10.1074/jbc.M110.158980	http://dx.doi.org/10.1074/jbc.M110.158980			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147772	Green Published, hybrid			2022-12-27	WOS:000286975700023
J	Bot, N; Schweizer, C; Ben Halima, S; Fraering, PC				Bot, Nathalie; Schweizer, Claude; Ben Halima, Saoussen; Fraering, Patrick C.			Processing of the Synaptic Cell Adhesion Molecule Neurexin-3 beta by Alzheimer Disease alpha- and gamma-Secretases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; PRESENILIN/GAMMA-SECRETASE; NEURITE OUTGROWTH; MEDIATED CLEAVAGE; NEUROLIGIN; BACE1; MUTATIONS; RECEPTOR; SYNAPSES	Neurexins (NRXNs) are synaptic cell adhesion molecules having essential roles in the assembly and maturation of synapses into fully functional units. Immunocytochemical and electrophysiological studies have shown that specific binding across the synaptic cleft of the ectodomains of presynaptic NRXNs and postsynaptic neuroligins have the potential to bi-directionally coordinate and trigger synapse formation. Moreover, in vivo studies as well as genome-wide association studies pointed out implication of NRXNs in the pathogenesis of cognitive disorders including autism spectrum disorders and different types of addictions including opioid and alcohol dependences, suggesting an important role in synaptic function. Despite extensive investigations, the mechanisms by which NRXNs modulate the properties of synapses remain largely unknown. We report here that alpha- and gamma-secretases can sequentially process NRXN3 beta, leading to the formation of two final products, an similar to 80-kDa N-terminal extracellular domain of Neurexin-3 beta (sNRXN3 beta) and an similar to 12-kDa C-terminal intracellular NRXN3 beta domain (NRXN3 beta-ICD), both of them being potentially implicated in the regulation of NRXNs and neuroligins functions at the synapses or in yet unidentified signal transduction pathways. We further report that this processing is altered by several PS1 mutations in the catalytic subunit of the gamma-secretase that cause early-onset familial Alzheimer disease.	[Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Stn 15, Lab Mol & Cellular Biol Alzheimer Dis, Brain Mind Inst,Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Stn 15, Lab Mol & Cellular Biol Alzheimer Dis, Brain Mind Inst,Sch Life Sci, CH-1015 Lausanne, Switzerland.	patrick.fraering@epfl.ch		Fraering, Patrick/0000-0002-5841-5327	Swiss National Foundation [310000-116652/1]; National Center for Competence in Research; Strauss foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Center for Competence in Research; Strauss foundation	This work was supported by Swiss National Foundation Grant 310000-116652/1 (to P. C. F. and L. Aeschbach) and the National Center for Competence in Research ("Neuronal Plasticity and Repair" (to P. C. F.)) and the Strauss foundation (to P. C. F. and C. S.).	Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hata Y, 1996, J NEUROSCI, V16, P2488; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Miller RK, 2009, MOL BIOL CELL, V20, P3608, DOI 10.1091/mbc.E09-03-0208; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang CB, 2010, ACTA CRYSTALLOGR E, V66, pO1047, DOI 10.1107/S1600536810012535	65	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2762	2773		10.1074/jbc.M110.142521	http://dx.doi.org/10.1074/jbc.M110.142521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084300	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000286464300042
J	Hoshino, D; Koshikawa, N; Seiki, M				Hoshino, Daisuke; Koshikawa, Naohiko; Seiki, Motoharu			A p27(kip1)-binding Protein, p27RF-Rho, Promotes Cancer Metastasis via Activation of RhoA and RhoC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTIONS; CELL-MIGRATION; BREAST-CANCER; INVASION; INHIBITION; PHOSPHORYLATION; MOTILITY; GTPASES; IDENTIFICATION; TRANSFORMATION	Rho family proteins regulate multiple cellular functions including motility and invasion through regulation of the actin cytoskeleton and gene expression. Activation of Rho proteins is controlled precisely by multiple regulators in a spatiotemporal manner. RhoA and/or RhoC are key players that regulate the metastatic activity of malignant tumor cells, and it is therefore of particular interest to understand how activation of these Rho proteins is controlled. We recently identified an upstream regulator of RhoA activation, p27RF-Rho (p27(kip1) releasing factor from RhoA) that acts by freeing RhoA from inhibition by p27(kip1). p27(kip1) is a cell cycle regulator when it is localized to the nucleus, but it binds RhoA and inhibits activation of the latter when it is localized to the cytoplasm. Here, we show that a metastatic variant of mouse melanoma B16 cells (F10) exhibits greater expression of p27RF-Rho, RhoA, and RhoC than the nonmetastatic parental cells (F0). Injection of F10 cells into mouse tail vein resulted in the formation of metastatic lung colonies, whereas prior knockdown of expression of either one of the three proteins using specific shRNA sequences decreased metastasis markedly. p27RF-Rho regulated the activation of RhoA and RhoC and thereby modulated cellular adhesion and motility, in addition to pericellullar proteolysis. The Rho activities enhanced by p27RF-Rho had a marked effect upon efficiency of lodging of F10 cells in the lung, which represents an early step of metastasis. p27RF-Rho also regulated metastasis of human melanoma and fibrosarcoma cells. Thus, p27RF-Rho is a key upstream regulator of RhoA and RhoC that controls spreading of tumor cells.	[Hoshino, Daisuke; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Minato Ku, Div Canc Cell Res, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Div Canc Cell Res, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Specific Coordination Fund for Promoting Science (to D. H.) and by a Grant-in-Aid for Scientific Research on Priority Areas, "Integrative Research toward the Conquest of Cancer," from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. S.).	Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Berton S, 2009, MOL CELL BIOL, V29, P5031, DOI 10.1128/MCB.00144-09; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Guillaumot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010977; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wu SD, 2009, MOL CELL, V35, P735, DOI 10.1016/j.molcel.2009.09.012; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001	40	23	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3139	3148		10.1074/jbc.M110.159715	http://dx.doi.org/10.1074/jbc.M110.159715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087931	Green Published, hybrid			2022-12-27	WOS:000286464300075
J	Homma, K; Dallos, P				Homma, Kazuaki; Dallos, Peter			Evidence That Prestin Has at Least Two Voltage-dependent Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; MOTOR PROTEIN PRESTIN; GUINEA-PIG COCHLEA; MEMBRANE CAPACITANCE; ANION-EXCHANGERS; GATING CHARGE; MOTILITY; ELECTROMOTILITY; SALICYLATE; TRANSPORT	Prestin is a voltage-dependent membrane-spanning motor protein that confers electromotility on mammalian cochlear outer hair cells, which is essential for normal hearing of mammals. Voltage-induced charge movement in the prestin molecule is converted into mechanical work; however, little is known about the molecular mechanism of this process. For understanding the electromechanical coupling mechanism of prestin, we simultaneously measured voltage-dependent charge movement and electromotility under conditions in which the magnitudes of both charge movement and electromotility are gradually manipulated by the prestin inhibitor, salicylate. We show that the observed relationships of the charge movement and the physical displacement (q-d relations) are well represented by a three-state Boltzmann model but not by a two-state model or its previously proposed variant. Here, we suggest a molecular mechanism of prestin with at least two voltage-dependent conformational transition steps having distinct electromechanical coupling efficiencies.	Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL 60208 USA; [Dallos, Peter] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Homma, K (corresponding author), 2240 Campus Dr, Evanston, IL 60208 USA.	k-homma@northwestern.edu	Dallos, Peter/Q-9360-2019	Dallos, Peter/0000-0002-9731-6591	National Institutes of Health [DC00089]; Hugh Knowles Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugh Knowles Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC00089 (to P. D.). This work was also supported by the Hugh Knowles Center.	Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; ASHMORE JF, 1990, NEUROSCI RES       S, V12, P39; Bai JP, 2006, NEUROSCI LETT, V404, P270, DOI 10.1016/j.neulet.2006.05.062; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Burnham K.P., 2002, MODEL SELECTION MULT, P60; Canis M, 2008, ACTA OTO-LARYNGOL, V128, P228, DOI 10.1080/00016480701411502; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Davis CQ, 1998, OPT ENG, V37, P1299, DOI 10.1117/1.601967; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Frolenkov GI, 2000, J NEUROSCI, V20, P5940, DOI 10.1523/JNEUROSCI.20-16-05940.2000; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 2000, JARO-J ASSOC RES OTO, V1, P64, DOI 10.1007/s101620010006; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; Iwasa KH, 1997, BIOPHYS J, V73, P2965, DOI 10.1016/S0006-3495(97)78325-5; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Kakehata S, 1996, J NEUROSCI, V16, P4881; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LINNET K, 1993, CLIN CHEM, V39, P424; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Scherer MP, 2005, BIOPHYS J, V88, pL27, DOI 10.1529/biophysj.105.059782; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sziklai I, 1996, HEARING RES, V95, P87, DOI 10.1016/0378-5955(96)00026-3; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	41	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2297	2307		10.1074/jbc.M110.185694	http://dx.doi.org/10.1074/jbc.M110.185694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071769	Green Published, hybrid			2022-12-27	WOS:000286191500069
J	Muralidhar, SA; Ramakrishnan, V; Kalra, IS; Li, W; Pace, BS				Muralidhar, Shalini A.; Ramakrishnan, Valya; Kalra, Inderdeep S.; Li, Wei; Pace, Betty S.			Histone Deacetylase 9 Activates gamma-Globin Gene Expression in Primary Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-HEMOGLOBIN INDUCTION; TRANSCRIPTION FACTOR; TRICHOSTATIN-A; DIFFERENTIATION; INHIBITORS; HDACS; ACETYLATION; REPRESSOR; THERAPY; DISEASE	Strategies to induce fetal hemoglobin (HbF) synthesis for the treatment of beta-hemoglobinopathies probably involve protein modifications by histone deacetylases (HDACs) that mediate gamma-globin gene regulation. However, the role of individual HDACs in globin gene expression is not very well understood; thus, the focus of our study was to identify HDACs involved in gamma-globin activation. K562 erythroleukemia cells treated with the HbF inducers hemin, trichostatin A, and sodium butyrate had significantly reduced mRNA levels of HDAC9 and its splice variant histone deacetylase-related protein. Subsequently, HDAC9 gene knockdown produced dose-dependent gamma-globin gene silencing over an 80-320 nM range. Enforced expression with the pTarget-HDAC9 vector produced a dose-dependent 2.5-fold increase in gamma-globin mRNA (p < 0.05). Furthermore, ChIP assays showed HDAC9 binding in vivo in the upstream G gamma-globin gene promoter region. To determine the physiological relevance of these findings, human primary erythroid progenitors were treated with HDAC9 siRNA; we observed 40 and 60% gamma-globin gene silencing in day 11 (early) and day 28 (late) progenitors. Moreover, enforced HDAC9 expression increased gamma-globin mRNA levels by 2.5-fold with a simultaneous 7-fold increase in HbF. Collectively, these data support a positive role for HDAC9 in gamma-globin gene regulation.	Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Li, Wei] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pace, BS (corresponding author), 800 W Campbell Rd, Richardson, TX 75080 USA.	bpace@utdallas.edu	RAMAKRISHNAN, VALYA/L-6415-2016	Pace, Betty/0000-0002-1275-4112	National Institutes of Health, NHLBI [HL69234]; Center for Applied Biology at the University of Texas at Dallas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069234] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Applied Biology at the University of Texas at Dallas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant HL69234. This work was also supported by funding through the Center for Applied Biology at the University of Texas at Dallas.	Asano H, 1999, MOL CELL BIOL, V19, P3571; Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Atweh GF, 2001, CURR OPIN HEMATOL, V8, P123, DOI 10.1097/00062752-200103000-00010; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Boosalis MS, 2001, BLOOD, V97, P3259, DOI 10.1182/blood.V97.10.3259; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Cao H, 2004, BLOOD, V103, P701, DOI 10.1182/blood-2003-02-0478; CHARACHE S, 1987, BLOOD, V69, P109; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; FIBACH E, 1993, STEM CELLS, V11, P36, DOI 10.1002/stem.5530110608; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hsiao CH, 2006, EXP HEMATOL, V34, P264, DOI 10.1016/j.exphem.2005.12.009; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lou TF, 2009, EXP BIOL MED, V234, P1374, DOI 10.3181/0811-RM-339; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; McElveen RL, 2005, CELL MOL BIOL, V51, P215, DOI 10.1170/T621; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Pace BS, 2004, CELL MOL BIOL, V50, P43; Perrine SP, 2005, ANN NY ACAD SCI, V1054, P257, DOI 10.1196/annals.1345.033; PERRINE SP, 1994, AM J PEDIAT HEMATOL, V16, P67; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Wittich S, 2005, ANTI-CANCER DRUG, V16, P635, DOI 10.1097/00001813-200507000-00008; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2343	2353		10.1074/jbc.M110.115725	http://dx.doi.org/10.1074/jbc.M110.115725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078662	hybrid, Green Published			2022-12-27	WOS:000286191500073
J	Qian, XS; Zhang, JD; Liu, JG				Qian, Xuesong; Zhang, Jidong; Liu, Jianguo			Tumor-secreted PGE(2) Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-1; MOUSE MAMMARY-CARCINOMA; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; BREAST-CANCER; GENE-EXPRESSION; ANTITUMOR IMMUNITY; CHEMOKINE RANTES; MURINE MODEL; IFN-GAMMA	One of the major characteristics of tumors is their ability to evade immunosurveillance through altering the properties and functions of host stromal and/or immune cells. CCL5 has been shown to play important roles in T cell proliferation, IFN-gamma, and IL-2 production, which promotes the differentiation and proliferation of Th1 cells important for immune defense against intracellular infection. In this study we found that tumor-bearing mice were more susceptible to bacterial infection and showed reduced CCL5 levels in serum during endotoxic shock. Our data further demonstrated that the soluble factors secreted by mammary gland tumor cells but not normal mammary gland epithelial cells inhibited CCL5 expression in macrophages in response to LPS, but not to TNF-alpha stimulation. The inhibitory effect of tumor-secreted molecules on LPS-induced CCL5 expression was regulated at the post-transcriptional level. Blocking PGE(2) synthesis by NS398 or through the use of PGE(2) receptor antagonists AH-6809 (EP2 antagonist) and AH-23848 ( EP4 antagonist) completely reversed the inhibitory effect of tumor-conditioned medium (TCM) on LPS-induced CCL5 expression. Moreover, PGE(2) and the cAMP analog forskolin could mimic tumor-mediated CCL5 inhibition, and the inhibitory effects of TCM, PGE(2), and cAMP analog on LPS-induced CCL5 expression could be completely reversed by the PKA inhibitor H89. Furthermore, blocking PGE(2) synthesis in vivo led to partial recovery of CCL5 production during endotoxic shock. Taken together, our data indicate that PGE(2) secreted from breast cancer cells suppresses CCL5 secretion in LPS-activated macrophages through a cAMP/PKA signaling pathway, which may result in suppression of host immune responses against subsequent bacterial infection.	[Qian, Xuesong; Zhang, Jidong; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, St Louis, MO 63104 USA	Saint Louis University	Liu, JG (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, 1100 S Grand Blvd,DRC Rm 811, St Louis, MO 63104 USA.	jliu9@slu.edu			NCI of the National Institutes of Health [K22CA137126]; NATIONAL CANCER INSTITUTE [K22CA137126] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant Number K22CA137126 from the NCI of the National Institutes of Health.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Azenshtein E, 2002, CANCER RES, V62, P1093; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Brault MS, 2003, INT REV IMMUNOL, V22, P199, DOI 10.1080/08830180305224; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Christensen CRL, 1998, CANCER RES, V58, P1238; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Erickson L, 2004, TRANSPL IMMUNOL, V13, P169, DOI 10.1016/j.trim.2004.06.003; Half E, 2002, CANCER RES, V62, P1676; Hollmann CA, 2001, ONCOGENE, V20, P7645, DOI 10.1038/sj.onc.1204980; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jayasinghe MM, 2008, BREAST CANCER RES TR, V111, P511, DOI 10.1007/s10549-007-9802-6; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Luboshits G, 1999, CANCER RES, V59, P4681; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; MILLER FR, 1983, INVAS METAST, V3, P22; Mitsuhashi M, 2004, J LEUKOCYTE BIOL, V76, P322, DOI 10.1189/jlb.1203641; Morecki S, 1998, INT J CANCER, V75, P894, DOI 10.1002/(SICI)1097-0215(19980316)75:6<894::AID-IJC12>3.0.CO;2-3; Morecki S, 2000, CANCER IMMUNOL IMMUN, V48, P613; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pulaski BA, 1998, CANCER RES, V58, P1486; Pulaski BA, 2000, CANCER IMMUNOL IMMUN, V49, P34, DOI 10.1007/s002620050024; Rakhmilevich AL, 2000, CANCER GENE THER, V7, P826, DOI 10.1038/sj.cgt.7700176; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson SC, 2003, CANCER RES, V63, P8360; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schrum S, 1996, J IMMUNOL, V157, P3598; Shi XY, 2004, J IMMUNOL, V172, P4111, DOI 10.4049/jimmunol.172.7.4111; Shi XY, 2004, INT J CANCER, V110, P570, DOI 10.1002/ijc.20145; Siveke JT, 1998, J IMMUNOL, V160, P550; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; VANOTTEREN GM, 1995, J IMMUNOL, V154, P1900; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Wang H, 1998, INT J MOL MED, V1, P915; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Wigler N, 2002, ISRAEL MED ASSOC J, V4, P940; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Xu XJ, 2008, J IMMUNOL, V180, P2125, DOI 10.4049/jimmunol.180.4.2125; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074	51	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2111	2120		10.1074/jbc.M110.154971	http://dx.doi.org/10.1074/jbc.M110.154971			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097507	Green Published, hybrid			2022-12-27	WOS:000286191500053
J	Walthers, D; Li, Y; Liu, YJ; Anand, G; Yan, J; Kenney, LJ				Walthers, Don; Li, You; Liu, Yingjie; Anand, Ganesh; Yan, Jie; Kenney, Linda J.			Salmonella enterica Response Regulator SsrB Relieves H-NS Silencing by Displacing H-NS Bound in Polymerization Mode and Directly Activates Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; TYPHIMURIUM TRANSLOCATED EFFECTORS; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; HORIZONTALLY ACQUIRED GENES; SINGLE DNA-MOLECULES; SEROVAR TYPHIMURIUM; YERSINIA-ENTEROCOLITICA; FILAMENTOUS STRUCTURES; VIRULENCE PROTEIN	The response regulator SsrB activates expression of genes encoded within and outside of a pathogenicity island (SPI-2), which is required for systemic infection of Salmonella. SsrB binds upstream of the sifA, sifB, and sseJ effector genes and directly regulates transcription. SsrB also relieves gene silencing by the nucleoid protein H-NS. Single molecule experiments with magnetic tweezers demonstrated that SsrB displaces H-NS from DNA only when it is bound in a polymerization (stiffening) mode and not when H-NS is bound to DNA in the bridging mode. Thus, in contrast to previous views, the polymerization binding mode of H-NS is the relevant form for counter-silencing by SsrB. Our results reveal that response regulators can directly activate transcription and also relieve H-NS silencing. This study adds to the repertoire of mechanisms by which NarL/FixJ subfamily members regulate transcription. Because SsrB-dependent promoters are diversely organized, additional mechanisms of transcriptional activation at other loci are likely.	[Walthers, Don; Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Li, You; Liu, Yingjie; Yan, Jie] Mechanobiol Inst, Dept Phys, Singapore 119007, Singapore; [Anand, Ganesh] Dept Biol, Singapore 119007, Singapore; [Li, You; Liu, Yingjie; Yan, Jie; Kenney, Linda J.] Natl Univ Singapore, Singapore 119007, Singapore	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National University of Singapore	Kenney, LJ (corresponding author), Univ Illinois, Dept Microbiol & Immunol, 835 S Wolcott Ave,MC 790, Chicago, IL 60612 USA.	kenneyl@uic.edu	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	National Institutes of Health [GM-058746]; Veterans Administration [1IO1BX000372]; Singapore Ministry of Education [R144000192112, R144000251112]; Mechanobiology Biology Institute, National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058746] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Singapore Ministry of Education(Ministry of Education, Singapore); Mechanobiology Biology Institute, National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant GM-058746. This work was also supported by Veterans Administration Grant 1IO1BX000372 (to L. J. K.), Singapore Ministry of Education Grants R144000192112 and R144000251112 (to J. Y.), and the Mechanobiology Biology Institute, National University of Singapore.	Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Banos RC, 2008, MICROBIOL-SGM, V154, P1281, DOI 10.1099/mic.0.2007/015610-0; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2002, J BACTERIOL, V184, P1493, DOI 10.1128/JB.184.5.1493-1497.2002; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mills SD, 1998, INFECT IMMUN, V66, P1806, DOI 10.1128/IAI.66.4.1806-1811.1998; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Ross W, 2009, METHODS, V47, P13, DOI 10.1016/j.ymeth.2008.10.018; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Savery N, 1996, PHILOS T ROY SOC B, V351, P543, DOI 10.1098/rstb.1996.0053; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905	47	71	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1895	1902		10.1074/jbc.M110.164962	http://dx.doi.org/10.1074/jbc.M110.164962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059643	Green Published, hybrid			2022-12-27	WOS:000286191500030
J	Fakas, S; Konstantinou, C; Carman, GM				Fakas, Stylianos; Konstantinou, Chrysanthos; Carman, George M.			DGK1-encoded Diacylglycerol Kinase Activity Is Required for Phospholipid Synthesis during Growth Resumption from Stationary Phase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATE PHOSPHATASES; NUCLEAR-MEMBRANE GROWTH; CDP-CHOLINE PATHWAY; SIGNALING FUNCTIONS; YEAST; ACID; PHOSPHATIDYLCHOLINE; PROTEIN; GENE; BIOSYNTHESIS	In the yeast Saccharomyces cerevisiae, triacylglycerol mobilization for phospholipid synthesis occurs during growth resumption from stationary phase, and this metabolism is essential in the absence of de novo fatty acid synthesis. In this work, we provide evidence that DGK1-encoded diacylglycerol kinase activity is required to convert triacylglycerol-derived diacylglycerol to phosphatidate for phospholipid synthesis. Cells lacking diacylglycerol kinase activity (e.g. dgk1 Delta mutation) failed to resume growth in the presence of the fatty acid synthesis inhibitor cerulenin. Lipid analysis data showed that dgk1 Delta mutant cells did not mobilize triacylglycerol for membrane phospholipid synthesis and accumulated diacylglycerol. The dgk1 Delta phenotypes were partially complemented by preventing the formation of diacylglycerol by the PAH1-encoded phosphatidate phosphatase and by channeling diacylglycerol to phosphatidylcholine via the Kennedy pathway. These observations, coupled to an inhibitory effect of dioctanoyl-diacylglycerol on the growth of wild type cells, indicated that diacylglycerol kinase also functions to alleviate diacylglycerol toxicity.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/AAQ-7594-2020; Fakas, Stylianos/R-9908-2019	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health [GM-28140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G.M.C.).	[Anonymous], 2003, LIPID ANAL; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACKSON BJ, 1984, J BACTERIOL, V160, P976, DOI 10.1128/JB.160.3.976-981.1984; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kosodo Y, 2001, YEAST, V18, pS242; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Omura S, 1981, Methods Enzymol, V72, P520; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	71	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1464	1474		10.1074/jbc.M110.194308	http://dx.doi.org/10.1074/jbc.M110.194308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071438	hybrid, Green Published			2022-12-27	WOS:000286005000059
J	Labro, AJ; Boulet, IR; Choveau, FS; Mayeur, E; Bruyns, T; Loussouarn, G; Raes, AL; Snyders, DJ				Labro, Alain J.; Boulet, Inge R.; Choveau, Frank S.; Mayeur, Evy; Bruyns, Tine; Loussouarn, Gildas; Raes, Adam L.; Snyders, Dirk J.			The S4-S5 Linker of KCNQ1 Channels Forms a Structural Scaffold with the S6 Segment Controlling Gate Closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; SHAKER K+ CHANNEL; KVLQT1 POTASSIUM CHANNELS; C-TYPE INACTIVATION; SELECTIVITY FILTER; ACTIVATION GATE; VOLTAGE SENSOR; PORE; MUTATIONS; PROTEINS	In vivo, KCNQ1 alpha-subunits associate with the beta-subunit KCNE1 to generate the slowly activating cardiac potassium current (I-Ks). Structurally, they share their topology with other Kv channels and consist out of six transmembrane helices (S1-S6) with the S1-S4 segments forming the voltage-sensing domain (VSD). The opening or closure of the intracellular channel gate, which localizes at the bottom of the S6 segment, is directly controlled by the movement of the VSD via an electromechanical coupling. In other Kv channels, this electromechanical coupling is realized by an interaction between the S4-S5 linker (S4S5(L)) and the C-terminal end of S6 (S6(T)). Previously we reported that substitutions for Leu(353) in S6(T) resulted in channels that failed to close completely. Closure could be incomplete because Leu(353) itself is the pore-occluding residue of the channel gate or because of a distorted electromechanical coupling. To resolve this and to address the role of S4S5(L) in KCNQ1 channel gating, we performed an alanine/tryptophan substitution scan of S4S5(L). The residues with a "high impact" on channel gating (when mutated) clustered on one side of the S4S5(L) alpha-helix. Hence, this side of S4S5(L) most likely contributes to the electromechanical coupling and finds its residue counterparts in S6(T). Accordingly, substitutions for Val(254) resulted in channels that were partially constitutively open and the ability to close completely was rescued by combination with substitutions for Leu(353) in S6(T). Double mutant cycle analysis supported this cross-talk indicating that both residues come in close contact and stabilize the closed state of the channel.	[Labro, Alain J.; Boulet, Inge R.; Mayeur, Evy; Bruyns, Tine; Raes, Adam L.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, B-2610 Antwerp, Belgium; [Choveau, Frank S.; Loussouarn, Gildas] INSERM, U915, F-44000 Nantes, France; [Choveau, Frank S.; Loussouarn, Gildas] CNRS, ERL3147, F-44035 Nantes, France; [Choveau, Frank S.; Loussouarn, Gildas] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France	University of Antwerp; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes	Snyders, DJ (corresponding author), Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, Univ Pl 1, B-2610 Antwerp, Belgium.	dirk.snyders@ua.ac.be	Choveau, Frank/AAF-3858-2022; Loussouarn, Gildas/D-3590-2015; Snyders, Dirk/A-2713-2013; Choveau, Frank/AFI-6500-2022; Loussouarn, Gildas/ABH-6043-2020	Loussouarn, Gildas/0000-0001-8007-5931; Snyders, Dirk/0000-0001-7142-6672; Loussouarn, Gildas/0000-0001-8007-5931; Labro, Alain J/0000-0002-0871-7511	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) [G.0152.06, G.0256.08, 1.5.044.07]; Belgian Federal Science Policy Office [P6/31]; University of Antwerp [GOA/TOP41.3016]; Tournesol [T2010.13]	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen)(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); University of Antwerp; Tournesol	This work was supported by Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) Grants G.0152.06 and G.0256.08 (to D. J. S.) and 1.5.044.07 (to A. J. L.), the Interuniversity Attraction Poles program P6/31 of the Belgian Federal Science Policy Office, GOA/TOP41.3016 (concerted action fund University of Antwerp), and Tournesol T2010.13 (to D. J. S. and G. L.).	Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Boulet IR, 2007, J PHYSIOL-LONDON, V585, P325, DOI 10.1113/jphysiol.2007.145813; Choveau F., 2010, J BIOL CHEM, P707; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Deschenes D, 2003, CAN J PHYSIOL PHARM, V81, P129, DOI 10.1139/Y02-162; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh T, 1998, HUM GENET, V103, P290, DOI 10.1007/s004390050819; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Labro AJ, 2010, J MOL CELL CARDIOL, V48, P1096, DOI 10.1016/j.yjmcc.2009.10.027; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Miceli F, 2009, CHANNELS, V3, P274; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ohlenschlager O, 2002, BIOPHYS J, V82, P2995, DOI 10.1016/S0006-3495(02)75640-3; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Panaghie G, 2008, BIOPHYS J, V95, P2759, DOI 10.1529/biophysj.108.133678; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Pusch M, 1998, BIOPHYS J, V75, P785, DOI 10.1016/S0006-3495(98)77568-X; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Shamgar L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001943; Smith JA, 2007, BIOCHEMISTRY-US, V46, P14141, DOI 10.1021/bi701597s; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	45	46	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					717	725		10.1074/jbc.M110.146977	http://dx.doi.org/10.1074/jbc.M110.146977			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059661	Green Published, hybrid			2022-12-27	WOS:000285782800071
